<SEC-DOCUMENT>0001493152-22-002747.txt : 20220131
<SEC-HEADER>0001493152-22-002747.hdr.sgml : 20220131
<ACCEPTANCE-DATETIME>20220131165558
ACCESSION NUMBER:		0001493152-22-002747
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		95
FILED AS OF DATE:		20220131
DATE AS OF CHANGE:		20220131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEA Industries Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		IRS NUMBER:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-261648
		FILM NUMBER:		22574737

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Surna Inc.
		DATE OF NAME CHANGE:	20100128
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SRNA="http://surna.com/20210930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_SRNA_surna.com_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20210101_20210930 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001482541 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentType_S%2D1/A -->
<!-- Field: Set; Name: xdx; ID: xdx_07C_XDX_forms%2D1.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_068_Number_5_Number -->
<!-- Field: Set; Name: xdx; ID: xdx_065_sqft_8_utr%2D%2Dsqft -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityCentralIndexKey">0001482541</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl0063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2019-12-31" id="xdx2ixbrl0106" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31" id="xdx2ixbrl0117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2019-12-31" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0252" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0258" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0273" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0359" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0405" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0406" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0408" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0426" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0448" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0460" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:GainOnForgivenessOfNotePayable" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0569" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssued" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0961" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0963" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0965" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercised" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0967" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0969" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0971" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssued" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0986" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0988" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercised" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0992" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0994" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1075" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1081" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1083" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1107" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1109" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1158" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1160" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1162" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1184" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1188" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1190" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1192" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl1196" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1213" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1215" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1217" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1219" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1221" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1223" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1225" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1227" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1234" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1241" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1243" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1245" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1247" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1249" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1251" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1259" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" id="xdx2ixbrl1266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1270" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1272" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1276" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1278" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1280" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1282" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1284" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1286" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1288" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1290" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1292" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1294" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1298" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1312" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1314" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1318" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1320" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl1322" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1358" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1360" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1374" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1382" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1384" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1394" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1396" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" id="xdx2ixbrl1398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1415" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1417" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1423" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1425" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1427" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1429" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1431" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1433" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1435" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1437" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1439" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1441" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1443" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" id="xdx2ixbrl1445" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl1476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-12-31" id="xdx2ixbrl1504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2019-12-31" id="xdx2ixbrl1505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1512" name="SRNA:NolsCarryforwardsTerm">P3Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl1593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2020-12-31" id="xdx2ixbrl1605" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" id="xdx2ixbrl1610" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2021-09-30" id="xdx2ixbrl1619" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-12-31" id="xdx2ixbrl1620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="AsOf2020-12-31" id="xdx2ixbrl1626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:RedeemableConvertiblePreferredStockSubscriptionReceivable" contextRef="AsOf2020-12-31" id="xdx2ixbrl1632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:RedeemableConvertiblePreferredStockAccruedDividends" contextRef="AsOf2020-12-31" id="xdx2ixbrl1635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2020-12-31" id="xdx2ixbrl1638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012021-09-30" id="xdx2ixbrl1755" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl1756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl1757" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl1758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RedeemablePreferredStockDividends" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl1766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RedeemablePreferredStockDividends" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl1768" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ConvertiblePreferredStockConvertedToSecurities" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl1771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ConvertiblePreferredStockConvertedToSecurities" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl1773" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1800" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1844" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1845" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1847" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1856" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1857" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1859" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1862" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1863" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1865" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1868" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1869" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1871" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1875" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1877" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1893" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1894" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1908" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1920" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1921" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1928" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1929" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1931" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1934" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1935" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1937" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1940" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1941" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1946" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1947" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1952" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1953" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1955" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1958" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1959" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1960" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl1984" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1986" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1987" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1989" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-07-012020-09-30" id="xdx2ixbrl1990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1991" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1993" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl1994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl1999" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2000" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2001" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2015" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl2029" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2032" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl2039" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2040" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2042" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl2045" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2048" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl2051" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2052" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl2054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" id="xdx2ixbrl2057" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2058" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl2059" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl2073" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:CommonStockIssuedForOtherExpense" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2124" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:IncreaseDecreaseInLeaseDeposit" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2127" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2145" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2174" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2177" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2178" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SubscriptionReceivableSeriesBPreferredStock" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:OptionsIssuedForAccruedEquityCompensation" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2190" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Dividends" contextRef="From2020-01-012020-09-30" id="xdx2ixbrl2193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30_us-gaap_CostOfSalesMember" id="xdx2ixbrl2292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30_custom_AdvertisingAndMarketingExpensesMember" id="xdx2ixbrl2300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30_custom_ProductDevelopmentCostsMember" id="xdx2ixbrl2308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2021-09-30" id="xdx2ixbrl2376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2592" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2594" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2600" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2602" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2616" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812" id="xdx2ixbrl2632" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812" id="xdx2ixbrl2634" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812" id="xdx2ixbrl2636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812" id="xdx2ixbrl2638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2652" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2654" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2656" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2658" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" id="xdx2ixbrl2666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2686" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2688" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2690" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2692" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2717" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl2724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl2732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl2734" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" id="xdx2ixbrl2736" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2738" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" id="xdx2ixbrl2742" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2772" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercised" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2774" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2776" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" contextRef="From2021-01-01to2021-09-30" id="xdx2ixbrl2778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2020-01-012020-12-31" id="xdx2ixbrl2825" name="SRNA:NolsCarryforwardsTerm">P3Y</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="srna-20210930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-01-17_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-01-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CustomerContractsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-27_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-262017-06-27_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-26</xbrli:startDate>
        <xbrli:endDate>2017-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-01-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-302018-01-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-30</xbrli:startDate>
        <xbrli:endDate>2018-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-302018-09-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-30</xbrli:startDate>
        <xbrli:endDate>2018-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-302019-09-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-30</xbrli:startDate>
        <xbrli:endDate>2019-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AgreementWithLandLordMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:AgreementWithLandLordMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-212020-04-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-21</xbrli:startDate>
        <xbrli:endDate>2020-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-212020-04-22_us-gaap_ExtendedMaturityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationAxis">us-gaap:ExtendedMaturityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-21</xbrli:startDate>
        <xbrli:endDate>2020-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-102020-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-10</xbrli:startDate>
        <xbrli:endDate>2020-12-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-10_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-092021-02-10_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-09</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_custom_LeasedEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SRNA:LeasedEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-012018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-012018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilThirtyTwoThousandAndTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:MrJamesRShipleyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-06</xbrli:startDate>
        <xbrli:endDate>2021-01-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-08</xbrli:startDate>
        <xbrli:endDate>2020-03-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-072020-06-09_custom_FormerEmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-07</xbrli:startDate>
        <xbrli:endDate>2020-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-012014-10-31_custom_SeriesTwoWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SRNA:SeriesTwoConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SeriesTwoWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-012017-12-31_custom_InvestmentBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-012017-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-06-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndNineteenSpecialEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-30</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-30</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-30</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilOneTwentyTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-29</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-17_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-27_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-27</xbrli:startDate>
        <xbrli:endDate>2022-01-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CustomerContractsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_OrderOrProductionBacklogMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquipmentAndSystemsSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_AdvertisingAndMarketingExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_ProductDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-292021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-29</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-292021-07-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-29</xbrli:startDate>
        <xbrli:endDate>2021-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-252021-07-27_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-25</xbrli:startDate>
        <xbrli:endDate>2021-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-07-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-07-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-242021-07-28_custom_LeaseTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-24</xbrli:startDate>
        <xbrli:endDate>2021-07-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:InventoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-092021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-09</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-292021-03-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-29</xbrli:startDate>
        <xbrli:endDate>2021-03-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-062021-04-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-06</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_us-gaap_ConvertiblePreferredStockMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_InvestorWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">SRNA:InvestorWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_InvestorWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">SRNA:InvestorWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_EquityMethodInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-07_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyTwoMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyThreeMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyThreeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyFourMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyFourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_FormerEmployeeMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61996156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-18</xbrli:startDate>
        <xbrli:endDate>2020-08-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_WarrantsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-09-30_custom_WarrantsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-09-26</xbrli:startDate>
        <xbrli:endDate>2021-09-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-03_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-04_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Number">
      <xbrli:measure>SRNA:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="xdx2ixbrl0264" toRefs="Footnote000461"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0265" toRefs="Footnote000461"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl0276" toRefs="Footnote000461"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
filed with the Commission on January 31, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
No. 333-261648</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90F_edei--AmendmentDescription_c20210101__20210930_zLzuJeJGynBd"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:AmendmentDescription">AMENDMENT NO. 1</ix:nonNumeric> TO</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
S-1</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER<br />
THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityRegistrantName_c20210101__20210930_zNj1ZZ5f0ehb" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityRegistrantName">CEA
Industries Inc.</ix:nonNumeric></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(formerly
known as Surna Inc.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20210101__20210930_zybTr7mQYMKj"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>0700</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20210101__20210930_z42QOVd1IuCf" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityTaxIdentificationNumber">27-3911608</ix:nonNumeric></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State
                                            or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">incorporation
    or organization)</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">(Primary
                                            Standard Industrial</span></p>
                                                                             <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">Classification
                                            Code Number)</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressAddressLine1_c20210101__20210930_z0ebAwUfs9i2" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine1">385
South Pierce Avenue</ix:nonNumeric></b></span><b><span style="font: 10pt Times New Roman, Times, Serif">, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20210101__20210930_zX1xSDo1H6A3"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressAddressLine2">Suite
C</ix:nonNumeric></b></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90F_edei--EntityAddressCityOrTown_c20210101__20210930_zj5PMQM2hVDj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressCityOrTown">Louisville,</ix:nonNumeric></b></span>
<span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--EntityAddressStateOrProvince_c20210101__20210930_zrqVGc3FSa97"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span></b></span>
<span id="xdx_908_edei--EntityAddressPostalZipCode_c20210101__20210930_zEy3uDPzdvg7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:EntityAddressPostalZipCode">80027</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--CityAreaCode_c20210101__20210930_z7Am2TVnwVBb" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:CityAreaCode">(303)</ix:nonNumeric>
</b></span><b><span id="xdx_904_edei--LocalPhoneNumber_c20210101__20210930_zvADOWZHUUKd" style="font: 10pt Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="dei:LocalPhoneNumber">993-5271</ix:nonNumeric></b></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Anthony
K. McDonald</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CEA
Industries Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>385
South Pierce Avenue, Suite C</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Louisville,
Colorado 80027<br />
(303) 993-5271</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><i>Copies
to:</i></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 37%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Andrew
                                            Hudders, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Golenbock
    Eiseman Assor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Bell
    &amp; Peskoe LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>711
    Third Avenue, 17th Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>New
    York, NY 10017</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(212)
    907-7300</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 31%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Rob
                                            Condon, Esq.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Dentons
    US LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>1221
    Avenue of the Americas</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>New
    York, NY 10020</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(212)
    768-6700</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Approximate
date of commencement of proposed sale to the public: </b>As soon as practicable after this registration statement becomes effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span id="xdx_90C_edei--EntityFilerCategory_c20210101__20210930_zd74IQKsn8Rj" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> <span style="font: 10pt Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accelerated
    filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Smaller
    reporting company <span id="xdx_901_edei--EntitySmallBusiness_c20210101__20210930_zInnZVNAaNF9"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 1in"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20210101__20210930_zbQzrwCdyMHg"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CALCULATION
OF REGISTRATION FEE</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Title of each class of securities to be registered(1)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Proposed<br /> maximum aggregate<br />
    offering price (2)(3)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount of<br /> registration fee</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Common Stock, par value $0.00001 per share</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">23,000,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,132.10</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Pre-funded warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Shares of Common Stock, par value $0.00001 per share, underlying the warrants(5)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">28,750,000</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,665.13</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Shares of Common Stock, par value $0.00001 per share, underlying the pre-funded warrants(6)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,000,000</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,132.10</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants to be issued to the representative of the underwriters(4)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common stock underlying warrants to be issued to the representative of the underwriters(7)</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,437,500</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">133.26</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Total:</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">76,187,500</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,062.59</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Registration Fee Previously Paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.699.02</span></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Registration Fee Paid Herewith</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,363.57</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.3pt; text-align: justify; text-indent: -22.3pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
    to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), there are also being registered such
    indeterminate number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or
    similar transactions.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Includes the offering
    price of any additional shares of common stock, pre-funded warrants and warrants that the underwriters have the right to purchase
    to cover over-allotments.</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The proposed maximum aggregate offering price of shares of common
    stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded
    warrants offered and sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be sold
    in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any shares of common stock sold in the
    offering. Accordingly, the proposed maximum aggregate offering price of the shares of common stock and pre-funded warrants (including
    the shares of common stock issuable upon exercise of the pre-funded warrants), if any, is $23,000,000.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">No registration fee required pursuant to Rule 457(g).</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The warrants are exercisable at a price per share of common stock
    equal to 125% of the common stock offering price.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">The pre-funded warrants are exercisable at an exercise price of
    $0.01 per share.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">We have agreed to issue to the representative of the underwriters
    warrants to purchase shares of common stock representing up to 5% of the common stock and pre-funded warrants issued in the offering.
    The representative&#8217;s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per
    share of the common stock offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule
    457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative&#8217;s warrants is $1,437,500,
    which is equal to 125% of $1,150,000 (5% of $23,000,000). </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date
as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; color: rgb(219,37,49)"><span style="font: 10pt Times New Roman, Times, Serif"><b>The
information contained in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #DB252E"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 39%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #D2232A"><span style="font-family: Times New Roman, Times, Serif"><b>PRELIMINARY
                           PROSPECTUS</b></span></p></td>
    <td style="width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 31%"><span style="font: 10pt Times New Roman, Times, Serif; color: #D2232A"><b>SUBJECT TO COMPLETION</b></span></td>
    <td style="width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #D2232A"><b>DATED JANUARY
    31, 2022</b></span>

<p style="margin: 0"></p>
<span style="font: 10pt Times New Roman, Times, Serif; color: #D2232A"><b></b></span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Up
to 2,962,963</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b> Shares of Common Stock</b></span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>2,962,963
Warrants for Common Stock</b></span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Up
to 2,962,963 Pre-Funded Warrants for Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><img src="logo.jpg" alt="https:||ceaindustries.com|wp-content|uploads|2021|11|Logo.png" style="width: 381px; height: 69px" /></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>CEA
Industries Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering up to 2,962,963 shares of our common stock, $0.00001 par value per share and warrants to purchase up to 2,962,963 shares
of our common stock, to be sold together on a one for one basis in a firm commitment public offering. The warrants have an exercise price
of $_ per share. The warrants are exercisable immediately and expire five years from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to each purchaser whose purchase of shares of our common stock in this offering would otherwise result in the purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%)
of our outstanding shares of common stock immediately following the consummation of this offering, the opportunity to purchase, if the
purchaser so chooses, pre-funded warrants to purchase shares of common stock (the &#8220;pre-funded warrants&#8221;), in lieu of shares
of common stock. Each pre-funded warrant will be exercisable for one share of our common stock. The purchase price of each pre-funded
warrant will equal the price per share of common stock are being sold to the public, minus $0.01, and the exercise price of each pre-funded
warrant will be $0.01 per share. For each pre-funded warrant that we sell, the number of shares of our common stock that we are offering
will be decreased on a one-for-one basis. With each pre-funded warrant, the purchaser will also purchase a warrant, on a one for one
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied to list our common stock and warrants on the Nasdaq Capital Market under the symbols &#8220;CEAD&#8221; and &#8220;CEADW,&#8221;
respectively. The pre-funded warrants will not be listed on the Nasdaq Capital Market. No assurance can be given that our application
will be approved or that an active trading market for our shares of common stock or warrants will develop. This offering will only occur
if a national securities exchange approves the listing of our shares of common stock and warrants. In order to obtain the NASDAQ listing
approval we effected a 1 for 150 reverse split of our common stock on January 27, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, shares of our common stock were quoted on the OTC Markets Group, Inc. OTCQB Marketplace under the symbol &#8220;CEAD.&#8221;
On January 28, 2022, the last reported sale price for our common stock as reported on the OTCQB Marketplace was $6.75 per share as adjusted
to reflect the 1-for-150 reverse stock split of our common stock that will be effected in connection with this offering. The final public
offering price will be determined through negotiation between us and the representative of the underwriters in the offering and the assumed
offering price used throughout this prospectus may not be indicative of the final offering price. At present, there is a very limited
market for our common stock. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The trading price of
our common stock has been, and may continue to be, subject to wide price fluctuations in response to various factors, many of which are
beyond our control, including those described in &#8220;Risk Factors.&#8221;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 9.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center">Per Share and
    Warrant</td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold">&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center">Per Pre-Funded
    Warrant and Warrant</td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold">&#160;</td><td style="font-size: 9pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-size: 9pt; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-size: 9pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-size: 10pt">Public offering price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 14%; font-size: 10pt; text-align: right"></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&#160; &#160;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&#160;</span></td><td style="text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Proceeds to us, before expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
                                            underwriters will receive compensation in addition to the discounts and commissions. The
                                            registration statement, of which this prospectus is a part, also registers for sale warrants
                                            to purchase shares of common stock to be issued to the representative of the underwriters.
                                            We have agreed to issue the warrants to the representative of the underwriters as a portion
                                            of the underwriting compensation payable to the underwriters in connection with this offering.
                                            See &#8220;Underwriting&#8221; beginning on page 83 for a description of compensation payable
                                            to the underwriters.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted a 45-day option to the representative of the underwriters to purchase up to 444,444 additional shares of common stock
(and/or 444,444 pre-funded warrants in lieu thereof, representing 15% of the shares of common stock and pre-funded warrants sold in the
offering,) and/or up to 444,444 additional warrants, representing 15% of the warrants sold in the offering, solely to cover over-allotments,
if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters expect to deliver the securities to purchasers on or about &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>ThinkEquity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="forms-1a_001.jpg" alt="" style="height: 867px; width: 670px" />&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="forms-1_002.jpg" alt="" style="height: 867px; width: 670px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">TABLE
OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_001">Prospectus
    Summary</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><a href="#ajz_002">THE
    OFFERING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif"><a href="#ajz_003">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_004">Risk
    Factors</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_005">Use
    of Proceeds</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">26</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_006">Market
    for our common stock</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_007">Dividend
    policy</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">27</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_008">Capitalization</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_009">Dilution</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif"><a href="#ajz_010">SELECTED
    HISTORICAL CONSOLIDATED FINANCIAL AND OTHER DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif"><a href="#ajz_011">MANAGEMENT&#8217;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_012">Business</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_013">Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">63</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_014">Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">70</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_015">Certain
    Relationships and Related Party Transactions</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_016">Principal
    Stockholders</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">76</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_017">Description
    of THE SECURITIES </a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">77</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font-family: Times New Roman, Times, Serif"><a href="#ajz_018">SHARES
    ELIGIBLE FOR FUTURE SALE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">82</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_019">Underwriting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">83</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_020">Legal
    Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">89</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_021">Experts</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">89</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ajz_022">Where
    you can find more information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">89</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#ra_011">Financial
    Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">F-1</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: -13.5pt"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>You
should rely only on the information contained in this prospectus or in any free writing prospectus that we may provide to you in connection
with this offering. Neither we nor any of the underwriters has authorized anyone to provide you with information different from, or in
addition to, that contained in this prospectus or in any such free writing prospectus. If anyone provides you with different or inconsistent
information, you should not rely on it. We can provide no assurance as to the reliability of any other information that others may give
you. Neither we nor any of the underwriters is making an offer to sell or seeking offers to buy these securities in any jurisdiction
where or to any person to whom the offer or sale is not permitted. The information in this prospectus is accurate only as of the date
on the front cover of this prospectus, and the information in any free writing prospectus that we may provide you in connection with
this offering is accurate only as of the date of such free writing prospectus. Our business, financial condition, results of operations
and prospects may have changed since those dates.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<div style="font: 10pt Times New Roman, Times, Serif"><div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_001"></span><b>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
summary highlights information contained in greater detail elsewhere in this prospectus and does not contain all of the information that
you should consider before deciding to invest in our securities. You should read the entire prospectus carefully, including the
&#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
and our consolidated financial statements and the related notes included in this prospectus, before making an investment decision. Some
of the statements in this prospectus constitute forward-looking statements. See &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221;
Unless otherwise indicated in this prospectus, &#8220;CEA Industries,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221;
and &#8220;our&#8221; refer to CEA Industries Inc. and, where appropriate, its subsidiaries.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">CEA
Industries Inc. (formerly Surna Inc.) is a technology, engineering, and services provider to the global controlled environment agriculture
(CEA) industry through our trade name, Surna Cultivation Technologies (&#8220;Surna&#8221;). We leverage our experience in this space
to bring value-added technology solutions to our customers that help improve their overall crop quality and yield, optimize energy and
water efficiency, and meet the required evolving state and local construction codes, permitting and regulatory requirements. In service
of the CEA industry, our principal service and product offerings include: (i) floor plans and architectural design of cultivation facilities,
(ii) licensed mechanical, electrical, and plumbing (MEP) engineering of commercial scale environmental control systems specific to cultivation
facilities, (iii) process cooling systems and other climate control systems, (iv) air handling equipment and systems, (v) LED lighting,
benching and racking solutions for indoor cultivation, (vi) automation and control devices, systems and technologies used for environmental,
lighting and climate control, and (vii) preventive maintenance services for CEA facilities. Our customers include commercial, state-
and provincial-regulated CEA growers in the U.S. and Canada as well as in other international locations. Customers are those growers
building new facilities and those expanding or retrofitting existing facilities, with both ranging in size from several thousand to more
than 100,000 square feet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Historically,
our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities that grow
cannabis. However, we have served facilities growing other crops and we intend to pursue such additional CEA verticals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Market</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">CEA
is among the fastest-growing industries in the world, with compounded annual growth of approximately 20% for the foreseeable future.
The world&#8217;s population is expected to grow from 8 billion in 2020 to 10 billion by 2050. This growth may constrain operators&#8217;
and developers&#8217; ability to satisfy the demand for food to serve the population in a sustainable manner. As a result, governments,
farmers and corporate enterprises are adopting new, technologically advanced farming techniques to meet demand and reduce environmental
and supply chain risk. CEA facilities including aquaponics, aeroponics, hydroponics, new soil-based farming and hybrid methods are emerging
in urban and suburban areas. All of these factors together are driving demand for indoor farms across the globe with the CEA market estimated
to grow from $4 billion in 2020 to $12.8 billion in 2026. Consequently, we believe that businesses such as CEA Industries that know how
to design, supply, and service these indoor farms will be in high demand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Competitive Strengths</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
competitive advantages derive principally from our extensive experience, our reputation, and our position in the market. We believe that
we are the oldest, most experienced firm serving the engineering needs of cannabis CEA facilities in the US, having started operations
in 2006 and having completed over 200 commercial projects to date. Our reputation and well-known brand name in the industry provide us
with repeat and referral business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
staff of over 30 includes horticultural experts and licensed professional engineers (PE). Over time, we have developed innovative ways
to help our customers meet the challenges of their businesses, including high energy costs, issues about water usage and waste materials,
supply-chain disruption due to Covid-19, and, in the case of cannabis growing, increasingly rigorous quality standards and declining
cannabis prices. Our long established expertise and experience helps CEA operators to prosper and to meet the challenges that they face
in the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</div>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
position ourselves in the market to gain early engagement with our customers at the pre-build and construction phases of their projects.
By offering architectural services, which are the first services a customer will require, we have the opportunity to build longer-term
relationships and trust. This early relationship building provides the opportunity to sell our range of products and services that customers
will require to both build out and then maintain their facilities, and to keep competitors out of our projects. Our custom-tailored approach
to engineering design, equipment sourcing, and the integration of complex equipment systems provides a single point of accountability
across all aspects of indoor growing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Growth Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
opportunity for growth is fueled by the increased demand for CEA facilities for both cannabis and non-cannabis crops worldwide. We have
a professional and dedicated team capable of meeting our growth agenda. The three key pillars of our corporate strategy for growing the
Company and increasing shareholder value are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Organic
growth</i></b><i>.</i> Historically, we provided only environmental control systems to our customers. In 2019 we developed and began
to sell a proprietary, hardware and software based environmental control system called SentryIQ&#174;. During May 2021 we announced and
began to implement an updated strategy to offer all of the architectural and engineering services that new facilities require for construction,
as well as preventative maintenance services that can serve for the life of the facility. These expanded offerings may double the revenues
we generate from any individual project. In addition, we should win more projects by being able to serve as a comprehensive, sole source
provider for CEA facility products and services and their implementation is well underway. There are strong industry tailwinds that are
driving our backlog in cannabis and non-cannabis verticals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Strategic
relationships, mergers, and acquisitions</i></b><i>.</i> As a long-time and well-known brand in the industry, with hundreds of completed
projects under our belt and a nationwide sales and marketing operation, we believe that we are an attractive potential partner for other
companies. In addition, our industry knowledge and contacts give us access and insight into the best possible acquisition opportunities
and strategic relationships. We plan to pursue accretive and synergetic acquisitions that utilize our core strengths to further expand
our reach into the horticulture and agriculture markets. Our recent name change to CEA Industries Inc. and our internal restructuring
were conducted to prepare us to acquire potential targets and to nurture internal growth initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Raise
capital and uplist to a senior exchange.</i></b> We have many growth opportunities that could be realized by increasing our financial
resources and upgrading our common stock listing to a national securities exchange. We believe we have a strong growth outlook that should
be enhanced by a capital infusion to meet our existing backlog and target new growth verticals, by acquisition or new development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, we sold to an institutional investor 3,300 shares of Series B Preferred Stock with a stated value of $1,000 per share,
or $3,300,000 of stated value in the aggregate, referred to as the Series B Preferred Stock, and a warrant to purchase up to 192,982
shares of common stock of the Company, for an aggregate purchase price of $3,000,000. We engaged ThinkEquity LLC, the representative
of the underwriters of this offering, as our placement agent, and paid ThinkEquity LLC a total cash fee of 9%, or $270,000, and its expenses,
less prepaid expenses, and issued to ThinkEquity LLC and its designees a warrant to purchase up to an aggregate of 34,737 shares
of common stock. We received net proceeds of approximately $2,715,000. The proceeds of the offering will be used for general corporate
purposes and working capital. On January 28, 2022, we agreed with the Series B investor to redeem 1,650 shares of our Series B Preferred
Stock for approximately $2.0 million following the closing of this offering. and the Series B investor will convert, upon completion
of the offering, its remaining 1,650 shares of Series B Preferred Stock, plus accrued and unpaid dividends into the securities being
offered hereby, at a rate equal to 75% of the public offering price. The securities being issued to the Series B investor will be subject
to a 90 day lock-up and will be restricted securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we increased our authorized capital to one billion shares of common stock, of which 850,000,000 are designated as common
stock and 150,000,000 are designated as preferred stock. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we were authorized to redeem all the outstanding Series A Preferred Stock, which was completed on November 4, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 12, 2021, we changed the name of the company from Surna Inc. to CEA Industries Inc. <b><br /></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Reverse Split; Authorized Capital</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to obtain NASDAQ listing approval we
effected a 1 for 150 reverse split of our common stock on January 27, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Also, on January 27, 2022, we adjusted our authorized
capital to permit us to issue up to 200,000,000 shares of common stock and up to 25,000,000 shares of preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Impact
of the COVID-19 Pandemic on Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread As a result, there have been many disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, and a general shortage of containers, and domestic truck driver
availability. While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries,
continue to experience severe congestion and extensive wait times for carriers at ports across the United States. There may be inflation
due to the disruption to the supply chain. In addition, restrictions imposed by local, state and federal agencies due to the COVID-19
pandemic has led to reduced personnel of importers, government staff and others in our supply chain. We have been working diligently
with our network of freight partners and suppliers to expedite delivery dates and provide solutions to reduce further impact and delays.
However, we are unable to determine the full impact of these delays and how long they will continue as they are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact of COVID-19 on our operational and financial performance will depend on future developments, including the duration
and spread of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S.
government, state and local government officials, and international governments to prevent disease spread, all of which are uncertain,
out of our control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Summary
Of Risk Factors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
business is subject to a number of risks and uncertainties, including those risks discussed at length in the section below titled &#8220;Risk
Factors.&#8221; These risks include, among others, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have limited revenues
    and have a working capital deficit. Our operating results have fluctuated significantly over the years. We will require capital to
    fund our business and pursue our growth strategy. Our independent registered public accounting firm has expressed concern about our
    ability to continue as a going concern.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We historically enter into
    contracts that are performed over a period of time; therefore we have a backlog amount in differing amounts from quarter to quarter.
    Converting backlog to revenue depends on many factors, such as the customer obtaining financing, building permits and construction
    of their facility. We may not be able to convert all of our contracts representing backlog into revenue.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Although our business is
    focused on the larger controlled environment agricultural sector and we are not cannabis plant touching, historically we have provided
    services and equipment to the cannabis industry segment. As a result we may be subject to the changes within that sector and certain
    of the regulations and enforcement issues of the cannabis industry.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We have material weaknesses
    in our controls and procedures for financial reporting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We are expanding our business
    and plan to undertake further strategic growth initiatives through product expansion and potential acquisitions. We may not be able
    to manage our growth effectively, which may affect a return on investment for investors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We will need to expand
    our customer base, developing customers operating in the CEA industry, expanding and developing our products and services for these
    potential customers and increase our marketing and achieving timely contract execution.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Due to supply disruptions
    and competing demand for products, we are experiencing supply issues similar to others in our industry. International trade disputes,
    tariffs, international shipping and domestic trucking issues all are contributing to our ability to obtain the products we need for
    contract performance. We may face inflationary increases on the cost of products, which may adversely affect our margins. The failure
    to get our products to fulfil our contracts would disrupt our business, harm our reputation, result in losses and potently cause
    us to lose our market.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We rely on third party
    manufacturers to supply the equipment we sell or lease. If the equipment does not perform to specifications or to our customers&#8217;
    satisfaction, there may be an adverse impact on our business and our revenues.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The build side of the CEA
    industry is very competitive. To be able to compete successfully, we will need to offer a wide range of products, have adequate capital
    for expansion, supply and execution, and develop robust marketing.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As we expand we will need
    to attract top quality talent. We are dependent on certain key sales, managerial and executive personnel for our current and future
    success.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cannabis remains illegal
    under federal law, and therefore, strict enforcement of federal laws regarding cannabis, particularly against our customers, would
    likely result in our inability to execute our business plan. We are subject to a number of the laws focused on business peripheral
    to the cannabis industry. Variations in state and local regulation and enforcement in states that have legalized cannabis may impose
    certain restrictions on cannabis-related activities that may adversely impact our business. Public opinion against cannabis may have
    an adverse impact on our business.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to this offering,
    public market trading of our common stock was infrequent on the OTCQB Marketplace. There is no assurance that we will have an active
    trading market. If there is a market, our common stock price may be volatile, and the price may decrease substantially. We do not
    intend on paying dividends.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
    will incur immediate dilution in the net tangible book value of the shares purchased in the offering, assuming no sale of any
    pre-funded warrants in lieu of common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
executive offices are located at 385 South Pierce Avenue ,Suite C, Louisville, Colorado 80027. Our telephone number is (303) 993-5271.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
website address is <span style="text-decoration: underline">www.ceaindustries.com</span>. The information on our website is deemed not to be incorporated in this prospectus
or to be part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<div style="border: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; padding: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ajz_002"></span>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    stock offered:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,962,963
    shares (assuming no sale of any pre-funded warrants and no exercise of the over-allotment option).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
    offered:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    to purchase up to 2,962,963 shares of common stock. Subject to certain ownership limitations, the warrants are immediately exercisable
    and tradable and expire on the fifth anniversary of the date of issuance.&#160;&#160;Each warrant will have an exercise price of
    $&#160;&#160;&#160;&#160;&#160;&#160;for a share of common stock. To better understand the terms of the warrants, you should carefully
    read the &#8220;Description of the Securities&#8221; section of this prospectus. You should also read the form of warrant, which
    is filed as an exhibit to the registration statement that includes this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-funded
    warrants</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> offered:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are also offering to those purchasers, if any, whose purchase of the common stock in this
                                            offering would result in the purchaser, together with its affiliates and certain related
                                            parties, beneficially owning more than 4.99% (or at the election of the purchaser, 9.99%)
                                            of our outstanding common stock immediately following the consummation of this offering,
                                            the opportunity to purchase, if they so choose, up to 2,962,963 pre-funded warrants, in lieu
                                            of the common stock that would otherwise result in ownership in excess of 4.99% (or 9.99%,
                                            as applicable) of our outstanding common stock.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purchase price of each pre-funded warrants will equal the price per share of common stock being sold to the public in this offering,
    minus $0.01, and the exercise price of each pre-funded warrant will be $0.01 per share.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    each pre-funded warrant we sell, the number of shares of common stock we are offering will be decreased on a one-for-one basis. The
    number of warrants sold in this offering will not change as a result of a change in the mix of the common stock and pre-funded warrants
    sold.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    pre-funded warrant will be immediately exercisable and may be exercised at any time until exercised in full or its expiration. To
    better understand the terms of the pre-funded warrants, you should carefully read the &#8220;Description of the Securities&#8221;
    section of this prospectus. You should also read the form of pre-funded warrant, which is filed as an exhibit to the registration
    statement that includes this prospectus.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common stock to be outstanding
    after this offering:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,567,165
    shares (or 5,011,609 shares if the underwriters exercise their over-allotment option in full), assuming no sale of any pre-funded
    warrants, and to the extent pre-funded warrants are sold it will reduce the number of shares of common stock on a one for one basis.
    If the warrants are exercised in full, assuming no pre-funded warrants are sold, then there will be 7,530,128 shares outstanding
    (or 8,419,017 shares if the underwriters exercise their over-allotment option in full).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-allotment option:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have granted a 45-day option to the representative of the underwriters to purchase up to
                                            444,444 additional shares of common stock and/or up to 444,444 pre-funded warrants, representing
                                            15% of the shares of common stock and pre-funded warrants sold in the offering and/or up
                                            to 444,444 additional warrants, representing 15% of the warrants sold in the offering. The
                                            securities may be purchased separately. </span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purchase price to be paid per additional share of common stock or pre-funded warrant by the underwriters shall be equal to the public
    offering price of one share of common stock or pre-funded warrant, as applicable, less the underwriting discount, and the purchase
    price to be paid per additional warrant by the underwriters shall be $0.00001.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of proceeds:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            estimate that the net proceeds to us from this offering will be approximately $18,125,500,
                                            or approximately $20,885,500 if the underwriters exercise their over-allotment
                                            option in full).</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to use a portion of the net proceeds of this offering for redemption of 1,650 shares of our Series B Preferred Stock,
    and the remaining proceeds for working capital and other general corporate purposes. See &#8220;Use of Proceeds.&#8221;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk factors:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should read the &#8220;Risk Factors&#8221; section of this prospectus beginning on page 9 for a discussion of factors to consider
    carefully before deciding to invest in shares of our common stock and warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed Nasdaq symbols:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEAD</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEADW</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    do not intend to apply for the listing of the pre-funded warrants on any national securities exchange or other trading market. Without
    an active trading market, the liquidity of the pre-funded warrants will be limited.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our shares of common stock
outstanding after this offering is based on 1,604,202 shares outstanding as of January 28, 2022, adjusted for the reverse
split of the common stock that took effect on January&#160;27, 2022. Unless we indicate otherwise or the context otherwise requires,
all information in this prospectus:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no exercise by the underwriters of their over-allotment option to purchase additional shares of common stock (or pre-funded warrants
    in lieu thereof) and/or warrants to purchase shares of common stock to cover over-allotments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes no exercise of
    the representative&#8217;s warrants to be issued to the representative of the underwriters in this offering;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no exercise of any of the warrants sold in the offering, including any per-funded warrants in lieu of the shares of common stock
    offered; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">gives
    effect to the 1-for- 150 reverse stock split with respect to our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">gives
    effect to the redemption of the Series A Preferred Stock, which took effect on November 4, 2021;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    approximately 325,926 shares of common stock and/or pre-funded warrants and approximately 325,926 warrants issuable upon the conversion of 1,650 shares of our Series B
    Preferred Stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    219,090 shares of common stock issuable upon the exercise of outstanding exercisable options at a weighted exercise price
    of $10.51 per share;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    227,719 shares of common stock issuable upon the exercise of outstanding warrants at a weighted exercise price of $9.59
    per share; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    610,415 shares of common stock reserved for future issuance pursuant to our 2017 and 2021 equity incentive plans; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    sale of any pre-funded warrants</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0.1in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Market
and Industry Data</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Unless
otherwise indicated, information contained in this prospectus concerning our industry, competitive position and the markets in which
we operate is based on information from independent industry and research organizations, other third-party sources and management estimates.
Management estimates are derived from publicly available information released by independent industry analysts and other third-party
sources, as well as data from our internal research, and are based on assumptions we made upon reviewing such data, and our experience
in, and knowledge of, such industry and markets, which we believe to be reasonable. In addition, projections, assumptions and estimates
of the future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty and risk
due to a variety of factors, including those described in &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking
Statements.&#8221; These and other factors could cause results to differ materially from those expressed in the estimates made by the
independent parties and by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SUMMARY
HISTORICAL CONSOLIDATED FINANCIAL AND OTHER DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following tables set forth our summary historical consolidated financial data as of, and for the periods ended on, the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
summary consolidated statements of operations data for the years ended December 31, 2020 and 2019 are derived from our audited consolidated
financial statements and notes that are included elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summary consolidated statements of operations data for the three and nine months ended September, 30, 2021 and 2020 and the summary consolidated
balance sheet data as of September 30, 2021, are derived from our unaudited interim consolidated financial statements and notes that
are included elsewhere in this prospectus. We have prepared the unaudited consolidated financial statements in accordance with generally
accepted accounting principles (GAAP) and on the same basis as the audited consolidated financial statements. Our historical results
are not necessarily indicative of our results in any future period and results from our interim period may not necessarily be indicative
of the results of the entire year. Pro forma share and per share amounts presented herein reflect the implementation of the 1-for-150
reverse stock split as if it had occurred at the beginning of the earliest period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Historical</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Historical</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Historical</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As Adjusted(1)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As of <br />
December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As of <br />
December 31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As of <br />
September 30</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As of <br />
September 30</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Balance sheet data</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 32%; text-align: left">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,561,268</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,683,293</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,953,597</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">20,099,097</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,047,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,813,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,908,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,054,456</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,998,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,903,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,117,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,117,776</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,402,949</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,146,964</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,672,322</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,672,322</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,596,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">616,447</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total shareholders (deficit) equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(355,631</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,333,698</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,359,813</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,765,687</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total liabilities and shareholders (deficit) equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,047,318</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,813,266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,908,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21,054,456</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Gives effect to this offering and gives effect to the cash redemption of 1,650 shares of our Series B Preferred Stock for approximately
$2.0 million after the closing of the offering. Assumes net proceeds to us from this offering of $18,125,500, based on an
assumed public offering price of $6.75 for each share of common stock and warrant, on a one for one basis, and no pre-funded warrants
are sold in the offering. See &#8220;Use of Proceeds.&#8221; An increase (decrease) of $1.00 in the public offering price
would increase (decrease) cash and cash equivalents and total assets by $3,134,815, assuming the number of shares of common stock
offered by us, as set forth on the cover page of this prospectus, remains the same. Similarly, an increase (decrease) of 100,000 shares
offered would increase (decrease) our total assets by approximately $675,000, assuming the public offering price remains the same.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ajz_003"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">This
prospectus includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding
future events or future results and therefore are, or may be deemed to be, &#8220;forward-looking statements.&#8221; All statements other
than statements of historical facts contained in this prospectus may be forward-looking statements. These forward-looking statements
can generally be identified by the use of forward-looking terminology, including the terms &#8220;believes,&#8221; &#8220;estimates,&#8221;
&#8220;continues,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;seeks,&#8221; &#8220;projects,&#8221; &#8220;intends,&#8221;
&#8220;plans,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would&#8221; or &#8220;should&#8221; or, in each case, their negative
or other variations or comparable terminology. They appear in a number of places throughout this prospectus, and include statements regarding
our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity,
prospects, growth, strategies, future acquisitions and the industry in which we operate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">These
forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our
actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results,
as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking
statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment
in which we operate. Important factors that could cause those differences include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    business prospects and the prospects of our existing and prospective customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    impact on our business and that of our customers of the current and future response by the government and business to the COVID-19
    pandemic, including what is necessary to protect our staff and the staff of our customers in the conduct of our business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    overall impact of the COVID-19 pandemic on the business climate in our industry and the willingness of our customers to undertake
    projects in light of economic uncertainties;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    overall financial condition, including our reduced revenue and business disruption, due to the COVID-19 pandemic business and economic
    response and its consequences;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    inherent uncertainty of product development;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">regulatory,
    legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">increasing
    competitive pressures in the CEA (Controlled Environment Agriculture) industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    ability to effectively operate our business, including servicing our existing customers and obtaining new business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    relationships with our customers and suppliers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments
    from our customers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">general
    economic conditions, our customers&#8217; operations and access to capital, and market and business disruptions including severe
    weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events,
    or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we
    operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    continuation of normal supply of products from our suppliers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in our business strategy or development plans, including our expected level of capital expenses and working capital;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to attract and retain qualified personnel;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to raise equity and debt capital to fund our operations and growth strategy, including possible acquisitions;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to identify, complete and integrate potential strategic acquisitions;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">future
    revenue being lower than expected;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    ability to convert our backlog into revenue in a timely manner, or at all; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our
    intention not to pay dividends.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">These
factors should not be construed as exhaustive and should be read with the other cautionary statements in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Although
we base these forward-looking statements on assumptions that we believe are reasonable when made, we caution you that forward-looking
statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and
industry developments may differ materially from statements made in or suggested by the forward-looking statements contained in this
prospectus. The matters summarized under &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Business&#8221; and elsewhere in this prospectus could cause
our actual results to differ significantly from those contained in our forward-looking statements. In addition, even if our results of
operations, financial condition and liquidity, and industry developments are consistent with the forward-looking statements contained
in this prospectus, those results or developments may not be indicative of results or developments in subsequent periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
light of these risks and uncertainties, we caution you not to place undue reliance on these forward-looking statements. Any forward-looking
statement that we make in this prospectus speaks only as of the date of such statement, and we undertake no obligation to update any
forward-looking statement or to publicly announce the results of any revision to any of those statements to reflect new information,
future events or developments, except as required by applicable law. Comparisons of results for current and any prior periods are not
intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be
viewed as historical data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ajz_004"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our common stock and warrants involves significant risks. Certain factors may have a material adverse effect on our business,
financial condition, and results of operations. You should carefully consider the risks and uncertainties described below, in addition
to other information contained in this prospectus, including our consolidated financial statements and related notes. The risks and uncertainties
described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe
are not material, may also become important factors that adversely affect our business. If any of the following risks actually occurs,
our business, financial condition, results of operations, and future prospects could be materially and adversely affected. In that event,
the trading price of our common stock and/or warrants could decline, and you could lose part or all of your investment.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Relating to Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
revenues have been limited, and we will need to obtain financing for future growth, and possibly our operations, which may not be available
to us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Historically,
we have raised equity and debt capital to support our operations. We anticipate we will require additional cash resources to finance
our growth or other future developments, including for the launch of new products and services and for strategic investments or acquisitions
we may decide to pursue. As of December 31, 2020, we had a working capital deficit of approximately $2,220,000 and our cash balance was
$2,285,000, and as of September 30, 2021 we had a working capital deficit of approximately $1.2 million and our cash balance was $2.3
million. We will need additional funds to complete the overall development of our business plan to achieve a sustainable sales level
where ongoing operations can be funded from operations. The
precise amount and timing of our funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including market demand for our products and services, the success of our product development efforts, the timing of receipts for customer
payments, the management of working capital, and the continuation of normal payment terms and conditions for our purchase of goods and
services. The continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance
payments from our customers, significantly impacts our ability to fund our ongoing operations. Without the proceeds from this offering,
we believe our current cash balances and cash flow from operations will be insufficient to fund our operations and growth for the next
12 months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>This
offering and any future equity offering will result in dilution to our shareholders; obtaining borrowed capital may not be possible for
us.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">To
the extent that we raise the equity in this offering and any future additional equity capital existing shareholders will experience a
dilution in the voting power and ownership of their common stock, and our earnings per share, if any, would be negatively impacted. Any
borrowings made to finance operations, which are difficult to obtain from most traditional banks due to the federal laws prohibiting
cannabis, could make us more vulnerable to a downturn in our operating results, a downturn in economic conditions, or increases in interest
rates on borrowings that are subject to interest rate fluctuations. The amount and timing of such additional financing needs will vary
principally depending on the timing of new product launches, investments and/or acquisitions, and the amount of cash flow from our operations.
If our resources are insufficient to satisfy our cash requirements, we may seek to issue additional equity or debt securities or obtain
a credit facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
COVID-19 pandemic has adversely impacted, and may continue to adversely impact, the Company&#8217;s operations and financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has resulted in significant economic uncertainty and disruption. The extent to which our business and financial results
are impacted will depend on numerous evolving factors which are uncertain and cannot be predicted, including: the duration and scope
of the pandemic; governmental, business and individuals&#8217; actions taken in response; the effect on our customers and customers&#8217;
demand for our services and products; the effect on our suppliers and disruptions to the global supply chain; our ability to sell and
manufacture our products; disruptions to our operations resulting from the illness of any of our employees; restrictions or disruptions
to transportation, including reduced availability of ground or air transport; the ability of our customers to pay for our services and
products; and any closures of our facilities, our suppliers&#8217; facilities, and our customers&#8217; facilities. The effects of the
COVID-19 pandemic have resulted and will result in additional expenses and lost or delayed revenue. We have been experiencing disruptions
to our business as we implement modifications to travel, work locations and cancellation of events, among other modifications. In addition,
the change in macroeconomic conditions may impact the proper functioning of financial and capital markets, foreign currency exchange
rates, commodity and energy prices, and interest rates. All of the factors mentioned above are also expected to have an inflationary
pressure on our cost of goods. Even after the COVID-19 pandemic subsides, we may continue to experience adverse impacts to our business
and financial results due to any economic recession or depression that occurs, and due to any major public health crises that may occur
in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Although
our current accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual
conditions could differ from our expectations, which could materially affect our results of operations and financial position. In particular,
a number of estimates have been and will continue to be affected by the ongoing COVID-19 pandemic. The severity, magnitude and duration,
as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing and difficult to predict. As a result,
our accounting estimates and assumptions may change over time in response to COVID-19. Such changes could result in future impairments
of goodwill, intangible assets, long-lived assets, incremental credit losses on accounts receivable, or excess and obsolete inventory.
Any of these events could amplify the other risks and uncertainties described in in this Annual Report and could have an adverse effect
on our business and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have determined that our ability to continue as a going concern is dependent on raising additional capital to fund our operations and
ultimately on generating future profits. Our independent registered public accounting firm has included a &#8220;going concern&#8221;
explanatory paragraph in its opinion on our financial statements, expressing substantial doubt that we can continue as an ongoing business
for the next 12 months. Our financial statements do not include any adjustments that may result from the outcome of this uncertainty.
If we are unable to successfully raise the capital we need, we may need to and believe we can reduce the scope of our business to fully
satisfy our future short-term liquidity requirements. If we cannot raise additional capital or reduce the scope of our business, we may
be otherwise unable to achieve our goals or continue our operations. While we believe that we will be able to raise the capital we need
to continue our operations, there can be no assurances that we will be successful in these efforts or will be able to resolve our liquidity
issues or eliminate our operating losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Even
if we obtain more customers, there is no assurance that we will be able to convert our backlog into revenue or make a profit.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
may be unable to convert the full contract value of our backlog in a timely manner, or at all. The performance of our obligations under
a sales contract, and the timing of our revenue recognition, is dependent upon our customers&#8217; ability to secure funding and real
estate, obtain a license and then build their cultivation facility so they can use our services and take possession of the equipment
we provide. Our sales contracts currently are not time specific as to when our customers are required to take delivery of our services
and equipment. More recently, we determined that some of our new construction facility projects are becoming larger and more complex
and, as a result, delays were more likely due to licensing and permitting, lack of or delay in funding, staged facility construction,
and/or the shifting priorities of certain customers with multiple facility projects in progress at one time. Even if we obtain more customers,
or increase the average size of our projects, there is no guarantee that we will be able to generate a profit. Because we are a small
company with limited capital, limited products and services, and limited marketing activities, we may not be able to generate sufficient
revenue to operate profitably. If we cannot operate profitably, we may have to suspend or cease operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
may extend credit to our customers in the future and, if we are unable to collect these accounts receivable, our future profitability
could be adversely impacted.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Historically,
we had little exposure to the collection risk on accounts receivable since we typically received payments from our customers in advance
of our performance of services or delivery of equipment. However, in certain situations, especially as we expand our products and services
offering for a customer&#8217;s entire facility lifecycle, we may extend credit to our customers in which case we are at risk for the
collection of account receivables. Accordingly, we will be at greater risk for the collection of account receivables. Our credit arrangements
are negotiated and may not protect us if a customer develops operational difficulty or incurs operating losses which could lead to a
bankruptcy. In these cases, we may lose most of the outstanding balance due. In addition, we are typically not able to insure our accounts
receivables. The risk is that we derive our revenue and profits from selling products and services to the emerging cannabis industry.
The failure of our customers to pay in full amounts due to us could negatively affect future profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Because
we currently do not maintain effective internal controls over financial reporting, we may be unable to accurately report our financial
results or prevent fraud, and investor confidence and the market price of our common stock may, therefore, be adversely impacted.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
reporting obligations as a public company place significant requirements on our management, operational and financial resources, and
systems, and will continue to do so for the foreseeable future. Annually, we are required to prepare a management report on our management&#8217;s
assessment of the effectiveness of our internal control over financial reporting. Management has concluded that our internal control
over financial reporting is currently not effective and shall report such in management&#8217;s report in our annual report on Form 10-K.
In the event that our status with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) changes to that of an accelerated filer
from a smaller reporting company, our independent registered public accounting firm will be required to attest to and report on our management&#8217;s
assessment of the effectiveness of our internal control over financial reporting. Under such circumstances, even if our management concludes
that our internal control over financial reporting is effective, our independent registered public accounting firm may still decline
to attest to our management&#8217;s assessment, or may issue a report that is qualified, if it is not satisfied with our controls, or
the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently
from us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
have identified a material weakness in our internal control over financial reporting and, if we do not remediate the material weakness
or are unable to implement and maintain effective internal control over financial reporting in the future, the accuracy and timeliness
of our financial reporting may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
currently do not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient
complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our
financial reporting requirements, (ii) there is inadequate segregation of duties due to the limitation on the number of our accounting
personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets
that we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance
on, for our financial reporting. A material weakness is a deficiency or a combination of deficiencies in internal control over financial
reporting such that there is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements
will not be prevented or detected on a timely basis. If we are unable to achieve effective internal control over financial reporting,
or if our independent registered public accounting firm determines we continue to have a material weakness in our internal control over
financial reporting, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of
our shares could decline, and our reputation may be damaged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
inability to effectively manage our growth could harm our business and materially and adversely affect our operating results and financial
condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
strategy envisions growing our business and expanding within the CEA industry. We plan to expand our product, sales, administrative and
marketing operations. Any growth in or expansion of our business is likely to continue to place a strain on our management and administrative
resources, infrastructure and systems. As with other growing businesses, we expect that we will need to further refine and expand our
business development capabilities, our systems and processes and our access to financing sources. We also will need to hire, train, supervise,
and manage new employees. These processes are time consuming and expensive, will increase management responsibilities and will divert
management attention. We cannot assure that we will be able to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">execute
    on our business plan and strategy;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">expand
    our products effectively or efficiently or in a timely manner;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">allocate
    our human resources optimally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">meet
    our capital needs;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">identify
    and hire qualified employees or retain valued employees; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">effectively
    incorporate the components of any business or product line that we may acquire in our effort to achieve growth.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
inability or failure to manage our growth and expansion effectively could harm our business and materially and adversely affect our operating
results and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
operating results may fluctuate significantly based on customer acceptance of our services and products, industry uncertainty, project
financing concerns, and the licensing and qualification of our prospective customers. As a result, period-to-period comparisons of our
results of operations are unlikely to provide a good indication of our future performance.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
expects that, under typical operating conditions, we will experience substantial variations in our revenues and operating results from
quarter to quarter. Our revenue recognition is dependent upon shipment of the equipment portions of our sales contracts, which, in many
cases, may be delayed while our customers complete permitting, prepare their facilities for equipment installation or obtain project
financing. Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which
are out of our control, make it difficult for us to predict when we will recognize revenue. If customers are unable to obtain licensing,
permitting or financing, our sales and revenue will decline, resulting in a reduction in our operating income or possible increase in
losses. Also, because of the coronavirus responses and our own cost savings actions, we cannot predict the course of our revenues and
operating results with accuracy at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
business is focused on providing engineering design, and equipment integration into CEA facilities. To date, the majority of our revenues
have been generated from clients that operate in the legal cannabis industry in the United States and Canada.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Although
we are implementing a plan to broaden our market reach beyond the legal cannabis industry and are placing sales efforts on expansion
into the rapidly growing non-cannabis CEA vertical farming segment, we continue to provide the majority of our facility engineering design
and equipment integration and solutions to facilities in the legal cannabis industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Now
that the non-cannabis CEA segment is gaining strong momentum in the agricultural industry, and since almost all of the equipment systems
that we sell originate in the general horticulture industry and are agnostic to the crop grown in a facility, we believe that the proportion
of non-cannabis revenues will increase over time, commensurate with our sales efforts and success. Notwithstanding our expansion plans,
a decrease in demand in the legal cannabis industry could have a material adverse effect on our revenues and the success of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
cannabis industry has been an emerging industry over the last several years, and cannabis has only been legalized in some states and
remains illegal in other states and under U.S. federal law, making it difficult to accurately forecast the demand for our engineering
and product solutions in this specific industry. Losing clients from the cannabis industry may have a material adverse effect on our
revenues and the success of our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
cannabis industry is still in its early stages of development in the United States and while the vast majority of U.S. states now have
legal cannabis and it remains illegal under U.S. federal law, making it difficult to accurately predict and forecast the demand for our
engineering and product solutions. If the U.S. Department of Justice (&#8220;DOJ&#8221;) did take action against the cannabis industry,
we believe those of our clients operating in the legal cannabis industry would be lost to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our operations, we rely heavily upon the various U.S. federal governmental memos issued in the past, including the memorandum issued
by the DOJ on October 19, 2009, known as the &#8220;Ogden Memorandum&#8221;, the memorandum issued by the DOJ on August 29, 2013, known
as the &#8220;Cole Memorandum&#8221; and other guidance, in the attempt to keep our operations acceptable to those state and federal
entities that regulate, enforce, or choose to defer enforcement of certain current regulations regarding cannabis. By doing this, we
seek to avoid the many possible consequences of providing grow equipment to the cannabis industry as our customers continue to comply
with their state and local jurisdictional laws, rules and regulations and the interpretations of relevant authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
legal cannabis industry is not yet well-developed, and many aspects of this industry&#8217;s development and evolution cannot be accurately
predicted, and therefore, the loss of any of our current clients or our inability to capture new client contracts may have a material
adverse effect on our business. While we have attempted to identify our business risks in the legal cannabis industry, you should carefully
consider that there are other risks that cannot be foreseen or are not described in this prospectus, which could materially and adversely
affect our business and financial performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>There
is heightened scrutiny by Canadian regulatory authorities related to the cannabis industry.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
seek customers in the CEA Canadian market, some of which are cannabis growers. Therefore, our existing and future operations may become
the subject of heightened scrutiny by those regulators and other authorities in Canada that oversee the cannabis industry. As a result,
we may become subject to direct and indirect interaction with public officials in one or both the United States and Canada. No assurance
can be provided that any heightened scrutiny will not in turn lead to the imposition of restrictions on our ability to operate in Canada,
in addition to those described herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>If
we do not successfully develop additional products and services, or if those products and services are developed but not successfully
commercialized, we could lose revenue opportunities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
future success depends, in part, on our ability to expand our product and service offerings. We are currently investigating a number
of new and improved product opportunities, and we intend to collaborate with manufacturing partners to optimize these products for the
CEA and cannabis market. The processes of identifying and commercializing new products is complex and uncertain, and if we fail to accurately
predict customers&#8217; changing needs and emerging technological trends our business could be harmed. We have already and may have
to continue to commit significant resources to commercializing new products before knowing whether our investments will result in products
the market will accept. We may be unable to differentiate our new products from those of our competitors, and our new products may not
be accepted by the market. There can be no assurance that we will successfully identify additional new product opportunities, develop
and bring new products to market in a timely manner, or achieve market acceptance of our products or that products and technologies developed
by others will not render our products or technologies obsolete or noncompetitive. Furthermore, we may not execute successfully on commercializing
those products because of errors in product planning or timing, technical hurdles that we fail to overcome in a timely fashion, or a
lack of appropriate resources. This could result in competitors providing those solutions before we do and a reduction in revenue and
earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
future success depends on our ability to grow and expand our customer base. Our failure to achieve such growth or expansion could materially
harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
success and the planned growth and expansion of our business depend on us achieving greater and broader acceptance of our products and
services and expanding our commercial customer base. There can be no assurance our sales efforts will be successful. There can be no
assurance that customers will purchase our services or products or that we will continue to expand our customer base. If we are unable
to effectively market or expand our product and service offerings, we will be unable to grow and expand our business or implement our
business strategy. This could materially impair our ability to increase sales and revenue, and materially and adversely affect our margins,
which could harm our business and cause our stock price to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
suppliers could fail to fulfill our orders for parts used to assemble our products, which would disrupt our business, increase our costs,
harm our reputation, and potentially cause us to lose our market.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
depend on third party suppliers around the world, including those in The People&#8217;s Republic of China, for materials used to assemble
our products. Any of these suppliers could fail to produce products to our specifications or in a workmanlike manner and may not deliver
the material or products on a timely basis. Our suppliers may also have to obtain inventories of the necessary parts and tools for production.
Any change in our suppliers&#8217; approach to resolving production issues could disrupt our ability to fulfill orders and could also
disrupt our business due to delays in finding new suppliers, providing specifications and testing initial production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
suppliers could experience uncontrollable delays in delivering our products.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have experienced some unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to
a significant increase in shipments to U.S. ports, less cargo being shipped by air,, unavailability of truckers and a general shortage
of containers. We expect this to continue for some time. These disruptions are also causing price increases, which may become an inflationary
force in the market place.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Equipment
failures or poor performance may negatively impact our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
rely on third party manufacturers for equipment which we sell or lease. From time to time, such equipment may not perform to specifications
or to our customers&#8217; satisfaction. Such equipment deficiencies may lead to down time impacting our revenue. Further, frequent downtime
at customers&#8217; sites due to equipment failures may result in such customers generating less revenue increasing credit default risk.
In addition, these failures may also result in additional time spent by our personnel decreasing profit margins on certain ancillary
services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>International
trade disputes could result in tariffs and other protectionist measures that could adversely affect the Company&#8217;s business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Tariffs
could increase the cost of our products and the components and raw materials that go into making them. These increased costs could adversely
impact the gross margin that we earn on sales of our products. Tariffs could also make our products more expensive for customers, which
could make our products less competitive and reduce customer demand. Countries may also adopt other protectionist measures that could
limit our ability to offer our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
inability to effectively protect our intellectual property would adversely affect our ability to compete effectively, our revenue, our
financial condition, and our results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
may be unable to obtain intellectual property rights to effectively protect our branding, products, and other intangible assets. Our
ability to compete effectively may be affected by the nature and breadth of our intellectual property rights. While we intend to defend
against any threats to our intellectual property rights, there can be no assurance that any such actions will adequately protect our
interests. If we are unable to secure intellectual property rights to effectively protect our branding, products, and other intangible
assets, our revenue and earnings, financial condition, or results of operations could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
also rely on non-disclosure and non-competition agreements to protect portions of our intellectual property portfolio. There can be no
assurance that these agreements will not be breached, that we will have adequate remedies for any breach, that third parties will not
otherwise gain access to our trade secrets or proprietary knowledge, or that third parties will not independently develop competitive
products with similar intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
may become subject to additional regulation of CEA facilities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
engineering and design services and solutions are focused on CEA facilities that are able to grow a wide variety of crops such as leafy
greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and
small fruits (such as strawberries, blackberries and raspberries), bell peppers, cucumbers, and tomatoes. Some of these crops and their
growing methodologies are subject to regulation by the United States Food and Drug Administration, environmental agencies, public utility
agencies and other federal, state or foreign agencies. Changes to any regulations and laws that complicate the design and engineering
of a subject CEA facility, such as waste water treatment and electricity-related mandates, make it possible that potential related zoning
and enforcement could decrease the demand for our services, and in turn negatively impact our revenues and business opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
CEA industry is highly competitive, and we have less capital and resources than many of our competitors, which may give them an advantage
in developing and marketing services and products similar to ours or make our services and products obsolete.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
are many competitors in the CEA industry, including some companies that focus on the cannabis industry. These companies generally offer
products and services similar or the same as those offered by us. There can be no guarantees that in the future other companies will
not enter this arena by developing products that are in direct competition with us or even superior in quality or price. The barriers
to entry into the CEA industry are not overly significant. Over time we anticipate growth in our competition. Some of our current and
future competition may have longer operating histories, greater name recognition, larger client bases and significantly greater financial,
technical, sales and marketing resources. One or more of these qualities may allow them to respond more quickly than us to market opportunities.
They may be able to devote greater resources to the marketing, promotion and sale of their products and/or services. Competitors may
also adopt more aggressive pricing policies and make more attractive offers to clients, employees, strategic partners, distribution channels
and advertisers. Increased competition is likely to result in price reductions, reduced gross margins and a potential loss of market
share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
we believe we are better positioned to meet the exacting demands of a controlled cultivation environment through precise temperature,
humidity, light, and process controls and to satisfy the evolving code and regulatory requirements being imposed at the state and local
levels, there can be no assurance that we will be able to successfully compete against these other contractors and suppliers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
will be required to attract and retain top quality talent to compete in the marketplace.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
believe our future growth and success will depend in part on our ability to attract and retain highly skilled managerial, product development,
sales and marketing, and finance personnel. Our ability to attract and retain personnel with the requisite credentials, experience and
skills will depend on several factors including, but not limited to, our ability to offer competitive wages, benefits and professional
growth opportunities. There can be no assurance of success in attracting and retaining such personnel. Shortages in qualified personnel
could limit our ability to increase sales of existing products and services and launch new product and service offerings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
are dependent upon certain key sales, managerial and executive personnel for our future success. If we lose any of our key personnel,
our ability to implement our business strategy could be significantly harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
depend on the industry knowledge, technical and financial skill, and network of business contacts of certain key employees. Our future
success will depend on the continued service of these key employees or our ability to engage others who are similarly situated in the
industry. While we may have employment agreements with certain of these key employees, they are free to terminate their employment with
us at any time, although they may be subject to certain restrictive covenants on their post-termination activities. We do not carry key-man
life insurance on the lives of our key employees. The departure of any one of our key employees could have a material adverse effect
on our ability to achieve our business objective and maintain the specialized services that we offer our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>System
security risks, data protection breaches, cyber-attacks and systems integration issues could disrupt our internal operations or services
provided to customers, and any such disruption could reduce our expected revenue, increase our expenses, damage our reputation and adversely
affect our stock price.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Experienced
computer programmers and hackers may be able to penetrate our network security and misappropriate or compromise our confidential information
or that of third parties, create system disruptions or cause shutdowns. Computer programmers and hackers also may be able to develop
and deploy viruses, worms, and other malicious software programs that attack or otherwise exploit any security vulnerabilities of the
products that we may sell in the future, especially our recently launched SentryIQ&#174; sensors, controls and automation platform. The
costs to us to eliminate or alleviate cyber or other security problems, bugs, viruses, worms, malicious software programs and security
vulnerabilities could be significant, and our efforts to address these problems may not be successful and could result in interruptions,
delays, cessation of service and loss of existing or potential customers that may impede our engineering, sales, manufacturing, distribution
or other critical functions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Portions
of our IT infrastructure may also experience interruptions, delays or cessations of service or produce errors in connection with systems
integration or migration work that takes place from time to time. We may not be successful in implementing new systems and transitioning
data, which could cause business disruptions and be more expensive, time consuming, disruptive and resource intensive. Such disruptions
could adversely impact our ability to fulfill orders and interrupt other processes. Delayed sales, lower profits, or lost customers resulting
from these disruptions could adversely affect our financial results, stock price and reputation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
incur significant costs as a result of being a public company, which will make it more difficult for us to achieve profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
a public company, we incur legal, accounting and other expenses, including costs associated with the periodic reporting requirements
applicable to a company whose securities are registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
as well as additional corporate governance requirements, including requirements under the Sarbanes-Oxley Act, and other rules implemented
by the SEC. These costs will make it more difficult for us to achieve profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Changes
in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could
significantly affect our financial results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">U.S.
generally accepted accounting principles (&#8220;GAAP&#8221;) and related pronouncements, implementation guidelines and interpretations
with regard to a wide variety of matters that are relevant to our business, such as, but not limited to, revenue recognition, stock-based
compensation, trade promotions, and income taxes are highly complex and involve many subjective assumptions, estimates and judgments
by our management. Changes to these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our
management could significantly change our reported results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
ability to use net operating losses to offset future taxable income may be subject to limitations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $19,322,000,
of which $11,196,261 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31,
2017 do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus
Aid, Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. It is uncertain
if and to what extent various states will conform to the newly enacted federal tax law. In addition, under Section 382 of the Internal
Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership
change,&#8221; which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the
corporation&#8217;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its
post-change income or taxes may be limited. We have experienced ownership changes in the past and we may experience additional ownership
changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. If an ownership
change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future operating results
by effectively increasing our future tax obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
may not be able to successfully identify, consummate or integrate acquisitions or to successfully manage the impacts of such transactions
on our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Part
of our business strategy includes pursuing synergistic acquisitions. We have expanded, and plan to continue to expand, our business by
making strategic acquisitions and regularly seeking suitable acquisition targets to enhance our growth. Material acquisitions, dispositions
and other strategic transactions involve a number of risks, including: (i) the potential disruption of our ongoing business; (ii) the
distraction of management away from the ongoing oversight of our existing business activities; (iii) incurring additional indebtedness;
(iv) the anticipated benefits and cost savings of those transactions not being realized fully, or at all, or taking longer to realize
than anticipated; (v) an increase in the scope and complexity of our operations; and (vi) the loss or reduction of control over certain
of our assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
pursuit of acquisitions may pose certain risks to us. We may not be able to identify acquisition candidates that fit our criteria for
growth and profitability. Even if we are able to identify such candidates, we may not be able to acquire them on terms or financing satisfactory
to us. We will incur expenses and dedicate attention and resources associated with the review of acquisition opportunities, whether or
not we consummate such acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Related to the Cannabis Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cannabis
remains illegal under federal law, and therefore, strict enforcement of federal laws regarding cannabis, particularly against our customers,
would likely result in our inability to execute our business plan.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
but three U.S. states have legalized, to some extent, cannabis for medical purposes. Thirty-seven states, the District of Columbia, Puerto
Rico and Guam have legalized some form of whole-plant cannabis cultivation, sales and use for certain medical purposes (medical states).
Eighteen of those states and the District of Columbia and Northern Mariana have also legalized cannabis for adults for non-medical purposes
(sometimes referred to as adult use). Ten additional states have legalized low-tetrahydrocannabinol (&#8220;THC&#8221;)/high-CBD extracts
for select medical conditions (CBD states).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
U.S. federal law, however, those activities are illegal. Cannabis, other than hemp (defined by the U.S. government as <i>Cannabis sativa
L</i>. with a THC concentration of not more than 0.3% on a dry weight basis), is a Schedule I controlled substance under the U.S. Controlled
Substances Act (21 U.S.C. &#167; 801, et seq.) (the &#8220;CSA&#8221;),. Even in states or territories that have legalized cannabis to
some extent, the cultivation, possession, and sale of cannabis all violate the CSA and are punishable by imprisonment, substantial fines
and forfeiture. Moreover, individuals and entities may violate federal law if they aid and abet another in violating the CSA, or conspire
with another to violate the law, and violating the CSA is a predicate for certain other crimes, including money laundering laws and the
Racketeer Influenced and Corrupt Organizations Act. The U.S. Supreme Court has ruled that the federal government has the authority to
regulate and criminalize the sale, possession and use of cannabis, even for individual medical purposes, regardless of whether it is
legal under state law. For over six years, however, the U.S. government has not enforced those laws against companies complying with
state cannabis law and their vendors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
likelihood of any future adverse enforcement against companies complying with state cannabis laws remains uncertain. In 2018, then-U.S.
Attorney General Jeff Sessions rescinded the DOJ&#8217;s previous guidance (the Cole Memo) that had given federal prosecutors discretion
not to enforce federal law in states that legalized cannabis, as long as the state&#8217;s legal regime adequately addressed specified
federal priorities. The Sessions Memo, which remains in effect, states that each U.S. Attorney&#8217;s Office should follow established
principles that govern all federal prosecutions when deciding which cannabis activities to prosecute. As a result, federal prosecutors
could and still can use their prosecutorial discretion to decide to prosecute even state-legal cannabis activities. Since the Sessions
Memo was issued nearly three years ago, however, U.S. Attorneys have not targeted state law compliant entities. The policy of not prosecuting
companies complying with state cannabis laws is likely to continue under current U.S. Attorney General Merrick Garland. At his confirmation
hearing, Attorney General Garland stated that he did not see enforcement of federal cannabis law as a high priority use of resources
for the DOJ:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#8220;This
</span><span style="font: 10pt Times New Roman, Times, Serif">is a question of the prioritization of our resources and prosecutorial
discretion. It does not seem to me a useful use of limited resources that we have, to be pursuing prosecutions in states that have legalized
and that are regulating the use of marijuana, either medically or otherwise. I don&#8217;t think that&#8217;s a useful use. I do think
we need to be sure there are no end-runs around the state laws that criminal enterprises are doing. So that kind of enforcement should
be continued. But I don&#8217;t think it&#8217;s a good use of our resources, where states have already authorized. That only confuses
people, obviously, within the state.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Additionally,
since 2014, versions of the U.S. omnibus spending bill have included a provision prohibiting the DOJ, which includes the Drug Enforcement
Administration, from using appropriated funds to prevent states from implementing their medical-use cannabis laws. In <i>USA vs. McIntosh</i>,
the U.S. Court of Appeals for the Ninth Circuit held that the provision prohibits the DOJ from spending funds to prosecute individuals
who engage in conduct permitted by state medical-use cannabis laws and who strictly comply with such laws. The court noted that, if the
spending bill provision were not continued, prosecutors could enforce against conduct occurring during the statute of limitations even
while the provision was previously in force. Other courts that have considered the issue have ruled similarly, although courts disagree
about which party bears the burden of proof of showing compliance or noncompliance with state law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the omnibus spending bill affords some protection to medical cannabis businesses, our policies do not prohibit our state-licensed cannabis
customers from engaging in the cannabis business for adult use that is permissible under state and local laws. Consequently, certain
of our customers currently (and may in the future) sell adult-use cannabis, if permitted by such state and local laws now or in the future,
and therefore may be outside any protections extended to medical-use cannabis under the spending bill provision. This could subject our
customers to greater and/or different federal legal and other risks as compared to businesses where cannabis is sold exclusively for
medical use, which could in turn materially adversely affect our business. Furthermore, any change in the federal government&#8217;s
enforcement posture with respect to state-licensed cannabis sales, including the enforcement postures of individual federal prosecutors
in judicial districts where we operate, would result in our inability to execute our business plan, and we would likely suffer significant
losses with respect to our customer base, which would adversely affect our operations, cash flow and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
President Biden&#8217;s campaign position on cannabis falls short of full legalization, he campaigned on a platform of relaxing enforcement
of cannabis proscriptions, including decriminalization generally. According to the Biden campaign website, it was stated: &#8220;A Biden
Administration will support the legalization of cannabis for medical purposes and reschedule cannabis as a CSA Schedule II drug so researchers
can study its positive and negative impacts. This will include allowing the VA to research the use of medical cannabis to treat veteran-specific
health needs.&#8221; He pledged to &#8220;decriminalize&#8221; cannabis, which could prompt his U.S. Attorney General to issue policy
guidance to U.S. Attorneys that they should not enforce federal cannabis prohibition against state law compliant entities and others
legally transacting business with them. While President Biden&#8217;s promise to decriminalize likely would mean that the federal government
would not criminally enforce the Schedule II status against state legal entities, and would expand opportunities for cannabis research
in the U.S., the implications of the potential re-scheduling are not entirely clear for state legal commercial cannabis operators. Although
the U.S. Attorney General could issue policy guidance to federal prosecutors that they should not interfere with cannabis businesses
operating in compliance with states&#8217; laws, any such guidance would not have the force of law. The President alone cannot legalize
medical cannabis, and as states have demonstrated, legalizing medical cannabis can take many different forms. While rescheduling cannabis
to the CSA&#8217;s Schedule II would ease certain research restrictions, it would not make the state medical or adult-use programs federally
legal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Furthermore,
while industry observers are hopeful that a Democrat-controlled Senate, along with a Biden presidency, will increase the chances of federal
cannabis policy reform, such as the Marijuana Opportunity Reinvestment and Expungement Act (or MORE Act), which was originally co-sponsored
by now Vice President Harris in the Senate, or banking reform, such as the SAFE Banking Act, which passed the House of Representatives
but has not yet passed the Senate, we cannot provide assurances about the content, timing or chances of passage of a bill legalizing
cannabis and the related aspects of the cannabis business. Accordingly, we cannot predict the timing of any change in federal law or
possible changes in federal enforcement. In the unlikely event that the federal government were to reverse its long-standing hands-off
approach to the state legal cannabis markets and start more broadly enforcing federal law regarding cannabis, we would likely be unable
to execute our business plan, and our business and financial results would be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
are and will be subject to applicable anti-money laundering laws and regulations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are subject to a variety of laws and regulations in the United States and Canada that involve money laundering, financial recordkeeping
and proceeds of crime, including the U.S. Currency and Foreign 125 Transactions Reporting Act of 1970 (commonly known as the Bank Secrecy
Act), as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism Act of 2001 (USA PATRIOT Act), the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), as amended and
the rules and regulations thereunder, and any related or similar rules, regulations or guidelines, issued, administered or enforced by
governmental authorities in the United States, Canada and internationally. Further, under U.S. federal law, banks or other financial
institutions that provide a cannabis business with a checking account, debit or credit card, small business loan, or any other service
could be found guilty of money laundering if certain other elements are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Despite
these laws, the FinCEN Memorandum states that in some circumstances, it is permissible for banks to provide services to cannabis-related
businesses without risking FinCEN enforcement. It refers to and incorporates supplementary Cole Memo guidance issued to federal prosecutors
relating to the prosecution of money laundering offenses predicated on cannabis-related violations of the CSA on the same day.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Notwithstanding
former Attorney General Sessions&#8217; revocation of the Cole Memo, the status of the FinCEN Memorandum has not been affected, nor has
the Department of the Treasury given any indication that it intends to rescind the FinCEN Memorandum itself. Though it was originally
intended for the Cole Memo and the FinCEN Memorandum to work in tandem, the FinCEN Memorandum appears to remain in effect as a standalone
document which explicitly lists the eight enforcement priorities originally cited in the rescinded Cole Memo. Although the FinCEN Memorandum
remains intact, indicating that the Department of the Treasury and FinCEN intend to continue abiding by its guidance, it is unclear whether
the current administration will continue to follow the guidelines of the FinCEN Memorandum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
face risks related to civil asset forfeiture due to the regulatory environment of the cannabis industry in the United States.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Because
the cannabis industry remains illegal under U.S. federal law, any property owned by participants in the cannabis industry, which are
either used in the course of conducting such business, or are the proceeds of such business, could be subject to seizure by law enforcement
and subsequent civil asset forfeiture. Even if the owner of the property were never charged with a crime, the property in question could
still be seized and subject to an administrative proceeding by which, with minimal due process, it could be subject to forfeiture. As
a result, the equipment that we lease to our customers in the United States may be subject to such seizure and forfeiture. Additionally,
a broad interpretation of the law could potentially result in the seizure and forfeiture of proceeds we generate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Public
Opinion and perception of the cannabis industry may have an adverse effect on our business reputation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Government
policy changes or public opinion may also result in a significant influence over the regulation of the cannabis industry in the United
States, Canada, or elsewhere. Public opinion and support for medical and adult-use marijuana has traditionally been inconsistent and
varies from jurisdiction to jurisdiction. While public opinion and support appears to be improving for legalizing medical and adult-use
marijuana, it remains a controversial issue subject to differing opinions surrounding the level of legalization (for example, medical
marijuana as opposed to legalization in general). A negative shift in the public&#8217;s perception of cannabis in the United States
or any other applicable jurisdiction could affect future legislation or regulation. Among other things, such a shift could cause state
jurisdictions to abandon initiatives or proposals to legalize medical and/or adult-use cannabis, thereby limiting the number of new state
jurisdictions into which we could expand. Any inability to fully implement our expansion strategy may have a material adverse effect
on our business, results of operations or prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
may have difficulty accessing bankruptcy courts.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Because
cannabis is illegal under federal law, federal bankruptcy protection is currently not available to parties who engage in the cannabis
industry or cannabis-related businesses. Recent bankruptcy rulings have denied bankruptcies for dispensaries upon the justification that
businesses cannot violate federal law and then claim the benefits of federal bankruptcy for the same activity and upon the justification
that courts cannot ask a bankruptcy trustee to take possession of, and distribute cannabis assets as such action would violate the CSA.
Therefore, we may not be able to seek the protection of the bankruptcy courts, and this could materially affect our business or our ability
to obtain credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
business efforts in Canada present opportunities, but no assurance can be given that our revenues and earnings will be improved on the
basis of our addressing the Canadian business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
addition to U.S. operations, we seek to sell products and services to CEA and cannabis growers in Canada, where medical and recreational
cannabis has been legal since 2018 across the country both federally and provincially (subject to certain restrictions relating to CBD).
We believe Canada, with its federal legal regime, represents a business opportunity for us, but we have noticed softening demand from
Canadian prospects due, in part, to limited capital being available for new facilities and an overbuilding of cultivation capacity following
federal legalization. As a result, Canada now appears to be in a period of correction. There can be no assurance that we will be able
to make any additional sales of products or services in Canada.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Variations
in state and local regulation and enforcement in states that have legalized cannabis may impose certain restrictions on cannabis-related
activities that may adversely impact our revenue and earnings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Variations
exist among states that have legalized, decriminalized, or created medical cannabis programs. For example, Alaska and Colorado have limits
on the number of cannabis plants that can be grown by an individual in the home. In most states, the cultivation of cannabis for personal
use continues to be prohibited except by those states that allow small-scale cultivation by the individual in possession of cannabis
for medicinal purposes or that person&#8217;s caregiver. Active enforcement of state laws that prohibit personal cultivation of cannabis
may indirectly and adversely affect our revenue and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
cannabis industry could face strong opposition from other industries.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
believe that established businesses in other industries may have a strong economic interest in opposing the development of the cannabis
industry. Cannabis may be seen by companies in other industries as an attractive alternative to their products, including recreational
marijuana as an alternative to alcohol, and medical marijuana as an alternative to various commercial pharmaceuticals. Many industries
that could view the emerging cannabis industry as an economic threat are well established, with vast economic and United States federal
and state lobbying resources. It is possible that companies within these industries could use their resources to attempt to slow or reverse
legislation legalizing cannabis. Any inroads these companies make in halting or impeding legislative initiatives that would be beneficial
to the cannabis industry could have a detrimental impact on our clients and, in turn on our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Changing
legislation and evolving interpretations of law, which could negatively impact our clients and, in turn, our operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Laws
and regulations affecting the medical and adult-use marijuana industry are constantly changing, which could detrimentally affect our
clients involved in that industry and, in turn, our operations. Local, state and federal cannabis laws and regulations are often broad
in scope and subject to constant evolution and inconsistent interpretations, which could require our clients and ourselves to incur substantial
costs associated with modification of operations to ensure compliance. In addition, violations of these laws, or allegations of such
violations, could disrupt our clients&#8217; business and result in a material adverse effect on our operations. In addition, it is possible
that regulations may be enacted in the future that will limit the amount of cannabis growth or related products that our commercial clients
are authorized to produce. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can it
determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have
on our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
fact that we provide products and services to companies in the cannabis industry may impact our ability to raise adequate capital for
future expansion, which could hinder our growth potential as well as our revenue and earnings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
very large percentage, if not all, of our customers are operating in an industry that is still illegal under U.S. federal law. With the
lingering uncertainty of federal enforcement, many potential investors, especially institutional investors, either refuse to invest in
the industry or are very reluctant to make such investments. Our inability to raise adequate capital for future expansion could substantially
hinder our growth potential as well as our revenue and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
success may be dependent on additional states legalizing recreational and/or medical cannabis use.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Continued
development of the recreational and medical cannabis markets is dependent upon continued legislative authorization of cannabis at the
state level for recreational and/or medical purposes. Any number of factors could slow or halt the progress. Furthermore, progress, while
encouraging, is not assured, and the process normally encounters setbacks before achieving success. While there may be ample public support
for legislative proposals, key support must be created in the relevant legislative committee or a bill may never advance to a vote. Numerous
factors impact the legislative process. Any one of these factors could slow or halt the progress and adoption of cannabis for recreational
and/or medical purposes, which would limit the overall available market for our products and services, which could adversely impact our
business, revenue and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
customers may have difficulty accessing the service of banks, which may make it difficult for them to purchase our products and services.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
a result of the federal illegality of marijuana, many banks do not provide banking services to the cultivation and distribution segments
of the cannabis industry, the argument being that they would be accepting for deposit funds derived from the operation of a federally
illegal business. On February 14, 2014, the U.S. Department of the Treasury Financial Crimes Enforcement Network (&#8220;FinCEN&#8221;)
released guidance to banks &#8220;clarifying Bank Secrecy Act (&#8220;BSA&#8221;) expectations for financial institutions seeking to
provide services to marijuana-related businesses.&#8221; In addition, there have been legislative attempts to allow banks to transact
business with state-authorized cannabis businesses. While these are positive developments, there can be no assurance that legislation
will be successful, or that, even with the FinCEN guidance, banks will decide to do business with cannabis companies, or that, in the
absence of actual legislation, state and federal banking regulators will not strictly enforce current prohibitions on banks handling
funds generated from an activity that is illegal under federal law. Moreover, the FinCEN guidance may be rescinded or amended at any
time in order to reconcile the now conflicting guidance of the Sessions Memo. At present, few banks have taken advantage of the FinCEN
guidance, resulting in many cannabis businesses still operating on an all-cash basis. This makes it difficult for cannabis businesses
to manage their businesses, pay their employees and taxes, and having so much cash on hand also creates significant public safety issues.
Many ancillary businesses that service cannabis businesses have to deal with the unpredictability of their clients or customers not having
a bank account. The inability of our customers to open bank accounts and otherwise access the services of banks, including obtaining
credit, may make it more difficult and costly for them to operate and more difficult for such customers to purchase our products and
services, which could materially harm our business, revenue and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
are subject to certain federal regulations relating to cash reporting.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
BSA, enforced by FinCEN, requires us to report currency transactions in excess of $10,000, including identification of the customer by
name and social security number, to the Internal Revenue Service. This regulation also requires us to report certain suspicious activity,
including any transaction that exceeds $5,000 that we know, suspect or have reason to believe involves funds from illegal activity or
is designed to evade federal regulations or reporting requirements and to verify sources of funds. Substantial penalties can be imposed
against us if we fail to comply with this regulation. If we fail to comply with these laws and regulations, the imposition of a substantial
penalty could have a material adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>State
and municipal governments in which our customers do business or seek to do business may have or may adopt laws that adversely affect
our ability to do business with such customers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the federal government has the right to regulate and criminalize cannabis, state and municipal governments may adopt or amend additional
laws and regulations that further criminalize or adversely affect cannabis businesses. States that currently have laws that decriminalize
or legalize certain aspects of cannabis, such as medical marijuana, could in the future, reverse course and adopt new laws that further
criminalize or adversely affect cannabis businesses. Additionally, municipal governments in certain states may have laws that adversely
affect cannabis businesses, even though there are no such laws at the state level. For example, municipal governments may have zoning
laws that restrict where cannabis operations can be located and the manner and size of which they can expand and operate. These municipal
laws, like the federal laws, may adversely affect our customers&#8217; ability to do business. Also, given the complexity and rapid change
of the federal, state and local laws pertaining to cannabis, our customers may incur substantial legal costs associated with complying
with these laws and in acquiring the necessary state and local licenses required by their business endeavors. All of the foregoing may
impact our customers&#8217; ability to purchase our products and services, which may adversely affect our business, revenue and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Most,
if not all, of our customers are impacted by Section 280E of the Code, which limits certain expenses marijuana companies can deduct.
This negative impact could affect the financial condition of our customers, which in turn may negatively affect the ability of our customers
to purchase our products and services.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Section
280E of the Code forbids businesses from deducting otherwise ordinary business expenses from gross income associated with the &#8220;trafficking&#8221;
of Schedule I or II substances, as defined by the CSA. The Internal Revenue Service (the &#8220;IRS&#8221;) has subsequently applied
Section 280E to state-legal cannabis businesses since marijuana is still a Schedule I substance. Section 280E states that no deductions
should be allowed on any amount &#8220;in carrying on any trade or business if such trade or business consists of trafficking in controlled
substances.&#8221; Section 280E affects all businesses that engage in the cultivation, sale or processing of marijuana. This includes
cultivators, medical dispensaries, marijuana retail stores and infused product manufacturers, as well as marijuana-derived concentrates
and oil manufacturers. Because Section 280E limits certain deductions, it can have a dramatic effect on the profitability of these businesses,
which in turn may adversely affect their ability to purchase our products and services. Such result may adversely impact our revenue
and earnings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>There
may be difficulty enforcing certain of our commercial agreements and contracts.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Courts
will not enforce a contract deemed to involve a violation of law or public policy. Because cannabis remains illegal under U.S. federal
law, parties to contracts involving the state legal cannabis industry have argued that the agreement was void as federally illegal or
against public policy. Some courts have accepted this argument in certain cases, usually against the company trafficking in cannabis.
While courts have enforced contracts related to activities by state-legal cannabis companies, and the trend is generally to enforce contracts
with state-legal cannabis companies and their vendors, there remains doubt and uncertainty that we will be able to enforce our commercial
agreements in court for this reason. We cannot be assured that we will have a remedy for breach of contract, which would have a material
adverse effect on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Due
to our involvement in the cannabis industry, we may have a difficult time obtaining the various insurances that are desired to operate
our business, which may expose us to additional risk and financial liability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Insurance
that is otherwise readily available, such as general liability and directors&#8217; and officers&#8217; insurance, is more difficult
for us to find, and more expensive, because we are product and service providers to companies in the cannabis industry. There are no
guarantees that we will be able to find such insurances in the future, or that the cost will be affordable to us. If we are forced to
go without such insurances, it may prevent us from entering into certain business sectors, may inhibit our growth, and may expose us
to additional risk and financial liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>A
drop in the retail price of cannabis products may negatively impact our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
fluctuations in economic and market conditions that impact the prices of commercially grown cannabis, such as increases in the supply
of cannabis and decreases in demand for cannabis, could have a negative impact on our clients that are cannabis producers, and therefore
could negatively impact our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Related to Our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
common stock price may be volatile and may decrease substantially. Correspondingly, the market price of our warrants may also be volatile.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock has fluctuated substantially, and we expect that it will continue to do so. The price of our common
stock, and correspondingly the price of the warrants, in the market on any particular day depends on many factors including, but
not limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt/107% Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt/107% Times New Roman, Times, Serif">price
and volume fluctuations in the overall stock market from time to time;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt/107% Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt/107% Times New Roman, Times, Serif">investor
demand for our shares;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    volatility in the market price and trading volume of companies related to the cannabis industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">variations
    in our operating results and market conditions specific to our business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    emergence of new competitors or new technologies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">operating
    and market price performance of other companies that investors deem comparable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in our Board of Directors (the &#8220;Board&#8221;) or management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">sales
    or purchases of our common stock by insiders, including sales of our common stock issued to employees, directors and consultants
    under our equity incentive plan which were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)
    under our S-8 registration statement;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">commencement
    of, or involvement in, litigation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes
    in governmental regulations, in particular with respect to the cannabis industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">actual
    or anticipated changes in our earnings, and fluctuations in our quarterly operating results;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">market
    sentiments about the cannabis industry;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">general
    economic conditions and trends; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">departures
    of any of our key employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the past, following periods of volatility in the market price of a company&#8217;s securities, securities class action litigation has
often been brought against that company. Due to the potential volatility of our stock price, we may therefore be the target of securities
litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources
from our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
addition, if the market for equity stocks of companies in our industry, or the stock market in general, experiences a loss of investor
confidence, the market price of our common stock could decline for reasons unrelated to our business, financial condition, or results
of operations. If any of the foregoing occurs, it could cause the price of our common stock to fall and may expose us to lawsuits that,
even if unsuccessful, could be costly to defend and a distraction to our Board of Directors and management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Our
Board of Directors is authorized to reclassify any unissued shares of our preferred stock into one or more classes, which could convey
special rights and privileges to its owners.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation permit our Board of Directors to reclassify any authorized but unissued shares of preferred stock into one
or more classes. Our Board of Directors will generally have broad discretion over the size and timing of any such classification, subject
to a finding that the classification and issuance of preferred stock is in our best interests. As of November 3, 2021, we are authorized
to issue up to 850,000,000 shares of common stock and 150,000,000 shares of preferred stock. As of November 30, 2021, we had 238,967,349
shares of common stock issued and outstanding and 3,300 shares of preferred stock issued and outstanding. In the event our Board of Directors
opts to classify a portion of our unissued shares of preferred stock into a class of preferred stock, those preferred shares would have
a preference over our common stock with respect to dividends and liquidation. The cost of any classification would be borne by our existing
common stockholders. The class voting rights of any preferred shares we may issue could make it more difficult for us to take some actions
that may, in the future, be proposed by the Board of Directors and/or the holders of our common stock, such as a merger, exchange of
securities, liquidation, or alteration of the rights of a class of our securities, if these actions were perceived by the holders of
preferred shares as not in their best interests. These effects, among others, could have an adverse effect on your investment in our
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2022, we implemented a change in the authorized capital of the company and a reverse stock split. As a result of the
change in authorized capital, we are authorized to issue 200,000,000 shares of common stock and 25,000,000 shares of preferred
stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Rule
144 contains risks for certain shareholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, we issue shares on an unregistered basis, which may be eligible for resale under SEC Rule 144 promulgated under the Securities
Act. In the event there are shares outstanding that can be sold under Rule 144, there may be market pressure on our stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>We
do not anticipate paying any cash dividends on our common stock in the foreseeable future.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
currently intend to retain our future earnings, if any, for the foreseeable future, to repay indebtedness and to fund the development
and growth of our business. We do not intend to pay any dividends to holders of our common stock in the foreseeable future. Any decision
to declare and pay dividends in the future will be made at the discretion of our Board taking into account various factors, including
our business, operating results and financial condition, current and anticipated cash needs, plans for expansion, any legal or contractual
limitations on our ability to pay dividends under our loan agreements or otherwise. As a result, if our Board does not declare and pay
dividends, the capital appreciation in the price of our common stock, if any, will be your only source of gain on an investment in our
common stock, and you may have to sell some or all of your common stock to generate cash flow from your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>The
market price of our shares of common stock may be adversely affected by the sale of shares by our management or large stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Sales
of our shares of common stock by our officers or senior managers through 10b5-1 plans or otherwise or by large stockholders could adversely
and unpredictably affect the price of our common stock. Additionally, the price of our shares of common stock could be affected even
by the potential for sales by these persons. We cannot predict the effect that any future sales of our common stock, or the potential
for those sales, will have on our share price. Furthermore, due to relatively low trading volume of our stock, should one or more large
stockholders seek to sell a significant portion of their stock in a short period of time, the price of our stock may decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Risks
Related to this Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>An
active, liquid trading market for our common stock and warrants does not currently exist and may not develop after this offering,
and as a result, you may not be able to sell your common stock or warrants at or above the public offering prices, or at
all</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied for our common stock and warrants to be traded on the Nasdaq Capital Market, under the symbols &#8220;CEAD&#8221;
and &#8220; CEADW&#8221;. Prior to this offering, shares of our common stock were quoted on the OTC Markets Group, Inc. OTCQB under
the symbol &#8220;SRNA.&#8221; Trading on the OTCQB marketplace has been infrequent and in limited volume. Although we have applied to
list our shares of common stock and warrants on Nasdaq in connection with this offering, an active trading market for shares of
our common stock and warrants may never develop or be sustained following this offering. If an active trading market does not
develop, you may have difficulty selling your shares of common stock and warrants at an attractive price, or at all. The public offering
prices for our common stock and warrants which are being sold in tandem, and the related exercise price of the warrants, were
determined by negotiations between us and the representative of the underwriters and may not be indicative of prices that will prevail
in the open market following this offering. Consequently, you may not be able to sell your common stock or warrants at or above
the public offering prices or at any other price or at the time that you would like to sell. An inactive market may also impair
our ability to raise capital and may impair our ability to expand our business by using our equity as consideration in an acquisition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are selling a substantial number of shares of our common stock and warrants to purchase common stock in this offering, which could
cause the price of our common stock to decline</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this offering, we will sell up to 2,962,963 shares of common stock (assuming no exercise by the underwriters of their over-allotment
option and no purchase of pre-funded warrants). Additionally, we are selling warrants to purchase shares of common stock, equal
to the number of shares of common stock being sold in the offering (assuming no purchase of pre-funded warrants and no exercise
by the underwriters of their overallotment option). The existence of the potential additional shares of our common stock in the public
market, or the perception that such additional shares may be in the market, could adversely affect the price of our common
stock. We cannot predict the effect, if any, that market sales of those shares of common stock or the availability of those shares of
common stock for sale will have on the market price of our common stock. Any decline in the price of a share of common stock will
also have a negative effect on the price in the market of a warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no public market for either the warrants or the pre-funded warrants being sold in this offering.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established public trading market for either the warrants or the pre-funded warrants being sold in this offering. We will list
the warrants on the Nasdaq Capital Market, however there is no assurance that any market will develop. We will not list the pre-funded
warrants on any securities exchange or nationally recognized trading system, including the Nasdaq Capital Market. Therefore, we do not
expect a market to ever develop for the pre-funded warrants. Without an active market, the liquidity of the pre-funded warrants will
be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
pre-funded warrants are speculative in nature.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the warrants nor the pre-funded warrants confer any rights of common stock ownership on their respective holders, such as voting rights
or the right to receive dividends, but rather merely represent the right to acquire shares of common stock at a fixed price. Commencing
on the date of issuance, holders of either the warrants or the pre-funded warrants may exercise their right to acquire the common stock
and pay the stated exercise price per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In
the event that our common stock price does not exceed the exercise price of the warrants or the pre-funded warrants during the period
when the warrants or the pre-funded warrants are exercisable, as applicable, such warrants may not have any value.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
holders of the warrants and the pre-funded warrants acquire shares of our common stock upon exercise thereof, holders of the warrants
and pre-funded warrants will have no rights with respect to the shares of our common stock. Upon exercise of the pre-funded warrants,
such holders will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after
the exercise date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no assurance that any of the warrants will be exercised and we will receive the exercise proceeds therefrom.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrants have an exercise price above the price of a share of common stock and warrant in this offering. If the price of our common stock
does not exceed the warrant exercise price, then it is unlikely that the warrants will be exercised. The warrants will expire on the
fifth anniversary of their issuance, which if they expire without being exercised the company will not receive any proceeds therefrom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally
for the warrants to be exercised for cash, the company must keep an effective registration statement available for issuance of the common
stock on exercise of the warrants. If the company fails to maintain an effective registration statement, then the warrants may be exercised
on a cashless basis, and the company will not receive any cash amount from their exercise.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>You
will incur immediate dilution in the net tangible book value of the shares you purchase in this offering</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price of our common stock is higher than the net tangible book value per share of outstanding common stock prior to completion
of this offering. Based on our pro forma net tangible book value as of September 30, 2021, giving effect to the 1-for-150 reverse
stock split subsequent to September 30, 2021, and giving further effect to the issuance and sale of 2,962,963 shares of common
stock and warrants sold on a one for one basis by us at the public offering price of $6.75 per share and warrant (assuming
no sale of the pre-funded warrants), if you purchase our common stock and warrants in this offering, you will suffer immediate
dilution of approximately $3.09 per share in net tangible book value. Dilution is the amount by which the offering price paid
by purchasers of our common stock in this offering will exceed the pro forma as adjusted net tangible book value per share of our common
stock upon completion of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>You
may be diluted by future issuances of preferred stock or additional common stock in connection with our incentive plans, acquisitions
or otherwise; future sales of such shares in the public market, or the expectations that such sales may occur, could lower our stock
price.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation authorizes us to issue shares of our common stock and options, rights, warrants and appreciation rights relating
to our common stock for the consideration and on the terms and conditions established by our Board in its sole discretion. We could issue
a significant number of shares of common stock in the future in connection with investments or acquisitions. Any of these issuances could
dilute our existing stockholders, and such dilution could be significant. Moreover, such dilution could have a material adverse effect
on the market price for the shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
future issuance of shares of preferred stock with voting rights may adversely affect the voting power of the holders of shares of our
common stock, either by diluting the voting power of our common stock if the preferred stock votes together with the common stock as
a single class, or by giving the holders of any such preferred stock the right to block an action on which they have a separate class
vote, even if the action were approved by the holders of our shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
future issuance of shares of preferred stock with dividend or conversion rights, liquidation preferences or other economic terms favorable
to the holders of preferred stock could adversely affect the market price for our common stock by making an investment in the common
stock less attractive. For example, investors in the common stock may not wish to purchase common stock at a price above the conversion
price of a series of convertible preferred stock because the holders of the preferred stock would effectively be entitled to purchase
common stock at the lower conversion price, causing economic dilution to the holders of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>A
portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near future. This
could cause the market price of our common stock to drop significantly, even if our business is doing well.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Subject
to certain exceptions, without the prior written consent of ThinkEquity LLC, as representative of the underwriters, we, during the period
ending 90 days after the date of this prospectus, and our officers and directors and our 5% or greater stockholders, during the period
ending 180 days after the date of this prospectus, have agreed not to: (1) offer, sell, contract to sell, pledge, grant any option to
purchase, make any short sale or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities
convertible into, exchangeable for or that represent the right to receive shares of common stock; (2) file any registration statement
with the SEC relating to the offering of any shares of common stock or any securities convertible into or exercisable or exchangeable
for common stock; or (3) enter into any swap or other arrangement that transfers, in whole or in part, any of the economic consequences
of ownership of common stock, subject to certain exceptions. ThinkEquity, in its sole discretion, may release the common stock and other
securities subject to the lock-up agreements described above in whole or in part at any time with or without notice. See &#8220;Underwriting.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
market price of our common stock may decline significantly when the restrictions on resale by our existing stockholders lapse. A decline
in the market price of our common stock might impede our ability to raise capital through the issuance of additional shares of common
stock or other equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_005"></span><b>USE
OF PROCEEDS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that the net proceeds to us from the sale of our common stock and warrants in this offering will be approximately $18,125,500
(or $20,885,500  if the underwriters exercise their over-allotment option in full), based on an assumed public
offering price of $6.75 per share and warrant, sold on a one for one basis and assuming no sales of any pre-funded
warrants, after deducting underwriting discounts and commissions and the estimated offering expenses payable by us. Each $1.00
increase (decrease) in the assumed public offering price would increase (decrease) the net proceeds to us from this offering by
approximately $2,962,963 (or $3,134,815 if the underwriters exercise their over-allotment option in
full), assuming the number of shares and warrants (and no sales of pre-funded warrants) we sell, as set forth on the cover
page of this prospectus, remains the same, after deducting underwriting discounts and commissions and the estimated offering
expenses payable by us. For each 100,000 share increase (decrease) in the number of shares and warrants sold in this
offering, the net proceeds to us from this offering will change by approximately $675,000 (or $675,000 if the
underwriters exercise their over-allotment option in full), assuming the assumed public offering price remains the same, after
deducting underwriting discounts and commissions and the estimated offering expenses payable by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use approximately
$2.0 million of the net proceeds to redeem 1,650 shares, or 50%, of our Series B Preferred Stock from our Series B investor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the remaining net proceeds for working capital and other general corporate business purposes. The expected use of
net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could change in
the future as our plans and business conditions evolve and change. As a result, our management will have broad discretion over how these
proceeds are used. Proceeds held by us will be invested in short-term investments until needed for the uses described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_006"></span><b>MARKET
FOR OUR COMMON STOCK</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Prior
to this offering, the shares of our common stock were quoted on the OTC Markets Group, Inc. OTCQB Marketplace under the symbol &#8220;CEAD.&#8221;
and quoted on the predecessor to the OTCQB Marketplace since April 5, 2011. Trading on the OTCQB Marketplace has been infrequent
and limited in volume, therefore the prices at which such transactions occurred may not necessarily reflect the price that would be paid
for our common stock in a more liquid market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">As
of September 30, 2021, there were approximately 130 record holders of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">We
have applied to list our common stock and warrants on the Nasdaq Capital Market under the symbols &#8220;CEAD&#8221; and &#8220;CEADW.&#8221;
However, we cannot assure you that a liquid trading market for our common stock or warrants will develop or be sustained after
this offering. You may not be able to sell your shares quickly or at the market price if trading in our common stock is not active. See
&#8220;Underwriting&#8221; for more information regarding our arrangements with the underwriters and the factors considered in setting
the public offering price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">There is no established trading
market for the pre-funded warrants. We do not expect a market for such securities to develop. In addition, we do not intend to apply
for the listing of the pre-funded warrants on any national securities exchange or other trading market. Without an active trading market,
the liquidity of the pre-funded warrants will be limited.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_007"></span><b>DIVIDEND
POLICY</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Since
our inception, we have not paid any dividends on our common stock, and we currently expect that, for the foreseeable future, all earnings,
if any, will be retained for use in the development and operation of our business. In the future, our Board may decide, at its discretion,
whether dividends may be declared and paid to holders of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_008"></span><b>CAPITALIZATION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">The
following table sets forth our cash and cash equivalents and capitalization as of September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">on
    an actual basis;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma basis to give effect (i) to the redemption of the Series A Preferred Stock for 2,802 shares of common stock subsequent
    to September 30, 2021, effective on November 4, 2021,</span> <span style="font-family: Times New Roman, Times, Serif">(ii) to the
    issuance of 6,803 shares to the CEO per the employment agreement dated November 24, 2021, (iii) to the forgiveness of the
    note payable and related accrued interest by the Small Business Administration Payroll Protection Program on November 30, 2021,
    (iv) to the 1-for-150 reverse stock split subsequent to September 30, 2021, effective on January 27, 2022; (v) to the issuance of 7,719
    shares of Common Stock to our Series B Preferred Stock investor on December 30, 2021 as payment for the quarterly dividend payment;
    and (vi) to the issuance of 3,367 shares in the aggregate to both our incoming directors on January 17, 2022; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis to give further effect to the issuance and sale by us in this offering of 2,962,963 shares of
    our common stock and warrants at the assumed public offering price of $6.75 per share and warrant on a one for one
    basis, assuming no sale of any pre-funded warrants, after deducting the underwriting discounts and commissions and estimated
    offering expenses that we expect to pay and the application of approximately $2.0 million of net proceeds from this offering to
    redeem 1,650 shares of our Series B Preferred Stock as described under &#8220;Use of Proceeds.&#8221;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">This
table should be read in conjunction with, and is qualified in its entirety by reference to, &#8220;Use of Proceeds,&#8221; &#8220;Selected
Historical Consolidated Financial and Other Data,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
Results of Operations&#8221; and our consolidated financial statements and related notes appearing elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of September 30, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Actual</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro forma</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Pro forma as adjusted</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; font-weight: bold; text-align: left">Cash and cash equivalents (2)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,283,879</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,260,381</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">18,405,881</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Capitalization:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total current debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Long-term debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Notes Payable and accrued interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517,468</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    long-term debt<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517,468</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Series B redeemable convertible preferred stock, $0.00001&#160;par value;&#160;3,300&#160;and&#160;0&#160;issued
    and outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,960,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,960,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,960,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Series B redeemable convertible preferred stock subscription receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,365,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,365,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,365,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Series B redeemable convertible preferred stock accrued
    dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total temporary equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,596,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,596,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,596,447</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Preferred stock 150,000,000 shares authorized, $0.00001 par value; 42,030,331
    issued and outstanding as of September 30, 2021; 25,000,000 shares authorized and 0 shares issued and outstanding on a pro-forma and
    on a pro-forma as adjusted basis</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">420</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Common Stock $0.00001 par value: 350,000,000 shares authorized and 236,526,638
    shares issued and outstanding as of September 30, 2021; 200,000,000 shares authorized and 1,604,202 shares issued and outstanding on
    a pro forma basis as of September 30, 2021; and 200,000,000 shares authorized and 4,567,165 issued and outstanding shares on a pro-forma
    as adjusted basis as of September 30, 2021.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,376</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Additional paid in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,017,065</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,067,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,212,971</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,379,674</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,935,704</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,935,704</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,359,813</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,868,217</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,277,308</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total capitalization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(245,898</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(271,770</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,873,755</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(1) Gives effect to the forgiveness of the notes payable by the SBA
on November 30, 2021</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">(2) Gives effect to the Company&#8217;s payment
of income tax liabilities from stock issued as compensation to the CEO on November 24, 2021</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span>&#160;</p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Each
$1.00 increase (decrease) in the assumed public offering price would increase (decrease) shareholder&#8217;s equity after this offering
by approximately $2,962,963 (or $3,134,815 million if the underwriters exercise their over-allotment option in
full), assuming the number of shares we sell, as set forth on the cover page of this prospectus, remains the same, after deducting underwriting
discounts and commissions and the estimated offering expenses payable by us, and further assuming no sale of any pre-funded warrants.
Similarly, each increase (decrease) of 100,000 shares in the number of shares of common stock offered by us would increase (decrease)
our shareholder&#8217;s equity by $675,000, assuming the assumed public offering price remains the same and after deducting underwriting
discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">The
information in the above table for the actual information and pro forma basis as of September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">assumes
    no exercise by the underwriters of their over-allotment option;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">assumes
    no exercise of the representative&#8217;s warrants to be issued to the representative of the underwriters </span><span style="font-family: Times New Roman, Times, Serif">in
    this offering;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">assumes no exercise of any of the warrants sold in the
    offering, including any per-funded warrants in lieu of the shares of common stock offered;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    approximately 325,926 shares of common stock and/or pre-funded warrants and approximately 325,926 warrants issuable
    upon the conversion of 1,650 shares of our Series B </span><span style="font-family: Times New Roman, Times, Serif">Preferred
    Stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">excludes
    219,090 shares of common stock issuable upon the exercise of outstanding exercisable options </span><span style="font-family: Times New Roman, Times, Serif">at
    a weighted exercise price of $10.50 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes
    227,719 shares of common stock issuable upon the exercise of outstanding warrants at a weighted exercise price of $9.70
    per share; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes
    610,415 shares of common stock reserved for future issuance pursuant to our 2017 and 2021 equity incentive plans.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_009"></span><b>DILUTION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our common stock in this offering, your interest will be diluted to the extent of the difference between the public offering
price per share of our common stock (assuming no value is attributed to the warrants and no pre-funded warrants are sold in the offering)
and the pro forma as adjusted net tangible book value per share of our common stock immediately after the closing of this offering (assuming
no value is attributed to the warrants and no pre-funded warrants are sold in the offering). Net tangible book value per share represents
our total tangible assets less our total liabilities, divided by the number of outstanding shares of common stock. Our net tangible book
value of our common stock as of September 30, 2021 was $(1,401,222), or $(0.88) per share. Our pro forma net tangible book value of our
common stock as of September 30, 2021 was $(1,401,222), or $(0.87) per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect the net proceeds from our sale of 2,962,963 shares of common stock in this offering at the assumed public offering
price of $6.75 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro
forma as adjusted net tangible book value as of September 30, 2021, would have been $16,724,278, or $3.66 per share (assuming no value
is attributed to the warrants and no pre-funded warrants are sold in the offering). This represents an immediate increase in pro forma
net tangible book value of $4.54 per share to our existing stockholders and an immediate dilution of $3.09 per share to investors purchasing
common stock in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
calculate dilution per share to new investors by subtracting the pro forma net tangible book value per share from the public offering
price paid by the new investor. The following table illustrates the dilution to new investors on a per share basis:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 84%">Assumed public offering price per share</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Pro forma net tangible book value per share as of September 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.87</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Increase in pro forma net tangible book value per share attributable to this offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.54</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Pro forma as adjusted net tangible book value per share after this offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.66</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dilution in pro forma net tangible book value per share in this offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.09</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
dilution information discussed above is illustrative only and will change based on the actual initial public offering price and other
terms of this offering determined at pricing. A $1.00 increase in the assumed initial public offering price of $6.75 to $7.75 per share
(assuming no value is attributed to the warrants and no pre-funded warrants are sold in the offering) would increase our pro forma as
adjusted net tangible book value as of September 30, 2021, after this offering by $0.60 per share, and would increase dilution to new
investors by $0.40 per ordinary share. An increase of 100,000 in the number of shares we are offering would increase our pro forma as
adjusted net tangible book value as of September 30, 2021, after this offering by $0.07 per share, and would decrease dilution to new
investors by $0.10 per share, assuming the assumed initial public offering price per ordinary share remains the same (assuming no value
is attributed to the warrants and no pre-funded warrants are sold in the offering).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriters&#8217; option to purchase additional shares to cover over-allotments is exercised in full, the pro forma as adjusted
net tangible book value per share after giving effect to this offering, assuming the public offering price of $6.75, would be $3.89 per
share, representing an immediate increase to existing stockholders of $4.76 per share, and immediate dilution to new investors in this
offering of $2.86 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes, on the pro forma as adjusted basis described above as of September 30, 2021, the differences between the
existing shareholders and the new investors in this offering with respect to the number of shares, including shares represented by shares
purchased from us, the total consideration paid to us and the average price per share based on an assumed public offering price of $6.75
per share before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Issued</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Average Price Per</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left">Existing shareholders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,604,202</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">35.12</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></p></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="width: 1%; text-align: left"></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n/a</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">New investors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,962,963</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64.88</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6.75</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,567,165</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,000,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">100</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6.75</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
foregoing calculations:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">assumes
    no exercise by the underwriters of their over-allotment option;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">assumes
    no exercise of the representative&#8217;s warrants to be issued to the representative of the underwriters in this offering;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumes
    no exercise of any of the warrants sold in the offering, including any per-funded warrants in lieu of the shares of common stock
    offered;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">on a pro forma basis gives effect (i) to
the redemption of the Series A Preferred Stock subsequent to September 30, 2021, effective on November 4, 2021, (ii) to the issuance
of 6,803 shares to the CEO per the employment agreement dated November 24, 2021, (iii) to the forgiveness of the note payable
and related accrued interest by the Small Business Administration Payroll Protection Program on November 30, 2021, (iv) to the 1-for-150
reverse stock split subsequent to September 30, 2021, effective on January 27, 2022; (v) to the issuance of 7,719 shares of Common Stock
to our Series B Preferred Stock investor on December 30, 2021 as payment for the quarterly dividend payment; and (vi) to the issuance
of 6,734 shares in the aggregate to both our incoming directors on January 17, 2022;</p>
<span style="font-family: Times New Roman, Times, Serif"></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes
    approximately 325,926 shares of common stock and/or pre-funded warrants and approximately 325,926 warrants issuable
    upon the conversion of 1,650 shares of our Series B Preferred Stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes 219,090 shares of common stock issuable upon the exercise of outstanding exercisable options at a weighted exercise price of $10.50
    per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes
    227,719 shares of common stock issuable upon the exercise of outstanding warrants at a weighted exercise price of $9.70
    per share; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">excludes
    610,415 shares of common stock reserved for future issuance pursuant to our 2017 and 2021 equity incentive plans; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no sale of any pre-funded warrants.</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_010"></span><b>SELECTED
HISTORICAL CONSOLIDATED FINANCIAL AND OTHER DATA</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
following tables set forth our summary historical consolidated financial data as of, and for the periods ended on, the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
summary consolidated statements of operations data for the years ended December 31, 2020 and 2019 and the summary consolidated balance
sheet data as of December 31, 2020 and 2019 are derived from our audited consolidated financial statements and notes that are included
elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
summary consolidated statements of operations data for the three and nine months ended September 30, 2021 and 2020 and the summary consolidated
balance sheet data as of September 30, 2021 are derived from our unaudited interim consolidated financial statements and notes that are
included elsewhere in this prospectus. We have prepared the unaudited consolidated financial statements in accordance with generally
accepted accounting principles (GAAP) and on the same basis as the audited consolidated financial statements. Our historical results
are not necessarily indicative of our results in any future period and results from our interim period may not necessarily be indicative
of the results of the entire year. Pro forma share and per share amounts presented herein reflect the implementation of the 1-for-150
reverse stock split as if it had occurred at the beginning of the earliest period presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Three Months Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Three Months Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Nine Months Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Nine Months Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Fiscal Year Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">For
    the Fiscal Year Ended</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">September
    30,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">September
    30,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">September
    30,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">September
    30,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">December
    31,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">December
    31,</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2021</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2019</span></td><td style="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Unaudited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Unaudited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Unaudited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Unaudited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Audited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font: bold 9pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Audited)</span></td><td style="font: bold 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Statement
    of Operations data:</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Revenues</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,706,436</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,634,669</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,582,470</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,127,018</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,514,272</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,224,454</span></td><td style="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost of Revenues</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,959,264</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,108,758</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,208,368</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,869,758</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,961,305</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,675,601</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gross Profit</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">747,172</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">525,911</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,374,102</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,257,260</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,552,967</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,548,853</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Operating
    expenses</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,189,715</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">808,575</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,386,317</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,091,874</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,915,591</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,859,442</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income(loss) from operations</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(442,543</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(282,664</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,012,215</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,834,614</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,362,624</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,310,589</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    non-operating income (expense)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">34,638</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,225</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">76,184</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,345</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">603,908</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27,977</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net
    income (loss)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(407,905</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(270,439</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(936,031</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,822,269</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,758,716</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,338,566</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income
    (loss) per share, basic and diluted</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.26</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.17</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.59</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.16</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.12</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.88</span></td><td style="font: 9pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Weighted average shares outstanding, basic and diluted</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,583,511</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,576,844</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,581,142</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,564,746</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,574,454</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="font: 9pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font: 9pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,517,748</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Unaudited)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Audited)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Audited)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Balance sheet data</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,953,597</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,683,293</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,561,268</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,908,956</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,813,266</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,047,318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,117,776</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,903,689</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,998,740</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,672,322</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,146,964</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,402,949</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total temporary equity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,596,447</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,359,813</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,333,698</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(355,631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total liabilities and stockholders&#8217; deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,908,956</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,813,266</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,047,318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_011"></span><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION<br />
AND RESULTS OF OPERATIONS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>The
following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information
appearing elsewhere in this prospectus, which include additional information about our accounting policies, practices, and the transactions
underlying our financial results. In addition to historical information, this prospectus contains forward-looking information that involves
risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to
the factors discussed under &#8220;Cautionary Statements&#8221; appearing elsewhere in this prospectus and the risks and uncertainties
described or identified in &#8220;Risk Factors&#8221; in this prospectus</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Please
also refer to &#8220;Non-GAAP Financial Measures&#8221; discussed elsewhere in this prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
following discussion should be read in conjunction with the Business section contained elsewhere in this prospectus, and our consolidated
financial statements and accompanying notes to consolidated financial statements included in this prospectus. Our Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is segregated into four sections, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Executive
Overview</i></b>. This section provides a summary of our operating performance and cash flows, industry trends and our strategic initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Critical
Accounting Policies and Estimates</i></b><i>.</i> This section describes the accounting areas where management makes critical estimates
to report our financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Results
of Operations</i></b><i>. </i>This section provides an analysis of our consolidated results of operations for the two comparative periods
presented in our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.1pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Liquidity,
Capital Resources and Financial Position</i></b><i>.</i> This section provides an analysis of cash flow, contractual obligations, and
certain other matters affecting our financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Impact
of the COVID-19 Pandemic on Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources.
Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still
allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we
were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be
predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this
uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact of the COVID-19 pandemic
to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced sales, increased losses and reduced
operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Executive
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">CEA
Industries Inc. is a technology, engineering, and services provider to the global controlled environment agriculture (CEA) industry.
The CEA industry is one of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard,
cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries,
blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market
dynamics or as part of their preferred farming practice. In service of the CEA, our principal service and product offerings include:
(i) floor plans and architectural design of cultivation facilities, (ii) licensed mechanical, electrical, and plumbing (MEP) engineering
of commercial scale environmental control systems specific to cultivation facilities, (iii) process cooling systems and other climate
control systems, (iv) air handling equipment and systems, (v) LED lighting, benching and racking solutions for indoor cultivation, (vi)
automation and control devices, systems and technologies used for environmental, lighting and climate control, and (vii) preventive maintenance
services for CEA facilities. Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as
well as in other international locations. Customers are those growers building new facilities and those expanding or retrofitting existing
facilities, with both ranging in size from several thousand to more than 100,000 square feet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Historically,
our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities that grow
cannabis, but we have served facilities growing other crops and we intend to pursue such facilities more in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
have three core assets that we believe are important to our going-forward business strategy. First, we have multi-year relationships
with customers and others in the CEA industry, notably in the cannabis segment. Second, we have specialized engineering know-how and
experience gathered from designing environmental control systems for CEA cultivation facilities since 2016. Third, we have a line of
proprietary environmental control products, which we are in the process of expanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">We
are an integrated provider of MEP (mechanical, electrical, plumbing) engineering design, proprietary environmental control equipment,
and controls and automation offerings serving the CEA industry. Historically, nearly all of our customers have been in the cannabis cultivation
business. We believe our employees have more experience than most other MEP firms serving this industry. Our customers engage us for
their environmental and climate control systems because they want experts to design their facilities, and they come to us because of
our reputation. We leverage our reputation and know-how against the many local contractors and MEP engineers who collectively constitute
our largest competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
three key pillars of our corporate strategy for growing the Company and increasing shareholder value are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Organic
growth</i>. We serve a market for the construction and expansion of controlled environment agriculture (CEA) facilities and businesses
that is projected to grow at a 20%+ compound annual growth rate for the foreseeable future. Our primary vertical market of cannabis cultivation
facilities has been joined by the similarly rapidly growing urban vertical farming market to create two market opportunity segments that
we are positioned to serve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
May of 2021 we announced a new strategy for our organic growth, which included:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">New
markets. We decided to expand our business development plan to pursue non-cannabis CEA facilities, at least doubling our total addressable
market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">New
products &amp; services. We decided to expand our product offerings from primarily environmental control to now offer all of the primary
technologies and services required in a CEA facility. Our primary objective in expanding our service and product offerings was to improve
our customers&#8217; operations and sustainability, increase customer acquisition, and enhance our revenue and revenue recurrence. Our
expanded offering now include: architectural design, lighting, benching, HVACD, sensing &amp; control systems, CO<sub>2</sub> dosing
and control, water filtration &amp; condensate reclamation, irrigation &amp; fertigation systems, and wastewater treatment. We also now
offer preventative maintenance services on a recurring subscription basis for cultivation facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">New
trade name. In May of 2021 we adopted the trade name Surna Cultivation Technologies instead of Surna Inc. because we believe that the
new name will more clearly identify our business to prospects and make us easier to find on various social media and search engines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Operations</i> &#8211; first and foremost we seek to help our customers build the most effective and efficient facility possible. We
believe that we are uniquely positioned to engineer all of the complex components of a CEA facility into a holistic whole because of
our dedicated engineering staff and our experience including over 200 commercial facilities. Our 15 years in the business has provided
us a wide network of technology vendors from which we curate a selection of the best products. In addition, we are the leading experts
in applying the most challenging component of the technical infrastructure, the environmental controls, and we have the knowledge required
to engineer the interactions among the required components. A professional engineer (PE) license is required for all MEP engineering
work, and this engineering competence is one of our greatest strengths.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sustainability
</i>&#8211; indoor cultivation facilities, like data centers, are resource intensive. Several U.S. states have implemented building code
changes that place limits on the energy consumption allowed within cultivation facilities, and we anticipate that more states will do
the same. Among our objectives is to provide our customers with the most energy-efficient alternatives for their infrastructure. Energy
and resource efficiency is a high priority to us as engineers, and our most senior engineering staff hold the LEED (Leadership in Energy
and Environmental Design) credential. Our CEO previously helped build a cleantech company, has been involved in the cleantech industry
for over five years, and published a book on selling energy efficient technologies. We believe that we are in a position to lead the
industry in sustainability initiatives which our customers will highly value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Acquisition</i> &#8211; By offering Facility Selection &amp; Design services we seek to build relationships with prospects at the earliest
opportunity in the lifecycle of the cultivation business. By expanding our offerings to include nearly every piece of the technical infrastructure
required in a facility we hope to engage at the earliest possible moment with the customer and earn the opportunity to provide all the
products and services required for the facility. Our post-start-up, lifecycle services will help us maintain a relationship with the
customer as long as the facility is in operation. Our observation is that our customers want to grow plants, not maintain the technical
infrastructure of complex systems, and we believe that they will accept our offer to do so, as some already have.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue
and Revenue Recurrence</i> &#8211; We believe that our revenue can be expanded by offering most of the primary technical infrastructure
components for a cultivation facility. For example, if we are able to provide all of the primary infrastructure components to a cultivation
facility, our revenue on a project could be up to 200% higher than if we provided the environmental controls systems alone. In the past
we did not have products or services to offer our customers after a facility was constructed. We have recently begun to offer preventative
maintenance services, and we believe that by expanding this service offering we will be able to gain long-term recurring revenue on a
subscription basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Seek
strategic relationships, mergers, and acquisitions to add to our existing business</i></b><i>. </i>We enjoy wide brand recognition in
the cannabis cultivation industry because of our longevity in the market segment (15 years) and the number of cultivation projects (over
200 commercial projects) we have served. Our core expertise is engineering the environmental controls of these facilities, which is a
sophisticated engineering challenge due to the high humidity (latent heat) and heat load (sensible heat) within these facilities. Not
only are the loads high, but the environmental conditions within these facilities must be held closely within limits that the facility&#8217;s
managers request. Engineering to meet these limits requires us to consider all of the primary components within the facility: lighting,
irrigation, HVACD, fertigation, sensors, controls, CO<sub>2 </sub>dosing, monitoring and alarms, facility physical limits such as power
availability, and energy consumption. We believe that the expertise gained in working with many of the primary components provides us
with a uniquely well-informed view of the efficacy of the many primary components on offer in the marketplace. We further believe that
this knowledge will help us make wise choices of which products to pursue for strategic relationships, and which providers to potentially
merge with or acquire. For smaller component providers we believe that our publicly traded platform and our existing sales and marketing
reach will make us an attractive partner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Raise
capital and uplist to a senior exchange.</i> In 2019 our revenue grew 59% year-over-year, and we had our first-ever cash flow
positive year. Despite the challenges brought on by the COVID-19 pandemic in the first half of 2020, we believe that our revenue growth
in 2019 and then in the Q3 2020 &#8211; Q3 2021 period validates our market opportunity and our business model. We also recognize that
the costs of being a small public company are substantial and require cash that could otherwise be used to sustain and grow the business.
We believe that there is only one solution to this issue: rapid revenue and margin growth. We believe that we have growth opportunities,
but we are capital constrained and must seek outside financing to pursue the growth we believe we can achieve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Revenue</span></i></b>.
Our 2020 revenue was $8,514,000. Our 2020 revenue represents a decrease of 44% compared to 2019. One of our MFO customers accounted for
28% of our 2020 revenue. We believe, among other things, that we need to build a diversified sales pipeline of Multi Facility Operators
or MFO&#8217;s (MFOs), which we believe will increase our consistency and predictability of revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Gross
Margin</span></i></b>. Our 2020 gross margin was 18.2%, a decrease from 29.9% in 2019. This decrease was primarily due to our fixed cost
base, a lower margin on equipment sales, and an increase in variable costs as a percent of revenue as described in <i>Results of Operations
</i>below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Profitability</span></i></b>.
Our 2020 adjusted net loss was $1,239,000 compared to a 2019 adjusted net income of $92,000. Our adjusted net income (loss) is a key
management metric and point of focus for us because it provides a proxy for the cash we generate from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Capital
Resources.</span></i></b> Our working capital remains negative, and we have limited capital resources, which are impediments to the overall
viability of our business as planned. The effect of the COVID-19 response has presented further challenges for us in 2020. Without increasing
our current revenue and adding new sources of revenue, we cannot predict our future. As discussed elsewhere in this prospectus, we have
taken steps to reduce costs. We cannot predict how long our cost cutting measures will sustain the Company or how long the current economic
situation will last.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span style="text-decoration: underline">Contract
Bookings.</span></i></b> Our bookings dropped significantly in the first half of 2020 but recovered in the second half, and our backlog
at December 31, 2020, was $8,448,000, a decrease of $1,110,000, or 12%, from our December 31, 2019 backlog. During 2020, we had net bookings
of $7,404,000, consisting of: (i) $10,343,000 of new sales contracts executed in 2020, (ii) $151,000 net positive changes orders, and
(iii) $3,089,000 in project cancellations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have
received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the
period for which we received an initial deposit, net of any adjustments including cancellations and change orders during the period),
(iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings,
less recognized revenue). Based on the current economic climate and our cost cutting measures, there is no assurance that we will be
able to continue to obtain the level of bookings that we have had in the past and or fulfill our current backlog, and we may experience
contract cancellations, project scope reductions and project delays.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the quarter ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br />
    2019</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">March
    31,<br />
    2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">June
                                            30,<br />
                                            2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,<br />
    2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br />
    2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Backlog, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,143,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,558,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,875,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,198,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net bookings, current period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,134,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,127,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,601,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,241,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,637,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Recognized revenue,
    current period</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,719,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,810,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,682,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,635,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,387,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Backlog, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,558,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,875,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,198,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
has historically been the case at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition
of our backlog as of December 31, 2020. As of December 31, 2020, $2,643,000 of our backlog, or 31%, was attributable to customer contracts
for which we have only received an initial advance payment to cover our engineering services (&#8220;engineering only paid contracts&#8221;).
There are always risks that the equipment portion of our engineering only paid contracts will not be completed or will be delayed, which
could occur if the customer is dissatisfied with the quality or timeliness of our engineering services, there is a delay or abandonment
of the project due to the customer&#8217;s inability to obtain project financing or licensing, or the customer determines not to proceed
with the project due to economic factors, such as declining cannabis wholesale prices in the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have provided an estimate in our consolidated financial statements for when we expect to recognize revenue on our remaining performance
obligations (i.e., our Q4 2020 backlog), using separate time bands, with respect to engineering only paid contracts and partial equipment
paid contracts. However, there continues to be significant uncertainty regarding the timing of our recognition of revenue in our Q4 2020
backlog. Refer to the <i>Revenue Recognition</i> section of Note 2 in our consolidated financial statements, included as part of this
prospectus for additional information on our estimate of future revenue recognition on our remaining performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining
performance obligations will actually generate revenues or when the actual revenues will be generated. Net bookings and backlog are considered
non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures
for recognized revenue, deferred revenue and remaining performance obligations. Further, we can provide no assurance as to the profitability
of our contracts reflected in remaining performance obligations, backlog and net bookings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">This
discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which
have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies
are particularly important to the understanding of our financial position and results of operations and require the application of significant
judgment by our management or can be materially affected by changes from period to period in economic factors or conditions that are
outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management uses
their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are based
on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance
of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate.
Actual results could materially differ from those estimates. For information regarding our critical accounting policies as well as recent
accounting pronouncements, please see both Note 2 from our December 31, 2020 audited financial statements and Note 1
from our September 30, 2021 unaudited financial statements, respectively, included in the Index to Financial Statements section of this
prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">This
section includes a summary of our historical results of operations, followed by detailed comparisons of our results for (i) the
three months and the nine months ended September 30, 2021 and 2020 and (ii) the years ended December 31, 2020 and 2019. We have
derived this data from our interim and annual consolidated financial statements included elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Nine
Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
revenue for the nine months ended September 30, 2021 was $10.6 million compared to $5.1 million for the same period last year, an increase
of $5.5 million, or 106%. We had a net loss of $0.9 million for the nine months ended September 30, 2021 as compared to a net loss of
$1.8 million for the same period last year, a decrease of $0.9 million, or 49%. Our adjusted net loss for the nine months ended September
30, 2021 was $0.7 million compared to $1.4 million for the same period last year, an decrease of $0.7 million, or 52%. Adjusted net income
(loss), a Non-GAAP metric, is defined as our GAAP net income (loss) after adjustment for our non-cash equity compensation expenses, other
non-cash equity expense, debt-related items and depreciation expense. The table below reflects this calculation. We consider this a key
financial metric as we focus on achieving breakeven on better operating cash flow. The GAAP financial measures most directly comparable
to adjusted net income (loss) is the GAAP net income (loss).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the nine months ended September 30, 2021:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">(in thousands of
    US Dollars)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">GAAP Net Income
    (Loss):</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(936</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(1,822</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-Cash Add Backs:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock Based Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">227</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">354</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation
    &amp; Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Non-Cash Add-Backs:</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">276</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">440</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Adjusted Net Income
    (Loss):</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(660</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>$</b></span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>(1,382</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>)</b></span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenues
and Cost of Goods Sold</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue
for the nine months ended September 30, 2021 was $10,582,000, compared to $5,127,000 for the nine months ended September 30, 2020, representing
an increase of $5,455,000, or 106% due to strong bookings in the first quarter of 2021 along with a COVID-19-driven slowdown impacting
revenue for the nine months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue increased by $4,339,000, or 112%, from $3,870,000 for the nine months ended September 30, 2020 to $8,208,000 for the nine
months ended September 30, 2021 primarily due to the increase in revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
gross profit for the nine months ended September 30, 2021 was $2,374,000 compared to $1,257,000 for the nine months ended September 30,
2020, an increase of 89%. Gross profit margin decreased by two percentage points from 24.5% for the nine months ended September 30, 2020
to 22.4% for the nine months ended September 30, 2021 primarily due to an increase in variable costs as a percent of total revenue, offset
by a decrease in fixed costs as a percent of total revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing overhead)
totaled $1,032,000, or 10% of total revenue, for the nine months ended September 30, 2021 as compared to $864,000, or 17% of total revenue,
for the nine months ended September 30, 2020. The increase of $168,000 was due to an increase in salaries and benefits (including stock-based
compensation) of $174,000, offset by a decrease in fixed overhead of $6,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs) totaled
$7,177,000, or 68% of total revenue, in the nine months ended September 30, 2021 as compared to $3,006,000, or 59% of total revenue,
in the nine months ended September 30, 2020. The increase in variable costs was primarily due to higher equipment costs as a result of
higher revenue and a reduction in the selling price of our equipment resulting in lower equipment margins. Other factors included: (i)
an increase in warranty of $167,000 which was partially the result of a reimbursement in 2020 from a customer for costs incurred in 2019
related to a failure later deemed to be non-warranty, (ii) an increase in travel of $71,000, offset by (iii) a decrease in outside engineering
services of $65,000, (iv) a decrease in other variable costs of $29,000 related to project management consulting services incurred in
2020, (v) a $24,000 decrease in excess and obsolete inventory, and (vi) a decrease in shipping and handling of $9,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
continue to focus on gross margin improvement through a combination of, among other things, more disciplined pricing, better absorption
of our fixed costs as we convert our increased bookings into revenue, and the implementation over time of lower-cost supplier alternatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
expenses increased to $3,386,000 for the nine months ended September 30, 2021, from $3,092,000 for the nine months ended September 30,
2020, an increase of $294,000, or 10%. The operating expense increase consisted of: (i) an increase in advertising and marketing expenses
of $236,000, (ii) an increase in selling, general and administrative expenses (&#8220;SG&amp;A expenses&#8221;) of $40,000, and (iii)
an increase in product development expense of $19,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in marketing expenses was primarily due to (i) an increase in advertising and promotion expense of $98,000, (ii) an increase
in salaries and benefits (including stock compensation) of $86,000, (iii) an increase of $65,000 for expenses related to trade shows,
offset by (iv) a decrease in outside services and other marketing expenses of $11,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in SG&amp;A expenses for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was
due primarily to: (i) an increase of $148,000 for commissions, (ii) an increase in salaries, benefits and other employee related costs
of $107,000, (iii) an increase of $98,000 for investor relations expenses, (iv) an increase in facilities, office and other expenses
of $32,000, (v) an increase in business taxes, licenses and fees of $19,000, offset by (vi) a decrease of $204,000 in stock related compensation
expense to employees, consultants and directors, (vii) a decrease in bad debt of $70,000, (viii) a decrease of $37,000 for depreciation,
(ix) a decrease of $27,000 in accounting and other professional fees, and (x) a decrease in cash paid for directors&#8217; fees of $15,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in product development costs was due to an increase in materials costs of $35,000 offset by a decrease in salaries and benefits
(including stock compensation) of $17,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had operating loss of $1,012,000 for the nine months ended September 30, 2021, as compared to an operating loss of $1,835,000 for the
nine months ended September 30, 2020, a decrease of $822,000, or 45%. The operating loss for the nine months ended September 30, 2021
included $160,000 of non-cash, stock-based compensation and $49,000 of depreciation expense, compared to $354,000 of non-cash, stock-based
compensation and $86,000 of depreciation expense for the nine months ended September 30, 2020. Excluding these non-cash items, our operating
loss decreased by $591,000, or 42%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Other
Income (Expense)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had other income (net) of $76,000 for the nine months ended September 30, 2021 compared to other income (net) of $12,000 for the nine
months ended September 30, 2020. Other income for the nine months ended September 30, 2021 primarily consisted of income of $138,000
related to the Employee Retention Credit as part of the CARES act, $48,000 for rental income from the sub-lease of a portion of our facility,
offset by $107,000 in expense related to the settlement of litigation with a former employee and $3,000 for interest expense. Other income
for the nine months ended September 30, 2020 consisted of approximately $24,000 in storage fees charged to a customer due to the delay
of their project, offset by interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Net
Income (Loss)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overall,
we had net loss of $936,000 for the nine months ended September 30, 2021 as compared to a net loss of $1,822,000 for the nine months
ended September 30, 2020, a decrease of $886,000, or 49%. The net loss for the nine months ended September 30, 2021 included $160,000
of non-cash, stock-based compensation, $67,000 of other stock-based expense (related to the settlement of litigation with a former employee),
and $49,000 of depreciation expense, compared to $354,000 of non-cash, stock-based compensation and $86,000 of depreciation expense for
the nine months ended September 30, 2020. Excluding these non-cash items, our net loss decreased by $722,000, or 52%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Bookings, Backlog and Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three months ended September 30, 2021, we executed new sales contracts with a total contract value of $5,693,000. During this same
period, we had positive change orders of $395,000 and cancellations of $488,000. The cancellations were based on discussions with customers
who have abandoned their projects. After adjustments for these change orders and cancellations, our net bookings in the three months
ended September 30, 2021 were $5,600,000, representing an increase of $4,680,000 (or 509%) from net bookings of $919,000 in the second
quarter of 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
backlog at September 30, 2021 was $9,881,000, an increase of $1,894,000, or 24%, from June 30, 2021. The increase in backlog is the result
of our higher net bookings in the third quarter. Our backlog at September 30, 2021 includes booked sales orders of $1,250,000 (13% of
the total backlog) from several customers that we do not expect to be realized until late 2022. We believe the sales orders in this portion
of our backlog have an elevated level of risk and may, ultimately, be delayed or cancelled by our customers. Therefore, investors should
not view backlog as earned revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have
received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the
period for which we received an initial deposit, net of any adjustments including cancelations and change orders during the period),
(iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings,
less recognized revenue).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="18" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the quarter ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,<br />
    2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,<br />
    2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">March
    31,<br />
    2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June
    30,<br />
    2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,<br />
    2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Backlog, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,198,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,578,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,987,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net bookings, current period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,241,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,637,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,497,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">919,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,600,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Recognized revenue, current period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,635,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,387,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,367,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,706,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Backlog, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,198,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,578,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,987,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,881,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
completion of a customer&#8217;s <i>new</i> build facility project is dependent upon the customer&#8217;s ability to secure funding and
real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the
time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven
by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;
(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where
there is no cap on the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed,
and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate
control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system;
(vii) the availability of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue
recognition of our backlog as of September 30, 2021. As of September 30, 2021, 12% of our backlog was attributable to customer contracts
for which we have only received an initial advance payment to cover our engineering services (&#8220;engineering only paid contracts&#8221;).
There are always risks that the equipment portion of our engineering only paid contracts will not be completed or will be delayed, which
could occur if the customer is dissatisfied with the quality or timeliness of our engineering services, there is a delay or abandonment
of the project due to the customer&#8217;s inability to obtain project financing or licensing, or the customer determines not to proceed
with the project due to economic factors, such as declining cannabis wholesale prices in the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
contrast, after the customer has made an advance payment for a portion of the equipment to be delivered under the contract (&#8220;partial
equipment paid contracts&#8221;), we typically are better able to estimate the timing of revenue recognition since the risks and delays
associated with licensing, permitting and project funding are typically mitigated once the initial equipment payment is received. As
of September 30, 2021, 88% of our backlog was attributable to partial equipment paid contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining
performance obligations (i.e., our Q3 2021 backlog), using separate time bands, with respect to engineering only paid contracts and partial
equipment paid contracts. There continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q3
2021 backlog. Refer to the <i>Revenue Recognition</i> section of <i>Note 1</i> in our condensed consolidated financial statements, included
as part of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance
obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining
performance obligations will generate revenues or when the revenues will be generated. Net bookings and backlog are considered non-GAAP
financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures for recognized
revenue, deferred revenue and remaining performance obligations. Further, we can provide no assurance as to the profitability of our
contracts reflected in remaining performance obligations, backlog and net bookings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
Condition, Liquidity and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, we had cash and cash equivalents of $2,284,000, compared to cash and cash equivalents of $2,285,000 as of December
31, 2020, a nominal decrease. The $1,000 decrease in cash and cash equivalents during the nine months ended September 30, 2021, was primarily
the result of cash used in our operating activities of $1,761,000, offset by proceeds from the sale of Series B preferred stock and warrants
(net of issuance costs) of $1,260,000 via a financing concluded in September 2021 and proceeds from a note payable of $514,000. Our cash
is held in bank depository accounts in certain financial institutions. During the nine months ended September 30, 2021, we held deposits
in financial institutions that exceeded the federally insured amount. During the nine months ended September 30, 2021, the Company transferred
a balance of $180,000 into a new bank account which was to be used for the sole purpose of paying certain warranty claims. The balance
on this restricted bank account as of September 30, 2021 was $0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, we had accounts receivable (net of allowance for doubtful accounts) of $32,000, inventory (net of excess and obsolete
allowance) of $480,000, and prepaid expenses of $1,143,000 (including $879,000 in advance payments on inventory purchases). While we
typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions
requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded
on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we continue
to pursue larger projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, we had total accounts payable and accrued expenses of $1,674,000, deferred revenue of $3,060,000, accrued equity
compensation of $109,000, other current liabilities of $37,000 and the current portion of operating lease liability of $238,000. As of
September 30, 2021, we had a working capital deficit of $1,164,000, compared to a working capital deficit of $2,220,000 as of December
31, 2020. The decrease in our working capital deficit was primarily related to (i) a decrease in deferred revenue of $665,000, (ii) an
increase in inventory of $153,000, (iii) a decrease in accounts payable and accrued liabilities of $110,000, and (iv) an increase in
prepaid expenses of $106,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future
earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Summary
of Cash Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following summarizes our approximate cash flows for the nine months ended September 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Nine Months Ended September 30,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;Net cash used in operating
    activities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,761,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">600,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;Net cash used in investing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(14,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Net cash provided
    by financing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,774,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">554,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Net decrease in
    cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,150,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
incurred a net loss for the nine months ended September 30, 2021 of $936,000 and have an accumulated deficit of $28,380,000 as of September
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cash
used in operations for the nine months ended September 30, 2021 was $1,761,000 compared to cash provided by operations of $600,000 for
the nine months ended September 30, 2020, an increase in cash usage of $2,361,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
increase in cash used in operating activities during the nine months ended September 30, 2021 was primarily attributable to: (i) a decrease
in cash used to fund working capital of $3,087,000, (ii) a decrease in net loss of $886,000, and (iii) a decrease of $160,000 in non-cash
operating charges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
significant changes in working capital related to: (i) a decrease in deferred revenue (which represents cash received from customers
in advance of the performance of services or the delivery of equipment) of $665,000, (ii) an increase in inventory of $153,000, (iii)
a decrease in accounts payable and accrued liabilities of $111,000, and (iv) an increase in prepaid expenses of $106,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
significant change in non-cash operating charges was due to (i) a decrease in share-based compensation of $202,000, (ii) a decrease in
depreciation and amortization expense of $36,000, and (iii) an increase in other share-based compensation of $67,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
$14,000 cash used in investing activities during the nine months ended September 30, 2021 was related to the purchase of property and
equipment of $15,000, offset by proceeds from the sale of property equipment of $1,000. Cash used in investing activities during the
nine months ended September 30, 2020 was related to the purchase of property and equipment of $4,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cash
flows from financing activities during the nine months ended September 30, 2021, was the result of cash proceeds from the sale of preferred
stock and warrant (net of issuance costs) of $1,260,000. Additionally, the Company entered into a note payable with its current bank
in the principal amount of $514,000, for working capital purposes. During the nine months ended September 30, 2020, the Company entered
into a note payable with its current bank in the principal amount of $554,000, for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
B Preferred Stock Financing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, Surna Inc. (the &#8220;Company&#8221;) sold to an institutional investor (the &#8220;Investor&#8221;), 3,300 shares
of Series B Convertible Preferred Stock, stated value $1,000 per share, currently convertible into 385,964 shares of common stock,
and a warrant to purchase up to 192,982 shares of common stock (&#8220;Investor Warrant&#8221;), for an aggregate purchase price
of $3,000,000 (&#8220;Consideration&#8221;). The Company received net proceeds of approximately $2,625,000, paid in two closings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Stock has an annual dividend of 8% and has an initial common stock conversion price of $8.55. The conversion
rate is subject to adjustment in various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental
transactions and upon a triggering event and subject to reset if the common stock of the Company sold in any subsequent equity transaction,
including a qualified offering, is sold at a price below the then conversion price. The Series B Preferred Stock is mandatorily convertible
on the third anniversary of its issuance. All conversions of the Series B Preferred Stock are subject to a blocker provision of 4.99%.
The Company will reserve 200% of the number of shares of common stock into which the Series B Preferred Stock and Investor Warrant may
be converted or exercised. On January 28,<sup> </sup> 2022, we agreed with the Series B investor to redeem 1,650 shares of our Series
B Preferred Stock for approximately $2.0 million following the closing of this offering, and at the completion of the offering, the Series
B investor will convert its remaining 1,650 shares of Series B Preferred Stock, plus accrued and unpaid dividends into the securities
being offered hereby, at a rate equal to 75% of the public offering price. The securities being issued to the Series B investor will
be subject to a 90 day lock-up.</span></p>

<p style="margin: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Stock agreements had several covenants to be performed by the Company, including to increase the authorized
capital of the Company, increase the reservation of shares of common stock to cover any conversions of the loan amount and exercise of
the warrants, and redeem the Class A Preferred Stock. On November 3, 2021, filed an amendment to its articles of incorporation increasing
the authorized capital to one billion shares of capital stock, of which 850,000,000 are designated as common stock and 150,000,000 are
designated as preferred stock. Also on November 3, 2021, we were authorized to redeem the outstanding Series A Preferred Stock, which
was completed on November 4, 2021. The Company also increased the number of shares reserved for conversion and exercise of the investor&#8217;s
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor was granted a right of participation in future private offerings and has agreed to a 90 day lock-up in connection
with a qualified offering. A &#8220;qualified offering&#8221; is the first public offering after the sale of the Series B Preferred
Stock in which the common stock of the Company is listed on a national exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor Warrant may be exercised until September 28, 2024, at an initial exercise price of $9.45, subject to adjustment. The
Investor Warrant provides for cashless exercise if the underlying shares of common stock are not registered for resale, and all issuances
of common stock upon exercise are subject to a 4.99% blocker provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company granted the Investor registration rights for the shares of common stock underlying the Series B Preferred Stock and the Investor
Warrants. The Company must file a registration statement no later than 180 days after the date of a qualified offering and have it effective
in 45 days if there is no Securities and Exchange Commission (&#8220;SEC&#8221;) review, or if there is a review, within 75 days. The
Company must keep the registration statement effective until all the shares registered have been sold or may be sold under Rule 144,
without regard to volume and holding period restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged ThinkEquity LLC (&#8220;ThinkEquity&#8221;) as its placement agent and paid a total cash fee of 9%, or $270,000, and
its expenses, less prepaid expenses, and issued to ThinkEquity and its designees a warrant to purchase up to an aggregate of 34,737
shares of common stock. The exercise price of the warrant initially will be $10.40 per share, subject to typical adjustment
provisions, and exercisable for a term of three years. The warrant has registration rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Comparison
of Years ended December 31, 2020 and 2019</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
revenue for the year ended December 31, 2020 was $8,514,000 compared to $15,224,000 for the year ended December 31, 2019, a decrease
of $6,710,000, or 44%. Overall, we had a net loss of $1,759,000 for the year ended December 31, 2020 as compared to a net loss of $1,339,000
for the year ended December 31, 2019, an increase of $420,000, or 31%. Our 2020 adjusted net loss was $1,239,000 compared to a 2019 adjusted
net income of $92,000. Our adjusted net income (loss) is our GAAP net income (loss) after addback for our non-cash equity compensation
expenses, debt-related items and depreciation expense. Historically, one of the most significant financial challenges we face is the
inconsistent and unpredictable revenue we generate quarter-over-quarter, and our revenue and cash flow remain difficult to predict.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenues
and Cost of Goods Sold</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue
for the year ended December 31, 2020 was $8,514,000 compared to $15,224,000 for the year ended December 31, 2019, a decrease of $6,710,000,
or 44%. This revenue decrease was partly the result of our decreased net bookings in 2020, which fell from $16,300,000 in 2019 to $7,405,000
in 2020, or 55%. We remain unable to consistently convert our backlog into revenue on a quarter-over-quarter basis. Our revenue conversion
is largely dependent on customer-centric factors&#8212;outside of our control&#8212;such as industry uncertainty, project financing concerns,
the licensing and qualification of our prospective customers, and other reasons such as a challenging business climate including an overall
post-COVID-19 economic downturn, which makes it difficult for us to predict when we will recognize revenue on our backlog.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of revenue decreased by $3,714,000 from $10,676,000 for the year ended December 31, 2019 to $6,961,000 for the year ended December 31,
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
gross profit for the year ended December 31, 2020 was $1,553,000 compared to $4,549,000 for the year ended December 31, 2019. Gross profit
margin decreased by approximately twelve percentage points from 29.9% for the year ended December 31, 2019 to 18.2% for the year ended
December 31, 2020. This decrease was primarily due to our fixed cost base, a lower margin on equipment sales, and an increase in variable
costs as a percent of revenue as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
revenue cost structure is comprised of both fixed and variable components. The fixed cost component represents engineering, manufacturing
and project management salaries and benefits and manufacturing overhead that totaled $1,167,000, or 13.7% of total revenue, for the year
ended December 31, 2020 as compared to $1,426,000, or 9.4% of total revenue, for the year ended December 31, 2019. The decrease of $259,000
was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $277,000, offset by an increase of $18,000
in fixed overhead. The variable cost component, which represents our cost of equipment, outside engineering costs, shipping and handling,
travel and warranty costs, totaled $5,795,000, or 68.1% of total revenue, in the year ended December 31, 2020 as compared to $9,250,000,
or 60.8% of total revenue, in the year ended December 31, 2019. In the year ended December 31, 2020 as compared to the prior year, our
cost of equipment decreased by $3,331,000 primarily due to the decrease in revenue and a decrease in our equipment margin of 3.5 percentage
points. Additionally in the year ended December 31, 2020 as compared to the year ended December 31, 2019: (i) our warranty costs increased
by $144,000, (ii) our excess and obsolete inventory and other variable overheads increased by $45,000, which were offset by (iii) a reduction
in outside engineering costs of $156,000, (iv) a reduction in shipping and handling costs of $89,000 and, (v) decreased travel of $69,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Expenses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
expenses decreased by 33% from $5,859,000 for the year ended December 31, 2019 to $3,916,000 for the year ended December 31, 2020, a
decrease of $1,944,000. The operating expense decrease consisted primarily of: (i) a decrease in selling, general and administrative
expenses (&#8220;SG&amp;A expenses&#8221;) of $1,567,000, (ii) a decrease in advertising and marketing expenses of $246,000 and, (iii)
a decrease in product development expenses of $131,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
decrease in SG&amp;A expenses for the year ended December 31, 2020 compared to the year ended December 31, 2019, was due primarily to:
(i) a decrease of $762,000 in stock-based compensation, (ii) a decrease of $191,000 in commissions, (iii) a decrease in travel of $122,000,
(iv) a decrease of $138,000 in accounting and other professional fees, (v) a decrease of $111,000 in loss on asset disposal, (vi) a decrease
of $69,000 in board fees, (vii) a decrease of $57,000 in salaries, benefits and other employee related costs, (viii) a decrease of $44,000
in bad debt expense, (ix) a decrease in depreciation of $40,000, (x) a decrease of $17,000 in facilities, insurance and office supplies
and, (xi) a decrease in investor relations costs of $15,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
decrease in marketing expenses were due primarily to: (i) a decrease of $205,000 for industry trade shows and events, (ii) a decrease
in stock-based compensation of $26,000, (iii) a decrease of $17,000 in travel, (iv) a decrease of $15,000 in collateral and other marketing
expenses, offset by (v) an increase of $20,000 for web development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
decrease in product development costs was due to (i) a decrease in materials costs of $88,000, (ii) a decrease in stock-based compensation
of $23,000, (iii) a decrease in salaries and benefits of $12,000 and, (iv) a decrease in travel of $7,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Operating
Loss</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
had an operating loss of $2,363,000 for the year ended December 31, 2020, as compared to an operating loss of $1,311,000 for the year
ended December 31, 2019, an increase of $1,052,000, or 80%. The operating loss included $406,000 of non-cash, stock-based compensation
expenses and $114,000 for depreciation and amortization in the year ended December 31, 2020 as compared to $1,277,000 for stock-based
compensation and $154,000 of depreciation and amortization for the year ended December 31, 2019. Excluding these non-cash items, our
operating loss increased by $1,964,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Other
Income (Expense)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
other income (net) increased by $632,000 from other expense (net) of $28,000 for the year ended December 31, 2019 to other income (net)
of $604,000 for the year ended December 31, 2020. This change is primarily due to loan forgiveness of $557,000 and income from a legal
judgement of $35,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Net
Loss</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overall,
we had a net loss of $1,759,000 for the year ended December 31, 2020 as compared to a net loss of $1,339,000 for the year ended December
31, 2019, an increase of $420,000. The net loss included $406,000 of non-cash, stock-based compensation costs and depreciation and amortization
expense of $114,000 in the year ended December 31, 2020 as compared to non-cash, stock-based compensation expense of $1,277,000 and depreciation
and amortization of $154,000 in the year ended December 31, 2019. Excluding these non-cash items, our net loss increased by $1,332,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Liquidity,
Capital Resources and Financial Position</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we had cash and cash equivalents of $2,285,000, compared to cash and cash equivalents of $922,000 as of December
31, 2019, an increase of 148%. The $1,363,000 increase in cash and cash equivalents during the year ended December 31, 2020 was primarily
the result of cash provided by our operating and financing activities. Our cash is held in bank depository accounts in certain financial
institutions. We currently have deposits in financial institutions that exceed the federally insured amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we had accounts receivable (net of allowance for doubtful accounts) of $33,000, inventory (net of excess and obsolete
allowance) of $327,000, and prepaid expenses and other of $1,038,000 (including $916,000 in advance payments on inventory purchases).
While we typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions
requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded
on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we pursue
larger projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, we had no indebtedness, total accounts payable and accrued liabilities of $1,785,000, deferred revenue of $3,724,000,
accrued equity compensation of $128,000, and the current portion of operating lease liability of $266,000. As of December 31, 2020, we
had a working capital deficit of $2,220,000, compared to a working capital deficit of $1,437,000 as of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future
earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Because
of the economic situation that developed during 2020, we cannot predict the continuing level of working capital that we will have in
the future. Additionally, we cannot predict that our future financial position will not deteriorate due to cancelled or delayed contract
fulfillment, reduced sales and our ability to perform our contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Summary
of Cash Flows</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following summarizes our cash flows for the years ended December 31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                            the Years Ended<br />
                                            December 31,</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by operating
    activities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">818,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">672,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash used in investing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by
    financing activities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">554,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net increase in cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,363,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">669,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
incurred a net loss for the year ended December 31, 2020 of $1,759,000 compared to a net loss for the year ended December 31, 2019 of
$1,339,000. We had an accumulated deficit of $27,444,000 as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cash
provided by operations for the year ended December 31, 2020 was $818,000 compared to cash provided by operations of $672,000 for the
year ended December 31, 2019, an increase of $146,000. The increase was primarily attributable to: (i) an increase in cash from working
capital of $1,370,000, offset by, (ii) a decrease in non-cash operating charges of $804,000, and (iii) an increase in net loss of $420,000.
Significant non-cash items included: (i) a gain on note payable forgiveness of $557,000, (ii) stock-related compensation of $277,000,
(iii) $190,000 for amortization of ROU asset, and (iv) depreciation and amortization expense of $120,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cash
used in investing activities for the year ended December 31, 2020 was $9,000, compared to cash used in investing activities of $3,000
for the year ended December 31, 2019. The change related to purchases of property and equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, cash from financing activities was $554,000 and $0, respectively. The cash from financing
activities was the result of a loan received from our bank on April 22, 2020 which was subsequently forgiven on December 11, 2020. <i>See
Note 9 &#8211; Note Payable and Accrued Interest</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
consolidated financial statements for the year ended December 31, 2020, have been presented on a going concern basis, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business. Our independent registered public accounting
firm included in its audit opinion on our consolidated financial statements for the year ended December 31, 2020, a statement that there
is substantial doubt as to our ability to continue as a going concern, and our consolidated financial statements for the year ended December
31, 2020 were prepared assuming that we would continue as a going concern. We have determined that our ability to continue as a going
concern is dependent on raising additional capital to fund our operations and ultimately on generating future profitable operations.
There can be no assurance that we will be able to raise sufficient additional capital or eventually have positive cash flow from operations
to address all of our cash flow needs. If we are not able to generate positive cash flow from operations or find alternative sources
of cash, our business and shareholders will be materially and adversely affected. The foregoing factors raise substantial doubt about
our ability to continue as a going concern for a period of one year from the date our condensed consolidated financial statements for
the year ended December 31, 2020, are issued. Our condensed consolidated financial statements do not include any adjustment that might
result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions,
its customers&#8217; operations and prospects for and ability to obtain project financing, and market and business disruptions, that
include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding of products; uncertainty
of product development and generation of revenues; dependence on outside sources of financing; risks associated with research, development;
dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized
companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing
to fulfill its development activities and generating a level of revenues adequate to support the Company&#8217;s cost structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced, or are
contemplating, new or expanded cultivation facilities and the overall impact of the Covid-19 pandemic. The extent to which COVID-19 will
impact the Company&#8217;s business and financial results will depend on future developments, which are uncertain and cannot be predicted.
See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal year 2020 measures of adjusting
the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet management&#8217;s expectations, or additional
capital is not available, there is substantial doubt about the Company&#8217;s ability to continue as a going concern. Other factors
that will impact the Company&#8217;s ability to continue operations include the market demand for the Company&#8217;s products and services,
the ability to service its customers and prospects, potential contract cancellations, project scope reductions and project delays, the
Company&#8217;s ability to fulfill its backlog, the management of working capital, and the continuation of normal payment terms and conditions
for purchase of the Company&#8217;s products. The Company believes its cash balances and cash flow from operations will be insufficient
to fund its operations for the next twelve months. If the Company is unable to increase revenues, or otherwise generate cash flows from
operations, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of one year from
the date the financial statements are issued. These consolidated financial statements do not include any adjustment that might result
from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Capital
Raising</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Without
the proceeds from this offering, we believe our cash balances and cash flow from operations will be insufficient to fund our operations
for the next 12 months. If we are unable to increase revenues or otherwise generate cash flows from operations, we will need to raise
additional funding to continue as a going concern. Based on management&#8217;s estimate for our operational cash requirements, during
the first quarter of 2020, we took steps to downsize and reorient our operations to reduce costs. We will need to obtain financing in
order to continue our operations and achieve our growth strategies. There can be no assurance that we will be able to raise the necessary
financing, when and if needed, on acceptable terms or at all. If our operating results do not meet management&#8217;s expectations, or
additional capital is not available, management believes it can downsize or reorient operations to reduce certain expenditures. The precise
amount and timing of our financing needs cannot be determined accurately at this time, and will depend on a number of factors, including
the market demand for our products and services, management of working capital, and continuation of normal payment terms and conditions
for purchase of our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&#8217;s ability to raise equity capital is also limited by the Company&#8217;s stock price, and any such
issuance could be highly dilutive to existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Inflation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, inflation has not had a material effect on our operations to date. However, it is possible that
inflation will have an impact going forward. .It is too early to determine if the impact from inflation will be material.
Management will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Contractual
Payment Obligations </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Refer
to Note 4 &#8211; <i>Leases </i>of our consolidated financial statements, which are included as part of this prospectus for the further
details on our obligations under a lease for our manufacturing and office space.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Commitments
and Contingencies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 45,000 restricted stock units that had not been settled due to a dispute with a former employee
over the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced
an arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
45,000 shares of the Company&#8217;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $10,000 in the Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $33,985, with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee is continuing to pursue separate litigation against the Company for recovery
of alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of our operations, we are subject to litigation matters and claims. Litigation can be expensive and
disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict and our view of
these matters may change in the future as the litigation and events related thereto unfold. An unfavorable outcome to any legal matter,
if material, could have an adverse effect on our operations or our financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, we may provide indemnifications of varying scope and terms to customers, vendors, lessors, business
partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of our breach of such
agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. In addition, we have
entered into indemnification agreements with our directors and certain of our officers and employees that will require us to, among other
things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees.
We maintain director and officer insurance, which may cover certain liabilities arising from our obligation to indemnify our directors
and certain of our officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Off-Balance
Sheet Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on
our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures,
or capital resources that are material to investors. As of December 31, 2020, we had no off-balance sheet arrangements. During 2020 and
2019, we did not engage in any off-balance sheet financing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ajz_012"></span>BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>History</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
were founded as Hydro Innovations in Texas in 2006 by cultivators to provide environmental control equipment to indoor cultivation facilities.
The Company moved to Colorado in 2013 and was merged into a Nevada corporation named Surna Inc. in 2014. It then began trading on the
OTCQB exchange as SRNA until the Company&#8217;s name was changed to CEA Industries Inc. in November of 2021, when its trading symbol
was changed to CEAD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Since
its inception, CEA Industries has been operating in the indoor agricultural sector, having served over 800 indoor cultivators with various
products and services and having provided environmental control engineering and equipment to over 200 commercial cultivation facilities.
We have licensed professional mechanical engineers on our staff and we can stamp drawings in any state or province. We believe we are
the oldest and most experienced firm serving this market. Our business has historically been in the U.S. and Canada, although we have
served several facilities outside North America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
website is <span style="text-decoration: underline">www.ceaindustries.com,</span> which contains a description of our Company and products. In addition, we also maintain
a branded technology product website at <span style="text-decoration: underline">www.surna.com</span>. These websites and the information contained on the websites are
not part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is an industry leader in CEA (Controlled Environment Agriculture) facility design, technologies, and services. The CEA industry
is one of the fastest-growing sectors of the United States&#8217; economy and is defined by type of facility. The CEA industry is composed
of any horticultural facility that is fully self-contained and has a controlled environment. Three facility types meet these criteria:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;&#160;&#160;&#160;Indoor
facilities</span><span style="font: 10pt Times New Roman, Times, Serif"> &#8211; environmentally sealed facilities for growing crops
and that require artificial lighting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;&#160;&#160;&#160;Vertical
farms</span><span style="font: 10pt Times New Roman, Times, Serif"> &#8211; a cultivation facility that is oriented vertically to
minimize ground square footage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;&#160;&#160;&#160;Greenhouses
</span><span style="font: 10pt Times New Roman, Times, Serif">&#8211; facilities that are made of translucent materials to use natural
sunlight on the crops.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Crops
grown in CEA facilities include: leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true
leaf stage), ethnic vegetables, ornamentals and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers,
tomatoes and cannabis and hemp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
provide full-service licensed architectural and mechanical, electrical, and plumbing (MEP) engineering services, carefully curated HVACD
equipment, proprietary controls systems, lighting, and benching and racking products. Our team of project managers, licensed professional
architects and engineers, technology and horticulture specialists and systems integrations experts help our customers by precisely designing
for their unique applications. Through our partnership with a certified service contractor network we provide maintenance services to
assist in a smooth build-out and ensure optimal facility performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
leverage our industry-leading experience to bring value-added solutions to our customers that help improve their overall crop quality
and yield, optimize energy and water efficiency, and satisfy evolving state and local construction codes, permitting and regulatory requirements.
Our revenue stream derives primarily from supplying our products, services and technologies to commercial indoor facilities ranging from
several thousand to more than 100,000 square feet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
CEA facility operators are facing multiple headwinds of high energy costs, issues about water usage and waste materials, and, in the
case of cannabis growing, increasingly rigorous quality standards and declining cannabis prices. To be competitive, among other things,
our customers must develop innovative ways to meet the demands of their business and reduce energy costs, 90% of which is typically related
to their HVACD (50%) and lighting systems (40%). HVACD systems have historically been our primary area of expertise. We often have the
advantage of early engagement with our customers at the pre-build and construction phases and the corresponding opportunity to build
longer-term relationships with our existing customers and their facilities. Going forward, our plan is to leverage our existing customer
relationships and attempt to sell them additional products and services, thereby becoming &#8220;stickier&#8221; to our customers, in
an effort to generate incremental revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have three core assets that we believe are important to our going-forward business strategy and that will contribute to our future growth.
First, we have a well-known brand name in the industry along with multi-year relationships with customers and others developed over our
fifteen years of service to the industry. This length of service and broad network of industry contacts will benefit not only our organic
growth initiatives, but also provides us with unique insight into other industry providers who may be appropriate for acquisition or
joint efforts. Second, we have unique and specialized engineering know-how and experience gathered from designing environmental control
systems for over 200 commercial CEA cultivation facilities. Third, we have an expanding line of proprietary and curated environmental
control systems and other products that are needed to build a CEA facility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>The
CEA Industry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">According
to leading market research firms like Headset and New Frontier Data, the North American cannabis industry is expected to experience compound
annual growth on the order of 20%-25% over the foreseeable future. More U.S. states are legalizing either medical or recreational use
of cannabis products, and sometimes both. Although the market is well aware of how the cannabis sector is growing, it seems to be less
aware of the non-cannabis CEA market, particularly the vertical farming segment which is growing nearly as fast as the cannabis market.
Since the technical infrastructure and requirements for growing any plant in a controlled environment are similar, we believe we can
bring our engineering expertise to this adjacent high growth market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Services and Equipment Solutions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
goal is to develop relationships with our prospects and customers that will afford us the opportunity to provide comprehensive services
and equipment for the complete lifecycle of indoor agriculture facilities. This lifecycle includes planning the business and the facility,
designing and engineering the facility, providing the many required infrastructure technologies, advising on and insuring proper installation
of the technologies, providing training and start-up support, and ultimately providing preventative and other ongoing services for insuring
proper maintenance and operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font: 10pt Times New Roman, Times, Serif">We
provide a comprehensive range of services and products as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Service
    Solutions</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Facility
    Design</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Licensed
    Architectural design, including space and operational planning</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Licensed
    Mechanical, Electrical, and Plumbing (MEP) engineering, including equipment layout and workflow</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Assessing
    equipment options based on facility requirements</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Specifying/recommending
    equipment for each facility</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment
    Selection and Specifying</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identifying,
    assessing and selecting equipment vendors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment
    Installation Advisory</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advising
    contractors to insure proper cultivation equipment installation</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Start-up
    Services</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Initial
    equipment start-up</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operator
    training</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lifecycle
    Services</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Preventative
    Maintenance Services (Subscription)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Product
    Solutions</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Proprietary,
    white-label environmental control products</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Proprietary
    Facility Control System</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">VAR
    of Cultivation and Environmental Control Products</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Service
Solutions: Facility Design Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
licensed architectural services provide facility design and layout to include space and workflow optimization. Our extensive experience
with CEA facilities brings extra value to our customers as we advise them on the design of their facility to maximize its productivity
and ROI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have professional engineers (PEs) on our staff to provide licensed, professional Mechanical, Electrical, and Plumbing (MEP) engineering
services to all non-cannabis customers, and to those customers in the cannabis growing industry that are in cannabis-legal states and
provinces. Our engineers perform mechanical engineering and we outsource electrical and plumbing engineering to several vendors with
whom we have long-term, trusted relationships. We believe we are the most experienced engineering firm serving the cannabis growing CEA
industry and we have leading edge, sophisticated engineering capabilities. We provide these services to facilities from several thousand
to over 100,000 square feet in size. Over time the size and sophistication of projects we have served has grown increasingly large, a
trend which we expect will continue as the industry builds ever larger facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
licensed MEP engineering services provide stamped drawings that our customers need to obtain building permits and to build their facilities
and specify equipment, and we can provide these services in any state or province. Our technical experience and know-how in engineering
indoor cultivation facilities allow us to deliver to our customers practical solutions to complicated problems in four primary areas:
(i) precision climate and environmental controls, (ii) energy and water efficiency, (iii) building code and permitting, and (iv) construction
support services and start-up of their environmental control equipment. Our engineering design typically includes all mechanical components
of a climate control system: cooling and heating, dehumidification, ventilation, air sanitation, and odor control. We provide load calculations,
equipment specifications, and engineered systems drawings for both the cultivation and comfort cooling portions of our customers&#8217;
facilities. We also have experience in, or knowledge of, state and local permitting and code compliance for facilities in states and
provinces where cannabis has been legalized for either recreational or medical use or is expected to be legalized, and we provide stamped,
engineered drawings in all states and provinces where we operate. We provide a drawing package to our customers that allows them to obtain
a building permit that is code compliant, identifies construction materials and alternates, and provides construction administration
information for their general and sub-contractors to follow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Service
Solutions: Equipment Selection and Specifying</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
goal as engineers is to identify the best technical solutions in the market and to offer a curated range of technologies to our customers
to best meet the needs of their facilities. Our engineers assess each facility&#8217;s requirements and recommend the best equipment
options for the customer. Our product development and R&amp;D groups search the market for the best technical solutions to offer our
customers. We offer a wide range of the best products in the market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Service
Solutions: Equipment Installation Advisory</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
do not offer construction services or perform equipment installation. Typically, a facility owner hires a general contractor (GC) to
manage the project, and the GC hires sub-contractors in specific trades to conduct the installation of each sub-system, such as environmental
control equipment. Our role in the construction process is to work with the GC and sub-contractors to provide the equipment that the
customer has ordered at the required time and place. Then, during the construction process, our technical services employees are available
to advise the construction contractors, and we conduct multiple site visits to insure the quality of the installation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Service
Solutions: Start-up Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">After
construction is completed our technical services employees will be on-site to inspect the installation and to conduct startup of the
systems that we have provided. We provide complete operator training for the facility personnel. After the facility is up and running,
we provide support as needed to include site visits and to insure that the facility is operating to its design specifications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Service
Solutions: Lifecycle Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">CEA
facilities are technically sophisticated and require multiple sub-systems, including: environmental control, lighting, CO<sub>2</sub>
dosing and control, water conditioning and reclamation, and fertigation/irrigation. We believe that facility operators will eventually
want to focus on their core business of growing plants and not be distracted by the unrelated, but necessary and technical, work of maintaining
these mission-critical sub-systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the summer of 2021, we developed and began selling preventive maintenance (PM) services to meet this demand from our existing clients.
Sold on a recurring subscription basis to existing cultivation facilities, the PM services are sold by us and are provided by third-party
service companies located near the customer&#8217;s facility. We have developed a network of service companies who can provide this service
across most of the geography where our customers and prospects are located. The PM services product is important for our business for
three primary reasons: first, it provides recurring revenue. Second, it establishes a long-term relationship with the customer. Third,
it offers the opportunity to be sold independently of our existing engineering offering and to any of the several thousand existing cultivation
facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Product
Solutions.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have historically been a provider of HVACD engineering and systems, and since 2019 we have broadened our product lines and now offer
a wide range of products and infrastructure technologies. Because many different technologies are required to operate an indoor cultivation
facility, our product strategy is to offer both proprietary (Surna Cultivation Technologies branded) and off the shelf products. Our
proprietary products are made by vendors on a contract manufacturing basis to our specifications. We offer a curated selection of products
and specify those that best meet the needs of our customer&#8217;s particular applications. Our product solutions can be divided into
three categories.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Solutions: White-label environmental control product</i></b><i>s</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Environmental
Control Systems. We offer a broad range of HVACD technologies, to include modular chilled water systems, custom air handling units, split
systems, packaged roof-top units, and self-contained and complex water chilled systems. We sell our proprietary products under the brand
names Surna, IsoStream, EnviroPro, EcoChill, StrataAir and SentryIQ. We have a national accounts relationship with Trane and we resell
their chillers under a joint label agreement. During 2019, we launched upgraded, white-labeled equipment lines of fan coils and air handlers.
In 2020 we introduced our first DX-based packaged systems. We offer various configurations of our Surna-branded fan coil units, which
provide greater efficiency, design flexibility and control for growers using modular chilled water systems. This expanded product line
allows us to serve customers across a wide range of application and budget requirements. We have chosen to offer white-label products
for two reasons. First, we can design the products to our own specifications, using our accumulated knowledge to develop products that
meet the particular and demanding challenges of indoor agriculture. Second, we can maintain better product margins by offering products
that are proprietary to us and are not otherwise available to potential competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Solutions: Proprietary Facility Control System</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Sensing
and Control Systems. In 2018 we began to develop, and in 2019 began to offer, a branded, proprietary controls and monitoring system (consisting
of sensors, controllers, software, monitoring and a user interface). Branded as SentryIQ&#174;, it is a sensors, controls and automation
(&#8220;SCA&#8221;) platform&#8212;a turnkey, single-vendor HVACD equipment and controls integration solution to new build projects as
well as existing facilities in the startup and operation phases. We have continued the rollout of SentryIQ&#174; and to date we have entered
into seventeen contracts to implement our SentryIQ&#174; SCA platform. This product line is important for tactical and strategic reasons,
and we hope to offer this as a standalone offering in the future. SentryIQ&#174; is our highest-margin product, with margins over 50%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cultivation
facilities must have SCA to operate their HVACD equipment. In simple form, SCA is the computerized thermostat in the room. The SCA also
functions as the &#8220;brains&#8221; in bringing multiple variables together for CEA grow operations. The occupant selects the desired
temperature set point, the wall thermostat (Sensor) detects the actual temperature, and when the space temperature deviates from the
desired set point the controller (Control) commands the environmental control components to supply heated, cooled, or dehumidified air
to bring the room temperature back to the set point. In the case of the indoor cultivation facilities, there are more environmental conditions
to monitor and control (such as temperature, relative humidity, CO2, lighting, vapor pressure deficit status, and more) than in a typical
residential home.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Indoor
CEA growers also need to vary and tightly control environmental conditions depending on the stage of plant growth (i.e., clone, vegetative
and flowering stages), the time of day, and the plant genetics. In a cultivation facility, the desired conditions change many times during
the plant&#8217;s growth cycle and even within a day, and this is most easily accomplished with a custom design, computerized environmental
control system (automation), similar to the most sophisticated building automation systems (BAS) found in commercial and process cooling
applications. This control system may also command lighting and CO2 dosing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
SentryIQ&#174; SCA package includes precision sensors to measure temperature, humidity, light, and CO2 levels&#8212;more accurately than
typical HVACD sensors and within tighter tolerance levels. Our controllers are purpose-built computers programmed by us to ensure our
industrial environmental control equipment follows the engineered sequences of operation to obtain desired set points. Our sensors connect
to our branded controllers through wires installed in the facility, and similarly they are wired to our HVACD equipment (e.g., chillers,
fan coils and dehumidifiers) to direct these pieces of equipment. The controllers also provide a custom user interface on a screen so
they can be easily programmed and controlled to achieve the customer&#8217;s environmental objectives and give the cultivator the ability
to access this data and react to alerts remotely.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
entered this aspect of our business to satisfy our customer&#8217;s needs that we did not previously address and that historically was
provided by third-party controls contractors. Our entry into the SCA market helps both our customers&#8217; and our businesses. Our customers
benefit because they are saved the extra work of finding and engaging an experienced CEA controls contractor, which allows them to get
their facility up and running more quickly by taking one decision off the table and thereby establishing a single point of responsibility
for controls implementation. We are also in a position to provide SCA because we know our proprietary equipment better than anyone, thereby
ensuring smooth integration with our equipment with no work scope shortcomings, what we refer to as &#8220;scope gap.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
a tactical perspective, and with limited incremental selling costs, our current sales team can now offer our SCA package to nearly every
prospect since every cultivation facility requires SCA technology. We believe this technology value-added solution gives us an opportunity
to achieve incremental project revenue at higher margins than we earn from our other equipment, typically on the order of 50% and more.
Strategically, through our SCA package, we are also able to deepen our long-term customer relationship by tethering us to the customer
through a controls interface (dashboard) to their facility. Future development will allow our customers to use artificial intelligence
(AI) by aggregating environment and growing data to optimize energy use, operating efficiency, and product quality and yield. While there
are several other total controls systems providers, we believe that our industry know-how, experience and reputation with climate control
environments gives us a compelling and competitive SCA offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.75in"></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Solutions: VAR of Cultivation and Environmental Control Products</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Some
of the technologies required in CEA facilities are non-proprietary and widely available, thus making it difficult to earn strong margins
on resale of these products. Products like pumps, valves, piping, etc. are commodities within the HVAC industry. However, we add value
by selecting, providing and integrating these products into our customer&#8217;s projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
offer the following CEA-specific products as a reseller from trusted suppliers, for example: (i) lighting - we have partnered with a
third party to offer energy efficient, cost competitive LED lighting products at attractive margins; and (ii) benching and racking -
we offer benching and racking products via a partnership with a well-respected and widely used third party manufacturer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Customers and Prospects</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
provide our services and products to customers who are building, upgrading, or expanding an indoor cultivation facility for any crop.
Our customers can be defined on a range of criteria.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
construction or the retrofit of an existing facility.</i> Nearly all of our business has historically been for new construction facilities
but we have done retrofit projects and we believe that over time more of such business will become available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Existing
commercial retrofit projects represent a business opportunity in the CEA industry.</i> The estimated 5,000+ existing cannabis producing
CEA facilities in North America are easier to identify than new build projects. We believe, based on evidence and our market knowledge,
that some of these exiting facilities are operating sub-optimally and have environmental control problems that our services and products
can help remediate. We also believe that the energy consumption of these facilities can be reduced, and we have commenced developing
services and products to help them realize savings. We believe that retrofit projects do not typically carry the financial uncertainties
associated with new build projects such as licensing, permitting and funding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Crop,
either cannabis or non-cannabis. Nearly all of our projects have been for cannabis cultivation facilities as that has been the focus
of our sales and marketing efforts, but we have recently performed services for several non-cannabis facilities. As non-cannabis markets
are growing at a pace previously seen in the cannabis markets, we are actively pursuing this market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Size
of facility.</i> We serve facilities ranging in size from 2,000 square feet to over 100,000 square feet. Most facilities are between
20,000 and 70,000 square feet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
type.</i> Most of our customers are new entrants into the industry and have no other cultivation facilities. Some customers have one
or more facilities which we classify as MFOs (multi-facility operators), and these are our favored prospects that we pursue aggressively
or who turn to us after we have served them on a previous facility. We currently do not have many projects with the largest, publicly
traded firms (typically referred to as &#8220;MSOs&#8221; for Multi-State Operators) although we are currently pursuing them as well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">MFOs
(Multi-Facility Owners). These are customers who already own cultivation facilities and they are our preferred customers for several
good reasons: they are likely already successful and cash-flowing, and they understand the challenges of building a new cultivation facility.
They are thus a less risky prospect with a much higher likelihood of successfully completing a project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">New
Entrants are often times investors coming from outside the CEA industry who are attracted by the growth opportunities available as the
CEA industry grows. We are particularly effective at winning business from such prospects because of our fifteen-year track record and
well-known brand name within the industry. However, the risks of a failed project with such prospects are higher because of the challenges
that must be overcome to successfully build and operate a CEA operation: ability to gain funding, ability to obtain licensure, ability
to find an appropriate facility, among many others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Sales
and Marketing </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have both marketing and sales organizations and employees. Marketing consists of a Vice-President of Marketing Communications and two
staff members. Our sales organization is comprised of a Vice-President of Sales and four sales representatives located across the country.
Our sales and marketing efforts focus on winning business from new entrants and smaller MFOs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Marketing
Strategy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Our
marketing activities are focused on generating new leads and to position us as a leader in the CEA facilities indoor cultivation market.
We lead with our company value proposition of offering a wide range of proprietary and curated products and services, giving more options
to our customers to satisfy their individual applications and goals, versus our competition that only offers single solutions for each
of their products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Brand
Image</i>. We emphasize our 15-year presence serving the industry and our status as an industry pioneer that was founded by cultivators
to provide service to cultivators. We have also positioned ourselves as an engineering company that is, we believe, the most experienced
such firm serving the cannabis segment of the CEA industry. We are well-known in the industry because of the many projects we have performed
and because of our longevity serving the same. We reinforce our message and positioning with regular blog posts on our website, with
interviews of our technical people in certain industry magazines, with talks and presentations at trade shows, and with technical white
papers. Some of our engineers sit on industry technical standards groups. Many of our projects are referred to us by previous customers,
and we reap the benefits of a virtuous cycle of many past projects leading to new projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Internet.
</i>Our marketing activities include a fresh, easy to navigate website that provides education through our SEO-optimized landing pages,
case studies, white papers, blogs and articles, advertising in various trade publications and digital outlets, social media and email
campaigns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Paid
Referrals.</i> We provide referral agreements to parties in the industry who are in a position to refer business to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Trade
Shows.</i> We make regular appearances at trade shows. We are also frequent speakers or panel members at trade show educational events.
Our co-founder, Brandy Keen, is a well-known industry pioneer and authority who writes regular blog posts and is a sought-after speaker
at industry events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><i>Investor
Relations/Public Relations</i><b>.</b> We actively manage our public image to both the industry and to investors. For the industry we
regularly publish press releases with positive company news including new product releases and major project wins. For the investor community
we retain an Investor Relations firm to provide regular coverage of Company developments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Sales
Strategy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 31.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Our
sales strategy is to call on leads developed by our marketing efforts, leads referred by existing customers, networking at industry events
and trade shows, and developing relationships with potential prospects. Our sales cycle is long, ranging from several months to a year
from first contact with a prospect to signing a contract. In the organic growth strategy update we announced in May of 2021 we specifically
added architectural services to our offering. Typically, architectural services are the first that will be needed when a facility is
to be built. By selling our architectural services to a prospect we gain an early foothold in the relationship with the prospect. By
offering most of the services and products that the prospect will need for their facility, we attempt to keep competitors out of the
relationship.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Sales,
Contract, and Fulfillment Cycle</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
sales cycles for our new build commercial projects can vary significantly depending on the size and complexity of the project. From pre-sales
and technical advisory meetings to sales contract execution, to engineering and design services and equipment delivery, and all the way
through installation and startup of the installed system, the full cycle can range from three months to two years. Since we do not install
any of the products we sell, our customers are required to use third-party installation contractors, which adds to the variability of
the sales cycle.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">When
a customer agrees to enter into a contract with us it can be for any or all of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">Architectural
design services;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">MEP
engineering services; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">Equipment
provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">To
enter into a contract we require a 5-10% deposit and a signed contract. We then require progress payments as architectural and/or engineering
work is completed, and before equipment is shipped. We generally do not ship equipment to a customer unless that equipment has been fully
paid. The sales and fulfillment cycle can be summarized as follows, with elapsed time from start:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">Start:
Early meetings to understand goals and resources;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">1-2
months: Proposal development and presentation;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">3
months: Contract acceptance (requires 5-10% deposit);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">3
months: Architectural and MEP engineering work begin;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">4-5
months: Architectural and MEP engineering work completed and equipment selections finalized (services paid for before release of construction
drawings);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">5
months: equipment ordered (40% deposit on equipment received prior to ordering);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">6-18
months: construction project commences, equipment delivered as required (fully paid for before shipping); and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">12-18
months: all equipment shipped and installed, project completed, operator training and system startup conducted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="forms-1a_003.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Gross
Margins and Revenue.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Architectural
and Engineering services fees can range from $10,000 to over $100,000, depending on the size of the project. Revenue from equipment sales
on individual projects has been over $3,000,000 but most typically ranges from $500,000 to $1,500,000. Our target gross margin from equipment
sales ranges from 25% to 60%, with services margins ranging from 10% to 20%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Corporate Growth Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
corporate strategy for growing the Company and increasing shareholder value are based on the following pillars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Pursue
aggressive organic growth.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
serve a market for the construction and expansion of CEA facilities and businesses that is projected to grow at a 20%+ compound annual
growth rate for the foreseeable future. Our primary vertical market of cannabis cultivation facilities has been joined by the similarly
rapidly growing urban vertical farming market to create two market opportunity segments that we are positioned to serve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May of 2021 we announced a new strategy for our organic growth, which included the following elements.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
markets</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Non-cannabis
CEA (vertical/urban farming). We have expanded our business development plan to pursue non-cannabis CEA facilities, at least doubling
our total addressable market. We have served several non-cannabis CEA facilities in the past and present and we have expanded our marketing
efforts to aggressively pursue this vertical market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
products &amp; services</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
decided to expand our product offerings from primarily environmental control to now offer all of the primary technologies and services
required in a CEA facility: architectural design, lighting, benching, HVACD, sensing &amp; control systems, CO<sub>2</sub> dosing and
control, water filtration &amp; condensate reclamation, irrigation &amp; fertigation systems, and wastewater treatment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>New
trade name</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May of 2021 we adopted the trade name Surna Cultivation Technologies instead of Surna Inc. because we believe that the new name will
more clearly identify our business to prospects and make us easier to find on various social media and search engines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Seek
strategic relationships, mergers, and acquisitions to add to our existing business</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
intend to grow our business through mergers, acquisitions, and strategic partnerships that serve our goal of being a leading and rapidly-growing
supplier to the CEA industry. Our strategy is to use our insight to select the right partners to align with and the right acquisition
targets to pursue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
experience and engineering advantages. Our core expertise, developed over many years, is engineering the environmental controls of CEA
facilities, which is a sophisticated engineering challenge due to the high humidity (latent heat) and heat load (sensible heat) within
these facilities. Not only are the loads high, but the environmental conditions within these facilities must be held closely within limits
that the facility&#8217;s managers request. Engineering to meet these limits requires us to consider all of the primary components within
the facility: lighting, irrigation, HVACD, fertigation, sensors, controls, CO<sub>2</sub> dosing, monitoring and alarms, facility physical
limits such as power availability, and energy consumption. This expertise uniquely informs our view on the requirements of CEA facilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Technical
advantages as a strategic partner and acquirer. We believe that the expertise gained in engineering many of the primary technical components
within a CEA facility provides us with a uniquely well-informed view of the efficacy of the many primary components on offer in the marketplace.
We further believe that this knowledge will help us make wise choices of which products to pursue for strategic relationships, and which
providers to potentially merge with or acquire.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Corporate
advantages as a strategic partner and acquirer. For smaller component providers we believe that our publicly traded platform and our
existing sales and marketing reach will make us an attractive partner. Our public status provides sources of capital and our sales and
marketing resources can help us bring other products to market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Raise
capital and uplist to a senior exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
2019 our revenue grew 60% year-over-year, and we had our first-ever cash flow positive year. Despite the challenges brought on by the
COVID-19 pandemic in the first half of 2020, we believe that our revenue growth in 2019 and then in the Q3 2020 &#8211; Q3 2021 period
validates our market opportunity and our business model. We also recognize that the costs of being a small public company are substantial
and require cash that could otherwise be used to sustain and grow the business. We believe that there is only one solution to this issue:
rapid revenue and margin growth. We believe that we have growth opportunities, but we are capital constrained and must seek outside financing
to pursue the growth we believe we can achieve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Competitive Advantages</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Operations</i>. First and foremost we seek to help our customers build the most effective and efficient facility possible. We believe
that we are uniquely positioned to engineer all of the complex components of a CEA facility into a holistic whole because of our dedicated
engineering staff and our experience in with over 800 cultivators including over 200 commercial facilities. Our 15 years in the business
has provided us a wide network of technology vendors from which we curate a selection of the best products. In addition, we are the leading
experts in applying the most challenging component of the technical infrastructure, the environmental controls, and we have the knowledge
required to engineer the interactions among the required components. A professional engineer (PE) license is required for all MEP engineering
work, and this engineering competence is one of our greatest strengths.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sustainability.
</i>Indoor cultivation facilities, like data centers, are resource intensive. Several U.S. states have implemented building code changes
that place limits on the energy consumption allowed within cultivation facilities, and we anticipate that more states will do the same.
Among our objectives is to provide our customers with the most energy-efficient alternatives for their infrastructure. Energy and resource
efficiency is a high priority to us as engineers, and our most senior engineering staff hold the LEED (Leadership in Energy and Environmental
Design) credential. Our CEO previously helped build a cleantech company, has been involved in the cleantech industry for over five years,
and published a book on selling energy efficient technologies. We believe that we are in a position to lead the industry in sustainability
initiatives which our customers will highly value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Customer
Acquisition</i>. By offering Facility Selection &amp; Design services we seek to build relationships with prospects at the earliest opportunity
in the lifecycle of the cultivation business. By expanding our offerings to include nearly every piece of the technical infrastructure
required in a facility we hope to engage at the earliest possible moment with the customer and earn the opportunity to provide all the
products and services required for the facility. Our post-start-up, lifecycle services will help us maintain a relationship with the
customer as long as the facility is in operation. Our observation is that our customers want to grow plants, not maintain the technical
infrastructure of complex systems, and we believe that they will accept our offer to do so, as some already have.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Revenue
and Revenue Recurrence.</i> We believe that our revenue can be expanded by offering most of the primary technical infrastructure components
for a cultivation facility. For example, if we are able to provide all of the primary infrastructure components to a cultivation facility,
our revenue on a project could be up to 200% higher than if we provided the environmental controls systems alone. In the past we did
not have products or services to offer our customers after a facility was constructed. We have recently begun to offer preventative maintenance
services, and we believe that by expanding this service offering we will be able to gain long-term recurring revenue on a subscription
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Our
Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
environmental control systems and our related engineering and design services compete with various national and local HVACD contractors
and traditional HVACD equipment suppliers who traditionally resell, design, and implement climate control systems for commercial and
industrial facilities, most of whom do not have the specific knowledge that we have about the complexities and challenges of CEA facilities.
We have positioned ourselves to differ from these competitors by providing a broad range of engineering and design services and environmental
control systems, across most major HVACD solutions, including modular chilled water systems, custom air handling units, split systems,
packaged roof-top units, and self-contained and complex chilled-water systems, each tailored specifically for managing the distinct challenges
involved in CEA facilities. We believe our industry-specific applications and experience in the CEA market allow us to deliver the right
solution to our cultivation customers. Unlike many of our competitors, our solutions are designed specifically for cultivators to provide
tight temperature/humidity control, reduce bio-security risk, reduce energy requirements, and minimize maintenance complexity, costs
and downtime. However, we are seeing more competitors enter into the CEA market, trying to mimic the same types of crop-specific climate
control systems and engineering services that we offer. We believe this increased competition may adversely impact our ability to obtain
new facility projects from both MFOs and independent smaller growers and could require us to accept lower gross margins on our projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
the cannabis segment of the CEA industry continues to mature and develop and legalization becomes more prevalent, we expect to see more
competition from agricultural product and service providers who seek to expand into this niche of the CEA market. Going forward, we intend
to expand our focus to include non-cannabis crops grown in controlled environments such as leafy greens (kale, Swiss chard, mustard,
cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables, ornamentals and small fruits (such as strawberries,
blackberries and raspberries), bell peppers, cucumbers, and tomatoes. Companies already operating in the non-cannabis CEA industry may
have longer operating histories, greater name recognition, larger client bases and significantly greater financial, technical, sales
and marketing resources. These competitors may adopt more aggressive pricing policies and make more attractive offers to existing and
potential clients, employees, strategic partners, distribution channels and advertisers. Increased competition is likely to result in
price reductions, reduced gross margins and a potential loss of market share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
rely on a combination of patent and trademark rights, licenses, trade secrets, and laws that protect intellectual property, confidentiality
procedures, and contractual restrictions with our employees and others to establish and protect our intellectual property rights. We
have several issued patents and pending patent applications; however, we do not believe that these issued and pending patents currently
provide us with any competitive advantage. We have registered trademark registrations around our core Surna brand (&#8220;Surna&#8221;)
in the United States and select foreign jurisdictions, as well as the Surna logo and the combined Surna logo and name in the United States.
Our Surna trademark is also registered in the European Union and Canada. Subject to ongoing use and renewal, trademark protection is
potentially perpetual. We actively protect our inventions, new technologies, and product developments by maintaining trade secrets and,
in limited circumstances, filing for patent protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Employees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
currently have 30 active full-time employees and two part-time employees. However, we may engage, and have in the past utilized, the
services of consultants, independent contractors, and other non-employee professionals. Additional employees may be hired in the future
depending on need, available resources, and our achieved growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Government
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>U.S.
Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
we do not generate any revenue from the direct sale of cannabis products, we have historically, and continue to, offer our services and
engineering solutions to indoor cultivators that are engaged in various aspects of the cannabis industry. Cannabis is a Schedule I controlled
substance and is illegal under federal law. Even in those states in which specific uses of marijuana has been legalized, such as medical
marijuana or for adult recreational purpose, its use remains a violation of federal laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
Schedule I controlled substance is defined as a substance that has no currently accepted medical use in the United States, a lack of
safety for use under medical supervision and a high potential for abuse. The Department of Justice defines Schedule I controlled substances
as &#8220;the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.&#8221; If
the federal government decides to enforce the Controlled Substances Act with respect to cannabis, persons that are charged with distributing,
possessing with intent to distribute, or growing cannabis could be subject to fines and terms of imprisonment, the maximum being life
imprisonment and a $50 million fine. Any such change in the federal government&#8217;s enforcement of current federal laws could cause
significant financial damage to us. While we do not intend to harvest, manufacture, distribute or sell cannabis or cannabis products,
we may be irreparably harmed by a change in enforcement by the federal or state governments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Previously,
the Obama administration took the position that it was not an efficient use of resources to direct federal law enforcement agencies to
prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical marijuana. The Trump administration
revised this policy but made no major changes in enforcement through Attorney General Sessions rescinding the Cole Memorandum. The Department
of Justice will continue to enforce the Controlled Substances Act with respect to cannabis under established principles in setting their
law enforcement priorities to prevent:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    distribution of cannabis products, such as marijuana, to minors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">criminal
    enterprises, gangs and cartels receiving revenue from the sale of cannabis;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    diversion of cannabis products from states where it is legal under state law to other states;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">state-authorized
    cannabis activity from being used as a cover or pretext for the trafficking of other illegal drugs or other illegal activity;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">violence
    and the use of firearms in the cultivation and distribution of cannabis products;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">driving
    while impaired and the exacerbation of other adverse public health consequences associated with cannabis product usage;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    growing of cannabis on public lands; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">cannabis
    possession or use on federal property.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Since
the use of marijuana is illegal under federal law, most federally chartered banks will not accept deposit funds from businesses involved
with marijuana. Consequently, businesses involved in the marijuana industry generally bank with state-chartered banks and credit unions
to provide banking to the industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
2014, Congress passed a spending bill containing a provision (the Rohrabacher-Farr amendment, now referred to as the Rohrabacher-Blumenauer
Amendment) blocking federal funds and resources allocated under the 2015 appropriations bill from being used to &#8220;prevent such States
from implementing their own State medical marijuana laws.&#8221; The Rohrabacher-Blumenauer Amendment, however, did not codify any federal
protections for medical marijuana patients and producers operating within state law. The Justice Department maintains that it can still
prosecute violations of the federal cannabis laws and continue cases already in the courts. The Rohrabacher-Blumenauer Amendment must
be re-enacted every year, and it was continued for 2016, 2017, 2018, 2019 and 2020, and currently, now known as the Joyce Amendment,
remains in effect through December 3, 2021. The continued re-authorization of the Joyce Amendment cannot be assured. If the Joyce Amendment
is no longer in effect, the risk of federal enforcement and override of state marijuana use and cannabis related laws would increase.
However, state laws do not supersede the prohibitions set forth in the federal drug laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
order to participate in either the medical or the adult use aspects of the cannabis industry, all businesses and employees must obtain
licenses from the state and, for businesses, local jurisdictions as well. As an example, Colorado issues four types of business licenses
including cultivation, manufacturing, dispensing, and testing. In addition, all owners and employees must obtain an occupational license
to be permitted to own or work in a facility. All applicants for licenses undergo a background investigation, including a criminal record
check for all owners and employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Colorado
has also enacted stringent regulations governing the facilities and operations of cannabis businesses that are involved with the plant
and its products. All facilities are required to be licensed by the state and local authorities and are subject to comprehensive security
and surveillance requirements. In addition, each facility is subject to extensive regulations that govern its businesses practices, which
includes mandatory seed-to-sale tracking and reporting, health and sanitary standards, packaging and labeling requirements, and product
testing for potency and contaminants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Laws
and regulations affecting the medical marijuana industry are constantly changing, which could detrimentally affect our proposed operations.
Local, state and federal medical marijuana laws and regulations are broad in scope and subject to evolving interpretations, which could
require us to incur substantial costs associated with compliance or alter our business plan. In addition, violations of these laws, or
allegations of such violations, could disrupt our business and result in a material adverse effect on our operations. It is also possible
that regulations may be enacted in the future that will be directly applicable to our business. We cannot predict the nature of any future
laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative
policies and procedures, when and if promulgated, could have on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Canadian
Regulations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Summary
of the Cannabis Act</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
October 17, 2018, the Cannabis Act came into force as law with the effect of legalizing adult recreational use of cannabis across Canada.
The Cannabis Act replaced the Access to Cannabis for Medicinal Purposes Regulations (&#8220;ACMPR&#8221;) and the Industrial Hemp Regulations,
both of which came into force under the Controlled Drugs and Substances Act (Canada) (the &#8220;CDSA&#8221;), which previously permitted
access to cannabis for medical purposes for only those Canadians who had been authorized to use cannabis by their health care practitioner.
The ACMPR replaced the Marihuana for Medical Purposes Regulations (Canada) (the &#8220;MMPR&#8221;), which was implemented in June 2013.
The MMPR replaced the Marihuana Medical Access Regulations (Canada) (the &#8220;MMAR&#8221;) which was implemented in 2001. The MMPR
and MMAR were initial steps in the Government of Canada&#8217;s legislative path towards the eventual legalization and regulating recreational
and medical cannabis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Cannabis Act permits the recreational adult use of cannabis and regulates the production, distribution and sale of cannabis and related
oil extracts in Canada, for both recreational and medical purposes. Under the Cannabis Act, Canadians who are authorized by their health
care practitioner to use medical cannabis have the option of purchasing cannabis from one of the producers licensed by Health Canada
and are also able to register with Health Canada to produce a limited amount of cannabis for their own medical purposes or to designate
an individual who is registered with Health Canada to produce cannabis on their behalf for personal medical purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the Cannabis Act, subject to provincial regulations, individuals over the age of 18 are able to purchase fresh cannabis, dried cannabis,
cannabis oil, and cannabis plants or seeds and are able to legally possess up to 30 grams of dried cannabis, or the equivalent amount
in fresh cannabis or cannabis oil. The Cannabis Act also permits households to grow a maximum of four cannabis plants. This limit applies
regardless of the number of adults that reside in the household. In addition, the Cannabis Act provides provincial and municipal governments
the authority to prescribe regulations regarding retail and distribution, as well as the ability to alter some of the existing baseline
requirements of the Cannabis Act, such as increasing the minimum age for purchase and consumption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Provincial
and territorial governments in Canada have made varying announcements on the proposed regulatory regimes for the distribution and sale
of cannabis for adult-use purposes. For example, Qu&#233;bec, New Brunswick, Nova Scotia, Prince Edward Island, Yukon and the Northwest
Territories have chosen the government-regulated model for distribution, whereas Saskatchewan and Newfoundland &amp; Labrador have opted
for a private sector approach. Alberta, Ontario, Manitoba, Nunavut and British Columbia have announced plans to pursue a hybrid approach
of public and private sale and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the new framework for regulating cannabis in Canada, the federal government has introduced new penalties under the Criminal
Code (Canada), including penalties for the illegal sale of cannabis, possession of cannabis over the prescribed limit, production of
cannabis beyond personal cultivation limits, taking cannabis across the Canadian border, giving or selling cannabis to a youth and involving
a youth to commit a cannabis-related offence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 11, 2018, the Canadian federal government published regulations in the Canada Gazette to support the Cannabis Act, including the
Cannabis Regulations, the new Industrial Hemp Regulations, along with proposed amendments to the Narcotic Control Regulations and certain
regulations under the Food and Drugs Act (Canada). The Industrial Hemp Regulations and the Cannabis Regulations, among other things,
outline the rules for the legal cultivation, processing, research, analytical testing, distribution, sale, importation and exportation
of cannabis and hemp in Canada, including the various classes of licenses that can be granted, and set standards for cannabis and hemp
products. The Industrial Hemp Regulations and the Cannabis Regulations include strict specifications for the plain packaging and labelling
and analytical testing of all cannabis products as well as stringent physical and personnel security requirements for all federally licensed
production sites. The Industrial Hemp Regulations and the Cannabis Regulations also maintain a distinct system for access to cannabis.
With the Cannabis Act now in force, cannabis has ceased to be regulated under the CDSA and is instead regulated under the Cannabis Act,
and both the ACMPR and the Industrial Hemp Regulations have been repealed effective October 17, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Additional
regulations were added in October 2019 governing the legal production and sale of three classes of cannabis, edibles, extracts and topicals.
A processing license will be required in order to manufacture, package and label cannabis edibles, extracts and topicals to consumers.
The licensing also has quality control and testing requirements for production to prevent contamination and address the risk of foodborne
illness associated with cannabis. Cannabis products will have THC and cannabidiol limits per unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Security
Clearances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Cannabis Regulations require that certain people associated with cannabis licensees, including individuals occupying a &#8220;key position&#8221;
directors, officers, large shareholders and individuals identified by the Minister of Health, must hold a valid security clearance issued
by the Minister of Health. Officers and directors of a parent corporation must be security cleared.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Cannabis Regulations, the Minister of Health may refuse to grant security clearances to individuals with associations to organized
crime or with past convictions for, or an association with, drug trafficking, corruption or violent offences. Individuals who have histories
of nonviolent, lower-risk criminal activity (for example, simple possession of cannabis, or small-scale cultivation of cannabis plants)
are not precluded from participating in the legal cannabis industry, and the grant of security clearance to such individuals is at the
discretion of the Minister of Health and such applications will be reviewed on a case-by-case basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Cannabis
Tracking System</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Cannabis Act, the Minister of Health is authorized to establish and maintain a national cannabis tracking system. The Cannabis Regulations
set out a national cannabis tracking system to track cannabis throughout the supply chain to help prevent diversion of cannabis into,
and out of, the illicit market. The Cannabis Regulations also provides the Minister of Health with the authority to make a ministerial
order that would require certain persons named in such order to report specific information about their authorized activities with cannabis,
in the form and manner specified by the Minister of Health.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Cannabis
Products</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Cannabis Regulations set out the requirements for the sale of cannabis products at the retail level permit the sale of dried cannabis,
cannabis oil, fresh cannabis, cannabis plants, and cannabis seeds, including in such forms as &#8220;pre-rolled&#8221; and in capsules.
The THC and cannabidiol content and serving size of cannabis products is limited by the Cannabis Regulations. These regulations also
cover labelling and packaging regulation and extensive prohibitions on representations that may be made with respect to cannabis products
covering areas such as health and cosmetic benefits, nutrition, comparisons to alcoholic beverages and diet benefits and dietary requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_013"></span><b>MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Information
about our Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s current directors are set forth below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 68%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Positions
    &amp; Committees</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chairman
    of the Board; Chief Executive Officer and President</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">James
    R. Shipley </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director;
    Compensation Committee Chair; Audit Committee Member</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Nicholas
    J. Etten</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">52</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Director; Nominating Committee Chair; Audit Committee Member</p>
<span style="font: 10pt Times New Roman, Times, Serif"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Troy L. Reisner</p>
</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">55</p>
</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Director;
                                            Audit Committee Chair; Compensation Committee Member</p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Marion Mariathasan</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">47</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Director;
                                            Nominating Committee Member</p>
</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Certain
information, as of the date of this prospectus, with respect to the Company&#8217;s current directors is set forth below. The business
address of each of the directors is 385 South Pierce Avenue, Suite C, Louisville, Colorado 80027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    and Year First Elected Director</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 73%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Background
    Information and Principal Occupation(s) During Past Five Years and Beyond</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald (2018)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
                                            McDonald was appointed a director on September 12, 2018. On November 28, 2018, Mr. McDonald
                                            was appointed our Chief Executive Officer and President. On June 24, 2020, Mr. McDonald was
                                            appointed Chairman of the Board. Mr. McDonald has been involved in building businesses in
                                            the cleantech, energy efficiency and heating, ventilation and air conditioning (&#8220;HVACD&#8221;)
                                            industries over the past 10 years. From 2008 to 2018, Mr. McDonald led sales and business
                                            development as Vice-President&#8212;Sales for Coolerado Corp., a manufacturer and marketer
                                            of innovative, energy-efficient air conditioning systems for commercial, government, and
                                            military use. Along with Coolerado&#8217;s CEO, Mr. McDonald was instrumental in growing
                                            the business to become an INC. 600 high-growth company award winner and assisted in raising
                                            $15 million of private funding from a cleantech investment fund. In 2015, Coolerado was acquired
                                            by Seeley International, Australia&#8217;s largest air conditioning manufacturer and an innovative
                                            global leader in the design and production of energy-efficient cooling and heating products,
                                            where Mr. McDonald served as National Account Manager. He is also the founder and Managing
                                            Partner of Cleantechsell.com and the author of Cleantech Sell: The Essential Guide To Selling
                                            Resource Efficient Products In The B2B Market.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Prior
    to joining Coolerado, Mr. McDonald spent over ten years in the private equity industry where he was involved in numerous transactions
    in the technology, manufacturing, and power development industries. As a business development officer at several private equity acquisitions
    groups Mr. McDonald identified, financed, or acquired numerous transactions with total enterprise value in excess of $200 million.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
    McDonald was also a consultant to international banks with KMPG from 1994 to 1997 and served as a director for Keating Capital, Inc.,
    a publicly traded business development company that made investments in pre-IPO companies. He previously served as a mentor for companies
    in the Clean Tech Open competition.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
    McDonald is a U.S. Army veteran and a graduate of the U.S. Military Academy at West Point, N.Y. where he earned a B.S. degree in
    Engineering and Economics. He also received an M.B.A. degree from the Harvard Business School.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Among
    the reasons for Mr. McDonald to be selected for service on the Board is his experience in sales, sales and operations management,
    mergers and acquisitions, the HVACD industry, his in-depth knowledge of climate control systems and technologies.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">James
    R. Shipley (2020)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 73%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
                                            Shipley was appointed a director on June 24, 2020. Mr. Shipley recently retired from AgTech
                                            Holdings where he was the Chief Strategy Officer of GroAdvisor and the Vice-President of
                                            Sales VividGro since 2017. Since 2017, Mr. Shipley has assisted in design and build consulting
                                            along with supply chain management for cultivation operations in 12 states covering more
                                            than 500,000 square feet of warehouse indoor cultivation and continues to consult independently
                                            with operators in North America. From 2014 to 2017 Mr. Shipley, acting in several executive
                                            roles, helped build multiple business lines for MJIC Inc. (now CNSX: MSVN ); these roles
                                            included being a member of the board of directors, Chairman and President. Mr. Shipley is
                                            currently president and a principal in RSX Enterprises Inc., a sales agency and marketing
                                            firm that sells and markets equipment for use in controlled environment agriculture on behalf
                                            of various manufacturers. Mr. Shipley has been active in the cannabis business, where he
                                            has founded various summits such as the Marijuana Investor Summit and been involved in many
                                            educational workshops and business expos. Previously, Mr. Shipley was an officer and chief
                                            revenue officer with Carrier Access Corporation (CACS), a public company trading on Nasdaq.
                                            Prior to Carrier Access, Mr. Shipley worked at Williams Companies in their telecommunications
                                            divisions.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Shipley was selected for service on the Board because of his experience in and commitment to the cannabis industry, his demonstrated
    and consistent record of success as an executive and entrepreneur, and his extensive network of contacts in the cannabis industry.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Nicholas
    J. Etten (2020)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
                                            Etten was appointed a director on June 24, 2020. Mr. Etten joined Acreage Holdings in 2018
                                            where he served as the Head of Government Affairs until 2021. Acreage is a vertically integrated,
                                            multi-state operator of cannabis licenses and assets in the U.S. In 2017 he founded the Veterans
                                            Cannabis Project where he continues to serve as Chairman. Veterans Cannabis Project (VCP)
                                            is an organization dedicated to advocating on behalf of cannabis access issues for U.S. military
                                            veterans. From 2015 to 2017, Mr. Etten set aside his career to provide care for his seriously
                                            ill son. Mr. Etten&#8217;s career has been focused on the growth equity market, and prior
                                            to Acreage, he held positions including Vice President of Global Business Development for
                                            FreightWatch International, and Director of Corporate Development for Triple Canopy. Mr.
                                            Etten was an investment professional at Trident Capital, where he focused on the cyber-security
                                            space, and an investment banker at Thomas Weisel Partners. Mr. Etten served on active duty
                                            as a U.S. Navy SEAL officer. He earned an MBA from the J.L. Kellogg Graduate School of Management
                                            at Northwestern University, and a BS in political science from the United States Naval Academy.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Etten was selected for service on the Board because of his experience in and commitment to the cannabis industry, his experience
    with multi-site cannabis operators, his demonstrated and consistent record of success as an executive, and his extensive network
    of contacts in the cannabis industry and investment banking world.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>

<tr style="vertical-align: top">
    <td style="width: 25%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troy
                           L. Reisner (2022)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 73%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troy
                                            Reisner was appointed as a director on January 17, 2022. Mr. Reisner is currently the Chief
                                            Financial Officer at Keystone Tower Systems, Inc., headquartered in Denver, Colorado. Keystone
                                            is a technology innovation and manufacturing company that is disrupting the commercial wind
                                            tower industry by bringing automated manufacturing technology that will produce towers 10x
                                            faster than current factories and the technology can be deployed on-site. At Keystone, Troy
                                            leads the finance and accounting functions, including raising capital and corporate governance
                                            matters, and serves as an executive team member. Prior to joining Keystone, Troy was a partner
                                            with Deloitte, a Big 4 public accounting firm until his retirement. Troy spent over 30 years
                                            with Deloitte in the accounting &amp; auditing practice serving in St. Louis, Missouri and
                                            Denver, Colorado. Troy was also part of Deloitte&#8217;s National Office in New York City
                                            where he served as part of an exclusive M&amp;A group. Troy brings significant cumulative
                                            knowledge and expertise in accounting &amp; auditing, including PCAOB auditing standards,
                                            M&amp;A transactions, financial due diligence, financial reporting, including expertise in
                                            SEC rules, regulations &amp; reporting, internal controls over financial reporting, and capital
                                            market and corporate governance experience and expertise.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">He
    earned a B.S. degree in Accounting from Southern Illinois University at Edwardsville and practiced as a Certified Public Accountant
    for over 30 years and is licensed (inactive) as a CPA in the State of Missouri.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Reisner was selected for service on the Board because of his long experience in the accounting industry and his experience working
    with public companies.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marion
                                            Mariathasan (2022)</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marion
                                            Mariathasan was appointed as a director on January 17, 2022. Mr. Mariathasan is the CEO and
                                            Co-Founder of Simplifya, the cannabis industry&#8217;s leading regulatory and operational
                                            compliance software platform. The company&#8217;s suite of products takes the guesswork out
                                            of confusing and continually changing state and local regulations. Featuring SOPs, badge
                                            tracking, document storage, tailored reporting and employee accountability features, the
                                            company&#8217;s Custom Audit software reduces the time clients spend on compliance by up
                                            to 45 percent.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Mariathasan is also a serial entrepreneur who has founded or advised numerous startups. He is currently an investor in 22 domestic
    and international companies that range from cannabis companies to dating apps - four of which he serves as a board member.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Mariathasan studied Architecture and Computer Science at the University of Kansas and Computer Information Systems with a minor in
    Business Management from Emporia State University. Marion is a regular guest speaker at events such as Denver Start-Up Week, Colorado
    University&#8217;s program on social entrepreneurship, various universities on the topic of entrepreneurship and the United Nations
    Global Accelerator Initiative.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Mariathasan was selected for service on the Board because of his experience in and commitment to the cannabis industry, his demonstrated
    and consistent record of success as an executive and entrepreneur, and his extensive network of contacts in the cannabis industry.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Each
of the directors on our Board of Directors was elected or appointed because he has demonstrated an ability to make meaningful contributions
to our business and affairs and has skills, experience and background that are complementary to those of our other Board members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Director
Independence </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Nasdaq marketplace rules require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and
nominations committees be independent, or, if a listed company has no nominations committee, that director nominees be selected or recommended
for the board&#8217;s selection by independent directors constituting a majority of the board&#8217;s independent directors. The Nasdaq
marketplace rules further require that audit committee members satisfy independence criteria set forth in Rule 10A-3 under the Exchange
Act and that compensation committee members satisfy the independence criteria set forth in Rule 10C-1 under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of this offering, our Board undertook a review of the independence of our directors and considered whether any director
has a material relationship with us that could compromise that director&#8217;s ability to exercise independent judgment in carrying
out that director&#8217;s responsibilities. Our Board has affirmatively determined that each of Messrs. Shipley, Etten, Reisner
and Mariathasan qualify as an independent director, as defined under the applicable corporate governance standards of Nasdaq.
These rules require that our Audit Committee be composed of at least three members, one of whom must be independent on the date of listing
on Nasdaq, a majority of whom must be independent within 90 days of the effective date of the registration statement containing this
prospectus, and all of whom must be independent within one year of the effective date of the registration statement containing this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Audit
Committee </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the commencement of this offering, our Board established an Audit Committee, which as of the date of this prospectus consists
of three independent directors, Mr. Reisner (Chairman), Mr. Shipley and Mr. Etten. The committee&#8217;s primary
responsibilities include recommending the selection of our independent registered public accounting firm; evaluating the appointment,
compensation and retention of our registered public accounting firm; receiving formal written statements from our independent registered
public accounting firm regarding its independence, including a delineation of all relationships between it and the Company; reviewing
with such independent registered public accounting firm the planning, scope and results of their audit of our financial statements; pre-approving
the fees for services performed; reviewing with the independent registered public accounting firm the adequacy of internal control systems;
reviewing our annual financial statements and periodic filings, and receiving our audit reports and financial statements. The Audit Committee
also considers the effect on the Company of any changes in accounting principles or practices proposed by management or the independent
registered public accounting firm, any changes in service providers, such as the accountants, that could impact the Company&#8217;s internal
control over financial reporting, and any changes in schedules (such as fiscal or tax year-end changes) or structures or transactions
that required special accounting activities, services or resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board has determined that each of our Audit Committee members are independent of management and free of any relationships that, in the
opinion of the Board, would interfere with the exercise of independent judgment and are independent, as that term is defined under the
enhanced independence standards for audit committee members in the Exchange Act and the rules promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has determined that Mr. Reisner is an &#8220;audit committee financial expert,&#8221; as that term is defined in the rules
promulgated by the SEC pursuant to the Sarbanes-Oxley Act of 2012. The Board has further determined that each of the members of the Audit
Committee shall be financially literate and that at least one member of the committee has accounting or related financial management
expertise, as such terms are interpreted by the Board in its business judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Compensation
Committee </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the commencement of this offering, our Board established a Compensation Committee, which as of the date of this prospectus consists
of two independent directors, Mr. Shipley (Chairman) and Mr. Resiner. The committee&#8217;s primary responsibilities
include approving corporate goals and objectives relevant to executive officer compensation and evaluate executive officer performance
in light of those goals and objectives, determining and approving executive officer compensation, including base salary and incentive
awards, making recommendations to the Board regarding compensation plans, and administering our stock plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
Compensation Committee determines and approves all elements of executive officer compensation. It also provides recommendations to the
Board with respect to non-employee director compensation. The Compensation Committee may not delegate its authority to any other person,
other than to a subcommittee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company compensation policies for executive officers has two fundamental objectives: (i) to provide a competitive total compensation
package that enables the Company to attract and retain highly qualified executives with the skills and experience required for the achievement
of business goals; and (ii) to align certain compensation elements with the Company&#8217;s annual performance goals. With respect to
each of the Company&#8217;s executive officers, the total compensation that may be awarded, including base salary, discretionary cash
bonuses, annual stock incentive awards, stock options, restricted stock units and other equity awards, and other benefits and perquisites
will be evaluated by the committee. Under certain circumstances, the committee may also award compensation payable upon termination of
the executive officer under an employment agreement or severance agreement (if applicable). The Board recognizes that its overall goal
is to award compensation that is reasonable when all elements of potential compensation are considered. The committee believes that cash
compensation in the form of base salary and discretionary cash bonuses provides our executives with short-term rewards for success in
operations, and that long-term compensation through the award of stock options, restricted stock units and other equity awards aligns
the objectives of management with those of our stockholders with respect to long-term performance and success. The Board also has historically
focused on the Company&#8217;s financial condition when making compensation decisions and approving performance objectives and compensation
has been weighted more heavily toward equity-based compensation. The committee will continue to periodically reassess the appropriate
weighting of cash and equity compensation in light of the Company&#8217;s expenditures in connection with commercial operations and its
cash resources and working capital needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nominating
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the commencement of this offering, our Board established a Nominating Committee, which as of the date of this prospectus consists
of two independent directors, Mr. Etten (Chairman) and Mr. Mariathasan. The committee&#8217;s primary responsibilities
include identifying individuals qualified to serve on the Board as directors and on committees of the Board, establishing procedures
for evaluating the suitability of potential director nominees consistent with the criteria approved by the Board, reviewing the suitability
for continued service as a director when his or her term expires and at such other times as the committee deems necessary or appropriate,
and determining whether or not the director should be re-nominated, and reviewing the membership of the Board and its committees and
recommending making changes, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
evaluating director nominees, the Nominating Committee will generally consider the following factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    appropriate size and composition of our Board of Directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">whether
    or not the person is an &#8220;independent&#8221; director as defined in Rule 5605(a)(2) promulgated by the Nasdaq Stock Market;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    needs of the Company with respect to the particular talents and experience of its directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    knowledge, skills and experience of nominees in light of prevailing business conditions and the knowledge, skills and experience
    already possessed by other members of the Board of Directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">familiarity
    with national and international business matters and the requirements of the industry in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">experience
    with accounting rules and practices;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the
    desire to balance the considerable benefit of continuity with the periodic injection of the fresh perspective provided by new members;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">all
    applicable laws, rules, regulations and listing standards, if applicable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
are no stated minimum criteria for director nominees, although the committee may consider such factors as it may deem are in the best
interests of the Company and its stockholders. The Nominating Committee also believes it is appropriate for certain key members of our
management to participate as members of the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Nominating Committee identifies nominees by first evaluating the current members of the Board willing to continue in service. Current
members of the Board with skills and experience that are relevant to our business and who are willing to continue in service are considered
for re-nomination, balancing the value of continuity of service by existing members of the Board with that of obtaining a new perspective.
If any member of the Board does not wish to continue in service, or if the Nominating Committee decides not to re-nominate a member for
re-election, the committee identifies the desired skills and experience of a prospective director nominee in light of the criteria above,
or determines to reduce the size of the Board. Research may also be performed to identify qualified individuals. To date, we have not
engaged third parties to identify or evaluate or assist in identifying potential nominees, nor do we anticipate doing so in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Stockholder
Communications with Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Stockholders
may communicate with the Board by sending a letter to the Corporate Secretary, CEA Industries Inc., 385 South Pierce Avenue, Suite C,
Louisville, Colorado 80027. Each communication must set forth the name and address of the stockholder on whose behalf the communication
is sent and should indicate in the address whether the communication is intended for the entire Board, the non-employee directors as
a group or an individual director. Each communication will be screened by the Corporate Secretary or his designee to determine whether
it is appropriate for presentation to the Board or any specified director(s). Examples of inappropriate communications include junk mail,
spam, mass mailings, resumes, job inquiries, surveys, business solicitations and advertisements, as well as unduly hostile, threatening,
illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material. Communications determined to be appropriate for
presentation to the Board, or the director(s) to whom they are specifically addressed, will be submitted to the Board or such director(s)
on a periodic basis. Any communications that concern accounting, internal control or auditing matters will be handled in accordance with
procedures adopted by the Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Code
of Business Conduct and Ethics </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
Board has adopted a Code of Business Conduct and Ethics, which is available for review on our website at <span style="text-decoration: underline">www.ceaindustries.com
</span>and is also available in print, without charge, to any stockholder who requests a copy by writing to us at CEA Industries Inc.,
385 South Pierce Avenue, Suite C, Louisville, Colorado 80027 Attention: Corporate Secretary. Each of our directors, employees and officers,
including our Chief Executive Officer, and all of our other principal executive officers, are required to comply with the Code of Business
Conduct and Ethics. There have not been any waivers of the Code of Business Conduct and Ethics relating to any of our executive officers
or directors in the past year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Meetings
and Committees of the Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
Board is responsible for overseeing the management of our business. We keep our directors informed of our business at meetings and through
reports and analyses presented to the Board and the committees of the Board. Regular communications between our directors and management
also occur outside of formal meetings of the Board and committees of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Board
Leadership Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board may, but is not required to, select a Chairman of the Board who presides over the meetings of the Board and meetings of the stockholders
and performs such other duties as may be assigned to him by the Board. The positions of Chairman of the Board and Chief Executive Officer
may be filled by one individual or two different individuals. Currently the positions of Chairman of the Board and Chief Executive Officer
are held by Mr. McDonald.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Board&#8217;s
Role in Risk Oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
risk management is primarily the responsibility of the Company&#8217;s management team, the Board is responsible for the overall supervision
of the Company&#8217;s risk management activities. The Board as a whole has responsibility for risk oversight, and each Board committee
has responsibility for reviewing certain risk areas and reporting to the full Board. The oversight responsibility of the Board and its
committees is enabled by management reporting processes that are designed to provide visibility to the Board about the identification,
assessment, and management of critical risks and management&#8217;s risk mitigation strategies in certain focus areas. These areas of
focus include strategic, operational, financial and reporting, succession and compensation and other areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Board oversees risks associated with their respective areas of responsibility. The Board oversees: (i) risks and exposures associated
with our business strategy and other current matters that may present material risk to our financial performance, operations, prospects
or reputation, (ii) risks and exposures associated with management succession planning and executive compensation programs and arrangements,
including equity incentive plans, and (iii) risks and exposures associated with director succession planning, corporate governance, and
overall board effectiveness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
provides regular updates to the Board regarding the management of the risks they oversee at each regular meeting of the Board. We believe
that the Board&#8217;s role in risk oversight must be evaluated on a case-by-case basis and that our existing Board&#8217;s role in risk
oversight is appropriate. However, we continually re-examine the manners in which the Board administers its oversight function on an
ongoing basis to ensure that they continue to meet the Company&#8217;s needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Executive
officers are appointed by our Board and serve at its discretion. Set forth below is information regarding our executive officers as of
the date of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 58%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Positions
    </b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">63</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer and President; Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">R.
    Brian Knaley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
McDonald&#8217;s biographical information is included with such information for the other members of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 25%"><span style="font: 10pt Times New Roman, Times, Serif">R.
    Brian Knaley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 73%"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
    Knaley was appointed a Chief Financial Officer on June 24, 2021. Mr. Knaley has more than 25 years of financial leadership including
    being a two-time public company CFO. He was most recently the CFO for Proximo Medical, a start-up company specializing in the commercialization
    of medical devices where he provided strategic management of accounting and finance functions including financial control, cash maximization
    and tax and regulatory compliance. Prior to Proximo, he served as Senior Vice President and Interim CFO of ViewRay, Inc., (Nasdaq:
    VRAY), a global manufacturer of MRI-guided radiation therapy systems. At ViewRay he delivered strategic leadership for this publicly
    listed company. Past positions also include CFO at ARC Group Worldwide, Inc. (Nasdaq: ARCW), a global manufacturer of precision metallurgic
    products and advanced 3D printing, Vice President and Corporate Controller of Spectranetics Corp. (Nasdaq: SPNC), a vascular intervention
    device maker. Other positions Mr. Knaley held were Corporate Controller for Arcelormittal USA (NYSE: MT), a steel and mining company
    and Vice President Finance/Audit Manager for Caterpillar, Inc. (NYSE: CAT), a Fortune 100 corporation that designs, develops, engineers,
    manufactures, markets, and sells machinery, engines, financial products, and insurance. Mr. Knaley holds a BA in Accounting from
    Thomas More College and a CPA license in the State of Ohio.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_014"></span><b>COMPENSATION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Director
Compensation Program </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 17, 2022, the Board
of Directors adopted a new compensation plan for independent directors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay its independent directors an annual cash fee of $15,000, payable quarterly in advance on the first business day of each
calendar quarter, and is the cash consideration for their participation in: (i) any regular and special meetings of the Board
and any committee participation and meetings thereof that are attended in person, (ii) any telephonic and other forms of electronic meetings
of the Board or of any committee thereof in which the director is a member, (iii) any non-meeting consultations with the Company&#8217;s
management, and (iv) any other services provided by them in their capacities as directors (other than services as the Chairman of
the Board and as the Chairman of the committees of the board of directors). After the Company is listed on a national stock exchange
the annual cash fee will increase to $25,000. The Company also pays the Audit Committee Chairman an additional annual fee of $10,000,
and the Chairmen of any other committees of the Board an additional annual fee of $5,000, payable quarterly in advance, for services
as a committee chairman.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of initial election or appointment, each independent director will receive an equity retention award in the form of restricted
stock units (&#8220;RSUs&#8221;). The aggregate value of the RSUs at the time of grant will be $25,000, with the number of shares underlying
the RSUs to be determined based on the closing price of the Company&#8217;s common stock on the date immediately prior to the date of
grant. Vesting of the RSUs will be as follows: (i) 50% at the time of grant, and (ii) 50% on the first anniversary of the grant date.
In addition, on the first business day of January each year following their initial election or appointment, each independent director
will receive an equity retention award in the form of RSUs. The aggregate value of the RSUs at the time of grant will be $25,000, with
the number of shares underlying the RSUs to be determined based on the closing price of the Company&#8217;s common stock on the date
immediately prior to the date of grant. These RSUs will be fully vested at date of grant. The board of directors or compensation committee
may grant other equity awards to directors in their discretion, under the terms of the Company incentive award plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reimburses independent directors for out-of-pocket expenses incurred in attending Board of Director and committee meetings
and undertaking certain matters on the Company&#8217;s behalf.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Each independent director is responsible
for the payment of any and all income taxes arising with respect to the issuance of any equity awarded under the plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Employee
directors do not receive separate fees for their services as directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Nevada Revised Statutes and pursuant to our charter and bylaws, as currently in effect, the Company may indemnify the Company&#8217;s
officers and directors for various expenses and damages resulting from their acting in these capacities. Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to our officers and directors pursuant to the foregoing provisions, we
have been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act,
and is therefore unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended
to provide the Company&#8217;s directors the maximum indemnification permitted under the Nevada Revised Statutes, unless otherwise limited
by the Company&#8217;s charter and bylaws. Each indemnification agreement provides that the Company shall indemnify the director or executive
officer who is a party to the agreement (an &#8220;Indemnitee&#8221;), including the advancement of legal expenses, if, by reason of
his corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed
proceeding. Each indemnification agreement further provides that the applicable provisions of the Company&#8217;s charter and bylaws
regarding indemnification shall control in the event of any conflict with any provisions of such indemnification agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Options: NewSection; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Director
Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation earned by or awarded or paid in 2020 and 2021 to the individuals who served as our
independent directors during such period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fees Earned or Paid in Cash</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards
                                            <sup>(1) (2)</sup></b></span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 32%; text-align: left">James R. Shipley</td><td style="width: 2%">&#160;</td>
    <td style="width: 11%; text-align: center">2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">19,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Nicholas J. Etten</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19,800</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">(1)
</span><span style="font: 10pt Times New Roman, Times, Serif">Reflects the dollar amount of the grant date fair value of awards,
measured in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718 (&#8220;Topic 718&#8221;) without adjustment
for estimated forfeitures. For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 14 to our
consolidated financial statements for the fiscal year ended December 31, 2020 included in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Reflects grants to each independent director on June 24, 2020 of non-qualified stock options to purchase 6,667 shares of the Company&#8217;s
common stock and on August 20th, 2021 of non-qualified stock options to purchase 769 shares of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of non-qualified stock options held as of December 31, 2020 and 2021 by each independent director are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Underlying Non-Qualified
    Stock Options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Underlying Restricted Stock
    Units</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left">James R. Shipley</td><td style="width: 2%">&#160;</td>
    <td style="width: 12%; text-align: center">2020</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">6,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">6,667</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,436</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Nicholas J. Etten</td><td>&#160;</td>
    <td style="text-align: center">2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,667</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,436</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Disclosure
Relating to Former Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Keating was a Director of the Company until his resignation in March 2020. During the period from January 1, 2020 until his resignation,
Mr. Keating received $7,500 fees paid or earned in cash and stock option non-qualified stock options to purchase 1,667 shares
of the Company&#8217;s common stock valued at $14,625 in respect of the annual 2020 grant in recognition of his prior services to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Simonton was a Director of the Company until his resignation in March 2020. During the period from January 1, 2020 until his resignation,
Mr. Keating received $7,500 fees paid or earned in cash and stock option non-qualified stock options to purchase 1,667 shares
of the Company&#8217;s common stock valued at $14,625 in respect of the annual 2020 grant in recognition of his prior services to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><sup>&#160;</sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Executive
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Summary
Executive Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes compensation earned by or awarded or paid to our named executive officers for the years ended December 31,
2021, 2020 and 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards <sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards <sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-equity Incentive Plan Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-qualified Deferred Compensation
    Earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K.
    McDonald - Chief Executive Officer </span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">216,731</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$&#160;</td><td style="width: 4%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">73,498</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$&#160;</td><td style="width: 4%; text-align: right">332,727</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">49,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">722,339</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>and President <sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">174,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">33,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,314</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">243,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">180,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,532</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">252,432</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard B. Knaley - Chief
    Financial Officer and Treasurer <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">120,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">122,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">246,467</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;Reflects
the dollar amount of the grant date fair value of awards granted in 2019, 2020 or 2021, measured in accordance with FASB
Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718 (&#8220;Topic 718&#8221;) without adjustment for estimated forfeitures.
For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 14 to our consolidated financial statements
for the fiscal year ended December 31, 2020 included in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;&#160;Mr.
McDonald was appointed Chief Executive Officer and President in November 2018. Amounts presented include all compensation for Mr. McDonald
for the full 2020 and 2021 years. Bonus includes cash bonus paid in recognition of services rendered and contributions to the
Company&#8217;s performance in 2020 and 2021. 2021 stock awards include 6,803 shares of common stock issued in relation
to a new employment agreement effective November 24, 2021. The 2021 option awards include incentive stock options to purchase 40,830
share of common stock and non-qualified stock options to purchase 4,453 shares of common stock both awarded in the November 24,2021 employment
agreement. Some of these options are subject to certain vesting (see Outstanding Equity Awards table, below) 2020 option awards
include non-qualified stock options to purchase 1,791 shares of common stock awarded in February 2021, based on Mr. McDonald&#8217;s
2020 performance. The options vested and became exercisable on the grant date. Other compensation in 2020 and 2021 includes (i)
employer-paid portion of health plan benefits ($7,780 and $8,282, respectively), (ii) employer matching contributions under our
401(k) plan ($7,535 and $10,685, respectively), and (iii) board pre-approved third party compensation expenses and associated taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Mr. Knaley was appointed Chief Financial Officer and Treasurer in June 2021. Amounts presented include all compensation for Mr. Knaley
for 2021. Option awards include non-qualified stock options to purchase 13,333 shares of common stock awarded subject to his employment
agreement. Some of these options are subject to certain vesting. Other compensation includes the employer-paid portion of health plan
benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Disclosure
Relating to Former Executives</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Bechtel was Chief Executive Officer and President from August 2017 until his resignation in November 2018. During the year ended December
31, 2019, Mr. Bechtel received salary of $7,561 in respect of services provided in the prior year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Smiens was Chief Financial Officer and Treasurer from July 2018, and Secretary from September 2018, until his termination of employment
in December 2018. During the year ended December 31, 2019, Mr. Smiens received salary of $18,454 in respect of services provided in the
prior year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding
Equity Awards </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding outstanding equity awards held by our named executive officers as of December
31, 2020 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-equity Incentive Plan Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Non-qualified Deferred Compensation
    Earnings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">All Other Compensation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left">Anthony K. McDonald - Chief</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 4%; text-align: right">2021</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">216,731</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">50,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">73,498</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">332,727</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">49,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 4%; text-align: right">722,339</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer and President
    <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">174,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">33,333</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,314</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">243,240</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard B. Knaley - Chief
    Financial Officer and Treasurer <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">120,192</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">122,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,275</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">246,467</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(1)</sup> Reflects the dollar amount of the
grant date fair value of awards granted in 2020 or 2021, measured in accordance with FASB Accounting Standards Codification (&#8220;ASC&#8221;)
Topic 718 (&#8220;Topic 718&#8221;) without adjustment for estimated forfeitures. For a discussion of the assumptions used to calculate
the value of equity awards, refer to Note 14 to our consolidated financial statements for the fiscal year ended December 31, 2021 included
in this Annual Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(2) </sup>Mr. McDonald was appointed Chief
Executive Officer and President in November 2018. Amounts presented include all compensation for Mr. McDonald for the full 2020 and 2021
years. Bonus includes cash bonus paid in recognition of services rendered and contributions to the Company&#8217;s performance in 2020
and 2021. 2021 stock awards include 1,020,408 shares of common stock issued in relation to a new employment agreement effective November
24, 2021. 2021 option awards include incentive stock options to purchase 40,830 shares of common stock and non-qualified stock options
to purchase 4,453 shares of common stock both awarded in the November 24,2021 employment agreement. Some of these options are subject
to certain vesting (see Outstanding Equity Awards table, below) 2020 option awards include non-qualified stock options to purchase 1,791
shares of common stock awarded in February 2021, based on Mr. McDonald&#8217;s 2020 performance. The options vested and became exercisable
on the grant date. Other compensation in 2020 and 2021 includes (i) employer-paid portion of health plan benefits ($7,780 and $8,282,
respectively), (ii) employer matching contributions under our 401(k) plan ($7,535 and $10,685, respectively), and (iii) board pre-approved
third party compensation expenses and associated taxes. .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>&#160;</sup></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><sup>(3) </sup>Mr. Knaley was appointed Chief
Financial Officer and Treasurer in June 2021. Amounts presented include all compensation for Mr. Knaley for 2021. Option awards include
non-qualified stock options to purchase 13,333 shares of common stock awarded subject to his employment agreement. Some of these options
are subject to certain vesting (see Outstanding Equity Awards table, below). Other compensation includes the employer-paid portion of
health plan benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Compensation
Arrangements with Named Executive Officers </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Anthony
K. McDonald </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 24, 2021, the Company entered into an employment agreement with Mr. McDonald, the Company&#8217;s Chief Executive Officer and
President. The initial term of the employment agreement commenced on November 24, 2021, for a one year term that is automatically extended
for an additional three years upon completion by the Company of a &#8220;qualified offering.&#8221; After the initial term (as may be
extended), the employment agreement automatically renews for one year periods unless notice of non-renewal is given 90 days prior to
the end of the then expiring term. A qualified offering is (A) the closing of a sale of the securities of the Company, whether in a private
placement or pursuant to an effective registration statement under the Securities Act of 1933, or (B) the occurrence of an up-listing
event (i.e., having the Company&#8217;s stock quoted on an alternative trading platform from the Over-the-Counter (OTC) exchange to a
major stock exchange).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
McDonald will be paid an annualized base salary of $275,000 per year, which will automatically increase to $350,000 per year upon the
completion of a Qualified Offering. The base salary will be reviewed at least annually prior to the end of each calendar year to ascertain
whether, in the judgment of the board of directors, it should be increased for the next calendar year. Mr. McDonald is eligible to receive
an annual incentive bonus under the Company&#8217;s annual incentive compensation plan and policy for each full completed calendar year
of employment during the term as determined by the board of directors in its sole discretion. Mr. McDonald will be eligible for an annual
target bonus of fifty percent of the base salary. Payment of the annual bonus may be made in the form of cash, stock, or a combination
thereof, as determined in the sole discretion of the board of directors. Mr. McDonald will also receive an immediate cash amount of $50,000,
payable promptly after the signing of the employment agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
McDonald, at the signing of the employment agreement was issued 6,803 shares of common stock, which has an aggregate fair market
value of $50,000, and was paid a gross up on that amount for federal state and local income tax. Mr. McDonald was awarded a stock option
to purchase 302 shares of common stock under the 2021 Stock Award Plan, that was approved by shareholders, with an exercise price
of $7.35 per share, the price of a share of common stock on the day immediately prior to the signing of the employment agreement.
The vesting of the options is at the rate of one-third on each of the date of the signing of the employment agreement and the first and
second anniversary of the signing of the employment agreement. The option, once vested, is exercisable for ten years from the date the
employment contract was signed. Vesting will be accelerated upon a change of control of the Company and certain termination events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
McDonald is entitled to participate in the Company employee benefit plans, including any group health and welfare insurance and profit
sharing and 401(k) plans that are sponsored generally by the Company for its employees, as may be offered from time to time. Notwithstanding
the foregoing, the Company may modify or terminate any employee benefit plan at any time. Mr. McDonald will be entitled to vacation,
personal days, sick days and expense reimbursement. If Mr. McDonald&#8217;s employment is terminated for cause, due to death, due to
disability or voluntary resignation, he will be paid his base salary to the date of termination, any unpaid annual bonus, COBRA benefits
and any unpaid expense reimbursement. If he is terminated without cause or he resigns for good reason, then he will be paid one year&#8217;s
base salary, and the annual bonus for that year. The employment agreement has typical activity restrictions for non-solicitation of customers
and employees of the Company and covenants for confidentiality, non-competition, inventions and protection of Company intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separately
from his prior employment agreement dated November 28, 2018, on January 2, 2020, the Board awarded Mr. McDonald a special one-time grant
of non-qualified stock options to purchase 6,667 shares of the Company&#8217;s common stock and a $20,000 cash bonus, in recognition
of his services as the Company&#8217;s Chief Executive Officer during 2019. These non-qualified stock options were immediately vested
on the date of grant, had a term of 10 years, and had an exercise price of $10.50 per share, the closing price of the Company&#8217;s
common stock on The OTC Markets on the day immediately preceding the grant date. Further, on February 16, 2021, Mr. McDonald was awarded
non-qualified stock options to purchase 1,791 shares of common stock under our 2017 Equity Incentive Plan. This grant was based
on his performance during 2020. The options vested and became exercisable on the grant date. The associated equity compensation expense
was accrued during 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>R.
Brian Knaley</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
June 28, 2021 the Company employed Mr. R. Brian Knaley as the Chief Financial Officer and Treasurer, and entered into an employment agreement,
which was approved by the Board on June 16, 2021. The initial term of the employment agreement commenced June 28, 2021 and will continue
until June 30, 2024. However, the Company and Mr. Knaley may terminate the employment, at any time, with or without cause, by providing
the other party with 30-days&#8217; prior written notice. In the event Mr. Knaley&#8217;s employment is terminated by the Company during
the initial term without cause, Mr. Knaley will be entitled to receive his base salary for an additional 30 days. Following the initial
term, the Company and Mr. Knaley may extend the employment agreement for additional one-year terms by mutual written agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Mr.
Knaley will receive an annualized base salary of $250,000. Upon uplisting of the Company to a national stock exchange (Nasdaq or NYSE),
his base salary will be increased to $275,000 annually. Mr. Knaley is also eligible to receive an annual incentive bonus. During 2021,
Mr. Knaley will be eligible for 50% of the incentive award allocated to executives. If a similar plan is in place for 2022 and subsequent
years, he will be eligible for 100% of the incentive award allocated to executives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2021, the Board granted Mr. Knaley non-qualified stock options to purchase 13,333 shares of the Company&#8217;s common
stock, which vest as follows: (i) 1,667 options vest and become exercisable on the grant date, (ii) 2,780 options vest
and become exercisable on June 30, 2022, if Mr. Knaley continues to be employed by the Company on that date, (iii) 4,433 options
vest and become exercisable on June 30, 2023, if Mr. Knaley continues to be employed by the Company on that date, and (iv) 4,453
options vest and become exercisable on June 30, 2024, if Mr. Knaley continues to be employed by the Company on that date. The exercise
price of these options will be based on the closing price of the Company&#8217;s common stock on June 25, 2021.&#9; In the event of a
change of control involving the Company, any remaining special stock bonuses related to any period ending after the date of the change
of control will become due and payable, provided Mr. Knaley continues to provide services to the Company on the date immediately preceding
the date of the change of control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_015"></span><b>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following describes certain agreements and transactions between the Company and its co-founders, Brandy and Stephen Keen (the &#8220;Co-founders&#8221;).
The Co-founders held various executive officer and director positions with the Company until May 2018. One of the Co-founders also was
a consultant to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the
Company, the Co-founders did not own more than 10% of the Company&#8217;s outstanding common stock at any time during 2020 or 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Equipment,
Demonstration and Product Testing Agreement</i>. In May 2017, we entered into a three-year equipment, demonstration and product testing
agreement with a licensed cannabis cultivation company affiliated with Mr. Keen. Under this agreement, we agreed to lease the cultivation
company certain cultivation equipment in exchange for a quarterly fee of $16,500, which was increased to $18,330 to reflect additional
leased equipment requested by the cultivation company (the &#8220;Lease Fee&#8221;). In consideration for access to the cultivation facility
to conduct demonstration tours and for the product testing and data to be provided by the cultivation company, we agreed to pay the cultivation
company a quarterly fee of $12,000 (the &#8220;Demo and Testing Fee&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
parties each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation company failed to
make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During the second quarter
of 2019, we notified the cultivation company of its breach for non-payment of the Lease Fee. In February 2020, the parties mutually agreed
to terminate this agreement and release each other from all claims related to this agreement, including any unpaid Lease Fees or Demo
and Testing Fees. We also agreed to transfer the equipment to the cultivation company for no additional consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment
Agreement</i>. In May 2018, we entered into an employment agreement with Ms. Keen, which provided for an initial base salary of $150,000
per year and certain sales incentive. Pursuant to the employment agreement, we awarded 32,000 restricted stock units (&#8220;RSUs&#8221;)
to Ms. Keen that vested at certain dates in the future, subject to her continued employment. These RSU&#8217;s have now fully vested
and Ms. Keen continues her employment with the Company under this agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises, Inc. (&#8220;RSX&#8221;), a company controlled
by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services to the Company focused on product offerings,
engineering requirements, key customer marketing outreach, and related matters, as mutually determined by the Company and RSX. The Company
will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the various consulting activities undertaken and provide
for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual property developed by RSX will belong
to the Company, and the contract provides for typical indemnification obligations and confidentiality provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 80; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_016"></span><b>PRINCIPAL
STOCKHOLDERS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the shares of our common stock beneficially owned by (i) each of our directors, (ii) each of our named executive
officers, (iii) all of our directors and executive officers as a group, and (iv) all persons known by us to beneficially own more than
5% of our outstanding common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has determined the beneficial ownership shown on this table in accordance with the rules of the SEC. Under these rules, shares
are considered beneficially owned if held by the person indicated, or if such person, directly or indirectly, through any contract, arrangement,
understanding, relationship or otherwise, has or shares the power to vote, to direct the voting of and/or to dispose of or to direct
the disposition of such shares. A person is also deemed to be a beneficial owner of shares if that person has the right to acquire such
shares within 60 days through the exercise of any warrant, option or right or through conversion of a security. Except as otherwise indicated
in the accompanying footnotes, the information in the table below is based on information as of the date of this prospectus. Unless otherwise
indicated in the footnotes to the following table, each person named in the table has sole voting and investment power with respect to
shares of common and preferred stock and the address for such person is c/o CEA Industries Inc. 385 South Pierce Avenue, Suite C, Louisville,
CO 80027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name of Beneficial Owner</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Owned Beneficially Before Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Before Offering <sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares Owned Beneficially After Offering</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage After Offering <sup>(2)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald <sup>(3)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">64,984</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">4.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">64,984</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1.4</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James R. Shipley <sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas J. Etten <sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marion
    Mariathasan <sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,684</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troy
    L Reisner <sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,684</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Executive Officers who are not Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Knaley <sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Executive Officers and Directors as a Group</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">91,140</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">5% or More Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John F. Jansen <sup>()</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.9</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1) Based on a total of 1,604,202 shares of
the Company&#8217;s common stock issued and outstanding as of January 28, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2) Based on a total of 4,567,165 shares,
after giving effect to the previously noted reverse split on January 27, 2022 of the Company as of January 28, 2022, and includes
the sale of 2,962,963 shares of common stock offered hereby, excluding the shares of common stock that may be sold under the overallotment
option, assuming no exercise of warrants issued in the offering and no issuance of pre-funded warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(3) Includes 8,119 outstanding shares of common
stock and 56,865 shares of common stock issuable upon options that are currently exercisable. Excludes 30,194 shares of
common stock issuable upon the exercise of options that vest in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) Represents 10,561 shares of common stock
issuable upon the exercise of currently exercisable options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(5) Represents 10,561 shares of common stock
issuable upon the exercise of currently exercisable options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(6) Excludes 1,684 shares of common stock issuable
upon vesting of a restricted stock unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(7) Excludes 1,684 shares of common stock issuable
upon vesting of a restricted stock unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(8) Excludes 13,333 shares of common stock
issuable upon exercise of options that vest in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(9) Beneficial ownership based on Schedule
13G dated May 25, 2018 filed by Mr. Jansen with the SEC, and share ownership reported by Mr. Jansen to the Company as of March 8, 2020.
The address for Mr. Jansen is 4910 Kaylan Court, Richmond, TX 77407.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ajz_017"></span>DESCRIPTION
OF THE SECURITIES</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
following is a summary of information concerning capital stock of the Company and the securities we are offering. The summaries
and descriptions below do not purport to be complete statements of the relevant provisions of the Company&#8217;s articles of incorporation,
as amended, amended and restated by-laws, and the pre-funded warrants, all of which are entirely qualified by these documents.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
articles of incorporation, as amended, taking into account the 1 for 150 reverse split of the common stock and adjustment
to the authorized shares made on January 27, 2022, currently authorizes us to issue up to 200,000,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Subject
to prior dividend rights of the holders of any shares of issued and outstanding preferred stock of the Company, holders of shares of
common stock are entitled to receive dividends when, as and if declared by the Board out of funds legally available for that purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Each
share of common stock is entitled to one vote on all matters submitted to a vote of stockholders. Holders of shares of common stock do
not have cumulative voting rights. The holders of a majority of the shares of common stock present and entitled to vote in the election
of directors can elect all directors standing for election.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
the event of any liquidation, dissolution or winding up of the Company, after the satisfaction in full of the liquidation preferences
of holders of any shares of issued and outstanding preferred stock, holders of shares of common stock are entitled to ratable distribution
of the remaining assets available for distribution to stockholders. The shares of common stock are not subject to redemption by operation
of a sinking fund or otherwise. Holders of shares of common stock are not currently entitled to pre-emptive rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
issued and outstanding shares of common stock are fully paid and non-assessable. Any additional shares of common stock that the Company
may issue in the future will also be fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our articles of incorporation,
as amended, taking into account the adjustment to the authorized shares made on January&#160;27,
2022, authorizes us to issue up to 25,000,000 shares of undesignated preferred stock, par value $0.00001 per share. We may
issue preferred stock from time to time in one or more series, without shareholder approval, when authorized by our Board. Our Board
had authorized 3,300 shares of Series B Convertible Preferred Stock (described below), all of which are issued and outstanding and
upon redemption will be returned to the status of authorized but unissued shares of preferred stock. No other shares of preferred
stock are issued or are outstanding.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
specific terms of any series of preferred stock will be governed by our articles of incorporation and by the certificate of designations
relating to that series. The Board has the right, without prior approval of the holders of common stock, subject to any rights of currently
issued preferred stock, to specify any and all terms of a series of preferred stock, including the rank, dividend and distribution rights,
voting rights, liquidation rights and redemption, conversion and preemption rights. The issuance of preferred stock could have the effect
of restricting dividends on our common stock, diluting the voting power of our common stock, impairing the liquidation rights of our
common stock, or delaying or preventing a change in control of us, all without further action by our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
B Preferred Stock</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Rank.
The Series B Preferred Stock ranks superior to all other classes, including the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Dividends.
The Series B Preferred Stock carries a dividend rate of 8% per annum, payable quarterly, in cash, and at the Company&#8217;s election,
in certain circumstances and subject to blocker provisions, payable in shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Liquidation
Preference. Each holder of Series B Preferred Stock shall be entitled to receive, prior to all other classes of capital stock, including
the Common Stock, for each share thereof, out of assets of the Company legally available therefore, a preferential amount in cash, per
share, equal to the greater of (A) 120% of the Stated Value ($1,000) plus all accrued and unpaid dividends thereon, on the date of such
payment, and (B) the amount per share such holder would receive if such holder converted such Series B Preferred Stock into Common Stock
immediately prior to the date of such payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Voting.
The Series B Preferred Stock has no voting rights other than those provided by statute on matters affecting the rights and obligations
of the Series B Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Conversion
Rights. The holders of the Series B Preferred Stock may convert the shares of Series B Preferred Stock into shares of Common Stock at
any time at an initial conversion price of $8.55. The conversion rate is subject to adjustment in various circumstances, including
stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering event and subject to reset if the
Common Stock of the Company sold in a subsequent equity transaction and in a Qualified Offering (i.e., the first public offering in which
the common stock is listed on a national exchange) is below the then conversion price. There are cash penalties imposed on the Company
if it fails to deliver timely the shares of Common Stock due upon a conversion. The Series B Preferred Stock is mandatorily convertible
on the third anniversary of its issuance. The Company is obligated to and has reserved shares of common stock for issuance on conversion
of the Series B Preferred Stock equal to 200% of the number of shares of common stock that may be issued on conversion of the Series
B Preferred Stock, and upon conversion, the Company will not use the reserved shares for issuance. On January 28, 2022, we agreed
with the Series B investor that it would convert 1,650 shares of Series B Preferred Stock, plus accrued and unpaid dividends into the
securities being offered hereby, at the completion of the offering, for approximately 325,926 shares of common stock and/or pre-funded
warrants and approximately 325,926 warrants, at a rate equal to 75% of the public offering price of $6.75. The securities being issued
to the Series B investor will be subject to a 90-day lock-up, and are restricted securities, subject to the Series B investor&#8217;s
registration rights and ability to sell the securities under Rule 144.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Redemption
Rights. The holders of the Series B Preferred Stock have the right to cause their shares to be redeemed in full at the redemption price,
which is 120% of the stated value of $1,000. The redemption right may be exercised by the holders at any time after the earlier of (x)
the consummation by the Company of a Qualified Offering (as described above), or (y) the first anniversary of the issuance of the Series
B Preferred Shares. The redemption price is also reset upon a triggering event. On January 28,<sup> </sup> 2022, we agreed with the
Series B investor to redeem 1,650 shares of our Series B Preferred Stock for approximately $2.0 million following the closing of this
offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Preemption
Rights. The Series B Preferred Stock does not have preemptive rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 83; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
to be Issued in this Offering</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief summary of certain terms and conditions of the warrants to be issued in connection with this offering and are subject
in all respects to the provisions contained in the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form.
The warrants will be issued in electronic book-entry form to the investors. You should review a copy of the form of warrant, which is
filed as an exhibit to the registration statement of which this prospectus forms a part, for a complete description of the terms and
conditions applicable to the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisability.
The warrants are exercisable at any time after their original issuance, , and at any time up to the date that is five years after their
original issuance. The warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed
exercise notice and, at any time a registration statement registering the issuance of the shares of common stock underlying the warrants
under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available funds
for the number of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares
of common stock underlying the warrants under the Securities Act is not effective or available, the holder may, in its sole discretion,
elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of
shares of common stock determined according to the formula set forth in the warrant. No fractional shares of common stock will be issued
in connection with the exercise of a warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional
amount multiplied by the exercise price or round up to the next whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
Limitation. A holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would
beneficially own in excess of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise,
as such percentage ownership is determined in accordance with the terms of the warrants. However, any holder may increase or decrease
such percentage to any other percentage not in excess of 9.99% upon at least 61 days&#8217; prior notice from the holder to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
Price. The exercise price per whole share of common stock purchasable upon exercise of the warrants is expected to be $ per share ( %
of public offering price of common stock) of common stock. The exercise price is also subject to appropriate adjustment in the event
of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our common
stock and also upon any distributions of assets, including cash, stock or other property to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferability.
Subject to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Listing. We have applied for the listing of the warrants offered in this offering on The Nasdaq Capital Market under the symbol &#8220;CEADW&#8221;.
No assurance can be given that such listing will be approved or that a trading market will develop.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fundamental
Transactions. In the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization
or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person
or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the holders of the warrants
will be entitled to receive upon exercise of the warrants the kind and amount of securities, cash or other property that the holders
would have received had they exercised the warrants immediately prior to such fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
as a Stockholder. Except as otherwise provided in the warrants or by virtue of such holder&#8217;s ownership of shares of our common
stock, the holder of a warrant does not have the rights or privileges of a holder of our common stock, including any voting rights, until
the holder exercises the warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Funded
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the pre-funded warrants that are being offered hereby in lieu of a share of common
stock is not complete and is subject to, and qualified in its entirety by, the provisions of the pre-funded warrant, the form of which
is filed as an exhibit to the registration statement of which this prospectus forms a part. Prospective investors should carefully review
the terms and provisions of the form of pre-funded warrant for a complete description of the terms and conditions of the pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duration
and Exercise Price. Each pre-funded warrant offered hereby will have an initial exercise price per share equal to $0.01. The pre-funded
warrants will be immediately exercisable and may be exercised at any time until the pre-funded warrants are exercised in full or they
expire. The exercise price and number of shares of common stock issuable upon exercise is subject to appropriate adjustment in the event
of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisability.
The pre-funded warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise (except in the case of
a cashless exercise as discussed below). There is no expiration date for the pre-funded warrants. A holder (together with its affiliates)
may not exercise any portion of the pre-funded warrant to the extent that the holder would own more than 4.99% (or at the election of
the holder prior to the issuance of any pre-funded warrants, 9.99%) of the outstanding shares of common stock immediately after exercise.
Any holder may increase such percentage to any percentage not in excess of 9.99% upon at least 61 days&#8217; prior notice to us. No
fractional shares of common stock will be issued in connection with the exercise of a pre-funded warrant. In lieu of fractional shares
of common stock, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price of such pre-funded
warrant or round up to the next whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless
Exercise. In lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise
price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock
determined according to a formula set forth in the pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<!-- Field: Page; Sequence: 84; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fundamental
Transaction. In the event of a fundamental transaction, as described in the pre-funded warrants and generally including any reorganization,
recapitalization or reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our
properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares
of common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding shares
of common stock, the holders of the pre-funded warrants will be entitled to receive upon exercise of the pre-funded warrants the kind
and amount of securities, cash or other property that the holders would have received had they exercised the pre-funded warrants immediately
prior to such fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferability.
Subject to applicable laws, a pre-funded warrant may be transferred at the option of the holder upon surrender of the pre-funded warrant
to us together with the appropriate instruments of transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Listing. We do not intend to list the pre-funded warrants on any securities exchange or nationally recognized trading system.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights
as a Stockholder. Except as otherwise provided in the pre-funded warrants or by virtue of such holder&#8217;s ownership of shares of
our common stock, the holders of the pre-funded warrants do not have the rights or privileges of holders of our common stock, including
any voting rights, until they exercise their pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Series B Related Warrants</b></p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
holder of the Series B Preferred Stock was sold, as part of the purchase of the Series B Preferred Stock, a warrant to purchase up to
192,283 shares of common stock, until September 28, 2024 at an initial exercise price of $9.45, subject to adjustment for
stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution
of rights. This warrant provides for cashless exercise if the underlying shares of common stock are not registered for resale by the
holder. This warrant is subject to the registration rights agreement described below. This warrant provides for various penalties payable
by the Company if it does not timely deliver the common stock issuable on exercise, and issuances upon exercise are subject to a 4.99%
blocker provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company also issued to ThinkEquity LLC and its designees placement agent warrants to purchase up to an aggregate of 34,737 shares
of common stock, as part of the compensation due to ThinkEquity LLC in acting as the placement agent for the transaction. Half of the
warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021. The exercise price per share of the
placement agent warrants is $10.395, subject to adjustment for stock splits, stock dividends and other typical adjustments and
changes in capitalization, including mergers and acquisitions and distribution of rights. The warrants are exercisable for three years,
until September 28, 2024 and November 3, 2024, respectively, based on the issuance date. The placement agent warrants have
registration rights described below, and may be included on the registration statement provided to the holder of the Series B Preferred
Stock for registration of the common stock underlying the preferred shares and the investor warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
Rights</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company entered into a registration rights agreement with the holder of the Series B Preferred Stock. Under the agreement, the Company
is obliged to register the common stock underlying and issuable upon conversion of the Series B Preferred Stock and exercise of the warrant
issued to the holder of the Series B Preferred Stock. The Company is obligated to file a registration statement for resale of the common
stock no later than 180 days after the date of a qualified offering, and have it effective 225 days after the Qualified Offering if there
is no SEC review of the resale registration statement, and if there is an SEC review, then 255 days after the date of the qualified offering.
The offering described in this prospectus is a qualified offering for the purposes of the registration obligations. The Company is to
keep the registration effective until all the shares registered have been sold or may be sold under Rule 144, without regard to volume
and holding period restrictions. Securities of other holders may not be included on any registration statement for the securities of
the holder of the Series B Preferred Stock, except those of holders of the warrants issued to ThinkEquity LLC and its designees, and
there are the typical cut back provisions for any limitation of the number of shares of common stock that may be included thereon due
to SEC policy. The registration rights agreement also has demand and piggyback registration rights. The registration rights agreement
provides for substantive cash penalties due to the Investor if any of the obligations to register shares are not fulfilled on a timely
basis. The registration rights agreement provides for typical securities indemnification to the holders in respect of the registration
statement. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
warrants issued to ThinkEquity LLC also have registration rights. The holders of these warrants have one demand registration right, upon
the request of 51% of the warrants outstanding, and unlimited piggyback registration rights for 7 years after the issuance date. If there
is a demand for registration, the Company is obligated to file a registration statement within sixty days and use its reasonable best
efforts to have the registration statement declared effective promptly thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 85; Value: 70 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized
but Unissued Shares</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
authorized but unissued shares of our common stock are available for future issuance without shareholder approval, subject to any limitations
imposed by the listing standards of The Nasdaq Capital Market. These additional shares may be used for a variety of corporate finance
transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred
stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or
otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-takeover
provisions</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">We
are governed by the provisions of Nevada Revised Statutes 78.378 to 78.3793 because we are incorporated in Nevada, which prohibits a
person who owns in excess of ten percent (10%) of our outstanding voting stock from merging, consolidating or combining with us for a
period of three years after the date of the transaction in which the person acquired in excess of ten percent (10%) of our outstanding
voting stock, unless the merger, consolidation or combination is approved in a prescribed manner. Any provision in our Articles of Incorporation
or our Bylaws or Nevada law that has the effect of delaying or deterring a change in control could limit the opportunity for our Shareholders
to receive a premium for their shares of our common stock and could also affect the price that some investors are willing to pay for
our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
of Liability and Indemnification of Directors and Officers</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
articles of incorporation and bylaws provide that our directors and officers will be indemnified by us to the fullest extent authorized
by Nevada law as it now exists or may in the future be amended, against all expenses and liabilities reasonably incurred in connection
with their service for or on our behalf. In addition, our articles of incorporation provides that our directors will not be personally
liable for monetary damages to us for breaches of their fiduciary duty as directors, except for liability (i) for any appropriation by
a director, in violation of his or her duties, of any business opportunity of the Corporation, (ii) for acts or omissions which involve
intentional misconduct or a knowing violation of the law, (iii) with respect to illegal dividends or redemptions, or (iv) for any transaction
from which the director received an improper personal benefit. Our bylaws also permit us to secure insurance on behalf of any officer,
director or employee for any liability arising out of his or her actions, regardless of whether Nevada law would permit indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">These
provisions may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions
also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action,
if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder&#8217;s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.
We believe that these provisions, insurance and the indemnity agreements are necessary to attract and retain talented and experienced
directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">There
is no pending litigation or proceeding involving any of our directors or officers where indemnification by us would be required or permitted.
We are not aware of any threatened litigation or proceeding that might result in a claim for such indemnification. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the
foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy
as expressed in the Securities Act and is, therefore, unenforceable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
transfer agent and registrar for our common stock and warrants is Continental Stock Transfer &amp; Trust
Company, One State Street Plaza, 30<sup>th </sup>Floor, New York, New York, 10004, and their general telephone number is 212-509-4000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_018"></span><b>SHARES
ELIGIBLE FOR FUTURE SALE</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Future
sales of substantial amounts of our common stock and/or warrants in the public market, or the perception that such sales may occur,
could adversely affect market prices prevailing from time to time. The majority of the outstanding shares of common stock have been outstanding
for many years and will be available for sale at any time after this offering. Therefore, there may be sales of substantial amounts of
our common stock in the public market after the completion of this offering, which may adversely affect the prevailing market price and
our ability to raise equity capital in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Upon
completion of this offering, excluding the shares of common stock and warrants to be issued to the Series B investor, 4,567,165
shares of common stock and 2,962,963 warrants will be outstanding, assuming that all none of the pre-funded warrants are sold
in the offering. Of these shares, 2,962,963 shares of our common stock (or 3,407,407 shares if the underwriters exercise
in full their option to purchase additional shares) and all the warrants sold in this offering will be freely transferable without
restriction or further registration under the Securities Act, except for any shares or warrants purchased by our &#8220;affiliates,&#8221;
as that term is defined in Rule 144 under the Securities Act. Of the shares of common stock that will be outstanding, approximately
486,674 shares of common stock and approximately 325,926 warrants, exercisable for a like number of shares of common stock are &#8220;restricted
shares&#8221; as defined in Rule 144. Restricted shares may be sold in the public market only if registered under the Securities Act
or if they qualify for an exemption from registration under Rule 144. As a result of the 90 or 180-day lock-up period described
below, the shares subject to lock-up arrangements will be available for sale in the public market only after 90 or 180 days from
the date of this prospectus (generally subject to resale limitations).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rule
144</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
general, a person who has beneficially owned restricted shares of our common stock for at least six months would be entitled to sell
such securities, provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time during
the 90 days preceding, the sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least 90 days before
the sale. Persons who have beneficially owned restricted shares of our common stock for at least six months but who are our affiliates
at the time of, or any time during the 90 days preceding, the sale, would be subject to additional restrictions, by which such person
would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of the following:
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">1%
                                            of the number of shares of our common stock then outstanding, which will equal approximately
                                            41,520 shares immediately after this offering; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">the
                                            average weekly trading volume of our common stock on the Nasdaq Capital Market during the
                                            four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">provided,
in each case, that we are subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales
both by affiliates and by non-affiliates must also comply with the manner of sale and notice provisions of Rule 144 to the extent applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lock-up
Agreements</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company, each of our directors and executive officers, and our 5% and greater stockholders and the holders of our Series B Preferred
Stock, have agreed not to or are otherwise restricted in their ability to, subject to certain limited exceptions, offer, pledge, sell,
contract to sell, grant any option to purchase, or otherwise dispose of our common stock, warrants, or any securities convertible
into or exchangeable or exercisable for common stock, or to enter into any hedge or other arrangement or any transaction that transfers,
directly or indirectly, the economic consequence of ownership of the shares of our common stock, in the case of the Company and our 5%
and greater stockholders, for a period of 90 days after the date of this prospectus, and in the case of our directors and executive officers for a period of 180 days after the date of this prospectus, without the prior written
consent of ThinkEquity, as representative of the underwriters. See &#8220;Underwriting&#8212;Lock-up Agreements.&#8221; The underwriters
do not have any present intention or arrangement to release any shares of our common stock subject to lock-up arrangements prior to the
expiration of the 90- or 180-day lock-up period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>


<!-- Field: Page; Sequence: 2; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_019"></span><b>UNDERWRITING</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an underwriting agreement, dated , &#160;&#160;&#160;&#160;&#160;2022, with ThinkEquity LLC, acting as the sole
book-running manager (sometimes referred to as the &#8220;Representative&#8221;). Subject to the terms and conditions of the underwriting
agreement, each of the underwriters named below have agreed to purchase, and we have agreed to sell to it, the number of shares of common
stock, pre funded warrants and warrants listed next to its name at the public offering price, less the underwriting discounts
and commissions, as set forth on the cover page of this prospectus and as indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Underwriters:</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares <br />
and Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Pre-Funded Warrants and
    Warrants</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">ThinkEquity LLC</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Total:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligations of the underwriters to pay for and accept delivery of the shares of common stock,
pre-funded warrants and warrants offered by this prospectus are subject to various conditions and representations and warranties,
including the approval of certain legal matters by its counsel and other conditions specified in the underwriting agreement. The shares
of common stock, pre-funded warrants and warrants are offered by the underwriters, subject to prior sale, when, as and if issued
to and accepted by the underwriters. The underwriters reserve the right to withdraw, cancel or modify the offer to the public and to
reject orders in whole or in part. The underwriters are obligated to take and pay for all of the shares of common stock, pre-funded
warrants and warrants offered by this prospectus if any such securities are taken.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have agreed to indemnify the underwriters and certain of their affiliates and controlling persons (within the meaning of Section 15 of
the Securities Act or Section 20 of the Exchange Act), among others, against specified liabilities, including liabilities under the Securities
Act, and to contribute to payments the underwriters may be required to make in respect thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Discounts
and Commissions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters propose to offer the shares of common stock, pre-funded warrants and warrants directly to the public at the public
offering prices set forth on the cover page of this prospectus. After the offering to the public, the offering prices and
other selling terms may be changed by the underwriters without changing the proceeds we will receive from the underwriters. Any shares,
pre-funded warrants and warrants sold by the underwriters to securities dealers will be sold at the public offering price less a
selling concession not in excess of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the public offering price, underwriting commissions and proceeds before expenses to us. The underwriting
commissions are 7% of the public offering price. We have also agreed to pay a non-accountable expense allowance to the
Representative equal to 1.0% of the gross proceeds received at the closing of the offering. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
                                            Share and</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    Pre-Funded Warrant and Warrant</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Without Over-Allotment Option</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    With Full Over-Allotment Option</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discount (7%)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accountable
    expense allowance (1%)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds,
    before expenses, to us</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to pay certain of the Representative&#8217;s expenses relating to the offering, including background checks of our directors
and executive officers, the fees and expenses of the Representative&#8217;s legal counsel and for the Representative&#8217;s use of Ipreo&#8217;s
book-building, prospectus tracking and compliance software for this offering, totaling $169,500.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total estimated expenses of the offering, including registration, filing and listing fees, printing fees and legal and accounting expenses,
but excluding underwriting discounts and commissions, are approximately $474,500.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Over-Allotment
Option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have granted the Representative
an over-allotment option. This option, which is exercisable for up to 45 days after the date of this prospectus, permits the Representative
to purchase up to an aggregate of up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional shares of common
stock and/or pre-funded warrants, representing 15% of the shares of common stock and pre-funded warrants sold in the offering and/or
up to additional warrants, representing 15% of the warrants sold in the offering. The purchase price to be paid per additional share
of common stock shall be equal to the public offering price of one share of common stock, less the underwriting discount,
the purchase price to be paid per pre-funded warrant shall be equal to the public offering price of one pre-funded warrant, and the purchase
price to be paid per additional warrant shall be US$0.00001.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Representative&#8217;s
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of this offering, we have agreed to issue to the Representative, or its designees, as compensation warrants to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares
of common stock, which is equal to 5% of the aggregate number of shares of common stock (or in lieu thereof the pre-funded warrants)
sold in this offering (the &#8220;Representative&#8217;s Warrants&#8221;). The Representative&#8217;s Warrants will be exercisable
at a per share exercise price equal to 125% of the public offering price per share and warrant in this offering. The Representative&#8217;s
Warrants are exercisable at any time and from time to time, in whole or in part, during the four year period commencing 180 days from
the effective date of the registration statement of which this prospectus is a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Representative&#8217;s Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA
Rule 5110(e)(1). The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate
these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call
transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180
days from the effective date of the registration statement. In addition, the warrants provide for registration rights upon request, in
certain cases. The one-time demand registration right provided will not be greater than five years from the effective date of the registration
statement in compliance with FINRA Rule 5110(g)(8)(C). The unlimited piggyback registration right provided will not be greater than seven
years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8)(D). We will bear all fees and expenses
attendant to registering the securities issuable on exercise of the warrants other than underwriting commissions incurred and payable
by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances
including in the event of a stock dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise
price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Discretionary
Accounts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
underwriters do not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Lock-Up
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We,
our executive officers and directors, our 5% and greater stockholders, and holders of our Series B Preferred Stock, have agreed pursuant
to &#8220;lock-up&#8221; agreements not to, or are subject to other restrictions so that they may not, without the prior written consent
of the Representative, directly or indirectly, offer to sell, sell, pledge or otherwise transfer or dispose of any of shares of (or enter
into any transaction or device that is designed to, or could be expected to, result in the transfer or disposition by any person at any
time in the future of) our common stock, enter into any swap or other derivatives transaction that transfers to another, in whole or
in part, any of the economic benefits or risks of ownership of shares of our common stock, make any demand for or exercise any right
or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any shares of common
stock or securities convertible into or exercisable or exchangeable for shares of common stock or any other of our securities or publicly
disclose the intention to do any of the foregoing, subject to customary exceptions, for, with respect to the Company and our 5% and greater
stockholders, a period of 90 days from the date of this prospectus, and with respect to our executive officers and directors, a period of 180 days from the date of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Right
of First Refusal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
have granted the Representative a right of first refusal, for a period of eighteen 18) months from the closing of the offering, to act
as sole and exclusive investment banker, book-runner, financial advisor, underwriter and/or placement agent, at the Representative&#8217;s
sole and exclusive discretion, for each and every future public and private equity and debt offering, including all of our equity linked
financings (each, a &#8220;Subject Transaction&#8221;), or any successor (or any of our subsidiaries), on terms and conditions customary
to the Representative for such Subject Transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Nasdaq
Capital Market</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have applied to list our shares of common stock and warrants on the Nasdaq Capital Market under the symbols &#8220;CEAD&#8221;
and &#8220;CEADW.&#8221; There is no established trading market for the pre-funded warrants. We do not expect a market for such securities
to develop. In addition, we do not intend to apply for the listing of the pre-funded warrants on any national securities exchange or
other trading market. Without an active trading market, the liquidity of the pre-funded warrants will be limited.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Price
Stabilization, Short Positions and Penalty Bids</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to facilitate the offering of our securities, the underwriters may engage in transactions that stabilize, maintain or otherwise
affect the price of our securities. In connection with the offering, the underwriters may purchase and sell our securities in the open
market. These transactions may include short sales, purchases on the open market to cover positions created by short sales and stabilizing
transactions. Short sales involve the sale by the underwriters of a greater number of securities than they are required to purchase in
the offering. &#8220;Covered&#8221; short sales are sales made in an amount not greater than the underwriters&#8217; option to purchase
additional securities in the offering. The underwriters may close out any covered short position by either exercising the over-allotment
option to purchase securities or purchasing securities in the open market. In determining the source of securities
to close out the covered short position, the underwriters will consider, among other things, the price of securities available
for purchase in the open market as compared to the price at which they may purchase securities through the over-allotment option
to purchase securities. &#8220;Naked&#8221; short sales are sales in excess of the over-allotment option to purchase securities.
The underwriters must close out any naked short position by purchasing securities in the open market. A naked short position
is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our securities in
the open market after pricing that could adversely affect investors who purchase in the offering. Stabilizing transactions consist of
various bids for or purchases of securities made by the underwriters in the open market before the completion of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Similar
to other purchase transactions, the underwriters&#8217; purchases to cover the syndicate short sales may have the effect of raising or
maintaining the market price of our securities or preventing or retarding a decline in the market price of our securities. As result,
the price of our securities may be higher than the price that might otherwise exist in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
underwriters make no representation or prediction as to the direction or magnitude of any effect that the transactions described above
may have on the price of our securities. In addition, neither we nor the underwriters make any representation that the underwriters will
engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Electronic
Offer, Sale and Distribution of Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
prospectus in electronic format may be made available on the websites maintained by the underwriters or selling group members, if any,
participating in the offering. The underwriters may agree to allocate a number of securities to underwriters and selling group
members for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriter and selling group
members that may make internet distributions on the same basis as other allocations. Other than the prospectus in electronic format,
the information on any underwriter&#8217;s website and any information contained in any other website maintained by an underwriter is
not part of this prospectus or the registration statement of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the underwriters and/or their affiliates may provide in the future, various advisory, investment and commercial banking
and other services to us in the ordinary course of business, for which they will receive customary fees and commissions. However, except
as disclosed in this prospectus, we have no present arrangements with the underwriters or any of their affiliates for any further services.
In connection with the offering of our Series B Preferred Stock in September 2021, we engaged the Representative as our placement
agent, and paid the Representative a total cash fee of 9% of the gross proceeds, equal to $270,000, and its expenses, less prepaid expenses,
and issued to the Representative and its designees warrants to purchase up to an aggregate of 34,737 shares of common stock, at an exercise
price per share of $10.395, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization,
including mergers and acquisitions and distribution of rights. The warrants are exercisable for three years, until September 28, 2024
and November 3, 2024, respectively, based on the issuance date. The warrants issued to the Representative in connection with the private
placement are deemed underwriting compensation by FINRA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pricing
of the Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price was determined by negotiations between us and the Representative. Among the factors considered in determining the
public offering price were our future prospects and those of our industry in general, our sales, earnings and certain other financial
and operating information in recent periods, and the price-earnings ratios, price-sales ratios, market prices of securities, and certain
financial and operating information of companies engaged in activities similar to ours. Neither we nor the underwriters can assure investors
that an active trading market for the securities will develop or that, after the offering, the securities will trade in
the public market at or above the public offering price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Offer
Restrictions Outside the United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Canada</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale
of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements
of applicable securities laws. Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies
for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies
for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s
province or territory for particulars of these rights or consult with a legal advisor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>China</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
information in this document does not constitute a public offer of the securities, whether by way of sale or subscription, in the People&#8217;s
Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region
and Taiwan). The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly
to &#8220;qualified domestic institutional investors.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>European
Economic Area&#8201;&#8212;&#8201;Belgium, Germany, Luxembourg and Netherlands</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under
the Directive 2003/71/EC (&#8220;Prospectus Directive&#8221;), as implemented in Member States of the European Economic Area (each, a
&#8220;Relevant Member State&#8221;), from the requirement to produce a prospectus for offers of securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">An
offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following
exemptions under the Prospectus Directive as implemented in that Relevant Member State:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
                                            legal entities that are authorized or regulated to operate in the financial markets or, if
                                            not so authorized or regulated, whose corporate purpose is solely to invest in securities;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
                                            any legal entity that has two or more of (i) an average of at least 250 employees during
                                            its last fiscal year; (ii) a total balance sheet of more than &#8364;43,000,000 (as shown
                                            on its last annual unconsolidated or consolidated financial statements) and (iii) an annual
                                            net turnover of more than &#8364;50,000,000 (as shown on its last annual unconsolidated or
                                            consolidated financial statements);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">to
                                            fewer than 100 natural or legal persons (other than qualified investors within the meaning
                                            of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent of
                                            the Company or any underwriter for any such offer; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">in
                                            any other circumstances falling within Article 3(2) of the Prospectus Directive, provided
                                            that no such offer of securities shall result in a requirement for the publication by the
                                            Company of a prospectus pursuant to Article 3 of the Prospectus Directive.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Hong
Kong</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the information in this document nor any other document relating to the offer has been delivered for registration to the Registrar of
Companies in Hong Kong, and its contents have not been reviewed or approved by any regulatory authority in Hong Kong, nor have we been
authorized by the Securities and Futures Commission in Hong Kong. This document does not constitute an offer or invitation to the public
in Hong Kong to acquire securities. Accordingly, unless permitted by the securities laws of Hong Kong, no person may issue or
have in its possession for the purpose of issue, this document or any advertisement, invitation or document relating to the securities,
whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public
in Hong Kong other than in relation to securities which are intended to be disposed of only to persons outside Hong Kong or only
to &#8220;professional investors&#8221; (as such term is defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong
Kong) (&#8220;SFO&#8221;) and the subsidiary legislation made thereunder) or in circumstances which do not result in this document being
a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance of Hong Kong (Cap. 32 of the
Laws of Hong Kong) (the &#8220;CO&#8221;) or which do not constitute an offer or an invitation to the public for the purposes of the
SFO or the CO. The offer of the securities is personal to the person to whom this document has been delivered by or on behalf
of our company, and a subscription for securities will only be accepted from such person. No person to whom a copy of this document
is issued may issue, circulate or distribute this document in Hong Kong or make or give a copy of this document to any other person.
You are advised to exercise caution in relation to the offer. If you are in any doubt about any of the contents of this document, you
should obtain independent professional advice. No document may be distributed, published or reproduced (in whole or in part), disclosed
by or to any other person in Hong Kong or to any person to whom the offer of sale of the securities would be a breach of the CO
or SFO.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Israel</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the &#8220;ISA&#8221;),
nor have such securities been registered for sale in Israel. The securities may not be offered or sold, directly or indirectly,
to the public in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection
with the offering or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or
completeness, or rendered an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly,
to the public of the securities offered by this prospectus is subject to restrictions on transferability and must be effected only in
compliance with the Israeli securities laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 7; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>United
Kingdom</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Neither
the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services
Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as
amended (&#8220;FSMA&#8221;)) has been published or is intended to be published in respect of the securities. This document is issued
on a confidential basis to &#8220;qualified investors&#8221; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and
the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document,
except in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not
be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other person in
the United Kingdom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Any
invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the
issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be
communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply to our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters
relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial
Promotions) Order 2005 (&#8220;FPO&#8221;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high
net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together
&#8220;relevant persons&#8221;). The investments to which this document relates are available only to, and any invitation, offer or agreement
to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document
or any of its contents.<br /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 8; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_020"></span><b>LEGAL
MATTERS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered hereby will be passed upon for us by Golenbock Eiseman Assor Bell &amp; Peskoe LLP, New York,
New York. Dentons US LLP, New York, New York, is acting as counsel for the underwriters.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_021"></span><b>EXPERTS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements of CEA Industries as of December 31, 2020 and 2019 and for the years then ended included in this prospectus
have been so included in reliance on the reports of Sadler, Gibb &amp; Associates, LLC and ACM LLP, respectively, each
an independent registered public accounting firm, which are included herein, given on the authority of said firm as experts in auditing
and accounting.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="ajz_022"></span><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act, with respect to the securities being offered
by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information set
forth in the registration statement or the exhibits and schedules filed therewith. Statements contained in this prospectus regarding
the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete,
and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit
to the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are subject to the information and periodic requirements of the Exchange Act and, in accordance therewith, file annual, quarterly and
current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information
statements and other information regarding registrants that file electronically with the SEC. The address is www.sec.gov. We also maintain
a website at <span style="text-decoration: underline">www.ceaindustries.com</span>. You may access our annual reports on Form 10-K, quarterly reports on Form10-Q, current
reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the
SEC free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. The reference
to our website does not constitute incorporation by reference of the information contained on or accessible through our website, and
you should not consider the contents of our website in making an investment decision with respect to our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 24pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 24pt"></p>


<!-- Field: Page; Sequence: 9; Value: 81 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="ra_011"></span>INDEX
TO FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page(s)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">Reports of Independent Registered Public Accounting Firms</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2
    - F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">Consolidated Balance Sheets as of December 31, 2020 and 2019</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">Consolidated Statements of Operations for the Years Ended December 31, 2020 and 2019</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029">Consolidated Statements of Changes in Shareholders&#8217; Deficit for the Years Ended December 31, 2020 and 2019</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030">Consolidated Statements of Cash Flows for the Years Ended December 31, 2020 and 2019</a></span></p> </td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031">Notes to Consolidated Financial Statements</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-9</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#cr_001">Condensed Consolidated Balance Sheets as of September 30, 2021 and December 31, 2020</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.65in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#cr_002">Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#cr_003">Condensed Consolidated Statements of Changes in Shareholders&#8217; Deficit for the Three and Nine Months Ended September 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#cr_004">Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#cr_005">Notes to the Condensed Consolidated Financial Statements</a></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-36</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline"><span id="a_026"></span>Report
of Independent Registered Public Accounting Firm</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">To
the Board of Directors and Shareholders of Surna Inc.:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Opinion
on the Financial Statements</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have audited the accompanying consolidated balance sheet of Surna Inc. (&#8220;the Company&#8221;) as of December 31, 2020, the related
consolidated statements of operations, changes in shareholders&#8217; deficit, and cash flows for the year ended December 31, 2020 and
the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements referred
to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of
its operations and its cash flows for the year ended December 31, 2020, in conformity with accounting principles generally accepted in
the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Explanatory
Paragraph Regarding Going Concern</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note
3 to the financial statements, the Company has experienced losses since its inception, has a net working capital deficiency and has an
accumulated deficit, which creates substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard
to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome
of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Basis
for Opinion</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures included examining on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides
a reasonable basis for our opinion.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also have audited the adjustments to the 2019 consolidated financial statements to retrospectively apply the effect of the reverse stock
split, as described in Note 16. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged
to audit, review, or apply any procedures to the 2019 consolidated financial statements of the Company other than with respect to the
adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2019 consolidated financial statements
taken as a whole.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Critical
Audit Matters</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated
or required to be communicated to the audit committee and that: (1) related to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgements. The communication of critical audit matters
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical matters
below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue
Recognition &#8211; Contracts with Multiple Performance Obligations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Critical
Audit Matter Description</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
described in Note 2 to the financial statements, the Company&#8217;s contracts with customers often include the promise to transfer multiple
goods and services to a customer. Distinct promises within a contract are referred to as performance obligations and are accounted for
as separate units of account. Management assesses whether each promised good or service is distinct for the purpose of identifying the
performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments
about the individual promised goods or services and whether such goods or services are separable from the other aspects of the contractual
relationship. The Company&#8217;s performance obligations include various distinct goods and services such as equipment and various engineering
services. When multiple performance obligations are identified within a contract, management exercises judgement in allocating the transaction
price amongst the various performance obligations. In addition, when discounts are provided for a particular contract, the discount is
allocated to each performance obligation proportionally based upon the stand-alone selling price of each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
determined that performing procedures related to the identification of performance obligations in revenue contracts and allocation of
the transaction price to the respective performance obligations is a critical audit matter as there was significant judgment by management
in identifying performance obligations in revenue contracts and allocating the consideration, which in turn led to a high degree of auditor
judgment, subjectivity and effort in performing procedures to evaluate whether performance obligations in revenue contracts were appropriately
identified by management and consideration was appropriately allocated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>How
the Critical Audit Matter Was Addressed in the Audit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Our
audit procedures related to the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
    gained an understanding of the internal controls related to the revenue recognition process, including controls related to the proper
    identification of performance obligations and allocation of the transaction price to the various performance obligations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
    examined revenue contracts, on a test basis, to test the accuracy and completeness of management&#8217;s identification of the performance
    obligations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
    evaluated management&#8217;s process for allocation of the transaction price to the identified performance obligations including
    evaluating the reasonableness of management&#8217;s estimate of stand-alone selling prices.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
Sadler, Gibb &amp; Associates, LLC</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">We
have served as the Company&#8217;s auditor since 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Draper,
UT</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
23, 2021, except for the reverse stock-split retrospectively presented in these financial statements described in Note 16, as to which
is dated January 28, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Report of Independent Registered Public Accounting
Firm</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shareholders and Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Surna Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Boulder, Colorado</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Opinion on the Consolidated Financial Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of Surna Inc. and subsidiary (the &#8220;Company&#8221;) as of December 31, 2019, the related consolidated statements of
operations, shareholders&#8217; (deficit) equity, and cash flows for the year then ended, and the related notes (collectively referred
to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in
all material respects, the financial position of the Company at December 31, 2019, and the results of their operations and their cash
flows for the year then ended<b>, </b>in conformity with accounting principles generally accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We were not engaged to audit, review, or apply
any procedures to the adjustments to retrospectively present the reverse stock split described in Note 16 and, accordingly, we do not
express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those
adjustments were audited by other auditors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern Uncertainty</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the consolidated financial statements,
the Company has suffered recurring losses from operations and has a working capital deficiency and a shareholders&#8217; deficit as of
December 31, 2019 that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to
these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that might result from
the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Change in Accounting Principle</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As discussed in Note 4 to the consolidated financial
statements, on January 1, 2019, the Company changed its method of accounting for leases due to the adoption of the Accounting Standards
Codification Topic 842, <i>Leases</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Basis for Opinion</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These consolidated financial statements are the
responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial
statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were
we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s
internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides
a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>/s/ ACM LLP</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We served as the Company&#8217;s auditor from
2017 to 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Greeley, Colorado</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">March 24, 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_027"></span>Consolidated
Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_zFb8VV4dj9bj" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20201231_zAwOoRqsfTBb" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20191231_zzJQauE5hbYf" style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AssetsAbstract_iB_zZO2HCwgAD15" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AssetsCurrentAbstract_i01B_zifkUl2L0A27" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current
    Assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzNrp_zXJBuOjQqx49" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,284,881</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">922,177</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzNrp_zCanO86WN9f5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    receivable (net of allowance for doubtful accounts of $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20201231_pp0p0"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,098</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_z9Hv60mYmo7a"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,673</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif">,
    respectively)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,480</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,357</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--InventoryNet_i02I_maCzNrp_zUcjBlNMToW5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Inventory,
    net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">327,109</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,231,243</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzNrp_zdbeFgHiooy6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,823</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">269,491</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AssetsCurrent_i02TI_mtCzNrp_maCzrGY_zuXEnL3piJEa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Current Assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,683,293</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,561,268</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--AssetsNoncurrentAbstract_i01B_zMkFZEEiNRb8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Noncurrent
    Assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzT5T_zSxU8Yk2goGf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">147,732</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">257,923</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--Goodwill_i02I_maCzT5T_zamkJXlmUkb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">631,064</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">631,064</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_maCzT5T_zhnfifju4UQ2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,227</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,930</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DepositsAssetsNoncurrent_i02I_maCzT5T_z514jzUEu5C3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Deposits</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0063">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maCzT5T_zug0ofsDv88g" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,950</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">534,133</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--AssetsNoncurrent_i02TI_mtCzT5T_maCzrGY_zcbPjTC3hF4d" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Noncurrent Assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,129,973</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,486,050</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--Assets_i01TI_mtCzrGY_z2lf8k5DJIbj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,813,266</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,047,318</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zg9VFzAmd0r1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES
    AND SHAREHOLDERS&#8217; DEFICIT</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_i01B_zU1YHclMfYY6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CURRENT
    LIABILITIES</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maCzXlR_zDR4uoDi408k" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,784,961</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,832,959</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maCzXlR_zDJuFqe7TUZ4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,724,189</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,444,472</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_maCzXlR_zBzfKLXvKWV4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    equity compensation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,434</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_i02I_pp0p0_maCzXlR_ziCLfHyPqbgj" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzXlR_zdHj27t09477" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current
    portion of operating lease liability</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">266,105</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,843</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--LiabilitiesCurrent_i02TI_mtCzXlR_maCzENU_zSDznfqsDZW" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Current Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,903,689</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,998,740</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zeFUOnpXgVo4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NONCURRENT
    LIABILITIES</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--LongTermNotesPayable_i02I_pp0p0_maCzbQ3_z6lH6tWon9ig" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Note
    payable and accrued interest</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--OtherLiabilitiesNoncurrent_i02I_maCzbQ3_znRvdeUC9Etc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,156</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0106">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCzbQ3_zNRwZgAIEX8i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, net of current portion</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">169,119</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,209</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--LiabilitiesNoncurrent_i02TI_mtCzbQ3_maCzENU_z2CgWOSf8aNk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Noncurrent Liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">243,275</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">404,209</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--Liabilities_i01TI_mtCzENU_maCz8IO_z7lVxiQGraUj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,146,964</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,402,949</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--CommitmentsAndContingencies_i01I_maCz8IO_zugt8CQW3CCl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments
    and Contingencies (Note 11)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0117">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0118">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--TemporaryEquityAbstract_i01B" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"><b>TEMPORARY EQUITY</b></span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_i02I_pp0p0_maRNIECzuQX_zXOoGd7lwA3j" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Series B Redeemable
    Convertible Preferred Stock, $0.00001 par value; 3,300 and 0 issued and outstanding, respectively</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--RedeemableConvertiblePreferredStockSubscriptionReceivable_i02I_pp0p0_maRNIECzuQX_zQ4sGaa6AQi8" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Series B Redeemable
    Convertible Preferred Stock Subscription Receivable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_ecustom--RedeemableConvertiblePreferredStockAccruedDividends_i02I_pp0p0_maRNIECzuQX_zskzdFXRW1J4" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Series B Redeemable
    Convertible Preferred Stock Accrued Dividends</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--RedeemableNoncontrollingInterestEquityCarryingAmount_i02TI_pp0p0_mtRNIECzuQX_maCz8IO_zQLTOyteBh98" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Total Temporary Equity</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_ziSd8mCkIGGa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SHAREHOLDERS&#8217;
    DEFICIT</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--PreferredStockValue_i02I_maSEzmWX_zA1lPu1I8MUi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Preferred
    stock, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zJY0g4eCsNt8"><span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20191231_zIEDmG3SMZP9" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">par
    value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zc6VmcVEvcHg"><span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20191231_zKc7li0Gykej"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000,000</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    authorized; <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20201231_zPQi62ZVEm8h"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20191231_z5BFiNgzJs31"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20201231_zTqbadQLpgM"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20191231_zL3MO98VCKHj"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    issued and outstanding</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--CommonStockValue_i02I_maSEzmWX_z04cN3Yv4NRd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock, $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20191231_zjt9Iq7dbFC5"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201231_z5Vkob0l8aT9" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">par
    value; <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20191231_zZIn370LaUxa"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    authorized; <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20201231_zL2b09B7Q4hj" title="Common Stock, Shares, Issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_zW81DIQn30Uk" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">and
    <span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20191231_zCDzLLb3Ba7f" title="Common Stock, Shares, Issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20191231_zvyUXlhTnPLa" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,521,444</ix:nonFraction></ix:nonFraction></span></span></span> <span style="font-family: Times New Roman, Times, Serif">shares
    issued and outstanding, respectively</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></p></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_i02I_maSEzmWX_z7IrTgwBamTc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional
    paid in capital</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,109,509</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,328,861</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzmWX_zegqLuEDLKyd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,684,927</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--StockholdersEquity_i02TI_maCz8IO_mtSEzmWX_z6MNdiSFfCq8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    Shareholders&#8217; Deficit</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">355,631</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCz8IO_zXAMMo278lza" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,813,266</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,047,318</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="a_028"></span><b>Consolidated
Statements of Operations</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" id="xdx_302_113_zaGwBHVY9Hgi" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_498_20200101__20201231_zzAKrpNTpAFe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_499_20190101__20191231_zqNNdg5pi3Cd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Years Ended</span></p>
                                                                                <p style="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">December
                                            31,</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCz3y3_zlroyQhCvAQl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue,
    net</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,514,272</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,224,454</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CostOfRevenue_msCz3y3_zN9u9GArqjH9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost
    of revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,961,305</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,675,601</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--GrossProfit_iT_mtCz3y3_maCzMen_zSPh8xcBeBk6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross
    profit</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,552,967</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,548,853</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OperatingExpensesAbstract_iB_zRDtjXxm5z6e" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    expenses:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--MarketingAndAdvertisingExpense_i01_maCzRig_zs75ViY5NIM1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">430,012</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">675,703</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzRig_z847kfw01Yrj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">390,229</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">521,044</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzRig_zY2dHmYdEGY5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,095,350</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,662,695</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OperatingExpenses_i01T_mtCzRig_msCzMen_zQCzBuwLnkSg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,915,591</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,859,442</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--OperatingIncomeLoss_i01T_mtCzMen_maCzAef_zF7EaPgKdKr9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,362,624</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,310,589</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zuPdxWjZIShc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    income (expense):</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--OtherNonoperatingIncomeExpense_i01_maCzaJp_z2axrFHxUkY9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other
    income (expense), net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">621,340</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,977</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_407_eus-gaap--InterestExpense_i01N_di_msCzaJp_zZJrYH7yAiJh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    expense</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,432</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0211">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzaJp_maCzAef_zt8NbvphUnj7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other income (expense)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">603,908</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,977</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzAef_maCzFfE_zuyyy9p4hWyi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    before provision for income taxes</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,758,716</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,338,566</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_msCzFfE_z0UyLgok7fg4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0219">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0220">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtCzFfE_maNILATzGaT_zAN6QvW4j3r2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,758,716</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,338,566</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--RedeemablePreferredStockDividends_iN_pp0p0_di_msNILATzGaT_zAdRPrKrywSh" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Convertible Preferred
    Series B Stock Redemption Value Adjustment</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--ConvertiblePreferredStockConvertedToSecurities_iN_pp0p0_di_msNILATzGaT_zYJL5xjAnWwa" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Convertible Preferred
    Series B Stock Dividends</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pp0p0_mtNILATzGaT_znzbPxfphrL2" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Net Loss Available
    to Common Shareholders</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--EarningsPerShareBasicAndDiluted_z3BJ8MNK9bte" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    per common share &#8211; basic and dilutive</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.12</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.88</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zJE5tP2tf2Rl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted
    average number of common shares outstanding, basic and dilutive</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,574,454</ix:nonFraction></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,517,748</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="a_029"></span><b>Consolidated
Statements of Changes in Shareholders&#8217; Deficit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_114_zdcDvWh46b6l" summary="xdx: Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_z63skkN5qyN7" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zYbM4qhalcJ7" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zTj44jKheDY8" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zDlKtie8B4Ud" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4BA_ze3uEgRHcwid" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Preferred
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares to be Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid in Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_432_c20190101__20191231_eus-gaap--StockholdersEquity_iS_zmGfnPejWsC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif">Balance December 31, 2018</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zWwJYQnrnzRc" title="Balance, shares" style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwHcv23AxNJ1" title="Balance, shares" style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,499,932</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--CommonstockSharesToBeIssued_iS_pp0p0_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z39f513d4977" title="Beginning balance, shares to be issued" style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">6,667</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,540,262</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,346,361</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,336</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_zZP684dgZ9Of" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued on settlement of restricted
    stock units and award of stock bonuses, vested restricted stock units canceled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zdWoshcw3Q7h" title="Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0252">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMRk2M0CZRof" title="Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares" style="text-align: right"><span id="xdx_F20_zpLLYrVd9VXk" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,933</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr957fACD2Jk" title="Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0253">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKg_____zt0rhazXrZof" title="Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIENoYW5nZXMgaW4gU2hhcmVob2xkZXJzJyBEZWZpY2l0AA__"><span style="-sec-ix-hidden: xdx2ixbrl0264">-</span></span></span><sup></sup></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#160;</span></span></td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIENoYW5nZXMgaW4gU2hhcmVob2xkZXJzJyBEZWZpY2l0AA__" id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_fKg_____zHCA8BiFrVV4" style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">*</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl0255">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span id="xdx_F2E_z5iCAh2xu0nb" style="font-family: Times New Roman, Times, Serif">Common shares issued as compensation for services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrD8npXpEBoe" title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0267">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzAUXXhpOmDl" title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,579</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0268">&#160;</span></span></td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIENoYW5nZXMgaW4gU2hhcmVob2xkZXJzJyBEZWZpY2l0AA__" id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20190101__20191231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKg_____z8BNS2fIUCJ8" style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></span></td><td style="text-align: left">*<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td>&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0270">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_i_pdd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses, shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_i_pdd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses, shares to be issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options accrued
    in 2019 and issued to employees and directors in 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of restricted
    stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_i_pdd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of restricted
    stock units and award of stock bonuses, shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDispute_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of legal
    dispute</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_i_pdd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares to be issued in settlement of
    legal dispute, shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--FairValueOfVestedStockOptionsGrantedToDirectors_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of series B preferred stock and warrants,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockDividend_iN_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--AdjustmentsToAdditionalPaidInCapitalRedemptionValue_i_pp0p0" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment to redemption value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Common shares issued as compensation for services, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested restricted stock units
    awarded to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0356">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0357">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,906</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0359">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,906</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zpBbQLyQwxEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees and consultants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0362">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">390,484</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0365">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">390,484</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested incentive stock bonuses
    awarded to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0368">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0369">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0371">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,209</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0374">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0375">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0376">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,338,566</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,338,566</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_438_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zNqxmpBoG3Mi" style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Balance December 31, 2019</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z9xJDTUdbLWk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpYQtA4bpyL6" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,521,444</ix:nonFraction></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonstockSharesToBeIssued_iS_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zIQYuDwTiPU6" title="Beginning balance, shares to be issued" style="text-align: right"><ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">10,400</ix:nonFraction></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,328,861</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,684,927</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">355,631</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_439_c20200101__20201231_eus-gaap--StockholdersEquity_iS_zlo2neW7psUa" style="display: none; vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">Beginning balance, value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z9scCNxDZqrj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5UbKsfPYjG9" title="Beginning balance, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,521,444</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--CommonstockSharesToBeIssued_iS_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z98yIMfLZ7Ag" title="Beginning balance, shares to be issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">10,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,328,861</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,684,927</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">355,631</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40F_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zq5Vh0RVTcz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zcB9uXuIH0De" title="Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0402">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0pn89xtq8o7" title="Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">55,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2vzLxgu98Jk" title="Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">10,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0405">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0406">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_zrOzmh5WgiQ5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested restricted stock units
    awarded to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0414">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0415">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_zGBLkyn2ujM5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options accrued
    in 2019 and issued to employees and directors in 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zlMTUQ7r40Fi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees and directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0426">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">252,020</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0429">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">252,020</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_ztGejnQhovgd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0433">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,758,716</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,758,716</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_43B_c20200101__20201231_eus-gaap--StockholdersEquity_iE_zr7Y3gJNRpAd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance December 31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zXk8GTj3whsf" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhBthx1IpXNf" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--CommonstockSharesToBeIssued_iE_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUzbvtCsoNzh" title="Balance, shares to be issued" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,109,509</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_43C_c20200101__20201231_eus-gaap--StockholdersEquity_iE_zB3q5O6Xltdb" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Ending balance, value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zbuBvsAYiG0k" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAvmwEy5RUn3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--CommonstockSharesToBeIssued_iE_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuh3QoiiiCQc" title="Ending balance, shares to be issued" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,109,509</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0B_z7g63Emm0Vae" style="text-align: right; width: 15pt">*</td><td style="text-align: justify"><i id="xdx_F11_zA4eKUwTxUX9"><ix:footnote id="Footnote000461" xml:lang="en-US">represents an amount less than $1.</ix:footnote></i></td></tr>
     </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="a_030"></span><b>Consolidated
Statements of Cash Flows</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zUGi0QKALBRk" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20200101__20201231_zZS8CO4OemAb" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49F_20190101__20191231_zJarBvbCodu7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Twelve Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">December
                                            31,</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zYfiS15i1X1j" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    Flows From Operating Activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_maCzEHn_z2wIKDq5gMye" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,758,716</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,338,566</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z2yS7WyUwFS7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash provided by (used in) operating activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DepreciationDepletionAndAmortization_i02_maCzEHn_zMsY3d2lffgh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation
    and intangible asset amortization expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,103</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161,180</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--GainOnForgivenessOfNotePayable_i02N_di_msCzEHn_zm3ZhPxYMIye" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gain
    on forgiveness of note payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:GainOnForgivenessOfNotePayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">557,203</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maCzEHn_zItk6hVJE2sl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,183</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">788,599</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--CommonStockIssuedForOtherExpense_i02_pp0p0_maCzEHn_zc5HOSBaC0sg" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common
    stock issued for other expense</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ProvisionForDoubtfulAccounts_i02_maCzEHn_z5bQE1erTJYi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision
    for doubtful accounts</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,425</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,651</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--InventoryWriteDown_i02_maCzEHn_zwOHsDy0mqCj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision
    for excess and obsolete inventory</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,669</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">223,971</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--GainLossOnDispositionOfAssets_i02N_di_msCzEHn_zp9eVXcE6bni" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss
    on disposal of assets</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,124</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">115,359</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maCzEHn_z5wyDRxVQh5h" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization
    </span><span style="font-family: Times New Roman, Times, Serif">of ROU Asset</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">190,183</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zS3F731dSRJ3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsAndNotesReceivable_i03N_di_msCzEHn_zpSy8oY8DxS7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    receivable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">91,452</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">39,179</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msCzEHn_zoP2qqIjwFJb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventory</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">882,466</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,386</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msCzEHn_zt2sHSfywms" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">768,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">141,143</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_403_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maCzEHn_zKNv394gimUl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,157</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,830</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maCzEHn_zT4hXVZSbyN" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,279,717</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">802,674</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_maCzEHn_zl9Jw8Y7N6Y6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    interest</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,203</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--IncreaseDecreaseInLeaseDeposit_i03_pp0p0_maCzEHn_znlTHB10TMpe" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease
    deposit</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maCzEHn_zqCV5bVTwMH" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, net</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">135,828</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,039</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInDeferredCompensation_i03_maCzEHn_z8WPcTrmdIx" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    equity compensation</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,434</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzEHn_maCzxee_zqXBBjfLRCy" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by operating activities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">818,036</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">671,833</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_znUvkW2r7Hef" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    Flows From Investing Activities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzhfm_zHgSd9tez6u5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Purchases
    of property and equipment</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,332</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,043</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_407_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_pp0p0_maCzhfm_zcWnjhFC7yYg" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from the sale of property equipment</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzhfm_maCzxee_zadNJmyjRzl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,332</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,043</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zG7x8btrq20j" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash
    Flows From Financing Activities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_i01_pp0p0_maCzH0S_zrOZg43v1BCe" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash
    proceeds from sale of preferred stock and warrants, net of issuance costs</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--ProceedsFromNotesPayable_i01_maCzH0S_z70Gv2bEmo7d" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of note payable</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0548">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzH0S_maCzxee_zciBbjV0hVFc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0551">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzxee_zyLuQBzM61Xk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    increase in cash</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,362,704</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">668,790</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zjJeh6hOo66i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash,
    beginning of period</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">922,177</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">253,387</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zpyf4JHbhw38" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash,
    end of period</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,284,881</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">922,177</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z32HuMPz9sR7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash
    investing and financing activities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--InterestPaidNet_i01_zm0gsVT85ta7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    paid</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxesPaidNet_i01_z70z3viiU7y5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes paid</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0568">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--SupplementalCashFlowInformationAbstract_iB" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Supplemental
    cash flow information:</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_i01_pp0p0" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Adjustment
    of carrying value of series B preferred stock to redemption value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--SubscriptionReceivableSeriesBPreferredStock_i01_pp0p0" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Subscription
    receivable - series B preferred stock</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--OptionsIssuedForAccruedEquityCompensation_i01_pp0p0" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    issued for accrued equity compensation</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--Dividends_i01_pp0p0" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    dividends</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_040_c20200101__20201231_zN95MymQfLG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="a_031"></span>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_80C_eus-gaap--NatureOfOperations_z957nDjNG1Pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span id="xdx_824_zE8VVKCFsFLi">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and
other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing sectors
of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the
first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers,
tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming
practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems and other climate
control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and engineering commercial
scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems and technologies used
for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated CEA growers in the
U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or
retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder, Colorado, we
leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall
crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory
requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources.
Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still
allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we
were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be
predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this
uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact of the COVID-19 pandemic
to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced sales, increased losses and reduced
operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Refer
to <i>Risk Factors</i>, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_809_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zJymfTBHykxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_82E_zGBpC3LVnpag">Basis of Presentation; Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTcPRP4mKzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 3 Going Concern</i> below, the accompanying consolidated financial statements have been prepared on a going-concern
basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance of debt
and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar to those encountered
by similarly situated companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="SRNA:ReverseStockSplitPolicyTextBlock"><p id="xdx_84B_ecustom--ReverseStockSplitPolicyTextBlock_zTl66P5IWeHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zfp1oBXX6f91">Reverse
Stock Split</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqon6yE9Vegg" title="Reverse stock split, Description"><ix:nonNumeric contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember" name="us-gaap:StockholdersEquityReverseStockSplit">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</ix:nonNumeric></span> The par value for
the Common Stock was not affected.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zs3k93Zgl0Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Principles
of Consolidation </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84B_eus-gaap--UseOfEstimates_zlmaiNJEfrt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis,
valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and
legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zl86gz0nfezg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"><p id="xdx_844_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z6ql9vwpH4G1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounts
Receivable and Allowance for Doubtful Accounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest.
An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which, in management&#8217;s
judgment, deserve current recognition in estimating bad debts. Based on the Company&#8217;s review, it establishes or adjusts the allowance
for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and December 31, 2019, the allowance
for doubtful accounts was $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20201231_zdjIevpfTdKh"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,098</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_zxkw667tEk6j"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,673</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zBZYSZAY5ym6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Inventory</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#8220;FIFO&#8221;) basis.
Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other
factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence
or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis for that inventory is established
and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete inventory was $<span id="xdx_904_eus-gaap--InventoryAdjustments_c20201231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"><ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,045</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--InventoryAdjustments_c20191231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"><ix:nonFraction name="us-gaap:InventoryAdjustments" contextRef="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,376</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zmAnTf818dk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Property
and Equipment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using
the straight-line method over their estimated useful lives, which is generally <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20200101__20201231_zNah8Ikifnz3"><ix:nonNumeric contextRef="From2020-01-012020-12-31" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">five
years</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. Leasehold improvements are amortized on
a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and
related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zDncFzdzn0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Long-lived
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate
the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#8217;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending
on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December 31, 2020 and
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>


<ix:exclude><!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zKICEDwa9Pej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill
and Intangible Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December
31<sup>st</sup> or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced
to less than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing
the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its
carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount
exceeds the reporting unit&#8217;s fair value. The Company determined that it has one reporting unit. The Company completed this assessment
as of December 31, 2020 and concluded that no impairment existed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#8217;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are also subject
to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zEjfko1IosTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Fair
Value Measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring
fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes the inputs used
in the valuation methodologies in measuring fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability,
either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3 - inputs are unobservable inputs based on the Company&#8217;s assumptions used to measure assets and liabilities at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level of input that is significant
to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
in its entirety requires management to make judgments and consider factors specific to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses,
approximate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zaxVqM2qYCHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Derivative
Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded
at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;)
to value the derivative instruments. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within
twelve months of the balance sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zgCRCRGtuXb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_z4lP7SDCLJWe" style="display: none">Schedule
of Revenue by Source</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment
    and systems sales</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" title="Total revenue" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,730,371</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" title="Total revenue" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,692,863</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering
    and other services</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">568,131</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,239,130</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping
    and handling</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,770</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">292,461</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,514,272</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,224,454</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zGjsAig9HX6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Revenue
Recognition Accounting Policy Summary</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract
with a customer to transfer a distinct good or service to the customer. Most of the Company&#8217;s contracts contain multiple performance
obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#8217;s project life-cycle from facility design and construction to equipment
delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some
of the Company&#8217;s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate
margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the
Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange
for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical rates of return are
insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes
revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and
certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected
by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and
shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other
Judgments and Assumptions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the
effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company
transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly,
the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contract
Assets and Contract Liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to
payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based
on the terms established in its contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional,
subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019, the
Company had no contract assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&#8217;s contract liabilities are recorded as a current
liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is
generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which was classified as a current liability,
was $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_c20201231_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,724,189</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_c20191231_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,444,472</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, the Company recognized revenue of $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,103,447</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2020, or <span id="xdx_90D_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20200101__20201231_zHtCzzzTCDCe"><ix:nonFraction name="SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">76</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
For the year ended December 31, 2019, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">473,682</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2019, or <span id="xdx_90A_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20190101__20191231_zq9x62DeXgN3" title="Deferred revenue"><ix:nonFraction name="SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">74</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining
Performance Obligations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate,
the uncertainty regarding the COVID-19 virus, and the Company&#8217;s recent cost cutting measures, there is no assurance that the Company
will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_c20201231_pp0p0"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,448,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31_us-gaap_CustomerContractsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,643,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20201231_z30QSaSK844a"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-COVID-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at December 31, 2020, includes booked sales orders of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">390,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus
COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"><p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to engineering only paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,355,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,643,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to partial equipment paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,703,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,805,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    remaining performance obligations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,058,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">390,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,448,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zeRp94luEPKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:StandardProductWarrantyPolicy"><p id="xdx_844_eus-gaap--StandardProductWarrantyPolicy_zxr65VYWAhla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Warranty</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company&#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&#8217;s option)
that fail to perform within stated specification. The Company&#8217;s third-party suppliers also warrant their products under similar
terms, which are passed through to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31" name="us-gaap:StandardProductWarrantyDescription">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.</ix:nonNumeric></span> <span style="font: 10pt Times New Roman, Times, Serif">The Company continues to
assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of December 31, 2020,
and December 31, 2019, the Company had an accrued warranty reserve amount of $<span id="xdx_90F_eus-gaap--ProductWarrantyAccrual_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"><ix:nonFraction name="us-gaap:ProductWarrantyAccrual" contextRef="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,365</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--ProductWarrantyAccrual_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"><ix:nonFraction name="us-gaap:ProductWarrantyAccrual" contextRef="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">185,234</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, which are included in accounts payable and accrued liabilities on the Company&#8217;s consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zEcqOoSPJnV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cost
of Sales</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs,
engineering, project management and service salaries and benefits, client visits and warranty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_znT1zQ2fQ3V3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7EXjLtBKGU"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">28</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUkoZNs5WGZd"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwGAS5FHOBnk"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2020. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZAensU29mbg"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s accounts receivable from two customers made up <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxScHmlvski4"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">48</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zA7ejDrKZqO8"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">38</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2020. The Company&#8217;s accounts receivable from three customers made up <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAipeN8Z20e6"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">59</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zXsXKQk317Hh"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z47qSd94Iapd"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
suppliers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_z0mqrL4McdJk"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_z4ZomONCErN7"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zwt5jRpeus13"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2020, and three suppliers accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_zBQ2j3z3t6Ic"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_zdHzBgLUz9J9"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zHfGZV1KqW99"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_zG7r1p9byb8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For the
years ended December 31, 2020 and December 31, 2019, the Company incurred $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">390,229</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">521,044</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, on product development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvislvwPapy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on
their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on
a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are
recognized ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the probability
assessment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the award
between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the
service inception date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the
award between the Company and the recipient has not yet been established. For awards in which the service inception date precedes the
grant date, compensation cost is accrued beginning on the service inception date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Subsequent
to December 31, 2020, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved annual incentive compensation awards
to certain employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020, were
not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of the annual
incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to the employee, subsequent
to December 31, 2020. The estimated compensation expense of $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyIncentiveAwardsMember_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,434</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the 2020 incentive awards was accrued
as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation expense
has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant by the Board.
At that time, the incentive award becomes equity-classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates
whose term is consistent with the expected term of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">405,617</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,292,065</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively. Such share-based compensation costs are classified in the Company&#8217;s consolidated financial statements in the same
manner as if such compensation was paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Share-based Compensation Costs&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation expense included in:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost
    of revenue</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,006</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">91,081</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,977</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,882</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" title="Total share-based compensation expense included in consolidated statement of operations" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,330</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,396</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,121,677</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    share-based compensation expense included in consolidated statement of operations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">405,617</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,292,065</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8A2_znBGzekj8KMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zZFabdYGDZd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets
and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change
in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized.
In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company
determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company
would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely
than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions
that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely
than not to be realized upon ultimate settlement with the related tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zBNKrztrBhN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basic
and Diluted Net Loss per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in periods
when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist
of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.
As of December 31, 2020, <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20201231_zgkHDLjgCbZd"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">194,757</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential common shares equivalents from
warrants and options were excluded from the diluted EPS calculations as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zwYc4ooBD3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commitments
and Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its
business, that cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters.
An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred
and the amount of loss can be reasonably estimated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="SRNA:OtherRisksAndUncertaintiesPolicyTextBlock"><p id="xdx_849_ecustom--OtherRisksAndUncertaintiesPolicyTextBlock_zQGam3vB1Cz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Risks and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that
such products will be successfully marketed. These factors could have a material adverse effect upon the Company&#8217;s financial results,
financial position, and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#8217;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty of
market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and equipment
to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states have legalized
medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well as its derivatives. Any
changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local cannabis laws and regulations
that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#8217;s customers. The Company&#8217;s
success is also dependent upon its ability to raise additional capital and to successfully develop and market its products. See Note
3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaIrUYsyqDmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Segment
Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the Company&#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zi6trV1w80E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06: &#8220;<i>Accounting for Convertible Instruments and Contracts In An Entity&#8217;s Own Equity&#8221;
(&#8220;ASU 2020-06&#8221;)</i> ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation
models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by requiring
the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04 using either
a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning after December 15,
2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020. The Company does not expect
this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_806_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z4lIc4LRbvJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_820_zqqYuD940TGg">Going Concern </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $<span id="xdx_90C_eus-gaap--NetIncomeLoss_iN_pn3p0_di_c20200101__20201231_zJ3H4c3Lw2C5"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" sign="-" unitRef="USD">1,759,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the year ended December 31, 2020 and had
an accumulated deficit of approximately $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20201231_z9pBLeLRLuL8"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" sign="-" unitRef="USD">27,444,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and a shareholders&#8217; deficit of approximately
$<span id="xdx_906_eus-gaap--StockholdersEquity_iNI_pn3p0_di_c20201231_zWh8G2raMCXd"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" sign="-" unitRef="USD">1,334,000</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">as
of December 31, 2020. Since inception, the Company has financed its activities principally through debt and equity financing, advance
payments from customers and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the
foreseeable future in connection with its operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions,
its customers&#8217; operations and prospects for and ability to obtain project financing, and market and business disruptions, that
include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding of products; uncertainty
of product development and generation of revenues; dependence on outside sources of financing; risks associated with research, development;
dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized
companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing
to fulfill its development activities and generating a level of revenues adequate to support the Company&#8217;s cost structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&#8217;s ability to raise equity capital is also limited by the Company&#8217;s stock price, and any such
issuance could be highly dilutive to existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s 2020 revenue of approximately $<span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20200101__20201231_zau6RkdsqZ09"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">8,514,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">which represents a decrease of <span id="xdx_90A_ecustom--DecreaseInRevenuePercentage_pid_dp_uPure_c20200101__20201231_z5jXNkx94AYj"><ix:nonFraction name="SRNA:DecreaseInRevenuePercentage" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">44</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">over the prior year. The Company&#8217;s revenue
recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred, and expects
to incur, additional operating expenses to support such growth. The Company generated approximately $<span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3p0_c20200101__20201231_zWkIAm3Re5T2"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">818,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in cash flow from operating activities in 2020.
However, as a result of the Company&#8217;s growth and its efforts to expand and upgrade its products, the Company&#8217;s working capital
deficit as of December 31, 2020 was approximately $<span id="xdx_904_ecustom--WorkingCapitalDeficit_c20201231_pp0p0"><ix:nonFraction name="SRNA:WorkingCapitalDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,220,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
compared to approximately $<span id="xdx_90C_ecustom--WorkingCapitalDeficit_c20191231_pp0p0"><ix:nonFraction name="SRNA:WorkingCapitalDeficit" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,437,000</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">as
of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced, or are
contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which COVID-19 will
impact the Company&#8217;s business and financial results will depend on future developments, which are uncertain and cannot be predicted.
See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal year 2020 measures of adjusting
the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet management&#8217;s expectations, or additional
capital is not available, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of
one year from the issuance of these financial statements. Other factors that will impact the Company&#8217;s ability to continue operations
include the market demand for the Company&#8217;s products and services, the ability to service its customers and prospects, potential
contract cancellations, project scope reductions and project delays, the Company&#8217;s ability to fulfill its backlog, the management
of working capital, and the continuation of normal payment terms and conditions for purchase of the Company&#8217;s products. The Company
believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next twelve months. If the
Company is unable to increase revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&#8217;s
ability to continue as a going concern for a period of one year from the date the financial statements are issued. These consolidated
financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_ziGpRPGOyK46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_826_zYz2L2QJNrzf">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not be updated,
and the disclosures required under the new lease standard will not be provided, for dates and periods prior to January 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new lease standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package
of practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease,
(ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
June 27, 2017, the Company entered into a lease for its manufacturing and office space (the &#8220;Facility Lease&#8221;), which commenced
September 29, 2017 and continues through August 31, 2022. The Company occupied its <span id="xdx_90E_eus-gaap--AreaOfLand_iI_usqft_c20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zCxTFRJSZlrl"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2017-06-27_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">12,700</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square foot space for $<span id="xdx_907_eus-gaap--PaymentsForRent_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2017-06-262017-06-27_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,967</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseDescription_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember"><ix:nonNumeric contextRef="From2017-06-262017-06-27_custom_FacilityLeaseMember" name="us-gaap:LesseeOperatingLeaseDescription">until
January 1, 2018</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. On January 2, 2018, the leased
space was expanded to <span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zLD8O78hFDn3"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2018-01-02_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">18,600</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet, and the monthly rental rate increased
to $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2017-12-302018-01-02_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,979</ix:nonFraction>
</span></span><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2017-12-302018-01-02_custom_FacilityLeaseMember" name="us-gaap:LesseeOperatingLeaseDescription">until
August 31, 2018</ix:nonNumeric></span><span style="font: 10pt Times New Roman, Times, Serif">. Beginning September 1, 2018 and 2019,
the monthly rent increased to $<span id="xdx_902_eus-gaap--PaymentsForRent_c20180830__20180902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2018-08-302018-09-02_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,549</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--PaymentsForRent_c20190830__20190902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2019-08-302019-09-02_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,135</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. <span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_FacilityLeaseMember" name="us-gaap:LesseeOperatingLeaseDescription">On
each September 1 through the end of the lease, the monthly rent will increase by 3%.</ix:nonNumeric></span></span> <span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the current lease, the Company made a security deposit of $<span id="xdx_902_eus-gaap--SecurityDeposit_c20170731_pp0p0"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2017-07-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,000</ix:nonFraction></span></span>
<span style="font: 10pt Times New Roman, Times, Serif">on July 31, 2017. The deposit of $<span id="xdx_906_eus-gaap--PaymentsForDeposits_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2020-01-012020-12-31_custom_FacilityLeaseMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,600</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">paid to the previous owner of the property was
forwarded to the current landlord. The Company has the option to renew the Facility Lease for an additional <span id="xdx_904_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zZZPUCkQqG86"><ix:nonNumeric contextRef="AsOf2020-12-31_custom_FacilityLeaseMember" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm">five
years</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember_pp0p0"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2020-01-012020-12-31_custom_AgreementWithLandLordMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">52,600</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to rent payments due during the period. <span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_AgreementWithLandLordMember" name="us-gaap:LesseeOperatingLeaseDescription">The
deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly
installments from January to December 2021.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Total
rent under the Facility Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly
rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease
liability on the Company&#8217;s condensed consolidated balance sheets. As of January 1, 2019, the remaining deferred rent of $<span id="xdx_909_eus-gaap--DeferredRentCreditCurrent_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="us-gaap:DeferredRentCreditCurrent" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,477</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was reclassified to the operating lease liability
under the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption of the new lease standard, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;)
on the balance sheet as an operating lease right-of-use asset in the amount of $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">714,416</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and as a lease liability of $<span id="xdx_900_eus-gaap--OperatingLeaseLiability_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">822,374</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
The renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably
certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will
include the renewal period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_903_eus-gaap--TenantImprovements_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MinimumMember_pp0p0"><ix:nonFraction name="us-gaap:TenantImprovements" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $<span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"><ix:nonFraction name="SRNA:UnamortizedAmountOfTenantImprovementAllowance" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,481</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was treated as a reduction in measuring the right-of-use
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non-lease component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zPeQ3QlkQHh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B9_zox0OD0dSWLg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                            the Year Ended</b></span></p> <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
    31, 2020</b></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--OperatingLeaseCost_c20200101__20201231_pp0p0" title="Operating lease cost" style="font-family: Times New Roman, Times, Serif; width: 26%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">216,889</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    cash outflow from operating lease</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" title="Operating lease cost" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,934</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 70%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 26%"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                            of</b></span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                            31, 2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z9hG7OHCzPY9" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">343,950</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, current</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">266,105</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, long-term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,119</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    lease term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20201231_zYcwBtbDKBub" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2020-12-31" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">1.7</ix:nonNumeric>
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount
    rate</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231_z4dVlHSoI0Pj" style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.00</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zXS3ptFh0oca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_896_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDVOneHTYVH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_z7dpdkWsmaYh" style="display: none">Schedule
of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years
    ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20201231_pp0p0" title="Year one" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">281,864</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20201231_pp0p0" title="Year two" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,891</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total
    minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20201231_pp0p0" title="Total minimum lease payments" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">452,755</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    imputed interest</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20201231_zf84W1QHLDxl" title="Less imputed interest" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,531</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present
    value of minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_c20201231_pp0p0" title="Present value of minimum lease payments" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">435,224</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_ziZvFyuCORWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><!-- Field: Split-Segment; Name: 001 --></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_806_eus-gaap--InventoryDisclosureTextBlock_zPjzClIgw3M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_82F_zPKrvMsluy87">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zsS4iWD1QIt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BE_zEPdvzgbpdO7" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Inventory</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20201231_zhtS2W1hrrFk" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20191231_zo0yO0tAWnze" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzovY_zcUBVogjx2p3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">201,778</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,041,369</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzovY_zpy2GKyYlvrg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work
    in progress</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,231</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,851</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzovY_zuABjAhGwkW7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw
    materials</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">214,145</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">257,399</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzovY_zAiPNf3CfCDc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance
    for excess &amp; obsolete inventory</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,045</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,376</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzovY_zVnz9ZDhw415" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory,
    net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">327,109</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,231,243</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zqkjaNFpCDU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,974</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,831</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">were
included in the inventory balance as of December 31, 2020 and 2019, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zLq72Q9WZrFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_822_ziit6XWN0ooh">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zh2Icee86gEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zVVsMRJAzqSi" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture
    and equipment</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">398,422</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">389,090</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvements</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">628,615</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20191231_pp0p0" title="Property and equipment, gross" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">619,283</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zvgMNUiNUWLa" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">480,883</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20191231_zXe8mqyRHIOi" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">361,360</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">147,732</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20191231_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">257,923</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zay1LsUH04ne" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense amounted to $<span id="xdx_900_eus-gaap--Depreciation_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,524</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the year ended December 31, 2020, of which $<span id="xdx_901_eus-gaap--Depreciation_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2020-01-012020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,394</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of revenue. Depreciation
expense amounted to $<span id="xdx_903_eus-gaap--Depreciation_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">157,860</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the year ended December 31, 2019, of which $<span id="xdx_902_eus-gaap--Depreciation_c20190101__20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-01-012019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,010</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2018, the Company&#8217;s property and equipment, net included the gross cost of the equipment leased to a cultivation
company affiliated with one of the Co-founders of $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentGross_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2018-12-31_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">176,042</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and accumulated depreciation of $<span id="xdx_90C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2018-12-31_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,120</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
During the year ended December 31, 2019, the Company wrote-off the carrying value of the leased equipment. See Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_807_eus-gaap--IntangibleAssetsDisclosureTextBlock_zn23HhHg5uvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_82E_zAfsIIV8kEIb">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zggo8d4spgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BD_z00zkFunFRg7" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Intangible Assets</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Patents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,110</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2019-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,234</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Website
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,713</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,713</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trademarks</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" title="Intangible assets" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31_us-gaap_TrademarksMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,830</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" title="Intangible assets" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2019-12-31_us-gaap_TrademarksMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,830</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,653</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231_pp0p0" title="Intangible assets" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,777</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0" title="Accumulated amortization" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">25,426</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20191231_pp0p0" title="Accumulated amortization" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,847</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0" title="Intangible assets, Net" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,227</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20191231_pp0p0" title="Intangible assets, Net" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,930</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zIYQ2Sxbhta8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Patents
when issued are amortized over <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zQm2Fs4aILp1"><ix:nonNumeric contextRef="From2020-01-012020-12-31_us-gaap_PatentsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">14</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years, and web site development costs are amortized
over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dt_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_zr0vOCDPfIR5"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_WebSiteDevelopmentCostsMember" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">five
years</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. Trademarks are not amortized since they
have an indefinite life. Amortization expense for intangibles amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">579</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20190101__20191231_pp0p0"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,320</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $<span id="xdx_907_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2020-01-012020-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,124</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20190101__20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2019-01-012019-12-31_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,778</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to patents that had been abandoned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z6vHbdZ5XbF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_820_z6RO0rWJixFa">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMqUwIW62Mn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_z1Ux5zTvOta1" style="display: none">Schedule
of Accounts Payable and Accrued Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zxlzjELyrpcg" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20191231_zUMOpS8dRv4d" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALze1T_zVrdMPSorzx7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">918,639</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,299,015</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALze1T_zFBTW1Sc3Wb3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales
    commissions payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,263</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">69,532</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z5w9hxoGV7C8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    payroll liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,071</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,052</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALze1T_zYMKGAUUdenl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    warranty accrual</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,365</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">185,234</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z9uRwMGS31Zj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">356,623</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,127</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALze1T_zJjZzcMGGVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,784,961</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,832,959</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zL2mw2kHjdM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and other accrued expenses includes $<span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_c20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember_pp0p0"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31_custom_ThreeCustomersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">402,651</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">relating to a one-time warranty issue experienced
on three customers&#8217; projects. The expenses related to parts and labor to repair units that had been delivered to these customers
prior to year-end. <span id="xdx_900_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_ThreeCustomersMember" name="us-gaap:StandardProductWarrantyDescription">Since
the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing
1% warranty reserve that we accrue on all sales.</ix:nonNumeric></span></span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zUhipQ9tARVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_822_zRV64zyByxm7">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 22, 2020, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_c20200422_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-04-22" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount was subject to interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200422_zRN0gwPbEHjk"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-04-22" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and was initially due on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422_zbAHUV3uPZS8"><ix:nonNumeric contextRef="From2020-04-212020-04-22" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">April 20, 2022</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
Subsequently, the term of the loan was potentially to be extended to <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_zmBiG8NphFna"><ix:nonNumeric contextRef="From2020-04-212020-04-22_us-gaap_ExtendedMaturityMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">April
20, 2025</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. The loan could be repaid in advance
without penalty. The loan was also potentially forgivable in full provided proceeds were used for payment of payroll expenses, rent,
utilities and mortgage interest and certain other terms and conditions were met. The loan had typical default provisions, including for
change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, interest of $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20200101__20201231_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,203</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was accrued in respect of this note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
December 11, 2020, the Company received notice from the bank that its loan received on April 22, 2020, in the principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20201211_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-12-11" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">554,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and all accrued interest of $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20201210__20201211_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2020-12-102020-12-11" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,203</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 16 Subsequent Events</i> below, on February 10, 2021, we received funding based on a loan agreement entered
into on February 5, 2021 with its current bank in the principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgfllgsM3e55"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaU1yJlYPVJj"><ix:nonNumeric contextRef="From2021-02-092021-02-10_us-gaap_SubsequentEventMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">February
5, 2026</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. The loan may be repaid in advance without
penalty. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment
of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zIS26wPCDtcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_827_zf7sf37DWYya">Related Party Agreements and Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Agreements
and Transaction with Company&#8217;s Co-Founders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following describes certain agreements and transactions between the Company and its co-founders (the &#8220;Co-founders&#8221;). The
Co-founders held various executive officer and director positions with the Company until May 2018. One of the Co-founders also was a
consultant to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the
Company, the Co-founders did not own more than <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20191231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z8J5rxDJzt6a"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2019-12-31_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s outstanding common stock at any time during 2019 or 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Equipment,
Demonstration and Product Testing Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2017, the Company entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis cultivation
company affiliated with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation company certain cultivation
equipment in exchange for a quarterly fee of $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,500</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which was increased to $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__srt--RangeAxis__srt--MaximumMember_pp0p0"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" contextRef="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,330</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to reflect additional leased equipment requested
by the cultivation company (the &#8220;Lease Fee&#8221;). In consideration for access to the cultivation facility to conduct demonstration
tours and for the product testing and data to be provided by the cultivation company, the Company agreed to pay the cultivation company
a quarterly fee of $<span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextRef="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">(the &#8220;Demo and Testing Fee&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and the cultivation company each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation
company failed to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During
the second quarter of 2019, the Company notified the cultivation company of its breach for non-payment of the Lease Fee. In February
2020, the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement, including
any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment to the cultivation company for no additional
consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2018, the Company recorded Demo and Testing Fees of $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_c20180101__20181231_pp0p0"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2018-01-012018-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as operating expenses in the consolidated statements
of operations. During the year ended December 31, 2018, the Company also recorded Lease Fees of $<span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20180101__20181231_pp0p0"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2018-01-012018-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,880</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as &#8220;Other income, net&#8221; in the consolidated
statements of operations. As of December 31, 2018, unpaid Lease Fees of $<span id="xdx_90F_ecustom--UnpaidLeaseFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_pp0p0"><ix:nonFraction name="SRNA:UnpaidLeaseFees" contextRef="From2018-01-012018-12-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">36,660</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in accounts receivable and unpaid
Demo and Testing Fees of $<span id="xdx_901_ecustom--UnpaidDemoAndTestingFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsPayableMember_pp0p0"><ix:nonFraction name="SRNA:UnpaidDemoAndTestingFees" contextRef="From2018-01-012018-12-31_us-gaap_AccountsPayableMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the third quarter of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by the cultivation
company, and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with a corresponding charge
to &#8220;Other income, net&#8221; in the consolidated statements of operations, (ii) reversed the accounts payable related to the unpaid
Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the remaining carrying value of the leased
equipment of $<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_c20190930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LeasedEquipmentMember_pp0p0"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-09-30_custom_LeasedEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,581</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which was included in property and equipment on the Company&#8217;s consolidated balance sheet. For the year ended December 31, 2019,
the net impact of the foregoing items on the consolidated statements of operations was a charge of $<span id="xdx_908_ecustom--NetOfImpactOfForegoingItemCharge_c20191231_pp0p0"><ix:nonFraction name="SRNA:NetOfImpactOfForegoingItemCharge" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">120,241</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Employment
Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2018, the Company and one of the Co-founders entered into an employment agreement which provided for an initial base salary of $<span id="xdx_908_eus-gaap--SalariesWagesAndOfficersCompensation_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"><ix:nonFraction name="us-gaap:SalariesWagesAndOfficersCompensation" contextRef="From2018-05-012018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per year and certain sales incentive. Pursuant
to the employment agreement, the Company awarded <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z05Qjf1Hc5I3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2018-05-012018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units (&#8220;RSUs&#8221;)
to the Co-founder that vested at certain dates in the future, subject to the co-founder&#8217;s continued employment. As of December
31, 2019: (i) the Company has issued <span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z40XgwlaABjg"><ix:nonFraction name="SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in settlement of vested
RSUs, (ii) <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_zHw22lz7BiGk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in settlement of RSUs
that vested December 31, 2019 were issued subsequent to December 31, 2019, (iii) the parties mutually agreed to cancel <span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzurGOfozEfj"><ix:nonFraction name="SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs, and (iii) <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__us-gaap--AwardDateAxis__custom--AprilThirtyTwoThousandAndTwentyMember_zpoKeuuaruzh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested on April 30, 2020, however, the
holder elected to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Consulting
Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed <i>in Note 16 Subsequent Events</i> below, on January 7, 2021, the Company entered into a consulting agreement with
RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services
to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually
determined by the Company and RSX. The Company will pay a monthly consulting fee of $<span id="xdx_900_eus-gaap--ProfessionalFees_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_pp0p0"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,500</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z6Rv5sxQ2HTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 &#8211; <span id="xdx_823_zE1e9NOcWSqa">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were <span id="xdx_907_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1D6Li7sAvne"><ix:nonFraction name="SRNA:NumberOfUnitsVestedButNotSettled" contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units that had not been
settled due to a dispute with a former employee over the required withholding taxes to be paid to the Company for remittance to the appropriate
tax authorities. The Company commenced an arbitration action against the former employee regarding the dispute. The former employee also
made claims in the arbitration action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020,
the Company issued the former employee <span id="xdx_904_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgCQ7KzD5kI1"><ix:nonFraction name="SRNA:NumberOfUnitsVestedAndSettled" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
in settlement of these restricted stock units after taking measures to mitigate the Company&#8217;s exposure to penalties and liability
for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $<span id="xdx_90E_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpLxiLuaWnmj"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the Company&#8217;s favor and a finding against
the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&#8217;s favor in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,985</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with interest at <span id="xdx_906_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_pid_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zFRXQvlE3aTi"><ix:nonFraction name="SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company
and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee
is continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015 calendar
year prior to his appointment as an executive officer of the Company. </span><span style="font-family: Times New Roman, Times, Serif">The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the
Company&#8217;s operations or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors,
business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company&#8217;s
breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties.
In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that
will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status
or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities
arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and
employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="SRNA:PreferredAndCommonStockNoteDisclosureTextBlock"><p id="xdx_80B_ecustom--PreferredAndCommonStockNoteDisclosureTextBlock_zCxvSCoTN7o8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_820_zRpOiKZM88v3">Preferred and Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYpDiNFqp1Ah"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of Series A preferred stock, par value
$<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zu9ytYekXata"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, issued and outstanding. The holders
of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one vote of the Company&#8217;s common
stock. The Series A preferred stock ranks senior to the Company&#8217;s common stock. The holders of shares of Series A preferred stock
are not entitled to receive dividends and have no conversion or preemptive rights. Upon liquidation, dissolution or winding up of the
Company&#8217;s business, after payment to the holders of any senior securities, the holders of Series A preferred stock are entitled
to receive a preferential cash payment per share of Series A preferred stock equal to the stated value of the preferred stock, prior
to any payment to the holders of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z2zCrGoKAMEj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares to an employee in settlement of certain
    RSUs that vested December 31, 2019;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zUvwXN23IDa8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,733</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares pursuant to a special incentive stock
    bonus approved by the Board for the period ended December 31, 2019; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpiXSBOC72bj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="SRNA:NumberOfUnitsVestedAndSettled" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in settlement of restricted stock units
    to a former employee after taking measures to mitigate the Company&#8217;s exposure to penalties and liability for the failure to
    properly withhold income taxes, as further discussed in <i>Note 11 &#8211; Commitments and Contingencies, Litigation</i> above.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2019, the Company issued shares of its common stock under the Company&#8217;s 2017 Equity Plan as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zbZ7TzICqGsh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,316</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to independent
    directors in lieu of cash director fees; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxwcxMqUfgda" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,263</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to independent
    directors as the 2019 equity retainer fee; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zt4rpsAgUuy5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,467</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to certain
    employees in settlement of vested restricted stock units; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4jIaQEQ20Ce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,467</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to certain
    employees as a stock incentive bonus.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="SRNA:WarrantsDisclosureTextBlock"><p id="xdx_800_ecustom--WarrantsDisclosureTextBlock_zcc9al3ZhTXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
13 &#8211; Outstanding Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_820_zTUUdnZyTWK6" style="display: none; font-family: Times New Roman, Times, Serif">Warrants</span><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zCmKGkVA2K1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B8_zujAupgcPZf3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining
    Life</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20190101__20191231_zHHR9lK7HwN9" title="Warrants Outstanding, Beginning Balance" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">266,735</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20190101__20191231_zlVMLuwIDdnh" title="Weighted Average Exercise Price, Beginning Balance" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20180101__20181231_zSNuiHD8JHdh" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2018-01-012018-12-31" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">21</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20190101__20191231_zhSwNkngcGkb" title="Aggregate Intrinsic Value, Beginning Balance" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightIssued_c20190101__20191231_zMw9X2Kx1Btl" title="Warrants, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20190101__20191231_zCu8XanGfln" title="Weighted Average Exercise Price, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20190101__20191231_pp0p0" title="Aggregate Intrinsic Value, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercised_c20190101__20191231_zhPUDpdKLO1d" title="Warrants, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20190101__20191231_znyF8jQQ4oBg" title="Weighted Average Exercise Price, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20190101__20191231_pp0p0" title="Aggregate Intrinsic Value, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20190101__20191231_z6UMikAfCEW6" title="Warrants, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpired" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">6,008</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20190101__20191231_zEAMgdPZrt5f" title="Weighted Average Exercise Price, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">99.00</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20190101__20191231_pp0p0" title="Aggregate Intrinsic Value, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20200101__20201231_zVRwMhcJq0uh" title="Warrants Outstanding, Ending Balance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">260,727</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20200101__20201231_zRNYZCxfgAh5" title="Weighted Average Exercise Price, Ending Balance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">36.00</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20190101__20191231_ziwiDyXx0GQb" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-01-012019-12-31" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">9</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231_zInNKgxYOnA" title="Aggregate Intrinsic Value, Ending Balance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightIssued_c20200101__20201231_zopjaADN6l4c" title="Warrants, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20200101__20201231_zyfHKcvn82Ch" title="Weighted Average Exercise Price, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20200101__20201231_pp0p0" title="Aggregate Intrinsic Value, Issued" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0990">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercised_c20200101__20201231_pdd" title="Warrants, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20200101__20201231_zHfHnhlfUiJ5" title="Weighted Average Exercise Price, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20200101__20201231_pp0p0" title="Aggregate Intrinsic Value, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0996">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_c20200101__20201231_zDGSBo1oskOf" title="Weighted Average Exercise Price, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpired" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">210,310</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20200101__20201231_zfD99jjPCIB3" title="Weighted Average Exercise Price, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">34.50</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20200101__20201231_pp0p0" title="Aggregate Intrinsic Value, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20200101__20201231_zscu6SOw7pni" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,417</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20200101__20201231_zuvwzPeDc3Yj" title="Weighted Average Exercise Price, Ending Balance" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_dtM_c20200101__20201231_zhdseHw7u8W3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding">6</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231_zXtxX1GvmqJ9" title="Aggregate Intrinsic Value, Ending Balance" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zQA9Rm4RkEwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zBewjAB52c1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B3_z7jcy62VIUX6" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Life of</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercise
    price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zcE4irsYhtVf" title="Exercise price" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-31_custom_WarrantsRangeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zDW7HNQQ1Ac1" title="Warrants Outstanding" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2020-12-31_custom_WarrantsRangeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,417</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20200101__20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zggF3MvAyLFe" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_WarrantsRangeMember" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">6</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zS3wsqRVSJG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
2 Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2014, the Company offered up to <span id="xdx_909_ecustom--NumberOfInvestmentUnitOffered_uNumber_c20141001__20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zHjPmVqdjLa7"><ix:nonFraction name="SRNA:NumberOfInvestmentUnitOffered" contextRef="From2014-10-012014-10-31_custom_SeriesTwoWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Number">60</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units at a price per unit of $<span id="xdx_909_ecustom--OfferedInvestmentsPricePerUnit_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_pp0p0"><ix:nonFraction name="SRNA:OfferedInvestmentsPricePerUnit" contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each unit consisted of (i) <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zrgeorm3TUI9"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock,
(ii) a $<span id="xdx_901_eus-gaap--ConvertibleDebt_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_pp0p0"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction>
</span></span><span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_zBWUXwaUvEm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
convertible promissory note (&#8220;Series 2 Convertible Note&#8221;), and (iii) warrants for the purchase of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zTK6mXbKh5n6"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Series 2 Warrants&#8221;). As of December 31, 2018, Series 2 Warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20181231__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_z8kLZbzSSqFl"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2018-12-31_custom_SeriesTwoWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,008</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were outstanding,
all of which expired unexercised during the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Warrants
Issued to Investment Bank</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a certain agreement for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year ended
December 31, 2017, the Company issued to an investment bank or its designees a warrant (&#8220;Banker Warrant&#8221;) to purchase, at
an exercise price $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_zuRSth8RyeLk"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_znQV77lcEGZ7"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock.
<span id="xdx_908_ecustom--WarrantDescription_c20170101__20171231__dei--LegalEntityAxis__custom--InvestmentBankMember"><ix:nonNumeric contextRef="From2017-01-012017-12-31_custom_InvestmentBankMember" name="SRNA:WarrantDescription">The Banker Warrants
were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q1
2017 Warrants </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2017, the Company issued <span id="xdx_904_ecustom--NumberOfInvestmentUnitOffered_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pdd"><ix:nonFraction name="SRNA:NumberOfInvestmentUnitOffered" contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Number">111,875</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units, for aggregate gross proceeds
of $<span id="xdx_90A_ecustom--ProceedsFromInvestment_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pp0p0"><ix:nonFraction name="SRNA:ProceedsFromInvestment" contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,685,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or $<span id="xdx_906_ecustom--ProceedsFromInvestmentPerUnit_pid_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zSquFoX6Hiz2"><ix:nonFraction name="SRNA:ProceedsFromInvestmentPerUnit" contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">24.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. <span id="xdx_907_eus-gaap--ConversionOfStockDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember"><ix:nonNumeric contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" name="us-gaap:ConversionOfStockDescription">Each
unit consisted of</ix:nonNumeric> 0.0067 of a share of the Company&#8217;s common stock and 0.0067 of a warrant for the purchase of one
share of the Company&#8217;s common stock (&#8220;Q1 2017 Warrants&#8221;)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">;
however, one investor declined receipt of the warrant to purchase <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zqUAtsZIDZPl"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,125</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock.
Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months after the issuance date and on or prior to
the close of business on the date that is the third anniversary of the issuance date, purchase up to the number of shares of the Company&#8217;s
common stock as set forth in the respective warrant. The exercise price per share of the common stock under the Q1 2017 Warrants is $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_z3P9Gln4yVJe"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numunitdecimalin" decimals="INF" unitRef="USDPShares">39.00</ix:nonFraction>,</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject to customary adjustments as provided in
the warrant. Each Q1 2017 Warrant was callable at the Company&#8217;s option commencing six months from the issuance date, provided the
closing price of the Company&#8217;s common stock was $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zTgfKbMg9Sek"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">63.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or greater for <span id="xdx_907_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zcQstdnhtHqj"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Number">five
</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive trading days. Commencing at any time
after the date on which such call condition was satisfied, the Company had the right, upon 30 days&#8217; notice to the holder, to redeem
the warrant shares at a price of $<span id="xdx_902_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zH3V3LQmCNog"><ix:nonFraction name="SRNA:RedeemWarrantSharesAtPrice" contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant share. The holder could have
exercised the warrant at any time (in whole or in part) prior to the redemption date at the exercise price. <span id="xdx_90F_ecustom--WarrantDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember"><ix:nonNumeric contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" name="SRNA:WarrantDescription">These
warrants expired unexercised in March 2020</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q4
2017 Warrants </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2017, the Company issued <span id="xdx_903_ecustom--NumberOfInvestmentUnitOffered_pid_uNumber_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zjrcqy87XBb4"><ix:nonFraction name="SRNA:NumberOfInvestmentUnitOffered" contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Number">98,227</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units for aggregate proceeds of
$<span id="xdx_90D_ecustom--ProceedsFromInvestment_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_pp0p0"><ix:nonFraction name="SRNA:ProceedsFromInvestment" contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,768,080</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or $<span id="xdx_90C_ecustom--ProceedsFromInvestmentPerUnit_pid_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zzkAH5M0CFf8"><ix:nonFraction name="SRNA:ProceedsFromInvestmentPerUnit" contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. <span id="xdx_90A_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zfgXqdgKNGOb"><ix:nonNumeric contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" name="us-gaap:ConversionOfStockDescription">Each
unit consisted of</ix:nonNumeric> 0.0067 of a share of the Company&#8217;s common stock and 0.0067 of a warrant for the purchase of one
share of the Company&#8217;s common stock (&#8220;Q4 2017 Warrants&#8221;)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Q4 2017 Warrants had an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zU2sxrMa7Fol"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">30.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to customary adjustments
as provided in the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&#8217;s option, provided
the closing price of the Company&#8217;s common stock was $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zZyaMJGvKfWj"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">54.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or greater for <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_z2DdIy82nATh"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Number">five
</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive trading days. Commencing at any time
after the date on which the call condition is satisfied, the Company had the right, upon notice to the holders, to redeem the shares
of common stock underlying each warrant at a price of $<span id="xdx_90A_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zCU6gPuPg0q"><ix:nonFraction name="SRNA:RedeemWarrantSharesAtPrice" contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, but such redemption could not
occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder. The holder could exercise the warrant
at any time (in whole or in part) prior to the redemption date at the exercise price. These warrants expired unexercised in December
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q2
2018 Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Company completed a private placement offering of investment units, with <span id="xdx_905_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zrRQkM65UTX3" title="Conversion of stock, Description"><ix:nonNumeric contextRef="From2017-12-012017-12-31_custom_QTwoTwoThousandEighteenWarrantsMember" name="us-gaap:ConversionOfStockDescription">each
unit consisting of</ix:nonNumeric> 0.0067 of a share of the Company&#8217;s common stock and 0.0067 of a Q2 2018 Warrant</span>. The
Q2 2018 Warrants have an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zTKOYgwhXLFb"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share of the common stock underlying each warrant, subject to customary adjustments as provided in the warrant. <span id="xdx_909_ecustom--WarrantDescription_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember"><ix:nonNumeric contextRef="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" name="SRNA:WarrantDescription">The
Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Q2 2018 Warrants are callable at the Company&#8217;s option, beginning on July 1, 2019 until the expiration thereof on June 30,
2021, provided the closing price of the Company&#8217;s common stock is $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zntzXCuyVY9c"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.00</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(subject
to adjustment as provided in the warrant) or greater for <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zLUu6QAHOowh"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" contextRef="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Number">five </ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive
trading days. Commencing at any time after the date on which the call condition is satisfied, the Company has the right, upon notice
to the holders, to redeem the shares of common stock underlying each warrant at a price of $<span id="xdx_905_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zYtbtzCVtgy5"><ix:nonFraction name="SRNA:RedeemWarrantSharesAtPrice" contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.50</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share, but such redemption may not occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder.
The holder may exercise the warrant (in whole or in part) prior to the redemption date at the exercise price. As of December 31,
2020, Q2 2018 Warrants to purchase <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20201231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zCB0c3z5WCib"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2020-12-31_custom_QTwoTwoThousandEighteenWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,417</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock were outstanding.</span></p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHus4OeE7m19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
14 &#8211; Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_827_zA8hsQCXhksl" style="display: none; font-family: Times New Roman, Times, Serif">Equity
Incentive Plans</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2017, the Board adopted and approved the Company&#8217;s 2017 Equity Incentive Plan (the &#8220;2017 Equity Plan&#8221;) in
order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants, and other
persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under the 2017 Equity
Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights
(&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit awards (&#8220;RSUs&#8221;), shares granted
as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zlxYg4jjtRHc"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">333,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Plan Shares&#8221;) for issuance of equity awards under the 2017 Equity Plan. As of December 31, 2020, the Company has granted,
under the 2017 Equity Plan, awards in the form of RSAs for services rendered by independent directors and consultants, non-qualified
stock options, RSUs and stock bonus awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_pp0p0"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,412</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which will be recognized over approximately <span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zSoRwIEeGmtj"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" format="ixt-sec:durmonth" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">3</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Awards </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the Company had accrued fees owed to the Company&#8217;s independent directors totaling $<span id="xdx_90F_eus-gaap--ProfessionalFees_c20180101__20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_pp0p0"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2018-01-012018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which were payable in equity. During the year ended December 31, 2019, the Company issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_zde8R2Nb5uo4"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,316</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of restricted stock, which were fully
vested at the time of the award, in settlement of these accrued fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company also awarded <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_zTjeQlFdhBCa"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,263</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of restricted stock under the 2017
Equity Plan to the Company&#8217;s independent directors and consultants as an equity retainer fee for 2019. These restricted shares
were fully vested at the time of the award and the aggregate value attributable to these shares was $<span id="xdx_908_eus-gaap--ProfessionalFees_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_pp0p0"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
as calculated using the fair value of the Company&#8217;s common stock on date the Board approved these awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of highly
subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective
input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions are based on the historical
volatility of the Company&#8217;s common stock over periods that are similar to the expected terms of grants and other relevant factors.
The Company derives the expected term based on an average of the contract term and the vesting period taking into consideration the vesting
schedules and future employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for
a maturity approximating the expected term calculated at the date of grant. The Company has never paid any cash dividends on its common
stock and the Company has no intention to pay a dividend at this time; therefore, the Company assumes that no dividends will be paid
over the expected terms of option awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock
price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such,
the Company may use different assumptions for options granted throughout the year. The valuation assumptions used to determine the fair
value of each option award on the date of grant were: expected stock price volatility <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zsOxy8k3Bi23"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">114.97</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
- <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zCWZnoTM6tsg"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">122.48</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%;
expected term in <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zG2vGczPXYe"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years and risk-free interest rate <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_z5Sav0TnmA9b"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
- <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zxe9fKIuxTi8"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.37</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Employee
and Consultant Options</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcZKUI45Pan1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8B6_zoOZ8meB3tJl" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate
                                            Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHBKVz3d9ybj" title="Number of options, outstanding beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">70,400</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zTWEXvTjdnT8" title="Weighted Average Exercise Price, Outstanding Beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.60</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zNwpKYKTDSW3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.4</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zgzSI45TX4pe" title="Aggregate Intrinsic Value, Outstanding Beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1075">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zDDkg8cG9qrd" title="Number of options, granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zK5g7z9t2Ts1" title="Weighted Average Exercise Price, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zQep3WVATrw1" title="Number of options, exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaaVkiZiXXGb" title="Weighted Average Exercise Price, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxgG6IIsWrh" title="Number of options, forfeited/cancelled" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,055</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zmNTgzd3zNnf" title="Weighted Average Exercise Price, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.40</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zN3Ibp9cFVzd" title="Number of options, expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">111</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zD10t41iwJUg" title="Weighted Average Exercise Price, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.75</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zbPacipgumw1" title="Number of options, outstanding ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,567</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zw11YTKON6c8" title="Weighted Average Exercise Price, Outstanding Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.40</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zPzdo4Shliml" title="Weighted Average Remaining Contractual Term, Outstanding Ending" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms">7.7</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zOIMwKM2am6c" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDCgJ4QGrFn1" title="Number of options, granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">44,113</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIM6Aysndxo8" title="Weighted Average Exercise Price, Outstanding Beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.50</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zY43UtNz898j" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">10.0</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3LC6cG45fO1" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zNjGeoPa0QN1" title="Number of options, exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDlANhNJoWxf" title="Number of options, forfeited/cancelled" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6Ew3pTqRk0g" title="Number of options, expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,673</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zU5YGgqPjKJ" title="Weighted Average Exercise Price, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.15</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8ZhNdDnOWQ3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired">4.3</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPUK0aeThoBk" title="Number of options, outstanding ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,007</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6WYf1SdH7he" title="Weighted Average Exercise Price, Outstanding Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.45</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zRb7gybkSoa4" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">8.3</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z579sq0saV2f" title="Aggregate Intrinsic Value, Exercisable Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zB5JVJ2l2cuf" title="Number of options, outstanding vested and expected to vest ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,007</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvulNuMUcy8" title="Weighted Average Exercise Price, Exercisable Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.45</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zosB5Mue8Ns" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">8.3</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPczGfNYhzbf" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zkW2C8oWMg4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQ7OcSsFA711" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended
December 31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zYLAeT2GN0hd" style="display: none; font-family: Times New Roman, Times, Serif">Summary
of Non-vested Non-qualified Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of<br />
    Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br />
    Average<br />
    Grant-Date<br />
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate<br />
    Intrinsic<br />
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date<br />
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2018</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,889</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.90</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Aggregated Intrinsic Value, Nonvested Beginning" style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1136">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">628,756</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">130,120</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_ziIADVJronFd" title="Number of Options Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,833</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.10</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">362,998</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z4otFMEETl5d" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,056</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.30</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">246,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Expired" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Expired" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2019</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.25</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Aggregated Intrinsic Value, Nonvested Ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,534</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">44,113</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.85</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">387,199</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXCKK685h3i1" title="Number of Options Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,446</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.30</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">536,733</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Aggregated Intrinsic Value, Nonvested Ending" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A4_zH5VULNPWGu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">189,568</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">390,485</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively. As of December 31, 2020, there was <span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_do_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--UnvestedOptionsMember_ziQOLr6P6Hzb">no
</span></span><span style="font: 10pt Times New Roman, Times, Serif">unrecognized share-based compensation related
to unvested options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had granted non-qualified options to purchase <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zjOsCl6XFrLa"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares which were performance-based. At December
31, 2020, non-qualified options to purchase <span id="xdx_902_ecustom--StockOptionToPurchaseThresholdsPerformanceBased_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCmIXE6qCABc"><ix:nonFraction name="SRNA:StockOptionToPurchaseThresholdsPerformanceBased" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were forfeited due to the failure
to satisfy the 2017, 2018 and 2019 revenue-based performance thresholds and <span id="xdx_900_ecustom--NumberOfSharesForfeitedForTerminations_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zURqBfLnTwVh"><ix:nonFraction name="SRNA:NumberOfSharesForfeitedForTerminations" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were forfeited due to employee terminations.
No compensation expense had been recognized with respect to these performance-based awards since the likelihood of performance levels
being obtained was determined to be remote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Director
Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zCFc8SR9IZg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8BA_zcDYgammV0ma" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Price</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                                                                                                     <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value
                                            ($000)</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zy3TzYmGCre6" title="Number of options, outstanding beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Outstanding Beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.25</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zshS2cAkVjq3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.6</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" title="Aggregate Intrinsic Value, Outstanding Beginning" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1211">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, forfeited/cancelled" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIRUPyMPay68" title="Number of options, expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1227">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, outstanding ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z2YgOar2oLTk" title="Weighted Average Exercise Price, Outstanding Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.25</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zsbtuxOZoko" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.6</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" title="Aggregate Intrinsic Value, Outstanding Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Exercisable Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.55</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zv26MUYTzBEf" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">8.5</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Exercised" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, forfeited/cancelled" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zvFXeLy3Gv6" title="Number of options, expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Number of options, outstanding ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Outstanding Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBadwX3bwOpk" title="Weighted Average Remaining Contractual Term, Outstanding Ending" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms">7.5</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1259">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    </span><span style="font-family: Times New Roman, Times, Serif">December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zT10DkoudON4" title="Number of options, exercisable ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,667</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" title="Weighted Average Exercise Price, Exercisable Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.95</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zGRvU3mtpzvc" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">8.0</ix:nonNumeric></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" title="Aggregate Intrinsic Value, Exercisable Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_z39nxoqjycD4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVPmqAZOqft3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_z6dVfrIDxM4k" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" title="Aggregated Intrinsic Value, Nonvested Beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zm5a7H28aOa7" title="Number of Options Nonvested, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1280">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1284">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1288">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1290">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1294">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" title="Aggregated Intrinsic Value, Nonvested Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1296">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" title="Grant Date Fair Value Nonvested, Beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif; display: none">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1298">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Granted" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Granted" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.55</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" title="Grant Date Fair Value Nonvested, Granted" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">373,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zUqshKLzVfoj" title="Number of Options Nonvested, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">36,667</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.45</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" title="Grant Date Fair Value Nonvested, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1312">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1314">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" title="Grant Date Fair Value Nonvested, Forfeited" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Expired" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1320">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" title="Grant Date Fair Value Nonvested, Expired" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,666</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" title="Weighted Average Grant-Date Fair Value, Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.35</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" title="Aggregated Intrinsic Value, Nonvested Ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,800</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zZZaEHtVwz09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company incurred $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,452</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, as compensation expense related to <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zorFiDlAh9W1"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zgLjXmKz4hs9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested options, respectively, issued to directors.
As of December 31, 2020, total unrecognized share-based compensation related to unvested options was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z5ajJHKaED88"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,412</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 2, 2020, the Company issued <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCJMuRRndbGh"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested stock options to directors valued
at $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">234,126</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in respect of a 2019 special equity award that
had been accrued for in full in the Company&#8217;s financial statements at December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
on January 2, 2020, the Company issued an additional <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z629wwxxrPqb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested, non-qualified stock options
under the 2017 Equity Plan valued at $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,266</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to directors. The options have a term of <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwOJpRME3kDg"><ix:nonNumeric contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zL05l7L0QKO8">10.50.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<i>, </i>the Company issued <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3ZOZCPBA0Bf"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options under the 2017
Equity Plan, valued at $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39,600</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
to newly appointed directors. The options vested <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zexqCu3FlxN9"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
upon grant and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--AwardDateAxis__custom--AprilOneTwentyTwentyOneMember_zGb2TJNf2Yta"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
on April 1, 2021, if the Director remains on the Board up to that time. The options have a term of <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxgj7tSgbHja"><ix:nonNumeric contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date of $<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxlFJc1Mq8I2">4.35.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, awards related to <span id="xdx_906_ecustom--ShareBasedCompensationArrangementStockIssuedAndOutstanding_iI_pid_c20201231__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvRJeyS1gO9"><ix:nonFraction name="SRNA:ShareBasedCompensationArrangementStockIssuedAndOutstanding" contextRef="AsOf2020-12-31_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">144,340</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zUL47KqzG6nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_z2FA4yRuxNM9" style="display: none">Schedule
of Restricted Stock Units Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Units</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zLYKEGtfMxV1" title="Number of Units, beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">65,782</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoDkvgGRpIGc" title="Weighted Average Grant Date Fair Value, beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">21.00</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvYraRHcwZTi" title="Aggregated Intrinsic Value, Outstanding beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">730,185</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdQ3rnxpf3vk" title="Number of Units, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zlr5yazLd559" title="Weighted Average Grant Date Fair Value, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvmcGADZuDF1" title="Number of Units, Vested and settled with share issuance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,467</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zGdtkvDbYGah" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">27.15</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8i7zPTqWT54" title="Number of Units, Forfeited/canceled" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,982</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3kiD56D7hE" title="Weighted Average Grant Date Fair Value, Forfeited/canceled" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">26.85</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z1v5CPqXGRS1" title="Number of Units, ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z0WChRCBfor6" title="Weighted Average Grant Date Fair Value, ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.20</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKotxyHZKuk" title="Aggregated Intrinsic Value, Outstanding ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z4iF9kJJZny8" title="Number of Units, beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zm8GkagaaVX8" title="Weighted Average Grant Date Fair Value, beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.20</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z9AmKkDNM4Qf" title="Aggregated Intrinsic Value, Outstanding beginning" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1380">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPi0nqYXNp68" title="Number of Units, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPCi3rYlC1Q2" title="Weighted Average Grant Date Fair Value, Granted" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zmibQryAVAH6" title="Number of Units, Vested and settled with share issuance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNTs2A2DAMye" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.15</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8l4ABzCc3S5" title="Number of Units, Forfeited/canceled" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,333</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoiWPQsO9Zf5" title="Weighted Average Grant Date Fair Value, Forfeited/canceled" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">27.00</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNoa43l0Eweb" title="Number of Units, ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zMxRx53UXhFg" title="Weighted Average Grant Date Fair Value, ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-size: 10pt">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zhY5J2MVHkTf" title="Aggregated Intrinsic Value, Outstanding ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zzAcU40pREgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,163</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,906</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested RSUs
issued to employees, directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation related to
unvested RSUs. The total intrinsic value of RSUs vested and settled with share issuance was $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">199,125</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,120</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019.
During the year ended December 31, 2020, the total intrinsic value of RSUs vested and settled with share issuance was $<span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,105,750</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
including the intrinsic value of $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pp0p0_c20180101__20181231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhUGJYhpbWK"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" contextRef="From2018-01-012018-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,035,750</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to RSUs that had vested in 2018 but had
not been settled until 2020 due to a dispute with a former employee over the required withholding taxes to be paid to the Company for
remittance to the appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pp0d_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsT85C7ji39"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" unitRef="Shares">5,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested. However, the holder elected
to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Incentive
Stock Bonuses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into certain &#8220;at-will&#8221; employment agreements with certain employees. Under these agreements, the employees
are eligible to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion, that the employee&#8217;s
performance has been average or better for the applicable special bonus period. This special stock incentive bonus is payable only if
the employee continues in the employment of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
accounting purposes, the Company treats these special incentive stock bonuses as vesting over each bonus&#8217;s service period based
on the fair value of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards are vested over
each service period because it is more likely than not that the Board will approve the award based on the &#8220;average or better&#8221;
employee performance standard. Since the awards are denominated in shares of common stock, the fair value of the vested bonus is charged
to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock"><p id="xdx_891_eus-gaap--ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_ziFEO8U93GXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_z52aX6sTffS9" style="display: none">Schedule
of Incentive Bonus Awards Granted to Employees</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Shares</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average
                                            Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Nonvested, Beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,200</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.80</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Aggregated Intrinsic Value, Nonvested Beginning" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">124,320</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Awarded" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Awarded" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1417">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zceX362Zxk0l" title="Number of Shares, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,200</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.80</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Forfeited" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Forfeited" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1425">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Unvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Nonvested, Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Ending" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Awarded" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Awarded" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zN2GIWIYIJF7" title="Number of Shares, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-Date Fair Value, Vested" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Forfeited" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Forfeited" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1441">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Number of Shares, Nonvested, Ending" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" title="Weighted Average Grant-date Fair Value, Ending" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1445">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_zyuIhDceAjI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">44,209</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested stock
bonus awards issued to employees, net of forfeitures of $<span id="xdx_90B_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90A_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. As of December 31, 2020, there was no unrecognized share-based compensation related to unvested stock bonus awards. The
total intrinsic value of stock bonus awards vested and settled with share issuance was $<span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,240</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively.</span></p>
<!-- Field: Split-Segment; Name: 003 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zFn74fOaMw41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
15 &#8211; <span id="xdx_821_zV4uM1NQFNTb">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
financial reporting purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended December
31, 2020 or 2019 due to the Company&#8217;s net operating losses (&#8220;NOLs&#8221;) in such periods and full valuation allowance recorded
against the net deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIiW34TQAIW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are
summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B2_zCTN8kcubVtb" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20200101__20201231_zWYVRZsLcYri" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20190101__20191231_zGHYoW3blb12" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes computed at the federal statutory rate</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">369,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">281,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">States
    taxes, net of federal benefits</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">69,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">53,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent
    differences</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">136,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--IncomeTaxReconciliationTrueUpAdjustments_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">True-up
    adjustments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:IncomeTaxReconciliationTrueUpAdjustments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:IncomeTaxReconciliationTrueUpAdjustments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment
    to net operating loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">86,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">476,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income tax (benefit) expense</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zyq5pdPWZQNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zekBiNAzsxq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zhtemzF3Nnt7" style="display: none">Schedule
of Deferred Tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20201231_zelcwOq4Sb3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20191231_zfefclUeptM9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    operating losses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,821,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,081,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">392,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,108,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,622,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">68,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">58,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_zshjP3fwbMSl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">68,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets before valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,040,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,564,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zCTUfLxwNkrl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,040,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,564,000</ix:nonFraction></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zbmvDjdR9RRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,322,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_90F_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20201231_pp0p0"><ix:nonFraction name="SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,196,261</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">will
expire, if not utilized, in the years <span id="xdx_907_ecustom--NetOperatingLossExpirationTerm_c20200101__20201231"><ix:nonNumeric contextRef="From2020-01-012020-12-31" name="SRNA:NetOperatingLossExpirationTerm">2034 through 2037</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_90D_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zOGGU7TACqT"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the <span id="xdx_901_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zRlhzWwnJjW3"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of
the Company&#8217;s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201231_zbdq5FyH17te"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
within a <span id="xdx_903_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zMkApDHh82mg" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1512">three</span></span></span><span style="font: 10pt Times New Roman, Times, Serif">-year
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020 and 2019. Based on the available
evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable
future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation
allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent
with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying value of the Company&#8217;s
deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary course
adjustments or proposed adjustments to the Company&#8217;s taxes or the Company&#8217;s net operating losses with respect to years under
examination as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014 through 2019, Alaska,
California and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income tax returns for the years
2018 and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes in its consolidated financial statements the impact of a tax position, if that position is more likely than not of
being sustained on audit, based on the technical merits of the position. The Company&#8217;s policy is to recognize interest and penalties
accrued on any unrecognized tax benefits as a component of operating expense. The Company does not believe there are any tax positions
for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within
twelve months of the reporting date. There were <span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_do_c20200101__20201231_zWYfcHjyipc5"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2020-01-012020-12-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no
</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties or interest liabilities accrued as
of December 31, 2020 or 2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020 and
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-012020-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zAR15HqRAUrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
16 &#8211; <span id="xdx_82B_zoP28A0e9LHg">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. The following events occurred after December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board approved annual incentive compensation awards to certain employees payable in non-qualified stock options, based on the Company&#8217;s
performance and each employee&#8217;s contributions to such performance for the 2020 year. A total of <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zulljffyN1ti"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,905</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options were granted
under the 2017 Equity Plan subsequent to December 31, 2020, with an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">19.50</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. These non-qualified stock options
were immediately vested at the date of the grant. The estimated compensation expense of $<span id="xdx_902_eus-gaap--DeferredCompensationLiabilityCurrent_c20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,434</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related to the 2020 incentive awards was accrued
as of December 31, 2020. The accrued compensation expense was classified as a current liability as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed <i>in Note 10 Related Party Agreements and Transactions </i>above, on January 7, 2021, the Company entered into a consulting
agreement with RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide
consulting services to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related
matters, as mutually determined by the Company and RSX. The Company will pay a monthly consulting fee of $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_zQO9a9zL5Q4k"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,500</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 9 Note Payable and Accrued Interest</i> above, on February 10, 2021, we received funding based on a loan
agreement entered into on February 9, 2021 with our current bank in the principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zst0UBycpj21"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zn6ZozLI9vE5"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default provisions, including
for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in Note 11 Commitments and Contingencies above, a former employee is pursuing litigation against the Company for recovery
of alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. </span><span style="font-family: Times New Roman, Times, Serif">The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zDQbs5fsQDje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember" name="us-gaap:StockholdersEquityReverseStockSplit">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
par value for the Common Stock was not affected. In connection with the aforementioned reverse stock split, the Company&#8217;s Board of Directors approved the reset of the authorized
capital of the Company to be <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zje09WBADQwh"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-01-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> shares of common stock and <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHNfuUnA6Fuf"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-01-27_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000,000</ix:nonFraction> shares of preferred stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect
to the Reverse Split for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 28, 2022, the Company
agreed with the Series B investor to redeem <span id="xdx_904_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXzzUF0tHDn2" title="Shares Redeemed"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,650</ix:nonFraction> shares of the Company&#8217;s Series B Preferred Stock for approximately $<span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhwDt3wU5Oq4" title="Redemption value"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million
following the closing of the Company&#8217;s offering.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></p>

</ix:nonNumeric><p id="xdx_814_zrOUNd35UV4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>PART
I &#8212; FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
1. FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="cr_001"></span>Condensed
Consolidated Balance Sheets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_111_zxkj5qlqGzX6" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_497_20210930_zmlpmsoGlIVd" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_z6eHJASvPSH5" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Unaudited)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsAbstract_iB_zFST51Tdsoq4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">ASSETS</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrentAbstract_i01B_zkmnOmam8bW7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Current Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACzdVq_zxNHjJJ9Pmof" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash and cash
    equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,283,879</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,284,881</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsReceivableNetCurrent_i02I_maACzdVq_zVxhogvqykx2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable (net
    of allowance for doubtful accounts of $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20210930_zPGVnlHYpof3"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">186,073</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20201231_ztgGJHh5BHe8"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,098</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif">,
    respectively)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,245</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,480</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--InventoryNet_i02I_maACzdVq_zrWciYFISQs6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Inventory, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">480,354</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">327,109</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACzdVq_zfzcmwJ6cUdi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,157,119</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,037,823</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsCurrent_i02TI_mtACzdVq_maAzwOm_zLneSGdTPUag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Current Assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,953,597</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,683,293</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsNoncurrentAbstract_i01B_z2dh3wcGdjQ1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Noncurrent Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maANzJ7U_zDoO6oLWoNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,967</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">147,732</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Goodwill_i02I_maANzJ7U_zDTPA1s8aU64" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">631,064</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">631,064</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_maANzJ7U_zxzpscgw1Ggh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,792</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,227</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--DepositsAssetsNoncurrent_i02I_maANzJ7U_zEV4arsp9Oki" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Deposits</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepositsAssetsNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1566">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_maANzJ7U_z7fL1ywoXFDi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">194,353</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,950</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--AssetsNoncurrent_i02TI_mtANzJ7U_maAzwOm_zZDy1MXXVXF4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Noncurrent Assets</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">955,359</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,129,973</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtAzwOm_zesG5YGQswHb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,908,956</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,813,266</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zoqdlBfqTjjh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">LIABILITIES AND SHAREHOLDERS&#8217;
    DEFICIT</span></td><td></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesCurrentAbstract_i01B_z9s0dkMMea63" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">CURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzWF2_zEIXmL3twMg5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable and accrued
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,674,088</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,784,961</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_maLCzWF2_zI2qikoeFuy5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,059,525</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,724,189</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--DeferredCompensationLiabilityCurrent_i02I_maLCzWF2_zPb5jQ4lXugf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued equity compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,945</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,434</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherLiabilitiesCurrent_i02I_maLCzWF2_z20Ry7LZndbd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,078</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1593">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maLCzWF2_zjqykCI1WJY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Current
    portion of operating lease liability</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,140</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">266,105</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_i02TI_mtLCzWF2_maLzT4M_zYdr0qGC0UQ" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Current Liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,117,776</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,903,689</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zO3OX9iaXrJ3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">NONCURRENT LIABILITIES</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--LongTermNotesPayable_i02I_maLNzZD6_zthqxcZiFGB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Note payable and accrued
    interest</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LongTermNotesPayable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">517,468</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1605">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilitiesNoncurrent_i02I_maLNzZD6_zZqUjLPb82V8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,078</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,156</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maLNzZD6_zQvI635jxtA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, net of current portion</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1610">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">169,119</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesNoncurrent_i02TI_mtLNzZD6_maLzT4M_zvueYSPfJG1a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Noncurrent Liabilities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,546</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">243,275</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Liabilities_i01TI_mtLzT4M_maLASEzjF8_zOTCGxiNEKI1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,672,322</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,146,964</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzjF8_zCUWWY5mSBpb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Commitments and Contingencies (Note 7)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1619">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1620">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--TemporaryEquityAbstract_i01B_z6EbDeYp35C5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">TEMPORARY EQUITY</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_i02I_maRNIECzMuK_zNHRltDdWp3f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series B Redeemable Convertible
    Preferred Stock, $<span id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_c20210930_zN8hNHQdO7nh"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></span></span>
    <span style="font-family: Times New Roman, Times, Serif">par value; <span id="xdx_90C_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20210930_zYFlkAdg0IV3"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,300</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">and <span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20210930_zgMhRIlhvqu6"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif">issued and outstanding, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,960,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1626">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--RedeemableConvertiblePreferredStockSubscriptionReceivable_i02I_maRNIECzMuK_zshWbiZn2Jr7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series B Redeemable Convertible
    Preferred Stock Subscription Receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:RedeemableConvertiblePreferredStockSubscriptionReceivable" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,365,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1632">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--RedeemableConvertiblePreferredStockAccruedDividends_i02I_maRNIECzMuK_zdCvtnW3mtUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Series
    B Redeemable Convertible Preferred Stock Accrued Dividends</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RedeemableConvertiblePreferredStockAccruedDividends" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1635">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RedeemableNoncontrollingInterestEquityCarryingAmount_i02TI_mtRNIECzMuK_maLASEzjF8_zbwv7Ac2x9c1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Temporary Equity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,596,447</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1638">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquityAbstract_i01B_z5Y1vj72ORDe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">SHAREHOLDERS&#8217; DEFICIT</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Preferred stock; <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20210930_zewRVPdKUEA5"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_z2V4y5Lroou8"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000,000</ix:nonFraction></ix:nonFraction></span></span>
    </span><span style="font-family: Times New Roman, Times, Serif">shares authorized</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--PreferredStockValue_i02I_maSEzfnh_zhyrxLpTQqg2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Series A Preferred stock,
    $<span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210930_zsCj54v4Li09"><span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zpdrYBxi97z8"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span></span>
    </span><span style="font-family: Times New Roman, Times, Serif">par value; <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20210930_z83WLJ1KIMXj"><span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20201231_zyD567XsNtU"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930_zTgmbtsR09Nj"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20201231_zP9fJuGaHek5"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>
    </span><span style="font-family: Times New Roman, Times, Serif">shares issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PreferredStockValue_i02I_maSEzfnh_zADnItFMVXx6" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Preferred stock; 150,000,000
    shares authorized Series A Preferred stock, $0.00001 par value; 42,030,331 shares issued and outstanding</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--CommonStockValue_i02I_maSEzfnh_zrxZghHPVAq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zjo4YJWkgTHc"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201231_z2FiPNjtqPRd" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-family: Times New Roman, Times, Serif">par value; <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20210930_z1ozOUzkvgUf"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_zxQgLSbMnbU5"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000,000</ix:nonFraction></ix:nonFraction></span>
    </span></span><span style="font-family: Times New Roman, Times, Serif">shares authorized; <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20210930_zCSZwQjDm67b" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20210930_zID9Gqm8qRe2" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></ix:nonFraction>
    </span></span></span><span style="font-family: Times New Roman, Times, Serif">and <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20201231_zssd8ez4dLj3" title="Common Stock, Shares, Issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20201231_ztIhXeUE9SFi" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></ix:nonFraction>
    </span></span></span><span style="font-family: Times New Roman, Times, Serif">shares issued and outstanding, respectively</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdditionalPaidInCapital_i02I_maSEzfnh_zDOrDOlHGnCe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Additional paid in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,019,425</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,109,509</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzfnh_zhvBFInSdc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,379,674</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockholdersEquity_i02TI_mtSEzfnh_maLASEzjF8_zgtv42nASNwj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,359,813</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzjF8_zY22yYyaxcO" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,908,956</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,813,266</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="cr_002"></span>Condensed
Consolidated Statements of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_z4fIXrKQD3b6" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20210701__20210930_zqQ7oK13tXqg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20200701__20200930_znOzhavQjv5b" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210101__20210930_zbebt4xMS4Wg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20200101__20200930_zOPX2uUdHTyi" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Three Months Ended September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Nine Months Ended September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzs8l_zWx141YtN1g8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Revenue, net</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,706,436</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,634,669</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,582,470</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,127,018</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CostOfRevenue_msGPzs8l_zHQas3ExPbVg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,959,264</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,108,758</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,208,368</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,869,758</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--GrossProfit_iT_mtGPzs8l_maOILzjBd_zsP2HPWh1co2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross profit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">747,172</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">525,911</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,374,102</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,257,260</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingExpensesAbstract_iB_zftsO9cAreEc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating expenses:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--MarketingAndAdvertisingExpense_i01_maOEzdye_zAtHLZm4xCj6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising and marketing
    expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">224,393</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,695</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,580</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:MarketingAndAdvertisingExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">333,669</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzdye_z47VxxEn0oM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">98,623</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,433</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">322,807</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">304,229</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maOEzdye_zBWOcitH3q3e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">866,699</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">634,447</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,493,930</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,453,976</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpenses_i01T_mtOEzdye_msOILzjBd_zOVRL02nys3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total operating expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,189,715</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">808,575</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,386,317</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,091,874</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzjBd_maILFCOzHrz_zr9ximvlVBa5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating loss</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">442,543</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">282,664</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,012,215</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,834,614</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zNYj44mmU1i1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income (expense):</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01_maNIEz4xD_znbVwsFWw5Qb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other income (expense),
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,934</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,621</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,452</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,018</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpense_i01N_di_msNIEz4xD_zD8d2jYhpfDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    expense</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,296</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,396</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,268</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,673</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NonoperatingIncomeExpense_i01T_mtNIEz4xD_maILFCOzHrz_zbkShav296Od" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total other income (expense)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,638</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,225</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,184</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,345</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzHrz_maNILznBy_z13lWNSf0bf4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss before provision for income taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">407,905</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">270,439</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">936,031</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_msNILznBy_zd0azr1yHTD9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Income taxes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1755">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1756">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1757">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1758">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_iT_mtNILznBy_maNILATzwys_z815OmICjJG3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">407,905</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">270,439</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">936,031</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--RedeemablePreferredStockDividends_iN_di_msNILATzwys_zumodwHt5Ojg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Convertible Preferred Series
    B Stock Redemption Value Adjustment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RedeemablePreferredStockDividends" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:RedeemablePreferredStockDividends" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1768">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ConvertiblePreferredStockConvertedToSecurities_iN_di_msNILATzwys_zgCeq23wIKB5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Convertible
    Preferred Series B Stock Dividends</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ConvertiblePreferredStockConvertedToSecurities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1771">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ConvertiblePreferredStockConvertedToSecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1773">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzwys_zJ1LKUVMPwPj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net Loss Available to
    Common Shareholders</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,672,199</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">270,439</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,200,325</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAndDiluted_znl62YZsLXM8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Loss per common share
    &#8211; basic and dilutive</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.69</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.17</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.02</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_zOGgTZcem3Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number
    of common shares outstanding, basic and dilutive</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,581,142</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,564,746</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="cr_003"></span>Condensed
Consolidated Statements of Changes in Shareholders&#8217; Deficit</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
the Three and Nine Months Ended September 30, 2021 and 2020</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_114_zMXfp5fQswRe" summary="xdx: Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesAPreferredStockMember_ziAY5XXFvNJ2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zAiaKmj5BfP4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z1K5VQgp9vD6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zm3QXwVeuJc4" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B8_zrZRFIYVbT0k" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Paid
                                            in</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Capital</span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_433_c20210701__20210930_eus-gaap--StockholdersEquity_iS_zmwOPx6gARM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%"><span style="font-family: Times New Roman, Times, Serif">Balance June 30, 2021</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zd4RHz2nxPR8" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD9ymAviYkJ6" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonstockSharesToBeIssued_iS_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYt4COvmtKA6" title="Balance, shares to be issued" style="padding-left: -20pt; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif; display: none"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,326,691</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,971,769</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,644,642</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_408_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zYuPeVPPn6Wi" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of restricted
    stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_z13wZRpljaY1" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of restricted
    stock units and award of stock bonuses, shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_ze0helzvbKp3" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested restricted stock units
    awarded to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDispute_zAMlgg6buiN4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of legal
    dispute</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_zT5IHXttDiw" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of legal
    dispute, shares</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zdHRGFXJ50P8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_zb0YVzSYPHDc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses, shares to be issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">-</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_z6RXYfgWxTmh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1844">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1845">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1847">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,545</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_zRvNSE3ugwej" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options accrued
    in 2019 and issued to employees and directors in 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FairValueOfVestedStockOptionsGrantedToDirectors_zbY402fPGCXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1856">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1857">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,762</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1859">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,762</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_zqPeBzwx8Gu" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of series B preferred stock and warrants,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1862">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1863">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">927,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1865">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">927,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueStockDividend_iN_di_zxTpLxCS3Sia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1868">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1869">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1871">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--AdjustmentsToAdditionalPaidInCapitalRedemptionValue_zBy4WtSNZGze" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment to redemption value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1874">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1875">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1877">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_402_ecustom--CommonstockSharesToBeIssued_iE_zP3iz0CcjHN8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance, shares to be issued ending balance</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zPgpXOE0YgI1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested
    stock options granted to employees and directors</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zBa5WnHlHYUh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1892">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1893">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1894">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">407,905</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">407,905</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_434_c20210701__20210930_eus-gaap--StockholdersEquity_iE_znR7B2mYZe3k" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWA4NAvW1QEk" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZolVRgX9oZc" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--CommonstockSharesToBeIssued_iE_c20210701__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5RnRPw5Igd7" title="Balance, shares to be issued" style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1908">-</span></span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,019,425</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,379,674</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,359,813</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Paid
                                            in</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Capital</span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20210101__20210930_eus-gaap--StockholdersEquity_iS_zF6NFFGiTDh3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%"><span style="font-family: Times New Roman, Times, Serif">Balance December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zoVXrRb7GD49" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zig9SyDZmL1" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,109,509</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,443,643</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,333,698</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDispute_zKe4XSv41tzf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of legal
    dispute</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1920">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXS2l2qXnPW4" title="Common shares to be issued in settlement of legal dispute, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1921">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left">*</td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1923">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--FairValueOfVestedStockOptionsGrantedToEmployees_zEqj3FfoIrQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1928">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1929">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,315</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1931">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToEmployees" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">158,315</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--FairValueOfVestedStockOptionsGrantedToDirectors_zmD6onbOdPIb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1934">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1935">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,174</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1937">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:FairValueOfVestedStockOptionsGrantedToDirectors" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,174</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_z9ivByVLYmXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Issuance of series B preferred stock and warrants,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1940">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1941">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">927,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1943">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">927,721</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueStockDividend_iN_di_zStadFzu1bpl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1946">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1947">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1949">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_ecustom--AdjustmentsToAdditionalPaidInCapitalRedemptionValue_zRihsz6zRRm8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment to redemption value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1952">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1953">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1955">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zoFz5G2OEUb3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1958">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1959">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1960">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">936,031</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">936,031</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_43C_c20210101__20210930_eus-gaap--StockholdersEquity_iE_zAxrnVyMZzYb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zENAZANQaIjj" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20210101__20210930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziQBmKUaAJlc" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,019,425</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">28,379,674</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,359,813</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_us-gaap--StatementClassOfStockAxis_us-gaap--SeriesAPreferredStockMember_zJrmoiqElmc9" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares to be Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zwsFL5lDM9ql" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zlkg6uFdxaEf" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid in Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zmNZ5g8FEf1i" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_4B6_z2gkLyu3tQne" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares to be Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid in Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43D_c20200701__20200930_eus-gaap--StockholdersEquity_iS_z6rILRi1neue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif">Balance June 30, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNqQPTOUJkj1" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfWf8B4k3iDe" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--CommonstockSharesToBeIssued_iS_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziTK8iUhjNrj" title="Balance, shares to be issued" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1984">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,060,657</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,236,757</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,175,664</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zi1Gy8GAqCH8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued or to be issued on settlement
    of restricted stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1986">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcdM10Okg1xd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1991">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1987">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1988">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1989">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1990">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_z1NXk9OGrODl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees and directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1993">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1994">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,426</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1996">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,426</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_zFvcawwhQz0c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1999">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2000">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2001">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">270,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">270,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_43A_c20200701__20200930_eus-gaap--StockholdersEquity_iE_zB1Vojx0uTq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zk5frVTkwe43" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zteKm2LzEVV2" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--CommonstockSharesToBeIssued_iE_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHGZ2hkasBne" title="Balance, shares to be issued" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2015">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,085,083</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,507,196</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,421,677</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Series
    A Preferred Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Common
    Stock</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Shares to be Issued</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Amount</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Additional
    Paid in Capital</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Shareholders&#8217;
    Deficit</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_43E_c20200101__20200930_eus-gaap--StockholdersEquity_iS_zHg03z6KITvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%"><span style="font-family: Times New Roman, Times, Serif">Balance December 31, 2019</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6N4Sou1VtYe" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztFYGIQc0gg4" title="Beginning balance, shares" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,521,444</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--CommonstockSharesToBeIssued_iS_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zl4HDXsAzNa" title="Beginning balance, shares to be issued" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonstockSharesToBeIssued" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,400</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,328,861</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">25,684,927</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">355,631</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_403_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_zT78xiFUPH04" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common shares issued in settlement of restricted
    stock units and award of stock bonuses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2029">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmWYojmHhOH2" title="Common shares issued in settlement of restricted stock units and award of stock bonuses, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">55,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLHhDlROf2p7" title="Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">10,400</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2032">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2033">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_zfCMw5uuUA3d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested restricted stock units
    awarded to employees</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2039">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2040">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2042">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,163</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_zKjF36iHyx09" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options accrued
    in 2019 and issued to employees and directors in 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2045">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2046">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2048">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,466</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ztLCIYQOXkP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Fair value of vested stock options granted
    to employees and directors</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2051">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2052">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,594</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2054">&#160;</span></span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">227,594</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_z4yqMadicSBh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2057">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2059">&#160;</span></span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_438_c20200101__20200930_eus-gaap--StockholdersEquity_iE_zHE7BUg1GFx8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Balance September 30, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zVBUMxWDkVa5" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zajsVuDUbqyj" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--CommonstockSharesToBeIssued_iE_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhzvKlyyErOf" title="Ending balance, shares to be issued" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2073">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,085,083</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,507,196</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,421,677</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p title="Ending balance, shares" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="cr_004"></span>Condensed
Consolidated Statements of Cash Flows</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_112_zzHR4Ox2Vodj" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_49F_20210101__20210930_zV2C1Amgt7Bk" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_499_20200101__20200930_zTf646CYo5hg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zRbihckTQcUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash Flows From Operating Activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_i01_maCzVxy_maNCPBUzgYt_zJCzlQVIJgZ1" style="vertical-align: bottom; background-color: White">
    <td style="width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">936,031</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,822,269</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z42AQ7iu8hre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustments to reconcile net loss to net cash
    provided by (used in) operating activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--DepreciationDepletionAndAmortization_i02_maCzVxy_maNCPBUzgYt_zEja6H9g1yH5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and intangible
    asset amortization expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,973</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,867</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maCzVxy_maNCPBUzgYt_ztZKXrYJhkJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,055</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">252,757</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--CommonStockIssuedForOtherExpense_i02_maCzVxy_maNCPBUzgYt_zkPXEKYw04q1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Common stock issued for
    other expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:CommonStockIssuedForOtherExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ProvisionForDoubtfulAccounts_i02_maCzVxy_maNCPBUzgYt_zw67eJrNDCOi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision for doubtful
    accounts</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,975</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,150</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWriteDown_i02_maCzVxy_maNCPBUzgYt_z1mjDvPMLHSe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Provision for excess and
    obsolete inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,764</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,117</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--GainLossOnDispositionOfAssets_i02N_di_msCzVxy_msNCPBUzgYt_ziGOg2kxv1Ue" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss on disposal of assets</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,042</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,124</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i02_maCzVxy_maNCPBUzgYt_zMJdTE5A9m3h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Amortization of ROU asset</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">149,597</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">141,871</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zRql9830sls7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Changes in operating assets and liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInAccountsAndNotesReceivable_i03N_di_msCzVxy_msNCPBUzgYt_z41HZTsUMHH7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,740</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,950</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msCzVxy_msNCPBUzgYt_zAQUBpyL6dS4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,481</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">714,709</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msCzVxy_msNCPBUzgYt_zI5kxcxbifOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Prepaid expenses and other</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,296</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">488,007</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maCzVxy_maNCPBUzgYt_zyrYto6VEoH" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable and accrued
    liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">110,872</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">397,181</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInContractWithCustomerLiability_i03_maCzVxy_maNCPBUzgYt_zcG8Dc0jOkeh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">664,663</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,044,830</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInInterestPayableNet_i03_maCzVxy_maNCPBUzgYt_zQzzxbQF0vce" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued interest</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,268</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInLeaseDeposit_i03_maNCPBUzgYt_zRtZXtKjizsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lease deposit</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:IncreaseDecreaseInLeaseDeposit" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,183</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2127">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzgYt_zANLgaNXbrwb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">197,085</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">79,521</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInDeferredCompensation_i03_maNCPBUzgYt_zx0ZHD7Puq02" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    equity compensation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">108,945</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredCompensation" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101,472</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_pp0p0_mtNCPBUzgYt_maCCERCz3tx_znoBq0VffZs2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net cash (used in)/provided
    by operating activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,761,260</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">599,635</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zphUWgDWaSi9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash Flows From Investing Activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzTCz_zVG7Zpgu4Oq" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Purchases of property and
    equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,316</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_maNCPBUzTCz_zEIhAaXBtHT5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from the sale of property equipment</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2145">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzTCz_maCCERCz3tx_zULaVm3eLsk3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net cash used in investing
    activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,816</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,500</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zhcppH1EPQff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash Flows From Financing Activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_i01_maNCPBUzLZ3_zxOVLvQUaM1b" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Cash proceeds from sale
    of preferred stock and warrants, net of issuance costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,259,874</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzLZ3_zoyNiKG4QH3g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of note payable</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">514,200</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzLZ3_maCCERCz3tx_z585YDNJRcbh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by
    financing activities</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,774,074</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCz3tx_zNxsInb7mnZe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net change in cash and cash equivalents</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,002</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,150,135</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zRcgx1L77alb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents,
    beginning of period</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,284,881</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">922,177</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zrU8oF5s4vMl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents,
    end of period</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,283,879</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,072,312</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zv6WbY8oFY5b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Supplemental cash flow information:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InterestPaidNet_i01_zA96mmqtBzs7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Interest
    paid</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeTaxesPaidNet_i01_zQ9f5lY91ne2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes paid</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2177">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2178">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zUjb2FfrixPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Non-cash investing and financing activities:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_i01_zOUlUjnntisl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Adjustment
    of carrying value of series B preferred stock to redemption value</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,262,847</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--SubscriptionReceivableSeriesBPreferredStock_i01_zpm29gXYf7sg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Subscription
    receivable - series B preferred stock</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SubscriptionReceivableSeriesBPreferredStock" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2187">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--OptionsIssuedForAccruedEquityCompensation_i01_zziP4I48SGYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Options
    issued for accrued equity compensation</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:OptionsIssuedForAccruedEquityCompensation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,434</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--Dividends_i01_zOQRfGe3prpj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued
    dividends</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,447</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2193">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_04F_c20210101__20210930_zkQp8REDFhof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="cr_005"></span>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_80A_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zUTsGew1ld59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span>General</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<b><span id="xdx_826_zJF70d4qYexf" style="display: none">Basis
of Presentation; Summary of Significant Accounting Policies</span></b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:DescriptionOfBusinessPolicyTextBlock"><p id="xdx_840_ecustom--DescriptionOfBusinessPolicyTextBlock_zCrEyYE0LZM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zpXOwa8Kf3E7" style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under the trade name of Surna Cultivation
Technologies. We are headquartered in Boulder, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled
Environment Agriculture (CEA) industry. We leverage our experience in this space to bring value-added technology solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy evolving state and local construction
codes, permitting and regulatory requirements. In service of the CEA industry, our principal service and product offerings include: (i)
architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based
process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting
and climate control, and (vi) preventive maintenance services for CEA facilities. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada and other international locations. Customers are those growers building new facilities and those expanding
or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities operating in the cannabis industry, ranging from several thousand to more than <span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20210930__srt--RangeAxis__srt--MinimumMember_z9XF0A7t1rH6"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-09-30_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">100,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet. Although most of our customers do,
we neither produce nor sell cannabis or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock"><p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zJ5g1hjT3xui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_862_zRL47ZLChTta" style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, a general shortage of containers, and domestic truck driver availability.
While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue
to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed
by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others
in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and
provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long
they will continue as they are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4LOmZMhz1B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zujbAruiUlK6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal
year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that
date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information,
refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December
31, 2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:ReverseStockSplitPolicyTextBlock"><p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zUg2Ott7hvRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zDkXudJYVMFg">Reverse
Stock Split</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbIYs7NwCvDd"><ix:nonNumeric contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember" name="us-gaap:StockholdersEquityReverseStockSplit">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</ix:nonNumeric></span> The par value for the Common Stock was not affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zOedN0ypY9x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86D_zLl5cOPbrYQ6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:GoingConcernPolicyTextBlock"><p id="xdx_844_ecustom--GoingConcernPolicyTextBlock_zDO8KhTKWmPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zH89du6fObc6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_848_eus-gaap--UseOfEstimates_zJVd4mMFskNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zN73GZSCE8s6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zkRbnsKyCUxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_861_zphXuS9sKzbi" style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_z6n3qvro9Dvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zPuTYzvaZqPj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were convertible into shares of the Company&#8217;s common stock. During
the three- and nine-month periods ended September 30, 2021 and 2020, the Company incurred a net loss and consequently the common share
equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such
inclusion would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, and 2020, there were respectively, <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210930_z5pG22FYYXFe"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">777,888</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span><span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200930_zC71P0oJdjQ4"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">293,383</ix:nonFraction>,</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zPdvc7qsrOn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zd0DSFrKazgl" style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at September 30, 2021 and concluded that no impairment
relating to goodwill existed at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:TemporaryEquityPolicyTextBlock"><p id="xdx_84B_ecustom--TemporaryEquityPolicyTextBlock_zE2Zaf4pfC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zRlN1JWL87Me" style="font: 10pt Times New Roman, Times, Serif"><b><i>Temporary
Equity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Shares
of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option
of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely
within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the
issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but
not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument
will become redeemable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company determined it is probable the Series B Preferred Stock will become redeemable at the option of the holder. As a result, on September
30, 2021, the Company adjusted carrying value of the Series B Preferred Stock to its redemption value of $<span id="xdx_901_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLCQ8hlTdHog"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,960,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and recorded a $<span id="xdx_900_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrG2hH9aUMTj"><ix:nonFraction name="SRNA:TemporaryEquityNonCashRedemptionValueAdjustment" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,262,847</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes, accordingly, the redemption value adjustment
is therefore added to the &#8220;Net Loss&#8221; to arrive at &#8220;Net Loss Attributable to Common Shareholders&#8217;&#8221; on the
Company&#8217;s Consolidated Statements of Operations. In addition, as the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zCxpnpInTo8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_860_zT8U5MdyHhtg" style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and nine months ended September 30, 2021, the Company recognized revenue of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210701__20210930_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">283,452</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210930_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,357,068</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2021. For the three and nine months ended September 30, 2020, the Company
recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200701__20200930_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,141</ix:nonFraction></span></span>
<span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200930_pp0p0"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,074,016</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligation_c20210930_pp0p0"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,881,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30_us-gaap_CustomerContractsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,161,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20210930_zfUHZeWvm788"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligationPercentage" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic disruption or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at September 30, 2021, includes booked sales orders of $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_uUSD_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OrderOrProductionBacklogMember_zQiH5yXcW5Ol"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30_us-gaap_OrderOrProductionBacklogMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,250,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until late 2022. The Company believes the sales orders in this portion of our backlog have an elevated level
of risk and may, ultimately, be delayed or cancelled by our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"><p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining performance obligations
    related to engineering only paid contracts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">112,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,049,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,161,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining performance
    obligations related to partial equipment paid contracts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,091,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,629,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,720,000</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total remaining performance
    obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,203,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,678,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,881,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zdZ6cVm80Sc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment and systems sales</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" title="Total revenue" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,523,948</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" title="Total revenue" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,481,961</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" title="Total revenue" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-09-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,933,313</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" title="Total revenue" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_EquipmentAndSystemsSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,575,855</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering and other services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,538</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">114,160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-09-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">464,269</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" title="Total revenue" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_EngineeringAndOtherServicesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">402,837</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping and handling</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,950</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">38,548</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-012021-09-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">184,888</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Total revenue" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_us-gaap_ShippingAndHandlingMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">148,326</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,706,436</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,634,669</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,582,470</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" title="Total revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,127,018</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zSYfASf65Z46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfQMiP6BT2ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_zA6zAZxFgwvj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the nine months ended September 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20210101__20210930_zjmEsX3sHaI3"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">150.2</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20210101__20210930_zHAcn2McUsf9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">152.51</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%;
expected term in years <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zPhzX5q4QUH2"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">10</ix:nonNumeric></span> and risk-free interest rate ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20210101__20210930_zkfR1HWzjVYc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.55</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20210101__20210930_zs7PKLO3x2L9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.49</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Share-based Compensation Costs</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based compensation expense included in:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,833</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-09-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,944</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">23,949</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-09-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,292</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30_custom_AdvertisingAndMarketingExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,500</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2308">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,444</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-09-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,029</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30_custom_ProductDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,332</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling, general and
    administrative expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,307</ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,221</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,735</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">306,448</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total share-based compensation
    expense included in consolidated statement of operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,307</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,998</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" title="Total share-based compensation expense included in consolidated statement of operations" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">354,229</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_ziNbaFNKOUKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and nine months ended September 30, 2021, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zNd3DhHNSvr2"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-07-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2021-01-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">108,945</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2021 Annual Employee Incentive Compensation Plan. Included in the expense for the three and nine months ended September
30, 2020, is an accrual for $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-07-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,575</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2020-01-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">101,472</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zgAxWufL4G8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zCLI7eHLyfci" style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3jKyMJ5YAS4"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">38</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_za4qYsaP3jh3"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z8bHMCB4y0h2"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2021 and three customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zApQM56jYBd2"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHTpxjPgaqK1"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1hn6lzZsVuc"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2021. Two customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPuKUHIkvXUg"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">39</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUGTRBLN1Dfd"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2020 and three customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zh5VodyGBjKh"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIBTh36OT6yc"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjBnFGuFf4Ak"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHhpAYN5FCRe"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">40</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zELcnQgAMOLf"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">26</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHU7QSoRrj07"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable as of September 30, 2021. As of September 30, 2020, four customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkftRueBQBp7"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">32</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zs0b7Bbnarb2"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zxDkjiX7Kwsj"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zpzVLaWk3dO8"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerFourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znKZgsEHZZg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_znjFYXzb42Jh" style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2021, the FASB issued ASU 2021-04, <i>Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. </i>This guidance clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges
of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective
for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively
to modifications or exchanges occurring on or after the effective date. The Company anticipates that the adoption of this guidance will
not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06,
Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company early adopted ASU 2020-06 effective January 1, 2021. The early
adoption of ASU 2020-06 impacted the Company&#8217;s accounting for the issuance of its Series B Redeemable Convertible Preferred Stock
as further discussed in <i>Note 8 Temporary Equity Series B Redeemable Convertible Preferred Stock</i> below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

</ix:nonNumeric><p id="xdx_85C_zPQM0qab7O4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zGCkOmB9jGb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_823_zIm2ibSzdefi">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package of
practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance sheet
as an operating lease right-of-use asset in the amount of $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_z3QIEFnCJWn8"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">714,416</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and as a lease liability of $<span id="xdx_904_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zHmT8Ig7tRDe"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">822,374</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
<span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210930_zltbRLvpqQs2"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="us-gaap:LesseeOperatingLeaseDescription">The Facility Lease commenced September
29, 2017 and continues through August 31, 2022.</ix:nonNumeric></span></span> <span style="font: 10pt Times New Roman, Times, Serif">The
Company has the option to renew the Facility Lease for an additional <span id="xdx_902_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210930__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_z7ONoruRGFhb"><ix:nonNumeric contextRef="AsOf2021-09-30_custom_FacilityLeaseMember" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm">five
years</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. However, the renewal option to extend
the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain of exercise.
The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal
period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_90E_ecustom--MonthlyRentDescription_c20210101__20210930" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="SRNA:MonthlyRentDescription">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%</ix:nonNumeric></span><span style="font: 10pt Times New Roman, Times, Serif">.
Total rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the
same monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to
operating lease liability on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zR1ThP9KYplj"><ix:nonFraction name="us-gaap:TenantImprovements" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $<span id="xdx_903_ecustom--UnamortizedAmountOfTenantImprovementAllowance_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zrgjzx7tGFi2"><ix:nonFraction name="SRNA:UnamortizedAmountOfTenantImprovementAllowance" contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,481</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was treated as a reduction in measuring the right-of-use
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non lease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and
non lease components as a single component and account for it as the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zE7BfvjDMl78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B0_zg5aAGk9vSug" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Months
                                            Ended</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseCost_c20210101__20210930_pp0p0" title="Operating lease cost" style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">162,667</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating cash outflow from operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeasePayments_c20210101__20210930_pp0p0" title="Operating cash outflow from operating lease" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">210,154</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">As
                                            of</span></p>
                                                                                                    <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">2021</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use asset</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_c20210930_pp0p0" title="Operating lease right-of-use asset" style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">194,353</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_c20210930_pp0p0" title="Operating lease liability, current" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,140</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, long-term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210930_pp0p0" title="Operating lease liability, long-term" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining lease term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210930_zpudGJ6rSd88" style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="AsOf2021-09-30" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">.9</ix:nonNumeric>
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20210930_zQoCqfVihB42" title="Discount rate" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.00</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zP0CoSboRq6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zl9F1dquxe55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of September 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Future Annual Minimum Lease Payments</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years ended
    December 31,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%"><span style="font-family: Times New Roman, Times, Serif">2021 (excluding the nine months ended September 30,
    2021)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_c20210930_zjvcD1tjTLH9" title="Remainder of fiscal year" style="width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">71,710</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20210930_zFkL3HCOoQE1" title="Year one" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">170,891</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total minimum lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20210930_pp0p0" title="Total minimum lease payments" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">242,601</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20210930_zLIQ6LKinbYa" title="Less imputed interest" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,461</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of
    minimum lease payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20210930_pp0p0" title="Present value of minimum lease payments" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">238,140</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zTti6psuUEP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 30, 2021, the Company entered into an agreement to sublease approximately <span id="xdx_90D_eus-gaap--AreaOfLand_iI_usqft_c20210430_zPfHJZENNDPi"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">6,900</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#8217; notice.
Unless 30-days&#8217; notice is provided sooner, this sublease will end upon termination of the Company&#8217;s Lease Agreement with
its current landlord. Rent was initially charged at $<span id="xdx_904_ecustom--RentalExpense_pp0p0_c20210429__20210430_zyyaoa9n2K69" title="Rental expense"><ix:nonFraction name="SRNA:RentalExpense" contextRef="From2021-04-292021-04-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,989</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month and increased to $<span id="xdx_90C_ecustom--RentalExpense_pp0p0_c20210629__20210702_z8eUGTfQbS24" title="Rental expense"><ix:nonFraction name="SRNA:RentalExpense" contextRef="From2021-06-292021-07-02" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,978</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month effective July 1, 2021. The Sublessor
is also responsible for its prorated share of utilities and other related costs. This new sublease does not change the Company&#8217;s
legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining financial
obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying value
of the Company&#8217;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#8217;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#8217;s operating lease
right of use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the <span id="xdx_902_eus-gaap--AreaOfLand_iI_usqft_c20210727_zl3I6KkR9xzg"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-07-27" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">18,952</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square foot office and manufacturing facility
in Boulder, CO, which was previously scheduled to expire on <span id="xdx_902_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zXeSy0kHheTf"><ix:nonNumeric contextRef="From2021-07-252021-07-27_custom_LeaseTerminationAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:LeaseExpirationDate1">August
31, 2022</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. The termination provides for the Company
to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company paid
a nominal lease termination fee on July 28, 2021. The termination was also contingent upon a successor tenant executing a new lease with
the landlord and the Company paying the remaining deferred rent and security deposit amounts (<i>See Contractual Payment Obligations
</i>section). The landlord and successor tenant entered into a lease agreement on July 27, 2021. The remaining deferred rent and security
deposit will be paid in conjunction with the final rent payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 28, 2021, the Company entered into an agreement to lease <span id="xdx_904_eus-gaap--AreaOfLand_iI_usqft_c20210728_z4RgX87I8D3f"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2021-07-28" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">11,491</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet of office and manufacturing space
in Louisville, CO. The lease commences on November 1, 2021 and continues through <span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zJDQ4X7f1m1i"><ix:nonNumeric contextRef="From2021-07-242021-07-28_custom_LeaseTerminationAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:LeaseExpirationDate1">January
31, 2027</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">. The Company has the option to renew
the lease for an additional 60-month period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_z04jK9JWDORa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_824_zMBy98biFY">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zzf4SyZLHGM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zyNsY9SHCwe5" style="display: none">Schedule
of Inventory</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210930_z5ce68v8Z4C4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z6T6rCooRhNa" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zqUs5jAD08x3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">319,335</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">201,778</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zVmUeZOf0Oil" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work in progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,595</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,231</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zamrk66e6vH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">237,705</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">214,145</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_zhYIxIekR7Ll" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for excess
    &amp; obsolete inventory</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">79,281</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:InventoryValuationReserves" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">93,045</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zIGhHlcMXc96" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">480,354</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">327,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zd3giabyIeY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_900_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20210101__20210930_znNmM1wONjjg"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,674</ix:nonFraction></span></span>
<span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20200101__20201231_z8GkUPR1Skph"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSoldOverhead" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,974</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in the inventory balance as of
September 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $<span id="xdx_90F_ecustom--PrepaidInventoryExpenses_c20210930_pp0p0"><ix:nonFraction name="SRNA:PrepaidInventoryExpenses" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">879,000</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0"><ix:nonFraction name="SRNA:PrepaidInventoryExpenses" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">916,000</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">in
advance payments for inventory for the periods ended September 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zrwtRk5xMaYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_821_zOTdUyJEQMn3">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJiv7xcnC4L1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zLZVCtZSs8k5" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-09-30_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">296,851</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMZDztKFreq3" title="Property and equipment, gross" style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">398,422</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-09-30_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z6OcIdjPZrR6" title="Property and equipment, gross" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-09-30_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zIUHCxMURVJ2" title="Property and equipment, gross" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,193</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20210930_pp0p0" title="Property and equipment, gross" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">527,044</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zokQaM4dbO78" title="Property and equipment, gross" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">628,615</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210930_zvp6VeXPSTq1" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">428,076</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zgUvrI5Finv7" title="Accumulated depreciation" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">480,883</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20210930_pp0p0" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">98,967</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zhCu01lBplz3" title="Property and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">147,732</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zUOwpMJ8p0y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20210101__20210930_zFO71rsB7aNe"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,538</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the nine months ended September 30, 2021. For the nine months ended September 30, 2021, $<span id="xdx_900_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zCCjntru6qIi"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,721</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of sales and $<span id="xdx_90E_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zSgVbMfsEve1"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,180</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to inventory with the remainder
recorded as selling, general and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z43nIkRhMPC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_825_zvk1TcGntuvh">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrHfPYmX2q3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zou4lBgXvTna" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Accounts Payable and Accrued Liabilities</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210930_zkBTLGzF71Vl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20201231_zdNzFzCMsHi9" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzbsH_zxSd7lz1MQwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">864,558</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">918,639</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzbsH_zU6BX7o3qF18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales commissions payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccruedSalesCommissionCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">48,263</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_z4CC0eQnScI4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued payroll liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">255,462</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">288,071</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzbsH_zwpWEPRMNvs7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product warranty accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,868</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,365</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_zn7eu27m6ee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">340,442</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">356,623</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzbsH_zMr6ODvSMOGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,674,088</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,784,961</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zttCbNds4Jbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zzSHV0N0TM24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_823_z3CYiRhxSaTk">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210_zH5lMReVvun9"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2021-02-10" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,200</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount bears interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210_z14UZe4s1tB7"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2021-02-10" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zwpeLY3NxQbh"><ix:nonNumeric contextRef="From2021-02-092021-02-10" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">February 5, 2026</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment
of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan
is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions,
including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments,
insolvency, dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three and nine months ended September 30, 2021, interest of $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210701__20210930_zkE22sd21pR6"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,296</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210101__20210930_zqtrNtTebagk"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,268</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was accrued, respectively, in respect of this
note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcGTgUN2iaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_824_zkQESrASBuFe">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were <span id="xdx_90E_ecustom--NumberOfUnitsVestedButNotSettled_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr0v6SJAu0x6"><ix:nonFraction name="SRNA:NumberOfUnitsVestedButNotSettled" contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted
stock units that had not been settled due to a dispute with a former employee over the required withholding taxes to be paid to the
Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against the former employee
regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid wages. As
stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee <span id="xdx_902_ecustom--NumberOfUnitsVestedAndSettled_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z17WdGRouHq7"><ix:nonFraction name="SRNA:NumberOfUnitsVestedAndSettled" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of the Company&#8217;s common stock in settlement of these restricted stock units after taking measures to mitigate the
Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an
interim award of approximately $<span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z83IRlsnuDBc"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
the Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award
in the Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company
costs of $<span id="xdx_904_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zJwNGM5Ovb86"><ix:nonFraction name="us-gaap:LossContingencyDamagesAwardedValue" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,985</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with interest at <span id="xdx_902_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zKbPCGWx94Wh"><ix:nonFraction name="SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage" contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the
Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This
former employee continued to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for
the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective March 30, 2021, this separate
litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed and will be obliged to
pay $<span id="xdx_906_eus-gaap--LossContingencyDamagesPaidValue_pp0p0_c20210329__20210330_zg8GiAEbIbOk"><ix:nonFraction name="us-gaap:LossContingencyDamagesPaidValue" contextRef="From2021-03-292021-03-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">over
eight months and to issue upon execution of the settlement agreement an aggregate of <span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210406__20210408_zBnLJLpv26P1"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-04-062021-04-08" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,667</ix:nonFraction>
shares </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of common stock of the Company.
These shares were issued on April 8, 2021 as &#8220;restricted securities,&#8221; subject to a lock-up agreement of six months,
without registration rights, and pursuant to a private placement exemption and were valued at $<span id="xdx_903_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210329__20210330_zl4c8v5acVtf"><ix:nonFraction name="SRNA:AggregateSharesIssuedUponExecutionOfSettlement" contextRef="From2021-03-292021-03-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement,
$<span id="xdx_901_eus-gaap--OtherNonoperatingExpense_c20210101__20210930_pp0p0"><ix:nonFraction name="us-gaap:OtherNonoperatingExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
in total, has been recognized in full in other expenses during the nine months ended September 30, 2021. As of September 30, 2021,
$<span id="xdx_902_eus-gaap--PaymentsForLegalSettlements_pp0p0_c20210101__20210930_zyrU8kltI1d8"><ix:nonFraction name="us-gaap:PaymentsForLegalSettlements" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
been paid in respect of the $<span id="xdx_906_eus-gaap--LitigationSettlementExpense_c20210101__20210930_pp0p0"><ix:nonFraction name="us-gaap:LitigationSettlementExpense" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">40,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash
portion of the settlement and the remaining $<span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210930_z3icA562jUUk"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
included in accounts payables and accrued liabilities. The issuance of the <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930_pdd"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock, valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210930_pp0p0"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,000</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
been recognized in common stock issued during the nine months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s operations
or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Leases</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#8217;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:TemporaryEquityTextBlock"><p id="xdx_804_ecustom--TemporaryEquityTextBlock_zyeOd45ANRwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_826_zyKj3TvutyTe">Temporary Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Series
B Redeemable Convertible Preferred Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, Surna Inc. (the &#8220;Company&#8221;) sold to an institutional investor (the &#8220;Investor&#8221;), <span id="xdx_90A_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zWBfeh5lB161"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,300</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Convertible Preferred Stock,
stated value $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zyShvMTCTPW3"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, currently convertible into <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zlsLpbEYhPMl"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">385,965</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, and a warrant to
purchase up to <span id="xdx_901_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember__srt--RangeAxis__srt--MaximumMember_z8NTY7KVPXS"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2021-09-262021-09-28_us-gaap_ConvertiblePreferredStockMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,982</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock (&#8220;Investor Warrant&#8221;),
for an aggregate purchase price of $<span id="xdx_904_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zu6Iagl612Af"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#8220;Consideration&#8221;). The Company will
receive net proceeds of approximately $<span id="xdx_90B_ecustom--TemporaryEquityNetProceeds_c20210926__20210928_z9WzIusTMoG8" title="Temporary equity net proceeds"><ix:nonFraction name="SRNA:TemporaryEquityNetProceeds" contextRef="From2021-09-262021-09-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,625,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has received net proceeds of approximately $<span id="xdx_900_ecustom--TemporaryEquityNetProceeds_c20210701__20210930_zjaujvOgy6I"><ix:nonFraction name="SRNA:TemporaryEquityNetProceeds" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,260,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the quarter and will receive the remaining
$<span id="xdx_90C_eus-gaap--EscrowDeposit_iI_c20210928_z2YUezDmOyY"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2021-09-28" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursuant
to the terms of the escrow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Stock has an annual dividend of <span id="xdx_90C_eus-gaap--PreferredStockDividendRatePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zlCYDAncZO02"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and has an initial common stock conversion price of $<span id="xdx_90F_eus-gaap--CommonStockConvertibleConversionPriceIncrease_pid_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zSQQvS8yH7ze"><ix:nonFraction name="us-gaap:CommonStockConvertibleConversionPriceIncrease" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numunitdecimalin" decimals="INF" unitRef="USDPShares">8.55</ix:nonFraction>.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion rate is subject to adjustment in
various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering
event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering,
is sold at a price below the then conversion price. The Series B Preferred Stock is mandatorily convertible on the third anniversary
of its issuance. All conversions of the Series B Preferred Stock are subject to a blocker provision of <span id="xdx_909_ecustom--PercentageOfPreferredStockConversionProvision_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z8c2PmowmfF3"><ix:nonFraction name="SRNA:PercentageOfPreferredStockConversionProvision" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.
The Company will reserve <span id="xdx_90F_ecustom--PercentageOfCommonStockReserve_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0d9woEHBsdi"><ix:nonFraction name="SRNA:PercentageOfCommonStockReserve" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">200</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the number of shares of common stock into which the Series B Preferred Stock and Investor Warrant may be converted or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pending
completion of an amendment to the certificate of incorporation to increase the number of authorized shares of common stock and redeem
the outstanding Series A Preferred Stock, as required by the Investor, $<span id="xdx_90E_eus-gaap--PreferredStockValueOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNbGvRSZCqO3"><ix:nonFraction name="us-gaap:PreferredStockValueOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Consideration was placed in escrow. The
Company filed a Schedule 14C to affect the amendment and expects the amendment process to be completed in early November, at which time
the escrowed amount will be released to the Company. If the amendment process is not achieved by December 7, 2021, then the Company will
redeem, at <span id="xdx_90C_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8hIvSe4Y7Sl"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the stated value of $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_pid_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6oU9KX0d8Tj"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, <span id="xdx_908_ecustom--DebtInstrumentRedeemableShares_iI_pid_uShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1f2Ow9Tpaxj" title="Redeemable shares"><ix:nonFraction name="SRNA:DebtInstrumentRedeemableShares" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,650</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Series B Preferred Stock, and pay
the dividend amount due thereon at <span id="xdx_90D_ecustom--DebtInstrumentRedemptionPricePercentageDividendDueThereon_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVTxKe9selXc" title="Redemption price percentage dividend due thereon"><ix:nonFraction name="SRNA:DebtInstrumentRedemptionPricePercentageDividendDueThereon" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
to the date of redemption. The Series B Preferred Stock will be redeemed at the demand by the holders, at <span id="xdx_904_eus-gaap--DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVymgD77fFgc"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the stated value of $<span id="xdx_90D_ecustom--DebtInstrumentRedeemptionStatedValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJCPKwPW8pw6"><ix:nonFraction name="SRNA:DebtInstrumentRedeemptionStatedValue" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
at any time after the earlier of (x) the consummation by the Company of a qualified offering, or (y) the first anniversary of the issuance
of the Series B Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Investor was granted a right of participation in future private offerings and has agreed to a 180-day lock-up in connection with a qualified
offering. A &#8220;qualified offering&#8221; is the first public offering after the sale of the Series B Preferred Stock in which the
common stock of the Company is listed on a national exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor Warrant may be exercised until <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zqeGoFx5RzX6"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_InvestorWarrantMember" format="ixt:datemonthdayyearen" name="us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">September
28, 2024</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at an initial exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uUSDPShares_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zlpQsIh0MOu3"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-30_custom_InvestorWarrantMember" format="ixt:numunitdecimalin" decimals="INF" unitRef="USDPShares">9.41</ix:nonFraction>,</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject to adjustment. The Investor Warrant provides
for cashless exercise if the underlying shares of common stock are not registered for resale, and all issuances of common stock upon
exercise are subject to a <span id="xdx_90B_ecustom--IssuanceOfCommonStockExercisePercentageProvision_pid_dp_uPure_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zIbASQMACAu9"><ix:nonFraction name="SRNA:IssuanceOfCommonStockExercisePercentageProvision" contextRef="From2021-01-012021-09-30_custom_InvestorWarrantMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
blocker provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company granted the Investor registration rights for the shares of common stock underlying the Series B Preferred Stock and the Investor
Warrants. The Company must file a registration statement no later than 180 days after the date of a qualified offering and have it effective
in 45 days if there is no Securities and Exchange Commission (&#8220;SEC&#8221;) review, or if there is a review, within 75 days. The
Company must keep the registration statement effective until all the shares registered have been sold or may be sold under Rule 144,
without regard to volume and holding period restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged ThinkEquity LLC (&#8220;ThinkEquity&#8221;) as its placement agent and paid a total cash fee of <span id="xdx_905_ecustom--PercentageOfPlacementAgentCashFee_pid_dp_uPure_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zkKvu7yQ7UE7" title="Percentage of placement agent cash fee"><ix:nonFraction name="SRNA:PercentageOfPlacementAgentCashFee" contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%,
or $<span id="xdx_90D_eus-gaap--InvestmentCompanyShareholderServiceFeeExpense_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zC5IYCbjCbQl"><ix:nonFraction name="us-gaap:InvestmentCompanyShareholderServiceFeeExpense" contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and its expenses, less prepaid expenses, and issued to ThinkEquity and its designees a warrant to purchase up to an aggregate of <span id="xdx_905_ecustom--WarrantToPurchaseCommonStockShares_pid_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zniC59FA7AYj" title="Warrants to purchase of common stock shares"><ix:nonFraction name="SRNA:WarrantToPurchaseCommonStockShares" contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,737</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The exercise price
of the warrant initially will be $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_z2kgrNrgMlhl"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-30_us-gaap_EquityMethodInvestmentsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.40</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to typical adjustment
provisions, and exercisable for a term of three years. The warrant has registration rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Probability
of Redemption: As it was considered probable the Series B Preferred stock will become redeemable outside of the Company&#8217;s control,
the Series B Preferred stock needs to be disclosed as temporary equity and restated at the balance sheet date at its redemption value
of <span id="xdx_906_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zua3LY9d3Dfe"><ix:nonFraction name="us-gaap:DebtInstrumentRedemptionPricePercentage" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">120</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">%
the stated value of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zr7TYjVvCTj9"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, or $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleLiquidationPreferenceValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zOxdEVN2QBe"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleLiquidationPreferenceValue" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,960,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">.
As a result, on September 30, 2021, the Company adjusted the carrying value of the Series B Preferred Stock to its redemption value of
$<span id="xdx_906_eus-gaap--TemporaryEquityAccretionToRedemptionValue_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNOlS2Egi2zg"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,960,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and recorded a $<span id="xdx_90C_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zHUgFEv6mycd"><ix:nonFraction name="SRNA:TemporaryEquityNonCashRedemptionValueAdjustment" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,262,847</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment
is therefore added to the &#8220;Net Loss&#8221; to arrive at &#8220;Net Loss Attributable to Common Shareholders&#8217;&#8221; on the
Company&#8217;s Consolidated Statements of Operations. In addition, since the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Series
B Redeemable Convertible Stock Subscription Receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zafp6uInVS2a"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,624,874</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">receivable under the Securities Purchase Agreement
relating to the Series B preferred stock and related warrants, $<span id="xdx_909_eus-gaap--EscrowDeposit_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zE1knPwY12g8"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was put into escrow pending the completion of
i) an amendment to the Articles of Incorporation to increase the number of authorized shares of common stock to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQbFzRpg8t7k"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">850,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares, (ii) <span id="xdx_907_eus-gaap--TemporaryEquityDescription_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zACZMVqRxdW2"><ix:nonNumeric contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember" name="us-gaap:TemporaryEquityDescription">the
redemption of the outstanding shares of Series A Preferred Stock of the Company for common stock at the rate of</ix:nonNumeric> one 0.0067 share
of common stock for each 100 shares of preferred stock that is currently issued and outstanding,</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the authorization of a reverse stock split of the common stock in connection with the listing of the common stock on an eligible market
(as defined in the Purchase Agreement), and, if the number of authorized shares of common stock is reduced in connection with such reverse
stock split, the subsequent increase of the authorized shares of capital stock of the Company within established limits, at any time
prior to June 30, 2022, and (iv) an amendment to the articles of incorporation to change the corporate name of the Company to CEA Industries
Inc. If these amendments are completed by December 7, 2021, then the remaining $<span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20211207__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGPpnFN9v8uc"><ix:nonFraction name="us-gaap:EscrowDeposit" contextRef="AsOf2021-12-07_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">funds held in escrow will be released to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly,
as of September 30, 2021, these funds were disclosed as Series B Redeemable Convertible Stock Subscription Receivable on the Company&#8217;s
consolidated balance sheet</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zLEMEAvq5Fn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_82C_zz7QT1VL2MP">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company has <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zRGC0qPCawdc"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares authorized at a $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zgPNbhg2GWK4"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
A Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company has <span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zti7WHe7QRh"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,030,331</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares issued and outstanding at the end of both
periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
B Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Company entered into a Securities Purchase Agreement (&#8220;Purchase Agreement&#8221;) with an institutional
investor (the &#8220;Investor&#8221;), pursuant to which the Investor purchased from the Company <span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodShares_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z5z12iiRU4nb"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_custom_PurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,300</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Preferred Stock with a stated
value of $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zd56CbRHW8mi" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, or $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zqvskA2dB5Hc"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,300,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of stated value in the aggregate (&#8220;Series
B Preferred Stock&#8221;), and a warrant to purchase up to <span id="xdx_905_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--RangeAxis__srt--MaximumMember_zOWckPCvqsVb"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">192,982</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company (&#8220;Investor
Warrant&#8221;), for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z72nQJTrrb54"><ix:nonFraction name="us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement" contextRef="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#8220;Consideration&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
a result of the PIPE Financing, referenced above and described in <i>Note 8</i>, the Company has <span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIjq8sNHF6H5"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,300</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares issued and outstanding as of September
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company was authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_zbiPacSZuf9h"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of common stock with a par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zgGn7QJ9Dp8h"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 31, 2020, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20201231_z3hDxtp71bC9"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,576,844</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued <span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210101__20210930_zfzi6EWxLpLd"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, valued at $<span id="xdx_90C_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210101__20210930_zl6dL0o0Gvyg"><ix:nonFraction name="SRNA:AggregateSharesIssuedUponExecutionOfSettlement" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">67,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as part of a legal settlements further described
in <i>Note 7 &#8211; Commitments and Contingencies &#8211; litigation above.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
effective September 30, 2021, <span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20210930_zIZVyOIDlQug"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,583,511</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zEfXpBuuBbVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_82D_z5vjtBg5QZIj">Equity Incentive Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2017
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Company&#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#8220;2017 Equity
Plan&#8221;), the Board of Directors (the &#8220;Board&#8221;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit
awards (&#8220;RSUs&#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">333,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Plan Shares&#8221;) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited,
expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination,
again be available for awards under the 2017 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2021
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#8220;2021 Equity Plan&#8221;), which was approved by the stockholders
on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zUKuM85eymW7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">666,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The 2021 Plan provides
for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the
&#8220;Code&#8221;), non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards and restricted
stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise
terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather
than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that
may be issued pursuant to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021, the Company issued no shares of its common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, the Company granted awards for <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,777</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options as described
below. Of the total awards granted, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zXv86LyB4JP7"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_TwoThousandSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,239</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were under the 2017 Equity Plan and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zu8021NWT1yc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_TwoThousandTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">230,770</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were issued under the 2021 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, of the <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numcommadecimal" decimals="INF" unitRef="Shares">333,3333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares authorized under the 2017 Plan for
equity awards, <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">163,692</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares have been issued, awards related to
<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,665</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options remain outstanding, and <span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,976</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain available for future equity
awards. As of September 30, 2021, of the <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1PiEc7JzJbk"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">666,667</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares authorized under the 2021 Equity Plan,
<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z6khA6M8EmRc"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relate to outstanding options and <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z45iGP1qUb5i"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">665,129</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain available for future equity
awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
was $<span id="xdx_905_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zOrSNtGUD6Hb"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,255</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in unrecognized compensation expense for unvested
non-qualified stock options at September 30, 2021 which will be recognized over approximately <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1ZU0vweRqA2"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3</ix:nonNumeric>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zKTPsPnJRnNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended
September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span id="xdx_8BB_znp5ywFL5g0c" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4gld8oXLul1" title="Number of Options, Outstanding Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,007</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV4oZm5nSTre" title="Weighted Average Exercise Price, Outstanding Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.45</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbwjmlEDTEwl" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">8.3</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfEQLj1v1Gg9" title="Aggregate Intrinsic Value, Outstanding Beginning" style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2585">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zVR5opud0Jkc" title="Number of Options, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,239</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOAZ8AjQNT2e" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQzVkmkVAe79" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">10.0</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhuARfgxtYmj" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAJjNruQHOWf" title="Number of Options, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2594">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zckRq9ht7oh" title="Number of Options, Forfeited/Cancelled" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,914</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyrSB7ZQtu54" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.30</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkhSYLxIW19e" title="Weighted Average Remaining Contractual Term, Forfeited" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited">6.6</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYWhXI9gTWQi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2600">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYzO59PB6VH7" title="Number of Options, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5tsk0SnBZ22" title="Number of Options, Outstanding Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">113,332</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zW3x9SeFnQe" title="Weighted Average Exercise Price, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.45</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUvpqxPDK4wf"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">7.9</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwoVKOVoNvQ7" title="Aggregate Intrinsic Value, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcxUwTQQjYnb" title="Number of Options, Exercisable Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">101,665</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuF817ZZFR2a" title="Weighted Average Exercise Price, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.75</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmipUx7wQY88"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.7</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgDgQ0Fv3lf4" title="Aggregate Intrinsic Value, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2616">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A8_ziZVULdxX17c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued a total of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--RelatedPartyTransactionAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zJ8lLFruyjeb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2021-09-30_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,239</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options to employees as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,906</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options were issued to 21 employees in
    respect of the Company&#8217;s 2020 Annual Incentive Awards. The options vested immediately, have a term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zoKzbu3P6TOl"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">10</ix:nonNumeric>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price of $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd">19.50.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztTM9FHDUKG5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,333</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options were issued to our newly appointed
    Chief Financial Officer. The options vest as follows: <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,667</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested immediately, <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyTwoMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,780</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2022, <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyThreeMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">665,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2023 and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyFourMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">668,000</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2024. The options have a term
    of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdbnHwa0m937"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">10</ix:nonNumeric>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price of $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">9.15.</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the nine months ended September 30, 2021, <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerEmployeeMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zo8KL30YriX7"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_FormerEmployeeMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,914</ix:nonFraction>
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested stock options were forfeited
    following the departure of 3 former employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6uz1kHQOHmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months
ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zImqUMghEN0d" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQQ0WxbcTUO3" title="Number of Options Nonvested, Beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2632">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zdouRiT9Kbyl" title="Weighted Average Grant-Date Fair Value, Beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2634">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ztXpy42QEQ7c" title="Aggregated Intrinsic Value, Nonvested Beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUsKV9NiRi5e" title="Grant Date Fair Value Nonvested, Beginning" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2638">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zujbP3yXyAv7" title="Number of Options Nonvested, Granted" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,239</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcEIwcqwY0Di" title="Weighted Average Grant-Date Fair Value, Granted" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.30</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmAwKRm0eX83" title="Grant Date Fair Value Nonvested, Granted" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2644">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zD5rouAApSL9" title="Number of Options Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,572</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5kngnBAUc07" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.80</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgRPVPqNdq8d" title="Aggregated Intrinsic Value, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,412</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4aUVWGA7vgb" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zca5jjCSo3wh" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zlysCjUo3WC5" title="Grant Date Fair Value Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2656">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zetnfKTZTJO8" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2658">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z7WwHfQCuoc3" title="Grant Date Fair Value Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zxcEFmi9RtM5" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,667</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zi6raECBmYgc" title="Weighted Average Grant-Date Fair Value, Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.15</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znjM5qNdlQnc" title="Aggregated Intrinsic Value, Nonvested Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaTJaeQ9A541" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,800</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zezsuorBi2S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the nine months ended September 30, 2021 and September 30, 2020, the Company recorded $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61996156" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,881</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20200101__20200930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,624</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zXNy04sZt6A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine
months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BA_zLEoLGV1DQue" style="display: none">Schedule
of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value ($000)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh1VE8UaYWrg" title="Number of Options, Outstanding Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,333</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyiSCSDM7sXe" title="Weighted Average Exercise Price, Outstanding Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJbcsxA6QD8a" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.5</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZwNzbalPCs4" title="Aggregate Intrinsic Value, Outstanding Beginning" style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2679">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zX9g4KSImHFa" title="Number of Options, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFwFKcg1vkv" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGohvJBQxzBc" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">10.0</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdPKPvrPRF8l" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKDOV5jhmzS9" title="Number of Options, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2688">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0NhSxzTxYud" title="Number of Options, Forfeited/Cancelled" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2690">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2189g8PNKub" title="Number of Options, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqWgJYn1Egoh" title="Number of Options, Outstanding Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,871</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8hlGNijGvJ7" title="Weighted Average Exercise Price, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2Q055u8ZUta" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">6.8</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFIMmyG9WhFg" title="Aggregate Intrinsic Value, Outstanding Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2699">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,</span><span style="font-family: Times New Roman, Times, Serif">
    September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zawOZjpZ9LN8" title="Number of Options, Exercisable Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,871</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsxjgS68DW64" title="Weighted Average Exercise Price, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpCvslrSsDhi" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">6.8</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3atSYHs8e1j" title="Aggregate Intrinsic Value, Exercisable Ending" style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zVzM1AvVUUw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3XQ8fS3Ywhg"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember_custom_NonQualifiedStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options to directors
as retroactive compensation for the first half of 2021 under the 2021 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" escape="true" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVVQyPWVcsz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the
nine months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zm0LwJwSl8qg" style="font: 10pt Times New Roman, Times, Serif; display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zK1aMeTWkwG2" title="Number of Options Nonvested, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,667</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfRIVlkOUuwl" title="Weighted Average Grant-Date Fair Value, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.35</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzHLUXNM13E7" title="Aggregated Intrinsic Value, Nonvested Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">31,000</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwCOEhNblof7" title="Grant Date Fair Value Nonvested, Beginning" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2717">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPQxCdlSzXq6" title="Number of Options Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,538</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbrjiGryUQe" title="Weighted Average Grant-Date Fair Value, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.75</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_iN_pdp0_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zERxLWFY9iQf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,154</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODpm85TDhe7" title="Grant Date Fair Value Nonvested, Granted" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhqZIy8eZ76g" title="Number of Options Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,205</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJhaKpnlMwX9" title="Weighted Average Grant-Date Fair Value, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.40</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmhZ7MTcgb16" title="Aggregated Intrinsic Value, Nonvested Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">29,846</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvi8PX2mQ4Qa" title="Grant Date Fair Value Nonvested, Vested" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2732">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4HOo16infre" title="Number of Options Nonvested, Forfeited" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2734">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGknfEHNDja" title="Number of Options Nonvested, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7bt2EGwK4N6" title="Number of Options Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2738">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfvFdw7YGJQg" title="Aggregated Intrinsic Value, Nonvested Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7ycd9P24fK7" title="Grant Date Fair Value Nonvested, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2742">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zkPaIltoQSFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021 and September 30, 2020, the Company incurred $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,174</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,970</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, as compensation expense related to <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,205</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,142</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested options, respectively, issued to directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<i>, </i>the Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxzGMq2rnrl"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="Shares">13,333</ix:nonFraction>
</span>non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested </span><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zMW8RvkBTfc7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction>%
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon grant and 50% on April 1, 2021, if the Director
remained on the Board up to that time. The options have a term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zThDsft0fbd1"><ix:nonNumeric contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
August 20, 2021, the Company issued <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pp0p0_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zojIelSV9eAb"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="Shares">1,538</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options under the 2021
Equity Plan to its directors. The options vested upon grant. The options have a term of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zXT5fN9NZONf"><ix:nonNumeric contextRef="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">10</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price equal to the closing
price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
has been no activity related to RSUs during the nine months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-012020-09-30_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,163</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">during the nine months ended September 30, 2020,
as compensation expense related to vested RSUs issued to employees, directors and consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pdd"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,333</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested. However, the holder elected
to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:WarrantsDisclosureTextBlock"><p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zLmaN214mUB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 - <span id="xdx_822_zZvDjqWyypN2">Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock"><p id="xdx_897_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z5O823WM7Gl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zT9rBdMJ3yq9" style="display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20210930_zjWAvLHPnk4i" title="Warrants Outstanding, Beginning Balance" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,417</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20210930_zVNGmDosj27a" title="Weighted Average Exercise Price, Beginning Balance" style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zgawyAW8NT94" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">6</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210930_zd9calbbkjh3" title="Aggregate Intrinsic Value, Beginning Balance" style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210930_pdd" title="Warrants, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightIssued" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,719</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210930_pdd" title="Weighted Average Exercise Price, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.00</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zSciqoAeDnDc" title="Weighted Average Life of Outstanding Warrants in Months, Issued" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms">36</ix:nonNumeric></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210930_pdp0" title="Aggregate Intrinsic Value, Issued" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2772">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210930_pdd" title="Warrants, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210930_pdd" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210930_pdp0" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210930_pdd" title="Warrants, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpired" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">50,417</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210930_pdd" title="Weighted Average Exercise Price, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.50</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210930_pp0p0" title="Aggregate Intrinsic Value, Expired" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" contextRef="From2021-01-01to2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20210930_zHLFpnVfVYkf" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,719</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20210930_zqb3GSU71sKi" title="Weighted Average Exercise Price, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.00</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zfdYLOWvWWl3" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">36</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210930_zmIv9vQYXBhd" title="Aggregate Intrinsic Value, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z27zHbV89978" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zgrijU5SXnZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8BC_zzmfRVkOy6i1" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Life of</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z537to8iv6U1" title="Exercise price" style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-30_custom_WarrantsRangeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.45</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zq4AHuDxnVph" title="Warrants Outstanding" style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-30_custom_WarrantsRangeMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">192,982</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Weighted Average Life of Outstanding Warrants in Months" style="width: 30%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z4vfo7shlyH2" title="Weighted Average Life of Outstanding Warrants in Months"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_WarrantsRangeMember" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">36</ix:nonNumeric></span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWfIKLSGAx6g" title="Exercise price" style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-30_custom_WarrantsRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.40</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zY4PmTbN1D6e" title="Warrants Outstanding" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-30_custom_WarrantsRangeOneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,737</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Weighted Average Life of Outstanding Warrants in Months" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zNYfLPBILEE9" title="Weighted Average Life of Outstanding Warrants in Months"><ix:nonNumeric contextRef="From2021-01-012021-09-30_custom_WarrantsRangeOneMember" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">36</ix:nonNumeric></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930_zstL5FZdVKdh" title="Warrants Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,719</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td title="Weighted Average Life of Outstanding Warrants in Months" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zQZPEEYKQMN" title="Weighted Average Life of Outstanding Warrants in Months"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" format="ixt-sec:durmonth" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">36</ix:nonNumeric></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z7B5RgfF2jO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 30, 2021, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210101__20210630_z1ebEzJbJ8wi"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,417</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued in connection with our Q2
2018 unit offering expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 28, 2021, we issued <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_znqNDbdtl9m"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">192,982</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zIqPacuiSBIj"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.45</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a <span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zCEc33Ar032d"><ix:nonNumeric contextRef="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">3</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
term to the Holders of our Series B redeemable convertible preferred stock and <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z4HtGMCpiH16"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,737</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHmIVZwGc5ji"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.40</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5a5OYmFxfIg"><ix:nonNumeric contextRef="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember" format="ixt-sec:duryear" name="SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">3</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
term to the placement agent in respect of the sale of the Series B redeemable convertible preferred stock. <i>See Note 8</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zMBnk2MfMPf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_82F_zNkEtzZJVBlf">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_c20210930_pp0p0"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,260,000</ix:nonFraction></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_900_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210930_pp0p0"><ix:nonFraction name="SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,196,261</ix:nonFraction></span></span> <span style="font: 10pt Times New Roman, Times, Serif">will
expire, if not utilized, in the years <span id="xdx_900_ecustom--NetOperatingLossExpirationTerm_c20210101__20210930"><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" name="SRNA:NetOperatingLossExpirationTerm">2034 through 2037</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_908_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_znCWXrxJQtik"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction>%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the <span id="xdx_90A_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_zhH5W4pCXr1d"><ix:nonFraction name="SRNA:NolsUsageAgainstTaxableIncomePercentage" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">limitation for NOLs arising in 2018, 2019 and
2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company&#8217;s NOLs carryforwards may be
limited in the event of cumulative changes in ownership of more than <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_uPure_c20210930_zx19LEtl67Gl"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction>%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">within a <span id="xdx_900_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zHVjGRvejb71" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl2825">three</span></span>-year
period</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2021 and December 31, 2020.
Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred
tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support
the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on
assumptions that are consistent with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates,
the carrying value of the Company&#8217;s deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUkNtcCooKgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
13 &#8211; Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_828_ztSWdZvbitn2" style="display: none; font-family: Times New Roman, Times, Serif">Related
Party Agreements and Transactions</span><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended
September 30, 2021, the Company paid $<span id="xdx_90D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20210701__20210930_zQN09FVZ86Q8"><ix:nonFraction name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,873</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in commissions under this agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zP1iivNZTJzb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
14 &#8211; <span id="xdx_82A_z2PEJ4LfiuGc">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after September 30, 2021, other than as set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we increased our authorized capital to one billion shares of capital stock, of which <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4zLWfurIhdj"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-11-03_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">850,000,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">are designated as common stock and <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztNDlqGT8Kli"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-11-03_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">are designated as preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we were authorized to redeem the outstanding Series A Preferred Stock, which was completed on November 4, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 4, 2021, we received the remaining $<span id="xdx_90F_eus-gaap--ReplacementReserveEscrow_iI_c20211104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z14mvNVr5na7"><ix:nonFraction name="us-gaap:ReplacementReserveEscrow" contextRef="AsOf2021-11-04_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,365,000</ix:nonFraction>
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from escrow in relation to the Series B Preferred
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z2bHrjzoD924" title="Reverse stock split, Description"><ix:nonNumeric contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember" name="us-gaap:StockholdersEquityReverseStockSplit">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</ix:nonNumeric></span> The par value for the Common Stock was not
affected. In connection with the aforementioned reverse stock split, the Company&#8217;s Board of Directors approved the reset of the authorized
capital of the Company to be <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVpBvvLoCOq6"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-01-17_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction></span> shares of common stock and <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z21iLzVisd8b"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-01-27_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,000,000</ix:nonFraction></span> shares of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 28, 2022, the Company
agreed with the Series B investor to redeem <span id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9d2g4ETonk5" title="Shares redeemed"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,650</ix:nonFraction> shares of the Company&#8217;s Series B Preferred Stock for approximately $<span id="xdx_90E_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv8nUM08RI24" title="Redemption value"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million
following the closing of the Company&#8217;s offering.</span></p>

</ix:nonNumeric><p id="xdx_81E_zPvnZBYI4rnc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Up
to 2,962,963</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b> Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>2,962,963
Warrants to Purchase Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Up
to 2,962,963 Pre-Funded Warrants to Purchase Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><img src="logo.jpg" alt="https:||ceaindustries.com|wp-content|uploads|2021|11|Logo.png" style="width: 381px; height: 69px" /></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>CEA
Industries Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 26%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>PRELIMINARY
PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 26%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>ThinkEquity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;,
2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
and including &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2022 (the
25<sup>th </sup>day after the date of this offering), all dealers effecting transactions in these securities, whether or not participating
in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation to deliver a prospectus
when acting as an underwriter and with respect to an unsold allotment or subscription.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">PART
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">INFORMATION
NOT REQUIRED IN PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
13.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
                   Expenses of Issuance and Distribution</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth all costs and expenses, other than underwriting discounts and commissions, paid or payable by us in connection
with the sale of the common stock being registered. All amounts shown are estimates except for the SEC registration fee, the FINRA filing
fee and the listing fee for the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">SEC
    registration fee</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,062.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">FINRA
    filing fee</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">3,269.22</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Nasdaq
    listing fee</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">5,000.00</p><p style="margin: 0"></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Accounting
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">39,668.00</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Legal
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">135,000.00<p style="margin: 0"></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Transfer
    agent fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,000.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Printing
    and related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,000.00<p style="margin: 0"></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Miscellaneous
    expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">244,500.19<p style="margin: 0"></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">474,500.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
14.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Indemnification
                   of Directors and Officers</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are a Nevada corporation. The Nevada Revised Statutes (&#8220;NRS&#8221;) provides that the articles of incorporation of a Nevada corporation
may contain a provision eliminating or limiting the personal liability of a director to the corporation or its shareholders for monetary
damages for breach of fiduciary duty as a director, except that any such provision may not eliminate or limit the liability of a director
(i) for any breach of the director&#8217;s duty of loyalty to the corporation or its shareholders, (ii) acts or omissions not in good
faith or which involve intentional misconduct or a knowing violation of law, (iii) acts specified in Section 78 (concerning unlawful
distributions), or (iv) any transaction from which a director directly or indirectly derived an improper personal benefit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
NRS provides that a Nevada corporation must indemnify a person who was wholly successful, on the merits or otherwise, in defense of any
threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative and whether
formal or informal, in which he or she was a party because the person is or was a director, against reasonable expenses incurred by him
or her in connection with the proceeding, unless such indemnity is limited by the corporation&#8217;s articles of incorporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
NRS provides that a Nevada corporation may indemnify a person made a party to a proceeding because the person is or was a director against
any obligation incurred with respect to a proceeding to pay a judgment, settlement, penalty, fine (including an excise tax assessed with
respect to an employee benefit plan) or reasonable expenses incurred in the proceeding if the person conducted himself or herself in
good faith and the person reasonably believed, in the case of conduct in an official capacity with the corporation, that the person&#8217;s
conduct was in the corporation&#8217;s best interests and, in all other cases, his or her conduct was at least not opposed to the corporation&#8217;s
best interests and, with respect to any criminal proceedings, the person had no reasonable cause to believe that his or her conduct was
unlawful. A corporation may not indemnify a director in connection with any proceeding by or in the right of the corporation in which
the director was adjudged liable to the corporation or, in connection with any other proceeding charging that the director derived an
improper personal benefit, whether or not involving actions in an official capacity, in which proceeding the director was judged liable
on the basis that he or she derived an improper personal benefit. Any indemnification permitted in connection with a proceeding by or
in the right of the corporation is limited to reasonable expenses incurred in connection with such proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the NRS, unless otherwise provided in the articles of incorporation, a Nevada corporation may indemnify an officer, employee, fiduciary,
or agent of the corporation to the same extent as a director and may indemnify such a person who is not a director to a greater extent,
if not inconsistent with public policy and if provided for by its bylaws, general or specific action of its board of directors or shareholders,
or contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 65; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation provide that we will indemnify to the fullest extent permitted by Nevada law any person made or threatened
to be made a party to any threatened, pending or completed action or proceeding, whether civil, criminal, administrative or investigative
(whether or not by or in the right of the Company) by reason of the fact that he or she is or was a director of the Company or is or
was serving as a director, officer, employee or agent of another entity at the request of the Company or any predecessor of the Company
against judgments, fines, penalties, excise taxes, amounts paid in settlement and costs, charges and expenses (including attorneys&#8217;
fees and disbursements) that he or she incurs in connection with such action or proceeding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Our
articles of incorporation also provide that to the fullest extent permitted by NRS 78, a director or officer of the Company will not
be personally liable to the company or its stockholders for damages for breach of fiduciary duty as a director or officer, provided that
the foregoing will not eliminate or limit the liability of a director or officer for: (a) acts or omissions which involve intentional
misconduct, fraud or a knowing violation of law; or (b) the payment of distributions in violation of NRS 78.300.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
15.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Recent
                   Sales of Unregistered Securities. </b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the three years preceding the filing of this registration statement, we have issued the following securities that were not registered
under the Securities Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor
purchased from the Company 3,300 shares of convertible Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000
of stated value in the aggregate, and a warrant to purchase up to 192,982 shares of common stock of the Company, for an aggregate
purchase price of $3,000,000. The warrant is exercisable until September 28, 2024, at an initial exercise price of $9.45, subject
to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions
and distribution of rights. The Series B Preferred Stock is convertible into shares of common stock, for no additional consideration.
The Company engaged ThinkEquity LLC as its placement agent of the Series B Preferred Stock and paid a cash fee of 9%, or $270,000, and
its expenses, less prepaid expenses, and issued to ThinkEquity and its designees a warrant to purchase up to an aggregate of 34,737
shares of common stock. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021.
The exercise price per share of the placement agent warrants is $10.40, subject to adjustment for stock splits, stock dividends
and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights. The securities
were not and have not been registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), and were issued pursuant
to an exemption under Section 4(a)(2) of the Act for transactions of an issuer not involving a public offering, and may not be offered
or sold in the United States absent registration under the Act or an exemption from such registration requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2021, the Company redeemed all the Series A Preferred Stock by the issuance of an aggregate of 2,802 shares of common
stock as provided by the amended Articles of Incorporation. The securities were not and have not been registered under the Act, and were
issued pursuant to an exemption under Section 4(a)(2) of the Act for transactions of an issuer not involving a public offering, and may
not be offered or sold in the United States absent registration under the Act or an exemption from such registration requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
16.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibits
                   and Financial Statement Schedules</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">(a)
Exhibits. We have filed the exhibits listed on the accompanying Exhibit Index of this Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">(b)
<i>Financial Statement Schedules</i>. All financial statement schedules are omitted because the information called for is not required
or is shown either in the consolidated financial statements or in the notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>ITEM
17.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Undertakings</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(a)
The undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -1in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) pursuant
to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering
price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">provided,
however, that Paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section
13 or section 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), that are incorporated by reference
in the registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser: If the registrant is subject to Rule 430C (&#167;230.430C
of this chapter), each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than
registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A (&#167;230.430A of this chapter),
shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided,
however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the
registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such
date of first use.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(5)
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424 (&#167;230.424 of this chapter);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(b)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
the registrant&#8217;s annual report pursuant to section 13(a) or section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated by reference in
the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(d)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(e)
For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule
424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared
effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">(f)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1
to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Louisville, State of Colorado, on the 31<sup>st</sup>_
day of January 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>CEA
    INDUSTRIES INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
    Anthony K. McDonald</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="a_001"></span>POWER
OF ATTORNEY</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>KNOW
ALL PERSONS BY THESE PRESENTS</i>, that each person whose signature appears below hereby constitutes and appoints Anthony K. McDonald
and R. Brian Knaley, acting separately, as his/her true and lawful attorney-in-fact and agent with full power of substitution, for him/her
in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments or any
abbreviated registration statement and any amendments thereto filed pursuant to Rule 462(b) increasing the number of securities for which
registration is sought), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities
and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every
act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could
do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or her substitute, may lawfully do or
cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Anthony K. McDonald</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer and Director</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Brian Knaley</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Financial Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0in"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Knaley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    James R. Shipley</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    R. Shipley</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Nicholas J. Etten</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    J. Etten</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Marion Mariathasan</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marion
    Mariathasan</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Troy L. Reisner</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2022</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Troy
    L. Reisner</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.1
    +</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Form
    of Underwriting Agreement </td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(a)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh31.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Articles
    of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form S-1 as filed on January 28,
    2010).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(b)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-1b.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Amendment
    to Articles of Incorporation (incorporated herein by reference to Exhibit 3.1(b) to the Annual Report on Form 10-K filed April 2,
    2018).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(c)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315214001395/ex3-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Certificate
    of Designations of Preferences, Rights, and Limitations of Preferred Stock (incorporated herein by reference to Exhibit 3.2 to the
    Current Report on Form 8-K as filed on May 12, 2014).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(d)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Certificate
    of Designations of Preferences, Rights, and Limitations of Class B Preferred Stock (incorporated herein by reference to Exhibit 3.1
    to the Current Report on Form 8-K as filed on September 30, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(e)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221027175/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Amendment
    to Articles of Incorporation to increase capitalization and redeem Class A Preferred Stock (incorporated herein by reference to Exhibit
    3.1 to the Current Report on Form 8-K filed November 4, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.1(f)
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029245/ex3-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Amendment
    to Articles of Incorporation to change corporate name (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form
    8-K filed November 12, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">3.1(g)*</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex3-1.htm">Amendment to Articles of Incorporation to effect a reverse split and fix capitalization.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">3.2
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Bylaws,
    as amended (incorporated herein by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed April 2, 2018).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">4.1
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh41.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Specimen
    Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed on January 28,
    2010).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">4.2
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex4-7.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Description
    of Securities (incorporated herein by reference to Exhibit 4.7 to the Annual Report on Form 10-K filed March 24, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">4.3
    +</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Form
    of the Underwriter Representative Warrant.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">4.4
    </span></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-3.htm" style="-sec-extract: exhibit">Form of Investor Warrant Agreement, dated as of September 28, 2021 (incorporated herein by reference to Exhibit 10.3 to the Current Report on Form 8-K filed November 4, 2021).</a></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">4.5
    </span></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-6.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant Agreement, dated as of September 28, 2021, by and between Surna Inc and ThinkEquity and designees (incorporated herein by reference to Exhibit 10.6 to the Current Report on Form 8-K filed November 4, 2021).</a></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">4.6 *</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-6.htm">Form of Warrant Agency Agreement for the Investor Warrants.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">4.7 *</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-6.htm">Form of Warrant<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> (included in Exhibit 4.6).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">4.8 *</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-8.htm">Form of Pre-Funded Warrant.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">5.1
    *</span><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="ex5-1.htm">Opinion of Golenbock Eiseman Assor Bell &amp; Peskoe LLP.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.1
    #</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221029932/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Executive
    Employment Agreement between the Company and Anthony K. McDonald dated effective November 24, 2021 (incorporated herein by reference
    to Exhibit 10.1 to the Current Report on Form 8-K filed November 26, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>10.2
    #</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221015205/ex10-1.htm" style="-sec-extract: exhibit">Executive Employment Agreement between the Company and Brian Knaley, dated June 28, 2021 (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed June 24, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.3
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315217008485/ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Surna
    Inc. 2017 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the Registration Statement on Form S-8 filed
    on August 3, 2017).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.4
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221008188/def14a.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Surna
    Inc. 2021 Equity Incentive Plan (incorporated herein by reference to Exhibit B to the Proxy Statement of the Registrant, for the
    annual meeting to be held May 28, 2021 filed on April 7, 2021).</span></a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 70; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">EX-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in"><span style="font: normal 10pt Times New Roman, Times, Serif">10.5
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-2.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Stock
    Repurchase Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.2 to the Current Report on Form 8-K filed May 31, 2018).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.6
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-3.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Preferred
    Stock Option Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference
    to Exhibit 10.3 to the Current Report on Form 8-K filed May 31, 2018).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.7
    </span></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed November 4, 2021).</a></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.8
    </span></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221024134/ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement, dated as of September 28, 2021, by and between Surna Inc. and the institutional investor (incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed November 4, 2021).</a></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">10.9
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315218002044/ex14.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Form
    of Placement Agent Agreement, dated as of September 28, 2021, by and between Surna Inc. and ThinkEquity (incorporated herein by reference
    to Exhibit 10.5 to the Current Report on Form 8-K filed November 4, 2021).14.1 Code of Business Code and Ethics adopted February
    13, 2018 (incorporated herein by reference to Exhibit 14 to the Current Report on Form 8-K filed February 14, 2018).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">21.1
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="https://www.sec.gov/Archives/edgar/data/1482541/000149315221006659/ex21-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-weight: normal">Subsidiaries
    (incorporated herein by reference to Exhibit 21,1 to the Annual Report on Form 10-K filed March 24, 2021).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">23.1
    *</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex23-1.htm">Consent
    of (ACM LLP) Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><b>23.2
    </b></span><b><span style="font-family: Times New Roman, Times, Serif">*</span></b></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="ex23-2.htm">Consent
    of Sadler, Gibb &amp; Associates, L.L.C. , Independent Registered Public Accounting Firm.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">23.2
    +</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="ex5-1.htm">Consent of Golenbock Eiseman Asssor Bell &amp; Peskoe LLP (incorporated by reference to Exhibit 5.1 of this Registration Statement, in which it is included)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">24.1
    *</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><a href="#a_001"><span style="font-size: 10pt; font-weight: normal">Power
    of Attorney (included on signature page of this Form S-1).</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">101.INS*
    </span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">XBRL
    Instances Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">XBRL
    Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL<b>*</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">XBRL
    Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">XBRL
    Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">XBRL
    Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">XBRL
    Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">#</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Denotes
    a management contract or compensatory plan or arrangement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">*</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">+</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">To
    be filed by amendment</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">EX-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_001.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_002.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_003.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>3
<FILENAME>ex4-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
AGENT AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
AGENT AGREEMENT (this &ldquo;<U>Warrant Agreement</U>&rdquo;) dated as of _________, 2022 (the &ldquo;<U>Issuance Date</U>&rdquo;) between
CEA Industries Inc., a company incorporated under the laws of the State of Nevada (the &ldquo;<U>Company</U>&rdquo;), and Continental
Stock Transfer &amp; Trust Company (the &ldquo;<U>Warrant Agent</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
pursuant to the terms of that certain Underwriting Agreement (&ldquo;<U>Underwriting Agreement</U>&rdquo;), dated February __, 2022,
by and among the Company and ThinkEquity LLC, as representative of the underwriters set forth therein, the Company is engaged in a public
offering (the &ldquo;<U>Offering</U>&rdquo;) of up to _________ shares (the &ldquo;<U>Shares</U>&rdquo;) of common stock, par value $0.00001
per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company, up to ________ pre-funded warrants (the &ldquo;<U>Pre-funded Warrants</U>&rdquo;)
to purchase up to __________ shares of Common Stock (the &ldquo;<U>Pre-funded Warrant Shares</U>&rdquo;), and warrants (the &ldquo;<U>Warrants</U>&rdquo;)
to purchase up to _________ shares of Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo;), including Shares, Pre-funded Warrants and
Warrants issuable pursuant to the underwriters&rsquo; over-allotment option;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company has filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) a Registration Statement on Form
S-1 (Registration No. 333-261648) (as the same may be amended from time to time, the &ldquo;<U>Registration Statement</U>&rdquo;) for
the registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Shares, Pre-funded Warrants,
Pre-funded Warrant Shares, Warrants and Warrant Shares, and such Registration Statement was declared effective on February __, 2022;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with
the terms set forth in this Warrant Agreement, in connection with the issuance, registration, transfer, exchange and exercise of the
Warrants;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company desires to provide for the provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective
rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants the valid, binding and legal obligations of
the Company, and to authorize the execution and delivery of this Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Appointment of Warrant Agent</U>. The Company hereby appoints the Warrant Agent to act as agent for the Company with respect to the
Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and
conditions set forth in this Warrant Agreement (and no implied terms or conditions).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<U>Form of Warrants</U>. The Warrants shall be registered securities and shall be initially evidenced by a global Warrant certificate
(&ldquo;<U>Global Certificate</U>&rdquo;) in the form of <U>Annex A</U> to this Warrant Agreement, which shall be deposited on behalf
of the Company with a custodian for The Depository Trust Company (&ldquo;<U>DTC</U>&rdquo;) and registered in the name of Cede &amp;
Co., a nominee of DTC. If DTC subsequently ceases to make its settlement system available for the Warrants, the Company may instruct
the Warrant Agent regarding making arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it
is no longer necessary to have the Warrants available in, registration in the name of Cede &amp; Co., a nominee of DTC, the Company may
instruct the Warrant Agent to provide written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Certificate,
and the Company shall instruct the Warrant Agent to deliver to each Holder (as defined below) separate certificates evidencing Warrants
(&ldquo;<U>Definitive Certificates</U>&rdquo; and, together with the Global Certificate, &ldquo;<U>Warrant Certificates</U>&rdquo;),
in the form of <U>Annex C</U> to this Warrant Agreement. The Warrants represented by the Global Certificate are referred to as &ldquo;<U>Global
Warrants</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<U>Issuance and Registration of Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1.
<U>Warrant Register</U>. The Warrant Agent shall maintain books (&ldquo;<U>Warrant Register</U>&rdquo;) for the registration of original
issuance and the registration of transfer of the Warrants. Any Person in whose name ownership of a beneficial interest in the Warrants
evidenced by a Global Certificate is recorded in the records maintained by DTC or its nominee shall be deemed the &ldquo;beneficial owner&rdquo;
thereof, provided that all such beneficial interests shall be held through a Participant (as defined below), which shall be the registered
holder of such Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2.
<U>Issuance of Warrants</U>. Upon the initial issuance of the Warrants, the Warrant Agent shall issue the Global Certificate and deliver
the Warrants in the DTC settlement system in accordance with written instructions delivered to the Warrant Agent by the Company. Ownership
of beneficial interests in the Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained
(i) by DTC and (ii) by institutions that have accounts with DTC (each, a &ldquo;<U>Participant</U>&rdquo;), subject to a Holder&rsquo;s
right to elect to receive a Warrant in certificated form in the form of <U>Annex C</U> to this Warrant Agreement. Any Holder desiring
to elect to receive a Warrant in certificated form shall make such request in writing delivered to the Warrant Agent pursuant to Section
2.2.8, and shall surrender to the Warrant Agent the interest of the Holder on the books of the Participant evidencing the Warrants which
are to be represented by a Definitive Certificate through the DTC settlement system. Thereupon, the Warrant Agent shall countersign and
deliver to the Person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be, as so requested.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.3.
<U>Beneficial Owner; Holder</U>. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent
may deem and treat the Person in whose name that Warrant shall be registered on the Warrant Register (the &ldquo;<U>Holder,</U>&rdquo;
which term shall include a Holder&rsquo;s transferees, successors and assigns and a &ldquo;Holder&rdquo; shall include, if the Warrants
are held in &ldquo;street name,&rdquo; a Participant or a designee appointed by such Participant) as the absolute owner of such Warrant
for purposes of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by
any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Warrant Agent or any agent of
the Company or the Warrant Agent from giving effect to any written certification, proxy or other authorization furnished by DTC governing
the exercise of the rights of a holder of a beneficial interest in any Warrant. The rights of beneficial owners in a Warrant evidenced
by the Global Certificate shall be exercised by the Holder or a Participant through the DTC system, except to the extent set forth herein
or in the Global Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.4.
<U>Execution</U>. The Warrant Certificates shall be executed on behalf of the Company by any authorized officer of the Company (an &ldquo;<U>Authorized
Officer</U>&rdquo;), which need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile
signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent, which need not be the same
signatory for all of the Warrant Certificates, and no Warrant Certificate shall be valid for any purpose unless so countersigned. In
case any Authorized Officer of the Company that signed any of the Warrant Certificates ceases to be an Authorized Officer of the Company
before countersignature by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be
countersigned by the Warrant Agent, issued and delivered with the same force and effect as though the person who signed such Warrant
Certificates had not ceased to be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by
any person who, at the actual date of the execution of such Warrant Certificate, shall be an Authorized Officer of the Company authorized
to sign such Warrant Certificate, although at the date of the execution of this Warrant Agreement any such person was not such an Authorized
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.5.
<U>Registration of Transfer</U>. At any time at or prior to the Expiration Date (as defined below), a transfer of any Warrants may be
registered and any Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate
or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or Warrant Certificates surrendered. Any Holder
desiring to register the transfer of Warrants or to split up, combine or exchange any Warrant Certificate shall make such request in
writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates evidencing
the Warrants the transfer of which is to be registered or that is or are to be split up, combined or exchanged. Thereupon, the Warrant
Agent shall countersign and deliver to the Person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be,
as so requested. The Warrant Agent may require reasonable and customary payment with respect to a registration of transfer of Warrants
or a split-up, combination or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Warrants
and issuance of Warrant Shares to the Holder), of a sum sufficient to cover any tax or governmental charge that may be imposed in connection
with such registration of transfer, split-up, combination or exchange, together with reimbursement to the Warrant Agent of all reasonable
expenses incidental thereto. All such fees and expenses shall be paid by the Company, and not by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.6.
<U>Loss, Theft and Mutilation of Warrant Certificates</U>. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security in customary form and amount, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates.
The Warrant Agent may receive compensation from the surety companies or surety bond agents for administrative services provided to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.7.
<U>Proxies</U>. The Holder of a Warrant may grant proxies or otherwise authorize any Person, including the Participants and beneficial
holders that may own interests through the Participants, to take any action that a Holder is entitled to take under this Warrant Agreement
or the Warrants; <U>provided</U>, <U>however</U>, that at all times that Warrants are evidenced by a Global Certificate, exercise of
those Warrants shall be effected on their behalf by Participants through DTC in accordance the procedures administered by DTC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.8.
<U>Warrant Certificate Request</U>. A Holder has the right to elect at any time or from time to time a Warrant Exchange (as defined below)
pursuant to a Warrant Certificate Request Notice (as defined below). Upon written notice by a Holder to the Warrant Agent for the exchange
of some or all of such Holder&rsquo;s Global Warrants for a Definitive Certificate evidencing the same number of Warrants, which request
shall be in the form attached hereto as <U>Annex E</U> (a &ldquo;<U>Warrant Certificate Request Notice</U>&rdquo; and the date of delivery
of such Warrant Certificate Request Notice by the Holder, the &ldquo;<U>Warrant Certificate Request Notice Date</U>&rdquo; and the deemed
surrender upon delivery by the Holder of a number of Global Warrants for the same number of Warrants evidenced by a Definitive Certificate,
a &ldquo;<U>Warrant Exchange</U>&rdquo;), the Warrant Agent shall promptly effect the Warrant Exchange and shall promptly issue and deliver
to the Holder a Definitive Certificate for such number of Warrants in the name set forth in the Warrant Certificate Request Notice. Such
Definitive Certificate shall be dated the original issue date of the Warrants, shall be manually executed by an authorized signatory
of the Company, shall be in the form attached hereto as <U>Annex C</U>, and shall be reasonably acceptable in all respects to such Holder.
In connection with a Warrant Exchange, the Company agrees to deliver, or to direct the Warrant Agent to deliver, the Definitive Certificate
to the Holder within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period
(as defined below) of the Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant Certificate Request
Notice (&ldquo;<U>Warrant Certificate Delivery Date</U>&rdquo;). If the Company fails for any reason to deliver to the Holder the Definitive
Certificate subject to the Warrant Certificate Request Notice by the Warrant Certificate Delivery Date, the Company shall pay to the
Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by such Definitive Certificate
(based on the VWAP of the Common Stock on the Warrant Certificate Request Notice Date), $10 per Business Day for each Business Day after
such Warrant Certificate Delivery Date until such Definitive Certificate is delivered or, prior to delivery of such Warrant Certificate,
the Holder rescinds such Warrant Exchange. The Company covenants and agrees that, upon the date of delivery of the Warrant Certificate
Request Notice, the Holder shall be deemed to be the holder of the Definitive Certificate and, notwithstanding anything to the contrary
set forth herein, the Definitive Certificate shall be deemed for all purposes to contain all of the terms and conditions of the Warrants
evidenced by such Warrant Certificate and the terms of this Warrant Agreement, other than Sections 3.3 and 8 herein, which shall not
apply to the Warrants evidenced by the Definitive Certificate. For purposes of clarity, if there is a conflict between the express terms
of this Warrant Agreement and the Warrant Certificate in the form of <U>Annex C</U> hereto with respect to terms of the Warrants, the
terms of the Warrant Certificate shall govern and control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Terms and Exercise of Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<U>Exercise Price</U>. Each Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate and of
this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $____ per whole
share, subject to the subsequent adjustments provided in Section 4 hereof. The term &ldquo;<U>Exercise Price</U>&rdquo; as used in this
Warrant Agreement refers to the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
<U>Duration of Warrants</U>. Warrants may be exercised only during the period (&ldquo;<U>Exercise Period</U>&rdquo;) commencing on the
Issuance Date and terminating at 5:00 P.M., New York City time (the &ldquo;<U>close of business</U>&rdquo;) on ______, 2027 (&ldquo;<U>Expiration
Date</U>&rdquo;)<SUP>1</SUP>. Each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder
and all rights in respect thereof under this Warrant Agreement shall cease at the close of business on the Expiration Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
<U>Exercise of Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.1.
<U>Exercise and Payment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exercise of the purchase rights represented by a Warrant may be made, in whole or in part, at any time or times during the Exercise Period
by delivery to the Company or the Warrant Agent of the Notice of Exercise in the form annexed as <U>Annex B</U> hereto (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period following the date the Holder delivers the Notice of Exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price
for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 3.3.6 below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
a Warrant Certificate to the Company until the Holder has purchased all of the Warrant Shares available thereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender such Warrant to the Company for cancellation within three (3) Trading
Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of a Warrant resulting in purchases of a
portion of the total number of Warrant Shares available thereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of a Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face thereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the foregoing in this Section 3.3.1, a Holder whose interest in a Warrant is a beneficial interest in certificate(s)
representing such Warrant held in registered form through DTC (or another established clearing corporation performing similar functions),
shall effect exercises made pursuant to this Section 3.3.1 by delivering to DTC (or such other clearing corporation, as applicable) the
appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing
corporation, as applicable), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms
of this Warrant Agreement, in which case this sentence shall not apply. Upon giving irrevocable instructions to its Participant to exercise
Warrants, solely for purposes of Regulation SHO, the holder whose interest in the Warrant is a beneficial interest shall be deemed to
have exercised such Warrant, regardless of when the applicable Warrant Shares are delivered to such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Insert the date that is the five-year anniversary of the Initial Exercise Date; provided, however, if such date is not a Trading
Day, insert the immediately following Trading Day.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.2.
<U>Issuance of Warrant Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Warrant Agent shall, on the Trading Day following the date of exercise of any Warrant, advise the Company, and the transfer agent
and registrar for the Company&rsquo;s Common Stock (the &ldquo;<U>Transfer Agent</U>&rdquo;), in respect of (i) the number of Warrant
Shares indicated on the Notice of Exercise as issuable upon such exercise with respect to such exercised Warrants, (ii) the instructions
of the Holder or Participant, as the case may be, provided to the Warrant Agent with respect to the delivery of the Warrant Shares and
the number of Warrants that remain outstanding after such exercise and (iii) such other information as the Company or the Transfer Agent
shall reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the
account of the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit or Withdrawal at Custodian system
(&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration statement
permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant is being exercised via
cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) two (2) Trading Days of, and (ii) the number
of Trading Days comprising the Standard Settlement Period after, the delivery to the Company of the Notice of Exercise (such date, the
&ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Warrant Shares with respect to which the Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Days of and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares
subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of
the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder
rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as the Warrants
remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period,
expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on
the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.3.
<U>Valid Issuance</U>. All Warrant Shares issued by the Company upon the proper exercise of a Warrant in conformity with this Warrant
Agreement shall be validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.4.
<U>No Fractional Exercise</U>. No fractional Warrant Shares will be issued upon the exercise of the Warrant. If, by reason of any adjustment
made pursuant to Section 4, a Holder would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share,
the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.5.
<U>No Transfer Taxes</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event Warrant Shares are to be issued in a name other than the name of the Holder, the Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the DTC (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.6.
<U>Restrictive Legend Events; Cashless Exercise Under Certain Circumstances</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall use its reasonable best efforts to maintain the effectiveness of the Registration Statement and the current status
of the prospectus included therein or to file and maintain the effectiveness of another registration statement and another current prospectus
covering the Warrants and the Warrant Shares at any time that the Warrants are exercisable. The Company shall provide to the Warrant
Agent and each Holder prompt written notice of any time that the Company is unable to deliver the Warrant Shares via DTC transfer or
otherwise without restrictive legend because (A) the Commission has issued a stop order with respect to the Registration Statement, (B)
the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently,
(C) the Company has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, (D) the
prospectus contained in the Registration Statement is not available for the issuance of the Warrant Shares to the Holder or (E) otherwise
(each a &ldquo;<U>Restrictive Legend Event</U>&rdquo;). To the extent that the Warrants cannot be exercised as a result of a Restrictive
Legend Event, the Company shall, at the election of the Holder, which shall be given within five (5) days of receipt of such notice of
the Restrictive Legend Event, either (A) rescind the previously submitted Notice of Exercise and the Company shall return all consideration
paid by registered holder for such shares upon such rescission or (B) treat the attempted exercise as a cashless exercise as described
in paragraph (ii) below and refund the cash portion of the exercise price to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If a Restrictive Legend Event has occurred, the Warrant may also be exercisable on a cashless basis. Notwithstanding anything herein
to the contrary, but without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to this Section 3.3.6(b) or to receive cash payments pursuant to Section 3.3.2(b) and Section 3.3.8 herein, the Company shall not be
required to make any cash payments or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. Upon a &ldquo;cashless
exercise&rdquo;, the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient (if such quotient would be
a positive number) obtained by dividing (A-B) (X) by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 3.3.1(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 3.3.1(a) hereof on a Trading Day prior to the opening of &ldquo;regular
                                            trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the
                                            federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y)
                                            the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
                                            or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
                                            L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
                                            if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
                                            Day and is delivered within two (2) hours thereafter (including until two (2) hours after
                                            the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 3.3.1(a)
                                            hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of
                                            such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and
                                            delivered pursuant to Section 3.3.1(a) hereof after the close of &ldquo;regular trading hours&rdquo;
                                            on such Trading Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of the Warrant, as adjusted as set forth herein; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of the Warrant in accordance
                                            with the terms of the Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised and the Company
agrees not to take any position contrary thereto. Upon receipt of a Notice of Exercise for a cashless exercise, the Warrant Agent will
promptly deliver a copy of the Notice of Exercise to the Company to confirm the number of Warrant Shares issuable in connection with
the cashless exercise. The Company shall calculate and transmit to the Warrant Agent in a written notice, and the Warrant Agent shall
have no duty, responsibility or obligation under this Section 3.3.6 to calculate, the number of Warrant Shares issuable in connection
with any cashless exercise. The Warrant Agent shall be entitled to rely conclusively on any such written notice provided by the Company,
and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with such written
instructions or pursuant to this Warrant Agreement. Notwithstanding anything herein to the contrary, on the Termination Date, the Warrant
shall be automatically exercised via cashless exercise pursuant to this Section 3.3.6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.7.
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of
Warrant Shares issuable in connection with any exercise, the Company shall promptly deliver to the Holder the number of Warrant Shares
that are not disputed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.8.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise.</U> In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 3.3.2 (b) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is
required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.9.
<U>Beneficial Ownership Limitation</U>. The Company shall not effect any exercise of a Warrant, and a Holder shall not have the right
to exercise any portion of a Warrant, pursuant to Section 3 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of such Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of such Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
non-converted portion of any other securities of the Company (including, without limitation, any other securities of the Company which
would entitle the holder thereof to acquire at any time shares of Common Stock, including, without limitation, any debt, preferred stock,
right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
the holder thereof to receive, shares of Common Stock (&ldquo;<U>Common Stock Equivalents</U>&rdquo;)) subject to a limitation on conversion
or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 3.3.9, beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in
this Section 3.3.9 applies, the determination of whether a Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of a Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether a Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of a Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 3.3.9, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within two (2) Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including such Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of a Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 3.3.9, provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock upon exercise of the Warrant held by the Holder and the provisions of this Section 3.3.9 shall continue to
apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 3.3.9 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of a Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.
<U>Adjustment upon Subdivisions or Combinations</U>. If the Company, at any time while the Warrants are outstanding: (i) pays a stock
dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of the Warrants), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including
by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock and such other capital stock of the Company (excluding
treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common
Stock and such other capital stock of the Company (excluding treasury shares, if any) outstanding immediately after such event, and the
number of shares issuable upon exercise of each Warrant shall be proportionately adjusted such that the aggregate Exercise Price of such
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 4.1 shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.
<U>Adjustment for Other Distributions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1.
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 4.1 above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of a Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2.
<U>Dividends</U>. If the Company, at any time during the Exercise Period, shall pay a dividend in cash, securities or other assets to
all holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the Warrants are convertible), other than
a transaction described in Sections 4.1, 4.2.1 or 4.3 (any such non-excluded event being referred to herein as a &ldquo;<U>Dividend</U>&rdquo;),
then the Exercise Price shall be decreased, effective immediately after the effective date of such Dividend, by the quotient of (i) the
gross amount of cash and/or fair market value (as determined by the Company&rsquo;s Board of Directors, in good faith) of all securities
or other assets paid to the holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the Warrants are
convertible) in respect of such Dividend divided by (ii) the sum of the number of shares of Common Stock (or other shares of the Company&rsquo;s
capital stock into which the Warrants are convertible) outstanding at the time of the Dividend plus the number of shares of Common Stock
then issuable upon exercise of all outstanding Warrants, provided, that the Exercise Price shall not be reduced below zero.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<U>Fundamental Transaction</U>. If, at any time while the Warrants are outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which all holders of Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common
Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which all outstanding shares of Common Stock are effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires
more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons
making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or
other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of a Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction (without regard to any limitation in Section 3.3.9 on the exercise of a Warrant), the
number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation. The
Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under the Warrants in accordance with the provisions of
this Section 4.3 pursuant to written agreements prior to or during such Fundamental Transaction. Upon the occurrence of any such Fundamental
Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of the Warrants referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under the Warrants with the same effect as
if such Successor Entity had been named as the Company therein. The Company shall instruct the Warrant Agent in writing to mail by first
class mail, postage prepaid, to each Holder, written notice of the execution of any such amendment, supplement or agreement with the
Successor Entity. Any supplemented or amended agreement entered into by the successor corporation or transferee shall provide for adjustments,
which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 4.3. The Warrant Agent shall
have no duty, responsibility or obligation to determine the correctness of any provisions contained in such agreement or such notice,
including but not limited to any provisions relating either to the kind or amount of securities or other property receivable upon exercise
of warrants or with respect to the method employed and provided therein for any adjustments, and shall be entitled to rely conclusively
for all purposes upon the provisions contained in any such agreement. The provisions of this Section 4.3 shall similarly apply to successive
reclassifications, changes, consolidations, mergers, sales and conveyances of the kind described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.
<U>Notices to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 4, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant Agreement constitutes,
or contains, material, non-public information regarding the Company or any of its subsidiaries, the Company shall simultaneously file
such notice with the Commission pursuant to a Current Report on Form 8-K. Provided such notice occurs within the Exercise Period, the
Holder shall remain entitled to exercise its Warrant during the period commencing on the date of such notice to the effective date of
the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
<U>Other Events</U>. If any event occurs of the type contemplated by the provisions of Sections 4.1 or 4.2 but not expressly provided
for by such provisions (including, without limitation, the granting of stock appreciation rights, Adjustment Rights, phantom stock rights
or other rights with equity features to all holders of Common Stock for no consideration), then the Company&rsquo;s Board of Directors
will, at its discretion and in good faith, make an adjustment in the Exercise Price and the number of Warrant Shares or designate such
additional consideration to be deemed issuable upon exercise of a Warrant, so as to protect the rights of the registered Holder. No adjustment
to the Exercise Price will be made pursuant to more than one sub-section of this Section 4 in connection with a single issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.
<U>Notices of Changes in Warrant</U>. Upon every adjustment of the Exercise Price or the number of Warrant Shares issuable upon exercise
of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise Price resulting
from such adjustment and the increase or decrease, if any, in the number of Warrant Shares purchasable at such price upon the exercise
of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the
occurrence of any event specified in Sections 4.1 or 4.2, then, in any such event, the Company shall give written notice to each Holder,
at the last address set forth for such holder in the Warrant Register, as of the record date or the effective date of the event. Failure
to give such notice, or any defect therein, shall not affect the legality or validity of such event. The Warrant Agent shall be entitled
to rely conclusively on, and shall be fully protected in relying on, any certificate, notice or instructions provided by the Company
with respect to any adjustment of the Exercise Price or the number of shares issuable upon exercise of a Warrant, or any related matter,
and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with any such certificate,
notice or instructions or pursuant to this Warrant Agreement. The Warrant Agent shall not be deemed to have knowledge of any such adjustment
unless and until it shall have received written notice thereof from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Restrictive Legends; Fractional Warrants</U>. In the event that a Warrant Certificate surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not register that transfer until the Warrant Agent has received an opinion of counsel for the Company
stating that such transfer may be made and indicating whether the Warrants must also bear a restrictive legend upon that transfer. The
Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the transfer of or delivery
of a Warrant Certificate for a fraction of a Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Other Provisions Relating to Rights of Holders of Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
<U>No Rights as Stockholder</U>. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Warrants,
shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall
anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered holder of
Warrants, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether
any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise), receive notice
of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise, prior to the issuance
to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
<U>Reservation of Common Stock</U>. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Warrant
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Concerning the Warrant Agent</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
Any instructions given to the Warrant Agent orally, as permitted by any provision of this Warrant Agreement, shall be confirmed in writing
by the Company as soon as practicable. The Warrant Agent shall not be liable or responsible and shall be fully authorized and protected
for acting, or failing to act, in accordance with any oral instructions which do not conform with the written confirmation received in
accordance with this Section 7.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
Whether or not any Warrants are exercised, for the Warrant Agent&rsquo;s services as agent for the Company hereunder, the Company shall
pay to the Warrant Agent such fees as may be separately agreed between the Company and Warrant Agent and the Warrant Agent&rsquo;s out
of pocket expenses in connection with this Warrant Agreement, including, without limitation, the fees and expenses of the Warrant Agent&rsquo;s
counsel. While the Warrant Agent endeavors to maintain out-of-pocket charges (both internal and external) at competitive rates, these
charges may not reflect actual out-of-pocket costs, and may include handling charges to cover internal processing and use of the Warrant
Agent&rsquo;s billing systems. All amounts owed by the Company to the Warrant Agent under this Warrant Agreement are due within 30 days
of the Company&rsquo;s receipt of an invoice. Delinquent payments are subject to a late payment charge of one and one-half percent (1.5%)
per month commencing 45 days from the invoice date. The Company agrees to reimburse the Warrant Agent for any attorney&rsquo;s fees and
any other costs associated with collecting delinquent payments. No provision of this Warrant Agreement shall require Warrant Agent to
expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties under this Warrant Agreement
or in the exercise of its rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.
As agent for the Company hereunder, the Warrant Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
shall have no duties or obligations other than those specifically set forth herein or as may subsequently be agreed to in writing by
the Warrant Agent and the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
shall be regarded as making no representations and having no responsibilities as to the validity, sufficiency, value, or genuineness
of the Warrants or any Warrant Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
shall not be obligated to take any legal action hereunder; if, however, the Warrant Agent determines to take any legal action hereunder,
and where the taking of such action might, in its judgment, subject or expose it to any expense or liability it shall not be required
to act unless it has been furnished with an indemnity reasonably satisfactory to it;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
may rely on and shall be fully authorized and protected in acting or failing to act upon any certificate, instrument, opinion, notice,
letter, telegram, telex, facsimile transmission or other document or security delivered to the Warrant Agent and believed by it to be
genuine and to have been signed by the proper party or parties;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
shall not be liable or responsible for any recital or statement contained in the Registration Statement or any other documents relating
thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
shall not be liable or responsible for any failure on the part of the Company to comply with any of its covenants and obligations relating
to the Warrants, including without limitation obligations under applicable securities laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
may rely on and shall be fully authorized and protected in acting or failing to act upon the written, telephonic or oral instructions
with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement (or supplementing or qualifying
any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions with respect to the performance
of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for advice or instructions in connection
with the Warrant Agent&rsquo;s duties hereunder, and the Warrant Agent shall not be liable for any delay in acting while waiting for
those instructions; any applications by the Warrant Agent for written instructions from the Company may, at the option of the Warrant
Agent, set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this Warrant Agreement and the date
on or after which such action shall be taken or such omission shall be effective; the Warrant Agent shall not be liable for any action
taken by, or omission of, the Warrant Agent in accordance with a proposal included in such application on or after the date specified
in such application (which date shall not be less than five (5) Business Days after the date such application is sent to the Company,
unless the Company shall have consented in writing to any earlier date) unless prior to taking any such action, the Warrant Agent shall
have received written instructions in response to such application specifying the action to be taken or omitted;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
may consult with counsel satisfactory to the Warrant Agent, including its in-house counsel, and the advice of such counsel shall be full
and complete authorization and protection in respect of any action taken, suffered, or omitted by it hereunder in good faith and in accordance
with the advice of such counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
may perform any of its duties hereunder either directly or by or through nominees, correspondents, designees, or subagents, and it shall
not be liable or responsible for any misconduct or negligence on the part of any nominee, correspondent, designee, or subagent appointed
with reasonable care by it in connection with this Warrant Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
is not authorized, and shall have no obligation, to pay any brokers, dealers, or soliciting fees to any Person; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
shall not be required hereunder to comply with the laws or regulations of any country other than the United States of America or any
political subdivision thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4.
In the absence of gross negligence or willful or illegal misconduct on its part, the Warrant Agent shall not be liable for any action
taken, suffered, or omitted by it or for any error of judgment made by it in the performance of its duties under this Warrant Agreement.
Anything in this Warrant Agreement to the contrary notwithstanding, in no event shall Warrant Agent be liable for special, indirect,
incidental, consequential or punitive losses or damages of any kind whatsoever (including but not limited to lost profits), even if the
Warrant Agent has been advised of the possibility of such losses or damages and regardless of the form of action. Any liability of the
Warrant Agent will be limited in the aggregate to the amount of fees paid by the Company hereunder. The Warrant Agent shall not be liable
for any failures, delays or losses, arising directly or indirectly out of conditions beyond its reasonable control including, but not
limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages or labor disputes, fires, civil disobedience,
riots, rebellions, storms, electrical or mechanical failure, computer hardware or software failure, communications facilities failures
including telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God or similar occurrences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5.
In the event any question or dispute arises with respect to the proper interpretation of the Warrants or the Warrant Agent&rsquo;s duties
under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall not be required to act and shall
not be held liable or responsible for its refusal to act until the question or dispute has been judicially settled (and, if appropriate,
it may file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered by a court of competent
jurisdiction, binding on all Persons interested in the matter which is no longer subject to review or appeal, or settled by a written
document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder. In addition, the Warrant
Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement by all the Holders
and all other Persons that may have an interest in the settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6.
The Company covenants to indemnify the Warrant Agent and hold it harmless from and against any loss, liability, claim or expense (&ldquo;<U>Loss</U>&rdquo;)
arising out of or in connection with the Warrant Agent&rsquo;s duties under this Warrant Agreement, including the costs and expenses
of defending itself against any Loss, unless such Loss shall have been determined by a court of competent jurisdiction to be a result
of the Warrant Agent&rsquo;s gross negligence or willful misconduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7.
The Company represents and warrants that (a) it is duly incorporated and validly existing under the laws of its jurisdiction of incorporation,
(b) the offer and sale of the Warrants and the execution, delivery and performance of all transactions contemplated thereby (including
this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result in a breach of or constitute
a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement or instrument
to which it is a party or is bound, (c) this Warrant Agreement has been duly executed and delivered by the Company and constitutes the
legal, valid, binding and enforceable obligation of the Company, (d) the Warrants will comply in all material respects with all applicable
requirements of law and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof in connection
with the offering of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8.
Set forth in <U>Annex D</U> hereto is a list of the names and specimen signatures of the persons authorized to act for the Company under
this Warrant Agreement. The Company shall, from time to time, certify to you the names and signatures of any other persons authorized
to act for the Company under this Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9.
The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities
hereunder after giving thirty (30) days&rsquo; notice in writing to the Company, or such shorter period of time agreed to by the Company.
The Company may terminate the services of the Warrant Agent, or any successor Warrant Agent, after giving thirty (30) days&rsquo; notice
in writing to the Warrant Agent or successor Warrant Agent, or such shorter period of time as agreed. If the office of the Warrant Agent
becomes vacant by resignation, termination or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant
Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it
has been notified in writing of such resignation or incapacity by the Warrant Agent, then the Warrant Agent or any Holder may apply to
any court of competent jurisdiction for the appointment of a successor Warrant Agent at the Company&rsquo;s cost. Pending appointment
of a successor to such Warrant Agent, either by the Company or by such a court, the duties of the Warrant Agent shall be carried out
by the Company. Any successor Warrant Agent (but not including the initial Warrant Agent), whether appointed by the Company or by such
court, shall be a Person organized and existing under the laws of any state of the United States of America, in good standing, and authorized
under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed, and except for executing
and delivering documents as provided in the sentence that follows, the predecessor Warrant Agent shall have no further duties, obligations,
responsibilities or liabilities hereunder, but shall be entitled to all rights that survive the termination of this Warrant Agreement
and the resignation or removal of the Warrant Agent, including but not limited to its right to indemnity hereunder. If for any reason
it becomes necessary or appropriate or at the request of the Company, the predecessor Warrant Agent shall execute and deliver, at the
expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor
Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any
and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties, and obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10.
In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and
the Transfer Agent not later than the effective date of any such appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11.
Any Person into which the Warrant Agent may be merged or converted or with which it may be consolidated or any Person resulting from
any merger, conversion or consolidation to which the Warrant Agent shall be a party or any Person succeeding to the shareowner services
business of the Warrant Agent or any successor Warrant Agent shall be the successor Warrant Agent under this Warrant Agreement, without
any further act or deed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Miscellaneous Provisions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.
Unless terminated earlier by the parties hereto, this Warrant Agreement shall terminate 90 days after the earlier of the Expiration Date
and the date on which no Warrants remain outstanding (the &ldquo;<U>Termination Date</U>&rdquo;). On the Business Day following the Termination
Date, the Warrant Agent shall deliver to the Company any entitlements, if any, held by the Warrant Agent under this Warrant Agreement.
The Warrant Agent&rsquo;s right to be reimbursed for fees, charges and out-of-pocket expenses as provided in Section 7 shall survive
the termination of this Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.
If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court, this Warrant Agreement shall
be construed and enforced as if such provision had not been contained herein and shall be deemed an Agreement among the parties to it
to the full extent permitted by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.
In the event of inconsistency between this Warrant Agreement and the descriptions in the Registration Statement, as they may from time
to time be amended, the terms of this Warrant Agreement shall control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4.
Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Company, the Warrant Agent or by the
holder of any Warrant to or on the Company or the Warrant Agent including, without limitation, any Notice of Exercise, shall be in writing
and delivered by e-mail, hand or sent by a nationally recognized overnight courier service, addressed (until another address is filed
in writing by the Company or the Warrant Agent) as set forth below and if to any holder any notice, statement or demand shall be given
to the last address set forth for such holder (if any) in the Warrant Register:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Warrant Agent, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 63pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.5.
Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth above prior to 5:30 p.m. (New York City time)
on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via e-mail at the
e-mail address set forth above on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii)
the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual
receipt by the party to whom such notice is required to be given. Notwithstanding any other provision of this Warrant Agreement, where
this Warrant Agreement provides for notice of any event to the Holder, if this Warrant Agreement is held in global form by DTC (or any
successor depositary), such notice shall be sufficiently given if given to DTC (or any successor depositary) pursuant to the procedures
of DTC (or such successor depositary), subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant
to the terms of this Warrant Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.6.
This Warrant Agreement shall be governed by and construed in accordance with the laws of the State of New York. All actions and proceedings
relating to or arising from, directly or indirectly, this Warrant Agreement may be litigated in courts located within the Borough of
Manhattan in the City and State of New York. The Company hereby submits to the personal jurisdiction of such courts and consents that
any service of process may be made by certified or registered mail, return receipt requested, directed to the Company at its address
last specified for notices hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.7.
This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto. This Warrant
Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without the prior written consent of the
other party, which the other party will not unreasonably withhold, condition or delay; except that (i) consent is not required for an
assignment or delegation of duties by the Warrant Agent to any affiliate of the Warrant Agent and (ii) any reorganization, merger, consolidation,
sale of assets or other form of business combination by the Warrant Agent or the Company shall not be deemed to constitute an assignment
of this Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.8.
No provision of this Warrant Agreement may be amended, modified or waived, except in a written document signed by both parties. The Company
and the Warrant Agent may amend or supplement this Warrant Agreement without the consent of any Holder for the purpose of curing any
ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions
with respect to matters or questions arising under this Warrant Agreement as the parties may deem necessary or desirable so long as such
amendment or supplement shall not adversely affect the interest of the Holders. All other amendments and supplements shall require the
vote or written consent of Holders of at least 50.1% of the then outstanding Warrants; provided that if any such amendment or supplement
disproportionately and adversely affects the rights of a Holder compared to other Holders, the prior written consent of such Holder shall
also be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9.
The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect
of the issuance or delivery of Warrant Shares upon the exercise of Warrants, but the Company may require the Holders to pay any transfer
taxes in respect of the Warrants or such shares. The Warrant Agent may refrain from registering any transfer of Warrants or any delivery
of any Warrant Shares unless or until the Persons requesting the registration or issuance shall have paid to the Warrant Agent for the
account of the Company the amount of such tax or charge, if any, or shall have established to the reasonable satisfaction of the Company
and the Warrant Agent that such tax or charge, if any, has been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.10.
Nothing in this Warrant Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be
construed, to confer upon, or give to, any Person other than the parties hereto and the Holders any right, remedy, or claim under or
by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.11.
A copy of this Warrant Agreement shall be available at all reasonable times at the office of the Warrant Agent designated for such purpose
for inspection by any Holder. Prior to such inspection, the Warrant Agent may require any such holder to provide reasonable evidence
of its interest in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.12.
This Warrant Agreement may be executed in any number of original, facsimile or electronic counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.13.
The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall not affect the interpretation
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.14.
If a Warrant is held in global form through DTC (or any successor depositary), such Warrant is issued subject to this Warrant Agent Agreement.
To the extent any provision of a Warrant conflicts with the express provisions of this Warrant Agent Agreement, the provisions of such
Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Certain Definitions</U>. As used herein, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Adjustment
Right</U>&rdquo; means any right granted with respect to any securities issued in connection with, or with respect to, any issuance,
sale or delivery (or deemed issuance, sale or delivery in accordance with Section 4) of Common Stock (other than rights of the type described
in Section 4.2 and 4.3 hereof) that could result in a decrease in the net consideration received by the Company in connection with, or
with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights)
but excluding anti-dilution and other similar rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of
which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means any day on which the Common Stock is traded on the Trading Market, or, if the Trading Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market in the United States on which the
Common Stock is then traded, provided that &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is are scheduled
to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on
such exchange or market, then during the hour ending at 4:00 P.M., New York City time).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the
New York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink Open Market&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, this Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
  INDUSTRIES INC.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINENTAL
    STOCK TRANSFER &amp; TRUST COMPANY</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A Form of Global Certificate</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
B Notice of Exercise</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
C Form of Certificated Warrant</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
D Authorized Representatives</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
E Form of Warrant Certificate Request Notice</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>[FORM
OF GLOBAL CERTIFICATE]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>UNLESS
THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;DTC&rdquo;),
TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE
&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR
TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
INDUSTRIES INC.<BR>
WARRANT CERTIFICATE<BR>
NOT EXERCISABLE AFTER ______, 2027</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
certifies that the person whose name and address appears below, or registered assigns, is the registered owner of the number of Warrants
set forth below. Each Warrant entitles its registered holder to purchase from CEA Industries Inc., a company incorporated under the laws
of the State of Nevada (the &ldquo;<B>Company</B>&rdquo;), at any time prior to 5:00 P.M. (New York City time) on ________, 2027, one
share of common stock, par value $0.00001 per share, of the Company (each, a &ldquo;<B>Warrant Share</B>&rdquo; and collectively, the
&ldquo;<B>Warrant Shares</B>&rdquo;), at an exercise price of $___ per share, subject to possible adjustments as provided in the Warrant
Agreement (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant Certificate, with or without other Warrant Certificates, upon surrender at the designated office of the Warrant Agent, may be
exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Warrants as the Warrant Certificate or
Warrant Certificates surrendered. A transfer of the Warrants evidenced hereby may be registered upon surrender of this Warrant Certificate
at the designated office of the Warrant Agent by the registered holder in person or by a duly authorized attorney, properly endorsed
or accompanied by proper instruments of transfer, a signature guarantee, and such other and further documentation as the Warrant Agent
may reasonably request and duly stamped as may be required by the laws of the State of New York and of the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions of the Warrants and the rights and obligations of the holder of this Warrant Certificate are set forth in the Warrant
Agent Agreement dated as of _______, 2022 (the &ldquo;<B>Warrant Agreement</B>&rdquo;) between the Company and Continental Stock Transfer
&amp; Trust Company (the &ldquo;<B>Warrant Agent</B>&rdquo;). A copy of the Warrant Agreement is available for inspection during business
hours at the office of the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned by an authorized signatory
of the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITNESS
the facsimile signature of a proper officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 240pt; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
    INDUSTRIES INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 240pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Countersigned:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINENTAL
STOCK TRANSFER &amp; TRUST COMPANY,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Warrant Agent</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><SUB>PLEASE
DETACH HERE</SUB></I><BR>
&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
No.:_________ Number of Warrants:__________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
CUSIP NO.: ___________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[ISSUER]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Name
  &amp; Address of Holder]</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________,
  Warrant Agent</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Mail:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By hand
  or overnight courier:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
  INDUSTRIES INC.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant Certificate
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 3.3.6(b)
of the Warrant Agreement (as defined in the Warrant Certificate), to exercise this Warrant with respect to the maximum number of Warrant
Shares purchasable pursuant to the cashless exercise procedure set forth in Section 3.3.6(b) of the Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 144px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 240px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 144px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 240px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
C</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[FORM
OF CERTIFICATED WARRANT]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CEA
INDUSTRIES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 65%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: __________, 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: __________, 2022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CUSIP:
    ______________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ISIN:
    _______________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after ___________, 2022 (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to the 5:00 P.M., New
York City time on ______, 2027 <SUP>2</SUP> (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from CEA Industries Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder,
the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security
held in book-entry form and The Depository Trust Company or its nominee (&ldquo;<U>DTC</U>&rdquo;) shall initially be the sole registered
holder of this Warrant, subject to a Holder&rsquo;s right to elect to receive a Warrant in certificated form pursuant to the terms of
the Warrant Agent Agreement, in which case this sentence shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in
this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of
which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>Insert the date that is the five-year anniversary of the Initial Exercise Date; provided, however, if such date is not a Trading
Day, insert the immediately following Trading Day.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.00001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-261648).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, with a mailing address of One State Street Plaza, 30th Floor,
New York, New York, 10004, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agent Agreement</U>&rdquo; means that certain Warrant Agent Agreement, dated as of the Initial Exercise Date, between the Company and
the Warrant Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Agent</U>&rdquo; means the Transfer Agent and any successor warrant agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock Purchase Warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink Open Market&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Exercise of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise and Payment</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times during the period commencing on the Initial Exercise Date and terminating at 5:00 P.M., New York City time on the Termination
Date (&ldquo;<U>Exercise Period</U>&rdquo;) by delivery to the Company of a duly executed facsimile copy (or e-mail attachment) of the
Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the date of exercise
as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by
wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c)
below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything herein to
the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all
of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such
notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this
paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof. </B>Notwithstanding the foregoing in this Section 2(a), a holder
whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry form through DTC
(or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a)
by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with
the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder&rsquo;s
right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agent Agreement, in which case this sentence
shall not apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price per share of the Common Stock under this Warrant shall be <B>$</B>_____, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in
whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number
of Warrant Shares equal to the quotient obtained (if such quotient would be a positive number) by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal
                                            securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
                                            on the Trading Day immediately preceding the date of the applicable Notice of Exercise or
                                            (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
                                            L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
                                            if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
                                            Day and is delivered within two (2) hours thereafter (including until two (2) hours after
                                            the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a)
                                            hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of
                                            such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and
                                            delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
                                            on such Trading Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Notwithstanding
anything herein to the contrary, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">but without limiting
the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to this Section 2(c) or to receive cash
payments pursuant to Section 3(d)(i) and Section 3(d)(iv) herein, <FONT STYLE="background-color: white">the Company shall not be required
to make any cash payments or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. If Warrant Shares are issued
in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant
Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary
to this Section 2(c).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
<FONT STYLE="background-color: white">anything</FONT> herein to the contrary, on the Termination Date, this Warrant shall be automatically
exercised via cashless exercise pursuant to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through
its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by
Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is earlier of
(i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received the earlier
of (i) two (2) Trading Days of and (ii) the number of Trading Days comprising the Standard Settlement Period following the delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each
Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company
agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable.
As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading
Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice
of Exercise</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional Warrant Shares will be issued upon the exercise of this Warrant. If a Holder would
be entitled, upon the exercise of this Warrant, to receive a fractional interest in a share, the Company shall, at its election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round
up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the DTC (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
non-converted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within two (2) Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder,
upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that
the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock and such other capital stock of the Company(excluding treasury shares, if
any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock such other
capital stock of the Company(excluding treasury shares, if any) outstanding immediately after such event, and the number of shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Dividends</U>. If the Company, at any time during the Exercise Period, shall pay a dividend in cash, securities or other assets to
all holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the Warrants are convertible), other than
a transaction described in Section 3(a), Section 3(b) or Section 3(d) (any such non-excluded event being referred to herein as a &ldquo;<U>Dividend</U>&rdquo;),
then the Exercise Price shall be decreased, effective immediately after the effective date of such Dividend, by the quotient of (i) the
gross amount of cash and/or fair market value (as determined by the Company&rsquo;s Board of Directors, in good faith) of all securities
or other assets paid to the holders of Common Stock (or other shares of the Company&rsquo;s capital stock into which the Warrants are
convertible) in respect of such Dividend divided by (ii) the sum of the number of shares of Common Stock (or other shares of the Company&rsquo;s
capital stock into which the Warrants are convertible) outstanding at the time of the Dividend plus the number of shares of Common Stock
then issuable upon exercise of all outstanding Warrants, provided, that the Exercise Price shall not be reduced below zero.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which all holders of Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common
Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which all outstanding shares of Common Stock are effectively
converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires
more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons
making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or
other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant),
the number of shares of Common Stock of the successor or acquiring corporation or of the Company. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written
agreements prior or during such Fundamental Transaction. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of the Warrants
referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company
and shall assume all of the obligations of the Company under the Warrants with the same effect as if such Successor Entity had been named
as the Company therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
                                            <U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register (as defined below), at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K. Provided such notice occurs within the Exercise Period, the Holder shall
remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.&#9;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at
the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. If this Warrant is not held in global form through DTC (or any successor depository), this Warrant may be divided
or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance
with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a
new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants
issued on transfers or exchanges shall be dated the original Issuance Date of this Warrant and shall be identical with this Warrant except
as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section
3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and non-assessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (A) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (B) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and (C) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 99pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict
of laws thereof. Each party agrees that all legal Proceedings concerning the interpretation, enforcement and defense of this Warrant
shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;).
Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any provision hereunder), and hereby irrevocably waives, and agrees not to assert in any suit, action or Proceeding, any claim that
it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue
for such Proceeding. If any party shall commence an action or Proceeding to enforce any provisions of this Warrant, then the prevailing
party in such action or Proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and other costs and expenses
incurred in the investigation, preparation and prosecution of such action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate Proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service, addressed to the Company, at 385 South Pierce Avenue ,Suite C, Louisville, Colorado 80027, Attention: CFO, email address:
[&nbsp;&nbsp;], or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and
all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally,
by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of
such Holder appearing on the books of the Warrant Agent. Any notice or other communication or deliveries hereunder shall be deemed given
and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail
address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission,
if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to
be given. Notwithstanding any other provision of this Warrant, where this Warrant provides for notice of any event to the Holder, if
this Warrant is held in global form by DTC (or any successor depositary), such notice shall be sufficiently given if given to DTC (or
any successor depositary) pursuant to the procedures of DTC (or such successor depositary), subject to a Holder&rsquo;s right to elect
to receive a Warrant in certificated form pursuant to the terms of the Warrant Agent Agreement, in which case this sentence shall not
apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Warrant Agent Agreement.</U> If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued
subject to the Warrant Agent Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant
Agent Agreement, the provisions of this Warrant shall govern and be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and either: (i) the Holder or the beneficial owner of this Warrant, on the other hand, or (ii) the vote or written consent
of the Holders of at least 50.1% of the then outstanding Warrants issued pursuant to the Warrant Agent Agreement, on the other hand;
provided that if any such modification, amendment or waiver disproportionately and adversely affects the rights of a Holder compared
to other Holders, the prior written consent of such Holder shall also be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CEA
    INDUSTRIES INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
  INDUSTRIES INC.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 144px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 240px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 144px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 240px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _____________________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 34%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
D</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUTHORIZED
REPRESENTATIVES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NAME]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[TITLE]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NAME]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[TITLE]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNEX
E</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[FORM
OF WARRANT CERTIFICATE REQUEST NOTICE]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
CERTIFICATE REQUEST NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTINENTAL
                                            STOCK TRANSFER &amp; TRUST COMPANY,</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            Warrant Agent for CEA Industries Inc. (the &ldquo;Company&rdquo;)</FONT></TD></TR>
                                                                                                </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned Holder of Common Stock Purchase Warrants (&ldquo;Warrants&rdquo;) in the form of Global Warrants issued by the Company hereby
elects to receive a Definitive Certificate evidencing the Warrants held by the Holder as specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder of Warrants in form of Global Warrants:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Holder in Definitive Certificate (if different from name of Holder of Warrants in form of Global Warrants):</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">____________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants in name of Holder in form of Global Warrants:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
    _________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants for which Definitive Certificate shall be issued: ________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants in name of Holder in form of Global Warrants after issuance:</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">______________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Definitive Certificate shall be delivered to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Definitive Certificate,
the Holder is deemed to have surrendered the number of Warrants in form of Global Warrants in the name of the Holder equal to the number
of Warrants evidenced by the Definitive Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>








</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>ex4-8.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
INDUSTRIES INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: ___, 2022</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Issue Date and until this Warrant is exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from CEA Industries Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
up to ______ shares of Common Stock (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price
of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $.00001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form S-1 (File No. 333-261648).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the OTCQB, OTCQX or Pink Open Market operated by OTC Markets Group, the NYSE American, the Nasdaq Capital Market, the Nasdaq
Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, One State Street Plaza, 30th Floor, New York, New York, 10004,
telephone number of 212-509-4000, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Pre-Funded Common Stock Purchase Warrants issued by the Company pursuant to the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Issue
Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or e-mail attachment) of the
Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the
date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price for the Warrant Shares specified
in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final
Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number
of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the
number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per Warrant Share,
was pre-funded to the Company on or prior to the Issue Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per share of Common Stock under this Warrant shall be $0.01, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares for the deemed surrender of the Warrant in whole or in part
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1in"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A)
    =</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
  applicable: (i) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding the date of the applicable Notice
  of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading
  Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
  hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)
  at the option of the Holder, either (x) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
  or (y) the Bid Price of the Common Stock as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such
  Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter
  pursuant to Section 2(a) hereof (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading
  Day), or (iii) the Closing Sale Price of the Common Stock on the date of the applicable Notice of Exercise if the date of such Notice
  of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close
  of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1in"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
  Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 1in"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
  number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
  exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
issue price for each such Warrant Share to be issued pursuant to the cashless exercise of a Warrant will be equal to (B), as defined
above, and the total issue price for the aggregate number of Warrant Shares issued pursuant to the cashless exercise of a Warrant will
be deemed paid and satisfied in full by the deemed surrender to the Company of the portion of such Warrant being exercised in accordance
with this Section 1(c). Notwithstanding anything herein to the contrary, the Company shall not be required to make any cash payments
or net cash settlement to the Holder in lieu of delivery of the Warrant Shares. If Warrant Shares are issued in such a cashless exercise,
the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the
registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on the Trading Market
as reported by Bloomberg as of such time of determination, or, if the Trading Market is not the principal securities exchange or trading
market for such security, the bid price of such security on the principal securities exchange or trading market where such security is
listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid price of such
security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of such time of
determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average of the bid
prices of any market makers for such security as reported on the Pink Open Market as of such time of determination. If the Bid Price
cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price of such security
as of such time of determination shall be the fair market value as mutually determined by the Company and the Holder. If the Company
and the Holder are unable to agree upon the fair market value of such security, then such fair market value shall be determined pursuant
to the provisions set forth in clause (d) of the definition of VWAP. All such determinations to be appropriately adjusted for any stock
dividend, share split, share consolidation, reclassification or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Sale Price</U>&rdquo; means, for any security as of any date, the last closing trade price for such security on the Trading Market, as
reported by Bloomberg, or, if the Trading Market begins to operate on an extended hours basis and does not designate the closing trade
price, then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Trading
Market is not the principal securities exchange or trading market for such security, the last trade price of such security on the principal
securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply,
the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by
Bloomberg, or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers
for such security as reported on the in the OTC Link or on the Pink Open Market. If the Closing Sale Price cannot be calculated for a
security on a particular date on any of the foregoing bases, Closing Sale Price of such security on such date shall be the fair market
value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value
of such security, then such fair market value shall be determined pursuant to the provisions set forth in clause (d) of the definition
of VWAP. All such determinations to be appropriately adjusted for any stock dividend, share split, share consolidation, reclassification
or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted for trading on a Trading Market other than the OTCQB, OTCQX or Pink Open Market operated by OTC Markets Group, the daily volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock
is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New
York City time)), (b) if the Common Stock is then quoted for trading on the OTCQB or OTCQX operated by OTC Markets Group, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Common Stock is then quoted for trading on the Pink Open Market operated by OTC Markets Group (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of Common Stock reported on the Pink Open Market, or (d) in
all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (the &ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period
after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the Holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the
Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject
to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing
to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered to said Holder or the Holder rescinds such exercise. The Company agrees to
maintain a transfer agent that is a participant in the Fast Automated Securities Transfer or FAST program so long as this Warrant remains
outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed
in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date
of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior
to 12:00 p.m. (New York City time) on the Issue Date, which may be delivered at any time after the time of execution of the Underwriting
Agreement, dated February [&bull;], 2022 between the Company and ThinkEquity LLC, the Company agrees to deliver the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, share
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue by (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at
the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Stock that would
have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases
Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Stock with an
aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the
Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver Common Stock upon exercise of the
Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company shall not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
non-converted portion of any other securities of the Company (including, without limitation, any other Common Share Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the
Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on its Common Stock or any other equity or equity equivalent securities payable in Common Stock
(which, for avoidance of doubt, shall not include any Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides
outstanding Common Stock into a larger number of shares, (iii) combines (including by way of reverse share split or consolidation) outstanding
Common Stock into a smaller number of shares, or (iv) issues by reclassification of Common Stock any shares of the Company, then in each
case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Stock (excluding treasury
shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock
outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall
become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right
to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time,
if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or amalgamation or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50%
of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making
or party to, or associated or affiliated with the other Persons making or party to, such share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the
right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such
Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant),
the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation
or is otherwise the continuing corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one shares of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares or other securities of such Successor Entity (or its parent entity) equivalent to the shares of
Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of or other
securities (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the
value of such shares or securities, such number of shares or securities and such exercise price being for the purpose of protecting the
economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of any such
Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
the Company or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger, amalgamation or arrangement to which the Company is a party, any sale or transfer of
all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other
securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up
of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to
the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, amalgamation, arrangement, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
amalgamation, arrangement sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of its
subsidiaries (the &ldquo;<U>Subsidiaries</U>&rdquo;), the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of
such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at
the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date of this
Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section
3. <FONT STYLE="background-color: white">Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo;
pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event, including
if the Company is for any reason unable to issue and deliver Warrant Shares upon exercise of this Warrant as required pursuant to the
terms thereof, shall the Company be required to net cash settle an exercise of this Warrant.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which shall in no event include the
posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company shall make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company shall take
all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed or quoted
for trading. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by
this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and non-assessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, amalgamation, arrangement
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company shall (i) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant
and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body
having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflict
of laws thereof. Each party agrees that all legal Proceedings concerning the interpretation, enforcement and defense of this Warrant
shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;).
Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any provision hereunder), and hereby irrevocably waives, and agrees not to assert in any suit, action or Proceeding, any claim that
it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue
for such Proceeding. If any party shall commence an action or Proceeding to enforce any provisions of this Warrant, then the prevailing
party in such action or Proceeding shall be reimbursed by the other party for its attorneys&rsquo; fees and other costs and expenses
incurred in the investigation, preparation and prosecution of such action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate Proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile or by e-mail, or sent by a nationally
recognized overnight courier service, addressed to the Company, at 385 South Pierce Avenue, Suite C, Louisville, Colorado 80027, Attention:
CFO, facsimile number: [ ], email address: [ ], or such other facsimile number, email address or address as the Company may specify for
such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder
shall be in writing and delivered personally, by facsimile, email or sent by a nationally recognized overnight courier service addressed
to each Holder at the facsimile number, email address or address of such Holder appearing on the books of the Company. Any notice or
other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or e-mail at the e-mail address set forth in this Section
prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or e-mail at the e-mail address set forth in this Section on a day that is not a Trading
Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent
by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to
be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>No Expense Reimbursement</U>. The Holder shall no way be required the pay, or to reimburse the Company for, any fees or expenses of
the Company&rsquo;s transfer agent in connection with the issuance or holding or sale of the Common Stock, Warrant and/or Warrant Shares.
The Company shall solely be responsible for any and all such fees and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
    INDUSTRIES INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CEA
    INDUSTRIES INC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
<FONT STYLE="font-size: 10pt">in lawful money of the United States; or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
<FONT STYLE="font-size: 10pt">the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth
in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in subsection 2(c).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 2.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 21%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 79%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 44%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 24%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 4%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 96%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _____________________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 13%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 43%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GOLENBOCK
EISEMAN ASSOR BELL &amp; PESKOE LLP</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>711
Third Avenue &ndash; 17<SUP>th</SUP> Floor</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
York, New York 10017</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
31, 2022</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
Industries Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">385
South Pierce Avenue, Suite C</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louisville,
Colorado 80027</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel for CEA Industries Inc., a Nevada corporation (the &ldquo;Company&rdquo;), in connection with the preparation and
filing of a Registration Statement on Form S-1 (File No. 333-261648) (the &ldquo;Registration Statement&rdquo;), including a related
prospectus filed with the Registration Statement (the &ldquo;Prospectus&rdquo;), with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
pursuant to the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), covering a public offering of up to 2,962,963
shares (the &ldquo;Shares&rdquo;) of common stock par value $0.00001 per share (the &ldquo;Common Stock&rdquo;), up to 2,962,963 warrants
(the &ldquo;Warrants&rdquo;) and up 2,962,963 pre-funded warrants (the &ldquo;Pre-Funded Warrants&rdquo;), each of such securities to
include those registered for the overallotment option of the underwriter, and the sale of warrants to be sold to the representative of
the underwriters to purchase 148,148 shares of Common Stock, subject to an increase in the number of shares if any of the overallotment
option of the underwriter is exercised (the &ldquo;Representative Warrants&rdquo;) and the Common Stock issuable on exercise of the Representative
Warrants. Each of the Warrants, Pre-Funded Warrants and Representative Warrants are exercisable for a like number of shares of Common
Stock. The Shares, Warrants, Pre-Funded Warrants and Representative Warrants are to be sold by the Company to investors pursuant to an
underwriting agreement (the &ldquo;Underwriting Agreement&rdquo;) to be entered into between the Company and the several underwriters
named therein and in the Prospectus. This opinion is being rendered in connection with the filing of the Registration Statement with
the Commission.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the
Company&rsquo;s Certificate of Incorporation, filed as Exhibit 3.1(a)-(g) to the Registration Statement, as currently in effect, (ii)
the Company&rsquo;s Bylaws, filed as Exhibit 3.2 to the Registration Statement, as currently in effect, (iii) the Registration Statement
and related Prospectus, (iv) the form of Underwriting Agreement, (v) the form of Warrant, (vi) the form of Pre-Funded Warrant, (vii)
the form of Representative Warrant, and (viii) such corporate records, agreements, documents and other instruments, and such certificates
or comparable documents of public officials or of officers and representatives of the Company, as we have deemed relevant and necessary
as a basis for the opinion hereinafter set forth.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photostatic copies, and the authenticity of the originals of such latter documents. We have also assumed that the authorization of
the board of directors of the Company is not changed from its authorization of January 17, 2022. We also assume that each of the Underwriting
Agreement, Warrant, Pre-Funded Warrant and Representative Warrant are duly executed by each of the parties thereto. As to certain questions
of fact material to this opinion, we have relied upon certificates or comparable documents of officers and representatives of the Company
and have not sought to independently verify such facts.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, and subject to the assumptions, limitations and qualifications stated herein, (i) we are of the opinion that the Shares
when issued and sold as contemplated in the Registration Statement and the related Prospectus, and upon payment and delivery in accordance
with the Underwriting Agreement, will be validly issued, fully paid and non-assessable, (ii) we are of the opinion that the Warrants,
Pre-Funded Warrants and Representative Warrants are the binding and enforceable obligations of the Company, and (ii) we are of the opinion
that the shares of Common Stock to be issued upon exercise of the Warrants, Pre-Funded Warrants, and Representative Warrants, when issued
in accordance with the terms of the their governing instruments and upon payment therefore, will be validly issued, fully paid and non-assessable.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to the corporation laws of the New York and the State of Nevada assuming that the corporate law of
the State of Nevada is the same as the corporate law of the State of New York, and we express no opinion as to the effect on the matters
covered by this letter of the laws of any other jurisdiction.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this letter as an exhibit to the Registration Statement and to the reference to our firm under the caption
&ldquo;Legal Matters&rdquo; in the Prospectus which is a part of the Registration Statement. In giving such consents, we do not thereby
admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations
of the Commission promulgated thereunder.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Golenbock Eiseman Assor Bell &amp; Peskoe LLP</I></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Golenbock
    Eiseman Assor Bell &amp; Peskoe LLP</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Consent
of Independent Registered Public Accounting Firm</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> CEA Industries Inc. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> Louisville, Colorado </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We hereby consent to the use in the Prospectus
constituting a part of this Registration Statement of CEA Industries Inc. (formerly known as Surna, Inc. and subsidiary) of our report
dated March 24, 2020, relating to the December 31, 2019 consolidated financial statements of Surna Inc. and subsidiary which is contained
in that Prospectus. Our report contains an explanatory paragraph regarding the Company&rsquo;s ability to continue as a going concern.
The December 31, 2019 consolidated financial statements have been adjusted to reflect a reverse stock split and such adjustments were
not audited by us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We also consent to the reference to us under the
caption &ldquo;Experts&rdquo; in the Prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> /s/ ACM LLP </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> Greeley, Colorado </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> January 31, 2022 </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEA
Industries Inc. (formerly Surna Inc.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louisville,
CO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> We hereby consent to
use in this registration statement on Form S-1/A of our report dated March 23, 2021, except for the reverse stock-split retrospectively
presented in these financial statements described in Note 16, as to which is dated January 28, 2022, relating to the December 31, 2020
consolidated financial statements of CEA Industries Inc. (formerly Surna Inc.) and subsidiary (which report expresses an unqualified
opinion of the consolidated financial statements and an explanatory paragraph referring to the Company&rsquo;s ability to continue as
a going concern), which appears in the Form 10-K for the fiscal year ended December 31, 2020. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>/s/
Sadler, Gibb &amp; Associates, LLC</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draper,
UT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> January 31, 2022 </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>ex107.htm
<DESCRIPTION>CALCULATION OF REGISTRATION FEE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 107</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: black 1.5pt solid">Title of each class of securities to be registered(1)</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Proposed<BR> maximum aggregate<BR> offering price (2)(3)</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: black 1.5pt solid">Amount of<BR> registration fee</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD STYLE="width: 63%">Common Stock, par value $0.00001 per share</TD>
    <TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD>
    <TD STYLE="width: 18%; text-align: right">23,000,000</TD>
    <TD STYLE="width: 1%; text-align: left; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD>
    <TD STYLE="width: 13%; text-align: right">2,132.10</TD>
    <TD STYLE="width: 1%; text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD>Pre-funded warrants to purchase shares of Common Stock, par value $0.00001 per share(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Shares of Common Stock, par value $0.00001 per share, underlying the warrants(5)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">28,750,000</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">2,665.13</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD>Shares of Common Stock, par value $0.00001 per share, underlying the pre-funded warrants(6)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">23,000,000</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">2,132.10</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: left">Warrants to be issued to the representative of the underwriters(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD STYLE="text-align: left">Common stock underlying warrants to be issued to the representative of the underwriters(7)</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">1,437,500</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">133.26</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 10pt">Total:</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">76,187,500</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">7,062.59</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: left; padding-left: 10pt">Registration Fee Previously Paid</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.699.02</FONT></TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204, 238, 255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Registration Fee Paid Herewith</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD>
    <TD STYLE="text-align: right">5,363.57</TD>
    <TD STYLE="text-align: left; font-weight: bold">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.3pt">&nbsp;</TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; border-collapse: collapse; font-size-adjust: none; font-stretch: normal; width: 100%">
  <TR STYLE="font: 10pt/normal Times New Roman, Times, Serif; vertical-align: top; font-size-adjust: none; font-stretch: normal">
    <TD STYLE="font: 10pt/normal Times New Roman, Times, Serif; width: 0.25in; text-align: justify; font-size-adjust: none; font-stretch: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: normal">(1)</FONT></TD>
    <TD STYLE="font: 10pt/normal Times New Roman, Times, Serif; text-align: justify; font-size-adjust: none; font-stretch: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: normal">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), there are also being registered such indeterminate number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</FONT></TD></TR>
  <TR STYLE="font: 10pt/normal Times New Roman, Times, Serif; vertical-align: top; font-size-adjust: none; font-stretch: normal">
    <TD STYLE="font: 10pt/normal Times New Roman, Times, Serif; text-align: justify; font-size-adjust: none; font-stretch: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: normal">(2)</FONT></TD>
    <TD STYLE="font: 10pt/normal Times New Roman, Times, Serif; text-align: justify; font-size-adjust: none; font-stretch: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Includes the offering price of any additional shares of common stock, pre-funded warrants and warrants that the underwriters have the right to purchase to cover over-allotments.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The proposed maximum aggregate offering price of shares of common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants offered and sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any shares of common stock sold in the offering. Accordingly, the proposed maximum aggregate offering price of the shares of common stock and pre-funded warrants (including the shares of common stock issuable upon exercise of the pre-funded warrants), if any, is $23,000,000.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No registration fee required pursuant to Rule 457(g).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The warrants are exercisable at a price per share of common stock equal to 125% of the common stock offering price.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The pre-funded warrants are exercisable at an exercise price of $0.01 per share.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">We have agreed to issue to the representative of the underwriters warrants to purchase shares of common stock representing up to 5% of the common stock and pre-funded warrants issued in the offering. The representative&rsquo;s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of the common stock offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative&rsquo;s warrants is $1,437,500, which is equal to 125% of $1,150,000 (5% of $23,000,000). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& 8,# 2(  A$! Q$!_\0
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M]Q7G>L_\A_4/^OJ3_P!"-.;?(KCFY<BN;@/C@C/_ !-O_'J[;P5_;']GW/\
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MYBL48@8R1W_6N1.K:A_:&S[9-M\W&-W;-=#X1_Y!$G_78_R%<D?^0I_VV_\
M9JVQ56;H497U8Y-\J.]UN62#1[F2)V1U4893@CD5SWAO4+RYU81SW,LB>6QV
MLV16]X@_Y 5U_NC^8KF/"G_(:'_7-OZ5T8J<EC::3TT_-E2?OHO^)-9NK:\%
MI;2&(!0S,.I)K*6YUU[?[0LEX8<$[QG&/6I/%/\ R')/]Q?Y5TVEQ&;PU%$I
M +PE03[Y%<_+4Q&)J1<VK7M8FSE)JYAZ!KEX^HQVUQ*98Y>/FZJ?K3;XZ\+V
MX,7VP1"1MN,XVYXJUIWABZL]0@N'GA98VR0N<_RKIIO]1)_NG^5;T,-6J4>6
MM)IIZ?=ZE1BVM3SU-5U2618TN[AG8X #')-;FB?VS_:B?;/M7D8;/F9QTXKG
M]*_Y"]G_ -=E_G7I-89;2E6_>2F]'W)IJ^MSS^]U;4$O[A$O)@JRL  QX&:?
M)+X@AB:21KU449+'.!5"^_Y"=S_UV;_T(UWNK_\ ($NO^N)_E65"G*M[1N;7
M+?KZ^?D**;OJ8?AS6KJXOA:7,AE5U)5FZ@CGK4GBJ]NK2XMA;SR1!E)(5L9Y
MK(\,_P#(>@^C?^@FK_C+_CYM?]QOYUI&M4E@)-MW3_R&F^0U_#5Q-=:49)Y6
MD?S"-S')Q@5S%_JNH1ZA<HEY,%65@ &/ S71>$_^0,?^NK?R%<CJ/_(4NO\
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MNS /_(P'_KZ_]GKJ_%?_ "!3_P!=%_K7&VC%]1@9CDF523^-=EXK_P"0*?\
MKHO]:O"N^&KL<?A9D^#O^/ZX_P"N8_G3_&7^OM/]UOYBF>#O^/ZX_P"N8_G3
M_&7^OM/]UOYBJ7_(M?K^H?\ +LO^$?\ D$2?]=C_ "%<D?\ D*?]MO\ V:NM
M\(_\@B3_ *['^0KDC_R%/^VW_LU1B?\ =J I?#$[KQ!_R KK_='\Q7,>%/\
MD-#_ *YM_2NG\0?\@*Z_W1_,5S'A3_D-#_KFW]*ZL7_OU+Y?FRI_&B[XFTFZ
MFO1=V\32HR@,%&2"/:LV*YUVSMPB"YCAC'>+@#\172ZEXBATV\-N\$CL%!RI
M'>K8NEO=&>Y52JR1,0#U'!ISPU*I6FZ=1J75(;BFW9G/:'XAO)=0CMKIQ*DA
MVAB "#VZ5UDW^HD_W3_*O/-%_P"0U:?]=!7H<W^HD_W3_*KRRK.I1ESN]G^@
MZ;;6IYSI7_(7L_\ KLO\Z])KS;2O^0O9_P#79?YUZ36>3_PY>OZ"I;,\SO\
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@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>forms-1a_001.jpg
<TEXT>
begin 644 forms-1a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" SD"?8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD9E12S$*H&22< "@!:KWE_:Z?%YEU.D2]LGD_0=3^
M%<YJOC.")7BTY3+(1CS6&%7W /)_3\:XZ[O;F^F,MU,\K^K'I]!V'TKR<5FU
M.E[M+WG^'_!/5PV5U*GO5/=7XG2:GXTGDEVZ<HBB'\<B@LWX= **Y2BO#GCL
M3.7,YOY'M0P6'C&R@CV.BBBOLCY **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HJEJ&JV6F1[KJ=5)&0@Y9OH/Z]*X?5O%5YJ2F*(?9H.X1
MCN;ZGT]OYUQ8K'TL.K2=WV7]:'9AL%5Q#NE9=_ZW.KU?Q-9:6?+'^D3_ //-
M&&%_WCVKAM2UF]U1R;B8^7G*Q+PH_#O]3S6?17SF*Q];$:-VCV7Z]SZ##8&E
M0U6K[_UL%%%%<1VA1110!['1117WI\,%%%% !1110 4444 %%%1M+M8C;^M
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MZ -"BJJ7>]=V,?C3OM'M0!8HJO\ :/:C[1[4 6**KFYP.E5UU$M,T?E].^:
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MD=* )Z*A\X^E'G'TH FHJ'SCZ4><?2@":BH?./I1YQ]* )J*A\X^E!F(&<4
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MGH: -"BLY]451D)G\::NK9',6/QH TZ*S_[33&<5(E]N&=G'UH N45!YY(R
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M&X^E $VX>M&X5#N/I1O/I0!-N]Z0M\IJ+<1022IH @C/[VK6X520_O*L9XH
MFW#%-5A3,T"@"5F&14%PPVT[FHINE #K=OW=6-W%5+;[A^M6* %!R:?FF=*
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MNG- "T4W>,XIU !1110 5'/_ *EOI4E1S_ZEOI0!':_ZL?2K%5[7_5CZ58H
M*KW71?K5BJ]UT7ZT .7_ %=2+TJ-?]73U/% #STJ-NM/)XJ-NM #^U*!0.E+
M0 W^*G4WO3J $;I3%ZT]NE,7K0!)5:[^ZOUJS5:[^ZOUH EA^Y4E1P_<J2@
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MB!VC- #E7)W&GX(^E&*0L!UH "12*"3DTBC<<U)VH 0<4K-@4TG'6D +'VH
M0 LV34G I.AH) %  3BJI)-TM3C+'VJ)_P#CZ7Z4 61TI:0=*6@ HHHH 0_=
M/TJI!_K?QJV?NGZ54@_UOXT 7*@NO]6/K4]077^K'UH DB^[3Z9%]VGT %%%
M% !1110!%<?ZEJ;;?=-.N/\ 4M3;;[IH G[55D_X^5^E6NU59/\ CY7Z4 61
MTI:0=*6@ HHHH 0]#51,F7 JV>AJK%_K: +*@"E[44UF].M  S9X'6E5<=:1
M5P.:=TH .E-9NPZTCL1PO)I57'/>@ "X&3UI!UR:>>E19P: 'LW84UAA#FE
MQSWI6'[L_2@""V&/I4W\50VU3?Q4 2#I10.E% !1110 =JC'WJD[5&/O4 24
MTF@G- % $5Q_J6IT'^K%)<?ZIJ6#_5B@"6BBD)H ": * *6@ HHHH *8U.)I
MC4 .7I2]J1>F*9+*(UZT -N' 4CO4,<VT=#^5+&/-;>QJQ\G3B@"+[1['\JC
M^T<]#5DF/VIF$)[4 ,%R/0_E2_:<] ?RJ4>6/2C*=@* *3R9D#$''TJZAR@(
MI'6-E*G S5=7\A\9RI]: +?TI>G--5@PR#3CTH 86YI"<FCO2=Z ) 12.P09
MIC$*N2:K8>9^^T4 /&Z=\G[E6D4*,"F* HP!3@] #L<TM)NI>M $;TB4YZ1*
M )!1110 4444 %%%% "-TIJ4YNE-2@!]%%% !111ZT 1G[U2#I49^]3AQ0 Z
MBBB@!,<U4NFP5^M7*S[P\CZT 7(3F.I*@MF_="IZ "H_^6E24S_EI0 O2G9I
M#24 (]*G2D>E3I0 ZBBB@ HHHH 8]*HXI&I5Z4 %*#1UI* %/2H^S5(3D5'_
M  M0!3A0&<D]:2Y4^8JGH:(&*W!IUPP:5.>E  ;5=J\4V>W"+D5;_@2HKS_4
MT 1Q6HD7)J3["GI4MK_JQ]*GH I_84]*1K-54G%7:9+_ *LT 9T, >1@:L?8
MD':F6W^N:KV* *GV)?2C["GI5RB@"G]A3TH^PIZ5<HH I_84]*/L*>E7** *
M?V%/2C["GI5RB@"G]A3TH^Q+Z5<HH I_8E]*;]D4O5VF ?O* *_V)?2C["GI
M5RB@"G]A3TH^PIZ5<HH I_84]*/L*>E7** *?V%?2C[$OI5RB@"E]B7TI?L:
M^E6CUIPZ4 4_L2^E'V-1VJY2=J ,N2'9( .]6%LU89(ID_\ KU^M75^Z* *W
MV)/2C[$F.E7** ,Z:V$:9%)%;!XLU:N_]73+;_CWH B>V"QEO2BS(&:L29\E
MOI5:U7=G/!H 63_CZ'I6!XW_ ./:Q_WG_D*W&!%T :P_&_\ Q[V/^\_\A7'F
M'^[2_KJ=> _WB/\ 70Y%*G7I4$=3KTKY*9]7$=1116984444 %%%% !1110!
M['1117WI\,%%%% !1110 4444 %57^\:M55?[QH B[TP_>I_>F'[U #^U(M+
MVI%H :.M5Q_Q^_A5@=:KC_C]_"@"WVI#TI1TI">* &YXJK!_K6^M6<9YJM O
M[QOK0!<W4WJ:7;2[:  =*":#0* $J*1/E)S4QJK(SE]A^Z: '(Q5>3G/2E5&
M8;F-(Z%8U"]!2M<*$[T $6=QY[U*[;0:9$N 3ZTUSO./2@!803\QJ8CC%,0C
M&%IYZ>] $$JE<'-2QYV\U!EFE*OT'2K(&!0 M%%% !4=Q_J6^E25'<?ZEOI0
M!':_ZL?2K%5[7_5CZ58H *KW71?K5BJUWT7ZT /7_5T\=*C3_5U*O2@ IIZT
M\BHSP: )!TI:C#&C<: '=Z=463FER: 'MTIB]:,FD&0: ):K771?K4NXU!=$
M[5^M $\/W*DS4$1.RGY- $F:,U'DT9- $F:,U'DT9- $F:,U'DT9- $F:,U'
MDT9- #STJ/O2[C29YH D!I<U%DTN30 _M3!]^C<<4P$[Z )LT&F9-&XT .!Q
M0:9DTN30 \=*7-1Y-&30 _M4:_?-+DTQ2=YH ESBHC/S@+FG')J&,X+ ]Z '
MMM<9Z&D!:,9SN%-F3Y01ZT*70<]* %BR2Q(ZU87I48]?6G D=* 'YI<U'DT9
M- $F:,U'DT9- $F:,U'DT9- $F:,U'DT9- $F:,U'DT9- $E-8\4W<:3DT
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M4 -Z4X&D(I* %[5FW9R^/2M(GBLJ<YF:@"Y:',0JP.*J61^4"KF* %SFF?\
M+2EIO_+2@"2D(I:* (VIR=*1Z5.E #J*** "BBB@!C4J]*1J5>E #J0BEHH
M:>E,_A:I#TJ,_=:@"I;X,YS1<J!,GO38@?/.*)R3,N: +?\  M1WG^JJ3^!:
MCO/]50!):_ZNIZ@M?]74] !39/N&G4V3[AH I6W^O>K]4+;_ %[U?H ****
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M_(Q3/XZ 'X%&*7(HR* $P*0T[--- "@#%+@4@-+D4 (0,4Q,;S3R>*8GWS0
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M* "BBB@ S2=:6D- #5'%.!I%Z4I% "TA% I: $!I:3% - "-TH'2E;I2#I0
MHI:04M %:YZK3XAE!FF7/+)4T?W!0 [@<4A.VAF YIH&XY- !C<>>E/Z"@"A
MC@4 (2!30"QYI -QI_3B@ QCB@G H)YIO+GZ4 )RQ]JB< 72X]*L]!BJS_\
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M3[*,T /\R/U%,+Q^U*;?KS59(OF.3WH MAX\#I3)G0IQBH8HB9&!-3_9\]Z
M&P31[<$U.LBMT-1"U4&HXU*S$9XS0!;!XHZ44'I0 C'I4%RV(ZDZFH+D_(:
M)+1LH2:L51LV.T_6K6XB@"3M2"F[LT!J 'T8I,TM $;BD44YZ1* '@8I:**
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MG7I4$=3KTKY*9]7$=1116984444 %%%% !1110!['1117WI\,%%%% !1110
M4444 %57^\:M55?[QH B[TP_>I_>F'[U #^U(M+VI%H :.M5BP%Y^%61UJJP
MS>?A0!8,R@<U$;J->].,"MW-1M8H1U- %74M=MM+TZ:]F61XHL;EC +') XR
M1ZUQES\6M!T[,DUGJ3#.?DC0_P WK9\:VOD^$;]AG'[O_P!&+7A&O1;K-F]
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MFG_Q=>1:1:1FUW$#)I);>:WFW1_=]*7M)%^TG:YZTOQ8T)IO+^RZB&]XT_\
MBZDD^*6BQC)M-1/TC3_XNO%;HL)%EZ&M*WN8Y(L-@FCVDA*M*]CU:/XK:'*Q
M"VNH@CL8D_\ BZF_X6;HV,FUO_\ OVG_ ,77E,<<)'F  &ACUK*5>2=D7[25
MKL]2?XIZ(@R;74/PC3_XNJ-U\7-!VC_1-2X/_/-/_BZ\SE&5(K(NHR,U<*LG
MN9^VE<]<'QN\-QX0V6JY]HH__CE7XOBYH$T7F+:ZCCT,:9_]#KYXGC_>5HV$
MC+&5S6CF^A;JM*Y[DWQB\/J>;34_^_4?_P 74UO\6=!N?N6VH#ZQI_\ %UX)
M-)M8U/87#1R@TI3E;0*=9W][8]^_X65H_P#S[7__ '[3_P"*H_X65H^?^/:_
M_P"_:?\ Q5>26UVDQ*=' S5D<CW%<SQ%0]2-*G)7/4O^%E:/_P ^U]_W[3_X
MJE_X63I'_/M??]\)_P#%5Y;WH'-'UB8_80/4?^%DZ1_S[7W_ '[3_P"*J-_B
M?HR'FUU#\(T_^+KS,U')&&6FL1.^I$Z"M>)Z:?BGHG_/IJ/_ '[3_P"+I1\4
M=%)_X]=0_P"_:?\ Q=>3.H6HTDY;VK7VS//E.479GKK_ !3T1.MIJ/\ W[3_
M .+J$_%O01_RZ:E_W[3_ .+KRC)F&*RK^0VS8(^E4JDFS*56:>A[2_Q@\/I]
MZUU+_OW'_P#%U#_PN7PZ&S]EU/\ []1__%UX,\S.QS4OD_*K9JN=C]I-;GOB
M_%W0&7(M=2Q_US3_ .+IP^+6A'_ETU+_ +]I_P#%UXG"H6(<U,C'M4NI(7MI
M'M ^+&AG_EUU'_OVG_Q=,/Q;T$'!M=1S_P!<T_\ BZ\;WE.3TIDFV0;E^]2]
MI(/;2/:/^%MZ!AO]&U'Y?^F:?_%TYOBOH:H&-KJ.#_TS3_XNO$8?NRD]:O)&
M9@@/04.I)#]K.Q[)%\4=%F'RVNH#ZQI_\737^*&BPO\ -;:@0?2-/_BZ\H \
MLC!P,5#,S.AXX%'M)6'[674]</Q5T+'_ ![:A_W[3_XNF+\3=%;)6VU#_OVG
M_P 77C4F'CRG4=:?;S\;<\^E'M)VT)]M.Y[ ?BKH_3[-J'_?M/\ XNAOBMH@
M_P"774/^_:?_ !=>1X))-1MS1[60O;3/8O\ A;.A8P;34L_]<T_^+J*7XQ>'
M8!\UKJ7X1Q__ !=>,SS>2F2>:YZXN_M,A&>AJU*3*A4G(^@3\:_#@&?L6JGZ
M11__ !=0_P#"\_#6[;]AU?/_ %QC_P#CE>$07 ^X?2HGP9B<T^9EJ<NI]"0_
M&?P[-]VSU0?6*/\ ^+JY!\5M#N'VI:ZC]3&G_P 77SY9*Y.$!-=#8HX&0,'O
M4N<NA+JR3L>SR?$_18^MO?\ X1I_\55.Z^,/AZT&7M=2/^[''_\ %UYC.RR$
M*.#WKG=9LI=NX9QFDJC;L'M97/:(_C9X<D("V6J\_P#3*/\ ^.5H+\5=$9-W
MV340/>-/_BZ^>[&/]X@KK84'RD]/2FZC3'[25SUU/B7H[IN%M?@>\:?_ !5,
M;XGZ,IP;74/^_:?_ !=>9>8@C)Z8K/:?]X2>AJ95)+8)57$]@'Q,T=AG[+?_
M /?M/_BZ1OB=HRC)MK__ +X3_P"+KRN*59(_2LK4KH)^ZC/S&DJLGHA.K)(]
M:G^+OA_)C-KJ)/M''_\ %U6MOB[X?:X\M++5"WKY4>/_ $.O%7ADQD9):MK1
M].%NOG2CD^M6ZC2"%63/:E^)6D$ _9K_ )_V$_\ BZ>OQ$TDC/V>]_[X3_XJ
MO)V8!@V>*=)(%C+LV!4QJ2ZE>T9ZFWQ)T=>MM??]\)_\75*X^+>@6PR]MJ/X
M1Q__ !=>*WNMN6*1GOBLB>XDE&9#5*<B?:2>Q[NOQK\.,VT66J_7RH\?^C*M
MK\7/#[)O%OJ&/^N:?_%U\Z^9D[4JU Q5 I/)-/F8Y5)):'OO_"W_  ^7"BTU
M,_\ ;*/_ .+J9_BWH$8R;74O^_:?_%UX?"HAC+MUJK=7K-G'2ESRN0JTV>XR
M?&CPY$.;/5#](H__ (NJS_'7PR@)-CJ_'_3&/_XY7@LLY/6JLIROUJE)FL9R
MZGT9#\6= U2 RQ6FI*OH\48/Z/4\'Q4T-/E^RZC_ -^T_P#BZ\2\.'_0V6M!
M?];BN>=>:;2/4I8>$XIL]E7XIZ*Q_P"/340/4QI_\71_PM/1,X^RZA_W[3_X
MNO(N?7BCO4?69EK"P/76^*>B+C-KJ/\ W[3_ .+IR_$32;D!TM[T#W1/_BJ\
M@FZ"M+3SF"M*=:4G9F5>A"$;Q/5O^%AZ2!C[/>_]\)_\51_PL/2?^?>]_P"^
M$_\ BJ\U[TAKHYF<;/1)?'NENV1!>=>Z+_\ %4/X]TLD$07G_?"__%5YW24<
MS$>E+\1-)50/L]]_WPG_ ,51_P +(T@?\NU]_P!\)_\ %5YH>E1'K1S,#TM_
MB'I,P.VWO1]43_XJI5^(ND*H4VU]_P!\)_\ %5Y=%U.*D[\TN9C/3_\ A8VD
M?\^U]_WPG_Q5'_"Q]'_Y]K[_ +X3_P"*KS"HIKB.!"78"CF872W/2+[XIZ':
MPL9+;4,>T:?_ !=9,7QK\-1I@V>J''I%'_\ '*\SU"1-1B**PP:Y.\TJ:%B4
M8D5,9MF7.[GOG_"\O# _Y<M6_P"_4?\ \<IP^.'AD_\ +GJO_?J/_P".5\X/
M',#R#Q0CL#BKNQW9](K\;?#3' LM5_[]1_\ QRIX_C%X>D;:+/4\^\4?_P 7
M7S?&[*V16M8W +#-2Y-$2G)'T#_PMC0?^?74?^_:?_%TA^+.@]/LFI?]^T_^
M+KQ>-MQ!SQ4Y90O'6L_:R)]K(]@'Q7T(=;34?^_:?_%T?\+;T#_GTU+_ +]I
M_P#%UXTQ8CGBH3GG%-5)"]M(]H/Q=T <_9-2_P"_<?\ \740^,WAT$C[%JG'
M_3*/_P"+KQCG)S59DPYQWJE-A[:1[D/C'X>;_ESU3_OU'_\ %U/%\5]"E^[:
M:B/K&G_Q=>)VEHSXS6K%;B,5G.NUL7&<F]3U[_A9FC$?\>U__P!^T_\ BJ4?
M$O1B.+6__P"_:?\ Q=>2;P!BGV\P#X/2LU7J7U-KH]1E^*VAP'#VFI?A$G_Q
M=,3XMZ#)TL]3_&)/_BZ\WD%M,<-C-5'AAC?"XVUI*M);"<CTRY^+.A;E'V+4
M^/\ IE'_ /%T\?%W0409L]3_ ._4?_Q=>:&.T:(\#-8E]*%RB4U5DS.4VMCV
M6/XN>'Y#_P >NI?C$G_Q=2+\7?#YR!::EQ_TR3_XNO#K<NPX'-3&WN%.<'%4
MZC(569[2?B_X?'/V34_^_4?_ ,73/^%OZ QYM-3_ ._2?_%UXL4)?!J_!9JR
M@TO:R+4Y,]?B^+>@OPMEJ?\ WZC_ /BZLCXGZ*P_X]-1_P"_:?\ Q=>21PK'
MVJTA&*I2D:79ZC_PLC2'/_'M?X_ZYI_\54@^)&C ?\>U]_W[3_XJO+=WI3"U
M6FPN>J'XEZ,/^7:__P"_:?\ Q55G^)6C><'-O?8'^PG_ ,57ELLP0$DUCWNH
M!00#0Y"YCV>3XN^'X?O6NHGZ1Q__ !=4Y/CAX9B/-GJI^D4?_P <KP6YO6<]
M:H2$DU/.RE<^A/\ A?'A?/\ QX:Q_P!^8O\ XY1_PO?PO_SX:Q_WYB_^.5\[
M\YZ5/#$6'2JYB7)H^B8?C5X<N.$L=6R?6*/_ ..5>M/B)I4C;Q:7X!/=$_\
MBJ^>K.7[/(I/2NK@UV%(1D@&IYV-5(=3VAOB%I*C)M[W_OA/_BJJS_$;2'4
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MVG_Q=+_PM#1?^?/4?^_:?_%UY>0E(=OK1]9D)4('J(^*&C'_ )<]1_[]I_\
M%TI^)VC#_ESU'_OVG_Q=>7*5IY9<52Q$A.A$]+/Q1T7!'V/4?^_:?_%U OQ,
MT=9-WV34,?\ 7-/_ (NO-F9,]J;E#2^L2']7B>GCXH:(#G['J/\ W[3_ .+I
MW_"T]$_Y\]1_[]I_\77EV%I-JFCZS('AHGJ@^*.BMTM-0'UC3_XN@?$O11R;
M:_\ ^_:?_%UY5@"@GBI>(F6L- ]2D^*NAIUM-1_"-/\ XNHS\6M"QQ::E_W[
M3_XNO);CK5;M6T*LFKLYZM.,79'L/_"V-![VFI?]^T_^+I1\6=!'/V34O^_:
M?_%UXV329J^=F5CV4_%O0>@M-2_[]I_\733\5]!(.;34N?\ IFG_ ,77CG>G
M#I1SL+(]?B^*VA)UM-1_[]I_\74G_"V=!SG[)J7_ '[3_P"+KQS HP*.=A9'
MLG_"V]!'_+IJ7_?N/_XNC_A;F@?\^>I?]^X__BZ\;(I,4<["Q[+_ ,+<T#_G
MSU+_ +]Q_P#Q=+_PMO0?^?34O^_<?_Q=>,XI0*.=A8]E_P"%M:#_ ,^FI?\
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MK'_>?^0KCS#_ ':7]=3KP'^\1_KH<C'4Z]*@CJ=>E?)3/JXCJ***S+"BBB@
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MMB7N5K20BX*$#;]*GO;,*1/$?J!5V*S0@G&&Q404HS*Y.VE?6Z#DLK,I1NY
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M52*AA)MVN9UI:,[ GI6O'$L:].:>D:H.!3@,USRES'KTJ2IQLB$ EZF>/<M
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MCMSQ0>*E5MR8%*XFV1;:<%QS2CK2D9Z4"N0R+\XH'!Q4DPX!IH'>@9]CV?\
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MM3BULF&4517.)*6;DFK27IC 7-4TQ^T?4U)U6WP8S4L,LI4DMQCI62TS3RJ
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M2GH1R77-9]U>,%..E2!M[&HKJ &(U"J-$K4P[BX+GK50DDU)+\LA'O495G;
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M*=2 =Q2D\9K4Z^A2NFRV*KIT-2SG+FHU'&:1+&GK333R*;BD(:1FD IV*,4
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M3GTIG;&5T0.^9#3Q]VJ*3-Y@1D(YJ^1\H]*0AIIN*D R:0CF@0S%&*D I<4
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M9-S8/:KO)Z4F#T9#(@;(JA+:$296M$J0:A=F##BFF-,6&,HHSUI+C)P!2F<
M@42'(#4$VUN?7MG_ ,>-O_US7^53U!9_\>4'_7-?Y5/6YUA1110 4444 %%%
M% !7(^.O]39?[S_R%==7(^.O]39?[S_R%<>8?[M+^NIUX#_>(_UT.0CJ=>E0
M1U.O2ODIGU<1U%%%9EA1110 4444 %%%% 'L=%%%?>GPP4444 %%%% !1110
M 56?J:LU6?J: (STJ,_>J0]*C/WJ '=J1:7M2+0 T=:K#_C]_"K(ZU7'_'[^
M% %H_=IJ]*=U%-Z4 <Q\0O\ D1-2_P"V7_HU*\#; SQDU[W\0^? FI?]LO\
MT:E>$NFTXZUQXCXCMP\5*#3+EFY:(9I]TP$;5!9MU!J:Y3?"R@\D5R]3H</=
MY48<E[M/R]C3/MSN>>*H/NBF='/>I48-@5V)(\*HFGJ:4%W*AR&)%7$U,(XW
MUB@D<]A4F\.N"*'%&5SI%NHYL%&%2%0X((SFN45W@?Y6)'UJU_:<L(4@Y]:G
ME92+MY:QYPRUB7VGX!>/[M:R:G'=+A@0V*1%W1.IP1ZTTVB-4SC9MT<F*='+
MGK5_4+< LPQQ63C#"MUJ;Q:DC0B()YJP/D.5JFB%DR#S3DDVG:<U)+1K13C@
M=#5^&48YEQ6&D@ SFK,=QA<TFKF$H=CHH9(L9,F3ZTLMZ,[(ADUBQS!ESG%:
M-K)"@R/O>]0U8$WL6&>8*""<TU+RY!P,T/<H#R:1)4'S#'-*]AW[%A+RZ93E
M<TS]YOWR+@5+;F8@NJC'TJTTG[H^: /PI/7J79M:L@%RH7Y>M21G>-S<5G32
M1JQ*L*@:_<G:HS]*:N3S6-UI8XDSP:CCN@^2!@"L&2ZD)Q@BM.QG26/8U$FT
MKC4[LMF^9OE3K39+A(QF1<DTC)Y?"5%=*/+ /4U'M+LIMHSYS \I,:@$U0N(
M#$ 5;FK4P:(A/XFZ&F-I]P^3@FM$[&5FR@K$]6YJ97<+SS4[:8Z1EV(!K.\P
MJY![5>C"S+!96!##!]:V[9TEL@KG)%<^&+#/%6+>XV':Q-*2N-.QH32F-<)3
MH)SD9/-4Y9,\J>*?"<L"34\NA%]39FC$UOD^E<G=)LF8#UKIXI/W)!-<U>M_
MI#_6G$TO>6A3+%&)/I5ZTN.AQ5,KO4>I-:=G8LEN6(SDYXJF.6Q-<2AX'KGI
M",GZUT@A\VW95'-<Y>1F)F4]<THVV'3%C0LF12C<C8(IUBX92/2KPC#1!B.3
M3;+8VQNO)E /0UTD)$Z$#H:Y=T*L/K73Z6A6V!)SQ655V5PBV9%W9,EX".A-
M;EM+L14+<XJ.XA:293CO5:XTRX4K*C]^E0[35F:4:DJ<KK8V?O<&E!YJK:R.
M!Y<OWAWJS7.]&>O&2DKHE'(J"3*]*5I-@JNS/*V #6D8\VYS5\1[/1;CB@D'
M(S3A:KC[M2PH0,$5(SA!S73&"2."<G-WD5FMU"\BH9?+1.@IUQ=J 169-,7!
MYH:70PG)(8]RAW+[U0N-I;BG2\GBJ[DYS5)6,EJ1^85:KMG=@/@U0;DTW.#D
M4WJ:<MSHTD61LYJ0':U8$%R8V4$GK6S XFQBLW&QFTRR1E=WI47+'.*DFD,:
M;1BJ[2E0!U^E3&XI6'.#FJTLWEJ2!FI0YD.*K7_[J \<GO5H2C=F1>3M(Y)K
M.*9R<U;F.X8/6H8XR2<FM4=D59!#; QDD\T\<<#Z4D4H$VWM3F0AB5[T Q;5
M!+>*A[#-;\,S,ZHHP/6L:WB=9%EVGIBKT1(E#<U+U,JFYK[YK=\AB15F&]+,
M.,^M9S7#\ ]#43320.&QP?:HLR83Y7H=0DBN.8@:5D1E*% H/>LNUUE?+^88
M(]:?)JD<C8.15WT.A2316N](W$LK5@W,#1.0:ZM'$B@AP0>U9.J1+OP.32V(
M<>J,!XR>],^S%AZ5L1V/F+D=?2I&L)%3D<4[BNS)CLP1\S8J;[""/E;-7GM7
MR.@'TK1L;7."5Z>M*]P7,V4K'0UE ,HX-79].TVSB+.BYQ5^ZO8K"VWG' Z"
MN#UC7GO)"L>56K439(DO;RS:4B.)2!5 S1YX0"LXL2<T D5?*5RFDLRDXJ8#
M(XZFLH2&K]E*6E0'I2:L3*-CH='T7SW660?+FNDGA6) B= *BLODMXPN,'K4
M\K!D..W%<M;5'5@I>_8K0^E3U!#W]:GKE9ZPY:BN.]2K4<XX- EN9TQP*1>4
M!I902<4T+A<5KT$.QACFN4U,XO",9KK)&PN:Y#5N+DM6M'XCEQ?PBV=\ELVU
MQ@5NVVLVT29C<!^U<8QRU 8@]374X'G-71V0U!KIBTDNX#M4AU*,Q>7M%<I:
MW+)E220:N1RX/&?QJ' R::-Z6(/ HW[%8U$^AP(OF-<]1P,520^80I9N.1S3
MS*S2;&8\#CFI6A-R6VTIIBVULA:AN;.2$D[>G>I4GE0':V >M&[<<$D_C1J%
MS-(!/'XU9@CY%6VBMR!P0?K2K$%&5(Q3N%QKA"F"<5G3 C(W9%7IY!L((Z5E
M&0M)C&11$:1(L 8#'>I#:;2&)J9.$':FR[CWR/:G<+LF6Y6)0%7)IIOI#TXJ
MINVMZ?6CK18+$CSNW5J6.=@14>SC.*"N*+(#06X.*D%P?6LU3@=:E23G !J;
M"L6VG)/6I$;(YJ&*!Y3P*OQVC+UQ2;2$.MHV8?,>*FFN!;KQUJ1$VK5#505B
M+*:A.[*2(9;[S&P35VU#.N46N:C9C*">F:ZBPU6""(*R'(JY1[">AI6D,F1E
M:V+;*L 16(GB&V7^'%68O$%J><XK.,+.[.M58*%KG19ILG*FL8:_:Y^^/SHD
MUZWV\,/SKHNK&3JQ[E]ER<5&55<UEC78&/W@/K3CJT#C 8'/H:P?>Q',GL/.
MJPK,T0(W"I/M8V;@:Q;F%"WG+P2:G@.8QSQ6;E?8[J&'OK(GDE,K9-,  HQZ
M4H K(]!*RL(.M.%%)F@JUD.HS25+'&6P:5R)R45J26\6XY(K110@&!4,$6,5
M< &*UIQ9YE6JYOR!3FE.*8Q IKS "MG)):F-Q'Q3 !432<TBN2:P=2[)YA+I
M1LS6.SX?%:\YS'69M!8FL[JYZF%^ .U7[8_)5(C JY:*66A)O1%8C^&.:/>V
M*L1V:!<FE$>SDTQIR#@5HH\J]X\K04VX)XIC6Q49IR3X/-3R3J4JZ:C)W*31
MFRY535'!9\FKTK!B:KG"@FM;)!NR.3@8%+%$S=*5$,CY[5H11A5J)3ML=5.%
MUJ9LML1UJMY6&YK7G(J@P!;BHA=N[-Y-*/*B6",<5*[8&!2)\J4QCSFIE*[-
M(1LB-AWJ+O4KGBHAUJ#4D44II%/%+77#X3S:WQC:7M2T=J9D-HQ2T4#$I,4M
M!- "4M-SS2YH$!I#0:2@8AIAIYIAI,<1*3-*1Q25)H+3L4T"G4R6+VI*6BJ)
M8F:1C2FFFF"&FD)XIV,TTTB@0\U.#BJZ=:L("Q  H1+-/3 2V:V2<"J-A 8U
M!-7F%:1($!I#33Q1NXJ@$(IAI^>:0C(I 1XS2$&GTA/%(",GU%5Y[-)AR*LD
M9II.!BD"9RVH:?\ 9F\Q1T-.1TN[%E/W@*VK^,26[<<XKC[>Y^RWQA8\$T6*
MN9=U"T<K*?6JI4BN@UJWRHE3FL,'=3&M1B\4_/<=:!@@FFG@\4%&OIE\PD5&
MKM+?YHU->>6C;;I3Z&O0[%MUJGTH,I(M#&*7..E"]*#2N%A-Q-(<THX[TC-1
M<5AC*34;+@5)R:212%S2'8K1/MEP:U8'#$5B9Q+6A;2_,*F+]XII)&T%!6LZ
M^@ 0FM"%L@57U$@0FM*D;Q'2^)')W2@DU4%OELU<EY8T*,5Q)V/421FWT95.
M*R"Q)Q72RVK7 VJ*J?\ "/3%\UI"2ZG#B+)W,V*/+"KZP%@,5<_L=K<!CVIZ
M +QBE*00I\VI"MJ HSUI8X0'JP>13%'S"IN=*BEHBY;H8R".E:L4BLG6L]/]
M73%G>(D]J<='J<N(I<RYT:V!VJ3@#%8)U5E?!%/&K'TK6W8\QU4G8V\"@8K"
M?6PO!!I%UQ.X-%O(/:HW7P!FJSG)K*;78R,<T@UF/%0XNX2FC8B8!JG:-91C
M%8":S'NYJ['K4 7[P'XU<4^HXS2*>KZ2Q4O&.:X^<R)(4<8Q7H"ZQ:R_*S#G
MWKE-?6$W&8B#GTJTDC5U%)6,7-/C8TJQDXXJU%:L>U4V2M18_G4#O5J"W\Q@
M&/%+';;1G'-2J"IXJ47RZ&M:Z?#& 0 :MS;5B*@5FVUR4ZU-+<AAP:LA.Q4-
MN7FS6[8QK&@R*H6ZAF!K43Y5%"11HQ[".@J0Q(PZ"LX2LM/%PWK5E7)Y+5>P
MJE(FTX-61=''-02L).14M$NQ!Y:MVJ(VX!SBK"H<T['3-%KD6*8CVDXIR'<I
M!%6"JYQ3?*Q181S^L6.\%@*YW[-AL&N[NXP8&)]*Y*=D,AXZ5%[,9G/'CBF>
M6!WYJQ/( #MJJK;V%4@5R>%0B$TKKO44Y5XR>E0M<HMPH[9I#C&[-N.SC^S(
M6 R*K,NTM@<"KT3B2(8["DAB4[MW>N>_<]E*RT,J <EL5'*<L:OW$2PY Z5G
M/R:I.XR(#K3P*0"G"J8K"TJTWK3P,"D AY859N)/)LJJCF0 5;OXM^G\=J%N
M85_A,!Y=YJ(TWH:=_#FNK8X;"*V#5F*4D@>E-BLI9AE11):RV[?.#BEH)V-*
M"<QG<!3KES*-Q.<U1B<[<=J5Y"HV\U%C/EU)+639/CUK<B.17,B3$H:N@@DW
M0AAZ4I+J*:)WQ56;'/K0[D-UJ*5Q4DI#5"D\]:E?B.H$E0M]*F,@E7CH*8V?
M7]G_ ,>5O_US7^535#9_\>4'_7-?Y5-6YTA1110 4444 %%%% !7(^.O]39?
M[S_R%==7(^.O]39?[S_R%<>8?[M+^NIUX#_>(_UT.0CJ=>E01U.O2ODIGU<1
MU%%%9EA1110 4444 %%%% 'L=%%%?>GPP4444 %%%% !1110 54D;#$5;JI)
M]XT -/2HSUIYZ5&?O4 /[4BTO:D6@!HZU7'_ !^_A5@=:KC_ (_?PH MCI2$
M<4M!Z4 <K\0%W>"-17_KG_Z,6O#)1\@->[^.QGP7J _ZY_\ HQ:\0FA98^17
M'B/B.["R2CJ5[8[9.:O8SGTJK!;N\H(%:0MN.3BN5JYM4JQCH<M?6PENL*.3
M4$FEW$:&1>@KHY[! _F*X)J6$*Z["<UNIM)'C5;<^AR*NZQX8<TH<,?2MK4;
M14;Y5XK!O8GCRT705M&29CRZDN\@^M3&,219'6L2'4&W;6[=:V[5A)'N4Y%$
ME8T47$JQ?+(5Z&EBO9(9FB8\$U8:,><"1@56OX<3*X^Z>]%T'+?09<@R$@=Z
MSGM)%?..*TA(GF#)I;B92,#K5*0)..Q2@(08-)-M!XI?+.>104!;!I]0N-1L
MU("Q.%II7:I/:KVFV,TSJX4E/6AM+4EC(EE4@,#5R+<9E7!K>2RCV#<@S4J6
M4*D-M -8.LB>12*YL4=%).#3X-.02 LQQ5IUYVXJ)W9!Q6:G)BLHN[-6&-$0
M!<8K'U^0I!\G%31R2A V3@T7=K]NMMIZFK4^A;?,K(XUIV)^\:>+LIRI-:]U
MH2VT0;O6?]F0@X'-;<R9#BNI7>]=AEB:U=$4S.6WFL*X!0\KQ6KH5Y$K[#\I
M-*?PZ%**W.DF)0CO5>Y8R.I'058EQM!ZTU4#\5S1=M12U=B,0QR[2PY%7%.T
M  #%1A #M%2XPM+G9<8V,75Y'484X!KGW9>AZUU-[;B9#QDUS-Q;-'(<H1S7
M13::,OM:BQ?,OR]:4 9^;@TU$,4J^AJ>1,MD#M5W'RBA6V%AR/2G6[GS5.>,
M\U#!,8)QNY5NH]*M/#LG#IRC47)E&QJEU6 DXZ5S%T&EN&(.!FMN9H5C ;TJ
MO#;1RG<HJ8Z"B[$=C8%F#$$CZ5NQ Q1E @-2P&-(AA1Q5B+RV!8UDYW>II&-
MUN5EC 3[@!/I7+:KI\TT[!%KM8D#'.*JSHJRY*TH3:U*M;4X:ULKBWD.\?+6
MFK#'TK7N;8S'8JXSSFJ)TZ9)-I4D=ZVYT]Q7OJ$.FM=0^8&[UN6=LT-NJYZ5
M2TLE08CQ@FM8$J<"N>I)WL5'N*J?,,BIW&5"BF+SS0T@5AFHBS39#'B7.#]Z
MFE<"G3."0PY--8X'6FU=Z&D*S@FB-@)#BIT153)[5 G+9J=\%, UUPC9'.Y.
M3NR.2Y6->M9TUX3GYJEO+<,N >:QYH)$/&30W?0QFV.EG+MUIF[UJOD@\TXL
M0,DT[&3'OBH74&E+DGK2$TP1 RXJ"1@*ML,CBJDD9R>*#:#&;\_A6AIU\L+X
M8\5F!6Z$4F=M#5RFKG3/,)V.P\54FN!"<%LUG07S1 C/6H)&>5BQ/-)*QFJ>
MNIO6<HDDQ4^K09LL]\5!HEN20Y]*NZRX2VVYK-OW]"U"RN<BZD YZT1>XJY&
ML4D@#L #U-:(TB.9-UNX8>U:.26Y<6<Y=(4<,HJ]"KO&"5K9&@&0#=6C;:<D
M$!5UR:EU58I[%#3X-T(W*,5-<0)Y7R( WTK02,1QG"XJJP8M]:S4KNYC)7*K
MQ@0 MPU02ONC ../6KEV@V@54>T,@ Z"M$^I%NACW$DBR':QP.N*EAN_-&#Q
M@5J26EG:(3( 2PP*RA'$C,RC&3P*I.YLFK%E)IX\.C-MK5T^WDN)?.E&5]ZQ
M([]H3M/S*.U;%OXAMA&$\O:?K18I,VC;VT(SW/M4<\D4<!SR:S)M;MF7.-Q'
MO6+>ZX9'X&T#MFGZ!S7V-I,S2\D ?6K-Q?P6,!RPR!7$2ZO/N^5R*I37$\Y)
M>0M5*/<I19?U76)+V1@K'8:QCG/-3J,1\]:B8<U:+6@W%&*7%%,JX <UH6B'
M>K#M52)<MTK8L8<L!BIDS.;T.ETV[+6_E_Q8XK21&$)+'FLS2X0K[L=*U5;<
M&&?PKCK,VP;_ 'B((\%C5@573[Y.*L=JYV>R*O6FS=*<M),/EI MR@P^:F/4
MC=:C>M$ R4_**Y/5N;C%=5)VKE-8R+C-;T=SEQ2O$RV'--I3DFC!KL/.0Z(X
M<5I%=N#ZUF1@[U^M;4JXCC/M4RW(F.B?#"IY?E8''6H;="T@XJS<.@('<5F]
MS-C4!/7I3R0M0F4X]!3T#-VH)L+D&I$D*C%)LQ1U'2D()$\U,5$FF2 []O%3
MHVU@?>NDL)()H0F1N]*-=D7%G*7$,BKT(Q44*/)TYKJ-2M$"D@5C640$Y^M/
M78NQ3EMR!EE/Y4ZWL1,^-V*Z1K>.6'#**S;BR^S_ +R,]*=FA6,^YL6MP3NX
M^M4T<'CJ:MW5PTR[:IKMA7/>@.6^P.0*CCGVN,GO4;R>8Q).*C'+ XSBG8I1
M.LL6#Q@BKR"L'3;K:,8XK:BD#?,*PDF0U8DD![50OAOAP:N,Y+>U-DL99X\J
MN:2:6Y+3>Q@^6%/W13P!6B='N<YV&F-I5U_SS-:<\>Y&I0*^PI!@'I5XZ9<C
M_EF:8=.N1_RR-/F7<6I48BD+<=35A[.=>/+.:C%G,SA2I!HNBHQ<G9$"I)(^
MU.AK;L+#RP#)UI]G8B%<MR:OX![5A.I?1'KX;#*"O+<KW*D1@=JDMA^ZI+A<
MI3[<8CK/H=B5F2XX%%+VHJ2A*3KQ3JF@A+')%)NQ,I*.K""W+<FK7E[!@5(@
M"# IW!ZTD>76JNH[$*E\\5+ND4<YJ:,(.:>[)BNB$=+MG/RV*+3-WIN_/6G3
M8SQ4&<5$^QFVT2Y6GH0358DTY&(J+#4B6?&PUGXY-6Y6)6JF:@]C"_ (W2KU
MHX5:I-R*O6L64K6GN&*^ LAO,X%(;0GFI(XMIS2FXP^W-=7*FM3RE9;E.2$I
M4;MQC-6KELKFLV1\]#1[)1'?4<Q YJL0TDF!TIK.2V,UH6D/&2.:B3Y=#HIP
MN/@@"J,U+(0BT]B%%9MS<9. :QU;.JZBAD\N3UJ.,9:H6;)]ZGBZ<]:TDU%6
M0H)R=V2D]J0TO:FDUDE<Z6^6(NS(I#%BI(Z<_2I>X1=XE;&**4TE=4?A//J_
M$%%%!Z51D(:2DI10,6C%(*6@!I%':@TV@ S2BF<YIRT *149%2U&1S2941II
M*4TTG%2:"@TX5%NJ4<U2(8M %*!Q3PO%,DCQ2'%/?BH<DO@<T A<FD9>15F*
MTDDQE3BM"'2QU(II#N8Z1L3P*TK&W)D!8<5I1Z>B]A5F.$)T%4D2V.4!0 !3
MFZ4ASD4K=*LDA-,-2$4A%("+=S3MU(PJ,Y%("0FF$TW/%&* %S4;MBG]*AD-
M #&^<%3WKA]>@:WNO-4'K7;CK6;JU@MS W&3BD!BV$Z7MJ5?[V.]8E_ ;:8C
ML:DC\W3KO# JN:UKZV6^M/,C&3CM3&G8YHG;TI=V0*8P*.4(Y%*BECP,TRD3
M0G$X^M>B:6V;1/I7G]O!(\PPI/-=_I@*VR@CM09S>IIKTI".*13Q3@1BDQ)D
M>TFE$?-.S1FD4  %,F8;::[X%57<FDV,@;F2K,.0U0J,O4XPM9IBD]#7@EPH
MS5749LH121-\O!JG>-FHK5'L7A]9&<PW-3E7D4AX%.C.YQ6)ZIHVD0')%:"*
MI/2J\"_(*G0X-*$M3R:LN:8RYB5T(K FC\N0UT,AS6?=6V5+8K2<TR\/4M*S
M,[8"N::!AJDR!Q3&'(J3O+:_ZNHB-P-+O 0#/-)FA@DFC.N(]K9J R )6G<1
M!T]ZB@TLS+R:VA45M3Q<5A7&5UL8\D@8TP$=ZWVT >M"^'MW>K56)@J;,,!3
M05!Z5O\ _"-MCAC^502Z')'W_2JO;<EPDC'VTA3-:1TN4#@9J,V$H/2CF1.I
M0*'CUH:'?C-:*Z?*>JY-._LV;&=AHYD%Y%*UM@S\UJK:A5X%0)93Q'.PUHPQ
M2,G*FBYT4IO9E)HO:HBF#6BT>WJ*@>+OBG;L=-RH!@4TY4\<U8,?%,*[?>A$
M2AV+UFXP/6M%6R*PHY"C9'7TK3@G#*.>:M$)VW+O7%/ J.-LU*,4QC2I)XIT
M<3D]*=&PW<U;#J%R#3&1BW)ZTC6A[&FS:E#;@EW K.D\2VZY^:I<D%TBZ]ML
M^8FJLDN#BHTUB*Y3[X%1M)&X^\*ELAM"7<ZBU89[5Q<K_OF.>,UT6JGR[<\\
M&N78DY^M):DC91N; Z4V"/Y^.G>IXXS(P4#-23 62D=VZT[]!I]!D]S&D6P=
M:R)6!D4@\T^:;<W%1*/WBFK2L:P5F=79,?(!/I5R("J5H?\ 1U'>K:\"N-GL
M+8JWW#$5EL?FK0O&Y-9;GYJN*)D+WHS2 TA(SBJL2.!(Z5*3\@)J%3S4K_ZN
MD-$43$W&*U;K_D'M65;-B<\<5J7>?L#?2JM[QQUG='*OC=5NVA1R!FJNUG.
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M&#3'D&.<4X1L2,G-1/$S/@GBN:Q;8I7Y0>QJE+E)1D<5I2[1$J@\@5G3Y>0
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MT?W!0 _'-(.M+WJ6&$L:39,I<JNPBBW'-7D&%X%,*>6*59#BIN>96K.;L2$
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M. H%4D*X 4M%% "$4A%.HI@1;::14V*:12 A(IA6IBM,84@("M%/;I43'%(
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MGJ,TDD Q(43H*E512=:#P.M-#%+8XII?%1.^*J3W.. :3EV'&+D[(L3W052
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M:H(_,'WNO6IFAV9.VWS 3TK1A6(J-O6J:1F9>.M3Q120G/6H3[DI68]X&SN
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M&/6H/*A9P3+BLVK,$F6X9,H>N:BF0O'CUJ2)5)PKYJ1E.[&!BKUL4S*\LP2
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M5_>T!5$<Q>7IB^[5,:F)" W6M6^\)ZB2S07$,J^C94_X?K6#=Z+JMGEY;&7
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M! W5!<O$R%T'S&L]'P<GK5)70C0DG.>5%0M=$'( J-GR 34+GBFD58T([E7
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MD<65O_US7^51WG0'WJ6S&;&W_P"N:_RJ*\!VCZUH;$\)_=BI0:KVY)BJ8'%
M#Z3/-'>F_P 5 #Z*!10 5R/CK_4V7^\_\A775R/CK_4V7^\_\A7'F'^[2_KJ
M=> _WB/]=#D(ZG7I4$=3KTKY*9]7$=1116984444 %%%% !1110!['1117WI
M\,%%%% !1110 4444 %5G^\:LU6?[QH C/2FTX]*;0 4444 ,'4U7'_'[^%6
M!U-5Q_Q^_A0!;H/2B@]* .9\=G'@O4#_ -<__1BUXKP37M7CS_D2M0_[9_\
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MCF!-8,+L0.:O1LP-82@BU(U))LBH,EN:B5B>M2;@*SL7>XDA^0U4)QFK+R@
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MH =]LC]37+>-)UFALPO9F_D*Z?;!_>%<OXS$8AL]A!^9L_I7'F'^[2_KJ=F
M_P!XC_70Y:.IUZ5!'4Z]*^2F?51'4445F6%%%% !1110 4444 >QT445]Z?#
M!1110 4444 %%%% !59_O&K-5G^\: (STIM./2FT %%%% #!U-5Q_P ?OX58
M'4U7'_'[^% %N@]**#TH Y[QFH;PE?!NG[O_ -&+7DB+$JDC%>K>.CCP7J!!
MQCR__1BUXNMZKRJF< 'FLIM)BT)+N"*7[V#5%H!&2%[58F5I9LJWRBF2Q$$
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M0^D0IW_"&>&_^@+9?]^Q6TJ,F]SEI584U:Q\\(,**D!YKZ%_X0_PY_T!K/\
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M*]"^$EM;W6N7RW$$4RBW! D0, =P]::5W8#SZG \5]._V/I?_0-L_P#OPO\
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M\,O^/^__ .N:_P S0(X802_\\W_[Y-!@EQ_JG_[Y-?05%58#Y[,,N?\ 5/\
M]\FD\F7_ )Y/_P!\FOH6BER@?/BVT[G"PR,?0*34HLKK_GUF_P"_9KWZBCE
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MK?!S4ZC4ETT.W&8&%"C&4-7?4Y2:7+ @\]ZLV]]+&,J3BJLL>PL!ZFG0HY7
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M4I3U;U)ED#'-6+3(N !T-4 "G?BIHIC$X.<U5B5OJ=!*N]-F<#O543Q1;DB
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M:,$JQ#:BY/K4"1DCVJQ"BQMD\U#U)YCZ@^'6?^$ T?/7R3_Z$:ZBN8^'A#>
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M@=0J_P"%4Q\1/%21[FUF8_55_P *?UB/8GZM+N?2%<G\2,?\(9<Y_P">D?\
MZ$*\"U+XI^,HFS!K,WTVK_A6'J'Q.\5ZG:-9ZCJ4D\#$$HRJ!D=.@JF^>+2.
M>I%QT.HG07%NR'TK@-3T:X@F9XT)7Z4J^)[P=Q22^(9YD*L%K.G"<#"TD8[*
M5//!IN33I)"Y)/<TS=70C1$T$;W$\<"8W2,$7/J3BONJRM8[*PM[2'/EP1K&
MF3DX P*^,_A]:K??$/P_ PW*;Z)R,9R%8-@CTXK[3H*L%%%%, HHHH ****
M/F[Q-IAM/'FM1J@4?:6D  P '^8?H:J8V=*[7XFVGV7Q<;@?\O4".>>XRO\
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M.3_=7@?U_.NQJCHMM]CT2RM]NTQPJI&,<XYJ]6B)"BBBF C,J*68A5 R23@
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M_(5QYA_NTOZZG7@/]XC_ %T.0CJ=>E01U.O2ODIGU<1U%%%9EA1110 4444
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M*6IE]6M-/5LI#%YC ?WF/^ 'YUZM7BWQ&'F>,;GC&V.,?^.@_P!:F6PF<PK
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MWZ\E\':DTWQM\41O(S"1709[F-U4#\ #7K53%W0VFMPHHHJA'F/Q<M?ETN[
M/!>-CCZ$?UKRX]:]K^*%K]H\(-+MR8)T?..@.5_]F%>*;2>E<5=>^>AAW[@E
M)C)QVIP%/C0L<#IWK!NQM*7*KL1$WG:OYU>BC"K3%C$8XIX!-0E=GG5:O,[#
MU49S2; QZT9 J-V-.]C%B3#"X!JDSMNP#4[[FZ56"%)?FYIJS,)WN7(5R,FM
M/01CQ-I6/^?R'_T,5E+)M6M'P[,#XETH?]/D7_H8I1^)%IH^AJ***]8U"BBB
M@#YQUAF&O7^/^?F3_P!"-1*S;>:FUAQ_;M_Q_P O$G_H1JL&R*\F>[,EN/\
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MUT.0CJ=>E01U.O2ODIGU<1U%%%9EA1110 4444 %%%% 'L=%%%?>GPP4444
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MJMYK%T+F]D#RA0N0H7C\*I8HYH% "@44X"D- QI%"L48,.H.:6D(H ^@X_\
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MP3_T$5I35C1(MT445H,*\1^(ZD>-+HD<,D9'_?(KVZO%/B4?^*QF_P"N4?\
M*DQ,X_OS3)& 7<:2658ERQK"O]2>9C%#^=22V3WFIA5*QGFK/@_Q:WA+7_[7
MDM/M?[IH_*\WR^N.<X/IZ5S<A$7S,<FJ$]PTIX.!4W8DSVY_VBE4X'A?/_<0
M_P#M=-_X:*X_Y%7_ ,J'_P!JKPP<G-,=B#5795V>Z']H[!X\*9_[B/\ ]JKE
M?'OQ;_X3SP\FD_V']B"W"S^;]K\SH&&,;!_>]>U>8Y.>*MV\+,Z(HR7.*&PN
MRM<;>%4'&*KD'%=1<>%KD1*X(Y'K6=)X?NUX"TE)!8^H_@]_R2K0_P#<D_\
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M%9EA1110 4444 %%%% 'L=%%%?>GPP4444 %%%% !1110 55<_,:M53ESO-
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ME;'6N9WN3SHW/MP'>OHSX=R>;X%TQ_5#_,U\IF9L]:^I?A>=WPZTDG_GF?\
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MY+>XB66&12KHXR&![&I** /"/'_PT;1&DU/2$9],/+Q9+-!_BOOV[^M>=XC
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MZ]8O_015(<30HHHJB@KYF^-EP4^(5R@_YX1?^@U],U\O?&\_\7)NA_TPB_\
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MXU4IXMO0<<E3Q[J#6 :@8S --\L$TXFG**  * *#UHI": ._^%_^MU3Z1?\
MLU>BUYS\+CF75/\ =B_]FKT:J6P@HHHI@%%%% !1110 4444 <_XKO\ 6]/T
M_P W1[1)N"9)#\S1CU"]_P!?I7BEU/<7%W)-=.[SLQ+E^N?>OHNN-\8>";?5
MX9;^R0IJ(&=JXVS>Q]_>IDK@>0Y%1N,TZ16C=D<%64X(/4&HBU9@QA4 U+9L
M!JMEG_GXC_\ 0A49--AD U6Q'_3S'_Z$*3$]CZ:7[H^E+2)]Q?I2UN,****
M/DGQLI/C[7L?\_\ -_Z&:R#"Q7I72^+UC_X3K7"Q'_']-_Z&:QY98DX!%<[>
MIR2D[F:]L^W(%?47PN!'PZT@'_GF?_0C7S]8PQW4?:OHSP!$(/!.FQCH$/\
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MU<'DU43DFK%P>34$0X)KICHC.6KL/Q2XS2$@4Y1EJ+C+,:XB&:L:("^K@GD
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M.O2H(ZG7I7R4SZJ(ZBBBLRPHHHH **** "BBB@#V.BBBOO3X8**** "BBB@
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M=$FOH'Q=IJ:IX7OX&3<R1&6/U#*,C'\OQKY[)-935F XG S5!+H?V_IZ _\
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M,L**** "BBB@ HHHH ]CHHHK[T^&"BBB@ HHHH **** "JS_ 'C5FJ<I.\T
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M_P"0KR"$?+7)5^,[J?\ !)*^H])<2:/9.,X:!",_05\O8XKZ>T/_ ) .G_\
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M(QG)1V.W%8R>(44^B^]]Q:!UHH'6LCD%HHHH8@H-%!J& E%%(S!5+,< #)I
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MB_BI USX%N(5;:6FC_\ 0JB?PL#P>ZU"2ZD,5OGZBK%E8K"-\@!<U:L[".W
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MN-L:\N_H/\:]'@@CMH$AB4+&@P *Y,36Y5RK<=DB2CO11WKRV(6@=:,T"HL
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M0^)'SM;Q[5 ITSX&*D VIFJ,TF6KBBCNJO00G%-S2;N*ZGP?X*O_ !+?12-
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M #$[T?0)_A7I]%"I070KZQ4[GE\?P2TB,Y_M6^/X)_A5I/@_I:+@:G>?DO\
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M_F"67_?L5NT4N5=A\S[F3;>%M M&#0:-8*P.0WD*2#]2,UJJJHH50%4#  &
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MG:YN99W^](Y8_4FF@U%GFI5.>*S&/!H!YI*4=: )1TH)I"<"FD\TQ'OVD_\
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M<=M37L+<*@+"K<K<;5IBML08IA.3FL'(T8J\4I-)FF,V.>U9V);$EE6,9)K
MU#4&?*H> :GU.[XVJ:QLDDYKIIPLKLRO<U/#UPR:I'N/#Y4_C_\ 7Q7:UP%@
M_E7<;_W6!KOZ<]R)[E.^7=Y8^M4I"$7%:%W@;3[&LISYC[5R23@ 5AO(TCI$
M=:V_VJY&X?NUY;W]JWUJM;P+;1"-?J3ZFK :M#)N[)!UJ4, I)Z#FH0<\U0U
MJ\-K8A$^_*=OX=Z"D9]W>M/=L5/!/'TJW;Y(&ZLG3X6E?>];198TX%;1N=,-
MBCJ,H08!P:QY6$N%>EU2X:2; S5#+ \YI/4F^IM126UK!VS65=W[S.0.%IK
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MZ"088 ^HK"_M#GJ*P:NS)ZE^:)6!Q7TC\'UV_#/31_MS?^C6KYB%^#W%>Q^
MOBUX>\->#[32[Z*_:XA:0L88E9?F<L,$L.QJH:/4<-&>Z45Y>?CSX2'_ "[Z
MK_WX3_XND_X7WX1_Y]]5_P"_"?\ Q=:W1I='J-%>6GX^>$!_R[ZK_P!^$_\
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M1]<V7_'C;_\ 7)?Y5/4-H,6< _Z9K_*IJU-0HHHH *0]*6D/2@!1THH'2B@
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MX(J65PII-R#O0!O?\)9XC$!']OZID#K]LD_QJO\ \)=XE48/B'5NG_/[)_\
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M/44D7W@:I:P[,H'I4I7D%S D.YV^M,QBG@#<<TXITK<H8.13U'(--VT]0<4
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M 8.IJL/^/W\*LCJ:K9_TW\* ++)GD=:0-V-/[4UER,T <;\5A_Q;/5_^V/\
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MBL.M0W&YB#Z"I+8EL!J0BS93;CM/W:653%+N7[I-5F;R9=@'7O5AY-R!#UH
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MZL.#Y?\ Z,6O"I-#3SMRCBO>O&9QX2OCV_=_^C%KQ\R8//2LYI7)93BLXK=
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MFZ@'_;05!+KNFP*2UTIQ_=!-+DD]D79FC0.M<C>?$'3K=BD-O/,_OA1^?/\
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M=L5!*X VBLI,ZZ&'E4?D5Y+>'SC(%&[UH;DT[@TF*B]SVJ<%"-D)11106A:
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M&:8L6XT:$V;(=['. :CVN6Z&MVSL4?J*M2:=&%) J74MH;QPKDN8Y<QDU+'
M<5>N85C;%0@X%6I71SU(<CL5W0#K3H]@["HIW^;%0;R#56(+DSKC@564@&H_
M-SU-*"*=@L3DJ152X7TI[$XXI,Y'-- BJI(J:.7$BD4[RPQZ4U8\,?:F[,I.
MSN=/9/YD*U::,$=*R])D^4+FMD#-<<E[Q[-.7-"Y6>V4KRHKD]9MS'<9 P*[
M9QM%<]KD&Y2X%:4Y6D9U87C<YR-&/>I]C^M5TEP2,U=24, ,UU,\IW&(CYY-
M6%1FP ,YJ6*(, :V-/LT(#MBHE*Q%[B6-BJP[G'-6PWE 'G I9I O"]!5:2<
MN-H%8ZL9=$PV%S61<W!>0[2:DEE?R]@J*WA#R?-5)6U$V+ '$E:2L"O/45 L
M967('%3H@)SFAF6HY2"<YJW$V>3TJLL(SUJTD9"X%9RL+4>T@Q@5G7\KQ1_+
MP#5\IQ[TV2 7$14K2BTBK',YR^>2QJQ<326]KSQD58:S,-P"5XS5RXLTN8QN
MZ8K5R07UU..6^E=S@D<U?A#,,L:74+6&T<;%%4UO@3M4UIOL:O5:&[9)F45T
M$.W9MZ8K#TM3PYZ5K/(I?*\5A4U=C%:,?/GJ.,4Q;E@ISGI4X97C :@Q(>E9
MW6S&TSFKZ<RS$$FJVX"M'4K-D8NHK)96[UT1VT---AS-N/6F,O%*%I^WY>:8
M%5@2>:<E/9.:;M(IC;)%:F/ECBA0:D"X.:0:(C2+:<FI"3T Q3'SFA"QH >$
M)89K2L809!G%4E'K5JWD*2#!J9W:-*4DIILV\8%-P,]*<IW(#[48XKD/=M="
MI,86']TU1UE5<"05;ZD+33"DJ-"_4]*N#2=V>9BZ#3YXG, \^PI1CM5R\TN2
M DK]VJ"L>1C!KJ33V.#<4D=N#6]IEXZQ!<<5@ Y;'>M6*>.TMLL0#4S5U8:O
M?0Z$WD$4.YV -<OJFKBXE*1_=K+O-1>XD;#';5,LW!%*%&VK.VE!1UZFBO/2
MIMPC'K56%]J9;K3\ENM#5CJN/WF0^U(T2D@@<T@(J1, 9I7L9S5T[EF(XC J
M<,",5!%RO-3A O-7<\J<>61!-,L2G=6!=W!F8X)(S5W49MYVJ:RP,9SUK2"Z
MEQC8:!Q4L4^S@DU"3UIN"36EC2US0(69<U4DBVGI3HG9..U3NHD7(ZU.Q.Q]
MHV)_T"V_ZY+_ "%6:H:7+OL(!W$:_P JO"K- Q0*6D/6@!::PXI12-TH 5>E
M+2+TI: "N1\=?ZFR_P!Y_P"0KKJY'QU_J;+_ 'G_ )"N/,/]VE_74Z\!_O$?
MZZ'(1U.O2H(ZG7I7R4SZN(ZBBBLRPHHHH **** "BBB@#V.BBBOO3X8****
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M% !2$\4ZFL.* %7I2TB]*6@ KD?'7^ILO]Y_Y"NNKD?'7^ILO]Y_Y"N/,/\
M=I?UU.O ?[Q'^NAR$=3KTJ".IUZ5\E,^KB.HHHK,L**** "BBB@ HHHH ]CH
MHHK[T^&"BBB@ HHHH **** "JS]35FJ,LNV1@>E  U1G[U,68;\'OTIYX- #
MQTHHHH 8.IJL0#><^E61U-5_^7S\* )N5/M3P<K01D8IA!0^U '*?$P;OA[J
MF.O[K_T:E?-;Y#FOICXBX;P#J?I^Z_\ 1J5\XSQ@,:RGN<]5VD50:6EP*7;F
MI(N ; I?, %)Y9--,+9H#0:\U$=P.AI&@8TBVS4#T)_,&>*D#Y%0"-E[4]58
MT$M#N^:"U*5;%1E&- K#7(J(U-Y3&@6[&@I$*KM.:G68'M2_9VI/L["@=T/:
M,,N<U"C/ ^Y<\4\AUI001@BD%S;TK6>B.>?6MWS]XR#7#JFP[U-;6FWN<*YJ
M)+L:1F:TSEE-5$MS(_-7#L(!!ZTBL$.:R&]2I=6&5R!61<6A4UTKS*R$<5CS
MG]X?2M$[&4D9:0D-S5H;47FDE89XJO-(=OO5[B3(;B0N<**HO&0>:NI=0H#G
MEJ8X\TY[&FM"MBGM"TH&>M63%[4TQ'TIW'<A.1T-,(]:G,5,8**=P(L$GI3P
M .M,9ST IIW&@995PM2"535'GUI0V*+!8NY'TIPZ9S4=MAW^:M6.VB< "I%R
MF?28S6B]ACI436<@Z T7%RE4#M3L8%/,+KU%&#W% B/&3S2A>:>$R>M2",B@
M&Q@ Q1L&:D"YZT':O4T7(28T+@4A<(#D4R2ZC0'GFLNXO"YPM"U-(TVQ;VX#
M<"J!Y-([%CR: *T2LCJ2L%*!S2@4O0T%"CBFL>:,\U/!:O<. HXI!>Q'%&TC
M[54MFNDTW3 JAW_*I=/TQ+5 SC)K1"F0[4&!2>HG+H'"C9&*GB@QRQJ6*W Q
M@9-:,4"1C=)V[47!)+<B@M"Z[F&$%2RW"Q)LC'3O45S<DC"<+4+<@YK*<]$D
M==&DF[R(W<L"35!YG60JG>KP'!SS4EM9B60,1Q6:>NIYV+A^\LA-,L\/YS#
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MT *]"-BFEP:0,,T 3EL"FDG%!/%!(VT 1,33>:4N*89%%(!&S41SFGM,H[U
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MDW:(VPB^SXPM:,\X*'/2JMM(50>8M/N)XSA<8S5J5HF;:*CNI0]N:S[V2*1
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MYI-R)VGWMCM4,LI!PO2HVG+845%(Q#  YH<A1A81SR!W[U+'MWCY<U$B_/\
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MO>M,S$G=4-X@90PZT7 HYI:"IH - !BI%!IH%2H*8#P!BC HHI &*7%%!XH
M#3<49HS0 TK32,4\M4;&F QC3*<>M)BD,6DP<T\"DH 2@THZTIZ4P*LIJJ2,
MU8F;FJQ&30 9%&:,4N*0"@TH-,QBEH >#5W3EW3"J(K1TO\ UM- ]CH=OR"J
MDG6KP^Y5.8<U1!%C-)M(I:*0#&%1FIC4+K0 TL.U-II!S030("12$TTF@9-
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MF&&(K:QE#67.F)#3B;P>A"!013PM-(); JC0;0J;VP <U)'$[M@#)K?L-*1
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MQV+K'@X]*BZ8]:>IW1 FFD'J*LXD&.*0;OPHP76GHZD;6ZTF6K,5'*FGSR$
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M4JT#'4AI:4#F@!HI'Z4_%1R'B@"C,QW5&#3Y:8.E,8O>E%%%(04H%)WIPH
M*T-+_P!;5"K^F?ZZF@9TB_=JO,.:G7H*AEZU3(*Y%-J0TPT@&4QP34F*4"@"
MHPQ43&K<D>:B,1- B%1N-6$CQ0D6VI.E ".0JX%4I3UJS)523J: (33&I[5&
M: "BFTN:!BGI3D&!FF9J0?=H$)NR:DS\M1;3FGC@4P*DW6JQJS,,DU7*\U+
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M+<BD?A1BJZ%#X^H^M:T,1<;CTK)CP"I/K6[&Z^4O7I6M*";U.+%K9CE0"GU
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M*#F@!:449H% "M43XI[5&W2@8WM49IQ.*C+<T . IP%-!I<T!<=2BFYIP84
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MS(?]3:_]<U_E6F!\HJS4>*6F@TZ@"O=_ZNHX/^/?\:DN_P#5U'!_Q[T /?\
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MZ#.V,_*HR,CJPR1N-;QBVC6--RU/GS1=$U?4X6GL-*OKJ%6V&2"W=U#8!QD
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M2;,U/L%*$K,T*Y3BJLL9)KL_#/@S5/%-P!:Q^7:*X2:Z?[L?&>!U8X[#U&<
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M2 '&0?Z'!Y'%2XM!>Y37J,58QQFH4J93BF@ H#2K&!3QS7L/@;_D4++ZR?\
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M&*IT#%I<TVO>?@A_R*-]_P!?[?\ HM*<5=V!NQX3FG!J^DOB?_R3G5_]V/\
M]&I7S5FG)68D[DFZEJ'=BOL&+_5)_NBB,;@W8^15.#5F$\U]0^(-#M/$6BW&
MFW:(5D4^6[+DQ/CY7'(Y'U&>1T-?-NJZ/=>']8N-,O0GGP-@E&RK C((]B"#
MZT2C8$[D]DW2M$]JRK-L,!6IU H0F)WI,4M%,1&RTWRLUW/PQ_Y&B;_KT?\
M]"6O7*I1N(^:S$,4PIBIG8F5OJ:7 (YJ0*A%02U?914,-E<:A>Q6=G"TUQ*V
MU$7J3_GOVHL,RF'-.M[6XO;A+>U@EGF?[L<2%F;C/ '/2O7?#?PEMDCCNO$$
MC2RL,FSB;:J=>&8'+=NF,$=2*]&LM/LM-A,5C:06L9.XI#&$!/3) [\"J4&*
MY\]Z=X$\2WV_RM&NE*8SYZB'KZ;\9_"I9/ACXO8\:/Q_U\P__%U]$44^1!<^
M7+OPEXALC-]HT2_18=WF2"W8H .IW 8(]\XK%9:^O:P]<\(:%XACD^WZ?$9G
M_P"7F-0DH(& =PY./0Y' XH< N?+3<"HC7HWC+X6:CH"27VF,]_IR*SR' $D
M*@_Q#/S#'<#L<@ 5YWM.:S:L,81Q3:G*\5]%?"C6&U;P-;QR%VEL7-JQ90!@
M8*@8Z@*5&3SD'ZTTKA<^;.]-<\5]6>-] /B7PC?Z=&J-<%/,@+*"1(O( R1@
MGE<YXW&OE.12I*GJ#@TI1L-.Y7;K49'-2L*B/6H'80CBF@4_M1B@+#:<.HKK
M/AMX>7Q)XYL+6:'S;2$FXN%RN-B] 0W4%BH(QT)^M?5H    P!VJXPYD2W8^
M0M-B^4&K-V 4.:](^*>M)J/B-+"&7?#8IM8#:0)3RV".>FT$'H0>*\XO0%@)
M-)JV@[Z&,/\ 6UHH/W>:P1=@7)&3UKUCX/:''K7B1[^?8T&FJL@0\[I&R%."
M",##'L00M+EO9'*XML\]FFQD5FRRL7XK[5KYU^-?AU-,\70ZI;P[+?48]SD;
M0#,O#8 YY&TDGJ6/-6X65QN%D>;@ KDU6G('2M%( Z=>:KM9EI,"I31"*2C(
MS0>*]:^!]N8?',YQ@?8)/_0TKZ%K2*NKFBC='P\.N:>@W5]O44^4KD/B1DP
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M6(0E/1<-4NSVI=OM2N!'Y>Y\]J@G*AL5>5>#67=,-Y(-5!79Q8NLX+ECNR:
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M!['1117WI\,%%%% !1110 4444 %59#R:M55<98T ,/2HCUJ5JB/6@!]%%%
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MN!7S3?V<MAJ5U9S,IDMY7B<J?E)4D'&>W%<]=N.W4Z<-9IWZ%<98Y-='X?\
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M&#7'6I\DM-COI5.>.NY#*.*^B/#'_(IZ/_UY0_\ H KYXEZ5]#^&/^14T?\
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MDC8)VJ!DG YZ"H-*OO[3T>RO_+\O[3 DVS=G;N4'&>,]:HH\V^-'W=$^L_\
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M.LV8N]/N%GAW%20""".Q!Y!^M/OM/M-3MFMKVWCGA/\ "ZYP<$9'H>3R.:\
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M@RQF.:>#Q1BEQ0 QFJ_X<S_PE.D?]?L/_H8J@16AX=_Y&C2/^OV'_P!#%"W
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M.#<E,8V\'ZU8158%6'%97L<_-8^H? G_ "(.@9_Y\(?_ $ 5T-8?@P!?!.B
M=!91?^@BJGBGQ?'X7U31HKF-3:7\CQ2R%MIB(V[6R3C;\QSGMSVP=KZ'5>RN
M)XZ\)Q>*M$**76^M@TEJRGJV.5() P< 9[<'U!^=)DEMYI+:YC:*:-BCHXP5
M(Z@BOK($$ @Y!Z$5Y1\6_!!O(7\2:=',]T@ NXD^8,@&-^,Y&  #CMSQ@DQ.
M%]3.I"^J/$KB(H2PZ50=SDBKKR]B:BFA&-PK-'.B!!D5UWPQMV_X6?H<F. \
MG_HIZY4)@#%=A\+F;_A8^C@_WY/_ $6U4MRHO5'T_7SCXO\ ^1MU?_K[D_\
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M5M:V]E;K;VL$4$"9VQQ(%5<G)P!QU-5-:UJQT#3)+^_EV1)P .6=NRJ.Y/\
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M,X[\5#36YA.G*&K.K^"?AF*X\7W6M2!7%A#B/+$,LDF0& '!&T.#G^\./3Z
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M?,5NH(R&Q]_!ZA>.QY('>J6B#<\8\5WIU'Q7J=P9EF4W#+'(F,%%.U<$<$8
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MHWW_ %_M_P"BTKP85[S\$?\ D4;[_K_;_P!%I50W%+8WOBA_R3G5_P#=B_\
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M!02C#H1G_.":T:NB=CP&BK6HV$^EZC/97 Q+"Y4\$ ^A&>QZBJM0,[7X9?\
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MGKKV/B:XT>6;%M?(7C0[C^]7GC' RN[)(YVCFL*>DC6=6,H)=3O_ (O>%?\
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MK\2MY>*C^SQA2S-R:KP.NY@R_,*@F>5LKM.#6E[GBRBU*TA+@0H25.36?-*
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MA_\ 0Q7T'79AG=,Y:ZLT>*^/1_Q6E_\ ]L__ $6M<W@UT/CYR/&^H+_US_\
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M9>^;JMI9JT96"(N<'Y@S'D'\%4_C6CV).%QS7LO@3_D3K+ZR?^AM7C1->R>
M_P#D3;'ZR?\ H;5,=QF]<WEM91"6[N(8(R=H:5PH)],FJG_"0:+_ -!>P_\
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M?05?/OQ-_P"1_P!1^D7_ *+6M:FQ,=SD<UU?PX.?'^E_63_T6U<F175?#?\
MY*!I7UD_]%M62W*>Q]#U\T>+/^1PUG_K]F_]#-?2]?,_BP_\5AK/_7[-_P"A
MFM*FQ,3'[5ZE\+_'(20>']6N\*<+8O)V/_/,MGZ;1]1G[HKRPGBJCSR03)+#
M(\<L;!D=#AE(Y!!'0UFG9W+:N?7E?/\ \5? _P#8&HG6;".*/2[N0+Y4?R^3
M(1DC&>AP2,<#D8&!GT_X=^,X_%NAA92XU*S5$NMPX<D'#@@ 8;!X['/;!/47
M]A::I836-] D]M,NV2-QP1_0]P1R#S6S2DC-.S/D+->\_!#_ )%&^_Z_V_\
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M!<PJ[*CAPC8^9<CN#D'Z5P7QC\/&YTN#7X%S+9XBGYZQ$\'D]F/89.[VKIO
MWA*Z\&Z7-ITNK_VA;M)YD0,!C,6>H'SL,'K@ <D]<UT5_9QZAIUS92LRQW$3
M1.4." P(./?FM6KJS-E='R!<R[L\53W8!SS6KKNE7.BZU=Z9>+MFMY"AX(##
MLPR 2",$''(-9<@V\"L$B*D[V168$G-21H6IV1C%.CD$9YJC)L^M?!(QX%T$
M?].$/_H KS;X_H7M] QV>?\ E'7I7@H[O VA$=["'_T 5YU\>2!!H6?[T_\
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MUR4DQ=L+G%=5\-$ \?Z8?^NO_HIZ%+WDCOA0M!RD?05?-?B<X\6ZS_U_3_\
MH9KZ4KYK\4?\C;K/_7]/_P"AFM,3LBL+\3,D\T44O05R'<'%&,T $FKUI:ES
MDBJ47)Z"E)16HRUM2Y&16U%"D*]NE"1I$HJ&YE/8UTQBHHXI3<W8]YT Y\.Z
M8?\ ITB_] %<)\7"0NCX_P"FW_LE=SX<_P"18TG_ *\X?_0!7"_%WIH__;;_
M -DK6?P&5+^(>8\T=>@Q0%[YI"<\+7(=O6P=.U2PQASN/ ]Z5(2 ">M.D.U<
M=*I*VI+=]$3#;"-V17L_@32$TWPU!.=K3WJBXD<>A'RKG . .W/):O)_"6C'
MQ'XDM[1QFV3][/S_ ,LUQD=0>20O'(SGM7O];TE?4YJVFA!=7MI81"6\NH;>
M,MM#S2! 3Z9/?@U3/B/0U&3K.G#ZW2?XUY_\3-4:?5H--23,-L@=T&1^\;U[
M'"XQZ;C7 S^7Y9)-$ZO*[(YY.RT/?3XFT #)UO31_P!O<?\ C2#Q-H##(US3
M2/47<?\ C7S=-)NRH''M3].?!DA8<#UJ8UF]T9QJ7/HMO%GAQ3AO$&E ^]Y'
M_C3H?%'AZXG2"#7=,EFD8(D:7<;,S'@  'DU\[W%G#.#\@SZXK+L[&;3M3BO
MK>4I-!*LL38!VLIR#@\'D5;FS6Z/K*O O&FD_P!A^*;J *BPS'SX JA0$8G@
M '@ Y7MTZ5[;H>JQ:YHMIJ4(VK.FXKR=K=&7) S@@C..<5R?Q7T&35O#*7EN
MA-Q82>82"V?*(P^ .#R%))Z!3SZJM#GB:4JGLW<\AW"ER/6LV&WF5_FD)'UI
M]P9(\;2:X_9.US?ZU'J=%X=_Y&C2?^OR'_T,5]#5\T^%Y93XKT8'I]N@S_WV
M*^EJZ<-%I.YC5JJHTT>'^/SM\<ZB3_TR_P#1:USC2JU;7Q'F,?CO41V_=?\
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M1%<W$5I:RW,[;(84,CM@G"@9)P/:OGK6=4EUK6;K4)AAIGR%X^51PJY &<
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MFT+/&4RR[@I(X;'L<'\*PO _AV30=*D:Z39>7#YD7(.U1D*."0>YS_M8[5U
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M*Y4!B0>BOGH!@!>W..N:4UU&F>8DCM2  TF*!610X@4RG$\4TT --:/AL?\
M%5:/_P!?L/\ Z&*S2:TO#9_XJK1_^OV'_P!#%-;@?3E?/OQ-_P"2@:C](O\
MT6M?05?/GQ./_%P-1^D7_HM:UJ;$QW.2KJ?AO_R4#2OK)_Z+:N6S74_#?_DH
M&E?63_T6U9+<M['T/7S+XL_Y''6O^OV;_P!#-?35?,GBW_D<=:_Z_IO_ $,U
MI4V(B8['"UGSMR:N2-@5G2MEJR+-/PYK]WX:URWU.SD<-&P\Q%; ECR-R'@\
M$>QP<'J!7U)H6M6GB+1;;5;$N;>=20'7#*0<$'W!!'IQQ7R+FN]^&'C?_A%]
M7-C=_-IM](JNQDP('Z!^3MQS\WL <\8-PE;04E<]J\;>$X/%V@269$27B?/:
MSR*3Y;<9''."!@]>QP2!7._!RSGT_P /:M972;+BWU.2*1<@X8(@(R.#S7HP
M.1D=*8D,4;R.D:*\K;I&50"YP!D^IP /H!6MM;D7TL<G\4?^2<:O_NQ?^C4K
MYGS7TO\ %+_DF^K_ .[%_P"C4KYES653<N&P\&OL2+_4I_NBOCH=*^Q8O]2G
M^Z*=/J*9X?\ &G_D;K+_ *\5_P#1CUP$5>@?&C_D;K+_ *\5_P#1CUY_'4RW
M&MBRO2IH9"KX%0I0#AQ20V>^^!_%7_"0:<8;IXQJ$'#*.#(O&'Q^AQ^F0*ZB
M>".YMY;>9=T4J%'7.,@C!'%?/.B:C<:7?07UJ5$T+97<,@\8(/U!(KWK1-7@
MUO2X;V!ERP D0'/EOW4_3_Z];1=S-G(>&_#LGA[QY<0@2-:/:.T$KC[PW)D<
M=QT[>N.:[^BBFE81\[3CYV^IJ  DU8E&7;ZFHP.*S&>X>$M9_MO0(9W.;B/]
MU-Q_&._0#D8/'3.*L^(-(CUS1;BQ<+O9<Q,?X7'0YP<>AQS@FO*_!OB)/#^J
ML;C=]DN $EVC)4@\-ZG&3P/7OC%>R12QSQ)+$ZO&X#*RG(8'H0:T6J$?/-]8
MW&GWDMI=Q-%/&<,K?YY'O54ID5[5XJ\%VWB$BYA=;:^48,FW*R#' ;].?3L>
M,>2:II=YHUV;6_@:&7 8 D$$'N".#4-6&9C14PQ^U6#(H[U$UP@[U($!C/I4
M3Q@#FI)+R,#BM?P[X/UGQ;*&MH_LUD.6NYE(0C."$_O'@\#CCDB@!_@+PPWB
M7Q*AD16L+-EEN=Q'S==JX(.<D<\8P#STKZ%  &!P*S="T*Q\.Z7'86$>V->6
M<\M(W=F/<G_ZPXIGB37K;PUH<^IW(WB, )$&"F1ST49_/OP"<'%:)60CS+XU
MZXCM9:'#+DQDW%P@VD D80$]0<;CCCAAUKQMNM:>K:E=:K?SWU[.\UQ,VYG8
M_I[ =,#I643S6;=V6AI-6]'U671-:LM3AW[[:99-J.4+ 'E<CH",@^QJDQJ-
MS4%'V187L&I:?;7UJ^^"XC66-L$95AD'!YKR'XX>&KB_O=$U*SB>269Q8$%U
M"[B<Q@9P<DE^>G Z=]WX+^(EU7PB=+D=VNM-;8=[%B8V)*')& !RH&3C;VR*
M]&EABN$V31)(FX-M=01D$$'GN" 1[BM_BB1LS/\ #NCQZ!X=L-*CV$6T*HS(
M@0.V/F; [DY)]S7!?&SQ EEX<AT:*;%Q?2!Y$&T_NEYYSR,MMP0.=IYKU"OE
MWXE>(6\1>-+V571K:V8VUN48,I12>0P'()RW?KC-*;M&P15V<_88\P'O6SG.
M*Q=/4[ZVXHWFE2*)&>1R%55&2Q/0 =S6*+9Z;\(]&6:\N]7FBW"#$,#':0&/
M+<=00-O/'WC7K$TT5O#)--(D<4:EW=V 55 R22>@%4/#^DQ:'H5IIT1R(4^9
ML$;F/+'!)QDDG%<?\8M9ET[P:;&VE\NXU!_*.-P/E#E\$=/X0<]0QXK=>[$S
M>ITP\9^%CT\2Z,?I?Q?_ !5.'B_PR>GB+2/_  -C_P#BJ^0)8_LO44V*].[&
M*GG?1$-M'V"?&'AA>OB/2!];Z+_XJD'C+PN>GB31_P#P.B_^*KY(DS,HP*5;
M9U )Z5'MGV-U"-KMGUO_ ,)CX7_Z&31__ Z+_P"*K6@GAN8(Y[>5)89%#))&
MP96!Z$$<$5\:?(@R>M?0OP7\2QZQX3;3&=VNM-;8=[%LQL24.2, #E0,G&WM
MD5<)\VYG*R>ASOQP\.,MW9^((401R*+:?:H!WC)5B<Y8D9'3@(.>E>.O&QYK
MZZ\1Z0NN^'-0TQE4FXA94WL54/U0DCG 8 _AWKY+NDFL[B6WN(VCFB8HZ.I!
M4C@@@]*F:L[F%1=2JD)+<TV2 EZ!=@.14<MW\W%+4BS/KGP.-O@301Z6$/\
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M%M^8<T-WU%&/*0].M!-*>1FFTB["&CAEVFG=:81S0)ZZ!"/*.QNYXHFA;S2
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M.,9JK<710$+4$MYA<50>8NU5&):B/EF9V)J(=>:.M*!FK*V%!_*G8I ,&EH
M1J;3L4 4#$Q3@*=MIPP!2 :!3A\W3KZ4*C2'Y16[I6B[\22#WI-CL0:=I3W+
M!W&!74VUI';(%1<M4T%N% 2-:U+:S"X=^M"U*1%;6;2$,_ ]*TE547:HHSV
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MXSWZUM6G&25CGP].4&^9%2@#<:55+' J_:VA8@D<5BHMLZ)344-M+7>PS6J
MD Q3-PB^515>:0D]:Z%:".63<V2SW*XX-5&<MSFFLWM36_2HE*YHH)(^A_#?
M_(K:1_UY0_\ H JU>:;8ZAL^VV5M<[,[/.B5]N>N,CCH/RKS#3?BG_9VE6EE
M_8WF?9X$BW_:L;MJ@9QLXZ5:'Q?R?^0%_P"3?_V%;JI"UCF=*=[V.[_X1O0O
M^@+IW_@*G^%'_"-Z$/\ F"Z;_P" J?X5Q'_"VC_T!/\ R;_^PI#\7 O71/\
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M$;\/XO?VJU-=16.CO_A?X;O-GE1W5GMSGR)B=V?7?N_3'6J!^#OA]NM]JO\
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M'4Z]*^2F?5Q'4445F6%%%% !1110 4444 >QT445]Z?#!1110 4444 %%%%
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MBEVDG&#6@(%':G!5!Z4N4KG**6S.>>!5N.!(^U2$^@IHR:=DB7*X\@4 YXI
M#1TIDC7R*CY-2.,BFJI[T# 9IV<"C;BC:6H ,T TNT+U--+**!"\TF*0R#M3
M2Q/2@!]&14?-'- $F:45&#3P: %/--IPH- #<TX&DQ1B@!9.8R*QG&)2*V<?
M*:Q[CB8TF4AA--)I3S2%:D8PG--IV*0]: #/%,-.-,S0 4O:DS1F@8E%+10
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M]"13LZ4R8YYI[#BHBI)QB@0J_,O-2Q?*?EZU&BE3STJS %#9- ,)ED9!GI4
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M%  *7-)0: $JM.W%6#TJG<'B@"E(_P U .:8WWJ<!BD4.Q2T@-+0(,T9I**
M%H%-S1F@8\=:M0U44\U;AH$74[584U6C%6$%,1*3D5&?O4[%-_BH E@&9!6Q
M&,1BLFV'[RM8'Y:J)+)!R*:5HC-/-420E*C9<58(IC)F@96-,-3LE0L,4A#"
M14+.!3W.!5.9\9H&+)(*K.0<TQW.:B9S0 -C--) %,)IA- #RV*B=LT%L4=:
M0R,TE2;:3% QC=*B)J5^E1=Z0"J,BI!Q2**?C!H&/C&2*U8!M2LZW7+BM+!"
MT 3J!C-#+3(LXJ6D(9CBDZ4\TTT ,<X%4+UOW=:#"LK4#@5$]T=%!6,)CF0_
M6KEIRPJF/OFKUJ/F&*IFLMF;<8^45(1P:@4D 4VXNEC4C/:F<4F07,H!P*JX
MQR:1F,AW"GI'O'S&A(Y9N[L(K+NS44S!Y>.U3$(F0.M0*RAVW4>8D[:(#*%%
M)%=@G%1.HD)P:;%#AJ862+Q<-S490-R*4J0,#O4RQXCS09[%.2(L*?!"HZT]
M^#3&/'%!0YQN; J5539@_>JF92I%2QDRGBF)BO@'%.@&7]J)(B!S4"2&)MJ\
MT!NC6>01IA:HRR%R<TUG./F/6FTDA# <,#75:7)O@ KF< 5K:1/\^TFLZJTN
M=F#G:5C?'6F2#*T\]0:"NX5SGK)E CYR*Y?Q%!MDW"NJE!$AK(UN 2V9;N*N
MD[2%45XG&9P15R,;B*ID8XJ>W;@CO7<SRZJT-,$A<5"V0:8'..M(I)>IL<MB
MU$H(YJ1GXPM)$/EHR ]22/0[1SUHY=N!4\<:LI/I0IV,>*";]18+4MR>W-2&
MY$>Y1VJ)KC9&1FLJ65FEP">32M<N"N=?IOSP;_6I9VPC'T%1Z8I6R6ENU8PM
MMKD?Q'NT5:FBG898,Q[UHIQ5&S4I;+G@U9\S HEJS9;$C/S4+OSFHWDJ(MFA
M1"X]GS4;MM!HJ"X?:A^E6D)LIS7(5^:#,'CP*P[V8ESAC5[229&PQR,=ZZ>2
MT;GB5-6V.FSL)HM2#C-7+B$'@57CMFW^U">AD:$8 3BJ-U"&.35X-LCV]Z=%
M:&<9-2A(YN2 9J!K8@5U4FEGL*SI;)T8C;6G-8M-F;;0[>>XJRLA'6G^44XQ
M3=O/2ANX,E\\ #-,D?< 1TJ-E':HW;:F,TK#BDV+:3F&;=VS756\HFA5T'(K
MD[4!GYK6M[W[.P!SMJ9FTJ7.W;HCI5U29$"]15RVO_.;8RGFLRTGMKA<L0*T
MH(HE<,AS^-0GJ<]I)ZD%W:6YE+2C'XUF*RPW)$1RM;]W MPN#G\*YZZM);:3
MS/X10U?0I2<'S(V8)-R\]Z1EVFLZQOEF.T$ BM1?G0^HKG:MHSUZ<U)71'33
M2\BDJ382EZ4&DH &ZT$>M+24 1,N#FD/(J5A4?2@9]"Q2AHH&'9!_*K@NU"C
MFL^%&$$0*XR@_E4_D/C@5ZIXS+7VQ2.M NU Y-5?L[X^[1]GD_NF@1--<B1<
M U);*HCR*K?9G_NTHCF5< $4 7=Q?Y1TIX C%40LXZ T%9SZT 6P-YR>E<OX
MXQY%D!_>?^0K=Q/UP1[5S7B]9!%:%\\LW]*X\P_W:7]=3KP'^\1_KH<S'4Z]
M*@CJ=>E?)3/JXCJ***S+"BBB@ HHHH **** /8Z***^]/A@HHHH **** "BB
MB@ JL_4U9JL_4T 1MTJ(_>J5JB/6@!]%%% #.YJMN O?PJSW-5L9O/PH M"D
M9<CWIH)4X-2=LB@#B?BB3_PK?5U/_3'_ -')7S,B\GZU].?%, _#C5C_ -<?
M_1R5\SIC)K.>YG/<D48-2JV:@9\'K35DPW6H,[$TQ^6J#/AC5B>7(X-4B><D
MU444AYD)XJ-FP:1GXQ41:JL,<S'-,)HW4AH&%%%)FF,4=:D I@%2 4A"TH'K
M1C\*=@]C0 HQ3Q3/IQ5ZPL9+IQ@<4GH+<B@MY9Y JCBNJTK1MN&*\U:TG1=H
MQLQWR:W"8;1 H(WU+>EV59)78ZWM(X$W,.1TJI?W+L=HR!4@O3(^W<#4<H#L
M-W2LIU4U9&<Y<RLBJIV)A1R:A5G9\%>]32LJR?(<^PIRL8BI(ZUCL8VN$UMN
MB)'I4>FRQV[8>I_-+%@O3%9R1/)<D.P/IBJB] ;Y9)HZ1)HI>12O*$JM;0^4
M@YI;A'*?+UK?F?+=G1=HAGV2N,T^)%5P5'%5H\>9M<X(JXGE\!7'%8I\SU)6
MKN::<H*#386W(,'(J3@UUK5&XAZ49H)]*.U,"A>J&((JC.=B\FM&](6(D]JY
MZ>5I6P#Q7%6^(<*+J,<]R6&P4Q(PIY[TJ( M.%9I'HPIJ"M$7I24451H+BBB
MC- D'M4D<98X YHBB:1P *V+>U6%-S=:N$&]S.I442*WM51=TE.FE)&U>!2R
M2!L\]*K'[I.:U=DK(R2;=V,9L\4U"%))I".,DTTGBL[FR0C29;IQ12=L4HJ1
MV%&31M.:3.6J8 ;/O#- /0BR5&*"1C)I2 HR35=F9SA>12;&EW LTK[%'%64
MLV5<XJU9680;V%6IQB+Y<5:IZ:G)B*VG+$RV80J-R@TUKAI& 08%5YRV\AC3
MX,L:SM9'DN;;L:(MC+&.><=:C6S:-B=Q)]Z<LY1<>E,:[(!=N%%.\6C9\I&R
M@$AJI%2)3Z5-]K25C@TC%2<FDKHQE9[!'G!S3MV.*B#8;VI6.#FBQ*985JL0
M0/-*/2H;2)IFX'%;D4:QK@#G%52I<SN]CIIQOJQ541H%%1S2;:5VSQ5&YN5&
M:[DK(U8RYG"*236'/J3C(6EOKII6(!XK,8,S84$_2DV9MDK333,.2:L1QEER
MZXHM(9U8$1'\JOM:7<XQY94?2N>5V82NS-=620$#BILJ<$BM2'1I-N)#^E7(
MM'A7&X9HY),J-.1DVUA]I?=C K0MM*>&YWY.VM2.&.$808I^[-;PARK4W4;
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M^:7=3 :=0,7-&:2B@0N:,TE%  13:?FD(H&)BFD4[!I*0#:*=2&@89HS244
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ML?WB9 Y%8M6T9Z\9)JZ(,44ZD(I%B48I:2@9]"*,+;_[@_E6B/N"LY?NV_\
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MMQP*:$R7;05S4AXYI,YJR1V!MJJRX>K!S3&7.30(BW8IC2$4K'&:A8YI /\
M,)IN\9YJ%B0*B=S0!9=UQ4&T.>:B#,:42;.M #S& *A=0*D\T-4;<FF Q3@U
M+O&TU"1BD)H 9(:KDU.]0,*!H1FXH!XIAIR]*0Q>V*3OBG8H'WJ0RU:PCJ:O
M "H(1\G%/;<*3 D;&::",U S.::K-NI#+633"W-&[ YIA<$T(!V<T"E&#3J&
M F:4&DZTAX%(:,_46^4USYY:MO4#P:Q.YI1.N.Q<L1^\%;Z\(*P[#_6"MS.
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ME(_>-?5GQ9;=\,-8_P"V/_HY*^5"/G-)DL0"G@9Y-(!3L$G%(0;:<O-*%).
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M]2T.!2%P*@>7)XH4[C2<C2XK_-3!\IZ5*,'VIV%VXQS46%:XJ%6&*LK'&F"
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M&:YV-RAXJPERX-".>KN;18>M-)%4A(Q4$FI4.X=:&S"<DB1@1UQ^%02Q[AD
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MU]%JW'O0>E*P61X#I?P2U>.7-Q>Z>Y!Z*[__ !%=?!\-M3M80D,UB".Y=_\
MXFO1(!B5L>M7,\T-)A8\K/PVUQVW/=6!_P"VC_\ Q%#?#76S_P O5A_W\?\
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M]-_[^/\ _$4?\*FU[_G[TW_OX_\ \17L8Z4<4>P@'UFH>.?\*FUW/-WIV/\
MKH__ ,15F'X;:E:.!)/9,Q]';_XFO6JJ70_?1TU1@B77FU8\^;X?:NZ@+<6(
M'N[_ /Q-5W^&VM-_R\V'_?Q__B*]23[@IQ(Q5."9"J21Y&GPVUF1B!<V''K(
M_P#\33S\,-:'_+UI_P#W\?\ ^(KTZ#_6/]:M&E[*)?MYGDW_  J_6S_R]:?_
M -_'_P#B*/\ A5NM_P#/UI__ '\?_P"(KUK-&X4>RB'MYGDO_"KM:'_+SI__
M '\?_P"(I4^%^M@Y-UI__?Q__B*]8WBDWT>RB'MYGE;?#'6CTN=/_P"_C_\
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M_P O-A_W\?\ ^(KUG:*7;1[" >SB>5K\-]7 YN;'_OM__B:5_AKJKCFXLO\
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M/7X;ZRO_ "\V/_?;_P#Q->I#I2$TN5#/+S\.M7 R;BQ_[[?_ .)I1\.M7/\
MR\V/_?;_ /Q->FMTI1TI\J \Q_X5WJX_Y>;'_OM__B::/A]JQ_Y>+(?5W_\
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M_B*B'PNUR896[T_\9'_^(KV"3_5GZ5%:_P"K%'*@N>2'X4:\!_Q]Z;_W\?\
M^(I8?AAK98K]JT_C_IH__P 17L+?=JO!_K7HY4*YY8?A;KA&/M6G?]_'_P#B
M*A?X4:ZW2[TW_OX__P 17L5%'*AW/&?^%2^(/^?S3?\ OY)_\12_\*FU\_\
M+WIO_?R3_P"(KV6BCE0CQD?"37<Y-WIO_?R3_P"(J7_A4VLXYNM/_P"_C_\
MQ%>PT4<J \>_X5-K8Z7>G_\ ?Q__ (B@?"K7P>+S3O\ OX__ ,17L-%'*@/(
MA\+==[W6G?\ ?Q__ (BD/PJUH_\ +UIW_?Q__B*]>HHY4!XXWPEUL]+K3O\
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M5O=)_&63_P"-U5E^ 7B=V^2_T<?6:7_XW7T;Q31U--*PU%(^<C\ _%2_\O\
MH_\ W^E_^-T+\ O%1;/]H:-_W^E_^-U]'$#'-1G*'/:BP6/GH? 3Q4O_ #$-
M&Q_UVE_^-U/#\#?$&=K7VEY]1+)_\17T#D,O%0Q_ZS%)Q3*C)QV/"3\#/$8X
M34-*/UDD'_LE1-\#/$H7)O\ 2MWM+)_\;KZ#Z4AZ4<B-?;S/GQ/@;XF/(O\
M2/\ O])_\;K3TKX/^);"Y,CWVELIZA99/_B*]KP4Y'2GHVX4N1$NK)JS/-/^
M%=:QCYKBP_[^/_\ $U&?AOJN<_:+'_OM_P#XFO4:0T^5&=CRIOAMK88L+FPY
M_P"FC_\ Q%96H?"+Q#?*=M[I@/O+)_\ $5[7C(J,@H<CI2<$Q6/#K?X-^*X
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M[H$585LT 5#%* ?F-1N)%4?,:T#S56Z4X7;ZT -5)&&=QI?*D_O&K$/W*DH
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M9XZ4 3 8I:13D4M #!]\T^F#[QI] "'I31UIYZ4P=30 =Z6D[TM !0O2BA:
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MI<T9H 6D(I,TN: $!IU-S1F@ :A1Q2=33L<4 !% -+10 G>FR?ZLT[O39/\
M5F@"G:_ZYZNGFJ5L,3-5WG- $9!4Y%/5LTX].:B(*'(Z4 2]J3-('#"E!Q0
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MU)367- #0!3P!3,$4;B* )**:&I0: %HHHH *0TM(: %HHHH **** "BBB@
MHHHH **** "BBDR* %HINX4A>@!]%1[C1DT /S1N%,P31M- #B]-W4H2EVT
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M(JSCVH ;N:C<U/P*,"@!FYJ-S4_ HP* &9:F9;>*EP*9_&* %RU&YJ=BEP*
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M5*K$<&@!67O5>Y/"Y]:M9JM=J"%^M $\7W*?4</W!4E !1110 4444 %%%%
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M%-(-&V@ !I2:0 TN* %6G4 8HH **** "BBB@ HHHH **** "FDTIZ4W&30
MG6FN#L-28P:27_5F@"E;\3-5[.15"W(,S5>'2@!QP14+ HV14E-^]0 "0$<=
M:5?6HG3:V5J17R* '9H/YTM'% $9&TY%.C8$T[ Q414H^1TH GHIJMN&:=0
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ME(&*:@ZT )M-+MXI]% #,"AL8H/6ANE "+4E1K3R:  FD[TH%(>M "CI24M
M% #6^Y0I&*)/NTB#(H 7(I0PI<48H :3S3Z81S3Z "BBB@!G\5/IG\5/H #T
MI@ZFGGI3!U- !_%2TG\5+0 4+THH7I0 DG^K/TJ*VQCBI9.4(%549XS]PF@"
MZ**K>>__ #S-'GO_ '#0!-_$:IRAFN5 ]*D\]]Q_=FFQEWG#%<"@ >W;8342
M=-IZBKY^Z:H%<7!H GB.911=G:5IGF!''K3) [2*2.* )EN%" $TY;E0.M.6
M)2N:3R1UH 3[0*7[0*41K3O(6@"-K@8ZT"X&.M*\(I5C4T -^T#M5>24M,"*
MN>2HI&A4<T ,AC/WFJ4KDY%"D'BGXXH 8K9X-/%-9?2D5NQH 5E!ICL?+.:E
MJ.4?(: &6W5JL56M>K59H **** "H+G_ %35/4%S_JFH ?#_ *L?2I*CA_U8
M^E24 %4Y3AZN52F&7H D@YD-6:K6_P#K#5F@ HHHH **** "HS_K!4E1_P#+
M04 244&B@ HHHH *.]%% %2X&73ZTV(8NC]*?<'#K]:9$<W1^E %WM11VHH
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M44 (.II],'4T[H*  T"@F@&@!::W6G4QNM "T444 (.M!ZB@=:#U% #ZB/\
MK!4M1'_6"@!PZT^F#K3Z "D/2EI#TH 1:=35IU !3/\ EI3Z9_RTH ?1110
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MGG.<BKX.33NE %-;/;WI\D.V%C5HU%/GR6^E #+<9B'TJ0$J<&H[;B,?2IB
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MW% #B:81W%*&R/>EH 16SP:)/]6:&7/2F.W[LYH 9;=6JS5>VZM5B@ HHHH
M*@N?]4U3U!<_ZIJ 'P_ZL?2I*CA_U8^E24 )FJDG#U<JE*-S_C0!)!_K":LU
M5@XD(JU0 4444 %%%% !4?\ RT%2=JC_ (Q0 \TM%% !1110 4=Z*2@"K<#+
MKGUIL7%R?I3KCAT/O21_\?1^E %P=**.U% $-S_JQ]:=#]RFW/\ JQ]:=#]R
M@"2BBB@ HHHH JW'7\:GR%0'VJO<YR,>M3*"0"?2@!0"W)I_L*,8I"P H &;
M INTMR: "3DT\<4  ''%!;%!.!3!ECDT &"3DTX#TI0*"P% ",=HIG+'VH&6
M.3TJ08 H ,8%-< J0>E*3CK3!EC0!5>W(#%.!4MJO[L>M3.,1GZ5%:C]V* +
M#?=JM" 97JRWW:KP?ZUZ +&T4;12T4 )M%&T4M% !1110 4444 %%%% !111
M0 G>FIWIW<TU.] #Z8ZAN#3Z* (UB4'('-/*@CFEHH C"!3Q4E%% !36Z4ZF
MMTH 4=*6D'2EH *:?O4ZFG[U #ATHH'2B@!AZTT=:<>M-'6@!]%%'>@!!UI6
M/:D'4T?Q4 &..:7'I1FB@ !P>:1NM!ZT&@!:*** $'6CO0/O4'@T .[5$3^\
M%2,VT<U$6!<&@"0=:?4:L&)Q3^] "TAZ4M(>E "+3J:M.H *9_RTI],_Y:4
M/HHHH **** "CM11VH :M.IJ]:=0 4444 %%%% !1110 4444 %%%% !1FC-
M,)R: $)R>*1Q^[-. Q1)_JS0!2MN9FJ]FJ5M_KFJ]C- $13!W+0&W'FI3TJ
MJ0VX4 3@<4M,5MPI] "'GBHBI4Y%2]:0C/6@!%?<*!UIC*5.13D8-]: ']*,
M9'-'?F@T 1,"N<5'$<OFK!P5JJNY9..E %L'-!IJN&Z4X\4 - RM1X*-D=*E
M'2F@9S0 JL&%*:B8%#D5(K!A0 F2*,;A3L4F.] $6&0\=*D!R.#022*C*E#N
M'3O0!)DGBE''%"D,,BEH H3'_2%^M71]T53FQ]H7'K5P?<% #OX:%H[4+0 Z
MFMTIU-;I0 HZ4M(.E+0 5DZW]V#ZG^E:U9.M_=@^I_I0!'8]1700?=%<_8]1
M700?=% %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J2G#&K=4
MY6 8T 1YIA-.+#%-W#'2@ R:.:%88I<B@!.<54.1=Y]JN$C%4RX6[R0<8H M
M+\PI<<5"9U!X!IPN5/8T *4*]#5>W&9&^M3FX4CH:KPRJLA^4]: +N*3;[TS
M[0N>AH^T+Z4 /V^]+BH_M">E'VA?2@!^#01Q3/M*^E(;A<=* ) *,5&MPN.E
M+]H7TH >1S0>U1FX7/2AKA>.* )>:$J/[0N.E-6X3/2@"Q^-%0_:%]*/M"^E
M $AX-.!R*@^T+Z&D^TKGH: +&/>H[C_4M]*;]H7/2F2S@Q-P: $MLB,9JR""
M*J0S*(QD&GBX4-C!H L, 156Y)4*/>I?M*^AJ"XF#A< ]: +4/W*DJ*)_DZ4
M_>* '44W>*-XH =13=]&\4 .HIAD IIEH DS32U1^9FC>/2@!^31C--WT;Z
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M](;=.*E/6ANE $?D)CO2"V3-/)-.6@!GV=*3R4J;/%-'6@"/R4I/(2I>].-
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M@!0"3D]*>.*!Z8H) %  3MJ/EC0,NWM4@ % "  4$XI20*8,L: #EC[4X<#
MI0,"@D"@!,XIOWC1RYQVI^ !Q0 QQB,_2H[;B(5+)_JSGTJ*UYC% $[?=JO!
M_K7JPWW:KP?ZUZ +-%%% !1110 4444 %%%% !1110 4444 )W--3O3NYIJ=
MZ 'T444 %%%% !1110 4UNE.IK=* %'2EI!TI: "FG[U.II^]0 X=**!THH
M8>M-'6G'K31UH ?1110 @ZFGTP=33Z $Z4 TM)TH 6FMUIV::W6@ HHHH 0?
M>H/44#K0>M #FZ5E,O\ I&/>M4]*SW7_ $H4 7(AA14M,7@4^@ I#TI:0]*
M$6G4U:=0 4S_ ):4^F?\M* 'T444 %%&:.M !1VHH[4 -7K3J:O6G4 %%%%
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M (Z3>:9YAWT 6**BWFC>: 'M2CI43.:7><4 2T'I46\T;SB@!ZTZH5<TN\T
M2T5%O-&\T 2T5%O-&\T 2T5%O-&\T 2T5%O-&\T 2T5%O-&\T 2T5%O-&\T
M2TUQE<4S>:#(<4 9\L967ZFIEM-PSD4ZXC,B@CK427$B+M(H D^PGUH^PGUI
M/MC^E'VM_2@!?L)]:/L)]12?:W]*/M<GI0 OV(]B*/L7O2?:W]*3[:V[&!0
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MUI=H%&T4 )M'K1M'K2[0* !0 FT>M&T>M*%%&T4 )M'K2%1CK3@HI'(5230
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M]:-I]:.:.?6@ I<TE% "@TM-I<T +1110 A^Z?I52#_6_C5L]#]*J0?ZW\:
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MII^]0 X=**!THH 8>M-'6G'K31UH ?1110 @ZFGTP=33Z  ]*0_=H/2C^&@
M7I2-UI!G%-.<T /S1FF<T4 .SS2'%-I: %R/2C</2FT4 *.3TI^!Z4U:=SZT
M -R/2C(]*0\&DH <"/2ER/2F44 /ROH*:,;Z2FC/F4 3<>E&!Z4W!HP: %8#
MTIP QTIIS2\T +M'I00,=*3FCF@!% ]*=M'I31FEP: %VCTHVCTI,&C!H 7:
M/2C:/2DP:,&@!=H]*-H]*3!HP: %VCTHVCTI,&C!H 7:/2C:/2DP:,&@!=H]
M*-H]*3!HP: %VCTI"!Z48-'- !@>E)Y:>@I<'%&#0 GEH?X11Y:>@I<&C!H
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M@"ZA.WFF.Y52:KLCB4*&)J63)95_.@"2-F= 34@%"+A<4Z@!M.IM.H ****
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M)H ?NI"XIN":4+0 F\T9)IVT4N!0 S!HVU)10 T**7:*6B@!,"EHHH ****
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M@!""ISVIX;(H/3%,QL.: ', 5Q3 "GTIY(*T 9&* #.>12\5&04.13P01Q0
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M[T (J!1P*26,2+C-248H K+"P&-YJ6.(+R3DU)10 AXJO+ 2=RL1]*LTC=*
M*Z0L>K&IU4*,"A:=0 QQD8IL<>P=>:>>HI10!#+#YIY/'I4B1A0,#I3Z* $[
MTM%% #:=3:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "8II6
MGTAH 9M]*,D5)2%10 T-2EN*0K32"*  #)IX7%(M/H ,4444 %%%)G% "T4W
M<*3?0 ^BH]U&2: 'YI-U-P30%S0 XO3=U+LI0HH ;DT<T_ HQ0 S!H"U)10
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MT^F#J:?0 4AZ4M(>E "+3J:M.H *B/\ K:EJ(_ZV@"2C% I: &M12'I3@*
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M4_TH CL>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110 4444 %%%%
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MY:>W2FQ_=- #L4C]*=37Z4 ,'6I1TJ(=:DSQ0 M-/6ES2$\T .'2BD!XHS0
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M*>/:DGDBA@>6:1(XHU+.[G"J!R22>@KF[3QWX9NM4738-6BDN7D,:C8P5F]
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M>M "<N?:I,8Z4 8XH/% !QUIA.\X'2@DL<#IZTX ** % Q2^])TIA)8X[>M
M 3N.!3E&* ,4O04 '2F,VXX%!)/2G*N* !5P*7I03BFDYZ4 (QS\HIRK@5G:
MKKFEZ!;"XU6^BMD/W0YRS\C.U1RV,C. <4S1?$ND>(HI9-)O4N1$0L@VLK+G
MID, <>_3@^E &KFF,>PZTK'TH5?7K0 *N*=VHIK-CIS0 %L\"J\Z_,GUJPJX
MYJ&YZICUH G7[@IU-3[M.H **** "BBB@!.]+2=Z6@ I#UI:0]: %I"<4M-H
M ,THQ1Q28H =36Z44-TH 4=*6D'2EH *:?O4ZFG[U #ATHH'2B@!AZTT=:<>
MM-'6@!]%%% "#J:?3!U-/H #TI.U*>E)VH %Z4C=:5>E(W6@ HHHH 0=:#UH
M'6@]: 'T444 ,'4T^F#J:?0 4AZ4M(>E #11N-"TIH 3<:9UEJ4"F?\ +2@"
M0=*3-&: * $(XI12-TH[4 *>: *!2F@ S3:,T9XH 1>M/IB]:?0 4444 %%%
M% !1110 4444 %%&:3K0 N::>:4"@]*  "EH'2B@ HHHH *#110 A^[6?Q]K
MYJ^>AJB>;O\ "@"TR[<$4L;!B?6GC&T"HBFURP_*@"849IJ/NI] "$<<U"5(
M.Y:F/2FCI0 *P(IW2HF4J<BGJP- #NM!HZ44 4+Q0""/6K-OS$#5>\ZCZU/;
M_P"JH FHHHH **** "D/2EI#TH <.E+2#I2T %%%% !2-TI:1NE  .E+2#I2
MT %9.M_=@^I_I6M63K?W8/J?Z4 1V/45T$'W17/V/45T$'W10!9HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "JS_>-6:K/U- $9-,)I[=*;0 WJ
M:4TM% #12D48I: &XI>U+10 VG"@44 %%%% !1110 4C=*.:1ONT "TZFK3J
M &MU%.'2FMU%.'2@ HHHH **** &TZFTZ@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ***3O0 9H)S1N%-+4 .S2%L4W)-&TF@ +48)IP6EQ0 T+3@N
M*6C- !129%&X4 +13=U)OH ?13-])O- $E%1[B:,F@!^:7-1\TF": ),TFX4
MW::790 N\4;Z391LH -U)N-.VT;: &[C1N-/VT8% #/F-&#3\"EQ0!"ZG IR
MJ<4K]!3EZ4 -V4FVI*;0 FW%&!2YI<<4 ( *7%(#3J $'6EI!UI: (O^6PJ6
MHO\ EJ*EH **** "BBB@!">*:G>G'I34[T *>E)'T-*3Q38S\IH >QJ,G-.8
MYIN10 #K2X-(.M/#"@!-II".:=NI"03F@ VFDP:=NHW T ,;[M /%#8Q2C&V
M@!ZGBES3 12[A0 'J*\>^-&N)+/8Z'#+GRLW%P@VD!B,(">H(&XXXX8'GMZU
M=W<-E:37=P^R""-I)&P3M51DG YZ"OES6]4DUK7+W4I=X:YF:0*SERBD\+GN
M , >PH H5[=\&M<2YT.XT:67,]I(9(D.T?NFY..YPV[)/3<O/:O.KWPA=VG@
M"P\0-;X\VX?S#A]PB8*(R1C &5<Y[[TZYXI^#]<?P]XIL;_S?+@$@CN"=Q!B
M8X;(7DX'('/('!H ^F_XJ?3!RU/H 0]*1>M./2FKUH ".: ?6G4TK0 A- !Q
M1MHQ0 V4'RS4=L#Y8YJ24'RC]*AMB=@!H L%21C-,!*G![T_;2%010!\[_%#
M_DH>I_2+_P!%)7H?P9 /@^\!_P"?]_\ T7'7G?Q.&WXA:F/:+_T4E>B?!@9\
M(WGI]O;_ -%QT >AY(..U2# 6@KQ3<[>O2@!< TF2I]J5>3FG$9H X#XP?:3
MX)7R/-\O[7'Y^S.-F&^]CMNV]>^/:O!*^M)8HY(GAFC62&12KHXR&!X((/45
MSVG?#_PKIU]#>VNDHMQ"V^-FED<*W8X9B,CMQP>: -'PZ;E?#>E?;/-^TFTB
M\[SL[]^P9W9YSGKFM"ZN[:RMGN;NXB@@3&Z25PBKDX&2>!R14QP>*X_XF K\
M/=5';$7_ *-2@#:3Q+H%Q(D,.MZ;)+(P5$2[C+,3P  #R:T@"I]J^7_"_P#R
M-NC?]?T'_HQ:^HN&% #@<\T$#%1_=IX((R* &\J>*<"*4\BF8VG- #S@\&F?
M</%.!SS2G&* $#9%))]PTF"IR*'8&,F@"M "'8U:!R,BH;<9+^E2$%3E: 'T
MP@J<BG@@BEH :&S56^U73M,\O^T+^UM!)G9]HF6/=CKC)YZC\ZLD%3D5Y+\;
MB#'H>/6?_P!IT >EVFM:5J,YBL-4LKJ55W%(+A'8#IG /3D5H*V[ZUX7\&?^
M1RN?^O%__0XZ]S9>XZT #YV&HK8DL]2,V8S4=K]YZ )SG!JK ?WOXU;/W3]*
MJ0?ZW\: +8I:** "BBB@ HHHH **** "BBB@ [55D/\ I*?2K7:JLG_'TGTH
M LCI7SK\4?\ DH>I?2+_ -%+7T4.E?.OQ1_Y*'J7TB_]%+0!Z%\%O^13O?\
MK^;_ -%I7H[+N%>;_!=L>%+T?]/S?^@)7I.: &*><&GTC#</>FJ2#@T >??&
M;_D3;?\ Z_D_] >O#K6VEO+N&UMTWS3.L<:Y RQ. ,GCJ:]R^,W_ ")EM_U_
M)_Z ]>.^&?\ D:]'_P"OZ#_T,4 ;/_"L/&)_Y@__ ),P_P#Q=+_PJ_QC_P!
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M!%IU-6G4 -;J*<.E-;[PI1TH 6BBB@ HHHH ;3J;3J "BC/-!Z4 (3244=Z
M%%!/-'04E #ATI#0>!29H 44M(*6@ HHI": %I,TTO3=Q- #RU-+<TWK2X-
M!UI>*3!I=IH 7(%&_P!J-M&R@ WTFZG;* HH ;DT<T\"@=: &8)HVU)10 S9
M1MI]% #=M&T4ZB@!-HHP*6B@ P**** "BBB@ HHHH **,T4 %%%% !11F@T
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M_%UA^ ?#5GXJUZ:QO99XXDMFF!@8!LAE'<'CYC7I*_!KPX1_Q^ZK_P!_8_\
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MBATKYU^*7_)0]2^D7_HI: /0?@PN[PE>_P#7\W_HM*]&!QP:\Z^"W_(IWO\
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M-:_Z_I__ $,U[E\+O^2>:9]9?_1KT 'Q,R/A[JH[8B_]&I7A?A;_ )&[1?\
MK_@_]&+7N_Q._P"2>:K](O\ T:E>$>%O^1NT7_K_ (/_ $8M 'U(0"*X_P")
MF1\/=5';$7_HU*Z\<UR?Q._Y)WJOTB_]&I0!X1X7_P"1MT;_ *_H/_1BU]1X
MR*^6_"__ "-NC?\ 7]!_Z,6OJ13D4 ,&4//W:^4]2O9-2U2[OIE19;F9Y7"
MA06))QGMS7U>5!KY';[Y^M 'I/@3QUX<\)Z$UO/9W[WTTA>>6.*,@]E )8'
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M57O.H^M6+?\ U0H EHHHH **** "@T4AH <.E+2#I2T %%%% !2-TI:1NE
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M6?\ (X:W_P!?\_\ Z&:]P^&'/P\TP>\O_HUZ )?B=_R3O5?I%_Z-2O"/"_\
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MT^+S)GY)/"HO=F/8#_ZPR2!7TCX7\.V_AC0H=-@;S&7+2RE0ID<]2<?D,YP
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M0-'M],L@_D0@@%VRS$G))]R23Z4 >/?&G_D:[+_KQ7_T-ZT/@D?WNM^ZP?\
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MU]/>#_\ D3-$_P"O&'_T 4 ;5(>M+2'K0 M!%%% #<4N*6B@!.](W2G4UNE
M"CI2T@Z4M !33]ZG4T_>H <.E% Z44 ,/6FCK3CUIHZT /HHHH 0=:?3.]/H
M 0]*/X:#TH[4 "]*:W6G+TIK=: %HHHH 0=:#UH'6@]: 'T444 ,'4T^F#J:
M?0 4AZ4M(>E #0*=M%(M.S0 TJ*8!^\I_6F@?O* ),4A-!-)0 AIPZ4-29XH
M <>E-I12]J &KQ2D\4W%+0 #K3J8O6GT %%%% !1110 4444 %%%% !1110
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M9':JUUC ^M61TJK=]OK0!.JY08]*56YP:$^X/I2LN: %/K2,N>E(K<[33NE
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M:=3%SFG<T +12<T<T +12<T<T +12<T<T +12<T<T +12<T<T +2'I1S1S0
MHZ4TTO-(:  >].IN* : %X-+33UIW:@ J+_EK4M1?\M: ).U-'WC3Z8/O&@!
M]%%% "&D7D4IZ4BT .I#Q2T4  I*6B@"&?H/K3DZ4V?H*<G2@!U%%% !1110
M 4AI:0T .'2EI!TI: "BBB@ I&Z4M(W2@ '2EI!TI: "LG6_NP?4_P!*UJR=
M;^[!]3_2@".QZBN@@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 56?[QJS59_O&@",]*;3CTIM !1110 4444 %%%% !111
M0 55O>(2?>K55;T_N30!)!_JQBGLH(J.WQY8YJ:@"-6P=IZT\_=I&3</2F X
M!#4 2#I364_>4<TY:7'- # V?J*>*BD!#;A^5/1L]>#0 I&13.4/M4M(1F@
M4@C-+47*'VJ0$,.* &.F[GO2*Y7Y33Z1U!% #L]Z.M1JQ!PU2 YH C92IW+3
ME?(IW:HV!4[A^5 $O6FD9I%8&G9H BSY9YZ5+G(R*0@,.148)C;'4']* )?K
M4<J;N1UJ0$$9HZT 0H^.&ZU*&IKH&''6F+D<&@";(-1,I4[EIW(I0WK0 TMN
MC/KBJEHN6)[9JQ*/E)'I4-D<C\: +@&*4D44QF XH &?''>A4R<FA$[FG]*
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M]A<VM]&H&Q<F*1^F>#\HQS_%T'X5C_\ "L/&/_0'_P#)F'_XNOHS.*:S8Z4
M> 67PE\4W1<3PVMEMQCSYP=WTV;NGOCK7H?ASX:Z5X<DCN9V^WWN1B26,!$(
M.047G!Z<DD\<8S7>*O<U%<]4^M $R_=%.IJ?=IU !1110 4444 )WI:3O2T
M%(:6B@!,TN128HQ0 N129HQ1CF@ ]::>E.]::>E #ATI:0=*6@ II^]3J:?O
M4 .'2B@=** &'K31UIQZT@')H =129Q2T %%%% !VH[44'I0 #I10** "CM1
M2$T  ZT=Z512=Z 'T444 ,'4T^F#J:?0 4AZ4M!Z4 -7K3J:.M.H *9_RTI]
M,_Y:4 /HHHH :U.'2FM2CI0 M%%% !2'I2T'I0 Q>M/IJ]:=0 4444 %%%%
M!1110 4444 %%%% !2'I2TAZ4 *.E-8TX=*8U #ATH(H'2EH ;3J** "H_\
MEK4E1_\ +6@"2F#[QI],'WC0 ^BBB@ /2FK3CTIJT .HHHH **** (9^@^M.
M3I39^@^M.3I0 ZBBB@ HHHH *0TM(: '#I2T@Z4M !1110 4C=*6D;I0 #I2
MT@Z4M !63K?W8/J?Z5K5DZW]V#ZG^E $=CU%=!!]T5S]CU%=!!]T4 6:***
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MD5L<'K4E $:M@X-/[4C+D4U6[&@ (#?6A6P<&E%*RY% "G%,QN% ..#3E/%
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M-  RYZ4BMV-/IK+F@!W04UESR*%;L:=0!4F/(!]:M+]T56N1@@^]39RH ]*
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M:0=*6@ K)UO[L'U/]*UJR=;^[!]3_2@".QZBN@@^Z*Y^QZBN@@^Z* +-%%%
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M!0T 10?Q5/C-5XFVL15CIS0 PY5L=J=G-*0&%,Y0^U #R 13 "I]J?GO0>:
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M=2;O:@"2DR*9DTG- $F:-PJ/!HVF@!^X4;J;M-+MH C+?O:>33=O[T4_&#0
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MQU)H <JCKWIW6DR.U(6 H 5FQTIJKGDT =S3LCM0 H%-8@<=Z"X ]Z0#/)H
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M *:2BD)YH 6BDYI#F@!<T9I,<4 <4 +FC-&VC;0 ;J-U&VC;0 9I":-M!&*
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MZ3<:=M%+M% #-QHR:?BEQ0!'S1@U)1^% $>TTNRGT4 1,O IRJ,4/T%.7I0
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MTH IOYRLHW#FI!'-C[XI)Q^\3ZU.C8&#0! T,Q'WAFFA)AQN%6VZ<4A7(]Z
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M#\\T;7]:>O4T^@"+:_K1M8]34M% $6UAWI<-ZT\C-)TH 9AL]:=M;UH!YI]
M#-K>M!#8ZT^D/2@"-0WK2E6]:<M.H BPP[TT9\WK4S55#?Z7CVH L?-ZTX=*
M444 1MUIR4UJ<E #J*** "@]**#TH :O6G4U>M.H *:3Z4I/:D%  .>M.I,B
MC- "T4F:,T +129HS0 M%)FEH *0]*6D/2@!1TI#2CI2&@!>U%':B@ HHHH
M*C_Y:U)4?_+6@"2F#[QI],'WC0 ^BBB@ /2FK3CTIJT .HHHH **** (9_X?
MK4@Z"HY_X?K3QTH 7.*;UI3UH/% #ATI&I1TI&H 3M3ATIO:G"@!:04M(: %
MHI,XHH ,TC4UY0G4T9WKD4 .'2ES49F1!@GFF?:D'>@"<UE:W]V#ZG^E:4<B
MR<@UF:T?E@^I_I0 RQZBN@@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 54EX)JW6?.SK*QS\OI0 IZ5&5!6G;@13<T ,1B
MORMT]:F!J,X88--#[3@T 3'FHBOS;AQ3]PQ0/6@!%?/7@T_-1,N3D=:<CYX/
M44 /*Y'-18*'VJ7-(0&&#0 !LCBEQ41!C/'2I P(S0 C+N'O35;!VGMWJ3.:
M:RAA[T .[<4AZ4Q7VG::<3Q0 PIW'%/5L\=Z <BFLO=>#0 \\&FMTY&:0/D^
M]./- #.4/M3D.>E..",&H5S&3CI0!8ICH&'OZTH.1D4Z@"%6P<&G'D\4CJ.W
M6FHQ!PU $V.*C<$'*]NU2=J* &J^X>A]*=U%1LISD?C3T;<,T *5!%1<H?45
M*#2$9% "ALT9J+F,^U2YXS0 QTW#/0TB,0<'\ZDZ\TQP&H ?FEJ)6V\-3BPH
M :R\Y%*K@_6DW&HV0YW+0!)(V4;Z53M6 SSWJR3N0^N*JVL>6)/K0!9 +MDG
MBI1@"@)Q2[: $W>U-9^PI68#@=:$0#D]: &JIZFG\^E/XHR,4 1X(JG>'<%7
MMGK5PDN<#I5:\7"KMXYH DBMD*#@4\6T?]T4Z'[@J7% $'V>/^Z*7R(_[HJ;
M%&* (A B]%%28P,4M% "8I:** "BBB@ HHHH **** "FDFG44 ,R?2C)]*?1
M0 S)]*7)]*=10!&Y.!Q2@G'2A^@I5Z4 )D^E&3Z4_-)D4 -R?2C)IV:-U #<
MFC)I=XI-] !DT9-&^DW&@!I)\T<4\FHLGS:?S0 [=1NI,&C:30 ;J-U&,4G%
M "[J3<: ":<%H 822*2,';4A4;:(_NF@!,>U+^%/HH 8"?2C)]*?10 S)]*,
MGTI]-/6@!,GTHR?2GCI10 S)]*7)IU% #,GTHR?2GT4 ,SR*?36ZBG4 %!Z4
M44 ,'WJ?3/XJ?0 4444 %%%% !1110 UNAI$Z4-R#2*"!0!)1D4E)0 ZBD I
M: "BBB@ Z4444 (:1>E*:1>E %:?/G1_6K!&14$W,L?UJR* (\\8-/!XI'7(
MR.M(I[&@!Q4$4T''!IU##/3K0 4,N::"0<&G9[4 -!P<'I3LYH8;A302O% #
MBH(I@^4X[5(#Q2, 10 @Y-*0#4:;M^T GZ5;2V)Y<X]A0!5SM.,\582&1NV!
M[\592)(_NCGUI] $ ME_B)-2K&B?=4#%.HH **** "BBB@ HHHH **** "BB
MB@ J-H8V'W0/IQ4E% %9K3^XWX&H6CDCZ@X]1TJ_10!G!J=G-6G@20Y(P?45
M7>WD3D?,/;K0 WM563_CY7Z5.&JO(<W*_2@"T*JW?0?6K0Z55NQG'UH F PH
M(]*<K41_='TI&7!S0 _K36&.12JV:4_I0 T-3L\4PKW%*&SQWH &7'(H#?G3
MZ85[B@!W44TKGVH5N<'K3J (U;G!J3I3&7G(I0W8T #+GI0K=C3CZ4UESTH
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M=CU%=!!]T5S]CU%=!!]T4 6:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M%*#0 C+GD=:%?(]Z=VIK+CD4 +CFD9<_6D5N:>?6@!JG/!ZT[I367N* W:@
M89Z4@;L:?CBFL >E #NU1,,GCK3@W!!I5ZT -23LW6G-]TFD=,\C@TPL0I!H
M 9!S(:L%:K0?ZRK= $>VE"T^B@ HHHH **** "BBB@ J"3J*GJ&3J* ')4E,
M2GT %%%% !1110 G>EI.]+0 4444 %%%% !1110 4UNE.IK=* %'2EI!TI:
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M74%335)'!ZTXYVF@"O /WAJP"14,)S*:LD9H  U+3-M("<T 244"B@ HHHH
M*,T44 %12CD5+44HY% #DZ4^FITIU !1110 444F* #O2TG>EH **** "BBB
M@ HHHH *:W2G4UNE "BEI!2T %-/WJ=33UH 4=*6D'2CF@!#UI12'K2B@!:8
MW6G\TT]: "BBB@ IK4ZFF@ 6G4U:=0 @ZT^F#K3Z $(I :=]:0B@!:*:#3J
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MO%&\4 +12;Q2[Q0 4G>EWBFEQF@!U%)O%&\4 +2$4N\4F\4 (%I=M+O%)O%
M >HIV33"XR*7>!W% "\T9I-XI0P- "9^:G$TW^*G"@!*7-+28H 3K1TI12T
M)FD)XH(H/2@!O8T)TH'0TJ]* %IHZU)4?\5 #\TE+2\4 -I<T$4E !1FG4A%
M  3Q35SBEH6@"M<9\V/'K4X;L>M0S\2Q_6IR,\B@!6X%-(XR.M&[CGK3@/3G
M/:@ B!D<+T/\JT%4*H4=!3(8_+3W/)J2@ HHHH **** "BBB@ HHHH ****
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M5N7A#5:RS^\^M %A9,'::?FFLH84BL1\IZT *YRAJE;[A<2$=*O/S&:J6O\
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MH8$\Q0"3N[\T 6GQC((S5FT3<-Y' Z526U+,%!.3[UK1HL<:HO0#% #J***
M"BBB@ HHHH **** "BBH;F[@M%5IY @8X'!.?RJ9SC"/-)V0TFW9$U%8DOB2
M-6_=6[L,=6;;_C6WVK##XRCB&U2E>VY4Z<H?$@HHHKI("BBB@ HHHH ****
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MI] !1110 4444 ,[FE6D[FE7I0 ZD/2EI#TH 04ZFK3J "F?\M*?3/\ EI0
MK@D8%-4,!@T_O2;@3B@",J >E/0<4C<FA6% #B@/)IAZU)GTJ-NO- #UZ4-T
MH6ANE #%ZT\]::O6E[T -/6G@4S^*I!TH :3Q35ZT]A31UH D[4444 %%%%
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M %9\<#K2HO<TBICD]:>#0 ?A02!R:"<"HF)D.!TH "2YP.E2*NWC%"@ 8I:
M$8#%,R!UITC!14: L<F@!53<V3T]*DV@=J.E.H 9BFN0. *5W X'4T(F.30
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M[59'2@!.@Z4M%% !1110 4444 %%%% !1110 5')U%25')U% #UZ4M(O2EH
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MPE?_ $Y?^1?_ *U>K_:V#_G_  ?^1A[.78Z2BN;_ .$L_P"G+_R+_P#6I/\
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M65J\9#13#./NG^8_K0 D;9%/;FJT#<"K!H 2G+UIM/2@!]%%% !11FH)9<#
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MM_=@^I_I0!'8]1700?=%<_8]1700?=% %FBBB@ HHHH **** "BBB@ HHHH
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M%'_(N7?T7_T(5ZV"_P!WJ?UT-(?"SS8FF$T$TTFO.2,3OO __('G_P"O@_\
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M* (VZTY.E-;K3DZ4 .-1'[V:E[5$W6@!ZT-TH'2D)XH :O6GTQ>M/H 8>M/
M%,/WJD% ",H I@ZU(W2HQUH EHHHH **** "FCK3J:.M #J0TM(:  =*#0.E
M!H !TI<U&2:,&@"2BF!B*4,* '49I,TM "=131]XT\]*8/O&@!V*6BB@ /2F
MK3CTIJT .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;I2TC=*
M  =*6D'2EH *R=;^[!]3_2M:LG6_NP?4_P!* (['J*Z"#[HKG['J*Z"#[HH
MLT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=/<K'*RGJ*T:H36
MT4DC,RY)H @-VE1-<*>1@5,;2'^X*C-K%G[M "+>*5IWVM?:D^R1YSMI1:Q?
MW10 W[4N:;]J57]JD%K%D_**7[+#TV"@!OVM!Z4?:U]J?]DA/\ H-I#C[@H
MC^THW85Q^L_%#1] U>?3+JUOI)H=NYHD0J<J&&,L#T/I79"UA_N"OGKXFH$^
M(>J*HP!Y7_HI* /1?^%T>'O^?+4_^_4?_P 77?\ VM?:ODZOH'X8:G;ZUX.@
MAD</=V/^CR@[00H^X<#MMP,GJ5;KC- '7-<J.1BE6[4BI?LD/]P4?9(?[@H
M9]K7VJO?ZM#8:=<WLRLT=O$TKA,%B%!)QGOQ5K[)#_<%>:_&'58+'1+?2('
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M44,RRID5)G-  W2FQ]#3FZ4V/[IH ?1110 4444 %-/6G4T]: %'2EI!TI:
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M^"^J7,/F:EJ5O9$J"L<:&9@3U#<J!CV)JY+\$'$3F+Q K2!3M5K3:">P)WG
M]\&@#=T[XO\ AV\V+>)=6+[-SL\>] W]T%<L?KM'3M7=V-Y;7]JMS9W$5Q _
MW9(G#*<<'D5\W>)/!6M>%BK7\*-;NVU;B%MT9.,X[$'Z@9P<9IGA?Q=J?A6_
M2:TF=[;=F6U9SY<@.,\=FX&&Z\=QQ0!].]J\;^+>LZIIOB.SBL=2O+6-K0,R
M03L@)WMS@'K7JVD:I#K6D6VHVZ2I%<('594*L/P/\QP>U>-_&C_D:+'_ *\A
M_P"AO0!U_P )-1OM2\.7DM]>7%U(MV5#SRLY V+P"3TKT$C KS;X+''A>_\
M^OT_^@)7I+'B@#F]2\=>&='O#:WNK1+.OWDC1I-I!P0=@.#QT/-;EI>VNH6Z
M7-G<17$#_=DB<,I]>17R[K=K?6>M7<.I)*MX)"9/-.6)/.<]\]<]Z]J^$EM?
MVWA!C>)*D4LYDMA(?^69 Y [ G)]\Y[T =[_ !5(*C[TX-B@!S=*C'6G$Y%-
M'6@"6BC/%% !1110 4T=:=31UH =3'I],>@!5I6Z4BT$\4 -6G_A3%ZU)0 F
M!32E+)(D,3RRNJ1HI9G8X"@=23V%9<7B?0)I4BBUS3'D=@JHMW&2Q/0 9Y-
M&E@BE#8I](5% ";J0?>H*XZ4@.#0!)12 YI<T !Z4U:4]*1: '4444 %%%%
M!1110 445&[D'B@"2B@4A.!0 M%1HQ+$4\4 +1110 4444 %(W2C-(W2@!1T
MI:1>E+0 5DZW]V#ZG^E:U9.M_=@^I_I0!'8]1700?=%<_8]1700?=% %FBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K/U-6:K/U- $9Z4S%//2
MFT %%%% #.YI],[T^@!HI>U+3>U  M?.OQ0_Y*+JO_;'_P!$I7T2M?.WQ0_Y
M*+JO_;'_ -$I0!A-H\P\-1:VIW0->/:..!L8(KKWR<@MVXV]>:ZOX2Z\VE^+
M!8.Z+;:BOEMO8*!(H)0Y(Y/50,C)?O@5T/P_T7_A(?A1K6E!]CSWC^6V< .J
M1,N3@\;@,\=,UY)%+);S)-#(\<L;!D=&(96'(((Z&@#ZXHK-T#6(=?T*SU2
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M2MN"3Q*ZAN1G!'7D_G4]><?$'X@ZMX3UZ"PL+>RDBDM5F)G1RVXLP[,./E%
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MPK9:M=)$D\^_<L((4;791C))Z =Z .A_G2$9&#4<D\4,#S32)''&I9W=L!5
MR22>@KRWQ)\9([>X\CP];17*+@M=7*L%;@Y"I\I].21T/'0T >I8*'(Z5(K
MC-?.A^)_C$]=8_\ ):'_ .(J]I?Q;\2V,V;Q[>_B+*666((0!U"E,8)]2#C
MX]0#WZHY%S7->%/'FC^*D$<3_9KX8!M9F 9CMR2G]\#!]^,D#(KIVZT 1HQ4
M[6J8=*XSXB>)=5\+:9:7^GQ64D4DQAE%PK%LD97;@CCY6SGV]ZY;PS\7)[BZ
MNVU];."T@MFE3[.C"223<H"*"QR3D_EDD &@#UPTQU_B7K7BFN_&35;J26+1
MK:*R@/"2RKYDO#=>?E&1@8PV.>>F,'_A9_C'_H,?^2T/_P 10!]%(^1[TX5X
MSX>^,-R+F&#7K:)H3M1KJ!2K+QRS+R&R<$[<8YP#P*]A@N(KF&.:&1'CD4,C
MH<A@>001U% $CCBH5RC>U3-TKS#Q/\7;2PFEL]#MTO)D;:;F4_N<C'W0#EQ]
MX9R!P"-PH ]0&&&:#7SQ<_%3Q;-</+%?Q6R-C$45NA5>.VX,??DU'_PM#QC_
M -!C_P EH?\ XB@#Z)9,CWIJ/M.UJ\O\+?&!;Z_2SU^WM[42L0EW"2L:'C <
M$G Z_-G XR ,FO474-TH ?UH[55N&N19SK:>5]J\MO)\[.S?CY=V.<9QG%>*
M_P#"Z/$?_/EI7_?J3_XN@#W!D*G<O6G(^:\S\3_&"TL)I;/0K=+V9&VFYE/[
MG(Q]T Y<?>&<@< C<*X.7XH>+I)WD34TB5F)$:6T>U!Z#*DX'N2: /HHTA&:
M\#TSXN>)K*;-X]OJ$3,NY98@C #J%*8P3ZD'&!QZ^P>%?%=AXLTH7=H?+F3"
MW%NQRT3?U!YP>_L00 "Y<(?/&>E7T^XM5+K_ %XJRTL5O;M--(D<4:EG=VPJ
M@<DDGH* ):C=RHXZUY=XA^,MO;326^@VB78"KMNYRRIN[C9@,1CC.1SV('/$
MS?%#Q=+.\BZFD09B1&EM&54>@RI.![DF@#Z% ;.35:[1E99 ._->#VOQ5\6V
M]RDLE_%<HN<Q2VZ!6X[[0I]^".E>A^%?BA8>(IH=.U&#[%?R?*C;LQ2M@< G
ME23G"G/0#<20* ._BD\Q 1S3\FL^&0V\NQC\OK46N>(M+\/6#7FHW21C:62(
M$>9*1CA%[GD>PSS@<T 37T>0#T.:9!).J\+D>YKR#Q!\7M2OI)(M(M8K.WZ)
M+(/,EX;K_=&1@8PV.>:PU^)?BY!A=6P/^O:'_P"(H ]_:6Y?@(/SIT=LS-ND
MZUXYH7QBU2TDBBUBUAO8!P\L2^7+RW7CY3@9&,+GCGKGU[0M<L/$6E1ZCI\N
M^)^&4\-&W=6'8C_ C((- &@,CC%#,54DTIJG=3Y_=IR3QQ0!"'\VX8U>0,3E
MJKVUOY:@L>:NB@!,FDR<4[BHV? P!DT 5,DWHX[5=R>*I(I6] )SD5=/44 +
MDTF6I:6@!,FFL"PP13R*!0!GO');2;T'R]ZM13B5<CK4K*"N#S6>\3VTA=<E
M2<D4 7R3MYZTV,G;212B6,'H?2GQCY: %W&C)HI10 F31DT[%)B@!,FD).:?
M33UH ,FC)HIV* &;C2<]:?BD- "9)HW&@<4O!H :V3S37W;:D)XII^Z* $0D
M+3MYI%'RTI'%  ":7)I%I30 9-(2:<,4&@!G.:7)H[4HH 0DT<XI>IH/ H 8
M2=IHC)V]*7L:5?NB@!<FFY.:DQ3!UH 7)HR:4B@4 )DT9-.Q330 GS&CFG"E
MH 9BE %*:!0!;MP!$/<FI:BM_P#4K^-2T %%%% !1110 4444 %%%% !1110
M!R?BC_D(Q?\ 7$?S-8=;?BG_ )"47_7$?S-81-?$Y@O]KJ>O^1TQ?NH":]!O
M_P#D%W7_ %Q?_P!!->>UZ#?_ /(+NO\ KB__ *":]+)_X=7T_1F4WL>>UTOA
M'[UY_P  _P#9JY@FNF\('+7G_ /_ &:N7*_]ZC\_R8I,K^+68ZC"FX[1%D#/
M .3_ ("N>)KLM<T.YU.\2:&2%56,*0Y(.<D]A[UG0^$;HS)Y\\(BS\WEDEL>
MV173B\%7J8B4HQ=F_P#(@H:/H\NJS]TMT/SR?T'O_*NSEEM-&T_) B@C&%4=
M2?0>I-$LMIHVGY($4$8PJCJ3Z#U)K@]4U2?5+GS9?E1>$C!X4?X^]=?[O+Z=
MEK-_U]WYDMV#5-4GU2Y\V7Y47A(P>%'^/O72ZYI%A;:%))#;*CQ ;6!.>6&<
MGO\ C7%UZ#XC_P"1=N?HO_H0K'"?O85IU-7;_,A.Z9YZ332:"::37GI&+8$T
MPF@FD)JDA'=^"?\ D$3_ /7<_P#H*US?BS_D8[KZ)_Z *Z/P1_R!Y_\ KX/_
M *"M<UXM/_%277T3_P! %>M67^QP_KN:R_AHHZ4?^)Q8_P#7Q'_Z$*] \5_\
MBS>?1/\ T-:\]THYUFQ_Z^(__0A7H7BO_D6;SZ)_Z&M5@U^XJ?UT%3^%GEY-
M-)H)II-<"1B>A^ O^0+<?]?!_P#05KJJY3P#_P @2X_Z^3_Z"M=77O8;^#$Z
MZ?PH****W+"BBB@ HHHH **** "BBB@#!\1(H>W?'S'()]AC_$U':GY14OB+
M&;7ZM_2J]LXXYH OKU%3#I4",OK4V]<=: '44W>OJ*-Z^HH =13=Z^HHWKZB
M@!U%-WKZT;U]: '44W>OK1O7UH =13=Z^M&]?6@!U%-WKZT;U]: '44W>OK1
MO7UH =13=Z^M&]?6@!U%-WKZTF\>M #LTR09(J"Y<@95JK?:6&.IH TU^[2U
M06]QU6I!>@_PXH MT57%VI]*>)T/\0H =+]PT1_=%,DD4H>0:=&?D&* ']Z6
MFYYI<T +129HS0 M%)FC=0 N* ,4F:,T +36Z4N::QXH <*6F@T9H 1Z:.M*
MU)WH D'2HWZ4NZFL<B@!D?0U)44;@ Y-*9D'<4 2 T[K5<W*#TI#> =!0!/C
MFI!TK/:\R>!33=MV!H TC3&JI!(SG<S$>U62X(ZT .7 I_%1!U'>E,@*]: )
M/I0,UGR3.C<$XI!>$=J -+I15 7WJM/%Z/2@"Y2<U7%VI]*>+A3W% #9>HJ9
M.E5Y'4D<U(' '6@":D/2H_,'K1O'K0 Y>M>8_%KQ@UC;#P_8RNEQ,H:YDC<?
M+&<_(>X)ZGIQCJ#7IF\>M?,/BG5VUWQ-?Z@2Y664^7O4 A!PH...  * #PSX
M=NO$^LQZ=:LB'!>21^B(,9.._4<>_;K7ONAZ':>'[*/3["/;&O+,?O2-W9CW
M-8'PFT1--\,-J,BLMS?MN.Y2N(U)"CD\@\MG ^]79C_CZSVH OKPHI:9O&!S
M2^8/6@!DT:31O%*BO&ZE61AD,#U!'<5PUC\)] MM;GOI5>XM20T%F^=D1SDY
M.<N/0'C'7-=T6'K2AP.] #QP, 8 [5X?\:/^1HL?^O(?^AO7MN\>M>(_&<Y\
M46./^?(?^AO0!T_P7_Y%>^_Z_3_Z E>D$\5YM\&6 \+WV?\ G]/_ * E>C[A
MZT 4KW1M*U*59;[3;.ZD4;5>>!7('H"1TJZ    , =!7C^O?%?7=+U_4+""T
MTYHK>X>)&>-RQ .!G#CFO3]!U"35- T^_G"++<6Z2NJ A02,G&<\4 :0ZT_%
M<SXVUO4?#_AQ]2TR&":2*1?-$^2JH>,X# YSM'XUP.B?&+4)]8MXM8BT^WT]
MB?.EBAD+*,'&/F/?'8T >QD\4T=:\5UWXQ:E<RRQ:+;16D'19I5WRGG[P'W1
MD=B&^M8'_"SO&'_07_\ ):'_ .(H ^CATHKR?PM\8/M=['9Z_;P6ZR-A;N$E
M40\8W*2>,Y^;/''&,FNB\:_$6R\+!;6V1+S477=Y>_"Q CAF(_#Y>X[CC(!V
MU%?/-W\5_%MQ<-+%?0VJ'&(H;="H^F\,?UIUG\6/%EK.9)KN"[7;CRY[=0N?
M7Y IS^- 'T)31UKE?!OCRP\70.@06M_%R]LS[LK_ 'E.!D>O''Y$]2&7/6@!
M](PK&\1^*-,\+Z>+O4)6^9ML<48!DD/?:"1T[D\?F*\EU7XR:W=&5-.M;6RB
M; 1R#+*OJ<GY3G_=[_C0![F*#7SG_P +/\8_]!C_ ,EH?_B*NZ;\6_$]G,6N
MY+>_C)&5EB"$ ==I3&"?<'Z4 >^D4H:L#PGXLL/%NF?:;7]U<1X$]LS9:,_U
M!['^1R*D\6ZK<:#X7OM3M4C>:!5*K*"5.6 YP0>_K0!:\1#_ (IG5O\ KSF_
M] -?-/AW_D9M)_Z_(?\ T,5UEY\7=?OK&XM);331'/$T3%8Y,@,,''S]>:XB
MRNGL;ZWNX@ID@E650W0E3D9]N* /K2BO"?\ A<_B/_GRTO\ []2?_%UZ-\/?
M%-]XMT>ZN[^*WCDBN/*40*P&-H/.2>>: .O/2FXR:=BO,O%'Q;M-,GFL]%MU
MO;A&VF>0_N01CI@Y?N.P]": /2QP:?7SK-\4O%TL[R)J20JQ)$:6T951Z#<I
M./J34MG\6/%EK/YDUW!=KMQY<]NH7Z_(%.?QH ^A#TI!7%>$?B3IOBB864L3
M66H%21$[!DD_W&XR<<X('MG!KL@1_>H DSQ1D&HSC'#53FD>-N&)H T:3-9P
MNV'8TX7A[J: -#-)FJBW8/7BGB=#_$* +&:B?[PH$BG^(4URI(^:@"?/%(3Q
M3,C^]2G&/O4 )']\U)DU A <_-3C*H_B% $O2C-5S<*/X@:8;H4 7,T5GF[I
MANV]#0!I9%(>E9\4CR/]X@5=X Y:@"04M,##UI=P]: '5DZW]V#ZG^E:FX>M
M96M$%8.<\G^E #+'J*Z"#[HKG['J*Z"#[HH LT444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !6;<7B13,A!R,5I50FMT>1F/4T 5C?QGLWY4GVZ/T
M/Y5*;5*;]E2@!GVZ/T/Y4?;H_0_E3_LJ4"V2@"+[='GH?RI?MR9QAORJ3[+'
M2_9DH C^W1^A_*D^VQXZ'\JD-JE+]F2@"$7L?H?RKY\^);B3X@ZHXZ'RO_12
M5]$?9HQ7SQ\35"?$/5%'0>5_Z*2@#T'X.W*P^$;M2#_Q_N>/^N<=<#\2](.F
M^,+FYCBV6M]_I$9&X@L?O@D]]V3@= PZ=*]!^#42R>$+LMU^WO\ ^BXZO_%#
MP[_:OA"6YMU4W%@WV@949,8!W@$D8&/F]]@&.E '/?!SQ$PM;W1+B0L(B)[=
M3N)"DX<9Z  [3CCEF//;U+[<GH?RKYA\.ZJ=$\16&I9<)!,#)L4%C&>' !XR
M5)'X]J^D[^_T_3M$FU>69&LXH?.#HRD2+C(VG."6X YY)% 'CGQ>UX:EXC@T
MU(]L>GQ\L1@L\@5CWZ8"=ASGVJ;X0:3')K%SK4Z.1:+Y<'RG!=P0Q!SC(7C'
M/WP>.*\[NKF:]NYKJX??--(TDC8 RQ.2<#CJ:^D?!GAO^P/"ME8SJHNMIDN,
M* ?,8Y()!.2.%SGD** /*_C'*)O%UHPSQ8(/_(DE:_P4G6'^W-P//D=/^VE9
M7QE01^+[0#_GP0_^1)*U_@E&)/[=SV^S_P#M2@#U;[<GHWY5Y+XW^',VH:U_
M:6A8(O)2US%*^!&[')D!/53R2.2#T!!P/71;I6=K&K:/X?MQ/JE[%;(WW0W+
M/R =JC);&1G .,T <CX:^%V@V2K+?H^HSJP8&7*(""2,(#R.F0Q8''OBNKE\
M(>&IH7B;0=-"NI4E+5$8 \<, "#[@YK@KOXU6$,RC3]%N)XMO+3S+$P;TP W
M'3G/X5@_\+G\1_\ /EI7_?J3_P"+H B^)'@.V\+_ &?4-,:4V-Q(T;QR,#Y+
M\E0#U((SUSC;R3FM?X*ZQ,+S4-$8;H&C^UH>!L8%4;MDY!7OQMZ<UR?B?X@Z
MMXKTV.QOK>RCBCF$P,".&W $=V/'S&MKX,?\CC=_]>#_ /HR.@#W2O#/C1_R
M.%G_ -@]/_1DE>Y]Z\,^-'_(X6?_ %X)_P"C)* .O^"__(G7?_7^_P#Z+CKT
M;-><?!?_ )$^[_Z_W_\ 1<=>C8H ^1:]&^'?P[A\1V[:KJS2K8K)LBA3*F8@
MC<2V/N=5^7G.>1CGSFOJG1=-CT71++38MA6VA6,LJ; [ <MCL2<D^YH K1>$
M/#4,*1)H.FE44*"]LCL0/5B"2?<G->;?$[P#8:;IQUW1X/LZ)(!=0*?D 8\.
MH)X^8A=HXY& ,'/L0(K&\7PQS>#-:66-)%%E,P#*",JA(/U! (]Q0!X1\.]6
M;2?&MB<OY5T?LLBJH)8/PO7H-^PDCG _ ^W:EI.EZY:&SU:U-Q DHE5=[)A@
M",Y4@]":^?\ PK_R.&B?]?\ !_Z,6OIWR$).: /+/&_@WPQI7@^^O=.TPPW4
M?E[)/.D;&9%!X9B.A->?>"-/LM5\7V%EJ,/G6DGF;X]Q7.(V(Y!!Z@5[/\38
M43X>:H1_TR_]&I7DOPR4/\0]+4]#YO\ Z*>@#U7_ (5[X*_Z K?^!,W_ ,57
M1:7#I^C:=%I^GP-#:Q9V1Y9L9)8\G)ZDUH_9TH^SI0!XQ\6?%DEU?_\ "/VO
MFQ6\&&N>0!,Q 91CKA0<^Y/3Y0:YCP;X/G\47X,A>'38F_?S@<G_ &$_VOT
MY/8' O[R34=1NKV5462XE>9P@PH+$DXSVYKU'PS\1_#6@>&['3&M=5>2&/\
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MX'?=@9/0,>G6O:O&EK#>>"M9BG3>BVDD@&2/F1=ZGCT90?PKYW\+?\C?HO\
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M<8BN5); 7/WP!U*\]CP2.,YKO9?BQX=N(7AFLM2>)U*NC11D,#P01OY%>-4
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M *$:]^\'Q@^#=&/_ $YQ?^@BO O&'_(YZU_U^R_^A&OH+P</^*,T7_KRB_\
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MA'59-&\4Z?=)*L:&58Y2[$)Y;'#;N1P!SSQD U]-+&IY&"#T(KY.G %Q*
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ME.&"D@X+>M>'Z-;Q7>NZ?;3KOBFN8XW7)&5+ $9'M7TOXB!'AG5?^O.;_P!
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MGX+_ /(XW?\ V#W_ /1D= 'N=>&?&C_D<;3_ +!Z?^C)*]SKPSXT?\CA9_\
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M<A7'GXS_ -LZ/@O*T1UO:A;/D=/^VE3_ !P  T+'_3Q_[3H^!X!.N_\ ;O\
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MN:,4E !0#2T8H ,TAH%+B@"*;_5FH;$_NC]:GF'[LU!8_P"J/UH M4H-%&*
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M5"EO!'"A.2L:!03Z\5YKXO/_ !4UW]$_] %=-X#_ .0+/_U\'_T%:Y?Q@?\
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MSKBZ6*1E..* )&IM,299!D$4[</6@!:*ADF6,<FB*X63H: )J*,YJ.241]:
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M=IG[[?E0!8TN8O)*KMEL @>W^36G5"U1(9QM4#/&:OT %%%% !1110 4444
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M%KTJO^ZP_KN;3_AHS]'/_$[L/^OF/_T(5Z1XP_Y%6]^B?^AK7FNCG_B>:?\
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MOF'O0!?HJ%+J-\9.T^AJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:EJ*/[YJ6@ HHHH 1NE(M*W2D6@!U-;I3J:W2@!1TI:0=*6@ K)UO[L'U/\
M2M:LG6_NP?4_TH CL>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110
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MCSAMY-/6\(49 H O9Q463(?]FJK7C,> *<+S X H N ;:=5'[;]*7[8<< 4
M6F8+30I)R:J"Z.[<PXI_VSOQ0!<%!.*I?;,^F*1KPD8&* +3,<X6J%ZNPASU
MSS4JW6![U6N)C*.10!*LT 3E3GZ4]9+?&=A_*FV<:R+EJM_9TH K&:WS]P_E
M2>9 6R4./I5@P1YIWV9* &)Y$@X6E:./H%JM<P^20RDTL=WA!G&: $CB$=X%
M'IFKKD*!ZUG>>?M(?C.*D-TQ;) ]J +@4ORU2#BJ8O2>,"FO>,1\H% %LL6;
M J*:V5ESCYO6HENL#H,TOVUB.@H 6TE/W'/S5<K($I^U!_:K0O6Z8% %F?\
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M*X &1V/'O6Y45M<1W=M%<0MNBE0.AQC((R.M2UVQ22LCI225D%%%%4,****
M"BBB@ HHHH *J:G.MOITSMCE=H&<9)X_^O\ A5NL77Y R16_')WGC\!_6@#%
MCE4L.#6Q;CY16+'&#-@5NP+A!0!-@'@C(]#3'M8V'R_*?:I!3Z ,^2VD0\#<
M/44R.5XS\I_#M6G4;PQR<LO/J* (8[P'B08]QTJRK*PRI!'L:IO9L,E"&'H>
MM0 O$W&584 :E%5([SM(/Q%6E=7&5((H 6BBB@ HHHH **** "BBB@ HHHH
M**** $;I4#]14S]*A<]* 'K4O:H1TJ4=* %HHHH 9+_JS1']T42_ZLT1_=%
M#N]+2=Z6@ HHHH **** "BBB@ IK=*=36Z4 *.E+2#I2T %-/WJ=33]Z@!PZ
M4UNE.'2FOTH ;%T-25%$>#4M !0>E%% #:0]*<124 -4^M*U&*1J !32YYIH
M%+B@!^ZC=3,&C!H ?NHW4S!HP: '[J-U,P:,&@".3[PJ<=*KR9!%2@G% $E(
M>E,R?2CG% #EIU1C-+\U !WIV:9S1@T /S1FF?-0=U  W6FN,QFE- S0!6BF
M\MB&!XJ4W2$9YIYB#<XJO/$H&!UH LAPZY%170)C4CM3XTVH*?C(YH K17*J
M,$'-3"Y0G%)Y*$U 8E,PVGI0!=#@C-!84T)@8H(P.: '%P!S561VD;:O2D):
M9MH^[T-3)&(P * %2,(O'6GYS1M)IP&!0!7N6PH'KQ3[=-D8'>H<&2<CL*MB
M@!::/O4ZFC[U #J#THH/2@!!TH/2E'2D;I0 TMBC=2#DT[ H 3(I<4A2DY%
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M '9HS3,&C!H ?FBFX-)@T ./2D4T8)H"X% #NHJ2U?#E#WZ5$#29*,&'4<T
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M %%%% !7*:A<?:;N212=O1>>PK>U6[^QZ?)(#AV^5>O4_3VS7)B7>0 #S[4
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MZ51DMG1<B4FI;)B8N3SF@"SWIV:3B@F@ - -&10: %IIZT T'K0 H-+3:7-
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MUTY\#:H?^6]G_P!]M_\ $TT^!=4_Y[V?_?;?_$U:PM;^5BY)=CF"::374_\
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MD_T&!R>*VA0;^(J-&3>I8T^QATS3X+.W7$<*!1P,GU)QW/4U9HHKL.L****
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M%&32BC% #2U-)I6I* %W4A;BG #%-<8% #(SP:DW5%'T-/H =NHW4@%.V\4
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M864-I:IY<$"".-,D[5 P!D\T /8 ]: H'0"E(Q2@9% #<#T%+VP*?M%,(P:
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MX^8\4 9,ULBJ2%YJ@.7*XKH'4,,8JL+.-7W]Z *T5LA0%EYISVR;3A:O@ #
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MF;:'GE5%+<G&2>O!_*O*O@KHO_(0UUG_ .G.- ?]UV)&/]S'/][CI6Q\:/\
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MA60#N>:A&D?O-[3EC_N__7H K6L'\;CYLU:(JR+0C_EI_P".TOV4_P#/3]*
M*4P/EFH+($Q'ZUHR69="!)SVR*AMK":%-K,A.>Q/^% !@TFTU,891GY<XJ,[
ME^\I'UH 3::,&EW"ER* &;300<T^FGK0 8-)M-/'2B@!N#3<'-24TB@!-II<
M&@&E^E #2#3'SMJ1NE-(^6@!L>2M/Q2(.*7D4 &TTN#0IIDLRPCGDGH!0 KJ
M,9<@#WJC*T9.$7CU-$DSRGYCQZ#I4L-H6PTG ]/6@"".-I#A1T_2KD5L$Y/+
M?RJ=5"J%48 I: &8-+@TZB@"-E.TT(#MI[?=-(G2@ P:3::?10 W!HVFG44
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M]* *KTT=:L-:2'^):C%O,.2GZB@!*8_2I"&4?,I'U%1.: &1=#4E,BZ&GD4
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MUO[L'U/]* (['J*Z"#[HKG['J*Z"#[HH LT444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !59^IJS59^IH C:FTYJ;0 E%+BB@!,TM%% !24M% "4M
M%% "&EHHH **** "BBB@ HHHH **,44 !J.:*.>%X9HTDBD4JZ.H*LIX((/4
M5)10!YMXA^#^F:BUQ=:1</8W,C%Q"P!@S@_* !E03@YR0.<#H!YSJ_PW\4:0
MQW:<]Y%N"B6R_>AB1G[H^8#J,E0,_49^CZ* /D2O0/"OQ4U71I!!JS2ZG9'
M!=_WL?S9)#'E^">&/88(%>OZ_P"%-&\2PE-2LT>4+M2X3Y94ZXPP[#<3@Y&>
MQKYZ\5>&KOPIK;Z==.D@*B2&5>DD9) ..QX((]1W&"0#Z8T^_M-4L(;ZQG2>
MVF7<DB]"/Z'L0>01@UP_Q<UQ]+\*I803;)]0D\L@;@?*49?!' Y**0>H8\>F
M%\$M4_Y"NDO-_=N88MO_  %VSC_KF,$_3O1\<?\ F _]O'_M.@#@O!GAIO%7
MB.'3R[QVX4RW$B8W+&/3/<D@=\9S@XKZ4M;.VL;9+>TMXK>!,[8HD"*N3DX
MX'))KY4LM0O=-F,UA>7%K*R[2\$K(Q7KC(/3@?E5[_A*_$?_ $']5_\  R3_
M !H ^HBM>>?%S0;6[\+MJY55O+%D D"_,\;,%V$YZ98-SG&#C&37D'_"5^(_
M^@_JO_@9)_C3)?$VO7$+PS:WJ4D4BE71[N0JRG@@@GD4 :/P_P!4DTKQQI<D
M>\K/,+9T5RH99/EY]0"0V/51]:^E :^1J^N-O% 'R]XK_P"1QUO_ *_Y_P#T
M8U>M_#/P1;:?H]OKEVF_4;N/?%NP1#&W3;@GEEP2>H!QQSGR3Q7_ ,CAK?\
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MWL+5E5"C &!2T 4CIEN[[I07.,8S@?I5J.&.( 1HJX&.!3Z* "BBB@ HHHH
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M44\$$9'(IC]10 X=*6D%+0 4444 ,E_U9HC^Z*)?]6:=#&SJ,#\: #O2@$G
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M'W1P73)&, ;00&/UY)KEOC5_R,UA_P!>8_\ 0VKH_@M_R+=__P!?A_\ 0%H
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MM,?]X4?:8_[PH FHJ'[3'_>%'VF/^\* )J*A^TQ_WA1]IC_O"@":BH?M,?\
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M@/45HRQ)-&T4J*\;J59&&0P/4$=Q7S#X<\3ZEX6U W>G2+\R[9(I 3'(.VX
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M?'2OF#QG_P CKK7_ %^2_P#H1H ^@_!G_(E:+_UYQ?\ H(K<K#\&?\B5HO\
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MQ7"ZS\)O#FISR3VXGT^1U/RV[#R]QSSM(/'L"!QVKO*0B@#R+_A1_'_(Q?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ*D!5NA% !D=@*8Z!^O!J3 HP/2@"IMECSLY^IIA264C>,#/:KV*,"@!JD*
M!2[Z7 HH 3?2[J** #=3J9CFG#I0 C_=J*'JU2O]VHH>K4 3]*0F@FC&: $
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M (8JJMJ#VJ9+?  Q0!!M9V+,26)R2>]2I"35I+?VJ=80.U %9(/:K"0XJ=4
MIX6@!BH!3PM.QBB@ HHHH **** "BBB@ HHHH **** &]Z=28I: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *G@B_C8?2F11[VYZ#K5L# P*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *" 001D'J*** ,JYA-M+E1^Z;H?3V
MH1LBM*6))HRCC(/Z5D8:&4QOU'I0!:!S2U&K9YJ2@"O+]X5,G2H9?O"IDZ4
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MJ\XQG9)M:&ZC&QMGQ3>_\\K?_OEO\:3_ (2J^_YY6_\ WRW^-8=)6"S#%?\
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M(/M0!+O'2D# G%5O*DC/R\CW-2QR!_E;AO2@"3<*7<*,"C H -PHW"C HP*
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MH -XHWBFE@&"T[:#0 ;Z-XHVBC:* #>*-XH(%&T4 &\4;Q1M%+MH 3>* V2
M!UI=M3V\?.\_A0!/&FQ ._>G444 %%%% !1110 4444 %%%4KO5+:R;9(S,_
M=4&2*SJUJ=&//4=EYE1BY.R1=HK(_P"$BM/^><__ 'R/\:/^$CL_^><__?(_
MQKD_M3!_\_%_7R+]A4[&O16/_P ))9_\\Y_^^1_C1_PDEG_SRG_[Y'^-/^T\
M'_S\7]?(7L:G8V**QO\ A);/_GE/_P!\C_&C_A)K+_GE<?\ ?(_QH_M+"?\
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MHCR: )B>:*.IHS0 M)F@FD'6@!0*6BDS0 W^*GTS^*GT )BD(I<T&@! *7%
M-+0 4QNM/S3#]Z@ QQUI<4N 124 +@4=**#0 G6C;0.*7- "8Q2\4E(: '<4
ME'%% "\4A%%+UH ;G%.SFFXS2<B@!XI:3-&: %HI,T9H 6BDS1F@!:*3-&:
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M3_T(5ZG7N94WR27F:TMF%%%%>H:A1110 4444 %%%% %6_M_M%L<#YT^9?\
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M['J*Z"#[HKG['J*Z"#[HH LT444 %%%% !1110 4444 %%%% !1110 4444
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MR.I5E."",$&F$UZA<6T%W"8KB)9$/9AT]QZ'WKG=2\)1,C2:>Q1P,B%CD-[
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M0E'VA*J_8CZG\Z/L1]3^= %KSU]:>KANE9[VC*N03^=%I*P?:: -*BD'(I:
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MR2_;;6+%LW^L"]$;Z=@?\]JYDFOG:M&5*;A(YI)IV8$TPF@FFDU*1);TP_\
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M0 44F<4O:@ HHI.M "T444 %%%% !1110 4444 %':BDYS0 M%'6B@ HHHH
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MXT^'6M3@<LE[,21CYVWC\CFO*6;TWO%_@1SH](HKEM.\7J\FS4(UC!SB6,'
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M##(V$_B.10!AV[5>!^2LVW/-:"'Y* 'Q5+4452T %%%% !WHHHH 0BC-+10
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M6#C^E5[J$E3BI74H=RTXN'C- %&VE,;%36B&##(-993?,P'K3Q++ V#DCV%
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M]*S3$V*O6YP@!H D;K3DII/-/3I0 ZBBB@ H/2B@]* &KUIU-7K3J "BBB@
MHHHH **** "BD)Q10 M%%1O*L8R: ',X6J5Q<DG:E1O-).VU.E6(;54Y8<T
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M]/\ OK%<OXLGFFUR3S$D1$ 2,.FW('4CU!.>:P2:NOCYQFXP6PI56G9'??\
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M^\*#=ICAA0!,[X&.]-1,G)JNMRA8EC4@O(^S"@"R!BC-5OMD?]X4CW:8X/-
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MUH M9Q65K9RL'U/]*M?:T_O"L_5)EE$0!S@F@!]CU%=!!]T5S]CU%=!!]T4
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MK+M!F0UI<XH ?13,FC)H 4_>I1TIO.:=VH ":3% IU !2$T$TE !UIU%(30
M$TG6CK3J "D)I2:;UH BN>836:.''I6E<C]RU9HXD7% &E'&GECY13FC3&=H
MI8AF,4YA\M &1)P[CUJ[9<*/I5.7F1O:KEER* ++#<I%"+MIU!H J7OW/QJB
M.6P#@U>NAE>:JHB[J '^1,0")#1Y$H).XYK00#8*&'!H R6)/4YJ]9GY351T
M7>?K5VT4!3B@!+S'E55MT._-6[H#RZCMP&Y[T 6EX%+WH[4"@ /6CI0.32D4
M +UI,4G2G4 -I>U!%&: #%)3J0B@ %!%'(I>M "4C=*4BD:@ 7I3J1>E+0 4
M444 %%%% !1110 4444 4KP'&:KVW,E:,JAE.:H1#;<D#I0!I#H*6D'04M !
M2'I2TC=* (SUI_:F=Z>O2@!LG^K-93_?:M63_5FLI_OM0!=LO]6*AO/]8*6V
MG6-,-4=Q()7!6@!;7_65J5DP.$?)JY]LC'7- %JBJOVR,>M O8_>@!MY_JZI
MQG,HJQ<7"RIA:K(=KACTH TS_J/PK+/6KIND,6!GI5(\\T :>F_>7ZFM:L*S
MG57C0]2P_G6[0 4444 %%%% !1110 4444 %%%% %>__ .0==?\ 7%_Y&O.B
M:]$U#_D&W7_7%_Y&O.B:^=SO^)#T?YE18$UHZ!<_9M9A)?:LF4;C.<]!^>*S
M* [(P96*L#D$'!!KR:,W3FIKHQ-GIEQ%Y]M+#NV^8A7.,XR,5YBW!(]*]*LK
ME;RRAN%Q\Z@D!LX/<9KB_$UF;757D"XCG^=2,]>_XYY_$5[^:T_:4XUH_P!)
MD2V,8FDHI*\1(R;"MOPOI\EUJ:W.'6&#DL.,MV&<^^?_ -=9-I:RWMW';0@&
M20X&3@5Z/IUA%IUE';Q@<#YV QN;N:]++\,ZE3G>R_,(*[N6F=47<[!1D#).
M.3P*6N'\7ZJ9[H6$3 Q1$%\8.7^OMG\\TG@_47COS922DQ2*?+4DG##GCL,C
M/Y5ZGUZ/M_96\K^9?M%S6.X9E1&=V"JHR23@ 5GPZ]I<]T;:.]C,N< '(!.<
M<$\'\*-=@^TZ%>1[MO[LOG&?N_-_2O+":,7BIT9)):!.;BSUZYM8+R$PW,*2
MQGLPSCW'H?>N$UWPI/I^ZXL@\]J%W-DC<GKGU'T_^O4.B>*;C2CY,^^XMC@!
M2W,?^[GMCM_*O0;6ZAO+9+BWD$D3C*L*2]CC(]G^/_!0O=J(\=)II-=;XM\.
MI9@ZC9KMA9L21 <(3W'H/Z_7CD":\RI2E3ERR,)1<79FKX=M'O=>M(UW (XD
M9@N<!>>?R _&O4[B=;:VEG<$I$A=@.N ,UQ_@+3@(I]1=6W,?*CR"!MZDCUY
MX_"M'QIJ0LM$:!682W1V+M)&%'+'^0Q[UZ>&7LJ#F^NO^1M#W87/-9I6FF>1
MV9F=BQ9CDD^]1$T$TTFO.2.8N:2?^)U8?]?$?_H0KVBO%=(/_$[L/^OF/_T(
M5[57IX+X6=%#9A1117:;A1110 4444 %%%% !1110 C,%4LQ 4#))Z"N/MN0
M?K757O\ QX7/_7)OY&N5LON"@#6@'%60.*KP#@59'2@  IV!31UIU !BDI:3
MO0!$OWJEQ42??J:@ P*BF;8A-2U!<_ZIOI0 ^-MZ T_ J*W_ -2OTJ7K0 8%
M!'%&:#TH 0#FG8IH^]3J #%&!12=Z $;I31UI[=*C'6@"4=*J7OW:MU3O?NT
M 1P6P= 2:E^QKG-/M?\ 5#Z58Q0!4^Q+1]C4U;HH J&S4\4?8E]JMTAZ4 5?
ML2^U(;115L4UJ *_V-31]B4>E6@.*7% %3[$M+]C4<U:HH I_8E)SFE^Q+5O
M%% %3[$M(+1<XJV:;_%0!7^Q+0+-35K% H JFS6@6BD^U6CTI%YH K?8EI?L
M:XYJU2&@"K]C0#M3?L:YJR3FG 8YH K?8UH^QKZU:)H H J_8UH^QK5ND)H
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M 4U5).30 JKDY-/^E'2C.* #'%1NV?E6E=LG H5<=>M  B8Z]:?2]*0X YH
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M5+[[M6^]5+W[M $EK_JA4^:@M?\ 5BK% "9HS2T4 )F@FEI#0 "D/-*.E&*
M =*6BB@ HHHH ****  ]*9_%3STIG\5 #^U(*7M2"@ /2D6E/2FKP* '$XIA
M.32DY-*!B@  Q1F@FE H  *6BD)H ":3%%.H :#2DXH-)UH ,T9Q2\#K1C-
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MI2L_.%Z]Z %=LG ZT(N.O6A$QUI] !F@G%)G%1DES[4 '+GCI4@ 44!<"EH
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MGCMFKN;?^\* ();B-H6R#DBK-GG[.OTJC>^62NTU>M.(%^E %D4444 %%%%
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M*V<9%02;RI /% $$763)[4^PX7\:AC5OG'H*DL@Q3(]: +^:,U'M?UHVOZT
M29HR*CVOZT;7H =)]P_2JEF%).?6K#JVP\]JJVB,">>] %W:OI1L7TH ;O3C
MG% #=B>E&Q>P%-VOZTY<CK0 ;%]*-J^@I6!/2F;7]: ';5]*JWH4(,#'-6-K
M^M5;T'RQGUH C-QLAVJ.:C,14AF/)IF"#STJQ/G:G- $<4?G.03C%6OL8_O5
M6ME8RG!K0VMZT 9]W"(P.:N69_<*/:JM^I&TGM4]J&,*D'J* +>:6HP&'6I!
MTH **** "BBB@ HHHH :W!R.M7T;>@8=Q5$]*GM9,@QGMR* +-%%% !1110
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MYS(* &VO^LK4K+M?]96I0 4444 5+W_5GZU2C_UHJ[>_ZL_6J4?^L% &D?\
M4?A66>M:A_U/X5EGK0!HV?\ J_QJ<Y!!'6J]G_JZLGI0!>1MZ!O44ZJ]J^04
M/;D58H **** "BBB@ HHHH **** *VH_\@N[_P"N+_\ H)KS*O3-2_Y!=W_U
MQ?\ ]!->95X6;_'#T?YF51DMO%]HNH8=VWS'5,XSC)Q7IMO;Q6MND$*!(T&
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MX^M;5@O[H<5E.OS"MJR7$(H M*!3B!B@#B@]* &@4[ I!UI2: $HP/2E HH
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M\AR__P"OF3_T(UGDU\Y->\_5G$]P)II-!--)H2$!-==X$L+.]EOGNK:*<QA
MHD7<!G=G@\=A7($UV_PZZZE_VR_]GKJPJ3JJY5/XD=U1117LG8%%%% !1110
M 4444 %%%% !1110 4444 %%%% !4%Y<BTM7E.,@84'N>U3US^LW7G7(@0_)
M'UP>K?\ UO\ &@#.7+N68DDG))[UH0)TJK"F36C$N!0!,HP*<WW30HIS?=-
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M" 1T-9IYJU:294H3RO3Z4 6**** "BBB@ HHHH **** *NI?\@N[_P"N+_\
MH)KS FO6:Y;5O"1N+GSK!XHE?EXW) !]L _E7F9CAIU;2AK;H9U(M[''$TPF
MM<^&-9_Y\_\ R*G^-)_PB^L_\^?_ )%3_&O)6&J_RO[C#EEV,<FF$ULGPMK7
M_/E_Y%3_ !II\*ZW_P ^7_D5/\:M8>K_ "O[@Y9=C&)II-;1\*:W_P ^7_D5
M/\:;_P (GKG_ #Y?^14_QJUAZO\ *_N%RR[&*332:V_^$2US_GQ_\BI_\533
MX2UW_GQ_\BI_\55*A4_E?W!RR[&(332:VSX0UW_GQ_\ (R?_ !5(?"&O?\^/
M_D9/_BJI4*G\K^X7++L89--)K=/@_7O^?#_R-'_\533X.U__ )\/_(T?_P 5
M5JC4_E8<DNQA$TPFMX^#?$'_ #X?^1H__BJ;_P (9X@_Z!__ )&C_P#BJM49
M]F+DEV,'I32:WSX+\0_] _\ \C1__%4T^"O$)_YA_P#Y&C_^*JE2GV8<DNQ@
M$TPFN@/@GQ%_T#O_ "-'_P#%4T^"/$?_ $#O_(\?_P 55JE/L')+L<^33":Z
M(^!_$?\ T#O_ "/'_P#%4Z'P%XBFF6-[1(5/6229"H^NTD_I5JG+L+DEV,G0
MD>7Q#IRQHSM]IC.%&3@,"3^0)KW>N5\+^"X-!?[7<R+<WI& P7"Q<<[?4^_'
M'8<YZJNRE!Q6IU48.*U"BBBM34**** "BBB@ HHHH @N[@6ML\IQD#Y1ZGM7
M++N=RS$EB<DFM'6;KS;@0*?EC^]@]3_G^M4X4R: (G3YA]:U[0?N16?*N&%:
M=H/W(H GI#TI:0]* &BG 4@ZTZ@ I.])UI<4 1)]\U)WJ-?O&I!UH "-W!J%
M[?G()J?\** &KD* :7BD+*.XI<@]* !:4]*1:<>E #%ZT^FKUIU "8I:!24
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M/>FJN3DT *JEN34G2DZ=*/>@ J-FR<"AW).%I57'UH 54VCWI_:DZ4'@9-
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MH *#S110!&KF*0.O;J/6M)6#J&4Y!K-(YJ:UEV/Y;'@]/8T 7:*** "BBB@
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MH8QN&'4?K3Z:PH T%8.H93D&EJG:R[&\MCP>A/\ *KE !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !574+M;2U9]P$A&$'J:LDA022 !R2>U<M?WC7MR6
MY$:\(I[4 0KN=RS$EB<DGO5Z".J\,>36C$F!0!4N1AA]:OVW^I%4[H?./K5R
MV_U(H FI#TI:0]* $'6EZTT4X4 &*#0:2@")?OFIAUJ)/OFI1UH ":CF8K&3
M3ZCN!F)A[4 5XXWE^8].U/*3(?E(Q4L&!$ *DQ0!!%<?-M;.:GS4,J J3T(J
M!;IA\@&2* +@XIV:JK.P/S  5.DJ2#@T 244@H-  W2H-I+<5.W2HUZT &QJ
MK7:D+S5WFJE[]V@!+=&\L8J?RV[FF6G^K%6".: (MC>M&QO6IL4F* (]C4;&
MJ6D/2@"/8U&QJE'2B@"+8U&UA4M% #5%*>:6B@"(JQ-&QJEHH 8H('-)WIYZ
M4S'- ",I/2FJC>M2$4T4 (5;'6D"'UJ3%&V@!NQO6DV-ZT\BDP: &[&]:78W
MK2@4NWZT ,V-ZB@HWK3\&C;0 P(WK2[6]13L4$4 1[&W=:D48ZTF.:7;0 XU
M&5:G8HQ0 S8Q[T\# YHVT8H 1>M#*2>* .:7;0 S8WK04;UI^WZT%: &!&]:
M78WJ*=MI=M #-C>HK+UA2%ASZG^E:^VLK6AA8/J?Z4 ,L>HKH(/NBN?L>HKH
M(/NB@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5G^\:LU6?[
MQH C/2FTX]*;0 4444 %%)FC- "T4F:,T +129HS0 M5;[_4GZU9S5:]YA/U
MH DM^(Q]*>S5%"P$0QZ4]1N^8T  4GDU(!1FDSF@!34;,3P*&?L*55P/>@!5
M7 IW2DS06P,F@!20.:C.7/H*3)D/M4@PM  !@8I<\49ICMCIUH &;'3K0J9Y
M-(BY.34F: #&*0\4N:B9B3@4 *Q).!3U4 4BC:*7I0 N*0D"@L *CY<^U !R
M[>U2 8H&,8%&: %--=L#CDTC/@8[TU%/WFZT *J]SUJ04E+G H ":B9BQVC\
MZ'?<=HIZKM% #2NV,@]<=:J6C8<CMGK5R0Y0_2J=KC!SZT 7@<TIJ$,4;GI4
MN\&@!&7/3K2*W8\4[<*8^",CK0!)014:R8X-/WB@",J5;(Z5!>,"B?7I5LL,
M<U2O$&$(]: +,0'E@XI^P=<4V)L(*?N% "!1Z4NP'M1N%&X4  4=A3J;N%&X
M4 .HINX4;A0 ZBF[A1N% #J*;N%&X4 .HINX4;J '44W=1N% "=Z:RYI<\T[
MJ* +5M/YJ88_..OO[U/65N,;AUZBM&&99X]P!'8CT- $E%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT9JHD/FR^85P* -"$?NQ4F*1.!3J $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
M3%&*6B@!I%  I6Z4@Z4 +BDVTHHS0!&>M2#I3&ZTX4 -89I$D:!]R\CN/6I,
M4QA0!H12K,@=#Q_*GUDI(]O)O3IW7UK3BE69 Z'C^5 #Z*** "BBB@ HHHH
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M0 5&/O&I*C'WC0 X]*1:4]*1: %ZTH%&,49H 3H:":#S1VH 1:?35I2:  T
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M((JW;WX8A)\*V/OD\'_"@"]1110 4444 %%%% !1110 4444 %%%% !1110
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MG![CL:T8+E)U&#ANZGJ*I,M0LK(X9#AAR"* -FBJ$&HIPEPP1O[YX4_X5?H
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M?B@ ;I48ZT\_=I@ZT 2U3O?NU<JG??=_"@"2U_U0^E6*KVO^J'TJQ0 4444
M%(>E+0>E "#I0:4=*0T )CTHP:*7B@!N>:?33UIPZ4 %%%% !3!]ZGTP?>-
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M-4;T]*O'I6=<!I), 'B@"&,X=?K6NIRHK*\EP5.#UK3B.4H ?37Z"G4U^@H
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M??J4=: &8-+@T^DQ0 PCI3MO%(>HIQZ4 - %.VTBTZ@!-M&VEHH 3;1MI:*
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M//;I1BX[BKZH%%+@$=* ,\+.!TH(N!U%7QA1S3,&1O0"@"F!<=0,CZT$7!/
M_6M#&!@4N .U &?LGQT_6FDSKQCFM!B%'O353/S&@"D%GSTY^M&R?/.?SJ_@
M9IW&.E &<5G/&./K3<RJ=O.:ONX P!DTU(^YZT 4PEP?7\Z-D_0_SK17'I2'
M ZT 9Q68>OYT 3'IFK9.]L 5*$"XXH H^7<'M^M!CG/0'\ZT<#TIK$** ,XK
M,O7-*%F(X%7-N\Y(J55 '2@#.V7'I^M4]0611%YGJ<5O8&*RM:^[!]3_ $H
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MN>IJ*YC9EPHS0 HOHB.M2"YC/>LU;&4CD8J5;!N[,/QH OB53WH=@<<U56R
M_C;\ZE: *!\QH G4\=:#]:8(LCJ:7RO<T .H--\KW-'E>YH =2C'K3/*]S1Y
M7N: ),CUHR/6H_*]S1Y7N: ),CUHR/6H_*]S1Y7N: ),CUHR/6H_*]S1Y7N:
M ',1B@$4QH^.II!'QU- $O&*0'%-\OW-'E^YH "1FG*1BH3%SU-2"/CJ: 'Y
M'K2$TSR_<TOE>YH >,4N1ZU'Y8]32>7[F@!^:4$5&(O<TOE#U- $F1ZTW/O3
M/+]S1Y7N: 'BER*C\OGJ:&0*"23@<F@"A-\TSGWJ\B8C4'' Q5!1N=1ZG%:
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M: '44W>OK1O7UH =6#XJ?%C#'Q\TF?R'_P!>MS>OK7,>*Y0TMM&/X5+?G_\
MJKDQ\N7#R(J/W6<[1117S)S'1>%KS;++:.WWOF0>_?\ I^5=37G=I<M:7<5P
MG5&SCU'>O0894GA25#E7 (->_EE;FI\CW7Y&]*5U8?2'I2TAZ5Z1J1=ZD'2F
M'[U2=J &2?ZLUE/]\UJR_P"J-93 M(0!0!=L\;*AN^9!30DR#.*81(YR1TH
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MJ(YE/M029#@=*D"[10 !=O I<]J44QW"T #/L'-,52YRW3M2!"YW-4X&!TH
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M$GH2<?I6HJ%CN:L[6ONP?4_TH 98]1700?=%<_8]1700?=% %FBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *K/]XU9JL_WC0!&>E-IQZ4V@ HHH
MH 0]*!TH/2@=* %HHHH **** "F/TI](1F@!%Z4ZBB@! *#R*6B@! *4444
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M!Z4#I0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI":  FDHZTZ@ I,T$TE !UIU%!H ,TG6CK2T %,/WJ>:9_%0 'J*?3#U%/H
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M[@8F;\*LPC="IQ[5%>?ZU?\ =J:U(,  /0G- #]AHV&I** (]O%&VGGI0.E
M#-M&TT\TM $84T%33NE!H ;L-&PT\4M $>PT;34E% &;=CYA]:LVZYB%5[S[
MX^M6[;_4B@!VVC;4E(>E # N:-M.6CK0 W;4<Z9C-3BF2<I0!EH"9<5I(OR"
MJ$0S<X]ZTUX% #=M&VGD\4E #=M&VI*0T 1A<TNPTY:=0!'L-&TU)10!'M-&
MTU)10!'MHVU)10!'MI.]2=JC[T 2#I2FD'2DH =12=J3- #JCDB#CI3\T&@#
M.DMWC;<F::7G(^[6EC-!1?2@#.\R;'W:EANN</Q5O8I'2JES;\;E% $[SKCY
M3DTB,O5CS52"55X8<^]3_:8_[HH L>:@[TUI%QG-0_:(CV%,>X1N * )#+N.
M!TIZNJ=ZB$\:KT%'VB/K@4 6#(N.M-$JCJ:A^T1D=!4?VA"WW>* )S(';D_+
M4GF+T!XJ'[1%TP*/M,7H* )_,7UIK3*!@&HC<QX^[3!/'DD@4 2*ZK\S'FHG
MN78X45&Y\YL+5N"W"+SS0!6\RX/1?UI/-FQ\PQ6@54=J-BD=* *,%QAL-UJ\
MK!AD57N+<%25&"*BMY2IVM0!=)PV>U1EC(<#IWI"3(^!TJ4*$7@4 -.V)>35
M5[LDX49IMQ(7EV=JFBMU7YB,T 5_-F8\"D)F8\BM#8H["C:OI0!G[YAP%I=\
MWI5X*N[I3A&OI0!G&2<=%I"9CR16D47THV+Z4 9V^8C&VE$LP_AJ^57TI0BX
MZ4 9WG3+U'%4]0D\P1^H)K;9$(Y K'U2-4,94CDF@!]CU%=!!]T5S]CU%=!!
M]T4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JL_4U9JL_4T
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M 2YH I*=0 4A-!-)0 =:=12$T !-)UHIU !TI,T$TF* #K3J3%+0 A-)13J
M 444V@!>M-QAJ<!2'[U "'J*?3#U%/H **** "BBB@ IK4ZFM0 AZ4X'BD/2
M@<T %.H'2B@ I,T9H H  *6BD-  30!0!5'6[K['H=[<=UB;;]2,#]2*'H#=
MCRG6+PW^LW=R3D/(=O.?E' _3%4P:CSFG UPMW9Y][ZDHY%/&<5&AXJ0&I8Q
MZYS3Q3 >:<* 'BESS30:.] T2 BEIHZU=TO3Y-3OX[:,'!Y=A_"O<TEKHAI7
MT-KPQHYN2;Z5?W:'$8]6]?PKI 7ARI%:4,$<$"0Q($C0850.E*8U)Y KNA!0
M5CKC'E5BB+QL8P:1[DN.AJ]Y*^E'DKZ"K*,YI))AMQQ5ZW38E2"-1VIV..*
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ME_JS5FJUF,1U9H **** "BBB@ HHHH *#THH/2@!!01D8H%+0!3N+8,<KUJ
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M_"O85RGAK3/[1U,&0$P0C>_N>P_SZ&O25Z8KHH0^TS>E'J*.E%%%=)N%%%%
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M-:2]*;_%0!GB69#R#4B7F.JFKC(K#D5";9&[4  NU(I1=)[4S[&GI2?8E]*
M)?M29ZBC[2G/(J+[$OI0+)>>* )!<ICM2_:D]JA%DOI3OL2>E $GVI/:D-TG
MM48LE]*/L*>E #_M*9SQ561P\P(]:F^QKGI4$D?ER "@"^&"KFHY TB$YQ2Q
M@O@'I4LHQ$0* ,^&3R7.>:>UV[?=4TV"-7E.:O+ BC@4 4?W\G<BG"U=A\SF
MM *!0>E %1+10>>:G6!!_"*5>M24 -"J.@IU%% "&@=*#0* %K)UO[L'U/\
M2M:LG6_NP?4_TH CL>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110
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M#UI:0]: '#I2]*3M1VH 3K3@* ** "FDT=:".*  <THX-(M!ZT *3FC% I:
M$!H-)0* $(IR]*1J >* %- % %+0 4AH)H%  !2T4A-  30* *6@!!UK-E_U
MS_[QK1K.E_UK_P"\: +X7:JKZ#%/'2D:E'2@!:*** "BBB@ HHHH **** $;
MH:B2I6Z&HTH ?3J!TI":  FDI>II: "@FD)I.M !UIU%&: #I3:.M+CB@!%Z
MTZFCK3J "D(I:#TH CQ2A:2G+0 ;:-M.HH ;MI=M+10 W;1MIU% #0M&VE%+
M0 W;05IU% #=M&VG44 -VTW;4AZ4PGF@  IW%(M+WH 6D/0TM(>E "+7G/Q%
MDSK%K'_=M]WYL?\ "O1EKR_Q[(S^)"">$A4#Z<G^M95?A,JS]PY<&I5.14(I
MZFN8X[DHIX-1J<T\4K%7'@\T\&F 4X#FE8+CP:>*C K:\-Z<=2UB)"/W4?[R
M0^P[?B<4U%MV*CJ[';^'M,_LS2(U=<32_O)/4$]!^ _K6P*:W2G+TKN2LK([
M$K*PO>BCO13&%%%% !1110 R3[M$7W:)/NT1?=H ?3&ZT^H+FXAM8FEGD"(O
M4FANP$V<#)/2E!!&1R*R+26;5I#.RF.Q4_NT/!D/J?;VK6!J8RYM5L).X$8H
M!I:0BJ&+2&@&EH 0&@L$!<]%Y-!%-?F-@>X(I2O9V&MQG]LVW_/0?E1_;-M_
MST'Y5S9 S28'I7QW]N5^QZ'U./<Z7^V;;_GH/RI1J4%RPC1\L>@KF<#TJUIW
MRW\7XC]*WP^<U9UHPDM&TB9X6*BVCH :6D(H!KZLX (H!I:CED2%"[G"BE*2
MBG*3LD-*^B)*0BL^VU-9)=DBA 3\IS_.M&L,-BJ.)CSTG=%3IR@[20@-<MXJ
MN=UQ#; \(-Q^IKJ&PH))P!R2:\^O[DW=]-.?XFX^G:N;,JO+2Y.YSU796*]%
M%%>"8!1110 4445(!6YX6?&I2+ZQ'O[BL.M;PX<:NHSU1A71A':O#U*A\2.S
M[T-TI.]*W2OJ3J%7I2TT4Z@!,>U&!2T4 %%%% $+9,PJ:DP.M YH 6HS]ZGF
MF-R: '@#%+BD7I2T  HHHH **** "BBB@ HHHH *#THH/2@!!2T@I: "BBB@
M!.]+2=Z6@ HHHH *#TI,T$T 1GK4B]*C/6G@X% #J:U+D4C&@!*4<T#&*0T
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MQ1B@!NZC=3L4;: &[J3/-/VTS'- "[J-U&VC;0 ;J6FE:,8- !WIU,[T[M0
MM%(#2T +BD;K2@TUNM "THZ4#I2]* "F]:#S2@4  %#=*6FF@!!3A2 4=* %
M-)FC.:7%  !0:,T$T -;FE4<4A%.7I0 M(30: *  "EHI#0 $T 4 4M !2>M
M!-(!F@ '6LZ7_7/_ +QK2'6LV7_7/_O&@#1:E'2FFG#I0 M%%% !1110 444
M4 %%%% "-T-1I4C=#424 2YXI.M+BEH *":":;UH .M.HI,XH #Q2=:.M.H
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M)P35CJTD25<HZL/8TXBN368HP*L5/J#BK\6JSQ\,P<?[0KZ&EF\-JL;>FO\
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M!Q2XH CHJ0BDZ4 ,HJ3@TQNM %='Q.PJT?NUGR-MN?J:O@Y6@!%%24Q*?TH
M.E-S1UI0*  "D;I3C36/% "+TI!]ZG)3?XJ '$\4U:4]*%H 7ZTZD(HS0 'B
MDZT=301@4 "\4ZFK1G- "YHQ0!2T 1_Q51N#^_'UJ\>N*HW/$H ZYH M[]H
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MFG229^5>:5K="V<<T](E7D"@ B78E/I:0CB@"-Y0HP.34<:%FWL?PJ41*"6
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M_P!XT :+4HZ5&G^J3_=%2#I0 M%%% !1110 4444 %%%% "-T-1I4A^[4:4
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M 6D(I:* &@XIK=:>149H H7/^MS5V!MT8-4KG[]36C_+MH MK2]::O6GCB@
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M **** "@T44 )T%)D4IIHQ0 9I.]/P*,4 &*8PY%24P_>% "$4N/EI6I/X:
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MH;I2=Z5NE?0G0*M+2+2T %%%-!YH =1110 4444 %(>M+2'K0 M-/6G4T]:
M%(H!I:::  ]:44E.% !1110 4444 %!Z44'I0 @I:04M !1110 G>EI.]+0
M4AZ4M(>E $?>I!TJ/O2[J )**CW4;J 'D4TT;J0G- #A3JCW4;J 'FC-,W4;
MJ )*3%,W4;Z  \&G@U&6S0&H 9>?ZD?[U1V0Y<XYXI;I\QA?4TVT."_X4 7:
M*9OHWT .;I30.*0MD4!J '"G5'NH#4 244S?1OH ?13-U)NH DII%-W4;J '
MYI:CW4;J )**CWTN^@!]%,WTFZ@!Y%)3=]&Z@!_:D'6F[J-U $E(>E,W4%J
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M>E #%ZT_FF+UJ2@!.:.:6B@!.<4=J#0* $K+UO[L'U/]*UJR=;^[!]3_ $H
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MB@ HHHH **** "@]**#TH 04M(*6@ HHHH 3O2TG>EH 3%)BEYH!H 2E!H-
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M )*0BF@D'FG=: $VB@*!3J,4 ,(I-U//2F'K0 [=3<Y-*%S2A<4 *.E+110
M4444 %%%% !1110 4444 (*6DSBC=0 M%)D49H .]+3<\TI-  324<4$T %
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M%I335H <!FEZ444 &:0T4IZ4 -6GTU>E% !2XH I: (_XJAFB5VYJ;^*FO\
M>% $?V5":7[''4P^]3Z (HX5C/%2=Z6B@ I#TI:0]* &KUI],7K3Z "BBB@!
M#0*6B@ K)UO[L'U/]*UJR=;^[!]3_2@".QZBN@@^Z*Y^QZBN@@^Z* +-%%%
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M !1110 4444 %(303BF$YH 0FDHI: "CDT8S3U6@!F#13R*:: $HQ3E%.(H
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M+0 Y3Q2=Z;TIPZT ./2D6E/2D6@!>E'6CK1TH 7%(>*4&D/- "+3@*:HI^:
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MK1D4S::-IH ?D49%,VFC:: 'Y%&13-IHVF@!^11D4S::-IH ?D49%,VFC::
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M2X;@D?P#I^N?TKJZZJ4;1.VE&T0HHHK0T"BBB@".3[M0B$LIYQ4\GW:(^5H
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M]T4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JL_4U9JL_4T
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M- H 6BBB@ HHHH **** "BBB@!O>@TI'-)CF@ [4E.-)CF@!129YI32 9YH
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M 4445%F 4E+28J6 [L*6D[4M2P%%+3<XI<U+0"T4F:6H8!5FQL)]0N!%"O\
MO-V4>]3Z9I%QJ3Y4;(0?FD/]/6NTLK*"P@$4"X'4D]2?>NO#8.55\TM(_F7"
M#>K&6&GPZ=;B*(<_Q.>K&K=%%>Y&*BK+8Z-@HHHI@!XII;/2@G/%"K0  4ZB
MB@!O>E(I.]*>E  *6@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH C:CM0U':@!!4\%N7 9N%]/6I+>WQAW'/8>E6: $  & ,"EHHH ****
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M 1QPJG0<U(<T]>E-<@#DT "D4I8#K5=K@#[O)I DDW+ @>U $4IWSC;5].%
MJ-(%3D<U+T%  >E1GK3^M,/!H *!2GI2+UH 1EW#FH]K*?EJP>E,'6@!@EYP
M:DW$]*&4,.E,\LKR,T /YHR:9O;HPQ5>:9D;Y1F@"T"12\FJB7G]X 5.MQ&W
M\0H DR11N-.#J>AHH 8,YIDF=PJ<"HG'S"@!W-&XTO>EQ0 W)I,FGTE #1FB
MG*,T&@!O>BE'6E/6@!N#2X-/I<4 1'-*"<4KTJT -YK+UG.V#/J?Z5L8K)UO
M[L'U/]* (['J*Z"#[HKG['J*Z"#[HH LT444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !65<^=]H;:3MX_E6K59^IH SB)L<L:8?.S]XU<D;G ZT@7
M YZT 50)O[QI#YV?O&K;-@>](H[F@"MMF_O&D/G#^(U;8[135RW)Z4 5@)C_
M !&C$P'WC5SA13,ECQTH K 3$?>-*1,!]XU; "TPDL<"@"L/./\ $:7;-_>-
M6U7 IKMV'6@"I^^SC<:=MF_O&K2KW-#,%XH IMYPXW&E"S?WC5I5/5NM*S!1
M0!4;SA_$: L^W[YS5D MSVJ3@"@"GB8#EC30)B?O&K62YXZ4\# H J;9NN\T
M@\[/WC5EF+<+3PO'O0!4VS?WC329L[=QJVSXX'6E5<<GK0!5VS'^,TA\Y?XB
M:MLV*103R: *H$Q'WC0?.'\1JX2!3.6/M0!6 F/\1I6$H&=QJWP*C;+GCI0!
M543D_>.*>5F_O&K2@ 4C-S@4 5"9M^ QIP6;^\:L@8/O2LV..YH I'SP?O&E
MQ.?XC5Q1Z]:&; H IGSA_$:4"8C[QJT 3R:<3@4 5")@/O&D F/\9JSR_P!*
M>,"@"IMF_O&F_OR>&-6BQ8X6G@8&* *H$N/O&F_OL_>-66;/ ZTX+@<]: *H
M$W]XTT^=G[QJTT@' ZTJ@GDT 5MLW]XTA\X?Q&K9.!30"W)H K 3'^(TN)@/
MO&K? %1Y9CQTH K8G/.XT8G'5C5T# J,L6.!0!6'G'^(TI6;/WC5L# ICN<[
M10!5/G \,33PLQ'WS5E5(ZTCMMH JDS*.I)I0LS#.XBK !^\>M.9BHS0!6Q,
M!DN32PW)^ZX(/O4HW-R>E,G@WC(^]0!,/6EW54AGVGRWZU:!XH 7-&[CI2<T
M<XH 1&^8\4[=[5&GWS3Z %+9I,T&C.: ' TZHQFK<$. ';KV% "PPX^9ASV'
MI4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "D=%=2K#*GJ*6B@#(EC:VF*D':?N
MGU%/5LBKUQ MQ$5(^8?=/H:RE8HQ1N&4X(H G'6I>U0*>:G'2@!KTU>M.>FK
MUH DH/2B@]* (CUJ0=*C/6I!TH 6FOTIU-?I0 RE7K24J]: )*B;K4M1-UH
M>M.IJTZ@!C?>IPZ4AZTHH 1NE-[4YNE-[4 "U)4:U)0 C=*C'6I&Z5&.M $M
M%%% !1110 4444 ':HCUJ7M41ZT 1W&?+&*2W"^7D=:G*AEP:JE'B?(/R^E
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MH_X2+2O^?K_R&W^%/ZU0_G7WH1J45E_\)'I/_/W_ .0V_P *3_A)-)_Y^_\
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M !1110 4444 %%%% !1110 4444 %%5;G4;2SD"3R[&(R!M)X_ 5!_;NF_\
M/S_XXW^%82Q5"#Y932?JBE"3UL:-%-CD2:)9$.48 @^HIU;)IJZ)"BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZE!A?M"]1PW^
M-:%(0""" 0>H- &'$^:N*>*H31FUNFC/3.5/J*M1ME: )7IJ]:5CD"D7K0!)
M0>E(3S1VH C/6I!49ZTX4 /IK]*=37Z4 1TY:;3EH DJ)NM2U&W6@!RTZFK3
MJ &G[U.'2FG[U.'2@!K=*;VIS=*;VH %J2HUJ2@!&Z5&.M2-TJ,=: ):***
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M]L 5 V7R.U %>5VFD\M#CWJU'&$7'>JT  N"!5V@!*!0>E H 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#UI:0]:  T-TI:1N
ME  M+35IU #3UI1TIIZT_M0 4444 %%%% !1110 4444 %(:6D-  *6D'2EH
M **** "BBB@ HHHH *:W6G4QNM #ATH-*.E(: "@C(]J6B@"C-$86\R/CU J
M5)O,BRO6GS_<-06* 19[YH G0=SUI[, *;N"T@&6R: '*I)R:1CA33RP5<U
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MTHH **** "BBB@ HHHH **** "B@T4 %%&:3- "]:NHH10!5>W3<^X]!5J@
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M6E'2@!&Z4WM3FZ4WM0 +4E1K4E "-TJ,=:D;I48ZT 2T4#I10 4444 %%%%
M!VJ(]:E[5$>M $BTUJ5>E(] "+4E1K4E !4;#!J2FL*  <BF-UIRTT_>H 4T
MB]:#2KUH <>E,'6G-TIHZT .IU '%)0 II,T48XH %IU-6E)H ":2BD)["@
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M/6EI,T +2'I033#R* '+3J:M.H :W6G=J:W6G=J "BBB@ HHI,T +129HS0
MM%)FC- "TAHS030 #I2T@Z4M !1110 4444 %%%% !36ZTZFMUH <.E(:4=*
M0T +1110!#/_ *NH;1@+?WS4\_W#5>T7]SGWH G1-QR:><#K1G IG+GT% "!
M2[9)XIS* AQ3\;1[5&^6!P: (+91Y[UL0ILB [GDUCV0)O2F,YZUN4 %%%%
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MCY^]3#;2#U- %T2QL<!LU)@5G11.K\BKX4D=:  .A. >:7 ]:B6#:Y.:D8$
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MC-4S/./^6?ZT@FN#SY?ZT 7J*I&:<<^7^M()IV_Y9_K0!>S15+S;@_\ +/\
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M)QU/2*RY?$6DPR&-[U"1_<5F'Y@$5SMWX@,_A>.#S?\ 2F;RI.3N* =<Y[\
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M.X8^1PQ_E_6K]5[Y!)8S*<X"EN/;G^E &+;MTJ^AXK+MSR*THSQ0!-10.E%
M!36IU-:@!1TH/2@=*#TH 0?>IU-'WJ=0 4444 %(>AI:0]* $6G4U:7K0 G6
MG 4 8HH 3/%)UI>II: #%%%(3F@ ZTHI *6@!K4@Z4-2KTH 4 8H(&*6D)H
M3%&.*4"E[4 ,7K3Z8M/H **** "BBB@ HHHH **** "BBB@!G\0I],_B%/H
M*K7?^I:K-5KO_4M0 ZV_U0^E3CI4%M_JA]*G'2@ HHHH **** "BBB@ HHHH
M **** *]W]REM?\ 4"DN_N4MK_J!0!/1110 4444 %(:6D- "CI10.E% !11
M10 4444 %%%% $<C[%R:@6X7.*?=+F*L^,9D H UE.Y:<.E-C&$%.H *NH-J
M*#U JF!E@#W.*O4 %%%% !1110 4444 %%%% !1110 5C>)?^08G_74?R-;-
M%8XBC[:E*G>UT.+L[GG)-(37HDL@AA>5@2J*6..N!6/_ ,)38_\ /*X_[Y7_
M !KYRKE-&BTJE9*_D;^U;V1R.:0G-==_PE5C_P \KC_OE?\ &C_A*K'_ )Y7
M'_?*_P"-9K X7_G^ON)<WV.0II-=A_PE=C_SRN?^^5_QH_X2RP_YY7/_ 'RO
M^-5]2PO_ #_7W$N3..)IM=E_PEMA_P \;G_OE?\ &D_X2ZP_YXW/_?*__%52
MP6&_Y_K[B&SC2::37:?\)=I__/&Y_P"^5_\ BJMZ=KUKJ=R8(8YE8*6RX &.
M/0^]:0P-"4E&-9-OR(9Q&GG_ (F=I_UV3_T(5UGB_P#Y Z?]=E_D:LZAXBLM
M.NC;RK,\B@$[%&!GZD5S>OZ]'JD<4-NDB1*=S;P,D]NF?Y]ZZ'&EAJ%2DIW;
M);23,*D)H)II->4D8M@33":"::35I$@332:":[GP.B_V9</M&\S8+8Y("CC]
M373AZ'MI\E[#C'F=CA":=#;SW,A2WADF?&=L:ECCZ"N[;QQIBD@P7?'^PO\
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MW_?U?\:YGQ3+:3/;R6TD#N=WF-&02>F,D58_X0[_ *?_ /R#_P#94G_"&_\
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MR0CMU!*#E9(Z2BBBO1-PHHHH **** "BBB@ HHHH *;(@EB>-LX8%3CWIU%
M'*P'FM.(\5E0GYJTX3P* +*GBEIJTZ@ IK4ZFM0 HZ4'I0.E!Z4 (/O4ZFC[
MU.H **** "D/0TM(>E "+TI12+3C0 4G6DZT[% " 8I:#3>M "YS0!2XHH *
M;12@4 -/2G#I2-0.E "YH H I: "FT4N.* &K3Z8*?0 4444 %%%% !1110
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MQ0 4QJ?3&H <.E!Z4"@]* $'6G4P=:?0 4444 %(>E+2'H: $6EZFFKTIXH
M,444F<T )UIPI *6@ I":,YH H  *6BFT (U.4<4T]*<.@H 6FTIH H !2]J
M*3.: &BGTQ:<: %HI.M+0 4444 %%%% !0:*KW,ICY% $]&>*H"XE(R%I%N)
M68@)0!>_BI^:H>9/N^Y2F2?^Y0!>S5:[YB:HO,G_ +E,D\Z1"-E %JV_U8^E
M3=JSA-+$ NWK4GFSGHE %T4M4?,N.\='FS_\\Z +U&:H^;/_ ,\Z!+/_ '*
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MH S%MI?6ITMY!U-7,>@H% %<1LJG-21YVT]ONTB\"@!1Q03124 +10.:4B@
M%!Z4G2E/2@!J]:?4:]:DH *:W2G4UNE "'I0.E(>E.6@!0:RM;^[!]3_ $K5
MQQ63K7W8/J?Z4 ,L>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %4I$)E))X]*NU5D(!- $3<5$Q+Y XQ3F)8]1BE(
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M04JM;R".-L]<T 6?)4=A1Y*^U5&N9&/RJ:/-F7D@T 6)85\L\5!;,<NH%/\
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M#!'\R*[%)8BE.4HJZZHJ_/%MH\[)IM%(37"D8@33":"::35I !->B?#_ /Y
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M ;$YZ8JPM-" +TYIR]: ''D4P=:<U-QS0 _M3<\4_P#AJ.@!RTI84@'%&TT
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M*=UP<^M $UO;!5!8<U8P .!2CBCO0!')"KCD50DB\J8>F:U*J7BCR]WO0!,
M&4'OB@-M.&IEO(&3FI2H- %2Y_UH^M74^X*H3[ED QD9ZU>3[@^E #J***
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MU-/6@!PZ4AI1TI#0 $=Z.E+VHH CE_U9^E5;4DQD#UJU-]PU!9C$/XT 6%
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M?\)?\BW;?5__ $(U7\4+]L\+?:#OCV%)=CKAN>,$=C\WZ58\(_\ (M6WU?\
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M4\+\S?7M_GWJC"F<4 6(DX%78A4,:8 JQ&.: )<T9I<4TD 4 ,/6GCI4985
M]UY1Q@F@"YDTUCQ59;Y?0TXW2$=* )*1/OFFB532HP+F@"?FHVZT_>*8S#-
M#U-+FF*PQ2[A0 $_,*&I"PS06% ",<K34Z&G,1MJ-7 !H E6E'6H?/44PWB@
M]* +1'%,JLUZ#V-212;Z )L4$<4NX8I"PQ0 JC(I=M(K#%+O% "[:-M)O%&\
M4 !6F'K3RPQ4989H > "*1@!2AABD9A0 *,TK#%-5A3F84 (HS3BE-5A3@P-
M "8%-(P:>13#UH *5:2E6@!S#BF#K3WZ4P=: ).U-_BIPZ4P_>H D[44@Z4M
M !1110 4444 -?[IH3H*'^Z:$Z"@!U%%% !1110 4AZ4M(>E #5ZT^F+UI]
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M-P]:7<* $VT;*7=1F@!NVD.:DIK4 )S1DTO;I3>IH 7=ZTX'--Q0M #Z***
M"BBB@ HHHH **** "F=Z?3.] #Z2DZTH%  !2T4A-  30!0!2T %(3030!0
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M22B22,>AK0& M9 ;D$]J>9GSU- &@6W<Y^6J-PP=L#M3?-;;@&EA<*V6[^M
M$>#GH:/P-:BA)!D 4[RE]!0!DX/H:,'T-:WE)Z"CRE]!0!E+D')!JV+H>7M&
M<_2K7E+Z"@1+Z"@"M;(2YD/4U=%( !TI: "BBB@ HHHH 0\BD23RI _;H13J
M:PH T 00"#D&EJI:2\^4Q_W3_2K= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7(8J '01U?1.*BB3%6E'% #2, 4@'-.>D7K0 NW-!6EI>U $=."\4T]:>.E
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M1QB-<#KW-/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 'KUJ2H@<4NZ@!S=*9W%!;(H]* )13)%#*0:=VIK4 1+#CZ5(D87D4Y3Q3J
M&2(&'-1B$=ZGI,T (%"K@4P]:D/2HS0 UH03GO1Y0')IV30230 J]*<W2D6E
M;I0 BT^F+TI10 N*C/6I":C/6@ I5ZTE /- #V/%,'6G'I3>] #B.*532]J8
M.#0!)3&%.'2@C- "*:=4?0T\'B@!:*** &O]VD3I2O\ =I$/'% #LTM)T% H
M 6BBB@ I">*#0>E #%ZU)4:_>J2@ HHHH 8]*G2AJ%H =63K?W8/J?Z5K5DZ
MW]V#ZG^E $=CU%=!!]T5S]CU%=!!]T4 6:*** "BBB@ HHHH **** "BBB@
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M.E $L5IA>M.^RC-60,"@]: *_P!EH^R^]6:* *AMAGJ*=]E]Q4QZBG"@"O\
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MRK05U=0R,&4]"#D4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 %%%% !3.]/IG>@!V*6BA5+MM6@!40R-@=.YJXB!%VBB-!&@44Z@ HHHH
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M3O#-K>FQRQL5='NT#*PX(()X-:<,T<\*30R))%(H9'1@593R"".HKY@\5_\
M(X:W_P!?\_\ Z,:OHKPJ/^*.T3_KP@_]%K0!L]:7%,R:,F@!QIK?=-'-(WW3
M0!!:?>D^M6B:IVF=TG^]5KF@!P%+3.<T<T (PW9!JC"HCNSNZ5SOC3X@6OA"
M:"U^R/>7DR^88@_EJD?(R6P>201@#L<XXS4\(>.+?QE?36XMFL[J)=XCW^8&
M3(&0V!R"1QCN,9YP =WYB =>*CW*YZ\5%+;LL1.[I4<$#L@.^@"XKH. :0R*
M3C-0"V<?QT?96SG?0 URJRCGO5L2*!UJN;,L<EJ7[*_]^@"P9$/>D$B^M0?9
M7_OT?97_ +] %C>OK2>8OK4 MGS]^D%J_/ST 61(F.M(9$]:J2P.@'STIMG(
M^_0!;\Q/6@R+ZU7%J^/OT?9G_OT 6/,7UI#(I[U!]F?^_1]E?^_0!)*Z^6>:
MKV954.3WIYM'/!>D6S9.0W% %AI4'>D#*>2:Y_Q+KVG>%K!;K4IG)D;;%#$
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MNZD)S0 9^<5(>E0D_.*?NH 0=:E'2HLTNZ@ ;K0O6D/)H!P: 'L>*8.:"<T
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MWL>FZ??7TRNT5M&\SA "Q51DXSWXKE=/^+>@:EJ5K8PV>I++<S)"A>*,*"Q
M&</TYK;\0?\ (HZ__P!>,_\ Z+:OG[PI_P CAHG_ %_P?^C%H ^I*,4F:,T
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MU+' %)'-',I:*1'4'&58$5/-&_+?4=GN/HHHJA!1110 4444 %%%% !1110
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MNC:1=7S[2EO&S[6?:&('"Y[$G 'N:^9[Z^N=2O9;R\F::XE;<[MU)_H.P X
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MCZU:NO\ 4T@*\: Q%N]1K_K!]:FB_P!2U0C_ %@^M &K#_JQ4E1P_P"K%24
M%%%% !1110 444'I0 @ZTM(*6@ HHHH 0=:6D[TM !1110 4444 %)@4M% "
M;13748I]-;I0!$!S4@'%-IZ]*   4A'S4O2D/6@!P Q2T#I10 4444 %%%%
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M+/BKPX1_R,&E?^!D?^-6+/4K+4(VEL;RWNHU;:7@E5P#Z$@]:^;/^$4\1?\
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M/0U43_C\_"K9Z&JB?\?GX4 7**** *4O_'U^%7%Z"J<O_'U^%7%Z"@!:***
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MK\1_$<6F>#KA(I]MQ>CR(@ I)!^\<'MMR,CIN%>%:#IAUG7K+3P&(GE"OM8
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MK7 _!7_D5[__ *_3_P"@+7I= %$QRD\9IVR7'>KE% %+9+CO0%EQ@@U=I,4
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MDUO5DZW]V#ZG^E $=CU%=!!]T5S]CU%=!!]T4 6:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JH[?.15NJ4R9)(ZT #5&QP#2AL\&D;H: *L/\
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M]I5AH]GH%IIUI%;0+Y_RQKC)Q$,D]2< <G).* +GP._YCW_;O_[4KUW->1?
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M\'_HQ:^HS7RYX4_Y'#1/^O\ @_\ 1BU]1F@!:*** "O'/C)X<F%Y;^(+:#=
MT8ANF2,#8P/RLQZG(.W..-H&>0*]CIDT4<\$D,T:212*5='7*L#P00>HH ^9
M/"OBJ_\ ">JB[M#OA?"W%NQPLJ_T(YP>WN"0?<=)^)'A?5T&-16SEVEC%>?N
MBH!Q]X_*3T. Q./H<<1XB^#ES]IFN/#]S$T!W.+2=BK)QD*K<ALG(&[&.,D\
MFN(O? WBC3YA%-H=ZS%=V8(_.7'^\F0#QTZT >N:W\2_#VD22>1<?VA<(,+'
M;<J21D9?[N.@)&2,].#7COB7Q3J?BJ^2ZU&1 (UVQ0Q B.,=\ D\GJ23GIV
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M^\"OZU8#!AE2#]#0 UT!&36A&@2-5'854B&Z51[YJ[0 4444 %%%% !1110
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MG 9H B*_.*=M%!'SB@K0 NT4;10%]Z7&* &XYHV\TN.:4B@!-M(5IPXI3TH
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M@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?[QJU59^IH B:FMRII[4QONF@"C'\ET?I5X=*IQ\W)SZ59!*G!H >W2JB?\
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M%+M%&V@ #"ER*:5H H =N%&X4FVEVT &X4;A1MI-M #&(WBG9 I&4;Q3MHH
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M%BIR.E #WH R*;NW"E#8% " E3@]/6LW6ONP?4_TK3)R.E9.KYQ#GIDX_2@
ML>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110 4444 %%%% !1110
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M\,W3JJ[Z/^M_S);-^'Q5<W&H0Q)!"D4DBI@Y+ $@'G(_E6]JSVT>F3->1M)
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MJ$WDVL6-\FTMC) ' !/4B@"S(.E*  *YO3O'?AK6M1AL-/U+SKJ7.Q/(D7.
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M_%6R :J6W_'P]7* &$ 4H4=:&I5Z4 & :38OI3J* &[ .U#8IU-:@ "CK2D
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M%+D4 )MII%24UJ $P:3)IXZ4WO0  TX'--H6@!]%%% !FBBB@ HHHH M6_\
MJ%_&I:AM23%]#4U !1110 4444 %%%% !1110 4444 4[O5+.QE$=S-L<KN
MVD\?@/:N;\1ZC:WXMOLTOF;-V[Y2,9QZCVH\6?\ (3B_ZXC_ -"-8D4,L[E(
M8GD8#)"*2<?A7S>88VK.<\,DK7\[]&4NYU]CKVFPV%O%)<X=(E5AL8X('TJQ
M_P )%I7_ #]?^0V_PKBI;&[AC,DMK.B#JS1D ?C58FDLTQ$$HN*T\F2SO?\
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M)AM %\P#=*P_B<]><#/H/8"M*NZ'-RKFW-XWMJ%%%%6,**** "BBB@ HHHH
M**** ,?7?^7?_@7]*H0]*M:X[&ZB3/RA,@>Y/_UJKPCB@"XG J=>E0)TJ<=*
M '=15&/_ (^G^M73TJG&?]);ZT 71THHQ2T %&.:** $I:** "BBB@ HHHH
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M[,7>FW<5S"?XHVSM.,X(ZJ>>AYJXKX.#0 _M4;KW%0:CJ5II&GRW]_+Y5M"
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M*G(Z5EZR<K!]3_2M<]*R-94 0GU)_I0 VQZBN@@^Z*Y^QZBN@@^Z* +-%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 56?[QJS59_O&@"-J8WW33V
MIC?=- %2'_CY/TJY5.'_ (^3]*N4 (>AJHO_ !^?A5L]#5-?^/S'M0!<QD5&
M05.14E(1GK0!4D.ZY_"KB]!5&3Y+H'VJZO(% #J*** "BBB@ HHHH *\*^-'
M_(XVG_8/3_T9)7NM>%?&C_D<;3_KP3_T9)0!C^"/&_\ PAIOC_9WVS[5Y?\
MRW\O;MW?[)SG=^E=9)\;?,&/^$>Q_P!OO_VNN?\ AQX+T[Q?_:7]H3W47V7R
MMGV=U7.[?G.5/]T5V<OP>\/(X5;S5.3WEC_^(H YV^^,NIR6PBTW3;>T8JP:
M25S,P)Z%>% (YZA@>/QX*:>^U_5Y)[FY66\N&+/+<2K&"<?WF(4# P!P.@'8
M5[%+\%]":!Q#?ZDDI4[&=T90<<$@*,CVR/K7GWBWX>:GX6A^V>8MY8;@IGC4
MJR$XQO7G )) ()'3."0* /7/ GA.#PEICH9/-OKC:UQ("=N1G"J/09//4Y)]
M .K +<FO ?A]XUNM#U:STZ[NLZ/+(49),8A+=&#$C: V"><8+'&:^@> * .3
M\=^*8_"NDK<!%ENY6\NWB9L G'+$9R5'&<=R!QG-> 7E_J>OZBLEU/<7MW*V
MQ <LQ)/"J!T&2<*..>!70?$O5/[4\=7VV;S(;7;;1_+C;M'S+TY^<OS_ $Q7
M>_"+PM:P:0OB*>-)+RX9UMV)SY48)4X&.&)#<\\8Z9((!@:/\&=5O+8RZI?1
M:<Y^[$J><W4YW88 =B,$]>U,U[X/:GIMBUUIMZFI&-2SPB$QR$#'W!EMQZG&
M0>.,DXKW(4AZT ?+_AKQ/J/A?4ENK*9Q$S+]H@!&V9 <[3D'!ZC=C(R<=:^D
M='UBTU[2+;4[(L;>=<KO7# @D$$>H((]..,UXI\7-#33/%27T$6R#4(_,)&T
M RJ</@#GH58D]2QY]-SX*:I_R%-)DF_NW,,6W_@+MG'_ %S&"?IWH ZOXI11
M2?#_ %%GC1FC:)D+*"5;S%&1Z'!(^A-> 6-]=:;=+=6<S03JK*LB?>4,I4X/
M8X)YZCM7T%\3^/AYJG_;+_T:E>$>'M*;7/$-CIH#%9Y0)-C $(.7()XR%!/X
M=Z -?PQX UGQ-&EU$BVVGEB#<S'AL$ [5ZL>3Z#((R#74R?!:Y:VD:TUN*2<
M8VI+;E%//.6#,1QGL:]=5([:U2&*-(XHU"HB#"J ,  #H*6T/#'WH ^7=9TB
M[T'5[G3+T(+B!@&V-E2" 00?0@@^O/.*]S^&7B>3Q#X::"[F>6_L6$<KN<LZ
M')1B<=>"O4GY<GK6!\;--W66E:JBQ#RY&MY&Q\[;AN4=.0-K]^-WN:P_@S-(
MOBF^A$CB)[%F9 QVDAT )'J-Q_,^M 'M%I]Z3ZUY/\1_B-<_;)M#T.:6W6WD
M*7-TA*.SJ>40]0 1R>_0<?>]!U[5/[&\,:OJ F\F2*%O*?;NQ(1M3C!_B*]>
M/7BOFJ**2>9(88WDED8*B(N69CP  .IH U/#_AG5?$]XUOIEOYFS:996.U(@
M3C+'\S@9)P< XKT.+X(2-"AFU]$E*C>J6A90W< EQD>^!]!7I'AGP_;>&-"@
MTRV;S-F6DE*!3*YZL<?D.N  ,G%;.* /G7Q?\.M3\*P_;!*E[I^X*9XU*LA.
M,;UYV@DD @D=,X) J[\,->UNW\26VF6B2WEE)Q+ S'; F<F12>%P221_%G'4
M@CWB:*.>&2&:-)(I%*NCC*LI&""#U%96C:/I^AJMEIMLMO;@EMJDDDGJ23DD
M_4] !VH Y/XT?\B=:?\ 803_ -%R5XG:7]U8K<K:SO$+F$P3;>"T9()7/H=H
MSZCCH37MGQH_Y$ZT_P"P@G_HN2O*O!6A+XB\665A*CM;;C)<;5)'EJ,D$@C
M/"YSP6% &OX7^&&L^(88KN=DT^PD4,DLHW.X.<%4!Z<#J1P01FNANO@A<I;.
MUIKL4LXQM26V,:GGG+!F(XSV->NV\4<$,<,,:1Q1J%1$&%4#@  =!4U 'RA=
M6M_H>JO;W"2VE]:R#(SAD8<@@C\""/8BOH3X?>))O$WA:.[NN;N&1H)W"A0[
M  A@ >ZLN>G.< #%>??&K2X[?6].U)-@:[A:.150 DQD?,3W)#@>P4?A>^!_
M77?^W?\ ]J4 >NFOESQ7_P CCK?_ %_S_P#HQJ^HS7RYXK_Y'#6_^O\ G_\
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MFB@".;.RJ?/V1OK5V7[E4Q_QZ-]: +41.Q>.U2Y/I3(ON+]*EQ0 W/M1Q3L
MT%: &X%&!ZT;:7:: $Q[TA!I=I]:1LB@!<GTI!G/2ER:-U "9/I3E%(#3P<T
M %%%% !1110 4444 3VI/SCL*L54MR!-SW%6Z "BBB@ HHHH **** "BBB@
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M110 4444 %%%% !1110!SFK,S:DZD\* ![#&:(!TJM-(DEY*ZL"K.2#[9JW
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MZ#'S<?0'UJOX$\/G7_$L"21E[2W(FG^7(('13P1R>QZ@&OH83E<!8R .  *
M/+I/@>XB<Q>(%:0 [5:SV@GL"=YP/?!KA?$'A'7/"-VCW<9"*5:.[MRQCW=0
M V!AACH<'BOHXW+?W&JMJ,,.J:;<6-U"7AG0HPP#U[C.1D=1[B@#YHUC5[O7
M+\WU\RO<,B(S@8W;5 R??BO=_A5_R3ZR_P"NDO\ Z&:\$U2Q?3-5NK&0@O;R
MM&2IR#@XKW+X73-'X$LQM)&^7I_OF@#NN]*R<<=:J_:6S]QJ7[2W]QORH L(
MW8]:?FJ33L>0C9IWVEL?<;\J +9YJ%U*G(J+[2W]QORH-R?[C4 3(<U(1D51
M69@V0AJ3[4QXV-0!/C)H&4-5Q<$'[C?E0;DG^!ORH N#%'0U36X8#[II?M+?
MW&H L,N>10K>O!JO]J/]QJ:9R?X&S]* +N?6LG6ONP?4_P!*MBY8#E&K.U24
MR"+*D8)ZT /L>HKH(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %5G^\:LU6?[QH C:F-]TT]J8WW30!4A_X^3]*N53A_X^
M3]*N4 (>AJHO_'Y^%6ST-5$_X_/PH N4444 4IQFYQ5A3MP#WJO+_P ??X59
M(RH]: 'YI:C1NQJ2@ HHHH ***2@ )->$_&8Y\8VO_7@G_HR2O=)&VH2:\&^
M+K%O%=JQ[V*?^C)* -[X'G UX_\ 7O\ ^U*]/^:6X..@KROX+-MBU_\ [=__
M &I7K-JOR;O6@"8.,8JEK.FV^L:1=6%TNZ&>,HW )'H1D$9!P0>Q JU(I7YE
MY/I7'^-_'-EX=TJ>W@N%DU>12D4,; M"2,[W'. ,@@$?-QVR0 ?/=?4OA^YG
MU#PYI=W</OFGM(I)&P!N8H"3@<#DU\P6EK-?7D%I;IOGGD6*-<@;F8X R>!R
M:^J]/LHM,TVUL869HK:%(4+G+$* !G'?B@#YE\5_\CAK?_7_ #_^C&J&U\/Z
MU?6R7%II%_<0/G;+%;.ZM@X."!@\@BNC^*&B-I/C*YG2+;:W_P#I$9&X@L?O
M@D]]V3@= PZ=*[+X/>)XI;"3P[=3(LT+&2T#'!=#DLHXY(.6ZDD,>RT >8?\
M(IXC_P"@!JO_ (!R?X4?\(IXC_Z &J_^ <G^%?4E)WH ^7/^$4\1?] #5?\
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M!O\ T):Z?Q'%)/H%U'#&\DA"X5%))^8=A7?A%_L<DO,N'P'F9--)JX=)U/\
MZ!UW_P!^6_PIITC4_P#H'7?_ 'X;_"O*5*?9_<_\C"S-SP_XJ^PQBTO][P#
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MG0;G_KZ/_H*UV%<=\-^=!N?^OH_^@K78UW4?X:.BG\""BBBM"PHHHH ****
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M4/C* ++1/]Z;^25>^$!/_"*WPQ_R^'_T!*T_B+H[:UX0E,:)]ILC]H4E1N*
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M?;(X]L-]&),K%M4..&&>A)QN/^]6U\'_ !*8Y9_#]S+\KYFMMS=#_$HR?Q
M_O&@#S__ (13Q'_T -5_\ Y/\*/^$4\1_P#0 U7_ , Y/\*^G]QHW4 ?,'_"
M*>(_^@!JO_@')_A7<_"G0M6T_P 7237VEWMK";1U$D]NZ+G<O&2.M=?XK^)=
MEX8UB/3?L<MW*,-<%7V>4#@C&1\QQSC@=.?3JM+UBPUJS6[TZZCN(3C)1LE3
MC.&'4'GH>: ,7XD*!\/]6_W$_P#1BUXS\..?B!I/^^__ *+:O9?B.?\ B@-6
M_P!Q/_1BUXU\./\ D?\ 2?\ ??\ ]%M0!]'*HYXI=H/:F@XIP:@#E_B.H'P_
MU;_<3_T8M>,?#CGX@:3_ +[_ /H#5[-\1VS\/]6'^PG_ *&M>,_#DX\?Z3_O
MO_Z U 'T?M'I7B/QI&/$UAC_ )\Q_P"AM7MNZO$OC0<^)K#_ *\Q_P"AM0!T
MGP6 /AF__P"OP_\ H"UZ7M%>:?!=L>&K_P#Z_#_Z M>E;Z  J,5\\_%/_D?[
MW_<B_P#0!7T,3D5\]?%/_D?[W_<B_P#0!0!ZG\*E!^']C_OR_P#H9KA/C2,>
M);#'_/F/_0VKN_A4?^+?V/\ UTE_]#-8/QET1KG3[/68(MS6Y,4[#<2$/*\=
M  <\\=10!G?!$ W>LY_YYQ?S:O8M@]*^8_"'B)_"_B*#40C/$ 4FC7&60]0,
M]\@'MTQD5])Z;JEGJ^GPWUC.LUO*,JZ_R/H1Z4 6=H]*-HI<BL7Q/XHL/"VE
M->7C;G;(A@4_-*WH/0>I[?D" >(?%&6*7Q_?F*1'"K&I*D'#! "/J#7JGPJ
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M^E7* $/0U43_ (_/PJV>AJHG_'Y^% %RBBB@"G,<7-6EZ"JDO_'U^%6P.!0
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MV> @7#Y-6]ZXZBLX1,UPY6IEMV*]>?K0!:++_>%*'7'WA51[9MO!I$@8CDT
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MP<?G^N:Z"YG6VMI)GZ(,X]?05RB$R.6))).22>M %B!.E7ECV\BH;=:NJ.*
M$0@]:?BHV3G(IRMNX[T 5[L5/"/W8J"[_I5F'_5+]* ';:3;3J* $VT;:6B@
M!-M&VEHH 3;1MI:* $VT;:6B@!-M,D'(J2HY.HH <HXI=M"]*6@!-M&VEHH
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MSD'<  I^G*F@#TC\*^39_P#CXD_WS_.OJKS9/2N2;X<>%&8L='!).3_I,O\
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M"3GK4VM?&#5K^WD@TZSAT])$VM)O,DJGU5N ...A/OZ==>?"CPW=2*\*7=F
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MFB3[0%V\8JRL,>T?+0!5ED\UEP.]7U^Z*8(4!X J2@ HHHH #Q32U*W2F@4
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M[:M!=013P/\ >BE0,K=^0>#0!\_:!\0]6TO7)[V^FDO+>\?==1,>_3<G8$#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L+6[[YQ:+T&&<\_@/ZUJWMTMG:M*>O11CJ>U<IM,K%F)+$Y)/
M>@":%,UHPI@53ME(."*TXUXH >!QS3,&-LC[M2]!01F@!H(-.-0D%&R.AJ4$
M$9H JW=68?\ 5+5:\JQ#_JA0!)1110 4444 %%%% !1FBD- "%L4N>*:1D4T
M,4X/3UH EJ.3M3QSS3'/(H >OW:6D7I2T %%%% !2'I2TAZ4 1]Z <4=Z,4
M.!%+NJ.B@!VX9IP84P#-+M- "EJ PI-IHVT .W"FYR:3;BB@!^X4C-FFTE !
M2T4E !WII_UE.II^_0 ZEHI* "BF2/L[4+)GKQ0 ^BCKTHZT %%%% !1110
M4444 %%%% !1110 444M %-^+A:LLO0BJS_\?"U;["@!%;/6EIK+CD4JD'CO
M0 N,\4S!0\=*?1C/6@".8YB;'I44,*LN33Y@5C.*6WSL% "B!!VH^SQU)10!
M']GCH^SQU+^%)0!']GCH^SQU)10!']GCH^SQU)10!']GCH^SQU)10!']G2C[
M.GO4E% $?V=/2CR(ZEQ24 1^0E'D)4E% $7V>/WH\A*EI: *914GP*MCH*JR
MD";)J83I@<B@"6DIGGQ^HH\^/U% $E)4?G)ZBE\]/44 2@XI2U0>>GJ*//3^
M\* )PPH+ BH/.C_O"CSD]: )A@4[<*@\Y/44"5#WH EW9I<@4F/2D(- #]XQ
M3"<TE':@!<TE(O>EH >/NT)0/NT)0 ^BDYI: "BBB@ -%%% !2=J!10 S^*G
MYP:9_%4E !]**3O1TH 6D- S0: $%% I3R* &+UJ2F+3Z "BDYI: $- H/2C
MM0 =JRM;^[!]3_2M7FLK6_NP?4_TH CL>HKH(/NBN?L>HKH(/NB@"S1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %5) &)!JW67<^>LS,F-O'\J
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MFO\ =IU-?[M %:T^])_O5;JI:?>D_P!ZK= !1110 P]359/^/S\*LGO59/\
MC\_"@"Q/_J6^E16O^J'TJ2X_U+?2H[7_ %0^E $RT^F#BGYH #TIJTIZ4BT
M.HHHH *0TM)WH I7K,H7![U8@R8QGK45XFX+]:GC&$H DJ-NM2"F,.: '#I2
MT#I10 4'I1FD/2@!%ZFE/>D7O2GI0!3'_'W^%6C]TU5'_'W^%6C]TT 5K;_C
MX>KE4[;_ (^'JY0 UJ5>E(U*O2@!:*** "FM3J:U "CI2T@Z4M !11S2'I0
M#K2U'YB@XI6D"#)H <3BF]::I\SD4XL%% #L8% I@E4G IQ(% #J0B@'(S2T
M (#2TAH!H "* :6D(H 6D(H!I: $%!Z&@BD/0T 5(_\ C['TJYFJ<?\ Q]CZ
M5<(H 1N@I /FH;I0#SB@!]%%% %.?_CY7Z5:7[HJK/\ \?*_2K2_=% #J***
M "BBB@!#TIF,T]NE,!Q0 $4C#Y*7-(WW*  #@4[!]:0=JDH 9R.]&33Z0]*
M&Y]J,@]J44N!0 W I#BG;136&* %%)M]Z7!I"30 H4YIP&*8&-/!S0 M%%%
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M110 4AZ4M(>E $?>@4=Z* $[TIH[T4 *M25&M.R: '44W)HR: !JCIYS3:
MT 9HH&: %VT;:=S2B@!FRF%?GJ>HS]^@ V4UD;L:E[4<=* *4I*GGFI %< #
M@U)*@;K0D:CD=: (]K1]\BGJV[VJ7C%-,0)R* #91LIXZ4M $>RC94E% $>R
MC94E% $>RC94E% $>RC;4E% $>VC;4E% &?(,7"U<"\#FJDHS<K5M25&#0 ;
M::T>.14M&* (EYZTX+FAU[BB-\\'K0!'.I$34VW!*"I;C_4M]*9:_<% $FRD
M( ZD5)5.ZR9% - $^5_O"C*_WA4(M@R@\TOV0>] $N5_O"C*_P!X5%]D'O1]
MD'O0!+E?[PHRO]X5%]D'O1]D'O0!+E?[PHRO]X5%]D'O1]D'O0!+E?[PHRO]
MX5%]D'O1]E'O0!+N7^\* 5_O"HC:CWI!:@^M $V5_O"C*_WA47V0>]'V0>]
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M5N@ HH-% ##WJB[LMU\JY.*NN=H-5K?$DNZ@!KR3NI'E4D3S(N/+J\100,4
M4Q//T\K]:=Y\W_/*K*@9I0!0!2:[D!P8Z<)YNT=)*/WP^M6U XH K>?-_P \
MJ//F_P">56]HHVB@"IY\^?\ 54">;_GG5O:*-HH HR23,!^ZIPGF QY57,"D
MP* *GVB;_GE2&>;_ )Y5=VBFD"@"K]HG_P">7ZT>?/\ \\ZM[11@>E %0W$H
M&2E-2[D?[L?%6I5&P\=JALP/*_&@!@GFY_=TOVB;_GG5H 9I=HH SMT_F[_+
MJ4SS;<>75PJ,4F!CI0!5M=WF,6&*N9IB ;C3\4 (QH!XH84H'% !FC-&*,4
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MFFC.!3L^U !D^E&X^E&[VHR* %#"EW"FX%&!0 [(I&I,4C4 /%,ZFEYI.<T
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M *UQ@(>!5<CY$X[U/<,-RCUJ(?,X'I0!<1 %'RBDE $9.T4\'WJ*X;"$9ZT
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M4W]V@!LN/M7/I4X!7!'2J3S%KC<5J?[2< ;: +0(--9>Z]:K&Y8'A*=]I/\
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M]Y-&\T 5Y_\ CY7Z5:7[HJG,W^DCCM5D/\HH EHJ/?1O/I0!)14>\^E&\^E
M#VZ4T4F\U5FN6C; 7- %O--;[AJJMTY_@J4RLR_=H G'04[MS48)P.*?F@!<
M4;:3<*7<* $VT;: :7.: &XI#FI*:U "<T9IP^E,ZDT +NIP.:;CFA: 'T44
M4 %%%% !1110 4 8HHH *9WI],[T .Q2T4G6@!K#-1$,C!E.&'0BIP*:R_E0
M!8M;OSCLD 63MCH:M5C21YJQ;WY0!)\X'\?^- &C12 A@"""#T(I: "BBB@
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M0!$0: ":D(XIJF@!-M)M-2?A2T 1X(%-J0]*9WH -II=M/'2EH CVT;:DHH
MCVFD(Q4M,:@!H&:@N@=M65J"[^[0 Z 'R5I^TTVW_P!2M2GI0 S%-\MLYIX%
M.SF@"G<C S4>TB1/4U;N$W1'BJF3C=C[M %ORR12;33HI \8QUIQZ>] $*H2
M33BI%*O -+VH 0C"U57D.?0U//(%CP.M0$X&WNU $UNI(W>M3,,#-$*[8@*2
MX;9$30!3SN+MZ5/:I_%ZU !A3[U=@7$0H >W2J!^9F/H:NR, F:I \/[T 36
MRY8MZU985';KB,&I2<"@"A+S**= A:5CVJ-CN+GTJS;+\N: )=IJK/DR*OK5
MWH*H,=TI.>AH $3=)M]*N;3BJ]LN96:K= %.?.\+ZU'MRX7TISG=-GT-.A&9
MF- $RK@TRXR%QZU,HYJ"X.94% $&T[%'?-747""JR_--CTJZ,8Q0!#.=L1'J
M*J#B-<=ZGN3EE7UJ+&2JCL: +,*83%9^M<+!]3_2M8= *RM;^[!]3_2@".QZ
MBN@@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 53EC5G)(YJY59^IH KF)/[M-:),=*F:F-]TT 4HT7[3C':K?E)Z"JT/\
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MY29Z4[: .*=2'I0 B]33J:O4TZ@!&Z4@Z4K=*0=* &!06.13O*0]J1/OFI*
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MY&01R"* -RBL>'49H2%E'F)Z_P 0_P :TH+J&X'[MQGNIX(H FHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJE=:I;VN5W>9(/X5[?4]
MJ +M9U[J\5L3'%B24'!'9?K6'J6JW5RA4-Y<9.-J'&1[GO4,,9*4 33W$UW)
MOE8GGA>P^@JM/$<#CO5Z.'VHN(<*/K0 ^TA^0<5?2/%,MDQ&.*L@8H 0+3NU
M%% %6[X45);,/)%1W@R%HA!6(8H LFC%(K9%** &,O<<&A'SP:>3BF,O<=:
M'4IYJ-7W''I4AYH J7?-6(O]4OTJO=U/'_JE^E $M%-!-+0!&?O5+41^_4M
M!12&C- "T4A;;UH!S0 M%&:.M !1110 4444 %%%% !2'I2FD/2@"/O2K2=Z
M!0 ^DZ&E%.H 3/%(1WHZ4H- " YZTO6@BD!]: $Z&G9I&Z4R@!YQ29XIM%
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MFM3R167JR;/*^IH 6QZBN@@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%%
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M !:E#4FVC;0 [<*0-BF[32[: ';J.O-,(Q3TZ4 (3Q3.]2,*CH 7-+GVI**
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M8%-"\TNTT (" :0HI.<"G;*-IH 0@ 8%(.!2E<"@#(H 0JK<D"GC"CBFE<4
M9H ?D5DZUC;!CU/]*U-IK*UD86#ZG^E #;'J*Z"#[HKG['J*Z"#[HH LT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !59_O&K-5G^\: (VIC?=-/
M:F-]TT 5(?\ CY/TJY5.'_CY/TJY0 C4U3SBEH YH =13>]*#0!3E_X^OPJX
MOW15.7_CZ_"K8Z"@!U%)S1S0 IZ54N_X/K5FJUW_  ?6@"Q']VGU&GW13N:
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M2=C3J:1P: *D?_'V/I5S%4X_^/L5=H 8W2F_\M!3VZ"FXRV: )**** *4_\
MQ\K]*MK]T55G_P"/E?I5I?NB@!U%%% !1110 C=*:*<:9@@T *10HR*3)I0:
M  CD4NT4A/(IV: $VTFTT^B@!GS4<T[%+B@!F:1C3\4UA0 #%&!2XIN.: '
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M&\T[91LH ;NHW&G;:-M %%SFY4U<#<54D&VY4]JN* 1F@!C<].M"R=CUI^W
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M(/NBN?L>HKH(/NB@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+110!3G_ ./E?I5I?NBJL_\ Q\K]*M+]T4 .HHHH **** $(R*9TJ0]*;Q0
MW-.4X%)@48H #UI]1D'/6EYH ?0:9DT9- #@*,"FAJ7=0 NVFLM.S36H -O'
M6DY%._&F]Z  $T\'-)2+0 ^BBB@ HHHH **** "BBB@ IG>GTSO0 ^FF@FE
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M:@"? /44@5<]*@$K)PP)J59 W3B@"2B@44 %%%% !1110 4444 %!Z44'I0
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M/RT@.1S0!&C'>:DW4Q>'-24 (33EZ5&S4H?B@"2BF@\4%N: '4UJ7/%,)S0
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MYC_D/Z5_X&1_XU-:>(-%O;E+>TU>PN)WSMCBN4=FP,G !R> :^;O^$5\1?\
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M "BBB@ IG>GTSO0 XF@"C%+0 4A-!H H  *4T4A- !VH H I: "D)H)H H
M*6BD)H ,T 4 9I: "D)H)I,4 %.HI,T -D^X:IVH#,0?6K<G*&JMG]X_6@"Q
MRA]C4@((H(SUJ, HWM0 _/S4[&:;GG-.H C9"#D4Y6R*<>>*C9=O(H K1?\
M'R_UJ]6?;Y,[Y]:T.U !111F@"I>_<'UKQ3_ (7+XBC)46>EX!QS%)_\77MU
MS&9%P*^3G_UC?4T ?6ZMN53GJ,U5O?NCGO448N/+7IT%#13R$!L8H N0?ZL5
M+3(E*I@T^@ HHJM?W]KIEC->WLZ0VT*[I)&/ ']3VQU)H 2\Z+4$VJZ=ID$1
MU"_M;3S,[/M$RQ[L=<9(SU'YUY!XQ^*MY?W,MGH+_9[)?E%SMQ+)P02,_='/
M'&[C.1T'GD<5YJE]LBCGN[N9BV%!DDD/4GN2>IH ^A#\3_!W3^V/_):;_P"(
MIT'Q$\)7EPD,6M1+(V<&6-XUZ9Y9E 'XFO'(?AIXOG@29-&<*ZA@'FC1L'U4
ML"#[$9JIJ?@;Q-I$/G7FCW BVLQ>+$H4#DEBA.T?7'?TH ^D;*^MKZW6>UN(
MIX6SMEB<.IP<'!''6K&!FOE'3M3OM)NUN]/NI;:=?XXVQD9!P?49 X/!KW#X
M??$)/$<2Z;J;I'JR#Y6X"W '<#LWJ/Q'&0 #OL<TUT#4ZE/- %&Y)'%7(?\
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M#T)0 ^BBB@ HHHH **** "BBB@ HHHH ***0YQQ0 O%5YYQ'4F'K/N@?,R:
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MYXJ3%1I]\U)0 U@* !BAJ4=* %P*3%+10 F*:PP*?37Z4  &<<4<>E*.E&*
M# HQ2=#3J &BEZ\T"DZ4 +28IPHH 3 -&*.]+F@!N*4<TM(>* # H(H!I30
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MZ#;>&]"MM.M40%%!ED5<&63'S.>3R?KP,#H*V[?B 4 /1LTX"HV&WD4]6!%
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M_P"QZ9G_ *Y2?_%U)_PN?Q'_ ,^6E?\ ?J3_ .+KIT^#WA\S^6;S4\>TD?\
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M%&H1$10 H'   Z"OF/Q9_P CCK?_ %_S_P#H9KZ@(Y%?+_BS_D<=;_Z_Y_\
MT8: /HCPF ?!VB?]>$'_ *+%<M\8X9)/!D+1QNRQWJ,Y4$A5VN,GT&2!]2*Z
MKPFO_%':)_UX0?\ H K)^)HQ\/-5^D7_ *-2@#YW262-9%21U61=KA6(#+D'
M!]1D _4"NS\,?#'6O$,,5Y,5L+"1=R2RC<[@YP50'IP.I'!!&:Q?!VCPZ]XM
MT[3;@X@ED+2#!^954L5X((R%QGMG-?3G(&,4 >8Z-\'H]+UJRU"76FG6VF68
M1I;!"Q4Y'.XX&0,\=/3K4_Q.\<R:+"NCZ5<(M_,I,\B-\]NAQC'HS9ZYR!SC
MD$>CY/I7RMK>IR:SKE[J4N\-<3,X5G+E%)X7/< 8 ]A0 [1-$OO$.J1Z?I\7
MF3/R6/"HO=F/8#_ZPR2!7JNF?!C3EM%_M74KJ2Z."WV7:B+P.!N4D\YYXSZ"
MM[X7:(FD>#X+AXMMU?\ [^1CM)*G[@!';;@X/0L>G2NTXH \IU?X+VQM@VB:
ME,LXZI>X97Y'\2J"N!GL<\=*\IN[2_T35'M[A);2^M9!T.&1AR""/P((]B*^
MK,#->>?%[0H;SPP-62*(75E(H:4Y#&)CMVC'7YF4\].<=>0"]\.?'#>*K&2T
MOMJZG:J"[ @"=>F\+V(_BP,9(]<#N*^8/!NI?V1XQTJ\+1(BW"H[RG"JC_(Q
M)R,85B<^U?3] 'RYXM_Y'+6_^O\ G_\ 0S4>D:3J?BC5X;&S#SW#*%WR,2L<
M:@#+'LJC _(#L*D\6_\ (Y:W_P!?\_\ Z&:]G^$FFVUIX)AO8U_?WLCO*Y S
M\K%  <9P ,X.>2?6@#/M?@IHJ6R+>:E?RSC.YX=D:GGC"E6(X]S7+^-/A9-H
M-G)J6D3RWEG'S+%(H\V)<#YLCAAG.>!@8ZC)'NE0W5K#>V<]I<)O@GC:.1<D
M;E88(R.>AH ^;/!?B:Y\,^(+>=+CR[.:1$NU8%E://)('.0"2".?P)!^F1R,
MU\BMPQ'O7UROW1]* /)/CC]S0OK/_P"TZ\FA^T2XM(/-?SI%Q"F3O?D+\HZG
MYB!]3ZUZS\<?N:%]9_\ VG7,?"?3;;4?&R/<KO\ LD#7$:D @N"J@D$=MV1[
M@&@#I?#WP966S:7Q#=RQ3/@I#9NOR#'.YBI!.>,#CCJ<\+XB^#EM;:7-=:)>
MW3SP1LY@G42&7'.%*@$'&<#!R<#CK7KM)F@#Y3TG6-1T&_%[IET]M<!2NY0"
M"#U!!R"/J.H![5I>&_#>J>--;:*)W.6\RZNY<L$!/+$]V/.!U)]@2*OBB*.#
MQ9K$,,:1Q1WLRHB* J@.<  =!7M_PITW^S_ UO(RRI)>2/<.L@QU.U2..A55
M/OG- &9#\%M!6%!-J&I/*%&]D>-5)[D H<#VR?K7G_COP')X0EAG@N'N;"X9
ME1VCPT9'(5B."<=#QG#<#%?1!-<?\4(8Y/A[J3R1HS1F)D+*"5;S%&1Z'!(^
MA- '!?!WQ!);:S+H4LB"VNE:6)2A+>< ,X([%0>O]T8QW]NKYQ^&/_)1-*^L
MO_HIZ^C2: .)^(OC<^%;".VL@C:G=*?+)((A4<;RO<^G&,@^F#X;IVF:KXFU
M5H+.&6]O9=TKDMR>Y9F8X')ZD]2.YK2\>ZE<ZGXVU1[AL^1.UO&H)PJ(2HP"
M>,XR?<D]Z]$^%5QX?T3PV]U=:S80WU[(3+'-<JC(JDJJD%OJV<#[WL* %TSX
M*Z<MFO\ :NI74ET<%OLI5$7@<?,I)YSSQGT%5-<^"Z);R3:'J,KR)'E;:Z"D
MR-GH'& ..F1UZD \>BGQ9X<_Z#^E?^!D?^-)_P )7X=_Z#^E?^!D?^- 'SCI
M6JZGX6UL75J7M[N!BDD4BD C/S(Z^G'(]NQ -?2GA_68?$&@V>J0#:MQ'DIR
M=C#AER0,X((SCG%>(?%:;2[KQ:EWIES;W(FMD::2"82*7!9>H) .T+Q_C74?
M!&ZF:VUFT+Y@C>*5%P.&8,&.>O1%_*@#>^+ME)=^!VEC9 MK<QS.&/)7E./?
M+C\,UX'%+)"Y>*1XV*E<HQ!P001]""0?8U]$_$S_ ))YJOTB_P#1J5X?X.TB
M'7O%NG:;<'$$LA,@P?F55+%>"",A<9SQG- '4^"OA;/K]HFI:M-+9V4G,4:*
M/,F7!^;)X49QC(.1GH,$]5=?!71&MW6TU+4(ISC:\I211SSE0JD\>XKTO@#
M[4E 'RQKNA7_ (=U633]0BV2IRK#E9%[,I[@_P#UC@@BO7/A'K+ZEHDVG3;V
MEL&4*YYS&V=HR3U!##H !MJA\;;3]WH]XMOWEBDF"?[I52W_ 'V0/K[UE_!>
M]DC\17]D%7RIK82L2.048 8]OG/Z4 =EXS^'G_"7:O#>G5?LGE0"'9]G\S.&
M8YSN'][]*\Q\;^!O^$-6Q/\ :/VS[49/^6'E[=NW_:.<[OTKZ(9=U>2?&S/E
MZ&#V,_\ [3H Y#P/X(_X3)[Y?[0^Q_90G_+'S-V[=_M#'W?UKL/^%'_]3%_Y
M)?\ VRF?!#_6ZW](/_:E>P?6@#)UNRO[K0[NTTV\^QW<D>V*?'W3_3(XR.1G
M(Y%?/=AX+U_4M;N-)BL'6YMV N#(0JQ G@ENX/48R2.1FOIG&>*IWM]9Z7")
M;Z[@MHBVT//($4GTR3UX/Y4 >9Z5\';#R=NJ:A<O<<9^RE41>!Q\RDGG//'T
M%6-2^"NFM9M_9>I7<=T.5^U;71N#P=J@CG'/./0U>N?BKX9LI0T<MS>!B<_9
MX2-N/7?M_3/2F_\ "Z/#G_/EJO\ WZC_ /BZ /&4DU'P[K9,<C6NH64Q4LC
ME'4X(]".H[@CVKZ6\,ZP->\-V&I[D+SQ R;%*J)!PX /. P(KYX\9ZW;>(O%
M5YJEHDJ03!-JS !AM15.<$CJ/6O;/A;_ ,D[TWZR_P#HUZ .QKY&D_UC?4U]
M<U\C2?ZQOJ: /K>/_5K]!3J;'_JU^@IU !1110!YW\9O^1,M_P#K^3_T!Z\O
M^'EK#>>/=)BG3>@E:3&2/F5&93QZ$ UZA\9O^1,M_P#K^3_T!Z\R^&\L</Q
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M;_M'/WOTIG@?P1_PF;WR_P!H_8_LH0_ZGS-V[=_M#'W?UKL?C;D0:'G^]/\
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MZ3R*&\BU*CRO8L0VXXQT QSR>M5?%OPD33-+FU'1;R:9;>/?+!<[=Q49+,K
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M<F@"T!@9/6@>M5VN30+DT 6B>]1,2YXJ%KDDX%'VC% %I  .E.JK]I-)]KH
MLEL4S!;D]*K_ &G)YIYN>* )AUI]5!<8-*UP2.* )F)/ I8U ZU7$QQQ2BY-
M %O%!Z56^TFF-<L: )]VXX'2I -M5%N,4[[4: +1I"<"JQN33?M.XY/:@"P
M7.3TIW0U7%S0;F@"SFFEO2JK7!QQ0DY'- %M5QUZUE:STA^I_I5W[2:SM4D,
M@BSZF@!UCU%=!!]T5S]CU%=!!]T4 6:*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ K.GNDCE9"1D5HU1FMXI)"S("3WH K&\0]Q2&\3U%2&TA'\
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M[R%71[N0JREQD$$\BO=V\)^'/^@!I?X6D?\ A2Q>%= AF2:+1=/21&#*Z6R
MJ1R"#C@T 7&NG;A$SFOE(]37UNL2+]T8K)_X13P[GG0-*_\  ./_  H UU "
MC'I3J** ,CQ5_P BAK?_ %X3_P#HMJ^<O"O_ "-^B?\ 7_!_Z,6OJ&6*.>%X
M9HTDBD4JZ.,JP/!!!ZBLV+PSH$$R30Z'IL<L;!D=+2,,I'((('!H U:*** .
M(^*>A-K'@^2>%$-Q8-]H!*C<4 .\ DC Q\WOL QTKY[KZZ(R*QO^$5\.C_F
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M7B+0H+BP1I;NQ9G$*G[Z,!NP,<M\HP,COU.!7B>@Z_J/AK4Q?:=(L<VW8X=
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M*0HN/NBG]:0T -"*?X12[%_NBA:=0 W8O]T4;%_NBG44 -V+_=%&Q?[HIU%
M#"B_W10(UQT%.- Z4 -\M?05EZTH58,#N?Z5KUDZW]V#ZG^E $=CU%=!!]T5
MS]CU%=!!]T4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JL_4
MU9JL_P!XT 1FFTX]*;0 4444 !J,??J2H_\ EI0!)1110 44F:6@ J"YYA-3
MU!=?ZHT 0V_W#4=YG8/K4D&=AXJ.[QL'/>@"Q9?Z@59JI9LH@&35GS%]: '4
M4SS%]:-ZGO0 ^HI_N&G@ANAIDWW#0 RS_P!3^-23?ZLYJ.T_U/XT^<_NF^E
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M5+0 .?K0!=Z=:B=3G<M2=:7VH C5LGWJ45"RX;(IZMGZT /ICIGFEH/2@"E
M,7#_ %J_5"(?Z0Y]ZO=Z %HHHH **** "BBB@ HHHH **** *MYG:*=;/^Z
M--N^0M.B3=",<4 3T9IBL1P>*?F@!&7(J/F,^U3"FL PH 7.0"*":B!*G':I
M,YZ4 5;O^E6(?]6OTJO>=/PJQ#_JEH DHHHH **** "BBB@ HHHH **** #-
M%1L?FIXZ4 +1110 4444 %%%% !0>E%!Z4 (*6D%+0 4444 1OUH%.84SI0
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M!1UI]0"9,_>%/,\?]X4 //2A*89H\?>%-6=!_$* +%(>E1^?'_>%!GCQ]X4
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MH ,"C:#0"*7- ";::PJ3--:@!,'UI-QIXZ4T=:  -3@<TE(* 'T444 %%%%
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M#C=3HVF5!@Y%3W? %26X'E"@"J?/8YS3@T_K5W ]*-HH H[YZ-\Y[U>P/2C
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M-(UY&!P: +&VC;5,WO'%,-Z_84 7L#UI/E'<5G&YD--,KD\F@#4X/2@#UJ&
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MM\)!]3_2@".QZBN@@^Z*Y^QZBN@@^Z* +-%%% !1110 4444 %%%% !1110
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M25>M%PF:JW0_>"KT Q&* ):*** "BBB@ HHHH *#THH/2@!!2T@I: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 1JC'6GMTIB]: '$4FP&G^U)
MB@!OEBFR* AQ4@-! /6@#+,4CL3MIPM';KD5I !>@I<<T 9ZV1[DU(+(=S5V
MB@"J+1%IXA4#(J8C--/% $4:#>:E\L4V/&\U)0!$4 <4_8*1OOBI* &;!2&,
M5)10!'L%'EBG$4 T )Y8H\L4^B@!GEBHI4 JQ4,U ""%609IC6J&IX_N"G8S
M0!3-DIZ&F-9XZ$U>Z4HP: ,TVCCUIA@D7G;6K00#0!7@!*X(Q4VP"G!0*7%
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M IK4ZFM0  TZFXXH'6@!2*!2TA%  .M%(.M.H :#BG4A%&<4 '>D!IWO2&@
MS1UI,XI>* *UPLK#Y.U):D9(;[X'-3RG$9J"+A-_0D4 .F8M^[7J:B6"9 <=
MZEME)!9NN:G/ S0!2@R)V#]:O#%58QNN&/:K7:@!.]*3@9-!QBJ\[D *O)SS
M0 W/GR\?=JSC  '2F0Q"-:D- #6Z5!(WF-L'W:DF?8OUXIMNA W-UH E10H
MIYI.M+0 4444 %%%% !1110 4TK3CQ3": $VFEY%)DTNXGM0 A/(IV^FD\]*
M7(H 7<*7(IO%&!ZT **6FX]Z,4 /IK4G-(2?2@!XY%,ZFER?2D!YH 7%"FDS
MS2J* 'T444 %%%% !1110 444F10 M,[T[(IO>@!>].I.*,T !- YHXHR* %
MI":,TE !UIU)D49H ":2C.:7- !1FD) YS2;U/<4 .ZF@4W>N.M!=0.M #\X
MIO6F"13WIPD4=Z 'XI#Q2>8OK2;U]: %IU,WIZTOF+ZT .)IM)O7UH#KCK0
M?Q4^H]Z[NM.\Q?6@!U(W2D\Q?6D,BXZT 4X?^/A_K5_/-4(B!.Q]ZN;USG-
M#Z*9YB^M+YB^M #J*;YB^M'F+ZT .I":8)%)ZTN]<=: 'T4WS%]:/,7UH =1
M3?,7UI-Z^M $%[T6I+;_ %(J&[8$+@U) RB$ F@"Q13?,7UH\Q?6@!U%-\Q?
M6CS%]: '4AI/,7UI/,3UH <.E+3/,7UI?,7UH =13?,7UH\Q?6@!U)]:C,J@
M]:=O4]Z 'T9IF]?6CS$]: '9-*#FF@CM2Y% "TAI<BDR* *5TN95JW%Q&*AG
M ,@J=>% H =129I: "BBB@ HHHH *#THH/2@!!2T@I: "BBB@ HHHH ****
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MJ!,X% #(E$42ANOK4H/>H) SOCL*G"_+B@!&.%)J")2\A<]ZL$9&#2J !@4
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M@"C]GE_OT?9Y?[]7LBDS0!1^SRY^_1]FE_OU=[T[B@"C]GE_OTGV>7'WZO\
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M[QH C/2FTX]*;0 4444 %1_\M*DIF/GH ?1110 4444 %0W/^I-35#<_ZHT
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M?ZU>S@T 4O*E_O&CRIO[QJ[GVHS0!2\J;^\:!%+G[QJ[FC- &>D4NYOF-/\
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M5ERV1UJ&Z?\ <'/K0!-#]P?2I:BB_P!6/I4HZ4 %%%% !1110 4444 %%%%
M##UI],/6GT %(:6D/2@!JT^F+3Z "BBB@ HHHH 8>6I:3O2T %%%% !1110
MA]:<M-/2G+0 M%%% !1110 C=*%H;I0M "T444 -:E7I2-2KTH 6BBB@ HZT
M44 &*3 I:* $Q2;13J* &<@TN<TN.::1S0 X'%!IH-.% !@4E.I"* %P*3'M
M2"G4 -IW%(11G%  0*2G4A% !Q1CVHZ4M #:7@T$4G2@!<4E.I"* $:D!I6H
M H 3/M1GVI^!1@4 ,S[49]J=@48% #<T[CTIIZT\=* # ]*,#THHH B?K3L#
M:.*23[U._A% #0BD=*0P(>U/7I3J *K6D6>E+':I&V5J9OO"GT (!QTI<#TH
MHH 3 HQ2T4 )BJ\]NLOWJL<TUJ (%LH@.E2"W1>@J4=*#TH C6-0>E2;1Z4@
M^]3J (5^\:FJ%?OFIJ "F-P:?36ZB@!,4;:?VHH 9MHVT^B@"&48C-9O27([
M&M61=RXJL8%#?6@">$[D!J6F(NQ0*=TH ":3K13J "@F@FF]: #K3J*"<4 (
M:BF^X:DIDWW* *MHN5)'7-3RMF-L]0*CLN5/UI]PFY"1QB@!MGDQBK+=*K6?
M,8JPY^6@!$I)N8Z5#UI)2/+- $%GPI^M622356S'RDY[U;&* $"YIVT49%&1
M0 8HQ1D49% "XHI,BC(H 6FMTI<BD) &: *4/_'PWUJ_5"+FX<X[U=[YH =3
M6I<C%(QH 5>E*>E-4C%+D4 1K]XU+42_>-2<9ZT +129%&10 M%)D49% %6\
MY"U+;\0BHKSD+4EO_J10!/129%&10 M%)D49% "TAHR*"10  T9I*7(H I7/
M^M'UJXOW!5*Y/[X?6KJD;10 V3JM/'2HY/O+4G% %.\.'6ID7,:D=14-V?WB
MU9B_U8^E %.Y8D@'KFKT?W!]*J774<=ZM1_<'TH ?1110!&_WQ3QTIC_ 'Z>
M.E "T444 %%%% !1110 4'I10>E ""EI!2T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 UNE,7K3VZ4Q>M #R* <4ZD(H *6F@XIPH **** "B
MBB@!I&*,\4XC-,(Q0 V/[[5+4,7,AJ:@!C??%/IC??%/H ,4A%+10 W.*<#F
MD(I.E #J*** "H9JFJ&:@"2/[@H(HC^X*=0 @/K2TTB@&@!U%&:* "BBB@!#
M2'BG48H 3/'- I#2B@!K4)0]"4 /HHHH **** "CM11VH C'6GYI@ZTZ@ IC
M2!3BE=]O'>FHG<T 2 YHZT4HH  *6BD)H ,T@%&,TZ@ IK=*4FFM0 J=*=34
MZ4Z@!&Z4U*<W2FI0 ^BBB@ /2H_XJD/2H_XJ '4444 %(W(I:1NE ##T-.3[
MN*:?NFG)TH 4]*%H/2A* 'T444 %%%% !BBBB@ HHHH 0T#I0:!TH 6LG6_N
MP?4_TK6K)UO[L'U/]* (['J*Z"#[HKG['J*Z"#[HH LT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !59_O&K-5GZF@",]*;3B:;0 449HR* "H_^
M6E25'_RTH DHI*7- !11FB@!",U!<H/).:G_ !J*YYA.* ,^U4&7\:L7: [,
M>M4XMT;D^].FG+X]C0!I(HV"G;15".>0K\M.\Z3GB@"XRC8?I68%_>XSQFI_
M-E*G(XIEK"9)-S4 :"+\HIL_W.*D'  IDWW#B@!EG_J?QJ27B-JBL_\ 4_C4
MLO\ JS0!#;@,#4JG:<&H;9OF(JRRAAS0 8!'-,Y0^U )4X/2I."* $!!%,9=
MIR*#\ASVIX.1F@!JG)J"\0&$FI64[LBHKI@8* )H>(Q]*D%1P_<'TJ6@ HHH
MH **** "BBB@ HHHH 8>M/IAZT^@ I#TI:0]* &K3Z8M/H **** "@]**#TH
M 9WI:3^*EH **** "BBB@!#TIRTT]*5: '4444 %%%% "-TH6ANE"T +1110
M UJ5>E(U*O2@!:*** "FGK3J0]: $IPI#S2=* '44W/-.H 0=:4T@ZTM $?>
MG YI!UH/!H <#2TF,T T !% I:0B@!:0B@&EH 0&EI"*3.* %(I,XIU(10 M
M!%-IU #:=F@TWH: !J5>E(U*.E "T444 %%%% #&ZT\=*8>M/[4 %%%% $<G
MWJ=_"*;)]ZG?PB@ 7I3J:O2G4 -;J*=3#UI] !1110 4444 %,:GTUJ %'2@
M]*!TH/2@!!]ZG4T?>IU $*_?-35"OWS4U !36ZBG4UNHH =10.E% !1110 A
M-12#)!]*FJ-NAH <#D9I>M1QG(P:EH *0F@FDZT '6G44$XH 0FDZT=:=0 5
M%/\ <-2$U'-DH: *UD>#]:M."R,!52U'!]<U;5NQH SU\R-MBM@U*5G(^_0Y
M'VHU</W* *2K.,_-0R3,,%JM@T[@"@"BD4R?=; I^VX_O_I5Q<8I>* *.VXS
M]^C;<?WZO<4<4 4=MQ_?HVW']^K_ !1Q0!0VW']^C;<?WZO\4<4 4-MQ_?HV
MSXY;BK_%(V,4 9:>9O(!YJ?9<8^_21?\?#^F:N]30!3VS_WJ1EGQ]^KW%(10
M!259\??_ $I0L^?O?I5OI3N* *"+/N;YZ7;<9^_5I?O&I/RH I;9_P"_^E&V
MX_O_ *5=XH_*@"EMN/[_ .E&VX_O_I5WBCB@#-E$HQO;-/19BHVM@5+>=%J2
MW/[D4 0;;C^_1MN/[_Z5=XI>* *.VX_O_I1MN/[_ .E7N*3B@"CMN/[]&VX_
MOU>X]J#^% %';<?WZ"MQQ\]7N"*.* ,]X)6.=U.VS]FJ]Q0?PH H%9\CYZ4K
M/_?JV_48IQ^Z: ,T+)*^2V<5;0L,*34-N")3Z9JXZ@\T 4[D-NZ]ZLH&V#FJ
ML[YD"^]7H_N"@!F&]:,-ZU+10!6?<' S4@#D=:BN&Q*M6$Y0&@!%#=S3Z**
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MGV0T?9#0(T3/.&VE3FE,ESV0UF_9#1]D- S2$MU_SS-(QN77&TUG?9#1]D-
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MAMHVT?VQ_<_'_@!_9']_\/\ @GJ.)L C-&)_>O+MM&VC^V/[GX_\ /[(_O\
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M_!/7=]+OKR';1MH_MC^Y^/\ P _LC^_^'_!/7M]-=_E)KR/;1MH_MC^Y^/\
MP _LC^_^'_!/3#._F-M%+YTQ'W37F6VE6,LP502Q.  .31_;']S\?^ ']D?W
M_P /^">E^9*&'RFE\Z;/W37%V7AV>8;[G=$O9<?,?\*W(=.6"(1QJ54=!G->
MCAZU2JN:4.5>NOW6//KTJ=-VC/F?I^MS9\Z;^Z:/.F_NFLK[(:/LAKI.8U?.
MF_NFCSIO[IK*^R&C[(: -3SIO[IH\V;^Z:R_LAH^R&@#4\Z;^Z::\TG<5F_9
M#1]D- SH(9,QC-2;ZYO[(:/LAH$=)OHWUS?V0T?9#0!TF_VI-U<Y]D-'V0T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !114]G97%_<""UB,DA&<#CCU)/2G&+D[+<3:
MBKO8@K2TW0K_ %3#00[8O^>LGRKW[]^G;-=3I/@ZWMPLNH$3S YV*?D'I[G^
M7/2NF1$C14C5411A548 'M7M87)Y2]ZN[+MU_P" >/B<VC'W:.K[]#)TGPW9
M:45E ,MR!_K7[<<X';^?/6MBBBO>I4H4H\L%9'A5*LZLN:;NPHHHK0@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <'XKU>]_M2>P28Q
MVR!1M3C=E<G)ZG[W3I7,445\7C9RE7GS.]F_S/L,'",:$.56ND%%%%<QTA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5T7A/2;74
MKF:2Y5G$&UE3/RMG/7UZ445V9?",\3&,E=?\ X\?.4,/*479_P#!._1$C14C
M5411A548 'M3J**^Q/D@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>forms-1_002.jpg
<TEXT>
begin 644 forms-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" .< LH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_2D3[B_2@"SYR^A_*CSU]#^504AZ4 3_ &A,XYSC-*)U/K50_P"L/TI>OUH
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M4K9+B>%-&U"7R9&1FC((X.,_I6QX>\;:5XDN&MK4S0W2@MY,R@%@.N".#]*
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MBT.+Q!\4[G3IF*;[ %''\+A>#2V<EQ\0_&=KJ"P/%HVFM\C/U<@YQ]20,XZ
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MDV-HR"1GM46T[ONOCZT ([,1R6Z]UIV]O[S_ /?--=?E^Z_7N:=M_P!B3\Z
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MG/DCK5V]O(-/L9KNZ<1V\"%W;V%,L-3M=3TV+4+:3-K(N]6<;<#OG/3% %D
M*H  5%&%4# 'X4Q;>%)FF6&,3/P7" ,?J>IKG;KXB^&[2<QM?F5@<9BB9E'X
M]_PK9TS6+#6;8W&G74=PB_>*GE/8CJ* +A (*L VX8((XQ445K;VYV000Q*W
MWA'&%!^N*P_^%@>&ER/[53.>?W;_ .%6]+\4Z-K5Z+;3;U9Y@A<J$8<#OR*
M-:&"*W39!%'$F<[8T"C/T%)'#%$[F**-"YW.44#<?4XZFDN[N"PM);JZD$<$
M*EW<]%%0Z;J=IK%FMWI\ZSV[$J'4$<CJ,'F@"=;>%)FF6&-96X:0( S?4]34
M3:;8NQ9K&U9B<DF!22?RJNVNV"Z\NC-,1?-%YH0J0"/3/KCG'M6C0!733K*)
MP\=E:HZG(985!!]CBI$MX4E>9(8UE?AI @#-]3U-24GXT ,<*T;!@&!SD$9S
M4=O;Q6XVP110J>2L:!03^%2GI^- /S8(Q0 UX(9G1IHHY&0Y0N@)4^V>E#6]
MN9Q.T$1F'20Q@L/QZT_%+^- ";@34<D%O+*LLD$3RI]UVC!9?H<9%+"<J?J:
M>KAA0!6.G6#.2UC:DGDDP+D_I3X;6TMF+06T$3$8+1Q!3C\!4_<TM ";A2;A
M_D4ZB@!C2*O4_I3?.3U/Y4DWWA_NFHUC(8#@Y'>@!\DJE0 3UI_G)ZG\JC>(
M@#[O7L*41'./DS]* "252N 3U':G><G/)_*HWB( ^[U["G>2?]C\J '><FXG
M)Z>E+YZ>I_*F>2=V/D_*CR3_ +'Y4 "2J"V2>3Z4_P Y/4_E42QGYON\'TIW
ME'_8_*@ CE54P2>OI3C.GJ?RJ..(LN?EZ]Q2/&=Q' QZ"@#.\4.KZ.-I_P"6
MJ_UKEATKI?$G.DG_ *Z)_6N:'2OG<T_C_(]_+?X/S"BBBO-/0/4****^T/D"
M*;[H^M0#O4\_W1]:KCO0 Q?O-]:7(Q[4B_>;UI1TR/Q% !&<;NO6G$_*?I38
M_P"+ZTYONGZ4 (A^4?2G9J-750,L.E/)]"* $\SG&.^*-_MWP*;CD<C'- 0;
M<9X]Z '@[E!I)/\ 5M]*7( ZTQY%:-L,#QZT *W5*?3&ZI3Z "D7I2TT$  9
MYH =11F@'- !2'J*6D/44 !ZBEI#U%+0 B]_K2TB]_K2T !%,/3\:?2 ;ACW
MH Y?Q]K9T;PQ,L1875W_ */#CKS]XC\/YBN4T:RF^'_BW2X[IV^S:G;+',>R
MR'M_P%L?@31KIU+Q=XZ>+0UAE71P-IF(\O<&Y)SP?FXQ_LTOBG1?&NJ:4TFL
M"QEAM,S#R2H<8'.,#GC^5 '4_$76I]$\--]D8I<73B!7'5002Q'O@8_&CPSX
M(TO1-,BDN[6&YO6C\R:690X4XR0 > !7/ZY-/XQ^&%K?P9DNK)PTZKR25!5C
M^1#5U/ACQ7I_B+2HB9XH[D1A)X'<*0<8)&>H- &,3X!N-;M+^&[LH[F)\JD.
M561_X20!U!JO\0FM4\8>'#J/E_9%+>=Y@RNW<,Y]JH>.M*T/2[C1ETB"TAG:
M['F+"^6VY&,C)XS6GX^MH;SQUX:M[F-9(97971NC N.* ,;QM-X+ET5O['6U
M-^67RS:H1QGG=VQC\<XJUXS%RO@/PT+[/VD2Q^9NZYV]_?&*BU?3+;P)XUM=
M26TC?1[DE=K)N\AN^,]Q]X>V16I\47630M)=6#*UVK*P.005X- #?B)=W.HZ
MGI7AJSD,8O2&F([C. #[#!/Y5TNG^$M$TRR6VAT^WE7&'DFC#N_N2:YCX@)/
MI&OZ/XEAC9X[8B.8#MR2,_4$BNRL-:T[4[-+JRO(7B<9Y< K[$'H: *6D^$]
M+T"ZO+K3XG1[E2"I<E47^Z!Z9YYK"^$__(N7@_Z?&_\ 05KH++Q3I6JZM<:5
M8W(FGCC+9491NQPW0X[UR_POO[>UM-1TNZE2&[CNF<QR,%)& #C/H10!-\2?
M^/[PUZ_;OZI3O&'_ "4KPM_OG_T*JWC6\BUCQ?X>TFSE2:6&X$DIC(;9R#@G
MZ*34WC.:.'XA^&)IG6.-6+,[G  W=2: .UOM.L]3B6*_M8;F-6W*LJ!@#ZUY
M_P"(]$TRW^(GART@L+:.VG!\V)8P%?D]1WKNEUW2F8*NJ6)8G  N$R3^=<GX
MI_Y*AX6^A_\ 0C0!J:WHNF:;H6JRV%A;VTALY%9HHPI(QTJ'X<L5\$67'&7[
M?[1K8U^W>[T;4((5)DDMW50#U.TXKF_AGJ]O)X72R\Y$N+9V#QNP!P3D'GZX
M_"@"'Q(P/Q1\,D@?=/'XM6?K[Z9'\5 VLB 67V1=WG#*YVG%6K^^BUKXLZ2E
MDZ3+8(3*Z<KD;B1GVR!]33-3L;75/BZMO>V\<\#688QMT)"G% &)XS;PW,ED
M/"XB.HM.,?958#&./;.[&,5O?$1H8]<\+-J>PPJQ^T[QE2,INSZCK5+3H(/
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MEL(]^/,=CN=\>I_ITJAKG@31=>NS=W,,D<[??D@?:7^HZ9]ZZ(\Y]:/<?B*
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M^\C!A^8J1C\I^E  GW1]*#G(IN[;&/I52?5[.VN$MY[JWCF<96-Y%5F^@)H
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M=#T:60*#^=/BN(9X!/#-')"1GS$<%<?4<4 2#I2?A58:KI^/^0A9_P#?]/\
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M9H 8^NW4US<1Z3I,E]';N8Y)C,L2EQU5,_>QW/ S5#7M9M[KP]9WZ),%BU*
M2Q%/WB.LF&3;_>S4ME)?>'$FL/[)N[Z#SGDMYK4J<J[%MK@D;2"2,]#52ZTG
M5?[&:6.")M1GU6.]: /\D>&'REN^%49([YH TVU^\MFB?4](EL;25Q&)S,DG
MEDG"^8H^[DX&><5:O[S4X+HQV.D27@1=S2&9(EY_A7.23^59VI2ZAXBLVTM=
M'NK)9G47$]R4V1H&!.S!.\G&!^=0:I82W&O7)U+2]1U*!ROV/[//LAC7:,AA
MN&&W9))SP10!/J6HQZMH&E7L*NB2ZC;91QAD828*GW!!%=#-*(4:1N54%B/H
M,_TKE[#1[Z#PCI=D]J4N(-1262,,#L03%B<]QCFNI=0[#=R/3UH YSPMIT&I
MZ=%KNI11W5]?@S!I5W"%"?E1 >% &.G4U=N]&L=-TW6)[&W6![FVD,BQG"$A
M&YV] ?4BJ=@NH^%H6L?[/GU'3D=C:RVI!DB0G.QU)'3/!':K?G:GJEAJ(ET_
M[)!);/';Q2L#,[E2,L <*.0 .M &+I>H^&%TFS6722T@@C#'^R6;)VC/.SGZ
MUM>)+AXM)CLK(E+J_=;2#:/N!OO-_P !0$_E4&G:UJ-IIEK;OX=U8O#"D;;3
M%@D* <?/[5'-I$WB#7?M6H)>6=K:0!;94F\MS(_,C94]AA?SH D\/0IH>I7>
M@1AA;(HNK('_ )YMPZ_@W/\ P*MRX/\ HLW!_P!6W\C7.WGAQM.N++5-*>^N
M;JUF :*:Y:3?"W#J-QX.,'_@-=).I:"55Y)1@/?B@#B_ !_LN.WTUCB"_M$O
MK;V? $JC\<-^)IFJ$ZKXML]1SFUL=2BL;?T+X9I6_,*OX5=FT;4D\%Z0;*+9
MK6F1H\2,1][&UT)Z<@_I5I]"ELM+T&RMD,IM+V*6=QWX8NY_X$WZT 7)]0U&
M&9XK'1I;Q4&YI#.L2G/\*YY)_*HI_%,$6B66IQVMQ*EW*L*PJ!YBN21@CU!4
MBLS4;"6?7+LZEI>HZE"[+]C^SS[(8UQR&&X8.[)).>*?I^D7T'A[0;62U*36
MNH"69 V0B!W.<]Q@CWH E>\F_P"$ITVYU2W2PV65TSJTP<*H,?)8<"M&+Q!&
MVE2ZE+:W$5KN"VX(S)<9.%*IU&XG@'Z\52\0>'QKNMV2SQR?94MI@TR'!CDW
M(4/UX/MQS4>H6.J:UH4MAJ$"->VLR2I+NVPW@4YZ@Y0D9!'8^U %Y-;NX9X%
MU729;&"X<1QS>>D@5C]T.!]W/3N,U2LM8U:3Q9?VDFFRFW00C!G3$(.[Y_4[
ML9QUXJE::-:3W]LL7A6[M]DBO++=W)V1XYRN&.\YQCC%:N;JQ\874WV"XGM[
MZ*!%GBP5C*;@V_)&.N: '>-&">$-1=ONJBD\=@ZT+XBN$O[5+W29[6UO9?*@
MG:56.X@E0Z#E<X]ZG\3VD]]X=O+>UC,DSA=J#J<.I_D#2Z_:S79T[[/&9/*U
M"&9\?PH,Y/ZT &IWVH13^38Z1+=JH#-*9DC7/]U<\D_E5<^)XVTNQN;>UFEG
MOI3##;,P1O,&=P8G@8VG/Z5F:Q8S3:Y<MJ6F:AJ5NY3[&+>?9"BXY5AN&&W9
M.3GC%):Z7+;>#+6RO]"^VA+B0RVR2#?&I=B&0D_,1D=P<4 =!97-W=12B\T^
M2QEC<#:[AU?OE6'4?@*6_N[ZV6,6>GM>RR-C"R!%08SEF/0?@:SO"]M<VS7F
MZ"\MK!ROV:WO)=\BG!WGJ2%/& 3V-,\2VMQ->6C/;7MYI:JXFM[.38YDXVLW
M()7&>,]: )%\221V&JSW=B]O<:8FZ>W+ALC&X%6'!!'\J9_PDUU&UK-<:3-#
M87<BQ1W#2+D%ONEDZJ":R8-#NETOQ-%;:7+:+>VZ"U@:7>S?*003DX.>V>,U
MOZ]:3WFD6\,$1DE2YMW90>BJZEC^ !H U45EW$]<\@4XX(HSACZ9X-!&.1^5
M #(ON?B:E/45#&<1Y]S4F\$CL?>@#(\5_P#(''_75?ZUR@Z5U?BK_D#C_KJO
M]:Y0=*^=S3^/\CW\M_@_,****\T] ]0HHHK[0^0(I_NCZU!4\WW14% $:_>;
M'Y4HZ>U-YWMM _&J-_KEEI<H2^N(X'9#(JMG+ $#C Y.2..M %]1E7 )&20"
M.U9^F:*NF275Q)=3WEW<@"2>?&[:H^50   !D_G2Z9K5GJDDD5G*&F3YFBD1
MHW4'H=K ''O4=OXDTZ]NA:VMP)93N!V(Q5,9SN;&%Z'J: -9/N+]*4]JPXO%
MND/,D*WB?.VQ)2CB)VZ8$A&T_G5V9R-:M4-VZ2&*0K:C[LH&,L>,Y7([]Z +
MYINT5D7/BK2[2Z>":Z7=&VV1E1V2,^C,!@?B:MW^J6VF6@NKR:..!B KY)W$
M]  .23[4 7, =J;)GRV[<5@7_C*P@TB[NK>4--;KQ#)'(C;B"5!4@$ XZ]*M
MVOB.QO-(DOOM$<<$8 F=PR!&(!QR.>O:@#1FA29/+D&Y'!5AZ@CD4Z&WBMX4
MBAC6..-0J*HP% Z 5GZ?KUCJER(;:8^<J[_+DC:-F7U 8#(^E)=>)]*LKI[>
M>[_>1$"4I&[K$?\ ;900OXT :N![4N!6'X4=9K*_DCD5T;4;@JRG((W<$'TJ
M/5_%EGI&MVMC/)A75VG;RW)C&W*XP.<_I0!T%&:S[[6]/TT0_:K@AYUW11HC
M.[CU"J"<?A4NG:E9:K;F>QG69 VUL9!5O0@\@_6@"WD>M-+#(JM?ZE9:5$DM
M].D$;MM5FZ$X)Q^0-57\2:7'9PW4D[I',Q6)6A<22$==J8W'ZXH TRW(X-!)
M/:J=GK%CJ-N\]K<*T<61+N!4QX&?F!P1QZU7L_%&E7]U';6UR3)-GRM\3HLN
M.3M8@!OPH U<GVI"2.XS6?J&O:?IEPMO=W#"=EW^5%&TCA?4A0<#W-9-WK6G
MIXBTK4?M:&S>QN-LBY.X[XP  .2<]L9H Z;DT!1WYJIINL6.KI*UC-O,+;9$
M9&1D/NK $5<%  ,49HHH 0GG\*CSGJ*D/7\*8,'CIF@"3N*#UH]*.] !11CF
MC% #9/N&D_C./04LGW#29R_![4 ./0D?B*/Y4']:,]Q^(H /8]*09\S\*7]1
M2#_6?A0 ^FQ_<%.J$,P4!<=* )&_UB?C0OWG^M- 9\-NZ>U*$8$G<.?:@!],
M'62L_4-<L=+G6&ZN<3.-PBCB:1]OKM4$@>]/_M:Q_LMM3^VQ?8L<R]AVQCKG
M/&.N: +R?<7Z4?\ +4?2L*7Q;IL=A<S17)+VZY,<D$BL"0=N5(S@D=:C@\06
MFL^'Q=?;Y+)E6+SY8D(,3L1\HW#D$\=^M '1U&GW??)Q5._U_3=-NC;75QLN
M H80JC.Y!SC  )/0]*ICQ;HR6T<JWF\.&;$<3NR '!+*!E<'UQ0!M?SH]A^)
MJG/J]A;:<E])=1BUD"E)1E@^>FT#DD^E0VOB'3+N&YDBN&"VH#3JT3JZ ]"5
M(S^E &D/3M3!]S_@7]:Q?#GBFUUZV8EUCGCWLZ!6"J@8@-N(QTP>M2VWBC2+
MJ:."&[RTC[8V:-E20YZ*Y&T_@: -JC^=4-1UNPTIXX[R<B60$I%&C2.1Z[5!
M./>LO2=0MM3\97MQ93K-"=/A&1V/F/D$'D'V- '1TA!R#67XAU.?3;*%+%4:
M^O)EMK8/]T,>K'V !-56\+%DWR:UJS7V/^/E;@J WM']W'MB@#?HK.N[\Z+H
M4ES?2BXEMH<NX3;YK]!@=LG Q[UF^&IM0L[R?2M9N&GNFC6\BD8]5;AT'LK<
M#V(H Z,=*,$#D5STLEUK^MW=A;W<MIIUAM2X> [99I6&=@;^%0,9QR2:DMM&
MATV_B:SUFZC4'$MK/<^<LO''#'*GIR* -Q>E!KF]03[7XN%I/J-W:6ZV E"P
MW)A#/YA&3Z\4:!=2)XBU#38=2DU*QAA202R,)&AD)(,9<=>!GU% '2BCN*AO
M+RWT^U>YO)TA@C&6=S@"J5CXATW4KG[/;7!$^W>(I8FC9E]0& R/I0!H!E4@
M%@">@)Y-.SGGM7(:)?:3K'B_49G(N+M)$%FSQ-F-%C&[;D87DM]:ZOG;A>0>
MAH D]:,"F#Y7QG(([T[M0 HZ4M(*.* %I!U-'% H ;-]T?44I&#D?E39?NC_
M 'A3NG7IZT +PPI >2#UHQSD4 !LT -^[(<=,4I&>1UH'^L.?2C[I]J %'((
M/Y4=, ]*,9Y'6C.1@T 1H"4QCC)IYS_$NX>U,49B('K3AC^!OP- &/XG_P"0
M/QG'G+C/XURXZ5U/B@YTC!ZB5?ZURPZ5\[FG\?Y'OY;_  ?F%%%%>:>@>H44
M45]H?($4_P!T57YJQ-]T5!0!&/O,#Z]:YC6KRUT[QSI=S?J?*CLIL3;2PA)9
M0&..@[9[9KIQ]]_3-9DEI,WBZWNQ'FV2QDB9^,!BZD#'T!H I_;[;7/%>E2:
M3,ES]C$C7-S%RBQLN!'NZ$EL'';%4=/M)KCX<ZC;V2XGG>Z^5>#(?-;(SZD#
M%=@BK&NV-511V48%-/7:!CZ"@#F-1\2:)>^&IK&W=9I9K<P1:<J'S0Y& FS&
M5P<<]L9JRL4\/B#08;B0-<IILZ/)ZN!$"?SK<CC42&78H<C!;:,_G6<EC?3>
M)EO[HVZ6MM%)%;K&27?>5)9L\#&WH* .1TZZ;3=)6SOO$SZ?/;[DFLGM(RV[
M)SM&,ONZ@\YS6F88M#'AFZN6F?3;2%XS--'AH7<#8SK_  \97VKK9$5I(V*J
M64_*Q )'T-#8)7W/(- &)JNJV6M>'M:BTRX6[D2S<,T(+ Y4X ;H3[5F:M?1
MZGH6D7>FWVZVLIHVN98(Q,8?W> Q0]=I()[CKVKL458U"QJJ*.@48%"(L8Q&
MJH.N%&* .0LI8=3U_3@/$\FJ26[M,JPVR;4^4@[W7[H.>G>IO#^MZ=H6D_V?
MJMREG?02/]H24$-,Q8G>H_C#9!XSZ5U"QH@(1%4'D[5 S2&-696*JS+]TL 2
M/H>U &!X',9T2Y,,#6\1O[@I$PP4!;@$=OI2^(+Z#3_$&@W5Y,L%LAN%:5SA
M5)08!/;.*WP,Y)H=4==KJK+Z,,B@#G/[1M=(\4WUUJ4JP17L,)M;J0X0HH.Y
M-W0')W8[YJ31IDU+Q+J.I6!S8O!%"9@N%GE4DEE]< @9_P *WV"NA1D#*?X6
M&1^5*,@    < >E &)XAA2:^T!95#K_:(.&&1D1N1^H%9NO^=9^+8[R;57TV
MVEM!%%=&%9%5@Q+(6;[N<@^^/:NMQGJ:1D5AM8!E/4$9!H X^SNS#_;&L66H
MS:W/#:B/_CV"12$$D8*_?(R<X['%4I]1-[>Z&?\ A(8]3/V^%FAM[95CBZ\[
MARO7 !/-=Z%5-JJH4#H , 4+&B9"(J@G)VJ!D^M '-6FI6>A:[K":M.EG-=3
MB>*>7Y5FBV@ !O\ 9((Q^-/$MIJ/BS1;JW4/%]BN7B8H5P=R#(!''4_G71.B
M2 "1%< Y 8 \TX]<G&: ,.T&WQQJA Y:RMR3ZG<];0;UXI<CVS2 ^V: %H[T
M@ZBE[T &.?PIF".PZ?G3\\_A1WH /2@]:.XH/6@ /?Z5&JH4&3SCUIY[_2F+
M$"@.3TH 8V=N!]W=2JG(VG'&::P &.>&ZT]2 1D_PT /*-_?_2F-N0@YS[4\
MNF.M,D*G 4Y- $@]1^5(/]9QZ4H]NM(/]9^% #ZB&1@X)&.U2TU/]6* &QX.
M[&<9I^*9!T/UJ2@#BKEY--\3:J;K7FT<7+K+"[P(R3($ P';NI!^7\>]+%;Z
M=)X;U"[N]3OIK:>]2;[8MMY921=H$BJ!@KD EL8ZUV3(L@*NBNN>C#(IW;';
M&* .0L-4GO)=4LDU&'6(A8LRW<,05E;! C8C@DYR,56N-1M;_P"'4*VMPDS0
M16J2JIR8VWIP1V/!KLHT6.8K&JHO7"C IPC1)/E15R"3A0,F@#'AC4_$*_E*
MCS%T^$*V.0"[YQ^0IGAB-%U7Q"5159]1^8@=1Y:?XG\ZW_?O4:#*^@SS0!Q=
MEJ4^F^$-'6&:&TBEF>-[N6/>EL-SD''3)(P,\#-6?#LQN?&D[C5CJ0%@H%SY
M*HIQ)RJD<-C/7MFNH4)\R.!M/!!'!IX,2@!=H X  QB@#A[60WW@C4-(M)PV
MI1M.7M1_K !,21M/J#^.:AGNH-2L([)O%<TZSLB"TBLD\U3D<;0,KMQUXQBN
M\(C\PLJKN(.6 Y/U-1JB;F8( [8!<*,G\: ,(7MGHGB?5'U698#=K$UM<R'"
M,BK@INZ ALG'?=3-!O+74/&VJ7-DA\I[*$&;85$Q#,"PSU';/?%=(]NCH5<!
ME]& (J2, (N !QB@#'\3V5S/:V=Y8Q&>ZTZY6Y2$'F4 $,H]]I./>FCQEH1B
M\QM02-AU@=2)E/\ =*8SGVK<IC1H9A(40N/XRHS^= '*:K-<^([_ $VRLU^Q
MF-1J%P+J+=LP<1*Z@]2<G&>PINL6^L:>UKKMU>VMRNFN6D2&U,;-"W$G.XY
M'S8]JZW[K$G'-*N"O08H YI+N/PUKM_<7>X:5JC)<I=JI9(Y-H4J^.@( (/2
MJ6MW&@:I=V;:7]CN]4>^@<R6\>^0(KC<2P'  '<UV@^[C'!XQ3(XTB4B-$0'
MJ%4#/Y4 <Y?:79:MXV>'4+6*YB_LS@2*#M)D(R/0X[T_PJW]F/<>'KA56>R^
M>&0*%^T0'[K\=6'W3]*Z$48S@\9]: ,3Q/\ N7TJ]FC:2QL[OS;E57=M&TA7
M('4*Q!_7M5;4M5LM>U#2;?2;A+RYANTG:6$[A!& =Y9N@R/EQWS[5TO(/6FH
MB1C$:*@)R0J@9H R-$).N^(NO-U%_P"B5K693C;Q@TY>]+WH CP%< 'BI./:
MDV\FEQ["@ &*.*0"G8H 3K2XHHH CF^Z/]X4X'/!IDO"@^XIQYY'7UH /N\'
MI2XY)%(.1@]:4?*<'I0 G#,?I2@\X/6D_P"6AQZ4O#4 )]WZ4K#.".M /8]:
M0_+TZ4 ,49BQ[_UIV 2%<<]C21Y\OCU-*QXPRD4 8_B< :/[^<N?UKEQTKJ/
M$V#HP*_\]ES^M<N.E?.YI_'^1[^6_P 'YA1117FGH'J%%%%?:'R!%.<**K[J
MGN/NCZU7 ]Z &@_.^/6DZNV&(X'2EV'<2&(S[57OKD6%LTQ;+'A5]34RDHIR
M>R!NQ)/.EG 99G<H",D#)YIT,JSPK*A;:XR,C%<O//>WL#SRLQA4@'LH/H!3
MD;4+&"*9&D$+@;<'<OTQ7G_7WSWY7RV_IF?M-3J1]30RDC&XCW%06\DK6JR7
M \I\99?2L*74+W4[GRK9F53]U5../4FNJKB(TTG:[>R*<K'1E"K)EB>>]#?>
M7/7-<Y-:ZIIZ>>96*KU*ONQ]0:UM*OCJ$&7.)8S\P X/H:5+$J<N22:?F"E=
MV-&EJK>WT5A#OE;D_=0=6KFIM6N[FY#><T:E@ B'  S17Q4*3L]6$II'7$TF
M3V%(4Y/-&WWKI*#'J:7@4!:Y2:>^FU.:"WFF+>8P50^.E85JWLK:7N3*5CJ]
MU&?:N9\G7(@6!N/^^P:L:5KDLMPMM=D$MPKXP<^AJ(XI.2C)-7[B4^YO9/I3
M69@Z#CFJ6LRW$.GLUJS;PPR5'('>H="FN9[1FNBYVM\C,.2,<UK[5>T]G8?-
MK8OBZA:?REGC,H)&P'G\J=-/%;@&:98P> 6.,USMH?\ BJW_ .NK_P C5KQ2
M?]%M^/XS_*LEB'[.4[;,7/HV;:%9$#HP96&00>#3MH]*H6;2KH430J&D$&4'
MJ<<5FZ#=W\UY(MPTKQ;26+C[K=L5I[:SBFMQ\VQT.*04F"?6@*.];%!GD4N1
M0>U+WH ;U;\*7O1_%^%+WH .XI#UI>XI#UH .IIOEJ!W_.G=Z4]#0!$Z@1D#
MUH"A6(Z\4Z3[E(?OGZ4 *0 .G%+CM^1H[<=*/Y4 '\Z0?ZW\*7V/X&D'^M_"
M@!]-3_5BG5$%?&#C [ T $)P#]:ER/6HL8('EKS0$.3\B\^] $@(R>:7-9VI
MWHT^ $1J9'.%![>]9$-MJ.I*9ED.W/4OM!^@KFJXE0ER13;\B7*SL=&/^/@_
M2G_\M1]*YA+R\TNX"7.YDZX)SD>H-="UPL4!N9&'E*FX$=2*JEB(U$^C6]P4
MKEBF)]WG@9-<U]HU'6;AQ S(B_PAMJJ/<]S36FU'1Y4,C%D8\ MN5O;ZUE]<
M7Q<KY>XN?R.H]S^5&/;)]*K+?Q-I_P!M_@V%L>GM7/H^IZW,[1.51>P;:J^W
MO6M2NHV25VQN5CJ"@/&.3^E,"@1X_P!JN>L]1O-,U 6M\S,C$ [CG&>A!]*V
M=1O5T_3WEX+[L(/5J<*T91<GI;<%)-7+GEJ?7\Z<!@8K$\-6\WDRW<TCGSC\
MJD\'U:MNKIS<XJ5K#B[JX4AZBEI#U%6,0H"<TX#%%%  .E)V-*.E)V- ""B@
M4N.* #O2=Z7TH[T -C8-G!I_>HH!A3]:E[T '<T4#J:*  =Z*!WHH *":*3G
M- #)?N@^XI3P?;O22D!/F /-0X&[.$QZ;J +!P>0>: 0<@XJ'Y?[J?\ ?5)\
MO]U/^^J )0<.>>,4IX.14/RY^ZG_ 'U1\O\ =3_OJ@";J.M .>":A^7^ZG_?
M5)@9SA,>FZ@"6+[GXFI#U%,B(,>0,>U.)Y % &/XJ &CC _Y:K_6N5'2NK\5
M?\@<?]=5_K7*#I7SN:?Q_D>_EO\ !^84445YIZ!ZA1117VA\@0W&=HQZU6RP
M["K4WW14% #03[5D^(D=[*-Q]U'RV/<5L8J*90RE9%W(1@CUK.M3]I!P[B:N
MK'-B\B;P^UKN E5P<>HSFMS3,_V7;\ C8*QM4TF.U@:XB9@NX#8>?R-58IKW
M3DBF4LL4G*YY5J\V%2="I^\6RMIV,DW%ZG5R()HVC<95A@CVJ&UTZ"R=F@3:
MS#!R2>*98WGVVV$R\9.&7T-6+FYBLX#-,V%'YD^@KTO<DE4_$UTW(M3G6WT^
M9I",,I4#U)K*\,QONN)!]W 7/OUJH[W6OWH"C:B]/[L8]_>NEM+6.SMUAB'R
MKU)ZD^M<L+UZRJ+X5^)"]Z5RG?Z1'?7,<SL5QPX'\0_I6-K,:0:G''$H5%5,
M ?6NK(R*Y;7^-93_ '4_G2QE.*@Y):MA422N=.2V3P*/G]J<6!)HKO-!N&]1
M7+VDBQ^)':1U11(^68X'>NJSBN--K]NUR: /LW2/SC/3-<>+O>#6]S.IT.G:
M_M$4LUU!@?[8-<Y!_P 3'Q")(%^0R[^G11W-6O\ A%7[72Y]T_\ KU5@N+GP
M]?&&8 QM@N!_$/4&LJLIR<?:JRN3)O3F.EOKK[#:27!3<$QP..],TZ__ +1M
MO.5-@#%<$YZ5#KI!T.9E.00I!_$5#X8P=*)_Z:M_2NISE[91Z6+N^:QG6A_X
MJU_^NK_R-6O%1/V6WS_ST/\ *JEH?^*P?_KJ_P#(U:\6M_HEM_UT/\JYDOW,
M_7_(C[#-#3C*NDV[?+M$0./PJ+2M9&IS21K"4*KNR6SGM4UADZ%!Z>1_2L+P
MF1]LN,]HA_.M^>47"*V95VFD='>7T5A#YMPX5>@ Y)/L*PY/%H#?N[7Y<_Q/
M@U2U5I-1\0"UW$ .(ESV]373V]A:VL0CC@0*#R2H)/U-+FJ5)-0=D@O*3T*-
MAX@COY5BP(9#T5NC?0UHWMU]ALY;AE+B,9V@XSS7->)M-ALFBN;91&LA*LJ]
M W7(]*T;NZ:\\'O._P!]HAN/J0P!_E3C4FN:,MT"D]4QK>++86XD\E_-)(\O
M<.!ZDU%!XPB>4"XMBB?WD;=C\*K^%-/AN6FN9T5_+(5%89 /7-7?%5I!_9GG
MK&JR1N "H R#V-0I57#GN3>;CS7-R.19422-@R,,J1W%+WK'\*RF714!S^[=
ME'TZ_P!:V#UKJA+FBF:Q=U<!UI3T-)G!IOF+CK5#"3[E(.2Q'T%(V7P,$*>Y
MIV. .A% "GU'XBCI]*#^M'N/QH /Y4@R)/PI>GT--R%DY/&* 'YI:9O7^\*-
MZ^HH 5O]8GXTZF$YD3\:?0!7N]/M[TJ;A"Q48&&(Q4L<200+%&,(BX I]9>K
MZPMD###AIR.3V3Z^]93=.E>H]!.RU,[Q%<(\D$2G+1J2V.V>U3ZP6M]!M(&X
M9MH;\!FHM'TLRNMY>?<SN16ZN?4^U3>*&#6UO@Y^<_RKA<9.$ZTM+_D9ZV<B
MYH,(BTF-L<R$N3_*FZQ$LNCS%NJ?.OM@U+H\BG2+;GHF#^=)J3!='NC@']V>
MM=:BO86\OT*^R9.D*UYHE[:KRV<K^//\Q46BZO'IZ26]TK*"V=P&2#W!%6/"
M@)6Z/;*C/YUJW.E65X^^:!2W=@2"?RK"E3E*$9Q>J)BFTFCG+NX_MW6(DMT*
MH,*">NW.234MRYUW6UMXF/V6(]1Z=S^/2K6LRVVCV)M[*-8Y;@8)'WMO<YZ^
MU45O!H%JL"1AKV0!Y"W2/T7W-)QM)J;\W^B)>CU^9UR*J(J( %48 '84M<DO
MB;4K613>6ZF-N0#&4)'L:Z>UO(;RW2:%LHXR,]179"K&>B-8R4MB:D8@$4NX
M>M,<!BOL:T*'T4"B@ '2D[&E'2D[&@!!WI1T%(*4=!0 F1Q2$^AIWI28YH :
MH(S@TN3GK3L<T8&>E #0>3S^E+SZ_I2\ FB@!.?7]*.?4?E2CO2T -Y]1^5'
M/J/RIU% #'7>I!/!]J;Y9_O+_P!\U+10! ZLHSE3S_=I=C>J_P#?-.F^X/J*
M<#R0>M $80ENJ]/[M(58*3E<CMMJ7[I)'2FR &,GVH :$8J#E>?]FE\MC_$O
M_?-.0?(OTI<4 -"E4V@]*5<],\T[ H(R1ZT 8WBK/]D#)_Y:K_6N5'2NJ\5?
M\@<?]=5_K7*CI7SN:?Q_D>_EO\'YA1117FGH'J%%%%?:'R!%-]T5!FIYONBH
M* #-4M2U"+3X@[@N[?<3U-7*BN+6*[A,4Z!E/YCW%3-2<7R[B=[:&-J.HVUY
MHS>6^),KF-CR.:JWE["=$MK96WRX!8#^#%2:CX?%M;M+;R22$$ 1[<G]*GTW
M0(6ACGNB[,1GRR, ?6O.<:\YN+6K5OD9>\V2:019:&US<!M@8N .I' %8\UT
MVK7P-S,L,?;/1![>IKJ[JU6[LWMRQ17 &5'2LD^%H?\ GZE_[Y%:5J%2T81U
M2'*+T2+5I>Z590"*&YC"CJ3U)]35RWOK:[9EMYDD91DA>PK)_P"$5A_Y^I?^
M^15S3-&33)7D29Y"Z[<, ,<UM3=9-)Q212YNQHUROB(_\3I/]U/YUU59E_H<
M=_>"X:=T( &T*".*>)IRJ0M$)IM:&FPR328(Z&E)I,GL*Z"P49/-<E:W$5MX
MFDDF<)&LDF6/XUUF .IK$N/#$$]Q)*;J4%V+8"CC-<]>$I<KCT9$TW:Q>.N:
M< 3]JC_6N9UB^_M?4$%LA( \M..6.:U5\)VX/S7,[#V4"M*QTFTT\[H(B9/[
M[G)_^M42A5JKEE9(EJ4M&0:U&8O#LB$Y*(BG\"*C\+#.DD_]-6_I6A?VGV^R
MDMV8HKX^8<D<YIFF:>-,M3 DAD!8MEA@\UKR/VJETL59\USG[,_\5DX_Z:R?
MR-6_%YQ:6W_70_RJY%H20ZN;\3N79F;9M&.:EU724U6*-))GC$;%@5 .>*S5
M*7LY1[LGE?*T+IY_XD$'_7O_ $K \(8:]N >GDC^8KIK>T6"Q2V#%E1-FX]>
MG6J6D:#'I4\DB3O*77;AE QSFK=-\T'V&XNZ,'6A)IGB(70&Y682J3W]172P
M:M97,*R1W$8!ZAF"D?4&IKVQM[^W,-S&&3J.Q!]0:Y^7P;$7S'>,%ST9 3^=
M+DG3DW'5,5I1>A5\3:K%?216UJ?,6,Y++T9CQ@>M:MY;-9>#7@?[Z0C=[$L"
M?YU+IOAVTTV42Y::8='<<+]!5Z_M%O[*6V>0HL@P6 R1SFB-.3YI2W8U%ZM[
MF-X,.;*Y_P"NH_E5KQ8<:%)_OI_.I](TI-'BDBCF:4.VXE@!CM4VJ:>FJV36
MKR-&I(;<HR>*I0:I\O4%%\EC-\'G.C'_ *[-_(5NGK5+2=,32+3[/'*T@+E]
MS#!YQ_A5WN:N"Y8I,J*LDA#T/TIJ_<![8IQS@_2FKG:,>G2K*%_E1VP?P-'O
MVI>WM0 ']:/YT'I@_@:,_G0 >X_*F]']L4[/YTW/[S(].E #N/PIIZ$'\Z=_
M*D;[I],4 (.L?TJ2HQUC^E24 96MZLUBHAA_USC.[^Z/\:R-,CLS(;B_N8\Y
MR(V)))]36WJ.BQZC<+*\SH0NW  -4SX6AQ_Q]2_]\BO/JTJTJO-:Z6QE)2;N
M7?[6L,)FZCXZ]:BUF$7^D%X"'VXD0C^(=_TJI_PC$.%_TF7YO]D5LVT M;6*
M ,65%VAC71%5*B<:BLBES/21B^'M3A6W-K/(J,I)0L< @]J-?U2$6)M89%>2
M0Y?:<A5S4U[X:M[F5I(I&A9CD@#*_EVIEEX8MXI!)/(TVT_=(PO_ ->LU"LH
M>SM\R;3MRECP[:M;Z6&<$-,V\@^G:M&:9(('FE.V.,;B?:G]O115'6-/DU.Q
M,,<WE'=NP1D-[&NA1Y(6CT+M9:&+I43ZWK$FH7 _<Q,-J]L_PK^'6JT\J6?C
M!Y+X9C$N[)' !'RG\.*ZFPLTT^SCMX^=HY/J>YJOJNB6^JJ/,)291A9%ZX]#
MZBLO8OE7?<AP=O,I>)K^S?2'C\Z.:5R#&%8,0?7VXI?":NNCH7Z-(Y7Z<?US
M5:#P7 LH,]T\B _=5=N?J:Z)$2(1QQ*%1!A0.@%7",G/GEH.*;ES,EH[T4=Z
MV- HS0:2@!1TI.QI1TI.QH 04HZ"D%*.E !Z4=Z/2CO0 O>D[TO>D[T '5C1
MBCN:.]  :6D/>EH ****  T449H 9-]P?44O#9ILOW!]13L<DCK0  X.#UIL
M@PC8Z8IW#4USB-@?2@!4^XOTIW:FI]Q?I3NU "TG<4M)W% &/XK_ .0./^NJ
M_P!:Y0=*ZOQ7_P @<?\ 75?ZUR@Z5\[FG\?Y'OY;_!^84445YIZ!ZA1117VA
M\@13?=%05/-]T5!0 4444 -+*O+'%)YJ<_,*C4LS%MH)[9/:G!FR1L7\Z '"
M5,?>%'FI_>%("_38OYT9?.-B_G0 IE3^\*/-3^\*3+YQL7\Z,OG&Q?SH 7S4
M'\0I/,4_Q 4A+?W%_.C>V<;!^= "[D_OBC?'_>%)O;)&P9'O02X'W%_.@!ZE
M2,C!%.J##JX.  3@@&IMHH 6C(]:3:*7 H 3</6C=2TF10 A/(XI>?2D+#(I
M<D]J $YI,\GFEQZFD7O0 =:,#CZT^F]OQH 4D49&:*2@ !^:E[TF>1]*4=:
M%[BD'4T'J*!G)H &^Z?I35^Z/7%.;H::O*KV.* %]Q^5)VXZ4O7ZTG.,_F*
M%/3VH]C^!H/0D=*/Y4 '7ZTWK)^%.]C^!IO_ "T]\4 .]Q^5(>%..F*7K]:0
M_=)'IS0 @ZQ_2I*C'6/Z5)0 4'H?I10>A^E $7:.G_RIG:.G^X_$4 'MVIJ?
M=&>@-.Z?2FI]T>F>* '>Y_*CW[T=.O7TI![=: %Z?6CV'XFDYZ#\Z4<CCH*
M#V'2D/+KZ<TO7Z4A^^OXT /H[T4=Z "DI:*  =*3L:4=*3L: $6G#I312YH
M/2CO2"E'6@!>](>M+WI#UH  >311D9-&10 >M+33]:=0 449HS0 &DQ2TE #
M)?N#ZBG#Y3[42+N7&<<TWRSS^\:@!Q'.1U_G228:)OI2",]-[4C1':?G;I0
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M<,/RHPV!R,?2C9_M-GZTA7T+>_- "@,6(W#CVI0&)^\,_2FJ@+-AF_.G"/\
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MOSHV<GYF_.@!_<TC?=/TI-G/WF_.D9/E/S-^= "]A1@9INS@<M^=&T>K?G0
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MIU)1S0 'I1V%!S5>SNC=PF3R)H=KLFV9-I.#C('H>HH LTAZ4<T'- #'3!+
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M-_:;>-KW^S&LE;[!!YGVI7(QN?&-M3-X<U"X3R+W7II+0\,L4"Q22#T+C]<
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M@=*UU'RCZ4ZD7[H^E "XHQ110 F/EIC#Y*?_  TT_<H  .N:4 8H[F@=*
M8Z4NT>E"]*6@!F!Y@'M3MHS2'_6#Z4[O0 FT4@ R:=2#J: &X^7- Z\T?PTO
M>@!5[TM(O>E/2@ ]*,9H]*!0 FVDQS]*=2=S0 =Z44G>E% "/T'UI/X_PIL_
MW1GID4U%"S<# Q0!*>E*>HI.U*>HH BN/N+_ +PJ_']P50N/N+_O"K\?W!0
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M4@.9_P#@- $G:E/44AZ4IZB@"*X^XO\ O"K\?W!5"X^XO^\*OQ_<% #J***
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M#;(A]0G-3F13V./I2IT9<_/-W8E%WNQ8R3&O)Q2)EE89P,GF@R*>S8^E$?S
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M"GRC]TWTJ'>WE;MHQCKF@!R%=J<C.*(_N?7]:6-%*(=HZ<TR-P%Q@G!YP*
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MV)_U;8H+L>/+;% #N#P!A?YT9W# Z4PNY&/+.*"[XQY9Q0 X@'@ 8^E& 3@
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MM?I5:[U"SLAMN[N" L#M$L@4GZ9HLM0L[T;;2[MYV106$4JL0/?% %N@4E%
M"TG<TA<*0I(#-T!/)^E00WUO<"=HI5*P2&*4G@(PZ@Y^M %@G!H I!UH#*6*
MAAN R1GD?A0 M%%%  *#U%'2DZXH 9<?<7_>%7X_N"L^<?*O/\0K0C^X* '4
M444 %%%% $4WW14%3S?=%04 %43J877ETR2%E,EN9XI=W#X.&7'J,@_C5[-8
M_B.TNY(+:]TN)9=0L9?,AC+;?,!&UES[@Y_"@")/$<7D7CBVFD6"Z^QPK&06
MN9>X7T /&3Z$]JDAU>]CO+>#5],^QK<N4AECG$J%L9"MP,$@'':LN]\.&3PO
M86:1QW-Q92B=HY"56X<Y\P%AT)W'!]<4W3],M)-4MGA\*M91PMYCSW4O*L!Q
ML4,=QSW.!0!I0:]=7^JW5G9::6BL[CR;BXEF"J!@'*C&6.#T_7FC3M=OM5:W
MN(-(8Z7<-M2X%PI=1_>9.PXZ9S4NC036L^K-.A19[]YHO]I2J@'VZ&L!;"X;
M4K:6QT&?2;Y;@/<7$4X^S,F[YN ?GW#/&T')H Z?3=374[2:=8C&L,TL)4G.
M[82,_CBJ!\2F;2]+GM;,R7&J9\B!Y0@& 2=S^P'8<U3M)-4TE;_3X=)EN!+<
MRRV]R'41;9#GY^<C&>@!S3$L98?"&D6-]H@U$0H%N(0P$D9 /S)G@G/H10!O
M6$MY=(SWED;*=&*E#()%;_:4CM]0*R=;U/6+7Q'IEO96GG0R"7Y1<*@G(3.#
MD<;>OO4OA>WN;2.\66&YMK)Y0;6VN)/,DC7'S9.3@$\@9.*=KWVA-3TF_M;.
M:[CM'E$L<.-^'3 (!(!Y'K0 RXUR\&KR:;9Z:UQ>+ D[9G"1H&R""V.Q&..M
M6+Z]U:&1_L>CO<11*&>1KI4W\9(08)./?%%G%.OB6]O7A:.">T@1<\G<I<L.
M/3(K$O=-EN-4OS?Z/=:G))(?LDOVC;;QQD#:"-PVD<YX)- &O<>((3ING7-G
M%-=2Z@ UM;Y"D\9)8GA0.YK)O+Z[EUW0K?4+ 6LIO"Z.DHEB8>6^1NX(/(X(
MJ2UTN^T[3?#]S%;>=>Z? UO/:[P"Z-C.TGC<" ?>K4YU75]9TB8:5):6-I=&
M20W#KYC?(P!V@G"C/KDYH ;-?FWT?Q!)I-@%N()I%FD60(6;RP3+SU(!''7B
MI/[0>;PK!<:YI:R*6M@J/*K^:690).!P03G%2Q:5=FT\2PF,*U]-(8"6&&!B
M50?;D&H'AO\ 4?"<%HVFW%M<6[VRE)F7YMCH68$$\8!H T=0UBX34GT_2['[
M;=QH))BTHCCB!^[N;!Y.#@ 57;Q,(-/U.:\LI(+O3HQ)-:EP=RGHRL."#SS[
M47"7ND:_>WUM8RWUI?!#(L#+YL3H-N<,1E2,=^"*H7VF:EJUEK=Y+:>1<7=F
M+6VM2ZE@H).6(X!))XSP!0!</B2[ADM)KS2)+?3KN1(HYS,"Z%ONET[ _7(S
MS6AJ%WJ<-P(M.TK[5\NYI9)Q$@Y^Z."2?PQ5?7[*XO=)M8;>/?(ES;R,N0,*
MK@L?P K.UK3YKC7YY;[2[S5;-D06L<$X5(C_ !!UW+U/.[F@!-;U-=7\%FZ6
M*2%OM<4<D4GWHW6=593CK@CK74S,R^:T:;W )5,XW'L,]JY&'0K]/!+Z?]D2
M.Y^W>:(4D!54\\/PQZ@+78$YD8]LT <9HEY,-#\0'4=*4V:SW4LJF=6#G/S1
MXQ_X]TK:GU4V\5C;:=8M<7-Q")(K=6"+'& .6;L!D#WJK%I=XOAO7K4P_O[J
M:Z:%=P^8/G;],U5U;0#+<:;?2Z:-16&T6VN+42;7&,$,G(!(.01GG- &M;:K
M-<-<V.H61L[U+<RA!()$D3D95AZ'@@C/(K.T;55TSP=H*)!)=7=S D<%O&0"
MY"Y))/  ')-/T72HH[BZN8= 73%,!BB:67=,Y/7*@D*O [YJ*VTK4;#2/#]Q
M#;B6]TV Q36I<*75E 8*W3<" 1Z\T 1:EJ%]+K.@6VI:;]ED-^'1XY1+&P"-
MD9P"#ST(KI;^6>&PF>UM_M$H4XC\P)GUY/3CFL*[;5=8U72)%TJ:TL[2[$LK
M7#J)#\I&0H)X&?7)]*Z20%HG ZE2/TH YKPG>7L7@FT8:9)(8H4$"1S*3.#W
MYQM_&M"QU>\?5DT[5-.%G/+$TL+1S"5'52 PS@8(R*S3IFIQ>!=-L8HY1/"(
MQ=012A))(P3O16[$\=_QIFBZ0;?Q/:WUKHLFG6:02QNT\NZ5V.T@L-QP.#WS
M0!>T[Q!=:G)*]OIA6S@EECFGEF .4)'R+CYN@].OM55?&-P=)BUE]&E32656
M>4S RJ#QN$>.5!]\GTK1T.SGM-#GMYTVRM-<L%R#PSL5_,$52N-*O'^'4>F+
M%F]%G%&8]P^\-N1GIV- %B+7KQ+VTCU#2FM+>]D\N"7S@[!B"0'4#Y2<>IIL
M^KVFFOXANDL<2V*QO<.I -Q\F1],#BK6M6DUW)I1@3>(+^.:3D#:@#9/ZBLO
M4M(O;B#Q4L4.XW\<:V_S#YR(\'Z<^M #YO$5W%-:2WFDO;V%VZQ1S-,"ZEON
MET[ _4]>:GO-8N1.^GZ98?;)X55IW>41QQ9Z M@Y8CG %+XDLY[S3+2&W3?(
MEQ [#(&%5P6/X 5!-#J.D7UY=V5C]NL[\K)(B2A)(I -N?FX*D =^* +6CZZ
M^H7]SI\MC+:7%I$CR"1@0=Q(&TCJ.,Y]ZTH,X?IUKG]!EO9O%FHR7\,<#FQ@
MVPH^\QKN? 9NA8\GCUKH8.C_ %H C4GR&Z=:M#H*JK_J&&1G-3*7"@;!^= $
MM%1[I/[@_.C=)_<'YT <\MM'X@\67XOT$MGI7EQ0V[<H967<TC#H2 0!FM=M
M%TZ2]MKS['$MS;G,<D:[",C&#C&1[&LV\L]1T_6Y=6TNW2Y6YC5+NT,FQG*_
M==">-P'!!ZU-!JFKWEW"L.CR6<"L#-+>.N2O]U%4G)]SQ0 /KE[<W4\>C:6+
MR*VD,4LTEP(E9Q]Y4X.2.F>!FH[CQ9##I$5\MG<N[70LY+48$L<N2"I'0G/Y
MYS4-FVI>'OM%HFDSWUL\\DUO+;NF1O;<5<,1C!)YYXJ Z-J36\$TT"?:I]72
M^GC1P1$H&,9[X &?>@"9?$E_;7BV-SHKB[NMS6JQ7"NCX^\';'RX')Z^U6K?
MQ!+Y>HI?6/V>\T^+SI(EE#JZ$$@JV.^TCD4Z2UF?Q#IERJCR8([A9&R/E+!=
MOYX-5[[3[F;4M>ECC!2ZTY((3N'S. ^1[?>% %23Q;<16]OJESH\T6F3*N'$
MH:4;ONDQCL3@=<\BKEAK5XFI6]IJ.F?9!>%A;N)Q)\RC)5@!P<?45%J.GW,_
MANSLXX]UQ&MKN3<.-C(6Y]@#5N]M)[G5]'GA3=';74DDK9QM4QL ?S(H BGU
MB^NKMAI6E&[@@D,;S/.(@[#[P3(.<'C)P,U'+XHBM].M[Z.SN)C<W MO(&!(
MDF6!4CU!7'ZUCR>'8=,NIXI_#LFIH\SR03P2X+!CG:X+#:03C/0BM*#1YH[7
M28X+"&U:#4$N)X89-RQC#9.3UZC- %V37=0B:&T;2E?59PTBVT=P"D<0XWO)
MC YXP :9J.HM_84TFN:-@13Q*83*KI(2Z[65O0$@\@=*DU*"\L==CU>RM6O8
MWM_LUQ!&P$@ ;<KKD@'J014.K+J.N>'YXQIDELYGA,4<LBEV575F8@'"]#QD
MT 7]3NM1AO%BT[31=L4):22<1(O/3/))_"L;5=3&J^ KV;R7@DCD$,L3D$HZ
MRJ",CK]:=K]C+<^(VDO--O-3L#"H@BMY@JQN"=V]=RYSQSSC%5K30[Z/P1J-
M@+-8IYKII(H$D# (9%888^P/Y4 =DWWNF>>U<MX;LX=:$VO7L4=Q/-/)' DH
MW+!$C%0J@\ G&2>]=3GG(_"N:MX=0\-SW*VEDU_ID\S3+%"X$MLS'+##'#*3
MDC!R,T 7;BTT_2/MFL06:QW"P,91%\GF*H+<@<9XZXJ74-56T\/C43$S*RQ-
MY8;!^<J.OMN_2JC2:GK<%Y;S6 T^TEMI(D^T,&E=V& <*2% ]\DUEWC:WJ'A
MF'3/[&D@FB\E9Y9)$\M@C+_J\')SC/.,4 :MR9(O&Z&&+SI%TI]L>[;O/FC
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MG27,VZ5\H0.-S<9[YSTK7TX7=CXEU*.2PF>WO+A9TND9?+4"-5(;G(.5].]
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M$!@PQSFI1UH -H]!1M'H*6B@".5%\MC@<#BLB]T1;ES>V]]>V5PR!':"0;7
MZ91@1GWK8E_U3?2H=K^3M^7&* *VD:3!I<+F-YII[@AYIYGW/(0,#)] .@'
MJU;C(?ZTZ-@$09'3FF1J=I(<C- #0!Y+,1R#Q5@$$ ^M0@;87'^U4GDIQQ^M
M $E+4?DIZ'\Z/)3T/YT /H'3K3/)3T/YT"!,=#^= $GXTA.!3?(3T/YTGD)Z
M'\Z &PJKAF*@Y/>G%$!^X*(!A6 Z!J<WWA0! 0%N!@ #%.MR K9('-(X!N0"
M,C%$"J58L <&@!9F!DCY'6B$@2R<TDJ*)$   -$**97! (% $^]?[PHWK_>%
M)Y2?W11Y2?W10 PD&;@Y^4TL7^I'TINT+-\HQ\IIT9 @!/3% #U^Z/I2.@;V
M/M0A#*"*=0!&58XR1@<YI)/]0:D_A-1R#]R30!*.E%-"C H*T .I#U%&T4FT
M4 -/_'P/]VG]ZC(_?@?[-/V\T #=10R[A2%>12[?>@!JQ\88YQWIZ@CJ<TFT
M4NT4 -/W7^E+'_JU^E(1\K 5'&7(VA@,=B* )Z2HQYA_C&/I0!(3]\?E0!*.
ME-/>F?O,X#C\J0^9NQO!]>* ):!4?[S.-X_*DQ)G&\?E0!+149$F<;QGZ4A\
MP8&\$_2@"4]12YJ$B3(&\9^E!$@_C&?I0 MP?D7_ 'A5^/[@K-E# +N8'YAQ
MBM*/[@H =1110 4444 13?=%05/-]T5!0 "B@44 1F$-US^!I4C"# SCZT^B
M@!-H]_SHVCW_ #I:* $VCW_.C:/?\Z6DY]: #:/?\Z-H]_SH_&EP?6@!H4>]
M-:(.!G/'H:?CWHQCO0 SRPF,9Z^M/VCW_.D/;GO2GCO0 ;1[_G1M'O\ G2_C
M2'KUH 3:,]Z-HW=Z7'O2="2?2@ P,XS^M)E>V:;N!4G/)_04Y>23V' H ."#
MS^M+M!YR:C"+L8]C4B+M6@!<4C# _&G4C]!0 M%%% !1110 AZ4HI#TI10 @
M&/SH[TM)WH 6BBB@!DO^J;Z4W^#\*?(,HP'4BHMQVXV-TH $12J?*.1S1&/E
M].30L(^0'.<<\T+E!MV'(_6@!I'[J0?[52 2C ^7BF[6,3\8R<@&DS,,<?I0
M!)^]_P!FC][_ +-1[I_3]*-T_I^E $G[W_8H'FX_@J/=/Z?I2AI_3]* '_O?
M]BC][_LTS=/Z?I2%I_3]* 'V_",#US4AZBF0*50[NN:>: (77=,>2,#J*:A*
M!U49YZYIV/WQ[<#FA,;&7/(ZB@!'.^10P*D>E.A&V5QG/%))@N@SD^U.C'[U
MA["@"7-%&*,4 1-_KO\ @)I!S;8]J?)'NY7AATIB[U3;Y>>/6@!T'$2U)FHE
M+JH'E]/>CS&_YY_K0!)D;:CDQY1]:0.W]S]:;(Y*$%,>] $PVXH.*!MH^6@!
M?EH^6D^6CY: &9'V@?[M29&:C.//'IMI_% $<KD.H7H:DR*9( 73ZT_Y: %!
M'K2[AZTWY:,K0  ]:1XP_/1NQI21CBC<* &!R"$?Y3Z^M.Z\#I2MAAAAD5&8
MU RA(:@!_;"]J3IP/SIF),8X_.C;(!P!^= $G3A:!QP.M,VR#L/SH6(MDR?D
M#0 _IP.2:3[O3DFFLOE$%.YP10PRX3)QC)/K0 [A<=R:7@#U)IABC'48'UII
M$/;)/M0 LPPJDGDL*T8_N"LIP,J51@,]36K']P4 .HHHH **** (IQE1S5?!
M]35B;[HJ"@!,'U-(5?/##'O3A10 S;)_>6C#C^):?49;)+=ATH /G_O+0"Y_
MB6A5^8>PY^M-VDY'''>@!V7_ +RT8?!Y6A1U. ,T[G!H 3$G]Y:,/_>%.P:,
M'UH ;A_44UTD;&' ^E2$'%)S0 P)(#RX-.(?_9_6ES2T -P_^S^M!#Y_A_6G
MTAZB@!N'_P!G]:,/G^']:=1WH ;A_P#8H^?_ &:?10 P[\?PTOS_ .S^M*>E
M+0 WY_\ 8_6D;?Q]VGTC]OK0 GS_ .S^M'S_ .S^M.HH 8=_^S^M&'']W]:<
M:6@!GS_[/ZT#S!V6G#I2T ,S)Z+1\_\ L_K3Z* &?/\ [/ZT8<'JM.'4T'K0
M GS_ .S^M'S_ .S^M.HH 9\^1]VE^?\ V?UI>]+0 QM^/X:=SQNQGVH?I0>H
MH 6BBB@!OS_[/ZTF'_V?UI]% #,/ZK^M&'_V?UI]% $:A^?N]?>EP_\ L_K2
MCO\ 6E- $123=N!7.*3R3M8L%)/-3CI10! 8F7!7:#3D1U8G*Y-2D44 -^?_
M &/UH^?_ &/UIU% #?G_ -G]:/G_ -G]:=1WH ;\_P#L_K30'_V:>V<BD /K
M0 @W?[-,EW>4<[:D /K2%=PP>E  -W^Q1\W^Q2>0GI2>2OI0 OS9_@I?F_V*
M3R$]*3R%]* &,',P *@XIVR7^^OY4X1*#Q2[!0!'Y+=68&E\GV7\S3]E&R@!
MGD^R_F:!#GLOYFG[* G% $?D\GA?S-!BXZ+^M2;.M&R@!GD^R_F:!#UX7\S2
MR#:F:>H'44 1F'CHOYFD\IA]UL?C4QZ4E $>R7_GH/RH"R_\]%_*I?YT"@""
M19!C<P/([4I5S+C< =O44Z;M]10!B<9_NT *(5R-W)]S3P !P *#U%% $=Q]
MQ?\ >%7X_N"J$_W%_P!X5?C^X* '4444 %%%% $4WW14%3SC*CZU7VB@!112
M;1304/>@!]($4=A3>.O:E^7&>U "@ # &*3:#Q@4H )(]*0J*  TO8TT@>]&
MT4 /HINT>M&WZT *>E!Z4FWZT;![T 'K12;!S2E1B@!U(>HHVBD*C(H 6CO2
M;11M&: '44FT4;10 'I2TTJ,4NT4 +FD?H/K37B5\9SQ[TGEJH^4'\Z )***
M* $/2E-(>E'<T "]*6D%+0 4444 (.IH[T>M'I0 M)2T4 )WI:3O2T (_2@]
M:'Z4'K0 M%%% !1110 4444 (O?ZT4+W^M!H 4=*,T#I2 XX- "FDHSFCJ:
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M!'(H/>@!'Z#I2*=SYIQ )&11C#"@!'I>ZTCTO=: %[FD7K2]S485B/E;'X4
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M/8,I>=KJ<RE0!V)Y'MCO6-X6>X;6XUU_S?[16V'V#S@.8.YX_P"6O3=WZ>]
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M*T(_N"J$_P!Q?]X5?C^X* '4444 %%%% $-PP51DXYJJ)%\TG<,8JU<?<&2
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MF-;)(I>$DKW7NM'*+F/I$2Q=/,C_ .^A2B6+_GI'_P!]"OGJPU5X-L5U\R=
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M6Q8Q12 @C(-*: #BC-,)I"V*+"N2;J7=4.\=Z<#FG8+DF:&=44LQP!U-,+!
M2QP!U)K.D9]2F$<9(@7[QJ;#',[ZI-M0E8$/)]:THU6) B !1T J-$6*,(@
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M93GS<\).UEHTD]/OZE^SA=I*UFD<Y/X236/$EW;37<AG0%C.1DN1C'?WHB\
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MG'45'J6N7BW*WR7DOVTIY,;)C.TG.,8QUK'&LV[*2ZLI'8BELU2=_M#N"_\
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M<10$GT-,"4;M/S\QD@)[]5I9KH&$R X3VZFJSQWLQ)("^Q-1G3Y2/WLP4=2
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MP^)39V4]M"Z*LXQ)LC&XCN-V,@'N!UJ.\ECL7MP3(!<6T=PNP\*&'2NPM;"
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M;"27RHRPC7EBPXSZ5IJ1H,CN8=H6VCD_X"3S^=5E=YY=IAC=QZC%67M#N^1
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MJ.^TY_I4:[>=P&!W.3_2BPKFS=Z_INJ->6^K1S16\EZ]W;/"H=T+<%64D Y
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MJSZ['_;5S>F%PDEG]FVY&03$$W?3(S4MMXAL(-*EMU6]D9X6C:WDD5K<L?\
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MG35HJWX:DSE*K*SZ&G\,U*^.+7..8I!U_P!FK8\+Q^*/B3K5I/</ J,\NZ,
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5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>forms-1a_003.jpg
<TEXT>
begin 644 forms-1a_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $# G # 2(  A$! Q$!_\0
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M@"GJVJ6VC:7<:C=EA! NYMHR3S@ >^2*H:CXHLM*\/?VW>Q7$5MN VX5GY.
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MSTH 2?Q@R7\L44$+Q*6"NTV%?:'/RX').W %.?Q7=Q0O.^F9C R$5R9#EI%
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M$3U'_GM#_P!]M_A7:44?V5ANS^\/91.+_P"$3U'_ )[0_P#?;?X4?\(GJ/\
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MY16VLT,@< ^A(/6@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\3V$EM;RLLRO,0HB\LEMQ"?+QQ_RT6GVOB*SO=1CL[<,['=N)&-N "./?^E
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M@"Q:V_AMKPVMM%&[-;L68,Q01C8,;B<="O Z8[4J3^&8H)0LL(CN-JNI9B"
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MPD%+501CDDD\%2!DGH"BX],5#%X:TJ)Y6^S!Q(^_8[$JI^7H.@^Z/_U5K44
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M0HN@'T4SSH_^>B?]]"CSH_\ GHG_ 'T*+H!]%(&##*D$>HI:8!1110 4444
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M +Z%%T!1&A:8J@"T3 .>IR3QUYYZ#KZ4G]@:7A1]C3"[L<G^+KW_ /U=JO\
MG1_\]$_[Z%'G1_\ /1/^^A1= 4#H&EL26LT8L<L22<_7GG_'GK4DVC:=.D:R
MVJ,L98J,GC)R?KSS5OSH_P#GHG_?0H\Z/_GHG_?0HN@**Z%I:R&06<>\R&7)
MR?F..?T'Y5&WAS3"T)6W\L1-N C8@'O@^HSSBM+SH_\ GHG_ 'T*<K!AE2"/
M8T70%>TL;>R#"W38" ,9S@#H/Y_F:LT44P&O_JV^AKB/"W_(97_=/\C7;O\
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M_GHG_?0H\Z/_ )Z)_P!]"BZ ?13/.C_YZ)_WT*/.C_YZ)_WT*+H!]%,\Z/\
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M^K,JO0D_X1?4O5?^^J/^$7U+U7_OJNWHJO[)P_G]_P#P!^RB<1_PB^I>J_\
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M7D>F3FKE-_>>B_G1^\]%_.KA%0BHKH-*V@ZD)P"?2D_>>B_G36\S:>%Z>M4
M\'(!]:6HU\S8.%Z>M._>>B_G0 ZD(#*01D'@@TG[ST7\Z/WGHOYT 5]/LXK*
MU\J(';N))/4\U:J*/?LZ+U/?WI_[ST7\ZF,5%*,5H@V'44W]YZ+^='[ST7\Z
MH!0<EO8XI:B7?E^%Z^OL*?\ O/1?SH =13?WGHOYT?O/1?SH 7/S%?;-+40W
M^8>%Z#O]:?\ O/1?SH =13?WGHOYT?O/1?SH Y35-'O)_$)ECB+1R$$,.@X
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MST7\Z/WGHOYT *#DGV.*6HEWY;A>OK[4_P#>>B_G0 ZBF_O/1?SH_>>B_G0
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M;&*=10 4444 %(PR5]CFEHH **** "FN-RX'J*=10 4444 %(PRI'J*6B@!
M,*!2T44 %%%% #4&U<&G444 %%%% "*,%O<YI:** "BBB@!,?.3[ 4M%% !1
M13)9$AB>60X1 6)] *&[:L"%KJ(:@EJ6_>E"P'M_G/Y59KSN;5)GUDWP.&#Y
M4>@]/RXKO[:=+JVCGC^ZZY'M7#A,8L1*2[/3T(A/FN2U@W7AQ-3OY[J^D;##
M9$B'[H'0D_KCWK>HKIJT85DE45T=%*M.DVX.S*.DV<VGV7V65Q(L;'RW'=3S
MS^M7J**N$%"*BMD1.;G)R>["BBBJ)"BBB@ K/UL$Z-<X&?E!_45H4$ C!Y%1
M4ASP<>Z$U=6/.],U6YTHR^3&C>9C.]2>F??WK1_X2S4/^>$'_?#?XUU?V&T_
MY]8/^_8H^P6?_/I!_P!^Q7EPP.)IQY85;+T,U"2V9RG_  EFH?\ /"#_ +X;
M_&C_ (2S4/\ GA!_WPW^-=7]@L_^?2#_ +]BC[!9_P#/I!_W[%7]4Q?_ #^'
MRS[G*?\ "6:A_P \(/\ OAO\:/\ A+-0_P">$'_?#?XUU?V"S_Y](/\ OV*/
ML%G_ ,^D'_?L4?5,7_S^#EGW.4_X2S4/^>$'_?#?XT?\)9J'_/"#_OAO\:ZO
M[!9_\^D'_?L4?8+/_GT@_P"_8H^J8O\ Y_!RS[G*?\)9J'_/"#_OAO\ &C_A
M+-0_YX0?]\-_C75_8+/_ )](/^_8H^P6?_/I!_W[%'U3%_\ /X.6?<Y3_A+-
M0_YX0?\ ?#?XTG_"6:@?^6$'_?!_QKK/L%G_ ,^D'_?L4?8+/_GT@_[]BCZI
MB_\ G\'+/N< ]Q+?:H+B2,!G8<*N!TQ7HP  P !]*B2TMHV#);Q*PZ%4 (J:
MM\'A94.9RE=L<(\NX4445VEA1110 4444 8?BI2=(& 3B49Q]#7.:=KEWIEL
M8(8HV4MNRRDG. /7VKOF174JZAE/4$9!J#[!9_\ /I!_W[%>=B,'4G6]K3GR
MNUC.4&W=,Y3_ (2S4/\ GA!_WPW^-'_"6:A_SP@_[X;_ !KJ_L%G_P ^D'_?
ML4?8+/\ Y](/^_8J/JF+_P"?P<L^YRG_  EFH?\ /"#_ +X;_&C_ (2S4/\
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M]SE/^$LU#_GA!_WPW^-'_"6:A_SP@_[X;_&NK^P6?_/I!_W[%'V"S_Y](/\
MOV*/JF+_ .?P<L^YRG_"6:A_SP@_[X;_ !H_X2S4/^>$'_?#?XUU?V"S_P"?
M2#_OV*/L%G_SZ0?]^Q1]4Q?_ #^#EGW.4_X2S4/^>$'_ 'PW^-'_  EFH?\
M/"#_ +X;_&NK^P6?_/I!_P!^Q1]@L_\ GT@_[]BCZIB_^?P<L^YRG_"6:A_S
MP@_[X;_&C_A+-0_YX0?]\-_C75_8+/\ Y](/^_8H^P6?_/I!_P!^Q1]4Q?\
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MS7'>&M&U6Q9'U&T4[KQI5(N1OB7RMNZ0HJB4DC'(X&#GBNQH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** *>JW_]F:;+=^7YGE[?DSC.6 ]#Z^E4
MIO$=K9>4MZKQR2 G"(Q './O 'G![5;UB2TBTN5KZ)I;?*AD52226 ' ]R*S
MS'X>N8I)W"2)"%WM(7/!)VGG[PR6P>1UQWH DL_$EM=7#0-#-#*9%2-6&2X(
M!SQTQGGT'UHD\4:?"\HE6XCCC9@TK1_*,,RY^FY2*A,_AZ#5!/YZ)-;;Q@*0
MJL1M;)Q][$9&,_P]*8-0\-RI(9DBC 9PZS1D?==R21VRP<@'D\\4 2MXNTT*
MP7S6E526CVC*GL#SW/IGWQ21>+; H6F2:+:JF0E,B/(X!/KP1QFHOM'AQ&A*
M0E\2>5N\MSM)!/SD]<8/7.*$E\+M&T,9@4. &.P_+@X&XD<8)XW>M %Z#Q!:
M3WB6GESQ3LY3;*@7! !]>>HZ9K6K T2QTB59&M8I9/L]QNWSYR7*JVX X[,,
M''TK?H **** ,=]=$?VB=H +*"9H'DW_ #[@.RXY!/ YS[8J&?Q790I<;8;A
MY(%.]-F,. YV$^OR-[?G52_OM(&IR+=::'4[O,E(R. X+;>F<1L,]<=,TP:G
MX:V^6UFP61=S%H^I 8D'G.<.W/?=U- &BWBK3HMAF$T2N[(&=.,AMI[],@C\
M*FM]<CN+J2(VUQ$B6PN#)(N,J2>@^@S_ /7K%&I^&I%C)L'.S>5'EDYVMO/?
MGYB3SWS5^%](AO5MUL@D=S:C$K9(D5OX.^>,=>@/% $L7BK39HW=/.*Q M,1
M'GR@.YQV^F:)_%.GVKO'<)<12(NYXVC^9>"0,#KG:<8R*R3=Z1%PNB.[8=F7
M(9CABIW#)W#$>>X&!3[F7PZVDQS?9F,=T&B)C/S*,[6+$]2-WN>>* -&3Q5:
M12S+)!<(L*@N2!D,2PVXSUPN?QI\?BBPF*B)+ARY*Q 1_P"M(Z[?IGOBLH:C
MX9D0'[%)PN02A!)).><YSR>?0GGG%*=0T#>EK!II94#GY1MV ?,2.<C[OUH
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M9Q2064$,KJ\D<:JS*NT$@=0.U34 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex3-1_001.jpg
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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MM7Q'J5]I&AW.H6%A%?26Z&1H)+@P[E ).TA&RWH,#ZBAZ;A'WMC5HKB_!GQ
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M&>GZEXWU7PO$#]JT^%)6?=P^[[P _P!G*_\ ?7M3L[VZBOI<Z2BBBD,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\0M9\/6%UHL=GIUJ+E[F>QE8H6P5C;$P&<'.[CITKT.65(8GED8+&BEF8G
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MW;]7^B_I1"E&DN9[F5X<\':M)]BO[>.+3&6%E>23]ZTV[(W!3PO!'Y5T-O\
M#/2UMXH;J]O[A(L^6OG;%7/7 '3-=F!4R+FHE'^9W!59-Z:'&M\,= 9,*;U.
M=P*W!Z^M9VJ_#O4&L;J*PU8SBY9'E2[4,SE,A</U[UZ;'#D9[4HCCDSY<B/C
MKM8'%<[J0B[)V-TJC5]SY[U/3#HDUR)@VG311QB.TDS*MRW1V#   =2#UYZB
MK\.J[1<17<'DWRQK!()05*18 VJ%'REN!NP<YYQGYO8-9T.QUBU-O?0+(O\
M"W1D/J#VKQW7="NK#6I;)DGNM3E=IH;Z:X 62,*25(;JV 1U]N>V].HXN_\
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MSN:_)!0@\@(IP_KSD'O5J31]8TNZCEEN'UFR8MYD"P(C(2#AL'A@.F,\<8'
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MQ@LV_P"8KGCH,8&.]'0"VGCCP_+;K-%=SRAO+VI%9S/(V_=M 0)N)^1B0!D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGOGD5,OB&T3PJNOW!*VPMO/?8,GIT [G/ ]:JS:-J4DDL\]['/>/');6\T<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?*^ ,G: HX4#  ''2A;:@R_1110 4444 %%%% !1110 4444 %%%% !1110
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M6*W\B"W7')"%G);KR6KA/AYH^H^+&\4^+[76[W3I=4O'BMVA2(AXD^[NWHS
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M3+74#?3>2!+>F#;\I;<,1OD85B?H.#FLV]T&U\9:;XD@NE!AO6^QQ2==HBR
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M=6:4PJ'C9=S 9XR.1@'D<<=:X9] UG_A)Y;E],66&>^M9+B=)4'F+##D-M+
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M6VH/R-^BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6O--L=1A
MDAOK*WN8I  Z3Q*ZL!G ((YZG\ZA?0])DTO^RWTNR;3N!]D:W0Q<<CY,8XP.
MU7Z* .?_ .$$\'_]"IH?_@NA_P#B:VH;2VMK1+2"WBBMD38D*(%15Z8"C@#V
MJ:B@#-LO#VB:9=R7=AH^GVES)G?-!;)&[9ZY8#)J"[\(>&;^[DN[SP[I%Q<R
M'<\TUE&[L?4L5R:V:* ,S4?#FAZP\;ZGHVG7KQKM1KFU24J/0;@<"J7_  @G
M@_\ Z%30_P#P70__ !-=!10!2T[1],T>W>#3-.L[&%VW-';0+$K'&,D* "<5
M2M_!WABTNH[JV\.:1#<1MO26.QB5U;U!"Y!K:HH\P\C/ET'1I]435)M)L)-0
M3&R[>V0RKCIAR,C'UJO>^$_#FI7;W=_X?TJZN7QNFGLXW=L# RQ&3P*V** ,
M0^#O"YN_M9\-Z/\ :=_F>=]ABW[\YW;MN<YYS5JYT#1KS48M1NM)L)[Z+'EW
M,MLC2I@Y&&(R,'I6C10!E:CX8T#5[G[3J>AZ9>W&T+YMS:1R-@=!E@3CFKME
M8VFFVB6EA:P6MM'G9#!&$1<G)PHX')JQ10 UT21"CJ&1A@JPR"*S].\/:)I$
MSS:9H^GV4LGWWMK9(V;ZE0,UI44 9.H>%_#^K77VK4M"TR]N-H7S;FTCD? Z
M#+ G%:-K:V]E:QVUI!%;V\2[8XHD"(@] !P!4M% $<MO#<*5FACD!4J0Z@\'
MJ.>QJOIVDZ;I$!@TS3[2RA)R8[:%8U)]<*!5RB@#'O?"?AO4[M[N_P##^E7=
MR^-\T]G'([8&!EB,GBI[WP_HNI6L%M?Z1875O;C$,4]LCI&,8^4$8'''%:-%
M >9FW_A[1-5B@BU'1]/O([<;84N+9)!&..%# XZ#IZ4'P_HITD:2='T\Z:#D
M6?V9/)SG.=F-O7GIUK2HH S=-\/Z+HKR/I6CZ?8M( ':UMDB+ =CM S5)O W
MA%F+-X5T0L3DDZ?%DG_OFM^B@"CINC:5HL3QZ5IMG8QR'<ZVL"Q!CZD*!FKU
M%% !1110 4444 %%%% !1110 4444 %<[J6N:Q#KLFG:?IFG3QQV\<S376HO
M!@NS*%P(7Y)4XYYKHJYBU\-"[\47VLZWI>F23*\0T^=',LL2)G'+(I0DDD@$
MCG';DZAT-,:_IT!C@U&_L+._\H22VKW:%H_E+'K@D *W.!PI-6K34K"_)%G>
MVUP0BR$0RJ^%;E6X/0X.#WQ7)6OAO7K;6(+]H]+F\B2[E&Z=P\DDK#8[-Y9Q
MA,KM'3 Y(Z;/AK1;O1-'GTZ:2 J)I7ADA!!*NQ8;A@8(W8QSP.M'2X=;$EUK
M5R]G/<Z5:VUS%"[(TMQ=&"/Y,[SN".< C' .3GMS6=)XPN8C DFE+YB1P27X
M%R<6PE;:BJ2@+MW((7 _ &YINCRQ^&-(TMOEBACC6Z#YW.%'(]\L!G/49]:H
MW?AB^NM=N7+VQTNYNX;Z7+MYK/$JA(L;<!=R*V[)/48[T[).W]?U_P  -T:@
MU>\379-/GTU4B:W>>WF6?<7V%00Z[?DSN!&"V1G.#Q5Z'4;:;2H]2$@%K)")
M@YZ;2,YK"%OX@DM=0%U;V4&H7B^3!-;3/.(UY^9BT:;0H.0O.3GGGBY>>'1)
MX=M-*L;ZYLA9J@A>(1L3L7"AO,1P1G!Z9R :3^'^OZ[#ZF;_ ,)I,^APZA%I
MD:27%]+:0I<W7EI\A<;G<(=F=A &#R0,\YJTOB^WGU"RTJV2$:M<6R736EU<
M")HT.,@\$EL9X [<D=:R7\':M'X=L-(6XMKP+:-#-)=.4\F5CN,T81,,P.<9
MVG_:!)S='A>^;6KAWEMQ9RW:7IN@Q-P9$B"*NTKM !&<Y.>FWDFGH3?0Z'4[
MB\MK)Y+"TCNK@<B.6?RD]>6VL1^ /..@Y&%)XQ<RZ4L&F[A>V\5RZRS[)%1V
M"X1=I\QE)!(R,#OVJ>_L-=CL8;*UFBU2-V/VF;4K@0.5/10(8=I'J,*2.,\Y
MJ&;0=2G\2173&S^RPSK/%<AV\^-0FTPJFW:$/))W=S\N>:2&]B:+Q1))K]WI
MXL 8+8NC2)-F7>J!^8MO"$, &W<GMWJ;PSK\OB"T>>2TB@7"/&T-QYRLC+N&
M3M7#CNO./4UC0^&=<4W$YGLHKO[/Y'FQRN3?8D#;ICM!0X#+A=VT.<'H*W/#
MFESZ59W"SI;PF>X:<6ULQ:*WR!E4)"Y&06)P.6/%-;">^ALT444AA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 9/B"'7)K*#^P+JU@NDN(WD%R/DEB!^=,@$J2.X!J_9VYM;58V;<^2SL.[
M$DD_F34]% !1110 4444 %%%% !7+>./"K>+-/M;5H;.YMX9O-EM+HL@G^4@
M 2J"T9!.<J#GIT)KJ:*+#3L><^%OA=I^A>(K76[?2K71Y;=9$,-GJ$]T)MP
M!9I N .> O7!SQ7HU%%.Y-@HHHI#"BBB@ HHHH **** "BBB@ HHHH X+QKX
M"7Q3K,5[=Z9INK6\<(BCMKFYELVC;));S8E9F!X&TC ZU;\#^ K+P=<7]S:6
M\=F+U8PUE!<2311%<\AY,,Q);K@=!Q7944+38'KN%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD> ;WQ1]BLKB$7IG:)\0J@SM;))QE<'D]Z])\+ZEJ>LPS:G/=6$VE7#%M/\
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MQ91C@')(%5?WOFW^)-O=MY6)O&/@S1=3TZZ5=,MI-;OW"PWK1CSXWR,.'^\
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MYW<U9TG1H-)6=U>2>ZN7\RYN9<;Y6Q@9P   !@ # %):?UY6^[_('K_7G?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]S/"_(@_X0;X3W'E1_:!JJ()-HW;?-)QGKC.*DUC3[(:S\7/]'B'DP0S1 #
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MZ\'BO0[CPSH-X]R]SHFFSM=%3<-+:1L9BO0OD?-CMFFOX6\/2W$-Q)H6EO-
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M1L;8WX3RQ=>2OF[?[N_&<>V:M4[Z?UVL%M?ZZNX4444@"BBB@ HHHH ****
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M^/X6_P Q1?,D_P"M6U^AVU%<S=>.M(@LM&G@6YO)=9 -A:P(HEF& 2?G*JN
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M1EA;4;R.W\YQ'&&/+L2   .3R0/QJ:^O[;3;5KBZ<K&"  J%V8GH%502Q/8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S==TC^W=)GT
MYKZZLXIU*2O;"/<R$$%?G5@ 0>H&?>M*BDTGHQIM.Z.=\'^#[;P7I?\ 9ECJ
M-_<V0),<5V8CY9))."J*3DGN3[8JB_P]LV\5ZCXCCUG58;Z_@:WE"&$HL9
M"@Q'&, @Y/3G-=A13>KNQ+31'G1^#NCGP[8Z%_;6M"QL;HW4"AX-RR'W\KD
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M.Z\^0 #A0<#"]3CW-;E%.X&-XD\/)XDL([.74;RSB25)2;7RLLRL&7.]&Z,
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MG W*/)P#M&.^>^3S6A#X;LP-*>\DEOKG2V9K:YN @<94KSL55Z''3L.];-%
M/4PM)\-?V3K5_J8UC4+I[XAIH9Q#LR  I&R-6& ,=?KD\UNT44>0!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;WFNW^2?ZB;TO_6]O^#^!L?%7Q=KG@C0H-7TK^SY(VG6!X;JW=B2P)W!ED7
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MT&W_ )9^7&X<8(.TE.<<GG ]OO\ P2?Z_AYA;7^N[7Z'M1\1:&-*&J'6=/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\>NPI%9/]IMQN*X4DYDR >H]AV/%:8\)^(/*^&]V-+?S-#4PWUN9HMZ915W
M[MI'RYX.<$<=J(JZ3?E^3O\ BE]XWU^?Z6_4U+#Q*3\1_$<)?6WEL]/23^RI
M5A$*XYW1L)"-S;AUQWR>@%72?BN[> V\5ZIX?U0V1G<>9:B%U";V5>#(&XP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/\S[7M]__#6.PN_B#H,'A6_\0V\\UW:V3-'*D4#B1)!QL92 4YQRP YK$O\
MQV;BT\)SV^I?V4^HW40GCN],N,3@@;HT8QX!)88;(!ZYP#7':9H^KWO@CXDV
M*:3J4=Q?WLMS:13VDD1F1FR"N]1DD#IUZ5>\6P7USHOPY2'2-6D:QNK::Z5-
M/F8PHBJ&+ *2"#G@\\=*4=6K]X_BG?\ $<M&TO[WX;':6_Q'TR?Q1K&DFWOU
MCTN-3+*MA._S88MD*AV@!1@G&[/&:T+#QUX?U728]4L+FZN+*2X%LDL=A<',
MAZ#&S.,\;L8SQG-<]X4TZ_T_XK>,Y[JPN4MM0^S26TYB/ENJH0?FZ9!XQU]J
MD\'>'=1T#QAK]AO7_A'Q,M]91]TDE#;E'HHP>/<&A=+]K_YA+K;O^G^9U?B7
M[4OAR_ELKZ:RN(87E2:%(V.54G&'5A@XYXS[BO,-*\0>*+WX(7/BZ7Q->C4T
MCEE4+;6OEC8[*%V^5T/!/.<C@CD'TSQ3<"W\,:C^YN9FDMWB2.VMWF=F92 -
MJ GKWQ@=Z\ET9;RU_9\NO#TVCZTNK&*:(6W]E7&XL[LR\[,8QWS@=^2*A_#.
MWE^92M[M^[_(TY/%/BG0_AII7C=]6?5%D2)[ZRNH(478YP3&T:*5.2/O;J]#
MB\7Z(Z:)OO4BEUJ,/8QN#F3Y0V.!@<$=>_%>83V>K^(/@[I7@O3]'U&/4GCA
MBNWO+.2WCME5@Q)>10&Z#A<FN\6V'AQ_"6B0^'I-3CA3R!J(12++:F-Y)!(W
M=.H_'I6KM=KST]+?Y_J9KX4^MM?OT.OKC/$\FK+XRT"QLM>OK&UU'SDECABM
MVV^6FX%3)$Q!)ZY)'IBNSKSWQREC>>+_  Y'J.CW>HV%J9WN@-)FNHE#1X3.
MV-E)R.@R1WQ4=5_7<KH_Z[&O=W=WX7TW5]1GUJZU>.V@&V&Z2%66;^%08HTX
M;<O7./QJ2&]U'1]<TRQU*^>]35!( S1(GD3*H?:NT#Y" WWMS<=361+INF:M
MX?UC0_#.CW&G)/%YX:739+*$3#;L 5T7))49P.,<]:T1YGB+Q#H][]CO;>'2
M1++,+B!HB9F38$7<!O #.=RY7I@FFO/^E9_J)^7]/0PM+\0:IK?Q#DMF\27>
MDP12MLT.[T=8VN8DXW),_P Q!X;@9 /XUN>-_$-]I$=C%IFU9'OK6.YE(!"1
MR2JNT C[S#/T )ZXJ>?[-XJGTV6.RO8)+"\$YENK1X&B*@@JI<#=NSCY<C&>
M>E<[XQT'Q2=+A2"^L;P/JUO.5BTJ4RC]\I#,1.<JH S\HX7J.M$?LI]_U7]?
M\ ;W;_K9F[XD\5I8:O%H\%_8V#^4+B[OKUPL=O$6VJ "0"[$$ $X&"3G@&'7
M]4N-&AT:UGUVX@L;IF2?6VCA+*V 8U)V>6H;)&XKC@#J<TGV>30_%=]J&I6<
MU[%JEI!$T]G9O*!(FX,AC7>R*P(())7@Y/KDP:1?:/H.AV&K:?+>:$/M'VVS
MB@-PT0=B84:- 2Z("5. <'!Z#(73^O/3\@Z_UV6IK2Z]J=KI^GVTLI\V_P!3
M^PV]\\0!:+!82%<;=Q"D#C!)!Q@XJQ;ZCJUMJ^H^'1=+>WD=I'=6=W<HJDAV
M9#YBH%!VD9^4+D''7DT+'3+.U\+7.GZI8ZC=:.UY_P 2VW\B:2XBCP"GW1OC
MPP;:S$%1MR14NE6$GAZ+5?$]]87LES-$D4-E$7N[A(4SL0G+%W))).2!QS@9
MINRO?^M%^-^P+R_K7\K#=&N/$^B^*)-+U[6(-9LY;.2\%REF+=K;:RC80I(*
MG)P2<_*:(/$.H1:-IGB>XNG>RU">%&LO*0+#%*^V-@<;MPW(6R2#S@"H?#7B
M5_$-]<6L_A7Q%87%W$WVB[U&Q\B)$ ("*V23C=P.,Y8\=*CATR[N_#6C>$9K
M:[6>PFMQ<W!@98C%"X8,K_=;=L7@$D;N0,4UTOY?GK^ GL_ZZ:?B7;G6]3N;
M+6M=L;IEM=)EECCLUC0K="(#S-Y(W Y# ;2 ,9.[I4T.K7GB76;VTTW4I=.B
MLH+>9"D4;M.95+#=O4_)C ^7!)S\PJA-97FG:/X@\.0VMU)/J<UP]E-' QB"
MS<DO(/E3:S-PQ!('&>E6-4TFVCDM[32M,O)=;M[1;:*['G00*F,#S9 5651U
MV?,<]AG-3T_K>W^93M?^MKZ?@;WAC63K_AVUU%T6.5PR2HIR%D1BK >V5-<S
MXUM?%T$>H:SI_C%=)L+:$M'9IID5PSD#^^YSECQCZ59E^',,FCZ5IT'B+7]-
M2PA,9_LR\\@3L3EG<8.23D_B:TO$-I/?W.BZ4D4LEJURL]U*5)4)"-RAFZ99
MPG'< TVDW_7W_F).R_K[OR-71X[V+1;)-2G^T7P@3[1+M"[I,?,<  #G/2KM
M%%#=W<25E8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\9\57M
MOI?QKL+'4?$&HV.AW-@]S<(VL3PQ>9E\8(D&WH,*N![5[-7EFM:3X@F^,=EX
MDB\,7MSI5I9/:/MGM0TI._YE5I1\OS#[V#[4E\2^?Y/];#^R_P"NJ_X)TFGW
M-MX=\+7GB.*;5;_3);=+Y();IKB6--N6V&9NF,'!;U]A3-*^)6CZM>:);I::
MA;_VU"\ME)/$H5RGWE.&)!_#!]:K7L>N:AX0UO2+?PS=65NNF_9+""6XMS),
MS*5_AD*J%&WJW<UQVF>$_%-O=?#LS>'KE4T)95O6^TVY WG *_O,G &3_4\5
M:LY6Z:?K_P  3TC=;Z_I;]3K[#Q[?:AXR\1:0FA7S6^DQ(I,3P;@Y#-N.Z0?
M> 4*!G_:QVYVT^(4NC?".#6;)]4UB6>\>VCN;\1I(C,YQN&\Y Z#!/3G K=T
MK0-9T;QYXTU0Z<US9ZI%%);/%-&"S(A!3#,,-DCKA?>N1M/ 7B@_!>/P_)I1
MBU6UU(7(@>XB/FIOW?*P8KG!_B(Z4H]/2-__  +7\ EUMY_^DZ?B>A3>/8K3
MQ'I6@WF@:Q;WNI@F N("@QG=EEE(X R0,GIC-=!INHOJ*W#-875H(9FA'G[/
MWFTX++L9OESZX/M7)^/]&?Q)H]HEE<QVGB#3[B&\MAY@,D67V\@=B,CT)'6N
MUMH!;6L4(8ML4 L>K'N3[GK0MOZ_KR%V/*O'EOXE\,:\WBOP[?W]S96(22_T
MJ6[EDCD1BVYE5F(7 '0# ZCIBNM\/7FD>);JW\3Z=?7SPS6V_P HWTOE(WW2
M&BW[ 1TZ=>>O-:=I/>3^(-0BN-%NH;-HU1+J5X6CEVELX57+#.[C*CH<XK"\
M*>!!X-U[7Y]+9?[-U!4EM[9F.V&4;MRX[*<K^''84EHOE=?Y%/5D]I\2=#O-
M6TVRB2Z\G5&D2QO=J&&=D.&488L#G^\H!IMS\1K"UUC6M*;2=6>ZTB#[3.$C
MB*O%UW*WF8Z'.#@^V>*XFV\%>+9-1\(ZO?:9"D]AJ4TEW:VLD21PQLWRF- 0
MN.,GJQ)YSVT;[0?$;>-?&VHQ>'[F2UU32_L=HXN+<;W"A<X,@(!Z\]ATSQ2E
M=+3S_)6&K.5NFGYM/\-3HM/^*&A:E>Z1#!!J"P:LS1VEW+ $B>10"4Y.[(R!
MG;MST)YJ_/XZTB#5)[,BX>*VN$M;F\55\B"9\;48DYR<@9 (&>2*\XA\)^*D
MT_X=PGP[<;]!G9[W_2;?@;ARO[SG@$UK:=\.)(?$>OVFKZ;=:AI6I7AOK>XB
MU)XHD8G=MEA61<D$##!6Z#I5V5_+7]/T;^XSN^7SLOU_R7WG?KXELF\6OX;$
M5S]M6U%V9/*_=;"V,;O6MBL9;C7O^$M:V-C;#0!:!ENO,_>F;/W=N>F/;\>U
M;-3T174X?2+R7QQJ^MM)>W4&D:==FQA@M)W@:61 "\C2(0_4X ! P#G.:=XE
MT>\L=!UV5=6U)K.+3FEM5%Y(DEO+&K'/F*P=P<@_,6Z<TZQTG4_"&M:M/INF
MOJ>EZG<&[,,$J)/!,P ? D9593@'[P(]#5[Q(^JZCX0U*&WT6X:>[M7@CM1+
M#YJLZ$9<EP@ )[,U3/X-.WXV_P RX6]IKM?\+G-:)+X5U'3M*AMO%UW+K5Q'
M%A(O$,\SB7:&;=$9B".#D$8[5V^O27!T_P"Q6<QAO+T^1#*.L>02SC_=4$CW
M ]:P;"^UB#0].LG\%ZF]S:Q1HKRW%H(U=5"[LB8MCKT4G':I'T^Z\0^(I1J^
ME:K9VMI'LM+J#4?(60D_.?W$V_YL+@,.B\X)Q6DTFVEM=F4+J*;WLBUX%U:Y
MU7PQ"M^Q.I63M9WF[J98SM+'_>&&_&J7Q.C=/!-[>P7=[:W-L%:*2UNY8""7
M4'.QANX/?-4=&TO5/#/CW4$T_1-1FT#4$C:6YFOHY2MP.#)^\E,C*5P#GGY>
M :T_B):ZEJ7A&ZTS2]+N+ZXNMJCRI(D6/#*V6,CKZ'IFDW>S]/S5_P!?DREH
MVO7];%B+7;#2-3@\-0PZI<WGV5KB/?YDN]01D>=*WS'+#JV!W(XJ6U\7Z==:
M.FH)'<JS7#6@M&0><9U)!CP#@D$'G.,#.<<UB[=:NOB#I.K'PUJ$%G#I\UM*
M\L]ME'=D8<+*21\G;U%8NF:#XDC@COCH<T-U8:Y<:C':37,/^DPS!P0I5V57
M4-_%@9[\Y!OO_6MOR_S$M%_7;_,(->70_'/BO6)]-U7RX=,MIY[1G5Y8OF?<
M1NDV8  .$;'''-=JWBNV36=(TYK*]']JPM-;W&U/*&U=Q5OFW!@,=L<]>M<M
M?^'M?UG6_$MR--2SM=6T5;.,W-ROF1R /@%4W#JW)W<=LU9;3O$-U?>$+R/1
M5@.EK)'<QW5V@(!C"9!3?GN1ZXYVT+9+^OM?K8;ZM?U\/_!.EM/$,=\@D@T^
M]:*4$VTN$VW("YRIW<9Z#?M)^G-<QHWQ+632+6\UC1]2M3>W[6ENR1I+&6\T
MH%W(QQC SN S@[=U3:'X=OM,\1P7%C9W6E6I#-J%N+I9+*9F4G,*;BR,'P2<
M(,9ZU@SZ!XCMO#6D:5'H%Q<R66N?;I)(;B *T8F:3Y=TBGD,,9QR#G'!(K7U
M\OSU_ 'UMY_D[?B==-KVE7>O:';W^EZE!J,D\PLQ/"56-E5PQ+ [""H.!D\$
M'%6;GQA96EQ#YUK>+833BW34=J>1YI;:%^]OY;C=MV^]9_B:WU:Y\6>%[JST
M6ZN;:RFDEN95FA41AXV3&&<$D9R<#&.A)XKG-)\(7VE:LNF7'@#P[J-JLS/'
MKLAB5PA8D;T*%V<>Q ..HHCTOY_G_D$NZ_K<[Z'7X9[MXH[2Z:!9O(%VH4Q-
M(&VLO#;A@CDE0/0DU%XNMQ/X5U)O.NH7AMY)HY+:YD@=6521\R$''MT-<^_A
MV_C\41ZAIEE<Z;=277FW<\%TIL[F+?@B2(MGS"F.0O!_BKH_%(NW\-7]O8Z?
M/?7%Q \*10O&I!92,DNRC ^N?:HG_#TW*C93\C \/Z]9:'HGAFRNFU6ZO-8@
M219)&FN=TACW-F1R=O0_*#[XQDULVOBRPG@U!YXKBSFL)UMY[>=5,@=L; -A
M8-NW+C!/7UKDDL_$+1^!T/A?4%_L=Q]K+7%K@ 0F/*XF.>6S]!Z\5%>^'/$6
MIW_BEH-,>REFOK:_TZXN98FBE> (-K!'+ -MR,CH><'BM9V<GVN_NNK?@W]Q
MG"_*N]E]^M_QL=UI>O)J-_<V$MA>V-W;JLABNE3YT;(#*R,RD9!XSD=P*UJY
MG1=6\5WEC=3ZMX8@TZ:*,^3;+J"S-</CCD#:@/N3U[8YZ*W>22VB>:+R960%
MX]P;8<<C(ZX]:DHDHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!7OK.+4+"XLI]_E7$;1/L8JVUA@X(Z'FJ^BZ3%HFEP6$4\\ZQ(J"6
MX8,[!0%&2 !T '2M"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH SFT+37UU=:-J/[1$7D^<'893.0"N<'!)P2,C)Q6C110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>_DNH;&
M62R@AGN%&4CFF,2-]6"L1Q[&K%,F_P!1)_NG^5*3LFQK<\]\,?$'Q!XM\/RZ
MQIOAC3Q$DKPB&;6&61W49(4>1COW(KT"UF-S9PSE-ADC5RA.=N1G%>)_!73;
MF3PU:ZJ-7FCLK/5+AIK1O+$.#$5WDX#9!8=6(]N]:7CXV&J_$/X<WT2I)%=3
MR 2@8,D?RE>>Z\DCZ^]6UJDNMOR)_F?:_P"#/6YYXK6WDGGD6*&-2SNYP% Z
MDFL.]\32#2-*U/2=*NM5@U":)1Y/!CB?_EJWL!_/M7DFE1QR_#/XG:>8D>TL
M[ZZ^S0E<K#C)&T=%P1D8[U#XATO2[7X;_#FYM+&SAN7O[,RR0Q*KLS1@L6(&
M23A2<]<"B*O;_MW\1RT3\N;\#W/^U[(ZW_8ZS*U]Y!N&B!R43(&3Z9)X^AJ]
M7DUIH^DW7Q_UU;S3K*5?[,BE430(W[PE06&1]X],]:K^&/"]EHWC'Q#X'GT6
M"?3+R2/4X9GB#@0@_P"K;/HPPOIDFICJEYK]?\M1-V;\K?BO\V>L:C?V^E:;
M=:A=OLM[:)I9&QG"J,G^58NG^(=2NK6TOIM%1;&]:/R)+>[$KHKXPTJ[5"]1
M]TOS[<UI:W-8V?AZ^DOXU;3X[=O/0CCRL?,/IC->51:!J7P\U31KWPEX@?4/
M#VIWD<']E3OY@VN22T1'7 R<@ X&233CK*WH-['K*:M92ZS+I,<RO>10B:6-
M3G8I.!GTSS^57:\ET#3]+3XX>,I[BTM$:W@MYH97A7,3%!N=21P3SDCK7):9
M>H?%O@74+"ZEN?M5_=02ZK(@BFODW#B0#/RCHNXY..@XI1UY?/\ 5O\ R')<
MO-Y?Y)_J>])JUE+K,NDQS*]Y%")I8U.=BDX&?3//Y5=KR;P]I.ER_'/QB;C3
M[-VCAMWA,D*DJS(-Q7(X)R<D=<UYXT-I#\,;>,I"DT'B\I&I #(,\@=QP!Q[
M"B.MO.WXRL*?NM^5_P (\W_ /IRBO+O&8N=,\3W6OK#!JNFQQ16]Y K[+NPR
M1\\)[JVX;E_BQCGMT\<7AX_$R2X749_^$@.FA6LS(=@@W9W;<8SGW_#O0M;
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MU<Q'_: /'XU5C\6^&IHEEB\0Z2\;2"$.M[&07/1<[OO>W6O+]-D&I>(_AR-
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M,E9<RL=P(/\ ",YX'-+I?R3^]7^Z^@WH_FU]SM_P3U2TO+6_MUN+.YAN(&)
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M J"\LK34;22TOK6&ZMI!AX9XPZ-SGE3P:GHH Y__ (03P?\ ]"IH?_@NA_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>'KW5(Y)K'8;"^MK4PR6[)]U\%VRV<YZ @XQ3+WPKXHU&?29[KQ+I;RZ9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?P_K5CXBU^>WU31I]'\0I9-#<VLZ ^=$2OS)(.)$!X]MQH6MP>AM?\)WX/\
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M@M#L,9X]-S#\:;5OZ\KCBFW;K_P;';6^I6%W=3VMM>VTUQ;D":*.56>(GIN
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M=VVFQPQ(4;<$\N-@LD?"]".O7BO1**:=@9S5IX7N[75=5U!=9<3:BT$C[+<
M(T8 (&2<J0,8Z\GDU$?#^I6&GZI<6>IPP:S?R)(]Q;:?^ZRN ,1,YY(X+%N^
M<C%=512 @=;EK)ECDB2Z,> [1ET#XZE002,]LCZUF:5HMQ#H4FE:S/9ZC$X9
M"([0Q*R-U5E9WSU/.1]*VJ*'K<%I8R?#>@P^&=$BTJWFEFAB>1D:4Y8*SE@"
M>^,XS[50TSP?#IGC+5?$$=V[+?JI%KMPD3X =P<\E@J]AT/K72T4[N]PZ6"N
M4C\'2Q6]QI::DG]A7$S3M:M;YF!9][*)=^ I.?X"PSPW3'5T4EIJ'D8>H:#/
MK-RT6IWR2:2'5UL88-F_'.)7+'>,\X 4<8.12>+M!N?$GARXT>UOH;);D;))
M)+8S?)Z* ZX.<<G/TK=HH#K<Q[W19=2T:WM;N[5;VW=)8[JWBV!)4.0P0LW'
M8@DY!/-0VVB7\4]SJ4VH6LNM2P"W2<6C+!&@8L (O,+')//S\X'3I6]10%C*
MTO1$L;N;4+FX:\U*X4)+<NH7"CHB*/NJ"2<<GU)K5HHH *Y:3PA(\-UI@U!1
MH-U*TLEF8,R LV]D63=@(3GC:3R<,.,=310!A7N@7#:A/>:7?1V+W<:Q7>ZW
M\S>JY"LGS#:X!QD[AC''%5]?\*-J7@S_ (1G3+N'3[8Q+;EY+<S$1@=  ZX/
M Y.>_%=+10&VIDS>'K#5;&UB\06&FZI- N \MDI0'N55RQ7.!W-8NF>![;PU
M8ZXVC/;6-[?RR2075OIZ%K96QM0+_&JD9QP.>@KL**.X=O(KV(N5L+<7KJ]T
M(U\YD7:"^.2!DXY[9-8TN@:A::G>7NAZG;VGVYQ)<PW=H;B,N%"[UVR(5)
M/)''3K70T47UN"VL9$FAM+I%Q9MJ%PMQ<2"62\0*) X((*C&T8"@#@]!G/.:
MDOAZ^O\ 4K2YU34K>XCL)#-9QQ6AC(DVE0TAWG?@,>%""NBHH Q] TS4]-MK
ME=2U&VOIYIFF\V*T,'7L09&S@8 Z< =>M4?"GAS5/#LE\ESJ]K=V=S/)<);Q
M6)A\EW;<P4F1OESDX(SD]>U=-10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML<?F#?(I9%[D#&3^H_.I* "BBL31/$)UG5-9L6L);1],G6%O-=6,F5W!AM)
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M$*9'"[V"+GN3T% #Z*** "BBB@ HHK"FUZ[EU6>STK3H[U;.5(KQFN?*:,L
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MMPQC!SUK";P/H+/IK_9[H'33FTVW\X\KMV?GCCG/''3BE'25_3]?\QO5??\
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M,GV**4S1*UW,SQ.>I1R^Y._W2.I]34+;7^M7^C7W#ZW_ *V7ZG,747B?2_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML,B21N,JZ,"&'J".M<%'K5I::_HNKWMW N@R:3Y,-Z[ 0Q3Y4G+G@;EP ?\
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M+"SMY8YYYI0"LRIN'EH5(;:2"22N".,D5?TK6H$UO1=(ETLB9M'^T1W[E/N
M1AD7&6')7.<#@=:2U_KR;_0'_7X?YG845SEEXDO;Z>QG@T=I-'OB1#>1S;G7
MJ5=X]N%1@."&)Y&0*JGQE/!K^G:?>Z6EM#J4\D%J6N?](R@8[GA*#:AVG!#-
MU7@9HMT ZF>>&U@DGN)8X88U+/)(P55 ZDD\ 4\$, 000>017G;>+=5A\/\
MBG4-:T.UOK"RNI83!!<AR44*"&61%&W').222?EK>N/%%U'XCMM"M-&+RW%@
MUW#-+<+'$=I4;> S ?,,G;] >PM5?^MK_D']?C8Z9AN4KDC(QD=16%I^C:K:
MP?8;K5X+O3A'Y8#696X8=]\GF%6)YS\@SFJ-OXV%WH>G74%AF_O[M[*.V>;;
M&LR%]P:3:?E'EMR%)/'%:.@^()-8NM0M)M-FM;C3Y!#<,94>(R%0V$(.XC#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!RFHZ1KLGCZRUNS@TY[*VLI;8K-=.DC%RK9P(V  * =>_
MMBN>7P=XJ7P?!I/DZ,;F/5_[0+?;9=A7SO.V_P"ISG)V]/?VKTRBFG;^O._Y
M@]?Z\K?D<+>>$];73O$6E6#Z>;'6A-*&GE</;32+AEP$(=2><Y4C/0TZV\->
M(8O$^BWMQ_9<]I9::]A.Z2R1N^XJ2RQE6'&P#!?G)/'2NBU37H].G^SQ65W?
MW*QB62"S5&>./.-Y#,N1D'@98X. <5J(XDC5P& 8 X88(^HI+;^NS7Y.P/\
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MENM/\&F75HV_M.ZN+:[D-HGF/L$I5@1A1P@X"]?R/;3>&X)=7MM46]O(KN*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYLQ'<@X4'MM/>AZJS!:$7PRT?0K[P597*+!?2?938RR"::6/:/E=564+Y8;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHWVGR:Y:2:-J\B3ZK>)'LNIN[QCCA68GOT_$&]KOP\\3:#;Z^/!6J6EEH]]
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M3K.!$LWP59X$C&9&R>AQD'COVQ7 ?$6_;XA?$WPKX7B.+3RXIYTSC!D42/\
ME&!CZFO2?BU.FE_"Z^CB_<6[&&V?RQC9"TBJP '^SD4 =!X5\7:1XRTV6_T:
M:22"*8P,9(RAW  ]#VP0?QK=KA_A9:LOAFZU0VQMH]6OI+RW@(P8X"%2)<?[
MB*?QKN* "BJ7]K67]M#1Q,#??9S<F(#.V,,%R?3)/'K@^E7: "BBB@ HHHH
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M /&S.5MQ[O@$_P"S0!Y5H'A+Q;K^BZ5XOTI;2\NI["73%AEEV+;PK%Y"N/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]:Y?3+C5M!U;2="NM0AU?3+Z-UT[4%"BZM]L9(+C!5QMX#@#W!S3>[7]=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[N9IT_T9/EE/5QQPQ[GK3X=%TJW-L8=,LXS:[OLY2!1Y.[[VS ^7/?'6KU%
M%.STC3-.GGGL=.M+::X.Z:2"!4:0^K$#D_6KE%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$!@01D'@B
MEHH QK#PKI.F2!K6*X5%(*0/>320QX.1LB9BBX/3 &.U;-%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%4M7U:QT/2Y]2U&<0VL(R[D$]\
M #DDD@ #K5>PUIKQXDFTO4+%I2?*%RB?, ,YRC,%^C8;VZT :M%%% !1110
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M:=\BX. 3GI[T =!16#8^+;+4M/FN;6UOGFM[A;:YLQ#^_@D) (9<]!G)()&
M2":W6.%)P3@=!0] %HJO87?V^P@N_L\]OYJ!_)N$V2)GLP[&DL;S[;%))]FN
M+?9*\6V=-A;:Q&X#NIQD'N* +-%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#\G"GG:3]S/3Y:]GX%UV'P]?P+_:4>HRK$MV7DLQ%>[9 SE-J99F4,-TPSR
MV1G'KE%(J_\ 7W_YGG6F^#FM+SPY<C2+B:.SN)V*Z@;7S;4.HVD"(!%4,"0J
M9QD=.WHM%%.Y*5@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex3-1_002.jpg
<TEXT>
begin 644 ex3-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P# ^$GPVT7Q
MSIFI3ZI)=H]M,B1_9Y%7@@DYRIKT/_AGGPEG_C\U?_O]'_\ $5F?LX@_V-KA
MW\?:(_EQT^4\_P"?2O;J /)?^&>O"6?^/S5\>GG1_P#Q%*/V>_"..;K5C_VW
M3_XBO6:* /)/^&>?"7.;W5^3Q^^CX_\ '*4?L]>$A_R^:L?^VT?_ ,17K5%
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M?L[^%1UU#5S_ -M8_P#XBD'[._A4'G4=8(_ZZQ__ !%>O44 >0_\,[^%<?\
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M ;K5CCOYZ<_^.4A_9Y\(ELB\U<#T\^/_ .(KUJB@#R9?V>_" ZW6K-]9T_\
MB*/^&>_"&<_:=6^GGI_\17K-% 'DP_9[\(@G_2M6/_;=/_B*/^&>O"'_ #]:
MM_W_ $_^(KUFB@#R<_L^>$,G_2-5YZ?OTX_\<I!^SUX0'6ZU8_\ ;=/_ (BO
M6:* /)O^&>O"&/\ CZU;_O\ I_\ $4@_9Z\(YYN]6/MYZ?\ Q%>M44 >3?\
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MC'[.0_XD&M'L;I/_ $"O:Z\5_9RESX?UJ+C*W2-V[I_]:O:J "BBB@ HHHH
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M0,?>PS>C815SI(O"WQ FB26+XI+)&ZAE==!MR&!Z$'=R*=_PB7Q#_P"BG_\
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M  17O_QFC_A,M+_Y]=<_\$5[_P#&: .@HKG_ /A,M+_Y]=<_\$5[_P#&:/\
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M "BBB@ HHHH *0]12TAZB@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCLKG[2Z^7=*F</\ -PRA"A)Z?.*$KM?+\?\ (;T_'\/\SWFBD&,#&,=L4M(
MHHHH *\_^*?_ #)7_8UV/_L]>@5Y_P#%/_F2O^QKL?\ V>@#T"BBB@ HHHH
M**** (Y@2HQZT4DS!5&?6B@#QO\ 9S+_ /".:P"R^7]K7 QR#L&?Z?D:]IKQ
MC]G1?^*7U<_]/H'_ (X*]GH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ II^\*=2'[PH 6BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH \__P";A?\ N5/_ &[I9-#U
MF6VU?3[.QN[&PN;"<&WDO4:/[0_*^0RMO49+;@VU>F!UI/\ FX7_ +E3_P!N
MZ] I6&G8\SN-!\0W(EMH+#5+:U?39+7;+JK2;W,(V,<SD*0X*G"Y.0=Q&:M:
M3I'BBV\66,LDE_%I$<*!87E\X*OE8:.4FXY;?EMPC<]/GQQ7H5%5?6_]=?\
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MEU>PU'1]*N-0D\5^(IXX%WND,-ANV]R-T ' YZ]N,GBKH\/:H1G_ (3+7/\
MOS9?_(]<C;^ M9_?1FST:R2>&]@=K>ZD<JDK!HT \I<JAR,9 &XD>E/U/X>:
ME?Z5Y47V*T$EVUQ)IUO,! FY%7Y'>!P&R"^?+!W,<$'DKH#W.K_X1[5/^ASU
MS_OS9?\ R/5;4-,O=,T^XOKGQIKJP01F1R(+(G ]/]'I?"WAN;1[S5KBZM[-
M9;JX\R&:&0R2;2B*VXE%P2R;CCJ3[5S<_P /=3DTC4;3R-(EEGM?LY9Y& O7
MWAA<3_NSB10#C&[KU Q@ZV#I<N7%QJ\%A9W/]I^,WENIVMQ;?9],25'&?O;X
MPI!VG!4D'\:U-+L+W5]/CO;?QEKZHY92DD%B&1E)5E(^S]000?I4NNZ#=:EI
MFCV-M9VL5O;3QR3Q17LMMY2JI&V)HTSQGC[G3MGBEJ'A&==>TJZTVTTV*STW
M8T;]+@C+>8I8HS$$-GAERV<YSFCN+6R-3_A'M4_Z'/7/^_-E_P#(]'_"/:I_
MT.>N?]^;+_Y'KSS1/!MUJ>EZO'!IRV%[<^7ON)HFB\P*^YHF62U7*MDY8^?G
M^(M@9Z_0_"=[I5SI$A@M"UK$8Y9Y;@32(GS$)&! @ ^8<C8, #:<"G8;WT-3
M_A'M4_Z'/7/^_-E_\CT?\(]JG_0YZY_WYLO_ )'KH**0'/\ _"/:I_T.>N?]
M^;+_ .1Z/^$>U3_H<]<_[\V7_P CUT%% '/_ /"/:I_T.>N?]^;+_P"1Z/\
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MZ2.$I;K)YCI(\A1 H^\<?IVI ?6V<T5X%X8^)FK^'+I+'62UW9*P0D\O&/\
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M_O8>4X/J1UP/05J_\+3_ .I"\<_^"?\ ^SH[?(.K/0**\_\ ^%I_]2%XY_\
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M61,9 Y!?^)L?AC\*Y.<I9+]J@D7RY!B-8G[CCGO3 HS2I974<MO)&0PX"9&
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M6'E)Y"\JRD89B<8.<YS["J_AWX?ZEH?A;5;7^TXSK5Z BWFW>%C10J(0PY&
M1T[]\5Z'10!Y$GPUUZXCU626+1=/ENM/-JL5AO6.5]P;S'!''0]!WK:A\!7>
MAW-NWAX6MO;W%@UKJ4+.P61PN%D7@_-DG/3(KT.B@#S'P7X,U?P]<Z>)]#\/
M 6XVR7T3N;@\$$CY>O.*],SR*4<"D[B@!U%%% !1110 4444 %%%% !1110
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M&P^X73< O/;+9/?- 'HM-(^8&G TA^\* '4444 %%%% !1110 4444 %%%%
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M?7]W'7K] !1110 4444 %%%% !1110 4444 %%%% !2$9&#2T4 ?,WCW0_\
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M-U_Q(-7NY9,&V:!X%^ZY*LH?/J QQ]!0 ^7XBZ!!=74$LDZ+;K(3,8OW;F,
MNJMW89'%5S\4/#VW3W4W3I>HLF]8LK K/L!D.?E^;([U7G^%>F7/A2PT*6[F
M86MRUPUQM&^4L3N!^H./P%.M/A=I5I:>(+5)Y#%JY^4;?^/89+ +ST#'/X4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH H:L6%JI7KO'\C146N/Y=DAR/]8.OT
M-% 'FW[/#!O E\-H!747Y'?]W'UKUVO(/V=PO_"$:@1][^T6S]/+C_\ KUZ_
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F*6B@ Q11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4AZBEI.XH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBD.: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,S7%9[) I /F#K]#14'B>X^S:;&^PMF8# ..QHH \W_9U
MCD'@[4Y"^8VORJIZ$1ID_CD?E7L5>2?L\J!X"O2!@G4I,GU_=QUZW0 4444
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M %%&:,B@ HI,BER* "BDR*,T +129%+F@ HHHH **** "BBB@ HHHH ****
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M_P"!'_UJ]$HH \]_X4UX6];_ /\  C_ZU!^#7A8Y^;4.?2YQ_2O0J* //?\
MA37A7.3]O)][G_ZU*/@YX6'>_P#_  (_^M7H-% 'GW_"F_"_/.H<_P#3S_\
M6IH^#/A<'._4/QN/_K5Z'10!YV?@SX8)SYFH#Z7'_P!:D/P7\,''[[4A@Y_X
M^?\ ZU>BT4 >=?\ "F/#0.1<:F#_ -? _P *&^#'AIL9N-3X_P"G@?X5Z+10
M!YR?@OX:( ^TZGQT_P!('_Q-!^"WAHX_TC4_PN!_\37HU% 'G/\ PICPYG(N
M]5'_ &\#_P")H_X4QX</6[U4\8_X^!_\37HU% 'G(^#'AT9Q>:J,^EP/_B:/
M^%+^'L8^W:M_X$CG_P =KT:B@#SI?@UH"J%&H:MC_KX'_P 33?\ A2_A_/\
MQ_ZM_P"! _\ B:]'HH \W_X4QH.?^0CJ_7/_ !\#_P")I?\ A3.A <:EJ_\
MX$#_ .)KT>B@#S@?!K11TU;6<>GVA?\ XFC_ (4YI Z:OK(_[>%_^)KT>B@#
MS<?!O20!C6M:&/\ IX'_ ,31_P *<TL<KK>M#_MX'_Q->D44 >:K\';!3D>(
M-<'_ &\#_"AOA#8>:H_M_6^>_P!H'^%>D]J:?OK0!YZ/A)9C[OB/7Q_V\C_X
MFC_A4EM_T,NO?^!(_P *]%HH \['PFA!&/$^O<?]/ _PII^$T?&/%.O9]?M
M_P *]&HH \[_ .%4)C'_  E.N_\ ?\?X4T?"A0<_\)7KW'87 ']*]&HH \\/
MPK';Q7KP/K]H_P#K4'X6N1C_ (2[7Q_V\#_"O0Z* //!\+9!T\7Z^/\ MO2G
MX7.1@>+=>'_;Q7H5% 'G?_"K9@,#QAK^/^N]'_"K9@1CQAKW'_3>O1** //?
M^%8W !"^,=>&?6>@?#.\YSXSUXY_Z;5Z%10!YXWPQNVQ_P 5GKPQ_P!-J!\,
MKX.&_P"$UUXX]9J]#HH \];X;:CV\;:X!_UT_P#KU!\'[Z^N['6X[Z^N+MX+
MWRU>=RQ  ]S7I!Z5YG\' /LOB%@02=2;/Y4 >FT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B>*21ID6#C]\/Y
M-12>*MO]F1;^GG#O_LM13 X#]GIL^ ;Q=N,:E)SZ_NXZ];KR?]GP ?#ZX(QD
MZA)G'^Y'7K%( HHHH **** "BBB@ HHHH **** "BBB@ KS>W_Y+Y>=R-)!^
MG*5Z17F]J,_'R^('32!S_P "2@#TBBBB@ HHHH **** "BBFO(D:%W8*H&26
M. * '45!;WMK=Y-O<0S =?+<-C\JGH *0].*6B@ 'O129IOG1>;Y7F)YG]S=
MS^5 #Z*@FO+6W=4FN(HV;[H=P"?IFI@P/0@T +1110 4449H **** "BBB@
MHHIAEC#A"ZAST7/)H ?1129 [T +1110 4444 %,(^=33LBFG[ZT /HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** $/2O,O@T/]$\1'C_ )"3=/I7
MIIZ5YE\&E(L_$))SG4V_E0!Z=1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#E_';(NB0F0X'VE?\ T%J*3QZJMH<&X9'VE?\ T%J*8'*?L_D?
M\*[DQ_S_ ,N?^^4KU2O*?V?CGX>3#)XU"7J/]A*]6I %%%% !1110 4444 %
M%%% !1110 4444 %>;:7G_A?.L9 _P"04O\ Z$E>DUYQI!+?'36\CIIB#K_M
M)0!Z/1110 4444 %%%% !1110 5YWK5O<OKGC.TB@=KF^T=&M"N<R!5=65?H
MS#I_>KT2H9+2"6ZBN7B4S0AA&^.5#8R/QP/RH Y7PMX-@TZRTVZN[G4;F[AM
MTVQ7=RSI Y7!VKT!&2/85RMW%K-]X&3P4/#^HI>B18#=,@%OL60-YF_/3 Z=
M:]:HH \O7P-=:G>^+)'FO[&>:[W64T=P\:/\@ZJ" P)X-.E_?:7HHU/P7>);
MK:O&1IZ,)[.56P0-I!V,!D$5Z=10!YA:6>M6^F:3JL]MJUPNGZK+)%;S_/=?
M970H-PSDD$YQUQ5C4)=8U.;7-8TS3+^VFFL8=-M%GB,<A8NQ:3'50N_K[5Z/
M10!YK;>%]5\+:II\T4[ZE!-:G39EAMA'Y:!2R.V#SA@1D_WC6+K/A35K;P!I
MTNE6,OVNYM(+74K14^9@I4AR.NY<$?1O:O9** .7UBSN)_&_AFZC@D:"!;KS
M9 ORIN0 9/;)KJ#THHH \_LM%U%_A<]DMLZW\4SW$<$@P7*7!D5>?[VT#\:7
M6[NY\9V-CI-MI.I6CO<PS7,MU;M&MNJ,&.&/#-Q@8]:[^C% '/>); W]UH43
M6QGMUOF-PI3<NPP2K\WME@/QKAI]$UNRU36]/>TFNK"VT&X@L)U5F,BLP*QG
MU9?NXZD 5ZU10!Y='X6N=#?PWJA&J:I;((DN;&YF>7[,Y48E5/\ 9.1C' /;
M%0ZK#.\]\]IINM:5KXN&,0L1(UK='/RL_&P@CKG!ZUZO1B@#/U2YN;30;NY@
MA::ZBMW=(HQDLX4X '?FN-U709K'X?Z;8-'=3C[5#-J36ZDSME][NN.=V[!R
M.< XKT*B@#@O!KOIEUK)6SU'^S+C4(ULWN(7,KEE =FW#?L!'WFZ"J?BB2XU
MG4+);;3]2CU:PU1!%$4<VSQ!_P#6MD;""ISG[P/TKTFC% 'DMEI5U#K.GRQV
MVH?VP-:EFNH7B?[(D3%\NN1L'RE<,/F))]ZFTZVC35]"CT73]9T^\2\D.H13
M>:8A%AMVYC\C9.-N/6O5,4F* .(\5:9J>O>*-)L[0I%:V"->RO/ 9(I')V(F
M 1DCYCU]*Y>'1+Q6TKPOJ-G)<V]CJY7S! PBDMWB=@1UP 6*]>,"O7\9II'S
M@TTP/&-1T/6[74]=T^>"ZNX+;P_+;6EUL9C.IDW*N<?> .W'^SFNH%[_ &]I
M_AO2;*SO5FMYK>:>6:TDB6%8@"WS,!R<;1CUKT+%%(#G?&KWW_"-RVVG+)]H
MO)([421J28ED8*S\>@).:Y[QAI5E;7GA^*::]T[2;.&9%N+!6#1MM554LH)5
M2,_4@5Z'10!Q'@:YDL/!MA8W%G<>?LG,$36[(9(U8[=_&%9@1UQDFN6U-(==
M\0275G#JEW#=:3<1WUN\1S9_*"L<6X !RPQM[XKV#%&* /#[_3]:\01S7,-W
M/J<5GI/ED?8F@.[S$;RMI/S/A#G'L,5UUO>0:UXHU+4XK9TTJ'13;S2S0E%=
MRQ8K\P&=HSGZUZ%BJFI:;;ZMI\MC=!F@E $BJV-PR#CZ'&#[47 SO!@D7P3H
M8F#"06,.=W7[@K<I%4(H50 H& !V%+0 4444 %%%% !1110 AZ5YE\%CG1];
MY)QJ3C)^@KTUONFO,/@F0="U@]_[1?/Y"@#U"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .3^($GE:# Q&?]*4
M=/\ 9:BH_B.S+X?MRO7[4O\ Z ]% '.? ''_  KEL')^W2Y]N%KU.O*_@ "/
MAU(?6_E/_CJ5ZI0 4444 %%%% !1110 4444 %%%% !1110 5YIH6/\ A>OB
M @G_ )!Z@_FE>EUYMH.W_A>'B+ Y^P)D_BE 'I-%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !3"?G44X4T_?6@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M C=#7F'P2).A:SD<_P!HO_(5Z>WW37F7P3.[P]JQ_P"HB_\ Z"M 'IU%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 <9\2B5\.VY'_/VO?\ V'HI?B5(L?AVW+-M'VM1G_@#T4P.?^ 2D?#C)Q\U
M[*1@^RUZE7EWP#S_ ,*W&0 /MLN/?A:]1I %%%% !1110 4444 %%%% !111
M0 4444 %>:>'@/\ A>/B4YZ6*#]4KTNO.->^&%[J?BJZUVP\2W6FRW"JK+ A
M!P!TR&'H* /1Z*\P/PT\3Y&/'^I?B&_^+IP^''BA0/\ BOM1S]&_^*H ]-HK
MS'_A7'BHD'_A/]1X]F_^*H_X5QXI_P"A_P!2YZ\-_P#%4 >G45YBOPW\4KC'
MC[4./4-_\70OP\\7(3M\?7N,<95O_BJ /3J*\R_X5_XS Q_PG]X?JA_^*I1X
M \9 '_BO[SG_ &#_ /%4 >F45YI_P@?C3! \>W/U\L__ !5(O@+QJ 1_PGUS
M_P!^S_C0!Z917F?_  @7C4\_\)]=>X$9_P :4> _&H_YGVY_[X/^- 'I=%>:
M_P#""^-1]WQY<?C$3_6@^!_'.>/'LP_[8_\ UZ /2J*\T/@CQWV\>R^V8:7_
M (0KQWQ_Q7DGO^YH ]*HKS0>"O'HR/\ A.W(]3#2_P#"%>/!G'CR0\=X* /2
MJ*\T'@OQ^/\ F>R?^V-#>#?B!_#XZ(^L- 'I=%>9_P#"&_$/K_PG7/IY _PI
M?^$/^(F[CQR-OH8!_A0!Z717F0\'_$7OXX0_]L!_A4B^$_B&,?\ %:Q_]^!_
MA0!Z317FI\)_$4G_ )'6(#': ?X4A\)_$;MXVB_[\#_"@#TNBO-!X5^)((QX
MU@Q[P#_XFE_X1CXE\?\ %:6W_@.O_P 30!Z517FG_",_$T9QXRM#];=?_B*3
M_A&OBAC'_"8V?_?@?_$4 >F45YD?#?Q1SQXPLL>\ _\ B*3_ (1OXH@C_BKK
M%AWS"/\ XB@#TVFG[ZUYF=!^*:GY?%-@1_UQ'_Q%-.@_%7>#_P )1IV<''[H
M?_&Z /4:*\S&@_%7Y?\ BJ=-XZ_N1_\ &Z0Z'\5^WB?2^O\ SR'3_OW0!Z;F
MBO,O[%^+&,?\))I73KY0_P#C=*=(^*^S \0:23[QC_XW0!Z917F)T?XL#[NO
MZ3_W[_\ M=/&E?%@#G7M'/\ VS_^PH ]+HKS0Z5\6,8&NZ.?4^7_ /:Z!IOQ
M8 /_ !.=(/\ P ?_ !% 'I=%>:BQ^+/.=3T3V^7_ .PH-A\6><:MH@X_N?\
MV% 'I5%>:"Q^+.>=3T7_ +Y_^PH%I\6@?^0AHA'NO_V- 'I=%>:_9OBR ?\
M3=$)]<?_ &-(;?XM9XN]$Q]/_L: /2\T5YJ;?XM \7>AGZC_ .QI?(^+.?\
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M%!,C_?F&-D3GLF,X'<U<\2ZQ(/%6M0:CK]SH\5E:QR:8L4@07#D$LV,?O/F
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M=/OTCAMXY$94!"#:3@YZD_C7J5A;26EE'#+=373J.9IMNYOKM 'Z4 6:***
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M'^ZMWD.V:8,9!R%:,%0!V)Q5[Q1XQU+1=9N-/L=/CNF33Q=H,G<6,H0C Z@
MDX')Q0!VU%<+#XVO/^$ U37I(;62[L7=-B!U5B",95L,IYZ&H+/QEKU]:Z;#
M%:Z?_:&I2NL199DCB1$#,6# $D9'3@^M 'H-%>6:C\3]1T]X[.>UL(+V*:XA
MNY)?-:%3&$(*E03@AQU'!KII?%.H+X1TC4%T](]3U-X88[>5R$1WY^8CG  )
M]: .MHKS;6/B'JVBS)I]U860U'[6('</(8=C)O5Q@%O8C%6(O'>IR^(+;2Q!
MIXWQPR2.3-\V\G[GR>W\6* /0:*\TTWXC:OK_G1Z/I%I)/:0&>Y^T7!C7[[*
MJJ<=2%SD\5I:;XVO]1\73:-]ELX8X91&^^1S(?D#'&%*^W7M0!W-%<CK7C&7
M2IO$$:V:R?V59172DOCS"Y8;3Z?=K);XAZC'XGBTZ?2H+>WD?:K3S%'<;,[E
M)&UAGC .?:@#T2BN-\$>+[SQ6C32P644(C#@0RNSJ2> P*@=CT)JI!X\U":S
M76VTF)- >Z-NDQG/G$;MBN4QC!?CKG% '>T5Y-!\9UN-+AN$TI1<F"XFFA:8
MCRQ& 4(XY# ]?KZ5VFJ>*3I6@:=K<]J392B-KMD)9H%=<A@,?, Q /UH Z6B
MLW0K^ZU/2(+V[M#:23@NL).65"?ESZ'&"1VK2H **** "BBB@ HHHH ****
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MUXUK8%OM-],BEB%Y"@  G/7MW%)\,?&#CP#K5@+L2WNCPS2V[.#AH@I*GGG
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M"\B:]>:N=8!6X@ED#J1M#>9&.P'\JK:'<:MK.G)XINO&$NG/_:+1FVE8>0J
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M$>X.#^%7<TM %6TLE@AMQ,PGN(HA&;AE&]L#D^V>M66574JP#*1@@]#2YHH
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M8V26EBAD+L,DEV8GG.,#J>]=310 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >:_&U=W@VS&,_\ $P3O_P!,Y**/C:<>#;,\_P#(
M03I_USDHH /@4?\ BV-K[7$W_H5>E5YI\"01\,;;/>YFQ_WU7I= !1110 44
M44 %%%% !1110 4444 %%%% !5/5-,M-8TZ:POHS);3 !T#%<@$'J.>U7**
M.*^&\,-II&KPQ*D<,>L72HJC 50V /R%=E-_J'/^R?Y53&D:>MC=60M8Q;7;
M.T\8& Y?[Q/UJXJ(D2QJH" ;0!V% 'AG@\3>#_"5CXGC>1M*OUE@U*  G8WF
M.$E'ICA3]:L07/VOPKX4T6&/4;Z1M/-P]C9W2VRE=V [R$@X'/%>NP:)IEKH
MYTF*SB73RK*8,94AB21SZDFL^_\ !7AO4K6RM;O2H'ALEVVZC*[%].#R/8T
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MB'GS1K%(_P#>12Q Q_P)OSH \ABUO5$UO0-0@FUQH-0U&.)[F[G18+A')X2
M$E1@ @]OQJ6:WGTBP\97]IJ5ZL_]L1PC-P< %XB3CUYQGTXKN;7X>>%K2Z%U
M#IBB5)5EC)E<B)@VX; 3A1GL.*N3>#]#GO+VZEL]TE\4:X'F-M<J05.W.,Y
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MB@!-H]*, '.!2T4 )L7.=HS]*-B\?*..G%+10 @10<A1GZ4@10<A0#]*=10
MT1HN<*!GK@=:4(HZ*!^%+10 W8FTKM&#U&*&C1L;D4XZ9'2G44 (55@0P!!Z
M@TT1(,811CIQTI]% #/)BV;?+3;G.,<4NQ=P;:-PXSBG44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 G--/\ K%I]-/WQ0 ZBBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)_P!H%E7P+8[EW?\
M$S3C_ME+13?VA$W^!K#G&-23_P!%244 :GP.51\+K @\F:8M['>:]&KSCX&Q
MA/A=9,#G?/,Q]OG(_I7H] !1110 4444 %%%% !12 YI: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBC- !1110 449HR* "BBC- !111F@ HHS10 4444
M %%%% !112 8S0 M%%&: "BBB@ HI,TM !1110 F:0_>6ESWII/SJ* 'T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y+^T&2/
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M-?#NEI:O=:G&!=Q^;;[%:3S5]5V@YZT ;P&*7%4M*U:QUO3X[[3IQ/;.2%<
MCD'!!!Y!!'>L?4O'WAG2=0DL;W5%CGC.V3$;LL9QG#, 0#SZT =+@4TH#Z_G
M6!JWCCPYH=Q]GU#4EBFV+)L6-G.P]&^4'CWI;#QOX<U/58]-LM5AGNI%+(J
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MU- )%$O[O<R');R]I&:W/#-M<:U/I/\ :FHWERMOIK3Q-'+)&'83$(S*2"Q
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M@;0 3CUR?:M&HG=@DA5"[*.%!&6XZ<T >=67B#Q5>> Y?$JW]GF.*Z>2$V^
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MC(K?NROEL0/DPW.3@<YH WM:\3_9_$%MH-C=645_/ \X-UDJ<%0J8!!RQ)_
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M* "BBB@ HHHH *BCBVO(Q(.]MW3IP!_2I:0=: #:OH*-J\\#GK2T4 (%"C
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M HHHH *.]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8_:+_P"18TCC_E]//_ #11^T63_PC.CCL;P_^@&B@#K_ (/?\DJT/(Q\DO\
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M?VM>$LP5F)8E5X[ @#./N^]74\9/=VUC#:VBKJEW=2VGV>9R%B>($R$D#)
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MU<+X=31?-" H91))(5SDD@D8&>._6MS5]172=(N]1>)Y4MHFE9(\;B%&3C)
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MB@ HHHH **** "N9U^"]@\0Z/K$%M-=VULLT,\,."Z^8%PX!(S@K@^QKIJ*
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MZ>S&:9LNTAC(+8SQG'' %=WBC H X/0[R'P?HMQ/=07<6F7FID6,'EDFWB<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4AZB@4TGYP* 'T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!XA^T=C^R="]?/E[_ .RM%)^T>?\ B5:",=9Y3G_@
M*T4 >@?"O'_"L= PV?\ 1^O_  (UV%<?\*V5OACH)7I]GQ^(8YKL* "BBB@
MHHHH **** "BBB@ HHHH **** "D'2EHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $
M.:9C+@]Z?FFG[XH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'AW[1_\ R#- _P"NTW_H*T4G[1[?\2_0$]99C^03_&B@#T+X
M6;?^%8Z!M&!]F_7<<UV%<A\+=O\ PK+0-N,?9AT]<G-=?0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )M&[/>EHHH *:3R*
M=32?G H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%(!C- "T444 %%%% !1110 4444 %%%
M% !1FBDQ0!X7^T@!]C\/'//F3\?@E%+^TA_QY^'O^ND_\DHH ](^&/\ R330
M/^O1?ZUUE<E\,/\ DF>@?-N_T1>?Q-=;0 4444 %%%% !1110 4444 %%%%
M!1110 444@Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 E-/WUI]-/WQ0 ZBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D.<''7M2T4  HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"OVC
MS_HGAW_?G_DE%)^T@/\ 1?#I_P!N?^244 >E_#)57X:^'PO3[(I_'O75URGP
MTS_PK7P_D8_T-.^:ZN@ HHHH **** "BBB@ HHHH **** "BBB@ HHH[T %%
M%% !112'/:@!:*.:3F@!:*** "BDYI: "BBB@ HHHH **** "BBB@ HHI.:
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M]I6HJMCKTTDZO 7D5&4X8@#D9(Y'&:]1\9P2W?@?6X8(WEEDL951$!+,2IP
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MOSW,6G7,5K9-,DFG7VY905;*G&'0C Y]^*WM5\/7E[J%W=V>HFREEL4MHG1
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M3EMPPR"%7IN<8Z8Z<>U:G@6YFF\6N(I8M3M19;3J'V!K:6( C;&_ 5C].>*
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M@ HH) ZTF?2@ YI/X@:=33C(H =11D44 %%%% !129%+0 4444 %%)D>M+0
M4444 %%%% !1110 9HI,"EQ0 9HHQ10 4444 %%!&:3 H 6BC%)@4 +1110
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F!2T44 !&:***
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M=95D*]-KC@@^O%>=Z)XRUYA:&]O;K[1<R6<LD<BQE%BEE8$+M4$94=#DCUH
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M!.\;D$Y8,ZD%LGDY)R>:T9M*L'TZ'3#;J+2(Q^7$N5"["&7&/0J/RK1I" :
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M.0&8^Y^M=M10!%;0):VT5O&,1Q($4>@ P*EHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /G/]HQ\^)]'3TLV/YN?\**9^T6?^*KTD9_Y<NG_ VHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%( 1U.: %HHHH **** "BBB@#YM_:*/_%8:6/^G ?^C&HIO[1.?^$T
MTTYX_L\?^C'HH ]\\*$'P?HA'3[!!C_OVM;%9/A<;?">C '(%C ,^OR+6M0
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MK0 445C^)/$=AX8TE[^_?"@[40=7;L!0!?OM0M-,M7NKVYBMX$ZO(P __77
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M:-->6-I'?Q--?0F>U4'_ %J#N#0,RU^''A8 AM,\S)R=\\A_]FK<TS1]/T>
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M\-6]OOB-Y/*3A84MV#$_CC%<3=^(G\6:JK>*/MUEI,#[TT^WM)7\WC^-@O\
MGVZT <[\2/$G_">>,-/L=&20I'^X@+ CS69L$_3I2:&8_A_\4H(@))X;8QVE
M[.3M4/(.3TZ DX]=M=W_ &GX!3Q)IVN06NH036$1ACCCTZ41D'."1MZC)Y]Z
MU=5\4>!M;L[NVO;2Y=;H*)F&G2AVV_=.X+G([4P.,^+'BK_A*TCTC0+>>^M;
M&4374\"%E)^Z "!R.3S6)!X8U[Q%J'A[P]J5O/I&D7 DDBA1,8"@DLV>2YQ_
M%Z^E>HZ/XT\%^'].BT_38;R"W0<*+&;)]R=N2:OGXF^&OE8F^Z\$V,O_ ,32
M \WG\*^+KG5-6\"Z?+,= 4QLLU]\P11@_*V.Y[#TK$\2>'-7\"VFE7US?A]<
M$ZPV,=JY(BB4'/&.Y(XQW/K7JNM?%G1+#2YI[..[GN<8BCDMGC#,>!DL/Q_"
MN?\ "VM>'K.235O$3W-WKEP=\K2V4C+;X.=J$CC'K[4 4]!^%6M>(+A-2\7Z
MA/L;#"!G+2-]2>%^E:&@Z)I,WQ.MSX7M/(T_2(W6\N,LPED/ 4$YS_\ K]J?
MKOQ+MM>D_LS1[M[2P<^7<Z@T;;@.XC []LG%;VE^+/#.B:4EII-G>/!& ?W5
ML1N/=B3C)H [S%>/^/?AIJ?B7Q_;7=N[-I]S&%N)9&!%OM[*.O(''N:UI?BW
M;&3RHM.EB?.,S!R![_(IJ _$-KEBLFMPV0)X$.FS2$#'JP'\J -33_AIH&@:
MN-8>222VLK<""WG.Z. @99_<]3[$FNLTO6].UC3(M1LKI)+67.QS\O3J,'D=
M*\[.O^&[H2+J/B;6[Q6&'C$,D:,/3"K4UAJ'PUTY%2WM&VKRJO;3.!^!!% '
M<W'B?1+9PDNIVP8G&!("<_A6;)XWL);>5K&TU&\9> (;1^3]2 *S[?QSX+LP
M5MD\H#_GG8NO\EJQ_P ++\,YQ]HN1_VZR?X4 <-\-/"_B+P[>W^IW^@2RW=Q
M\L3/.B;5/))R<\\?E78Z/I&NZ%%<1Z3H^GVT=S<-/()[MG.X@=PO3CISUJT/
MB3X9)Q]KG'UM9/\ XFG#XD^%B,_V@X[<P2#_ -EH YN\\%>-3XDO]<TO6-,T
M^YOT5)ML9? 4 #!93CH*V-(\,>+["&1)_%HE:1][.UMYA!]!N/ J[_PLCPMM
MS_:7'3_4O_A1_P +'\+<?\3(_P#?E_\ "@"$>%O$*W+SIXI"2R8$CIIT09P.
MF3[=J;?>!KG59+>34M>FN6MW$D1-K%\K#OT-6#\1_"P/_(3_ /(3_P"%)_PL
MKPKC/]I<?]<G_P * ([CP3=7-]%?2Z_.]U$"(I6M(2R9]#MR*9!X'O;2>[GM
M?$4T4]TV^:46<.YSC')QSTJP/B/X5)P=3 /O$X_I0/B1X4+8_M1?^_3_ .%
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M 4F.<Y-+10 48HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$!_J.,#Z"LC5? -Q#'XA_L[02N_4;7[&(T&?*&"^W_9SUK1TK0M1@\3ZFO\
M8%XFL/<W<D6M&3$*QNI\O_?[#;VZTP/1-)T#P]I,!ATZQLXEB^]M 8K]2>:U
MXFB=?W14J./E(P*\*\-^&-:6QU<MI5_:7"Z--;3*T'EK=3'./XCO/?<,5[!X
M6T.T\/Z#;6=I;"W)17F4=3(5 8GWXI ;&T>E&!Z4M% ";1Z48%+10 FT>@HV
MCT%+10 FT>@HV@]A2T4 -V+Z#\J-B^@_*G44 -\M/[H_*D\I/[B_E3Z* &^6
MG]U?RI/*3^XOY4^B@!GE1_W%_*CR8\_ZM?RI]% $9@B/6)/^^11]GA'2)/\
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M<4 !XZ4M&** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/-#%Q?0&9PUG=1VDIVC!=\\CGD##9/\ LFH8_B!IC6ZW$MIJ%O#);FYMWEA
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MCA@C7<\DC!54>I)Z5@7_ (WTBWM-.GM+F"]&H7 M[?RIU"L>Y+$X&,?F0.]
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MI:IJ,<\MNTD[Y18B.6PO.01@#I5"X^*UR8K1[33 S-9)=S1F.60L6)&Q"BD
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M& )#%,9(U!0DE20#S].U9NF>)=8AO]0\^R2XTP:NUFMR;G]XA9@J@)MQM#$
M_-GG.*0&AIG@N.SM]0MIYUDM[RRALRL<?E[0B,I(P<#.X\=JP[?X:7'D-#<7
M-@@C2.*%[>W8,P61'+.68\D(!A<#FNBT;Q8-9OH;.*S*RBU,UUE\B!Q)LV=.
M3E9/3[OO7/\ CS7M>TZ_OK:QDCAM4T2XN0ZR?.KJ5 8#;U!( Y[D]J -G4_"
MMY-K,NL6%[!'>"6*6!9HBR#9&\;!L$'D.>1TQWK*U3P+JNH3_;7O;"XO;B P
MW1N(Y-B?,S*8@K#@;R,-G.!GO2W7Q!N]#M7CUK3((+L) 8-MYNCD\S<!N;8-
MI&QB>#[9K=\(>*X_%=G=2K"L4EK.89/+D\R-C@$,C8&0<^@H MWF@Q77A1]"
M63RT^S"!'"CY=H 4X]B!Q6(?"6I:E?+J>KWMI]N22V"BVC;RQ'%+YA'S'.YC
MW[?G39OB (8!_P 2N5[J.6ZCN8$?)A$/\6<<[BT>.GW_ &JIKGB[7K:+[!_9
MD-GJYEM7C N?,C>*294(W%!@Y^4\<!LC- '4^)M,O-7\/75C87(MKF4+MD+,
MHX8$@E>0" 1D<\URFB^ -0L=7.H7-W:;GO8;IHXO,8*$CD3:&<DG[X.3[TME
M\4;.\\00Z<MO#Y<MVUF"MQNEWC(W>7M^X2,9W9[XKNKV7R;&>7)&R-FR.O S
M0!Y]XG\-7,B6&EVTLPNKW5)Y6G@B.V.VDW&56;H."![G&*[36])_M7PW>Z3"
MZP_:+9H%8KD+D8'%<1IGQ%O?[':X71Y;JUL8+9KJZEN560^:BG(7;@D;LGH*
M[3Q%K1T'2?MH@CE.]4_>SK"BY/WF8] /H3[4 <WXF\#W.KZD;FU-@RS6R6\H
MNUDS'MSADV$9X8_*>.!4%UX#U6.;=8:C%Y!NI)FMGDEA1E:-$7+1D'*["<=#
MFI--^(T^M,MKI>D1W=]YTL;B.\'D!8PA+B3;R#O4 8ZU2M_&^KW7@^66RT][
MJ\CL)+JXF,RH806<( ,'<P"$XXZ#UIZ@36OP_P!4LM-MK*.]LY NFW=A,[JX
M_P!:^]64<]. 03^)K5U#P3_:/B26]EN\:=-"?,M #S/L,8DS_N-C\!6)!XMU
MEY-,BM4,[R:C!;7?F,H&&M%E;;A>!R6^H]#Q;TSQU<3Z="MAI=UJ4\5J;NZ:
M29$9$+L%&< ,QVG P.!UHU M^%_!]WI%]:S7GV0BSMS!$\4TTC/G +8<X3@?
M=&?KQ6AKFD:M+JWV_2&LB\UH;287;, BYR&4 ')Y.1QGCGBLR7XB;//NH](E
MDTRW>W66Z\Y01YRHRD)U.-XSS6CXQUW4-$&C'3[<3&[U&*VD!./E8'(]NG7M
MBC4!?"?A9O#4M]F=9DG$"1MSNVQQ*G/OD$_C46M:'K#ZW=:AI#V#?;;);.9;
MPM^[VLQ#K@$'[YRIQG YIMGXV^TWM@LFES0Z?J,SP6=YYBL)&7)Y4<J"%)!Y
M_"D\3Z]JFF:Y8V=E;J\$UG<S2ON *E N",^F?QS2 AM/"%Y8N+2*:![!39.)
M'9O-W0% 01C&"%SG/7M5/5? E[<>(9=;MYH9)?M$CI;M<2P H\42?ZR/Y@P,
M>>A!S3+7XD-9:5"^MZ9-;S-8Q7,3-*F)MS!.>@0[F!YZ ^U='X:\56_B)[R%
M$C2XM&42"*=9D(894AUX/<=N13U I^&_"MQHUY:7$KV^([26%TB+G#O-YG!;
M)([9)R3SWK;O-/DN-9T^]5E"6RRAE/4[P ,?E6'?>-TL/$D6E36("27*6JR_
M:4#EG PPBSN*Y.,_6N//B'Q=/>F226X@M7N[M_W)A.R* D%%RO/OGDXXQ0 W
M6[6[\+Z;>:7;^7-<WVF+;NCV\L@D8%P!$54@G#X*G&#@^M=9;>%;Y+.^0O:E
M[K4+6[7<#\J1B+(/'WOW9Q]:C_X3XQI=M'H]U<PV;01/,LB R22A-H"Y'/SC
M/:EM_B"SWZ6USH=U;J+\:=-,9494F894#!RPQCGMF@#:\,Z;>:1IT]G=K#M%
MU-)$\3D[T=RXR"!@_-C'/3K7GVCB]N]9TO0;>.(VM@]XQ=X)$FC#+(J^9E0J
M_? X)W=:Z"X^(^'N;9-*>.X^SW$MLLD\99C&I/SH&W(#@GFE\/>.);PP?VE;
M30RS-:Q.IV[(GEB+JPQR0Q Z]"10!+#X)N8]6T:X^U1?98+:%+^ 9_?20J1$
MPX[%L\_W5]*Q[?X>ZFL)LY%MC%!;W,4,\E_<2>89$9%_='Y8^&YQN]A6G=_%
M'3[>5XX[*20H))#NFCC#1([)N7<PW9*M@#L/<5T=WXDM;7PNOB!8Y9K(PI.=
M@&X1M@[L$]@<GZ&C4"#3M#N+/7HKYI(_)33([,HN?OJQ.?I@UFZ_X:U&_P!7
MO;FU6UV316CH99",R02L^U@%/RL&QGMCI4\_CB'^V)]*L--NKZ[BD$8$115<
MA [$,Q PH90?=@*RC\2H_MPG&GW TE+&6>>1@HDCE2384*[O7Y?<D=N: .C\
M/V.HPW.HW^I0VUO/>2(1!;RF15"H%!+%1ECSVZ8KFKGPGKUSXB2YDDB:VCU+
M[6'^UN%\OH%$(7;N /+$G./>NA\.>++?Q#-<VP@-O=6P5WB\U)1M;."&0D=C
MQU%077C)(-0FACTR[FM8+E+26[0H$69L87!.2,LH)Q@$T 8[>$Q8>&+"#4Y+
M:*"RTNYM[F52?E9]A#+QS@J3]:U_A_9W<'A.VN=18R:A?9NKB0C!8M]W([80
M*,>U85AX]U6:TM+^XT:>2*6UNII(+?9E1%(!ORS=-I(QU)J]<_$_2+<EUM[F
M6WCCADGF4H!&)%#+\I8,V PS@'%(!I\/:W$NH:;#;::UK<W=Q="\D8E_W@;"
ME=O#9;&X'A1^%8Q\#^)<_9GF@>$&S97BN3"BB$)N5D5,R-\IP6..G3&*Z>T\
M=VEWJ;VWV"[AM5NIK3[;+L$32QAB0/FST4X.*K'XB:=<V&FW%K'= 7VQE;R@
MWE@SI%AANX)+$#Z$]L4 8X\&:W]IND2WM8[1H[@/;O<M)#<;V!&P$;H#D9.#
MC/0&NE\&Z5J.F1:@;\.BSS!XHY9Q/( $ ):0 %N1QG)  YJO:?$32[JUOKO[
M-=QVEK&T@G95*R@/LP,,2&)Q@-@\UI>'O%5KX@ENH$MI[6ZM@K203["=K9VL
M"K,".#WXH Q)?#>IOJ$UJ+> 6DNK+J1OEDPX *G9MQG=E<9SC!_"NA\,Z;)I
M.@06<RHLJ%V8(<CYG9NO?K69J'CRSL+N]@.FZC-]EF6W,D4:[7E8 A%)89.#
MGTXJ./X@V,R11P:?J$U\\LD36,:(94V ,Q/S;<8*X.><C% &-<^#M;NKG4(+
M<I8VUS'=+(?M)EC<R9V[%(W1Y/+8./KV;:>#-1GD-Q<6GDMOM%\NYOC<$K',
MKMCC   ( Z\GI72V7C73KZQDNXX+I8TL6OB'0!O+5F4C&?O90\51'CRWCE;9
M;7EXTUTD%M!! JN"T"RX)9\'@DYXQT]Z ,_5O".IR^(FU>&)9(TNI76"WN3
M[*\,*!MW3.8V!'HU9=SX'U:U%BEC8?OQ L;3I?!XT(D9]DD<JD.@SP1S].*Z
M2W^)>AS.S21W<%L4E>*ZEC'ES>4I9]N"3T4D9 S@XJSHOBR;6/%$NFG3;FRB
MCLEN<74>V0EG(!&"1MQ^.: -#Q-83ZAHWE6\"7,D<\4WD.P590CABI)XYQWX
MKF++PQJ-UK\.KW6G0V,9U-+D6BR*QC1;=X]Q(X+,Q7@>@KLM8U>WT33GO;E9
M7165 D*;W=F8*JJO<DD5RM[XZDN_[-M](M9XKNXU 6ES'<VQ,EKA"YW(&')
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M3O9?E;/R[FSU]:J2>)?%)TM8VU2+RTOF2.2._A$LD83.WS2OEL5)R>F?PI6
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M&&YPO*"-#C*@ D$D$^M<MX?\6:C>^-+"(:I/<V=[-<*R2+"B84-MV("9%P5
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MNIVDRW#Z#/<W4FC3VZ,5)VR&9CAB""/W9]1GIWI@>HZA/HPM%-Z+:2WGN$B
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M=R2I"'((4HJGH-IZ4@.PT"WTCPQ%=:9!=O<7*S1R77[H;MTN$0E44!1@ <#
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MJ,/A"PCU-+QKB\D5)S<K;O-F(3$<R;<=>2?3)SBNAHH **15"*%!)QZG)I:
M"BBB@ HHHH **** "BBB@ HHHH ^6?CTH'Q+D/K:1$_K12_'K'_"RI,=K2+/
MZT4 ?3M@5;3[<J25,2D9Z]!5BH+)0EC HS@1J.?I4] !1110 4444 %%%% !
M1110 4444 %%%% !1@444 &!1@444 &!1@>E%% !BC%%% !1BBB@ P/2C%%%
M !@48%%% !BC%%% !@>E&*** # ]*,"BB@ Q28%+10 48HHH 3 ]*1XTDC9'
M4,C##*1D$>E.HH R=)\,Z/H<LDNG6202.NTL"6.W^Z,DX'L.*O065M;3W$\,
M2I+<.'E8=7(  )_  58HH ,"C HHH ,#THHHH 3 ]*,#.<4M% ";01@C--*C
M<O XI]-/WA0 N!Z4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@'H.]7_#'A>]\/0:KIGVB)])ED9[%,'?"'SE#VP#T_&L>?P#JDWPWTWPFM_
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MLW]BTFR&P ^TW3, BN3C9CJ3]!5^?Q5H=OI]OJ,NIVZ6<_\ JI2W#_3OQ^E
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M[->&&U P&$>P* >P&[=QV#$^W2>&/%VNZ[>6=M)!IZ9>5IY8W#JR((SA=K,
MW[SN3T]Z=@.^Q1112 **** "BBB@ HHHH **** "BBB@#Y6^._\ R4VX_P"O
M:'^5%)\=L_\ "SKG)R/LT./;Y:* /J>'_4IC.,#K3Z;&,(!G.!UIU !1110
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MJ>B@!J1I&H5%"J.  , 4T01+(T@C0.WWF"C)^IJ2B@!@B0'(0 ].E*(T!R%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!,TA/(I0*:?O"@!]%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 ?*7QS8GXH7H/:"$#_O@44WXXG/Q2
MU#VBA_\ 18HH ^KE^Z*6D7[HI: "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH 0'(I"#O6E'2FD_O%% #Z*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3_ (XD'XIZASTB
MA!_[]K11\;_^2I:B1WCA_P#1:T4 ?5ZG*@TM-3[@^E.H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 4444 %%%% !VIA/SJ*=VII^^M #Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ^3?C;_R535./X(?_ $4M%'QM(_X6IJGLD/\
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M2: 'T4RCO0 ^D' IM'<4 /HIF:#0 ^BF>M+0 [-(#FD--7K^- $E%-]:!WH
M=13:.XH =29IIH- #Z*C!.!S3J '44WO2T +124AH =13110 ZBDI.] #LT4
MVEH 6BD%% "T4E)WH =12&CM0 M%)10 M%)10 M%%% !1110 4444 %%%% !
M1110 4444 %!I#10!\E?&G_DJ^L=.D'_ *)2BE^-8Q\5=6_W8?\ T4E% '__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex3-1_003.jpg
<TEXT>
begin 644 ex3-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Z Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?.X06ES$5DR<X..01P>0<5M/<0QR)')*B.^=BLP!;'7 [T--.S0$M%)FC-2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M")?\*/94NX?6*G8;_P )KXK_ .A8TS_P<K_\11_PFOBO./\ A%]-_P#!P/\
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M5RG&<N:0M3:TV[:^T^"Z>W>W,J[Q%(1N4'IG'?&..U6J1:6LQA1110 4444
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M_P _5W_X&R\_^/4?\("G/^E7?_@;+_\ %4>PI_S!]:G_ "E\_$<CKX1\3?\
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M'Y&K%)0!X=J-U<>%K$Z+>:M!8ZQ9*([2[NHSY5U #\C @$;@ORD=B#]:PO\
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M5O\ ]^E_PH]J/V*/ /\ A-_%@Z>*?#7XRBE'CCQ9_P!#1X9_&8"O??[+L/\
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY'G.M7+#4]3T/4=.TN=QI4URMVEH$D#!3CN>F.O'Z<^R>#P!X)T$#H-.M_\
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MMKA8+2V2\P52"3*@MTRA)90??CN.*>^FZOH<=M?A&M@CXC>-U)B?'W2H/RG
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M%95K9L)Y99=-FMY;.$695QNN%C4MNW%SN/)(V@XY^7&!C%1+9Z$?!S2RR_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%E 0X8*%P !U!4E\C'0QY%>E>$K@RS7*D .40D\<\D9 ]/45Y[H6(;5=Q(W
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MFX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN-AU37XK>&"UNM12..W"A4N(6"$(H"].F<C^O>MNT\6W^GV:Q75Q;W\A7?\
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M=X;&KH#B338D4D_=CZD@A47/ _V@V/H?PT'M(;K7[V>]FE@AGF'ENV,O^[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '/^,_\ D7A_U^6G_I1'7-_#SC1S_P!=)NW_ $T:NC\:?\B\O_7[:?\
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M>%:QSXUU+@?\A/2/_0S7NM95OB.BC\"%HHHK(U"BBB@ HHHH **** "BBB@
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M0"GUA)W9M%6"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SGC;_D 1CUOK
M7_T>E8'P]_Y 8SZR?^AM6_XW_P"0#%_U_6O_ *.2N?\ AY_R DX[R=O]LUUT
M?X4CBQ/\2)YUXH.?&?B?VT)NWTKVSP5_R(?A[_L&6W_HI:\3\3_\CGXJ[?\
M$C;I]5KVSP7_ ,B)X>_[!EM_Z*6LJVYO0^%&Y1116)L%%%% !1110 4444 %
M%%% !1110!POQ%_X_/"G_87'_HF2F?#[CPX__7>?_P!&/4GQ%_X^O"N/^@N/
M_1,E,^'V/^$<<>L\_;_IJ]=5+^$SBQ'\1'"ZI_R.U\>?^0OI'_H1KW7O7A.I
M_P#([7__ &%](_\ 0S7NW>LJWQ'11^!"T445D:A1110 4444 %%%% !1110
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M?^PSI'_H1KW2LJWQ'11^!"T445D:A1110 4444 %%%% !1110 4444 %%%%
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M_!]H-= GACQ-J"J!XXT35E7H+K3(9?UR36<ZB3M4@FRX14E>$FCR'^TP_/\
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MCC_D P_]?UK_ .C5K"^'G_(!3CN__H9K=\<?\@*#_K^MO_1JUA?#S_D (?\
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M@_Z_K;_T:M8?P\_Y%^,?[_\ Z$:W/'7_ " K?_K_ +;_ -&K6'\.^?#\>?\
M;_\ 0C771_A2.'$_Q(GF_B7_ )'#Q;UXT7H?JE>W>#/^1%\/?]@RV_\ 12UX
MCXD_Y'#Q<,CG1OZI7MW@S_D1?#__ &#;;_T4M9UMSHH_ C<HHHK V"BBB@ H
MHHH **** "BBB@ HHHH X3XBC_3_  H?35#_ .B9*3P ?^*9Z_\ +6;O_P!-
M&H^(O_(1\*?]A-O_ $3)1X _Y%D_]=9O_1C5U4OX3.*O_%1PUZ/^*XO""?\
MD.:/_-J]TKPJ^/\ Q75W_P!AW2/YM7NHK*M\1T4?@0M%%%9&H4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 1RQ)/"\4@RC@J0#C@^XK-T+1(/#]@;
M&UD=K<2,Z!^2N><9[\_Y/6M:DHNUH!P2.?$OQ+C\R.2.TT>'S(XYD*%Y&/WM
MIP<9[_[ ]16KX_U(Z;X/O/+8B:YQ;Q@=26X/_CNZNG**6#%06'0XY%8.N>%X
M];NK:Z:]N(I;602PIP\6\="4/7\Q6BFG)7V0K%'2[F\\.V.DZ'+I3^8[K D\
M4@>$\%G))PP. YQCJ.">37265G!IUC%:6RB.&%=JC/:LJ4^(VN[:W\FP\C>#
M+?1L<JHZA8F!P3TSN8#-:]W ;JRGM]VSS8V3=CID8S4S=]6!S.B:I=^+I;R]
M@O9K/3(9C#;K J;I2 "78L#QR, 8]\U>LKW4;;6Y]'O)TGW0&XM+IH\,P!PR
MN!@$@E?NXR#VJA\/%:U\./IL\?E7=C<213IWSG<#[@@C!IT5PFJ?$9_)??%I
M=F8Y&7H)I&'R_P#?(_/Z5I)+F:Z(70BT+7-?UJ\U6W#Z=#]@N3;EC!(=^"1G
M[_'3]:Z#2I=3D6Y34XH4DCFVQO!D+(FU3N&>>I(^HKC/">F'4=2\3O\ ;;RV
M;^TI5S;2[>[<].>M=MI%D^G:1;6<DGF/"@0OG.[W^M35LM$-'-7WB;5=#\4&
MWU);>32-J%[F*,H8-Y8*7R3QE2,\#O['1UJW+:KH]RMY=+;S7/E2Q1W#+'(#
M&Q7@'IN4?7-2WD,#>*[:.>-'CO+&:)T=<J^QD(!!Z\,U<GJ>C:CX6O;9;%I+
MC0)KR!_+=BQLV$JGC_9/(S[\\X)J/+*W1_G_ ,$+,FTZ2T\*_$+5[-H62WOH
M4N(%AA9VW9P555!/4O[<5U6B:B^H7.H>=8R6<B2*425 KM$5&UFP3W#_ )8[
M5B>+8+I?$^@:AIUI/<7-O(PF6%.?)/!RQPH_B R1UK4N(M=U2>TW1P:=9Q3I
M+*IE\R64*P.WC"J#@<Y/^*FTTF!AZMIE]X0U*;7]"C:;3Y3OO[ $\>LB>G]/
M<<#I/"K!_">DL.0;6,C_ +Y%:XZ4(BQH$10JC@ # %0YW5F.Q1L[6>"^OIY9
MU,5Q('CB5?N@(JY)[D[<^V>]:%%%2 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% ',>._P#D!6_./]/MO_1@K%^'G'AZ/Z/W_P!HUM>._P#D
M!VW_ %_VW_HP5B_#S_D7HO\ =?/_ 'T:ZZ/\*1PXG^)$\V\2'/B_Q=S_ ,P8
M<?\  DKV_P &?\B-X?\ ^P;;?^BEKQ'Q)_R-OB__ + P]^K)7MO@S_D1?#W_
M &#;;_T4M95MSHH_ C<HHHK$V"BBB@ HHHH **** "BBB@ HHHH X/XBG_B9
M>%!_U$G_ /1$E'P_Q_PC!Y_Y:R_^C&I/B*<:GX4YQ_Q,G_\ 1$E.\ $_\(N,
MG_EI+_Z&U=5+^$_4XJ_\5'"7N/\ A.[KD<:_H_X\FO=:\'OR/^$ZN>F?^$@T
M?_T(U[Q65;XCHH_ A:***R-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I#2T4 4+S1[&_D\RX@R^W:75F1BOH2""1ST/%/MM.M;&
MS^RV4*6L6.!"H7!]?K[FKE%%WL!CZ/X=L]"EN7LWN,W+;Y1+(7#-_>Y[\UKB
MEHH;;U8&?<:19W6I6]_,DC7%N<Q-YS@)GKA0<<]^.1UJ^RAE*D @\$'O2T4
M(*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#E_'O\ R [;_K_M_P#T,5C?#T8\.0_[
MA_\ 0C6QX]_Y =MP#_I\'_H8K'^'@QX;@[8C/\S^E=='^%(X<3_$B>:^(?\
MD;/&7'']DKU_WHZ]P\&_\B-X?_[!MM_Z*6O#_$/_ "-GC+IG^RD//^]'7N'@
MW_D1] _[!MO_ .BUK*M\1TT?@1MT445B:A1110 4444 %%%% !1110 4444
M<%\1/^0IX4XS_P 3"3_T1)2^ /\ D51_OR_^AM3?B+SJ_A0<?\?TO7_K@].^
M'_\ R*B]\O)_Z&U==/\ A/U.*O\ Q4<#>\^.KKT_X2'1_P"9KWD5X+>_\CW<
M\9_XJ+2/PY->]"L*OQ'11^!"T445F:A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+>/?^0%;?]?T'
M_H8K(^'@QX;A_P!P_P#H1K6\?8_L2SS_ -!"#_T*LGX>C_BFH./^69_F:ZZ7
M\*1PXG^)$\T\0\>*_&6/^@4G_H4=>X>#?^1'\/\ _8-M_P#T6M>'>(O^1K\9
M>VE1]?\ >CKW'P;_ ,B/H'_8-M__ $6M95OB.FC\"-NBBBL34**** "BBB@
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MEM?N_P R7M->;M]_^1ZIXFDN_P"Q9K33I%CU&\!M[9V_@8J<M_P$ G\*\S^
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M"3U/7-=XWC;PQ!\/=,F?7;#:4MH\"=2VY3'N&T'.5!!([4[+EDM_>)UYHO\
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MX('3/?'3\*J]TV]_SW)M9I+;\MCR3X_Q1MXH\&ED4EY75LCJ-\?'ZFO=P
M!@#H*^?/CSK6FS>+?#$,-];RR6,SFZ6.0,8?GCX;'0\'@UZQJ?Q+\':9IDUZ
M?$6F7'EH6$-M=)+(Y[ *I)S4Q=J=_-E25ZGR7YLX;]I!%/@K3'*C<-0 !QR
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MGP3!8[F_@Q:3(44X\QALW!F(P3GI7&>$/"^FZ'\4;_7?#=P(?"4=@3/.TO\
MHY<\E4<G#*  V<D#D9I0Z)]GK]^X3UNUY:?<M##T'4],T+]H[Q+<ZC>6MA;"
M*0>9/(L:ECY9P,]2>>*]BT>+3=>FL?%EM%&)I8)(TF5,-)"S KD]?X0>?4UX
MKX8\1Z$G[0FOZC<:G9)IMS%+&ES+,JPOPG\1."#@_6O5-+\7^&H-1TKPKX>U
M"UOI)&<A;1Q)'!"H9SDK\H[*!GO3A\$%UM^K_0)/WI?UT7ZG;4444@"BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)/DDG*CY2<^JX_'-$=4_+\G_ ,'\QRT:_K7^OR-3QYXJO?!GAZ36H-+AO[:
MCSU:[,+KE@HVC8P;D\\C'O5SPCKE[XD\.VNKW>GPV*W:"6&*.Y,QV$9!8E%P
M?89^M<[\:_\ DDVM?]LO_1J5Q/C2V@E_9GT>:2&-Y8;>T,3LH+(25!P>V0<5
M-[1D^S7XE-?#YW_ ]UK,\0ZE<Z/H%[J5K:Q74EK$TQAEG,095&6^8*W. <<?
MB*\D@']E?&3P.EEF%;W156Z"D_OL(Y&[U/ Y/I4.DL/%-U\3=3UB,7%U8+-;
M6?F=;:,+(,1_W2=HR1UIS32=NG-^#L*&KC?KR_\ DVIZAX%\5_\ ":^%+;7/
ML7V/SF=?)\WS,;6*_>P/3TKI*^9[JWAE_9<LYGA1Y(;XF-RH)3,I!P>V1Q72
MR6T$'QL\ 2Q0QQR3Z0K2LJ@%R(G +'N< #Z 5;2<^5=[?^2W_0A/2_DW]SL>
MYUD1^)+"?Q5)X>@E66]AMC<3A3GRAN 4'W.<_0>]>5+J%SX2^)%Q9>+=-9[;
M5M1$MAK<!.X?.#'"[=T& -O;DX/4/\,Z-I<_[0OBQ)M-LY$@ACGA5X%(CD_=
MG>N1PV23D<Y-3%7MYI_@AR]U/Y?BSVFL2;6[Z/QA;:*NB74EE+;-,^I@_NHV
M!P$/'4_7OT/)'EG@WP_8:MX]^)>A31>5I\[HC1P?)MR7Y&.!U)Z=:LBRM],_
M:0M8[6$*!HN6P/FD(5AECW.% R?2DFO=;ZJ_X-_H.6E[=-/Q7^9[+17@'A"'
MQ-X\T;4-:T^/38]<35=R:I=WDBS0*NUO)5%B;]W@D8W ')R*U/$>H77A#XA7
MMYXITLW6B:JT:6^K0$^99# !C#=ER,E?XNO/(II:I/K_ ))_K^'F@>E_+_-H
M]FN6N$MI&M8HY;@*3&DLAC5F[ L%8@>^#]*X3P-\1-2\9ZWJ=@?#]O91:9+Y
M5U*=0,AW98 (OE#=RIZD<>O2N_4AE# Y!&0:\8^"J+)XG^(".H9&U##*PR"-
M\O!HC\37DW^*_P Q2?NI^:/:**^8K33[1/A[\2W2W13::HOV;:,>3B7 V#^'
MCCCM78:KXANKY/AAH^HSNUAJT4<M_N;BY.U0$?\ O*2W(/7(HBN:UNMOQ3?Z
M#>B;?2_X-+]3VVBL;P[X9L?#$-W!ISW MKB<SK!(X,<&>JQJ -J]\>];-( H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#COB*<:3IG_82C_P#07JEX _Y%
M:UY_Y=UJ[\1?^05I8]=2C_\ 0'JEX P?"MI_U[KU_P _YYKJI?PI'#B?XD3R
MSQ#D^(/'!//^A6_K_?CKW;P=_P B/H'_ &#;?_T6M>$^(!C7_'(_Z<[<?^/Q
MU[MX._Y$?0/^P;;_ /HM:SK?$=-'X$;=%%%8FH4444 %%%% !1110 4444 %
M%%% 'GOQ"/\ Q5'A3']Z[_\ 153^ O\ D38,?W3_ #-0?$'_ )&CPI_O7G_H
MJK'@+_D3;?TVG^9KJI_PGZG#B/XJ//EP?B!(>/\ D9+#_P!%/7O=>")_R4&3
MG_F9+#_T4]>]UC5^(Z:7P(****S-0HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@##U_PCI'B26UN+V&1+VT;=;7EO(8YH3[,.WL<CVJ6TT%HO+^W:MJ&J>6
MP>,79B4*1T)$2(&QU&X'!YK7HH6@;G#W7PRM;OQ>OBEO$.MIJR K%*AM]L:8
M(VA3"1C#$<Y/OGFM.+PC*NHO?S^)M;N;DV[V\32M !"&QET58@N[Y1R0:Z6B
MCI8/,QM'T!]&T5]-CUG4;D'=Y=Q<^4TL6>X(C 8Y)/S!N>N1Q6)X4^&MAX/U
M:YU#3=8U=_M3%[BWF>$PRL<\E5C&,$\;<>G3BNTHHOK<.ECGO%_A*W\9Z2=+
MO=1O[6R<YEBM#&OFX((W%D8\$=B/?-9%W\,K&_\ !D7A2YUS6'TR)E*#= '"
MK]U-PBZ C/K[XXKN**+:6'<XA?AG9#Q#I.N2:[K,MYI42P6V\P;1& 1M($0S
MD$Y/7G@BKES\/])FU+5KV&XO;3^UX3%?PV\BK'-P0&.5)##)Z$ ]P<FNKHH>
MN_G^._WB6FWE^&WW'(I\-?#D7@VY\*I#<C3)VWE6N&=D;((92V0IR,\#&>HJ
M ?#/31KVC:U_:VK&^TF%8(7:2(AT (PP,>.02#C'KUYKM:*=W>_]=OR#I8YR
MZ\&:??369N[F]GM;2X^UQVDDBM'YV20Y)7?P2<+NV^U.C\&Z;!XRG\46\MU#
M?7,(BN$20>7,!C!((R"-HZ$=.<UT-%): ]?Z^9RF@^ K3P]XEU'7;;5=3FN=
M2;==1SF$QN><<+&",9XP?KFB7P%9R^.T\7G5-274$01+$IB\KR_[F#'G!R><
MYYZUU=%"TMY ];WZG+Z3X$TS0M;O]1TNYO;6._;?<V*2*;=WR3NP5+*>?X6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ]LXK1IMW$E8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH XGXF#.F:/G_H)K_Z)EJ'P#_R*EGCK]E3M_LU+\3/^09HW_837
M_P!$RU%X!_Y%2S_Z]4_]!KKI?PI'#B?XD3RO5Q_Q/O''!&$L_;_EI'7O7A;_
M )%#1?\ KP@_]%K7@NK_ /(P>-R?[EGT'_32.O>O"_\ R*.B_P#7A!_Z+6LJ
MWQ'31^!&M1116)J%%%% !1110 4444 %%%% !1110!YW\0?^1M\*_P"Y??\
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M:*KK&,$.(Y-Q5N#M((/<"O4Z*%H_ZZV_R![?U_74PK[P;H.HW^F7MQ9OY^F
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ML^O_ !ZI_P"@BNNE_"9PXG^+$\IU49U_QM];+T_YZQU[YX9X\*:/_P!>,/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .(^)G_(+T@>NH_^T)J9X$Q_PB5G_P!>J?\ H(I_Q-.-+TC_
M +"/_M":F>!!_P 4I9_]>J?^@BNNE_"?J<.)_B1/*M1)'B#QKC(S)8]3_P!-
M8Z]\\.?\BOI/_7E#_P"@"O ]1P=?\:CC_6V/4_\ 39*]\\.#'AC21_TYP_\
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MVS-YI=W'=6V]H_-CY4LIP<'O]15ZO+K#5M0T_2GM-.ANGFO_ !#?PEK41&5
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M)<O;ZI93):MMN&CN$80GT?!^4_6JM]XKT*PTW4+Y]5LWBL(]]P(YU8ID94$
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M'I3#X@T46DUT=7L/LT(4RS?:4V1AAE=QS@9'(SUIUSKND6=M;W-UJMC!;W)
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MU+XK\0Q>'=#N;I)[$7JQ.]M!=W B$Q49('4DX!X _+K6EI=T]]I%E=RA1)/
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M>@6#0FWLG7R8'MD#7$K@0OC='@L<KP,#H.V*N2>(]#B6S:36=.1;W_CU+72
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MG_H(KJI?PF<.)_B+T/*;L9\0^,!S@W-@./\ KLE>_P"A#'A[3 .UI%_Z *\
MN_\ D8_&'_7UI_\ Z.2OH#0_^1?TW_KUB_\ 0!65;XCJI? B_11161H%%%%
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M_+^KB_X/W:_YGG6C>'VD\%7RV.BRVT\6M/.89+!H))+3[0KE$#J"045?E''
M!H\:V,6J66O:[_9TPT]X;%(X[NU:)Y)EG.YA'( P.U@N2!D$CI7K"W,#W3VR
MSQFXC4.\0<;U4Y )'4 X.#[&LWQ)X?C\3:0VFS7UW:0LZN[6NP,VTY RZL,9
M / SQ]:5WI\OT7Z?>5W^?ZO]?N/.?&6E-K-GXJU*UT:]>VN--AM((&T^3S)K
MA'8AUCV[AM! #X ]#CFM34K2UM_&7A._T[0;G_CVG\^2'39$QOB"HLCA/E.0
M1AL%>IQ7H\:E(D1G:0JH!=L9;W. !GZ"G4NEOZV:_46^_P#6W^1Y1X9LK_\
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MY;=SAV2.1U8-'R3R00.V:W-3UK6;47L]O/I?V,7,5O#--$5$.1\[MF0>;@D
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M[HCN^8,VT<YSQ56UM_77_(E/2_\ 73_,] DU73HM1CTZ2_M4OI5+1VS3*)'
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MZ_K[S=\2>'X_$VD-ILU]=VD+.KNUKL#-M.0,NK#&0#P,\?6M6-2D2(SM(54
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MK2?B U^-)N+O2OL5CJ=G-=Q3-<AV3R\%@RA< ;3D$$^X%/?QG?\ D6TC:3#
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M3-*_F2.7#@ EP#C;@#(]")[?P8T(@L&OT?1+:Z^UPVGV?$BN',BJ9-V"@8Y
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M#QZ_LO!5GXUO;5KJR^QW&B2W#P37N^(R,X?<%9BH)'S\#_:'K5#2-7\.0_\
M"*S7&M6D,M[H$\>HSF^$<DC;4"B23<&W!@X&3D8('2O<**CI;^NO^?X%+37^
MNG^7XGC'A4:/>2?#J^NH[2ZD^P7$7G.@D;SU*%5S@G>#N([CD^M=OXQ:V76-
M&&M_9QX<(F^UFZQY'FX'E"3/R[?OXW<9QWQ7844Y.X+]#Q)+33+GQ;X?T[4;
MK?IMS<ZA':6LUTRJ]J5VQ )D?*6+A3CD8 ) %=?\5OL-KX+MEGNS:JE]:I&?
MM319'F*&'WANPFX\YQC/;-=]11?1>3_R_P @ZOT_S_S_  /)O$6@V:ZP^F?V
MCI6DZ5/:JVF2WMNTX69W=G:W?S4"2Y92,9.,8X&*SM7EMF\2W>GWVI6XU5I[
M,Q:I<7R64EM&$3S8U!D$H# -_J\@E\$@J:]JKGQH>J1WEX(]8B.GWCM)+%+9
M[YE+#!"2;PH    9&P!UH3LT!PJ#3+SQ%XXTJ/6[>(&2S(-U,;E/E&61PS9,
M9;Y6&0!N(XJ!?[!O+_PO=7ND:7:VD5W=P"6W4/;R8CW(\+8&%)Y7'0@XZ9KU
MZ*-(84BC&$10JCT I]+:W]=_\Q/7^O3_ "/$=$7PZOP\&H22"Y:35'LYIS>;
MH_+-R65;ACN_=$;2<C)#=?FS206NE-IVEPZE;V$UM8^*IH2A@S'#$RN515;)
M5"=N%[_+CM7M]%-.SOZ?A;_+\1_\'\;_ .?X'C5C>VC3:_!#>1SZ3'XE5M2W
M7!EVVIB RY))\OS!@YXP"#P#5?6FTBWU*S^S7T,'AY]>M#9)%=>5;E=F9C&
M0IC#;.F0"3TR:]MHH3M;RM^%O\M EK?^N_\ G^1P/@+5=#M;CQ#I]KJ%A%!'
MK3QVUNDR!5WHI"HN>["3 '<-CI7?444=@ZL****0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN[M[MO.5 %=^6QM Z^^?PK%UGX;KJ4>KVEOJ2VVG:O=1W=Y UMO8NK*6V-O
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MT<B]#C8,J?7((]#5RS^'=QIWB'1-2L]9C6#2;%K*.WEM"Y<-G)+>8,<D8&.
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M>>OZ4VN7?S_!7_R?S'%<VG73\7;_ #7R/7;C5K&UU2STV:?;=W@<P1[&.\(
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M* "BBB@ HHHH \\^*W_'MHG'_+U-WQ_R[35?\'\^&+?!!_T9.G'\(K/^*_\
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M8+6W3[D4$81%^@' JI:>'M$L+V6]L]'T^VNY@PEGAMD1WR<G+ 9.3R<UI44
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M;%2VEI;6%K':V=O%;V\8PD4*!$4>@ X%344 1?9K?SI)O(B\V1 COL&YU&<
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MH==T[CM_KC7T+9<6%O\ ]<E_D*^>K8_\5!XAZ?\ (>T[_P!'&OH6R_X\;?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \Y^+'^JT/K_ *^XZ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >;?%HD#0\?\]+K_TFDK9\+\>&X0?^
M>"_^@BL;XM'C0_\ ?NO_ $FDK:\+\>&XAQ_J%_\ 01772_A/U.'$?Q%Z'D6G
MG_BI-6_[&?3>G/\ RV-?14?^K7Z"OG73C_Q4FJY/7Q/IW_HXU]%)_JU^@K&M
M\1U4OA0ZBBBLC0**** "BBB@ HHHH **** "BBB@#R[Q]_R.L1R/^0%==O\
M;6N@\,<>#[7CI G!_P!T5S_C[_D=4 _Z %U_Z&M=#X8 '@^U'I G_H(KLI_P
MEZG!7_B_(\Q\"_\ )48..NKZA_Z(KWZO ? G_)4(/^PMJ'_HD5[]7-5^([*?
MPH****@L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD=O/7/Y9JNGBWP](VU=8M,^\@'\Z^;)K/RIBDR*''/0-3DL?.C=\($7 +%0
M">GX\?SK3ZM*U[/[O^"1[5'U!;ZII]V<6]];3'TCE5OY&K>17RLEG<)*T<2.
MLB#)\MB"!Z\5K:?XL\1Z+(!;ZG< #I%/\ZG\#S^M1*@U_7_#E*HCZ3S1FO)]
M$^,*DK%KED4SQ]HMOF7ZE>H_#->E:9JECK%FEWI]U%<0/T>-@1GT^M92BX[E
MII[%ZBDI:D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5YOK/AS0[[XQZ:+O1M/N!<:7<2S"6V1Q(ZO& S9') . 3
M7I%<K=^&=7N/'%MXBCUBRCCMX&MDM6T]F)C8J6R_G#YLKP=N!Z&A?$G_ %LP
M>S_KJCE]/DE^'NHWERJC_A$+J^DBEA5>--?=@.!_SR;N.QYKK?".D:1IIU67
M2["SMEFO&RUM$J;U !49 Y')QVY-3Z1HE]!::A:ZU>V6I07DCN8X[(PJ ^=R
MD&1]P].GXT_PMX:MO">D-I=G+));"9Y(A(<E%8Y"9[@=![8H6VO;_+0'Y=_\
MSBKKP]X=T/XCZC'>Z58C3=>TQY&W0K@21'=(!QQN4JQQW7/6L7PK!9W/P[N/
M!MQI=O%=G4ULW@>-2Q5\2"5N.7$0/S=<H*](\6>$K;Q9%IRSW#P&RNUN R#)
M=<$/&>1PRD@_UIJ>#;2/Q])XK69A+):B!K<#Y2XX$G7KM^7IT-..FC]/N=U_
MD$M=5_71_P"9R+^#_#R_%P:?!HUC;6[>'W8""W1-KF7;O&!P^#C=UI9O!WAB
M/XLV&GKX>TK[&=%E<P?8X]A82H Q&.6QD9ZUTY\,:J?'R^)3J]GY0MC9_9/L
M#9\K?O\ O^;][/?;CVI9O#.J2^/8?$BZO:+#%;FU%H;%BQB9@S?/YOWLC@[<
M =C1'[-_/]?\P?6WE^G^1S.J^$6\-:]97W@FT@MKRTLI9);1$"+?QATS&Y'\
M6"=K=<XS6C9)X6\;:]I^LC2K&Z::PG287-LC2(ZM$I20$?>7<PP>Q/8UTDFE
MZJ_BJ+5%U*U6QCA:'[(;-BY#%23YGF8SE1_#TR.>M54\(6]EXHOO$.ERI:WE
MY:F&1'C+Q&3((E*AEY^4 @$9XY'=+;7S_7\_ZZB?6W];?E_70\X\,:-HTWA8
MP3> 8[H2ZC-;'4S;VI5$:Y9,@[_-&T' ^7C [5T?BRWETKQ0NK:OH,FO>'A:
MQQ1B*,32:?(I.Z01'KD$$NO(VUJ:+X6\4:#I#:;9^)-*\LR2RB1]'<N&D<N<
M?Z1C@L<<?G6HVAZO;32S:;KBI)*D:,M[:^>GRKMW8#HV\]SNQP..]-O:W]:)
M?TRNK_KK<Y/5K<ZEX9T'4= B_P"$FT"":26YL'D):ZC8G&=_WV0D_*_4CU%=
M!X&U#0M2MKV;0S- H=5FT^=&C>R8+C9L/W![#Y<YQ3[+P?)I,%J-*U5X)X/M
M#LTD(>.:29@[%T!'R@C@*5/OZW=#\/OINH:AJEY=)=:E?[!/)%#Y,85 0H5-
MS$8R>2Q)_2C37^NWW_UW)>R_KO\ U_PQR>L:!HND_%'3]1GTNR:UUVVFLK@O
M"I7SL;PQR.KKO4^O>N<\*/86GACQ7X<BTNVC:>Z7[%')"K>?#<G$#-Q\P7.>
M>@'M7IGC#PM#XNT,:=)<R6KK/'-'<1CYXV4YXY&"1D9SWJO<>";&;QGI?B-)
M&B>PMC;_ &=1\LG]PGG^'+8X/7MBE&UK/;;Y;_GI\QM]5OO\]ORU^1R%_P"'
M-%\.?$;PY'IGA2&[\O3IV\JT@@5RZ-%ME)D9 6'/.<\U8TO3=.U3XO:C/>^%
MDLI&TA',=Y#;NSLTCJS_ +MG&2ORDDY(&#Q747GAS5;GQM9Z_'JUG'!:PO;K
M:M8LS-&Y4OE_-'S97@[<#T-,/AO65\:7/B&+6+%5EM/LBV[Z>[;4!+*2WG#)
MW'G@ CC ZTT]F_/\0M:Z7E^%CS_P]I&C#1M5CD\ 0WRC5;J 7WV:U*1IYQ4=
M7$@"@]EXQQ6AXBTWPKI'Q&@DU?1(;NU&ANTN---RS,CJ [A$."%&-YQCID5T
MVC>%_$^AV5Q:VGB+22L]Q+<L\FCR%@\C%CC_ $G& 3QD?G4T'A35X_%EKK4N
MN6T\<-G]B>&2P8O(A(9B7\W&XL/[N #C'>EV_K[-OS!]?ZZW_(YG3-$G/PC\
M0IJ\"RV,JW-UIEM<LLQM[?83$,Y(!'48/&13O"^CZ1-:^&%_X05=.F9(I?[4
M,%JI9TCW@AHW9\L1_$!D9[UN2^"]6M].U+2-)UZVM]&O%=([6YT\S-:JX(98
MW$J87DD @XZ=*MV&@^)K33[+36\0Z?\ 8[=(XF,&EO',\:X& YG8*2!C.WOQ
M33UOZ?@OZ]1-:6]?QM_7D8GA.UMO'$^OZEXBM8-06'4Y;.UM;E!)%;QQ<#:C
M9&XY)+8SSZ5S?B-$33OB#X9N46]L-,LTOM/^T#S#:,Z'Y5)Y&#DKZ XZ5Z'_
M ,(O=:;J=]?>'=1@L#J$@ENH+FT,\328P74*Z%6/&>2#CIGFJ6H> Y+GP]K%
MA;:HJ7VM,?[0O[FU\UI%*[0JJK(% & .H'/!)S4O;Y?CI_P7?S*3U^?X:_IH
M4?"VB:3)?Z7/'X,319[6V%Q'=B&W1YF*[",Q,V5PQ)#8/(KT!E5U*LH92,$$
M9!%4-,M+RQT6&TN[N&>XACV>?#;F-3@8!V%F.<8[\^W2H?#\>K1Z%&FJW@NK
MX%A]I-N(?,&3M9HP?E.,<9_*KD[M_P!=2(II*YR?P[T;2[#Q)XQDL].M+=XM
M3\F-H850I'Y4;;!@<+GG XS27,T^C?$7Q'=Z5I,%Q,=)M[B8-,(%<J\N2S!6
M)8@ #Y3TY(XK;\,>&M4T+5-6N[S5K2\34I_M,D<-BT)23:J\$RO\N%Z$9SWJ
M.Z\+:M-X@UC4XM9LXUU"R6S2)K!F\I5+$,6\T;C\[9X';ICF6VDK;V_&W^9:
MM=W[_K_D0WWCJ6/0K/5K'2EDMI[#[>\M[<_9HD3 .SS-C R'/"G P#S4MIXP
MN[O6=$@&E0QZ;J]H;J"[DNR'&$#&,H(\;OF_O<@$]L50LOA]?6L.FQR:Y!.M
MGIQT[#V&0%[21@R'9)C )^;..@J>^^'XU+P1IGAZYU:43Z>83%?0Q>6ZA %.
MT _+E<CJ>O?I5.UW;O\ AK^6C)5[?U_7="W7CF[L[2V671U?4+SS)+:"V>>X
M1H4('F,T<#.H.X8^0CD<C-;NA:F?$6A+<W>EW-D9=T<MI>0LIX.#PP!*GL2!
MD'D#I69XF\'2ZN^G7>CZQ-HFIZ<K1V]S%$LJ^6V R,AP&'RC\JV-.L;^QT?[
M//JCWU_M):\N(@ SXX/EIM 4<?*"/KDYJ=+,>MT<'X.UZ7P_X=T6T_LE1IMU
MJEQ8I,LX5HV,TNS$8&"G&/O CTQ6O)\0G?51#8Z#J%]8BY-J]Q!;7#,&#E&8
M8B\HH".3YH/!XJNG@#64T;2]/'B*R)T_4FU!9#I;?.Q8L%(\[IEW_#'3&38M
M? NJ:9KEQ/I?BR[M-&N9VN)M,%LCC>QRVV0_,BD\X7GKSWI]=?ZT7_!$^MOZ
MU?\ P!EE\1+BYL]0U&;P]/;Z=I]Q/;W4C7*-*CQ@8 1<[BS';P3SCKFH+GXC
MZE;:?J=TWA:Y LK<W2O*+B")T4\J7EMUQ)@Y"@$'GYJO:9X#DBT#7M'U;4HK
MRWUB>6X=K>U,#1/)RV,R/G!P1Z8YS3+;P/JTNA:CI&N^+[S5;:YMVMH0;:.(
MPJ1C)(R9&]R?PI?\#_@_B/K\_P#AOP+EUXNNK37AIW]D><DFEOJ,3PW(WOL*
M@Q[64*/O<'=VJIIWCN[OQH$K:(L%OKL3FU9[O++($+@.H3 4@?>!)]5%$G@K
M5YM0M-2D\2(+VVT^2Q 2P40NK8Y*ERW8$@,.1P0,BHK/P)JMI;^%H1KUHR:
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M7[KZ?>M"-;:_T[:_=N=Y1114E'F?Q<.#H?..;S_TF>MWPT"/#D8Y_P!0OO\
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ME8;SE5X ]!GI27=D;6VMHY+.[MI\XFDD!Q]0*<MK++J4L&F2?;$BC\W>HP<
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MOG71S_Q4.H=_^*KL/_1K5]%#[H[5A5^(ZJ7PH6BBBLS0**** "BBB@ HHHH
M**** "BBB@#ROQ]_R.\G3CP[<?\ HU:Z7PZ/^*2MN?\ EBO7_=%<UX^_Y'>7
M_L7)NW_345TOA\?\4E;_ /7%?Y"NRG_"7J<%?^+\CR[X?\_$RV]M5U'_ -$K
M7T!7S]\/1GXEVQY_Y"FHG_R$M?0-<U3XCLI_"@HHHJ"PHHHH **** "BBB@
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M"O.J1LSIB[H6BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHK OM?O/M]W9Z/IT5_+8JC70DN?)QN!(5/E;<^ #@[1R.:+@
M;<]Q#:V\EQ<31PPQJ6>21@JJ!U))X JG)KVC1:=%J,FK6"6,I CN6N4$3D]
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M_!!.3\K<]:Q/%'PQ\*:E?K>76FFXUC4;M5-Q)<2]/O,=H8+\J*0!C' SFA=
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M-J^BJPJ_$==/X4%%%%9EA1110 4444 %%%% !1110 4444 >4>/_ /D=[O\
M[%J7G_MM75:!_P BI!_UR7M["N4\?_\ ([WF.<>&I.O_ %VKK-"_Y%:#_KDO
M\A79#^$O4X*_\7Y'E?PYY^),''_,2U+_ -%I7T!7S]\-^?B1!T_Y".I'_P A
MQU] US5/B.RG\(4445!84444 %%%% !1110 4444 07TWV;3[F?_ )YQ,_Y
MFOEZ)!<:A)O8@22R-D#)'S$U].ZK&9='O8UZO;R*/Q4U\QVX87^%F6%ED?YS
MT7DCM71A]_FC*H2RV7EPNSL5( 91CJ#_ "-4%BM7M%D6=OM1E^:+&!M'6M>[
M9C:NCZDLY(#!55L'\2!65%,IL(XOL)#K*=UR,]^ #6N+;<M>Q%'8ZK2)C#=P
M%AT88KTNVN/LLR3+$KD'DDG.*\LW?9Q&VQY&9N /:N\TN_%[8)*058##*?\
M/->5*^YV(W-8L$>Y74%?=:SD;ATVMC^563>Z=;:>;=(%+E3P #[9JG;3QS02
MZ=/*OES@J#N'R-V_6N&OK+7=,O3%.6609"MM/SC/&#T]*M2TU(5-MW1TCW8L
MD(A:6%@H/*X!/L1TJ$WMI)<(9Q(SC&?.8L!^?U-8?V_5X[=+1E\SCYRR*Q)S
MV.1C]:KW$FKR3E]WF9Y"OMROMP.?6G>XI09TZZ?I=Q.3$V&9=VP-@'WK.M+C
M3XFNK:]V95@![CG_  J/19I8+HF\@D:1@S9"C &<G'TK$B66]UF18<%Y4!+L
M, #>_/'04^A"BWHSM;&73K>,W,4J;L;8HRW*^K'WK&UPM-*@1@R[?6HH/#E\
M\IB\ZWR#S\S#G\JIW<$FGS&*9PQ4X.TDUG)-FJLMC"\111&"WWN542 ,1U K
M)LS;0:LPM9@\ R0\JYSD=Q]:UM>!\F(A#*3(,1CDM[5C;EN=4E80+:!@%\OG
MY, 9]^QKJPW3U1G5_0T+F]6>VDB+!3P J( &(/7BNW^"LI&JZW$>CP6[ ?1I
M?\17 S6\"1>9#<K)C[RE2I'YUW7P75FUO5WQPEK #^+2?X5VXE15[=OU,*1[
M11117GG2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'EWQ?\ ^/G0O^N=_P#^DYKIM!_Y *]?]4/_ $&N9^+V?M>@CC_5
M7_\ Z3FNFT(?\2%>G^J'\JZZ?\+YG#B/XB]#R#0A_P 3ZZ/KXNL^O^\U?15?
M.N@\Z[=$?]#;9_\ H35]%#I6%7XCKI_"@HHHK,L**** "BBB@ HHHH ****
M"BBB@#R?X@?\CK??]BS)W_Z;&NLT'_D5H,_\\U_D*Y+X@<>-K_\ [%E__1QK
MK="S_P (O!Z^6O\ *NRG_"7J<%?^+\CRKX;<_$>#'_/_ *EW_P!B.OH&OG[X
M:'_BXT''6_U+_P! CKZ!KFJ?$=E/X4%%%%06%%%% !1110 4444 %%%% "$
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M!'"LTH0R,>@7/4T 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \M^+_\ Q^:#[0Z@?_)>NHT+_D C_KF.WM7+_%__
M (_=!Z_ZC4.W_3"NHT+C01V_=C^5==/^%\SAQ'\1>AX_H'.N7'_8W6G_ *$]
M?15?.OA\?\3R<_\ 4W6O;W>OHH=*PJ_$=5/X4%%%%9F@4444 %%%% !1110
M4444 %%%% 'DOQ _Y'74>.GAENG_ %V:NNT0?\4Q#_N#^0KD/B /^*VU(]O^
M$8;_ -'-78:)C_A&8>GW!W]A793_ (2]3@K_ ,7Y'E/PRP?B)!_U_:D?_'(J
M^@:^?_AC_P E#@_Z_-2[_P"S%7T!7-4^([*?PH****@L**** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@#J0<@)W5QI7_KN=I17!^(]9\G3O"]I8:->7>FZC+&AA4PXDB\IF$+>9(.2
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M6)3Z+N))'N>OMTJ_13;;O<'J8-A8:C/<ZQ%K-CIWV"]?*+%<M*778J%75HU
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M8Y*@9(XXY70[#Q%I-G- NE:2LTBO*]TVJRS23SXX:3-NO!.!P>!P!@ 5UM%
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M.,D<K@YYS45QX0^UWVE7MSKVK2W&FS--&S>0/,8C:=P$0&-I(^7;USUYIZ7
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M]!:OHJOG;PKSJMN>1_Q5R]1_LM7T36%3XCKA\(4445F6%%%% !1110 4444
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MO!/@W_R-B_[M_P!3S]^WKWKO7-/XCNAL+1114%!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E7Q;Q
M_:^D9_Z!VH?^@Q5V&F_\@5O]WU]JY#XL?\AG2.O_ "#M0_\ 08J[#3C_ ,21
MO]W^E==/^%\SAK_Q?D>-^#_^0I9?]C8?_1;5]$5\[>#N=3L.?^9K/_HIJ^B:
MYZFYV0V"BBBH*"BBB@ HHHH **** "BBB@ HHHH \@\??\C1KW//_"/Q_P#H
M^6NXL?\ D75^G>N&\??\C/KW/_,!C[?]-Y:[FR_Y%Y?]VNR'\)>IP5OXK]#R
MSX-#_BJA[)?_ /H=M7O/>OG/X<ZE<Z5?/?Z?!;7\\4MU%)9-=B&8JYB(= 1A
MO]61BO:-!\;:5KEV;';<V&I 9-E?1>5(1ZKV<?[I/OBN::=[G9!Z'2T4E+4%
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M )^[_G_I^F_^*H_X0*T[7=]C/_/]-_\ %4>RI_S!]8G_ "D__"Q?^I1\2_\
M@-%_\<H_X6,/^A2\2_\ @-'_ /'*@_X0*T[7=_\ ^!TW_P 51_P@5KS_ *7?
M_P#@=-_\53]E3_F#ZQ/^4G_X6,/^A3\2_P#@+'_\<H_X6,H_YE/Q+_X"Q_\
MQRH#X"M?^?N__P# Z;_XJC_A [;G_3+_ *_\_P!-_P#%4>RI_P P?6)_RD__
M  L9?^A3\3?^ D?_ ,<H_P"%C+_T*?B;U_X](_\ XY4'_""6N#_IE_\ ^!TW
M_P 51_P@=MC_ (_+_GG_ (_I?_BJ/94_YA_6)_RD_P#PL=/^A3\3?^ D?_QR
ME_X6,G_0J>)O_ -/_CE5_P#A [;)_P!,O_\ P-E_^*H_X02V_P"?R_\ _ Z7
M_P"*H]E3_F%]8G_*6/\ A8\7_0J^)O\ P#3_ ..4?\+'B_Z%7Q-_X!I_\<JO
M_P ();\#[;J!_P"WZ7_XJC_A!+?&/MM_C_K^E_\ BJ/94_Y@^L3_ )2?_A9$
M6,_\(MXF_P# )/\ XNE_X6/%G'_"+>)O_ -/_BZ@/@6 _P#+]J'7_G^E_P#B
MJ3_A!81_R_:A[?Z=+_\ %4>RI?S!]8G_ "D__"R(<9_X1;Q-C_KR3_XNC_A9
M$/\ T*WB;_P"3_XNH?\ A!H<_P#']?\ _@;+_P#%4G_""P_\_P!?_P#@;+_\
M51[*G_,'UF?\I-_PLJ#/_(K>)_\ P!7_ .+H_P"%E0?]"MXG_P# %?\ XNH3
MX%A_Y_M0S_U_2_\ Q5*? T)Y^W7_ #_T_2_XT>RI_P P?69_RDO_  LJ#_H5
M_$__ ( K_P#%T#XE6_\ T+'B8?\ ;B/_ (NHO^$&CZ_;]0_\#9?_ (JC_A!H
MNOV_4/;_ $V7_&CV5+^8/K,_Y27_ (67;_\ 0L>)O_ $?_%T?\++M_\ H5_$
M_P#X #_XNHO^$&C_ .?_ %#_ ,#9?\:7_A!X\?\ '_J'_@;+_C2]E3_F#ZQ/
M^4?_ ,+,M_\ H5_$_P#X +_\71_PLRV_Z%?Q/_X K_\ %U'_ ,(1'_S_ .H?
M^!LO^-'_  A$?_00U#_P-E_QI^RI_P P?69_RDG_  LVV_Z%CQ-_X K_ /%T
M?\+-MO\ H6/$_P#X K_\74?_  A"?]!#4/\ P-E_QH_X0A>VH:C_ .!LO^-'
MLJ?\P?69_P I)_PLVUSC_A&?$W_@ /\ XN@?$VU/_,L^)O\ P '_ ,73/^$)
M4=-0U#_P-E_QI/\ A"1S_P 3#4<_]?LO^-+V5/\ F#ZS/^4D_P"%FVO_ $+7
MB;_P '_Q5'_"S;3&?^$:\2_^  _^*J/_ (0D?]!'4,=/^/V3_&C_ (0G_J(Z
MA_X&R?XT_8T_Y@^LS_E)#\3K,?\ ,M^)?_ #_P"RH_X6;9_]"YXE_P# #_[*
MH_\ A"1_T$=0_P# R3_&E_X0HY_Y"6H?^!LG^-'L:?\ ,/ZQ/^4?_P +-L_^
MA<\2?^ '_P!E1_PLVR_Z%WQ+_P""_P#^RJ/_ (0HA<?VEJ'O_ILGK]:/^$*)
M(_XF6H=1_P ODG^-'L:?\P?6)_RDO_"S;+_H7?$G_@O_ /LJ/^%G6(Z^'O$@
M_P"X?_\ 95%_PA9S_P A/4>G_/Y)_C0/!1Q_R$M0Z?\ /Y)_C1[&G_,'UB?\
MI)_PLZQ'7P_XC'UT_P#^RI?^%G6'_0 \1_\ @N/^-0_\(6V<C4]0]O\ 3)/\
M:7_A"VSC^TM0_P# R3_&CV-/^8/K,OY27_A9NGCKH/B/_P %Q_QH_P"%G:?_
M - +Q%_X+C_C47_"&-Q_Q,]0Z_\ /Y)_C1_PAC]]3U#_ ,"W_P :/8T_Y@^L
MR_E)?^%G:<3_ ,@+Q%_X+C_C1_PL[3L9_L/Q%C_L''_&HO\ A#'/']IZA_X%
MOC^='_"&O_T$]0_\"W_QH]C3_F#ZS+^4E_X6=IW_ $ _$7_@N;_&E_X6=IO_
M $!?$/\ X+6_QJ+_ (0U\'_B9ZAU_P"?M_\ &D_X0V3/&IZA_P"!;_XT>QI_
MS!]9E_*3?\+.TS_H"^(?_!:U'_"SM,_Z WB'_P %KU%_PALO_04U#\+I_P#&
MC_A#I>^J:AQ_T]/1[&G_ #!]9E_*2_\ "S]+Q_R!_$'_ (+7H/Q/TH==(\0?
M^"UZB'@Z7(_XF>H?^!34?\(?+G_D)ZA_X%-1[&G_ #!]9E_*2_\ "S]*_P"@
M1X@_\%CT?\+/TC_H%:]_X+9*B_X0^;_H*:@/^WIJ/^$0GQ_R%-0Z_P#/TU'L
M:?\ ,'UF7\I+_P +/TCC_B5:_P#^"R2C_A:&CCDZ9KV/^P9)_A47_"(3_P#0
M4U#_ ,"6I1X0G_Z"FH?^!+4>QI_S"^LR_E)/^%H:,#@Z;KH/_8,D_P *7_A:
M&BCKI^N#_N&2_P"%0CPC<?\ 04O_ /P):C_A$;G_ *"E_P#^!+4>QI_S!]9E
M_*2_\+0T7_H'ZY_X+)?\*7_A:&B?\^.M_P#@LE_PJ'_A$KCMJM_C_KY-+_PB
M=US_ ,374/PN#1[&'\P?69?RDH^*&AD?\>6MC_N&3?X4O_"T-!!Q]EUG_P %
MDW_Q-0_\(E=?]!6_]O\ 2#1_PB=V/^8K?_\ @0:7L8?S!]9E_*2_\+1T'_GU
MUG_P63?_ !- ^*.@'_EVUG_P63?_ !-1#PI=_P#05O\ K_S\'_"C_A%+OI_:
MU]_X$4>QA_,'UF7\I-_PM'P__P \-7_\%DW_ ,31_P +1\/_ //#5_\ P63?
M_$U"/"UYG_D+7V?^N_\ ]:C_ (1:]YQJU]_W_P#_ *U/V,/Y@^M2_E)?^%I>
M'?\ GEJ__@LF_P#B:7_A:/AWNFJCZZ9/_P#$U#_PBUZ.FK7W_?[_ .M1_P (
MO?\ _07OO^_W_P!:CV$/YA_67_*3?\+2\-_W=4_\%L__ ,31_P +2\-?]1/_
M ,%L_P#\34/_  C%_P#]!>^_[_?_ %J7_A&+_G_B;WW_ ']'^%'L(?S"^M/^
M4F_X6CX:'4ZG_P""V?\ ^(I/^%I^&?[VI?\ @MG_ /B*B/AB_P"VKWV?>4?X
M4?\ ",ZA_P!!>^]?]:/\*/80_F']:?\ *3?\+2\,?W]1_P#!;/\ _$4?\+2\
M,9YDU#_P6S__ !%0_P#"-:B/^8O?=O\ EH/\*!X;U$8_XF][U_YZ#_"CV$/Y
MA?6G_*3?\+3\+?\ /:_S_P!@Z?\ ^(H_X6GX5QGS[_'_ &#I_P#XBH1X;U'_
M *#%]_W\7_"@>&]2[:O>_P#?:_\ Q-'L(?S#^M/^5DW_  M/PJ#@W-]_X+KC
M_P"(H_X6GX4_Y^KW_P %UQ_\147_  CFI8_Y"][_ -]K_P#$TG_".:GG_D,7
MO_?:_P#Q-+V,/Y@^M/\ E9-_PM3PGC/VN\_\%UQ_\12CXI^$LX^W76<X_P"0
M?<?_ !%0_P#".:EC_D+WG_?2?_$T?\([J?'_ !-[PX_VD_\ B:/80_F#ZT_Y
M63?\+4\(8S]ON<=?^0?<?_&Z/^%I^$.?^)A<\?\ 4/N/_B*A/AW4S_S%KP_\
M"3_XFC_A'=4Q_P A:]'XI_\ $T>PA_,'UK^ZR4_%7P</^8C<_AIMR?\ VG2?
M\+8\&_\ 02NO_!;=?_&ZC/A[5,Y_M:\Z_P!Y/_B:/^$>U7_H+79_X$G_ ,31
M["'\P?6G_*Q__"V?!G_02N?_  6W/_QNC_A;/@S_ *"=Q_X+KG_XW3!X>U0?
M\Q:[_-/_ (FD_P"$?U7_ *"UW^:?_$T>PA_,'UK^ZR3_ (6QX+_Z"EQ_X+KG
M_P"-TO\ PMCP7_T%9O\ P7W'_P ;J/\ X1_51_S%;O\ \A__ !%)_P (_JO?
M5KK_ ,A__$T>PC_,'UK^Z2_\+8\%_P#05E_\ +C_ .-USGB;Q?H_B^]TK3M.
MN7N--MI7U#4G,$D8"0KE$.]1G+$'C^Z*WO\ A']6Q_R%KO\ ./\ ^)J"^\)W
M^H6,]G<ZG=O!.I21<H,@]LA::HQ_F#ZS_=,#X613:O\ VEX@N@?,U&Z:4 GH
M@X49]N:W/&-Q)=RV^F0RF,SN4>0'_5Q@$NWY CZD5L:'I$7AO1!:Q+M2)0B#
M.3BN!URXN-5U1M,A=D-]/#IIE3JJRL6E(SW$<8_.M4[7EV.>W/)1[G5?#>S-
MZEUXF9#%!=J+;38,8$5I&2 1[N<M] M;WC'6+O1?#[RZ=&DFHW$B6UJLAPHD
M<XW'V4;F_P" UM6MK#8V<-I;H(X((UCC0=%51@#\A7(_$>*:;2K".)MKO<2H
MA]':UG"_J<?C7$O>D>B_=6AY7K&N:9X8)>(R:EK5VNZ2^=_W\I/1@W.Q>P"]
M@.U%YI7C>QL_M7B33$U#2<>9(C.K3VR]=R,/G#*.>_3\MSX9Z1HO]G6>I7%J
MES?E@TDUQ\[)(IQ@9^[C'Z5Z=JVH03:=)$0&5E((/.:ZYPDY)):'%&K%)N^I
MD^ O$-U>K=Z)JMP+C4+ (Z70 'VNW<?))C^]P0WOCUKM:\H\%6XM_'ME;0,Q
M2UT21)"QS\IF7RP?R8UZN.E<M6/+-Q.RG/GBI!1114%A1110 4444 %%%% !
M1110 4444 <7XT\+7E_<PZWHBQMJ<$9AEMY&VI>09SY9/\+ Y*GU)SP>.&7Q
M/9V+M!>W!TVY3[]K?_N94/X\$>A!(/%>V8&<U!=6-M>A1<1[]O(^8C^5=%'$
M3I:+8YZV%A6UEN>+V5E?^,]39M%EWH1Y4NJLI6*TC/58LX+R$=QP.,D<5['I
M6EVNBZ5:Z;8QB.VMHQ'&OL.Y]2>I/<G-7 H48 XI:SJ5'4=V:4J4:<>6(5X_
M\4VBM?%EO*U]:V4UQI3)%-<MA/,CN(W4'@^K5[!5>XL;>Z96FCW%<X^8C^51
M%\KN6U=6/GJ+QAXEB0)'XN\,A1T^;M_WS3_^$U\4?]#=X9Z?W_\ [&O?#HU@
M?^6'_C[?XTAT73S_ ,N__C[?XUK[9F/L(G@O_":^*>?^*N\,_P#??_V-(?&O
MBGG'BSPR?^VG_P!:O>3H.FGK;?\ C[?XT?V%II!'V;@]?G;W]_<T>U8>PB>$
M?\)KXIS_ ,C7X8_[^?\ UJ3_ (3;Q4!G_A*O#!_[:?\ UJ]V_P"$?TL_\NO_
M )$;_&D_X1W2L?\ 'K_Y$;_&CVS'[%'A?_";^*AQ_P )3X8]?]9_]:C_ (3;
MQ4?^9H\,?]_?_K5[I_PCNE9_X]?_ "(W^-#^'-*=V=K7+,<D^8W^-'M0]@CP
MP>-O%9Z>*/#'U\W_ .M1_P )MXKZ?\)/X8Q_UU'^%>Y?\(UI'_/I_P"1'_QI
M/^$9TC_GT_\ (C_XT>U#V"/#AXV\69S_ ,)/X7_[_4?\)OXLQ_R,OA?_ +_"
MO</^$8T?_GS_ /(K_P"-)_PBVC'_ )<__(K_ .-'M?(7L(GB'_";^+!_S,OA
M;_O\*7_A-_%N/^1E\+_]_P 5[;_PBFB_\^7_ )%?_&C_ (131/\ GR_\BO\
MXT>U'[%'B7_";^+>?^*D\+_]_P 4#QQXMQ_R,GA?_O\ BO;?^$4T3_GR_P#(
MK_XTG_")Z)_SY?\ D5_\:/:^0>PB>)_\)QXM_P"AC\+_ /@0*7_A./%O_0Q>
M%_\ P('^->U?\(CH?_/C_P"17_\ BJ/^$1T+_GQ_\BO_ /%4>U\@]@CQ4>-_
M%V?^1B\+?^! _P :/^$X\7=O$/A;_P "1_C7M/\ PB&A?\^/_D9__BJ/^$/T
M'_GP_P#(S_\ Q5'M1>PB>+_\)QXM_P"AA\+?^!*_XT?\)SXN!_Y&#PK_ .!*
M_P"->S_\(=H/_/A_Y&D_^*I/^$-T#_GP_P#(TG_Q5'M0]@CQG_A.?%V,?V_X
M5_&Z'^-+_P )SXO_ .@_X6_\"E_QKV7_ (0SP_\ \^'_ )&D_P#BJ3_A"_#_
M /T#_P#R-)_\51[7R'[%'C?_  G/B[_H/>%?_ I?\:!XY\7?]![PK_X%+_C7
MLG_"%>'C_P P_P#\C2?_ !5)_P (3X>_Z!__ )&D_P#BJ/:A[%'CG_"=>+O^
M@[X5_P# I?\ &C_A.?%V!G7?"G_@6O\ \57L1\#^'6ZZ=_Y'D_\ BJ/^$&\.
M?] [_P CR?\ Q5'M1>P1XZ/'7B\_\QSPK_X%K_\ %4O_  G7B[_H-^%?_ M?
M_BJ]A_X0;PY_T#O_ "/)_P#%4G_"">&_^@;_ .1Y/_BJ/:C]BCQ__A.?%_\
MT&_"O_@6O_Q5'_"<^+\_\AKPK_X%K_\ %5Z__P ()X:_Z!O_ )'D_P#BJ/\
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M\F)?_BJ3_A6_A/\ Z!/_ ),2_P#Q5'M?(/8(\I_X3OQE_P!!/PMT_P"?U?\
MXNC_ (3OQED?\3+PMU_Y_5_^+KU7_A6OA'_H$_\ DS+_ /%4?\*U\(_] G_R
M9E_^*H]KY![%'E0\=>,_^@AX7/\ V^K_ /%TO_"=^,^VH>%__ U?_BZ]3/PT
M\($8.D?^3,O_ ,52?\*R\'DY_LC_ ,F9O_BZ/:A[!'EW_"=>,P/^/[POU'_+
MZO\ \71_PG7C0C_C^\+_ /@:O_Q=>H'X8>#CUT?_ ,F9O_BZ3_A5_@[_ * _
M_DS-_P#%T>U#V"/,/^$[\9@_\?OA<_\ ;XO_ ,71_P )WXTQS=^%S_V^+_\
M%UZ?_P *N\&_] ?_ ,FIO_BZ0_"SP83DZ-_Y-3?_ !='M0]@CS(>._&F3BY\
M,=?^?Q?_ (NC_A._&O\ S\>&.G_/ZO\ \<KTL_"KP6?^8+_Y-3?_ !=)_P *
MH\$_] 7_ ,FIO_BZ/:A[!'FO_"=^-O\ GX\,_P#@8O\ \<I1X\\;'I-X9[?\
MOB__ !RO2?\ A4_@G_H"_P#DU-_\72'X3^"#_P P3_R:F_\ BZ/:A[!'F_\
MPG?C;_GKX9/_ &^+_P#'*/\ A._&W_/7PU_X&K_\<KT@_"7P0?\ F"?^3<W_
M ,72?\*D\#_] 3_R;F_^+H]J'L$><GQWXW_O^&__  ,7_P".4?\ "=>-\??\
M-_\ @:O_ ,<KT7_A47@;_H!_^3<__P 73?\ A4'@0_\ ,"_\FY__ (NCVH>P
M1Y[_ ,)WXW Z^'"?^OU?_BZ/^$Z\<>OAS_P,7_XNO0O^%/\ @3:5_L+@G/\
MQ]S]?^^Z3_A3O@+_ * /_DY/_P#%T>U\@]@CS[_A.O''_4N_^!J__'*4^._'
M&1\OAW_P-7_XNN_/P;\ GKH/_DY/_P#%TW_A3/@#&/[ [Y_X_)__ (NCVOD'
ML$<'_P )WXX'.SP]_P"!J?\ Q='_  G?CC/^K\/_ /@:G_Q==W_PI?X?_P#0
M _\ )R?_ .+I/^%*_#WG_BG^O_3Y<?\ QRCVOD'L4<,/'?CC_GEX?_\  U?_
M (NC_A._' !_<Z!_X'+_ /%UW!^"GP])R?#_ /Y.W'_QRC_A2?P\_P"A?_\
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M#_R<G_\ BZ/^%-^ ?^@#_P"3D_\ \73]JNP>Q1PW_"?>.?\ H':/Q_T^K_\
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M)_\ XNC_ (4Q\/\ _H ?^3D__P 71[5=OZ^X/8_U_3.-_P"$^\<_]"_9<_\
M3T#_ %I?^$^\<_\ 0O6G_@4/\:[$_!CX?GKH'_DY/_\ %T?\*8^'_P#T /\
MR<G_ /BZ/:KM_7W![$X[_A/_ !S_ -"Y:G_MZ'^-+_PG_CGI_P (U;?^!0_Q
MKL/^%,?#_P#Z '_DY/\ _%TG_"E_A_\ ] #_ ,G)_P#XNCVJ[?U]P>Q.0_X6
M!XYZGPS;_A=+_C2_\+ \<X_Y%>'\+D5U_P#PICX?_P#0 _\ )R?_ .+I1\&?
M  Z:!_Y.3_\ Q='M5V_K[@]BOZ_X<X__ (3_ ,<?]"O%P/\ GY%+_P + \<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>16
<FILENAME>srna-20210930.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaDmbP9z5Z8aekhvWB4bTnKfy4qkiLptyB36hh2gR0O -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:SRNA="http://surna.com/20210930" elementFormDefault="qualified" targetNamespace="http://surna.com/20210930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://surna.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" id="StatementsOfChangesInShareholdersDeficit">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
	  <link:definition>00000007 - Disclosure - Description of Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" id="BasisOfPresentationSummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000009 - Disclosure - Going Concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases" id="Leases">
	  <link:definition>00000010 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory" id="Inventory">
	  <link:definition>00000011 - Disclosure - Inventory</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000012 - Disclosure - Property and Equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssets" id="IntangibleAssets">
	  <link:definition>00000013 - Disclosure - Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000014 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterest" id="NotePayableAndAccruedInterest">
	  <link:definition>00000015 - Disclosure - Note Payable and Accrued Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" id="RelatedPartyAgreementsAndTransactions">
	  <link:definition>00000016 - Disclosure - Related Party Agreements and Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PreferredAndCommonStock" id="PreferredAndCommonStock">
	  <link:definition>00000018 - Disclosure - Preferred and Common Stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Warrants" id="Warrants">
	  <link:definition>00000019 - Disclosure - Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlans" id="EquityIncentivePlans">
	  <link:definition>00000020 - Disclosure - Equity Incentive Plans</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000021 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000022 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/TemporaryEquity" id="TemporaryEquity">
	  <link:definition>00000023 - Disclosure - Temporary Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StockholdersDeficit" id="StockholdersDeficit">
	  <link:definition>00000024 - Disclosure - Stockholders&#8217; Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000027 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryTables" id="InventoryTables">
	  <link:definition>00000028 - Disclosure - Inventory (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000029 - Disclosure - Property and Equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
	  <link:definition>00000030 - Disclosure - Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/WarrantsTables" id="WarrantsTables">
	  <link:definition>00000032 - Disclosure - Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlansTables" id="EquityIncentivePlansTables">
	  <link:definition>00000033 - Disclosure - Equity Incentive Plans (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000034 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" id="ScheduleOfRevenueBySourceDetails">
	  <link:definition>00000035 - Disclosure - Schedule of Revenue by Source (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" id="ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails">
	  <link:definition>00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" id="ScheduleOfShare-basedCompensationCostsDetails">
	  <link:definition>00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
	  <link:definition>00000039 - Disclosure - Going Concern (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" id="ScheduleOfLeaseCostDetails">
	  <link:definition>00000040 - Disclosure - Schedule of Lease Cost (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" id="ScheduleOfFutureAnnualMinimumLeasePaymentsDetails">
	  <link:definition>00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfInventoryDetails" id="ScheduleOfInventoryDetails">
	  <link:definition>00000043 - Disclosure - Schedule of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryDetailsNarrative" id="InventoryDetailsNarrative">
	  <link:definition>00000044 - Disclosure - Inventory (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000045 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000046 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
	  <link:definition>00000047 - Disclosure - Schedule of Intangible Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
	  <link:definition>00000048 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" id="AccountsPayableAndAccruedLiabilitiesDetailsNarrative">
	  <link:definition>00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" id="NotePayableAndAccruedInterestDetailsNarrative">
	  <link:definition>00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" id="RelatedPartyAgreementsAndTransactionsDetailsNarrative">
	  <link:definition>00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" id="PreferredAndCommonStockDetailsNarrative">
	  <link:definition>00000054 - Disclosure - Preferred and Common Stock (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" id="ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails">
	  <link:definition>00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" id="ScheduleOfWarrantsOutstandingDetails">
	  <link:definition>00000056 - Disclosure - Schedule of Warrants Outstanding (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
	  <link:definition>00000057 - Disclosure - Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000058 - Disclosure - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" id="SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails">
	  <link:definition>00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" id="ScheduleOfRestrictedStockUnitsActivityDetails">
	  <link:definition>00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" id="ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails">
	  <link:definition>00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" id="EquityIncentivePlansDetailsNarrative">
	  <link:definition>00000062 - Disclosure - Equity Incentive Plans (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" id="ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails">
	  <link:definition>00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
	  <link:definition>00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000065 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000066 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/TemporaryEquityDetailsNarrative" id="TemporaryEquityDetailsNarrative">
	  <link:definition>00000067 - Disclosure - Temporary Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
	  <link:definition>00000068 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="SRNA_EquipmentAndSystemsSalesMember" name="EquipmentAndSystemsSalesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EngineeringAndOtherServicesMember" name="EngineeringAndOtherServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyTwoMember" name="TwoThousandAndTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneMember" name="TwoThousandAndTwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PurchasesOfInventoryMember" name="PurchasesOfInventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierOneMember" name="SupplierOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierTwoMember" name="SupplierTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierThreeMember" name="SupplierThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" name="TwoThousandAndTwentyIncentiveAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdvertisingAndMarketingExpensesMember" name="AdvertisingAndMarketingExpensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProductDevelopmentCostsMember" name="ProductDevelopmentCostsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FacilityLeaseMember" name="FacilityLeaseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AgreementWithLandLordMember" name="AgreementWithLandLordMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CoFoundersMember" name="CoFoundersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WebSiteDevelopmentCostsMember" name="WebSiteDevelopmentCostsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" name="EquipmentDemonstrationAndProductTestingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_LeasedEquipmentMember" name="LeasedEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AprilThirtyTwoThousandAndTwentyMember" name="AprilThirtyTwoThousandAndTwentyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_MrJamesRShipleyMember" name="MrJamesRShipleyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FormerEmployeeMember" name="FormerEmployeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityPlanMember" name="TwoThousandAndSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IndependentDirectorsMember" name="IndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IndependentDirectorsOneMember" name="IndependentDirectorsOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeMember" name="WarrantsRangeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesTwoWarrantsMember" name="SeriesTwoWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesTwoConvertibleNotesMember" name="SeriesTwoConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InvestmentBankMember" name="InvestmentBankMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QOneTwoThousandSeventeenWarrantsMember" name="QOneTwoThousandSeventeenWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QFourTwoThousandSeventeenWarrantsMember" name="QFourTwoThousandSeventeenWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QTwoTwoThousandEighteenWarrantsMember" name="QTwoTwoThousandEighteenWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" name="TwoThousandAndSeventeenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandSeventeenEquityPlanMember" name="TwoThousandSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnvestedOptionsMember" name="UnvestedOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" name="TwoThousandAndNineteenSpecialEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoNewIndependentDirectorsMember" name="TwoNewIndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AprilOneTwentyTwentyOneMember" name="AprilOneTwentyTwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesDirectorsandConsultantsMember" name="EmployeesDirectorsandConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncentiveStockBonusAwardsMember" name="IncentiveStockBonusAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" name="TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerFourMember" name="CustomerFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_LeaseTerminationAgreementMember" name="LeaseTerminationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InventoryMember" name="InventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesBRedeemableConvertiblePreferredStockMember" name="SeriesBRedeemableConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InvestorWarrantMember" name="InvestorWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneEquityPlanMember" name="TwoThousandAndTwentyOneEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandTwentyOneEquityPlanMember" name="TwoThousandTwentyOneEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwentyOneEmployeesMember" name="TwentyOneEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyTwoMember" name="JuneThirtyTwentyTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyThreeMember" name="JuneThirtyTwentyTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_JuneThirtyTwentyTwentyFourMember" name="JuneThirtyTwentyTwentyFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" name="TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeOneMember" name="WarrantsRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" name="RedeemableConvertiblePreferredStockSubscriptionReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RedeemableConvertiblePreferredStockAccruedDividends" name="RedeemableConvertiblePreferredStockAccruedDividends" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ConvertiblePreferredStockConvertedToSecurities" name="ConvertiblePreferredStockConvertedToSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonstockSharesToBeIssued" name="CommonstockSharesToBeIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" name="CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" name="CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" name="CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" name="CommonSharesToBeIssuedInSettlementOfLegalDispute" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" name="CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" name="FairValueOfVestedStockOptionsGrantedToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" name="FairValueOfVestedStockOptionsGrantedToDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" name="AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" name="AdjustmentsToAdditionalPaidInCapitalRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" name="FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_GainOnForgivenessOfNotePayable" name="GainOnForgivenessOfNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockIssuedForOtherExpense" name="CommonStockIssuedForOtherExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncreaseDecreaseInLeaseDeposit" name="IncreaseDecreaseInLeaseDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" name="AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SubscriptionReceivableSeriesBPreferredStock" name="SubscriptionReceivableSeriesBPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OptionsIssuedForAccruedEquityCompensation" name="OptionsIssuedForAccruedEquityCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosurePreferredAndCommonStockAbstract" name="DisclosurePreferredAndCommonStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" name="PreferredAndCommonStockNoteDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosureWarrantsAbstract" name="DisclosureWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DisclosureTemporaryEquityAbstract" name="DisclosureTemporaryEquityAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TemporaryEquityTextBlock" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" name="OtherRisksAndUncertaintiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DescriptionOfBusinessPolicyTextBlock" name="DescriptionOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" name="ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TemporaryEquityPolicyTextBlock" name="TemporaryEquityPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" name="ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" name="RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" name="RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" name="ContractWithCustomerLiabilityRevenueRecognizedPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" name="TemporaryEquityNonCashRedemptionValueAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DecreaseInRevenuePercentage" name="DecreaseInRevenuePercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnamortizedAmountOfTenantImprovementAllowance" name="UnamortizedAmountOfTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_MonthlyRentDescription" name="MonthlyRentDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RentalExpense" name="RentalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PrepaidInventoryExpenses" name="PrepaidInventoryExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnpaidLeaseFees" name="UnpaidLeaseFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnpaidDemoAndTestingFees" name="UnpaidDemoAndTestingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOfImpactOfForegoingItemCharge" name="NetOfImpactOfForegoingItemCharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedButNotSettled" name="NumberOfUnitsVestedButNotSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedAndSettled" name="NumberOfUnitsVestedAndSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" name="RestrictedStockUnitsSharesIssuedInterestPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" name="AggregateSharesIssuedUponExecutionOfSettlement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" name="StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" name="StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" name="ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" name="ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" name="ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" name="ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfInvestmentUnitOffered" name="NumberOfInvestmentUnitOffered" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OfferedInvestmentsPricePerUnit" name="OfferedInvestmentsPricePerUnit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantDescription" name="WarrantDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProceedsFromInvestment" name="ProceedsFromInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProceedsFromInvestmentPerUnit" name="ProceedsFromInvestmentPerUnit" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RedeemWarrantSharesAtPrice" name="RedeemWarrantSharesAtPrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" name="StockOptionToPurchaseThresholdsPerformanceBased" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfSharesForfeitedForTerminations" name="NumberOfSharesForfeitedForTerminations" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" name="ShareBasedCompensationArrangementStockIssuedAndOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncomeTaxReconciliationTrueUpAdjustments" name="IncomeTaxReconciliationTrueUpAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" name="NetOperatingLossCarryForwardExpectedToExpireAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossExpirationTerm" name="NetOperatingLossExpirationTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsUsageAgainstTaxableIncomePercentage" name="NolsUsageAgainstTaxableIncomePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTerm" name="NolsCarryforwardsTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TemporaryEquityNetProceeds" name="TemporaryEquityNetProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PercentageOfPreferredStockConversionProvision" name="PercentageOfPreferredStockConversionProvision" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PercentageOfCommonStockReserve" name="PercentageOfCommonStockReserve" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DebtInstrumentRedeemableShares" name="DebtInstrumentRedeemableShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" name="DebtInstrumentRedemptionPricePercentageDividendDueThereon" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DebtInstrumentRedeemptionStatedValue" name="DebtInstrumentRedeemptionStatedValue" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IssuanceOfCommonStockExercisePercentageProvision" name="IssuanceOfCommonStockExercisePercentageProvision" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PercentageOfPlacementAgentCashFee" name="PercentageOfPlacementAgentCashFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantToPurchaseCommonStockShares" name="WarrantToPurchaseCommonStockShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts" name="CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsIssuedWithPreferredStockFinancing" name="WarrantsIssuedWithPreferredStockFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CashBalanceTransferredToBankAccount" name="CashBalanceTransferredToBankAccount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTermDescription" name="NolsCarryforwardsTermDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesAPreferredStockValue" name="SeriesAPreferredStockValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" name="IncreaseDecreaseOperatingLeaseLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>17
<FILENAME>srna-20210930_cal.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20210930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210930.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20210930.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20210930.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210930.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquity" xlink:href="srna-20210930.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficit" xlink:href="srna-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210930.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20210930.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210930.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210930.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210930.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210930.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210930.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210930.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210930.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210930.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210930.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20210930.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210930.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20210930.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210930.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210930.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20210930.xsd#ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210930.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20210930.xsd#ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:href="srna-20210930.xsd#TemporaryEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:href="srna-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:label="loc_SRNARedeemableConvertiblePreferredStockSubscriptionReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="loc_SRNARedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockAccruedDividends" xlink:label="loc_SRNARedeemableConvertiblePreferredStockAccruedDividends" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="loc_SRNARedeemableConvertiblePreferredStockAccruedDividends" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="loc_us-gaapRedeemablePreferredStockDividends" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapRedeemablePreferredStockDividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:label="loc_SRNAConvertiblePreferredStockConvertedToSecurities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_SRNAConvertiblePreferredStockConvertedToSecurities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="loc_SRNAGainOnForgivenessOfNotePayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAGainOnForgivenessOfNotePayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="loc_SRNACommonStockIssuedForOtherExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNACommonStockIssuedForOtherExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000019 - Disclosure - Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000020 - Disclosure - Equity Incentive Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquity" xlink:title="00000023 - Disclosure - Temporary Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficit" xlink:title="00000024 - Disclosure - Stockholders&#8217; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000027 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000028 - Disclosure - Inventory (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000032 - Disclosure - Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000033 - Disclosure - Equity Incentive Plans (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000035 - Disclosure - Schedule of Revenue by Source (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Going Concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000040 - Disclosure - Schedule of Lease Cost (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000042 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000043 - Disclosure - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000044 - Disclosure - Inventory (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000045 - Disclosure - Schedule of Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000047 - Disclosure - Schedule of Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000053 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000054 - Disclosure - Preferred and Common Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="00000056 - Disclosure - Schedule of Warrants Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000057 - Disclosure - Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000062 - Disclosure - Equity Incentive Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000066 - Disclosure - Subsequent Events (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Temporary Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000068 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>srna-20210930_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20210930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210930.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20210930.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20210930.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210930.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquity" xlink:href="srna-20210930.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficit" xlink:href="srna-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210930.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20210930.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210930.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210930.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210930.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210930.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210930.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210930.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210930.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210930.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210930.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20210930.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210930.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20210930.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210930.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210930.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20210930.xsd#ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210930.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20210930.xsd#ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:href="srna-20210930.xsd#TemporaryEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:href="srna-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalRedemptionValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalRedemptionValue_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000019 - Disclosure - Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000020 - Disclosure - Equity Incentive Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquity" xlink:title="00000023 - Disclosure - Temporary Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficit" xlink:title="00000024 - Disclosure - Stockholders&#8217; Deficit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000027 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000028 - Disclosure - Inventory (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000032 - Disclosure - Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000033 - Disclosure - Equity Incentive Plans (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000035 - Disclosure - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="loc_SRNAEquipmentAndSystemsSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEquipmentAndSystemsSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_250" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="loc_SRNAAdvertisingAndMarketingExpensesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAAdvertisingAndMarketingExpensesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="loc_SRNAProductDevelopmentCostsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAProductDevelopmentCostsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_310" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="loc_us-gaapChangeInAccountingEstimateByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="loc_us-gaapInventoryValuationAndObsolescenceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:to="loc_us-gaapInventoryValuationAndObsolescenceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaapOrderOrProductionBacklogMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOrderOrProductionBacklogMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="loc_SRNAPurchasesOfInventoryMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_SRNAPurchasesOfInventoryMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OneCustomerMember" xlink:label="loc_SRNAOneCustomerMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNAOneCustomerMember_140" xlink:type="arc" order="143" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerFourMember" xlink:label="loc_SRNACustomerFourMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerFourMember_580" xlink:type="arc" order="583" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierOneMember" xlink:label="loc_SRNASupplierOneMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierOneMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierTwoMember" xlink:label="loc_SRNASupplierTwoMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierTwoMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierThreeMember" xlink:label="loc_SRNASupplierThreeMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierThreeMember_220" xlink:type="arc" order="223" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_600" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_600" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryAdjustments_600" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_600" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_600" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_600" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage_600" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_600" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_600" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription_600" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProductWarrantyAccrual_600" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_600" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_600" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_600" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_600" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAreaOfLand_600" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_600" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:label="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment_600" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_600" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_600" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_600" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_600" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_600" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Going Concern (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000040 - Disclosure - Schedule of Lease Cost (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000042 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AgreementWithLandLordMember" xlink:label="loc_SRNAAgreementWithLandLordMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAAgreementWithLandLordMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="loc_SRNALeaseTerminationAgreementMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNALeaseTerminationAgreementMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand_230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit_230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForDeposits_230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm_230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredRentCreditCurrent_230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_230" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_230" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTenantImprovements_230" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_230" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAMonthlyRentDescription_230" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RentalExpense" xlink:label="loc_SRNARentalExpense_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARentalExpense_230" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_230" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000043 - Disclosure - Schedule of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000044 - Disclosure - Inventory (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000045 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000047 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ThreeCustomersMember" xlink:label="loc_SRNAThreeCustomersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_SRNAThreeCustomersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableModificationsLineItems" xlink:label="loc_us-gaapFinancingReceivableModificationsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:label="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember_140" xlink:type="arc" order="143" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmploymentAgreementMember" xlink:label="loc_SRNAEmploymentAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEmploymentAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsReceivableMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsPayableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeasedEquipmentMember" xlink:label="loc_SRNALeasedEquipmentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNALeasedEquipmentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="loc_SRNAAprilThirtyTwoThousandAndTwentyMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilThirtyTwoThousandAndTwentyMember_130" xlink:type="arc" order="134" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidLeaseFees" xlink:label="loc_SRNAUnpaidLeaseFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAUnpaidLeaseFees_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="loc_SRNAUnpaidDemoAndTestingFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAUnpaidDemoAndTestingFees_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="loc_SRNANetOfImpactOfForegoingItemCharge_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANetOfImpactOfForegoingItemCharge_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaapSalariesWagesAndOfficersCompensation_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSalariesWagesAndOfficersCompensation_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction_170" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000053 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_80" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_80" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_80" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense_80" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements_80" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense_80" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_80" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000054 - Disclosure - Preferred and Common Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeeMember" xlink:label="loc_SRNAEmployeeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="00000056 - Disclosure - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000057 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="loc_SRNASeriesTwoWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNASeriesTwoWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQOneTwoThousandSeventeenWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQOneTwoThousandSeventeenWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQFourTwoThousandSeventeenWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQFourTwoThousandSeventeenWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="loc_SRNAQTwoTwoThousandEighteenWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQTwoTwoThousandEighteenWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="loc_SRNASeriesTwoConvertibleNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SRNASeriesTwoConvertibleNotesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestmentBankMember" xlink:label="loc_SRNAInvestmentBankMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SRNAInvestmentBankMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="loc_SRNANumberOfInvestmentUnitOffered_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfInvestmentUnitOffered_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="loc_SRNAOfferedInvestmentsPricePerUnit_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAOfferedInvestmentsPricePerUnit_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantDescription" xlink:label="loc_SRNAWarrantDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantDescription_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestment" xlink:label="loc_SRNAProceedsFromInvestment_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestment_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="loc_SRNAProceedsFromInvestmentPerUnit_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestmentPerUnit_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockDescription_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="loc_SRNARedeemWarrantSharesAtPrice_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARedeemWarrantSharesAtPrice_200" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_200" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_200" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_200" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_170" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_170" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_170" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_170" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_170" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_170" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_170" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_170" xlink:type="arc" order="27" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000062 - Disclosure - Equity Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneEquityPlanMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneEquityPlanMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="loc_SRNATwoNewIndependentDirectorsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNATwoNewIndependentDirectorsMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember_430" xlink:type="arc" order="432" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnvestedOptionsMember" xlink:label="loc_SRNAUnvestedOptionsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAUnvestedOptionsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="loc_SRNATwentyOneEmployeesMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNATwentyOneEmployeesMember_410" xlink:type="arc" order="412" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAFormerEmployeeMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="loc_SRNAAprilOneTwentyTwentyOneMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilOneTwentyTwentyOneMember_200" xlink:type="arc" order="204" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyTwoMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyTwoMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyThreeMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyThreeMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyFourMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyFourMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_580" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_580" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_580" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees_580" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_580" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_580" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_580" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_580" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_580" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_580" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_580" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_580" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased_580" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="loc_SRNANumberOfSharesForfeitedForTerminations_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfSharesForfeitedForTerminations_580" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_580" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_580" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_580" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding_580" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_580" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_580" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_580" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_580" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_580" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_580" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_580" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_580" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000066 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProfessionalFees_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReplacementReserveEscrow" xlink:label="loc_us-gaapReplacementReserveEscrow_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapReplacementReserveEscrow_110" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Temporary Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestorWarrantMember" xlink:label="loc_SRNAInvestorWarrantMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_SRNAInvestorWarrantMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsMember" xlink:label="loc_us-gaapEquityMethodInvestmentsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapEquityMethodInvestmentsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNetProceeds" xlink:label="loc_SRNATemporaryEquityNetProceeds_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNATemporaryEquityNetProceeds_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEscrowDeposit_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:label="loc_us-gaapCommonStockConvertibleConversionPriceIncrease_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockConvertibleConversionPriceIncrease_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPreferredStockConversionProvision" xlink:label="loc_SRNAPercentageOfPreferredStockConversionProvision_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfPreferredStockConversionProvision_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfCommonStockReserve" xlink:label="loc_SRNAPercentageOfCommonStockReserve_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfCommonStockReserve_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaapPreferredStockValueOutstanding_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValueOutstanding_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:label="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferencePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferencePerShare_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemableShares" xlink:label="loc_SRNADebtInstrumentRedeemableShares_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedeemableShares_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:label="loc_SRNADebtInstrumentRedemptionPricePercentageDividendDueThereon_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedemptionPricePercentageDividendDueThereon_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_160" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemptionStatedValue" xlink:label="loc_SRNADebtInstrumentRedeemptionStatedValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedeemptionStatedValue_160" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_160" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_160" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IssuanceOfCommonStockExercisePercentageProvision" xlink:label="loc_SRNAIssuanceOfCommonStockExercisePercentageProvision_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAIssuanceOfCommonStockExercisePercentageProvision_160" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPlacementAgentCashFee" xlink:label="loc_SRNAPercentageOfPlacementAgentCashFee_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfPlacementAgentCashFee_160" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentCompanyShareholderServiceFeeExpense" xlink:label="loc_us-gaapInvestmentCompanyShareholderServiceFeeExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentCompanyShareholderServiceFeeExpense_160" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantToPurchaseCommonStockShares" xlink:label="loc_SRNAWarrantToPurchaseCommonStockShares_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantToPurchaseCommonStockShares_160" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue" xlink:label="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferenceValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferenceValue_160" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_160" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:label="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment_160" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_160" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDescription" xlink:label="loc_us-gaapTemporaryEquityDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityDescription_160" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000068 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchaseAgreementMember" xlink:label="loc_SRNAPurchaseAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAPurchaseAgreementMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_100" xlink:type="arc" order="12" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>19
<FILENAME>srna-20210930_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="us-gaap_InventoryValuationAndObsolescenceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationAndObsolescenceMember" xlink:to="us-gaap_InventoryValuationAndObsolescenceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationAndObsolescenceMember_lbl" xml:lang="en-US">Inventory Valuation and Obsolescence [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="SRNA_EquipmentAndSystemsSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentAndSystemsSalesMember" xlink:to="SRNA_EquipmentAndSystemsSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EquipmentAndSystemsSalesMember_lbl" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="SRNA_EngineeringAndOtherServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EngineeringAndOtherServicesMember_lbl" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="us-gaap_CustomerContractsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerContractsMember" xlink:to="us-gaap_CustomerContractsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerContractsMember_lbl" xml:lang="en-US">Customer Contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="SRNA_TwoThousandAndTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_lbl" xml:lang="en-US">2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="SRNA_TwoThousandAndTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneMember_lbl" xml:lang="en-US">2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerOneMember" xlink:label="SRNA_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerTwoMember" xlink:label="SRNA_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerThreeMember" xlink:label="SRNA_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OneCustomerMember" xlink:label="SRNA_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OneCustomerMember" xlink:to="SRNA_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="SRNA_PurchasesOfInventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchasesOfInventoryMember" xlink:to="SRNA_PurchasesOfInventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PurchasesOfInventoryMember_lbl" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierOneMember" xlink:label="SRNA_SupplierOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierOneMember" xlink:to="SRNA_SupplierOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierOneMember_lbl" xml:lang="en-US">Supplier One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierTwoMember" xlink:label="SRNA_SupplierTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierTwoMember" xlink:to="SRNA_SupplierTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierTwoMember_lbl" xml:lang="en-US">Supplier Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierThreeMember" xlink:label="SRNA_SupplierThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierThreeMember" xlink:to="SRNA_SupplierThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierThreeMember_lbl" xml:lang="en-US">Supplier Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:to="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_lbl" xml:lang="en-US">2020 Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdvertisingAndMarketingExpensesMember" xlink:to="SRNA_AdvertisingAndMarketingExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember_lbl" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="SRNA_ProductDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProductDevelopmentCostsMember" xlink:to="SRNA_ProductDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProductDevelopmentCostsMember_lbl" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FacilityLeaseMember" xlink:label="SRNA_FacilityLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FacilityLeaseMember_lbl" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AgreementWithLandLordMember" xlink:label="SRNA_AgreementWithLandLordMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AgreementWithLandLordMember" xlink:to="SRNA_AgreementWithLandLordMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AgreementWithLandLordMember_lbl" xml:lang="en-US">Agreement with Landlord [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CoFoundersMember" xlink:label="SRNA_CoFoundersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CoFoundersMember" xlink:to="SRNA_CoFoundersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CoFoundersMember_lbl" xml:lang="en-US">Co-Founders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="SRNA_WebSiteDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WebSiteDevelopmentCostsMember" xlink:to="SRNA_WebSiteDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WebSiteDevelopmentCostsMember_lbl" xml:lang="en-US">Web Site Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ThreeCustomersMember" xlink:label="SRNA_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ThreeCustomersMember" xlink:to="SRNA_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="us-gaap_LoanRestructuringModificationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanRestructuringModificationAxis" xlink:to="us-gaap_LoanRestructuringModificationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanRestructuringModificationAxis_lbl" xml:lang="en-US">Loan Restructuring Modification [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="us-gaap_ExtendedMaturityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedMaturityMember" xlink:to="us-gaap_ExtendedMaturityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedMaturityMember_lbl" xml:lang="en-US">Extended Maturity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:to="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_lbl" xml:lang="en-US">Equipment, Demonstration and Product Testing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeasedEquipmentMember" xlink:label="SRNA_LeasedEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeasedEquipmentMember" xlink:to="SRNA_LeasedEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_LeasedEquipmentMember_lbl" xml:lang="en-US">Leased Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmploymentAgreementMember" xlink:label="SRNA_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmploymentAgreementMember" xlink:to="SRNA_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:to="SRNA_AprilThirtyTwoThousandAndTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember_lbl" xml:lang="en-US">April 30, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConsultingAgreementMember" xlink:label="SRNA_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConsultingAgreementMember" xlink:to="SRNA_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MrJamesRShipleyMember" xlink:label="SRNA_MrJamesRShipleyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MrJamesRShipleyMember" xlink:to="SRNA_MrJamesRShipleyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_MrJamesRShipleyMember_lbl" xml:lang="en-US">Mr. James R. Shipley [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FormerEmployeeMember" xlink:label="SRNA_FormerEmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FormerEmployeeMember_lbl" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeeMember" xlink:label="SRNA_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeeMember" xlink:to="SRNA_EmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsMember" xlink:label="SRNA_IndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsMember" xlink:to="SRNA_IndependentDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="SRNA_IndependentDirectorsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_IndependentDirectorsOneMember_lbl" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeMember" xlink:label="SRNA_WarrantsRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeMember_lbl" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="SRNA_SeriesTwoWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoWarrantsMember" xlink:to="SRNA_SeriesTwoWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SeriesTwoWarrantsMember_lbl" xml:lang="en-US">Series 2 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="SRNA_SeriesTwoConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoConvertibleNotesMember" xlink:to="SRNA_SeriesTwoConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SeriesTwoConvertibleNotesMember_lbl" xml:lang="en-US">Series 2 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestmentBankMember" xlink:label="SRNA_InvestmentBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestmentBankMember" xlink:to="SRNA_InvestmentBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InvestmentBankMember_lbl" xml:lang="en-US">Investment Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QOneTwoThousandSeventeenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember_lbl" xml:lang="en-US">Q1 2017 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QFourTwoThousandSeventeenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember_lbl" xml:lang="en-US">Q4 2017 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:to="SRNA_QTwoTwoThousandEighteenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember_lbl" xml:lang="en-US">Q2 2018 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="SRNA_NonQualifiedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="SRNA_EmployeesAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesAndConsultantsMember_lbl" xml:lang="en-US">Employees And Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="SRNA_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DirectorsMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:to="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_lbl" xml:lang="en-US">2019 Special Equity Award [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="SRNA_TwoNewIndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoNewIndependentDirectorsMember" xlink:to="SRNA_TwoNewIndependentDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoNewIndependentDirectorsMember_lbl" xml:lang="en-US">Two New Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="SRNA_AprilOneTwentyTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilOneTwentyTwentyOneMember" xlink:to="SRNA_AprilOneTwentyTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AprilOneTwentyTwentyOneMember_lbl" xml:lang="en-US">April 1, 2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="SRNA_IncentiveStockBonusAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncentiveStockBonusAwardsMember_lbl" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesMember" xlink:label="SRNA_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="us-gaap_OrderOrProductionBacklogMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrderOrProductionBacklogMember" xlink:to="us-gaap_OrderOrProductionBacklogMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrderOrProductionBacklogMember_lbl" xml:lang="en-US">Order or Production Backlog [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerFourMember" xlink:label="SRNA_CustomerFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerFourMember" xlink:to="SRNA_CustomerFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerFourMember_lbl" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="SRNA_LeaseTerminationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeaseTerminationAgreementMember" xlink:to="SRNA_LeaseTerminationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_LeaseTerminationAgreementMember_lbl" xml:lang="en-US">Lease Termination Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InventoryMember" xlink:label="SRNA_InventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InventoryMember_lbl" xml:lang="en-US">Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="SRNA_SeriesBRedeemableConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="SRNA_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestorWarrantMember" xlink:label="SRNA_InvestorWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestorWarrantMember" xlink:to="SRNA_InvestorWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InvestorWarrantMember_lbl" xml:lang="en-US">Investor Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsMember" xlink:label="us-gaap_EquityMethodInvestmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsMember" xlink:to="us-gaap_EquityMethodInvestmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsMember_lbl" xml:lang="en-US">Equity Method Investments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchaseAgreementMember" xlink:label="SRNA_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchaseAgreementMember" xlink:to="SRNA_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:label="SRNA_TwoThousandAndTwentyOneEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandAndTwentyOneEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneEquityPlanMember_lbl" xml:lang="en-US">2021 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:label="SRNA_TwoThousandTwentyOneEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandTwentyOneEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TwoThousandTwentyOneEquityPlanMember_lbl" xml:lang="en-US">2021 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="SRNA_TwentyOneEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwentyOneEmployeesMember" xlink:to="SRNA_TwentyOneEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwentyOneEmployeesMember_lbl" xml:lang="en-US">21 Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:to="SRNA_JuneThirtyTwentyTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember_lbl" xml:lang="en-US">June 30, 2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:to="SRNA_JuneThirtyTwentyTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember_lbl" xml:lang="en-US">June 30, 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyFourMember" xlink:to="SRNA_JuneThirtyTwentyTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember_lbl" xml:lang="en-US">June 30, 2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Plan and 2021 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeOneMember" xlink:label="SRNA_WarrantsRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeOneMember_lbl" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (net of allowance for doubtful accounts of $186,073 and $165,098, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NONCURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Note payable and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">TEMPORARY EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_lbl" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 3,300 and 0 issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:label="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:to="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable_lbl" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock Subscription Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockAccruedDividends" xlink:label="SRNA_RedeemableConvertiblePreferredStockAccruedDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemableConvertiblePreferredStockAccruedDividends" xlink:to="SRNA_RedeemableConvertiblePreferredStockAccruedDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RedeemableConvertiblePreferredStockAccruedDividends_lbl" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock Accrued Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US">Total Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock; 150,000,000 shares authorized Series A Preferred stock, $0.00001 par value; 42,030,331 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 350,000,000 shares authorized; 1,583,511 and 1,576,844 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Advertising and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockDividends" xlink:to="us-gaap_RedeemablePreferredStockDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RedeemablePreferredStockDividends_lbl" xml:lang="en-US">Convertible Preferred Series B Stock Redemption Value Adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:label="SRNA_ConvertiblePreferredStockConvertedToSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:to="SRNA_ConvertiblePreferredStockConvertedToSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SRNA_ConvertiblePreferredStockConvertedToSecurities_lbl" xml:lang="en-US">Convertible Preferred Series B Stock Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Loss Available to Common Shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share &#8211; basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of common shares outstanding, basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="SRNA_CommonstockSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_CommonstockSharesToBeIssued_lbl" xml:lang="en-US">Beginning balance, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common shares issued as compensation for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_lbl" xml:lang="en-US">Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xml:lang="en-US">Common shares issued in settlement of restricted stock units and award of stock bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xml:lang="en-US">Common shares issued in settlement of restricted stock units and award of stock bonuses, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xml:lang="en-US">Common shares issued in settlement of legal dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_lbl" xml:lang="en-US">Common shares to be issued in settlement of legal dispute, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xml:lang="en-US">Fair value of vested stock options granted to directors</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_lbl" xml:lang="en-US">Issuance of series B preferred stock and warrants, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Accrued dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue_lbl" xml:lang="en-US">Adjustment to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested restricted stock units awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees and directors</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:to="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_lbl" xml:lang="en-US">Fair value of vested incentive stock bonuses awarded to employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_CommonstockSharesToBeIssued_2_lbl" xml:lang="en-US">Ending balance, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and intangible asset amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="SRNA_GainOnForgivenessOfNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SRNA_GainOnForgivenessOfNotePayable_lbl" xml:lang="en-US">Gain on forgiveness of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="SRNA_CommonStockIssuedForOtherExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockIssuedForOtherExpense" xlink:to="SRNA_CommonStockIssuedForOtherExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockIssuedForOtherExpense_lbl" xml:lang="en-US">Common stock issued for other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of ROU asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xml:lang="en-US">Lease deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash (used in)/provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from the sale of property equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Cash proceeds from sale of preferred stock and warrants, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" xlink:label="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" xlink:to="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_lbl" xml:lang="en-US">Adjustment of carrying value of series B preferred stock to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SubscriptionReceivableSeriesBPreferredStock" xlink:label="SRNA_SubscriptionReceivableSeriesBPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SubscriptionReceivableSeriesBPreferredStock" xlink:to="SRNA_SubscriptionReceivableSeriesBPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SubscriptionReceivableSeriesBPreferredStock_lbl" xml:lang="en-US">Subscription receivable - series B preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OptionsIssuedForAccruedEquityCompensation" xlink:label="SRNA_OptionsIssuedForAccruedEquityCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OptionsIssuedForAccruedEquityCompensation" xlink:to="SRNA_OptionsIssuedForAccruedEquityCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OptionsIssuedForAccruedEquityCompensation_lbl" xml:lang="en-US">Options issued for accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends" xlink:label="us-gaap_Dividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Dividends_lbl" xml:lang="en-US">Accrued dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation; Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation; Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="SRNA_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note Payable and Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Agreements and Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosurePreferredAndCommonStockAbstract" xlink:label="SRNA_DisclosurePreferredAndCommonStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosurePreferredAndCommonStockAbstract" xlink:to="SRNA_DisclosurePreferredAndCommonStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosurePreferredAndCommonStockAbstract_lbl" xml:lang="en-US">Preferred And Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" xlink:label="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" xlink:to="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock_lbl" xml:lang="en-US">Preferred and Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="SRNA_DisclosureWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureWarrantsAbstract" xlink:to="SRNA_DisclosureWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosureWarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="SRNA_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Equity Incentive Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureTemporaryEquityAbstract" xlink:label="SRNA_DisclosureTemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureTemporaryEquityAbstract" xlink:to="SRNA_DisclosureTemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DisclosureTemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityTextBlock" xlink:label="SRNA_TemporaryEquityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityTextBlock" xlink:to="SRNA_TemporaryEquityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TemporaryEquityTextBlock_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Financial Statement Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ReverseStockSplitPolicyTextBlock" xlink:label="SRNA_ReverseStockSplitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ReverseStockSplitPolicyTextBlock" xlink:to="SRNA_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Reverse Stock Split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Basis of Consolidation and Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Product Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Product Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Income (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xml:lang="en-US">Other Risks and Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xml:lang="en-US">Impact of the COVID-19 Pandemic on Our Business</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="SRNA_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityPolicyTextBlock" xlink:label="SRNA_TemporaryEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityPolicyTextBlock" xlink:to="SRNA_TemporaryEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TemporaryEquityPolicyTextBlock_lbl" xml:lang="en-US">Temporary Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue by Source</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xml:lang="en-US">Schedule of Remaining Performance Obligations Expected to be Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Non-vested Non-qualified Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Incentive Bonus Awards Granted to Employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Total remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total share-based compensation expense included in consolidated statement of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US">Inventory Adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_2_lbl" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="us-gaap_StandardProductWarrantyDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyDescription" xlink:to="us-gaap_StandardProductWarrantyDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyDescription_lbl" xml:lang="en-US">Standard Product Warranty Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="us-gaap_ProductWarrantyAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrual" xlink:to="us-gaap_ProductWarrantyAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrual_lbl" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration Risk, Percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Research and Development Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of Land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:label="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:to="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment_lbl" xml:lang="en-US">Temporary equity non cash redemption value adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DecreaseInRevenuePercentage" xlink:label="SRNA_DecreaseInRevenuePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DecreaseInRevenuePercentage" xlink:to="SRNA_DecreaseInRevenuePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DecreaseInRevenuePercentage_lbl" xml:lang="en-US">Decrease in revenue percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WorkingCapitalDeficit" xlink:label="SRNA_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WorkingCapitalDeficit" xlink:to="SRNA_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Schedule Of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash outflow from operating lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating lease liability, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liability, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureLeasesAbstract" xlink:to="SRNA_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="SRNA_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Schedule Of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Year one</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Year two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">Remainder of fiscal year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for Rent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Lessee, Operating Lease, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="us-gaap_PaymentsForDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForDeposits_lbl" xml:lang="en-US">Payments for Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xml:lang="en-US">Deferred Rent Credit, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Operating Lease, Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="us-gaap_TenantImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TenantImprovements_lbl" xml:lang="en-US">Tenant Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xml:lang="en-US">Unamortized amount of tenant improvement allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MonthlyRentDescription" xlink:label="SRNA_MonthlyRentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_MonthlyRentDescription_lbl" xml:lang="en-US">Monthly rent description</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RentalExpense" xlink:label="SRNA_RentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RentalExpense" xlink:to="SRNA_RentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RentalExpense_lbl" xml:lang="en-US">Rental expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess &amp; obsolete inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Cost, Overhead</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="SRNA_PrepaidInventoryExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PrepaidInventoryExpenses_lbl" xml:lang="en-US">Prepaid inventory expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Sales commissions payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xml:lang="en-US">Product warranty accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:label="us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable_lbl" xml:lang="en-US">Financing Receivable, Troubled Debt Restructuring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableModificationsLineItems" xlink:label="us-gaap_FinancingReceivableModificationsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivableModificationsLineItems" xlink:to="us-gaap_FinancingReceivableModificationsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivableModificationsLineItems_lbl" xml:lang="en-US">Financing Receivable, Troubled Debt Restructuring [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidLeaseFees" xlink:label="SRNA_UnpaidLeaseFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidLeaseFees" xlink:to="SRNA_UnpaidLeaseFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnpaidLeaseFees_lbl" xml:lang="en-US">Unpaid lease fees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="SRNA_UnpaidDemoAndTestingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidDemoAndTestingFees" xlink:to="SRNA_UnpaidDemoAndTestingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnpaidDemoAndTestingFees_lbl" xml:lang="en-US">Unpaid demo and testing Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOfImpactOfForegoingItemCharge" xlink:to="SRNA_NetOfImpactOfForegoingItemCharge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge_lbl" xml:lang="en-US">Net of impact of foregoing item charge</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesWagesAndOfficersCompensation" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation_lbl" xml:lang="en-US">Salary and Wage, Excluding Cost of Good and Service Sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_lbl" xml:lang="en-US">Number of shares vested and to be settled with issued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xml:lang="en-US">Number of Units, Vested but not settled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="SRNA_NumberOfUnitsVestedAndSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_lbl" xml:lang="en-US">Number of units, vested and settled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="us-gaap_LossContingencyDamagesAwardedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesAwardedValue" xlink:to="us-gaap_LossContingencyDamagesAwardedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesAwardedValue_lbl" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xml:lang="en-US">Restricted stock units shares issued interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xml:lang="en-US">Aggregate common shares issued upon execution of settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other Nonoperating Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US">Payments for Legal Settlements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="us-gaap_LitigationSettlementExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementExpense" xlink:to="us-gaap_LitigationSettlementExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LitigationSettlementExpense_lbl" xml:lang="en-US">Litigation Settlement, Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_lbl" xml:lang="en-US">Number of common stock shares issued in settlement of vested restricted stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_lbl" xml:lang="en-US">Number of shares issued for stock incentive bonus</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DisclosureWarrantsAbstract" xlink:to="SRNA_DisclosureWarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DisclosureWarrantsAbstract_2_lbl" xml:lang="en-US">Schedule Of Outstanding Warrants To Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="SRNA_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Warrants, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xml:lang="en-US">Weighted Average Exercise Price, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="SRNA_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="SRNA_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Warrants, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="SRNA_NumberOfInvestmentUnitOffered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfInvestmentUnitOffered" xlink:to="SRNA_NumberOfInvestmentUnitOffered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfInvestmentUnitOffered_lbl" xml:lang="en-US">Number of investment unit offered</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="SRNA_OfferedInvestmentsPricePerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfferedInvestmentsPricePerUnit" xlink:to="SRNA_OfferedInvestmentsPricePerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OfferedInvestmentsPricePerUnit_lbl" xml:lang="en-US">Offered investments, price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantDescription" xlink:label="SRNA_WarrantDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantDescription" xlink:to="SRNA_WarrantDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantDescription_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestment" xlink:label="SRNA_ProceedsFromInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestment" xlink:to="SRNA_ProceedsFromInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProceedsFromInvestment_lbl" xml:lang="en-US">Proceeds from investment</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="SRNA_ProceedsFromInvestmentPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestmentPerUnit" xlink:to="SRNA_ProceedsFromInvestmentPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProceedsFromInvestmentPerUnit_lbl" xml:lang="en-US">Proceeds from investment per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xml:lang="en-US">Conversion of stock, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="SRNA_RedeemWarrantSharesAtPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemWarrantSharesAtPrice" xlink:to="SRNA_RedeemWarrantSharesAtPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RedeemWarrantSharesAtPrice_lbl" xml:lang="en-US">Redeem warrant shares at a price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_4_lbl" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited/Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Number of options, forfeited/cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_lbl" xml:lang="en-US">Weighted average remaining contractual term, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xml:lang="en-US">Number of options, outstanding vested and expected to vest ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Number of options, outstanding ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of options, exercisable ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Options, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xml:lang="en-US">Number of Options Nonvested, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Number of Options Nonvested, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_3_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_3_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of Units, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Units, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Units, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Number of Units, Forfeited/canceled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Units, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_lbl" xml:lang="en-US">Number of Shares, Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Number of Shares, Awarded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Awarded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Shares, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_3_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnvestedOptionsMember" xlink:label="SRNA_UnvestedOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedOptionsMember" xlink:to="SRNA_UnvestedOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnvestedOptionsMember_lbl" xml:lang="en-US">Unvested Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:to="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_lbl" xml:lang="en-US">Stock option to purchase - thresholds - performance based</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfSharesForfeitedForTerminations" xlink:to="SRNA_NumberOfSharesForfeitedForTerminations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations_lbl" xml:lang="en-US">Number of shares forfeited for terminations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:to="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_lbl" xml:lang="en-US">Share based compensation arrangement stock issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_lbl" xml:lang="en-US">Intrinsic value of vested and settled with issuance of share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xml:lang="en-US">Shares Granted, Value, Share-based Payment Arrangement, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income taxes computed at the federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">States taxes, net of federal benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:to="SRNA_IncomeTaxReconciliationTrueUpAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments_lbl" xml:lang="en-US">True-up adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Adjustment to net operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Reported income tax (benefit) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax assets before valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xml:lang="en-US">Net operating loss carry forward expected to expire amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="SRNA_NetOperatingLossExpirationTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossExpirationTerm_lbl" xml:lang="en-US">Net operating loss expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xml:lang="en-US">NOLs usage against taxable income, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="SRNA_NolsCarryforwardsTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsCarryforwardsTerm_lbl" xml:lang="en-US">NOLs carryforwards term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Income Tax Examination, Penalties and Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_2_lbl" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodShares_lbl" xml:lang="en-US">Shares redeemed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRedeemedOrCalledDuringPeriodValue_lbl" xml:lang="en-US">Redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReplacementReserveEscrow" xlink:label="us-gaap_ReplacementReserveEscrow" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReplacementReserveEscrow" xlink:to="us-gaap_ReplacementReserveEscrow_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReplacementReserveEscrow_lbl" xml:lang="en-US">Replacement Reserve Escrow</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:to="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement_lbl" xml:lang="en-US">Temporary Equity, Aggregate Amount of Redemption Requirement</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNetProceeds" xlink:label="SRNA_TemporaryEquityNetProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityNetProceeds" xlink:to="SRNA_TemporaryEquityNetProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TemporaryEquityNetProceeds_lbl" xml:lang="en-US">Temporary equity net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EscrowDeposit_lbl" xml:lang="en-US">Escrow Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:to="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConvertibleConversionPriceIncrease_lbl" xml:lang="en-US">Common Stock, Convertible, Conversion Price, Increase</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPreferredStockConversionProvision" xlink:label="SRNA_PercentageOfPreferredStockConversionProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfPreferredStockConversionProvision" xlink:to="SRNA_PercentageOfPreferredStockConversionProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PercentageOfPreferredStockConversionProvision_lbl" xml:lang="en-US">Percentage of preferred stock conversion provision</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfCommonStockReserve" xlink:label="SRNA_PercentageOfCommonStockReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfCommonStockReserve" xlink:to="SRNA_PercentageOfCommonStockReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PercentageOfCommonStockReserve_lbl" xml:lang="en-US">Percentage of common stock reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="us-gaap_PreferredStockValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValueOutstanding" xlink:to="us-gaap_PreferredStockValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValueOutstanding_lbl" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_lbl" xml:lang="en-US">Debt Instrument, Convertible, Liquidation Preference, Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemableShares" xlink:label="SRNA_DebtInstrumentRedeemableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedeemableShares" xlink:to="SRNA_DebtInstrumentRedeemableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DebtInstrumentRedeemableShares_lbl" xml:lang="en-US">Redeemable shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:label="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:to="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon_lbl" xml:lang="en-US">Redemption price percentage dividend due thereon</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_lbl" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemptionStatedValue" xlink:label="SRNA_DebtInstrumentRedeemptionStatedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedeemptionStatedValue" xlink:to="SRNA_DebtInstrumentRedeemptionStatedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DebtInstrumentRedeemptionStatedValue_lbl" xml:lang="en-US">Debt instrument redeemption stated value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:to="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_lbl" xml:lang="en-US">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IssuanceOfCommonStockExercisePercentageProvision" xlink:label="SRNA_IssuanceOfCommonStockExercisePercentageProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IssuanceOfCommonStockExercisePercentageProvision" xlink:to="SRNA_IssuanceOfCommonStockExercisePercentageProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IssuanceOfCommonStockExercisePercentageProvision_lbl" xml:lang="en-US">[custom:IssuanceOfCommonStockExercisePercentageProvision]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPlacementAgentCashFee" xlink:label="SRNA_PercentageOfPlacementAgentCashFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfPlacementAgentCashFee" xlink:to="SRNA_PercentageOfPlacementAgentCashFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PercentageOfPlacementAgentCashFee_lbl" xml:lang="en-US">Percentage of placement agent cash fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentCompanyShareholderServiceFeeExpense" xlink:label="us-gaap_InvestmentCompanyShareholderServiceFeeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentCompanyShareholderServiceFeeExpense" xlink:to="us-gaap_InvestmentCompanyShareholderServiceFeeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentCompanyShareholderServiceFeeExpense_lbl" xml:lang="en-US">Investment Company, Shareholder Service Fee Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantToPurchaseCommonStockShares" xlink:label="SRNA_WarrantToPurchaseCommonStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantToPurchaseCommonStockShares" xlink:to="SRNA_WarrantToPurchaseCommonStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantToPurchaseCommonStockShares_lbl" xml:lang="en-US">Warrants to purchase of common stock shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue" xlink:to="us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue_lbl" xml:lang="en-US">Debt Instrument, Convertible, Liquidation Preference, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_lbl" xml:lang="en-US">Proceeds from Issuance of Long-term Debt and Capital Securities, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDescription" xlink:label="us-gaap_TemporaryEquityDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDescription" xlink:to="us-gaap_TemporaryEquityDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityDescription_lbl" xml:lang="en-US">Temporary Equity, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:to="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable_doc" xml:lang="en-US">Redeemable Convertible Preferred Stock Subscription Receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemableConvertiblePreferredStockAccruedDividends" xlink:to="SRNA_RedeemableConvertiblePreferredStockAccruedDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RedeemableConvertiblePreferredStockAccruedDividends_doc" xml:lang="en-US">Redeemable Convertible Preferred Stock Accrued Dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:to="SRNA_ConvertiblePreferredStockConvertedToSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ConvertiblePreferredStockConvertedToSecurities_doc" xml:lang="en-US">Convertible Preferred Series B Stock Dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xml:lang="en-US">Fair value of vested stock options granted to directors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xml:lang="en-US">Fair value of vested stock options granted to employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:to="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_doc" xml:lang="en-US">Fair value of vested incentive stock bonuses awarded to employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_doc" xml:lang="en-US">Fair value of vested stock options accrued in 2019 and issued to employees and direstors in 2020.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xml:lang="en-US">Common shares issued in settlement of restricted stock units and award of stock bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xml:lang="en-US">Common shares issued in settlement of restricted stock units and award of stock bonuses shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockIssuedForOtherExpense" xlink:to="SRNA_CommonStockIssuedForOtherExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockIssuedForOtherExpense_doc" xml:lang="en-US">Common stock issued for other expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xml:lang="en-US">Increase decrease in lease deposit.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts" xlink:label="SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts" xlink:to="SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CashProceedsFromSaleOfPreferredStockAndWarrantsNetOfIssuanceCosts_doc" xml:lang="en-US">Cash proceeds from sale of preferred stock and warrants net of issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OptionsIssuedForAccruedEquityCompensation" xlink:to="SRNA_OptionsIssuedForAccruedEquityCompensation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OptionsIssuedForAccruedEquityCompensation_doc" xml:lang="en-US">Options issued for accrued equity compensation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SubscriptionReceivableSeriesBPreferredStock" xlink:to="SRNA_SubscriptionReceivableSeriesBPreferredStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SubscriptionReceivableSeriesBPreferredStock_doc" xml:lang="en-US">Subscription receivable - series B preferred stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsIssuedWithPreferredStockFinancing" xlink:label="SRNA_WarrantsIssuedWithPreferredStockFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsIssuedWithPreferredStockFinancing" xlink:to="SRNA_WarrantsIssuedWithPreferredStockFinancing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsIssuedWithPreferredStockFinancing_doc" xml:lang="en-US">Warrants issued with preferred stock financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" xlink:to="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue_doc" xml:lang="en-US">Adjustment of carrying value of series B preferred stock to redemption value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonstockSharesToBeIssued_doc" xml:lang="en-US">Common stock shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xml:lang="en-US">Description Of Business [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xml:lang="en-US">Impact Of Covid 19 Pandemic On Our Business [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going Concern [Policy Tex Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityPolicyTextBlock" xlink:to="SRNA_TemporaryEquityPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TemporaryEquityPolicyTextBlock_doc" xml:lang="en-US">Temporary Equity [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneMember_doc" xml:lang="en-US">2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_doc" xml:lang="en-US">2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentAndSystemsSalesMember" xlink:to="SRNA_EquipmentAndSystemsSalesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EquipmentAndSystemsSalesMember_doc" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EngineeringAndOtherServicesMember_doc" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdvertisingAndMarketingExpensesMember" xlink:to="SRNA_AdvertisingAndMarketingExpensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdvertisingAndMarketingExpensesMember_doc" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProductDevelopmentCostsMember" xlink:to="SRNA_ProductDevelopmentCostsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProductDevelopmentCostsMember_doc" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="SRNA_CashBalanceTransferredToBankAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashBalanceTransferredToBankAccount" xlink:to="SRNA_CashBalanceTransferredToBankAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CashBalanceTransferredToBankAccount_doc" xml:lang="en-US">Cash balance transferred to bank account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:to="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TemporaryEquityNonCashRedemptionValueAdjustment_doc" xml:lang="en-US">Temporary Equity Non Cash Redemption Value Adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerFourMember" xlink:to="SRNA_CustomerFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerFourMember_doc" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FacilityLeaseMember_doc" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_MonthlyRentDescription_doc" xml:lang="en-US">Monthly rent description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xml:lang="en-US">Unamortized amount of tenant improvement allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeaseTerminationAgreementMember" xlink:to="SRNA_LeaseTerminationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_LeaseTerminationAgreementMember_doc" xml:lang="en-US">Lease Termination Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PrepaidInventoryExpenses_doc" xml:lang="en-US">Prepaid inventory expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InventoryMember_doc" xml:lang="en-US">Inventory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_doc" xml:lang="en-US">Number of Units, Vested but not settled .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_doc" xml:lang="en-US">Number of units, vested and settled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FormerEmployeeMember_doc" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xml:lang="en-US">Restricted stock units shares issued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xml:lang="en-US">Aggregate common shares issued upon execution of settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="SRNA_SeriesBRedeemableConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesBRedeemableConvertiblePreferredStockMember_doc" xml:lang="en-US">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityNetProceeds" xlink:to="SRNA_TemporaryEquityNetProceeds_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TemporaryEquityNetProceeds_doc" xml:lang="en-US">Temporary Equity Net Proceeds.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityTextBlock" xlink:to="SRNA_TemporaryEquityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TemporaryEquityTextBlock_doc" xml:lang="en-US">Temporary [Equity Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfPreferredStockConversionProvision" xlink:to="SRNA_PercentageOfPreferredStockConversionProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PercentageOfPreferredStockConversionProvision_doc" xml:lang="en-US">Percentage Of Preferred Stock Conversion Provision.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfCommonStockReserve" xlink:to="SRNA_PercentageOfCommonStockReserve_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PercentageOfCommonStockReserve_doc" xml:lang="en-US">Percentage Of Common Stock Reserve.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedeemableShares" xlink:to="SRNA_DebtInstrumentRedeemableShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DebtInstrumentRedeemableShares_doc" xml:lang="en-US">Debt Instrument Redeemable Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:to="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon_doc" xml:lang="en-US">Debt Instrument Redemption Price Percentage Dividend Due There on.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DebtInstrumentRedeemptionStatedValue" xlink:to="SRNA_DebtInstrumentRedeemptionStatedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DebtInstrumentRedeemptionStatedValue_doc" xml:lang="en-US">Debt Instrument Redeemption Stated Value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IssuanceOfCommonStockExercisePercentageProvision" xlink:to="SRNA_IssuanceOfCommonStockExercisePercentageProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IssuanceOfCommonStockExercisePercentageProvision_doc" xml:lang="en-US">Issuance Of Common Stock Exercise Percentage Provision.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PercentageOfPlacementAgentCashFee" xlink:to="SRNA_PercentageOfPlacementAgentCashFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PercentageOfPlacementAgentCashFee_doc" xml:lang="en-US">Percentage Of Placement Agent Cash Fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantToPurchaseCommonStockShares" xlink:to="SRNA_WarrantToPurchaseCommonStockShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantToPurchaseCommonStockShares_doc" xml:lang="en-US">Warrant To Purchase Common Stock Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestorWarrantMember" xlink:to="SRNA_InvestorWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InvestorWarrantMember_doc" xml:lang="en-US">Investor Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RentalExpense" xlink:to="SRNA_RentalExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RentalExpense_doc" xml:lang="en-US">Rental Expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchaseAgreementMember" xlink:to="SRNA_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PurchaseAgreementMember_doc" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandTwentyOneEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandTwentyOneEquityPlanMember_doc" xml:lang="en-US">2021 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NonQualifiedStockOptionsMember_doc" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandAndTwentyOneEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneEquityPlanMember_doc" xml:lang="en-US">2021 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesAndConsultantsMember_doc" xml:lang="en-US">Employees And Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_doc" xml:lang="en-US">2017 Equity Plan and 2021 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DirectorsMember_doc" xml:lang="en-US">Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xml:lang="en-US">Weighted average remaining contractual term, granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_doc" xml:lang="en-US">Share based Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted Average Remaining Contractual Term, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xml:lang="en-US">Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xml:lang="en-US">Number of Options, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_doc" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited In Period Fair Value1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwentyOneEmployeesMember" xlink:to="SRNA_TwentyOneEmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwentyOneEmployeesMember_doc" xml:lang="en-US">21 Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:to="SRNA_JuneThirtyTwentyTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyTwoMember_doc" xml:lang="en-US">June 30, 2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:to="SRNA_JuneThirtyTwentyTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyThreeMember_doc" xml:lang="en-US">June 30, 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_JuneThirtyTwentyTwentyFourMember" xlink:to="SRNA_JuneThirtyTwentyTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_JuneThirtyTwentyTwentyFourMember_doc" xml:lang="en-US">June 30, 2024 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_doc" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">Warrants issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xml:lang="en-US">Weighted average exercise price of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants issued.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssueWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Issue Weighted Average Remaining Contractual Terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, ending balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Sharebased Compensation Arrangement  By Sharebased Payment Award NonOptions Issued Weighted Average Remaining Contractual Terms.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">Warrants exercised during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted average exercise price of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">Warrants expired during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted average exercise price of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeMember_doc" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeOneMember_doc" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xml:lang="en-US">Net operating loss carry forward expected to expire amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossExpirationTerm_doc" xml:lang="en-US">Net operating loss expiration term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xml:lang="en-US">NOLs usage against taxable income percentage.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NolsCarryforwardsTermDescription" xlink:label="SRNA_NolsCarryforwardsTermDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTermDescription" xlink:to="SRNA_NolsCarryforwardsTermDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsCarryforwardsTermDescription_doc" xml:lang="en-US">NOLs carryforwards term Description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants_doc" xml:lang="en-US">Adjustments To Additional Paid In Capital Issuance Of Series B Preferred Stock And Warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue_doc" xml:lang="en-US">Adjustments To Additional Paid In Capital Redemption Value.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesAPreferredStockValue" xlink:label="SRNA_SeriesAPreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesAPreferredStockValue" xlink:to="SRNA_SeriesAPreferredStockValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesAPreferredStockValue_doc" xml:lang="en-US">Series A Preferred Stock Value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CoFoundersMember" xlink:to="SRNA_CoFoundersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CoFoundersMember_doc" xml:lang="en-US">Co-Founders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:to="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_doc" xml:lang="en-US">Equipment, Demonstration and Product Testing Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidLeaseFees" xlink:to="SRNA_UnpaidLeaseFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnpaidLeaseFees_doc" xml:lang="en-US">Unpaid lease fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidDemoAndTestingFees" xlink:to="SRNA_UnpaidDemoAndTestingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnpaidDemoAndTestingFees_doc" xml:lang="en-US">Unpaid demo and Testing Fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeasedEquipmentMember" xlink:to="SRNA_LeasedEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_LeasedEquipmentMember_doc" xml:lang="en-US">Leased Equipment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOfImpactOfForegoingItemCharge" xlink:to="SRNA_NetOfImpactOfForegoingItemCharge_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge_doc" xml:lang="en-US">Net of impact of foregoing item charge.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmploymentAgreementMember" xlink:to="SRNA_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_doc" xml:lang="en-US">Number of shares vested and to be settled with issued shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:to="SRNA_AprilThirtyTwoThousandAndTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember_doc" xml:lang="en-US">April 30, 2020 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConsultingAgreementMember" xlink:to="SRNA_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MrJamesRShipleyMember" xlink:to="SRNA_MrJamesRShipleyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_MrJamesRShipleyMember_doc" xml:lang="en-US">Mr. James R. Shipley [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_doc" xml:lang="en-US">Number of common stock shares issued in settlement of vested restricted stock, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeeMember" xlink:to="SRNA_EmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeeMember_doc" xml:lang="en-US">Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_doc" xml:lang="en-US">Number of shares issued for stock incentive bonus.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsMember" xlink:to="SRNA_IndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IndependentDirectorsMember_doc" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IndependentDirectorsOneMember_doc" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_doc" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xml:lang="en-US">Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfInvestmentUnitOffered" xlink:to="SRNA_NumberOfInvestmentUnitOffered_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfInvestmentUnitOffered_doc" xml:lang="en-US">Number of investment unit offered.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoWarrantsMember" xlink:to="SRNA_SeriesTwoWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesTwoWarrantsMember_doc" xml:lang="en-US">Series 2 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfferedInvestmentsPricePerUnit" xlink:to="SRNA_OfferedInvestmentsPricePerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OfferedInvestmentsPricePerUnit_doc" xml:lang="en-US">Offered investments, price per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoConvertibleNotesMember" xlink:to="SRNA_SeriesTwoConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesTwoConvertibleNotesMember_doc" xml:lang="en-US">Series 2 Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_GainOnForgivenessOfNotePayable_doc" xml:lang="en-US">Gain On Forgiveness Of Note Payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:label="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:to="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_doc" xml:lang="en-US">Increase Decrease Operating Lease Liability Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestmentBankMember" xlink:to="SRNA_InvestmentBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InvestmentBankMember_doc" xml:lang="en-US">Investment Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantDescription" xlink:to="SRNA_WarrantDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantDescription_doc" xml:lang="en-US">Warrant description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QOneTwoThousandSeventeenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember_doc" xml:lang="en-US">Q1 2017 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestment" xlink:to="SRNA_ProceedsFromInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProceedsFromInvestment_doc" xml:lang="en-US">Proceeds from investment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestmentPerUnit" xlink:to="SRNA_ProceedsFromInvestmentPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProceedsFromInvestmentPerUnit_doc" xml:lang="en-US">Proceeds from investment per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemWarrantSharesAtPrice" xlink:to="SRNA_RedeemWarrantSharesAtPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RedeemWarrantSharesAtPrice_doc" xml:lang="en-US">Redeem warrant shares at a price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QFourTwoThousandSeventeenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember_doc" xml:lang="en-US">Q4 2017 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:to="SRNA_QTwoTwoThousandEighteenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember_doc" xml:lang="en-US">Q2 2018 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_doc" xml:lang="en-US">Other Risks And Uncertainties [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedOptionsMember" xlink:to="SRNA_UnvestedOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnvestedOptionsMember_doc" xml:lang="en-US">Unvested Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:to="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_doc" xml:lang="en-US">Stock option to purchase - thresholds - performance based.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfSharesForfeitedForTerminations" xlink:to="SRNA_NumberOfSharesForfeitedForTerminations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations_doc" xml:lang="en-US">Number of shares forfeited for terminations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:to="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xml:lang="en-US">2019 Special Equity Award [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoNewIndependentDirectorsMember" xlink:to="SRNA_TwoNewIndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoNewIndependentDirectorsMember_doc" xml:lang="en-US">Two New Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilOneTwentyTwentyOneMember" xlink:to="SRNA_AprilOneTwentyTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AprilOneTwentyTwentyOneMember_doc" xml:lang="en-US">April 1, 2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:to="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_doc" xml:lang="en-US">Share based compensation arrangement stock issued and outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_doc" xml:lang="en-US">Intrinsic value of vested and settled with issuance of share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncentiveStockBonusAwardsMember_doc" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_doc" xml:lang="en-US">Contract with customer liability revenue recognized percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OneCustomerMember" xlink:to="SRNA_OneCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OneCustomerMember_doc" xml:lang="en-US">One Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchasesOfInventoryMember" xlink:to="SRNA_PurchasesOfInventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PurchasesOfInventoryMember_doc" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierOneMember" xlink:to="SRNA_SupplierOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierOneMember_doc" xml:lang="en-US">Supplier One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierTwoMember" xlink:to="SRNA_SupplierTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierTwoMember_doc" xml:lang="en-US">Supplier Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierThreeMember" xlink:to="SRNA_SupplierThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierThreeMember_doc" xml:lang="en-US">Supplier Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:to="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_doc" xml:lang="en-US">2020 Incentive Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsCarryforwardsTerm_doc" xml:lang="en-US">NOLs carryforwards term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WebSiteDevelopmentCostsMember" xlink:to="SRNA_WebSiteDevelopmentCostsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WebSiteDevelopmentCostsMember_doc" xml:lang="en-US">Web Site Development Costs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ThreeCustomersMember" xlink:to="SRNA_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DecreaseInRevenuePercentage" xlink:to="SRNA_DecreaseInRevenuePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DecreaseInRevenuePercentage_doc" xml:lang="en-US">Decrease in revenue percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WorkingCapitalDeficit" xlink:to="SRNA_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:to="SRNA_IncomeTaxReconciliationTrueUpAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments_doc" xml:lang="en-US">Income tax reconciliation True-up adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AgreementWithLandLordMember" xlink:to="SRNA_AgreementWithLandLordMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AgreementWithLandLordMember_doc" xml:lang="en-US">Agreement with Landlord [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_doc" xml:lang="en-US">Weighted average remaining contractual term, expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_doc" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xml:lang="en-US">Weighted Average Grant Date Fair Value, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_doc" xml:lang="en-US">Number of non-vested options outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_doc" xml:lang="en-US">Weighted average grant-date fair value of non-vested options outstanding.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_doc" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual terms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" xlink:to="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PreferredAndCommonStockNoteDisclosureTextBlock_doc" xml:lang="en-US">Preferred and common stock disclosure text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_doc" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ReverseStockSplitPolicyTextBlock" xlink:to="SRNA_ReverseStockSplitPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ReverseStockSplitPolicyTextBlock_doc" xml:lang="en-US">Reverse Stock Split [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IndependentDirectorsOneMember_3_lbl" xml:lang="en-US">Independent Directors [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:to="SRNA_TwoThousandTwentyOneEquityPlanMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandTwentyOneEquityPlanMember_3_lbl" xml:lang="en-US">2021 Equity Plan [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_2_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockDividends" xlink:to="us-gaap_RedeemablePreferredStockDividends_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemablePreferredStockDividends_2_lbl" xml:lang="en-US">Redeemable Preferred Stock Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:to="SRNA_ConvertiblePreferredStockConvertedToSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ConvertiblePreferredStockConvertedToSecurities_3_lbl" xml:lang="en-US">ConvertiblePreferredStockConvertedToSecurities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonstockSharesToBeIssued_4_lbl" xml:lang="en-US">CommonstockSharesToBeIssued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_GainOnForgivenessOfNotePayable_3_lbl" xml:lang="en-US">GainOnForgivenessOfNotePayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_2_lbl" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">WarrantsDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityTextBlock" xlink:to="SRNA_TemporaryEquityTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TemporaryEquityTextBlock_3_lbl" xml:lang="en-US">TemporaryEquityTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_3_lbl" xml:lang="en-US">DescriptionOfBusinessPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_GoingConcernPolicyTextBlock_3_lbl" xml:lang="en-US">GoingConcernPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TemporaryEquityPolicyTextBlock" xlink:to="SRNA_TemporaryEquityPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TemporaryEquityPolicyTextBlock_3_lbl" xml:lang="en-US">TemporaryEquityPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_3_lbl" xml:lang="en-US">ContractWithCustomerLiabilityRevenueRecognizedPercentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_3_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>20
<FILENAME>srna-20210930_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/Cover" xlink:href="srna-20210930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210930.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20210930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20210930.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210930.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210930.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20210930.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20210930.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210930.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans" xlink:href="srna-20210930.xsd#EquityIncentivePlans" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquity" xlink:href="srna-20210930.xsd#TemporaryEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficit" xlink:href="srna-20210930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210930.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210930.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20210930.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210930.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansTables" xlink:href="srna-20210930.xsd#EquityIncentivePlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20210930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210930.xsd#ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210930.xsd#ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210930.xsd#ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20210930.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20210930.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:href="srna-20210930.xsd#ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210930.xsd#ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210930.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfInventoryDetails" xlink:href="srna-20210930.xsd#ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210930.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20210930.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210930.xsd#ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20210930.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210930.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20210930.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20210930.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210930.xsd#ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsDetailsNarrative" xlink:href="srna-20210930.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210930.xsd#SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210930.xsd#ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20210930.xsd#ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:href="srna-20210930.xsd#EquityIncentivePlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20210930.xsd#ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20210930.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:href="srna-20210930.xsd#TemporaryEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:href="srna-20210930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityPreferredCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:label="loc_SRNARedeemableConvertiblePreferredStockSubscriptionReceivable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_SRNARedeemableConvertiblePreferredStockSubscriptionReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemableConvertiblePreferredStockAccruedDividends" xlink:label="loc_SRNARedeemableConvertiblePreferredStockAccruedDividends" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_SRNARedeemableConvertiblePreferredStockAccruedDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="loc_us-gaapRedeemablePreferredStockDividends" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRedeemablePreferredStockDividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConvertiblePreferredStockConvertedToSecurities" xlink:label="loc_SRNAConvertiblePreferredStockConvertedToSecurities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_SRNAConvertiblePreferredStockConvertedToSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalRedemptionValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="loc_SRNAGainOnForgivenessOfNotePayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SRNAGainOnForgivenessOfNotePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CommonStockIssuedForOtherExpense" xlink:label="loc_SRNACommonStockIssuedForOtherExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SRNACommonStockIssuedForOtherExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" xlink:label="loc_SRNAAdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_SRNAAdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SubscriptionReceivableSeriesBPreferredStock" xlink:label="loc_SRNASubscriptionReceivableSeriesBPreferredStock" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_SRNASubscriptionReceivableSeriesBPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OptionsIssuedForAccruedEquityCompensation" xlink:label="loc_SRNAOptionsIssuedForAccruedEquityCompensation" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_SRNAOptionsIssuedForAccruedEquityCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaapDividends" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapDividends" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosurePreferredAndCommonStockAbstract" xlink:label="loc_SRNADisclosurePreferredAndCommonStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PreferredAndCommonStockNoteDisclosureTextBlock" xlink:label="loc_SRNAPreferredAndCommonStockNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosurePreferredAndCommonStockAbstract" xlink:to="loc_SRNAPreferredAndCommonStockNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000019 - Disclosure - Warrants">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="loc_SRNAWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans" xlink:title="00000020 - Disclosure - Equity Incentive Plans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquity" xlink:title="00000023 - Disclosure - Temporary Equity">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureTemporaryEquityAbstract" xlink:label="loc_SRNADisclosureTemporaryEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityTextBlock" xlink:label="loc_SRNATemporaryEquityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureTemporaryEquityAbstract" xlink:to="loc_SRNATemporaryEquityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficit" xlink:title="00000024 - Disclosure - Stockholders&#8217; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ReverseStockSplitPolicyTextBlock" xlink:label="loc_SRNAReverseStockSplitPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAReverseStockSplitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaapReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="loc_SRNAOtherRisksAndUncertaintiesPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAOtherRisksAndUncertaintiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="loc_SRNADescriptionOfBusinessPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNADescriptionOfBusinessPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="loc_SRNAGoingConcernPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAGoingConcernPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityPolicyTextBlock" xlink:label="loc_SRNATemporaryEquityPolicyTextBlock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNATemporaryEquityPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000027 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000028 - Disclosure - Inventory (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000029 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000030 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000032 - Disclosure - Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansTables" xlink:title="00000033 - Disclosure - Equity Incentive Plans (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000034 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRevenueBySourceDetails" xlink:title="00000035 - Disclosure - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="loc_SRNAEquipmentAndSystemsSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEquipmentAndSystemsSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AdvertisingAndMarketingExpensesMember" xlink:label="loc_SRNAAdvertisingAndMarketingExpensesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAAdvertisingAndMarketingExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProductDevelopmentCostsMember" xlink:label="loc_SRNAProductDevelopmentCostsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAProductDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="loc_us-gaapChangeInAccountingEstimateByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapChangeInAccountingEstimateByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="loc_us-gaapInventoryValuationAndObsolescenceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:to="loc_us-gaapInventoryValuationAndObsolescenceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrderOrProductionBacklogMember" xlink:label="loc_us-gaapOrderOrProductionBacklogMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOrderOrProductionBacklogMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardDateAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="loc_SRNAPurchasesOfInventoryMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_SRNAPurchasesOfInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OneCustomerMember" xlink:label="loc_SRNAOneCustomerMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNAOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CustomerFourMember" xlink:label="loc_SRNACustomerFourMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierOneMember" xlink:label="loc_SRNASupplierOneMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierTwoMember" xlink:label="loc_SRNASupplierTwoMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SupplierThreeMember" xlink:label="loc_SRNASupplierThreeMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapPlanNameAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInventoryAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapProductWarrantyAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:label="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DecreaseInRevenuePercentage" xlink:label="loc_SRNADecreaseInRevenuePercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_SRNADecreaseInRevenuePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WorkingCapitalDeficit" xlink:label="loc_SRNAWorkingCapitalDeficit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_SRNAWorkingCapitalDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfLeaseCostDetails" xlink:title="00000040 - Disclosure - Schedule of Lease Cost (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000042 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureLeasesAbstract" xlink:label="loc_SRNADisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AgreementWithLandLordMember" xlink:label="loc_SRNAAgreementWithLandLordMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAAgreementWithLandLordMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeaseTerminationAgreementMember" xlink:label="loc_SRNALeaseTerminationAgreementMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNALeaseTerminationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredRentCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTenantImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAMonthlyRentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RentalExpense" xlink:label="loc_SRNARentalExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfInventoryDetails" xlink:title="00000043 - Disclosure - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000044 - Disclosure - Inventory (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="loc_SRNAPrepaidInventoryExpenses" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_SRNAPrepaidInventoryExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000045 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000046 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000047 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000048 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ThreeCustomersMember" xlink:label="loc_SRNAThreeCustomersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_SRNAThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:label="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableModificationsLineItems" xlink:label="loc_us-gaapFinancingReceivableModificationsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="loc_us-gaapFinancingReceivableModificationsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFinancingReceivableTroubledDebtRestructuringsTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancingReceivableModificationsLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmploymentAgreementMember" xlink:label="loc_SRNAEmploymentAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_LeasedEquipmentMember" xlink:label="loc_SRNALeasedEquipmentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNALeasedEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="loc_SRNAAprilThirtyTwoThousandAndTwentyMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilThirtyTwoThousandAndTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidLeaseFees" xlink:label="loc_SRNAUnpaidLeaseFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAUnpaidLeaseFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="loc_SRNAUnpaidDemoAndTestingFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAUnpaidDemoAndTestingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="loc_SRNANetOfImpactOfForegoingItemCharge" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANetOfImpactOfForegoingItemCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaapSalariesWagesAndOfficersCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSalariesWagesAndOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000053 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaapLitigationSettlementExpense" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapLitigationSettlementExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000054 - Disclosure - Preferred and Common Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosurePreferredAndCommonStockAbstract" xlink:label="loc_SRNADisclosurePreferredAndCommonStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosurePreferredAndCommonStockAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeeMember" xlink:label="loc_SRNAEmployeeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="loc_SRNAClassOfWarrantOrRightIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="loc_SRNAClassOfWarrantOrRightExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="loc_SRNAClassOfWarrantOrRightExpired" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="00000056 - Disclosure - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsDetailsNarrative" xlink:title="00000057 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureWarrantsAbstract" xlink:label="loc_SRNADisclosureWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="loc_SRNASeriesTwoWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNASeriesTwoWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQOneTwoThousandSeventeenWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQOneTwoThousandSeventeenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQFourTwoThousandSeventeenWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQFourTwoThousandSeventeenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="loc_SRNAQTwoTwoThousandEighteenWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQTwoTwoThousandEighteenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="loc_SRNASeriesTwoConvertibleNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SRNASeriesTwoConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestmentBankMember" xlink:label="loc_SRNAInvestmentBankMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SRNAInvestmentBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="loc_SRNANumberOfInvestmentUnitOffered" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfInvestmentUnitOffered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="loc_SRNAOfferedInvestmentsPricePerUnit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAOfferedInvestmentsPricePerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantDescription" xlink:label="loc_SRNAWarrantDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestment" xlink:label="loc_SRNAProceedsFromInvestment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="loc_SRNAProceedsFromInvestmentPerUnit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestmentPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="loc_SRNARedeemWarrantSharesAtPrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARedeemWarrantSharesAtPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_3" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_3" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlansDetailsNarrative" xlink:title="00000062 - Disclosure - Equity Incentive Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneEquityPlanMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneEquityPlanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityPlanMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="loc_SRNATwoNewIndependentDirectorsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNATwoNewIndependentDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_UnvestedOptionsMember" xlink:label="loc_SRNAUnvestedOptionsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAUnvestedOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndTwentyOneEquityPlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityPlanMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwentyOneEmployeesMember" xlink:label="loc_SRNATwentyOneEmployeesMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNATwentyOneEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="loc_SRNAAprilOneTwentyTwentyOneMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilOneTwentyTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_2" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyTwoMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyTwoMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyThreeMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyThreeMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_JuneThirtyTwentyTwentyFourMember" xlink:label="loc_SRNAJuneThirtyTwentyTwentyFourMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_SRNAJuneThirtyTwentyTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="loc_SRNANumberOfSharesForfeitedForTerminations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfSharesForfeitedForTerminations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:label="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="loc_SRNANetOperatingLossExpirationTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossExpirationTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="loc_SRNANolsUsageAgainstTaxableIncomePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsUsageAgainstTaxableIncomePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="loc_SRNANolsCarryforwardsTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsCarryforwardsTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000066 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:label="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReplacementReserveEscrow" xlink:label="loc_us-gaapReplacementReserveEscrow" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapReplacementReserveEscrow" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/TemporaryEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Temporary Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DisclosureTemporaryEquityAbstract" xlink:label="loc_SRNADisclosureTemporaryEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNADisclosureTemporaryEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SRNASeriesBRedeemableConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="loc_us-gaapConvertiblePreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_InvestorWarrantMember" xlink:label="loc_SRNAInvestorWarrantMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_SRNAInvestorWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsMember" xlink:label="loc_us-gaapEquityMethodInvestmentsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapEquityMethodInvestmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNetProceeds" xlink:label="loc_SRNATemporaryEquityNetProceeds" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNATemporaryEquityNetProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit" xlink:label="loc_us-gaapEscrowDeposit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEscrowDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockConvertibleConversionPriceIncrease" xlink:label="loc_us-gaapCommonStockConvertibleConversionPriceIncrease" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockConvertibleConversionPriceIncrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPreferredStockConversionProvision" xlink:label="loc_SRNAPercentageOfPreferredStockConversionProvision" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfPreferredStockConversionProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfCommonStockReserve" xlink:label="loc_SRNAPercentageOfCommonStockReserve" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfCommonStockReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValueOutstanding" xlink:label="loc_us-gaapPreferredStockValueOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValueOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentage" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:label="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferencePerShare" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemableShares" xlink:label="loc_SRNADebtInstrumentRedeemableShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedeemableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:label="loc_SRNADebtInstrumentRedemptionPricePercentageDividendDueThereon" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedemptionPricePercentageDividendDueThereon" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaapDebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_DebtInstrumentRedeemptionStatedValue" xlink:label="loc_SRNADebtInstrumentRedeemptionStatedValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNADebtInstrumentRedeemptionStatedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:label="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_IssuanceOfCommonStockExercisePercentageProvision" xlink:label="loc_SRNAIssuanceOfCommonStockExercisePercentageProvision" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAIssuanceOfCommonStockExercisePercentageProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PercentageOfPlacementAgentCashFee" xlink:label="loc_SRNAPercentageOfPlacementAgentCashFee" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAPercentageOfPlacementAgentCashFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentCompanyShareholderServiceFeeExpense" xlink:label="loc_us-gaapInvestmentCompanyShareholderServiceFeeExpense" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentCompanyShareholderServiceFeeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_WarrantToPurchaseCommonStockShares" xlink:label="loc_SRNAWarrantToPurchaseCommonStockShares" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantToPurchaseCommonStockShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue" xlink:label="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferenceValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleLiquidationPreferenceValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_TemporaryEquityNonCashRedemptionValueAdjustment" xlink:label="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNATemporaryEquityNonCashRedemptionValueAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:label="loc_us-gaapProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDescription" xlink:label="loc_us-gaapTemporaryEquityDescription" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000068 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_PurchaseAgreementMember" xlink:label="loc_SRNAPurchaseAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:label="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityAggregateAmountOfRedemptionRequirement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210930.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872083768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT NO. 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CEA
Industries Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001482541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3911608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">385
South Pierce Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
C<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">993-5271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328863957752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,283,879<span></span>
</td>
<td class="nump">$ 2,284,881<span></span>
</td>
<td class="nump">$ 922,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowance for doubtful accounts of $186,073 and $165,098, respectively)</a></td>
<td class="nump">32,245<span></span>
</td>
<td class="nump">33,480<span></span>
</td>
<td class="nump">138,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">480,354<span></span>
</td>
<td class="nump">327,109<span></span>
</td>
<td class="nump">1,231,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,157,119<span></span>
</td>
<td class="nump">1,037,823<span></span>
</td>
<td class="nump">269,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">3,953,597<span></span>
</td>
<td class="nump">3,683,293<span></span>
</td>
<td class="nump">2,561,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">98,967<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">631,064<span></span>
</td>
<td class="nump">631,064<span></span>
</td>
<td class="nump">631,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">6,792<span></span>
</td>
<td class="nump">7,227<span></span>
</td>
<td class="nump">11,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">24,183<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">194,353<span></span>
</td>
<td class="nump">343,950<span></span>
</td>
<td class="nump">534,133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Noncurrent Assets</a></td>
<td class="nump">955,359<span></span>
</td>
<td class="nump">1,129,973<span></span>
</td>
<td class="nump">1,486,050<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,908,956<span></span>
</td>
<td class="nump">4,813,266<span></span>
</td>
<td class="nump">4,047,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,674,088<span></span>
</td>
<td class="nump">1,784,961<span></span>
</td>
<td class="nump">1,832,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,059,525<span></span>
</td>
<td class="nump">3,724,189<span></span>
</td>
<td class="nump">1,444,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued equity compensation</a></td>
<td class="nump">108,945<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">238,140<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
<td class="nump">217,843<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">5,117,776<span></span>
</td>
<td class="nump">5,903,689<span></span>
</td>
<td class="nump">3,998,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NONCURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Note payable and accrued interest</a></td>
<td class="nump">517,468<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="nump">74,156<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">169,119<span></span>
</td>
<td class="nump">404,209<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Noncurrent Liabilities</a></td>
<td class="nump">554,546<span></span>
</td>
<td class="nump">243,275<span></span>
</td>
<td class="nump">404,209<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">5,672,322<span></span>
</td>
<td class="nump">6,146,964<span></span>
</td>
<td class="nump">4,402,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>TEMPORARY EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount', window );">Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 3,300 and 0 issued and outstanding, respectively</a></td>
<td class="nump">3,960,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable', window );">Series B Redeemable Convertible Preferred Stock Subscription Receivable</a></td>
<td class="num">(1,365,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemableConvertiblePreferredStockAccruedDividends', window );">Series B Redeemable Convertible Preferred Stock Accrued Dividends</a></td>
<td class="nump">1,447<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Total Temporary Equity</a></td>
<td class="nump">2,596,447<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; 150,000,000 shares authorized Series A Preferred stock, $0.00001 par value; 42,030,331 shares issued and outstanding</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 350,000,000 shares authorized; 1,583,511 and 1,576,844 shares issued and outstanding, respectively</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">25,019,425<span></span>
</td>
<td class="nump">26,109,509<span></span>
</td>
<td class="nump">25,328,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(28,379,674)<span></span>
</td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(25,684,927)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Deficit</a></td>
<td class="num">(3,359,813)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; DEFICIT</a></td>
<td class="nump">$ 4,908,956<span></span>
</td>
<td class="nump">$ 4,813,266<span></span>
</td>
<td class="nump">$ 4,047,318<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RedeemableConvertiblePreferredStockAccruedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Convertible Preferred Stock Accrued Dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RedeemableConvertiblePreferredStockAccruedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Convertible Preferred Stock Subscription Receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328867877896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts Receivable, Allowance for Credit Loss, Current</a></td>
<td class="nump">$ 186,073<span></span>
</td>
<td class="nump">$ 165,098<span></span>
</td>
<td class="nump">$ 151,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">1,583,511<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">1,583,511<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary Equity, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary Equity, Shares Issued</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864216200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 3,706,436<span></span>
</td>
<td class="nump">$ 1,634,669<span></span>
</td>
<td class="nump">$ 10,582,470<span></span>
</td>
<td class="nump">$ 5,127,018<span></span>
</td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">$ 15,224,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">2,959,264<span></span>
</td>
<td class="nump">1,108,758<span></span>
</td>
<td class="nump">8,208,368<span></span>
</td>
<td class="nump">3,869,758<span></span>
</td>
<td class="nump">6,961,305<span></span>
</td>
<td class="nump">10,675,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">747,172<span></span>
</td>
<td class="nump">525,911<span></span>
</td>
<td class="nump">2,374,102<span></span>
</td>
<td class="nump">1,257,260<span></span>
</td>
<td class="nump">1,552,967<span></span>
</td>
<td class="nump">4,548,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing expenses</a></td>
<td class="nump">224,393<span></span>
</td>
<td class="nump">89,695<span></span>
</td>
<td class="nump">569,580<span></span>
</td>
<td class="nump">333,669<span></span>
</td>
<td class="nump">430,012<span></span>
</td>
<td class="nump">675,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">98,623<span></span>
</td>
<td class="nump">84,433<span></span>
</td>
<td class="nump">322,807<span></span>
</td>
<td class="nump">304,229<span></span>
</td>
<td class="nump">390,229<span></span>
</td>
<td class="nump">521,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">866,699<span></span>
</td>
<td class="nump">634,447<span></span>
</td>
<td class="nump">2,493,930<span></span>
</td>
<td class="nump">2,453,976<span></span>
</td>
<td class="nump">3,095,350<span></span>
</td>
<td class="nump">4,662,695<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,189,715<span></span>
</td>
<td class="nump">808,575<span></span>
</td>
<td class="nump">3,386,317<span></span>
</td>
<td class="nump">3,091,874<span></span>
</td>
<td class="nump">3,915,591<span></span>
</td>
<td class="nump">5,859,442<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(442,543)<span></span>
</td>
<td class="num">(282,664)<span></span>
</td>
<td class="num">(1,012,215)<span></span>
</td>
<td class="num">(1,834,614)<span></span>
</td>
<td class="num">(2,362,624)<span></span>
</td>
<td class="num">(1,310,589)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">35,934<span></span>
</td>
<td class="nump">13,621<span></span>
</td>
<td class="nump">79,452<span></span>
</td>
<td class="nump">29,018<span></span>
</td>
<td class="nump">621,340<span></span>
</td>
<td class="num">(27,977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,296)<span></span>
</td>
<td class="num">(1,396)<span></span>
</td>
<td class="num">(3,268)<span></span>
</td>
<td class="num">(16,673)<span></span>
</td>
<td class="num">(17,432)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">34,638<span></span>
</td>
<td class="nump">12,225<span></span>
</td>
<td class="nump">76,184<span></span>
</td>
<td class="nump">12,345<span></span>
</td>
<td class="nump">603,908<span></span>
</td>
<td class="num">(27,977)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(407,905)<span></span>
</td>
<td class="num">(270,439)<span></span>
</td>
<td class="num">(936,031)<span></span>
</td>
<td class="num">(1,822,269)<span></span>
</td>
<td class="num">(1,758,716)<span></span>
</td>
<td class="num">(1,338,566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(407,905)<span></span>
</td>
<td class="num">(270,439)<span></span>
</td>
<td class="num">(936,031)<span></span>
</td>
<td class="num">(1,822,269)<span></span>
</td>
<td class="num">$ (1,758,716)<span></span>
</td>
<td class="num">$ (1,338,566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Convertible Preferred Series B Stock Redemption Value Adjustment</a></td>
<td class="num">(2,262,847)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,262,847)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ConvertiblePreferredStockConvertedToSecurities', window );">Convertible Preferred Series B Stock Dividends</a></td>
<td class="num">(1,447)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss Available to Common Shareholders</a></td>
<td class="num">$ (2,672,199)<span></span>
</td>
<td class="num">$ (270,439)<span></span>
</td>
<td class="num">$ (3,200,325)<span></span>
</td>
<td class="num">$ (1,822,269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share &#8211; basic and dilutive</a></td>
<td class="num">$ (1.69)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (2.02)<span></span>
</td>
<td class="num">$ (1.16)<span></span>
</td>
<td class="num">$ (1.12)<span></span>
</td>
<td class="num">$ (0.88)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding, basic and dilutive</a></td>
<td class="nump">1,583,511<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="nump">1,581,142<span></span>
</td>
<td class="nump">1,564,746<span></span>
</td>
<td class="nump">1,574,454<span></span>
</td>
<td class="nump">1,517,748<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ConvertiblePreferredStockConvertedToSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Series B Stock Dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ConvertiblePreferredStockConvertedToSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328865496648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Shareholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th">
<div>Preferred Stock [Member] </div>
<div>Series A Preferred Stock [Member]</div>
</th>
<th class="th" colspan="2"><div>Common Stock [Member]</div></th>
<th class="th" colspan="2"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 24,540,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (24,346,361)<span></span>
</td>
<td class="nump">$ 194,336<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2018</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,499,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Beginning balance, shares to be issued at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,933<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">75,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common shares issued as compensation for services, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,579<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">278,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">278,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">390,484<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">390,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees', window );">Fair value of vested incentive stock bonuses awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">44,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">44,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,338,566)<span></span>
</td>
<td class="num">(1,338,566)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,328,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(25,684,927)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,400)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued', window );">Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">503,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued in settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares', window );">Common shares issued in settlement of restricted stock units and award of stock bonuses, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">227,594<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">227,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,822,269)<span></span>
</td>
<td class="num">(1,822,269)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,085,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,507,196)<span></span>
</td>
<td class="num">(1,421,677)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,328,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(25,684,927)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Beginning balance, shares to be issued at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,400)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued', window );">Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">503,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">252,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">252,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,758,716)<span></span>
</td>
<td class="num">(1,758,716)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,109,509<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,060,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,236,757)<span></span>
</td>
<td class="num">(1,175,664)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Beginning balance, shares to be issued at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,426<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">24,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(270,439)<span></span>
</td>
<td class="num">(270,439)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,085,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,507,196)<span></span>
</td>
<td class="num">(1,421,677)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,109,509<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Beginning balance, shares to be issued at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute', window );">Common shares issued in settlement of legal dispute</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">67,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares', window );">Common shares to be issued in settlement of legal dispute, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">158,315<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">158,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants', window );">Issuance of series B preferred stock and warrants, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">927,721<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">927,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Accrued dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,447)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue', window );">Adjustment to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,262,847)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,262,847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(936,031)<span></span>
</td>
<td class="num">(936,031)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,019,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,379,674)<span></span>
</td>
<td class="num">(3,359,813)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,326,691<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,971,769)<span></span>
</td>
<td class="num">(1,644,642)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Beginning balance, shares to be issued at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,545<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants', window );">Issuance of series B preferred stock and warrants, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">927,721<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">927,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Accrued dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,447)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue', window );">Adjustment to redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,262,847)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,262,847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(407,905)<span></span>
</td>
<td class="num">(407,905)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,019,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (28,379,674)<span></span>
</td>
<td class="num">$ (3,359,813)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Ending balance, shares to be issued at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">represents an amount less than $1.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Issuance Of Series B Preferred Stock And Warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Redemption Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options accrued in 2019 and issued to employees and direstors in 2020.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued in settlement of restricted stock units and award of stock bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued in settlement of restricted stock units and award of stock bonuses shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonstockSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonstockSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested incentive stock bonuses awarded to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864340792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (936,031)<span></span>
</td>
<td class="num">$ (1,822,269)<span></span>
</td>
<td class="num">$ (1,758,716)<span></span>
</td>
<td class="num">$ (1,338,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and intangible asset amortization expense</a></td>
<td class="nump">54,973<span></span>
</td>
<td class="nump">90,867<span></span>
</td>
<td class="nump">120,103<span></span>
</td>
<td class="nump">161,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_GainOnForgivenessOfNotePayable', window );">Gain on forgiveness of note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557,203)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">51,055<span></span>
</td>
<td class="nump">252,757<span></span>
</td>
<td class="nump">277,183<span></span>
</td>
<td class="nump">788,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockIssuedForOtherExpense', window );">Common stock issued for other expense</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">20,975<span></span>
</td>
<td class="nump">13,150<span></span>
</td>
<td class="nump">13,425<span></span>
</td>
<td class="nump">32,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventory</a></td>
<td class="num">(13,764)<span></span>
</td>
<td class="num">(5,117)<span></span>
</td>
<td class="nump">21,669<span></span>
</td>
<td class="num">(223,971)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="nump">8,042<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">115,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU asset</a></td>
<td class="nump">149,597<span></span>
</td>
<td class="nump">141,871<span></span>
</td>
<td class="nump">190,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable</a></td>
<td class="num">(19,740)<span></span>
</td>
<td class="nump">27,950<span></span>
</td>
<td class="nump">91,452<span></span>
</td>
<td class="nump">39,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(139,481)<span></span>
</td>
<td class="nump">714,709<span></span>
</td>
<td class="nump">882,466<span></span>
</td>
<td class="num">(71,386)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other</a></td>
<td class="num">(119,296)<span></span>
</td>
<td class="num">(488,007)<span></span>
</td>
<td class="num">(768,333)<span></span>
</td>
<td class="num">(141,143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(110,872)<span></span>
</td>
<td class="num">(397,181)<span></span>
</td>
<td class="nump">26,157<span></span>
</td>
<td class="nump">23,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(664,663)<span></span>
</td>
<td class="nump">2,044,830<span></span>
</td>
<td class="nump">2,279,717<span></span>
</td>
<td class="nump">802,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">3,268<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,203<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncreaseDecreaseInLeaseDeposit', window );">Lease deposit</a></td>
<td class="num">(24,183)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability, net</a></td>
<td class="num">(197,085)<span></span>
</td>
<td class="num">(79,521)<span></span>
</td>
<td class="num">(135,828)<span></span>
</td>
<td class="num">(20,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued equity compensation</a></td>
<td class="nump">108,945<span></span>
</td>
<td class="nump">101,472<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in)/provided by operating activities</a></td>
<td class="num">(1,761,260)<span></span>
</td>
<td class="nump">599,635<span></span>
</td>
<td class="nump">818,036<span></span>
</td>
<td class="nump">671,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(15,316)<span></span>
</td>
<td class="num">(3,500)<span></span>
</td>
<td class="num">(9,332)<span></span>
</td>
<td class="num">(3,043)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from the sale of property equipment</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(13,816)<span></span>
</td>
<td class="num">(3,500)<span></span>
</td>
<td class="num">(9,332)<span></span>
</td>
<td class="num">(3,043)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Cash proceeds from sale of preferred stock and warrants, net of issuance costs</a></td>
<td class="nump">1,259,874<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of note payable</a></td>
<td class="nump">514,200<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,774,074<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
<td class="nump">554,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="num">(1,002)<span></span>
</td>
<td class="nump">1,150,135<span></span>
</td>
<td class="nump">1,362,704<span></span>
</td>
<td class="nump">668,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,284,881<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
<td class="nump">253,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">2,283,879<span></span>
</td>
<td class="nump">2,072,312<span></span>
</td>
<td class="nump">2,284,881<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue', window );">Adjustment of carrying value of series B preferred stock to redemption value</a></td>
<td class="nump">2,262,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SubscriptionReceivableSeriesBPreferredStock', window );">Subscription receivable - series B preferred stock</a></td>
<td class="nump">1,365,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OptionsIssuedForAccruedEquityCompensation', window );">Options issued for accrued equity compensation</a></td>
<td class="nump">128,434<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Accrued dividends</a></td>
<td class="nump">$ 1,447<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment of carrying value of series B preferred stock to redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockIssuedForOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for other expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockIssuedForOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_GainOnForgivenessOfNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain On Forgiveness Of Note Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_GainOnForgivenessOfNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncreaseDecreaseInLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in lease deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncreaseDecreaseInLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OptionsIssuedForAccruedEquityCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options issued for accrued equity compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OptionsIssuedForAccruedEquityCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SubscriptionReceivableSeriesBPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subscription receivable - series B preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SubscriptionReceivableSeriesBPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872943608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--NatureOfOperations_z957nDjNG1Pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span id="xdx_824_zE8VVKCFsFLi">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and
other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing sectors
of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the
first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers,
tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming
practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems and other climate
control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and engineering commercial
scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems and technologies used
for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated CEA growers in the
U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or
retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder, Colorado, we
leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall
crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory
requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources.
Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still
allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we
were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be
predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this
uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact of the COVID-19 pandemic
to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced sales, increased losses and reduced
operating cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Refer
to <i>Risk Factors</i>, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868725832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation; Summary of Significant Accounting Policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zJymfTBHykxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_82E_zGBpC3LVnpag">Basis of Presentation; Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTcPRP4mKzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 3 Going Concern</i> below, the accompanying consolidated financial statements have been prepared on a going-concern
basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance of debt
and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar to those encountered
by similarly situated companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p id="xdx_84B_ecustom--ReverseStockSplitPolicyTextBlock_zTl66P5IWeHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zfp1oBXX6f91">Reverse
Stock Split</span></i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqon6yE9Vegg" title="Reverse stock split, Description">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span> The par value for
the Common Stock was not affected.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zs3k93Zgl0Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Principles
of Consolidation </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--UseOfEstimates_zlmaiNJEfrt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis,
valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and
legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zl86gz0nfezg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z6ql9vwpH4G1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounts
Receivable and Allowance for Doubtful Accounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest.
An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which, in management&#8217;s
judgment, deserve current recognition in estimating bad debts. Based on the Company&#8217;s review, it establishes or adjusts the allowance
for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and December 31, 2019, the allowance
for doubtful accounts was $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20201231_zdjIevpfTdKh">165,098
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_zxkw667tEk6j">151,673</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zBZYSZAY5ym6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Inventory</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#8220;FIFO&#8221;) basis.
Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other
factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence
or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis for that inventory is established
and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete inventory was $<span id="xdx_904_eus-gaap--InventoryAdjustments_c20201231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0">93,045
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--InventoryAdjustments_c20191231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0">71,376</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zmAnTf818dk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Property
and Equipment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using
the straight-line method over their estimated useful lives, which is generally <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20200101__20201231_zNah8Ikifnz3">five
years</span></span><span style="font: 10pt Times New Roman, Times, Serif">. Leasehold improvements are amortized on
a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and
related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zDncFzdzn0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Long-lived
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate
the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#8217;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending
on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December 31, 2020 and
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zKICEDwa9Pej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill
and Intangible Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December
31<sup>st</sup> or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced
to less than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing
the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its
carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount
exceeds the reporting unit&#8217;s fair value. The Company determined that it has one reporting unit. The Company completed this assessment
as of December 31, 2020 and concluded that no impairment existed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#8217;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are also subject
to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zEjfko1IosTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Fair
Value Measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring
fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes the inputs used
in the valuation methodologies in measuring fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability,
either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3 - inputs are unobservable inputs based on the Company&#8217;s assumptions used to measure assets and liabilities at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level of input that is significant
to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
in its entirety requires management to make judgments and consider factors specific to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses,
approximate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zaxVqM2qYCHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Derivative
Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded
at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;)
to value the derivative instruments. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within
twelve months of the balance sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zgCRCRGtuXb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_z4lP7SDCLJWe" style="display: none">Schedule
of Revenue by Source</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment
    and systems sales</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">7,730,371</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">13,692,863</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering
    and other services</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">568,131</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,239,130</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping
    and handling</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">215,770</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">292,461</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">8,514,272</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">15,224,454</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zGjsAig9HX6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Revenue
Recognition Accounting Policy Summary</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract
with a customer to transfer a distinct good or service to the customer. Most of the Company&#8217;s contracts contain multiple performance
obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#8217;s project life-cycle from facility design and construction to equipment
delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some
of the Company&#8217;s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate
margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the
Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange
for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical rates of return are
insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes
revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and
certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected
by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and
shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other
Judgments and Assumptions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the
effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company
transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly,
the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contract
Assets and Contract Liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to
payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based
on the terms established in its contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional,
subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019, the
Company had no contract assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&#8217;s contract liabilities are recorded as a current
liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is
generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which was classified as a current liability,
was $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_c20201231_pp0p0">3,724,189</span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_c20191231_pp0p0">1,444,472</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, the Company recognized revenue of $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20201231_pp0p0">1,103,447
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2020, or <span id="xdx_90D_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20200101__20201231_zHtCzzzTCDCe">76%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
For the year ended December 31, 2019, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190101__20191231_pp0p0">473,682
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2019, or <span id="xdx_90A_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20190101__20191231_zq9x62DeXgN3" title="Deferred revenue">74%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining
Performance Obligations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate,
the uncertainty regarding the COVID-19 virus, and the Company&#8217;s recent cost cutting measures, there is no assurance that the Company
will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_c20201231_pp0p0">8,448,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0">2,643,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20201231_z30QSaSK844a">31%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-COVID-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at December 31, 2020, includes booked sales orders of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0">390,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus
COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to engineering only paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,355,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,643,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to partial equipment paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,703,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,805,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    remaining performance obligations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,058,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">390,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A7_zeRp94luEPKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_eus-gaap--StandardProductWarrantyPolicy_zxr65VYWAhla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Warranty</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company&#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&#8217;s option)
that fail to perform within stated specification. The Company&#8217;s third-party suppliers also warrant their products under similar
terms, which are passed through to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231" style="font: 10pt Times New Roman, Times, Serif">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.</span> <span style="font: 10pt Times New Roman, Times, Serif">The Company continues to
assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of December 31, 2020,
and December 31, 2019, the Company had an accrued warranty reserve amount of $<span id="xdx_90F_eus-gaap--ProductWarrantyAccrual_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0">173,365
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--ProductWarrantyAccrual_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0">185,234</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, which are included in accounts payable and accrued liabilities on the Company&#8217;s consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zEcqOoSPJnV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cost
of Sales</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs,
engineering, project management and service salaries and benefits, client visits and warranty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_znT1zQ2fQ3V3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7EXjLtBKGU">28%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUkoZNs5WGZd">11%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwGAS5FHOBnk">10%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2020. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZAensU29mbg">44%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s accounts receivable from two customers made up <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxScHmlvski4">48%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zA7ejDrKZqO8">38%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2020. The Company&#8217;s accounts receivable from three customers made up <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAipeN8Z20e6">59%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zXsXKQk317Hh">16%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z47qSd94Iapd">10%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
suppliers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_z0mqrL4McdJk">27%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_z4ZomONCErN7">25%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zwt5jRpeus13">12%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2020, and three suppliers accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_zBQ2j3z3t6Ic">30%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_zdHzBgLUz9J9">17%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zHfGZV1KqW99">12%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_zG7r1p9byb8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For the
years ended December 31, 2020 and December 31, 2019, the Company incurred $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pp0p0">390,229
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20190101__20191231_pp0p0">521,044</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, on product development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvislvwPapy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on
their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on
a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are
recognized ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the probability
assessment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the award
between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the
service inception date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the
award between the Company and the recipient has not yet been established. For awards in which the service inception date precedes the
grant date, compensation cost is accrued beginning on the service inception date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Subsequent
to December 31, 2020, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved annual incentive compensation awards
to certain employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020, were
not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of the annual
incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to the employee, subsequent
to December 31, 2020. The estimated compensation expense of $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyIncentiveAwardsMember_pp0p0">128,434
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the 2020 incentive awards was accrued
as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation expense
has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant by the Board.
At that time, the incentive award becomes equity-classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates
whose term is consistent with the expected term of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0">405,617
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0">1,292,065
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively. Such share-based compensation costs are classified in the Company&#8217;s consolidated financial statements in the same
manner as if such compensation was paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Share-based Compensation Costs&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation expense included in:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost
    of revenue</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">31,006</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">91,081</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">8,333</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">33,977</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">21,882</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">45,330</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">344,396</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,121,677</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    share-based compensation expense included in consolidated statement of operations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">405,617</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,292,065</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p id="xdx_8A2_znBGzekj8KMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zZFabdYGDZd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets
and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change
in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized.
In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company
determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company
would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely
than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions
that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely
than not to be realized upon ultimate settlement with the related tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zBNKrztrBhN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basic
and Diluted Net Loss per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in periods
when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist
of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.
As of December 31, 2020, <span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20201231_zgkHDLjgCbZd">194,757
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential common shares equivalents from
warrants and options were excluded from the diluted EPS calculations as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zwYc4ooBD3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commitments
and Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its
business, that cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters.
An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred
and the amount of loss can be reasonably estimated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p id="xdx_849_ecustom--OtherRisksAndUncertaintiesPolicyTextBlock_zQGam3vB1Cz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Risks and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that
such products will be successfully marketed. These factors could have a material adverse effect upon the Company&#8217;s financial results,
financial position, and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#8217;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty of
market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and equipment
to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states have legalized
medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well as its derivatives. Any
changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local cannabis laws and regulations
that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#8217;s customers. The Company&#8217;s
success is also dependent upon its ability to raise additional capital and to successfully develop and market its products. See Note
3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaIrUYsyqDmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Segment
Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the Company&#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zi6trV1w80E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06: &#8220;<i>Accounting for Convertible Instruments and Contracts In An Entity&#8217;s Own Equity&#8221;
(&#8220;ASU 2020-06&#8221;)</i> ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation
models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by requiring
the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04 using either
a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning after December 15,
2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020. The Company does not expect
this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation; Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zUTsGew1ld59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
1 &#8211; <span>General</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<b><span id="xdx_826_zJF70d4qYexf" style="display: none">Basis
of Presentation; Summary of Significant Accounting Policies</span></b></span></p>

<p id="xdx_840_ecustom--DescriptionOfBusinessPolicyTextBlock_zCrEyYE0LZM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zpXOwa8Kf3E7" style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under the trade name of Surna Cultivation
Technologies. We are headquartered in Boulder, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled
Environment Agriculture (CEA) industry. We leverage our experience in this space to bring value-added technology solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy evolving state and local construction
codes, permitting and regulatory requirements. In service of the CEA industry, our principal service and product offerings include: (i)
architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based
process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting
and climate control, and (vi) preventive maintenance services for CEA facilities. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada and other international locations. Customers are those growers building new facilities and those expanding
or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities operating in the cannabis industry, ranging from several thousand to more than <span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20210930__srt--RangeAxis__srt--MinimumMember_z9XF0A7t1rH6">100,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet. Although most of our customers do,
we neither produce nor sell cannabis or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zJ5g1hjT3xui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_862_zRL47ZLChTta" style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, a general shortage of containers, and domestic truck driver availability.
While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue
to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed
by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others
in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and
provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long
they will continue as they are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4LOmZMhz1B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zujbAruiUlK6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal
year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that
date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information,
refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December
31, 2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zUg2Ott7hvRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zDkXudJYVMFg">Reverse
Stock Split</span></i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbIYs7NwCvDd">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span> The par value for the Common Stock was not affected.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zOedN0ypY9x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86D_zLl5cOPbrYQ6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_844_ecustom--GoingConcernPolicyTextBlock_zDO8KhTKWmPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zH89du6fObc6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_848_eus-gaap--UseOfEstimates_zJVd4mMFskNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zN73GZSCE8s6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zkRbnsKyCUxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_861_zphXuS9sKzbi" style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_z6n3qvro9Dvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zPuTYzvaZqPj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were convertible into shares of the Company&#8217;s common stock. During
the three- and nine-month periods ended September 30, 2021 and 2020, the Company incurred a net loss and consequently the common share
equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such
inclusion would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, and 2020, there were respectively, <span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210930_z5pG22FYYXFe">777,888
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span style="-sec-ix-redline: true"><span><span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200930_zC71P0oJdjQ4">293,383</span>,</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zPdvc7qsrOn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zd0DSFrKazgl" style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at September 30, 2021 and concluded that no impairment
relating to goodwill existed at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_ecustom--TemporaryEquityPolicyTextBlock_zE2Zaf4pfC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zRlN1JWL87Me" style="font: 10pt Times New Roman, Times, Serif"><b><i>Temporary
Equity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Shares
of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option
of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely
within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the
issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but
not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument
will become redeemable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company determined it is probable the Series B Preferred Stock will become redeemable at the option of the holder. As a result, on September
30, 2021, the Company adjusted carrying value of the Series B Preferred Stock to its redemption value of $<span id="xdx_901_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLCQ8hlTdHog">3,960,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and recorded a $<span id="xdx_900_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrG2hH9aUMTj">2,262,847
</span></span><span style="font: 10pt Times New Roman, Times, Serif">non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes, accordingly, the redemption value adjustment
is therefore added to the &#8220;Net Loss&#8221; to arrive at &#8220;Net Loss Attributable to Common Shareholders&#8217;&#8221; on the
Company&#8217;s Consolidated Statements of Operations. In addition, as the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zCxpnpInTo8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_860_zT8U5MdyHhtg" style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and nine months ended September 30, 2021, the Company recognized revenue of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210701__20210930_pp0p0">283,452
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210930_pp0p0">3,357,068</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2021. For the three and nine months ended September 30, 2020, the Company
recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200701__20200930_pp0p0">9,141</span></span>
<span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200930_pp0p0">1,074,016</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligation_c20210930_pp0p0">9,881,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0">1,161,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20210930_zfUHZeWvm788">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic disruption or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at September 30, 2021, includes booked sales orders of $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_uUSD_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OrderOrProductionBacklogMember_zQiH5yXcW5Ol">1,250,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until late 2022. The Company believes the sales orders in this portion of our backlog have an elevated level
of risk and may, ultimately, be delayed or cancelled by our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining performance obligations
    related to engineering only paid contracts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,049,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,161,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining performance
    obligations related to partial equipment paid contracts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,091,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,629,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,720,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total remaining performance
    obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,203,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,678,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,881,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_zdZ6cVm80Sc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment and systems sales</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,523,948</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,481,961</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">9,933,313</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">4,575,855</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering and other services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">110,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">114,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">464,269</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">402,837</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping and handling</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">71,950</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">38,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">184,888</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">148,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,706,436</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,634,669</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">10,582,470</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">5,127,018</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A3_zSYfASf65Z46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfQMiP6BT2ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_zA6zAZxFgwvj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the nine months ended September 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20210101__20210930_zjmEsX3sHaI3">150.2</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20210101__20210930_zHAcn2McUsf9">152.51</span></span><span style="font: 10pt Times New Roman, Times, Serif">%;
expected term in years <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zPhzX5q4QUH2">10</span> and risk-free interest rate ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20210101__20210930_zkfR1HWzjVYc">0.55%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20210101__20210930_zs7PKLO3x2L9">1.49</span></span><span style="font: 10pt Times New Roman, Times, Serif">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Share-based Compensation Costs</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based compensation expense included in:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">6,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,944</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">23,949</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">2,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">13,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">7,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2308">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">5,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">14,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">16,332</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling, general and
    administrative expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0">29,307</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">41,221</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">102,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">306,448</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total share-based compensation
    expense included in consolidated statement of operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,307</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">55,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">160,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">354,229</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_ziNbaFNKOUKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and nine months ended September 30, 2021, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zNd3DhHNSvr2">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">108,945</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2021 Annual Employee Incentive Compensation Plan. Included in the expense for the three and nine months ended September
30, 2020, is an accrual for $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">31,575
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">101,472</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zgAxWufL4G8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zCLI7eHLyfci" style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3jKyMJ5YAS4">38</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_za4qYsaP3jh3">23</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z8bHMCB4y0h2">11</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2021 and three customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zApQM56jYBd2">25</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHTpxjPgaqK1">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1hn6lzZsVuc">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2021. Two customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPuKUHIkvXUg">39</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUGTRBLN1Dfd">30</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2020 and three customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zh5VodyGBjKh">18</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIBTh36OT6yc">17</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjBnFGuFf4Ak">11</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHhpAYN5FCRe">40</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zELcnQgAMOLf">26</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHU7QSoRrj07">22</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable as of September 30, 2021. As of September 30, 2020, four customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkftRueBQBp7">32</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zs0b7Bbnarb2">23</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zxDkjiX7Kwsj">21</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zpzVLaWk3dO8">10</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znKZgsEHZZg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_znjFYXzb42Jh" style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2021, the FASB issued ASU 2021-04, <i>Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. </i>This guidance clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges
of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective
for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively
to modifications or exchanges occurring on or after the effective date. The Company anticipates that the adoption of this guidance will
not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06,
Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company early adopted ASU 2020-06 effective January 1, 2021. The early
adoption of ASU 2020-06 impacted the Company&#8217;s accounting for the issuance of its Series B Redeemable Convertible Preferred Stock
as further discussed in <i>Note 8 Temporary Equity Series B Redeemable Convertible Preferred Stock</i> below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p id="xdx_85C_zPQM0qab7O4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872949256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z4lIc4LRbvJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_820_zqqYuD940TGg">Going Concern </span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $<span id="xdx_90C_eus-gaap--NetIncomeLoss_iN_pn3p0_di_c20200101__20201231_zJ3H4c3Lw2C5">1,759,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the year ended December 31, 2020 and had
an accumulated deficit of approximately $<span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20201231_z9pBLeLRLuL8">27,444,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and a shareholders&#8217; deficit of approximately
$<span id="xdx_906_eus-gaap--StockholdersEquity_iNI_pn3p0_di_c20201231_zWh8G2raMCXd">1,334,000</span></span> <span style="font: 10pt Times New Roman, Times, Serif">as
of December 31, 2020. Since inception, the Company has financed its activities principally through debt and equity financing, advance
payments from customers and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the
foreseeable future in connection with its operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions,
its customers&#8217; operations and prospects for and ability to obtain project financing, and market and business disruptions, that
include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding of products; uncertainty
of product development and generation of revenues; dependence on outside sources of financing; risks associated with research, development;
dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized
companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing
to fulfill its development activities and generating a level of revenues adequate to support the Company&#8217;s cost structure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&#8217;s ability to raise equity capital is also limited by the Company&#8217;s stock price, and any such
issuance could be highly dilutive to existing shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s 2020 revenue of approximately $<span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20200101__20201231_zau6RkdsqZ09">8,514,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">which represents a decrease of <span id="xdx_90A_ecustom--DecreaseInRevenuePercentage_pid_dp_uPure_c20200101__20201231_z5jXNkx94AYj">44%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">over the prior year. The Company&#8217;s revenue
recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred, and expects
to incur, additional operating expenses to support such growth. The Company generated approximately $<span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3p0_c20200101__20201231_zWkIAm3Re5T2">818,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in cash flow from operating activities in 2020.
However, as a result of the Company&#8217;s growth and its efforts to expand and upgrade its products, the Company&#8217;s working capital
deficit as of December 31, 2020 was approximately $<span id="xdx_904_ecustom--WorkingCapitalDeficit_c20201231_pp0p0">2,220,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
compared to approximately $<span id="xdx_90C_ecustom--WorkingCapitalDeficit_c20191231_pp0p0">1,437,000</span></span> <span style="font: 10pt Times New Roman, Times, Serif">as
of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced, or are
contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which COVID-19 will
impact the Company&#8217;s business and financial results will depend on future developments, which are uncertain and cannot be predicted.
See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal year 2020 measures of adjusting
the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet management&#8217;s expectations, or additional
capital is not available, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of
one year from the issuance of these financial statements. Other factors that will impact the Company&#8217;s ability to continue operations
include the market demand for the Company&#8217;s products and services, the ability to service its customers and prospects, potential
contract cancellations, project scope reductions and project delays, the Company&#8217;s ability to fulfill its backlog, the management
of working capital, and the continuation of normal payment terms and conditions for purchase of the Company&#8217;s products. The Company
believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next twelve months. If the
Company is unable to increase revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&#8217;s
ability to continue as a going concern for a period of one year from the date the financial statements are issued. These consolidated
financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869417560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zGCkOmB9jGb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
2 &#8211; <span id="xdx_823_zIm2ibSzdefi">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016 the FASB issued ASU 2016-02, <i>Leases (Topic 842) </i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package of
practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance sheet
as an operating lease right-of-use asset in the amount of $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_z3QIEFnCJWn8">714,416
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and as a lease liability of $<span id="xdx_904_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zHmT8Ig7tRDe">822,374</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
<span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210930_zltbRLvpqQs2">The Facility Lease commenced September
29, 2017 and continues through August 31, 2022.</span></span> <span style="font: 10pt Times New Roman, Times, Serif">The
Company has the option to renew the Facility Lease for an additional <span id="xdx_902_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210930__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_z7ONoruRGFhb">five
years</span></span><span style="font: 10pt Times New Roman, Times, Serif">. However, the renewal option to extend
the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain of exercise.
The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal
period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_90E_ecustom--MonthlyRentDescription_c20210101__20210930" style="font: 10pt Times New Roman, Times, Serif">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%</span><span style="font: 10pt Times New Roman, Times, Serif">.
Total rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the
same monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to
operating lease liability on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zR1ThP9KYplj">100,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $<span id="xdx_903_ecustom--UnamortizedAmountOfTenantImprovementAllowance_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zrgjzx7tGFi2">81,481
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was treated as a reduction in measuring the right-of-use
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non lease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and
non lease components as a single component and account for it as the lease.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zE7BfvjDMl78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B0_zg5aAGk9vSug" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Months
                                            Ended</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseCost_c20210101__20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">162,667</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating cash outflow from operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeasePayments_c20210101__20210930_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"><span style="font-family: Times New Roman, Times, Serif">210,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">As
                                            of</span></p>
                                                                                                    <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">2021</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use asset</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_c20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease right-of-use asset"><span style="font-family: Times New Roman, Times, Serif">194,353</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, current"><span style="font-family: Times New Roman, Times, Serif">238,140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, long-term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, long-term"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining lease term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210930_zpudGJ6rSd88" style="font: 10pt Times New Roman, Times, Serif">.9
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20210930_zQoCqfVihB42" style="text-align: right" title="Discount rate"><span style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p id="xdx_8A1_zP0CoSboRq6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zl9F1dquxe55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of September 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Future Annual Minimum Lease Payments</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years ended
    December 31,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%"><span style="font-family: Times New Roman, Times, Serif">2021 (excluding the nine months ended September 30,
    2021)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_c20210930_zjvcD1tjTLH9" style="width: 22%; text-align: right" title="Remainder of fiscal year"><span style="font-family: Times New Roman, Times, Serif">71,710</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20210930_zFkL3HCOoQE1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Year one"><span style="font-family: Times New Roman, Times, Serif">170,891</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total minimum lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20210930_pp0p0" style="text-align: right" title="Total minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">242,601</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20210930_zLIQ6LKinbYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less imputed interest"><span style="font-family: Times New Roman, Times, Serif">(4,461</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of
    minimum lease payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Present value of minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">238,140</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zTti6psuUEP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 30, 2021, the Company entered into an agreement to sublease approximately <span id="xdx_90D_eus-gaap--AreaOfLand_iI_usqft_c20210430_zPfHJZENNDPi">6,900
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#8217; notice.
Unless 30-days&#8217; notice is provided sooner, this sublease will end upon termination of the Company&#8217;s Lease Agreement with
its current landlord. Rent was initially charged at $<span id="xdx_904_ecustom--RentalExpense_pp0p0_c20210429__20210430_zyyaoa9n2K69" title="Rental expense">5,989
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month and increased to $<span id="xdx_90C_ecustom--RentalExpense_pp0p0_c20210629__20210702_z8eUGTfQbS24" title="Rental expense">11,978
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month effective July 1, 2021. The Sublessor
is also responsible for its prorated share of utilities and other related costs. This new sublease does not change the Company&#8217;s
legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining financial
obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying value
of the Company&#8217;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#8217;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#8217;s operating lease
right of use asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the <span id="xdx_902_eus-gaap--AreaOfLand_iI_usqft_c20210727_zl3I6KkR9xzg">18,952
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square foot office and manufacturing facility
in Boulder, CO, which was previously scheduled to expire on <span id="xdx_902_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zXeSy0kHheTf">August
31, 2022</span></span><span style="font: 10pt Times New Roman, Times, Serif">. The termination provides for the Company
to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company paid
a nominal lease termination fee on July 28, 2021. The termination was also contingent upon a successor tenant executing a new lease with
the landlord and the Company paying the remaining deferred rent and security deposit amounts (<i>See Contractual Payment Obligations
</i>section). The landlord and successor tenant entered into a lease agreement on July 27, 2021. The remaining deferred rent and security
deposit will be paid in conjunction with the final rent payment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
July 28, 2021, the Company entered into an agreement to lease <span id="xdx_904_eus-gaap--AreaOfLand_iI_usqft_c20210728_z4RgX87I8D3f">11,491
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet of office and manufacturing space
in Louisville, CO. The lease commences on November 1, 2021 and continues through <span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zJDQ4X7f1m1i">January
31, 2027</span></span><span style="font: 10pt Times New Roman, Times, Serif">. The Company has the option to renew
the lease for an additional 60-month period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_ziGpRPGOyK46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_826_zYz2L2QJNrzf">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not be updated,
and the disclosures required under the new lease standard will not be provided, for dates and periods prior to January 1, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
new lease standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package
of practical expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease,
(ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
June 27, 2017, the Company entered into a lease for its manufacturing and office space (the &#8220;Facility Lease&#8221;), which commenced
September 29, 2017 and continues through August 31, 2022. The Company occupied its <span id="xdx_90E_eus-gaap--AreaOfLand_iI_usqft_c20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zCxTFRJSZlrl">12,700
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square foot space for $<span id="xdx_907_eus-gaap--PaymentsForRent_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0">12,967
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per month <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseDescription_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember">until
January 1, 2018</span></span><span style="font: 10pt Times New Roman, Times, Serif">. On January 2, 2018, the leased
space was expanded to <span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zLD8O78hFDn3">18,600
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet, and the monthly rental rate increased
to $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0">18,979
</span></span><span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember" style="font: 10pt Times New Roman, Times, Serif">until
August 31, 2018</span><span style="font: 10pt Times New Roman, Times, Serif">. Beginning September 1, 2018 and 2019,
the monthly rent increased to $<span id="xdx_902_eus-gaap--PaymentsForRent_c20180830__20180902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0">19,549
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--PaymentsForRent_c20190830__20190902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0">20,135</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. <span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember">On
each September 1 through the end of the lease, the monthly rent will increase by 3%.</span></span> <span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the current lease, the Company made a security deposit of $<span id="xdx_902_eus-gaap--SecurityDeposit_c20170731_pp0p0">51,000</span></span>
<span style="font: 10pt Times New Roman, Times, Serif">on July 31, 2017. The deposit of $<span id="xdx_906_eus-gaap--PaymentsForDeposits_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0">1,600
</span></span><span style="font: 10pt Times New Roman, Times, Serif">paid to the previous owner of the property was
forwarded to the current landlord. The Company has the option to renew the Facility Lease for an additional <span id="xdx_904_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zZZPUCkQqG86">five
years</span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember_pp0p0">52,600
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to rent payments due during the period. <span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember">The
deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly
installments from January to December 2021.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Total
rent under the Facility Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly
rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease
liability on the Company&#8217;s condensed consolidated balance sheets. As of January 1, 2019, the remaining deferred rent of $<span id="xdx_909_eus-gaap--DeferredRentCreditCurrent_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">26,477
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was reclassified to the operating lease liability
under the new lease standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Upon
adoption of the new lease standard, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;)
on the balance sheet as an operating lease right-of-use asset in the amount of $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">714,416
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and as a lease liability of $<span id="xdx_900_eus-gaap--OperatingLeaseLiability_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">822,374</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
The renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably
certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will
include the renewal period in its lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company
not to exceed $<span id="xdx_903_eus-gaap--TenantImprovements_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MinimumMember_pp0p0">100,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $<span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0">81,481
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was treated as a reduction in measuring the right-of-use
asset.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non-lease component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zPeQ3QlkQHh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B9_zox0OD0dSWLg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                            the Year Ended</b></span></p> <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
    31, 2020</b></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--OperatingLeaseCost_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 26%; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">216,889</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    cash outflow from operating lease</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">160,934</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 70%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 26%"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                            of</b></span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                            31, 2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z9hG7OHCzPY9" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">343,950</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, current</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">266,105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, long-term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,119</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    lease term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20201231_zYcwBtbDKBub" style="font: 10pt Times New Roman, Times, Serif">1.7
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount
    rate</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231_z4dVlHSoI0Pj" style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<p id="xdx_8A4_zXS3ptFh0oca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDVOneHTYVH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_z7dpdkWsmaYh" style="display: none">Schedule
of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years
    ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Year one"><span style="font-family: Times New Roman, Times, Serif">281,864</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Year two"><span style="font-family: Times New Roman, Times, Serif">170,891</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total
    minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">452,755</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    imputed interest</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20201231_zf84W1QHLDxl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Less imputed interest"><span style="font-family: Times New Roman, Times, Serif">(17,531</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present
    value of minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Present value of minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">435,224</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AF_ziZvFyuCORWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"/></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869397848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_z04jK9JWDORa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
3 &#8211; <span id="xdx_824_zMBy98biFY">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zzf4SyZLHGM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zyNsY9SHCwe5" style="display: none">Schedule
of Inventory</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210930_z5ce68v8Z4C4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z6T6rCooRhNa" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zqUs5jAD08x3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">319,335</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,778</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zVmUeZOf0Oil" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work in progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zamrk66e6vH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,145</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_zhYIxIekR7Ll" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for excess
    &amp; obsolete inventory</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(79,281</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(93,045</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zIGhHlcMXc96" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">480,354</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_zd3giabyIeY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_900_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20210101__20210930_znNmM1wONjjg">17,674</span></span>
<span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20200101__20201231_z8GkUPR1Skph">17,974
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in the inventory balance as of
September 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $<span id="xdx_90F_ecustom--PrepaidInventoryExpenses_c20210930_pp0p0">879,000</span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0">916,000</span></span> <span style="font: 10pt Times New Roman, Times, Serif">in
advance payments for inventory for the periods ended September 30, 2021, and December 31, 2020, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--InventoryDisclosureTextBlock_zPjzClIgw3M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_82F_zPKrvMsluy87">Inventory</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_891_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zsS4iWD1QIt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BE_zEPdvzgbpdO7" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Inventory</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20201231_zhtS2W1hrrFk" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20191231_zo0yO0tAWnze" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzovY_zcUBVogjx2p3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,778</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041,369</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzovY_zpy2GKyYlvrg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work
    in progress</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,231</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,851</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzovY_zuABjAhGwkW7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw
    materials</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,145</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">257,399</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzovY_zAiPNf3CfCDc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance
    for excess &amp; obsolete inventory</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(93,045</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,376</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzovY_zVnz9ZDhw415" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory,
    net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327,109</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,231,243</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A3_zqkjaNFpCDU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Overhead
expenses of $<span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0">17,974</span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20190101__20191231_pp0p0">31,831</span></span> <span style="font: 10pt Times New Roman, Times, Serif">were
included in the inventory balance as of December 31, 2020 and 2019, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869414776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zrwtRk5xMaYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
4 &#8211; <span id="xdx_821_zOTdUyJEQMn3">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJiv7xcnC4L1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zLZVCtZSs8k5" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">296,851</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMZDztKFreq3" style="width: 18%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">398,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z6OcIdjPZrR6" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zIUHCxMURVJ2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20210930_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">527,044</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zokQaM4dbO78" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">628,615</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210930_zvp6VeXPSTq1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(428,076</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zgUvrI5Finv7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(480,883</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">98,967</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zhCu01lBplz3" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">147,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_zUOwpMJ8p0y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense was $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20210101__20210930_zFO71rsB7aNe">54,538</span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the nine months ended September 30, 2021. For the nine months ended September 30, 2021, $<span id="xdx_900_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zCCjntru6qIi">4,721
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of sales and $<span id="xdx_90E_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zSgVbMfsEve1">1,180
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to inventory with the remainder
recorded as selling, general and administrative expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zLq72Q9WZrFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_822_ziit6XWN0ooh">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zh2Icee86gEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zVVsMRJAzqSi" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture
    and equipment</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">398,422</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">389,090</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvements</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">628,615</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">619,283</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zvgMNUiNUWLa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(480,883</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20191231_zXe8mqyRHIOi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(361,360</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">147,732</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">257,923</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A4_zay1LsUH04ne" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation
expense amounted to $<span id="xdx_900_eus-gaap--Depreciation_c20200101__20201231_pp0p0">119,524</span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the year ended December 31, 2020, of which $<span id="xdx_901_eus-gaap--Depreciation_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0">6,394
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of revenue. Depreciation
expense amounted to $<span id="xdx_903_eus-gaap--Depreciation_c20190101__20191231_pp0p0">157,860</span></span> <span style="font: 10pt Times New Roman, Times, Serif">for
the year ended December 31, 2019, of which $<span id="xdx_902_eus-gaap--Depreciation_c20190101__20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0">7,010
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was allocated to cost of revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2018, the Company&#8217;s property and equipment, net included the gross cost of the equipment leased to a cultivation
company affiliated with one of the Co-founders of $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentGross_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0">176,042</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and accumulated depreciation of $<span id="xdx_90C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0">39,120</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
During the year ended December 31, 2019, the Company wrote-off the carrying value of the leased equipment. See Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872987448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_807_eus-gaap--IntangibleAssetsDisclosureTextBlock_zn23HhHg5uvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_82E_zAfsIIV8kEIb">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zggo8d4spgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BD_z00zkFunFRg7" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Intangible Assets</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Patents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">8,110</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">12,234</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Website
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">22,713</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">22,713</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trademarks</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">1,830</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">1,830</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">32,653</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">36,777</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(25,426</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(24,847</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"><span style="font-family: Times New Roman, Times, Serif">7,227</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"><span style="font-family: Times New Roman, Times, Serif">11,930</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A9_zIYQ2Sxbhta8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Patents
when issued are amortized over <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zQm2Fs4aILp1">14
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years, and web site development costs are amortized
over <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dt_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_zr0vOCDPfIR5">five
years</span></span><span style="font: 10pt Times New Roman, Times, Serif">. Trademarks are not amortized since they
have an indefinite life. Amortization expense for intangibles amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20200101__20201231_pp0p0">579
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20190101__20191231_pp0p0">3,320
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $<span id="xdx_907_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0">4,124
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20190101__20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0">7,778</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to patents that had been abandoned.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869420344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z43nIkRhMPC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
5 &#8211; <span id="xdx_825_zvk1TcGntuvh">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrHfPYmX2q3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zou4lBgXvTna" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Accounts Payable and Accrued Liabilities</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210930_zkBTLGzF71Vl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20201231_zdNzFzCMsHi9" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzbsH_zxSd7lz1MQwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">864,558</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">918,639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzbsH_zU6BX7o3qF18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales commissions payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_z4CC0eQnScI4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued payroll liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">255,462</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,071</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzbsH_zwpWEPRMNvs7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product warranty accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,868</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_zn7eu27m6ee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">356,623</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzbsH_zMr6ODvSMOGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,674,088</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,784,961</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zttCbNds4Jbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z6vHbdZ5XbF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_820_z6RO0rWJixFa">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMqUwIW62Mn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_z1Ux5zTvOta1" style="display: none">Schedule
of Accounts Payable and Accrued Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zxlzjELyrpcg" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20191231_zUMOpS8dRv4d" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALze1T_zVrdMPSorzx7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">918,639</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,299,015</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALze1T_zFBTW1Sc3Wb3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales
    commissions payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,263</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,532</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z5w9hxoGV7C8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    payroll liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,071</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,052</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALze1T_zYMKGAUUdenl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    warranty accrual</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,365</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">185,234</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z9uRwMGS31Zj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">356,623</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,127</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALze1T_zJjZzcMGGVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,784,961</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,832,959</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AE_zL2mw2kHjdM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and other accrued expenses includes $<span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_c20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember_pp0p0">402,651
</span></span><span style="font: 10pt Times New Roman, Times, Serif">relating to a one-time warranty issue experienced
on three customers&#8217; projects. The expenses related to parts and labor to repair units that had been delivered to these customers
prior to year-end. <span id="xdx_900_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember">Since
the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing
1% warranty reserve that we accrue on all sales.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869395064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note Payable and Accrued Interest</a></td>
<td class="text"><p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zzSHV0N0TM24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
6 &#8211; <span id="xdx_823_z3CYiRhxSaTk">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210_zH5lMReVvun9">514,200</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount bears interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210_z14UZe4s1tB7">1</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zwpeLY3NxQbh">February 5, 2026</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment
of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan
is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions,
including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments,
insolvency, dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the three and nine months ended September 30, 2021, interest of $<span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210701__20210930_zkE22sd21pR6">1,296
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210101__20210930_zqtrNtTebagk">3,268
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was accrued, respectively, in respect of this
note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zUhipQ9tARVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_822_zRV64zyByxm7">Note Payable and Accrued Interest</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
April 22, 2020, the Company entered into a note payable with its current bank in the principal amount of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_c20200422_pp0p0">554,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
for working capital purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
loan amount was subject to interest at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200422_zRN0gwPbEHjk">1</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and was initially due on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422_zbAHUV3uPZS8">April 20, 2022</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
Subsequently, the term of the loan was potentially to be extended to <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_zmBiG8NphFna">April
20, 2025</span></span><span style="font: 10pt Times New Roman, Times, Serif">. The loan could be repaid in advance
without penalty. The loan was also potentially forgivable in full provided proceeds were used for payment of payroll expenses, rent,
utilities and mortgage interest and certain other terms and conditions were met. The loan had typical default provisions, including for
change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, interest of $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20200101__20201231_pp0p0">3,203
</span></span><span style="font: 10pt Times New Roman, Times, Serif">was accrued in respect of this note payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
December 11, 2020, the Company received notice from the bank that its loan received on April 22, 2020, in the principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20201211_pp0p0">554,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and all accrued interest of $<span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20201210__20201211_pp0p0">3,203</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 16 Subsequent Events</i> below, on February 10, 2021, we received funding based on a loan agreement entered
into on February 5, 2021 with its current bank in the principal amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0">514,200
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgfllgsM3e55">1</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaU1yJlYPVJj">February
5, 2026</span></span><span style="font: 10pt Times New Roman, Times, Serif">. The loan may be repaid in advance without
penalty. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment
of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869420344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements and Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Agreements and Transactions</a></td>
<td class="text"><p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUkNtcCooKgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
13 &#8211; Related Party Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_828_ztSWdZvbitn2" style="display: none; font-family: Times New Roman, Times, Serif">Related
Party Agreements and Transactions</span><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended
September 30, 2021, the Company paid $<span id="xdx_90D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20210701__20210930_zQN09FVZ86Q8">26,873
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in commissions under this agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zIS26wPCDtcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_827_zf7sf37DWYya">Related Party Agreements and Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Agreements
and Transaction with Company&#8217;s Co-Founders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following describes certain agreements and transactions between the Company and its co-founders (the &#8220;Co-founders&#8221;). The
Co-founders held various executive officer and director positions with the Company until May 2018. One of the Co-founders also was a
consultant to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the
Company, the Co-founders did not own more than <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20191231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z8J5rxDJzt6a">10</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s outstanding common stock at any time during 2019 or 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Equipment,
Demonstration and Product Testing Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2017, the Company entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis cultivation
company affiliated with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation company certain cultivation
equipment in exchange for a quarterly fee of $<span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0">16,500</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which was increased to $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__srt--RangeAxis__srt--MaximumMember_pp0p0">18,330
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to reflect additional leased equipment requested
by the cultivation company (the &#8220;Lease Fee&#8221;). In consideration for access to the cultivation facility to conduct demonstration
tours and for the product testing and data to be provided by the cultivation company, the Company agreed to pay the cultivation company
a quarterly fee of $<span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0">12,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">(the &#8220;Demo and Testing Fee&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company and the cultivation company each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation
company failed to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During
the second quarter of 2019, the Company notified the cultivation company of its breach for non-payment of the Lease Fee. In February
2020, the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement, including
any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment to the cultivation company for no additional
consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2018, the Company recorded Demo and Testing Fees of $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_c20180101__20181231_pp0p0">32,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as operating expenses in the consolidated statements
of operations. During the year ended December 31, 2018, the Company also recorded Lease Fees of $<span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20180101__20181231_pp0p0">48,880
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as &#8220;Other income, net&#8221; in the consolidated
statements of operations. As of December 31, 2018, unpaid Lease Fees of $<span id="xdx_90F_ecustom--UnpaidLeaseFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_pp0p0">36,660
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in accounts receivable and unpaid
Demo and Testing Fees of $<span id="xdx_901_ecustom--UnpaidDemoAndTestingFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsPayableMember_pp0p0">24,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">were included in accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the third quarter of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by the cultivation
company, and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with a corresponding charge
to &#8220;Other income, net&#8221; in the consolidated statements of operations, (ii) reversed the accounts payable related to the unpaid
Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the remaining carrying value of the leased
equipment of $<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_c20190930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LeasedEquipmentMember_pp0p0">107,581</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which was included in property and equipment on the Company&#8217;s consolidated balance sheet. For the year ended December 31, 2019,
the net impact of the foregoing items on the consolidated statements of operations was a charge of $<span id="xdx_908_ecustom--NetOfImpactOfForegoingItemCharge_c20191231_pp0p0">120,241</span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Employment
Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2018, the Company and one of the Co-founders entered into an employment agreement which provided for an initial base salary of $<span id="xdx_908_eus-gaap--SalariesWagesAndOfficersCompensation_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0">150,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per year and certain sales incentive. Pursuant
to the employment agreement, the Company awarded <span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z05Qjf1Hc5I3">32,000
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units (&#8220;RSUs&#8221;)
to the Co-founder that vested at certain dates in the future, subject to the co-founder&#8217;s continued employment. As of December
31, 2019: (i) the Company has issued <span style="-sec-ix-redline: true"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z40XgwlaABjg">13,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in settlement of vested
RSUs, (ii) <span style="-sec-ix-redline: true"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_zHw22lz7BiGk">6,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock in settlement of RSUs
that vested December 31, 2019 were issued subsequent to December 31, 2019, (iii) the parties mutually agreed to cancel <span style="-sec-ix-redline: true"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzurGOfozEfj">6,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs, and (iii) <span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__us-gaap--AwardDateAxis__custom--AprilThirtyTwoThousandAndTwentyMember_zpoKeuuaruzh">5,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested on April 30, 2020, however, the
holder elected to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Consulting
Agreement</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed <i>in Note 16 Subsequent Events</i> below, on January 7, 2021, the Company entered into a consulting agreement with
RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services
to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually
determined by the Company and RSX. The Company will pay a monthly consulting fee of $<span id="xdx_900_eus-gaap--ProfessionalFees_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_pp0p0">6,500
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872025192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcGTgUN2iaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
7 &#8211; <span id="xdx_824_zkQESrASBuFe">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were <span style="-sec-ix-redline: true"><span id="xdx_90E_ecustom--NumberOfUnitsVestedButNotSettled_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr0v6SJAu0x6">45,000 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted
stock units that had not been settled due to a dispute with a former employee over the required withholding taxes to be paid to the
Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against the former employee
regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid wages. As
stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee <span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--NumberOfUnitsVestedAndSettled_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z17WdGRouHq7">45,000 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of the Company&#8217;s common stock in settlement of these restricted stock units after taking measures to mitigate the
Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an
interim award of approximately $<span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z83IRlsnuDBc">10,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
the Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award
in the Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company
costs of $<span id="xdx_904_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zJwNGM5Ovb86">33,985</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with interest at <span id="xdx_902_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zKbPCGWx94Wh">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the
Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This
former employee continued to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for
the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective March 30, 2021, this separate
litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed and will be obliged to
pay $<span id="xdx_906_eus-gaap--LossContingencyDamagesPaidValue_pp0p0_c20210329__20210330_zg8GiAEbIbOk">40,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">over
eight months and to issue upon execution of the settlement agreement an aggregate of <span style="-sec-ix-redline: true"><span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210406__20210408_zBnLJLpv26P1">6,667
shares </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of common stock of the Company.
These shares were issued on April 8, 2021 as &#8220;restricted securities,&#8221; subject to a lock-up agreement of six months,
without registration rights, and pursuant to a private placement exemption and were valued at $<span id="xdx_903_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210329__20210330_zl4c8v5acVtf">67,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement,
$<span id="xdx_901_eus-gaap--OtherNonoperatingExpense_c20210101__20210930_pp0p0">107,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
in total, has been recognized in full in other expenses during the nine months ended September 30, 2021. As of September 30, 2021,
$<span id="xdx_902_eus-gaap--PaymentsForLegalSettlements_pp0p0_c20210101__20210930_zyrU8kltI1d8">35,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
been paid in respect of the $<span id="xdx_906_eus-gaap--LitigationSettlementExpense_c20210101__20210930_pp0p0">40,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash
portion of the settlement and the remaining $<span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210930_z3icA562jUUk">5,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is
included in accounts payables and accrued liabilities. The issuance of the <span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930_pdd">6,667</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock, valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210930_pp0p0">67,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has
been recognized in common stock issued during the nine months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s operations
or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Leases</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has a lease agreement for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#8217;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z6Rv5sxQ2HTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 &#8211; <span id="xdx_823_zE1e9NOcWSqa">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were <span style="-sec-ix-redline: true"><span id="xdx_907_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1D6Li7sAvne">45,000
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units that had not been
settled due to a dispute with a former employee over the required withholding taxes to be paid to the Company for remittance to the appropriate
tax authorities. The Company commenced an arbitration action against the former employee regarding the dispute. The former employee also
made claims in the arbitration action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020,
the Company issued the former employee <span style="-sec-ix-redline: true"><span id="xdx_904_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgCQ7KzD5kI1">45,000
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
in settlement of these restricted stock units after taking measures to mitigate the Company&#8217;s exposure to penalties and liability
for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $<span id="xdx_90E_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpLxiLuaWnmj">10,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the Company&#8217;s favor and a finding against
the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&#8217;s favor in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $<span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0">33,985</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
with interest at <span id="xdx_906_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_pid_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zFRXQvlE3aTi">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company
and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee
is continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015 calendar
year prior to his appointment as an executive officer of the Company. </span><span style="font-family: Times New Roman, Times, Serif">The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict and the Company&#8217;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the
Company&#8217;s operations or its financial position, liquidity or results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Commitments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors,
business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company&#8217;s
breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties.
In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that
will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status
or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities
arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and
employees of acquired companies, in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872873752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosurePreferredAndCommonStockAbstract', window );"><strong>Preferred And Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PreferredAndCommonStockNoteDisclosureTextBlock', window );">Preferred and Common Stock</a></td>
<td class="text"><p id="xdx_80B_ecustom--PreferredAndCommonStockNoteDisclosureTextBlock_zCxvSCoTN7o8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_820_zRpOiKZM88v3">Preferred and Common Stock</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, and 2019, there were <span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYpDiNFqp1Ah">42,030,331
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of Series A preferred stock, par value
$<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zu9ytYekXata">0.00001
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, issued and outstanding. The holders
of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one vote of the Company&#8217;s common
stock. The Series A preferred stock ranks senior to the Company&#8217;s common stock. The holders of shares of Series A preferred stock
are not entitled to receive dividends and have no conversion or preemptive rights. Upon liquidation, dissolution or winding up of the
Company&#8217;s business, after payment to the holders of any senior securities, the holders of Series A preferred stock are entitled
to receive a preferential cash payment per share of Series A preferred stock equal to the stated value of the preferred stock, prior
to any payment to the holders of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z2zCrGoKAMEj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,667
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares to an employee in settlement of certain
    RSUs that vested December 31, 2019;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zUvwXN23IDa8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,733
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares pursuant to a special incentive stock
    bonus approved by the Board for the period ended December 31, 2019; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpiXSBOC72bj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in settlement of restricted stock units
    to a former employee after taking measures to mitigate the Company&#8217;s exposure to penalties and liability for the failure to
    properly withhold income taxes, as further discussed in <i>Note 11 &#8211; Commitments and Contingencies, Litigation</i> above.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the year ended December 31, 2019, the Company issued shares of its common stock under the Company&#8217;s 2017 Equity Plan as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zbZ7TzICqGsh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,316
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to independent
    directors in lieu of cash director fees; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxwcxMqUfgda" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,263
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to independent
    directors as the 2019 equity retainer fee; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zt4rpsAgUuy5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,467
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to certain
    employees in settlement of vested restricted stock units; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4jIaQEQ20Ce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,467
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued to certain
    employees as a stock incentive bonus.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosurePreferredAndCommonStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosurePreferredAndCommonStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PreferredAndCommonStockNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred and common stock disclosure text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PreferredAndCommonStockNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872025192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zLmaN214mUB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
11 - <span id="xdx_822_zZvDjqWyypN2">Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z5O823WM7Gl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zT9rBdMJ3yq9" style="display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20210930_zjWAvLHPnk4i" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20210930_zVNGmDosj27a" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zgawyAW8NT94" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210930_zd9calbbkjh3" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Issued"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Issued"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.00</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zSciqoAeDnDc" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Life of Outstanding Warrants in Months, Issued">36</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2772">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(50,417</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210930_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20210930_zHLFpnVfVYkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20210930_zqb3GSU71sKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zfdYLOWvWWl3" style="font-family: Times New Roman, Times, Serif">36</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210930_zmIv9vQYXBhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_z27zHbV89978" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zgrijU5SXnZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8BC_zzmfRVkOy6i1" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Life of</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z537to8iv6U1" style="width: 30%; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.45</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zq4AHuDxnVph" style="width: 30%; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">192,982</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 30%; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z4vfo7shlyH2" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWfIKLSGAx6g" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.40</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zY4PmTbN1D6e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">34,737</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zNYfLPBILEE9" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930_zstL5FZdVKdh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zQZPEEYKQMN" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AE_z7B5RgfF2jO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 30, 2021, <span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210101__20210630_z1ebEzJbJ8wi">50,417
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants issued in connection with our Q2
2018 unit offering expired unexercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
September 28, 2021, we issued <span style="-sec-ix-redline: true"><span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_znqNDbdtl9m">192,982
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zIqPacuiSBIj">9.45
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a <span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zCEc33Ar032d">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
term to the Holders of our Series B redeemable convertible preferred stock and <span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z4HtGMCpiH16">34,737
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants with an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHmIVZwGc5ji">10.40
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and a <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5a5OYmFxfIg">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year
term to the placement agent in respect of the sale of the Series B redeemable convertible preferred stock. <i>See Note 8</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_ecustom--WarrantsDisclosureTextBlock_zcc9al3ZhTXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
13 &#8211; Outstanding Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_820_zTUUdnZyTWK6" style="display: none; font-family: Times New Roman, Times, Serif">Warrants</span><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_892_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zCmKGkVA2K1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B8_zujAupgcPZf3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining
    Life</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20190101__20191231_zHHR9lK7HwN9" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">266,735</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20190101__20191231_zlVMLuwIDdnh" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20180101__20181231_zSNuiHD8JHdh" style="font-family: Times New Roman, Times, Serif">21</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20190101__20191231_zhSwNkngcGkb" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightIssued_c20190101__20191231_zMw9X2Kx1Btl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20190101__20191231_zCu8XanGfln" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercised_c20190101__20191231_zhPUDpdKLO1d" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20190101__20191231_znyF8jQQ4oBg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20190101__20191231_z6UMikAfCEW6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(6,008</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20190101__20191231_zEAMgdPZrt5f" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(99.00</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20200101__20201231_zVRwMhcJq0uh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">260,727</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20200101__20201231_zRNYZCxfgAh5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">36.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20190101__20191231_ziwiDyXx0GQb" style="font-family: Times New Roman, Times, Serif">9</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231_zInNKgxYOnA" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightIssued_c20200101__20201231_zopjaADN6l4c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20200101__20201231_zyfHKcvn82Ch" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0990">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercised_c20200101__20201231_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20200101__20201231_zHfHnhlfUiJ5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0996">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_c20200101__20201231_zDGSBo1oskOf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(210,310</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20200101__20201231_zfD99jjPCIB3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(34.50</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20200101__20201231_zscu6SOw7pni" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20200101__20201231_zuvwzPeDc3Yj" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_dtM_c20200101__20201231_zhdseHw7u8W3" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231_zXtxX1GvmqJ9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zQA9Rm4RkEwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zBewjAB52c1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B3_z7jcy62VIUX6" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Life of</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercise
    price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zcE4irsYhtVf" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zDW7HNQQ1Ac1" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20200101__20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zggF3MvAyLFe" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AD_zS3wsqRVSJG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
2 Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2014, the Company offered up to <span id="xdx_909_ecustom--NumberOfInvestmentUnitOffered_uNumber_c20141001__20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zHjPmVqdjLa7">60
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units at a price per unit of $<span id="xdx_909_ecustom--OfferedInvestmentsPricePerUnit_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_pp0p0">50,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
Each unit consisted of (i) <span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zrgeorm3TUI9">1,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock,
(ii) a $<span id="xdx_901_eus-gaap--ConvertibleDebt_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_pp0p0">50,000
</span></span><span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_zBWUXwaUvEm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
convertible promissory note (&#8220;Series 2 Convertible Note&#8221;), and (iii) warrants for the purchase of <span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zTK6mXbKh5n6">333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Series 2 Warrants&#8221;). As of December 31, 2018, Series 2 Warrants to purchase <span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20181231__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_z8kLZbzSSqFl">6,008
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were outstanding,
all of which expired unexercised during the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Warrants
Issued to Investment Bank</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a certain agreement for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year ended
December 31, 2017, the Company issued to an investment bank or its designees a warrant (&#8220;Banker Warrant&#8221;) to purchase, at
an exercise price <span style="-sec-ix-redline: true">$<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_zuRSth8RyeLk">52.50
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, <span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_znQV77lcEGZ7">3,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock.
<span id="xdx_908_ecustom--WarrantDescription_c20170101__20171231__dei--LegalEntityAxis__custom--InvestmentBankMember">The Banker Warrants
were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q1
2017 Warrants </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2017, the Company issued <span style="-sec-ix-redline: true"><span id="xdx_904_ecustom--NumberOfInvestmentUnitOffered_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pdd">111,875
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units, for aggregate gross proceeds
of $<span id="xdx_90A_ecustom--ProceedsFromInvestment_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pp0p0">2,685,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or <span style="-sec-ix-redline: true">$<span id="xdx_906_ecustom--ProceedsFromInvestmentPerUnit_pid_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zSquFoX6Hiz2">24.00
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. <span id="xdx_907_eus-gaap--ConversionOfStockDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember">Each
unit consisted of <span style="-sec-ix-redline: true">0.0067 of a</span> share of the Company&#8217;s common stock and <span style="-sec-ix-redline: true">0.0067 of a</span> warrant for the purchase of one
share of the Company&#8217;s common stock (&#8220;Q1 2017 Warrants&#8221;)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">;
however, one investor declined receipt of the warrant to purchase <span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zqUAtsZIDZPl">3,125
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock.
Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months after the issuance date and on or prior to
the close of business on the date that is the third anniversary of the issuance date, purchase up to the number of shares of the Company&#8217;s
common stock as set forth in the respective warrant. The exercise price per share of the common stock under the Q1 2017 Warrants is <span style="-sec-ix-redline: true">$<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_z3P9Gln4yVJe">39.00,</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject to customary adjustments as provided in
the warrant. Each Q1 2017 Warrant was callable at the Company&#8217;s option commencing six months from the issuance date, provided the
closing price of the Company&#8217;s common stock was <span style="-sec-ix-redline: true">$<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zTgfKbMg9Sek">63.00
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or greater for <span id="xdx_907_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zcQstdnhtHqj">five
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive trading days. Commencing at any time
after the date on which such call condition was satisfied, the Company had the right, upon 30 days&#8217; notice to the holder, to redeem
the warrant shares at a price of <span style="-sec-ix-redline: true">$<span id="xdx_902_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zH3V3LQmCNog">1.50
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant share. The holder could have
exercised the warrant at any time (in whole or in part) prior to the redemption date at the exercise price. <span id="xdx_90F_ecustom--WarrantDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember">These
warrants expired unexercised in March 2020</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q4
2017 Warrants </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2017, the Company issued <span style="-sec-ix-redline: true"><span id="xdx_903_ecustom--NumberOfInvestmentUnitOffered_pid_uNumber_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zjrcqy87XBb4">98,227
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment units for aggregate proceeds of
$<span id="xdx_90D_ecustom--ProceedsFromInvestment_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_pp0p0">1,768,080</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or <span style="-sec-ix-redline: true">$<span id="xdx_90C_ecustom--ProceedsFromInvestmentPerUnit_pid_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zzkAH5M0CFf8">18.00
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. <span id="xdx_90A_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zfgXqdgKNGOb">Each
unit consisted of <span style="-sec-ix-redline: true">0.0067 of a</span> share of the Company&#8217;s common stock and <span style="-sec-ix-redline: true">0.0067 of a</span> warrant for the purchase of one
share of the Company&#8217;s common stock (&#8220;Q4 2017 Warrants&#8221;)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Q4 2017 Warrants had an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zU2sxrMa7Fol">30.00
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to customary adjustments
as provided in the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&#8217;s option, provided
the closing price of the Company&#8217;s common stock was <span style="-sec-ix-redline: true">$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zZyaMJGvKfWj">54.00
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">or greater for <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_z2DdIy82nATh">five
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive trading days. Commencing at any time
after the date on which the call condition is satisfied, the Company had the right, upon notice to the holders, to redeem the shares
of common stock underlying each warrant at a price of <span style="-sec-ix-redline: true">$<span id="xdx_90A_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zCU6gPuPg0q">1.50
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, but such redemption could not
occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder. The holder could exercise the warrant
at any time (in whole or in part) prior to the redemption date at the exercise price. These warrants expired unexercised in December
2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Q2
2018 Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Company completed a private placement offering of investment units, with <span id="xdx_905_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zrRQkM65UTX3" title="Conversion of stock, Description">each
unit consisting of <span style="-sec-ix-redline: true">0.0067 of a</span> share of the Company&#8217;s common stock and <span style="-sec-ix-redline: true">0.0067 of a</span> Q2 2018 Warrant</span>. The
Q2 2018 Warrants have an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zTKOYgwhXLFb">37.50 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share of the common stock underlying each warrant, subject to customary adjustments as provided in the warrant. <span id="xdx_909_ecustom--WarrantDescription_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember">The
Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Q2 2018 Warrants are callable at the Company&#8217;s option, beginning on July 1, 2019 until the expiration thereof on June 30,
2021, provided the closing price of the Company&#8217;s common stock is <span style="-sec-ix-redline: true">$<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zntzXCuyVY9c">60.00 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(subject
to adjustment as provided in the warrant) or greater for <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zLUu6QAHOowh">five </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consecutive
trading days. Commencing at any time after the date on which the call condition is satisfied, the Company has the right, upon notice
to the holders, to redeem the shares of common stock underlying each warrant at a price of <span style="-sec-ix-redline: true">$<span id="xdx_905_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zYtbtzCVtgy5">1.50 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share, but such redemption may not occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder.
The holder may exercise the warrant (in whole or in part) prior to the redemption date at the exercise price. As of December 31,
2020, Q2 2018 Warrants to purchase <span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20201231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zCB0c3z5WCib">50,417 </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869397848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plans</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zEfXpBuuBbVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
10 &#8211; <span id="xdx_82D_z5vjtBg5QZIj">Equity Incentive Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2017
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Company&#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#8220;2017 Equity
Plan&#8221;), the Board of Directors (the &#8220;Board&#8221;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit
awards (&#8220;RSUs&#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates <span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">333,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Plan Shares&#8221;) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited,
expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination,
again be available for awards under the 2017 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2021
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#8220;2021 Equity Plan&#8221;), which was approved by the stockholders
on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to <span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zUKuM85eymW7">666,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The 2021 Plan provides
for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the
&#8220;Code&#8221;), non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards and restricted
stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise
terminates without having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather
than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that
may be issued pursuant to this Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021, the Company issued no shares of its common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, the Company granted awards for <span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">21,777
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options as described
below. Of the total awards granted, <span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zXv86LyB4JP7">20,239
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were under the 2017 Equity Plan and <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zu8021NWT1yc">230,770
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">were issued under the 2021 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, of the <span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">333,3333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares authorized under the 2017 Plan for
equity awards, <span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930_pdd">163,692
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares have been issued, awards related to
<span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">162,665
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options remain outstanding, and <span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">6,976
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain available for future equity
awards. As of September 30, 2021, of the <span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1PiEc7JzJbk">666,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares authorized under the 2021 Equity Plan,
<span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z6khA6M8EmRc">1,538
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relate to outstanding options and <span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z45iGP1qUb5i">665,129
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain available for future equity
awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">There
was $<span id="xdx_905_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zOrSNtGUD6Hb">90,255
</span></span><span style="font: 10pt Times New Roman, Times, Serif">in unrecognized compensation expense for unvested
non-qualified stock options at September 30, 2021 which will be recognized over approximately <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1ZU0vweRqA2">3
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zKTPsPnJRnNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended
September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span id="xdx_8BB_znp5ywFL5g0c" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4gld8oXLul1" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV4oZm5nSTre" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbwjmlEDTEwl" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfEQLj1v1Gg9" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2585">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zVR5opud0Jkc" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20,239</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOAZ8AjQNT2e" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQzVkmkVAe79" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhuARfgxtYmj" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAJjNruQHOWf" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2594">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zckRq9ht7oh" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(1,914</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyrSB7ZQtu54" style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">18.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkhSYLxIW19e" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Forfeited">6.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYWhXI9gTWQi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2600">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYzO59PB6VH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5tsk0SnBZ22" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">113,332</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zW3x9SeFnQe" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUvpqxPDK4wf">7.9</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwoVKOVoNvQ7" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcxUwTQQjYnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">101,665</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuF817ZZFR2a" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.75</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmipUx7wQY88">7.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgDgQ0Fv3lf4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2616">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p id="xdx_8A8_ziZVULdxX17c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued a total of <span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--RelatedPartyTransactionAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zJ8lLFruyjeb">20,239
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options to employees as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,906
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options were issued to 21 employees in
    respect of the Company&#8217;s 2020 Annual Incentive Awards. The options vested immediately, have a term of <span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zoKzbu3P6TOl">10
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd">19.50.</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztTM9FHDUKG5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,333
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock options were issued to our newly appointed
    Chief Financial Officer. The options vest as follows: <span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">1,667
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested immediately, <span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">2,780
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2022, <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">665,000
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2023 and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">668,000
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on June 30, 2024. The options have a term
    of <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdbnHwa0m937">10
    </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">9.15.</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the nine months ended September 30, 2021, <span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerEmployeeMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zo8KL30YriX7">1,914
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested stock options were forfeited
    following the departure of 3 former employees.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6uz1kHQOHmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months
ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zImqUMghEN0d" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQQ0WxbcTUO3" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2632">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zdouRiT9Kbyl" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2634">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ztXpy42QEQ7c" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUsKV9NiRi5e" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2638">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zujbP3yXyAv7" style="width: 11%; text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20,239</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcEIwcqwY0Di" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.30</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmAwKRm0eX83" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2644">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zD5rouAApSL9" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(8,572</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5kngnBAUc07" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgRPVPqNdq8d" style="text-align: right" title="Aggregated Intrinsic Value, Vested"><span style="font-family: Times New Roman, Times, Serif">66,412</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4aUVWGA7vgb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zca5jjCSo3wh" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zlysCjUo3WC5" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2656">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zetnfKTZTJO8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2658">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z7WwHfQCuoc3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zxcEFmi9RtM5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11,667</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zi6raECBmYgc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.15</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znjM5qNdlQnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaTJaeQ9A541" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">104,800</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_zezsuorBi2S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the nine months ended September 30, 2021 and September 30, 2020, the Company recorded $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0">29,881
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20200101__20200930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0">171,624
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zXNy04sZt6A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine
months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BA_zLEoLGV1DQue" style="display: none">Schedule
of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value ($000)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh1VE8UaYWrg" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">49,333</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyiSCSDM7sXe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJbcsxA6QD8a" style="font-family: Times New Roman, Times, Serif">7.5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZwNzbalPCs4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2679">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zX9g4KSImHFa" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,538</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFwFKcg1vkv" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGohvJBQxzBc" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdPKPvrPRF8l" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKDOV5jhmzS9" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2688">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0NhSxzTxYud" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2690">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2189g8PNKub" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqWgJYn1Egoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,871</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8hlGNijGvJ7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2Q055u8ZUta" style="font-family: Times New Roman, Times, Serif">6.8</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFIMmyG9WhFg" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2699">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,</span><span style="font-family: Times New Roman, Times, Serif">
    September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zawOZjpZ9LN8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,871</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsxjgS68DW64" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpCvslrSsDhi" style="font-family: Times New Roman, Times, Serif">6.8</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3atSYHs8e1j" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A6_zVzM1AvVUUw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued <span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3XQ8fS3Ywhg">1,538
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options to directors
as retroactive compensation for the first half of 2021 under the 2021 Equity Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVVQyPWVcsz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the
nine months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zm0LwJwSl8qg" style="font: 10pt Times New Roman, Times, Serif; display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zK1aMeTWkwG2" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,667</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfRIVlkOUuwl" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">4.35</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzHLUXNM13E7" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif">31,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwCOEhNblof7" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2717">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPQxCdlSzXq6" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,538</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbrjiGryUQe" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_iN_pdp0_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zERxLWFY9iQf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODpm85TDhe7" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhqZIy8eZ76g" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(8,205</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJhaKpnlMwX9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">5.40</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmhZ7MTcgb16" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Forfeited"><span style="font-family: Times New Roman, Times, Serif">(29,846</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvi8PX2mQ4Qa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2732">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4HOo16infre" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2734">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGknfEHNDja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7bt2EGwK4N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2738">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfvFdw7YGJQg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7ycd9P24fK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2742">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_zkPaIltoQSFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021 and September 30, 2020, the Company incurred $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0">21,174
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0">55,970</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, as compensation expense related to <span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">8,205
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">10,142
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested options, respectively, issued to directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<i>, </i>the Company issued <span style="-sec-ix-redline: true"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxzGMq2rnrl">13,333
</span></span>non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested </span><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zMW8RvkBTfc7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50%
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon grant and 50% on April 1, 2021, if the Director
remained on the Board up to that time. The options have a term of <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zThDsft0fbd1">5
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
August 20, 2021, the Company issued <span style="-sec-ix-redline: true"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pp0p0_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zojIelSV9eAb">1,538
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options under the 2021
Equity Plan to its directors. The options vested upon grant. The options have a term of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zXT5fN9NZONf">10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and an exercise price equal to the closing
price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">There
has been no activity related to RSUs during the nine months ended September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">25,163
</span></span><span style="font: 10pt Times New Roman, Times, Serif">during the nine months ended September 30, 2020,
as compensation expense related to vested RSUs issued to employees, directors and consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, <span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pdd">5,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested. However, the holder elected
to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHus4OeE7m19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
14 &#8211; Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_827_zA8hsQCXhksl" style="display: none; font-family: Times New Roman, Times, Serif">Equity
Incentive Plans</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2017, the Board adopted and approved the Company&#8217;s 2017 Equity Incentive Plan (the &#8220;2017 Equity Plan&#8221;) in
order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants, and other
persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under the 2017 Equity
Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights
(&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit awards (&#8220;RSUs&#8221;), shares granted
as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates <span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zlxYg4jjtRHc">333,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s common stock
(&#8220;Plan Shares&#8221;) for issuance of equity awards under the 2017 Equity Plan. As of December 31, 2020, the Company has granted,
under the 2017 Equity Plan, awards in the form of RSAs for services rendered by independent directors and consultants, non-qualified
stock options, RSUs and stock bonus awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_pp0p0">6,412</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
which will be recognized over approximately <span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zSoRwIEeGmtj">3
</span></span><span style="font: 10pt Times New Roman, Times, Serif">months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Awards </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the Company had accrued fees owed to the Company&#8217;s independent directors totaling $<span id="xdx_90F_eus-gaap--ProfessionalFees_c20180101__20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_pp0p0">15,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
which were payable in equity. During the year ended December 31, 2019, the Company issued <span style="-sec-ix-redline: true"><span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_zde8R2Nb5uo4">1,316
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of restricted stock, which were fully
vested at the time of the award, in settlement of these accrued fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company also awarded <span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_zTjeQlFdhBCa">5,263
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of restricted stock under the 2017
Equity Plan to the Company&#8217;s independent directors and consultants as an equity retainer fee for 2019. These restricted shares
were fully vested at the time of the award and the aggregate value attributable to these shares was $<span id="xdx_908_eus-gaap--ProfessionalFees_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_pp0p0">60,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
as calculated using the fair value of the Company&#8217;s common stock on date the Board approved these awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Non-Qualified
Stock Options</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of highly
subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective
input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions are based on the historical
volatility of the Company&#8217;s common stock over periods that are similar to the expected terms of grants and other relevant factors.
The Company derives the expected term based on an average of the contract term and the vesting period taking into consideration the vesting
schedules and future employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for
a maturity approximating the expected term calculated at the date of grant. The Company has never paid any cash dividends on its common
stock and the Company has no intention to pay a dividend at this time; therefore, the Company assumes that no dividends will be paid
over the expected terms of option awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock
price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such,
the Company may use different assumptions for options granted throughout the year. The valuation assumptions used to determine the fair
value of each option award on the date of grant were: expected stock price volatility <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zsOxy8k3Bi23">114.97</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
- <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zCWZnoTM6tsg">122.48</span></span><span style="font: 10pt Times New Roman, Times, Serif">%;
expected term in <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zG2vGczPXYe">5
</span></span><span style="font: 10pt Times New Roman, Times, Serif">years and risk-free interest rate <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_z5Sav0TnmA9b">0.2</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
- <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zxe9fKIuxTi8">2.37</span></span><span style="font: 10pt Times New Roman, Times, Serif">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Employee
and Consultant Options</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcZKUI45Pan1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8B6_zoOZ8meB3tJl" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate
                                            Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHBKVz3d9ybj" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">70,400</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zTWEXvTjdnT8" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.60</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zNwpKYKTDSW3" style="font-family: Times New Roman, Times, Serif">8.4</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zgzSI45TX4pe" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1075">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zDDkg8cG9qrd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zK5g7z9t2Ts1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"/><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zQep3WVATrw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaaVkiZiXXGb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxgG6IIsWrh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,055</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zmNTgzd3zNnf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">17.40</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zN3Ibp9cFVzd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(111</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zD10t41iwJUg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.75</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zbPacipgumw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">67,567</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zw11YTKON6c8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">14.40</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zPzdo4Shliml" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.7</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zOIMwKM2am6c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDCgJ4QGrFn1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">44,113</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIM6Aysndxo8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zY43UtNz898j" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3LC6cG45fO1" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zNjGeoPa0QN1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDlANhNJoWxf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6Ew3pTqRk0g" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,673</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zU5YGgqPjKJ" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8ZhNdDnOWQ3" style="font-family: Times New Roman, Times, Serif">4.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPUK0aeThoBk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6WYf1SdH7he" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zRb7gybkSoa4" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z579sq0saV2f" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zB5JVJ2l2cuf" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding vested and expected to vest ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvulNuMUcy8" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zosB5Mue8Ns" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPczGfNYhzbf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A1_zkW2C8oWMg4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQ7OcSsFA711" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended
December 31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zYLAeT2GN0hd" style="display: none; font-family: Times New Roman, Times, Serif">Summary
of Non-vested Non-qualified Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of<br/>
    Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/>
    Average<br/>
    Grant-Date<br/>
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate<br/>
    Intrinsic<br/>
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date<br/>
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2018</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">48,889</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.90</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1136">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">628,756</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">130,120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_ziIADVJronFd" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(32,833</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11.10</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">362,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z4otFMEETl5d" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,056</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif">246,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2019</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11.25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">149,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">44,113</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.85</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">387,199</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXCKK685h3i1" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(57,446</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">536,733</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>
<p id="xdx_8A4_zH5VULNPWGu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0">189,568
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0">390,485
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively. As of December 31, 2020, there was <span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_do_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--UnvestedOptionsMember_ziQOLr6P6Hzb">no
</span></span><span style="font: 10pt Times New Roman, Times, Serif">unrecognized share-based compensation related
to unvested options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had granted non-qualified options to purchase <span style="-sec-ix-redline: true"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zjOsCl6XFrLa">68,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares which were performance-based. At December
31, 2020, non-qualified options to purchase <span style="-sec-ix-redline: true"><span id="xdx_902_ecustom--StockOptionToPurchaseThresholdsPerformanceBased_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCmIXE6qCABc">40,000
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were forfeited due to the failure
to satisfy the 2017, 2018 and 2019 revenue-based performance thresholds and <span style="-sec-ix-redline: true"><span id="xdx_900_ecustom--NumberOfSharesForfeitedForTerminations_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zURqBfLnTwVh">28,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares were forfeited due to employee terminations.
No compensation expense had been recognized with respect to these performance-based awards since the likelihood of performance levels
being obtained was determined to be remote.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><i>Director
Options</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zCFc8SR9IZg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8BA_zcDYgammV0ma" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Price</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                                                                                                     <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value
                                            ($000)</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zy3TzYmGCre6" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20.25</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zshS2cAkVjq3" style="font-family: Times New Roman, Times, Serif">8.6</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1211">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIRUPyMPay68" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1227">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z2YgOar2oLTk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20.25</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zsbtuxOZoko" style="font-family: Times New Roman, Times, Serif">7.6</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">43,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.55</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zv26MUYTzBEf" style="font-family: Times New Roman, Times, Serif">8.5</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zvFXeLy3Gv6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">49,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBadwX3bwOpk" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.5</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1259">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    </span><span style="font-family: Times New Roman, Times, Serif">December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zT10DkoudON4" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercisable ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">42,667</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.95</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zGRvU3mtpzvc" style="font-family: Times New Roman, Times, Serif">8.0</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A3_z39nxoqjycD4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVPmqAZOqft3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_z6dVfrIDxM4k" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zm5a7H28aOa7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1280">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1284">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1288">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1290">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1294">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1296">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font: 10pt Times New Roman, Times, Serif; display: none">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1298">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">43,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.55</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">373,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zUqshKLzVfoj" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(36,667</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">344,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1312">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1314">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1320">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,666</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">4.35</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif">5,800</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">29,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zZZaEHtVwz09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company incurred $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0">62,452
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, as compensation expense related to <span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zorFiDlAh9W1">10,000
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zgLjXmKz4hs9">0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vested options, respectively, issued to directors.
As of December 31, 2020, total unrecognized share-based compensation related to unvested options was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z5ajJHKaED88">6,412</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 2, 2020, the Company issued <span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCJMuRRndbGh">26,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested stock options to directors valued
at $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">234,126
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in respect of a 2019 special equity award that
had been accrued for in full in the Company&#8217;s financial statements at December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
on January 2, 2020, the Company issued an additional <span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z629wwxxrPqb">3,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fully vested, non-qualified stock options
under the 2017 Equity Plan valued at $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">29,266
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to directors. The options have a term of <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwOJpRME3kDg">5
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date of <span style="-sec-ix-redline: true">$<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zL05l7L0QKO8">10.50.</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<i>, </i>the Company issued <span style="-sec-ix-redline: true"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3ZOZCPBA0Bf">13,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options under the 2017
Equity Plan, valued at $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd">39,600</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
to newly appointed directors. The options vested <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zexqCu3FlxN9">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
upon grant and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--AwardDateAxis__custom--AprilOneTwentyTwentyOneMember_zGb2TJNf2Yta">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
on April 1, 2021, if the Director remains on the Board up to that time. The options have a term of <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxgj7tSgbHja">5
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years and have an exercise price equal to the
closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the grant date of <span style="-sec-ix-redline: true">$<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxlFJc1Mq8I2">4.35.</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, awards related to <span style="-sec-ix-redline: true"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementStockIssuedAndOutstanding_iI_pid_c20201231__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvRJeyS1gO9">144,340
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares remain issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Restricted
Stock Units</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zUL47KqzG6nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_z2FA4yRuxNM9" style="display: none">Schedule
of Restricted Stock Units Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"/><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Units</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zLYKEGtfMxV1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units, beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">65,782</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoDkvgGRpIGc" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvYraRHcwZTi" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"><span style="font-family: Times New Roman, Times, Serif">730,185</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdQ3rnxpf3vk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zlr5yazLd559" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvmcGADZuDF1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(7,467</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zGdtkvDbYGah" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">27.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8i7zPTqWT54" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(7,982</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3kiD56D7hE" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">26.85</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z1v5CPqXGRS1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z0WChRCBfor6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">19.20</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKotxyHZKuk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z4iF9kJJZny8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, beginning"><span style="font-family: Times New Roman, Times, Serif">50,333</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zm8GkagaaVX8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"><span style="font-family: Times New Roman, Times, Serif">19.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z9AmKkDNM4Qf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1380">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPi0nqYXNp68" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPCi3rYlC1Q2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zmibQryAVAH6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(45,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNTs2A2DAMye" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">18.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8l4ABzCc3S5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(5,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoiWPQsO9Zf5" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">27.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNoa43l0Eweb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zMxRx53UXhFg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-size: 10pt">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zhY5J2MVHkTf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zzAcU40pREgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0">25,163
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0">278,906
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested RSUs
issued to employees, directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation related to
unvested RSUs. The total intrinsic value of RSUs vested and settled with share issuance was $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">199,125
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">79,120
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019.
During the year ended December 31, 2020, the total intrinsic value of RSUs vested and settled with share issuance was $<span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0">1,105,750</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
including the intrinsic value of $<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pp0p0_c20180101__20181231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhUGJYhpbWK">1,035,750
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to RSUs that had vested in 2018 but had
not been settled until 2020 due to a dispute with a former employee over the required withholding taxes to be paid to the Company for
remittance to the appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, <span style="-sec-ix-redline: true"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pp0d_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsT85C7ji39">5,333
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs vested. However, the holder elected
to cancel the RSUs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Incentive
Stock Bonuses</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has entered into certain &#8220;at-will&#8221; employment agreements with certain employees. Under these agreements, the employees
are eligible to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion, that the employee&#8217;s
performance has been average or better for the applicable special bonus period. This special stock incentive bonus is payable only if
the employee continues in the employment of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
accounting purposes, the Company treats these special incentive stock bonuses as vesting over each bonus&#8217;s service period based
on the fair value of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards are vested over
each service period because it is more likely than not that the Board will approve the award based on the &#8220;average or better&#8221;
employee performance standard. Since the awards are denominated in shares of common stock, the fair value of the vested bonus is charged
to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p id="xdx_891_eus-gaap--ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_ziFEO8U93GXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_z52aX6sTffS9" style="display: none">Schedule
of Incentive Bonus Awards Granted to Employees</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"/><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Shares</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average
                                            Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Shares, Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11,200</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif">124,320</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1417">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zceX362Zxk0l" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(11,200</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1425">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Unvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zN2GIWIYIJF7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1441">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1445">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AB_zyuIhDceAjI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the years ended December 31, 2020 and 2019, the Company recorded $<span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">44,209
</span></span><span style="font: 10pt Times New Roman, Times, Serif">as compensation expense related to vested stock
bonus awards issued to employees, net of forfeitures of $<span id="xdx_90B_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90A_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">0</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. As of December 31, 2020, there was no unrecognized share-based compensation related to unvested stock bonus awards. The
total intrinsic value of stock bonus awards vested and settled with share issuance was $<span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0">58,240
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868716248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zMBnk2MfMPf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
12 &#8211; <span id="xdx_82F_zNkEtzZJVBlf">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_c20210930_pp0p0">20,260,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_900_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210930_pp0p0">11,196,261</span></span> <span style="font: 10pt Times New Roman, Times, Serif">will
expire, if not utilized, in the years <span id="xdx_900_ecustom--NetOperatingLossExpirationTerm_c20210101__20210930">2034 through 2037</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_908_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_znCWXrxJQtik">80%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the <span id="xdx_90A_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_zhH5W4pCXr1d">80%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">limitation for NOLs arising in 2018, 2019 and
2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company&#8217;s NOLs carryforwards may be
limited in the event of cumulative changes in ownership of more than <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_uPure_c20210930_zx19LEtl67Gl">50%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">within a <span id="xdx_900_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zHVjGRvejb71" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl2825">three</span></span>-year
period</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2021 and December 31, 2020.
Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred
tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support
the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on
assumptions that are consistent with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates,
the carrying value of the Company&#8217;s deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
<td class="text"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zFn74fOaMw41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
15 &#8211; <span id="xdx_821_zV4uM1NQFNTb">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
financial reporting purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended December
31, 2020 or 2019 due to the Company&#8217;s net operating losses (&#8220;NOLs&#8221;) in such periods and full valuation allowance recorded
against the net deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIiW34TQAIW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are
summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B2_zCTN8kcubVtb" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20200101__20201231_zWYVRZsLcYri" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20190101__20191231_zGHYoW3blb12" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes computed at the federal statutory rate</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(369,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(281,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">States
    taxes, net of federal benefits</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(69,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent
    differences</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(136,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--IncomeTaxReconciliationTrueUpAdjustments_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">True-up
    adjustments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">199,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment
    to net operating loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(86,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">476,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income tax (benefit) expense</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A8_zyq5pdPWZQNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zekBiNAzsxq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zhtemzF3Nnt7" style="display: none">Schedule
of Deferred Tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20201231_zelcwOq4Sb3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20191231_zfefclUeptM9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    operating losses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,821,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,081,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">118,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,108,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,622,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_zshjP3fwbMSl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets before valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,040,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,564,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zCTUfLxwNkrl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,040,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,564,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A4_zbmvDjdR9RRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0">19,322,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_90F_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20201231_pp0p0">11,196,261</span></span> <span style="font: 10pt Times New Roman, Times, Serif">will
expire, if not utilized, in the years <span id="xdx_907_ecustom--NetOperatingLossExpirationTerm_c20200101__20201231">2034 through 2037</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to <span id="xdx_90D_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zOGGU7TACqT">80</span></span><span style="font: 10pt Times New Roman, Times, Serif">%.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the <span id="xdx_901_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zRlhzWwnJjW3">80</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of
the Company&#8217;s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201231_zbdq5FyH17te">50</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
within a <span id="xdx_903_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zMkApDHh82mg" title="::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1512">three</span></span></span><span style="font: 10pt Times New Roman, Times, Serif">-year
period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required
in determining the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020 and 2019. Based on the available
evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable
future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation
allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent
with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying value of the Company&#8217;s
deferred tax assets could be materially impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary course
adjustments or proposed adjustments to the Company&#8217;s taxes or the Company&#8217;s net operating losses with respect to years under
examination as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014 through 2019, Alaska,
California and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income tax returns for the years
2018 and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes in its consolidated financial statements the impact of a tax position, if that position is more likely than not of
being sustained on audit, based on the technical merits of the position. The Company&#8217;s policy is to recognize interest and penalties
accrued on any unrecognized tax benefits as a component of operating expense. The Company does not believe there are any tax positions
for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within
twelve months of the reporting date. There were <span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_do_c20200101__20201231_zWYfcHjyipc5">no
</span></span><span style="font: 10pt Times New Roman, Times, Serif">penalties or interest liabilities accrued as
of December 31, 2020 or 2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020 and
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869236824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zP1iivNZTJzb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
14 &#8211; <span id="xdx_82A_z2PEJ4LfiuGc">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after September 30, 2021, other than as set out below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we increased our authorized capital to one billion shares of capital stock, of which <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4zLWfurIhdj">850,000,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">are designated as common stock and <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztNDlqGT8Kli">150,000,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">are designated as preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 3, 2021, we were authorized to redeem the outstanding Series A Preferred Stock, which was completed on November 4, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
November 4, 2021, we received the remaining $<span id="xdx_90F_eus-gaap--ReplacementReserveEscrow_iI_c20211104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z14mvNVr5na7">1,365,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from escrow in relation to the Series B Preferred
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z2bHrjzoD924" title="Reverse stock split, Description">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span> The par value for the Common Stock was not
affected.</span> In connection with the aforementioned reverse stock split, the Company&#8217;s Board of Directors approved the reset of the authorized
capital of the Company to be <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVpBvvLoCOq6">200,000,000</span> shares of common stock and <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z21iLzVisd8b">25,000,000</span> shares of preferred stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true">On January 28, 2022, the Company
agreed with the Series B investor to redeem <span id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9d2g4ETonk5" title="Shares redeemed">1,650</span> shares of the Company&#8217;s Series B Preferred Stock for approximately $<span id="xdx_90E_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv8nUM08RI24" title="Redemption value">2.0</span> million
following the closing of the Company&#8217;s offering.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zAR15HqRAUrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
16 &#8211; <span id="xdx_82B_zoP28A0e9LHg">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
accordance with ASC 855, <i>Subsequent Events</i>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. The following events occurred after December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board approved annual incentive compensation awards to certain employees payable in non-qualified stock options, based on the Company&#8217;s
performance and each employee&#8217;s contributions to such performance for the 2020 year. A total of <span style="-sec-ix-redline: true"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zulljffyN1ti">6,905
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified stock options were granted
under the 2017 Equity Plan subsequent to December 31, 2020, with an exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd">19.50
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. These non-qualified stock options
were immediately vested at the date of the grant. The estimated compensation expense of $<span id="xdx_902_eus-gaap--DeferredCompensationLiabilityCurrent_c20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0">128,434
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related to the 2020 incentive awards was accrued
as of December 31, 2020. The accrued compensation expense was classified as a current liability as of December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed <i>in Note 10 Related Party Agreements and Transactions </i>above, on January 7, 2021, the Company entered into a consulting
agreement with RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide
consulting services to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related
matters, as mutually determined by the Company and RSX. The Company will pay a monthly consulting fee of $<span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_zQO9a9zL5Q4k">6,500
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 9 Note Payable and Accrued Interest</i> above, on February 10, 2021, we received funding based on a loan
agreement entered into on February 9, 2021 with our current bank in the principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zst0UBycpj21">514,200
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zn6ZozLI9vE5">1</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default provisions, including
for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in Note 11 Commitments and Contingencies above, a former employee is pursuing litigation against the Company for recovery
of alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. </span><span style="font-family: Times New Roman, Times, Serif">The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zDQbs5fsQDje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span></span> <span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
par value for the Common Stock was not affected. In connection with the aforementioned reverse stock split, the Company&#8217;s Board of Directors approved the reset of the authorized
capital of the Company to be <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zje09WBADQwh">200,000,000</span> shares of common stock and <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHNfuUnA6Fuf">25,000,000</span> shares of preferred stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect
to the Reverse Split for all periods presented.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true">On January 28, 2022, the Company
agreed with the Series B investor to redeem <span id="xdx_904_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXzzUF0tHDn2" title="Shares Redeemed">1,650</span> shares of the Company&#8217;s Series B Preferred Stock for approximately $<span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhwDt3wU5Oq4" title="Redemption value">2.0</span> million
following the closing of the Company&#8217;s offering.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872904360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureTemporaryEquityAbstract', window );"><strong>Temporary Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_TemporaryEquityTextBlock', window );">Temporary Equity</a></td>
<td class="text"><p id="xdx_804_ecustom--TemporaryEquityTextBlock_zyeOd45ANRwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
8 &#8211; <span id="xdx_826_zyKj3TvutyTe">Temporary Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Series
B Redeemable Convertible Preferred Stock</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, Surna Inc. (the &#8220;Company&#8221;) sold to an institutional investor (the &#8220;Investor&#8221;), <span id="xdx_90A_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zWBfeh5lB161">3,300
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Convertible Preferred Stock,
stated value $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zyShvMTCTPW3">1,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, currently convertible into <span style="-sec-ix-redline: true"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zlsLpbEYhPMl">385,965
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, and a warrant to
purchase up to <span style="-sec-ix-redline: true"><span id="xdx_901_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember__srt--RangeAxis__srt--MaximumMember_z8NTY7KVPXS">192,982
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock (&#8220;Investor Warrant&#8221;),
for an aggregate purchase price of $<span id="xdx_904_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zu6Iagl612Af">3,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#8220;Consideration&#8221;). The Company will
receive net proceeds of approximately $<span id="xdx_90B_ecustom--TemporaryEquityNetProceeds_c20210926__20210928_z9WzIusTMoG8" title="Temporary equity net proceeds">2,625,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Company has received net proceeds of approximately $<span id="xdx_900_ecustom--TemporaryEquityNetProceeds_c20210701__20210930_zjaujvOgy6I">1,260,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the quarter and will receive the remaining
$<span id="xdx_90C_eus-gaap--EscrowDeposit_iI_c20210928_z2YUezDmOyY">1,365,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursuant
to the terms of the escrow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Stock has an annual dividend of <span id="xdx_90C_eus-gaap--PreferredStockDividendRatePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zlCYDAncZO02">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and has an initial common stock conversion price of <span style="-sec-ix-redline: true">$<span id="xdx_90F_eus-gaap--CommonStockConvertibleConversionPriceIncrease_pid_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zSQQvS8yH7ze">8.55.</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion rate is subject to adjustment in
various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering
event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering,
is sold at a price below the then conversion price. The Series B Preferred Stock is mandatorily convertible on the third anniversary
of its issuance. All conversions of the Series B Preferred Stock are subject to a blocker provision of <span id="xdx_909_ecustom--PercentageOfPreferredStockConversionProvision_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z8c2PmowmfF3">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.
The Company will reserve <span id="xdx_90F_ecustom--PercentageOfCommonStockReserve_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0d9woEHBsdi">200</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the number of shares of common stock into which the Series B Preferred Stock and Investor Warrant may be converted or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pending
completion of an amendment to the certificate of incorporation to increase the number of authorized shares of common stock and redeem
the outstanding Series A Preferred Stock, as required by the Investor, $<span id="xdx_90E_eus-gaap--PreferredStockValueOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNbGvRSZCqO3">1,365,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Consideration was placed in escrow. The
Company filed a Schedule 14C to affect the amendment and expects the amendment process to be completed in early November, at which time
the escrowed amount will be released to the Company. If the amendment process is not achieved by December 7, 2021, then the Company will
redeem, at <span id="xdx_90C_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8hIvSe4Y7Sl">120</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the stated value of $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_pid_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6oU9KX0d8Tj">1,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, <span id="xdx_908_ecustom--DebtInstrumentRedeemableShares_iI_pid_uShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1f2Ow9Tpaxj" title="Redeemable shares">1,650
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Series B Preferred Stock, and pay
the dividend amount due thereon at <span id="xdx_90D_ecustom--DebtInstrumentRedemptionPricePercentageDividendDueThereon_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVTxKe9selXc" title="Redemption price percentage dividend due thereon">8</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
to the date of redemption. The Series B Preferred Stock will be redeemed at the demand by the holders, at <span id="xdx_904_eus-gaap--DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVymgD77fFgc">120</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the stated value of $<span id="xdx_90D_ecustom--DebtInstrumentRedeemptionStatedValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJCPKwPW8pw6">1,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
at any time after the earlier of (x) the consummation by the Company of a qualified offering, or (y) the first anniversary of the issuance
of the Series B Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Investor was granted a right of participation in future private offerings and has agreed to a 180-day lock-up in connection with a qualified
offering. A &#8220;qualified offering&#8221; is the first public offering after the sale of the Series B Preferred Stock in which the
common stock of the Company is listed on a national exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor Warrant may be exercised until <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zqeGoFx5RzX6">September
28, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at an initial exercise price of <span style="-sec-ix-redline: true">$<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uUSDPShares_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zlpQsIh0MOu3">9.41,</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject to adjustment. The Investor Warrant provides
for cashless exercise if the underlying shares of common stock are not registered for resale, and all issuances of common stock upon
exercise are subject to a <span id="xdx_90B_ecustom--IssuanceOfCommonStockExercisePercentageProvision_pid_dp_uPure_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zIbASQMACAu9">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
blocker provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company granted the Investor registration rights for the shares of common stock underlying the Series B Preferred Stock and the Investor
Warrants. The Company must file a registration statement no later than 180 days after the date of a qualified offering and have it effective
in 45 days if there is no Securities and Exchange Commission (&#8220;SEC&#8221;) review, or if there is a review, within 75 days. The
Company must keep the registration statement effective until all the shares registered have been sold or may be sold under Rule 144,
without regard to volume and holding period restrictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company engaged ThinkEquity LLC (&#8220;ThinkEquity&#8221;) as its placement agent and paid a total cash fee of <span id="xdx_905_ecustom--PercentageOfPlacementAgentCashFee_pid_dp_uPure_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zkKvu7yQ7UE7" title="Percentage of placement agent cash fee">9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%,
or $<span id="xdx_90D_eus-gaap--InvestmentCompanyShareholderServiceFeeExpense_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zC5IYCbjCbQl">270,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and its expenses, less prepaid expenses, and issued to ThinkEquity and its designees a warrant to purchase up to an aggregate of <span style="-sec-ix-redline: true"><span id="xdx_905_ecustom--WarrantToPurchaseCommonStockShares_pid_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zniC59FA7AYj" title="Warrants to purchase of common stock shares">34,737
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. The exercise price
of the warrant initially will be <span style="-sec-ix-redline: true">$<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_z2kgrNrgMlhl">10.40
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, subject to typical adjustment
provisions, and exercisable for a term of three years. The warrant has registration rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Probability
of Redemption: As it was considered probable the Series B Preferred stock will become redeemable outside of the Company&#8217;s control,
the Series B Preferred stock needs to be disclosed as temporary equity and restated at the balance sheet date at its redemption value
of <span id="xdx_906_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zua3LY9d3Dfe">120</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
the stated value of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zr7TYjVvCTj9">1,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share, or $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleLiquidationPreferenceValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zOxdEVN2QBe">3,960,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
As a result, on September 30, 2021, the Company adjusted the carrying value of the Series B Preferred Stock to its redemption value of
$<span id="xdx_906_eus-gaap--TemporaryEquityAccretionToRedemptionValue_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNOlS2Egi2zg">3,960,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and recorded a $<span id="xdx_90C_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zHUgFEv6mycd">2,262,847
</span></span><span style="font: 10pt Times New Roman, Times, Serif">non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment
is therefore added to the &#8220;Net Loss&#8221; to arrive at &#8220;Net Loss Attributable to Common Shareholders&#8217;&#8221; on the
Company&#8217;s Consolidated Statements of Operations. In addition, since the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Series
B Redeemable Convertible Stock Subscription Receivable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the net proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zafp6uInVS2a">2,624,874
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">receivable under the Securities Purchase Agreement
relating to the Series B preferred stock and related warrants, $<span id="xdx_909_eus-gaap--EscrowDeposit_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zE1knPwY12g8">1,365,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was put into escrow pending the completion of
i) an amendment to the Articles of Incorporation to increase the number of authorized shares of common stock to <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQbFzRpg8t7k">850,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares, (ii) <span id="xdx_907_eus-gaap--TemporaryEquityDescription_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zACZMVqRxdW2">the
redemption of the outstanding shares of Series A Preferred Stock of the Company for common stock at the rate of <span style="-sec-ix-redline: true">one 0.0067</span> share
of common stock for each 100 shares of preferred stock that is currently issued and outstanding,</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the authorization of a reverse stock split of the common stock in connection with the listing of the common stock on an eligible market
(as defined in the Purchase Agreement), and, if the number of authorized shares of common stock is reduced in connection with such reverse
stock split, the subsequent increase of the authorized shares of capital stock of the Company within established limits, at any time
prior to June 30, 2022, and (iv) an amendment to the articles of incorporation to change the corporate name of the Company to CEA Industries
Inc. If these amendments are completed by December 7, 2021, then the remaining $<span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20211207__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGPpnFN9v8uc">1,365,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">funds held in escrow will be released to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly,
as of September 30, 2021, these funds were disclosed as Series B Redeemable Convertible Stock Subscription Receivable on the Company&#8217;s
consolidated balance sheet</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureTemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureTemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary [Equity Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328873044472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Deficit</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zLEMEAvq5Fn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Note
9 &#8211; <span id="xdx_82C_zz7QT1VL2MP">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company has <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zRGC0qPCawdc">150,000,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares authorized at a $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zgPNbhg2GWK4">0.00001
</span></span><span style="font: 10pt Times New Roman, Times, Serif">par value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
A Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company has <span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zti7WHe7QRh">42,030,331
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares issued and outstanding at the end of both
periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series
B Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2021, the Company entered into a Securities Purchase Agreement (&#8220;Purchase Agreement&#8221;) with an institutional
investor (the &#8220;Investor&#8221;), pursuant to which the Investor purchased from the Company <span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodShares_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z5z12iiRU4nb">3,300
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series B Preferred Stock with a stated
value of $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zd56CbRHW8mi" title="Preferred stock, par value">1,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, or $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zqvskA2dB5Hc">3,300,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of stated value in the aggregate (&#8220;Series
B Preferred Stock&#8221;), and a warrant to purchase up to <span style="-sec-ix-redline: true"><span id="xdx_905_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--RangeAxis__srt--MaximumMember_zOWckPCvqsVb">192,982
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock of the Company (&#8220;Investor
Warrant&#8221;), for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z72nQJTrrb54">3,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#8220;Consideration&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
a result of the PIPE Financing, referenced above and described in <i>Note 8</i>, the Company has <span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIjq8sNHF6H5">3,300
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares issued and outstanding as of September
30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, and December 31, 2020, the Company was authorized to issue <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_zbiPacSZuf9h">350,000,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of common stock with a par value of $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zgGn7QJ9Dp8h">0.00001
</span></span><span style="font: 10pt Times New Roman, Times, Serif">per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
December 31, 2020, <span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20201231_z3hDxtp71bC9">1,576,844</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
of common stock were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2021, we issued <span style="-sec-ix-redline: true"><span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210101__20210930_zfzi6EWxLpLd">6,667
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, valued at $<span id="xdx_90C_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210101__20210930_zl6dL0o0Gvyg">67,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as part of a legal settlements further described
in <i>Note 7 &#8211; Commitments and Contingencies &#8211; litigation above.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequently,
effective September 30, 2021, <span style="-sec-ix-redline: true"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20210930_zIZVyOIDlQug">1,583,511</span></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock were issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328857908888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Financial Statement Presentation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4LOmZMhz1B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zujbAruiUlK6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal
year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that
date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information,
refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December
31, 2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTcPRP4mKzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Financial
Statement Presentation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect reported amounts and related disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
further discussed in <i>Note 3 Going Concern</i> below, the accompanying consolidated financial statements have been prepared on a going-concern
basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance of debt
and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar to those encountered
by similarly situated companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split</a></td>
<td class="text"><p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zUg2Ott7hvRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zDkXudJYVMFg">Reverse
Stock Split</span></i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbIYs7NwCvDd">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span> The par value for the Common Stock was not affected.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_ecustom--ReverseStockSplitPolicyTextBlock_zTl66P5IWeHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zfp1oBXX6f91">Reverse
Stock Split</span></i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqon6yE9Vegg" title="Reverse stock split, Description">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</span> The par value for
the Common Stock was not affected.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation and Reclassifications</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zOedN0ypY9x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86D_zLl5cOPbrYQ6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Basis
of Consolidation and Reclassifications</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zs3k93Zgl0Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Principles
of Consolidation </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&#8220;Hydro&#8221;). Intercompany transactions, profit, and balances are eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_848_eus-gaap--UseOfEstimates_zJVd4mMFskNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_863_zN73GZSCE8s6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--UseOfEstimates_zlmaiNJEfrt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Use
of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis,
valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and
legal contingencies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zl86gz0nfezg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash
and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z6ql9vwpH4G1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounts
Receivable and Allowance for Doubtful Accounts</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest.
An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which, in management&#8217;s
judgment, deserve current recognition in estimating bad debts. Based on the Company&#8217;s review, it establishes or adjusts the allowance
for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and December 31, 2019, the allowance
for doubtful accounts was $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20201231_zdjIevpfTdKh">165,098
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_zxkw667tEk6j">151,673</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zBZYSZAY5ym6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Inventory</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#8220;FIFO&#8221;) basis.
Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other
factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence
or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis for that inventory is established
and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete inventory was $<span id="xdx_904_eus-gaap--InventoryAdjustments_c20201231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0">93,045
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90C_eus-gaap--InventoryAdjustments_c20191231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0">71,376</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zmAnTf818dk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Property
and Equipment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using
the straight-line method over their estimated useful lives, which is generally <span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20200101__20201231_zNah8Ikifnz3">five
years</span></span><span style="font: 10pt Times New Roman, Times, Serif">. Leasehold improvements are amortized on
a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and
related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zDncFzdzn0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Long-lived
Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate
the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#8217;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending
on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December 31, 2020 and
2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zPdvc7qsrOn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zd0DSFrKazgl" style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#8217;s fair value. The Company determined that it has one reporting unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at September 30, 2021 and concluded that no impairment
relating to goodwill existed at September 30, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zKICEDwa9Pej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Goodwill
and Intangible Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December
31<sup>st</sup> or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced
to less than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing
the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its
carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount
exceeds the reporting unit&#8217;s fair value. The Company determined that it has one reporting unit. The Company completed this assessment
as of December 31, 2020 and concluded that no impairment existed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#8217;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are also subject
to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zEjfko1IosTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Fair
Value Measurement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring
fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes the inputs used
in the valuation methodologies in measuring fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability,
either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level
3 - inputs are unobservable inputs based on the Company&#8217;s assumptions used to measure assets and liabilities at fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
financial asset or liability&#8217;s classification within the hierarchy is determined based on the lowest level of input that is significant
to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
in its entirety requires management to make judgments and consider factors specific to the asset or liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses,
approximate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zaxVqM2qYCHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Derivative
Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded
at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;)
to value the derivative instruments. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within
twelve months of the balance sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zCxpnpInTo8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_860_zT8U5MdyHhtg" style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s
project life cycle from facility design and construction to equipment delivery and system installation and start-up.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#8217;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s
customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the three and nine months ended September 30, 2021, the Company recognized revenue of $<span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210701__20210930_pp0p0">283,452
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210930_pp0p0">3,357,068</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2021. For the three and nine months ended September 30, 2020, the Company
recognized revenue of $<span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200701__20200930_pp0p0">9,141</span></span>
<span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200930_pp0p0">1,074,016</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, related to the deferred revenue at January 1, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of September 30, 2021, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligation_c20210930_pp0p0">9,881,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0">1,161,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20210930_zfUHZeWvm788">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic disruption or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at September 30, 2021, includes booked sales orders of $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_uUSD_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OrderOrProductionBacklogMember_zQiH5yXcW5Ol">1,250,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until late 2022. The Company believes the sales orders in this portion of our backlog have an elevated level
of risk and may, ultimately, be delayed or cancelled by our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining performance obligations
    related to engineering only paid contracts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,049,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,161,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining performance
    obligations related to partial equipment paid contracts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,091,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,629,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,720,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total remaining performance
    obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,203,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,678,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,881,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AD_zdZ6cVm80Sc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment and systems sales</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,523,948</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,481,961</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">9,933,313</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">4,575,855</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering and other services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">110,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">114,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">464,269</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">402,837</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping and handling</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">71,950</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">38,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">184,888</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">148,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,706,436</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,634,669</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">10,582,470</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">5,127,018</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A3_zSYfASf65Z46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zgCRCRGtuXb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Revenue
Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
January 1, 2018, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with
Customers</i> and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected
the modified retrospective method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_z4lP7SDCLJWe" style="display: none">Schedule
of Revenue by Source</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment
    and systems sales</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">7,730,371</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">13,692,863</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering
    and other services</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">568,131</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,239,130</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping
    and handling</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">215,770</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">292,461</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">8,514,272</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">15,224,454</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8AA_zGjsAig9HX6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Revenue
Recognition Accounting Policy Summary</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract
with a customer to transfer a distinct good or service to the customer. Most of the Company&#8217;s contracts contain multiple performance
obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#8217;s project life-cycle from facility design and construction to equipment
delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some
of the Company&#8217;s contracts with customers contain a single performance obligation, typically engineering only services contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate
margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the
Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each promise is fulfilled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange
for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical rates of return are
insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes
revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and
certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected
by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and
shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other
Judgments and Assumptions</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the
effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company
transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly,
the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contract
Assets and Contract Liabilities</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to
payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based
on the terms established in its contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional,
subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019, the
Company had no contract assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&#8217;s contract liabilities are recorded as a current
liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is
generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which was classified as a current liability,
was $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_c20201231_pp0p0">3,724,189</span></span> <span style="font: 10pt Times New Roman, Times, Serif">and
$<span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_c20191231_pp0p0">1,444,472</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">For
the year ended December 31, 2020, the Company recognized revenue of $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20201231_pp0p0">1,103,447
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2020, or <span id="xdx_90D_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20200101__20201231_zHtCzzzTCDCe">76%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.
For the year ended December 31, 2019, the Company recognized revenue of $<span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190101__20191231_pp0p0">473,682
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the deferred revenue at January 1,
2019, or <span id="xdx_90A_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20190101__20191231_zq9x62DeXgN3" title="Deferred revenue">74%</span></span><span style="font: 10pt Times New Roman, Times, Serif">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Remaining
Performance Obligations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate,
the uncertainty regarding the COVID-19 virus, and the Company&#8217;s recent cost cutting measures, there is no assurance that the Company
will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2020, the Company&#8217;s remaining performance obligations, or backlog, was $<span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_c20201231_pp0p0">8,448,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
of which $<span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0">2,643,000</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
or <span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20201231_z30QSaSK844a">31%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#8217;s engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-COVID-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at December 31, 2020, includes booked sales orders of $<span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0">390,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">from several customers that the Company does
not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus
COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to engineering only paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,355,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,643,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to partial equipment paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,703,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,805,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    remaining performance obligations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,058,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">390,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p id="xdx_8A7_zeRp94luEPKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--StandardProductWarrantyPolicy_zxr65VYWAhla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Warranty</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company&#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&#8217;s option)
that fail to perform within stated specification. The Company&#8217;s third-party suppliers also warrant their products under similar
terms, which are passed through to the Company&#8217;s customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231" style="font: 10pt Times New Roman, Times, Serif">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.</span> <span style="font: 10pt Times New Roman, Times, Serif">The Company continues to
assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of December 31, 2020,
and December 31, 2019, the Company had an accrued warranty reserve amount of $<span id="xdx_90F_eus-gaap--ProductWarrantyAccrual_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0">173,365
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--ProductWarrantyAccrual_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0">185,234</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, which are included in accounts payable and accrued liabilities on the Company&#8217;s consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zEcqOoSPJnV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Cost
of Sales</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs,
engineering, project management and service salaries and benefits, client visits and warranty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zgAxWufL4G8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zCLI7eHLyfci" style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3jKyMJ5YAS4">38</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_za4qYsaP3jh3">23</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z8bHMCB4y0h2">11</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2021 and three customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zApQM56jYBd2">25</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHTpxjPgaqK1">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1hn6lzZsVuc">12</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2021. Two customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPuKUHIkvXUg">39</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUGTRBLN1Dfd">30</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the three months ended September 30, 2020 and three customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zh5VodyGBjKh">18</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIBTh36OT6yc">17</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjBnFGuFf4Ak">11</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s revenue for the nine months ended September 30, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHhpAYN5FCRe">40</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zELcnQgAMOLf">26</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHU7QSoRrj07">22</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable as of September 30, 2021. As of September 30, 2020, four customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkftRueBQBp7">32</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zs0b7Bbnarb2">23</span></span><span style="font: 10pt Times New Roman, Times, Serif">%,
<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zxDkjiX7Kwsj">21</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zpzVLaWk3dO8">10</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
of the Company&#8217;s accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_znT1zQ2fQ3V3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Concentrations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7EXjLtBKGU">28%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUkoZNs5WGZd">11%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwGAS5FHOBnk">10%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2020. One customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZAensU29mbg">44%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s revenue for the year ended
December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s accounts receivable from two customers made up <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxScHmlvski4">48%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zA7ejDrKZqO8">38%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2020. The Company&#8217;s accounts receivable from three customers made up <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAipeN8Z20e6">59%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zXsXKQk317Hh">16%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z47qSd94Iapd">10%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, of the total balance as of December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Three
suppliers accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_z0mqrL4McdJk">27%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_z4ZomONCErN7">25%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zwt5jRpeus13">12%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2020, and three suppliers accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_zBQ2j3z3t6Ic">30%</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_zdHzBgLUz9J9">17%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zHfGZV1KqW99">12%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">of the Company&#8217;s purchases of inventory
for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Product Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_zG7r1p9byb8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Product
Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For the
years ended December 31, 2020 and December 31, 2019, the Company incurred $<span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pp0p0">390,229
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20190101__20191231_pp0p0">521,044</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, on product development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfQMiP6BT2ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_zA6zAZxFgwvj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the nine months ended September 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20210101__20210930_zjmEsX3sHaI3">150.2</span></span><span style="font: 10pt Times New Roman, Times, Serif">%
to <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20210101__20210930_zHAcn2McUsf9">152.51</span></span><span style="font: 10pt Times New Roman, Times, Serif">%;
expected term in years <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zPhzX5q4QUH2">10</span> and risk-free interest rate ranged from <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20210101__20210930_zkfR1HWzjVYc">0.55%
</span></span><span style="font: 10pt Times New Roman, Times, Serif">to <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20210101__20210930_zs7PKLO3x2L9">1.49</span></span><span style="font: 10pt Times New Roman, Times, Serif">%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Share-based Compensation Costs</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based compensation expense included in:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">6,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,944</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">23,949</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">2,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">13,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">7,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2308">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">5,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">14,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">16,332</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling, general and
    administrative expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0">29,307</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">41,221</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">102,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">306,448</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total share-based compensation
    expense included in consolidated statement of operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,307</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">55,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">160,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">354,229</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A4_ziNbaFNKOUKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Included
in the expense for the three and nine months ended September 30, 2021, is an accrual for $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zNd3DhHNSvr2">0
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">108,945</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2021 Annual Employee Incentive Compensation Plan. Included in the expense for the three and nine months ended September
30, 2020, is an accrual for $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">31,575
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0">101,472</span></span><span style="font: 10pt Times New Roman, Times, Serif">,
respectively, for the 2020 Annual Employee Incentive Compensation Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvislvwPapy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Accounting
for Share-Based Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on
their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on
a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are
recognized ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the probability
assessment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the award
between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the
service inception date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the
award between the Company and the recipient has not yet been established. For awards in which the service inception date precedes the
grant date, compensation cost is accrued beginning on the service inception date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Subsequent
to December 31, 2020, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved annual incentive compensation awards
to certain employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020, were
not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of the annual
incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to the employee, subsequent
to December 31, 2020. The estimated compensation expense of $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyIncentiveAwardsMember_pp0p0">128,434
</span></span><span style="font: 10pt Times New Roman, Times, Serif">related to the 2020 incentive awards was accrued
as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation expense
has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant by the Board.
At that time, the incentive award becomes equity-classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates
whose term is consistent with the expected term of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0">405,617
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and $<span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0">1,292,065
</span></span><span style="font: 10pt Times New Roman, Times, Serif">for the years ended December 31, 2020 and 2019,
respectively. Such share-based compensation costs are classified in the Company&#8217;s consolidated financial statements in the same
manner as if such compensation was paid in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>


<p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Share-based Compensation Costs&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation expense included in:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost
    of revenue</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">31,006</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">91,081</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">8,333</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">33,977</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">21,882</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">45,330</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">344,396</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,121,677</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    share-based compensation expense included in consolidated statement of operations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">405,617</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,292,065</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<p id="xdx_8A2_znBGzekj8KMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zZFabdYGDZd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets
and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change
in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized.
In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company
determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company
would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely
than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions
that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely
than not to be realized upon ultimate settlement with the related tax authority.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (Loss) Per Common Share</a></td>
<td class="text"><p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_z6n3qvro9Dvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zPuTYzvaZqPj" style="font: 10pt Times New Roman, Times, Serif"><b><i>Income
(Loss) Per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">During
the nine months ended September 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were convertible into shares of the Company&#8217;s common stock. During
the three- and nine-month periods ended September 30, 2021 and 2020, the Company incurred a net loss and consequently the common share
equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such
inclusion would have been anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2021, and 2020, there were respectively, <span style="-sec-ix-redline: true"><span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210930_z5pG22FYYXFe">777,888
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span style="-sec-ix-redline: true"><span><span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200930_zC71P0oJdjQ4">293,383</span>,</span></span></span><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zBNKrztrBhN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Basic
and Diluted Net Loss per Common Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in periods
when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist
of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.
As of December 31, 2020, <span style="-sec-ix-redline: true"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20201231_zgkHDLjgCbZd">194,757
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential common shares equivalents from
warrants and options were excluded from the diluted EPS calculations as their effect is anti-dilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zwYc4ooBD3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commitments
and Contingencies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its
business, that cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters.
An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred
and the amount of loss can be reasonably estimated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OtherRisksAndUncertaintiesPolicyTextBlock', window );">Other Risks and Uncertainties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_ecustom--OtherRisksAndUncertaintiesPolicyTextBlock_zQGam3vB1Cz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Other
Risks and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that
such products will be successfully marketed. These factors could have a material adverse effect upon the Company&#8217;s financial results,
financial position, and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Consolidated Financial Statements</b></span></p>

<div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#8217;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty of
market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and equipment
to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states have legalized
medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well as its derivatives. Any
changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local cannabis laws and regulations
that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#8217;s customers. The Company&#8217;s
success is also dependent upon its ability to raise additional capital and to successfully develop and market its products. See Note
3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaIrUYsyqDmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Segment
Information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the Company&#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znKZgsEHZZg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86F_znjFYXzb42Jh" style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
May 2021, the FASB issued ASU 2021-04, <i>Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. </i>This guidance clarifies and reduces diversity in an issuer&#8217;s accounting for modifications or exchanges
of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective
for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively
to modifications or exchanges occurring on or after the effective date. The Company anticipates that the adoption of this guidance will
not have a material impact on its consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06,
Debt &#8212; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40) (&#8220;ASU 2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company early adopted ASU 2020-06 effective January 1, 2021. The early
adoption of ASU 2020-06 impacted the Company&#8217;s accounting for the issuance of its Series B Redeemable Convertible Preferred Stock
as further discussed in <i>Note 8 Temporary Equity Series B Redeemable Convertible Preferred Stock</i> below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
March 2020, the FAS issued ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#8221; (&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
January 2020, the FASB issued ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</i> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#8217;s consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zi6trV1w80E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Recently
Issued Accounting Pronouncements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
August 2020, the FASB issued ASU 2020-06: &#8220;<i>Accounting for Convertible Instruments and Contracts In An Entity&#8217;s Own Equity&#8221;
(&#8220;ASU 2020-06&#8221;)</i> ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation
models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by requiring
the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04 using either
a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning after December 15,
2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020. The Company does not expect
this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
December 2019, the FASB issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DescriptionOfBusinessPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_840_ecustom--DescriptionOfBusinessPolicyTextBlock_zCrEyYE0LZM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_866_zpXOwa8Kf3E7" style="font: 10pt Times New Roman, Times, Serif"><b><i>Description
of Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. (the &#8220;Company&#8221;) was incorporated in Nevada on October 15, 2009 and operates under the trade name of Surna Cultivation
Technologies. We are headquartered in Boulder, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Surna
Inc. is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled
Environment Agriculture (CEA) industry. We leverage our experience in this space to bring value-added technology solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy evolving state and local construction
codes, permitting and regulatory requirements. In service of the CEA industry, our principal service and product offerings include: (i)
architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based
process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting
and climate control, and (vi) preventive maintenance services for CEA facilities. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada and other international locations. Customers are those growers building new facilities and those expanding
or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities operating in the cannabis industry, ranging from several thousand to more than <span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20210930__srt--RangeAxis__srt--MinimumMember_z9XF0A7t1rH6">100,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">square feet. Although most of our customers do,
we neither produce nor sell cannabis or its related products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock', window );">Impact of the COVID-19 Pandemic on Our Business</a></td>
<td class="text"><p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zJ5g1hjT3xui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_862_zRL47ZLChTta" style="font: 10pt Times New Roman, Times, Serif"><b><i>Impact
of the COVID-19 Pandemic on Our Business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations
around the world, with an impact on our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, a general shortage of containers, and domestic truck driver availability.
While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue
to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed
by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others
in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and
provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long
they will continue as they are out of our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Surna
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes
to Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>September
30, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(in
US Dollars except share numbers)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(Unaudited)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p id="xdx_844_ecustom--GoingConcernPolicyTextBlock_zDO8KhTKWmPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zH89du6fObc6" style="font: 10pt Times New Roman, Times, Serif"><b><i>Going
Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zkRbnsKyCUxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_861_zphXuS9sKzbi" style="font: 10pt Times New Roman, Times, Serif"><b><i>Cash,
Cash Equivalents and Restricted Cash</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_TemporaryEquityPolicyTextBlock', window );">Temporary Equity</a></td>
<td class="text"><p id="xdx_84B_ecustom--TemporaryEquityPolicyTextBlock_zE2Zaf4pfC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_869_zRlN1JWL87Me" style="font: 10pt Times New Roman, Times, Serif"><b><i>Temporary
Equity</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Shares
of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option
of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely
within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the
issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but
not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument
will become redeemable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
Company determined it is probable the Series B Preferred Stock will become redeemable at the option of the holder. As a result, on September
30, 2021, the Company adjusted carrying value of the Series B Preferred Stock to its redemption value of $<span id="xdx_901_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLCQ8hlTdHog">3,960,000
</span></span><span style="font: 10pt Times New Roman, Times, Serif">and recorded a $<span id="xdx_900_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrG2hH9aUMTj">2,262,847
</span></span><span style="font: 10pt Times New Roman, Times, Serif">non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes, accordingly, the redemption value adjustment
is therefore added to the &#8220;Net Loss&#8221; to arrive at &#8220;Net Loss Attributable to Common Shareholders&#8217;&#8221; on the
Company&#8217;s Consolidated Statements of Operations. In addition, as the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DescriptionOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description Of Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DescriptionOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Going Concern [Policy Tex Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impact Of Covid 19 Pandemic On Our Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OtherRisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Risks And Uncertainties [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OtherRisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ReverseStockSplitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Stock Split [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ReverseStockSplitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_TemporaryEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_TemporaryEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869144184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Revenue by Source</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment and systems sales</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,523,948</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,481,961</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">9,933,313</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">4,575,855</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering and other services</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">110,538</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">114,160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">464,269</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">402,837</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping and handling</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">71,950</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">38,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">184,888</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">148,326</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total revenue</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">3,706,436</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,634,669</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">10,582,470</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">5,127,018</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the Company&#8217;s revenue by source:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BC_z4lP7SDCLJWe" style="display: none">Schedule
of Revenue by Source</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equipment
    and systems sales</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">7,730,371</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">13,692,863</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Engineering
    and other services</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">568,131</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">1,239,130</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Shipping
    and handling</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">215,770</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">292,461</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">8,514,272</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"><span style="font-family: Times New Roman, Times, Serif">15,224,454</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Remaining Performance Obligations Expected to be Recognized</a></td>
<td class="text"><p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining performance obligations
    related to engineering only paid contracts</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">112,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,049,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,161,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining performance
    obligations related to partial equipment paid contracts</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,091,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,629,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,720,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total remaining performance
    obligations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,203,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,678,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,881,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
remaining performance obligations expected to be recognized through 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Remaining Performance Obligations Expected to be Recognized</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to engineering only paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,355,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,643,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to partial equipment paid contracts</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,703,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,805,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    remaining performance obligations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,058,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">390,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,448,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation Costs</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Share-based Compensation Costs</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Three Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine Months Ended</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based compensation expense included in:</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">6,833</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,944</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">23,949</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising and marketing expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2300">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">2,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">13,292</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">7,500</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product development costs</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2308">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">5,444</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">14,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">16,332</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling, general and
    administrative expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0">29,307</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">41,221</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">102,735</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">306,448</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total share-based compensation
    expense included in consolidated statement of operations</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">29,307</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">55,998</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">160,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">354,229</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following is a summary of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Share-based Compensation Costs&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share-based
    compensation expense included in:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Cost
    of revenue</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">31,006</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">91,081</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">8,333</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">33,977</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">21,882</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">45,330</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">344,396</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,121,677</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    share-based compensation expense included in consolidated statement of operations</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">405,617</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"><span style="font-family: Times New Roman, Times, Serif">1,292,065</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328870349736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zE7BfvjDMl78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B0_zg5aAGk9vSug" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">For
                                            the Nine</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Months
                                            Ended</span></p>
                                                                  <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseCost_c20210101__20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">162,667</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating cash outflow from operating lease</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--OperatingLeasePayments_c20210101__20210930_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"><span style="font-family: Times New Roman, Times, Serif">210,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">As
                                            of</span></p>
                                                                                                    <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">September
                                            30,</span></p>
                                                                                <p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">2021</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease right-of-use asset</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_c20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease right-of-use asset"><span style="font-family: Times New Roman, Times, Serif">194,353</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, current</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, current"><span style="font-family: Times New Roman, Times, Serif">238,140</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating lease liability, long-term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, long-term"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining lease term</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210930_zpudGJ6rSd88" style="font: 10pt Times New Roman, Times, Serif">.9
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20210930_zQoCqfVihB42" style="text-align: right" title="Discount rate"><span style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zPeQ3QlkQHh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B9_zox0OD0dSWLg" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Lease Cost</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>For
                                            the Year Ended</b></span></p> <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>December
    31, 2020</b></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease cost</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--OperatingLeaseCost_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 26%; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">216,889</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    cash outflow from operating lease</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Operating lease cost"><span style="font-family: Times New Roman, Times, Serif">160,934</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 70%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 26%"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>As
                                            of</b></span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><b>December
                                            31, 2020</b></span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z9hG7OHCzPY9" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">343,950</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, current</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">266,105</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    lease liability, long-term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,119</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Remaining
    lease term</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20201231_zYcwBtbDKBub" style="font: 10pt Times New Roman, Times, Serif">1.7
                                            </span><span style="font: 10pt Times New Roman, Times, Serif">years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Discount
    rate</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231_z4dVlHSoI0Pj" style="font-family: Times New Roman, Times, Serif">5.00</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Annual Minimum Lease Payments</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zl9F1dquxe55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of September 30, 2021 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Future Annual Minimum Lease Payments</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years ended
    December 31,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%"><span style="font-family: Times New Roman, Times, Serif">2021 (excluding the nine months ended September 30,
    2021)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_c20210930_zjvcD1tjTLH9" style="width: 22%; text-align: right" title="Remainder of fiscal year"><span style="font-family: Times New Roman, Times, Serif">71,710</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20210930_zFkL3HCOoQE1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Year one"><span style="font-family: Times New Roman, Times, Serif">170,891</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total minimum lease payments</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20210930_pp0p0" style="text-align: right" title="Total minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">242,601</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less imputed interest</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20210930_zLIQ6LKinbYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less imputed interest"><span style="font-family: Times New Roman, Times, Serif">(4,461</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present value of
    minimum lease payments</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Present value of minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">238,140</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDVOneHTYVH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_z7dpdkWsmaYh" style="display: none">Schedule
of Future Annual Minimum Lease Payments</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Years
    ended December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Year one"><span style="font-family: Times New Roman, Times, Serif">281,864</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Year two"><span style="font-family: Times New Roman, Times, Serif">170,891</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Total
    minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">452,755</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    imputed interest</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20201231_zf84W1QHLDxl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Less imputed interest"><span style="font-family: Times New Roman, Times, Serif">(17,531</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Present
    value of minimum lease payments</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Present value of minimum lease payments"><span style="font-family: Times New Roman, Times, Serif">435,224</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328857894696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zzf4SyZLHGM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BB_zyNsY9SHCwe5" style="display: none">Schedule
of Inventory</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20210930_z5ce68v8Z4C4" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20201231_z6T6rCooRhNa" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zqUs5jAD08x3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished goods</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">319,335</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,778</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zVmUeZOf0Oil" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work in progress</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,595</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zamrk66e6vH8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw materials</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">237,705</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,145</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_zhYIxIekR7Ll" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance for excess
    &amp; obsolete inventory</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(79,281</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(93,045</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zIGhHlcMXc96" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">480,354</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zsS4iWD1QIt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Inventory
consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BE_zEPdvzgbpdO7" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Inventory</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49A_20201231_zhtS2W1hrrFk" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_495_20191231_zo0yO0tAWnze" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzovY_zcUBVogjx2p3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Finished
    goods</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">201,778</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,041,369</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzovY_zpy2GKyYlvrg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Work
    in progress</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,231</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,851</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzovY_zuABjAhGwkW7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Raw
    materials</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,145</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">257,399</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzovY_zAiPNf3CfCDc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allowance
    for excess &amp; obsolete inventory</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(93,045</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(71,376</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzovY_zVnz9ZDhw415" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Inventory,
    net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">327,109</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,231,243</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872018072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJiv7xcnC4L1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zLZVCtZSs8k5" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture and equipment</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">296,851</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMZDztKFreq3" style="width: 18%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">398,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z6OcIdjPZrR6" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold improvements</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zIUHCxMURVJ2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20210930_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">527,044</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zokQaM4dbO78" style="text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">628,615</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated depreciation</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210930_zvp6VeXPSTq1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(428,076</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zgUvrI5Finv7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(480,883</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property and equipment,
    net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">98,967</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zhCu01lBplz3" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">147,732</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zh2Icee86gEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Property
and equipment consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zVVsMRJAzqSi" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Property and Equipment</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Furniture
    and equipment</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">398,422</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">389,090</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Vehicles</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">15,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Leasehold
    improvements</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">215,193</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">628,615</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"><span style="font-family: Times New Roman, Times, Serif">619,283</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zvgMNUiNUWLa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(480,883</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20191231_zXe8mqyRHIOi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"><span style="font-family: Times New Roman, Times, Serif">(361,360</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">147,732</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif">257,923</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328873010408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zggo8d4spgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Intangible
assets consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BD_z00zkFunFRg7" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Intangible Assets</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif">Patents</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">8,110</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">12,234</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Website
    development costs</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">22,713</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">22,713</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Trademarks</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">1,830</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">1,830</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">32,653</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="font-family: Times New Roman, Times, Serif">36,777</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accumulated
    amortization</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(25,426</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif">(24,847</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"><span style="font-family: Times New Roman, Times, Serif">7,227</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"><span style="font-family: Times New Roman, Times, Serif">11,930</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872018072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrHfPYmX2q3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zou4lBgXvTna" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Accounts Payable and Accrued Liabilities</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_493_20210930_zkBTLGzF71Vl" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September
    30,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20201231_zdNzFzCMsHi9" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">December
    31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzbsH_zxSd7lz1MQwa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">864,558</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">918,639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzbsH_zU6BX7o3qF18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales commissions payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">40,758</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,263</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_z4CC0eQnScI4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued payroll liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">255,462</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,071</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzbsH_zwpWEPRMNvs7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product warranty accrual</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,868</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,365</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_zn7eu27m6ee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other accrued expenses</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">340,442</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">356,623</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzbsH_zMr6ODvSMOGd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,674,088</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,784,961</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMqUwIW62Mn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Accounts
payable and accrued liabilities consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B2_z1Ux5zTvOta1" style="display: none">Schedule
of Accounts Payable and Accrued Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49B_20201231_zxlzjELyrpcg" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_491_20191231_zUMOpS8dRv4d" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As
    of December 31,</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALze1T_zVrdMPSorzx7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts
    payable</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">918,639</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,299,015</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALze1T_zFBTW1Sc3Wb3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales
    commissions payable</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">48,263</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">69,532</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z5w9hxoGV7C8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accrued
    payroll liabilities</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">288,071</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,052</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALze1T_zYMKGAUUdenl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Product
    warranty accrual</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">173,365</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">185,234</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z9uRwMGS31Zj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">356,623</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">110,127</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALze1T_zJjZzcMGGVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,784,961</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,832,959</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328870282680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock', window );">Schedule of Outstanding Warrants to Purchase Common Stock</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z5O823WM7Gl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September
30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zT9rBdMJ3yq9" style="display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Life</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20210930_zjWAvLHPnk4i" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20210930_zVNGmDosj27a" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zgawyAW8NT94" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210930_zd9calbbkjh3" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Issued"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Issued"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.00</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zSciqoAeDnDc" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Life of Outstanding Warrants in Months, Issued">36</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2772">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(50,417</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210930_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20210930_zHLFpnVfVYkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20210930_zqb3GSU71sKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.00</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zfdYLOWvWWl3" style="font-family: Times New Roman, Times, Serif">36</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210930_zmIv9vQYXBhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zCmKGkVA2K1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B8_zujAupgcPZf3" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Outstanding Warrants to Purchase Common Stock</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Average</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Remaining
    Life</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Price</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20190101__20191231_zHHR9lK7HwN9" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">266,735</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20190101__20191231_zlVMLuwIDdnh" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20180101__20181231_zSNuiHD8JHdh" style="font-family: Times New Roman, Times, Serif">21</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20190101__20191231_zhSwNkngcGkb" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightIssued_c20190101__20191231_zMw9X2Kx1Btl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0961">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20190101__20191231_zCu8XanGfln" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0963">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0965">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercised_c20190101__20191231_zhPUDpdKLO1d" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0967">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20190101__20191231_znyF8jQQ4oBg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0971">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20190101__20191231_z6UMikAfCEW6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(6,008</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20190101__20191231_zEAMgdPZrt5f" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(99.00</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding at December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20200101__20201231_zVRwMhcJq0uh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">260,727</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20200101__20201231_zRNYZCxfgAh5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">36.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20190101__20191231_ziwiDyXx0GQb" style="font-family: Times New Roman, Times, Serif">9</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231_zInNKgxYOnA" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightIssued_c20200101__20201231_zopjaADN6l4c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0986">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20200101__20201231_zyfHKcvn82Ch" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0988">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0990">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercised_c20200101__20201231_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20200101__20201231_zHfHnhlfUiJ5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0994">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0996">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_c20200101__20201231_zDGSBo1oskOf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(210,310</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20200101__20201231_zfD99jjPCIB3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(34.50</span></span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20200101__20201231_zscu6SOw7pni" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20200101__20201231_zuvwzPeDc3Yj" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_dtM_c20200101__20201231_zhdseHw7u8W3" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231_zXtxX1GvmqJ9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants Outstanding</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zgrijU5SXnZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at September 30, 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8BC_zzmfRVkOy6i1" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Life of</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding Warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z537to8iv6U1" style="width: 30%; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.45</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zq4AHuDxnVph" style="width: 30%; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">192,982</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 30%; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z4vfo7shlyH2" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWfIKLSGAx6g" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.40</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zY4PmTbN1D6e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">34,737</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zNYfLPBILEE9" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930_zstL5FZdVKdh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">227,719</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zQZPEEYKQMN" title="Weighted Average Life of Outstanding Warrants in Months">36</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zBewjAB52c1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information about warrants outstanding at December 31, 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span id="xdx_8B3_z7jcy62VIUX6" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Warrants Outstanding</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Life of</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding
    Warrants</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Exercise
    price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Outstanding</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif">In
    Months</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zcE4irsYhtVf" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Exercise price"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">37.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zDW7HNQQ1Ac1" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrants Outstanding"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,417</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20200101__20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zggF3MvAyLFe" style="font-family: Times New Roman, Times, Serif">6</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864267432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zUL47KqzG6nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B4_z2FA4yRuxNM9" style="display: none">Schedule
of Restricted Stock Units Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"/><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Units</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zLYKEGtfMxV1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units, beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">65,782</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoDkvgGRpIGc" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">21.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvYraRHcwZTi" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"><span style="font-family: Times New Roman, Times, Serif">730,185</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdQ3rnxpf3vk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zlr5yazLd559" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1360">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvmcGADZuDF1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(7,467</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zGdtkvDbYGah" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">27.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8i7zPTqWT54" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(7,982</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3kiD56D7hE" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">26.85</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z1v5CPqXGRS1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z0WChRCBfor6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">19.20</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKotxyHZKuk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1374">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z4iF9kJJZny8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, beginning"><span style="font-family: Times New Roman, Times, Serif">50,333</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zm8GkagaaVX8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"><span style="font-family: Times New Roman, Times, Serif">19.20</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z9AmKkDNM4Qf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1380">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPi0nqYXNp68" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1382">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPCi3rYlC1Q2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zmibQryAVAH6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(45,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNTs2A2DAMye" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">18.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/canceled</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8l4ABzCc3S5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(5,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoiWPQsO9Zf5" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">27.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNoa43l0Eweb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zMxRx53UXhFg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1396">&#160;</span><span style="font-size: 10pt">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zhY5J2MVHkTf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1398">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock', window );">Schedule of Incentive Bonus Awards Granted to Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_891_eus-gaap--ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_ziFEO8U93GXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_z52aX6sTffS9" style="display: none">Schedule
of Incentive Bonus Awards Granted to Employees</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"/><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Shares</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average
                                            Grant-Date</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Fair
                                            Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 52%"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Shares, Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11,200</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif">124,320</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1417">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zceX362Zxk0l" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(11,200</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1425">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Unvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1427">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1429">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Awarded</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1433">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zN2GIWIYIJF7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1437">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1441">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1445">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcZKUI45Pan1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8B6_zoOZ8meB3tJl" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate
                                            Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHBKVz3d9ybj" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">70,400</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zTWEXvTjdnT8" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.60</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zNwpKYKTDSW3" style="font-family: Times New Roman, Times, Serif">8.4</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zgzSI45TX4pe" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1075">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zDDkg8cG9qrd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zK5g7z9t2Ts1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.00</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"/><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zQep3WVATrw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1081">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaaVkiZiXXGb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxgG6IIsWrh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,055</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zmNTgzd3zNnf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">17.40</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zN3Ibp9cFVzd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(111</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zD10t41iwJUg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.75</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zbPacipgumw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">67,567</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zw11YTKON6c8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">14.40</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zPzdo4Shliml" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.7</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zOIMwKM2am6c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDCgJ4QGrFn1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">44,113</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIM6Aysndxo8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.50</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zY43UtNz898j" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3LC6cG45fO1" style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zNjGeoPa0QN1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1107">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDlANhNJoWxf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1109">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6Ew3pTqRk0g" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,673</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zU5YGgqPjKJ" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.15</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8ZhNdDnOWQ3" style="font-family: Times New Roman, Times, Serif">4.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPUK0aeThoBk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6WYf1SdH7he" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zRb7gybkSoa4" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z579sq0saV2f" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1121">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zB5JVJ2l2cuf" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding vested and expected to vest ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvulNuMUcy8" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zosB5Mue8Ns" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPczGfNYhzbf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1128">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQ7OcSsFA711" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended
December 31, 2020 and 2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BE_zYLAeT2GN0hd" style="display: none; font-family: Times New Roman, Times, Serif">Summary
of Non-vested Non-qualified Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of<br/>
    Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/>
    Average<br/>
    Grant-Date<br/>
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate<br/>
    Intrinsic<br/>
    Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date<br/>
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2018</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">48,889</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.90</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1136">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif">628,756</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">130,120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_ziIADVJronFd" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(32,833</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11.10</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">362,998</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z4otFMEETl5d" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(16,056</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">15.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif">246,344</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1160">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2019</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">13,333</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11.25</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">149,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">44,113</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.85</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">387,199</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXCKK685h3i1" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(57,446</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">536,733</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1186">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1190">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2020</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1192">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zCFc8SR9IZg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_8BA_zcDYgammV0ma" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Number
                                            of</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Options</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Exercise</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Price</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Weighted</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Average</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Remaining</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Contractual</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Term</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Aggregate</span></p>
                                                                                                                                                                     <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Intrinsic</span></p>
                                                                                <p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Value
                                            ($000)</span></p></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zy3TzYmGCre6" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20.25</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zshS2cAkVjq3" style="font-family: Times New Roman, Times, Serif">8.6</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1211">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1213">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1217">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1219">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1221">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIRUPyMPay68" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1225">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1227">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,000</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z2YgOar2oLTk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20.25</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zsbtuxOZoko" style="font-family: Times New Roman, Times, Serif">7.6</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">43,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.55</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zv26MUYTzBEf" style="font-family: Times New Roman, Times, Serif">8.5</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1245">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zvFXeLy3Gv6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1249">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">49,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBadwX3bwOpk" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending">7.5</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1259">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,
    </span><span style="font-family: Times New Roman, Times, Serif">December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zT10DkoudON4" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercisable ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">42,667</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.95</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zGRvU3mtpzvc" style="font-family: Times New Roman, Times, Serif">8.0</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVPmqAZOqft3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below: </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_z6dVfrIDxM4k" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1270">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zm5a7H28aOa7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1280">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1284">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1288">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1290">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December
    31, 2019</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1294">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1296">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font: 10pt Times New Roman, Times, Serif; display: none">-</span><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1298">&#160;</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">43,333</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">8.55</span></span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif">373,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zUqshKLzVfoj" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(36,667</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.45</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif">344,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1312">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1314">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1320">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1322">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,666</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">4.35</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif">5,800</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">29,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zKTPsPnJRnNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended
September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"><span id="xdx_8BB_znp5ywFL5g0c" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4gld8oXLul1" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">95,007</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV4oZm5nSTre" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbwjmlEDTEwl" style="font-family: Times New Roman, Times, Serif">8.3</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfEQLj1v1Gg9" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2585">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zVR5opud0Jkc" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20,239</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOAZ8AjQNT2e" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQzVkmkVAe79" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhuARfgxtYmj" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAJjNruQHOWf" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2594">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zckRq9ht7oh" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(1,914</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyrSB7ZQtu54" style="text-align: right"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">18.30</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkhSYLxIW19e" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Forfeited">6.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYWhXI9gTWQi" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2600">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYzO59PB6VH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5tsk0SnBZ22" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">113,332</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zW3x9SeFnQe" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.45</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUvpqxPDK4wf">7.9</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwoVKOVoNvQ7" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable, September
    30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcxUwTQQjYnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">101,665</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuF817ZZFR2a" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.75</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmipUx7wQY88">7.7</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgDgQ0Fv3lf4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2616">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6uz1kHQOHmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months
ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B0_zImqUMghEN0d" style="display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQQ0WxbcTUO3" style="text-align: right" title="Number of Options Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2632">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zdouRiT9Kbyl" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2634">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ztXpy42QEQ7c" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUsKV9NiRi5e" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2638">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zujbP3yXyAv7" style="width: 11%; text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">20,239</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcEIwcqwY0Di" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">12.30</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmAwKRm0eX83" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2644">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zD5rouAApSL9" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(8,572</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5kngnBAUc07" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">16.80</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgRPVPqNdq8d" style="text-align: right" title="Aggregated Intrinsic Value, Vested"><span style="font-family: Times New Roman, Times, Serif">66,412</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4aUVWGA7vgb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2652">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zca5jjCSo3wh" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2654">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zlysCjUo3WC5" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2656">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zetnfKTZTJO8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2658">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z7WwHfQCuoc3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zxcEFmi9RtM5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">11,667</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zi6raECBmYgc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.15</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znjM5qNdlQnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaTJaeQ9A541" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif">104,800</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember', window );">2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zXNy04sZt6A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine
months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8BA_zLEoLGV1DQue" style="display: none">Schedule
of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value ($000)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh1VE8UaYWrg" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">49,333</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyiSCSDM7sXe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJbcsxA6QD8a" style="font-family: Times New Roman, Times, Serif">7.5</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZwNzbalPCs4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2679">&#160;</span><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zX9g4KSImHFa" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,538</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFwFKcg1vkv" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGohvJBQxzBc" style="font-family: Times New Roman, Times, Serif">10.0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdPKPvrPRF8l" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKDOV5jhmzS9" style="text-align: right" title="Number of Options, Exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2688">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0NhSxzTxYud" style="text-align: right" title="Number of Options, Forfeited/Cancelled"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2690">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2189g8PNKub" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqWgJYn1Egoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,871</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8hlGNijGvJ7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2Q055u8ZUta" style="font-family: Times New Roman, Times, Serif">6.8</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFIMmyG9WhFg" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2699">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable,</span><span style="font-family: Times New Roman, Times, Serif">
    September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zawOZjpZ9LN8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">50,871</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsxjgS68DW64" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">10.05</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpCvslrSsDhi" style="font-family: Times New Roman, Times, Serif">6.8</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3atSYHs8e1j" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVVQyPWVcsz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the
nine months ended September 30, 2021, are presented in the table below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B4_zm0LwJwSl8qg" style="font: 10pt Times New Roman, Times, Serif; display: none">Summary
of Non-vested Non-qualified Stock Option Activity</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of Options</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#65279;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Nonvested, December 31, 2020</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zK1aMeTWkwG2" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">6,667</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfRIVlkOUuwl" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">4.35</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzHLUXNM13E7" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"><span style="font-family: Times New Roman, Times, Serif">31,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwCOEhNblof7" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2717">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPQxCdlSzXq6" style="text-align: right" title="Number of Options Nonvested, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">1,538</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbrjiGryUQe" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">9.75</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_iN_pdp0_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zERxLWFY9iQf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,154</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODpm85TDhe7" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhqZIy8eZ76g" style="text-align: right" title="Number of Options Nonvested, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">(8,205</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJhaKpnlMwX9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif">5.40</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmhZ7MTcgb16" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Forfeited"><span style="font-family: Times New Roman, Times, Serif">(29,846</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvi8PX2mQ4Qa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2732">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Forfeited</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4HOo16infre" style="text-align: right" title="Number of Options Nonvested, Forfeited"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2734">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGknfEHNDja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Nonvested, September 30, 2021</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7bt2EGwK4N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2738">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfvFdw7YGJQg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7ycd9P24fK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2742">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328872915192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIiW34TQAIW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are
summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8B2_zCTN8kcubVtb" style="font: 10pt Times New Roman, Times, Serif; display: none">Schedule
of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20200101__20201231_zWYVRZsLcYri" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_490_20190101__20191231_zGHYoW3blb12" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Income
    taxes computed at the federal statutory rate</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(369,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(281,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">States
    taxes, net of federal benefits</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(69,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(53,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Permanent
    differences</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(136,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_ecustom--IncomeTaxReconciliationTrueUpAdjustments_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">True-up
    adjustments</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">115,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">199,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Adjustment
    to net operating loss</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(86,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">476,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Reported
    income tax (benefit) expense</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zekBiNAzsxq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B3_zhtemzF3Nnt7" style="display: none">Schedule
of Deferred Tax Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20201231_zelcwOq4Sb3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2020</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" id="xdx_49C_20191231_zfefclUeptM9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2019</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    operating losses</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,821,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,081,000</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity
    compensation</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">118,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">392,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">169,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">149,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,108,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,622,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Other
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_zshjP3fwbMSl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(68,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(58,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets before valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,040,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,564,000</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zCTUfLxwNkrl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Less
    valuation allowance</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,040,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,564,000</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864029304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Revenue by Source (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,706,436<span></span>
</td>
<td class="nump">$ 1,634,669<span></span>
</td>
<td class="nump">$ 10,582,470<span></span>
</td>
<td class="nump">$ 5,127,018<span></span>
</td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">$ 15,224,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember', window );">Equipment and Systems Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,523,948<span></span>
</td>
<td class="nump">1,481,961<span></span>
</td>
<td class="nump">9,933,313<span></span>
</td>
<td class="nump">4,575,855<span></span>
</td>
<td class="nump">7,730,371<span></span>
</td>
<td class="nump">13,692,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember', window );">Engineering and Other Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">110,538<span></span>
</td>
<td class="nump">114,160<span></span>
</td>
<td class="nump">464,269<span></span>
</td>
<td class="nump">402,837<span></span>
</td>
<td class="nump">568,131<span></span>
</td>
<td class="nump">1,239,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 71,950<span></span>
</td>
<td class="nump">$ 38,548<span></span>
</td>
<td class="nump">$ 184,888<span></span>
</td>
<td class="nump">$ 148,326<span></span>
</td>
<td class="nump">$ 215,770<span></span>
</td>
<td class="nump">$ 292,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EquipmentAndSystemsSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868042520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Remaining Performance Obligations Expected to be Recognized (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">$ 1,161,000<span></span>
</td>
<td class="nump">$ 2,643,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">8,720,000<span></span>
</td>
<td class="nump">5,805,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">9,881,000<span></span>
</td>
<td class="nump">8,448,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember', window );">2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">112,000<span></span>
</td>
<td class="nump">2,355,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">3,091,000<span></span>
</td>
<td class="nump">5,703,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">3,203,000<span></span>
</td>
<td class="nump">8,058,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">1,049,000<span></span>
</td>
<td class="nump">288,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">5,629,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">$ 6,678,000<span></span>
</td>
<td class="nump">$ 390,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to engineering only paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to partial equipment paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328861472456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Share-based Compensation Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 29,307<span></span>
</td>
<td class="nump">$ 55,998<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">$ 354,229<span></span>
</td>
<td class="nump">$ 405,617<span></span>
</td>
<td class="nump">$ 1,292,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,833<span></span>
</td>
<td class="nump">29,944<span></span>
</td>
<td class="nump">23,949<span></span>
</td>
<td class="nump">31,006<span></span>
</td>
<td class="nump">91,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember', window );">Advertising and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">13,292<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">8,333<span></span>
</td>
<td class="nump">33,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember', window );">Product Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,444<span></span>
</td>
<td class="nump">14,029<span></span>
</td>
<td class="nump">16,332<span></span>
</td>
<td class="nump">21,882<span></span>
</td>
<td class="nump">45,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 29,307<span></span>
</td>
<td class="nump">$ 41,221<span></span>
</td>
<td class="nump">$ 102,735<span></span>
</td>
<td class="nump">$ 306,448<span></span>
</td>
<td class="nump">$ 344,396<span></span>
</td>
<td class="nump">$ 1,121,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_AdvertisingAndMarketingExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_ProductDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866497864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 17, 2022</div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 27, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts Receivable, Allowance for Credit Loss, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,098<span></span>
</td>
<td class="nump">$ 151,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract with Customer, Liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,059,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,724,189<span></span>
</td>
<td class="nump">1,444,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,452<span></span>
</td>
<td class="nump">$ 9,141<span></span>
</td>
<td class="nump">3,357,068<span></span>
</td>
<td class="nump">$ 1,074,016<span></span>
</td>
<td class="nump">$ 1,103,447<span></span>
</td>
<td class="nump">$ 473,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,881,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,881,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,448,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Standard Product Warranty Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,623<span></span>
</td>
<td class="nump">84,433<span></span>
</td>
<td class="nump">$ 322,807<span></span>
</td>
<td class="nump">304,229<span></span>
</td>
<td class="nump">$ 390,229<span></span>
</td>
<td class="nump">$ 521,044<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,307<span></span>
</td>
<td class="nump">55,998<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="nump">$ 354,229<span></span>
</td>
<td class="nump">$ 405,617<span></span>
</td>
<td class="nump">$ 1,292,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777,888<span></span>
</td>
<td class="nump">293,383<span></span>
</td>
<td class="nump">194,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,491<span></span>
</td>
<td class="nump">18,952<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember', window );">2020 Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember', window );">2021 Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 31,575<span></span>
</td>
<td class="nump">$ 108,945<span></span>
</td>
<td class="nump">$ 101,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Revenue Benchmark [Member] | One Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Standard and Extended Product Warranty Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,365<span></span>
</td>
<td class="nump">$ 185,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,643,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember', window );">Order or Production Backlog [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember', window );">Inventory Valuation and Obsolescence [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Inventory Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,045<span></span>
</td>
<td class="nump">$ 71,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, Description</a></td>
<td class="text">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability revenue recognized percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=SRNA_PurchasesOfInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=SRNA_PurchasesOfInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328863908152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="nump">$ 407,905<span></span>
</td>
<td class="nump">$ 270,439<span></span>
</td>
<td class="nump">$ 936,031<span></span>
</td>
<td class="nump">$ 1,822,269<span></span>
</td>
<td class="nump">$ 1,758,716<span></span>
</td>
<td class="nump">$ 1,338,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">28,379,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,379,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,443,643<span></span>
</td>
<td class="nump">25,684,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">3,359,813<span></span>
</td>
<td class="nump">1,421,677<span></span>
</td>
<td class="nump">3,359,813<span></span>
</td>
<td class="nump">1,421,677<span></span>
</td>
<td class="nump">1,333,698<span></span>
</td>
<td class="nump">355,631<span></span>
</td>
<td class="nump">$ 1,644,642<span></span>
</td>
<td class="nump">$ 1,175,664<span></span>
</td>
<td class="num">$ (194,336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 3,706,436<span></span>
</td>
<td class="nump">$ 1,634,669<span></span>
</td>
<td class="nump">10,582,470<span></span>
</td>
<td class="nump">5,127,018<span></span>
</td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">15,224,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DecreaseInRevenuePercentage', window );">Decrease in revenue percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by (Used in) Operating Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,761,260)<span></span>
</td>
<td class="nump">$ 599,635<span></span>
</td>
<td class="nump">$ 818,036<span></span>
</td>
<td class="nump">671,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,220,000<span></span>
</td>
<td class="nump">$ 1,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DecreaseInRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in revenue percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DecreaseInRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864378968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Lease Cost (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 162,667<span></span>
</td>
<td class="nump">$ 216,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflow from operating lease</a></td>
<td class="nump">210,154<span></span>
</td>
<td class="nump">160,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">194,353<span></span>
</td>
<td class="nump">343,950<span></span>
</td>
<td class="nump">$ 534,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">238,140<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
<td class="nump">217,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, long-term</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 169,119<span></span>
</td>
<td class="nump">$ 404,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Discount rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869217816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Future Annual Minimum Lease Payments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year one</a></td>
<td class="nump">$ 170,891<span></span>
</td>
<td class="nump">$ 281,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Year two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">242,601<span></span>
</td>
<td class="nump">452,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(4,461)<span></span>
</td>
<td class="num">(17,531)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">238,140<span></span>
</td>
<td class="nump">$ 435,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of fiscal year</a></td>
<td class="nump">$ 71,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328858543480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 27, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2018 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 27, 2017 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land | ft&#178;</a></td>
<td class="nump">11,491<span></span>
</td>
<td class="nump">18,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lessee, Operating Lease, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Facility Lease commenced September
29, 2017 and continues through August 31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 194,353<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
<td class="nump">$ 534,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,140<span></span>
</td>
<td class="nump">$ 435,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_MonthlyRentDescription', window );">Monthly rent description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RentalExpense', window );">Rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,978<span></span>
</td>
<td class="nump">$ 5,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred Rent Credit, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance', window );">Unamortized amount of tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember', window );">Facility Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of Land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600<span></span>
</td>
<td class="nump">12,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,135<span></span>
</td>
<td class="nump">$ 19,549<span></span>
</td>
<td class="nump">$ 18,979<span></span>
</td>
<td class="nump">$ 12,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lessee, Operating Lease, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">until
August 31, 2018<span></span>
</td>
<td class="text">until
January 1, 2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
each September 1 through the end of the lease, the monthly rent will increase by 3%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDeposits', window );">Payments for Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember', window );">Agreement with Landlord [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Lessee, Operating Lease, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly
installments from January to December 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_LeaseTerminationAgreementMember', window );">Lease Termination Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease Expiration Date</a></td>
<td class="text">Jan. 31,  2027<span></span>
</td>
<td class="text">Aug. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_MonthlyRentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly rent description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_MonthlyRentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized amount of tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnamortizedAmountOfTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental payment required by lease over rental income recognized, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919140-209958<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_LeaseTerminationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_LeaseTerminationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328858479976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 319,335<span></span>
</td>
<td class="nump">$ 201,778<span></span>
</td>
<td class="nump">$ 1,041,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in progress</a></td>
<td class="nump">2,595<span></span>
</td>
<td class="nump">4,231<span></span>
</td>
<td class="nump">3,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">237,705<span></span>
</td>
<td class="nump">214,145<span></span>
</td>
<td class="nump">257,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess &amp; obsolete inventory</a></td>
<td class="num">(79,281)<span></span>
</td>
<td class="num">(93,045)<span></span>
</td>
<td class="num">(71,376)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 480,354<span></span>
</td>
<td class="nump">$ 327,109<span></span>
</td>
<td class="nump">$ 1,231,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869186600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Cost, Overhead</a></td>
<td class="nump">$ 17,674<span></span>
</td>
<td class="nump">$ 17,974<span></span>
</td>
<td class="nump">$ 31,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PrepaidInventoryExpenses', window );">Prepaid inventory expenses</a></td>
<td class="nump">$ 879,000<span></span>
</td>
<td class="nump">$ 916,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PrepaidInventoryExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid inventory expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PrepaidInventoryExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328867887384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 527,044<span></span>
</td>
<td class="nump">$ 628,615<span></span>
</td>
<td class="nump">$ 619,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(428,076)<span></span>
</td>
<td class="num">(480,883)<span></span>
</td>
<td class="num">(361,360)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">98,967<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">296,851<span></span>
</td>
<td class="nump">398,422<span></span>
</td>
<td class="nump">389,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 215,193<span></span>
</td>
<td class="nump">$ 215,193<span></span>
</td>
<td class="nump">$ 215,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864186456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119,524<span></span>
</td>
<td class="nump">$ 157,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="nump">$ 527,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,615<span></span>
</td>
<td class="nump">619,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="nump">428,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,883<span></span>
</td>
<td class="nump">361,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="nump">$ 866,699<span></span>
</td>
<td class="nump">$ 634,447<span></span>
</td>
<td class="nump">2,493,930<span></span>
</td>
<td class="nump">$ 2,453,976<span></span>
</td>
<td class="nump">3,095,350<span></span>
</td>
<td class="nump">4,662,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 176,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,394<span></span>
</td>
<td class="nump">$ 7,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_CoFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328858789160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 32,653<span></span>
</td>
<td class="nump">$ 36,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(25,426)<span></span>
</td>
<td class="num">(24,847)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, Net</a></td>
<td class="nump">7,227<span></span>
</td>
<td class="nump">11,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">8,110<span></span>
</td>
<td class="nump">12,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember', window );">Web Site Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">22,713<span></span>
</td>
<td class="nump">22,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 1,830<span></span>
</td>
<td class="nump">$ 1,830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328864269240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of Intangible Assets, Finite-lived</a></td>
<td class="nump">$ 4,124<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember', window );">Web Site Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-Lived Intangible Assets, Remaining Amortization Period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328869102232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 864,558<span></span>
</td>
<td class="nump">$ 918,639<span></span>
</td>
<td class="nump">$ 1,299,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Sales commissions payable</a></td>
<td class="nump">40,758<span></span>
</td>
<td class="nump">48,263<span></span>
</td>
<td class="nump">69,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll liabilities</a></td>
<td class="nump">255,462<span></span>
</td>
<td class="nump">288,071<span></span>
</td>
<td class="nump">169,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty accrual</a></td>
<td class="nump">172,868<span></span>
</td>
<td class="nump">173,365<span></span>
</td>
<td class="nump">185,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">340,442<span></span>
</td>
<td class="nump">356,623<span></span>
</td>
<td class="nump">110,127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,674,088<span></span>
</td>
<td class="nump">$ 1,784,961<span></span>
</td>
<td class="nump">$ 1,832,959<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328858798872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts Payable and Accrued Liabilities, Current</a></td>
<td class="nump">$ 1,784,961<span></span>
</td>
<td class="nump">$ 1,674,088<span></span>
</td>
<td class="nump">$ 1,832,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Standard Product Warranty Description</a></td>
<td class="text">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember', window );">Three Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts Payable and Accrued Liabilities, Current</a></td>
<td class="nump">$ 402,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Standard Product Warranty Description</a></td>
<td class="text">Since
the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing
1% warranty reserve that we accrue on all sales.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866468376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableModificationsLineItems', window );"><strong>Financing Receivable, Troubled Debt Restructuring [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Debt Instrument, Increase, Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,296<span></span>
</td>
<td class="nump">$ 3,268<span></span>
</td>
<td class="nump">$ 3,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableModificationsLineItems', window );"><strong>Financing Receivable, Troubled Debt Restructuring [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember', window );">Extended Maturity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableModificationsLineItems', window );"><strong>Financing Receivable, Troubled Debt Restructuring [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableModificationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableModificationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866986104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements and Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 07, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,623<span></span>
</td>
<td class="nump">$ 84,433<span></span>
</td>
<td class="nump">$ 322,807<span></span>
</td>
<td class="nump">$ 304,229<span></span>
</td>
<td class="nump">$ 390,229<span></span>
</td>
<td class="nump">$ 521,044<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOfImpactOfForegoingItemCharge', window );">Net of impact of foregoing item charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related Party Transaction, Amounts of Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember', window );">Leased Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnpaidLeaseFees', window );">Unpaid lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnpaidDemoAndTestingFees', window );">Unpaid demo and testing Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_EmploymentAgreementMember', window );">Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod', window );">Number of shares vested and to be settled with issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Equipment, Demonstration and Product Testing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Equipment, Demonstration and Product Testing Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from Contract with Customer, Including Assessed Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Salary and Wage, Excluding Cost of Good and Service Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod', window );">Number of shares vested and to be settled with issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member] | April 30, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember', window );">Mr. James R. Shipley [Member] | Consulting Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOfImpactOfForegoingItemCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net of impact of foregoing item charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOfImpactOfForegoingItemCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares vested and to be settled with issued shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnpaidDemoAndTestingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid demo and Testing Fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnpaidDemoAndTestingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnpaidLeaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid lease fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnpaidLeaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesWagesAndOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesWagesAndOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_CoFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_EquipmentDemonstrationAndProductTestingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_EquipmentDemonstrationAndProductTestingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_AprilThirtyTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_AprilThirtyTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866426696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Loss Contingency, Damages Paid, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from Issuance of Private Placement</a></td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other Nonoperating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember', window );">Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage', window );">Restricted stock units shares issued interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedButNotSettled', window );">Number of Units, Vested but not settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Loss Contingency, Damages Awarded, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate common shares issued upon execution of settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AggregateSharesIssuedUponExecutionOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedButNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Units, Vested but not settled .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedButNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units shares issued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868053544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stock (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock', window );">Number of common stock shares issued in settlement of vested restricted stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="nump">7,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus', window );">Number of shares issued for stock incentive bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,733<span></span>
</td>
<td class="nump">7,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employee [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for stock incentive bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock shares issued in settlement of vested restricted stock, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866974712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Outstanding Warrants to Purchase Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DisclosureWarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Beginning Balance</a></td>
<td class="nump">50,417<span></span>
</td>
<td class="nump">260,727<span></span>
</td>
<td class="nump">266,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="nump">$ 36.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">21 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssued', window );">Warrants, Issued</a></td>
<td class="nump">227,719<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued', window );">Weighted Average Exercise Price, Issued</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercised', window );">Warrants, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpired', window );">Warrants, Expired</a></td>
<td class="num">(50,417)<span></span>
</td>
<td class="num">(210,310)<span></span>
</td>
<td class="num">(6,008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="num">$ (34.50)<span></span>
</td>
<td class="num">$ (99.00)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Expired</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Ending Balance</a></td>
<td class="nump">227,719<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="nump">260,727<span></span>
</td>
<td class="nump">266,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="nump">$ 36.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms', window );">Weighted Average Life of Outstanding Warrants in Months, Issued</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants expired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of outstanding warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DisclosureWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DisclosureWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased Compensation Arrangement  By Sharebased Payment Award NonOptions Issued Weighted Average Remaining Contractual Terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Life of Outstanding Warrants in Months, Ending Balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328863962712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="nump">$ 36.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">227,719<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="nump">260,727<span></span>
</td>
<td class="nump">266,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember', window );">Warrants Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 9.45<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">192,982<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember', window );">Warrants Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 10.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">34,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328860623640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 28, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>Number </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>Number </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>Number </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2014 </div>
<div>USD ($) </div>
<div>Number </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations', window );">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,727<span></span>
</td>
<td class="nump">266,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 9.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding | shares</a></td>
<td class="nump">192,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 10.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of Warrant or Right, Outstanding | shares</a></td>
<td class="nump">34,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SRNA_InvestmentBankMember', window );">Investment Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Banker Warrants
were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember', window );">Series 2 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OfferedInvestmentsPricePerUnit', window );">Offered investments, price per unit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,008<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember', window );">Series 2 Warrants [Member] | Series 2 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible Debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Investment Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember', window );">Q1 2017 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">These
warrants expired unexercised in March 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestment', window );">Proceeds from investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestmentPerUnit', window );">Proceeds from investment per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of stock, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
unit consisted of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember', window );">Q4 2017 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestment', window );">Proceeds from investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,768,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestmentPerUnit', window );">Proceeds from investment per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of stock, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
unit consisted of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember', window );">Q2 2018 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion of stock, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">each
unit consisting of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Debt Instrument, Convertible, Threshold Consecutive Trading Days | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfInvestmentUnitOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investment unit offered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfInvestmentUnitOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OfferedInvestmentsPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offered investments, price per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OfferedInvestmentsPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ProceedsFromInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ProceedsFromInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ProceedsFromInvestmentPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from investment per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ProceedsFromInvestmentPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RedeemWarrantSharesAtPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeem warrant shares at a price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RedeemWarrantSharesAtPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SRNA_InvestmentBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SRNA_InvestmentBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SRNA_SeriesTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SRNA_SeriesTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328857853624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Jan. 02, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,113<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="nump">$ 20.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="nump">$ 20.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.95<span></span>
</td>
<td class="nump">$ 8.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="nump">$ 20.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.95<span></span>
</td>
<td class="nump">$ 8.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options, exercisable ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,332<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,332<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options, exercisable ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited', window );">Weighted Average Remaining Contractual Term, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="nump">67,567<span></span>
</td>
<td class="nump">70,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="nump">$ 14.40<span></span>
</td>
<td class="nump">$ 15.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,113<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.50<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,673)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.15<span></span>
</td>
<td class="nump">$ 15.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted', window );">Aggregate Intrinsic Value, Outstanding Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired', window );">Weighted average remaining contractual term, expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="nump">67,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="nump">$ 14.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of options, outstanding vested and expected to vest ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="nump">$ 14.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,007<span></span>
</td>
<td class="nump">67,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,673<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember', window );">2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember', window );">2017 Equity Plan and 2021 Equity Plan [Member] | Non-qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,871<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,871<span></span>
</td>
<td class="nump">49,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options, exercisable ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Outstanding Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328866749080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Non-vested Non-qualified Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,666<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.55<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,667)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.45<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="nump">6,666<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,666<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="nump">11,667<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="nump">$ 9.15<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="nump">$ 104,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="nump">20,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="nump">$ 12.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="num">(8,572)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="nump">$ 16.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Vested</a></td>
<td class="nump">$ 66,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="nump">11,667<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="nump">$ 9.15<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="nump">104,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="num">$ (66,412)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 149,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,113<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.85<span></span>
</td>
<td class="nump">$ 9.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 387,199<span></span>
</td>
<td class="nump">$ 130,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,446)<span></span>
</td>
<td class="num">(32,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.30<span></span>
</td>
<td class="nump">$ 11.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 536,733<span></span>
</td>
<td class="nump">$ 362,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,056)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 246,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="nump">48,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.25<span></span>
</td>
<td class="nump">$ 12.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 149,534<span></span>
</td>
<td class="nump">$ 628,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 149,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember', window );">2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="nump">$ 9.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="num">(8,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Vested</a></td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</a></td>
<td class="num">(1,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Forfeited</a></td>
<td class="num">$ (29,846)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited In Period Fair Value1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328863910120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Restricted Stock Units Activity (Details) - 2017 Equity Incentive Plan [Member] - Employees, Directors and Consultants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, beginning</a></td>
<td class="nump">50,333<span></span>
</td>
<td class="nump">65,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning</a></td>
<td class="nump">$ 19.20<span></span>
</td>
<td class="nump">$ 21.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 730,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Units, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Units, Vested and settled with share issuance</a></td>
<td class="num">(45,000)<span></span>
</td>
<td class="num">(7,467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</a></td>
<td class="nump">$ 18.15<span></span>
</td>
<td class="nump">$ 27.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Units, Forfeited/canceled</a></td>
<td class="num">(5,333)<span></span>
</td>
<td class="num">(7,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited/canceled</a></td>
<td class="nump">$ 27.00<span></span>
</td>
<td class="nump">$ 26.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 19.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868435240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Incentive Bonus Awards Granted to Employees (Details) - Incentive Stock Bonus Awards [Member] - 2017 Equity Incentive Plan [Member] - Employees [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1', window );">Number of Shares, Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1', window );">Weighted Average Grant-date Fair Value, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Awarded</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-date Fair Value, Awarded</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Shares, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(11,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Shares, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-date Fair Value, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328854547160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 20, 2020</div></th>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jan. 02, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,055<span></span>
</td>
<td class="nump">$ 252,757<span></span>
</td>
<td class="nump">$ 277,183<span></span>
</td>
<td class="nump">$ 788,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | 21 Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember', window );">Non-qualified Stock Options [Member] | Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,125<span></span>
</td>
<td class="nump">79,120<span></span>
</td>
<td class="nump">$ 1,035,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement', window );">Intrinsic value of vested and settled with issuance of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember', window );">Incentive Stock Bonus Awards [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement', window );">Intrinsic value of vested and settled with issuance of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited', window );">Shares Granted, Value, Share-based Payment Arrangement, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember', window );">2021 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember', window );">Employees, Directors and Consultants [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,163<span></span>
</td>
<td class="nump">$ 25,163<span></span>
</td>
<td class="nump">$ 278,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer [Member] | Non-qualified Stock Options [Member] | June 30, 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer [Member] | Non-qualified Stock Options [Member] | June 30, 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember', window );">Chief Financial Officer [Member] | Non-qualified Stock Options [Member] | June 30, 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">333.3333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,113<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,446<span></span>
</td>
<td class="nump">32,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockOptionToPurchaseThresholdsPerformanceBased', window );">Stock option to purchase - thresholds - performance based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfSharesForfeitedForTerminations', window );">Number of shares forfeited for terminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member] | Employees And Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,881<span></span>
</td>
<td class="nump">171,624<span></span>
</td>
<td class="nump">$ 189,568<span></span>
</td>
<td class="nump">$ 390,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,113<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,174<span></span>
</td>
<td class="nump">$ 55,970<span></span>
</td>
<td class="nump">$ 62,452<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,205<span></span>
</td>
<td class="nump">10,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Director [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Two New Independent Directors [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding', window );">Share based compensation arrangement stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Two New Independent Directors [Member] | Non-qualified Stock Options [Member] | April 1, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,667<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,333<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,333,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember', window );">2019 Special Equity Award [Member] | Director [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneEquityPlanMember', window );">2021 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember', window );">2021 Equity Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, Capital Shares Reserved for Future Issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">665,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based Payment Arrangement, Noncash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember', window );">2021 Equity Plan [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember', window );">2021 Equity Plan [Member] | Directors [Member] | Non-qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfSharesForfeitedForTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares forfeited for terminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfSharesForfeitedForTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement stock issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested and settled with issuance of share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockOptionToPurchaseThresholdsPerformanceBased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock option to purchase - thresholds - performance based.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockOptionToPurchaseThresholdsPerformanceBased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_TwentyOneEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_TwentyOneEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_TwoThousandSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=SRNA_JuneThirtyTwentyTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_TwoNewIndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_TwoNewIndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_AprilOneTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_AprilOneTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868586536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes computed at the federal statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (369,000)<span></span>
</td>
<td class="num">$ (281,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">States taxes, net of federal benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,000)<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(136,000)<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncomeTaxReconciliationTrueUpAdjustments', window );">True-up adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Adjustment to net operating loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(86,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,000<span></span>
</td>
<td class="nump">204,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Reported income tax (benefit) expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncomeTaxReconciliationTrueUpAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation True-up adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncomeTaxReconciliationTrueUpAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868501128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 4,821,000<span></span>
</td>
<td class="nump">$ 4,081,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other deferred tax assets</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="nump">149,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">5,108,000<span></span>
</td>
<td class="nump">4,622,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other deferred tax liabilities</a></td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">58,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(68,000)<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax assets before valuation allowance</a></td>
<td class="nump">5,040,000<span></span>
</td>
<td class="nump">4,564,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(5,040,000)<span></span>
</td>
<td class="num">(4,564,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328868329384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 20,260,000<span></span>
</td>
<td class="nump">$ 19,322,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount', window );">Net operating loss carry forward expected to expire amount</a></td>
<td class="nump">$ 11,196,261<span></span>
</td>
<td class="nump">$ 11,196,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossExpirationTerm', window );">Net operating loss expiration term</a></td>
<td class="text">2034 through 2037<span></span>
</td>
<td class="text">2034 through 2037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsUsageAgainstTaxableIncomePercentage', window );">NOLs usage against taxable income, percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsCarryforwardsTerm', window );">NOLs carryforwards term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Income Tax Examination, Penalties and Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carry forward expected to expire amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsCarryforwardsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs carryforwards term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsCarryforwardsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsUsageAgainstTaxableIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs usage against taxable income percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsUsageAgainstTaxableIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328858686888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 28, 2022</div></th>
<th class="th"><div>Jan. 07, 2021</div></th>
<th class="th"><div>Jan. 02, 2021</div></th>
<th class="th"><div>Jan. 17, 2022</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
<th class="th"><div>Nov. 04, 2021</div></th>
<th class="th"><div>Nov. 03, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred Compensation Liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
January 17, 2022, the Company&#8217;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Shares redeemed</a></td>
<td class="nump">1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption value</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReplacementReserveEscrow', window );">Replacement Reserve Escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Consulting Agreement [Member] | Mr. James R. Shipley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred Compensation Liability, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReplacementReserveEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents those amounts set aside for the repair and replacement of real or personal property in the foreseen future. Such amount may be funded from sales revenue (for example; timeshare sales) or operating revenues; in a lump sum or installments (such as monthly); as per internal policy (for example: hotel operators), as required by contractual agreement (for example: sales contract); or by the terms of debt agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.2,10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReplacementReserveEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328857693576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 07, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary Equity, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_TemporaryEquityNetProceeds', window );">Temporary equity net proceeds</a></td>
<td class="nump">$ 2,625,000<span></span>
</td>
<td class="nump">$ 1,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow Deposit</a></td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
<td class="nump">$ 36.00<span></span>
</td>
<td class="nump">$ 37.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember', window );">Equity Method Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.40<span></span>
</td>
<td class="nump">$ 10.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PercentageOfPlacementAgentCashFee', window );">Percentage of placement agent cash fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentCompanyShareholderServiceFeeExpense', window );">Investment Company, Shareholder Service Fee Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantToPurchaseCommonStockShares', window );">Warrants to purchase of common stock shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=SRNA_InvestorWarrantMember', window );">Investor Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable', window );">Class of Warrant or Right, Date from which Warrants or Rights Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 28,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.41<span></span>
</td>
<td class="nump">$ 9.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IssuanceOfCommonStockExercisePercentageProvision', window );">[custom:IssuanceOfCommonStockExercisePercentageProvision]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary Equity, Shares Authorized</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary Equity, Par or Stated Value Per Share</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of Warrant or Right, Exercise Price of Warrants or Rights</a></td>
<td class="nump">$ 9.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">385,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Temporary Equity, Aggregate Amount of Redemption Requirement</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</a></td>
<td class="nump">192,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Temporary Equity, Aggregate Amount of Redemption Requirement</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred Stock, Dividend Rate, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockConvertibleConversionPriceIncrease', window );">Common Stock, Convertible, Conversion Price, Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PercentageOfPreferredStockConversionProvision', window );">Percentage of preferred stock conversion provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PercentageOfCommonStockReserve', window );">Percentage of common stock reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Debt Instrument, Convertible, Liquidation Preference, Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DebtInstrumentRedeemableShares', window );">Redeemable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,650<span></span>
</td>
<td class="nump">1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon', window );">Redemption price percentage dividend due thereon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DebtInstrumentRedeemptionStatedValue', window );">Debt instrument redeemption stated value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue', window );">Debt Instrument, Convertible, Liquidation Preference, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,960,000<span></span>
</td>
<td class="nump">3,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Temporary Equity, Accretion to Redemption Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_TemporaryEquityNonCashRedemptionValueAdjustment', window );">Temporary equity non cash redemption value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,262,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet', window );">Proceeds from Issuance of Long-term Debt and Capital Securities, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,624,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDescription', window );">Temporary Equity, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the
redemption of the outstanding shares of Series A Preferred Stock of the Company for common stock at the rate of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</a></td>
<td class="nump">$ 192,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred Stock, Value, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="nump">$ 1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Debt Instrument, Convertible, Liquidation Preference, Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DebtInstrumentRedeemableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Redeemable Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DebtInstrumentRedeemableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DebtInstrumentRedeemptionStatedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Redeemption Stated Value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DebtInstrumentRedeemptionStatedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Redemption Price Percentage Dividend Due There on.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IssuanceOfCommonStockExercisePercentageProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance Of Common Stock Exercise Percentage Provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IssuanceOfCommonStockExercisePercentageProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PercentageOfCommonStockReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Common Stock Reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PercentageOfCommonStockReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PercentageOfPlacementAgentCashFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Placement Agent Cash Fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PercentageOfPlacementAgentCashFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PercentageOfPreferredStockConversionProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Preferred Stock Conversion Provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PercentageOfPreferredStockConversionProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_TemporaryEquityNetProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Net Proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_TemporaryEquityNetProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_TemporaryEquityNonCashRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Non Cash Redemption Value Adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_TemporaryEquityNonCashRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantToPurchaseCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant To Purchase Common Stock Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantToPurchaseCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the warrants or rights are exercisable, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConvertibleConversionPriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockConvertibleConversionPriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentCompanyShareholderServiceFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for shareholder services. Includes, but is not limited to, fee and expense for transfer and dividend disbursing agent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentCompanyShareholderServiceFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the type or class of security that is classified as temporary equity, including its redemption features (for example, sinking fund, at option of holders, out of future earnings), conversion features, and the rights of holders, if any, in the event of default, including the effect, if any, on junior securities in the event a required dividend, sinking fund, or other redemption payment(s) is not paid. Include also a description of stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquityMethodInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=SRNA_InvestorWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=SRNA_InvestorWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=SRNA_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140328860550488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficit (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2021</div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from Issuance of Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="nump">67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583,511<span></span>
</td>
<td class="nump">1,576,844<span></span>
</td>
<td class="nump">1,521,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement', window );">Temporary Equity, Aggregate Amount of Redemption Requirement</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</a></td>
<td class="nump">$ 192,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate common shares issued upon execution of settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AggregateSharesIssuedUponExecutionOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SRNA="http://surna.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="srna-20210930.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-17_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-17</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_CustomerContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-06-27_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-27</instant>
        </period>
    </context>
    <context id="From2017-06-262017-06-27_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-26</startDate>
            <endDate>2017-06-27</endDate>
        </period>
    </context>
    <context id="AsOf2018-01-02_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-02</instant>
        </period>
    </context>
    <context id="From2017-12-302018-01-02_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-30</startDate>
            <endDate>2018-01-02</endDate>
        </period>
    </context>
    <context id="From2018-08-302018-09-02_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-30</startDate>
            <endDate>2018-09-02</endDate>
        </period>
    </context>
    <context id="From2019-08-302019-09-02_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2019-09-02</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2017-07-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AgreementWithLandLordMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:AgreementWithLandLordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-02</instant>
        </period>
    </context>
    <context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-02</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_WebSiteDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-04-22</instant>
        </period>
    </context>
    <context id="From2020-04-212020-04-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="From2020-04-212020-04-22_us-gaap_ExtendedMaturityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationAxis">us-gaap:ExtendedMaturityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-21</startDate>
            <endDate>2020-04-22</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-12-11</instant>
        </period>
    </context>
    <context id="From2020-12-102020-12-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-12-10</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-10_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-10</instant>
        </period>
    </context>
    <context id="From2021-02-092021-02-10_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-09</startDate>
            <endDate>2021-02-10</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="From2018-01-012018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_us-gaap_AccountsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-30_custom_LeasedEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SRNA:LeasedEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="From2018-05-012018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="From2018-05-012018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilThirtyTwoThousandAndTwentyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:MrJamesRShipleyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:ConsultingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-01-07</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-08</startDate>
            <endDate>2020-03-09</endDate>
        </period>
    </context>
    <context id="From2020-06-072020-06-09_custom_FormerEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-07</startDate>
            <endDate>2020-06-09</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_WarrantsRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_WarrantsRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2014-10-012014-10-31_custom_SeriesTwoWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-10-31</instant>
        </period>
    </context>
    <context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SRNA:SeriesTwoConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-10-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_SeriesTwoWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="From2017-01-012017-12-31_custom_InvestmentBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="From2017-12-012017-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndNineteenSpecialEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-01-02</endDate>
        </period>
    </context>
    <context id="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-01-02</endDate>
        </period>
    </context>
    <context id="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-01-02</endDate>
        </period>
    </context>
    <context id="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-23</startDate>
            <endDate>2020-06-24</endDate>
        </period>
    </context>
    <context id="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilOneTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-23</startDate>
            <endDate>2020-06-24</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-29</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-02</instant>
        </period>
    </context>
    <context id="AsOf2022-01-17_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-17</instant>
        </period>
    </context>
    <context id="AsOf2022-01-27_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-27</startDate>
            <endDate>2022-01-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CustomerContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_OrderOrProductionBacklogMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OrderOrProductionBacklogMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquipmentAndSystemsSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EquipmentAndSystemsSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EngineeringAndOtherServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_ShippingAndHandlingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_AdvertisingAndMarketingExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:AdvertisingAndMarketingExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_ProductDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:ProductDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_FacilityLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-02</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="From2021-04-292021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-04-29</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-06-292021-07-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-06-29</startDate>
            <endDate>2021-07-02</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-07-27</instant>
        </period>
    </context>
    <context id="From2021-07-252021-07-27_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-25</startDate>
            <endDate>2021-07-27</endDate>
        </period>
    </context>
    <context id="AsOf2021-07-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="From2021-07-242021-07-28_custom_LeaseTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:LeaseTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-24</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:InventoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-02-10</instant>
        </period>
    </context>
    <context id="From2021-02-092021-02-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-02-09</startDate>
            <endDate>2021-02-10</endDate>
        </period>
    </context>
    <context id="From2021-03-292021-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-03-29</startDate>
            <endDate>2021-03-30</endDate>
        </period>
    </context>
    <context id="From2021-04-062021-04-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-04-06</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_us-gaap_ConvertiblePreferredStockMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="From2021-09-262021-09-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_InvestorWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">SRNA:InvestorWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_InvestorWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">SRNA:InvestorWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_EquityMethodInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-07_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-07</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_custom_PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-22</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:TwentyOneEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyTwoMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyThreeMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyFourMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">SRNA:JuneThirtyTwentyTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_FormerEmployeeMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61996156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember_custom_NonQualifiedStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-23</startDate>
            <endDate>2020-06-24</endDate>
        </period>
    </context>
    <context id="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-18</startDate>
            <endDate>2020-08-20</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_WarrantsRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_WarrantsRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_WarrantsRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-09-30_custom_WarrantsRangeOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-28</instant>
        </period>
    </context>
    <context id="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">SRNA:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-03_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="AsOf2021-11-04_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001482541</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-04</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Number">
        <measure>SRNA:Number</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-09-30">0001482541</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-09-30">true</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-01-01to2021-09-30">S-1/A</dei:DocumentType>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0063"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0106"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpense
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0220"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0258"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0264"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0273"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0359"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0406"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares
      contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0408"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0448"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0460"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:GainOnForgivenessOfNotePayable
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0551"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssued
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0961"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0963"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0965"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercised
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0967"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0969"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0971"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssued
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0986"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0988"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0990"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercised
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0992"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0994"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1075"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1081"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1083"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1099"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1107"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1109"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1128"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1136"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1158"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1160"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1162"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1184"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1186"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1188"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1192"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1194"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl1196"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1213"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1215"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1217"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1219"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1221"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1223"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1225"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1227"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1234"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1241"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1243"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1245"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1247"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1249"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1251"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      id="xdx2ixbrl1266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1270"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1272"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1276"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1278"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1280"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1282"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1284"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1286"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1288"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1290"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1292"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1294"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1296"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1298"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1312"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1314"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1316"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1318"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1320"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl1322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1358"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1360"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1374"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1382"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1384"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1394"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1396"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      id="xdx2ixbrl1398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1415"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1417"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1423"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1425"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1
      contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1427"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1
      contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1429"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1431"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1433"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1435"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1437"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1439"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1441"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1
      contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1443"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1
      contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      id="xdx2ixbrl1445"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl1475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl1476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl1505"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:NolsCarryforwardsTerm contextRef="From2020-01-012020-12-31" id="xdx2ixbrl1512">P3Y</SRNA:NolsCarryforwardsTerm>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermNotesPayable
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl1610"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl1619"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1626"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:RedeemableConvertiblePreferredStockSubscriptionReceivable
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1632"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:RedeemableConvertiblePreferredStockAccruedDividends
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl1638"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012021-09-30"
      id="xdx2ixbrl1755"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl1756"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl1757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl1758"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl1766"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl1768"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ConvertiblePreferredStockConvertedToSecurities
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl1771"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ConvertiblePreferredStockConvertedToSecurities
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl1773"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1800"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1844"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1845"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1847"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1856"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1857"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1859"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1862"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1863"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1865"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1868"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1869"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1871"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1874"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1875"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1877"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1893"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1894"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1908"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1920"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1921"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1923"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1928"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1929"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1931"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1934"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1935"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1937"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1940"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1941"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1947"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1949"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1952"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1953"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1955"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1958"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1959"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1960"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1984"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1986"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1987"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1988"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1989"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-07-012020-09-30"
      id="xdx2ixbrl1990"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1991"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1993"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl1994"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl1999"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2000"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2001"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2015"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2029"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2032"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2033"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2039"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2040"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2042"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2045"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2046"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2048"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2051"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2057"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2059"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl2073"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:CommonStockIssuedForOtherExpense
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2091"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2124"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:IncreaseDecreaseInLeaseDeposit
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2127"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2174"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2178"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SubscriptionReceivableSeriesBPreferredStock
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2187"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:OptionsIssuedForAccruedEquityCompensation
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="From2020-01-012020-09-30"
      id="xdx2ixbrl2193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30_us-gaap_CostOfSalesMember"
      id="xdx2ixbrl2292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30_custom_AdvertisingAndMarketingExpensesMember"
      id="xdx2ixbrl2300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30_custom_ProductDevelopmentCostsMember"
      id="xdx2ixbrl2308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2021-09-30"
      id="xdx2ixbrl2376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2592"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2594"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2600"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2602"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2616"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812"
      id="xdx2ixbrl2632"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812"
      id="xdx2ixbrl2634"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812"
      id="xdx2ixbrl2636"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61995812"
      id="xdx2ixbrl2638"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2644"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2652"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2654"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2656"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2658"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2660"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      id="xdx2ixbrl2666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2679"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2686"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2688"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2690"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2692"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2706"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2717"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl2724"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl2732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl2734"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      id="xdx2ixbrl2736"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2738"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2740"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      id="xdx2ixbrl2742"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2772"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercised
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2774"
      unitRef="Shares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2776"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-09-30"
      id="xdx2ixbrl2778"
      unitRef="USD"
      xsi:nil="true"/>
    <SRNA:NolsCarryforwardsTerm contextRef="From2020-01-012020-12-31" id="xdx2ixbrl2825">P3Y</SRNA:NolsCarryforwardsTerm>
    <dei:AmendmentDescription contextRef="From2021-01-01to2021-09-30">AMENDMENT NO. 1</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-09-30">CEA Industries Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-09-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-09-30">27-3911608</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-09-30">385 South Pierce Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-09-30">Suite C</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-09-30">Louisville,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-09-30">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-09-30">80027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-01-01to2021-09-30">(303)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-01to2021-09-30">993-5271</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-09-30">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">922177</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">151673</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">33480</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">138357</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1231243</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1037823</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">269491</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3683293</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">2561268</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">257923</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">11930</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">51000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">534133</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1129973</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1486050</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4047318</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1832959</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1444472</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">503466</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">217843</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5903689</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">3998740</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">74156</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">404209</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">243275</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">404209</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6146964</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4402949</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1576844</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1576844</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">1521444</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">1521444</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">16</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">15</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">26109509</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">25328861</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-27443643</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-25684927</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-355631</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4047318</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">8514272</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">15224454</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">6961305</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">10675601</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1552967</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">4548853</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">430012</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">675703</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">390229</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">521044</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3095350</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">4662695</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3915591</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">5859442</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-2362624</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1310589</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">621340</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-27977</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">17432</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">603908</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-27977</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1758716</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1338566</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1758716</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">-1.12</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">-0.88</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">1574454</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">1517748</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1499932</us-gaap:SharesOutstanding>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="Shares">6667</SRNA:CommonstockSharesToBeIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24540262</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-24346361</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" decimals="0" unitRef="USD">194336</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">14933</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <SRNA:CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">3733</SRNA:CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6579</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">75000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">278906</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">278906</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">390484</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">390484</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees
      contextRef="From2019-01-012019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">44209</SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">44209</SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1521444</us-gaap:SharesOutstanding>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="Shares">10400</SRNA:CommonstockSharesToBeIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25328861</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-355631</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1521444</us-gaap:SharesOutstanding>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="Shares">10400</SRNA:CommonstockSharesToBeIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25328861</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-355631</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">55400</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-10400</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-1</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">252020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">252020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1758716</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1758716</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26109509</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26109509</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-1758716</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">120103</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">161180</us-gaap:DepreciationDepletionAndAmortization>
    <SRNA:GainOnForgivenessOfNotePayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">557203</SRNA:GainOnForgivenessOfNotePayable>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">277183</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">788599</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">13425</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">32651</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">21669</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-223971</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-4124</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-115359</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">190183</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-91452</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-39179</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-882466</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">71386</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">768333</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">141143</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">26157</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">23830</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">2279717</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">802674</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3203</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-135828</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-20039</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">128434</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">503466</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">818036</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">671833</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">9332</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">3043</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-9332</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-3043</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">554000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">554000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1362704</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">668790</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" decimals="0" unitRef="USD">253387</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:NatureOfOperations contextRef="From2020-01-012020-12-31">&lt;p id="xdx_80C_eus-gaap--NatureOfOperations_z957nDjNG1Pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
1 &#x2013; &lt;span id="xdx_824_zE8VVKCFsFLi"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. (the &#x201c;Company&#x201d;) was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and
other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing sectors
of the United States&#x2019; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the
first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers,
tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming
practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems and other climate
control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and engineering commercial
scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems and technologies used
for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated CEA growers in the
U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those expanding or
retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder, Colorado, we
leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their overall
crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory
requirements. Although our customers do, we neither produce nor sell cannabis or its related products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Impact
of the COVID-19 Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources.
Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still
allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we
were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, cannot be
predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term. Despite this
uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact of the COVID-19 pandemic
to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced sales, increased losses and reduced
operating cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Refer
to &lt;i&gt;Risk Factors&lt;/i&gt;, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_809_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zJymfTBHykxa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
2 &#x2013; &lt;span id="xdx_82E_zGBpC3LVnpag"&gt;Basis of Presentation; Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTcPRP4mKzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect reported amounts and related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed in &lt;i&gt;Note 3 Going Concern&lt;/i&gt; below, the accompanying consolidated financial statements have been prepared on a going-concern
basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance of debt
and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar to those encountered
by similarly situated companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p id="xdx_84B_ecustom--ReverseStockSplitPolicyTextBlock_zTl66P5IWeHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zfp1oBXX6f91"&gt;Reverse
Stock Split&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqon6yE9Vegg" title="Reverse stock split, Description"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt; The par value for
the Common Stock was not affected.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zs3k93Zgl0Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zlmaiNJEfrt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis,
valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and
legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zl86gz0nfezg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z6ql9vwpH4G1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounts
Receivable and Allowance for Doubtful Accounts&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest.
An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which, in management&#x2019;s
judgment, deserve current recognition in estimating bad debts. Based on the Company&#x2019;s review, it establishes or adjusts the allowance
for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and December 31, 2019, the allowance
for doubtful accounts was $&lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20201231_zdjIevpfTdKh"&gt;165,098
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_zxkw667tEk6j"&gt;151,673&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zBZYSZAY5ym6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#x201c;FIFO&#x201d;) basis.
Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other
factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence
or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis for that inventory is established
and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete inventory was $&lt;span id="xdx_904_eus-gaap--InventoryAdjustments_c20201231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"&gt;93,045
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90C_eus-gaap--InventoryAdjustments_c20191231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"&gt;71,376&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zmAnTf818dk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Property
and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using
the straight-line method over their estimated useful lives, which is generally &lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20200101__20201231_zNah8Ikifnz3"&gt;five
years&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. Leasehold improvements are amortized on
a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and
related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zDncFzdzn0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Long-lived
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate
the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#x2019;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending
on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December 31, 2020 and
2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zKICEDwa9Pej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill
and Intangible Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December
31&lt;sup&gt;st&lt;/sup&gt; or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced
to less than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing
the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its
carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount
exceeds the reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit. The Company completed this assessment
as of December 31, 2020 and concluded that no impairment existed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#x2019;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are also subject
to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zEjfko1IosTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring
fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes the inputs used
in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability,
either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
3 - inputs are unobservable inputs based on the Company&#x2019;s assumptions used to measure assets and liabilities at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
financial asset or liability&#x2019;s classification within the hierarchy is determined based on the lowest level of input that is significant
to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement
in its entirety requires management to make judgments and consider factors specific to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses,
approximate fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zaxVqM2qYCHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Derivative
Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded
at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;)
to value the derivative instruments. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within
twelve months of the balance sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zgCRCRGtuXb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_z4lP7SDCLJWe" style="display: none"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment
    and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,730,371&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,692,863&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering
    and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;568,131&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,239,130&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping
    and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,770&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;292,461&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,514,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,224,454&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zGjsAig9HX6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition Accounting Policy Summary&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract
with a customer to transfer a distinct good or service to the customer. Most of the Company&#x2019;s contracts contain multiple performance
obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#x2019;s project life-cycle from facility design and construction to equipment
delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some
of the Company&#x2019;s contracts with customers contain a single performance obligation, typically engineering only services contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate
margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the
Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each promise is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange
for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#x2019;s historical rates of return are
insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes
revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and
certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected
by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and
shipping is recorded when control over the sale of goods passes to the Company&#x2019;s customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Other
Judgments and Assumptions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the
effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company
transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly,
the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Contract
Assets and Contract Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to
payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based
on the terms established in its contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional,
subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019, the
Company had no contract assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&#x2019;s contract liabilities are recorded as a current
liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is
generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which was classified as a current liability,
was $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_c20201231_pp0p0"&gt;3,724,189&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_c20191231_pp0p0"&gt;1,444,472&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the year ended December 31, 2020, the Company recognized revenue of $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20201231_pp0p0"&gt;1,103,447
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the deferred revenue at January 1,
2020, or &lt;span id="xdx_90D_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20200101__20201231_zHtCzzzTCDCe"&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
For the year ended December 31, 2019, the Company recognized revenue of $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190101__20191231_pp0p0"&gt;473,682
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the deferred revenue at January 1,
2019, or &lt;span id="xdx_90A_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20190101__20191231_zq9x62DeXgN3" title="Deferred revenue"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Remaining
Performance Obligations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate,
the uncertainty regarding the COVID-19 virus, and the Company&#x2019;s recent cost cutting measures, there is no assurance that the Company
will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_c20201231_pp0p0"&gt;8,448,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"&gt;2,643,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
or &lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20201231_z30QSaSK844a"&gt;31%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-COVID-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at December 31, 2020, includes booked sales orders of $&lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0"&gt;390,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from several customers that the Company does
not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus
COVID-19, the Company believes that several of its current contracts may be delayed or canceled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,355,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,643,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,703,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,805,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    remaining performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,058,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,448,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zeRp94luEPKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--StandardProductWarrantyPolicy_zxr65VYWAhla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Product
Warranty&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company&#x2019;s warranty provides for the repair, rework, or replacement of products (at the Company&#x2019;s option)
that fail to perform within stated specification. The Company&#x2019;s third-party suppliers also warrant their products under similar
terms, which are passed through to the Company&#x2019;s customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231" style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#x2019;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Company continues to
assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of December 31, 2020,
and December 31, 2019, the Company had an accrued warranty reserve amount of $&lt;span id="xdx_90F_eus-gaap--ProductWarrantyAccrual_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"&gt;173,365
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--ProductWarrantyAccrual_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"&gt;185,234&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, which are included in accounts payable and accrued liabilities on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zEcqOoSPJnV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cost
of Sales&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs,
engineering, project management and service salaries and benefits, client visits and warranty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_znT1zQ2fQ3V3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7EXjLtBKGU"&gt;28%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUkoZNs5WGZd"&gt;11%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwGAS5FHOBnk"&gt;10%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s revenue for the year ended
December 31, 2020. One customer accounted for &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZAensU29mbg"&gt;44%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s revenue for the year ended
December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s accounts receivable from two customers made up &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxScHmlvski4"&gt;48%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zA7ejDrKZqO8"&gt;38%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, of the total balance as of December 31, 2020. The Company&#x2019;s accounts receivable from three customers made up &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAipeN8Z20e6"&gt;59%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zXsXKQk317Hh"&gt;16%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z47qSd94Iapd"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, of the total balance as of December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
suppliers accounted for &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_z0mqrL4McdJk"&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_z4ZomONCErN7"&gt;25%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zwt5jRpeus13"&gt;12%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s purchases of inventory
for the year ended December 31, 2020, and three suppliers accounted for &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_zBQ2j3z3t6Ic"&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_zdHzBgLUz9J9"&gt;17%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zHfGZV1KqW99"&gt;12%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s purchases of inventory
for the year ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_zG7r1p9byb8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Product
Development&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For the
years ended December 31, 2020 and December 31, 2019, the Company incurred $&lt;span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pp0p0"&gt;390,229
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20190101__20191231_pp0p0"&gt;521,044&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, on product development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvislvwPapy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on
their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on
a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are
recognized ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the probability
assessment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the award
between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the
service inception date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the
award between the Company and the recipient has not yet been established. For awards in which the service inception date precedes the
grant date, compensation cost is accrued beginning on the service inception date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subsequent
to December 31, 2020, the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) approved annual incentive compensation awards
to certain employees payable in non-qualified stock options, based on the Company&#x2019;s performance and each employee&#x2019;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020, were
not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of the annual
incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to the employee, subsequent
to December 31, 2020. The estimated compensation expense of $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyIncentiveAwardsMember_pp0p0"&gt;128,434
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the 2020 incentive awards was accrued
as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation expense
has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant by the Board.
At that time, the incentive award becomes equity-classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates
whose term is consistent with the expected term of the option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0"&gt;405,617
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0"&gt;1,292,065
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the years ended December 31, 2020 and 2019,
respectively. Such share-based compensation costs are classified in the Company&#x2019;s consolidated financial statements in the same
manner as if such compensation was paid in cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of such share-based compensation costs included in the Company&#x2019;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Share-based Compensation Costs&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based
    compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,006&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,081&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising
    and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,977&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,882&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,330&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling,
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;344,396&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,121,677&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    share-based compensation expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,617&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,292,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p id="xdx_8A2_znBGzekj8KMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zZFabdYGDZd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets
and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change
in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized.
In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company
determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company
would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely
than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions
that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely
than not to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zBNKrztrBhN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basic
and Diluted Net Loss per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in periods
when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist
of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.
As of December 31, 2020, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20201231_zgkHDLjgCbZd"&gt;194,757
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;potential common shares equivalents from
warrants and options were excluded from the diluted EPS calculations as their effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zwYc4ooBD3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commitments
and Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its
business, that cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters.
An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred
and the amount of loss can be reasonably estimated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--OtherRisksAndUncertaintiesPolicyTextBlock_zQGam3vB1Cz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that
such products will be successfully marketed. These factors could have a material adverse effect upon the Company&#x2019;s financial results,
financial position, and future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#x2019;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty of
market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and equipment
to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states have legalized
medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well as its derivatives. Any
changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local cannabis laws and regulations
that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#x2019;s customers. The Company&#x2019;s
success is also dependent upon its ability to raise additional capital and to successfully develop and market its products. See Note
3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaIrUYsyqDmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Segment
Information&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the Company&#x2019;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zi6trV1w80E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06: &#x201c;&lt;i&gt;Accounting for Convertible Instruments and Contracts In An Entity&#x2019;s Own Equity&#x201d;
(&#x201c;ASU 2020-06&#x201d;)&lt;/i&gt; ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation
models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by requiring
the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04 using either
a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning after December 15,
2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020. The Company does not expect
this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTcPRP4mKzKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States
of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect reported amounts and related disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed in &lt;i&gt;Note 3 Going Concern&lt;/i&gt; below, the accompanying consolidated financial statements have been prepared on a going-concern
basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance of debt
and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar to those encountered
by similarly situated companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <SRNA:ReverseStockSplitPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84B_ecustom--ReverseStockSplitPolicyTextBlock_zTl66P5IWeHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zfp1oBXX6f91"&gt;Reverse
Stock Split&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqon6yE9Vegg" title="Reverse stock split, Description"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt; The par value for
the Common Stock was not affected.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SRNA:ReverseStockSplitPolicyTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember">On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_840_eus-gaap--ConsolidationPolicyTextBlock_zs3k93Zgl0Ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Principles
of Consolidation &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84B_eus-gaap--UseOfEstimates_zlmaiNJEfrt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets as it applies to impairment analysis,
valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals, inventory allowances, and
legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zl86gz0nfezg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash
and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="From2020-01-012020-12-31">&lt;p id="xdx_844_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_z6ql9vwpH4G1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounts
Receivable and Allowance for Doubtful Accounts&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear interest.
An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which, in management&#x2019;s
judgment, deserve current recognition in estimating bad debts. Based on the Company&#x2019;s review, it establishes or adjusts the allowance
for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and December 31, 2019, the allowance
for doubtful accounts was $&lt;span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20201231_zdjIevpfTdKh"&gt;165,098
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_c20191231_zxkw667tEk6j"&gt;151,673&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">151673</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zBZYSZAY5ym6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#x201c;FIFO&#x201d;) basis.
Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration and other
factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated excess, obsolescence
or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis for that inventory is established
and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete inventory was $&lt;span id="xdx_904_eus-gaap--InventoryAdjustments_c20201231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"&gt;93,045
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90C_eus-gaap--InventoryAdjustments_c20191231__us-gaap--ChangeInAccountingEstimateByTypeAxis__us-gaap--InventoryValuationAndObsolescenceMember_pp0p0"&gt;71,376&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryAdjustments
      contextRef="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember"
      decimals="0"
      unitRef="USD">93045</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments
      contextRef="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember"
      decimals="0"
      unitRef="USD">71376</us-gaap:InventoryAdjustments>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84D_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zmAnTf818dk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Property
and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using
the straight-line method over their estimated useful lives, which is generally &lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dc_c20200101__20201231_zNah8Ikifnz3"&gt;five
years&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. Leasehold improvements are amortized on
a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and
related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-012020-12-31">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zDncFzdzn0Wj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Long-lived
Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate
the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#x2019;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending
on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December 31, 2020 and
2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_845_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zKICEDwa9Pej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill
and Intangible Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December
31&lt;sup&gt;st&lt;/sup&gt; or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced
to less than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing
the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its
carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount
exceeds the reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit. The Company completed this assessment
as of December 31, 2020 and concluded that no impairment existed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#x2019;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are also subject
to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84E_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zEjfko1IosTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Fair
Value Measurement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring
fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between
market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes the inputs used
in the valuation methodologies in measuring fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability,
either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level
3 - inputs are unobservable inputs based on the Company&#x2019;s assumptions used to measure assets and liabilities at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
financial asset or liability&#x2019;s classification within the hierarchy is determined based on the lowest level of input that is significant
to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement
in its entirety requires management to make judgments and consider factors specific to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses,
approximate fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_848_eus-gaap--DerivativesPolicyTextBlock_zaxVqM2qYCHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Derivative
Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded
at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations.
For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;)
to value the derivative instruments. The classification of derivative instruments, including whether such instruments should be recorded
as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the
balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within
twelve months of the balance sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zgCRCRGtuXb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_z4lP7SDCLJWe" style="display: none"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment
    and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,730,371&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,692,863&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering
    and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;568,131&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,239,130&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping
    and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,770&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;292,461&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,514,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,224,454&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zGjsAig9HX6h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition Accounting Policy Summary&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract
with a customer to transfer a distinct good or service to the customer. Most of the Company&#x2019;s contracts contain multiple performance
obligations that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#x2019;s project life-cycle from facility design and construction to equipment
delivery and system installation and start-up. The Company does not provide construction services or system installation services. Some
of the Company&#x2019;s contracts with customers contain a single performance obligation, typically engineering only services contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and components and then adding an appropriate
margin, based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the
Company may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each promise is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange
for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#x2019;s historical rates of return are
insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the Company recognizes
revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales, use, value added, and
certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing transaction and collected
by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue and cost for freight and
shipping is recorded when control over the sale of goods passes to the Company&#x2019;s customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Other
Judgments and Assumptions&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the
effects of a significant financing component since the Company expects, at contract inception, that the period between when the Company
transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly,
the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Contract
Assets and Contract Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to
payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based
on the terms established in its contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional,
subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019, the
Company had no contract assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&#x2019;s contract liabilities are recorded as a current
liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to recognize revenue is
generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which was classified as a current liability,
was $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityCurrent_c20201231_pp0p0"&gt;3,724,189&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_903_eus-gaap--ContractWithCustomerLiabilityCurrent_c20191231_pp0p0"&gt;1,444,472&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the year ended December 31, 2020, the Company recognized revenue of $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20201231_pp0p0"&gt;1,103,447
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the deferred revenue at January 1,
2020, or &lt;span id="xdx_90D_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20200101__20201231_zHtCzzzTCDCe"&gt;76%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
For the year ended December 31, 2019, the Company recognized revenue of $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190101__20191231_pp0p0"&gt;473,682
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the deferred revenue at January 1,
2019, or &lt;span id="xdx_90A_ecustom--ContractWithCustomerLiabilityRevenueRecognizedPercentage_pid_dp_uPure_c20190101__20191231_zq9x62DeXgN3" title="Deferred revenue"&gt;74%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Remaining
Performance Obligations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project. Further, based on the current economic climate,
the uncertainty regarding the COVID-19 virus, and the Company&#x2019;s recent cost cutting measures, there is no assurance that the Company
will be able to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_903_eus-gaap--RevenueRemainingPerformanceObligation_c20201231_pp0p0"&gt;8,448,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_908_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"&gt;2,643,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
or &lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20201231_z30QSaSK844a"&gt;31%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-COVID-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at December 31, 2020, includes booked sales orders of $&lt;span id="xdx_904_eus-gaap--RevenueRemainingPerformanceObligation_c20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_pp0p0"&gt;390,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from several customers that the Company does
not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus
COVID-19, the Company believes that several of its current contracts may be delayed or canceled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,355,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,643,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,703,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,805,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    remaining performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,058,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,448,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zeRp94luEPKl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_890_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6N6LosOQmml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_z4lP7SDCLJWe" style="display: none"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 55%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment
    and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20201231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_zP4UcY0w39i5" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,730,371&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20190101__20191231__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_z7PlMZv4MmDg" style="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,692,863&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering
    and other services&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;568,131&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,239,130&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping
    and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,770&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;292,461&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,514,272&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,224,454&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">7730371</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">13692863</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">568131</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">1239130</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">215770</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">292461</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">8514272</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">15224454</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1444472</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">1103447</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.76</SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">473682</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.74</SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">8448000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2020-12-31_us-gaap_CustomerContractsMember"
      decimals="0"
      unitRef="USD">2643000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.31</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">390000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_89A_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zhAszGg5IUVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B7_zxQxwS6D4oRh" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zALLfWKZCFQ2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20201231__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zFKJNNS2tcJ" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20201231_zkS49uhCNgL7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_zXqAREgaGgXc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,355,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,643,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_zJDTVXe23gq6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    performance obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,703,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,805,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_z72vEZs75VW6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    remaining performance obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,058,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;390,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,448,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">2355000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">288000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2643000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">5703000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">102000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5805000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">8058000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">390000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">8448000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:StandardProductWarrantyPolicy contextRef="From2020-01-012020-12-31">&lt;p id="xdx_844_eus-gaap--StandardProductWarrantyPolicy_zxr65VYWAhla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Product
Warranty&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months
from shipment. The Company&#x2019;s warranty provides for the repair, rework, or replacement of products (at the Company&#x2019;s option)
that fail to perform within stated specification. The Company&#x2019;s third-party suppliers also warrant their products under similar
terms, which are passed through to the Company&#x2019;s customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_902_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231" style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#x2019;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The Company continues to
assess the need to record a warranty reserve at the time of sale based on historical claims and other factors. As of December 31, 2020,
and December 31, 2019, the Company had an accrued warranty reserve amount of $&lt;span id="xdx_90F_eus-gaap--ProductWarrantyAccrual_c20201231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"&gt;173,365
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--ProductWarrantyAccrual_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AccountsPayableAndAccruedLiabilitiesMember_pp0p0"&gt;185,234&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, which are included in accounts payable and accrued liabilities on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:StandardProductWarrantyDescription contextRef="From2020-01-012020-12-31">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&#x2019;s warranty policy, an accrual is established at 1% of the
trailing 18 months revenue.</us-gaap:StandardProductWarrantyDescription>
    <us-gaap:ProductWarrantyAccrual
      contextRef="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember"
      decimals="0"
      unitRef="USD">173365</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember"
      decimals="0"
      unitRef="USD">185234</us-gaap:ProductWarrantyAccrual>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zEcqOoSPJnV9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cost
of Sales&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs,
engineering, project management and service salaries and benefits, client visits and warranty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-012020-12-31">&lt;p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_znT1zQ2fQ3V3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z7EXjLtBKGU"&gt;28%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUkoZNs5WGZd"&gt;11%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zwGAS5FHOBnk"&gt;10%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s revenue for the year ended
December 31, 2020. One customer accounted for &lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zZAensU29mbg"&gt;44%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s revenue for the year ended
December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s accounts receivable from two customers made up &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxScHmlvski4"&gt;48%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zA7ejDrKZqO8"&gt;38%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, of the total balance as of December 31, 2020. The Company&#x2019;s accounts receivable from three customers made up &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAipeN8Z20e6"&gt;59%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zXsXKQk317Hh"&gt;16%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z47qSd94Iapd"&gt;10%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, of the total balance as of December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
suppliers accounted for &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_z0mqrL4McdJk"&gt;27%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_z4ZomONCErN7"&gt;25%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zwt5jRpeus13"&gt;12%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s purchases of inventory
for the year ended December 31, 2020, and three suppliers accounted for &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierOneMember_zBQ2j3z3t6Ic"&gt;30%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierTwoMember_zdHzBgLUz9J9"&gt;17%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20190101__20191231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesOfInventoryMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SupplierThreeMember_zHfGZV1KqW99"&gt;12%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Company&#x2019;s purchases of inventory
for the year ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember"
      decimals="INF"
      unitRef="Pure">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember"
      decimals="INF"
      unitRef="Pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember"
      decimals="INF"
      unitRef="Pure">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-01-012020-12-31">&lt;p id="xdx_849_eus-gaap--ResearchAndDevelopmentExpensePolicy_zG7r1p9byb8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Product
Development&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For the
years ended December 31, 2020 and December 31, 2019, the Company incurred $&lt;span id="xdx_902_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231_pp0p0"&gt;390,229
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_c20190101__20191231_pp0p0"&gt;521,044&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, on product development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">390229</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">521044</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2020-01-012020-12-31">&lt;p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zvislvwPapy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on
their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on
a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are
recognized ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the probability
assessment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the award
between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the
service inception date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the
award between the Company and the recipient has not yet been established. For awards in which the service inception date precedes the
grant date, compensation cost is accrued beginning on the service inception date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Subsequent
to December 31, 2020, the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) approved annual incentive compensation awards
to certain employees payable in non-qualified stock options, based on the Company&#x2019;s performance and each employee&#x2019;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020, were
not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of the annual
incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to the employee, subsequent
to December 31, 2020. The estimated compensation expense of $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyIncentiveAwardsMember_pp0p0"&gt;128,434
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to the 2020 incentive awards was accrued
as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation expense
has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant by the Board.
At that time, the incentive award becomes equity-classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates
whose term is consistent with the expected term of the option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0"&gt;405,617
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0"&gt;1,292,065
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the years ended December 31, 2020 and 2019,
respectively. Such share-based compensation costs are classified in the Company&#x2019;s consolidated financial statements in the same
manner as if such compensation was paid in cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of such share-based compensation costs included in the Company&#x2019;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Share-based Compensation Costs&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based
    compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,006&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,081&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising
    and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,977&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,882&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,330&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling,
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;344,396&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,121,677&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    share-based compensation expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,617&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,292,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p id="xdx_8A2_znBGzekj8KMe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember"
      decimals="0"
      unitRef="USD">128434</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">405617</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1292065</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zV7jrOn6JQm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of such share-based compensation costs included in the Company&#x2019;s consolidated statements of operations for
the years ended December 31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BC_zQm6u6iXaWi3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Share-based Compensation Costs&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based
    compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost
    of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,006&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;91,081&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising
    and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_ztmgWaaaW9u6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zjc5Mp0HYeAk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,977&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zjtvmgLLi3h9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,882&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_zp5pUnlNn191" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;45,330&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling,
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;344,396&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,121,677&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    share-based compensation expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;405,617&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20190101__20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,292,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">31006</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">91081</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">8333</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">33977</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">21882</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">45330</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">344396</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">1121677</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">405617</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">1292065</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zZFabdYGDZd2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of assets
and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change
in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized.
In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company
determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company
would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely
than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions
that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely
than not to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zBNKrztrBhN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basic
and Diluted Net Loss per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in periods
when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist
of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.
As of December 31, 2020, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20201231_zgkHDLjgCbZd"&gt;194,757
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;potential common shares equivalents from
warrants and options were excluded from the diluted EPS calculations as their effect is anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">194757</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_843_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zwYc4ooBD3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commitments
and Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its
business, that cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters.
An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred
and the amount of loss can be reasonably estimated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <SRNA:OtherRisksAndUncertaintiesPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_849_ecustom--OtherRisksAndUncertaintiesPolicyTextBlock_zQGam3vB1Cz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that
such products will be successfully marketed. These factors could have a material adverse effect upon the Company&#x2019;s financial results,
financial position, and future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#x2019;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty of
market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and equipment
to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states have legalized
medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well as its derivatives. Any
changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local cannabis laws and regulations
that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#x2019;s customers. The Company&#x2019;s
success is also dependent upon its ability to raise additional capital and to successfully develop and market its products. See Note
3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:OtherRisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zaIrUYsyqDmf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Segment
Information&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly
by the Company&#x2019;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zi6trV1w80E4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the FASB issued ASU 2020-06: &#x201c;&lt;i&gt;Accounting for Convertible Instruments and Contracts In An Entity&#x2019;s Own Equity&#x201d;
(&#x201c;ASU 2020-06&#x201d;)&lt;/i&gt; ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation
models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by requiring
the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04 using either
a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning after December 15,
2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020. The Company does not expect
this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_806_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z4lIc4LRbvJ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
3 &#x2013; &lt;span id="xdx_820_zqqYuD940TGg"&gt;Going Concern &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $&lt;span id="xdx_90C_eus-gaap--NetIncomeLoss_iN_pn3p0_di_c20200101__20201231_zJ3H4c3Lw2C5"&gt;1,759,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the year ended December 31, 2020 and had
an accumulated deficit of approximately $&lt;span id="xdx_905_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20201231_z9pBLeLRLuL8"&gt;27,444,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and a shareholders&#x2019; deficit of approximately
$&lt;span id="xdx_906_eus-gaap--StockholdersEquity_iNI_pn3p0_di_c20201231_zWh8G2raMCXd"&gt;1,334,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as
of December 31, 2020. Since inception, the Company has financed its activities principally through debt and equity financing, advance
payments from customers and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the
foreseeable future in connection with its operating activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions,
its customers&#x2019; operations and prospects for and ability to obtain project financing, and market and business disruptions, that
include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding of products; uncertainty
of product development and generation of revenues; dependence on outside sources of financing; risks associated with research, development;
dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized
companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing
to fulfill its development activities and generating a level of revenues adequate to support the Company&#x2019;s cost structure.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&#x2019;s ability to raise equity capital is also limited by the Company&#x2019;s stock price, and any such
issuance could be highly dilutive to existing shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s 2020 revenue of approximately $&lt;span id="xdx_908_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20200101__20201231_zau6RkdsqZ09"&gt;8,514,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;which represents a decrease of &lt;span id="xdx_90A_ecustom--DecreaseInRevenuePercentage_pid_dp_uPure_c20200101__20201231_z5jXNkx94AYj"&gt;44%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;over the prior year. The Company&#x2019;s revenue
recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred, and expects
to incur, additional operating expenses to support such growth. The Company generated approximately $&lt;span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3p0_c20200101__20201231_zWkIAm3Re5T2"&gt;818,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;in cash flow from operating activities in 2020.
However, as a result of the Company&#x2019;s growth and its efforts to expand and upgrade its products, the Company&#x2019;s working capital
deficit as of December 31, 2020 was approximately $&lt;span id="xdx_904_ecustom--WorkingCapitalDeficit_c20201231_pp0p0"&gt;2,220,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
compared to approximately $&lt;span id="xdx_90C_ecustom--WorkingCapitalDeficit_c20191231_pp0p0"&gt;1,437,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as
of December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced, or are
contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which COVID-19 will
impact the Company&#x2019;s business and financial results will depend on future developments, which are uncertain and cannot be predicted.
See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal year 2020 measures of adjusting
the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet management&#x2019;s expectations, or additional
capital is not available, there is substantial doubt about the Company&#x2019;s ability to continue as a going concern for a period of
one year from the issuance of these financial statements. Other factors that will impact the Company&#x2019;s ability to continue operations
include the market demand for the Company&#x2019;s products and services, the ability to service its customers and prospects, potential
contract cancellations, project scope reductions and project delays, the Company&#x2019;s ability to fulfill its backlog, the management
of working capital, and the continuation of normal payment terms and conditions for purchase of the Company&#x2019;s products. The Company
believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next twelve months. If the
Company is unable to increase revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&#x2019;s
ability to continue as a going concern for a period of one year from the date the financial statements are issued. These consolidated
financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">-1759000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-27444000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="-3" unitRef="USD">-1334000</us-gaap:StockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">8514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <SRNA:DecreaseInRevenuePercentage
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.44</SRNA:DecreaseInRevenuePercentage>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="USD">818000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <SRNA:WorkingCapitalDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2220000</SRNA:WorkingCapitalDeficit>
    <SRNA:WorkingCapitalDeficit contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1437000</SRNA:WorkingCapitalDeficit>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_ziGpRPGOyK46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
4 &#x2013; &lt;span id="xdx_826_zYz2L2QJNrzf"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
February 2016, the FASB issued ASU 2016-02, &lt;i&gt;Leases (Topic 842)&lt;/i&gt;(&#x201c;ASC 842&#x201d; or the &#x201c;new lease standard&#x201d;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not be updated,
and the disclosures required under the new lease standard will not be provided, for dates and periods prior to January 1, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
new lease standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#x201c;package
of practical expedients&#x201d; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease,
(ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
June 27, 2017, the Company entered into a lease for its manufacturing and office space (the &#x201c;Facility Lease&#x201d;), which commenced
September 29, 2017 and continues through August 31, 2022. The Company occupied its &lt;span id="xdx_90E_eus-gaap--AreaOfLand_iI_usqft_c20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zCxTFRJSZlrl"&gt;12,700
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square foot space for $&lt;span id="xdx_907_eus-gaap--PaymentsForRent_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"&gt;12,967
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per month &lt;span id="xdx_90E_eus-gaap--LesseeOperatingLeaseDescription_c20170626__20170627__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember"&gt;until
January 1, 2018&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. On January 2, 2018, the leased
space was expanded to &lt;span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zLD8O78hFDn3"&gt;18,600
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square feet, and the monthly rental rate increased
to $&lt;span id="xdx_90B_eus-gaap--PaymentsForRent_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"&gt;18,979
&lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_90C_eus-gaap--LesseeOperatingLeaseDescription_c20171230__20180102__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember" style="font: 10pt Times New Roman, Times, Serif"&gt;until
August 31, 2018&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. Beginning September 1, 2018 and 2019,
the monthly rent increased to $&lt;span id="xdx_902_eus-gaap--PaymentsForRent_c20180830__20180902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"&gt;19,549
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--PaymentsForRent_c20190830__20190902__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"&gt;20,135&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively. &lt;span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember"&gt;On
each September 1 through the end of the lease, the monthly rent will increase by 3%.&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant
to the current lease, the Company made a security deposit of $&lt;span id="xdx_902_eus-gaap--SecurityDeposit_c20170731_pp0p0"&gt;51,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;on July 31, 2017. The deposit of $&lt;span id="xdx_906_eus-gaap--PaymentsForDeposits_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_pp0p0"&gt;1,600
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;paid to the previous owner of the property was
forwarded to the current landlord. The Company has the option to renew the Facility Lease for an additional &lt;span id="xdx_904_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20201231__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_zZZPUCkQqG86"&gt;five
years&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $&lt;span id="xdx_90B_eus-gaap--PaymentsForRent_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember_pp0p0"&gt;52,600
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;to rent payments due during the period. &lt;span id="xdx_908_eus-gaap--LesseeOperatingLeaseDescription_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--AgreementWithLandLordMember"&gt;The
deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly
installments from January to December 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Total
rent under the Facility Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly
rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease
liability on the Company&#x2019;s condensed consolidated balance sheets. As of January 1, 2019, the remaining deferred rent of $&lt;span id="xdx_909_eus-gaap--DeferredRentCreditCurrent_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;26,477
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was reclassified to the operating lease liability
under the new lease standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Upon
adoption of the new lease standard, the Company recognized its lease for manufacturing and office space (the &#x201c;Facility Lease&#x201d;)
on the balance sheet as an operating lease right-of-use asset in the amount of $&lt;span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAsset_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;714,416
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and as a lease liability of $&lt;span id="xdx_900_eus-gaap--OperatingLeaseLiability_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;822,374&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
The renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably
certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will
include the renewal period in its lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#x2019;s contractors for tenant improvements made by the Company
not to exceed $&lt;span id="xdx_903_eus-gaap--TenantImprovements_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MinimumMember_pp0p0"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $&lt;span id="xdx_900_ecustom--UnamortizedAmountOfTenantImprovementAllowance_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_pp0p0"&gt;81,481
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was treated as a reduction in measuring the right-of-use
asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non-lease component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#x2019;s depository bank.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zPeQ3QlkQHh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B9_zox0OD0dSWLg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Lease Cost&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For
                                            the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 70%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseCost_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 26%; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;216,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    cash outflow from operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,934&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 26%"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z9hG7OHCzPY9" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;343,950&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liability, current&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266,105&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liability, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,119&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    lease term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20201231_zYcwBtbDKBub" style="font: 10pt Times New Roman, Times, Serif"&gt;1.7
                                            &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231_z4dVlHSoI0Pj" style="font-family: Times New Roman, Times, Serif"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zXS3ptFh0oca" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDVOneHTYVH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_z7dpdkWsmaYh" style="display: none"&gt;Schedule
of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Year one"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;281,864&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Year two"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;170,891&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;452,755&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20201231_zf84W1QHLDxl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Less imputed interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,531&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present
    value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiability_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Present value of minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;435,224&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_ziZvFyuCORWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"/&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:AreaOfLand
      contextRef="AsOf2017-06-27_custom_FacilityLeaseMember"
      decimals="INF"
      unitRef="sqft">12700</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent
      contextRef="From2017-06-262017-06-27_custom_FacilityLeaseMember"
      decimals="0"
      unitRef="USD">12967</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2017-06-262017-06-27_custom_FacilityLeaseMember">until
January 1, 2018</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:AreaOfLand
      contextRef="AsOf2018-01-02_custom_FacilityLeaseMember"
      decimals="INF"
      unitRef="sqft">18600</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent
      contextRef="From2017-12-302018-01-02_custom_FacilityLeaseMember"
      decimals="0"
      unitRef="USD">18979</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2017-12-302018-01-02_custom_FacilityLeaseMember">until
August 31, 2018</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:PaymentsForRent
      contextRef="From2018-08-302018-09-02_custom_FacilityLeaseMember"
      decimals="0"
      unitRef="USD">19549</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2019-08-302019-09-02_custom_FacilityLeaseMember"
      decimals="0"
      unitRef="USD">20135</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2020-01-012020-12-31_custom_FacilityLeaseMember">On
each September 1 through the end of the lease, the monthly rent will increase by 3%.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:SecurityDeposit contextRef="AsOf2017-07-31" decimals="0" unitRef="USD">51000</us-gaap:SecurityDeposit>
    <us-gaap:PaymentsForDeposits
      contextRef="From2020-01-012020-12-31_custom_FacilityLeaseMember"
      decimals="0"
      unitRef="USD">1600</us-gaap:PaymentsForDeposits>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="AsOf2020-12-31_custom_FacilityLeaseMember">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:PaymentsForRent
      contextRef="From2020-01-012020-12-31_custom_AgreementWithLandLordMember"
      decimals="0"
      unitRef="USD">52600</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2020-01-012020-12-31_custom_AgreementWithLandLordMember">The
deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly
installments from January to December 2021.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:DeferredRentCreditCurrent
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">26477</us-gaap:DeferredRentCreditCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">714416</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">822374</us-gaap:OperatingLeaseLiability>
    <us-gaap:TenantImprovements
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:TenantImprovements>
    <SRNA:UnamortizedAmountOfTenantImprovementAllowance
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">81481</SRNA:UnamortizedAmountOfTenantImprovementAllowance>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_zPeQ3QlkQHh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B9_zox0OD0dSWLg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Lease Cost&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;For
                                            the Year Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 70%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseCost_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 26%; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;216,889&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    cash outflow from operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,934&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 70%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 26%"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December
                                            31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z9hG7OHCzPY9" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;343,950&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liability, current&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266,105&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating
    lease liability, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,119&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    lease term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20201231_zYcwBtbDKBub" style="font: 10pt Times New Roman, Times, Serif"&gt;1.7
                                            &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount
    rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20201231_z4dVlHSoI0Pj" style="font-family: Times New Roman, Times, Serif"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">216889</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">160934</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2020-12-31">P1Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.0500</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_896_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDVOneHTYVH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_z7dpdkWsmaYh" style="display: none"&gt;Schedule
of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years
    ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Year one"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;281,864&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Year two"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;170,891&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Total minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;452,755&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20201231_zf84W1QHLDxl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Less imputed interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,531&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present
    value of minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiability_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Present value of minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;435,224&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">281864</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">170891</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">452755</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">17531</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">435224</us-gaap:OperatingLeaseLiability>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_806_eus-gaap--InventoryDisclosureTextBlock_zPjzClIgw3M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
5 &#x2013; &lt;span id="xdx_82F_zPKrvMsluy87"&gt;Inventory&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zsS4iWD1QIt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BE_zEPdvzgbpdO7" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Inventory&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20201231_zhtS2W1hrrFk" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20191231_zo0yO0tAWnze" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzovY_zcUBVogjx2p3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,778&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,041,369&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzovY_zpy2GKyYlvrg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work
    in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,231&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,851&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzovY_zuABjAhGwkW7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw
    materials&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,145&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;257,399&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzovY_zAiPNf3CfCDc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance
    for excess &amp;amp; obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(93,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,376&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzovY_zVnz9ZDhw415" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventory,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;327,109&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,231,243&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zqkjaNFpCDU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Overhead
expenses of $&lt;span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20200101__20201231_pp0p0"&gt;17,974&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_90B_eus-gaap--CostOfGoodsAndServicesSoldOverhead_c20190101__20191231_pp0p0"&gt;31,831&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;were
included in the inventory balance as of December 31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zsS4iWD1QIt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BE_zEPdvzgbpdO7" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Inventory&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20201231_zhtS2W1hrrFk" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20191231_zo0yO0tAWnze" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzovY_zcUBVogjx2p3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,778&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,041,369&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzovY_zpy2GKyYlvrg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work
    in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,231&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,851&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzovY_zuABjAhGwkW7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw
    materials&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,145&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;257,399&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzovY_zAiPNf3CfCDc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance
    for excess &amp;amp; obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(93,045&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,376&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--InventoryNet_iTI_pp0p0_mtINzovY_zVnz9ZDhw415" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventory,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;327,109&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,231,243&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">201778</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1041369</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4231</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">3851</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">214145</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">257399</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">93045</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">71376</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1231243</us-gaap:InventoryNet>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">17974</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">31831</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zLq72Q9WZrFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
6 &#x2013; &lt;span id="xdx_822_ziit6XWN0ooh"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zh2Icee86gEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B4_zVVsMRJAzqSi" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,422&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;389,090&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,615&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;619,283&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zvgMNUiNUWLa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(480,883&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20191231_zXe8mqyRHIOi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(361,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,732&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;257,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zay1LsUH04ne" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation
expense amounted to $&lt;span id="xdx_900_eus-gaap--Depreciation_c20200101__20201231_pp0p0"&gt;119,524&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for
the year ended December 31, 2020, of which $&lt;span id="xdx_901_eus-gaap--Depreciation_c20200101__20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0"&gt;6,394
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was allocated to cost of revenue. Depreciation
expense amounted to $&lt;span id="xdx_903_eus-gaap--Depreciation_c20190101__20191231_pp0p0"&gt;157,860&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for
the year ended December 31, 2019, of which $&lt;span id="xdx_902_eus-gaap--Depreciation_c20190101__20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0"&gt;7,010
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was allocated to cost of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2018, the Company&#x2019;s property and equipment, net included the gross cost of the equipment leased to a cultivation
company affiliated with one of the Co-founders of $&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentGross_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"&gt;176,042&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
and accumulated depreciation of $&lt;span id="xdx_90C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20181231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"&gt;39,120&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
During the year ended December 31, 2019, the Company wrote-off the carrying value of the leased equipment. See Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zh2Icee86gEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B4_zVVsMRJAzqSi" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture
    and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,422&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;389,090&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,615&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;619,283&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zvgMNUiNUWLa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(480,883&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20191231_zXe8mqyRHIOi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(361,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,732&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;257,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">398422</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">389090</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">628615</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">619283</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">480883</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">361360</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">257923</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">119524</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2020-01-012020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">6394</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">157860</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2019-01-012019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">7010</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2018-12-31_custom_CoFoundersMember"
      decimals="0"
      unitRef="USD">176042</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_custom_CoFoundersMember"
      decimals="0"
      unitRef="USD">39120</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_807_eus-gaap--IntangibleAssetsDisclosureTextBlock_zn23HhHg5uvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
7 &#x2013; &lt;span id="xdx_82E_zAfsIIV8kEIb"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zggo8d4spgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BD_z00zkFunFRg7" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,110&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,234&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Website
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,653&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,777&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(25,426&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,847&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,227&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,930&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zIYQ2Sxbhta8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Patents
when issued are amortized over &lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zQm2Fs4aILp1"&gt;14
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years, and web site development costs are amortized
over &lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dt_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_zr0vOCDPfIR5"&gt;five
years&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. Trademarks are not amortized since they
have an indefinite life. Amortization expense for intangibles amounted to $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20200101__20201231_pp0p0"&gt;579
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20190101__20191231_pp0p0"&gt;3,320
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the years ended December 31, 2020 and 2019,
respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $&lt;span id="xdx_907_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20200101__20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"&gt;4,124
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_908_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20190101__20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0"&gt;7,778&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, related to patents that had been abandoned.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zggo8d4spgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible
assets consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BD_z00zkFunFRg7" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,110&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,234&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Website
    development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebSiteDevelopmentCostsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,713&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_c20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,653&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,777&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(25,426&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(24,847&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intangible
    assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,227&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,930&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">8110</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2019-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">12234</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">22713</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">22713</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-12-31_us-gaap_TrademarksMember"
      decimals="0"
      unitRef="USD">1830</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2019-12-31_us-gaap_TrademarksMember"
      decimals="0"
      unitRef="USD">1830</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">32653</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">36777</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-25426</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-24847</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7227</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">11930</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="From2020-01-012020-12-31_us-gaap_PatentsMember">P14Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="From2020-01-012020-12-31_custom_WebSiteDevelopmentCostsMember">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">579</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">3320</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2020-01-012020-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">4124</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2019-01-012019-12-31_us-gaap_PatentsMember"
      decimals="0"
      unitRef="USD">7778</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z6vHbdZ5XbF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
8 &#x2013; &lt;span id="xdx_820_z6RO0rWJixFa"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMqUwIW62Mn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B2_z1Ux5zTvOta1" style="display: none"&gt;Schedule
of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20201231_zxlzjELyrpcg" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20191231_zUMOpS8dRv4d" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALze1T_zVrdMPSorzx7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;918,639&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,299,015&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALze1T_zFBTW1Sc3Wb3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales
    commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,263&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z5w9hxoGV7C8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,071&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,052&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALze1T_zYMKGAUUdenl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product
    warranty accrual&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,365&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;185,234&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z9uRwMGS31Zj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356,623&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,127&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALze1T_zJjZzcMGGVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,784,961&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,832,959&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zL2mw2kHjdM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and other accrued expenses includes $&lt;span id="xdx_909_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_c20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember_pp0p0"&gt;402,651
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;relating to a one-time warranty issue experienced
on three customers&#x2019; projects. The expenses related to parts and labor to repair units that had been delivered to these customers
prior to year-end. &lt;span id="xdx_900_eus-gaap--StandardProductWarrantyDescription_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__custom--ThreeCustomersMember"&gt;Since
the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing
1% warranty reserve that we accrue on all sales.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_896_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zMqUwIW62Mn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B2_z1Ux5zTvOta1" style="display: none"&gt;Schedule
of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20201231_zxlzjELyrpcg" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20191231_zUMOpS8dRv4d" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALze1T_zVrdMPSorzx7" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts
    payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;918,639&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,299,015&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALze1T_zFBTW1Sc3Wb3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales
    commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,263&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;69,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z5w9hxoGV7C8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,071&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,052&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALze1T_zYMKGAUUdenl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product
    warranty accrual&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,365&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;185,234&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALze1T_z9uRwMGS31Zj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356,623&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,127&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALze1T_zJjZzcMGGVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,784,961&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,832,959&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">918639</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1299015</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">48263</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">69532</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">288071</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">169052</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">173365</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">185234</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">356623</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">110127</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">1832959</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2020-12-31_custom_ThreeCustomersMember"
      decimals="0"
      unitRef="USD">402651</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:StandardProductWarrantyDescription contextRef="From2020-01-012020-12-31_custom_ThreeCustomersMember">Since
the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing
1% warranty reserve that we accrue on all sales.</us-gaap:StandardProductWarrantyDescription>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_80C_eus-gaap--DebtDisclosureTextBlock_zUhipQ9tARVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
9 &#x2013; &lt;span id="xdx_822_zRV64zyByxm7"&gt;Note Payable and Accrued Interest&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 22, 2020, the Company entered into a note payable with its current bank in the principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_c20200422_pp0p0"&gt;554,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
for working capital purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
loan amount was subject to interest at &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200422_zRN0gwPbEHjk"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and was initially due on &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422_zbAHUV3uPZS8"&gt;April 20, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
Subsequently, the term of the loan was potentially to be extended to &lt;span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20200421__20200422__us-gaap--LoanRestructuringModificationAxis__us-gaap--ExtendedMaturityMember_zmBiG8NphFna"&gt;April
20, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. The loan could be repaid in advance
without penalty. The loan was also potentially forgivable in full provided proceeds were used for payment of payroll expenses, rent,
utilities and mortgage interest and certain other terms and conditions were met. The loan had typical default provisions, including for
change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, interest of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20200101__20201231_pp0p0"&gt;3,203
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was accrued in respect of this note payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
December 11, 2020, the Company received notice from the bank that its loan received on April 22, 2020, in the principal amount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20201211_pp0p0"&gt;554,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and all accrued interest of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20201210__20201211_pp0p0"&gt;3,203&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed in &lt;i&gt;Note 16 Subsequent Events&lt;/i&gt; below, on February 10, 2021, we received funding based on a loan agreement entered
into on February 5, 2021 with its current bank in the principal amount of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_pp0p0"&gt;514,200
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgfllgsM3e55"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and is due on &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zaU1yJlYPVJj"&gt;February
5, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. The loan may be repaid in advance without
penalty. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment
of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-04-22" decimals="0" unitRef="USD">554000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-04-22" decimals="INF" unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-04-212020-04-22">2022-04-20</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-04-212020-04-22_us-gaap_ExtendedMaturityMember">2025-04-20</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">3203</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-12-11" decimals="0" unitRef="USD">554000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2020-12-102020-12-11"
      decimals="0"
      unitRef="USD">3203</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-02-092021-02-10_us-gaap_SubsequentEventMember">2026-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zIS26wPCDtcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
10 &#x2013; &lt;span id="xdx_827_zf7sf37DWYya"&gt;Related Party Agreements and Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Agreements
and Transaction with Company&#x2019;s Co-Founders&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following describes certain agreements and transactions between the Company and its co-founders (the &#x201c;Co-founders&#x201d;). The
Co-founders held various executive officer and director positions with the Company until May 2018. One of the Co-founders also was a
consultant to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the
Company, the Co-founders did not own more than &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20191231__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z8J5rxDJzt6a"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s outstanding common stock at any time during 2019 or 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Equipment,
Demonstration and Product Testing Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2017, the Company entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis cultivation
company affiliated with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation company certain cultivation
equipment in exchange for a quarterly fee of $&lt;span id="xdx_900_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"&gt;16,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
which was increased to $&lt;span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerIncludingAssessedTax_c20170501__20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__srt--RangeAxis__srt--MaximumMember_pp0p0"&gt;18,330
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;to reflect additional leased equipment requested
by the cultivation company (the &#x201c;Lease Fee&#x201d;). In consideration for access to the cultivation facility to conduct demonstration
tours and for the product testing and data to be provided by the cultivation company, the Company agreed to pay the cultivation company
a quarterly fee of $&lt;span id="xdx_904_eus-gaap--DueToRelatedPartiesCurrentAndNoncurrent_c20170531__us-gaap--TypeOfArrangementAxis__custom--EquipmentDemonstrationAndProductTestingAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"&gt;12,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(the &#x201c;Demo and Testing Fee&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company and the cultivation company each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation
company failed to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During
the second quarter of 2019, the Company notified the cultivation company of its breach for non-payment of the Lease Fee. In February
2020, the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement, including
any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment to the cultivation company for no additional
consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2018, the Company recorded Demo and Testing Fees of $&lt;span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_c20180101__20181231_pp0p0"&gt;32,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as operating expenses in the consolidated statements
of operations. During the year ended December 31, 2018, the Company also recorded Lease Fees of $&lt;span id="xdx_90C_eus-gaap--OperatingLeaseExpense_c20180101__20181231_pp0p0"&gt;48,880
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as &#x201c;Other income, net&#x201d; in the consolidated
statements of operations. As of December 31, 2018, unpaid Lease Fees of $&lt;span id="xdx_90F_ecustom--UnpaidLeaseFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsReceivableMember_pp0p0"&gt;36,660
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;were included in accounts receivable and unpaid
Demo and Testing Fees of $&lt;span id="xdx_901_ecustom--UnpaidDemoAndTestingFees_c20180101__20181231__us-gaap--FairValueByAssetClassAxis__us-gaap--AccountsPayableMember_pp0p0"&gt;24,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;were included in accounts payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the third quarter of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by the cultivation
company, and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with a corresponding charge
to &#x201c;Other income, net&#x201d; in the consolidated statements of operations, (ii) reversed the accounts payable related to the unpaid
Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the remaining carrying value of the leased
equipment of $&lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentNet_c20190930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--LeasedEquipmentMember_pp0p0"&gt;107,581&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
which was included in property and equipment on the Company&#x2019;s consolidated balance sheet. For the year ended December 31, 2019,
the net impact of the foregoing items on the consolidated statements of operations was a charge of $&lt;span id="xdx_908_ecustom--NetOfImpactOfForegoingItemCharge_c20191231_pp0p0"&gt;120,241&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Employment
Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2018, the Company and one of the Co-founders entered into an employment agreement which provided for an initial base salary of $&lt;span id="xdx_908_eus-gaap--SalariesWagesAndOfficersCompensation_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_pp0p0"&gt;150,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per year and certain sales incentive. Pursuant
to the employment agreement, the Company awarded &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_pid_c20180501__20180531__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z05Qjf1Hc5I3"&gt;32,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;restricted stock units (&#x201c;RSUs&#x201d;)
to the Co-founder that vested at certain dates in the future, subject to the co-founder&#x2019;s continued employment. As of December
31, 2019: (i) the Company has issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_z40XgwlaABjg"&gt;13,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock in settlement of vested
RSUs, (ii) &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember_zHw22lz7BiGk"&gt;6,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock in settlement of RSUs
that vested December 31, 2019 were issued subsequent to December 31, 2019, (iii) the parties mutually agreed to cancel &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_pid_c20190101__20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zzurGOfozEfj"&gt;6,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs, and (iii) &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20191231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--CoFoundersMember__us-gaap--AwardDateAxis__custom--AprilThirtyTwoThousandAndTwentyMember_zpoKeuuaruzh"&gt;5,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs vested on April 30, 2020, however, the
holder elected to cancel the RSUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Consulting
Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed &lt;i&gt;in Note 16 Subsequent Events&lt;/i&gt; below, on January 7, 2021, the Company entered into a consulting agreement with
RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services
to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually
determined by the Company and RSX. The Company will pay a monthly consulting fee of $&lt;span id="xdx_900_eus-gaap--ProfessionalFees_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_pp0p0"&gt;6,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2019-12-31_custom_CoFoundersMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember"
      decimals="0"
      unitRef="USD">16500</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="From2017-05-012017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">18330</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent
      contextRef="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember"
      decimals="0"
      unitRef="USD">12000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2018-01-012018-12-31"
      decimals="0"
      unitRef="USD">32000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2018-01-012018-12-31"
      decimals="0"
      unitRef="USD">48880</us-gaap:OperatingLeaseExpense>
    <SRNA:UnpaidLeaseFees
      contextRef="From2018-01-012018-12-31_us-gaap_AccountsReceivableMember"
      decimals="0"
      unitRef="USD">36660</SRNA:UnpaidLeaseFees>
    <SRNA:UnpaidDemoAndTestingFees
      contextRef="From2018-01-012018-12-31_us-gaap_AccountsPayableMember"
      decimals="0"
      unitRef="USD">24000</SRNA:UnpaidDemoAndTestingFees>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2019-09-30_custom_LeasedEquipmentMember"
      decimals="0"
      unitRef="USD">107581</us-gaap:PropertyPlantAndEquipmentNet>
    <SRNA:NetOfImpactOfForegoingItemCharge contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">120241</SRNA:NetOfImpactOfForegoingItemCharge>
    <us-gaap:SalariesWagesAndOfficersCompensation
      contextRef="From2018-05-012018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember"
      decimals="0"
      unitRef="USD">150000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2018-05-012018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember"
      decimals="INF"
      unitRef="Shares">32000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod
      contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember"
      decimals="INF"
      unitRef="Shares">13333</SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember"
      decimals="INF"
      unitRef="Shares">6667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod
      contextRef="From2019-01-012019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">6667</SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember"
      decimals="INF"
      unitRef="Shares">5333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember"
      decimals="0"
      unitRef="USD">6500</us-gaap:ProfessionalFees>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z6Rv5sxQ2HTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
11 &#x2013; &lt;span id="xdx_823_zE1e9NOcWSqa"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2019, there were &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_ecustom--NumberOfUnitsVestedButNotSettled_pid_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1D6Li7sAvne"&gt;45,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;restricted stock units that had not been
settled due to a dispute with a former employee over the required withholding taxes to be paid to the Company for remittance to the appropriate
tax authorities. The Company commenced an arbitration action against the former employee regarding the dispute. The former employee also
made claims in the arbitration action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020,
the Company issued the former employee &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgCQ7KzD5kI1"&gt;45,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock
in settlement of these restricted stock units after taking measures to mitigate the Company&#x2019;s exposure to penalties and liability
for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $&lt;span id="xdx_90E_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpLxiLuaWnmj"&gt;10,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in the Company&#x2019;s favor and a finding against
the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&#x2019;s favor in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $&lt;span id="xdx_90D_eus-gaap--LossContingencyDamagesAwardedValue_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_pp0p0"&gt;33,985&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
with interest at &lt;span id="xdx_906_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_pid_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zFRXQvlE3aTi"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company
and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee
is continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015 calendar
year prior to his appointment as an executive officer of the Company. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict and the Company&#x2019;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the
Company&#x2019;s operations or its financial position, liquidity or results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Commitments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors,
business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company&#x2019;s
breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties.
In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that
will require the Company to, among other things, indemnify them against certain liabilities that may arise by reason of their status
or service as directors, officers, or employees. The Company maintains director and officer insurance, which may cover certain liabilities
arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors, and
employees of acquired companies, in certain circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <SRNA:NumberOfUnitsVestedButNotSettled
      contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">45000</SRNA:NumberOfUnitsVestedButNotSettled>
    <SRNA:NumberOfUnitsVestedAndSettled
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">45000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="0"
      unitRef="USD">33985</us-gaap:LossContingencyDamagesAwardedValue>
    <SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="INF"
      unitRef="Pure">0.08</SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage>
    <SRNA:PreferredAndCommonStockNoteDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_80B_ecustom--PreferredAndCommonStockNoteDisclosureTextBlock_zCxvSCoTN7o8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
12 &#x2013; &lt;span id="xdx_820_zRpOiKZM88v3"&gt;Preferred and Common Stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, and 2019, there were &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYpDiNFqp1Ah"&gt;42,030,331
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares of Series A preferred stock, par value
$&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zu9ytYekXata"&gt;0.00001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per share, issued and outstanding. The holders
of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one vote of the Company&#x2019;s common
stock. The Series A preferred stock ranks senior to the Company&#x2019;s common stock. The holders of shares of Series A preferred stock
are not entitled to receive dividends and have no conversion or preemptive rights. Upon liquidation, dissolution or winding up of the
Company&#x2019;s business, after payment to the holders of any senior securities, the holders of Series A preferred stock are entitled
to receive a preferential cash payment per share of Series A preferred stock equal to the stated value of the preferred stock, prior
to any payment to the holders of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z2zCrGoKAMEj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,667
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares to an employee in settlement of certain
    RSUs that vested December 31, 2019;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zUvwXN23IDa8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,733
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares pursuant to a special incentive stock
    bonus approved by the Board for the period ended December 31, 2019; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_ecustom--NumberOfUnitsVestedAndSettled_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpiXSBOC72bj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares in settlement of restricted stock units
    to a former employee after taking measures to mitigate the Company&#x2019;s exposure to penalties and liability for the failure to
    properly withhold income taxes, as further discussed in &lt;i&gt;Note 11 &#x2013; Commitments and Contingencies, Litigation&lt;/i&gt; above.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the year ended December 31, 2019, the Company issued shares of its common stock under the Company&#x2019;s 2017 Equity Plan as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zbZ7TzICqGsh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,316
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were issued to independent
    directors in lieu of cash director fees; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxwcxMqUfgda" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,263
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were issued to independent
    directors as the 2019 equity retainer fee; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_ecustom--StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zt4rpsAgUuy5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,467
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were issued to certain
    employees in settlement of vested restricted stock units; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_z4jIaQEQ20Ce" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,467
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were issued to certain
    employees as a stock incentive bonus.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:PreferredAndCommonStockNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember"
      decimals="INF"
      unitRef="Shares">6667</SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock>
    <SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember"
      decimals="INF"
      unitRef="Shares">3733</SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus>
    <SRNA:NumberOfUnitsVestedAndSettled
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">45000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">1316</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">5263</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember"
      decimals="INF"
      unitRef="Shares">7467</SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock>
    <SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember"
      decimals="INF"
      unitRef="Shares">7467</SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus>
    <SRNA:WarrantsDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_800_ecustom--WarrantsDisclosureTextBlock_zcc9al3ZhTXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
13 &#x2013; Outstanding Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_820_zTUUdnZyTWK6" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zCmKGkVA2K1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B8_zujAupgcPZf3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    Life&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20190101__20191231_zHHR9lK7HwN9" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266,735&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20190101__20191231_zlVMLuwIDdnh" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20180101__20181231_zSNuiHD8JHdh" style="font-family: Times New Roman, Times, Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20190101__20191231_zhSwNkngcGkb" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightIssued_c20190101__20191231_zMw9X2Kx1Btl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20190101__20191231_zCu8XanGfln" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercised_c20190101__20191231_zhPUDpdKLO1d" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20190101__20191231_znyF8jQQ4oBg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20190101__20191231_z6UMikAfCEW6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,008&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20190101__20191231_zEAMgdPZrt5f" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(99.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20200101__20201231_zVRwMhcJq0uh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,727&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20200101__20201231_zRNYZCxfgAh5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20190101__20191231_ziwiDyXx0GQb" style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231_zInNKgxYOnA" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightIssued_c20200101__20201231_zopjaADN6l4c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20200101__20201231_zyfHKcvn82Ch" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercised_c20200101__20201231_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20200101__20201231_zHfHnhlfUiJ5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0996"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_c20200101__20201231_zDGSBo1oskOf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(210,310&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20200101__20201231_zfD99jjPCIB3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20200101__20201231_zscu6SOw7pni" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20200101__20201231_zuvwzPeDc3Yj" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_dtM_c20200101__20201231_zhdseHw7u8W3" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231_zXtxX1GvmqJ9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zQA9Rm4RkEwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zBewjAB52c1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information about warrants outstanding at December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B3_z7jcy62VIUX6" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Life of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise
    price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zcE4irsYhtVf" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zDW7HNQQ1Ac1" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20200101__20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zggF3MvAyLFe" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zS3wsqRVSJG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Series
2 Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2014, the Company offered up to &lt;span id="xdx_909_ecustom--NumberOfInvestmentUnitOffered_uNumber_c20141001__20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zHjPmVqdjLa7"&gt;60
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;investment units at a price per unit of $&lt;span id="xdx_909_ecustom--OfferedInvestmentsPricePerUnit_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_pp0p0"&gt;50,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Each unit consisted of (i) &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zrgeorm3TUI9"&gt;1,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock,
(ii) a $&lt;span id="xdx_901_eus-gaap--ConvertibleDebt_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_pp0p0"&gt;50,000
&lt;/span&gt;&lt;/span&gt;&lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember__us-gaap--DebtInstrumentAxis__custom--SeriesTwoConvertibleNotesMember_zBWUXwaUvEm8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
convertible promissory note (&#x201c;Series 2 Convertible Note&#x201d;), and (iii) warrants for the purchase of &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20141031__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_zTK6mXbKh5n6"&gt;333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock
(&#x201c;Series 2 Warrants&#x201d;). As of December 31, 2018, Series 2 Warrants to purchase &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20181231__us-gaap--StatementEquityComponentsAxis__custom--SeriesTwoWarrantsMember_z8kLZbzSSqFl"&gt;6,008
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were outstanding,
all of which expired unexercised during the year ended December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Warrants
Issued to Investment Bank&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to a certain agreement for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year ended
December 31, 2017, the Company issued to an investment bank or its designees a warrant (&#x201c;Banker Warrant&#x201d;) to purchase, at
an exercise price &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_zuRSth8RyeLk"&gt;52.50
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__dei--LegalEntityAxis__custom--InvestmentBankMember_znQV77lcEGZ7"&gt;3,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock.
&lt;span id="xdx_908_ecustom--WarrantDescription_c20170101__20171231__dei--LegalEntityAxis__custom--InvestmentBankMember"&gt;The Banker Warrants
were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Q1
2017 Warrants &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2017, the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_ecustom--NumberOfInvestmentUnitOffered_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pdd"&gt;111,875
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;investment units, for aggregate gross proceeds
of $&lt;span id="xdx_90A_ecustom--ProceedsFromInvestment_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_pp0p0"&gt;2,685,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
or &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_906_ecustom--ProceedsFromInvestmentPerUnit_pid_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zSquFoX6Hiz2"&gt;24.00
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per unit. &lt;span id="xdx_907_eus-gaap--ConversionOfStockDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember"&gt;Each
unit consisted of &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; share of the Company&#x2019;s common stock and &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; warrant for the purchase of one
share of the Company&#x2019;s common stock (&#x201c;Q1 2017 Warrants&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;;
however, one investor declined receipt of the warrant to purchase &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zqUAtsZIDZPl"&gt;3,125
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock.
Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months after the issuance date and on or prior to
the close of business on the date that is the third anniversary of the issuance date, purchase up to the number of shares of the Company&#x2019;s
common stock as set forth in the respective warrant. The exercise price per share of the common stock under the Q1 2017 Warrants is &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_z3P9Gln4yVJe"&gt;39.00,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;subject to customary adjustments as provided in
the warrant. Each Q1 2017 Warrant was callable at the Company&#x2019;s option commencing six months from the issuance date, provided the
closing price of the Company&#x2019;s common stock was &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zTgfKbMg9Sek"&gt;63.00
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;or greater for &lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zcQstdnhtHqj"&gt;five
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consecutive trading days. Commencing at any time
after the date on which such call condition was satisfied, the Company had the right, upon 30 days&#x2019; notice to the holder, to redeem
the warrant shares at a price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_902_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember_zH3V3LQmCNog"&gt;1.50
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per warrant share. The holder could have
exercised the warrant at any time (in whole or in part) prior to the redemption date at the exercise price. &lt;span id="xdx_90F_ecustom--WarrantDescription_c20170301__20170331__us-gaap--StatementEquityComponentsAxis__custom--QOneTwoThousandSeventeenWarrantsMember"&gt;These
warrants expired unexercised in March 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Q4
2017 Warrants &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2017, the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_ecustom--NumberOfInvestmentUnitOffered_pid_uNumber_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zjrcqy87XBb4"&gt;98,227
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;investment units for aggregate proceeds of
$&lt;span id="xdx_90D_ecustom--ProceedsFromInvestment_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_pp0p0"&gt;1,768,080&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
or &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90C_ecustom--ProceedsFromInvestmentPerUnit_pid_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zzkAH5M0CFf8"&gt;18.00
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per unit. &lt;span id="xdx_90A_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zfgXqdgKNGOb"&gt;Each
unit consisted of &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; share of the Company&#x2019;s common stock and &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; warrant for the purchase of one
share of the Company&#x2019;s common stock (&#x201c;Q4 2017 Warrants&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Q4 2017 Warrants had an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zU2sxrMa7Fol"&gt;30.00
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to customary adjustments
as provided in the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&#x2019;s option, provided
the closing price of the Company&#x2019;s common stock was &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zZyaMJGvKfWj"&gt;54.00
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;or greater for &lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_z2DdIy82nATh"&gt;five
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consecutive trading days. Commencing at any time
after the date on which the call condition is satisfied, the Company had the right, upon notice to the holders, to redeem the shares
of common stock underlying each warrant at a price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90A_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20171231__us-gaap--StatementEquityComponentsAxis__custom--QFourTwoThousandSeventeenWarrantsMember_zCU6gPuPg0q"&gt;1.50
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, but such redemption could not
occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder. The holder could exercise the warrant
at any time (in whole or in part) prior to the redemption date at the exercise price. These warrants expired unexercised in December
2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Q2
2018 Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2018, the Company completed a private placement offering of investment units, with &lt;span id="xdx_905_eus-gaap--ConversionOfStockDescription_c20171201__20171231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zrRQkM65UTX3" title="Conversion of stock, Description"&gt;each
unit consisting of &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; share of the Company&#x2019;s common stock and &lt;span style="-sec-ix-redline: true"&gt;0.0067 of a&lt;/span&gt; Q2 2018 Warrant&lt;/span&gt;. The
Q2 2018 Warrants have an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zTKOYgwhXLFb"&gt;37.50 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
share of the common stock underlying each warrant, subject to customary adjustments as provided in the warrant. &lt;span id="xdx_909_ecustom--WarrantDescription_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember"&gt;The
Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Q2 2018 Warrants are callable at the Company&#x2019;s option, beginning on July 1, 2019 until the expiration thereof on June 30,
2021, provided the closing price of the Company&#x2019;s common stock is &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zntzXCuyVY9c"&gt;60.00 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(subject
to adjustment as provided in the warrant) or greater for &lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dc_c20180601__20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zLUu6QAHOowh"&gt;five &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consecutive
trading days. Commencing at any time after the date on which the call condition is satisfied, the Company has the right, upon notice
to the holders, to redeem the shares of common stock underlying each warrant at a price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_905_ecustom--RedeemWarrantSharesAtPrice_iI_pid_c20180630__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zYtbtzCVtgy5"&gt;1.50 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per
share, but such redemption may not occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder.
The holder may exercise the warrant (in whole or in part) prior to the redemption date at the exercise price. As of December 31,
2020, Q2 2018 Warrants to purchase &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20201231__us-gaap--StatementEquityComponentsAxis__custom--QTwoTwoThousandEighteenWarrantsMember_zCB0c3z5WCib"&gt;50,417 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


</SRNA:WarrantsDisclosureTextBlock>
    <SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_892_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_zCmKGkVA2K1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B8_zujAupgcPZf3" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    Life&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20190101__20191231_zHHR9lK7HwN9" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;266,735&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20190101__20191231_zlVMLuwIDdnh" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20180101__20181231_zSNuiHD8JHdh" style="font-family: Times New Roman, Times, Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20190101__20191231_zhSwNkngcGkb" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightIssued_c20190101__20191231_zMw9X2Kx1Btl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0961"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20190101__20191231_zCu8XanGfln" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0963"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0965"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercised_c20190101__20191231_zhPUDpdKLO1d" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0967"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20190101__20191231_znyF8jQQ4oBg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightExpired_c20190101__20191231_z6UMikAfCEW6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,008&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20190101__20191231_zEAMgdPZrt5f" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(99.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20190101__20191231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_c20200101__20201231_zVRwMhcJq0uh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;260,727&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_pid_c20200101__20201231_zRNYZCxfgAh5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20190101__20191231_ziwiDyXx0GQb" style="font-family: Times New Roman, Times, Serif"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231_zInNKgxYOnA" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ClassOfWarrantOrRightIssued_c20200101__20201231_zopjaADN6l4c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_pid_c20200101__20201231_zyfHKcvn82Ch" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0988"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercised_c20200101__20201231_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_pid_c20200101__20201231_zHfHnhlfUiJ5" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0994"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0996"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClassOfWarrantOrRightExpired_pid_c20200101__20201231_zDGSBo1oskOf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(210,310&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_pid_c20200101__20201231_zfD99jjPCIB3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(34.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_c20200101__20201231_zscu6SOw7pni" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_pid_c20200101__20201231_zuvwzPeDc3Yj" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding_dtM_c20200101__20201231_zhdseHw7u8W3" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231_zXtxX1GvmqJ9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2018-12-31" decimals="INF" unitRef="Shares">266735</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2018-12-31"
      decimals="INF"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2018-01-012018-12-31">P21M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2018-12-31" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightExpired
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">-6008</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="USDPShares">-99.00</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">260727</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">36.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2019-01-012019-12-31">P9M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightExpired
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">-210310</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="USDPShares">-34.50</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">50417</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding contextRef="From2020-01-012020-12-31">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_891_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zBewjAB52c1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information about warrants outstanding at December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B3_z7jcy62VIUX6" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Life of&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise
    price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zcE4irsYhtVf" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zDW7HNQQ1Ac1" style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20200101__20201231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zggF3MvAyLFe" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-31_custom_WarrantsRangeMember"
      decimals="INF"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2020-12-31_custom_WarrantsRangeMember"
      decimals="INF"
      unitRef="Shares">50417</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-012020-12-31_custom_WarrantsRangeMember">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:NumberOfInvestmentUnitOffered
      contextRef="From2014-10-012014-10-31_custom_SeriesTwoWarrantsMember"
      decimals="INF"
      unitRef="Number">60</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:OfferedInvestmentsPricePerUnit
      contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember"
      decimals="0"
      unitRef="USD">50000</SRNA:OfferedInvestmentsPricePerUnit>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember"
      decimals="INF"
      unitRef="Shares">1667</us-gaap:CommonStockSharesIssued>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember"
      decimals="INF"
      unitRef="Shares">333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2018-12-31_custom_SeriesTwoWarrantsMember"
      decimals="INF"
      unitRef="Shares">6008</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember"
      decimals="INF"
      unitRef="USDPShares">52.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember"
      decimals="INF"
      unitRef="Shares">3333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <SRNA:WarrantDescription contextRef="From2017-01-012017-12-31_custom_InvestmentBankMember">The Banker Warrants
were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020</SRNA:WarrantDescription>
    <SRNA:NumberOfInvestmentUnitOffered
      contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="Number">111875</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:ProceedsFromInvestment
      contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="0"
      unitRef="USD">2685000</SRNA:ProceedsFromInvestment>
    <SRNA:ProceedsFromInvestmentPerUnit
      contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">24.00</SRNA:ProceedsFromInvestmentPerUnit>
    <us-gaap:ConversionOfStockDescription contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">Each
unit consisted of</us-gaap:ConversionOfStockDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="Shares">3125</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">39.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">63.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="Number">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <SRNA:RedeemWarrantSharesAtPrice
      contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">1.50</SRNA:RedeemWarrantSharesAtPrice>
    <SRNA:WarrantDescription contextRef="From2017-03-012017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">These
warrants expired unexercised in March 2020</SRNA:WarrantDescription>
    <SRNA:NumberOfInvestmentUnitOffered
      contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="Number">98227</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:ProceedsFromInvestment
      contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="0"
      unitRef="USD">1768080</SRNA:ProceedsFromInvestment>
    <SRNA:ProceedsFromInvestmentPerUnit
      contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">18.00</SRNA:ProceedsFromInvestmentPerUnit>
    <us-gaap:ConversionOfStockDescription contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">Each
unit consisted of</us-gaap:ConversionOfStockDescription>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">30.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">54.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="From2017-12-012017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="Number">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <SRNA:RedeemWarrantSharesAtPrice
      contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">1.50</SRNA:RedeemWarrantSharesAtPrice>
    <us-gaap:ConversionOfStockDescription contextRef="From2017-12-012017-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">each
unit consisting of</us-gaap:ConversionOfStockDescription>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:WarrantDescription contextRef="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">The
Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021</SRNA:WarrantDescription>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">60.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="From2018-06-012018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember"
      decimals="INF"
      unitRef="Number">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <SRNA:RedeemWarrantSharesAtPrice
      contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">1.50</SRNA:RedeemWarrantSharesAtPrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2020-12-31_custom_QTwoTwoThousandEighteenWarrantsMember"
      decimals="INF"
      unitRef="Shares">50417</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_804_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zHus4OeE7m19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
14 &#x2013; Equity Incentive Plan&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_827_zA8hsQCXhksl" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Equity
Incentive Plans&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2017, the Board adopted and approved the Company&#x2019;s 2017 Equity Incentive Plan (the &#x201c;2017 Equity Plan&#x201d;) in
order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants, and other
persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under the 2017 Equity
Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock appreciation rights
(&#x201c;SARs&#x201d;), restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock unit awards (&#x201c;RSUs&#x201d;), shares granted
as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pid_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zlxYg4jjtRHc"&gt;333,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock
(&#x201c;Plan Shares&#x201d;) for issuance of equity awards under the 2017 Equity Plan. As of December 31, 2020, the Company has granted,
under the 2017 Equity Plan, awards in the form of RSAs for services rendered by independent directors and consultants, non-qualified
stock options, RSUs and stock bonus awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_pp0p0"&gt;6,412&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
which will be recognized over approximately &lt;span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtM_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember_zSoRwIEeGmtj"&gt;3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Restricted
Stock Awards &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2018, the Company had accrued fees owed to the Company&#x2019;s independent directors totaling $&lt;span id="xdx_90F_eus-gaap--ProfessionalFees_c20180101__20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_pp0p0"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
which were payable in equity. During the year ended December 31, 2019, the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsMember_zde8R2Nb5uo4"&gt;1,316
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of restricted stock, which were fully
vested at the time of the award, in settlement of these accrued fees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2019, the Company also awarded &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_zTjeQlFdhBCa"&gt;5,263
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of restricted stock under the 2017
Equity Plan to the Company&#x2019;s independent directors and consultants as an equity retainer fee for 2019. These restricted shares
were fully vested at the time of the award and the aggregate value attributable to these shares was $&lt;span id="xdx_908_eus-gaap--ProfessionalFees_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--IndependentDirectorsOneMember_pp0p0"&gt;60,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
as calculated using the fair value of the Company&#x2019;s common stock on date the Board approved these awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Non-Qualified
Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of highly
subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in the subjective
input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions are based on the historical
volatility of the Company&#x2019;s common stock over periods that are similar to the expected terms of grants and other relevant factors.
The Company derives the expected term based on an average of the contract term and the vesting period taking into consideration the vesting
schedules and future employee behavior with regard to option exercise. The risk-free interest rate is based on U.S. Treasury yields for
a maturity approximating the expected term calculated at the date of grant. The Company has never paid any cash dividends on its common
stock and the Company has no intention to pay a dividend at this time; therefore, the Company assumes that no dividends will be paid
over the expected terms of option awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock
price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such,
the Company may use different assumptions for options granted throughout the year. The valuation assumptions used to determine the fair
value of each option award on the date of grant were: expected stock price volatility &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zsOxy8k3Bi23"&gt;114.97&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
- &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zCWZnoTM6tsg"&gt;122.48&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%;
expected term in &lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zG2vGczPXYe"&gt;5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years and risk-free interest rate &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_z5Sav0TnmA9b"&gt;0.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
- &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zxe9fKIuxTi8"&gt;2.37&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Employee
and Consultant Options&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcZKUI45Pan1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span id="xdx_8B6_zoOZ8meB3tJl" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
                                            Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHBKVz3d9ybj" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;70,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zTWEXvTjdnT8" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zNwpKYKTDSW3" style="font-family: Times New Roman, Times, Serif"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zgzSI45TX4pe" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1075"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zDDkg8cG9qrd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zK5g7z9t2Ts1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zQep3WVATrw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaaVkiZiXXGb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxgG6IIsWrh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,055&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zmNTgzd3zNnf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zN3Ibp9cFVzd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(111&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zD10t41iwJUg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zbPacipgumw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,567&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zw11YTKON6c8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zPzdo4Shliml" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zOIMwKM2am6c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDCgJ4QGrFn1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,113&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIM6Aysndxo8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zY43UtNz898j" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3LC6cG45fO1" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zNjGeoPa0QN1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDlANhNJoWxf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1109"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6Ew3pTqRk0g" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zU5YGgqPjKJ" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8ZhNdDnOWQ3" style="font-family: Times New Roman, Times, Serif"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPUK0aeThoBk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6WYf1SdH7he" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zRb7gybkSoa4" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z579sq0saV2f" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1121"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zB5JVJ2l2cuf" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding vested and expected to vest ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvulNuMUcy8" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zosB5Mue8Ns" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPczGfNYhzbf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zkW2C8oWMg4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQ7OcSsFA711" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended
December 31, 2020 and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BE_zYLAeT2GN0hd" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of&lt;br/&gt;
    Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Grant-Date&lt;br/&gt;
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;br/&gt;
    Intrinsic&lt;br/&gt;
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date&lt;br/&gt;
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,889&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1136"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,756&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;130,120&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_ziIADVJronFd" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;362,998&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z4otFMEETl5d" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;246,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1160"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,113&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;387,199&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXCKK685h3i1" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,446&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;536,733&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1190"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1196"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A4_zH5VULNPWGu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the years ended December 31, 2020 and 2019, the Company recorded $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0"&gt;189,568
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"&gt;390,485
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively. As of December 31, 2020, there was &lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_pp0p0_do_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--UnvestedOptionsMember_ziQOLr6P6Hzb"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;unrecognized share-based compensation related
to unvested options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2020, the Company had granted non-qualified options to purchase &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zjOsCl6XFrLa"&gt;68,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares which were performance-based. At December
31, 2020, non-qualified options to purchase &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecustom--StockOptionToPurchaseThresholdsPerformanceBased_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCmIXE6qCABc"&gt;40,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares were forfeited due to the failure
to satisfy the 2017, 2018 and 2019 revenue-based performance thresholds and &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_ecustom--NumberOfSharesForfeitedForTerminations_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zURqBfLnTwVh"&gt;28,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares were forfeited due to employee terminations.
No compensation expense had been recognized with respect to these performance-based awards since the likelihood of performance levels
being obtained was determined to be remote.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Director
Options&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zCFc8SR9IZg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span id="xdx_8BA_zcDYgammV0ma" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contractual&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                                                                                                     &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value
                                            ($000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zy3TzYmGCre6" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zshS2cAkVjq3" style="font-family: Times New Roman, Times, Serif"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1211"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIRUPyMPay68" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z2YgOar2oLTk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zsbtuxOZoko" style="font-family: Times New Roman, Times, Serif"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zv26MUYTzBEf" style="font-family: Times New Roman, Times, Serif"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zvFXeLy3Gv6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1251"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBadwX3bwOpk" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1259"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,
    &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zT10DkoudON4" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercisable ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zGRvU3mtpzvc" style="font-family: Times New Roman, Times, Serif"&gt;8.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_z39nxoqjycD4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVPmqAZOqft3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_z6dVfrIDxM4k" style="display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zm5a7H28aOa7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1284"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1288"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1290"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1292"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;-&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1298"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;373,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zUqshKLzVfoj" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(36,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;344,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1312"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1314"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1322"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,666&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,800&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zZZaEHtVwz09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended December 31, 2020 and 2019, the Company incurred $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0"&gt;62,452
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, as compensation expense related to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zorFiDlAh9W1"&gt;10,000
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zgLjXmKz4hs9"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;vested options, respectively, issued to directors.
As of December 31, 2020, total unrecognized share-based compensation related to unvested options was $&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z5ajJHKaED88"&gt;6,412&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
January 2, 2020, the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zCJMuRRndbGh"&gt;26,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;fully vested stock options to directors valued
at $&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndNineteenSpecialEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;234,126
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in respect of a 2019 special equity award that
had been accrued for in full in the Company&#x2019;s financial statements at December 31, 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further
on January 2, 2020, the Company issued an additional &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z629wwxxrPqb"&gt;3,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;fully vested, non-qualified stock options
under the 2017 Equity Plan valued at $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;29,266
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to directors. The options have a term of &lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20191230__20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zwOJpRME3kDg"&gt;5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and have an exercise price equal to the
closing price of the Company&#x2019;s common stock on The OTC Markets on the day immediately preceding the grant date of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20200102__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zL05l7L0QKO8"&gt;10.50.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
June 24, 2020&lt;i&gt;, &lt;/i&gt;the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3ZOZCPBA0Bf"&gt;13,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;non-qualified stock options under the 2017
Equity Plan, valued at $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;39,600&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
to newly appointed directors. The options vested &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zexqCu3FlxN9"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
upon grant and &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_dp_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--AwardDateAxis__custom--AprilOneTwentyTwentyOneMember_zGb2TJNf2Yta"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
on April 1, 2021, if the Director remains on the Board up to that time. The options have a term of &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxgj7tSgbHja"&gt;5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and have an exercise price equal to the
closing price of the Company&#x2019;s common stock on The OTC Markets on the day immediately preceding the grant date of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20200624__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zxlFJc1Mq8I2"&gt;4.35.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2020, awards related to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementStockIssuedAndOutstanding_iI_pid_c20201231__srt--TitleOfIndividualAxis__custom--TwoNewIndependentDirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvRJeyS1gO9"&gt;144,340
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares remain issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Restricted
Stock Units&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zUL47KqzG6nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_z2FA4yRuxNM9" style="display: none"&gt;Schedule
of Restricted Stock Units Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
                                            Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zLYKEGtfMxV1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,782&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoDkvgGRpIGc" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvYraRHcwZTi" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;730,185&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdQ3rnxpf3vk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zlr5yazLd559" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and settled with share issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvmcGADZuDF1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zGdtkvDbYGah" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8i7zPTqWT54" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,982&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3kiD56D7hE" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z1v5CPqXGRS1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z0WChRCBfor6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKotxyHZKuk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z4iF9kJJZny8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zm8GkagaaVX8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19.20&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z9AmKkDNM4Qf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPi0nqYXNp68" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPCi3rYlC1Q2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and settled with share issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zmibQryAVAH6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNTs2A2DAMye" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8l4ABzCc3S5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoiWPQsO9Zf5" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNoa43l0Eweb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zMxRx53UXhFg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1396"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zhY5J2MVHkTf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zzAcU40pREgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the years ended December 31, 2020 and 2019, the Company recorded $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0"&gt;25,163
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_pp0p0"&gt;278,906
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as compensation expense related to vested RSUs
issued to employees, directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation related to
unvested RSUs. The total intrinsic value of RSUs vested and settled with share issuance was $&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;199,125
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;79,120
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the years ended December 31, 2020 and 2019.
During the year ended December 31, 2020, the total intrinsic value of RSUs vested and settled with share issuance was $&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;1,105,750&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
including the intrinsic value of $&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_pp0p0_c20180101__20181231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhUGJYhpbWK"&gt;1,035,750
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;related to RSUs that had vested in 2018 but had
not been settled until 2020 due to a dispute with a former employee over the required withholding taxes to be paid to the Company for
remittance to the appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
April 30, 2020, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pp0d_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdsT85C7ji39"&gt;5,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs vested. However, the holder elected
to cancel the RSUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Incentive
Stock Bonuses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has entered into certain &#x201c;at-will&#x201d; employment agreements with certain employees. Under these agreements, the employees
are eligible to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion, that the employee&#x2019;s
performance has been average or better for the applicable special bonus period. This special stock incentive bonus is payable only if
the employee continues in the employment of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
accounting purposes, the Company treats these special incentive stock bonuses as vesting over each bonus&#x2019;s service period based
on the fair value of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards are vested over
each service period because it is more likely than not that the Board will approve the award based on the &#x201c;average or better&#x201d;
employee performance standard. Since the awards are denominated in shares of common stock, the fair value of the vested bonus is charged
to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_ziFEO8U93GXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_z52aX6sTffS9" style="display: none"&gt;Schedule
of Incentive Bonus Awards Granted to Employees&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
                                            Grant-Date&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
                                            Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Shares, Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1417"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zceX362Zxk0l" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1425"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zN2GIWIYIJF7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1441"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1445"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zyuIhDceAjI7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the years ended December 31, 2020 and 2019, the Company recorded $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;44,209
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as compensation expense related to vested stock
bonus awards issued to employees, net of forfeitures of $&lt;span id="xdx_90B_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90A_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationForfeited_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively. As of December 31, 2020, there was no unrecognized share-based compensation related to unvested stock bonus awards. The
total intrinsic value of stock bonus awards vested and settled with share issuance was $&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesMember_pp0p0"&gt;58,240
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for the years ended December 31, 2020 and 2019,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember"
      decimals="INF"
      unitRef="Shares">333333</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember"
      decimals="0"
      unitRef="USD">6412</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">P3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ProfessionalFees
      contextRef="From2018-01-012018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:ProfessionalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember"
      decimals="INF"
      unitRef="Shares">1316</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember"
      decimals="INF"
      unitRef="Shares">5263</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProfessionalFees
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember"
      decimals="0"
      unitRef="USD">60000</us-gaap:ProfessionalFees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Pure">1.1497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Pure">1.2248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Pure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Pure">0.0237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_89A_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcZKUI45Pan1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span id="xdx_8B6_zoOZ8meB3tJl" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
                                            Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zHBKVz3d9ybj" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;70,400&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zTWEXvTjdnT8" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.60&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zNwpKYKTDSW3" style="font-family: Times New Roman, Times, Serif"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zgzSI45TX4pe" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1075"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zDDkg8cG9qrd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zK5g7z9t2Ts1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zQep3WVATrw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaaVkiZiXXGb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zaxgG6IIsWrh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,055&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zmNTgzd3zNnf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zN3Ibp9cFVzd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(111&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zD10t41iwJUg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zbPacipgumw1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,567&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zw11YTKON6c8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zPzdo4Shliml" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iS_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zOIMwKM2am6c" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDCgJ4QGrFn1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,113&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIM6Aysndxo8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zY43UtNz898j" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3LC6cG45fO1" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zNjGeoPa0QN1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zDlANhNJoWxf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1109"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6Ew3pTqRk0g" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,673&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zU5YGgqPjKJ" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z8ZhNdDnOWQ3" style="font-family: Times New Roman, Times, Serif"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPUK0aeThoBk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z6WYf1SdH7he" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zRb7gybkSoa4" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z579sq0saV2f" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1121"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zB5JVJ2l2cuf" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding vested and expected to vest ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBvulNuMUcy8" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zosB5Mue8Ns" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zPczGfNYhzbf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">70400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">15.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">16055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">17.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">111</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">15.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">67567</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">14.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P7Y8M12D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">44113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">10.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">16673</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">15.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P4Y3M18D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">95007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">12.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y3M18D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">95007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">12.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_89E_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQ7OcSsFA711" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended
December 31, 2020 and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BE_zYLAeT2GN0hd" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of&lt;br/&gt;
    Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Grant-Date&lt;br/&gt;
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;br/&gt;
    Intrinsic&lt;br/&gt;
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date&lt;br/&gt;
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,889&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.90&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1136"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,756&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;130,120&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_ziIADVJronFd" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;362,998&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_z4otFMEETl5d" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(16,056&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;246,344&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1160"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1168"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;44,113&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;387,199&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_zXCKK685h3i1" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,446&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;536,733&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1188"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1190"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1192"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1196"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">48889</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.90</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">628756</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">9.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">130120</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">32833</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">11.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">362998</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">16056</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">15.30</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">246344</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">11.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">149534</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">44113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">8.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">387199</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">57446</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">9.30</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">536733</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">189568</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">390485</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687"
      decimals="INF"
      unitRef="Shares">68333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <SRNA:StockOptionToPurchaseThresholdsPerformanceBased
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687"
      decimals="INF"
      unitRef="Shares">40000</SRNA:StockOptionToPurchaseThresholdsPerformanceBased>
    <SRNA:NumberOfSharesForfeitedForTerminations
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember61985687"
      decimals="INF"
      unitRef="Shares">28333</SRNA:NumberOfSharesForfeitedForTerminations>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zCFc8SR9IZg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span id="xdx_8BA_zcDYgammV0ma" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contractual&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                                                                                                     &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value
                                            ($000)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zy3TzYmGCre6" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of options, outstanding beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zshS2cAkVjq3" style="font-family: Times New Roman, Times, Serif"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1211"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1213"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1217"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zIRUPyMPay68" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1225"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z2YgOar2oLTk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zsbtuxOZoko" style="font-family: Times New Roman, Times, Serif"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1234"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zv26MUYTzBEf" style="font-family: Times New Roman, Times, Serif"&gt;8.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, forfeited/cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1245"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zvFXeLy3Gv6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1249"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1251"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, outstanding ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zBadwX3bwOpk" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Outstanding Ending"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1259"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,
    &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zT10DkoudON4" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of options, exercisable ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;42,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zGRvU3mtpzvc" style="font-family: Times New Roman, Times, Serif"&gt;8.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">20.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">20.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">43333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">8.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">49333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">10.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">42667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="USDPShares">10.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2020-01-012020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p id="xdx_89D_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zVPmqAZOqft3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below: &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_z6dVfrIDxM4k" style="display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1270"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20181231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zm5a7H28aOa7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1284"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1288"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1290"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1292"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;-&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1298"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;43,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8.55&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;373,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zUqshKLzVfoj" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(36,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;344,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1312"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1314"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1320"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdp0" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1322"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,666&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,800&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_c20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">43333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">8.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">373000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">36667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">9.45</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">344000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">6666</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">4.35</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">5800</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">62452</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember"
      decimals="INF"
      unitRef="Shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">6412</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">26667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-12-302020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">234126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">3333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">29266</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-12-302020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">39600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-06-232020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <SRNA:ShareBasedCompensationArrangementStockIssuedAndOutstanding
      contextRef="AsOf2020-12-31_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">144340</SRNA:ShareBasedCompensationArrangementStockIssuedAndOutstanding>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zUL47KqzG6nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B4_z2FA4yRuxNM9" style="display: none"&gt;Schedule
of Restricted Stock Units Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
                                            Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zLYKEGtfMxV1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;65,782&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoDkvgGRpIGc" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_pp0p0_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvYraRHcwZTi" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;730,185&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zdQ3rnxpf3vk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zlr5yazLd559" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and settled with share issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zvmcGADZuDF1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,467&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zGdtkvDbYGah" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8i7zPTqWT54" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,982&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z3kiD56D7hE" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z1v5CPqXGRS1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z0WChRCBfor6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20190101__20191231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zCKotxyHZKuk" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1374"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z4iF9kJJZny8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zm8GkagaaVX8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19.20&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iS_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z9AmKkDNM4Qf" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Aggregated Intrinsic Value, Outstanding beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1380"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPi0nqYXNp68" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1382"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zPCi3rYlC1Q2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1384"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and settled with share issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zmibQryAVAH6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(45,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNTs2A2DAMye" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and settled with share issuance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_z8l4ABzCc3S5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zoiWPQsO9Zf5" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited/canceled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zNoa43l0Eweb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Units, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zMxRx53UXhFg" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant Date Fair Value, ending"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1396"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iE_c20200101__20201231__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember_zhY5J2MVHkTf" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Aggregated Intrinsic Value, Outstanding ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">65782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">21.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
      contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="0"
      unitRef="USD">730185</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">7467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">27.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">7982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">26.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">50333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">19.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">50333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">19.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">18.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="Shares">5333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">27.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="0"
      unitRef="USD">25163</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember"
      decimals="0"
      unitRef="USD">278906</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">199125</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">79120</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement
      contextRef="From2020-01-012020-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">1105750</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="From2018-01-012018-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">1035750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="Shares">5333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_891_eus-gaap--ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_ziFEO8U93GXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020
and 2019 are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_z52aX6sTffS9" style="display: none"&gt;Schedule
of Incentive Bonus Awards Granted to Employees&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"/&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average
                                            Grant-Date&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
                                            Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested,
    December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of Shares, Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Grant-date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_c20181231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;124,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1415"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1417"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zceX362Zxk0l" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(11,200&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20190101__20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1425"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested, December
    31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20191231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1429"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Awarded&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-date Fair Value, Awarded"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zN2GIWIYIJF7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1441"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Unvested,
    December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1443"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_c20201231__us-gaap--AwardTypeAxis__custom--IncentiveStockBonusAwardsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-date Fair Value, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1445"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1
      contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">11200</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1
      contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="USDPShares">16.80</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
      contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="USDPShares">124320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="Shares">11200</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember"
      decimals="INF"
      unitRef="USDPShares">16.80</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">44209</us-gaap:ShareBasedCompensation>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement
      contextRef="From2020-01-012020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">0</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement
      contextRef="From2019-01-012019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember"
      decimals="0"
      unitRef="USD">58240</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zFn74fOaMw41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
15 &#x2013; &lt;span id="xdx_821_zV4uM1NQFNTb"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
financial reporting purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended December
31, 2020 or 2019 due to the Company&#x2019;s net operating losses (&#x201c;NOLs&#x201d;) in such periods and full valuation allowance recorded
against the net deferred tax assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIiW34TQAIW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are
summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B2_zCTN8kcubVtb" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20200101__20201231_zWYVRZsLcYri" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20190101__20191231_zGHYoW3blb12" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    taxes computed at the federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(369,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(281,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;States
    taxes, net of federal benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(69,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent
    differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(136,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationTrueUpAdjustments_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;True-up
    adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;199,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    to net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(86,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;476,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reported
    income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zyq5pdPWZQNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zekBiNAzsxq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B3_zhtemzF3Nnt7" style="display: none"&gt;Schedule
of Deferred Tax Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zelcwOq4Sb3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_zfefclUeptM9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,821,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,081,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equity
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;118,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;392,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,108,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,622,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_zshjP3fwbMSl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,564,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zCTUfLxwNkrl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,564,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zbmvDjdR9RRk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div style="margin: 0pt 0pt 0pt auto; font-family: Times New Roman, Times, Serif; width: 100%"&gt;&lt;div style="border-top: Black 1.5pt solid; margin-top: 0pt; font: 1pt Times New Roman, Times, Serif; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&#x201c;NOLs&#x201d;) of approximately $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20201231_pp0p0"&gt;19,322,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_90F_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20201231_pp0p0"&gt;11,196,261&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;will
expire, if not utilized, in the years &lt;span id="xdx_907_ecustom--NetOperatingLossExpirationTerm_c20200101__20201231"&gt;2034 through 2037&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to &lt;span id="xdx_90D_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zOGGU7TACqT"&gt;80&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the &lt;span id="xdx_901_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_dp_uPure_c20201231_zRlhzWwnJjW3"&gt;80&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of
the Company&#x2019;s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201231_zbdq5FyH17te"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
within a &lt;span id="xdx_903_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zMkApDHh82mg" title="::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;-year
period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#x2019;s judgment is required
in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020 and 2019. Based on the available
evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable
future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation
allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions that are consistent
with the Company&#x2019;s plans. Should the actual amounts differ from the Company&#x2019;s estimates, the carrying value of the Company&#x2019;s
deferred tax assets could be materially impacted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company is subject to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary course
adjustments or proposed adjustments to the Company&#x2019;s taxes or the Company&#x2019;s net operating losses with respect to years under
examination as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014 through 2019, Alaska,
California and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income tax returns for the years
2018 and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes in 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes in its consolidated financial statements the impact of a tax position, if that position is more likely than not of
being sustained on audit, based on the technical merits of the position. The Company&#x2019;s policy is to recognize interest and penalties
accrued on any unrecognized tax benefits as a component of operating expense. The Company does not believe there are any tax positions
for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within
twelve months of the reporting date. There were &lt;span id="xdx_904_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_do_c20200101__20201231_zWYfcHjyipc5"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;penalties or interest liabilities accrued as
of December 31, 2020 or 2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020 and
2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_897_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zIiW34TQAIW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are
summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B2_zCTN8kcubVtb" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20200101__20201231_zWYVRZsLcYri" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20190101__20191231_zGHYoW3blb12" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Income
    taxes computed at the federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(369,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(281,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;States
    taxes, net of federal benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(69,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(53,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Permanent
    differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(136,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--IncomeTaxReconciliationTrueUpAdjustments_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;True-up
    adjustments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;199,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    to net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(86,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_i_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;476,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;204,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iTC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Reported
    income tax (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-369000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-281000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-69000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-53000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-136000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">17000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <SRNA:IncomeTaxReconciliationTrueUpAdjustments
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">115000</SRNA:IncomeTaxReconciliationTrueUpAdjustments>
    <SRNA:IncomeTaxReconciliationTrueUpAdjustments
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">199000</SRNA:IncomeTaxReconciliationTrueUpAdjustments>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">-17000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">-86000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">476000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="USD">204000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zekBiNAzsxq7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B3_zhtemzF3Nnt7" style="display: none"&gt;Schedule
of Deferred Tax Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20201231_zelcwOq4Sb3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20191231_zfefclUeptM9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,821,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,081,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equity
    compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;118,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;392,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;169,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;149,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,108,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,622,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iNI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_zshjP3fwbMSl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(68,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(58,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGross_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,564,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_zCTUfLxwNkrl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,040,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,564,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTIC_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4821000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4081000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">118000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">392000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">169000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">149000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5108000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4622000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-68000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-58000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">68000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">58000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5040000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4564000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5040000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">4564000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">19322000</us-gaap:OperatingLossCarryforwards>
    <SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11196261</SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount>
    <SRNA:NetOperatingLossExpirationTerm contextRef="From2020-01-012020-12-31">2034 through 2037</SRNA:NetOperatingLossExpirationTerm>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-012020-12-31">&lt;p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zAR15HqRAUrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
16 &#x2013; &lt;span id="xdx_82B_zoP28A0e9LHg"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 855, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. The following events occurred after December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board approved annual incentive compensation awards to certain employees payable in non-qualified stock options, based on the Company&#x2019;s
performance and each employee&#x2019;s contributions to such performance for the 2020 year. A total of &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zulljffyN1ti"&gt;6,905
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;non-qualified stock options were granted
under the 2017 Equity Plan subsequent to December 31, 2020, with an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;19.50
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share. These non-qualified stock options
were immediately vested at the date of the grant. The estimated compensation expense of $&lt;span id="xdx_902_eus-gaap--DeferredCompensationLiabilityCurrent_c20210102__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"&gt;128,434
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;related to the 2020 incentive awards was accrued
as of December 31, 2020. The accrued compensation expense was classified as a current liability as of December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed &lt;i&gt;in Note 10 Related Party Agreements and Transactions &lt;/i&gt;above, on January 7, 2021, the Company entered into a consulting
agreement with RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide
consulting services to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related
matters, as mutually determined by the Company and RSX. The Company will pay a monthly consulting fee of $&lt;span id="xdx_903_eus-gaap--ProfessionalFees_pp0p0_c20210106__20210107__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember__srt--TitleOfIndividualAxis__custom--MrJamesRShipleyMember_zQO9a9zL5Q4k"&gt;6,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for up to 50 hours per month for the various
consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual
property developed by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality
provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed in &lt;i&gt;Note 9 Note Payable and Accrued Interest&lt;/i&gt; above, on February 10, 2021, we received funding based on a loan
agreement entered into on February 9, 2021 with our current bank in the principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zst0UBycpj21"&gt;514,200
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for working capital purposes. Consistent with
the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan
amount bears interest at &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zn6ZozLI9vE5"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default provisions, including
for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
further discussed in Note 11 Commitments and Contingencies above, a former employee is pursuing litigation against the Company for recovery
of alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome, the amount of any settlement loss for
this case is not reasonably estimable as of the date of the issuance of these financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zDQbs5fsQDje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt;&lt;/span&gt; &lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
par value for the Common Stock was not affected. In connection with the aforementioned reverse stock split, the Company&#x2019;s Board of Directors approved the reset of the authorized
capital of the Company to be &lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zje09WBADQwh"&gt;200,000,000&lt;/span&gt; shares of common stock and &lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHNfuUnA6Fuf"&gt;25,000,000&lt;/span&gt; shares of preferred stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect
to the Reverse Split for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;On January 28, 2022, the Company
agreed with the Series B investor to redeem &lt;span id="xdx_904_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXzzUF0tHDn2" title="Shares Redeemed"&gt;1,650&lt;/span&gt; shares of the Company&#x2019;s Series B Preferred Stock for approximately $&lt;span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zhwDt3wU5Oq4" title="Redemption value"&gt;2.0&lt;/span&gt; million
following the closing of the Company&#x2019;s offering.&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">6905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">19.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="0"
      unitRef="USD">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-062021-01-07_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember"
      decimals="0"
      unitRef="USD">6500</us-gaap:ProfessionalFees>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember">On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-01-17_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-01-27_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">1650</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      unitRef="USD">2000000.0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2283879</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">186073</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">32245</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">33480</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">480354</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1157119</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1037823</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">3953597</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3683293</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">98967</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">631064</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">6792</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">7227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">24183</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">194353</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">955359</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1129973</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">4908956</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1674088</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">3059525</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">108945</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">37078</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">238140</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">5117776</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">5903689</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">517468</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">37078</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">74156</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">554546</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">243275</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">5672322</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">6146964</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">3300</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">3960000</us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount>
    <SRNA:RedeemableConvertiblePreferredStockSubscriptionReceivable contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-1365000</SRNA:RedeemableConvertiblePreferredStockSubscriptionReceivable>
    <SRNA:RedeemableConvertiblePreferredStockAccruedDividends contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1447</SRNA:RedeemableConvertiblePreferredStockAccruedDividends>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2596447</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">420</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1583511</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1583511</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1576844</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1576844</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">16</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">16</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">25019425</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">26109509</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-28379674</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-27443643</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-3359813</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">4908956</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4813266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">3706436</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1634669</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">10582470</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">5127018</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">2959264</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1108758</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">8208368</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">3869758</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">747172</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">525911</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">2374102</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">1257260</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">224393</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">89695</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">569580</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">333669</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">98623</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">84433</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">322807</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">304229</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">866699</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">634447</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">2493930</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">2453976</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1189715</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">808575</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">3386317</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">3091874</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-442543</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-282664</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-1012215</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1834614</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">35934</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">13621</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">79452</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">29018</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1296</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1396</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">3268</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">16673</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">34638</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">12225</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">76184</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">12345</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-407905</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-270439</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-936031</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-407905</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-270439</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-936031</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:NetIncomeLoss>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">2262847</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">2262847</us-gaap:RedeemablePreferredStockDividends>
    <SRNA:ConvertiblePreferredStockConvertedToSecurities
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1447</SRNA:ConvertiblePreferredStockConvertedToSecurities>
    <SRNA:ConvertiblePreferredStockConvertedToSecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1447</SRNA:ConvertiblePreferredStockConvertedToSecurities>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-2672199</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-270439</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-3200325</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.69</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">-2.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">-1.16</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Shares">1583511</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">1581142</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">1564746</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1583511</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26326691</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27971769</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">-1644642</us-gaap:StockholdersEquity>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">14545</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">14545</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">14762</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">14762</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">927721</SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">927721</SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1447</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1447</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-2262847</SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-2262847</SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-407905</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">-407905</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1583511</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25019425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-28379674</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-3359813</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26109509</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-1333698</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares
      contextRef="From2021-01-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6667</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeShares>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">158315</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">158315</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">21174</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">21174</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">927721</SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">927721</SRNA:AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1447</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1447</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-2262847</SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-2262847</SRNA:AdjustmentsToAdditionalPaidInCapitalRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-936031</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-936031</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1583511</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25019425</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-28379674</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">-3359813</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26060657</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27236757</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-06-30" decimals="0" unitRef="USD">-1175664</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">24426</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">24426</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-270439</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">-270439</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26085083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27507196</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">-1421677</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1521444</us-gaap:SharesOutstanding>
    <SRNA:CommonstockSharesToBeIssued
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">10400</SRNA:CommonstockSharesToBeIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">15</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25328861</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">-355631</us-gaap:StockholdersEquity>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">55400</SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-10400</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">1</SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">-1</SRNA:CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">227594</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">227594</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">420</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1576844</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">16</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">26085083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-27507196</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">-1421677</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-936031</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-1822269</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">54973</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">90867</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">51055</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">252757</us-gaap:ShareBasedCompensation>
    <SRNA:CommonStockIssuedForOtherExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">67000</SRNA:CommonStockIssuedForOtherExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">20975</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">13150</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-13764</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-5117</us-gaap:InventoryWriteDown>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-8042</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-4124</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">149597</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">141871</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">19740</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-27950</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">139481</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-714709</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">119296</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">488007</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-110872</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-397181</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-664663</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">2044830</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">3268</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <SRNA:IncreaseDecreaseInLeaseDeposit
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-24183</SRNA:IncreaseDecreaseInLeaseDeposit>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-197085</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-79521</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">108945</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">101472</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-1761260</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">599635</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">15316</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">3500</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1500</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-13816</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">-3500</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1259874</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">514200</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">554000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1774074</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">554000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">-1002</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">1150135</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" decimals="0" unitRef="USD">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2283879</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-09-30" decimals="0" unitRef="USD">2072312</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <SRNA:AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">2262847</SRNA:AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue>
    <SRNA:SubscriptionReceivableSeriesBPreferredStock
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1365000</SRNA:SubscriptionReceivableSeriesBPreferredStock>
    <SRNA:OptionsIssuedForAccruedEquityCompensation
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">128434</SRNA:OptionsIssuedForAccruedEquityCompensation>
    <us-gaap:Dividends
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">1447</us-gaap:Dividends>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80A_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zUTsGew1ld59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
1 &#x2013; &lt;span&gt;General&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;b&gt;&lt;span id="xdx_826_zJF70d4qYexf" style="display: none"&gt;Basis
of Presentation; Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--DescriptionOfBusinessPolicyTextBlock_zCrEyYE0LZM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_866_zpXOwa8Kf3E7" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description
of Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. (the &#x201c;Company&#x201d;) was incorporated in Nevada on October 15, 2009 and operates under the trade name of Surna Cultivation
Technologies. We are headquartered in Boulder, Colorado.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled
Environment Agriculture (CEA) industry. We leverage our experience in this space to bring value-added technology solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy evolving state and local construction
codes, permitting and regulatory requirements. In service of the CEA industry, our principal service and product offerings include: (i)
architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based
process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting
and climate control, and (vi) preventive maintenance services for CEA facilities. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada and other international locations. Customers are those growers building new facilities and those expanding
or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities operating in the cannabis industry, ranging from several thousand to more than &lt;span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20210930__srt--RangeAxis__srt--MinimumMember_z9XF0A7t1rH6"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square feet. Although most of our customers do,
we neither produce nor sell cannabis or its related products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zJ5g1hjT3xui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_862_zRL47ZLChTta" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Impact
of the COVID-19 Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations
around the world, with an impact on our business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, a general shortage of containers, and domestic truck driver availability.
While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue
to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed
by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others
in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and
provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long
they will continue as they are out of our control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4LOmZMhz1B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_863_zujbAruiUlK6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal
year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that
date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information,
refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December
31, 2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zUg2Ott7hvRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zDkXudJYVMFg"&gt;Reverse
Stock Split&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbIYs7NwCvDd"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt; The par value for the Common Stock was not affected.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zOedN0ypY9x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86D_zLl5cOPbrYQ6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis
of Consolidation and Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--GoingConcernPolicyTextBlock_zDO8KhTKWmPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_869_zH89du6fObc6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#x2019;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#x2019;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#x2019;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--UseOfEstimates_zJVd4mMFskNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_863_zN73GZSCE8s6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zkRbnsKyCUxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_861_zphXuS9sKzbi" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash,
Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_z6n3qvro9Dvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86B_zPuTYzvaZqPj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
(Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the nine months ended September 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were convertible into shares of the Company&#x2019;s common stock. During
the three- and nine-month periods ended September 30, 2021 and 2020, the Company incurred a net loss and consequently the common share
equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such
inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2021, and 2020, there were respectively, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210930_z5pG22FYYXFe"&gt;777,888
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span style="-sec-ix-redline: true"&gt;&lt;span&gt;&lt;span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200930_zC71P0oJdjQ4"&gt;293,383&lt;/span&gt;,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zPdvc7qsrOn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_866_zd0DSFrKazgl" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the nine months ended September 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at September 30, 2021 and concluded that no impairment
relating to goodwill existed at September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--TemporaryEquityPolicyTextBlock_zE2Zaf4pfC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_869_zRlN1JWL87Me" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Temporary
Equity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Shares
of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option
of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely
within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the
issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but
not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument
will become redeemable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company determined it is probable the Series B Preferred Stock will become redeemable at the option of the holder. As a result, on September
30, 2021, the Company adjusted carrying value of the Series B Preferred Stock to its redemption value of $&lt;span id="xdx_901_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLCQ8hlTdHog"&gt;3,960,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and recorded a $&lt;span id="xdx_900_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrG2hH9aUMTj"&gt;2,262,847
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes, accordingly, the redemption value adjustment
is therefore added to the &#x201c;Net Loss&#x201d; to arrive at &#x201c;Net Loss Attributable to Common Shareholders&#x2019;&#x201d; on the
Company&#x2019;s Consolidated Statements of Operations. In addition, as the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zCxpnpInTo8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_860_zT8U5MdyHhtg" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#x2019;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#x2019;s
project life cycle from facility design and construction to equipment delivery and system installation and start-up.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#x2019;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#x2019;s
customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the three and nine months ended September 30, 2021, the Company recognized revenue of $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210701__20210930_pp0p0"&gt;283,452
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210930_pp0p0"&gt;3,357,068&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, related to the deferred revenue at January 1, 2021. For the three and nine months ended September 30, 2020, the Company
recognized revenue of $&lt;span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200701__20200930_pp0p0"&gt;9,141&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200930_pp0p0"&gt;1,074,016&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, related to the deferred revenue at January 1, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligation_c20210930_pp0p0"&gt;9,881,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"&gt;1,161,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
or &lt;span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20210930_zfUHZeWvm788"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic disruption or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at September 30, 2021, includes booked sales orders of $&lt;span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_uUSD_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OrderOrProductionBacklogMember_zQiH5yXcW5Ol"&gt;1,250,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from several customers that the Company does
not expect to be realized until late 2022. The Company believes the sales orders in this portion of our backlog have an elevated level
of risk and may, ultimately, be delayed or cancelled by our customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance obligations
    related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,049,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,161,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance
    obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,091,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,629,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,720,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total remaining performance
    obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,203,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,678,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,881,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zdZ6cVm80Sc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,523,948&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,481,961&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,933,313&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,575,855&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,538&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;114,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;464,269&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;402,837&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,950&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;38,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;184,888&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,326&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,706,436&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,634,669&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,582,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,127,018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zSYfASf65Z46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfQMiP6BT2ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86F_zA6zAZxFgwvj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the nine months ended September 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20210101__20210930_zjmEsX3sHaI3"&gt;150.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20210101__20210930_zHAcn2McUsf9"&gt;152.51&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%;
expected term in years &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zPhzX5q4QUH2"&gt;10&lt;/span&gt; and risk-free interest rate ranged from &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20210101__20210930_zkfR1HWzjVYc"&gt;0.55%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;to &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20210101__20210930_zs7PKLO3x2L9"&gt;1.49&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Share-based Compensation Costs&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,944&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,949&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2300"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,292&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product development costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2308"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,444&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,332&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling, general and
    administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0"&gt;29,307&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;306,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total share-based compensation
    expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,307&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;354,229&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_ziNbaFNKOUKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Included
in the expense for the three and nine months ended September 30, 2021, is an accrual for $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zNd3DhHNSvr2"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;108,945&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, for the 2021 Annual Employee Incentive Compensation Plan. Included in the expense for the three and nine months ended September
30, 2020, is an accrual for $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;31,575
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;101,472&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, for the 2020 Annual Employee Incentive Compensation Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zgAxWufL4G8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86E_zCLI7eHLyfci" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3jKyMJ5YAS4"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_za4qYsaP3jh3"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z8bHMCB4y0h2"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the three months ended September 30, 2021 and three customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zApQM56jYBd2"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHTpxjPgaqK1"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1hn6lzZsVuc"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the nine months ended September 30, 2021. Two customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPuKUHIkvXUg"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUGTRBLN1Dfd"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the three months ended September 30, 2020 and three customers accounted for &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zh5VodyGBjKh"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIBTh36OT6yc"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjBnFGuFf4Ak"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the nine months ended September 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHhpAYN5FCRe"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zELcnQgAMOLf"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHU7QSoRrj07"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s accounts receivable as of September 30, 2021. As of September 30, 2020, four customers accounted for &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkftRueBQBp7"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zs0b7Bbnarb2"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zxDkjiX7Kwsj"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zpzVLaWk3dO8"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znKZgsEHZZg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86F_znjFYXzb42Jh" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2021, the FASB issued ASU 2021-04, &lt;i&gt;Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. &lt;/i&gt;This guidance clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges
of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective
for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively
to modifications or exchanges occurring on or after the effective date. The Company anticipates that the adoption of this guidance will
not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06,
Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s
Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company early adopted ASU 2020-06 effective January 1, 2021. The early
adoption of ASU 2020-06 impacted the Company&#x2019;s accounting for the issuance of its Series B Redeemable Convertible Preferred Stock
as further discussed in &lt;i&gt;Note 8 Temporary Equity Series B Redeemable Convertible Preferred Stock&lt;/i&gt; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
March 2020, the FAS issued ASU No. 2020-04 &#x201c;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#x201d; (&#x201c;ASU 2020-04&#x201d;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU No. 2020-01, &lt;i&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#x2014;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815&lt;/i&gt; (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#x2019;s
consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#x2019;s consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zPQM0qab7O4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <SRNA:DescriptionOfBusinessPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_840_ecustom--DescriptionOfBusinessPolicyTextBlock_zCrEyYE0LZM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_866_zpXOwa8Kf3E7" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Description
of Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. (the &#x201c;Company&#x201d;) was incorporated in Nevada on October 15, 2009 and operates under the trade name of Surna Cultivation
Technologies. We are headquartered in Boulder, Colorado.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Surna
Inc. is an engineering and design company focused on selling environmental control and other technologies and services to the Controlled
Environment Agriculture (CEA) industry. We leverage our experience in this space to bring value-added technology solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy evolving state and local construction
codes, permitting and regulatory requirements. In service of the CEA industry, our principal service and product offerings include: (i)
architectural design and licensed engineering of commercial scale thermodynamic systems specific to cultivation facilities, (ii) liquid-based
process cooling systems and other climate control systems, (iii) air handling equipment and systems, (iv) LED lighting, benching and
racking solutions for indoor cultivation, (v) automation and control devices, systems and technologies used for environmental, lighting
and climate control, and (vi) preventive maintenance services for CEA facilities. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada and other international locations. Customers are those growers building new facilities and those expanding
or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services and technologies
to commercial indoor facilities operating in the cannabis industry, ranging from several thousand to more than &lt;span id="xdx_905_eus-gaap--AreaOfLand_iI_usqft_c20210930__srt--RangeAxis__srt--MinimumMember_z9XF0A7t1rH6"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square feet. Although most of our customers do,
we neither produce nor sell cannabis or its related products.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:DescriptionOfBusinessPolicyTextBlock>
    <us-gaap:AreaOfLand
      contextRef="AsOf2021-09-30_srt_MinimumMember"
      decimals="INF"
      unitRef="sqft">100000</us-gaap:AreaOfLand>
    <SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_844_ecustom--ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_zJ5g1hjT3xui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_862_zRL47ZLChTta" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Impact
of the COVID-19 Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
COVID-19 pandemic has prompted national, regional, and local governments, including those in the markets that the Company operates in,
to implement preventative or protective measures to control its spread. As a result, there have been disruptions in business operations
around the world, with an impact on our business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
our response to the COVID-19 pandemic and the government and business response, the Company took and continues to take measures to adjust
its operations as necessary. In early 2020 the Company took measures to reduce expenses in light of reduced orders and to preserve cash,
many of which were reversed by the end of the year when orders picked up and the overall business climate improved. Because the pandemic
continues in different parts of the world and in different ways in the United States, the Company continues to actively monitor its operations
and sales efforts and will make adjustments to its operations as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We
are experiencing unexpected and uncontrollable delays with our international supply of products and shipments from vendors due to a significant
increase in shipments to U.S. ports, less cargo being shipped by air, a general shortage of containers, and domestic truck driver availability.
While these delays have moderately improved in recent months, we, along with many other importers of goods across all industries, continue
to experience severe congestion and extensive wait times for carriers at ports across the United States. In addition, restrictions imposed
by local, state and federal agencies due to the COVID-19 pandemic have led to reduced personnel of importers, government staff and others
in our supply chain. We have been working diligently with our network of freight partners and suppliers to expedite delivery dates and
provide solutions to reduce further impact and delays. However, we are unable to determine the full impact of these delays and how long
they will continue as they are out of our control.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;While
the Company is continuing to navigate the financial, operational, and personnel challenges presented by the COVID-19 pandemic, the full
extent of the impact on our operational and financial performance will depend on future developments, including the duration and spread
of the pandemic, the potential uncertainty related to and proliferation of new strains, and related actions taken by the U.S. government,
state and local government officials, and international governments to prevent disease spread, all of which are uncertain, out of our
control and cannot be predicted at this time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z4LOmZMhz1B3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_863_zujbAruiUlK6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Financial
Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the fiscal
year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that
date but does not include all the information and footnotes required by GAAP for complete financial statements. For further information,
refer to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December
31, 2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <SRNA:ReverseStockSplitPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_841_ecustom--ReverseStockSplitPolicyTextBlock_zUg2Ott7hvRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zDkXudJYVMFg"&gt;Reverse
Stock Split&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbIYs7NwCvDd"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt; The par value for the Common Stock was not affected.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

</SRNA:ReverseStockSplitPolicyTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember">On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zOedN0ypY9x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86D_zLl5cOPbrYQ6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis
of Consolidation and Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&#x201c;Hydro&#x201d;). Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <SRNA:GoingConcernPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_844_ecustom--GoingConcernPolicyTextBlock_zDO8KhTKWmPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_869_zH89du6fObc6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Going
Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#x2019;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#x2019;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#x2019;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:GoingConcernPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_848_eus-gaap--UseOfEstimates_zJVd4mMFskNl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_863_zN73GZSCE8s6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use
of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zkRbnsKyCUxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_861_zphXuS9sKzbi" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash,
Cash Equivalents and Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_z6n3qvro9Dvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86B_zPuTYzvaZqPj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income
(Loss) Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the nine months ended September 30, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and shares
of convertible preferred stock and restricted stock units that were convertible into shares of the Company&#x2019;s common stock. During
the three- and nine-month periods ended September 30, 2021 and 2020, the Company incurred a net loss and consequently the common share
equivalents of these potentially dilutive equity instruments have not been included in the calculations of loss per share because such
inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2021, and 2020, there were respectively, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20210101__20210930_z5pG22FYYXFe"&gt;777,888
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span style="-sec-ix-redline: true"&gt;&lt;span&gt;&lt;span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_c20200101__20200930_zC71P0oJdjQ4"&gt;293,383&lt;/span&gt;,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;potentially dilutive equity instruments outstanding
in respect of shares of convertible preferred stock and warrants and options outstanding to purchase Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">777888</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2020-01-012020-09-30"
      decimals="INF"
      unitRef="Shares">293383</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zPdvc7qsrOn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_866_zd0DSFrKazgl" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&#x2019;s fair value. The Company determined that it has one reporting unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the nine months ended September 30, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at September 30, 2021 and concluded that no impairment
relating to goodwill existed at September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <SRNA:TemporaryEquityPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84B_ecustom--TemporaryEquityPolicyTextBlock_zE2Zaf4pfC71" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_869_zRlN1JWL87Me" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Temporary
Equity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Shares
of preferred stock that are redeemable for cash or other assets are classified as temporary equity if they are redeemable, at the option
of the holder, at a fixed or determinable price on a fixed or determinable date or upon the occurrence of an event that is not solely
within the control of the issuer. Redeemable equity instruments are initially carried at the fair value of the equity instrument at the
issuance date, net of issuance costs, which is subsequently adjusted to redemption value (including the amount for dividends earned but
not yet declared or paid) at each balance sheet date if the instrument is currently redeemable or if it is probable that the instrument
will become redeemable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company determined it is probable the Series B Preferred Stock will become redeemable at the option of the holder. As a result, on September
30, 2021, the Company adjusted carrying value of the Series B Preferred Stock to its redemption value of $&lt;span id="xdx_901_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLCQ8hlTdHog"&gt;3,960,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and recorded a $&lt;span id="xdx_900_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrG2hH9aUMTj"&gt;2,262,847
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes, accordingly, the redemption value adjustment
is therefore added to the &#x201c;Net Loss&#x201d; to arrive at &#x201c;Net Loss Attributable to Common Shareholders&#x2019;&#x201d; on the
Company&#x2019;s Consolidated Statements of Operations. In addition, as the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:TemporaryEquityPolicyTextBlock>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">3960000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <SRNA:TemporaryEquityNonCashRedemptionValueAdjustment
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">2262847</SRNA:TemporaryEquityNonCashRedemptionValueAdjustment>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84E_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zCxpnpInTo8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_860_zT8U5MdyHhtg" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 1, 2018, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with
Customers&lt;/i&gt; and all the related amendments (&#x201c;ASC 606&#x201d; or the &#x201c;revenue standard&#x201d;) to all contracts and elected
the modified retrospective method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&#x2019;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#x2019;s
project life cycle from facility design and construction to equipment delivery and system installation and start-up.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#x2019;s actual selling price for the same good or service, however, this input is generally
not available for the Company&#x2019;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&#x2019;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#x2019;s
customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the three and nine months ended September 30, 2021, the Company recognized revenue of $&lt;span id="xdx_904_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210701__20210930_pp0p0"&gt;283,452
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20210101__20210930_pp0p0"&gt;3,357,068&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, related to the deferred revenue at January 1, 2021. For the three and nine months ended September 30, 2020, the Company
recognized revenue of $&lt;span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200701__20200930_pp0p0"&gt;9,141&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90B_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20200101__20200930_pp0p0"&gt;1,074,016&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, related to the deferred revenue at January 1, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#x2019;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#x2019;s cultivation facility project is dependent upon the customer&#x2019;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&#x2019;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, the Company&#x2019;s remaining performance obligations, or backlog, was $&lt;span id="xdx_905_eus-gaap--RevenueRemainingPerformanceObligation_c20210930_pp0p0"&gt;9,881,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_90E_eus-gaap--RevenueRemainingPerformanceObligation_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerContractsMember_pp0p0"&gt;1,161,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
or &lt;span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20210930_zfUHZeWvm788"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
was attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value
of the Company&#x2019;s engineering services (&#x201c;engineering only paid contracts&#x201d;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&#x2019;s engineering services, delay or abandonment of the project because of the customer&#x2019;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic disruption or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&#x201c;partial equipment paid contracts&#x201d;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&#x2019;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at September 30, 2021, includes booked sales orders of $&lt;span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_iI_pp0p0_uUSD_c20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OrderOrProductionBacklogMember_zQiH5yXcW5Ol"&gt;1,250,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from several customers that the Company does
not expect to be realized until late 2022. The Company believes the sales orders in this portion of our backlog have an elevated level
of risk and may, ultimately, be delayed or cancelled by our customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance obligations
    related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,049,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,161,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance
    obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,091,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,629,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,720,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total remaining performance
    obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,203,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,678,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,881,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zdZ6cVm80Sc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,523,948&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,481,961&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,933,313&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,575,855&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,538&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;114,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;464,269&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;402,837&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,950&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;38,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;184,888&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,326&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,706,436&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,634,669&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,582,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,127,018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zSYfASf65Z46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">283452</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">3357068</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">9141</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">1074016</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">9881000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-09-30_us-gaap_CustomerContractsMember"
      decimals="0"
      unitRef="USD">1161000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.12</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-09-30_us-gaap_OrderOrProductionBacklogMember"
      decimals="0"
      unitRef="USD">1250000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_891_eus-gaap--RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_zW1gwuKqu4ii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
remaining performance obligations expected to be recognized through 2022 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B3_zBrzdubfJJI2" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Remaining Performance Obligations Expected to be Recognized&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyOneMember_zBvLls7NoWR3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20210930__us-gaap--AwardDateAxis__custom--TwoThousandAndTwentyTwoMember_zQ6huXzn6eVh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20210930_zKpxek2HFTs5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zG6skbBlNVH9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance obligations
    related to engineering only paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;112,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,049,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,161,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_iI_pp0p0_maRRPOzwi6_maRRPOzaPO_zgkDikJmqWi2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining performance
    obligations related to partial equipment paid contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,091,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,629,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,720,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueRemainingPerformanceObligation_iTI_pp0p0_mtRRPOzwi6_mtRRPOzaPO_zh3tAYyet70h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total remaining performance
    obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,203,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,678,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,881,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">112000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">1049000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1161000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">3091000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">5629000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">8720000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneMember"
      decimals="0"
      unitRef="USD">3203000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyTwoMember"
      decimals="0"
      unitRef="USD">6678000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">9881000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_z2PRKi4QUA9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth the Company&#x2019;s revenue by source:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BA_zukfLw9RT5hb" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Revenue by Source&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment and systems sales&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,523,948&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,481,961&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,933,313&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EquipmentAndSystemsSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,575,855&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Engineering and other services&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;110,538&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;114,160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;464,269&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--EngineeringAndOtherServicesMember_pp0p0" style="text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;402,837&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Shipping and handling&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,950&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;38,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;184,888&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,326&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,706,436&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,634,669&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,582,470&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,127,018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">3523948</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">1481961</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-09-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">9933313</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_EquipmentAndSystemsSalesMember"
      decimals="0"
      unitRef="USD">4575855</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">110538</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">114160</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-09-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">464269</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_EngineeringAndOtherServicesMember"
      decimals="0"
      unitRef="USD">402837</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">71950</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">38548</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-012021-09-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">184888</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_us-gaap_ShippingAndHandlingMember"
      decimals="0"
      unitRef="USD">148326</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">3706436</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">1634669</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">10582470</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">5127018</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_845_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfQMiP6BT2ef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86F_zA6zAZxFgwvj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Accounting
for Share-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#x201c;Black-Scholes Model&#x201d;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the nine months ended September 30, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility ranged from &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20210101__20210930_zjmEsX3sHaI3"&gt;150.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
to &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20210101__20210930_zHAcn2McUsf9"&gt;152.51&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%;
expected term in years &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--StatementEquityComponentsAxis__custom--NonQualifiedStockOptionsMember_zPhzX5q4QUH2"&gt;10&lt;/span&gt; and risk-free interest rate ranged from &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20210101__20210930_zkfR1HWzjVYc"&gt;0.55%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;to &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20210101__20210930_zs7PKLO3x2L9"&gt;1.49&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Share-based Compensation Costs&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,944&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,949&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2300"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,292&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product development costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2308"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,444&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,332&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling, general and
    administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0"&gt;29,307&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;306,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total share-based compensation
    expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,307&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;354,229&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_ziNbaFNKOUKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Included
in the expense for the three and nine months ended September 30, 2021, is an accrual for $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_zNd3DhHNSvr2"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_900_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;108,945&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, for the 2021 Annual Employee Incentive Compensation Plan. Included in the expense for the three and nine months ended September
30, 2020, is an accrual for $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;31,575
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_pp0p0"&gt;101,472&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
respectively, for the 2020 Annual Employee Incentive Compensation Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">1.502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">1.5251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">0.0055</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Pure">0.0149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zTlTeXyA9cDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
and nine months ended September 30, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8BB_zFEPA7Zpygse" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Share-based Compensation Costs&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Three Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine Months Ended&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Share-based compensation expense included in:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,833&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,944&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_pp0p0" style="width: 12%; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,949&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Advertising and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_zcITSufZXXK1" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2300"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,292&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--AdvertisingAndMarketingExpensesMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,500&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product development costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2308"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,444&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,029&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--ProductDevelopmentCostsMember_pp0p0" style="text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,332&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling, general and
    administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0"&gt;29,307&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,221&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,735&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;306,448&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total share-based compensation
    expense included in consolidated statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AllocatedShareBasedCompensationExpense_c20210701__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,307&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AllocatedShareBasedCompensationExpense_c20200701__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,998&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AllocatedShareBasedCompensationExpense_c20210101__20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;160,000&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AllocatedShareBasedCompensationExpense_c20200101__20200930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total share-based compensation expense included in consolidated statement of operations"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;354,229&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">6833</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-09-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">29944</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">23949</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">2500</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-09-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">13292</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30_custom_AdvertisingAndMarketingExpensesMember"
      decimals="0"
      unitRef="USD">7500</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">5444</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-09-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">14029</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30_custom_ProductDevelopmentCostsMember"
      decimals="0"
      unitRef="USD">16332</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">29307</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">41221</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">102735</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      unitRef="USD">306448</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">29307</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30"
      decimals="0"
      unitRef="USD">55998</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">160000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30"
      decimals="0"
      unitRef="USD">354229</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-07-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2021-01-012021-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">108945</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-07-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">31575</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2020-01-012020-09-30_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember"
      decimals="0"
      unitRef="USD">101472</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zgAxWufL4G8j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86E_zCLI7eHLyfci" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z3jKyMJ5YAS4"&gt;38&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_za4qYsaP3jh3"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210701__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z8bHMCB4y0h2"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the three months ended September 30, 2021 and three customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zApQM56jYBd2"&gt;25&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zHTpxjPgaqK1"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1hn6lzZsVuc"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the nine months ended September 30, 2021. Two customers accounted for &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zPuKUHIkvXUg"&gt;39&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200701__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zUGTRBLN1Dfd"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the three months ended September 30, 2020 and three customers accounted for &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zh5VodyGBjKh"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIBTh36OT6yc"&gt;17&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjBnFGuFf4Ak"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s revenue for the nine months ended September 30, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Three
customers accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zHhpAYN5FCRe"&gt;40&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zELcnQgAMOLf"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zHU7QSoRrj07"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s accounts receivable as of September 30, 2021. As of September 30, 2020, four customers accounted for &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zkftRueBQBp7"&gt;32&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zs0b7Bbnarb2"&gt;23&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%,
&lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zxDkjiX7Kwsj"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20200930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zpzVLaWk3dO8"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the Company&#x2019;s accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-07-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2021-01-012021-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember"
      decimals="INF"
      unitRef="Pure">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerFourMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znKZgsEHZZg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86F_znjFYXzb42Jh" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recently
Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
May 2021, the FASB issued ASU 2021-04, &lt;i&gt;Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified
Written Call Options. &lt;/i&gt;This guidance clarifies and reduces diversity in an issuer&#x2019;s accounting for modifications or exchanges
of freestanding equity-classified written call options due to a lack of explicit guidance in the FASB Codification. The guidance is effective
for interim and annual periods beginning after December 15, 2021. Early adoption is permitted. The guidance is to be applied prospectively
to modifications or exchanges occurring on or after the effective date. The Company anticipates that the adoption of this guidance will
not have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06,
Debt &#x2014; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s
Own Equity (Subtopic 815-40) (&#x201c;ASU 2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The Company early adopted ASU 2020-06 effective January 1, 2021. The early
adoption of ASU 2020-06 impacted the Company&#x2019;s accounting for the issuance of its Series B Redeemable Convertible Preferred Stock
as further discussed in &lt;i&gt;Note 8 Temporary Equity Series B Redeemable Convertible Preferred Stock&lt;/i&gt; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
March 2020, the FAS issued ASU No. 2020-04 &#x201c;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&#x201d; (&#x201c;ASU 2020-04&#x201d;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
January 2020, the FASB issued ASU No. 2020-01, &lt;i&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&#x2014;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815&lt;/i&gt; (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&#x2019;s
consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
December 2019, the FASB issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &#x2013; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&#x2019;s consolidated results of operations, cash flows and financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--LesseeOperatingLeasesTextBlock_zGCkOmB9jGb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
2 &#x2013; &lt;span id="xdx_823_zIm2ibSzdefi"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
February 2016 the FASB issued ASU 2016-02, &lt;i&gt;Leases (Topic 842) &lt;/i&gt;(&#x201c;ASC 842&#x201d; or the &#x201c;new lease standard&#x201d;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &#x201c;package of
practical expedients&#x201d; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Upon
adoption, the Company recognized its lease for manufacturing and office space (the &#x201c;Facility Lease&#x201d;) on the balance sheet
as an operating lease right-of-use asset in the amount of $&lt;span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_z3QIEFnCJWn8"&gt;714,416
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and as a lease liability of $&lt;span id="xdx_904_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zHmT8Ig7tRDe"&gt;822,374&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
&lt;span id="xdx_906_eus-gaap--LesseeOperatingLeaseDescription_c20210101__20210930_zltbRLvpqQs2"&gt;The Facility Lease commenced September
29, 2017 and continues through August 31, 2022.&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has the option to renew the Facility Lease for an additional &lt;span id="xdx_902_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dc_c20210930__us-gaap--TypeOfArrangementAxis__custom--FacilityLeaseMember_z7ONoruRGFhb"&gt;five
years&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. However, the renewal option to extend
the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain of exercise.
The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal
period in its lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_90E_ecustom--MonthlyRentDescription_c20210101__20210930" style="font: 10pt Times New Roman, Times, Serif"&gt;Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
Total rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the
same monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to
operating lease liability on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the landlord agreed to pay the Company or the Company&#x2019;s contractors for tenant improvements made by the Company
not to exceed $&lt;span id="xdx_904_eus-gaap--TenantImprovements_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member__srt--RangeAxis__srt--MaximumMember_zR1ThP9KYplj"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $&lt;span id="xdx_903_ecustom--UnamortizedAmountOfTenantImprovementAllowance_iI_pp0p0_c20190102__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zrgjzx7tGFi2"&gt;81,481
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was treated as a reduction in measuring the right-of-use
asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a non lease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and
non lease components as a single component and account for it as the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#x2019;s depository bank.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zE7BfvjDMl78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B0_zg5aAGk9vSug" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Lease Cost&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Months
                                            Ended&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseCost_c20210101__20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162,667&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating cash outflow from operating lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_c20210101__20210930_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;210,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                                    &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_c20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease right-of-use asset"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194,353&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease liability, current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, current"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease liability, long-term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2376"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210930_zpudGJ6rSd88" style="font: 10pt Times New Roman, Times, Serif"&gt;.9
                                            &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20210930_zQoCqfVihB42" style="text-align: right" title="Discount rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zP0CoSboRq6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zl9F1dquxe55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of September 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years ended
    December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 (excluding the nine months ended September 30,
    2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_c20210930_zjvcD1tjTLH9" style="width: 22%; text-align: right" title="Remainder of fiscal year"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,710&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20210930_zFkL3HCOoQE1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Year one"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;170,891&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20210930_pp0p0" style="text-align: right" title="Total minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;242,601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20210930_zLIQ6LKinbYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less imputed interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,461&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of
    minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Present value of minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zTti6psuUEP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 30, 2021, the Company entered into an agreement to sublease approximately &lt;span id="xdx_90D_eus-gaap--AreaOfLand_iI_usqft_c20210430_zPfHJZENNDPi"&gt;6,900
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#x2019; notice.
Unless 30-days&#x2019; notice is provided sooner, this sublease will end upon termination of the Company&#x2019;s Lease Agreement with
its current landlord. Rent was initially charged at $&lt;span id="xdx_904_ecustom--RentalExpense_pp0p0_c20210429__20210430_zyyaoa9n2K69" title="Rental expense"&gt;5,989
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per month and increased to $&lt;span id="xdx_90C_ecustom--RentalExpense_pp0p0_c20210629__20210702_z8eUGTfQbS24" title="Rental expense"&gt;11,978
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per month effective July 1, 2021. The Sublessor
is also responsible for its prorated share of utilities and other related costs. This new sublease does not change the Company&#x2019;s
legal relationship or financial obligations with its landlord. The Company continues to be responsible for all the remaining financial
obligations under its existing lease with the landlord. Accordingly, entering into the new sublease did not impact the carrying value
of the Company&#x2019;s operating lease right of use asset or operating lease liability. Moreover, after an initial two-month transitional
period, the rental rate per square foot under the new sublease is identical to the rental rate per square foot for the Company&#x2019;s
existing lease with its landlord which indicates that there is no impairment to the carrying value of the Company&#x2019;s operating lease
right of use asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 27, 2021, the Company entered into a Lease Termination Agreement with its current landlord for the &lt;span id="xdx_902_eus-gaap--AreaOfLand_iI_usqft_c20210727_zl3I6KkR9xzg"&gt;18,952
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square foot office and manufacturing facility
in Boulder, CO, which was previously scheduled to expire on &lt;span id="xdx_902_eus-gaap--LeaseExpirationDate1_dd_c20210725__20210727__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zXeSy0kHheTf"&gt;August
31, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. The termination provides for the Company
to vacate the facility no later than November 15, 2021. In exchange for early termination from its lease obligation, the Company paid
a nominal lease termination fee on July 28, 2021. The termination was also contingent upon a successor tenant executing a new lease with
the landlord and the Company paying the remaining deferred rent and security deposit amounts (&lt;i&gt;See Contractual Payment Obligations
&lt;/i&gt;section). The landlord and successor tenant entered into a lease agreement on July 27, 2021. The remaining deferred rent and security
deposit will be paid in conjunction with the final rent payment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
July 28, 2021, the Company entered into an agreement to lease &lt;span id="xdx_904_eus-gaap--AreaOfLand_iI_usqft_c20210728_z4RgX87I8D3f"&gt;11,491
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;square feet of office and manufacturing space
in Louisville, CO. The lease commences on November 1, 2021 and continues through &lt;span id="xdx_904_eus-gaap--LeaseExpirationDate1_dd_c20210724__20210728__us-gaap--TypeOfArrangementAxis__custom--LeaseTerminationAgreementMember_zJDQ4X7f1m1i"&gt;January
31, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;. The Company has the option to renew
the lease for an additional 60-month period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">714416</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">822374</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2021-01-01to2021-09-30">The Facility Lease commenced September
29, 2017 and continues through August 31, 2022.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="AsOf2021-09-30_custom_FacilityLeaseMember">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <SRNA:MonthlyRentDescription contextRef="From2021-01-01to2021-09-30">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%</SRNA:MonthlyRentDescription>
    <us-gaap:TenantImprovements
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MaximumMember"
      decimals="0"
      unitRef="USD">100000</us-gaap:TenantImprovements>
    <SRNA:UnamortizedAmountOfTenantImprovementAllowance
      contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">81481</SRNA:UnamortizedAmountOfTenantImprovementAllowance>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_89B_eus-gaap--LeaseCostTableTextBlock_zE7BfvjDMl78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
lease cost, cash flows and other information related to the Facility Lease were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8B0_zg5aAGk9vSug" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Lease Cost&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Nine&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Months
                                            Ended&lt;/span&gt;&lt;/p&gt;
                                                                  &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseCost_c20210101__20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease cost"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;162,667&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating cash outflow from operating lease&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeasePayments_c20210101__20210930_pp0p0" style="text-align: right" title="Operating cash outflow from operating lease"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;210,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
                                            of&lt;/span&gt;&lt;/p&gt;
                                                                                                    &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
                                            30,&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseRightOfUseAsset_c20210930_pp0p0" style="width: 22%; text-align: right" title="Operating lease right-of-use asset"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;194,353&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease liability, current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseLiabilityCurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, current"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,140&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Operating lease liability, long-term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseLiabilityNoncurrent_c20210930_pp0p0" style="text-align: right" title="Operating lease liability, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2376"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20210930_zpudGJ6rSd88" style="font: 10pt Times New Roman, Times, Serif"&gt;.9
                                            &lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_uPure_c20210930_zQoCqfVihB42" style="text-align: right" title="Discount rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">162667</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">210154</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">194353</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">238140</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-09-30">P0Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.0500</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_89A_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zl9F1dquxe55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Future
annual minimum lease payments on the Facility Lease as of September 30, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B4_z1ctsVWb7Edh" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Future Annual Minimum Lease Payments&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Years ended
    December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021 (excluding the nine months ended September 30,
    2021)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_c20210930_zjvcD1tjTLH9" style="width: 22%; text-align: right" title="Remainder of fiscal year"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,710&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20210930_zFkL3HCOoQE1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Year one"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;170,891&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_c20210930_pp0p0" style="text-align: right" title="Total minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;242,601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_c20210930_zLIQ6LKinbYa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less imputed interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,461&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Present value of
    minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Present value of minimum lease payments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,140&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">71710</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">170891</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">242601</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">4461</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">238140</us-gaap:OperatingLeaseLiability>
    <us-gaap:AreaOfLand contextRef="AsOf2021-04-30" decimals="INF" unitRef="sqft">6900</us-gaap:AreaOfLand>
    <SRNA:RentalExpense
      contextRef="From2021-04-292021-04-30"
      decimals="0"
      unitRef="USD">5989</SRNA:RentalExpense>
    <SRNA:RentalExpense
      contextRef="From2021-06-292021-07-02"
      decimals="0"
      unitRef="USD">11978</SRNA:RentalExpense>
    <us-gaap:AreaOfLand contextRef="AsOf2021-07-27" decimals="INF" unitRef="sqft">18952</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1 contextRef="From2021-07-252021-07-27_custom_LeaseTerminationAgreementMember">2022-08-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:AreaOfLand contextRef="AsOf2021-07-28" decimals="INF" unitRef="sqft">11491</us-gaap:AreaOfLand>
    <us-gaap:LeaseExpirationDate1 contextRef="From2021-07-242021-07-28_custom_LeaseTerminationAgreementMember">2027-01-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_z04jK9JWDORa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
3 &#x2013; &lt;span id="xdx_824_zMBy98biFY"&gt;Inventory&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zzf4SyZLHGM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_zyNsY9SHCwe5" style="display: none"&gt;Schedule
of Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210930_z5ce68v8Z4C4" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_z6T6rCooRhNa" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zqUs5jAD08x3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,335&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,778&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zVmUeZOf0Oil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,595&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zamrk66e6vH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;237,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,145&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_zhYIxIekR7Ll" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for excess
    &amp;amp; obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(79,281&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(93,045&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zIGhHlcMXc96" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;480,354&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;327,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zd3giabyIeY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Overhead
expenses of $&lt;span id="xdx_900_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20210101__20210930_znNmM1wONjjg"&gt;17,674&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_909_eus-gaap--CostOfGoodsAndServicesSoldOverhead_pp0p0_c20200101__20201231_z8GkUPR1Skph"&gt;17,974
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;were included in the inventory balance as of
September 30, 2021, and December 31, 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included approximately $&lt;span id="xdx_90F_ecustom--PrepaidInventoryExpenses_c20210930_pp0p0"&gt;879,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and
$&lt;span id="xdx_900_ecustom--PrepaidInventoryExpenses_c20201231_pp0p0"&gt;916,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;in
advance payments for inventory for the periods ended September 30, 2021, and December 31, 2020, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zzf4SyZLHGM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory
consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BB_zyNsY9SHCwe5" style="display: none"&gt;Schedule
of Inventory&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20210930_z5ce68v8Z4C4" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20201231_z6T6rCooRhNa" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzlUp_zqUs5jAD08x3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;319,335&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;201,778&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzlUp_zVmUeZOf0Oil" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,595&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,231&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzlUp_zamrk66e6vH8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;237,705&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,145&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzlUp_zhYIxIekR7Ll" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allowance for excess
    &amp;amp; obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(79,281&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(93,045&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--InventoryNet_iTI_pp0p0_mtINzlUp_zIGhHlcMXc96" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inventory, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;480,354&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;327,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">319335</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">201778</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">2595</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">4231</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">237705</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">214145</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">79281</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">93045</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">480354</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">327109</us-gaap:InventoryNet>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">17674</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="USD">17974</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">879000</SRNA:PrepaidInventoryExpenses>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">916000</SRNA:PrepaidInventoryExpenses>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_801_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zrwtRk5xMaYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
4 &#x2013; &lt;span id="xdx_821_zOTdUyJEQMn3"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJiv7xcnC4L1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zLZVCtZSs8k5" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,851&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMZDztKFreq3" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z6OcIdjPZrR6" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zIUHCxMURVJ2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20210930_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;527,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zokQaM4dbO78" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,615&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210930_zvp6VeXPSTq1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(428,076&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zgUvrI5Finv7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(480,883&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,967&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zhCu01lBplz3" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,732&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zUOwpMJ8p0y2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation
expense was $&lt;span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20210101__20210930_zFO71rsB7aNe"&gt;54,538&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for
the nine months ended September 30, 2021. For the nine months ended September 30, 2021, $&lt;span id="xdx_900_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zCCjntru6qIi"&gt;4,721
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was allocated to cost of sales and $&lt;span id="xdx_90E_eus-gaap--SellingGeneralAndAdministrativeExpense_pp0p0_c20210101__20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember__us-gaap--IncomeStatementLocationAxis__custom--InventoryMember_zSgVbMfsEve1"&gt;1,180
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was allocated to inventory with the remainder
recorded as selling, general and administrative expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_890_eus-gaap--PropertyPlantAndEquipmentTextBlock_zJiv7xcnC4L1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Property
and equipment consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zLZVCtZSs8k5" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;296,851&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMZDztKFreq3" style="width: 18%; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;398,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_z6OcIdjPZrR6" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20210930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zIUHCxMURVJ2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;215,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_c20210930_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;527,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zokQaM4dbO78" style="text-align: right" title="Property and equipment, gross"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;628,615&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210930_zvp6VeXPSTq1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(428,076&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zgUvrI5Finv7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(480,883&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Property and equipment,
    net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentNet_c20210930_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;98,967&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zhCu01lBplz3" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,732&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-09-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">296851</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">398422</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-09-30_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_VehiclesMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2021-09-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">527044</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">628615</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">428076</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">480883</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">98967</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">54538</us-gaap:Depreciation>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember"
      decimals="0"
      unitRef="USD">4721</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-09-30_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember"
      decimals="0"
      unitRef="USD">1180</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z43nIkRhMPC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
5 &#x2013; &lt;span id="xdx_825_zvk1TcGntuvh"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrHfPYmX2q3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BF_zou4lBgXvTna" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210930_zkBTLGzF71Vl" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20201231_zdNzFzCMsHi9" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzbsH_zxSd7lz1MQwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;864,558&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;918,639&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzbsH_zU6BX7o3qF18" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_z4CC0eQnScI4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzbsH_zwpWEPRMNvs7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product warranty accrual&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,868&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_zn7eu27m6ee3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;340,442&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356,623&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzbsH_zMr6ODvSMOGd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,674,088&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,784,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zttCbNds4Jbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zrHfPYmX2q3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts
payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BF_zou4lBgXvTna" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20210930_zkBTLGzF71Vl" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;September
    30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20201231_zdNzFzCMsHi9" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;December
    31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzbsH_zxSd7lz1MQwa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;864,558&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;918,639&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maAPAALzbsH_zU6BX7o3qF18" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales commissions payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;40,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;48,263&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_z4CC0eQnScI4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;255,462&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;288,071&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maAPAALzbsH_zwpWEPRMNvs7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Product warranty accrual&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;172,868&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;173,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzbsH_zn7eu27m6ee3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;340,442&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;356,623&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzbsH_zMr6ODvSMOGd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,674,088&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,784,961&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">864558</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">918639</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">40758</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">48263</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">255462</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">288071</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">172868</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">173365</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">340442</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">356623</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">1674088</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zzSHV0N0TM24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
6 &#x2013; &lt;span id="xdx_823_z3CYiRhxSaTk"&gt;Note Payable and Accrued Interest&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210210_zH5lMReVvun9"&gt;514,200&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
for working capital purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
loan amount bears interest at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20210210_z14UZe4s1tB7"&gt;1&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
and is due on &lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20210209__20210210_zwpeLY3NxQbh"&gt;February 5, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full provided proceeds are used for payment
of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions are met. If any portion of the loan
is not forgiven, payments will commence 10 months following the end of the 24-week deferral period. The loan has typical default provisions,
including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments,
insolvency, dissolution or termination of the business as a going concern and bankruptcy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the three and nine months ended September 30, 2021, interest of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210701__20210930_zkE22sd21pR6"&gt;1,296
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20210101__20210930_zqtrNtTebagk"&gt;3,268
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;was accrued, respectively, in respect of this
note payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-02-10" decimals="0" unitRef="USD">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2021-02-10" decimals="INF" unitRef="Pure">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-02-092021-02-10">2026-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1296</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">3268</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_803_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zcGTgUN2iaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
7 &#x2013; &lt;span id="xdx_824_zkQESrASBuFe"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2019, there were &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_ecustom--NumberOfUnitsVestedButNotSettled_c20190101__20191231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr0v6SJAu0x6"&gt;45,000 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;restricted
stock units that had not been settled due to a dispute with a former employee over the required withholding taxes to be paid to the
Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against the former employee
regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid wages. As
stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_ecustom--NumberOfUnitsVestedAndSettled_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z17WdGRouHq7"&gt;45,000 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of the Company&#x2019;s common stock in settlement of these restricted stock units after taking measures to mitigate the
Company&#x2019;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an
interim award of approximately $&lt;span id="xdx_90A_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200308__20200309__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z83IRlsnuDBc"&gt;10,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
the Company&#x2019;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award
in the Company&#x2019;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company
costs of $&lt;span id="xdx_904_eus-gaap--LossContingencyDamagesAwardedValue_pp0p0_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zJwNGM5Ovb86"&gt;33,985&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
with interest at &lt;span id="xdx_902_ecustom--RestrictedStockUnitsSharesIssuedInterestPercentage_dp_uPure_c20200607__20200609__srt--TitleOfIndividualAxis__custom--FormerEmployeeMember_zKbPCGWx94Wh"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the
Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed. This
former employee continued to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for
the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective March 30, 2021, this separate
litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed and will be obliged to
pay $&lt;span id="xdx_906_eus-gaap--LossContingencyDamagesPaidValue_pp0p0_c20210329__20210330_zg8GiAEbIbOk"&gt;40,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;over
eight months and to issue upon execution of the settlement agreement an aggregate of &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210406__20210408_zBnLJLpv26P1"&gt;6,667
shares &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of common stock of the Company.
These shares were issued on April 8, 2021 as &#x201c;restricted securities,&#x201d; subject to a lock-up agreement of six months,
without registration rights, and pursuant to a private placement exemption and were valued at $&lt;span id="xdx_903_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210329__20210330_zl4c8v5acVtf"&gt;67,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The settlement agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement,
$&lt;span id="xdx_901_eus-gaap--OtherNonoperatingExpense_c20210101__20210930_pp0p0"&gt;107,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
in total, has been recognized in full in other expenses during the nine months ended September 30, 2021. As of September 30, 2021,
$&lt;span id="xdx_902_eus-gaap--PaymentsForLegalSettlements_pp0p0_c20210101__20210930_zyrU8kltI1d8"&gt;35,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
been paid in respect of the $&lt;span id="xdx_906_eus-gaap--LitigationSettlementExpense_c20210101__20210930_pp0p0"&gt;40,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;cash
portion of the settlement and the remaining $&lt;span id="xdx_907_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_c20210930_z3icA562jUUk"&gt;5,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;is
included in accounts payables and accrued liabilities. The issuance of the &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210101__20210930_pdd"&gt;6,667&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock, valued at $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210101__20210930_pp0p0"&gt;67,000 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has
been recognized in common stock issued during the nine months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#x2019;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#x2019;s operations
or its financial position, liquidity or results of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company has a lease agreement for its manufacturing and office space. Refer to &lt;i&gt;Note 2 Leases&lt;/i&gt; above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Other
Commitments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&#x2019;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <SRNA:NumberOfUnitsVestedButNotSettled
      contextRef="From2019-01-012019-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">45000</SRNA:NumberOfUnitsVestedButNotSettled>
    <SRNA:NumberOfUnitsVestedAndSettled
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">45000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-03-082020-03-09_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="0"
      unitRef="USD">33985</us-gaap:LossContingencyDamagesAwardedValue>
    <SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage
      contextRef="From2020-06-072020-06-09_custom_FormerEmployeeMember"
      decimals="INF"
      unitRef="Pure">0.08</SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="From2021-03-292021-03-30"
      decimals="0"
      unitRef="USD">40000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-04-062021-04-08"
      decimals="0"
      unitRef="USD">6667</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <SRNA:AggregateSharesIssuedUponExecutionOfSettlement
      contextRef="From2021-03-292021-03-30"
      decimals="INF"
      unitRef="Shares">67000</SRNA:AggregateSharesIssuedUponExecutionOfSettlement>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">107000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">35000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LitigationSettlementExpense
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">40000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">5000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">6667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">67000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <SRNA:TemporaryEquityTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_804_ecustom--TemporaryEquityTextBlock_zyeOd45ANRwi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
8 &#x2013; &lt;span id="xdx_826_zyKj3TvutyTe"&gt;Temporary Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Series
B Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2021, Surna Inc. (the &#x201c;Company&#x201d;) sold to an institutional investor (the &#x201c;Investor&#x201d;), &lt;span id="xdx_90A_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zWBfeh5lB161"&gt;3,300
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series B Convertible Preferred Stock,
stated value $&lt;span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zyShvMTCTPW3"&gt;1,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, currently convertible into &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zlsLpbEYhPMl"&gt;385,965
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, and a warrant to
purchase up to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember__srt--RangeAxis__srt--MaximumMember_z8NTY7KVPXS"&gt;192,982
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock (&#x201c;Investor Warrant&#x201d;),
for an aggregate purchase price of $&lt;span id="xdx_904_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zu6Iagl612Af"&gt;3,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(&#x201c;Consideration&#x201d;). The Company will
receive net proceeds of approximately $&lt;span id="xdx_90B_ecustom--TemporaryEquityNetProceeds_c20210926__20210928_z9WzIusTMoG8" title="Temporary equity net proceeds"&gt;2,625,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Company has received net proceeds of approximately $&lt;span id="xdx_900_ecustom--TemporaryEquityNetProceeds_c20210701__20210930_zjaujvOgy6I"&gt;1,260,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in the quarter and will receive the remaining
$&lt;span id="xdx_90C_eus-gaap--EscrowDeposit_iI_c20210928_z2YUezDmOyY"&gt;1,365,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;pursuant
to the terms of the escrow.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B Preferred Stock has an annual dividend of &lt;span id="xdx_90C_eus-gaap--PreferredStockDividendRatePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zlCYDAncZO02"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and has an initial common stock conversion price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90F_eus-gaap--CommonStockConvertibleConversionPriceIncrease_pid_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zSQQvS8yH7ze"&gt;8.55.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The conversion rate is subject to adjustment in
various circumstances, including stock splits, stock dividends, pro rata distributions, fundamental transactions and upon a triggering
event and subject to reset if the common stock of the Company sold in any subsequent equity transaction, including a qualified offering,
is sold at a price below the then conversion price. The Series B Preferred Stock is mandatorily convertible on the third anniversary
of its issuance. All conversions of the Series B Preferred Stock are subject to a blocker provision of &lt;span id="xdx_909_ecustom--PercentageOfPreferredStockConversionProvision_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z8c2PmowmfF3"&gt;4.99&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%.
The Company will reserve &lt;span id="xdx_90F_ecustom--PercentageOfCommonStockReserve_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z0d9woEHBsdi"&gt;200&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the number of shares of common stock into which the Series B Preferred Stock and Investor Warrant may be converted or exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Pending
completion of an amendment to the certificate of incorporation to increase the number of authorized shares of common stock and redeem
the outstanding Series A Preferred Stock, as required by the Investor, $&lt;span id="xdx_90E_eus-gaap--PreferredStockValueOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNbGvRSZCqO3"&gt;1,365,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;of the Consideration was placed in escrow. The
Company filed a Schedule 14C to affect the amendment and expects the amendment process to be completed in early November, at which time
the escrowed amount will be released to the Company. If the amendment process is not achieved by December 7, 2021, then the Company will
redeem, at &lt;span id="xdx_90C_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z8hIvSe4Y7Sl"&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the stated value of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_pid_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6oU9KX0d8Tj"&gt;1,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per share, &lt;span id="xdx_908_ecustom--DebtInstrumentRedeemableShares_iI_pid_uShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1f2Ow9Tpaxj" title="Redeemable shares"&gt;1,650
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares of the Series B Preferred Stock, and pay
the dividend amount due thereon at &lt;span id="xdx_90D_ecustom--DebtInstrumentRedemptionPricePercentageDividendDueThereon_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVTxKe9selXc" title="Redemption price percentage dividend due thereon"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
to the date of redemption. The Series B Preferred Stock will be redeemed at the demand by the holders, at &lt;span id="xdx_904_eus-gaap--DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVymgD77fFgc"&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
of the stated value of $&lt;span id="xdx_90D_ecustom--DebtInstrumentRedeemptionStatedValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zJCPKwPW8pw6"&gt;1,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
at any time after the earlier of (x) the consummation by the Company of a qualified offering, or (y) the first anniversary of the issuance
of the Series B Preferred Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Investor was granted a right of participation in future private offerings and has agreed to a 180-day lock-up in connection with a qualified
offering. A &#x201c;qualified offering&#x201d; is the first public offering after the sale of the Series B Preferred Stock in which the
common stock of the Company is listed on a national exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Investor Warrant may be exercised until &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zqeGoFx5RzX6"&gt;September
28, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, at an initial exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_uUSDPShares_c20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zlpQsIh0MOu3"&gt;9.41,&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;subject to adjustment. The Investor Warrant provides
for cashless exercise if the underlying shares of common stock are not registered for resale, and all issuances of common stock upon
exercise are subject to a &lt;span id="xdx_90B_ecustom--IssuanceOfCommonStockExercisePercentageProvision_pid_dp_uPure_c20210101__20210930__us-gaap--ClassOfWarrantOrRightAxis__custom--InvestorWarrantMember_zIbASQMACAu9"&gt;4.99&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
blocker provision.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company granted the Investor registration rights for the shares of common stock underlying the Series B Preferred Stock and the Investor
Warrants. The Company must file a registration statement no later than 180 days after the date of a qualified offering and have it effective
in 45 days if there is no Securities and Exchange Commission (&#x201c;SEC&#x201d;) review, or if there is a review, within 75 days. The
Company must keep the registration statement effective until all the shares registered have been sold or may be sold under Rule 144,
without regard to volume and holding period restrictions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company engaged ThinkEquity LLC (&#x201c;ThinkEquity&#x201d;) as its placement agent and paid a total cash fee of &lt;span id="xdx_905_ecustom--PercentageOfPlacementAgentCashFee_pid_dp_uPure_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zkKvu7yQ7UE7" title="Percentage of placement agent cash fee"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%,
or $&lt;span id="xdx_90D_eus-gaap--InvestmentCompanyShareholderServiceFeeExpense_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zC5IYCbjCbQl"&gt;270,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
and its expenses, less prepaid expenses, and issued to ThinkEquity and its designees a warrant to purchase up to an aggregate of &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_ecustom--WarrantToPurchaseCommonStockShares_pid_c20210101__20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_zniC59FA7AYj" title="Warrants to purchase of common stock shares"&gt;34,737
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock. The exercise price
of the warrant initially will be &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--FairValueByAssetClassAxis__us-gaap--EquityMethodInvestmentsMember_z2kgrNrgMlhl"&gt;10.40
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, subject to typical adjustment
provisions, and exercisable for a term of three years. The warrant has registration rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Probability
of Redemption: As it was considered probable the Series B Preferred stock will become redeemable outside of the Company&#x2019;s control,
the Series B Preferred stock needs to be disclosed as temporary equity and restated at the balance sheet date at its redemption value
of &lt;span id="xdx_906_eus-gaap--DebtInstrumentRedemptionPricePercentage_dp_uPure_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zua3LY9d3Dfe"&gt;120&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;%
the stated value of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleLiquidationPreferencePerShare_iI_uUSDPShares_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zr7TYjVvCTj9"&gt;1,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per share, or $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleLiquidationPreferenceValue_iI_uUSD_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zOxdEVN2QBe"&gt;3,960,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
As a result, on September 30, 2021, the Company adjusted the carrying value of the Series B Preferred Stock to its redemption value of
$&lt;span id="xdx_906_eus-gaap--TemporaryEquityAccretionToRedemptionValue_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zNOlS2Egi2zg"&gt;3,960,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and recorded a $&lt;span id="xdx_90C_ecustom--TemporaryEquityNonCashRedemptionValueAdjustment_pp0p0_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zHUgFEv6mycd"&gt;2,262,847
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;non-cash redemption value adjustment. This redemption
value adjustment is treated as similar to a dividend on the preferred stock for GAAP purposes; accordingly, the redemption value adjustment
is therefore added to the &#x201c;Net Loss&#x201d; to arrive at &#x201c;Net Loss Attributable to Common Shareholders&#x2019;&#x201d; on the
Company&#x2019;s Consolidated Statements of Operations. In addition, since the Company does not have a balance of retained earnings, the
redemption value adjustment was recorded against additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Series
B Redeemable Convertible Stock Subscription Receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Of
the net proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zafp6uInVS2a"&gt;2,624,874
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;receivable under the Securities Purchase Agreement
relating to the Series B preferred stock and related warrants, $&lt;span id="xdx_909_eus-gaap--EscrowDeposit_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zE1knPwY12g8"&gt;1,365,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was put into escrow pending the completion of
i) an amendment to the Articles of Incorporation to increase the number of authorized shares of common stock to &lt;span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQbFzRpg8t7k"&gt;850,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares, (ii) &lt;span id="xdx_907_eus-gaap--TemporaryEquityDescription_c20210101__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zACZMVqRxdW2"&gt;the
redemption of the outstanding shares of Series A Preferred Stock of the Company for common stock at the rate of &lt;span style="-sec-ix-redline: true"&gt;one 0.0067&lt;/span&gt; share
of common stock for each 100 shares of preferred stock that is currently issued and outstanding,&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)
the authorization of a reverse stock split of the common stock in connection with the listing of the common stock on an eligible market
(as defined in the Purchase Agreement), and, if the number of authorized shares of common stock is reduced in connection with such reverse
stock split, the subsequent increase of the authorized shares of capital stock of the Company within established limits, at any time
prior to June 30, 2022, and (iv) an amendment to the articles of incorporation to change the corporate name of the Company to CEA Industries
Inc. If these amendments are completed by December 7, 2021, then the remaining $&lt;span id="xdx_902_eus-gaap--EscrowDeposit_iI_c20211207__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGPpnFN9v8uc"&gt;1,365,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;funds held in escrow will be released to the
Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Accordingly,
as of September 30, 2021, these funds were disclosed as Series B Redeemable Convertible Stock Subscription Receivable on the Company&#x2019;s
consolidated balance sheet&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</SRNA:TemporaryEquityTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">3300</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">1000</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">385965</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2021-09-262021-09-28_us-gaap_ConvertiblePreferredStockMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">192982</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="AsOf2021-09-28_us-gaap_ConvertiblePreferredStockMember"
      decimals="0"
      unitRef="USD">3000000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <SRNA:TemporaryEquityNetProceeds
      contextRef="From2021-09-262021-09-28"
      decimals="0"
      unitRef="USD">2625000</SRNA:TemporaryEquityNetProceeds>
    <SRNA:TemporaryEquityNetProceeds
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">1260000</SRNA:TemporaryEquityNetProceeds>
    <us-gaap:EscrowDeposit contextRef="AsOf2021-09-28" decimals="0" unitRef="USD">1365000</us-gaap:EscrowDeposit>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">8.55</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <SRNA:PercentageOfPreferredStockConversionProvision
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">0.0499</SRNA:PercentageOfPreferredStockConversionProvision>
    <SRNA:PercentageOfCommonStockReserve
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">2</SRNA:PercentageOfCommonStockReserve>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      unitRef="USD">1365000</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Pure">1.20</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="AsOf2021-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">1000</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <SRNA:DebtInstrumentRedeemableShares
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">1650</SRNA:DebtInstrumentRedeemableShares>
    <SRNA:DebtInstrumentRedemptionPricePercentageDividendDueThereon
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">0.08</SRNA:DebtInstrumentRedemptionPricePercentageDividendDueThereon>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">1.20</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <SRNA:DebtInstrumentRedeemptionStatedValue
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">1000</SRNA:DebtInstrumentRedeemptionStatedValue>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="From2021-01-012021-09-30_custom_InvestorWarrantMember">2024-09-28</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-30_custom_InvestorWarrantMember"
      decimals="INF"
      unitRef="USDPShares">9.41</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:IssuanceOfCommonStockExercisePercentageProvision
      contextRef="From2021-01-012021-09-30_custom_InvestorWarrantMember"
      decimals="INF"
      unitRef="Pure">0.0499</SRNA:IssuanceOfCommonStockExercisePercentageProvision>
    <SRNA:PercentageOfPlacementAgentCashFee
      contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember"
      decimals="INF"
      unitRef="Pure">0.09</SRNA:PercentageOfPlacementAgentCashFee>
    <us-gaap:InvestmentCompanyShareholderServiceFeeExpense
      contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember"
      decimals="0"
      unitRef="USD">270000</us-gaap:InvestmentCompanyShareholderServiceFeeExpense>
    <SRNA:WarrantToPurchaseCommonStockShares
      contextRef="From2021-01-012021-09-30_us-gaap_EquityMethodInvestmentsMember"
      decimals="INF"
      unitRef="Shares">34737</SRNA:WarrantToPurchaseCommonStockShares>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-30_us-gaap_EquityMethodInvestmentsMember"
      decimals="INF"
      unitRef="USDPShares">10.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Pure">1.20</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">1000</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferenceValue
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">3960000</us-gaap:DebtInstrumentConvertibleLiquidationPreferenceValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">3960000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <SRNA:TemporaryEquityNonCashRedemptionValueAdjustment
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">2262847</SRNA:TemporaryEquityNonCashRedemptionValueAdjustment>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
      contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">2624874</us-gaap:ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">1365000</us-gaap:EscrowDeposit>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">850000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:TemporaryEquityDescription contextRef="From2021-01-012021-09-30_us-gaap_SeriesBPreferredStockMember">the
redemption of the outstanding shares of Series A Preferred Stock of the Company for common stock at the rate of</us-gaap:TemporaryEquityDescription>
    <us-gaap:EscrowDeposit
      contextRef="AsOf2021-12-07_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">1365000</us-gaap:EscrowDeposit>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zLEMEAvq5Fn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
9 &#x2013; &lt;span id="xdx_82C_zz7QT1VL2MP"&gt;Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, and December 31, 2020, the Company has &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231_zRGC0qPCawdc"&gt;150,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares authorized at a $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20201231_zgPNbhg2GWK4"&gt;0.00001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;par value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Series
A Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, and December 31, 2020, the Company has &lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zti7WHe7QRh"&gt;42,030,331
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares issued and outstanding at the end of both
periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Series
B Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 28, 2021, the Company entered into a Securities Purchase Agreement (&#x201c;Purchase Agreement&#x201d;) with an institutional
investor (the &#x201c;Investor&#x201d;), pursuant to which the Investor purchased from the Company &lt;span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodShares_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z5z12iiRU4nb"&gt;3,300
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series B Preferred Stock with a stated
value of $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zd56CbRHW8mi" title="Preferred stock, par value"&gt;1,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, or $&lt;span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pid_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zqvskA2dB5Hc"&gt;3,300,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of stated value in the aggregate (&#x201c;Series
B Preferred Stock&#x201d;), and a warrant to purchase up to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_c20210926__20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__srt--RangeAxis__srt--MaximumMember_zOWckPCvqsVb"&gt;192,982
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock of the Company (&#x201c;Investor
Warrant&#x201d;), for an aggregate purchase price of $&lt;span id="xdx_90A_eus-gaap--TemporaryEquityAggregateAmountOfRedemptionRequirement_iI_c20210928__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z72nQJTrrb54"&gt;3,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(&#x201c;Consideration&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
a result of the PIPE Financing, referenced above and described in &lt;i&gt;Note 8&lt;/i&gt;, the Company has &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20210930__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIjq8sNHF6H5"&gt;3,300
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares issued and outstanding as of September
30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, and December 31, 2020, the Company was authorized to issue &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_zbiPacSZuf9h"&gt;350,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;shares of common stock with a par value of $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20210930_zgGn7QJ9Dp8h"&gt;0.00001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
December 31, 2020, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20201231_z3hDxtp71bC9"&gt;1,576,844&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares
of common stock were issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2021, we issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20210101__20210930_zfzi6EWxLpLd"&gt;6,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, valued at $&lt;span id="xdx_90C_ecustom--AggregateSharesIssuedUponExecutionOfSettlement_c20210101__20210930_zl6dL0o0Gvyg"&gt;67,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;as part of a legal settlements further described
in &lt;i&gt;Note 7 &#x2013; Commitments and Contingencies &#x2013; litigation above.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Consequently,
effective September 30, 2021, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_c20210930_zIZVyOIDlQug"&gt;1,583,511&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock were issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_custom_PurchaseAgreementMember"
      decimals="INF"
      unitRef="Shares">3300</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">3300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2021-09-262021-09-28_us-gaap_SeriesBPreferredStockMember_srt_MaximumMember"
      decimals="0"
      unitRef="USD">192982</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement
      contextRef="AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      unitRef="USD">3000000</us-gaap:TemporaryEquityAggregateAmountOfRedemptionRequirement>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2021-09-30_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      unitRef="Shares">3300</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">1576844</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">6667</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <SRNA:AggregateSharesIssuedUponExecutionOfSettlement
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">67000</SRNA:AggregateSharesIssuedUponExecutionOfSettlement>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">1583511</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80D_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zEfXpBuuBbVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
10 &#x2013; &lt;span id="xdx_82D_z5vjtBg5QZIj"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;2017
Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Company&#x2019;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#x201c;2017 Equity
Plan&#x201d;), the Board of Directors (the &#x201c;Board&#x201d;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#x201c;SARs&#x201d;), restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock unit
awards (&#x201c;RSUs&#x201d;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;333,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s common stock
(&#x201c;Plan Shares&#x201d;) for issuance of equity awards under the 2017 Equity Plan. If any shares subject to an award are forfeited,
expire, or otherwise terminate without issuance of such shares, the shares will, to the extent of such forfeiture, expiration, or termination,
again be available for awards under the 2017 Equity Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;2021
Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#x201c;2021 Equity Plan&#x201d;), which was approved by the stockholders
on July 22, 2021. The 2021 Equity Plan permits the Board to grant awards of up to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210322__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zUKuM85eymW7"&gt;666,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock. The 2021 Plan provides
for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the
&#x201c;Code&#x201d;), non-qualified stock options, stock appreciation rights (&#x201c;SARs&#x201d;), restricted stock awards and restricted
stock unit awards and other equity linked awards to our employees, consultants and directors. If an equity award (i) expires or otherwise
terminates without having been exercised in full or (ii) is settled in cash (&lt;i&gt;i.e.&lt;/i&gt;, the holder of the award receives cash rather
than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that
may be issued pursuant to this Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;During
the nine months ended September 30, 2021, the Company issued no shares of its common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2021, the Company granted awards for &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;21,777
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;non-qualified stock options as described
below. Of the total awards granted, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--AwardTypeAxis__custom--TwoThousandSeventeenEquityPlanMember_zXv86LyB4JP7"&gt;20,239
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;were under the 2017 Equity Plan and &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandTwentyOneEquityPlanMember_zu8021NWT1yc"&gt;230,770
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;were issued under the 2021 Equity Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2021, of the &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;333,3333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares authorized under the 2017 Plan for
equity awards, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930_pdd"&gt;163,692
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares have been issued, awards related to
&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;162,665
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;options remain outstanding, and &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;6,976
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares remain available for future equity
awards. As of September 30, 2021, of the &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1PiEc7JzJbk"&gt;666,667
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares authorized under the 2021 Equity Plan,
&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z6khA6M8EmRc"&gt;1,538
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;relate to outstanding options and &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z45iGP1qUb5i"&gt;665,129
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares remain available for future equity
awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
was $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zOrSNtGUD6Hb"&gt;90,255
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;in unrecognized compensation expense for unvested
non-qualified stock options at September 30, 2021 which will be recognized over approximately &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_z1ZU0vweRqA2"&gt;3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Non-Qualified
Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zKTPsPnJRnNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended
September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&lt;span id="xdx_8BB_znp5ywFL5g0c" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4gld8oXLul1" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV4oZm5nSTre" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbwjmlEDTEwl" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfEQLj1v1Gg9" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2585"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zVR5opud0Jkc" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,239&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOAZ8AjQNT2e" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQzVkmkVAe79" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhuARfgxtYmj" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2592"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAJjNruQHOWf" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zckRq9ht7oh" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,914&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyrSB7ZQtu54" style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkhSYLxIW19e" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Forfeited"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYWhXI9gTWQi" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2600"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYzO59PB6VH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5tsk0SnBZ22" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;113,332&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zW3x9SeFnQe" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUvpqxPDK4wf"&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwoVKOVoNvQ7" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable, September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcxUwTQQjYnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,665&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuF817ZZFR2a" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmipUx7wQY88"&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgDgQ0Fv3lf4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2616"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A8_ziZVULdxX17c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2021, we issued a total of &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20210930__us-gaap--RelatedPartyTransactionAxis__custom--EmployeesAndConsultantsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zJ8lLFruyjeb"&gt;20,239
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;stock options to employees as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,906
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;stock options were issued to 21 employees in
    respect of the Company&#x2019;s 2020 Annual Incentive Awards. The options vested immediately, have a term of &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_zoKzbu3P6TOl"&gt;10
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwentyOneEmployeesMember_pdd"&gt;19.50.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztTM9FHDUKG5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,333
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;stock options were issued to our newly appointed
    Chief Financial Officer. The options vest as follows: &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;1,667
    &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;vested immediately, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyTwoMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;2,780
    &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;on June 30, 2022, &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;665,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;on June 30, 2023 and &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--StatementScenarioAxis__custom--JuneThirtyTwentyTwentyFourMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;668,000
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;on June 30, 2024. The options have a term
    of &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zdbnHwa0m937"&gt;10
    &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_c20210930__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_pdd"&gt;9.15.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
    the nine months ended September 30, 2021, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FormerEmployeeMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_zo8KL30YriX7"&gt;1,914
    &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;fully vested stock options were forfeited
    following the departure of 3 former employees.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6uz1kHQOHmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months
ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zImqUMghEN0d" style="display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQQ0WxbcTUO3" style="text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zdouRiT9Kbyl" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ztXpy42QEQ7c" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUsKV9NiRi5e" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2638"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zujbP3yXyAv7" style="width: 11%; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,239&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcEIwcqwY0Di" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmAwKRm0eX83" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2644"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zD5rouAApSL9" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5kngnBAUc07" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgRPVPqNdq8d" style="text-align: right" title="Aggregated Intrinsic Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,412&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4aUVWGA7vgb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2652"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zca5jjCSo3wh" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2654"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zlysCjUo3WC5" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2656"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zetnfKTZTJO8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2658"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z7WwHfQCuoc3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2660"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zxcEFmi9RtM5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zi6raECBmYgc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znjM5qNdlQnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaTJaeQ9A541" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zezsuorBi2S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For
the nine months ended September 30, 2021 and September 30, 2020, the Company recorded $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"&gt;29,881
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;and $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensation_c20200101__20200930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EmployeesAndConsultantsMember_pp0p0"&gt;171,624
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;as compensation expense related to vested options
issued to employees and consultants, net of forfeitures, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zXNy04sZt6A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine
months ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BA_zLEoLGV1DQue" style="display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value ($000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh1VE8UaYWrg" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyiSCSDM7sXe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJbcsxA6QD8a" style="font-family: Times New Roman, Times, Serif"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZwNzbalPCs4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2679"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zX9g4KSImHFa" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFwFKcg1vkv" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGohvJBQxzBc" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdPKPvrPRF8l" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKDOV5jhmzS9" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2688"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0NhSxzTxYud" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2690"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2189g8PNKub" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2692"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqWgJYn1Egoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,871&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8hlGNijGvJ7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2Q055u8ZUta" style="font-family: Times New Roman, Times, Serif"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFIMmyG9WhFg" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;
    September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zawOZjpZ9LN8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,871&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsxjgS68DW64" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpCvslrSsDhi" style="font-family: Times New Roman, Times, Serif"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3atSYHs8e1j" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2706"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zVzM1AvVUUw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2021, we issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember_z3XQ8fS3Ywhg"&gt;1,538
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;non-qualified stock options to directors
as retroactive compensation for the first half of 2021 under the 2021 Equity Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVVQyPWVcsz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the
nine months ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B4_zm0LwJwSl8qg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zK1aMeTWkwG2" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfRIVlkOUuwl" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzHLUXNM13E7" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwCOEhNblof7" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPQxCdlSzXq6" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbrjiGryUQe" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_iN_pdp0_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zERxLWFY9iQf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODpm85TDhe7" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2724"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhqZIy8eZ76g" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,205&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJhaKpnlMwX9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmhZ7MTcgb16" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,846&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvi8PX2mQ4Qa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2732"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4HOo16infre" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2734"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGknfEHNDja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7bt2EGwK4N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfvFdw7YGJQg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7ycd9P24fK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2742"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zkPaIltoQSFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the nine months ended September 30, 2021 and September 30, 2020, the Company incurred $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"&gt;21,174
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_903_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pp0p0"&gt;55,970&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, as compensation expense related to &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;8,205
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200101__20200930__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_pdd"&gt;10,142
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;vested options, respectively, issued to directors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
June 24, 2020&lt;i&gt;, &lt;/i&gt;the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pn6n6_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zxzGMq2rnrl"&gt;13,333
&lt;/span&gt;&lt;/span&gt;non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested &lt;/span&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_pid_uPure_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zMW8RvkBTfc7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50%
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon grant and 50% on April 1, 2021, if the Director
remained on the Board up to that time. The options have a term of &lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200623__20200624__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_zThDsft0fbd1"&gt;5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and have an exercise price equal to the
closing price of the Company&#x2019;s common stock on The OTC Markets on the day immediately preceding the grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
August 20, 2021, the Company issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pp0p0_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zojIelSV9eAb"&gt;1,538
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;non-qualified stock options under the 2021
Equity Plan to its directors. The options vested upon grant. The options have a term of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200818__20200820__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyOneEquityPlanMember_zXT5fN9NZONf"&gt;10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years and an exercise price equal to the closing
price of the Company&#x2019;s common stock on The OTC Markets on the day immediately preceding the grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration: underline"&gt;Restricted
Stock Units&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;There
has been no activity related to RSUs during the nine months ended September 30, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company recorded $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensation_c20200101__20200930__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsandConsultantsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0"&gt;25,163
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;during the nine months ended September 30, 2020,
as compensation expense related to vested RSUs issued to employees, directors and consultants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
April 30, 2020, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200429__20200430__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pdd"&gt;5,333
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;RSUs vested. However, the holder elected
to cancel the RSUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">333333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">666667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">21777</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_TwoThousandSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">20239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_TwoThousandTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">230770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">333.3333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">163692</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">162665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">6976</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">666667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">1538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">665129</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="0"
      unitRef="USD">90255</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zKTPsPnJRnNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended
September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&lt;span id="xdx_8BB_znp5ywFL5g0c" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4gld8oXLul1" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,007&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zV4oZm5nSTre" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zbwjmlEDTEwl" style="font-family: Times New Roman, Times, Serif"&gt;8.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zfEQLj1v1Gg9" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2585"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zVR5opud0Jkc" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,239&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zOAZ8AjQNT2e" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQzVkmkVAe79" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zhuARfgxtYmj" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2592"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zAJjNruQHOWf" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2594"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zckRq9ht7oh" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,914&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zyrSB7ZQtu54" style="text-align: right"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zkhSYLxIW19e" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Remaining Contractual Term, Forfeited"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYWhXI9gTWQi" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2600"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zYzO59PB6VH7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5tsk0SnBZ22" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;113,332&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zW3x9SeFnQe" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUvpqxPDK4wf"&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zwoVKOVoNvQ7" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable, September
    30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcxUwTQQjYnb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;101,665&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zuF817ZZFR2a" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmipUx7wQY88"&gt;7.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgDgQ0Fv3lf4" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2616"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">95007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">P8Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">20239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">1914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">18.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">P6Y7M6D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">113332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">P7Y10M24D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">101665</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2021-09-30_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">20239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember"
      decimals="INF"
      unitRef="Shares">6906</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwentyOneEmployeesMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      unitRef="Shares">13333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember"
      decimals="INF"
      unitRef="Shares">1667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyTwoMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">2780</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyThreeMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">665000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_JuneThirtyTwentyTwentyFourMember_srt_ChiefFinancialOfficerMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">668000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_srt_ChiefFinancialOfficerMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_FormerEmployeeMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">1914</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember_z6uz1kHQOHmc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months
ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zImqUMghEN0d" style="display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zQQ0WxbcTUO3" style="text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zdouRiT9Kbyl" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_ztXpy42QEQ7c" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zUsKV9NiRi5e" style="text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2638"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zujbP3yXyAv7" style="width: 11%; text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,239&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zcEIwcqwY0Di" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zmAwKRm0eX83" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2644"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zD5rouAApSL9" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,572&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z5kngnBAUc07" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zgRPVPqNdq8d" style="text-align: right" title="Aggregated Intrinsic Value, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;66,412&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z4aUVWGA7vgb" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2652"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zca5jjCSo3wh" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2654"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zlysCjUo3WC5" style="text-align: right" title="Grant Date Fair Value Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2656"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zetnfKTZTJO8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2658"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_z7WwHfQCuoc3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Grant Date Fair Value Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2660"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zxcEFmi9RtM5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zi6raECBmYgc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Grant-Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.15&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_znjM5qNdlQnc" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pp0p0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanMember__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_zaTJaeQ9A541" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,800&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">20239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">12.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">8572</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">16.80</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">66412</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="Shares">11667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="INF"
      unitRef="USDPShares">9.15</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested
      contextRef="AsOf2021-09-30_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">104800</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember61996156"
      decimals="0"
      unitRef="USD">29881</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember"
      decimals="0"
      unitRef="USD">171624</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember">&lt;p id="xdx_896_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zXNy04sZt6A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine
months ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BA_zLEoLGV1DQue" style="display: none"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value ($000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zh1VE8UaYWrg" style="width: 11%; text-align: right" title="Number of Options, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;49,333&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zyiSCSDM7sXe" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJbcsxA6QD8a" style="font-family: Times New Roman, Times, Serif"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zZwNzbalPCs4" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2679"&gt;&#160;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zX9g4KSImHFa" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFwFKcg1vkv" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zGohvJBQxzBc" style="font-family: Times New Roman, Times, Serif"&gt;10.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zdPKPvrPRF8l" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zKDOV5jhmzS9" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2688"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z0NhSxzTxYud" style="text-align: right" title="Number of Options, Forfeited/Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2690"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2189g8PNKub" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2692"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zqWgJYn1Egoh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,871&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z8hlGNijGvJ7" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z2Q055u8ZUta" style="font-family: Times New Roman, Times, Serif"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pdp0_c20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zFIMmyG9WhFg" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2699"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercisable,&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;
    September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zawOZjpZ9LN8" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,871&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zsxjgS68DW64" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable Ending"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zpCvslrSsDhi" style="font-family: Times New Roman, Times, Serif"&gt;6.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--AwardTypeAxis__custom--NonQualifiedStockOptionsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z3atSYHs8e1j" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic Value, Exercisable Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2706"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">49333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">10.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">1538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">9.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">50871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">10.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">P6Y9M18D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">50871</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">10.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-012021-09-30_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndTwentyOneEquityPlanMember_custom_NonQualifiedStockOptionsMember"
      decimals="INF"
      unitRef="Shares">1538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember">&lt;p id="xdx_892_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_hsrt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zVVQyPWVcsz8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the
nine months ended September 30, 2021, are presented in the table below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span id="xdx_8B4_zm0LwJwSl8qg" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Summary
of Non-vested Non-qualified Stock Option Activity&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted
    Average Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate
    Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Grant-Date
    Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#xfeff;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zK1aMeTWkwG2" style="width: 11%; text-align: right" title="Number of Options Nonvested, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,667&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfRIVlkOUuwl" style="width: 11%; text-align: right" title="Weighted Average Grant-Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zzHLUXNM13E7" style="width: 11%; text-align: right" title="Aggregated Intrinsic Value, Nonvested Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;31,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iS_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zwCOEhNblof7" style="width: 11%; text-align: right" title="Grant Date Fair Value Nonvested, Beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2717"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zPQxCdlSzXq6" style="text-align: right" title="Number of Options Nonvested, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,538&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvbrjiGryUQe" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Granted"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_iN_pdp0_di_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zERxLWFY9iQf" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,154&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zODpm85TDhe7" style="text-align: right" title="Grant Date Fair Value Nonvested, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2724"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zhqZIy8eZ76g" style="text-align: right" title="Number of Options Nonvested, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(8,205&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zJhaKpnlMwX9" style="text-align: right" title="Weighted Average Grant-Date Fair Value, Vested"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1_pdp0_c20210101__20210930__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember__srt--TitleOfIndividualAxis__custom--DirectorsMember_zmhZ7MTcgb16" style="text-align: right" title="Aggregated Intrinsic Value, Nonvested Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(29,846&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_pp0p0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zvi8PX2mQ4Qa" style="text-align: right" title="Grant Date Fair Value Nonvested, Vested"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2732"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z4HOo16infre" style="text-align: right" title="Number of Options Nonvested, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2734"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zLGknfEHNDja" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options Nonvested, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nonvested, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7bt2EGwK4N6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_zfvFdw7YGJQg" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregated Intrinsic Value, Nonvested Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_iE_pdp0_c20210101__20210930__srt--TitleOfIndividualAxis__custom--DirectorsMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_z7ycd9P24fK7" style="border-bottom: Black 2.5pt double; text-align: right" title="Grant Date Fair Value Nonvested, Ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2742"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="Shares">6667</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="INF"
      unitRef="USDPShares">4.35</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1
      contextRef="AsOf2020-12-31_custom_DirectorsMember_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember"
      decimals="0"
      unitRef="USD">31000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">1538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">9.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">1154</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="Shares">8205</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="INF"
      unitRef="USDPShares">5.40</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1
      contextRef="From2021-01-012021-09-30_custom_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember_custom_DirectorsMember"
      decimals="0"
      unitRef="USD">-29846</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="0"
      unitRef="USD">21174</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="0"
      unitRef="USD">55970</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2021-01-012021-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">8205</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-01-012020-09-30_srt_DirectorMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Shares">10142</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="-6"
      unitRef="Shares">13333000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember"
      decimals="INF"
      unitRef="Pure">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-06-232020-06-24_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndSeventeenEquityPlanMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember"
      decimals="0"
      unitRef="Shares">1538</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-08-182020-08-20_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember_custom_TwoThousandAndTwentyOneEquityPlanMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-012020-09-30_custom_EmployeesDirectorsandConsultantsMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      unitRef="USD">25163</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2020-04-292020-04-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      unitRef="Shares">5333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <SRNA:WarrantsDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_804_ecustom--WarrantsDisclosureTextBlock_zLmaN214mUB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
11 - &lt;span id="xdx_822_zZvDjqWyypN2"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z5O823WM7Gl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September
30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zT9rBdMJ3yq9" style="display: none"&gt;Schedule
of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20210930_zjWAvLHPnk4i" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20210930_zVNGmDosj27a" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zgawyAW8NT94" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210930_zd9calbbkjh3" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Issued"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zSciqoAeDnDc" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Life of Outstanding Warrants in Months, Issued"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2776"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210930_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20210930_zHLFpnVfVYkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20210930_zqb3GSU71sKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zfdYLOWvWWl3" style="font-family: Times New Roman, Times, Serif"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210930_zmIv9vQYXBhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z27zHbV89978" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zgrijU5SXnZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information about warrants outstanding at September 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8BC_zzmfRVkOy6i1" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted Average Life of&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z537to8iv6U1" style="width: 30%; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zq4AHuDxnVph" style="width: 30%; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,982&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 30%; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z4vfo7shlyH2" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWfIKLSGAx6g" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zY4PmTbN1D6e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,737&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zNYfLPBILEE9" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930_zstL5FZdVKdh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zQZPEEYKQMN" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z7B5RgfF2jO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
June 30, 2021, &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_c20210101__20210630_z1ebEzJbJ8wi"&gt;50,417
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants issued in connection with our Q2
2018 unit offering expired unexercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
September 28, 2021, we issued &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_znqNDbdtl9m"&gt;192,982
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants with an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zIqPacuiSBIj"&gt;9.45
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and a &lt;span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember_zCEc33Ar032d"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-year
term to the Holders of our Series B redeemable convertible preferred stock and &lt;span style="-sec-ix-redline: true"&gt;&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z4HtGMCpiH16"&gt;34,737
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants with an exercise price of &lt;span style="-sec-ix-redline: true"&gt;$&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zHmIVZwGc5ji"&gt;10.40
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and a &lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20210926__20210928__us-gaap--StatementClassOfStockAxis__custom--SeriesBRedeemableConvertiblePreferredStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z5a5OYmFxfIg"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-year
term to the placement agent in respect of the sale of the Series B redeemable convertible preferred stock. &lt;i&gt;See Note 8&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</SRNA:WarrantsDisclosureTextBlock>
    <SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_897_ecustom--ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_z5O823WM7Gl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September
30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zT9rBdMJ3yq9" style="display: none"&gt;Schedule
of Outstanding Warrants to Purchase Common Stock&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Aggregate&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Number&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intrinsic&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20210101__20210930_zjWAvLHPnk4i" style="width: 11%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20210930_zVNGmDosj27a" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zgawyAW8NT94" style="font-family: Times New Roman, Times, Serif"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iS_pp0p0_c20210101__20210930_zd9calbbkjh3" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightIssued_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Issued"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Issued"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms_dtM_c20210101__20210930_zSciqoAeDnDc" style="font-family: Times New Roman, Times, Serif" title="Weighted Average Life of Outstanding Warrants in Months, Issued"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Issued"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightExercised_c20210101__20210930_pdd" style="text-align: right" title="Warrants, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_c20210101__20210930_pdd" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2776"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_c20210101__20210930_pdp0" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ClassOfWarrantOrRightExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(50,417&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_c20210101__20210930_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_c20210101__20210930_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20210930_zHLFpnVfVYkf" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20210930_zqb3GSU71sKi" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zfdYLOWvWWl3" style="font-family: Times New Roman, Times, Serif"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_iE_pp0p0_c20210101__20210930_zmIv9vQYXBhd" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">50417</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">37.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2021-01-01to2021-09-30">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightIssued
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">227719</SRNA:ClassOfWarrantOrRightIssued>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">9.00</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms contextRef="From2021-01-01to2021-09-30">P36M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightExpired
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="Shares">-50417</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired
      contextRef="From2021-01-01to2021-09-30"
      decimals="INF"
      unitRef="USDPShares">37.50</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue
      contextRef="From2021-01-01to2021-09-30"
      decimals="0"
      unitRef="USD">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">227719</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-30"
      decimals="INF"
      unitRef="USDPShares">9.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-09-30">P36M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zgrijU5SXnZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes information about warrants outstanding at September 30, 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span id="xdx_8BC_zzmfRVkOy6i1" style="font: 10pt Times New Roman, Times, Serif; display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Weighted Average Life of&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding Warrants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In
    Months&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z537to8iv6U1" style="width: 30%; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.45&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_zq4AHuDxnVph" style="width: 30%; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;192,982&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 30%; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeMember_z4vfo7shlyH2" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zWfIKLSGAx6g" style="padding-bottom: 1.5pt; text-align: right" title="Exercise price"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zY4PmTbN1D6e" style="border-bottom: Black 1.5pt solid; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,737&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--WarrantsRangeOneMember_zNYfLPBILEE9" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20210930_zstL5FZdVKdh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;227,719&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Life of Outstanding Warrants in Months"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtM_c20210101__20210930_zQZPEEYKQMN" title="Weighted Average Life of Outstanding Warrants in Months"&gt;36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-30_custom_WarrantsRangeMember"
      decimals="INF"
      unitRef="USDPShares">9.45</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-09-30_custom_WarrantsRangeMember"
      decimals="INF"
      unitRef="Shares">192982</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-09-30_custom_WarrantsRangeMember">P36M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-30_custom_WarrantsRangeOneMember"
      decimals="INF"
      unitRef="USDPShares">10.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-09-30_custom_WarrantsRangeOneMember"
      decimals="INF"
      unitRef="Shares">34737</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-012021-09-30_custom_WarrantsRangeOneMember">P36M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-09-30" decimals="INF" unitRef="Shares">227719</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-09-30">P36M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">50417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">192982</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">9.45</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember">P3Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">34737</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">10.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-09-262021-09-28_custom_SeriesBRedeemableConvertiblePreferredStockMember_us-gaap_PrivatePlacementMember">P3Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_801_eus-gaap--IncomeTaxDisclosureTextBlock_zMBnk2MfMPf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
12 &#x2013; &lt;span id="xdx_82F_zNkEtzZJVBlf"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;As
of September 30, 2021, the Company has U.S. federal and state net operating losses (&#x201c;NOLs&#x201d;) of approximately $&lt;span id="xdx_908_eus-gaap--OperatingLossCarryforwards_c20210930_pp0p0"&gt;20,260,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
of which $&lt;span id="xdx_900_ecustom--NetOperatingLossCarryForwardExpectedToExpireAmount_c20210930_pp0p0"&gt;11,196,261&lt;/span&gt;&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;will
expire, if not utilized, in the years &lt;span id="xdx_900_ecustom--NetOperatingLossExpirationTerm_c20210101__20210930"&gt;2034 through 2037&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;,
however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used against taxable income to &lt;span id="xdx_908_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_znCWXrxJQtik"&gt;80%&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.
In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the &lt;span id="xdx_90A_ecustom--NolsUsageAgainstTaxableIncomePercentage_iI_pid_uPure_c20210930_zhH5W4pCXr1d"&gt;80%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;limitation for NOLs arising in 2018, 2019 and
2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company&#x2019;s NOLs carryforwards may be
limited in the event of cumulative changes in ownership of more than &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_uPure_c20210930_zx19LEtl67Gl"&gt;50%
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;within a &lt;span id="xdx_900_ecustom--NolsCarryforwardsTerm_dxL_c20200101__20201231_zHVjGRvejb71" title="::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2825"&gt;three&lt;/span&gt;&lt;/span&gt;-year
period&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Surna
Inc.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Notes
to Condensed Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;September
30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(in
US Dollars except share numbers)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;(Unaudited)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&#x2019;s judgment is required
in determining the Company&#x2019;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of September 30, 2021 and December 31, 2020.
Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred
tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support
the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on
assumptions that are consistent with the Company&#x2019;s plans. Should the actual amounts differ from the Company&#x2019;s estimates,
the carrying value of the Company&#x2019;s deferred tax assets could be materially impacted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">20260000</us-gaap:OperatingLossCarryforwards>
    <SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount contextRef="AsOf2021-09-30" decimals="0" unitRef="USD">11196261</SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount>
    <SRNA:NetOperatingLossExpirationTerm contextRef="From2021-01-01to2021-09-30">2034 through 2037</SRNA:NetOperatingLossExpirationTerm>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2021-09-30" decimals="INF" unitRef="Pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zUkNtcCooKgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
13 &#x2013; Related Party Transactions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_828_ztSWdZvbitn2" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Related
Party Agreements and Transactions&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
company entered into a manufacturer representative agreement with RSX Enterprises in March 2021 to become a non-exclusive representative
for the Company to assist in marketing and soliciting orders. James R. Shipley, a current director of the Company, has a significant
ownership interest in RSX.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Under
the manufacturer representative agreement, RSX will act as a non-exclusive representative for the Company within the United States, Canada
and Mexico and may receive a commission for qualified customer leads. The agreement has an initial term through December 31, 2021 with
automatic one-year renewal terms unless prior notice is given 90 days prior to each annual expiration. During the three months ended
September 30, 2021, the Company paid $&lt;span id="xdx_90D_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_c20210701__20210930_zQN09FVZ86Q8"&gt;26,873
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;in commissions under this agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="From2021-07-012021-09-30"
      decimals="0"
      unitRef="USD">26873</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-09-30">&lt;p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zP1iivNZTJzb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note
14 &#x2013; &lt;span id="xdx_82A_z2PEJ4LfiuGc"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;In
accordance with ASC 855, &lt;i&gt;Subsequent Events&lt;/i&gt;, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after September 30, 2021, other than as set out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 3, 2021, we increased our authorized capital to one billion shares of capital stock, of which &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4zLWfurIhdj"&gt;850,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;are designated as common stock and &lt;span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20211103__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztNDlqGT8Kli"&gt;150,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;are designated as preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 3, 2021, we were authorized to redeem the outstanding Series A Preferred Stock, which was completed on November 4, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 4, 2021, we received the remaining $&lt;span id="xdx_90F_eus-gaap--ReplacementReserveEscrow_iI_c20211104__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z14mvNVr5na7"&gt;1,365,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;from escrow in relation to the Series B Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220101__20220117__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z2bHrjzoD924" title="Reverse stock split, Description"&gt;On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.&lt;/span&gt; The par value for the Common Stock was not
affected.&lt;/span&gt; In connection with the aforementioned reverse stock split, the Company&#x2019;s Board of Directors approved the reset of the authorized
capital of the Company to be &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20220117__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVpBvvLoCOq6"&gt;200,000,000&lt;/span&gt; shares of common stock and &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20220127__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z21iLzVisd8b"&gt;25,000,000&lt;/span&gt; shares of preferred stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
Common Stock, warrants, options and per share amounts set forth herein are presented to give retroactive effect to the Reverse Split
for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="-sec-ix-redline: true"&gt;On January 28, 2022, the Company
agreed with the Series B investor to redeem &lt;span id="xdx_902_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_pid_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9d2g4ETonk5" title="Shares redeemed"&gt;1,650&lt;/span&gt; shares of the Company&#x2019;s Series B Preferred Stock for approximately $&lt;span id="xdx_90E_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_pn5n6_c20220127__20220128__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv8nUM08RI24" title="Redemption value"&gt;2.0&lt;/span&gt; million
following the closing of the Company&#x2019;s offering.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-11-03_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">850000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2021-11-03_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:ReplacementReserveEscrow
      contextRef="AsOf2021-11-04_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="0"
      unitRef="USD">1365000</us-gaap:ReplacementReserveEscrow>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2022-01-012022-01-17_srt_ScenarioForecastMember">On
January 17, 2022, the Company&#x2019;s Board of Directors approved a reverse stock split at a ratio of one-for-one hundred and fifty.
Such reverse stock split was implemented effective January 27, 2022.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-01-17_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-01-27_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">25000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Shares">1650</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2022-01-272022-01-28_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      unitRef="USD">2000000.0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#xdx2ixbrl0264"
          xlink:label="xdx2ixbrl0264"
          xlink:type="locator"/>
        <link:footnote id="Footnote000461" xlink:label="Footnote000461" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">represents an amount less than $1.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0264"
          xlink:to="Footnote000461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0265"
          xlink:label="xdx2ixbrl0265"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0265"
          xlink:to="Footnote000461"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0276"
          xlink:label="xdx2ixbrl0276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0276"
          xlink:to="Footnote000461"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M5R"I<?F*KINMCY6):9:H@"IKDOG%;HEU;HD)9P69?AE/KK_<WT;7D^D__Q&
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M 'R^*,#AMS?JVRB[KRM=_A]02P,$%     @ ZX8_5"D'= F> P  P@T  !@
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MO3^SWU]8L^F.C)^-M6;=?5WIS)6:%N!^7QICWR[: (?_G+C]/U!+ P04
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MFR(]5(_W_Y061;JO7C[):"NSTD!]_Y"FQ><W98#S[VC<_A=02P,$%     @
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M_1%>Q%C"D]#6'P'*.*;4R;8(, IC(9RXPZ:6C$DQ8H*!2S$_F>JW><<'6Q-
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MXOOUJX<!$2:8G 6/=GJ?N6-083BV0D1<L.(.SP-R9(2&<LJR;::/E?3D<;'
M6Q#&'LXD?$.]#++)+HD:Z\Y \9#*.")7,27D&O[4AEO"7/6@?$AX5T*LHTM"
M8Q$)?H3?1>\S+-#^Q*(H0/1!G!G3.<'_,&-?X,&]LOC[%/$1S"(,+ED08+XR
M0YW)^"4#(9+-+,QK!U1$21ER'"#1E'P4IIEL4,<=4P0H0Z 6Q1NV,JZ>#[HO
M(0=D"JJ?LR]X[2 NI>]=FN?LHTS" #U$C4WD=@61IM&S.;^5R=@PY\H@J <F
M>2'0SEC66 ,E@!KDH:\7CUM^ 3XM/^6WZ%ZY-V3X(6 6ZL$=8"P!R;=,DH:;
ML#J2ECIM>-ACKO'<,)(+_FT12L5^"7>H$+=YA!,EVS(QP,^,.LS56,WV@XB#
MYHF@00/G]5OM[B$VVHE$X#C("N7#&"BL+.D+F!;J14_%P !,!@P)M(5QP;3X
M=5H,80_!\!H<QH,$0S>QV7R62>8_=3!]2MRI,G)%,[+2G3[U7=97;G!&QD\F
M3]W+8)^+=:S5$?[Y^""[)*4W47*@R;"BGE[F)EK/14!]PM"+N9(JPX(A+RY9
M/7(S>5!I)YX#.6NG&IYT!EWRZ[Y*"Q)KUKM&WG%"N^"W,B@'B4H4)^H@:3VU
MWGI( >A<^ICB-)Z-OR9]3_*%8^B*N12&Q='S],,V$'>CY33Z.]48:;(%M499
M1K/AQ@E@QX:%%4?4ZU%E')&]H5VF81Z3:,]#[V2<S;6F]]Y4DXX,P@OR8/3A
MHK'H"N/K25YSHKXB)C5*%[7WGLN<_7QOXKUZI>7E37WMO7QY\H$$3&OD,Q"/
M^5"6_*UD>CI]:;K.'U@^+<^?J=YD^<<;68VMJ\4/3V<JY$\_^2;Y3CZW;'T"
MK>6258P"+\#OM<=[^7##!TS?WZ[^"U!+ P04    " #KAC]4ZS&<R2E0   J
M"0$ &    'AL+W=O<FMS:&5E=',O<VAE970X+GAM;.U]69/;UKG@^_D5*$T\
M)56!%+?>+-M5K;:<.->.-6HIF:FI>0!)L!LQ"3  J!;SZ^?;SSD V-UV[MS*
MPU0E<I,$SOKMZS</5?UK<Y_G;?)EMRV;;U_<M^W^Z]>OF]5]OLN:<;7/2_AE
M4]6[K(6/]=WK9E_GV9I>VFU?SR:3\]>[K"A??/<-??>^_NZ;ZM!NBS)_7R?-
M8;?+ZN/;?%L]?/MB^D*_^%#<W;?XQ>OOOMEG=_EMWG[:OZ_ATVL;95WL\K(I
MJC*I\\VW+ZZG7]^<X?/TP%^+_*$)_DYP)\NJ^A4__+C^]L4$%Y1O\U6+(V3P
MG\_Y3;[=XD"PC'_(F"]L2GPQ_%M'_X'V#GM99DU^4VW_5JS;^V]?7+Y(UODF
M.VS;#]7#GW+9#RUP56T;^C=YX&?/SU\DJT/35CMY&5:P*TK^;_9%SB%XX7)R
MXH69O#![[@MS>6%.&^65T;:^S]KLNV_JZB&I\6D8#?^@LZ&W83=%B;=XV];P
M:P'OM=^]S9JB2:I-\K[.F[QL,SS<-\DM7RK^<%O<E<6F6&5EFURO5M6A;(OR
M+GE?;8M5D3??O&YA&3C8ZY5,^9:GG)V8\BKYN2K;^R9Y5Z[S]<#[-X^_/YT]
M,L!KV+\=PDP/X>WLT1%O\_TXF4_29#:938<6]/CKW^<K>'U*KT\>6<[<[F1.
MX\U/C#=PRLG_OEXV;0U _W\>F6!A$RQH@L5_X:7?/#[E7ZHV=[/DO_^WR]ET
M^B;YEU>0_%"46;DJLJV[A;=S("QM-%CR\3YW0-CV6<V?8<SV/D]65=G &&MX
M9YUL=)"DT4&:I"CQ(22017L$=&SO@=C8 O9U 6_LM["$N[S,ZVR[/>+O^1X'
MA'=QDD]E@9]H98V#F:]W>0U[25[B <PF;_YX??V>_IR^>07$\!^' I8.>%T"
MY:2MM!5\^C5/\J8M=CA*DI7K)&N VNYQ.PW,D[5)MMD /801]E6-,V8[7"<_
M7.=;VN2Z:%;;JCG #./DNG&;0PUKK.G[0]/PJO%^DGGRQPKW>%.5J[PNDP_Y
MY[QN<CCA:O5K<KO?%FWR2^G^G)4'O*7I!8'\+*4]WU2[?58>Z88OWC3)VRJK
MUWCJW\/>5FU5PZKV^[KZC,N$Q='0<.XX=$-#XWX2NBU\K2KS$5S""/Z;W!_*
M=8WOE7AGF_8X=K>'U?W@* \97.$.+@C/$=[)Z8B 5R2Z[IFL&TYCNW6P[AV
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MY#"Y)3,VK-/I@9+,X%5F@1<5-5I0ZG,V1!@&,VHT"4*OF8UJD"YV6?TK*[$
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M,V6C9CB:7"4O/U9[(/3GD_-7J2Z +4@WD>?4W9A? "GFID)#)6G-Q/@;D:<
MZ4_X6VC@Y5%\U5\G@%OY^K"EH(@/_N=;^AFQGHPQ_XOT\7<]?=R1/HZ7X\R>
MR5;?8T/>+[2VH7GT(KV83]+YQ12=(O/T_&J67I[/W3M0H<J<C/'..Z90CB&)
M[NS\,IV"]CM-9_,K^&OB;N^+_5Z?!K*V)K_U;'J67ES 0F#8Q?G4?:Q @76Z
MVS\DE^G9=)'.+F;DDDEGLT6Z.%L,7G0WS.QH\6@AAS)VN"%+(L]#PB72!()S
MHKS7MS=XI^/D$WG!6:KGIU5\3U'$&/2=(^W(4)_:%6SLSLR-[C@BS;Q$'84$
M%"38 >C-:+5 _)8354%"7QL#26T,R[O0XGWVRCAW:+'<HU?-+]B%SGYQ!W#4
M4.XOEPT-^>J^)!G?+CA#]Q8J6*K^H8[.L7^X"XZ.JI%[D="R9<%"0HT$R+Q)
MTK$4M=M7)=-SUGI E@-1*@N7?T^!+#2+GH5M&PZ<; YH0!ZMCJNM(")(9:SD
M@7(+0J*);$!N6*5#K=^68EOQV$"T"=B[MQW#1Y#7#OO8;K:N<C:<B2H=SV)G
MA]<Z,*[^#M0/MN6>O-LX'L.N.DO0&1!?=0";0/V.>[Q+=+P$]UR5\(4MT69!
M94$_V!I"=9C5< 1XCGAA?80XI 'S"2QA2SAA\#_)P&HHAD;HE/DQ4^MAL"4]
M OYJD)N*#9DY#?G>!F ^"G 1A<8C9X<SR(88PGM[=KK-$[LS;GTJ7$<6''C?
M29 +'QF0Q2PJRY1&QTHC@^(25:ZN0BEB9U^)8B-C-*5ISDVVR[MD*$WN0:D#
M[,"%D=PKHYO7B,) LL\9Z/*A&OXDA<+YG[HP%NA#H%5XC<_)PK'$(S9\_,@L
M:PPDHN *=*#F-2'0_O[8$+%#SPRL$::" 5<F#PF92<TF:_2E 3@FJ-[E*+DS
MQ61^ZC"*!&2KM=(VA%"Q%:(<I$KL"D3W1*GA%BU21_TM&'3H#"0\2$C/6@[+
M_(C$S]/'3Z2CS)-)-0?)TH#3@LK(K*P+"YR5$1E7CQF@V'K-O(2#B&$V=!8!
M<[[#H($@DL X!L=D$PSQ8Y%_&M?FM7*4O,7%D0RZ.$[ $T&-"R*G$,.('.R6
M&(:J.@>%_^'VV+!F_N2.T09T60.A$Q2'HK D< P1F5Z':SJ4\J8[&=LW!DE6
M@A+B'T1?UFOKT# -OU-'%L*:&!-$I&A1Y#*$-%L&K9@=VQ;=2*8,B:#:#%-%
M"P4-R3J3216'&C27;0H,.!XG?U3"D3JFY#(8._^($9C4X/%O1_XM)$[D=U4!
M2H+D0D%)E#HOMY#KL^2 .K(L()J)(IU_886;XH2B@Q![L&P>?V8LCL@.(8?B
M(9J16MIB*"'8N7A>Y^GME@"6=X4;=[IQW5_3W5U@'@8LP>A6.3?15RD&$,9L
M[AE!AVUI011PS9'!&$4""$1N<:!<@:V.@[$ OE>8JL&XRJH"@$K*O[*#/ 9$
M$XU8^>:G*"B-!7&<+5YV.WALJAOT'9:YN-Z1+7]A.=8<^8&9[S3D8@1_FWU!
MLW<^OANG0C*1**1JPD$;$T>,*JK#7 C5].*KP)A$]DFF5!G<*?#,$J='B^L!
MJ$B-A'W (YEYVZ'L= 3POCZ0F25<,Y/:+6\:?=WA>=G&O;YP30H.2H;'],39
M&DBB(]SNE7;&QQV&%E&L!7F0:DJVHT-I1,EC1ZDX8&,<UDB0&-SWF0:*#DH+
M*N2.8UT./7=X]:?(K8^Q-LH\S#GUUDR8Y'5F8MHAF &8')NB75#,J9(X.6ZD
M1,<]A_">D'A/4:+(<!Y@EY G5E(>R":A.Q$X@<O?%5N,LRKSSOE4&Z(9Z"^H
M<24C6IW$11?B=T$C)4.8,&S[ *L_(#FFJ%\ ,%+Q&_8V ( HG,I9BW<N$4@T
M <]UU!0*75)B0/R0F2^*622+4LK7::%=PS$85)IP/S%-P/!V/"@*'I58<*=$
MQ\X[H'T6,"X^\]]G@_H%3\G].?(/7 <>F_""O"8FCDL/ZA;S29QG_5F]&G1=
MX=%L(KW2<PI%+<!\D &.*L'M\5)P4H?L:EV0 ;M4<\=H.AG-9R.TD?7Y6T!D
M3]!V]A7&3-K+"S%#%;;G.*]*5/J0T8AE$-9M$B5JMJM\B.FF'!HG,@P^M1=E
M]UYXBF"R>&^9* 4#.7]R62QA=*PP@>F&LZ5DG/#B@@C+[@@41K+$4'B.E=$<
M@)A .Y;7GLK0"'#!IO>:E5V+N:=(6/?G;:S6 K5VL*RCAQ@704S2@YCY8C*"
M_\W.1HN3/(6]U2MFOB1HBN90+57O\TM&\:%4IQ2?K4;!.7_W44!)0*%]E)G=
MNI%"Q,H'9-0<*T"$)Z#@&(#2NY&/1%]XP6(:,[;/O!$@$P"EL4Q#7&+9AA&5
MK.;1NR1BBNR>JL;,WK@UB.X%1L5PJJ$ZY?C'.E??'1MI2#2$C582_*E<V6+@
M3"S@V O.:X@EA+%9IS6BD/)<%(%^"GP6]J"<K00Y=O.*_BG3G8)5SUIC@F:
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M02^-9^+L^J;<ZZ!TD_S(9_][;;+75$?I<<$^.+ GN&XLT++&<0F2_V4ZF4Q
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MGP)YHZJ13017;$ZS"(M$Z<9[2/'S""VA$AN.EWM7:&)LT$90@ER#LJ?:J&D
M831\P:J&^_!ZSI&@H/"!NU.$Y;5&&7YL=^6F0)JJ1_ILC+8\):6*D$*M;8=Z
MR5DV:U#6VUK;6$X<C19T*R)[5Z/9]2&-[,,H2E 6<T3S\9V3_:E#+C+TNXU
M']CC%+1GQ5N?6& R;[]'1T%VH@!XG0=>Q8!X!::\P@%E5%=BB(3Y,'!LT.N3
MVG4<AA/*2&"B4S6=B3BX@^I9X(NXQ!$O<81+'&G%&N42Z !KL W.H_GN%++>
MM*%) XDGNWT3K8 ]?!Z=.#),BD$/!FD!07U74\M,6$:(T<HR%#!1K#A(H-B2
M&?TOL,>?L%$-ML.]D;:YU!67GQ5P>8G-;%[10RM^B%OGDE:XVQ^D&=>Z %J
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M$EAR:/=<. Q?%']<F#P32QJY+RY'5TYR@(I \0J]M38NB6 !22):8XLI[V9
M69=2'DIS34K/>,$JY,6E'@[1.0_QJ>MJF@$V5*2E9EL9-R;&@6@E[/4S^:2+
MAN@K[S,E<F-LEF%0MI8&X.)"8P'*D5QF12K6:0PO5LB@0O@GXH?6K'0^'4ET
MFX/LR#W2)V0RGV+0F/MTFWR/G BC>M@#P3X8]J TKY*7G\KL@#BZ?N4'=C9P
M9%HBX17#1@CHF?7)RQ1MSVM].M JSF(+",\>L\QK"WE! $7[ XN#WGPEFCWP
MM*!8*MLO?1A(1*%QRFOT::XR*VGRQ^OK]V;)8I46[8V[J(6BK^%H]E#",F^Z
MH"3F'S"%?3H9_0]Z[,,!*!)\FDP3JL!P)^Z$Y';T/\?)^R DE\E2?9!^'VKP
MD*0A\25W5U%BE'I0Y3(5]\+VZ,)8F,&C#T^XVZ(/#R0-;L-?*096HEV&$_4D
M4+4H!5M]BB[AA@OEJ9?B81)KB?A!:JPZ2!:4 HT!K\(T&1.VQ$= H:_[$ K[
MH3^@RILN*:9?"RSB%$LZ-^0-DI?.(6Z&-(DA#2$']0#E9114@Z[;5DI#)=C;
MS74^? 23S+PIT"+D-/L2%]?U:TVUV$JG8>F0"\SGZ*B&[B- !0D'KSQC#[GC
MY"*@3Q9$JQ8/:M1RG_< ;5-5+0);DUA?4R"Y""8L(&D)QN&(*\R1,4;N1\8(
MSXWT:;S/GT$M%.0;UBU%">4@!L'U:XYH_4 >5&1ABH__,9 S;2?KXHP#F8.7
M]?L(&Y61,-Y-#;CNJJ",JF;N?6"U#,@L^D1O06!JH[ZJ%ZF4NAGR<@PD[OCT
M'-7XQ-W:T-#HX$F(NTHQV!&<R@B36.]!\:Y%;]D4&Q3?*>)V:!0R]JN]  VA
MY(U!I-!USV3=:';9.@V)P"&\"SV-?,<8%<$,20N:HU>/V[;B91=EYTSA>NX*
M:C4 O%4:V(M;2&Y.SI9/E:@ E=YBI[L?:>R])YZY*N!_R.-.R6RV^2V0$-9(
MLT#+#M\C :2UBNQ;N8>'^PKY6?502FY1L2XRM(7]Z;BN*Q 1RNJSLHB??KHQ
M?D8_^XIQE%"MGHV@_#.'B6V*EB4@(3T2'[@M**RM&W1**0E_1$AV-P+)/5'@
MMYS. ,>G; X6+SLVJYYLWD$JK0F-CV 8OG56XZ ?$RJ#F,7VOM_2((ICE*9W
MI[SV U6M3<U<.\_=)+J#\Q@*!HM<,CPXU2CJK!(/R2>7,XP0J//BS*]!,8M<
MK&:=+UE-DKQG*V>7.N^RS\D%JH(&%_N27@Q6^R\HW/VSK[P1E*PG/WJ8NJ81
M+"3E-J@DMALL0V71?16B7$Z--7VD7[=-5V!T0;>#[39:1B^8TU?[ G'(#.HZ
MLYJO^"'L0,[MP4MD!9P/1+"E*I.WAJ/!I+,MVM,CWO<3<!M&0V8%J:!+[$/N
MNA=%UIN#^- TTDVS@(E2;*SN;!5YZSGCU>I(4Z1F$,H91_FSD+.NB/]CF)[S
MTILOP1BDIG#76'_=JVQ?M%P'*.I,FH:56NRB"DZD)2KH:R^*EN\[OE$58,K\
M&;N/]YPOBX<E,1J$LE'=/"WB5U(7#Z]=!=TV,TPA8G-3J&FEWOCG-=XLK-_,
MH0BIBS7>'C!)< ;HNBPJ#?=EC:UZ47=5JXIIMK^HYH78*M/@@DCK%-N,W(/F
M6Q)U]/HS$RXK6SJ4$XTKUKHAI\H1FIO#A?0NN-V&D<,SD1!=F+8$\*<8 =J3
MAW2J?BN<L .K1(/S+ZTO;S9V<1@R@J&W "&S;#,-^#.[J$?JT,0N .=+?%(W
M(RV:%2!]=QMT>Z7KH;I5KR(\#U!&@54DUQ-L3%)W@5KRUQH2P\,%6P/L/2"U
MQTX";NC6 DQ[9#XM#FKMGJQ)@(^*ZQFPNL(NQ@EBB/Q'Z>ST?!% 2)"I("@/
M!>';I%>1=5'J5-JB8-<4(DH@6S2A76F<?&HH)>F==5CUW,.AK;\)FJ]2TDZ0
M0\KA4R)+W@?QF$&OG1-Y#RI3>*5<C><4V-8&[T4-;P;2N$^J0,]97MA/TOQ(
M07BOU;QP?.VQ',/)*%0]Q0[I5)8L&Y1+WSV;U+S><18ATZZB #O).B4(7A7U
MZK!# #?J&' P%N^H2F!K$>L;BF(C4OAWWQN0NFNP*[FNCQ8:\]C=D6ZL6C\:
M^%#C!X4JXX1-PGW:7 ," O4-OM9ZJ;Q"CEEC%Y:"*?GE]1#'R7_D01-M'W B
M%:2%: <RNI-.Q)V2+F$A2@Z?"DLYAUTATY,]J?%XC96:R6*HZB[5LW^J'N93
MR_#9%E29JD5W/E6TH\OH_!X%3H<Y<:F+GGM&*E)0.U%"3M'B.U!XC*W 4C'+
MIX2(?9C#;*,8W'\/4^T->7SQW^1=$/C,RJO%7-/OJ(M+BVP.+I(X75X,.W:T
MV<T.VWP'M?_1="86,VD=TZ59)D)TJMTPMA,7#?,$(D%BEX$<Q1A##8HKD=!(
M/31U)3)EHN$5&'= 8KB5&]-.]J<1[V\XM)5H8T]=LT+#HK(1^Q&)'SU)M+=2
MET" (: SUGS*ES]1AL+[_Y_[\?]S/YZ?^[%"%NO^ZQ,\>O>G"1[NOSK!(_F>
M((ZS(IYED*>D<ZEB5.<<US*8VQ%" ').I4P^:"0X (ZR0,CAY)>24L4I5;-6
M]O)D<0TB0 \25& # )NK#"J'%:MP*=&1$,D=F;MB1*=CULOG'5*_>F!&^$5Y
M#J(%6J&'"/!PS2X$'_.<#V&3+[*'SK# LL?*^$!J=I1:HYD7W@:L#1PP@8#5
M;\J]##K,<IW%. &'FY'T#R4=!IVX7N+%Q45Z>7E),4*SJWDZOYR[Y^XU@#='
M@2PT,.&07?Y3@/4O S+:9:LU*: ?>QFI.7=<9BO7L-&->A(UEK)/1N2D9V.&
ME_]\H"BVZ2*8D=)U/A?Y@WB]. N'M"TN,K*EGAT4H[FI#>3(IB7)_-;R@AA]
MI BHWTUL:W$-G$B=(73T_C&-CFDKYUMHLK$BU IBL4 D7-23_X'NV4)B(?V>
MDI9R4&UC9>BC0WY%UG#CIWZ];GB]=@>V+$UQ]LQ(K\_RKY\\!6UM.S2PNPMN
M+O2YHB8N&52 4&6X:4SSN<L]"PKRL]1&HQUTCT'I@<[48<==%Z_8I^\$I37#
MFPF,>JI4<M>>[MY_,W/I!14*N?)-SBVA/NX8T8_.DL+N%&>8FD+D5M;/+S:[
MJX?!FZ+;ZHZ3NRW(("AE)85+F4QRZ:9 <I,\F,1Z@>:!^*-8A.WK.$A,;G:@
MYUX'%W)IAL1A$0%,9* K'%$+AV,ZP8TZAUE6(7&@<!ZA;@:2%*W.<3'],?\]
MM*Z/6G;!O6-V<&L21)>X6U<S^"H'-9J*7%-4(?I(:F\PT5(4<1$X7^!!&<_&
MQZ3Y(5-5QRK+X<)/K!FD[/CE0G!5[<M6,#.BY)GRY .L!-4^VXYJ<E&E";*F
M" 5/-/N>ZAM66TR^EUX.XM[7;M,488#VPAH=X'8H XR5Z^$7PH(Y#M-J'O8)
M8&\$>=21D(OKY6*;* ,A!NBW7'9>:%81U[_R%5_97Z$]:7GBE[%O0$@<7B\I
M-#FVGM0V\8?6:1W1-;J5)4D5JT>A>L<E+., $#KZ8A-$&EG'<4W>",$*&>]F
M,$\V'D"[SI&6Y=^/2UD$Q+8W8@Y(1$7WWV)8F( [QS ,#QU#9Q)!9R=O !7H
M'H;&5,FN)&;C.NS)M4E,=^\6*^I3E%Z=<]X(TV<M-D*=:&;GL_1R<>&P AHA
M;F\,;[/&8RS"65SW"6J'!>I0RR@NC4@XH%OAQI<6CLD)PA8%WH PB '%8LV*
MJ/<CBW.%1,^@?R&11$&.EY#H :UF(0$$M*JZ+KCG1N>9Y+ICE0@M(&*5$*ZN
MP_&V>GT)(K)]&T4(_A+6G@G#J\6?.%@2$$Y248F44PD30ES$7+]4Q(^3YT1!
M+AX([C "M0U].8BV(U+DR?W&H3P8:OXAL)R&H3Q4U?VR"\@512H&&;FW9*[%
M&C*?]H3^&M5Q??O)@A11^AY-KI*7'ZL]B!SGD_-7J2Z [6@WD2'6^<2R3V9K
M]PE?/&/Z:(=LZJZ[*SB[H-<FV]<#0&!"^_6&R@JL*>(/'D/FGE R%6=@,LQ9
M3,(X^5G2LH:59-V,!'PE.\PVW&_SD^;HL+14+]O75[=11RP6@GW /"^!*0M3
MIQH]ZX(CB:P^PG"R92>O$B4^$$U+SUHP6J"!G07+MV8-_0[/3CN?8$ATLCJN
MM#N&]8$-LE*CQJ@8<&]+L:WX7,]$VL$&D=O2)PIHL=/3]@V6>BWCBR;N&D^L
MR^[Z!! I616=(?/M3% -Y/ "\?D$([@8#*VI) ;?<UVUFDW.3X*$"",>=CNX
M*!MJQ%K5V;/3;9[8G=56/>5OD06+]T<EANB1>$$'A QSJRT15,E05Y3[0ZO-
M^5 1];\E])MV!^VY@]E=%4UIJAL6N^QB:8K)$9QD01Y6&]V"K5T4^G$R^*&'
MP#C_4Q?&@:/#74##<S)_&E&U4\>/2BFQ4I);@\+D^WM08"@-/2YC826OM*FX
M5ESQ?<TQ_1VA>I>CY8()BO1=UB;<<6>G;O0P=^958D'=EH_Z6S#H8.=8]JM(
M\HQ4HO=8S^KGXR="*;XFY"TISCH'Z<: T[R"7/LRD+(]E6LI+&FM'4[#&B&[
MK+[#]%)#C<Q3T"!LB1^+NXDMCT$4$6CSN;8'%ZFHS%KQK7?(1=P$,P 3A\'9
M:%-$_-\MI68?.1$MYY MTV*"ZR 5U7\UF#E!8DCR$!<;8JY*Y1::X$YZ8[$E
ME!2;BW\@T GKJD=$BW*L-,IQR\ EGFX1Z[@1DN\1'7IS2-3U_NA A=$Z<#W2
MWVM B3&/C]!%]-!S3VLM$SY0VJW;UXK:N5ER'S<X%U:KPH7M3]FF8IK/5B<]
MM>FUBM.^AZ$'TBA5$.-0:[X(2(^'NA04#IN[4BP-[!OS%B5/DM-+,^S?EW6R
MH?N"*LN7CIZB]-T-)^[#;/&RP[?[QS80A.IK<4N)*Q\V(YG&8=_D7L !)P)0
M"=B7^?ANG*HYZX 9TBHKKZW*O\7OD>^(7GSE#1_2$I%33(/<*DQ%T[IZL57:
MB51IQ3)DIR..0RND/XU")A/0K6Q:,^6TEHMNW,N:)\U=_;-U8BO@>_45'Z,(
M&RJ31,7,)1%2,W>I_5T1*!(1*%NCGQC<J?UD4#8F E!WJNTDMKNDX@&G!&+?
M8=.N:Y"MZ*V9I)5(B3 ?(,:):JIO%$W8#TB.FQL^<V# "7&P"2I&D"VK9!MT
MW%G'8U=@06TKZ1(C.Q$XR=?.VG+]FX1GA'=$E68:'RD\HA,2QT\AR<9AC:^P
M3DVG5>A2DJ'I8JG*9M0IE<JL*ELW\QM*8"X.S)%D[DASIH ,J;BE+:).PE5<
M4KX)]Q/3)2K&@FITT,[3*>$;ZL3@>YZB] %8*V5''$MEB/L:BK8NN.I<<GU[
M@]KP:#H9S6<C5+>](V* 0)Z@RT$?(U%ZUP%?C#FHE:TF![ZH<B&3\('=IA .
M]#.0P'JRU!JOCG("U!'!6*AUI;5QG0&9YX^97_R ]AVH[)QKH@WP]-L])DAO
MI)1;;P2-X+5848D*&KL><7TZ=BR (9O>JPQV+7KPW?,V-FG6O!TLZ_A\B)DO
M)B/XW^QLM'BT^BP%$EL%,!&)JZ4J-'[)&1<9D_KM7+U0RP[ZNP>0JEO-2PFH
MZ[U5INZ7;6DU/CGPA8>5MIO^C4AEO:A+@#/*27P-_<A%TUB@AW6$:$YUIA49
M-4V>4?F>A03NK,RMGZ@-.!X+=DNK5D46AA[Z;CC&TDE,%3-ZQ-T[)NN(COFJ
M@3XNUE!+#I@OHS9.UA%L Z<%\^:B,033&I--8$3R;>=0V%4;7!1E&L3A9.O/
MA H2G2^T6,V])MQIWX3?EK]Z I#],9/1>W8Y3Q=G,^G5,4_G9Q?IY/RRUTVR
MTSBDNTBD6I&A$_UT/_R>O-LX<,6=6O=5.EVP>Q$['$PN%NED>OZOKWJ"4LT3
MO>;)4+7,5K]NJ[O4>UI%>[J[JW,J]_"4'A79SV(R&4SF>A1 V]%YSZSO==DG
MGJ=5 RF)K25[V#%#Q%%-XC$[/9N,I@O-L..'I))B2^E+7!F,S8":CXXJ\V,V
M9:P7(K;/V)Q<^D!4LT%8I8EJX_HTKL=UPA1F61+B-,6%/\V1K"D!E4#L'6L0
MF.$XQEO7/;3< 9+\H]0U<T'2@F]U'8H,E*+1^%Z17'Y0+=G2C<?'CDM)-L6"
M, +;$W*I33&H7F@]/2J(5+1D':$"E5WCGA3&P!H65I^7I +#68^RI?C=GCAV
MR:HC.EI3C=T>^*,51^+SJ:, .8(/V\# (4) &4@R?*P->RY04J#"L]37Q[+E
MTL ,IQ[TODU^J&3CT>Z-#&IHJ4+9PMSEO3&"M)P&,T1]%AN;R!'J*><C=2Q<
M4"%CJCKI36Y4#A#_+.KA1345QPF@TX$JENTIK+D)_*]FR1O 'Q*HL P2)LN0
ME.MU!@X_YI3_S!M(-?NVYF)J:WK0!,L@4<NWA>A 2DI'B,Y&JND"&E5>H_5;
M4J!\)IYOCD = <*LO:)NVA&MGOMS%?N,\["Y*YN/0=3"E5K9+SQ%S>]]P[4X
M68,2"RU6-)3R7D'M9S7XXNA>).P6H.%KU++.OLCI&RG3R4^)1Z:-RM5)R:)"
M;*Q82=4)5#3!:%8["IOG<1@OEGT2W.V>EII5R8ZX4@9'3%1SYW@EC2]&S\';
M986N3^F,',9BRRG"=;WABJ*#.* Y<@+@@Q!L9/ -%10UJ-3L5T98 EO6Q;0X
M14JT*B[P2.7AZ.<0PU3#WF/7N]"?9NCEE_-2&'5#U@BVY P77762%BQNMGS]
MZ@W7)O57(,;4K.N0#*',HL$[LY T#6C?9&4AE5!X8II%I@E+L5%8$E81?4/O
MXD/PE "4&7S:XYZ64)1&!HDD'6/GHJ#[OX=YY73([Y ;ZDD&%,MV& * HN;E
M);83FX!X:3EH*'5.S^WK&A-3OP+I"!6_;J)&7Z-%Z!RV2Y!BQ$E)&G-'T4]=
M78%)L-H/O2P919EVMS]H[]/P@JB:,:Z"NMK9FGTYB8]* 4AH!2[MF;3W#%$P
MIH6A-;$+?F!X29SEW&U?A #/20P-!*V^3CQG#\;E->RDN; A2'UFPW062VG)
MUC5+ E*$]/DGEO)22')8 CI596A*5U% (]@5A;N^?8RM,RE B&!?_$-Y4>4]
MGY]LFU>/9&8EX_"E?I%.BU%#P5K2UT$::$<WZ#P<3:]<6#Y!JK3Z@.RH7.N:
M:LU0X8KK32L :">/,+S+UM*$*09923-FR.@[$]O*+2WPPM2:T'9IL$J,'6FX
MA[=!8.WUU! 2M\74=6Q%89)(V [4^;3(H6Q(;[^IK0V$EA/TQ@R"M^#N.O7,
M[:I5\//T%V73@GIG -A6.I?2@7#+1XTE4X(1(&=H@8P+[MUEM<4KQK44^N32
M=AVV5WRN-&\ZBQ<8;!E!$S;1&2BWFVJ124XMQT=K62PBR6XP(CCUVMJRJK!R
M+1NUI)HMV0NFZ>R,@_NB^M&!>-!5--"69-F!JW[[*.K#C.8%*704ZME!>9(\
M7HR6[0^P@ H:\_[4_HY*^F<"(RS_OZ7#1T)+L0:8*JE]JU!8][0Q86EVE5,%
M(?00A!(0F\J>5GW#UH"QIU=KS."&Q;&7<,_2)FX$:C84S(JT27X))GD73_+!
M)G$D!] ,W!WSPU,+#IM^/\5E !"F,V+:9#9:7-G?PLR'IW,GC-5/T:%DGDZN
M6$@X2\]G.MME>C%C8*0M#F-2-">:YF:3N;Q_GIY?7,K?7CKY&'609?&#;)Q<
M1&L8P1FCET?):>]>H_U\2S];"]>/9-+[F2UY[V)+'DES^N!?T.)W^CF[[4EB
M?U%$?:\[@: 1'L39;)Y>+2[IVA:P^:OS*1W$U7R>SJ=S['Z:GEV<I9=G9^Y=
M)_)/$OA5^)E.)^G9_!+^NP (F"2+\T4Z.[]*%I-9>CF_<+?JP\5WK7W"!<QY
M-DGFE^D9+&-ZN<#$L62ZN$SGLW.[4^M%FUY,SM/%_)P6?#Y?I.<P _P-4U_.
MTL4%7N-9.IU=I)/I91 *2DHW=\)]V^^I>R*2@OEEH]4R"JV8CRS_9*-9<K1Q
MK,UC";#];N/DA75/Y46&9/6.D]R\S=)B]K4'-7:EU#27WU!'Q(5NXZ).!GNF
M2X]3[:L;F?M-FB8MLBE:ZQEAOIDZHD$=CPV>Q=A=LV-:XA?NL*'-VM)DU7=G
MH8+:CJ2V14F<%-6\O;MO1RB?!H4N2&2"<ZIUPB2<,%B=] W1F7VYGTZ[7EX[
M-ZU2.3:(N]"R<</E@N\JU$Q$]B_M*/J')" BI2/C8TW%^]^_B/XXX^1=1FO7
M9"\=(O9U2,!)HQ+Y,M"#>:^^#HI92KL;LT0[_-!8.= .>]SE;4JB3;<A=]>9
M5')M 2PEC &=V\BW(<X""Q/A=$HJV&_+H/O6^,E&JDX)-@]=L]JL>JL*$<4-
MHHF5C6'G6PP=4N[*IF*'H:3]A(DSUG+ <E*VU!^HF\772D7%0MT".)*VXM5#
MIMR6GG"R1:-&PEF=EB:DS[# ,[S!7GI[YUR2MV@^&P$WK)#M_,(:T7N@<'C,
M/U<@<47]L.+'Z?=(8W8##R36,5OKUB V!85S/"$.$@"CJ^&$P25PM<$("E_8
M0H0_$")'&V3=:@VE(+=H\U1#^Z/FZD?/H0V0^KS"K)8WVE#-<5.OHZ4I0:BD
MTF$@(\=M@_-HW]0 2(RT4;D7R1YBMB/5<<FQ)R5(Z*ZQ"H5O=BW#V++XUMGZ
MYD\U=9UUU\FILR('!)4$+LB :%'O03OA8"\$W]S&1^&PH80GU-T[_0"SHT.3
M@8]'#0<BBZ;\36-Y@5Q+':&+23-?Z8OG^XD'%^_H(OH%]2,THMC/\&(4@Z)+
MH8S[KY^Z!@X/EABRZ=ED/$N^0JOB]&PV/ILF7[WI7!-<+NX9Y+A),AF?G?'#
MX\55\M6_AWGR40+4%Z=.RU%=\H3N3!_(+6A 0A5W9A+BYF]";8*"(J'TV D8
ME=)X)X5%E9XHWK&J-SF7S]/,F? K"L ="':*XC1<0+!@I9DW<VGA.S3=^[#R
MH"%GC-I8\K4ZYDR?Q"5@'7)RAO#<.F>S<^B >7=W@$5[,B3K$!+)'1A1ML<
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MXS@2O?,K$)KE1%N+75V+EXA:IJ?K4%,57=/=AXDY0"0DH@T"; "TK/GZ>9D
M*<HE.SKJ8DLBD,CE9;X'7N^<OPN-4E$\M,:&FUD38_=F/@]5HUH9SEVG+)YL
MG&]EQ%>_G8?.*UGSIM;,5XO%#_-6:CN[O>;?OOC;:]='HZWZXD7HVU;Z_3ME
MW.YFMIP-/_RLMTVD'^:WUYW<JJ\J_M)]\?@V'ZW4NE4V:&>%5YN;V=OEFW>7
MM)X7_*K5+DP^"XID[=P=??E8W\P6Y) RJHID0>+?O7JOC"%#<../;',V'DD;
MIY\'ZS]R[(AE+8-Z[\QONH[-S>S53-1J(WL3?W:[GU2.YP79JYP)_%?L\MK%
M3%1]B*[-F^%!JVWZ+Q]R'O[,AE7>L&*_TT'LY0<9Y>VU=SOA:36LT0<.E7?#
M.6VI*%^CQU.-??'VGT[;K7CO;*6\O9Y'F*0'\RIO?Y>VKY[8OER)3\[&)HA_
MV%K5QP;F\&5T:#4X]&[UK,4/JCH7%\M2K!:KQ3/V+L8 +]C>Q1/V/ONMM/I_
MDC!04J#!&5W+! E;BR]>!65C^L%MQ(_:2EMI:<17_*B OQC$?]ZN0_1 T'^?
M\>AR].B2/;K\WI0_NYVZ]$WH9*5N9AWY[N_5[/9?+JKB0OS]+Z]6R^65.#I"
M_+M1A:PJUW;2[NE!-69!U6(S!AP. 3?R7HFU4E;@C$YZK),!C4N[8R,C_BC8
M9XM K#%D,VK;*ZP34FQ=/H<<*,6NT57#2U3;&9P2"C* *6)R:2CU.$'A;*H*
M/0UX$#:R&AX;+=?:Z*A5$-KR$DN-26?W/BA:L^X#TA7".0<].-C )_70*:\5
M'*IQ;M5[3QX:AS.#P*9*"1W)<*4Z.I$MC"'B9^R@+ B+24G;V..N\^Y!8S@H
MLQ=_%<ORY8O7Y6*Q*# NV<.]DEXHZ@T!9*MVK?R(;HZTD74A:3I5?=L;K@B&
MBJYT/'7 ZF5Y>7G))]!F*4*#XC3.U,H'KO[+JR?W%^3@Q05O1[(+//_&IW/Q
M->5BR$-Y5&K*9 (,_*1\\51-->F0T4IWTL#3V'C7;QNXLHX<IOJCUW$_@,UN
M2R'K>S)3='*?,+?QKLTC#\'P+J_N%3 U/(,31E&&"$G4CJCS)VE!'F2!2XS?
M1'2I7CBBUA0#()(+348K&1H!?MJ D 8D4;W02TJNC1*;/O:>4D#GV$P?.QT;
MCAA\Z(%,@.<0^S'<- #5KW_'1G(%B.DYQ4BWU^&.T-9J UC@86Q< JZ#$WY\
M@D[<*G8VZ-C+%#(9QUDE!6?ZFCS8*@MGC%!PU+6Z(H=3R*$LR-DQG0,VLO=8
MP.:!CI"21H!E2'&/[<DYMXY@=5K#L4QKAX7@\#N5BCMTG:AU\'V7SN<Y421?
M%8,(.5^CY>\HWO>??_WXX6SYN@1$.NH/ AW2?*>HV6KDM>ZE@9705Q5,;WJ#
ME?<0$1W5NLS'<QG( X^_] 6FX6_=(Z0KT=/XH1CBOC@\F-KAS2F+PY@9,'?U
MR#-X'S0B"1@V\(B6CAFYRI7%!',8I50OQ@MA2OJJ*:=G7A7'AF.C?7V&(8NL
MA[[KC![@#W(W<NW@F_/P!_Y'-8Y#1 4M@^_($SU"8>/^*N]K.^3F@%M@:JM\
MB8D>H_)GE>QTI-&KZF+$U;GXQ<0\*5+3RTBYXS2E[&VPBQID B)@?8@F4C"Y
M=RB'\0BJ"4Q<KQK# ,<<TE< ;"CPAGB$4'M4H,. F=:*[ A#ZZ8U.]B&1<JE
M\T=4E;L ?>%"1)=YP 'N8NCUWLKBHX7V("H-Y-'[*4N>E 5H>J^*"N-[35S$
M%.EIJ#W!D5C%^8-Q+S4:G\<C&N_Q=*39$_H-C7'.0>MZ3N>N44FUZ UX2(%5
M2L'2EH8UF2Y0WC:029R/27S$8F/TDQY/?N3S,RZHJ.@]!\9M-06_WI],(D9+
M=4=COU)I)%"@Z->FT$@$YP',;&J*NX$Z!B_4VO0DP^EH]: #%W+*84>3=#R)
MV3(7^10MOBI?+!,K)J4!S9)D'6F16E68.FG,7E[^K7#W*G$S/$>BB*%/IRD?
M6$ NN*U-[>3L@7Q&S<.4@R![BV-K7:4NX3I9TEJ(D\H(9'IJ/W+@+'\I1[DS
MI=A!;J2GF=>*@=?**;$=Z(B6V9"<&;!/U1!;"-38' N:W$>D:![G<OF*,TGT
M1TQ)-)GX]Q3S$5)9-Q0_N1WR1<Y1TI%^W(LHY:>0DSQ*&4(>U0;LDX@;020D
MU:+OMA[]S"N&F5Z>-$<7/]:;";_%(( D3^EO==>.7'RLK,K5:L'*J$PSD=0>
MT?<W$N_RXN73"FKY^E@+<!^-S;_9H)"IH0@7@)$FC+JD9N6]!/OGWH3IH1VI
M[E,N?\3<N\8EO0ZW6Q:X)0\ &DVCXF;:MK@DT[3A').F0(GT?6(^".U!7 ^(
M))Q*&LD(I3K4,C.W8",0'0E8ZH$Q#E]3"X[+*/@BFSA5O%$\T+&'RT@"4$BY
M2Q0SX9<)0X3A>H& #XR?E9ZU+E+F<U^J^KSXJA3/>+'\(7E>]_YP'33Z3AG=
M.%>S*AN(CFY'28CDJPT NY.^SF[R+]0B%.!&APKK6?DSW%I,'SB=;@SU[SU/
M/;X $7!AJ:*K$.%[U&7$3V=5']GRN/\HPG/QD0N"P2;SSMH)BK>EESGMJ(O'
M3*<Y(K,\<U-]7$Q&/YG(4#2*&X[$,&M:Z%),/"RK74_"?@U1=+*H$X9YYF*8
M1*>@BQGGNW VWYC&9(Y,XH9@3]U7S\5GUL]T6X142O3+R'D&>*=\/"B;(^6:
MM2[@SB#-=[O'!H<AE80[+N8@QCRQ)F?E!\^U="DZ1]VDJ3"9;0C,%03?4+Y!
ME8<*/C^&S_"P5D;NGQB:$Y>FVFLMJSOCMF6.>P 1C;I'8_9 73E]HX3.U_)\
MLQ-)DR18#]<33F(')=UD9GXNH4?45:S1H&C_D#)(%+66AI(SN=Y]0UITY#"&
MM9UH*PX_\]!D[5!CB[DFXDX9S->6WW0-?3>][O5VT'5 31(;@R3E1N/;W8Z4
MUL"[!S?#8S^_K^6*[VLY\6W+U:R?F].=QC.(FA*CE*H2U-';I.+DGCR7AHYB
M7N0YF.!!S=K2V]-!-8RN(%:06L8'YWF\T)V+4Z_BYI,WH>BK+;_O):$&_9Q>
MBHZ_CJ^4WZ8WJ8?EZ7WT)]R9@!1<,C;8NCA_^6*&6QZ_XTU?HNOXO>K:130Q
M?VP4!(NG!7B^<6CB_(4.&%^TW_X?4$L#!!0    ( .N&/U1:]IP1:@\  "@W
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;.U;W7/;-A)_QU^!\:4W
M]@PMB_I6FF3&<2[3=-HF$S=W<X\0"4F8D@0+D);=O_YV%P!)2923IA^YA[PD
M%@4L=A>[O_VBGNVT^<5NI:SX?9X5]OG9MJK*IU=7-MG*7-B!+F4!WZRUR44%
M'\WFRI9&BI0VY=G5:#B<7>5"%6<OGM&S=^;%,UU7F2KD.\-MG>?"/+R4F=X]
M/XO/PH/W:K.M\,'5BV>EV,A;67THWQGX=-50254N"ZMTP8U</S^[CI_>3' ]
M+?BWDCO;^9NC)"NM?\$/;]+G9T-D2&8RJ9""@/_NY(W,,B0$;/SJ:9XU1^+&
M[M^!^FN2'619"2MO=/8?E5;;YV>+,Y[*M:BSZKW>?2>]/%.DE^C,TK]\Y];&
MXS.>U+;2N=\,'.2J</^+>Z^'SH;%\,2&D=\P^M0-8[]A3((ZSDBL5Z(2+YX9
MO>,&5P,U_(-T0[M!&E7@+=Y6!KY5L*]Z\8,$'=AG5Q70PB=7B=_WTNT;G=BW
MY#_JHMI:_J\BE6G/_IO']\>C1PA<@1"-)*,@R<O1HQ1O93G@XV'$1\-1W,?0
MX]M?R02VQ[1]^ @[XT:Q8Z(W_AV*W2,T:0A-B-#D=]_0H_O0_9_:4B3R^1GX
MMY7F3IZ]^$E7DHWX/_^Q&,7QM]S1YF\*]EJN3 UN#.+',UYM)7]]??N2*VMK
MF?+KVP_TQ>5P%(5-YS_K4B5\,1E=\)^WDA7@LK8212I,RDNC[U0*JP0OZGPE
M#==KKDOT7)'!M^B]"?PE[TN9*EE4EJN"5T8 /."B 9+D-SHO1?' M\)R<GQ@
MI=)<E&7V0#RB'*/AMR#E+P Y< ;K(TVK0-K=5B5;+C) +MH=R /)0E> 2<*"
M8/8I/U<7L%C"&@-DE*U4L>$:_RZ5 1Z$ 48W,B>^$S!C0$N0-$/%1+!;73"D
M3Y]YD@%9M0:>"+= #WTD::V-\!'L[YP/=W>G=(WZ <V 7"FL3RHXUL+A.UUG
M*?^U%IE:/W  =9Z(4E7P\3<ZCM7@78:DQ?MQ'(5;.E:RR*SNU[3=:E-=5M+D
MGHB\ESG=)YT*2O4B 'Y5H&00U*B-PMO&30S$SD"W0 N^ N?/R?DCVES6IM2X
M%1;1B:@;/!0$U9M".;PO4I[#";7Q>C?RUUJ%#V@\)V3\4((:1.J,+]J[>$__
M-Q!6 1&W$SG*15&OP9!J@ZS@T7H--PADT:'X><?V7HM$9:IZ<&[A3>V":\?0
M2F2BP'T(T PU#(HII1%T_^Y @Y'F4J\O:_B )E@%<42NZZ)"M3SA\W@23>(9
M0V:0CM^<*;%RY],J.#T:SR=\P/!J]WD#D\E!6PE("UA9271+-EHBXL5S$A)-
M616UQ&LRNMYL^76]@1@4<'%$%L.Z%H-L.M6BO1B)-U ='TTV I>8ILICP!JB
M-WN0PE@^X-_IG;R3)O*W#D1@14M6WE>R2%D/767)=5619'6*U^@4UZ-28.!0
M8_OL>U*( L#@"NP^D88\FUQ6FD19Z?3:VL^FSH2!I?).9+6HI.V3 %4+[@Q'
M5'C*XR?L6^A.@6-YZ;JD&=B0TB1O:[GH: -^6YM"L#<%A#-$>\M @3<:8*"P
MH"#XR^I,I0(]_#7X9Y$@J-Q6\,"Y4FL;(9@"(A7LPRU_I;,,[TO>)[ &;%H8
MZ>'=7O#S#X6HX7IE>L%?2G#] DR<-=0XF5"\B$@=4@ 2VWIEP8GA5-Y9QE/G
M=2@M2N040GB1H<IA=0MJ!^80U&7HT^J!C[]!5]  B(<[D]K0DU6MLK1U1KB?
M!.3:./S#& )JX_K.[R( A-MJX1WO%]#&"#(Y#,*85BJ -@BZD$LB:6>5S(K\
M0)! W[L;9-DM98?.J5JOI4&OY2M9[:0L@AFTNSU,H%X)-0"W@KRE4*FSN42;
ME(1BA_C3@9"B:WR4),R_I0CGK2?I6L\>MED 6M1MCY.Z"X2U:08\<+$QTFFW
M% ][QJ[-J>,KC.H:3 ]Q!+! @&@JQR3#&VTN4KKOSGZ&WDQWF.!Y3W@\'$;#
MX9!'S"4".] KKU$LI%I@49#U$=\/DZE$&X!K1F4+NB\TFRXS1!A/MZ5$[Z(
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MTF1P 7R//;3P 0]H?ASWXG]02P,$%     @ ZX8_5*"!:%=1!   A@H  !D
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MG^63D%;IE\G(HCM:'!4[TYO>-'K#-(<O2MJ-@9]E*<I7[&]/VX?1"0<CQ#&
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M&UA&A]J$P3DZZY^<C[>Y2UMR&.*PH0I#LK-WXPC2<M^-*#:9Y<NZ@;B-K.%
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MJKAT)-MR6^^Y6,46"^,5A@&/:9T'+=7C7)XV:.'VU@$TK@<DWW<$?RP ^@7
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M=B]HS[^8!)<F4[QQ.&ST4):P=1=01;?8-:+K$(L:L V0L>\H$_PQF:B/]?;
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M="H.J +J$NCQHDQO8/]N$/Z[\BUK85W4H(*:G*:.$SO!9"[N%/C!_?Z$]BX
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M3>AQ,>S3I;B%*,R\KIFS"[BA+T_@>^XU S3#4Y/7$"))##K%@W72:MOHK\;
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M\GHU$BY^:HLWP3;\M2JU(=B:+TLE,09H 7XO+#2@NZ$-AN^=#[\ 4$L#!!0
M   ( .N&/U1F,RH-O0L  *8?   9    >&PO=V]R:W-H965T<R]S:&5E=#(S
M+GAM;*U96W/;-A9^YZ_ >-L=>X:1)5FVY5P\X[AI-SN]>.)V^PR1D(2&)!@
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ML+QPFH*T'QRY46%FXC(DNT#F4<-+78$XL(=66(Y-E;Q@*L[J31PL).U'._9
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MF#11R7)8J^2M;6_F1^NB#2/O/QNX+):<<6AC3O7J< S+7@SO;=1BSQ[\$;[
MA*"Q*R'!Y8<[)$'>4&<+X. N)ZR#7&\AY'CNVJRA7MX#=4OZK=RE!;032U7T
M=F?'5E-)MYJZZU661,8,.5B?(6]@\433QU;+T2'.7T)%L[7=:NM%DO7KQ7:_
M<NB7O_/>;Z>EL@O^A9B:*<PSX6?4[FWW(_1=^.UU<SS\@OV3M M4 O3Y<UP=
M#JXO3T*SVCYX4_,OL3/CO2GYSZ620&LZ@.]S@SXV/A"#[J?YV_\ 4$L#!!0
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M\ 2A5PH1X#N!^P/SQ.NGIU\#(X79 >$BTT!I%]Q-H*T;?"7PDZID*T4FHAS
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M"&%+"*L[R@DOD8(Q!<=SEU;"D]U5V=<IBH\<3D%%,!*J4PPV\ WA'^IH$OV
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M@T655NC]%IR(L;?N:[#$7O!](& [VUX$I:/L6YI] #73G'D75<^*=8G+ D*
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M#3L@)#M'"+A*;?$#>$A4>(=4']BRZQ3KC<7LM-WN"6U(A$W%N3PXY*_I01+
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M5W2-7R5-\MVW8.C?I)=IGE.6<@&R!M4>^RF\; /R;/;UQ?S95_"D^_EWW^[
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MA\2PJK?7^F#DQBV <VEHG72/:UKX45D!NE]*:78':V#_%V+V-U!+ P04
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M*P2T0BC>KX)\"X*TEWQ)V\R0G\T,N3>ECK!V</4( EL8:;[T%G0_U&A7^[V
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M%<1'+LV923U213+&+YFM\BB=RWN// 1;CK%$X%'RY Z,ZL>IH4^P#@CL-9$
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M1J]ARR[,<_P MT);]3AU(]<)_ ;W2@*OD< ;E$!O%68OH3F3Z,<]*QZ9^&=
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M$CLT9PG"!.CW*\[586(2M/\VR3M02P,$%     @ ZX8_5&' Y14Q P  I@L
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M9!14UQ1V$RVKMDVZD]HT7>UP91II4!9@WB^DU)N)[;R&UGSV"U!+ P04
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M +Y?<JX>/^C7TOFO2$[^!U!+ P04    " #KAC]4B4$.VF0$   +$   &0
M 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6S-5UUOXC@4_2L6VI5:J=/$ 0*,
M (F!=J:K3A<5=?9AM \F7,!J$K.V ^V_WVLG3:A(7+3[,GTHL>-S[[D?/HZ'
M!R&?U19 DY<D3M6HM=5Z]]GS5+2%A*EKL8,4WZR%3)C&H=QX:B>!K2PHB;W
M]T,O83QMC8=V;B['0Y'IF*<PET1E2<+DZQ>(Q6'4HJVWB4>^V6HSX8V'.[:!
M!>BGW5SBR"NMK'@"J>(B)1+6H]:$?OX:^ 9@5_S@<%!'S\2$LA3BV0SN5J.6
M;QA!#)$V)AC^[&$*<6PL(8]_"J.MTJ<!'C^_6;^UP6,P2Z9@*N*_^$IO1ZU^
MBZQ@S;)8/XK#-R@"ZAI[D8B5_4\.^=K>H$6B3&F1%&!DD/ T_V4O12*. +33
M  @*0' NH%T VN<".@6@<RZ@6P"ZYP+" A">"^@5@)XM5IY=6YH9TVP\E.)
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MD+=L:_(](SC(0'%D(LMRS!B'B3&;9,]6;#:A!Q&%"5DQP ]QC-E_<Q+1X]2
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M!G<-&5R8L,+ZTT"H+3SUBVS8+Q)$B\.KK*8K"!57G&;#0:!-'2,;=HR4@D!
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M]VE:-#^4?R7M])?ZKOX+4$L#!!0    ( .N&/U3QCHDC>PH  (A8   9
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;,U<76_CMA+]*X31AQ;8V"*IST42
M(+:WMPMT>X,&W3X4?5!LQA'6EKR2G&R _O@KR;)'-L6Q)=*]FX?$=L3AG!'%
M<S@<\_HU2;]DST+DY-MJ&6<W@^<\7[\?C;+9LUB%V3!9B[CXSU.2KL*\>)LN
M1MDZ%>&\:K1:CIAEN:-5&,6#V^OJL_OT]CK9Y,LH%O<IR3:K59B^C<4R>;T9
MT,'N@]^CQ7->?C"ZO5Z'"_$@\C_6]VGQ;K2W,H]6(LZB)":I>+H9W-'W4VH%
M98OJDL^1>,T:KTF)Y3%)OI1O/LYO!E;IDEB*65[:"(L_+V(BELO25.'(U]KJ
M8-]IV;#Y>F?]YPI]@>8QS,0D6?X9S?/GFX$_('/Q%&Z6^>_)ZR^B1N24]F;)
M,JM^D]?Z6FM 9ILL3U9UX\*#511O_X;?ZD@T&A1VVANPN@$[;N J&O"Z 3]N
M8"L:V'4#NXK,%DH5AVF8A[?7:?)*TO+JPEKYH@IFU;J '\7EC7_(T^*_4=$N
MOWW8WG"2/)'?DOCJ162YF%<OOV["9?04%>\>\F3VA?QW7=VHN_)&1?D;^7$J
M\C!:9C^1*_+'PY3\^,-/UZ.\<*DT/)K5W8^WW3-%]P'YE,3Y<T8^Q',Q;VD_
MP=M3AA@8%;'8!X3M C)FJ,4'L1X2;KTCS&*TS2&\^53,BN:T:FZU-)^>W9P&
M"!J^O[V\LF<K[!5F//+AZZ:\81_CF8C+IXS<+\.8_/5)K!Y%^C?YATRCM'@,
MDS3;?XAT;>^[MJNNN2J0SV$JKLIG<DXFR:J8J;)P.X+2-(P7HI@]<O+X1IK7
MW8=OU<=WKV$Z)W_]6I@D'W.QRC"'G+U##AJ+WS8EM'*D;X=R5@[S[8!_5PZ?
M*%ZTW>^M4;<R6DZC+[=N\7,]>FG>5;3G<O)^GZW#F;@9%+-S)M(7,;@E""1W
M#\E%(?U936M%X.Y>1%K,T^0_16CSJV(F$.3G,$K)YW"Y$1BZK7V_@<X><N<(
M'>I$=W3>'IV'HKM;+%*Q"$M\'^,\C0JVF>T0[6\=@FUKW6E@<WS+.L*&NM =
MF[_'YJ/8JAM%CF[4>0/2EV"QP))PH=UWQQ7L<07]'[(*=/LT'TA/F<V+GR-0
M:-_=05$+6-(R\J A".L>FH^:/W0<J_%#C^#B3O7 VU %5&]X8D"I-$"YQYLC
M]- I!DZQ_F/K<_6WU1\FC:TK7DSAWG&TT=Y[1!M(FN(L?>[H0C!R:7 %0]L.
MFC_'<%&?>L %84!MO<&%X+3EL67;ZK$%VH!JB(-BA?$D(I5+^MQ?WQ##(H*"
MBJ!F9 0>!WV54,?!L-R@H#<H+CA.#DP\ (:E! 4M07$Q@2O;;^M"WK=[K"\2
MZEMF6&U0D!L4UQMG*V D"OJJHHZ"87G"0)XP7)Z<5I-J^+CI'EZ#R&"XR.@_
MY^*&.]PR X8.P8.881IB9BP641RWZ_\QD_6,O"*=X-UW"9%A6<1 %C$SL@B/
MEJR,Y!7N!/>D2[0,JRH&JHKAJNJ\U3(>*UE=R2OF">Y'EUCI&SJ,%:@]AJN]
MD_,E'B;GG!7X!/>A!SS0<PS7<STS7;75$ZDNO.\>L$">,5R>Z6>[Z@Y.I+MP
M-WH@!"''<"&GF_%B<FZH)>6%.]$#'Z@UAJLUC:Q7;?E4V@MWH#LV#AJ,XQKL
MO%3[A]5ZF;P)D9&[N,R+Q]EFF1=!.2OUSD%:<?I])-\Y"!ZN(7B4]WW,9;5#
MJ92\F>"=][COC1T6,RH%@=B6O*''$@5WHP="4!;<A+) \!D2#!,#A@Y# (*!
M:PH&!+VL%JAER[(*]Z '.) +7$,NJ!.]8R[K!68Q'K3GXCCP/#?#\YAK,M%3
M-N0*SX"?N>:N#>:28=;EP+I<8T]&F6L=<WE/YLIW/-8>1!N(TC:SEZ+VS):W
M4J@[]!6. 6G:FIL>B$>&\P@VT*JM0:M8$F6,&^[A,U"FC5.F5IYUC!OOX7>C
MH@$GPIYYUC%NMH?'P%NV+F\A7ALF)!L(R=8@)'QL&%Z<VD!:-DY:_?-YN.$>
M/@.=V3B=&4FPX7WT<!]XS<9YS4#&"^^AN_,.L*"CF;)'_<:-]_ ;2-+!21(+
MNIH?';DFP'5MJM 2#K"?<Y%%I7/>HA+OO$>4@2&=2R\JG;,6E;@;/1 "ESJ7
M753BYCLL*@T8.@Q!HQ[Q8HM*1ZY*;%U4XA[T  <<[N <KIV!>K=[I'?S"HEB
M<B_2*"E%P#Y>K=%QI=GF"IMN@.0=G.3_A1R? ^SM^-]'CL\!1G8T5II(B:VI
M'7A'7K+2@S+"PRI;(&O7S))5"7'JMBQ9Z9 Y"L^ CMW^='S.C@%NOD/H#1@Z
M# %H !?7 !J;"KCE+NB9G.2S X?;BOL+0L#%A4#?>MK:[$%!K4WI<4%MRV78
M P/L[N+L;J!>MN[AL%[6ETK3Y:N"H:=ZK(":74UJQAR7$[[<]ZA4@-ER'>46
M98I:1K?QI0"-Y;.ZMM*5T[E7CF?;QQO ;==QYBL'#;"K:R;OBT"0T[[!D%M8
MC75+DV)BI@HL0,ZN9J88 =&RB<M=3RJ&;[F.NRP(%'E0%UC<U6!QM"X+-]QE
M/FW)/5/7<MQV;!XPN6>&R3&84Z^%S!W5[H('7.YIYI_1V./&.\3>D]?JS':Y
MK> R#XC:TUFLJRL4<;-=D!E>SWM XYZA];PR"E.\AQ[. YE[FO7ZV+TS52QF
MP- A?- "WJ6^&H ;[@*^9;F/S(:@%#P-I8 F(''#'=(OGJPF:,LWOUHNLWW?
M5^PU>XVO&)K1'%@P)EZKAF#'6K7M,C9400"IX9DH&L/OIJ$O DQ,&9H:,'08
M3E _GF:-&AY)0PIHXLGU;D<KRCI0\G4N\SW5W."#4O)QI=0SEX-;[3 ":D-G
M+DU]4%D^KK+T<SEU!V?F<GS01SZNCW1S.;CY+J$WK)-\T$F^9F4 @MY4"7]M
MZ-Q<C@\ZRL=U5#-[7.6,PWA>'3-Q\&'?<QE\$#2^\WTDCGT0(OXE*M;'N-4.
MLZW?6OKN*>XXJ O_TA7K_HF*]4/'&J</7+30?(R;[Q+XEB0&57Z?UP<6]R]5
M:3[&+7?!9KBX( #N#C2X&ZE1#%HXU^&*A%( E!N8H5S,,YESU7G> "@WT-P[
MP%PRS)(!L&2@L2F@+L((Y&3_E<\L51"!UP(SR7[$,SF+[PP5?!L SP6:27S$
M(</[Y@$P87"IVC?<< ^?@>8"C=HWI,(0-]O#8^"_0.,;\WB431^LTSA91R,M
MCRY* SF;KE8W!?ON/2I?7SI[,MYU<I[&H5;C$!O+Q.;X">=:3K-1"Q1JL89W
MFMQSPC'3Q]58C?-J+)R ^A4![JP>K*RHHYCGJ=4X4,;2*<Q6*KT39CM(O9VE
M<Q^QQKDT%DYB^DN(70_G/E^-8V,LG*MT5Q$G['>*OUSRA3ZFC3-A+,U#83!\
M^@2WPV?Z<!FK<;J,A9/E_[.4;^?;X4XP,FDT3HZQ3)2/HV)@U\5!I2$+?/LX
M^SIJG-"Z$NFB.NDV([-D$^?;LTGWG^Z/T[VKSI ]^GQ2'K-;G?P*9K9G]'X*
MTX(N,K(43X5):UCN&:7;4V^W;_)D79T#^YCD>;*J7CZ+<"[2\H+B_T])DN_>
ME!WL#Q^^_1]02P,$%     @ ZX8_5%O 4D8/!   "0\  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C N>&ULK5==;^(Z$/TK5G0?=J66? &!"I#HQ]Y;:7NW
M:M7NPVH?3#* U<1F;:=L__T=.VD($++EMB^0.#/'Y\S88\]H+>236@)H\CM+
MN1H[2ZU79ZZKXB5D5'7$"CA^F0N948VO<N&JE02:6*<L=0//Z[L99=R9C.S8
MK9R,1*Y3QN%6$I5G&94OYY"*]=CQG=>!.[98:C/@3D8KNH![T ^K6XEO;H62
ML RX8H(3"?.Q,_7/+OR><; 6CPS6JO9,C)29$$_FY3H9.YYA!"G$VD!0_'N&
M"TA3@X0\?I6@3C6G<:P_OZ)_L>)1S(PJN!#I=Y;HY=@9."2!.<U3?2?6_T I
MR!*,1:KL+UF7MIY#XEQID97.R"!CO/BGO\M U!S\_@&'H'0(=AVZ!QS"TB&T
M0@MF5M8EU70RDF)-I+%&-/-@8V.]40WC)HWW6N)7AGYZ<H_K(LE3(&).[D!I
MR6(-";G7(GXB#YQI1:8FTDR_D$^7H"E+U6=R2@+/C\C5K]R,7_,8N,D&N4TI
M)S]N()N!_(E65]DJ%2\ ZH1<,HF9$U(1RA-R(;C"0%..^#7[A_M+\NFOSR-7
MHS1#T(U+&>>%C." ##\@-X+KI2)7/(%D&\#%F%2!"5X#<QZT(EY"W"&A?X)*
M Z^!T,6;W?UA"YVPRE-H\<)#>5I2":=FP9K@9;B+%;7[8"HEY0O G:7)[(74
M[6[IBQV>KJE,R(^O"$FN-63J9PNA;D6H:PEU#Q#Z-S=),\O&KI(3,H,%XYSQ
M15/V"JR^Q3*5Y7G2\\(P'+G/]9#N6_5[T2"HK+:(]BJBO5:BW^U.QG!,GT%B
M92)_8\ TP=T"Y MEDCS2-(<_\"^F&-28^<-.L$._,.K5C *_F7N_XMYOY3Y=
M+"0LJ&%_S7%O8O6,7_E^R[7"#90@XW;NK5.88^),K6@,8P?/ 07R&9P):5KP
M_3UY4>CY@UZSQ*B2&!VWCFQZ=K=PH:05Z0@E[\?9DCJHI X^9"6V1*!U@B,B
M\'Z<K0@,JP@,CTOV(QXY&!!S)"C0.L7G-=-+HDP9(TRIG.+ATA2)X5ZM..WV
M/,_;V9,-9E&W'S6O6=_;G)K>AZ3R_^LK"6R5G$''[^WH:S +HKK9ML#:M< _
M+E-X:9H#0S%N;"BGS>NS1-V*=V^_T#>91<-#E=X/-JR##TG+&\4$^P4]VE42
M[,>_WSE4%/W-<>^'Q\4?;*5OI-F*=$11*($.G]+;6C8W!;_]JO#6K+1(;)W@
M&(G=]H-\6^'FBN&WWS'>>DZW*&R=X!B%[P<J@N#6FHH,Y,+V6HK$(N>ZN$97
MHU4_-[5=S,[XN>GS;+.R@2F:Q!LJ\=ZB2 ISA/0Z$7*71=]5O&BQLJW+3&AL
MA.SC$GM5D,8 O\^%T*\O9H*J^YW\!U!+ P04    " #KAC]40267<I8#  #T
M#0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6RM5UUOVC 4_2M7T1XV
MJ6T^H)16@ 2DVRJM$UJU[J'J@TDNP6IB,]N!\>]G.R$-'43-VA>('9_C>\ZU
M;^S!AHLGN414\"=+F1PZ2Z565ZXKHR5F1)[Q%3+]9L%%1I1NBL25*X$DMJ L
M=0//Z[D9H<P9#6S?3(P&/%<I93@3(/,L(V([P91OAH[O[#I^T&2I3(<[&JQ(
M@G>H?JYF0K?<BB6F&3)).0.!BZ$S]J]"/S  .^*>XD;6GL%(F7/^9!HW\=#Q
M3$288J0,!=%_:YQBFAHF'<?ODM2IYC3 ^O.._;,5K\7,B<0I3W_16"V'3M^!
M&!<D3]4/OOF*I:!SPQ?Q5-I?V)1C/0>B7"J>E6 =0499\4_^E$;4 '[O"" H
M <%+0/<(H%,".J\%=$M USI32+$^A$21T4#P#0@S6K.9!VNF16OYE)F\WRFA
MWU*-4Z,[O9#B/$7@"[AA$3*3!IAPEDL8;XB()7P1A"F,07&XSE8IWR)*^!BB
M(C25G^"TAKM3/'K:1S_<8C9'\:C'!9Y_ =>_<ZJV-<PL):P^ZGF.6N<'<$$N
MB4 Y<)66;8)WHU+BI) 8')'H!W#+F5I*N&8QQOL$KO:K,BW8F38)&AE#C,Z@
MXY]H18%W(*#IJ^'^Y0%X^'IXOT%-IUH"'<O7.;8$C*^G9O/$,.69KBB2V#TY
M%CKS">I=KF"^A?JX&=G:;IMD>/BF*>%&828?&P+J5@%U;4#=(P%]STW:S8JT
M4\H3^,[9&J5>A"<FAY0EAU9!(ZFIGU=R12(<.KI 2A1K=$9P*'GOQ!,6/#W+
M8\KO>N3[NAP/W/4!;\XK;\X;O?EE"YG.P'B-0A?F8G>>QD0A?"94P#U)<VRR
MJ9&_A4WOQ!,6//VZ3;VS_F&7>I5+O4:7QDDB,"'&IQNF!-6?J6CG3+668(()
M9>RP36$QP7D]K*#;"8ZD[Z(*[*+ETK8[Z&55*C+52-4B4V_GV=/:K[3VWV6I
M-CC0.$$+!][.L^? 9>7 9<MLW]N5=TAJ(U,+J9?_5)W3AK+C>\_G!.]_LAF^
MS.9QA<T3M)!8$KVN9/BUDY#?,EOZ9+E >DQ.(UL;.6\GVE<</"L.WF6'-OO0
M.$<;']Y.5/C@UH[#&8K$7BLD1#QGJCCD5;W5U65L#^PO^B?^U;2X@#S3%/>A
M6R+TMT-"B@M-Z9U=Z ^%**X814/QE3UTS[G21WC[N-37,A1F@'Z_X%SM&F:"
MZJ(W^@M02P,$%     @ ZX8_5#;!X[<7#@  ,'(  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C(N>&ULU5U;;]NX$OXK1' .L NDCH8B=5FD =)<&G=/VR#=
M=A\6YT&UF5BH+;F2G#2+\^,/=;%)6R0E7Y1J']KXPB%G-$-^,T-R?/H4)]_2
M"6,9^C&;1NGKHTF6S7\[.4E'$S8+TD$\9Q'_YCY.9D'&WR8/)^D\8<&X()I-
M3[!E.2>S((R.SDZ+SVZ3L]-XD4W#B-TF*%W,9D'R_(9-XZ?71W"T_. N?)AD
M^0<G9Z?SX(%]8MGG^6W"WYVL>AF',Q:E81RAA-V_/CJ'WWX'BG.*HLF7D#VE
MTFN4R_(UCK_E;X;CUT=6SA*;LE&6]Q'P/X_L@DVG>5><D>]5KT>K07-"^?6R
M]^M">B[-UR!E%_'TSW"<35X?>4=HS.Z#Q32[BY]N6"41S?L;Q=.T^!\]56VM
M(S1:I%D\JX@Y![,P*O\&/ZHG(1$ T1#@B@"W); K KLM :D(2%L"6A'0M@1.
M1>"T)7 K G># .L(O(K VR2@&@*_(O#;L@364G-6:Y*5LDNC*ZVD,+'+( O.
M3I/X"25Y>]Y?_J*PTX*>6U88Y7/J4Y;P;T-.EYU=?5^$V3,:1B,6Y<:-;J=!
ME*)?+ED6A-,4?0B2),B_^!6]0I\_7:)?_O7KZ4G&1\[I3T;5*&_*4;!FE//%
MPP!AZYC_PY:"_,),_FX1<7*B);]L&'V>#)"M'_VJ8?2 CVYA+?FUF?P3FZ]&
M!P7YV_;DJM%OS.27;,3)04L^;$T.OH+\77MR3T'^NYG\?< 5A['JT9UP.U\9
M.UX9.R[ZLW7/<A(D[%6^ H_113SCN)0&Q<)^SHT\>F <*S+T]1G)[6Z#Y^+C
M\Z<@&:.__L.[1,.,S=+_&ABR5PS9!4-$QU 6C[ZA89HN^$B7BR2,'M M2\)X
M?%PRD1ZC#QR6BA:IRO;*_IVB_QP_'\\<QW%/3QX57)$55\3,U;Z/Z1A=!V&"
MO@33!4/GG/?9/*?GPES]F',LY>V_Q%/>YS1?>^Z"C!VC]V$4SA8SE8QF;H%:
M VS]VZ -NI*;]E#NX(=.;C.WW(\94##)[:SD=GZ6W'=A^@U=)XS/F2ACW)ZS
M9G6;F;4&E)J$=E="N_T36J]K,[,P(+Y):&\EM-=:Z)4P0EZ^V,31*$@GA;U&
M*5-Q6HY I16'@D7I:LDI0:W>"E/L4G>]V8VBF>N"9Z\W&]:;N9Y'?5^]SOFK
MI^%W;0(?%K.O+$'Q?;5<H_-'[C8%7Z<,\7@'O>7]9*J'Z->6;7!LQ\=J@< 2
MWIQE%(GK[]7W13 -[T/.; DO'TN[1'^]9SFS)MP"R6V$?D I"' 'W%=U5IS)
M^L3@NAH<!N$>@-D_:*-.]#]T-9M/XV>6\QOELD<I#R@YJ^UT+MP"(#W1N4!L
MZ!RR=]8YK>O<PK9F30(!QF &N)8ZQR"IO8V:!3""VQ,U"]B"]KBUHYH_+M'Y
MXR)+^>08<U_[&/U9I%QXZ_-'E@0/#-VQ/!&5^^%\&F5),,JX*M ?+%&B=@/;
M8*%G%B2IZ1D(L(+.T6KU# JC3E$8K:*-#RS+I\!UG-RS,%LDZF@#ZKCE^):C
M-GDL4 OOCUK<Y/,<&I^I2[-O8_58 !KN":!A*5KM'-!6&O_"O5"F6.U46L9U
M- ,?B$;+ LRP&<SN. M)6$1!I8H_1R$WPE_N/GU.?VVE3(%4N"=(A052X<Z1
M:I6KX\]QD7^1HH_9A&LSFP214/7YPT/"'GC D8<?21BEX:B,4I96H,HBX3J:
M@>\#WO#KAXIV+F]FK3=[5S63/7:P;.I22V-% AZQ&1Z%3(]%Y,4M^;&0"O$U
M':4LRZ;\]5.835#(@[(@&A5MTORQ*@5WZH+S>$;/J<!1W'F$N<OTO:S8DB6B
MMFUKQ!$8C,U@)E+$Y>Q]$T>+M&14XXRVF=("_K#?CREM"]BRS;!U@&CZIAI"
M5M;&7!HJFA""+8VC:0O$L^%%9U(UG%&4>A/J8:*9:K9 2KL%4J:E6Y-/DVJY
M:U10Y>ZHET2[#H,U>4Q-UF614L)FF,QSW<NE/M^,:3.-;(&,=D^0T1;(:/<U
MAOO=KJ.9X^@3Z+9 *=N,4M@"=VLE"F2Q>Q*AV0(=[,XCM%T#\8JSEH&X+1#'
M-@=<*R [1I=APD99G*3%TJA*L'#@V]N_)0)YB-4/ R "38@930X AF])'1XP
M!6<C&WQ3-:/F9D-5,]?3AJM$H TQH\W%)&0\5 XC#HEA,$4?[^_#$;=<R1;V
MS,,2@1;$[HDE2+N'G6\?=I*L:6"[1;*&"$PCG6/:3J$[481Q^OU@ 6>D\QW"
MO7-/1!&HV=JXA@@P)>8P[4"SF3=[M^ 3J3JJ@5M-<P&OQ.O)-!?P2%XN'[F5
MB==SD'Q9U[C=5$ J-0=SW9B!W<8,J !9VI,D)15@2/N9I*3UT,MQJ&7I#$$@
M*C7'7]T8 FEE" )C:4_"."H=GNDGY%%5#.?I#4& 'FT?PZV?CVRE2P% M"?1
M'!5P0\W1'&=CQADH+/L8703S,.,SH0K+>)S#DD?.1!Z572]RP"X.J.4)(E4>
MA=;C,]O6(S<5"$3;(Y NY*@R6I6!7<1IQC_-N*>7<3E&\4,4_IT;VODL7BBC
MRYN*!SF*< AH#FHX FZ<_7.'+7DOW:A"&]7'N?6H9&G@R49<Z=G$Y $[ JH<
M<SS88O;P)7(8C1DW^'$NO@BR6TPO1P"4TY-#GXZ &,<,,;=)?,_2_%H"GU77
M3+FNO:OZ6-M"T>.;(Z##:0C/]CUS.JP&6/?$01-6.P) '#. =&TQTG%(IR<6
M(S#",0<I;2QF6/6QME19>HL1:. TY/;VMY@Z!%#L: # $0#@F %@/X1VQ6+M
M]B3=YHKEU34OKX=$Z&NWGG=S?%<SH5VQ\KJ=AP:50+>+9#0IOL\E*KY3RE&/
M"4R>ABL6;+?AG/[/RVZ[]1/^X& >ZFAD$CC@=IZF$S*=C\>%UR%L\'R13>(D
M]U"44I6\^>N:&AAT)6#$/02,['5DTA50XO8$2ESIW+L92H32UE-RZDU0MWZ8
M@!" S5R[HIDA.><*Z'%?[N#?%D'EC:L +)<09U-L16B#/:W8 MC<O8%M_TT&
M3^"?UQ/\\P3^>>VWFUX"6VX\!49Z6@OW!$AZ#2!9J"TNU(:R&,TK=M KE$TX
M?Y-X.D[YFSE+BAO4^2F,0APEDW4 )'H/T!/XYS6<0U]-F;1\:/?+@Q/%0\M8
M,@NCXODK9Y-7QS!L>'8"PKQ_Y$[350/;M'&CR1-HYQT"[5[B'H$G0-'K"2AZ
M A2]]F?U=KX850^_L.]YL'DS2@&5+G?IR,8NMZ([\'SJ>)MWH^KM;-\BGL9!
M]*2[8F;LW<Y1\.I0J'(4%,T,CH(G$--[N=VH RX%PP:VO7(I0*1*O2%,T#AX
M-JT-OH!MWYS/>Q$OPA>0[?=D\\H7X.MW'J$>\J;S30.[ &3@NZ:+H+Z =+_S
MD/:0EYUO&M@%C ?$,XHNW ;_Y]]OUQU":6!-?0BE>D+[>A6^\"K\GW83?H<;
MX3<-W#;=__>%9^+W\":\84XT;% .;/-B(-P?W^S^=)QZ]X7/X??DG(LO71)O
M\"SVSG[[BMO>VOT2L.3+WH< ^)W5!I9T'=SJ";B#)5T(M]K$UONH;CE"NYT+
ML*2;W5;3,?\VNEOJJYVZI)O<5D_.CX EW>6VVJ-.9_OY2R;:;>B#)=W;MMJ#
MQZXQY'*,M2 2P-T(#M^JVE'JNQL75&Y4[7BH2?%&6*9JI\D:@27=)+=Z>07N
M>LF7/&T];&T6*5$UXPL=T1J#=&'=,@?/.T[O_>,QL*0;Y59/[M2!7,&DH83)
M2V=VKY8,;6X;;DXE13-82ZY64TG13C>5UNJMF!/>6V5CKI:]K:5<?>SHG ZY
MRDI#F95VEOW'4UQ"J]'Y.("YR\54H"=W)4"NJ0*=!Z-;F?O%DJ&6*3B0B[$T
M5&/9RD8O0%%!Q?8=W6X%R"54&FJH]#0;>-'$=W,,#W(=%^@<?4NSSZ$W%[&H
MN)L6)P[S><_E5PMI9HM: \L8KX-<&*9-99AR0PR-9!D#2<:T6%7",@[(;_#%
M0J=*'Q$466I";-U%99"KN#24<?D)RR=O=CY/PBDJRX!"JW55JMX"N"?;PR"5
M<P'<^0;Q3L;?P%:S\4OU8:"A0,QV3F8[/)7JN0#N"YY*E5\ F_%TNUVK96]K
MVU9UYV_8,&I>^?RW=!Z,V.NC>5*>OCLZ0T:1)%CMOG3,3H=@0%'LQ5Z[';]\
M.$;^=WDX$M0WU(/9=0X<P/642L$ [LD=#Y *ND!#19=MIXIBAU<Y58RC[F(-
M$KKB?^0V\$43WTK';_G<S:1NM87L+K>0'<4.\E(U[7:CC5UME+*4W(0MRN6\
M)"(WL-6,R%))'6BHJ=.#B](7H*BR4P1XEJ4_"P92L1UHJ+:3UX)'G^:LN!Y9
M+;W5(M5M:LN6"Z?VQ3>1:N^ W:]8_VK)T%H:2%_?!J2B/=!0M6?+?)2BT@ZV
M"0=W'2>2!]!8:V?[@DD@%=N!OE3; :G<#O2WW@ZH"N[8ENMJEQ8)OQMJ[NRD
M2ZEN#O2E< Y(E7.@H73.0>_R@**(CN-0#OT:[4AU;Z"A\,U!=KBJ,>2=)M_"
M5'-<$:12.$ Z/]+4397@!K[MYJP?D8MTO^"]GBU7!J)(+5/;TZE60IONZ^GL
M?ED)%%5U3&7B0"JL PV5=;0+W@'<):D&#I"^8)Q4\P;( >/3ZV5O;8U/ J6&
M2C<F'7626)"JU@#M"Z!)56J OEP4=,"%^$T3WVWJM4N5<> %2^/L& R^ 46=
M',6L.)%^02[_+<7W0?(0<FN=LGM.9@WR.Y=)^>N$Y9LLGA<_*O<USK)X5KR<
ML&#,DKP!__X^CK/EF_QWZE8_$GGV?U!+ P04    " #KAC]4/.048;@#  !9
M#0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6RM5]N.XC@0_952M _=
MTC2Y0;@(D!IH>N=A)-1,[SZL]L$D%<A.8F=M!WK^?NPD9-C&R2)-OX#MU#EU
M7+Y4>7IB_)LX($IXRU(J9M9!RGQBVR(\8$9$C^5(U9>8\8Q(U>5[6^0<252"
MLM3V'">P,Y)0:SXMQS9\/F6%3!.*&PZBR#+"OR\P9:>9Y5KG@9=D?Y!ZP)Y/
M<[+'+<K7?,-5SVY8HB1#*A)&@6,\LQ[=R;/K:$!I\4>")W'1!CV5'6/?=.=S
M-+,<K0A3#*6F(.KOB$M,4\VD=/Q;DUJ-3PV\;)_9U^7DU61V1."2I7\FD3S,
MK)$%$<:D2.4+._V.]80&FB]DJ2A_X53;.A:$A9 LJ\%*09;0ZI^\U8&X "@>
M,\"K =Y[0+\%X-< _U8/_1K0O]7#H 8,W@."%D!0 X);/0QKP+!<K"JZY=*L
MB"3S*6<GX-I:L>E&N;XE6JU(0O56W$JNOB8*)^=;M;>C(D5@,;SVMCU88X2<
MI+"51!:2\>_PF88L0_A*WN"%2 1"(WC!G'&)$6PX.R;EOE3'XL(4!=RM4)(D
M%??P *_;%=S]=C^UI=*L/=MAK6]1Z?-:]/GPA5%Y$/!$(XP,^%4W?OQ_^'4W
MWO4Z"&P5[";BWCGB"Z^3<8MY#WSG$WB.YQH$+6^'.Z9X_)KWIU_SONZ&KS!4
M<+<5_GPSW!UW+(7?;'Z_Y/-;^"YV]BH18<I$P1'^>MP)R=4=^7>'BW[CHE^Z
MZ'>[D.6)4,V\T*>&2) 'A+@^:Z(Y:UP=,%-8*R>#THG.+L?Y@Q^,'4<%\7@9
M/X.=-W(O[?XSBT$SBT'G+/1EH/27L_@$5&5(=5V<U>^08IQ(8=)=T0:7>DRR
M#68#OU5UT*@..E5O4.4JBE1"E,0Q<J0A&E4&U^Y=/[B6>6WG#EM5#AN5PTZ5
M7WF!#T4.)/I'7?<JRYLC.;SV[0ZN)1K,QN-6C:-&XZA3XV.C#22KUC]7:R\3
MN@=U:HR"1X:@#J\%&\Q&0:O@<2-XW"EX>2!TCY!0.)*T(%75DZJZBZ@]8%([
MOI+1'QIVP+69Y_1;U;K.SRSL=.IM\FG2W!=P5Q^L>\ W57D*D^Y%-Z\N9"<B
M)R'.+%6I"N1'M.9@RCH?1;3Z***GCR):?Q31\P<05?O#OBC8,N3[LA;7^:&@
MLLHMS6A3[S^65>Z[\84[6;J&\94[>3*-K_6[H2P<?[JM'AU?"-\G5$"*L9+@
M](;J3N95'5]U),O+,G+'I"I*R^9!O7V0:P/U/69,GCO:0?.:FO\ 4$L#!!0
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M0)5:=Z^'ZP'J*^8K4@A$8:DB>V=#]<WBU4Q2+23;F+8^9U(-">9VK>8XX-I
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M9<+T^J%S'P0LP5/;HI(,S<W]^%L98T.PA3-M\B'8:)_5KK2[STJ<KH7\JA8
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MZ7<<O_D:__P>_%,_:)0G8<=C&)E\/[!T]TI0GJ B:N3PL"99)" ;[VD  X>
MGGZ,?J1FC=L3&"CL+Q<=Y\"^!D3?#EAMCV\H=*5184VC*G9Y4!F_KKD#=@Y/
M$#L(R.0TE&-56?OE-VJ0N6P-,HI+'?RB+>/-7H*(XGLN.WJVM10AO_;S5,\T
MV#=4/6\,]34J^CW3W!<>0WW#[U26,=378.D/.K9K>V^(>33*^7:@:0T5R@P_
MZ8@RU5(EM7]N&D#8U%S#FC\ UE[2:O;([X=@7R.9_R60S-IJJA5[D+F/JMS/
MM/:FB7RWZ3WA.V@84$RWP.9,%L#/R]>%RAO!LN+EDP<F!$N*RSTE(>62 +[?
M,B:.-_)]ENJEK8M_ %!+ P04    " #KAC]4I\N'1-L$  #,%0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970V."YX;6RU6&USHS80_BL:M].YF_$%) PX5\<S
M29SX,M.TGKAW]^&F'Q18V\P!\DDB3CK]\96 \&(#)FF3#S&"?99]M*MGA28[
MQK^+#8!$CU$8B[/!1LKM1\,0W@8B*D[8%F+U9,5X1*4:\K4AMARHGX*BT""F
MZ1@1#>+!=)+>6_#IA"4R#&)8<"22**+\Z0)"MCL;X,'SC;M@O9'ZAC&=;.D:
MEB _;Q=<C8S"BQ]$$(N Q8C#ZFQPCC_.R5@#4HLO >Q$Y1II*O>,?=>#&_]L
M8.J(( 1/:A=4_3S )82A]J3B^)$['13OU,#J];/WZY2\(G-/!5RR\&O@R\W9
M8#Q /JQH$LH[MOL$.2%;^_-8*-+_:)?9NNX >8F0+,K!*H(HB+-?^IA/1 6
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M'^PIB:(D\2. ^15$$8; TX@CF +0@"%15)V#!^=1N#NGPO:WH,EO4$L#!!0
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M@9"=EDP)R/0C(6,$F1&0&2_DL?*YTXM0+NQ,'#9>&^4]@OM"P'WAA3N47ON
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MBJP&15:#(JM!D=6@R&K^4]9[Y]9_'#\^R\XV_5L^&_^:MW@!4$L! A0#%
M  @ ZX8_5 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #KAC]4G,2-Q^X    K @  $0
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M=#(N>&UL4$L! A0#%     @ ZX8_5"D'= F> P  P@T  !@
M ("!SQ0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .N&
M/U10F..;=P<  $4A   8              " @:,8  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " #KAC]4^8$!(7 ,  !38P  &
M        @(%0(   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ ZX8_5%X-&.9!"0  Z2H  !@              ("!]BP  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( .N&/U1/Q3-:Z @  (L3   8
M              " @6TV  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " #KAC]4ZS&<R2E0   J"0$ &               @(&+/P  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ ZX8_5%O]_?=J"0
M=!<  !@              ("!ZH\  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( .N&/U1:]IP1:@\  "@W   9              " @8J9
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ ZX8_5*"!
M:%=1!   A@H  !D              ("!*ZD  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " #KAC]4 X6WPX $  #8"P  &0
M    @(&SK0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M .N&/U1++!/WI@,  +,'   9              " @6JR  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ ZX8_5"DV6*XV!   R H  !D
M             ("!1[8  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " #KAC]4##KW^A\&  "L$0  &0              @(&TN@  >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( .N&/U1.0^W=0@H
M  D<   9              " @0K!  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ ZX8_5*T/MQ01"P  :R<  !D              ("!
M@\L  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #KAC]4
M2+B-:#H%   Z#@  &0              @('+U@  >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( .N&/U2V?*NV\0D  !HA   9
M      " @3S<  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ ZX8_5#IX"&&;%@  2U@  !D              ("!9.8  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #KAC]4=4KV.%4*  #B(
M&0              @($V_0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( .N&/U3U86U:'0@  /L4   9              " @<(' 0!X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ ZX8_5&8S*@V]
M"P  IA\  !D              ("!%A ! 'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " #KAC]4#*  OKH$  "&"P  &0
M@($*' $ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .N&
M/U146 S7J$D  .DH 0 9              " @?L@ 0!X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ ZX8_5+*"M\E-!@  J!,  !D
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M=#,P+GAM;%!+ 0(4 Q0    ( .N&/U1F;]%*3P,  *,(   9
M  " @5-_ 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
MZX8_5"#>+,3G P  O@P  !D              ("!V8(! 'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " #KAC]4\'KJ<%H(  #\*   &0
M            @('WA@$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( .N&/U1B.;@S] ,  !T*   9              " @8B/ 0!X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ ZX8_5)409.O2 P
M/ X  !D              ("!LY,! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " #KAC]4.JM1 E(#  !7#0  &0              @(&\
MEP$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .N&/U0P
MNR^]"P0  ! 0   9              " @46; 0!X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ ZX8_5)K2W("3"P  =3\  !D
M     ("!AY\! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
M" #KAC]4&$Y,-K\$  !8$   &0              @(%1JP$ >&PO=V]R:W-H
M965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( .N&/U3I- *)6@,  +<*   9
M              " @4>P 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L!
M A0#%     @ ZX8_5/C!+$:H @  4 <  !D              ("!V+,! 'AL
M+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #KAC]41[M:S0('
M   $'0  &0              @(&WM@$ >&PO=V]R:W-H965T<R]S:&5E=#0R
M+GAM;%!+ 0(4 Q0    ( .N&/U3#RASBU0(  "((   9              "
M@?"] 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ ZX8_
M5'K)V[EV @  >08  !D              ("!_, ! 'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " #KAC]48<#E%3$#  "F"P  &0
M        @(&IPP$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( .N&/U2)BT)^+00  &D1   9              " @1'' 0!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ ZX8_5%TY'';E @  _@D
M !D              ("!=<L! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " #KAC]4(=]F?,T"  #D"   &0              @(&1S@$
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( .N&/U0B!%)3
M! ,  ! )   9              " @971 0!X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ ZX8_5 O1H1?* P  -@H  !D
M ("!T-0! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #K
MAC]4QQ#D#G,#  "$#0  &0              @('1V $ >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( .N&/U2Y\%%"\08  %$B   9
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M970U-BYX;6Q02P$"% ,4    " #KAC]40_G2NIL(   [+0  &0
M    @($3]0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (
M .N&/U0):LM3N0P  +5O   9              " @>7] 0!X;"]W;W)K<VAE
M971S+W-H965T-3@N>&UL4$L! A0#%     @ ZX8_5/&.B2-["@  B%@  !D
M             ("!U0H" 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"
M% ,4    " #KAC]46\!21@\$   )#P  &0              @(&'%0( >&PO
M=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( .N&/U1!)9=RE@,
M /0-   9              " @<T9 @!X;"]W;W)K<VAE971S+W-H965T-C$N
M>&UL4$L! A0#%     @ ZX8_5#;!X[<7#@  ,'(  !D              ("!
MFAT" 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #KAC]4
M/.048;@#  !9#0  &0              @('H*P( >&PO=V]R:W-H965T<R]S
M:&5E=#8S+GAM;%!+ 0(4 Q0    ( .N&/U3^'-6@!@,  "4*   9
M      " @=<O @!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%
M  @ ZX8_5,WF+XY' P  Y0D  !D              ("!%#," 'AL+W=O<FMS
M:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " #KAC]4+J<&7@,&  "5&@
M&0              @(&2-@( >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+
M 0(4 Q0    ( .N&/U0C?I#OT@<  , E   9              " @<P\ @!X
M;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ ZX8_5*?+AT3;
M!   S!4  !D              ("!U40" 'AL+W=O<FMS:&5E=',O<VAE970V
M."YX;6Q02P$"% ,4    " #KAC]4E>+I.B #   8$@  #0
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:+GAM;%!+!08     3 !, ,L4  !"6 (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>383</ContextCount>
  <ElementCount>551</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>109</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfChangesInShareholdersDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Shareholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/DescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GoingConcern</Role>
      <ShortName>Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note Payable and Accrued Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterest</Role>
      <ShortName>Note Payable and Accrued Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Related Party Agreements and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/RelatedPartyAgreementsAndTransactions</Role>
      <ShortName>Related Party Agreements and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Preferred and Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PreferredAndCommonStock</Role>
      <ShortName>Preferred and Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Equity Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlans</Role>
      <ShortName>Equity Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Temporary Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/TemporaryEquity</Role>
      <ShortName>Temporary Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Stockholders??? Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StockholdersDeficit</Role>
      <ShortName>Stockholders??? Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Inventory</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/IntangibleAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Warrants</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Equity Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlansTables</Role>
      <ShortName>Equity Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlans</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Schedule of Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRevenueBySourceDetails</Role>
      <ShortName>Schedule of Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails</Role>
      <ShortName>Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails</Role>
      <ShortName>Schedule of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GoingConcernDetailsNarrative</Role>
      <ShortName>Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/GoingConcern</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfLeaseCostDetails</Role>
      <ShortName>Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails</Role>
      <ShortName>Schedule of Future Annual Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/LeasesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfInventoryDetails</Role>
      <ShortName>Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Inventory (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryDetailsNarrative</Role>
      <ShortName>Inventory (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/InventoryTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IntangibleAssetsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative</Role>
      <ShortName>Note Payable and Accrued Interest (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/NotePayableAndAccruedInterest</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Agreements and Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/RelatedPartyAgreementsAndTransactions</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Preferred and Common Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PreferredAndCommonStockDetailsNarrative</Role>
      <ShortName>Preferred and Common Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PreferredAndCommonStock</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails</Role>
      <ShortName>Schedule of Outstanding Warrants to Purchase Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Schedule of Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfWarrantsOutstandingDetails</Role>
      <ShortName>Schedule of Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/WarrantsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails</Role>
      <ShortName>Summary of Non-vested Non-qualified Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails</Role>
      <ShortName>Schedule of Incentive Bonus Awards Granted to Employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Equity Incentive Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlansDetailsNarrative</Role>
      <ShortName>Equity Incentive Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlansTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails</Role>
      <ShortName>Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/SubsequentEvents</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Temporary Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/TemporaryEquityDetailsNarrative</Role>
      <ShortName>Temporary Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/TemporaryEquity</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Stockholders??? Deficit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>Stockholders??? Deficit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/StockholdersDeficit</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" original="forms-1a.htm">forms-1a.htm</File>
    <File>ex23-1.htm</File>
    <File>ex23-2.htm</File>
    <File>ex3-1.htm</File>
    <File>ex4-6.htm</File>
    <File>ex4-8.htm</File>
    <File>ex5-1.htm</File>
    <File>srna-20210930.xsd</File>
    <File>srna-20210930_cal.xml</File>
    <File>srna-20210930_def.xml</File>
    <File>srna-20210930_lab.xml</File>
    <File>srna-20210930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>forms-1_002.jpg</File>
    <File>forms-1a_001.jpg</File>
    <File>forms-1a_003.jpg</File>
    <File>logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1381">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "forms-1a.htm": {
   "axisCustom": 0,
   "axisStandard": 29,
   "contextCount": 383,
   "dts": {
    "calculationLink": {
     "local": [
      "srna-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "srna-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "srna-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "srna-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "srna-20210930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 705,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 181,
    "http://surna.com/20210930": 118,
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 302
   },
   "keyCustom": 109,
   "keyStandard": 442,
   "memberCustom": 64,
   "memberStandard": 37,
   "nsprefix": "SRNA",
   "nsuri": "http://surna.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://surna.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Leases",
     "role": "http://surna.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Inventory",
     "role": "http://surna.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Property and Equipment",
     "role": "http://surna.com/role/PropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Intangible Assets",
     "role": "http://surna.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Accounts Payable and Accrued Liabilities",
     "role": "http://surna.com/role/AccountsPayableAndAccruedLiabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Note Payable and Accrued Interest",
     "role": "http://surna.com/role/NotePayableAndAccruedInterest",
     "shortName": "Note Payable and Accrued Interest",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Related Party Agreements and Transactions",
     "role": "http://surna.com/role/RelatedPartyAgreementsAndTransactions",
     "shortName": "Related Party Agreements and Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Commitments and Contingencies",
     "role": "http://surna.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:PreferredAndCommonStockNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Preferred and Common Stock",
     "role": "http://surna.com/role/PreferredAndCommonStock",
     "shortName": "Preferred and Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:PreferredAndCommonStockNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Warrants",
     "role": "http://surna.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:WarrantsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://surna.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Equity Incentive Plans",
     "role": "http://surna.com/role/EquityIncentivePlans",
     "shortName": "Equity Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Income Taxes",
     "role": "http://surna.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Subsequent Events",
     "role": "http://surna.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Temporary Equity",
     "role": "http://surna.com/role/TemporaryEquity",
     "shortName": "Temporary Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Stockholders\u2019 Deficit",
     "role": "http://surna.com/role/StockholdersDeficit",
     "shortName": "Stockholders\u2019 Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)",
     "role": "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation; Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)",
     "role": "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation; Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Leases (Tables)",
     "role": "http://surna.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Inventory (Tables)",
     "role": "http://surna.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Property and Equipment (Tables)",
     "role": "http://surna.com/role/PropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://surna.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Intangible Assets (Tables)",
     "role": "http://surna.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)",
     "role": "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "shortName": "Accounts Payable and Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Warrants (Tables)",
     "role": "http://surna.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Equity Incentive Plans (Tables)",
     "role": "http://surna.com/role/EquityIncentivePlansTables",
     "shortName": "Equity Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Income Taxes (Tables)",
     "role": "http://surna.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Schedule of Revenue by Source (Details)",
     "role": "http://surna.com/role/ScheduleOfRevenueBySourceDetails",
     "shortName": "Schedule of Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30_custom_EquipmentAndSystemsSalesMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)",
     "role": "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
     "shortName": "Schedule of Remaining Performance Obligations Expected to be Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Schedule of Share-based Compensation Costs (Details)",
     "role": "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
     "shortName": "Schedule of Share-based Compensation Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-07-012020-09-30_us-gaap_CostOfSalesMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)",
     "role": "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Going Concern (Details Narrative)",
     "role": "http://surna.com/role/GoingConcernDetailsNarrative",
     "shortName": "Going Concern (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "SRNA:DecreaseInRevenuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://surna.com/role/StatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-07-012021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Schedule of Lease Cost (Details)",
     "role": "http://surna.com/role/ScheduleOfLeaseCostDetails",
     "shortName": "Schedule of Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Schedule of Future Annual Minimum Lease Payments (Details)",
     "role": "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails",
     "shortName": "Schedule of Future Annual Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-07-28",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AreaOfLand",
      "reportCount": 1,
      "unitRef": "sqft",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Leases (Details Narrative)",
     "role": "http://surna.com/role/LeasesDetailsNarrative",
     "shortName": "Leases (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Schedule of Inventory (Details)",
     "role": "http://surna.com/role/ScheduleOfInventoryDetails",
     "shortName": "Schedule of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryFinishedGoods",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - Inventory (Details Narrative)",
     "role": "http://surna.com/role/InventoryDetailsNarrative",
     "shortName": "Inventory (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostOfGoodsAndServicesSoldOverhead",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Schedule of Property and Equipment (Details)",
     "role": "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "shortName": "Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30_us-gaap_FurnitureAndFixturesMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - Property and Equipment (Details Narrative)",
     "role": "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "Property and Equipment (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Schedule of Intangible Assets (Details)",
     "role": "http://surna.com/role/ScheduleOfIntangibleAssetsDetails",
     "shortName": "Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Intangible Assets (Details Narrative)",
     "role": "http://surna.com/role/IntangibleAssetsDetailsNarrative",
     "shortName": "Intangible Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit",
     "role": "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
     "shortName": "Condensed Consolidated Statements of Changes in Shareholders' Deficit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_PreferredStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)",
     "role": "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
     "shortName": "Accounts Payable and Accrued Liabilities (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31_custom_ThreeCustomersMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-02-10",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - Note Payable and Accrued Interest (Details Narrative)",
     "role": "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
     "shortName": "Note Payable and Accrued Interest (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-02-092021-02-10",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - Related Party Agreements and Transactions (Details Narrative)",
     "role": "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
     "shortName": "Related Party Agreements and Transactions (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2018-01-012018-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-03-292021-03-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyDamagesPaidValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "role": "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-03-292021-03-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyDamagesPaidValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - Preferred and Common Stock (Details Narrative)",
     "role": "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
     "shortName": "Preferred and Common Stock (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "SRNA:PreferredAndCommonStockNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember",
      "decimals": "INF",
      "lang": null,
      "name": "SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - Schedule of Outstanding Warrants to Purchase Common Stock (Details)",
     "role": "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails",
     "shortName": "Schedule of Outstanding Warrants to Purchase Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": null,
      "lang": "en-US",
      "name": "SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - Schedule of Warrants Outstanding (Details)",
     "role": "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails",
     "shortName": "Schedule of Warrants Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30_custom_WarrantsRangeMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - Warrants (Details Narrative)",
     "role": "http://surna.com/role/WarrantsDetailsNarrative",
     "shortName": "Warrants (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "SRNA:WarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-012021-06-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - Schedule of Stock Option Activity (Details)",
     "role": "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
     "shortName": "Schedule of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - Summary of Non-vested Non-qualified Stock Option Activity (Details)",
     "role": "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails",
     "shortName": "Summary of Non-vested Non-qualified Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://surna.com/role/StatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - Schedule of Restricted Stock Units Activity (Details)",
     "role": "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
     "shortName": "Schedule of Restricted Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - Schedule of Incentive Bonus Awards Granted to Employees (Details)",
     "role": "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
     "shortName": "Schedule of Incentive Bonus Awards Granted to Employees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-01-01to2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - Equity Incentive Plans (Details Narrative)",
     "role": "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
     "shortName": "Equity Incentive Plans (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)",
     "role": "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails",
     "shortName": "Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - Schedule of Deferred Tax Assets (Details)",
     "role": "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "shortName": "Schedule of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - Income Taxes (Details Narrative)",
     "role": "http://surna.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredCompensationLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - Subsequent Events (Details Narrative)",
     "role": "http://surna.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "Subsequent Events (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2022-01-17_us-gaap_SubsequentEventMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - Temporary Equity (Details Narrative)",
     "role": "http://surna.com/role/TemporaryEquityDetailsNarrative",
     "shortName": "Temporary Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "SRNA:TemporaryEquityTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2021-09-262021-09-28",
      "decimals": "0",
      "lang": null,
      "name": "SRNA:TemporaryEquityNetProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - Stockholders\u2019 Deficit (Details Narrative)",
     "role": "http://surna.com/role/StockholdersDeficitDetailsNarrative",
     "shortName": "Stockholders\u2019 Deficit (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "AsOf2021-09-28_us-gaap_SeriesBPreferredStockMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - Description of Business",
     "role": "http://surna.com/role/DescriptionOfBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies",
     "role": "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies",
     "shortName": "Basis of Presentation; Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Going Concern",
     "role": "http://surna.com/role/GoingConcern",
     "shortName": "Going Concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "forms-1a.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 109,
   "tag": {
    "SRNA_AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment of carrying value of series B preferred stock to redemption value.",
        "label": "Adjustment of carrying value of series B preferred stock to redemption value"
       }
      }
     },
     "localname": "AdjustmentOfCarryingValueOfSeriesBPreferredStockToRedemptionValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital Issuance Of Series B Preferred Stock And Warrants.",
        "label": "Issuance of series B preferred stock and warrants, net"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesBPreferredStockAndWarrants",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_AdjustmentsToAdditionalPaidInCapitalRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital Redemption Value.",
        "label": "Adjustment to redemption value"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalRedemptionValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested stock options accrued in 2019 and issued to employees and direstors in 2020.",
        "label": "Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_AdvertisingAndMarketingExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advertising and Marketing Expenses [Member]",
        "label": "Advertising and Marketing Expenses [Member]"
       }
      }
     },
     "localname": "AdvertisingAndMarketingExpensesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_AggregateSharesIssuedUponExecutionOfSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate common shares issued upon execution of settlement.",
        "label": "Aggregate common shares issued upon execution of settlement"
       }
      }
     },
     "localname": "AggregateSharesIssuedUponExecutionOfSettlement",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_AgreementWithLandLordMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Landlord [Member]",
        "label": "Agreement with Landlord [Member]"
       }
      }
     },
     "localname": "AgreementWithLandLordMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_AprilOneTwentyTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 1, 2021 [Member]",
        "label": "April 1, 2021 [Member]"
       }
      }
     },
     "localname": "AprilOneTwentyTwentyOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_AprilThirtyTwoThousandAndTwentyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 30, 2020 [Member]",
        "label": "April 30, 2020 [Member]"
       }
      }
     },
     "localname": "AprilThirtyTwoThousandAndTwentyMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_ClassOfWarrantOrRightExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercised during the period.",
        "label": "Warrants, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercised",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants exercised.",
        "label": "Aggregate Intrinsic Value, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisedAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants expired during the period.",
        "label": "Warrants, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants expired.",
        "label": "Aggregate Intrinsic Value, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpiredAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants issued during the period.",
        "label": "Warrants, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of warrants issued.",
        "label": "Aggregate Intrinsic Value, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightIssuedAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate intrinsic value of outstanding warrants.",
        "label": "Aggregate intrinsic value of outstanding warrants",
        "periodEndLabel": "Aggregate Intrinsic Value, Ending Balance",
        "periodStartLabel": "Aggregate Intrinsic Value, Beginning Balance"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants exercised.",
        "label": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercised",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants expired.",
        "label": "Weighted Average Exercise Price, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price of warrants issued.",
        "label": "Weighted Average Exercise Price, Issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_CoFoundersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Co-Founders [Member]",
        "label": "Co-Founders [Member]"
       }
      }
     },
     "localname": "CoFoundersMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued in settlement of restricted stock units and award of stock bonuses.",
        "label": "Common shares issued in settlement of restricted stock units and award of stock bonuses"
       }
      }
     },
     "localname": "CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued in settlement of restricted stock units and award of stock bonuses shares.",
        "label": "Common shares issued in settlement of restricted stock units and award of stock bonuses, shares"
       }
      }
     },
     "localname": "CommonSharesIssuedInSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued.",
        "label": "Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued"
       }
      }
     },
     "localname": "CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.",
        "label": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses"
       }
      }
     },
     "localname": "CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.",
        "label": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares"
       }
      }
     },
     "localname": "CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.",
        "label": "Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued"
       }
      }
     },
     "localname": "CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares to be issued in settlement of legal dispute.",
        "label": "Common shares issued in settlement of legal dispute"
       }
      }
     },
     "localname": "CommonSharesToBeIssuedInSettlementOfLegalDispute",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common shares to be issued in settlement of legal dispute shares.",
        "label": "Common shares to be issued in settlement of legal dispute, shares"
       }
      }
     },
     "localname": "CommonSharesToBeIssuedInSettlementOfLegalDisputeShares",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_CommonStockIssuedForOtherExpense": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock issued for other expense.",
        "label": "Common stock issued for other expense"
       }
      }
     },
     "localname": "CommonStockIssuedForOtherExpense",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CommonstockSharesToBeIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock shares to be issued.",
        "label": "CommonstockSharesToBeIssued",
        "periodEndLabel": "Ending balance, shares to be issued",
        "periodStartLabel": "Beginning balance, shares to be issued"
       }
      }
     },
     "localname": "CommonstockSharesToBeIssued",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ConsultingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Agreement [Member]",
        "label": "Consulting Agreement [Member]"
       }
      }
     },
     "localname": "ConsultingAgreementMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability revenue recognized percentage.",
        "label": "ContractWithCustomerLiabilityRevenueRecognizedPercentage",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedPercentage",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_ConvertiblePreferredStockConvertedToSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Series B Stock Dividends.",
        "label": "ConvertiblePreferredStockConvertedToSecurities",
        "negatedLabel": "Convertible Preferred Series B Stock Dividends"
       }
      }
     },
     "localname": "ConvertiblePreferredStockConvertedToSecurities",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_CustomerFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Four [Member]",
        "label": "Customer Four [Member]"
       }
      }
     },
     "localname": "CustomerFourMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One [Member]",
        "label": "Customer One [Member]"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Three [Member]",
        "label": "Customer Three [Member]"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two [Member]",
        "label": "Customer Two [Member]"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_DebtInstrumentRedeemableShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Redeemable Shares.",
        "label": "Redeemable shares"
       }
      }
     },
     "localname": "DebtInstrumentRedeemableShares",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_DebtInstrumentRedeemptionStatedValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Redeemption Stated Value.",
        "label": "Debt instrument redeemption stated value"
       }
      }
     },
     "localname": "DebtInstrumentRedeemptionStatedValue",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_DebtInstrumentRedemptionPricePercentageDividendDueThereon": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Redemption Price Percentage Dividend Due There on.",
        "label": "Redemption price percentage dividend due thereon"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageDividendDueThereon",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_DecreaseInRevenuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in revenue percentage.",
        "label": "Decrease in revenue percentage"
       }
      }
     },
     "localname": "DecreaseInRevenuePercentage",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/GoingConcernDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_DescriptionOfBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Business [Policy Text Block]",
        "label": "DescriptionOfBusinessPolicyTextBlock",
        "verboseLabel": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_DirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors [Member]",
        "label": "Directors [Member]"
       }
      }
     },
     "localname": "DirectorsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_DisclosureLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "terseLabel": "Schedule Of Future Annual Minimum Lease Payments",
        "verboseLabel": "Schedule Of Lease Cost"
       }
      }
     },
     "localname": "DisclosureLeasesAbstract",
     "nsuri": "http://surna.com/20210930",
     "xbrltype": "stringItemType"
    },
    "SRNA_DisclosurePreferredAndCommonStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred And Common Stock"
       }
      }
     },
     "localname": "DisclosurePreferredAndCommonStockAbstract",
     "nsuri": "http://surna.com/20210930",
     "xbrltype": "stringItemType"
    },
    "SRNA_DisclosureTemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity"
       }
      }
     },
     "localname": "DisclosureTemporaryEquityAbstract",
     "nsuri": "http://surna.com/20210930",
     "xbrltype": "stringItemType"
    },
    "SRNA_DisclosureWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "verboseLabel": "Schedule Of Outstanding Warrants To Purchase Common Stock"
       }
      }
     },
     "localname": "DisclosureWarrantsAbstract",
     "nsuri": "http://surna.com/20210930",
     "xbrltype": "stringItemType"
    },
    "SRNA_EmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee [Member]",
        "label": "Employee [Member]"
       }
      }
     },
     "localname": "EmployeeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EmployeesAndConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees And Consultants [Member]",
        "label": "Employees And Consultants [Member]"
       }
      }
     },
     "localname": "EmployeesAndConsultantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EmployeesDirectorsandConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees, Directors and Consultants [Member]",
        "label": "Employees, Directors and Consultants [Member]"
       }
      }
     },
     "localname": "EmployeesDirectorsandConsultantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees [Member]",
        "label": "Employees [Member]"
       }
      }
     },
     "localname": "EmployeesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EmploymentAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employment Agreement [Member]",
        "label": "Employment Agreement [Member]"
       }
      }
     },
     "localname": "EmploymentAgreementMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EngineeringAndOtherServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engineering and Other Services [Member]",
        "label": "Engineering and Other Services [Member]"
       }
      }
     },
     "localname": "EngineeringAndOtherServicesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EquipmentAndSystemsSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment and Systems Sales [Member]",
        "label": "Equipment and Systems Sales [Member]"
       }
      }
     },
     "localname": "EquipmentAndSystemsSalesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_EquipmentDemonstrationAndProductTestingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment, Demonstration and Product Testing Agreement [Member]",
        "label": "Equipment, Demonstration and Product Testing Agreement [Member]"
       }
      }
     },
     "localname": "EquipmentDemonstrationAndProductTestingAgreementMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_FacilityLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility Lease [Member]",
        "label": "Facility Lease [Member]"
       }
      }
     },
     "localname": "FacilityLeaseMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested incentive stock bonuses awarded to employees.",
        "label": "Fair value of vested incentive stock bonuses awarded to employees"
       }
      }
     },
     "localname": "FairValueOfVestedIncentiveStockBonusesAwardedToEmployees",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_FairValueOfVestedStockOptionsGrantedToDirectors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested stock options granted to directors.",
        "label": "Fair value of vested stock options granted to directors"
       }
      }
     },
     "localname": "FairValueOfVestedStockOptionsGrantedToDirectors",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_FairValueOfVestedStockOptionsGrantedToEmployees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of vested stock options granted to employees.",
        "label": "Fair value of vested stock options granted to employees"
       }
      }
     },
     "localname": "FairValueOfVestedStockOptionsGrantedToEmployees",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_FormerEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Employee [Member]",
        "label": "Former Employee [Member]"
       }
      }
     },
     "localname": "FormerEmployeeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_GainOnForgivenessOfNotePayable": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain On Forgiveness Of Note Payable.",
        "label": "GainOnForgivenessOfNotePayable",
        "negatedLabel": "Gain on forgiveness of note payable"
       }
      }
     },
     "localname": "GainOnForgivenessOfNotePayable",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_GoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Going Concern [Policy Tex Block]",
        "label": "GoingConcernPolicyTextBlock",
        "verboseLabel": "Going Concern"
       }
      }
     },
     "localname": "GoingConcernPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impact Of Covid 19 Pandemic On Our Business [Policy Text Block]",
        "label": "Impact of the COVID-19 Pandemic on Our Business"
       }
      }
     },
     "localname": "ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_IncentiveStockBonusAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incentive Stock Bonus Awards [Member]",
        "label": "Incentive Stock Bonus Awards [Member]"
       }
      }
     },
     "localname": "IncentiveStockBonusAwardsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_IncomeTaxReconciliationTrueUpAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation True-up adjustments.",
        "label": "True-up adjustments"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTrueUpAdjustments",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_IncreaseDecreaseInLeaseDeposit": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in lease deposit.",
        "label": "Lease deposit"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseDeposit",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_IndependentDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Independent Directors [Member]",
        "label": "Independent Directors [Member]"
       }
      }
     },
     "localname": "IndependentDirectorsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_IndependentDirectorsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Independent Directors [Member]",
        "label": "Independent Directors [Member] [Default Label]",
        "verboseLabel": "Independent Directors [Member]"
       }
      }
     },
     "localname": "IndependentDirectorsOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_InventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory [Member]",
        "label": "Inventory [Member]"
       }
      }
     },
     "localname": "InventoryMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_InvestmentBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Bank [Member]",
        "label": "Investment Bank [Member]"
       }
      }
     },
     "localname": "InvestmentBankMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_InvestorWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investor Warrant [Member]",
        "label": "Investor Warrant [Member]"
       }
      }
     },
     "localname": "InvestorWarrantMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_IssuanceOfCommonStockExercisePercentageProvision": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance Of Common Stock Exercise Percentage Provision.",
        "label": "[custom:IssuanceOfCommonStockExercisePercentageProvision]"
       }
      }
     },
     "localname": "IssuanceOfCommonStockExercisePercentageProvision",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2024 [Member]",
        "label": "June 30, 2024 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyFourMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2023 [Member]",
        "label": "June 30, 2023 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyThreeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_JuneThirtyTwentyTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 30, 2022 [Member]",
        "label": "June 30, 2022 [Member]"
       }
      }
     },
     "localname": "JuneThirtyTwentyTwentyTwoMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_LeaseTerminationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Termination Agreement [Member]",
        "label": "Lease Termination Agreement [Member]"
       }
      }
     },
     "localname": "LeaseTerminationAgreementMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_LeasedEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leased Equipment [Member]",
        "label": "Leased Equipment [Member]"
       }
      }
     },
     "localname": "LeasedEquipmentMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_MonthlyRentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly rent description.",
        "label": "Monthly rent description"
       }
      }
     },
     "localname": "MonthlyRentDescription",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_MrJamesRShipleyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mr. James R. Shipley [Member].",
        "label": "Mr. James R. Shipley [Member]"
       }
      }
     },
     "localname": "MrJamesRShipleyMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_NetOfImpactOfForegoingItemCharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net of impact of foregoing item charge.",
        "label": "Net of impact of foregoing item charge"
       }
      }
     },
     "localname": "NetOfImpactOfForegoingItemCharge",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carry forward expected to expire amount.",
        "label": "Net operating loss carry forward expected to expire amount"
       }
      }
     },
     "localname": "NetOperatingLossCarryForwardExpectedToExpireAmount",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_NetOperatingLossExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss expiration term.",
        "label": "Net operating loss expiration term"
       }
      }
     },
     "localname": "NetOperatingLossExpirationTerm",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_NolsCarryforwardsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs carryforwards term.",
        "label": "NOLs carryforwards term"
       }
      }
     },
     "localname": "NolsCarryforwardsTerm",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_NolsUsageAgainstTaxableIncomePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NOLs usage against taxable income percentage.",
        "label": "NOLs usage against taxable income, percentage"
       }
      }
     },
     "localname": "NolsUsageAgainstTaxableIncomePercentage",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_NonQualifiedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-qualified Stock Options [Member]",
        "label": "Non-qualified Stock Options [Member]"
       }
      }
     },
     "localname": "NonQualifiedStockOptionsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_NumberOfInvestmentUnitOffered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investment unit offered.",
        "label": "Number of investment unit offered"
       }
      }
     },
     "localname": "NumberOfInvestmentUnitOffered",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "SRNA_NumberOfSharesForfeitedForTerminations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares forfeited for terminations.",
        "label": "Number of shares forfeited for terminations"
       }
      }
     },
     "localname": "NumberOfSharesForfeitedForTerminations",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_NumberOfUnitsVestedAndSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of units, vested and settled.",
        "label": "Number of units, vested and settled"
       }
      }
     },
     "localname": "NumberOfUnitsVestedAndSettled",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_NumberOfUnitsVestedButNotSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Units, Vested but not settled .",
        "label": "Number of Units, Vested but not settled"
       }
      }
     },
     "localname": "NumberOfUnitsVestedButNotSettled",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_OfferedInvestmentsPricePerUnit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offered investments, price per unit.",
        "label": "Offered investments, price per unit"
       }
      }
     },
     "localname": "OfferedInvestmentsPricePerUnit",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_OneCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Customer [Member]",
        "label": "One Customer [Member]"
       }
      }
     },
     "localname": "OneCustomerMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_OptionsIssuedForAccruedEquityCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options issued for accrued equity compensation.",
        "label": "Options issued for accrued equity compensation"
       }
      }
     },
     "localname": "OptionsIssuedForAccruedEquityCompensation",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_OtherRisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Risks And Uncertainties [Policy Text Block]",
        "label": "Other Risks and Uncertainties"
       }
      }
     },
     "localname": "OtherRisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_PercentageOfCommonStockReserve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Common Stock Reserve.",
        "label": "Percentage of common stock reserve"
       }
      }
     },
     "localname": "PercentageOfCommonStockReserve",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_PercentageOfPlacementAgentCashFee": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Placement Agent Cash Fee.",
        "label": "Percentage of placement agent cash fee"
       }
      }
     },
     "localname": "PercentageOfPlacementAgentCashFee",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_PercentageOfPreferredStockConversionProvision": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Preferred Stock Conversion Provision.",
        "label": "Percentage of preferred stock conversion provision"
       }
      }
     },
     "localname": "PercentageOfPreferredStockConversionProvision",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_PreferredAndCommonStockNoteDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred and common stock disclosure text block.",
        "label": "Preferred and Common Stock"
       }
      }
     },
     "localname": "PreferredAndCommonStockNoteDisclosureTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_PrepaidInventoryExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid inventory expenses.",
        "label": "Prepaid inventory expenses"
       }
      }
     },
     "localname": "PrepaidInventoryExpenses",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/InventoryDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ProceedsFromInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from investment.",
        "label": "Proceeds from investment"
       }
      }
     },
     "localname": "ProceedsFromInvestment",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ProceedsFromInvestmentPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from investment per unit.",
        "label": "Proceeds from investment per unit"
       }
      }
     },
     "localname": "ProceedsFromInvestmentPerUnit",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_ProductDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Development Costs [Member]",
        "label": "Product Development Costs [Member]"
       }
      }
     },
     "localname": "ProductDevelopmentCostsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_PurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Agreement [Member]",
        "label": "Purchase Agreement [Member]"
       }
      }
     },
     "localname": "PurchaseAgreementMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_PurchasesOfInventoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases of Inventory [Member]",
        "label": "Purchases of Inventory [Member]"
       }
      }
     },
     "localname": "PurchasesOfInventoryMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_QFourTwoThousandSeventeenWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q4 2017 Warrants [Member]",
        "label": "Q4 2017 Warrants [Member]"
       }
      }
     },
     "localname": "QFourTwoThousandSeventeenWarrantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_QOneTwoThousandSeventeenWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q1 2017 Warrants [Member]",
        "label": "Q1 2017 Warrants [Member]"
       }
      }
     },
     "localname": "QOneTwoThousandSeventeenWarrantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_QTwoTwoThousandEighteenWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 2018 Warrants [Member]",
        "label": "Q2 2018 Warrants [Member]"
       }
      }
     },
     "localname": "QTwoTwoThousandEighteenWarrantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_RedeemWarrantSharesAtPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeem warrant shares at a price.",
        "label": "Redeem warrant shares at a price"
       }
      }
     },
     "localname": "RedeemWarrantSharesAtPrice",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_RedeemableConvertiblePreferredStockAccruedDividends": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Accrued Dividends.",
        "label": "Series B Redeemable Convertible Preferred Stock Accrued Dividends"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockAccruedDividends",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RedeemableConvertiblePreferredStockSubscriptionReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Subscription Receivable.",
        "label": "Series B Redeemable Convertible Preferred Stock Subscription Receivable"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockSubscriptionReceivable",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueRemainingPerformanceObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining performance obligations related to engineering only paid contracts.",
        "label": "Remaining performance obligations related to engineering only paid contracts"
       }
      }
     },
     "localname": "RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueRemainingPerformanceObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining performance obligations related to partial equipment paid contracts.",
        "label": "Remaining performance obligations related to partial equipment paid contracts"
       }
      }
     },
     "localname": "RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental Expense.",
        "label": "Rental expense"
       }
      }
     },
     "localname": "RentalExpense",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units shares issued interest percentage.",
        "label": "Restricted stock units shares issued interest percentage"
       }
      }
     },
     "localname": "RestrictedStockUnitsSharesIssuedInterestPercentage",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "SRNA_ReverseStockSplitPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Stock Split [Policy Text Block]",
        "label": "Reverse Stock Split"
       }
      }
     },
     "localname": "ReverseStockSplitPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Outstanding Warrants To Purchase Common Stock [Table Text Block]",
        "label": "Schedule of Outstanding Warrants to Purchase Common Stock"
       }
      }
     },
     "localname": "ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_SeriesBRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Redeemable Convertible Preferred Stock [Member]",
        "label": "Series B Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_SeriesTwoConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series 2 Convertible Notes [Member]",
        "label": "Series 2 Convertible Notes [Member]"
       }
      }
     },
     "localname": "SeriesTwoConvertibleNotesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_SeriesTwoWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series 2 Warrants [Member]",
        "label": "Series 2 Warrants [Member]"
       }
      }
     },
     "localname": "SeriesTwoWarrantsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares vested and to be settled with issued shares.",
        "label": "Number of shares vested and to be settled with issued shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Outstanding Granted.",
        "label": "Aggregate Intrinsic Value, Outstanding Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement stock issued and outstanding.",
        "label": "Share based compensation arrangement stock issued and outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementStockIssuedAndOutstanding",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested and settled with issuance of share.",
        "label": "Intrinsic value of vested and settled with issuance of share"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased Compensation Arrangement  By Sharebased Payment Award NonOptions Issued Weighted Average Remaining Contractual Terms.",
        "label": "Weighted Average Life of Outstanding Warrants in Months, Issued"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsIssuedWeightedAverageRemainingContractualTerms",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average life of outstanding warrants in months, ending balance.",
        "label": "Weighted Average Life of Outstanding Warrants in Months",
        "verboseLabel": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails",
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average life of outstanding warrants in months, beginning balance.",
        "label": "Weighted Average Life of Outstanding Warrants in Months, Beginning Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance.",
        "label": "Weighted Average Life of Outstanding Warrants in Months, Ending Balance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTermsEnding",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited In Period Fair Value1.",
        "label": "Aggregated Intrinsic Value, Nonvested Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedInPeriodFairValue1",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.",
        "label": "Grant Date Fair Value Nonvested, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Aggregated Intrinsic Value, Nonvested Ending",
        "periodEndLabel": "Aggregated Intrinsic Value, Nonvested Ending",
        "periodStartLabel": "Aggregated Intrinsic Value, Nonvested Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.",
        "label": "Grant Date Fair Value Nonvested, Ending",
        "periodEndLabel": "Grant Date Fair Value Nonvested, Ending",
        "periodStartLabel": "Grant Date Fair Value Nonvested, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.",
        "label": "Grant Date Fair Value Nonvested, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.",
        "label": "Grant Date Fair Value Nonvested, Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Number of Shares, Nonvested, Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Grant Date Fair Value, Expired.",
        "label": "Weighted Average Grant-Date Fair Value, Expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired",
        "label": "Grant Date Fair Value Nonvested, Expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options, Expired.",
        "label": "Number of Options Nonvested, Expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Weighted Average Grant-date Fair Value, Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term, Ending.",
        "label": "Weighted Average Remaining Contractual Term, Outstanding Ending [Default Label]",
        "verboseLabel": "Weighted Average Remaining Contractual Term, Outstanding Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term, expired.",
        "label": "Weighted average remaining contractual term, expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Forfeited.",
        "label": "Weighted Average Remaining Contractual Term, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term, granted.",
        "label": "Weighted Average Remaining Contractual Term, Granted"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options outstanding weighted average remaining contractual terms",
        "label": "Weighted Average Remaining Contractual Term, Outstanding Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for stock incentive bonus.",
        "label": "Number of shares issued for stock incentive bonus"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common stock shares issued in settlement of vested restricted stock, shares.",
        "label": "Number of common stock shares issued in settlement of vested restricted stock, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_StockOptionToPurchaseThresholdsPerformanceBased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock option to purchase - thresholds - performance based.",
        "label": "Stock option to purchase - thresholds - performance based"
       }
      }
     },
     "localname": "StockOptionToPurchaseThresholdsPerformanceBased",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_SubscriptionReceivableSeriesBPreferredStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription receivable - series B preferred stock.",
        "label": "Subscription receivable - series B preferred stock"
       }
      }
     },
     "localname": "SubscriptionReceivableSeriesBPreferredStock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_SupplierOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier One [Member]",
        "label": "Supplier One [Member]"
       }
      }
     },
     "localname": "SupplierOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_SupplierThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Three [Member]",
        "label": "Supplier Three [Member]"
       }
      }
     },
     "localname": "SupplierThreeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_SupplierTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplier Two [Member]",
        "label": "Supplier Two [Member]"
       }
      }
     },
     "localname": "SupplierTwoMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TemporaryEquityNetProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Net Proceeds.",
        "label": "Temporary equity net proceeds"
       }
      }
     },
     "localname": "TemporaryEquityNetProceeds",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_TemporaryEquityNonCashRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Non Cash Redemption Value Adjustment.",
        "label": "Temporary equity non cash redemption value adjustment"
       }
      }
     },
     "localname": "TemporaryEquityNonCashRedemptionValueAdjustment",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_TemporaryEquityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity [Policy Text Block]",
        "label": "TemporaryEquityPolicyTextBlock",
        "verboseLabel": "Temporary Equity"
       }
      }
     },
     "localname": "TemporaryEquityPolicyTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary [Equity Text Block]",
        "label": "TemporaryEquityTextBlock",
        "verboseLabel": "Temporary Equity"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_ThreeCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Customers [Member]",
        "label": "Three Customers [Member]"
       }
      }
     },
     "localname": "ThreeCustomersMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwentyOneEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "21 Employees [Member]",
        "label": "21 Employees [Member]"
       }
      }
     },
     "localname": "TwentyOneEmployeesMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoNewIndependentDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two New Independent Directors [Member]",
        "label": "Two New Independent Directors [Member]"
       }
      }
     },
     "localname": "TwoNewIndependentDirectorsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndNineteenSpecialEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Special Equity Award [Member]",
        "label": "2019 Special Equity Award [Member]"
       }
      }
     },
     "localname": "TwoThousandAndNineteenSpecialEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Incentive Plan [Member]",
        "label": "2017 Equity Incentive Plan [Member] [Default Label]",
        "verboseLabel": "2017 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenEquityIncentivePlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Plan and 2021 Equity Plan [Member]",
        "label": "2017 Equity Plan and 2021 Equity Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndSeventeenEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Incentive Plan [Member]",
        "label": "2017 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyIncentiveAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Incentive Awards [Member]",
        "label": "2020 Incentive Awards [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyIncentiveAwardsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyOneEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Plan [Member]",
        "label": "2021 Equity Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyOneEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 [Member]",
        "label": "2021 [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandAndTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 [Member]",
        "label": "2022 [Member]"
       }
      }
     },
     "localname": "TwoThousandAndTwentyTwoMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandSeventeenEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Plan [Member]",
        "label": "2017 Equity Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandSeventeenEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Incentive Awards [Member]",
        "label": "2021 Incentive Awards [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_TwoThousandTwentyOneEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Plan [Member]",
        "label": "2021 Equity Plan [Member] [Default Label]",
        "verboseLabel": "2021 Equity Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyOneEquityPlanMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_UnamortizedAmountOfTenantImprovementAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized amount of tenant improvement allowance.",
        "label": "Unamortized amount of tenant improvement allowance"
       }
      }
     },
     "localname": "UnamortizedAmountOfTenantImprovementAllowance",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_UnpaidDemoAndTestingFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unpaid demo and Testing Fees.",
        "label": "Unpaid demo and testing Fees"
       }
      }
     },
     "localname": "UnpaidDemoAndTestingFees",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_UnpaidLeaseFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unpaid lease fees.",
        "label": "Unpaid lease fees"
       }
      }
     },
     "localname": "UnpaidLeaseFees",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "SRNA_UnvestedOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested Options [Member]",
        "label": "Unvested Options [Member]"
       }
      }
     },
     "localname": "UnvestedOptionsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_WarrantDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant description.",
        "label": "Warrant description"
       }
      }
     },
     "localname": "WarrantDescription",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "SRNA_WarrantToPurchaseCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant To Purchase Common Stock Shares.",
        "label": "Warrants to purchase of common stock shares"
       }
      }
     },
     "localname": "WarrantToPurchaseCommonStockShares",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "SRNA_WarrantsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Disclosure [Text Block]",
        "label": "WarrantsDisclosureTextBlock",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsDisclosureTextBlock",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "SRNA_WarrantsRangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Range [Member]",
        "label": "Warrants Range [Member]"
       }
      }
     },
     "localname": "WarrantsRangeMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_WarrantsRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Range One [Member]",
        "label": "Warrants Range One [Member]"
       }
      }
     },
     "localname": "WarrantsRangeOneMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_WebSiteDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Web Site Development Costs [Member]",
        "label": "Web Site Development Costs [Member]"
       }
      }
     },
     "localname": "WebSiteDevelopmentCostsMember",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "SRNA_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital deficit.",
        "label": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://surna.com/20210930",
     "presentation": [
      "http://surna.com/role/GoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r646",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://surna.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_ChiefFinancialOfficerMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Financial Officer [Member]"
       }
      }
     },
     "localname": "ChiefFinancialOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r203",
      "r365",
      "r369",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r376",
      "r378",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r605",
      "r608",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r376",
      "r378",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r605",
      "r608",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r203",
      "r365",
      "r369",
      "r607"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r201",
      "r365",
      "r368",
      "r552",
      "r604",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r201",
      "r365",
      "r368",
      "r552",
      "r604",
      "r606"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r288",
      "r327",
      "r374",
      "r376",
      "r378",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r605",
      "r608",
      "r632",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r288",
      "r327",
      "r374",
      "r376",
      "r378",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r605",
      "r608",
      "r632",
      "r633"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r140",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r140",
      "r144",
      "r377"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r140",
      "r144",
      "r260",
      "r377",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r204",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts payable and accrued liabilities",
        "totalLabel": "Total",
        "verboseLabel": "Accounts Payable and Accrued Liabilities, Current"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r578",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities [Default Label]",
        "verboseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r57",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r39",
      "r205",
      "r206"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable (net of allowance for doubtful accounts of $186,073 and $165,098, respectively)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r61"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales commissions payable"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r55",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r40",
      "r418",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r415",
      "r416",
      "r417",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r133",
      "r134",
      "r135",
      "r136",
      "r144",
      "r212",
      "r213",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r271",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r441",
      "r442",
      "r443",
      "r444",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r526",
      "r554",
      "r555",
      "r556",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "Fair value of vested restricted stock units awarded to employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Fair value of vested stock options granted to employees and directors"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r380",
      "r407",
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Total share-based compensation expense included in consolidated statement of operations",
        "verboseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r45",
      "r209",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r107",
      "r234",
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AreaOfLand": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land held.",
        "label": "Area of Land"
       }
      }
     },
     "localname": "AreaOfLand",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r123",
      "r184",
      "r193",
      "r199",
      "r216",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r457",
      "r460",
      "r487",
      "r535",
      "r537",
      "r573",
      "r591"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r77",
      "r123",
      "r216",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r457",
      "r460",
      "r487",
      "r535",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r123",
      "r216",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r457",
      "r460",
      "r487",
      "r535"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total Noncurrent Assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncurrent Assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r381",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r381",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Financial Statement Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r129",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation; Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r52",
      "r109"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r22",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r22",
      "r110",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r102",
      "r109",
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r102",
      "r496"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r140",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r140",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities."
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r120",
      "r123",
      "r148",
      "r149",
      "r152",
      "r155",
      "r157",
      "r163",
      "r164",
      "r165",
      "r216",
      "r272",
      "r277",
      "r278",
      "r279",
      "r283",
      "r284",
      "r325",
      "r326",
      "r330",
      "r334",
      "r487",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.",
        "label": "Class of Warrant or Right, Date from which Warrants or Rights Exercisable"
       }
      }
     },
     "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r350",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise price",
        "periodEndLabel": "Weighted Average Exercise Price, Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance",
        "verboseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails",
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants Outstanding",
        "periodEndLabel": "Warrants Outstanding, Ending Balance",
        "periodStartLabel": "Warrants Outstanding, Beginning Balance",
        "verboseLabel": "Class of Warrant or Right, Outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails",
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r67",
      "r259",
      "r581",
      "r596"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (Note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r256",
      "r257",
      "r258",
      "r263",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r268",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockConvertibleConversionPriceIncrease": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision.",
        "label": "Common Stock, Convertible, Conversion Price, Increase"
       }
      }
     },
     "localname": "CommonStockConvertibleConversionPriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value",
        "verboseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r38",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r38",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.00001 par value; 350,000,000 shares authorized; 1,583,511 and 1,576,844 shares issued and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r203",
      "r485",
      "r486",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r203",
      "r485",
      "r486",
      "r621",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r203",
      "r485",
      "r486",
      "r621",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r169",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r173",
      "r174",
      "r203",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r203",
      "r485",
      "r486",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Basis of Consolidation and Reclassifications"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r352",
      "r353",
      "r366"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue",
        "verboseLabel": "Contract with Customer, Liability, Current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockDescription": {
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of stock, Description"
       }
      }
     },
     "localname": "ConversionOfStockDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r33",
      "r575",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r325",
      "r326",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldOverhead": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indirect cost incurred related to good produced and service rendered.",
        "label": "Cost, Overhead"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldOverhead",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/InventoryDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r90",
      "r123",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r487"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r172",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r302",
      "r309",
      "r310",
      "r311",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Note Payable and Accrued Interest"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r122",
      "r128",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r312",
      "r313",
      "r314",
      "r315",
      "r507",
      "r574",
      "r575",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.",
        "label": "Debt Instrument, Convertible, Liquidation Preference, Per Share"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleLiquidationPreferenceValue": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.",
        "label": "Debt Instrument, Convertible, Liquidation Preference, Value"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleLiquidationPreferenceValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r285",
      "r312",
      "r313",
      "r505",
      "r507",
      "r508"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r63",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r64",
      "r288",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r65",
      "r122",
      "r128",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r312",
      "r313",
      "r314",
      "r315",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r372",
      "r373"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Accrued equity compensation",
        "verboseLabel": "Deferred Compensation Liability, Current"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentCreditCurrent": {
     "auth_ref": [
      "r32",
      "r509",
      "r525"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as current.",
        "label": "Deferred Rent Credit, Current"
       }
      }
     },
     "localname": "DeferredRentCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Net deferred tax assets before valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Other deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r433"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r425",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r107",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r107",
      "r182"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and intangible asset amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r127",
      "r463",
      "r464",
      "r465",
      "r466",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Equity Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r348",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Accrued dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r126",
      "r275",
      "r277",
      "r278",
      "r282",
      "r283",
      "r284",
      "r530",
      "r579",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Loss per common share \u2013 basic and dilutive"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Income (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued payroll liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r81",
      "r82",
      "r83",
      "r130",
      "r131",
      "r132",
      "r134",
      "r141",
      "r143",
      "r162",
      "r220",
      "r341",
      "r348",
      "r415",
      "r416",
      "r417",
      "r443",
      "r444",
      "r478",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r611",
      "r612",
      "r613",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.",
        "label": "Equity Method Investments [Member]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r577",
      "r627"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtendedMaturityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan modification for an extension of the term of a loan in which it must be paid.",
        "label": "Extended Maturity [Member]"
       }
      }
     },
     "localname": "ExtendedMaturityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset."
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r481",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableModificationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Troubled Debt Restructuring [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableModificationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r235",
      "r236",
      "r240",
      "r242",
      "r553",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r240",
      "r557"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r235",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r240",
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Intangible assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r107",
      "r246",
      "r251"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r230",
      "r231",
      "r537",
      "r572"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r232",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r89",
      "r123",
      "r184",
      "r192",
      "r195",
      "r198",
      "r200",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r487"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r107",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r245",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r85",
      "r184",
      "r192",
      "r195",
      "r198",
      "r200",
      "r570",
      "r582",
      "r585",
      "r602"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r252",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r428",
      "r430",
      "r436",
      "r445",
      "r447",
      "r449",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r125",
      "r142",
      "r143",
      "r183",
      "r426",
      "r446",
      "r448",
      "r603"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income taxes",
        "totalLabel": "Reported income tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r80",
      "r423",
      "r424",
      "r430",
      "r431",
      "r435",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Income taxes computed at the federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Adjustment to net operating loss"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "States taxes, net of federal benefits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.",
        "label": "Increase (Decrease) in Accounts and Notes Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r106",
      "r549"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "verboseLabel": "Accrued equity compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Accrued interest"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r106",
      "r518"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Operating lease liability, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r150",
      "r151",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r233",
      "r238"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r84",
      "r181",
      "r504",
      "r506",
      "r584"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r101",
      "r103",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryAdjustments": {
     "auth_ref": [
      "r75",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.",
        "label": "Inventory Adjustments"
       }
      }
     },
     "localname": "InventoryAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r74",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r75",
      "r117",
      "r161",
      "r225",
      "r227",
      "r229",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationAndObsolescenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A revision in the estimate of excess and obsolete inventory to reduce the carrying amount of inventory to net realizable value.",
        "label": "Inventory Valuation and Obsolescence [Member]"
       }
      }
     },
     "localname": "InventoryValuationAndObsolescenceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r74",
      "r228"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Allowance for excess &amp; obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Provision for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCompanyShareholderServiceFeeExpense": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for shareholder services. Includes, but is not limited to, fee and expense for transfer and dividend disbursing agent.",
        "label": "Investment Company, Shareholder Service Fee Expense"
       }
      }
     },
     "localname": "InvestmentCompanyShareholderServiceFeeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Schedule of Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeOperatingLeaseDescription": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of lessee's operating lease.",
        "label": "Lessee, Operating Lease, Description"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Schedule of Future Annual Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Year one"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Year two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Remainder of fiscal year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r60",
      "r123",
      "r194",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r458",
      "r460",
      "r461",
      "r487",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r44",
      "r123",
      "r216",
      "r487",
      "r537",
      "r576",
      "r594"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r62",
      "r123",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r458",
      "r460",
      "r461",
      "r487",
      "r535",
      "r536",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r33",
      "r34",
      "r123",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r458",
      "r460",
      "r461",
      "r487",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Noncurrent Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NONCURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoanRestructuringModificationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by concessions made to the terms of loan contracts.",
        "label": "Loan Restructuring Modification [Axis]"
       }
      }
     },
     "localname": "LoanRestructuringModificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoanRestructuringModificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concessions made to the terms of loan contracts, including but not limited to, interest rate reductions, maturity extensions, principal forgiveness, and payment deferral."
       }
      }
     },
     "localname": "LoanRestructuringModificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Note payable and accrued interest"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r259",
      "r261",
      "r262"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r259",
      "r261",
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Advertising and marketing expenses"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r166",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Description of Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/DescriptionOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r102",
      "r105",
      "r108"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in)/provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GoingConcernDetailsNarrative",
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r78",
      "r79",
      "r83",
      "r86",
      "r108",
      "r123",
      "r133",
      "r137",
      "r138",
      "r139",
      "r140",
      "r142",
      "r143",
      "r153",
      "r184",
      "r192",
      "r195",
      "r198",
      "r200",
      "r216",
      "r272",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r480",
      "r487",
      "r583",
      "r601"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss",
        "negatedLabel": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GoingConcernDetailsNarrative",
      "http://surna.com/role/StatementsOfCashFlows",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r146",
      "r147",
      "r154",
      "r157",
      "r184",
      "r192",
      "r195",
      "r198",
      "r200"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net Loss Available to Common Shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r184",
      "r192",
      "r195",
      "r198",
      "r200"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r517",
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Present value of minimum lease payments",
        "verboseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfFutureAnnualMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Current portion of operating lease liability",
        "verboseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r512"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability, net of current portion",
        "verboseLabel": "Operating lease liability, long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r514",
      "r518"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating cash outflow from operating lease"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r511"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use asset",
        "verboseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization of ROU asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r520",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r519",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrderOrProductionBacklogMember": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.",
        "label": "Order or Production Backlog [Member]"
       }
      }
     },
     "localname": "OrderOrProductionBacklogMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r129",
      "r145",
      "r178",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "verboseLabel": "Basis of Presentation; Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r61"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r61",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForDeposits": {
     "auth_ref": [
      "r99",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.",
        "label": "Payments for Deposits"
       }
      }
     },
     "localname": "PaymentsForDeposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r381",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r37",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value",
        "verboseLabel": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r37",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r37",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock; 150,000,000 shares authorized Series A Preferred stock, $0.00001 par value; 42,030,331 shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding"
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r50",
      "r51"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with security instrument that either represents a creditor or an ownership relationship with the holder of the investment security with a maturity of beyond one year or normal operating cycle, if longer. Includes proceeds from (a) debt, (b) capital lease obligations, (c) mandatory redeemable capital securities, and (d) any combination of (a), (b), or (c).",
        "label": "Proceeds from Issuance of Long-term Debt and Capital Securities, Net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Cash proceeds from sale of preferred stock and warrants, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from issuance of note payable"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from the sale of property equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r269",
      "r270",
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r61",
      "r264",
      "r266"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product warranty accrual"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r623",
      "r624"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r55",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r54",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, gross",
        "verboseLabel": "Property, Plant and Equipment, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r250",
      "r537",
      "r586",
      "r595"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "verboseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r53",
      "r250",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r26",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r87",
      "r224"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r46",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "totalLabel": "Total Temporary Equity"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form.",
        "label": "Series B Redeemable Convertible Preferred Stock, $0.00001 par value; 3,300 and 0 issued and outstanding, respectively"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemablePreferredStockDividends": {
     "auth_ref": [
      "r147",
      "r341",
      "r348"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.",
        "label": "Redeemable Preferred Stock Dividends",
        "negatedLabel": "Convertible Preferred Series B Stock Redemption Value Adjustment"
       }
      }
     },
     "localname": "RedeemablePreferredStockDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r375",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r529",
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r375",
      "r529",
      "r530",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r375",
      "r529",
      "r532",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r527",
      "r528",
      "r530",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Agreements and Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReplacementReserveEscrow": {
     "auth_ref": [
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents those amounts set aside for the repair and replacement of real or personal property in the foreseen future. Such amount may be funded from sales revenue (for example; timeshare sales) or operating revenues; in a lump sum or installments (such as monthly); as per internal policy (for example: hotel operators), as required by contractual agreement (for example: sales contract); or by the terms of debt agreements.",
        "label": "Replacement Reserve Escrow"
       }
      }
     },
     "localname": "ReplacementReserveEscrow",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r422",
      "r551",
      "r634"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Product development costs",
        "verboseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Product Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r41",
      "r348",
      "r418",
      "r537",
      "r593",
      "r615",
      "r620"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/GoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r130",
      "r131",
      "r132",
      "r134",
      "r141",
      "r143",
      "r220",
      "r415",
      "r416",
      "r417",
      "r443",
      "r444",
      "r478",
      "r611",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r179",
      "r180",
      "r191",
      "r196",
      "r197",
      "r201",
      "r202",
      "r203",
      "r364",
      "r365",
      "r552"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue, net",
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GoingConcernDetailsNarrative",
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r179",
      "r180",
      "r191",
      "r196",
      "r197",
      "r201",
      "r202",
      "r203",
      "r364",
      "r365",
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "totalLabel": "Total remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Schedule of Remaining Performance Obligations Expected to be Recognized"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SalariesWagesAndOfficersCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salary and Wage, Excluding Cost of Good and Service Sold"
       }
      }
     },
     "localname": "SalariesWagesAndOfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r173",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable": {
     "auth_ref": [
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financing receivable modified as troubled debt restructuring.",
        "label": "Financing Receivable, Troubled Debt Restructuring [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableTroubledDebtRestructuringsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r235",
      "r239",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r47",
      "r48",
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Summary of Non-vested Non-qualified Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r55",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r394",
      "r399",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Schedule of Share-based Compensation Costs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r381",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r386",
      "r399",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r68",
      "r120",
      "r163",
      "r164",
      "r317",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r330",
      "r334",
      "r339",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r350",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Warrants Outstanding"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityDeposit": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
        "label": "Security Deposit"
       }
      }
     },
     "localname": "SecurityDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative expenses",
        "verboseLabel": "Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://surna.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based compensation",
        "verboseLabel": "Share-based Payment Arrangement, Noncash Expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of Units, Forfeited/canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Weighted Average Grant Date Fair Value, Forfeited/canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Number of Units, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Weighted Average Grant Date Fair Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Aggregated Intrinsic Value, Nonvested Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of Units, ending",
        "periodStartLabel": "Number of Units, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, ending",
        "periodStartLabel": "Weighted Average Grant Date Fair Value, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of Units, Vested and settled with share issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Weighted Average Grant Date Fair Value, Vested and settled with share issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansTables",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails",
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Number of options, exercisable ending",
        "periodEndLabel": "Number of Options, Exercisable Ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Weighted Average Exercise Price, Exercisable Ending",
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable Ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Number of Options, Expired",
        "negatedLabel": "Number of Options, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Number of options, forfeited/cancelled",
        "negatedLabel": "Number of Options, Forfeited/Cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Aggregate Intrinsic Value, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Number of Options, Granted",
        "terseLabel": "Number of Shares, Awarded",
        "verboseLabel": "Number of Options Nonvested, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted Average Grant-Date Fair Value, Granted",
        "verboseLabel": "Weighted Average Grant-date Fair Value, Awarded"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Aggregate Intrinsic Value, Outstanding Ending",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r388",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Number of options, outstanding ending",
        "periodEndLabel": "Number of Options, Outstanding Ending",
        "periodStartLabel": "Number of Options, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Weighted Average Exercise Price, Outstanding Ending",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending",
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "periodEndLabel": "Number of options, outstanding vested and expected to vest ending"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": {
     "auth_ref": [
      "r379",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r379",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r379",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted Average Exercise Price, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Weighted Average Exercise Price, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted Average Exercise Price, Granted",
        "verboseLabel": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r381",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.",
        "label": "Schedule of Incentive Bonus Awards Granted to Employees"
       }
      }
     },
     "localname": "ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
        "periodEndLabel": "Aggregated Intrinsic Value, Outstanding ending",
        "periodStartLabel": "Aggregated Intrinsic Value, Outstanding beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r405",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Aggregate Intrinsic Value, Exercisable Ending",
        "periodEndLabel": "Aggregate Intrinsic Value, Exercisable Ending"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Number of Options Nonvested, Ending",
        "periodEndLabel": "Number of Options Nonvested, Ending",
        "periodStartLabel": "Number of Options Nonvested, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Number of Options Nonvested, Forfeited",
        "negatedLabel": "Number of Options Nonvested, Forfeited",
        "verboseLabel": "Number of Shares, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited.",
        "label": "Weighted Average Grant-Date Fair Value, Forfeited",
        "verboseLabel": "Weighted Average Grant-date Fair Value, Forfeited"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Weighted Average Grant-Date Fair Value, Ending",
        "periodEndLabel": "Weighted Average Grant-Date Fair Value, Ending",
        "periodStartLabel": "Weighted Average Grant-Date Fair Value, Beginning"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Aggregated Intrinsic Value, Vested",
        "negatedLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "negatedLabel": "Number of Options Nonvested, Vested",
        "negatedTerseLabel": "Number of Shares, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Weighted Average Grant-Date Fair Value, Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails",
      "http://surna.com/role/SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfRevenueBySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StandardProductWarrantyDescription": {
     "auth_ref": [
      "r265",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.",
        "label": "Standard Product Warranty Description"
       }
      }
     },
     "localname": "StandardProductWarrantyDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Product Warranty"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r120",
      "r123",
      "r148",
      "r149",
      "r152",
      "r155",
      "r157",
      "r163",
      "r164",
      "r165",
      "r216",
      "r272",
      "r277",
      "r278",
      "r279",
      "r283",
      "r284",
      "r325",
      "r326",
      "r330",
      "r334",
      "r341",
      "r487",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r70",
      "r81",
      "r82",
      "r83",
      "r130",
      "r131",
      "r132",
      "r134",
      "r141",
      "r143",
      "r162",
      "r220",
      "r341",
      "r348",
      "r415",
      "r416",
      "r417",
      "r443",
      "r444",
      "r478",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r611",
      "r612",
      "r613",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r162",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/ScheduleOfShare-basedCompensationCostsDetails",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit",
      "http://surna.com/role/TemporaryEquityDetailsNarrative",
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of preferred stock and warrants for common stock issued.",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Granted, Value, Share-based Payment Arrangement, Forfeited"
       }
      }
     },
     "localname": "StockGrantedDuringPeriodValueSharebasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Common shares issued as compensation for services, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://surna.com/role/EquityIncentivePlansDetailsNarrative",
      "http://surna.com/role/PreferredAndCommonStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r341",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Number of Options, Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockDividend": {
     "auth_ref": [
      "r70",
      "r341",
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued to shareholders as a dividend during the period.",
        "label": "Stock Issued During Period, Value, Stock Dividend",
        "negatedLabel": "Accrued dividends"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Shares redeemed"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Redemption value"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r37",
      "r38",
      "r341",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r38",
      "r42",
      "r43",
      "r123",
      "r211",
      "r216",
      "r487",
      "r537"
     ],
     "calculation": {
      "http://surna.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "negatedLabel": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total Shareholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets",
      "http://surna.com/role/GoingConcernDetailsNarrative",
      "http://surna.com/role/StatementsOfChangesInShareholdersDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r348",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Reverse stock split, Description"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r503",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r503",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r503",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r503",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r538",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
        "label": "Going Concern"
       }
      }
     },
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/GoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEMPORARY EQUITY"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAggregateAmountOfRedemptionRequirement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of redemption requirements for each class or type of redeemable stock classified as temporary equity for each of the five years following the latest balance sheet date. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.",
        "label": "Temporary Equity, Aggregate Amount of Redemption Requirement"
       }
      }
     },
     "localname": "TemporaryEquityAggregateAmountOfRedemptionRequirement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDescription": {
     "auth_ref": [
      "r18",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type or class of security that is classified as temporary equity, including its redemption features (for example, sinking fund, at option of holders, out of future earnings), conversion features, and the rights of holders, if any, in the event of default, including the effect, if any, on junior securities in the event a required dividend, sinking fund, or other redemption payment(s) is not paid. Include also a description of stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Description"
       }
      }
     },
     "localname": "TemporaryEquityDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r18",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical",
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/TemporaryEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TenantImprovements": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.",
        "label": "Tenant Improvements"
       }
      }
     },
     "localname": "TenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r133",
      "r134",
      "r135",
      "r136",
      "r144",
      "r212",
      "r213",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r271",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r441",
      "r442",
      "r443",
      "r444",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r526",
      "r554",
      "r555",
      "r556",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/LeasesDetailsNarrative",
      "http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative",
      "http://surna.com/role/StockholdersDeficitDetailsNarrative",
      "http://surna.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r167",
      "r168",
      "r170",
      "r171",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/WarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average number of common shares outstanding, basic and dilutive"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://surna.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e777-108305"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953676-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953682-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=51888271"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.2,10)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r635": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r636": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r637": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r638": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r639": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r641": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r642": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r643": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r644": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r645": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r646": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r647": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r648": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r649": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r651": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r652": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r653": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r654": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r655": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001493152-22-002747-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-002747-xbrl.zip
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MSR(SSEPR3\R[YSX;5-\1W.>&SU!+ P04   (" #KAC]4UGX6"<,#  #%$P
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M7::$#Z04(A![,26[S)16O\12)*P[H6$3&KLLQ*)@R530] 2>'TBA]#>?WGZ
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MN6EJ&A:G0R>;U^W 70\?&@(-D#A.<+5;/R,[I+$SP>ER3=C<BM@SQC73_[)
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M%G2O:Y(MEW7"Z@K0;39=I"5S$B2I^5$=#[5R"PJ22>-F7L2[A-QKRE?@K$>
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M"FQQ9TXLGD7O^?1GG[A5G5LU"0(U:2Y7=1J$,=!,WL4!"8UZ*.2'I@4!\L.
M#$U,8S1V& 4\7.U4R*TV=?-76P8IZ=UF*?=H(L)X\=ILDUUMYB+[L>T-5U:/
MIUD?NC.B@$[R;#&>6-V_+ "=$FT$NV?Y\L3KV*;;RZ&=C\J6*9L8ZDF^I%;
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M=,GQDG1H0BZ('U:ZY2Y*;B7+FO)Y@$R4G8BNR_VB,;NT[&.KKT MUY523NI
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M,$<X_"_1G:&M4[)3:/+? 7^"45]6YDVJ.)5! ]61@UAS%D$"(9\K=5V?%]1
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M.@]AM8_BFK[F#EK=3D7$^9 VQ$M9RBG](FV_L*1?*>\VMKA?$^G]BXL$34M
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M_'I<^__]]/6+-R__#A[DUW^Y^?67G_\_4$L#!!0   @( .N&/U2&,ECKXTL
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MA1OE$_8GAI&_>7/@JTAS,*R:[E3,5J]E9BE!)S^]YC(]?"]V"1#HZ08(=*-
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M+95UHR%RF",6?BHO$!6F*'4W19?.)2DY<8SYQHZYF=*KULE9D$29IVB,H<+
M7M&Z#3I=R.A]T2H$O9YATQNK2XN!PX!+W;TE48O(K%LECV0AV&/-32+4'S[G
M*OKJ2KQ2O^+3J0BA7'&A9+D0'=,\GBWB[5^!N 97Z_(!EY#J$$*'$@O&Y\BK
M' ;<!W#TRS%XD"V)=[UQH $$^, >:XM+&&;"I>ZY>75["RN4"-=>V1:]]Y4+
M"S;*5ZPLU:M1C96 !$R9W I6Q# ,).A](JLRR]TD-CSQ'*W@2[D["/Q#AMP8
MEB(>7YJ04TA+;%%=G"YUQ3LV 60VRA!E49?$%8QG1L&))]W#8*HVYJO;57ID
M%'B0A2NT=9*9P>G\N34IW)JN=O-B:&U\#(85J*M01*[[',[Y3BTOB92Q-Q+,
M+@D+UWTE8[[V,@Q_,^<*:T 'KG-@\$A#KF"3,E8.X T960//II)P?G8-HC3&
MQ^8U;!3%H *.-2QL/PB_%T 3=#VV\YVJB>[#6C9*<M#UNY)9YRRIE#KCU_3;
MT2TJ:#F:,/2VLE*G*6!0;LOG!A^62C/!+))RKJ5HG?9ATV)D_N"/,]T(0]RH
M:\E-VQ'K\/EHUXT51I%JU_;M- V'%E,1^*0-XVLU\[9,-$2&RP29==1Q!*ZU
M A<.E15[[ Y><+D^]5C,S$H^W?GIIS\CDY*@872ZBCB%#.3)[4#J1O%Q+W69
MQ3#Z"9]E=-IUI+K?<R%&2[;4??D7.&0NY$@F+&=7XX:,&,P)3DG5R(I1:_+W
M51Q@A^&P71/[%?I=C^SWG&<F.%9)' ABDE?\2Q8\NN9Z-^&RRQW?,Y5VI06N
M6!O-)I.C!5XS1R42INY$^V@"F"T14^VJG2!XO[!]6G84Z60*W__A\8N3C^]?
MEM6+1_@G=?AUD,P:=%9Z-=V>FF>9:IG5(B[B61$O'%XKI):LBEJZ@R8(+\3+
M1F=Y)$QK<]":B@&^E,"FH(;&+$!U24J<A^&W)_.6DI"&14'[Z8]H2]P*;<=Q
M.'<0U@'K]:*\& X>"51T7(/D(V."XG[OJHT0K]8Z&ZQ1J#<2&S^,!J@7LBC@
MCBD,.F'!,)V_,BDT,@XI/E4!HCO#T1F1%3BU]6UX;^R_RQ9G)]PFDC:F<B#N
MN+*$MY\Y@.];JE-:HZ#W$B3:#QLDVHTBT7[8(-'6#HEVF_BS-3KE]VX:R""B
MBS.><,X*LZ8@9LB*LF_ 5.7M4 YN4I,W-J&84Y-L21X*&3?'.DZ0BKNUE'3H
MT9& I8*V0!!\<DS<9Y3P6!#95$#[[642D5CG$P9:,.)G_3<T.9Q_EQC61X_/
MMZ@+)U4@F/S<_,TIN''\35VI "+K>\M;9'P)M?1YGDRTHS/)ZQ&SDXLMJW-5
M^.Z&%]3DAU]JJB,_,69?RGK$RQ/0^_C/SSC9@4BQHN%PT)/@4>-\/@(3J_3*
MQ; (ZY+9TM I5R[SND3M+.OZP'<.V\90SK$:O6T0&*I)S@>\&$10V.P+%0:D
M.#A2M(0#*(8A84QL6B8>8 "KM) Z@\!D#]J%GEK(*0P:B8USAX/.]^"\T6UQ
M$I ;>X#S4Q<<"Z79ZH*[+N=.JC@9L$K.HQ?(Y:!^EE/0LWL\71&>Y2ZE?:D-
MYC:>N6(JU6+_P/9GK\6G^!?CWSC4G31W[4_F3"AXANR,3,C?=!&Z!);TP3".
MOX7M3_E)F"(EDD#K;C97AG.O1!M(Q;*Z7+*17W'0/:6'1Q;F/8EJ.XK-U5J"
MB92E6VE4]O<TL 8/H.@)#J_R28^UPBS4MG_0-I?P&D]H))=P/2K)[:B$QB%Z
M!R* ",2RL_+='HM61@8^#=)V&A64<V^[%]., X?2)YO]?Y6F9?-B<S+O)&@\
M4!>67W*&XL)$(]T0KX8I<]R ^ASEV(P]UG$N/HO]GD.'WA%$"RA]W^OW6PJ,
MEFIMEVLBJ"N(QP*,-24-%-"!DVLQ2!K#%+QL&.BYX-?-$H<Q 4,H?R:OG03%
MK5A-2[&[U6 P_!2KO2D+#BJL6XUO:;@%CKF8:(%R0S3N+<!Q*2<HSWF>$*^Q
M0B1PT'8KZK"\[2H1:[6,5+I@%V9&-<\X#>!$1 NNM]6IQ<;NV&Y*]/O@P4/[
M=C<GX-P,5PLC$1EP3ME)B;2,F$)XRT8;;>F0]# 2U'HKQ*XE=4V'D89AV"?Y
MXB"KJODNP2?!?,!6TA>,R!\'MG5R\LH,<7C Y +6\5ZW?,<?6MNP+/<I37>+
M*#":\!:S@MW)S5@F9YLG+7T5Y]97&)*Q@>B(X@J/U"5Y"7K+91T<>E)4NJAA
MIQ'O*1)85J4FNA$X/^\(PU^^=E?^ /W3E\1'_[J)C]YH?/2OF_CHVL5'-_U2
M[^.$QFSNOP?+]P-:OH=N=(LM_4/N76>[H(<$T'Z$K4%MQ??3!*,M!5D<E-VC
M-FG60=7P/S_:QFAA\!VQO=.69^*+J>I\@#*;5UI'0R_H5-4%O68<+^"B2FWM
M(B5:5P$$AP-F(O92!P)#[-W0>AOXVP4;MW9(L>U"V.^5BP2?.6VV&QPZ[0A
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M-0]@@$'/S /C A#@RH+NIR_:_V]J+@T=332P+P\P$_@5W>2C6_69()Y?+CV
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MRJ]+MZ$3165%Q-Y];AK2LR.YJ\ =4*1P<40!ZYC=@6SQK14YO!;D<"2SR/=
M+S+[6BB#H=R8O+;WLPLX,J<P"Q,D@!N3(C1]71P=P:HT6F 1^Q^":!UJQ]$M
M1967QQN+%Z*O'K:N<T:A[F6S>Y(>&>F!@(;F>)"D#X/^,\Y<4W_![4S1E[=[
M)[=*5_']I!='JC7G*>+P*A]BH/Z=RH%8LE29&G(8OVT>H'DQNW*>\_RLRJ(<
M)(6'G]OQ=^/;%6VJX,C\)/+M_[CVCR'_HWT[=/+?]+T3,7Y\D,$B)>RA\/Z]
M!USUTWG71:[/>VFB+'1]"Z@D))!/X9NQ*8%<O.?=-:P@BY(41LOWS$^+^W_+
MBTD T.<+N<7]%+XB(OQ92KD[Z09&1!) 1TK#\,*Q%S4"V%K_L!3RK\)R!+TS
M!Y]W,G8W?O5MA+^XVX7,)YT(@PYA(!VYC+(YHM"P!7F^9 <9^32_YX^EZ"OO
MF<PEG\$$&Z46MKNP8"X37Y+"_2KSF2 7->_W@63#=O.)#2Y%>#1>T5>A MXB
M=77K%;?@J+O]]IDFL8E6IHDZ"8A)1J)P:WT$J7".UB+=S[!S;$78LT[^&KM%
MH/^U6\A@&826E1+\#!]GJ:U2]($.;8[VZ^A$O-?VZ,?)-F$/8L BR>JA*R R
M/D\?>9LB ?<)>#V3\2Q<= A<V+6>705Y@I9/@*OW)]HE_3P!7T*E4.2O&_/^
M$7876%CN*KM92&M/0"N$P=)6E?:Y/Y=K#C+=,.%++([ T1%TE?>F:O8RNSE/
MQ)>X:2<%QT#Y*%<I9FH,7%@NIWL34+#'N]TY@0HCF1;4XA.@OQSEAXBI,HN\
MTR[;U[9T_[*<J'-&DU9XS0]LK*0 1[O"$J8'Q$M!@8970[>='UQ%6VN#R_%=
MRJ7@KZPFZ3-FNY+.YUE\/!HO'_"C9GP%-Z949&/G-N:K//G7AWF[S^*^4.>>
M10P@I@E$Z=L=,V34; QA8G?+Y.EICX!0M%;9_OJUQ,R& 7M3AO)@X38Z14)C
MTH"Q@-\$PP7?#7R.?I,%#O%$?]TO14W=IMZB" 0<6Z!E@/H+VAX/,U^.7?<(
M@S2$318?@98\3_&H3]/,I9+AA9TV-"@TT9XE&3MAP.$+YJ_5GLKU<J%K\B2*
M20,Q,2D<**L;D#PK5X_>>?50%N+YJ6',"?_ECX,@ X'52.P)7P&*]0>Z$PT1
MZC.3U#7_?-C<CN.@=M\0;],A<E,I]HWFY'O$:V^27V%C3\"03D9&:R%%&>#2
MM)U8:#:_%!7"E'BBD/HG(KT4I8O:G>U(U1&"UU6^LN]<I3WPTOS\5F&D(YB?
MFIKB> SI-X0^6V3U3M5: >9XQ+(/&T^W7C='*_IM@/25X5= 25_Y;OW\-R4A
M&38^*<H8?ZEG-30W23FJ=8^;KVI56C?S9#7$G+HZUT']<M[9VX'S5<'M3EU
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M?@+6VR^)&_)]!DRFVP_&?&A*]#&Y<@S7LIW8(.;M/OQSS0EPBGT?XJ*\F"<
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M'9^L$]15'K<YW-0LVZ2U])6T^[U/AZ!A;6W@;$8IK?GK[ ,:=);,O$8<8W>
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MD+:C8\IP6"B&;83?""]"UH;0Q +)H[I&L%+*H+:<)5VNQN=,!!GCKR ^Q",
M [LH"\5)EU9R7 CB@)%HZ<"]P-%+)C[JP&E*:&5*>7WX0GT&WSRG:[3<SXV4
MK99#$OE'KU=)*(*3IV&PIRDW>:9#"?/]OGMF, RUXB]^!&O2UH+4X]003'BA
MZ$XM\ E86)UF=LJM3%S#+/*7<^Q+1]+@6>4,V/UJAL"*)6/M5+P_J^7X>7DX
MPGR3X'SA#W#L0'&ZB<,/YAMVE&G'^LJK1IZ1E-2\>=<V7*+1;1W8+,4B- "\
M#:\DZA7 >K2 !Q<_ 9;FH5Y;A+&?9>GYWXI14O0196&4%*KKGWGLS39YD(DL
MT5HZ= Y3QWU?S@)-3DVE3&403^X$.I'@DBP<);\-&J^B$/+<Y=N;Y.;),?2R
M+7U7E_\A;O#S.8NUYA51#C*#:A3(;U0/A5M=O6V*^XA\YV/=V,EJ[!8/$4N8
M%*DGC);FWP_,]5NLE[DG0G9X7" C @9GF%MSL;JLDBGG$[ST.VY[%#_$NJQ4
MKGTI(\Y2,M9GU,\DT^VIC6P)<L_Z-[),Z/UN5N&JF?DZ%B+D5?+,M98M*S6Q
M]1<+U58Q'++'--^#TRA&?(E*#]B@EFN/"B]2-%(>K+^_O ZLEVYAGVNP4X_3
M;@HZ7F;6EDT<%$PZ7_^A4%WH,*Y-X9BQ)&G)(T^K5C/)E=_0$+9^)RQQ8AK!
M]DEW;8@.<LH$/E!CI?EU1M10#1]LKFJ0^Y:R;ODSYYOU;T4$%SS1G:QG _\$
M*$U9E[_5%L:R+,S6'6;-B#G9X!-UXWM@R,CVP,H58O>PD@GRV(KA8/OZV?L7
M+-TG?U'78K9+9:(.4U*3YMV$]#&/=JZQ9]9:T(3@J4P)CX#\I0!MH$$LDJ95
M@5JC3M22;R3G;<SM&+)$X3)+>OZ2'L>QMJN>LK"SOYT&G'2<>205*Z>PAV Y
MSX,PQ7Q;<=.&"*UI-XL48'36P'/-H)?<W52.*&BD1FI:$I&'=CF'%BSN-0A\
MKZ5XVS:</V-$<5I21.F/3$2$Y(OI(U,UT4I1@8[R"K'1;VE#V=FFET\OX+30
M&H:-P1>*%'-1/XVXQX3DW0+1JBDL+RFYL=2(E!?23EZEM[31X1KN$ZQTCK@B
M:YD:6$>_#/UTXZ#.!SB%/P'A6>#N\HLNZYQ.Z225I,'/[5THVRI/@.?9$X"0
M>[I*;'7=C-NO_1I/V[2MY3P'CN#"NLK0-+8Y [LO>90Z2JSJ++$UJ1PQLFX<
MJF+PJ.J%S/W4Q_X55ZIAH66DMUC='F,?IT,D$]CRO>]&&_DB"[--!2ZFW@X[
MHH7[6_XXI130DLKEQ5G4DO(R$TX6C9$:;WH"_-15"B4G_NKV$2Z>@(O]%A,H
MU7E]<O?U3\/-\?;":S0FLR4D:!R-4?9],A^0?.G_*)1L"&)JI"W\+O3RGQP[
M^OZG5*3,[PD E8<] 2I39?D_-'<=EL2!(;D=*ML-6@.AAKUA=6N"4H/3H[R?
M1%1539B,45#FWPXPDT=+ANN/&3LJ[;IR,NU3)K%J/+%O>X>,(Z+B2=D6(AU^
M0[2 V=8S)D4-\R2UJYHES(]'_GRG)&_1 8?+OCHE[=GZ,ZEYF&IDW]!$N#2&
M7R>(E8)M'UHG4[#7$*/AJLQ/^<6#*=RO[_@)<!P:71?-F_$4F!\-Q3/%DR!5
M,^IOTJ%@L'NWM=%.%H4/LG/:EJ>W+6=BH;I(>]OV"Y3XV?MDZ($&]GM78!RI
MQC%)4:S8W%XC/'$.P_]+ OIJ>F[D-U^OM@-!M<HIIR7BM^V5*EY&]C1FW:F?
M6P <639^(F1J86P"?;D)9N-IZPP*3%VM4NQMH>NXF,K(U-=VBPXWBB_*2#2F
M;>J.9.=W%.*U<W>;S,?"#;<"(K"TA5UA9?HX0]:V:_=[K$>!T]4?M*1E^GYP
M\!6K^5A4GDGF5QC:O6U[B!D@^V- .(;2&;VX21JE +/MGJG1NS%5JJ^/&.*J
M3/B.K&S/EX6D9_FRJQ!34'XRY7R+4G/)<RM4";7SW#TNH$>OMC%V'24_=E[;
MC8QC;.![OQ<67RD49UY">!%B.<92H?H90;"%GIV#UTFH"/S+7L+LQIUDERO<
M%<;CW*S*O_S[!\M&+2=6+@N("Y37U-[H(Z!JW4&AI67E\U41@?>N^\%<_81W
M)N@)T,C\CGZ=>B!*.AOAF"YDY@"]0E?BU!%+1F1LW%8=Y1OE<JU1J)I\X"P:
MLC1_\4NHK9?0/Q8QS /+4JK[*F[%S/9%J8GFQ[%*I5T:91]*3-HP9I/VL8JL
MNH@AQFH"I:FUJ<PQ8B"(%4='RL><X"I../?UA-M7A8D2LK\TR$J#L<AM\DZE
M2R2WUEQE["<9*P@N'*72$9+._N[U*'QDG-"9LOP6 4U_CG6R]_2Y?:=9F'%W
M83LGM2C63D-[QY?:9;+H34*[FW7Q)Y*42)*Z71$1_L)FX/Q))]8C1A<[='$F
M9<+\(&@;26361L 4CI2B)?'=VUE/Y6;Y\7>=@W]UH5C2+UO844BF)5'[RLQN
M'*"Z$&CT=W['JQ3E(^RT+U9&0!6DQV_,3A4F+'+.K+"B.;$A4Q#)X^]AZI7A
M^6'3L!D).2:#/PN%NVNM!9N>FQ'PIWPGY3_>[A(PZXZ=5%"F,9WJ$RK$MY$^
MH2#U>,>M_FG*B<Q4NF6RK/893OE/LX9%_$B^<_98%U(X0H7>G Y/7=80Z9>)
MZ;R+-,>//;7>)KZ$=T=3L[RX>P(?D\87FB)E(H;PDLA4.:^K%D\Y/W$?F2P?
M=,VX[,:]"%?VE<.%+E.7_C!>>#R<JE?6=[5[5PD?:/D5,.+&O%W'8%_>4]](
M8TT9RSDV+5=&JPKO-3?R?S=E.FW49@9^B%D+'M3^12 I?9("3%I[G\_]]()*
M)_9.J..&_AF@393IO T3.59 <NO1:F^=6FUF_[N'IX>H._PFF4K/)] A%KJE
M.1_?'!Q2NB"G2[X_8.+T^N5B_!PQ$N+A;\&!7N0=18M$O$7+65KE"1B9+#+C
M%:1FM)IPUJS?L-&PP3C6X3<^2"2OL*_$C%CUD&$W=I]G3HK0V/ =6N97,8*Q
M8;I 8LFM3Z^H=SD?&9,JQT^R3B.3C*_R6"BGE#6I,;"Z7[ZB%>[E+\^;$L1<
MC()J 3M"S 5B17OCELWQ2DOZ^@%LYNI? U%OE4!KHH1[4],+;<1]\I-.H8?6
M,\A-]=']56EOWI"DMX%@5$5_67+6S+3Z[D6\I!2DC"R9BY"DH],.G6@<1Q&=
M2[R="XHU+*AT(8?1,E9G"SV,8,XF98X.4KI-0& ,B26I\,;0,94[28:9TI^M
M[_YM*JW9J"#_W<QL* LY\SM!1BKE_<>9"<R<8Z3[X6=3+ K=4C2?G\DQS]=:
M: ]V^GS:&5,_^0H5#=0W>J0TG"N_CNERI.6OISD_+_IJ3MF6^4_4G^\)PD&O
M+[)0A831S-P3EOT(#:W"6$J?[7J&=5?%ZN(3T%%BO_H$_!S^_>\E9_^LH-M:
M[V0Y4YT\_4FY39D)Z&?*5NX*^M=]7G(L-I]5[@F%O*P$]5@EW^MU7[YV@.*P
M\>ARAL\?/LY:UI8)R.:<=7F_2RY^67Q3/ZHT8FWE1%=J_8B^EJ+VT%FQIFXR
M7D=SJA=M]7.NS#PFISM":KEW]KV[/?:>6N;[Q"&Y,:NRZ$%KUL^)+F0WGX]]
M5N7OQEX,P# EB3(8R8BU>\2:<CE+91T>&#-D'HKI'U00M=XF%I"5=1>Y,'16
M%I)_;J(QB%+\%/9GRNIMIDZ+0&)2X;YB"^M?^*A(OY&./:$-H6"U#/]Z9L'>
MZS%7#[&ZV*G<F6;?1&/,Z!"R$8=%@RAW(.'DW1/PK4"^:9IYHNM+PJ1 [>_.
M0O9SC:^,DJPXDO.?FN/K&W"UCM%M4/XD$?$I%TW9T/IZMZJRXKAZ6C8OQ8Z2
M9GZ1,P_X&(S$S_M&'+9Z;S<L5:BQGS(3R!R4C<!]5#K (-=BQ>NGX!X03V.,
M^_=>\<7FS/%:QHMIQV0K@T8[4@>W/4HUB",?A8NP8,0T([.16EQ/TE6L>76J
M(TX$T21.0,L.3+ JS6F]2,ML)FYE@4F/H*5ACJJU>FDQ/68CK9SPA+^7K\=B
M>[^O][6*E_^ZA\=NED0&$T%$_NK"N:3 MB_9AB3J&J;$PG$QO9 S5BUK2#D>
M?)K5,?G(VO;+>59ZGII@R%OQK"V'*/?,?U;:U?E\>8:39N2U!58!5L$M6*YB
M?MC9\:2FU_B\#L7$TP<-8Q->"UBXS']3N>41^-!@D<4I:R(]"UG2.8=NJ8Z&
M;EBS]&XOSYB;_HKOPJQAD[Q <D&B]?M> ,DSL7S%*5^N4Y^7;T&<T!)_3]B0
M:4S7N*5A0V@]Q\^_@9_8K%._C%%7W3[V:QYO79RY6IJW-^]OT'OH'TFIKW:B
M9"\2AI>FE,.'1>2(C+[RM 2KGR083GDC),*/[^:,7KE[Z U1&Z%32HA%;/VX
MI/ K/4%?T%G@WMYE92XEK9@K.WF[0I5&ME/T!DJ(>,4UBC>_*.]F-FKMX997
MW)BR/"(?:;QAR4N9T.LZJ@7$>,K0.!.77CNSVMKEO]L[&@KJ[UU5#4;$?2C*
M/(W3E9RIT3'G%#=TH>HAZY)N>O%KSW@_*V4@0+Q9E[5[7-O<?I[YJ!E=@UCW
M<(4>\65<0,;<!G=[A1;4+5>["U%21GE[:4YLMWA? PX0 ],27Q:A.N<O^%;#
M.(-$DE?')/DI$@ .UJ:;E'@8 88I[L[B5.IOZJKK+(PH@B>@G]1G5A5>-XB5
M,'U3\C__/E.1/@R).A=^:+B!L/T,8QP6!D\]9]GWXILH!?<Y!XJ?+KS&%141
M+:]3*1+H]H[D=SRLP6?%O'=;B4ET<@<AJ\[B5"6F3"!P!):"]$89H*^4\!65
MB 9!4,T[^6=Y\MOI[B259=U%7YH,3YOYG"U%  #%W4[LI4QG%-'$: X2&]^F
MT./F."%GSW>0>DPYPVDF*VP"R\HZ$E4:R4)Z5(A&MGM?9^^;@35%UA_IH19=
MX3W-XG^BR]8]CZK>TJW3VOS PZV%.SF;4FO5B3OOO0E[7Y]S/(C$T1>Q92]X
MG86^G5JK)C$:5MLB5^!OF;=$8AV30!;+N?L'"7G=8@E>9)VOA5XRD!.)1,FX
MF=Y]"6#)B$R!' #G_(%,YA8[C==PCLH Z9;FAGBNF8-N#BDJGG54Q4^^HGP'
M$V7S-Y&]%]*Q]T>X?8@&J.E=E)*4I/;\!_.^7":![Z L8DVD!(;[*)LJV0UA
MR_AAA#-\&XJ%Q6SX6+YJWID5&OM)5"3F46DE[4.Q/-^3O40-.$3BD_1H)TK+
M,Y8]VI<_B,;GVAS@/@'6\3CMWP&+50_E536*0#*3ZO98?H+Q.A+_T@+*[XLX
M7@S"^CV)[I(-ED9"/]35S1>&[(U([!L[=B!Y@".^2<U)71M$'N>Q>#4XW46"
MF%JP$8:6E>9-P))>I&E1O^U!-&.,65<5K=J&(A0 RT)W(Z^=Z*(JT=]7T_HD
MPWRYAVBSH)J:S4=+$<VM^B"3UV>*.177+,5)$*KU&D]:2K?H>]]!&##)W+\Z
M)B-<G)Y1952XT'K5@#;>$\.R^JG/+_,'*6Y?F7K-F62"CQ-97=T AWPFHZ="
M. N_H(8OR7.0I9-I\5[ZF%/S+JBM8"\)W=;E:Z>S+OR34FWDZZE 9/#BC/QR
M74%!2&V9U)&9U7+OAE5X7.-)! !LIEWU/H=?FV/X+MO%YLT]D>6Q=1$+?YCK
M_S<^WCJJK:![%S[!0BG20G!MH6BAQ=V+%]?BKL4="@0HT.).\> .18)+:8NV
MN =W=_<O?=^[UKWW6^MW_Y@D,V?.S)R=9^_][#/RSMS<7&3GQW-M=  58AG.
M"'JR>51\FI6;+QR 9=RY6FB-HK02/!DC+S@,DB+9B%1!-;\-3;@:%$9_G>TT
M:O6F<U\,5_@)]9>\:Y4 7<Y_$U!X9J.Q5G_OF )4944G_2' #9+6JI<^^PM!
M[Y$'XCHF&58E[C=OQL2L?CEL[\L_#V1PVD1 J=]3FI??2^I7CV[J.%0Z<T;]
M9%RQH7:LG$ +/%1^F*Q^^&.OO%_M%T'Q9]JC6V!3R*S2&N7$K^M&]1%@E1G]
M7G#LD$X9\G=$/_YB-X$B5K;\"=A!(W(I;C(O^#=1VE!8U]3L6HV%3NNUJ02V
MTN]/>4YK!#W^=:"1<9M+OQ-GC</S>U[%9IXI;7(VE-!GI9Q-8+X?0,+P6:E9
M5S.'G@SS@B,N:36%TAZ4 K\?0QL\!0'![[8NJ+^6NNY<$"%<C.3<2>"Q3'+2
M.B(^]JCQR@62=BN4' ?DJ2\;C>MA7#LC LVHPTFT2'S9X"F-=UZ*+AE-_MNW
MG&[@,_/5/=KKLA:FA55, IW]TO.>"L[:$,X549(71-Y:%U//8SVC)ID5OF8O
M&@C#*17-5!EW;\%A6HT^<7D5BQ\G'44;MPL7Y[LL;V-0J1^_L_!UMA 8>#*V
M3$H9\^T:C4K\@@LT,OK,!<?B*DP]6[$FY+4FV<V)17T]WJ4D5;D?%&U"ZZC:
M?)$>7L9](;JZ[H %71BYG_,UA?)NE>^VG.9NJ>DORK.]J@]C6^:YKAHV]NC[
MT=-F>65K+S%XXL?RH='F((V[-5Q:6+/1C:I_#L^4$36/DK$3-4[_K,; [F9^
M/J1MKC[-/72\T0MWQC(IU /C@1"5M(<N+7Y6.DRQXVOY>7KQ.(6"G?!01LUQ
M#[9+4=%+*"]Q 493F[C(U,JRC4B>IXU#/8K*][EODJ+?I)6K(-;$:@Q?X#@\
ME/**\MTD:N*O(^FLS>F"29VG K-5Q2@9\QJ+'=^PGMUJ-[5FO@AB3_;D0RG1
MN0I3'*_T'[)W>G?K^:7@:YZED0H)=DP!8(VA24,$9$&S% 7Y-^$N9*\N$LJ]
M.E13>QM;Y)Y]J/T]$T7$WN(@31R_J+MS/1NR1A4*I3O/0_DFHMWM@GFHM"^&
M): VBL4'0\^G5*108035^HV<0_*-U_PU9ORW'@$O]6;W[5VQI[^PQ+QISO,H
MUE2 C\.H_GMAE.SRTMZ4UM2[N'Z,MT4(*,0%4S2)\BV>/'N6C"YG7+#8<]@K
M]F@.FTW1WRUA<'9I4QJ?L5#1P Y4,9('AD<@5I2T)Z-Q:%6_<=M .1S7+9(J
M%^FA_N FG385'3_(="0_ N -B*J4=Q',)P2B:F3]*1""#.,U_6U_+[II0$ D
MMW_QJG0WN,O^& CV"!@,W&0S"S)5\XS^Q/\@9A8=7.]KV>Q\N3C&G?HJ?V!E
MU[>:RCZ^6S;UZH?ICE@/,EXLNKBU=^WRT4A[W^=ZP4ZK/]?5__ICX_.#+;F/
M%!Y=JF/[](U7KL6S,VP,F0?MFDN]GR9[ATI0":=?EMO5<VNHSDBC<YTC,$2"
MH/Q1,K_37AV&%E8WN*=]J/C[W*8_; !7&N5CMS:8XJ+;MK]+2(1FV*0QEKO?
MIC:O;V?IW9.[71>^<5F+Z9S>3OL\T4RK5U%G"_1ZMWD.R?4C<H3-W7*>"QK)
M'X_8&V P7!FE9GM>.3W!0P*1;.'VM;2^?5K6%@9!:8[;YN!!5UU+DCKVY?2R
MY-2S65E#3JZ1Y1Q/5#.!1P"/U,AVUUS*AM:T](-R_V\4F>'AZ5=^0S3#&/1E
MI3-VAE23N6-L1 ?O:IT&,%_C:BQA;"G#+6VG1G9\B.(\"Q<=ZFO2>)J2,7]W
M4\\OL4M.V=!DK5;9[JEJ<3\E*V7<@ABK?*F.E"X-KH280OF?,IF,G]_SX1'T
ME<HY['.4\_3!1=1P+XV:<7T\2UI%*[811 GWV:5S!9EG^*((?!7)]UU?%_*N
M?IE3<6X;2'1_P7RG"4Z BPV\B/J0%%[&<3_Z U\D# X8>U%TNRDD8.,X/N]H
M9"+ AJ WHGG<J%T%W>"(_B;#F5C[@UY#'F*COZR1B*1F@RR?L-?2*%6G[$IK
M;M[VPG!=;Z6G9(\5SR<+F#L)]]ZFZY7@/LL-;N)U S-X"&[DCQ0J*OQNCBXP
M=C4]DGKRC8W(6R/^@Y\3)NDC@+5H7!E"BLKT0$2*Y#V]  !0@+;%2+)>A-"W
M#Q-IXG8@:)9#I=\YR.R@6^X^N&='F+6F:_KQ(/3$(=K2A'&:P?B]']H/7/#:
MA<LJNGW2I*5,X% +87%2#"C?K6 MWD5WM47Q0,403G',@W"0U NTN*".3Y$9
MJ]5=:MFJO W-R!%\#A5^?]].9&V_GV064248QC(%$ QXYFCRE!:K" !OT9^2
MT4N\+&9@L U,V!6CF"@LL,JQ:_YI.U:0,:7^=27+*,DRPAK > 3,@]BOQG[7
MI\5$<.F5N>,13U<:TC-J@UVPH3*4RIL&!+FR0!SA#WX05&@L1C_#$OIV'V.1
MPO8SKF[_7,*.I[ ]QOE*"NTL%_36$DH4?19<7' HAL%_Q_2-]OOV]=CIT+*,
M#R#,*&Q]@$R \$,262F$5&AU,LOWGBGB&2.NLCQ@9N4 GI^7+^E%.'?;E ,D
MFZ&[RFH@4M%?8GB,BXOW3%%-F/Q#<*%FLPH.B2*0DB(@*RRSCO2WSMORPLVC
M>.?9(8!(+BD)'YT97$%1^=P42DZ%NV=%6K22"I8\+V%$#6_RYEHDL"W<-;2G
MT&_^\[05LX\##14TVQSK;]33]EKKQBV+?)SMX%QPNZ*H3:Y]NG[A@QRQ-3YS
M8% 3D-PM,&7>6X-2&;Z;%<G!-%\]2P+#E?BED75BH-;'3>+^)22"8_[7,RVM
M3A0>VB E%W;-2FYRO4<@3*6BXN?[82G;^-*,;[,^3C)FG97]7#H;+&2E;_09
M?Q1ACM!=JVK3)(2@TD/9EZ.4?[-<R\>PNUU)U/,#+9O4L85>IEP&VK]?J6IF
MJUY_H91)SEX)$%B\/%2%]=]@GXI1&"07B*0OXU":I)'+%J2N^C:9+23_<HUU
M'J.+Q#[BU/HDR-YTG'_ ;58",H;I7S.'.S,PYSM-#QG.5.9(?.I=LA=Z)H.1
MA2T/&,!P 53D(U%-2OHM14G*UF7P%) K&8X'E /OY<B5BT6C;4D/8./EM#6.
MA ,"@[U!HRQTIQIKSG78E7/NJR251U_N?O:7-08GHR:<<Y/E.EABHM:#G/(8
MCF'8+WRM<KVR-?RT+*#SY8KVKB]^<C O%1Y 0_MZ_,8',$ZF5([K2US-P_I]
M&<733539L7]\'U*=%3XVH)W-R]$&I8Q 7^9' A%0, D,.X!@1G_(SLK;['G6
MKE*37N)G*@O@6;_P14*,C_5Q\F?34W(5V6GWP/&OB4CK7\B9;3M7R&5MB0^1
M6+WJCWQP _7;UNI?13\"BC6U1M7?QFV)47989]\ZXS<'CV=D6'TOW"6ZZ<Z:
M;-Z?V*_HWZ[4?1<ZWCWPU)E!,%J,F@>IH+?E<CU<94%M&(RH:0J-=]R5BW,&
M!V1:Q7TN*;8%\?P\(<Q76YA \&B)G2<91HFG)<)H^N!<ICWP;_+Q8>S+QCD%
MT _ DQN!UQ+IY-7%P3?ZZB77.W"Q)JIH$N":@C!(KEBU"E.!AV^\V1M$"\<=
M-:>E'5YM$_U9<?_MDHJJ4?/#7KN7.1;Q_C/JYCMWDTOET>;GTIS!W7[6J 2_
M'X$F/^8+:X0"N6 'S[JFISVYK#:-.]9OZBFXUCA<C]579=3^+/US:U/H/H.-
MB>#GYU#/9(=@VO6>3[?:"KW"-L5?27Y;%S_IPX)90CFX))1:5MA:YZ4>@5PM
M>*H2SW&PDN%9VQ:*$+H3:"5_%9'@2)]"]1,*"N?+1\D,!Y3J&G/#@6C'9M$%
MR))K9Z'"S^ #IIXL&2-=0.007,#&3Z>&*XVGJWJ2094(9'!2%S *+9WG/P+)
M852)K=P P_R-VO=!S%TQX1A=R9.S;3%LU6_5A_<VTV@ASD-F<E2?VH456:C>
M]DL!9E<9H+S;ZS_9DTW.H\TQ!,9;/ZKN+O215"#Z_T4%-K&8VW>R5@]B*K11
M%Z!D>(-7Y_D[^Z&T@:,I)G.RIIS[FH>54B&U[_5>>VF><W/$A[OXTCC\3AA,
M=B*U]&3$[$-E2'/C*#\J+]:SBXR,U'XC=-GP7>BDED0#ZLLH E6/@S\E>9E*
M)OXTL 'L<L]N&#"U*'QMQ-I1:+7/+1!WSL41S]X8XZRBU\>B6YZ"VO_)(@7)
MWL??N MF,\^D:MQ/J$<+RU66-GX9DT/L[X6[5(\D,O<E,V2=\2[HGP^X)NCN
MI/EX;V@QM\FW[_F)5]@S7^T\LQA\%7GW Q<OIT !OXA-CC[[&Y/!]$A!:4/#
MB(YDN];:_3BE;E,)W*XE/7;!5;H BAD&8(\8$6(I#6GAI\GH*](KF\BJ)PR0
M^^WFPWI*"I94B)KDBMK3U=.>>A>R;KS5Q(M."K%=Z$<8KO5K";2-6R&:LAGT
MOQ!AK#[<8I3;Z*[5S+'"9] :L*XZAW**HYGX&?NX_5?4#QS-;]0_?!/ Y2_5
M_=OP;'MOLGSV%W821>!"SG!A4]9(VE838I'V[5JDJ^ZMYKYP9MA 1<3*#E%V
M_X=5CB#I']YW)6/*A(T8-LEOO="C.?7W<QZ!\(I'8+?L$:#5:E4+&+&_>N"\
M*WOUQ7]0O?ZO_@V/?<Z'9P)O+4QBQ9?&ZF/D<RQ'*T,()'+RGUF 2WH(TV'S
MBP/>+^>XJHA&=1IO*V8)B^IKP^V<3S^Z\>5#OC%,0O/:/JI8Q2G$B>\K+$#)
M)SJP#,\"B)>1OW%78L\+#ICP= &!-,=DF.?=]ORVLJ38<X% 4M1):(Y.=*MZ
M_FUBV&%V < $X&:HK3:L6>_WR",5F7HP-J#BCLDO9LGFOXMB_KFB3%7T3\:K
MJ-^Y  DGO,F"WO/BZB!P<NOPL[6[B*$V0!:S;R.%.[-D(4H$>&=K[AH";F@S
ME[0OWI&W_( [=_ZFCAI6:=N8],1%BN?NJTMM]4C,U96H?, =G%I^ __D5*'Q
MB6M30N6309EB[F'XSRY04UQ88DGC\_'P4ITOX\IY>G.02IU"AOG-P 3]*00W
MI>7R;^S>B+L7]:4QKG-CNO8R,DG8D1](CIXZ:%W<3!KI&Q&SK!^P!= 67XHF
MD5STG97^"2"P>03L'W!"JK?W]6]$BBK^[A,D2>V1VU8UM-FI-4?%:W]TT!((
M@AY'*V^_QT+[M[2W:5=8^O3].'K%*2?M,]S5#*L<\&B]._G$V-EE2M#M]^")
MDI]U%L0,!0WH=!-_LG2SC08S,#!8"'YIG7ISS _09O/=E2J#)\H<*C/F5@KL
M<-EVEO^[ 48S4@*:,0;M@J@  FH>7'D%#&9BF(PPM=5P0'#4L^ LKPW@X<')
M( OP"0>%B.JFM &4 Q#<PG  [,-(N05#";+.W^0"^ORW1%82C_Q:1N7%E+^A
M#D@&MO"]]W& /06#8[UASUQPF:E3;DL> 3^U3QWSRK<[T%=@7.]52%%PG,I=
MTW\NJ)X\ NZBAZ5 >O&N&/]26MCZPT[ HL8WTD$"JO1B%)WVS15;R7'UES0]
ML>S[2@RQZ$CC50S*B\2[MNV8;%(=;>X@#/C?;]K^9^.%T^T1Z3/Q\?L>\_B_
M4 885H:;7WVEW,MSOE0]F;XDK X/M\ N,#?HE<8\+]]5OXAU.J"O+'<U/:$_
MNM4]0-%T<M[A3)L;X[Q/<?Q!:UQNKRX7/8G1^/4;VQ(/50"MIFG:I9)LH=H?
M2$:EMU85#R&#1-$A43_"@T.Q:\?=A2:-)ZI;,Q3SHMC>;>MU9AH:XN];%[F5
M5#/OBUD3CN.$4"-)+38'TUKH *>)S(8RK$IA+EY3E," ]^7XIIZ?B&5L)$<2
MZGA:_]%?Q^85\4LG8I%[V[RVR0X?E*CB-M$6DLO+RN3124%!]] 7)U5J/@F[
M^M_;?/ISK[17)"X+7#(?XBC/_[H*$O;@@H_QMG40?VTPBBB<&34TWX/.*\LC
MP]?A#]R)__Z&S-<6?,7\K\I,5.DJW=;JE5%BLA$9.OC6E:?BC8ZJ^FWY$=1?
M*?/=I?!%/D2#?79JPU<5JV;A?3"\6K>80<XQ[IZ(MJ7)2\Z2X6W$PPBDUD \
M\&&:>U#\$2"@?O:5QBCV3T>1%.6 +I)L:]X:L/F-/0)5FL:-34?GQZ'&V/9!
M2P'/SC%JRICZ>A!E+ GT9QL">KM5WQ%R3NI.[YWX#M^/53T"=?:MZXI0=GV"
MK"3<9O'A#0M^-";P,2%>Z%NWW(#ML@#Y'=>4>M5MTX/K<BM=ZJLRHX?FCA-N
MNZYW]\F+HJ?#CP!SB77 RO> FYU'H'>BBJCAYE7#O9MH?U/\_=_[@-Z8[P,X
M?/W-BBV?6MZ)K1X5UU68V[K*D?U4*3WH^[@)5S1)R!'?7@N0_WF42OVQ<<@Z
M[+3B>IT8LR)5VR;?S3,%Z34VYO@TMX"UA#T67&4BZ&(+_-KU3CE8 ZZ5H'H,
MP.?$<%_J7YQSC\U.ZR)^TT:C8>'1%=/=*[+9)M&-4\8_[5>6B K[0MN19/HC
M5')$+\\/QWIAWB]T4"]4;84]$[8J-,6]8L]#3A^^,?/.[@5S?QNJ>^]9!7E+
M8>N1[R!2G7+)8TJP00\:JVIV:1SS* D3[!4K?TP<Z$Z,!NABWC@M^22HBJ]B
M9JFPL88S7,8UF!V5/D#&EIML*JVD EZ'2)G$XNE/+!+JBM^G;I;;UD@OH<"P
M@Z?'F32=-IMXTV.X!WK7/JC210738I=0=KWQZ3DJ+S0@! T=S"?Z(0-@W6EA
MNU+\C7#+:D]MT&3B&5=J9^%U1#1<\HG(.LU:-;6X[,PG[&=%345F4('G8EA^
M,BN,VV>PASK?F&XHWKHL!]T=DX\?#N\+\[7C<,#?QB9]ZO9GU.X.(TCOWM2?
M:\>$/TZ4S _0;AG;/Y1/__Q:P]CD2Y<"A1S:4X@99@24Z3RE;/>I.?;;Y2+:
MA!F1]O/$>0'MXC."FO'!8\*?0K'OBEC)XJ?WLR9$ONLNBM<%-EHBR(](B^O\
M7O?O>GM?<C81-C>=BTSPAI-PP]MQ_5WORD*ZE0@J6-]<D^Y:O=P(QHR0BZK^
M^[E)M#^]_%W-UBG13K; K?%XLU"X6X2##SW>IES)6P.JK27J^2SX9&Y;2&N'
M1'M?0CZ+H75*?=D?*Y:KT[LNJ=R=X^WM5VVC-4$S<QBRPIV$9C^A2<W"-7FB
MF;9SVUK:,>W6D 8/M*  YI])_/+/,PR+OQ6.6F^R'8@VN'^)G\>"_0SRV1^4
MXV;]D^FII^?U[3Z9=MS'4S1&'E[^QSYO.MV7<9+? >,)M:^C:U;[A)0C1J#M
M=SJ3*G/0&NNHJ-0E5X8]?>'=XM97'V%_*_WPXO O@"8)X &!][WY"F?Y %G0
M*XEJ KI5XO;LBN"MH2?S]"$UT1R<X]KFS-T^M#I]"J:VTC3/%1I]QB@P6/;L
M),)&Q'*AH-&$Z@)*)D$R0'PAT0T2A$Q *H4:P9;-0N*W#2@9+')I=&VS0I!B
M)# K$1CV%GI(;+U!)A1K&-KFU%D>,B13BSZK Q;\9-9E1/).BE3%L-T7\@DZ
M+PJOK6[__#M:HDX%#;<\CU]]Z-+&@[?T$5CDVFY?N@EW$HKU&48S>>)0-G9;
M%Z+#Q*\?/6MKU"Q'R50#F#$@H&3/PX.3-N_3C%ACCM_<GRJ)G[P934':_@)U
M:V$F;6'. 4&4( Z9"L#,JTQT!I7A0;?JO%+#K;+L?Q]PEO<_'W FQ3M/B&'K
MW;Y5S @,J(W#,>NN@AO9]B\)QB?ZPU<F61K?J\,L1+]=$G*J.7]J^;J ($%$
MY]E[Y_$F7R6P?)L^X2]M2/F>B8^8T?O4B Y]P-9(BPGK@K<H.-+%/Q-[OM]W
MS^S'*Q:2$^V;N_?;Z@\MX&<WZ%S%WP@OT[HF]1V(MT'[8&WOZD1N;+J$F^^$
M;C;@AH ?\7*^9K\8>D>U4-C<4J;94NOKTD7X@U1UM$8Y!$D"LTL"#N-TM7+4
M1CZ[R[I$C+R<*#A(L@#"R;_]C,X_9QB?^..[:U=OT9!*9T'ZPA>K#VFGM:BO
M;U(>K@E=WX\DO$]:D\N2V&W !GJXX;P?N#+4I-@<NJ-<VE^*'@LH7ZI?3VE^
M2+FA\+P,6BYRHP'5,=*&>Z6YE#Q]1Y^N2_:10Y$><\M&+K]OCP7V735AP$6K
MX;F>5YH<O5-<>;Q%S*J!);!CA[_ZZYFR,UWACHI!A#'C*O>0(7X*2XSTNS&/
M:J_=-">T^U+1R:9,T]M;(Q7QCY^A0G6KR?P5FD>9C:+<?_>$$[%&JT?MN4Z;
M,;\FW!ZX!-Q,X(?HEB5KR287L))BP$DC?M6\X&?\4G3T,N_H^V"\\CVWX[8N
M\46V8TW\_+?<=A&3/HJ-U$*;U??PMW2A8CKU.L:GNB>BM@6C71].]3?WANZT
ME$2WR[-[)SJ(,W3U J8D[TK7=/$ER]*/!5,L+6?JS-)2-$?5-<.YXJTBI;L"
M57"]RB>8?/EE6AB23NK8L@)6Q,'WOH^ _(^C4+*+):HLV0?39CM?J: NUF B
M#<7T&,-,V^0X6$^!,MU7P7X#C^5$;->T!L53\0ORB.:W[CGTJ2LOW##6+?%+
MA.^EW+[;3FJ_+8^;DP;MD ;%G6,4ME4W=#2\G>LF%8C^3:UBEYW264W\US.2
M6)@4))K))C>6X#S!KJOJ0_A)L;3+CTYKLNBOSJ#"&VFS;G"%[8(>=TJP(?AV
M&W-^3P$E(%.A\,IC3#%1(3G-9&3.J4-<NVJ?Z*%?SRHVM_>M#G;<H'44OXB-
M@@<W<9GOMP5L_IJF1Z R[UJSBHC"6BV@/7NP:)0K?V0EGG'#1K)^10<4/<%3
M4E189CY912N='SJ7QQ!>@%%R<HY.W&?&V[DIP(Z\>^ NQ"$+KB W1B!;=ROD
M4@=M\OO[UKOG2G-AH_)I,A-';GG\LS-1>=O['[ZF&:[!9X652#[G5L9HM"[S
MD?K'R"$BI0$.@,_SKH=]C!\P(A_<_BVK3Q^YKU8:VE0<.N00%E!!;;QC*LH!
MGQ8%,$O?%HU!@.#R /GX/$JS&XU$4%+%SH!I+DG %-_@X4',<7D4AR#GB\:.
MIAC^WJBO=-GJ>C[1$51Y3C6M@Y_9Y@ <=1&B,.KC\S?W)RQ#9?)UI:>ZVQ\M
M7M$?&#Q,?O]IN2,B<%X,_R;U$&N(0NU )R'ZQ?.>N>B.]MERP*C%=<<,8:T]
M (>' UU)Q-9F!L\UF1G(PGL+_I[%12SO*Q$V\-3V%O?+2?0 P8BH (W/.NDZ
MYMKQDBD(%T)7=<,KVX4-K7@F,B*S>*#_P: DV9"D(5R<[H1K5GF>]NDC,%4^
MSL+H*_BIKVZ_7^=HOTQOVR3CV1C/"5Z1[4B:>1 X3;V>KWO%K^2^#:)):::<
MH%[]MH<WT=.ADQ1GSRY')IXH1F+?(B>BX-W-0C5]CI.H*P%.V:SHSXXPW0JA
M$JM5</R5)3O;7MP/M$]%1RO-Z4^YQO96&V(R\Q)V?-.J2K>2;TICWB:F2A-)
M[<9([K"\,;W6]NMU\CAE\DI[&#@+BQF,MM$/)M'"%C^_6$GY:;N;E^,?19MT
MXWSOJ@D[TG_*R#DO] 5O7G,VNZ3RZ_.7SWOP0]Z1J B M#'[AK)T<9F:7#ET
M!4=D?*:'&0<PXJ$0M_P]&QEYI6[H,[7HH%BUZ$3 1W7AWXPCRF7^H<)" C)L
MT1D)%TP3' 9L;/!\= '&W'  !Z*:!I@O.OE)O<%)^]B!_!:DB!<8!G!Q\70_
M!F-.;X=[XBBZ?IFFE@<T;B/.BCP*B^:,"@3A "N#LX+<G J&:/@CL(8KNHOT
M1+KK8/F=_]_Y0X,;V3W75 ]Z=]3?5*4(-[("=Y"QB%_."9JZW\C_FN '24%4
M4!683WH@6;:NIUA1"IQ$B"?["8@,TAKIKKLMT$^-G@6(=\G]LNS3L^F.3-)/
MJZ9(2!=J/!SE#2@?8KUO=ZX.$."X[OY7]],X]6\FH2[1W^@O6.^1!0LSW9W7
MPR@'RH?AO#WWRW)M-=*=<8?B;. YHT$H58%L;R=D)QBW$A= 6X+:VN="B2)C
M=!5S4U"@!$[G>>ZL]%+ "Z%H)N^S_-<<3"[*MH"2#2<RKJ8JC/,=!DU&XHK4
MW3@Z=D,A<=+2UODP@#HMI8W>FUI>=1)*W)A/J0@NAEG10S%NB[85C9J%G94<
M0M-:2R_X8.B7U$D,#@)JYS>CKI$/IE#(V47>] -&\'#<:,RZ&-BH@K<\.T00
M69+^"+ *'XOA(NN_6%82,$VIFHR]'Y4IXOH_]150\:$N@%"%;8L]]XC.OBO)
MS"NZC?FM MI'I&6[6<&X#K+E;?U&MK,800N;)WF+;90"YV?Y5//6(!\_ZPOJ
MK_F;L+MM&=KH("B>R6CLR>[VP!NC@G\;5H91MPZE*+> _(+_D]=(%>$FCBBD
M <*,A[),,KJ X5E8Q1L?R4DHX,VE&I<@+050U=6-G1>I_/<H5K+W:J,JJ*]N
M@W>8?JV+C,NVI)#V<"V^/KWMAH&?#\H8;<K1D]'?J&$.*>[+CE 6;3HD F=(
MG!7L*ZJ>1"O+ZU.X<P$[2BN1U,@@4X8>RB'T?\-+<R4GBL8E8/(_9.5_7DY2
M>)L+*]GD4STOO8:AYZ8G*"0@A=73[QNLM)MQ#IF^%M]AFG?MQH2A4T2ZO8QN
MI<I-J ('RQCB84")J\ 5E%["UKN=N\B\+B!-2^(";N/]:Q@26$AE11YJ:Y!W
M&P0E)4<9=,VR5<K(@I-$Z<KTKV[9?,HYO!X&L4D$+W*-L>"6=R3Q2"%@2VM4
M&^FDZ-/)NV)$M);N0Y ]:MWPN>PW@'/"@,( 0"[C\Q:=W&\+P0AZ0@II.H.8
MQ2F(/0FR><MA,U.XYL %--+F%&Y.36;&J981@6FOBE&4QE-A3C;6(/"_W5J\
M# ,]']5;D/H.R=PZ8%($:/W&D, #G:UD*(.W%0V?_=L]&Y!)V?:?/5<>FQ4
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M<>]G'L;\W0K9_]T+&L=R&,SF]'=#0\JXX[ 4T/J/.MHQ4"-[X7'QMT16N1]
MFJZS_/]T$Y>P+HJL#;2%D) 6[BVY+&:2RY0A\W=8#NO@*GE]:.,F(=E=XT?G
M22A'JUIGG7/,];_3#DW^3>:XY@7/_2VZGF+[?V@L[XOPRE&P\$X)OA6_47^%
M/C[$1&ZC]"O)(_"'$VG!Z]]OLF07D)L/NG0DH4B+GOQ]<'OROZX!6DI-^O>,
MO\.:'S3:S:BO+0,$Q/:'#H8VQ3"FA*=.\BT^16N+RJO2NDU[7>;]_0/50.(
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MN_B<$F=TDL^0_#C^.1LWCJE>SK,7+Z-?8%O1DAJ+'-\S8QS=S[?]'LC?J;)
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MKX/!I&O/O'H:8;C!AWY,,8PX#80QKA4Y8T@>AWZ:/[X6]4+:%%#CY>=[V,*
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M=Q N!IV-*9WE'UB#0#VZ@B/#Q_+_66X0*.,J!D-S6-157KUCTFN83+AZ!+
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MF^GUQJ2'V7R%OVS_,6?T5*ZBJ%_WT.>04\E8R5^6V$>639SQ'RM51JX[;H
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M H6@ZB;>Y&^K%IA\D4D!&O,I-2"$\6GON]:*;P!2X>L! -C-5,?CVK=AY (
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M!EBV I'=_2-#S_TT@P<RK=:VOKG.CV*G/8,\=)&V4XHQ92.:T9S1RCBC!##
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ML_./.+VQ4N:ZX[[5J B^/K6?*(XUJ-><M^R(,D>V%Y7!T^72;/5.PD_(*M5
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MOH=$/%WBT]Z^*=U:.Z%9ILW-.O.5887VWTMB-7S=8^UQTD->'[TT_P/SB7-
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MLW#57%@B%1PH>NY+(XPD\ZG*(AR@]3E9IG-:)3U[!SSW,G-RLE[S&+IP1WK
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MUP(T>G7%C9WEHA\P1SH3L;_9(((S@9'0TEW<27&E7"IY,+2SBY,<*! "%*@
M#H,&J<>F:II]M)?W.F7"P!]K2R1E0I_IS5_1X+CQ!>&V@MI'*HSMM0L  ">2
M/7&![FC06J+,.NW?VJ#4X;N#S8HDC$<B@J0J[<$9[CK5<>(YWCO;>[ 7[<-L
MC]2?FW9'XU:CT&<6ENVFZ?</<O<3)<1",DH%"$ J>GWC]<UD61N+[6RB6DT]
MPF52".,[ACJ2.V/>BPS<M=:>.>&6VEA\Q(UB.5R&4*$PP[Y YJQ-K\L(B>VC
M@MXX95G\N%"%=U/&[))./3.*YK4[N6&Y>UGTQXKA>"DBD,*GTW1?$EVF^UL+
MAXL;OF7C']:D=BG=W-Q#%=PLBI'J#+)(I&2,-N&/3FDFUJ[GOM1N&$>[4(S'
M/A>,$@G'I]T5J7FFA?#TM]=0*;A+M(]R,?NE&)&/J!6;?:!?6<,<UW:75I!*
M<!YHB,^WL?K3N@+47BJZM8[)+58HOL2LL1V[CAB20?4')X]*G&OZG=SVTMEI
MMG;""99\Q1D;F'3.3G;_ +(P*M6WAZ6WTD27&G31Q(VPR21%>?>J_P#PCM_-
M"USIT-T+92=\P4[!CK]: *4<=P5NK190R795IBJX*E6+  ]N371F:"[OK:[U
M"U@FE@B*L?+YG8)M3>"<8&!TJI)H>LZ1ID%[)9B2WFR250@H 0!GMSGBDTYK
MC5)S#:V=R\JC+*J$A1[GH*- U,R262"6%F7[.\+!HRO0D'(-:T.MW?\ :MSJ
M$<D7GWD9CDVH-J@C'RCMC QZ56OM/O;F?R8+.XEFB;;)&D9+(3T!';\:HBUN
M%U0V36MQ'>A@OD%"')^G>LZFQI3-J*\D-O:0AALM"QCP.>6W'/XU)=:G=S%^
M0N^Y^U;E&"LG.,>W-3_V9/INDS/?6\D=PMPB+O&WY2K$^QY'6HK2*XO6VV]K
M-*<A?D0D9Z]?P/Y5BHZ%WUN13ZP\\RL]A91S"99FE2(AG=3G/7 R>N,9K.D$
MPCOQ#( +TYE1EW#[^_Y?3FM.ZL[A;O[*UI,+D#=Y>P[L8SG'<56.DZI<W<EG
M;:?<&>, R )R@/3/IFNB"TU,I/70Q;+49M(N)"((RLJ>7-%*N^*1,YPPZ]0"
M"#Q5P>)+A/-0:=826,D:QM:B,E"%.0Q.=VX'N34XL9+=)-\+C8VR0LI&UO0^
MAX/%(=$@DMIYI(KJ&41J\31)\A!;&6]O0^M5RD\PC>(&OE<(T%H6M1:".-,(
ML8;< !ZY[U2.H74<5M!=PAHX-X24#GYCDYK6TCPG=W.HZ>U_8R3:=/,JO-M*
M$J?<?SK)T[2]6NO..FVUS,L7++L+ #Z^OM0M!/4M13QS#,;@_C4F<5B_:K:=
MB)HW@E7@E!C!]QVJS'+<K'F"2.Y7MV:JYB;%^6X$*$GD]AZU''"TV))N3V7L
M*AM9(V<^<6$Q_OC^56FD1/O.!^-4(?G%-DC25=KJ&![&H7U*WC^_(M59=;MP
M"$W$^H%*XTF1W-BMN^;1B)2?N8S6A;6NQ 9&+.1SSTK'_M@1G,,)#'NQIIU"
M^G/R*03Z*:GF17*V= ?+7JQ_[ZJ&6YMD&&8'ZM6"UO?RN%?S-S=%)JPF@SD
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M !DY'YU%(;SRR[3#'0!1U/I3YNP6[FF&V@D\ 5";@;_G 51WS5/[(ZLINII
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MGVW ^S&LC65DU34[FZ\N$QRN2B$8VIT5>/0 "F!)=:1>PF._FC,-NQ0$/C<
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M]L\563[*9UR.,],Y%6GD6#F.VWKZK@BJYD)H9'<6T)+B-RY[[>*CEEED;?%
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M%-F0CH.?EROZ4R.&[N&_X^H@/]GG]*AADEB!SMD'4E3R:<;B-V)12H/53WH
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M2/RJU<EV&O)-<./N#!P&XZ_6I$6[3'[[:/7)/\ZB!CV@,F<=PF!2,4<!7CE
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M \S*#T'2HVNHY),DDJO0>M,D\E<)L*GOQTI"T>!A"1V(ZTQ'9?"^5'\9?*K
M_9WZXQVKW>/[@KP?X62!O%P 0C_1W^;\J]XC^X*SEN6AU%%%2,**** //OC
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M-*'4A%+HAW/_ ,2X8D4+CS/WI?CTX.*BU*^GG:YF "QR2LX!(S@DG'ZU19Y
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M>6]P%N]9$MS$0;=KD>0A;K_M,.H"G'7K2974H1:%/#/=VSR1$6T/GM*,E'3
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M7C:BEI6:@AU:-"_.2IC-1]8*D[(-?\VVV$[HIO\8[5["&L@R2^8ZZO%]?Q2
M;=<KOZ3/2C3??+ 1._INBV+4A^@UJC\!\I2*&DDL>![09ZY/NNGH7/C3BV]'
M1R8I8*QS<,Z'@TY,;!U1)M?"<#8ULAGY VQ_YMI$C=U#ZC?!(LK7$.7".%[8
M8-"6E$T17X%.,D76W '2WOA@^W3N24U\)Y\C_OCJ/!GY_B.+RLQPFJ/<%H=Z
ME@_Z#6#;%+*)'RQ(1.'WV(JO-S>6.EXU>9[*NLR3AP,\:0,+*G'+"^!SRW_
MJ(!5B<\]J'5OA[+."D#/"<T:6*Q:?5:=N+.G7=/+# %\A+X'GCP\%F?P_%*$
M>=#+-LC92[1J!$*F,JA/7 BFLI9&;6M->/_>93XL&%-@?C=\I*J)&6=_,:FW
M)>5:0%E19+9 &)LJ^%B:2X7\PT@#74T?(,OF:\W4DQ%^@\2&')=?1/3O$KTN
M=<$/D1,IW4DA>7"EJ0K,A5773_EKAG!\%@9V8ERM"L/J:K/,C)6F-BCB1=C3
M0<XC,9"N0D1X]JG5E9,L BPH>#OJZX<.O@/(W<K*<J\V1.4:<PQTU-LW!R6<
M@ V(NJH5)+=[B?%/9;1QMEVY=S;\Z@EBSTI.1<%R[A\AM*_2=O(KG86.M0(J
M7KVEK,O00&L3OJEH\;*GU3J76$]0S;:B_"Y68-VP<G8^ZH^6!"4XXHH!C[/;
MI]2=Q::W=!<7W3DMN[V_(BD(,@93?E?A?LC#WAOP^8*UD^8GQ+8*ZYGFIUAE
M?IB*O8O]1 !Y )D0J9>C"]O%][X055/9+T8HY>,.TMGC'#;X$OO> 4Q+Q;Y#
M/P\\;KS]Q5@EOW4'\&?(L?Q4"87+2UO63<& ]+O\^A7#,_36%(WSPTU]Q0?K
M^Z'Z[;]N!X;ZV >*#277F3.YCG?10&,T!E1#%[I1ZTZW3[UI&DBY7Z4H%5^:
M=AVDEZ+*E]%@ZP?^E0>5*&S!6<7:(SVJFIF&5>[MGK1X)WO/0CV^ZNW3]$R+
MIM@^Z<:XN8Y@O0/XA/5^WY$!L<7Q$56#O.B2RQJ^''M(O2'!VK8,417E"1JU
M8M*+LSMLH95:[?V$L*CHGE]SSK;5.9*J8O%]UH7V/J_TV[FUR&@:X.)]QXVZ
MR@V+5ZO8FCFOY6J!.O U9/#E)?E&ZDW@83'#"JLY.J/0-OH,#@S1=P""$O'W
M[\B:V\\7[X4?.9HD[V=+0>OH+LKCSY=KGZ98\X@8+/KKGB;BTPV1AL:CY41E
M\3H(.!W@LSL".IA6?!I?@75<SX4_6HD83^@E7/X=A4 V1RQHN*SF&?_:Z\*V
M?>LA,>+7TH9'RYX1NYR#LX68_O34);Y6 6YTGFR-#K))Z;&D[CA8+;#7?F2S
M5&W%->2-7@_?MA"+!H[\_N&JY-U?Y%C0G-B39!\JT^DAN&M.?EI91HX4"\RS
M*!A__%WZ[5PWW2LL!=>O(BGB_,$/R[J^W@&<^OENX?4KNEC)\YHDZF&FW8ZU
MY_79%U5.S4G\.;H'E^0_'&-AD G?T]M82]S]^B=F;RD9X@EV@-#O^S]H/E;
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MUR8B[HT61THX2.K96*_:;9[6>21?$A7'38K%"R/#R[(_;NNF=JE(L)0:RU)
M)LE>MS=>,IYL\Z'A?I'/=ZM=VA"+W[N"K$)6S\D46%H^6K1^9)$AEB#CF'1!
M6Q EX6K2"U!K5<&DR)WG>GP'U@2CVH7GGG,< 3[O&.DTMAS*U;.D>31[-2NY
MVQ/4M:A_ND&@L'+9FJ<2ZM5<5\HX=U%I/+$+? OC2HJ\R1C\"YU$[DO>U+(;
M:^10^D6JR(PFH1][/2417[;#SQ-<&#9UA(I3,Y\AC1B--.QXGX2]%JO+-E,K
M':Z-3F5:6"W"@@HT]886?1&%EXB,*%UK8$>[$W'T']L\J _I=OK9N12')A8<
MH>MV0!,EL-H1!2GZR*5VN=@:>@T RYHF?>J:IT1W10=#H+2.%M;&G0:O .\9
M=NW;G@?P[:Z_?]M'OA!?8*B@V"SB;-+9U1]:QA+*(0/1F'Q1DE4']MC8)6)7
M)-/@">^=!&HM?S9[OCZH$]YI?EIQ?[[>:G#T*C&;=1,&V_* :')?^VD+0IMD
M_<L,SS^WFFK4;OA.@#WV&=L%7M \YS\^:NS#HNK<G$ZO:[S0?&U<'YN@Y(-U
M5$*[3Z(Z?@C\V>PLKO.,F7K6XJ6D4HK#(F4]EGVA^^\Y+?K:RD58T8+\CB>8
MK,=&'(?2K?O7+5 R3[A:55RB5T;N-T03C8UU>#EC:7IVWDV+[2=F.&82T.0P
M5E%,V&]]8ZA\K>F_4F>7O2C*Y>K\#>EPJ[QJG!N[4YDIZ7H!WT&COW3&!-^\
M0!4FR"/6)8$;W+XGLMPF"#5CQC0'*I!'Y'+PP1(=Z45,98,:)Y8#'M!K.N5;
M=CC5'%) (?EYKY(*O>&;%_2*%*%KJ(:C3>VZBYLQG>S<"$5S7L'X0=HM"*C.
MJ/$B9)XH7MU3Q 5_?G393(J0+&/RK3A1Q)]INI1\&3=]@&=!8 S,+C317+D'
M!X%$R1!DZ&N*,7OOM8[@1I_**@>8IT9Z-:O;.T$ESBNL2!S'S GG6W;O"X27
MS2"C24&R$SBPYRR%'50A)B%R:H3T&R8$>,TGJ,X?C'Q<_3*4N<H\E_0A-?EA
MN59)9;#Z?,&D:MXR]=45J:/4M>ET4>+"YF/7M^PJ=->+IB@JR;+F8UYZ^A8"
MS C*M/P&&0P]DUF$8RE70_Q+0^DOT;?M;QOO &3^<5;R2:\5S5X$!+]265S\
MT4@N,5GY1=2A+)0F15*UO/R2)HQHL@K*YP6U2?2Y [RN2"#L6TF(EIHJ."?!
MS)=IR0=DK2KCRYNBZGX_1CI2GIU/%\G+4?3C2,AXDM1@Q^SRASY5=ET+XJ.@
MM5!>]H7U+OU. )!"YZKL$>Q&7,5?%\T=.@A\J'?8C]8;6I)T%3#Z]@$;_IOF
M]1^#PE9R:!VU2I%\/;%"_,]TWNF:43'$@^\'-\@?9P6I5Y?:[6 V1^KL9QAP
M"<:(35VU0Z'Y*]/>6P:2+C>7H>2DP?QAWD9JIB =>.(J;>UXA8C9I^"@H'+1
MJ18SI%DY)D#SL &/XTC^BW].E/>Q?=D61;Y3U!ZK52X2<FF024(UXHYBJ12Q
MKE4_NJ ][,846Z<_!5D=4D^?9F:NOIG/F!5/8_#0>T,BX_/SJ7.N9W95)='H
MDH(6>.+P@J+243PJE/E/A$;JVUI>X;R<?>X2^9$P[N/,_6B2(/YW&C&](L5&
M=P"+'&D D3>JN,W0"H@43Y!?9H;.\BM/N*^]>ESK;AXJR[G^W';BY'Y,I+0U
ME]RV(V$X'_'Z343&&\KF.J<IV8>U/R-/TC-7WFH24B&6'7]6HON4!2[Q3! .
MV057!!NT3WIG[-3M2DW_D([D8<FGL"F.@.(^ &ZL*ZKI.1MJWP&PZ[+!A,R>
M\HL0PV"=@J$*!SFBB:\^,28H1 6C!%44/>2D4J_;Z@F_C'3!0[&M'T#E/LD7
MOEV6?]"/E ,V#6 =#%M29PUVH=_2<FQ<I\<XF$A*3^$"(:5>"YBF7\XC"ALM
M0#H'AK#;+^Y$(&>!?L*^H12XW,L$=2/9@\L1EW:V.@*+ULALQMFE-Y ;KJ-K
MFW:!).(D1_*3_)=-Q"J7*&K4K\^KWO*DYG^\>CCT8LB:$GEP3:CB]K:\-(9Y
MO>N3(O\,JBSD[%)+0>5C6HRO07Y>A^SGW0U@.H17IT=<1$(B:0J2+OMA *L<
M6S8#57Q8OR(/?(8>;%MG+V-_6&;;YR?P9^Y:A8^)5.BC *4TI.ZI5;>HS+(M
M[*"B0"KL@XR7G5NA37UC8SQN(*=B^(6>NX_:",/28BRDV!SLSN4P$RB A^<+
M8FX<<H]JH"BM4@*^HQ5-#WC%-G]NE^[85U5A-=[._=LA4+8RG3[=&4)>]]+@
M2R8',B:XG\"4/SX(M1#J\_E4:?E#T(BT&S\E8=S322/'Y;+H8*.E!7>E&5*X
ME)NNY,+W.<!2RA;!Z8G,#*7/(8-VZZ%H6I6[J[.C;-UKONCD9"Y)IF]GL$,K
MO2GOH5C\\MWR%UN&CC:LM5A=O8'VAX7#[R&+IOU85%/10/1/$*LUXP]F5-+Q
MH<;]@<V7H&IH(GNR,]10@D X"^NS^4\KO:8_K\C\AU8-&#;V_.4:J[S_WN!D
M%9E"'>S@1ZS1<@=0/2^Y72J+;19.W.+,*WG^]XK6C&#('2#)3^,.4-5QDU36
M*\A[84>-D)JIO8;8M ,G5#;/VL/VWU>1QY_+#_\DW309@N0;=4O%2;FUN?OX
MK[Z,JW$M2QE,ZBS?- L>%T+1#FB#;!R.#D#8M9ZYQ'4_5%AKV)H-@\LR/_%5
M]/BRA6Y0E_("SZ7V0]ZLNZ'B+E'37VT3<;7(Q;+DIQD"-XKJV/9,V^69GZ)T
MRQ/.6#7V=#P-U.A(<DN>4M7%1%2/4)+4+[#T\7*)OYY3LVFF>/TCHO%\1 *=
ME>RE4AX[-5@?Y%URG,X*E<6Q$=(M[\NE?Z-M^"PR&AZ(/M8N$Q*GEIOBC"M_
MUL0@_BSP%R!%,WQBV ZT]:V'ZQ)ZLIP4Y^&[+EDP*_:P\V!V 9%51:6\6$[\
MW#Q06X!_55>2W9V7[MM;U=(SL@LW>K'X?!LJ@&<Q-H.M-OB-D)!L6TD*"2,@
M/A_*B6F,3K(:?J*23)HC(+@P:ADXF202-;S)@F?0SZW"\EO4C*>Z1&8](F=3
MRX@)7UOV09\I11P.U.1QW%LP=N9W"S#>[\\>V:"HKQ_/TN##6?8S9#-\](IN
M /IWMI]?&TDG5%'EXM7N8&BIHVD\4U9;[?\T$UCCM/O0/36UD@ E?R/V[\HE
MI#@620:,@YFPDG? ])/KK7Y:G,+X'Q9TP5:5LD[26NW&1)C",3&ZNH;\FL_A
M2+T@0!.R6X*E9L28=(!W$+X'Z5J<_RY75'*1'PJBEJ3:X-+[6E@#H[&<*)5>
M2F/7O-==UNNDQ 3!'K5S[:;Y4\RR6@JFS-PE.EL198-Y:,>N=\&K$U_ZGD0L
MTKZOFRJ9:H\;P^..%U.3.UT)AK7(/AUU7J12H%?"S0.'9PV$I+D]:M(DJ+<
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M?73FYV3%H:ST/5<6( $=)3+ _V-@W,W]'U!+ P04  @("  !AS]4
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MPLM!3KK7[T-B4;*7@'<8#L/[]($U&XT<!@;& 7E1W\7(+HA%NH:;-$!NI.$
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M7!UA+6)$)MS;)KU4'6?4M1W&?"_$&>R=/[;^XX] O"T5?88V-5S*B0/20O.
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M>ZED]E+!>)#F3N'F3C$(J&[I8JY$FK;'2IIYTLQ;V9<I\V:W*7"7=J($SE+
MD89FR0S-J@-*6JJ%6ZHEAU!HX$J+35ILV7@::RA8D097*0RN@M==VDLELY<*
MQH,T=PHW=XI!0*4#<WD3:>)H86G<2>-N*;2N_2@=Z91(W"Z-VY)W\YH+=^G5
M2. L!1SI%I7,+:HZH*1?5;A?57((C>TEI([[[8MA&0-O4&VLX/%@3ZK5$TV@
M\<_8O ITK]?4G'A*R?>,AMQ57>N%K=PEVY'G*!A*6_@]L7>)'<)"G$NXU%$U
M=T-4R@W(!I?<&:\$3 Y@QY[1,4F;4N+2B]$7]4_;89@:LW>3:;&IHF4*(AX<
MG3@/SJ-CZQX[_NM"U;Z;=F^+@3&;)%N"C\3CFE[>8.RC!XML!CK8T7HH=*>>
MD#0V8;GV\-UVK7TPX4U=^ZE]V/Q3-\%+&^)\\,"P$043C3ZK9M4/X42/0@CX
M!P?,RE=#BR)A]J2+MC5+UH9M:CF<1% I$52^:KBI;J]$4"D15#Y_=VHL52*H
ME @J7RAUKAT$SJ-%X-%6#\CYX/:)3_$-!]&\>1<MB:IF#4D<E1!'%;2))(Y*
MB*,*6D821R7$487LHR UV3>&0T[-7U5+-^'CI@(HR$=.FW+1,J@J-I'$3LFP
M4R$[2&*G9-BID.TCL5,R[)39WDGVO^+)PF?R"K,GQ.)%C8^F:HF-$N+R>]OZ
MS5--7&Q>MO0PQ-*"BMO8P1X(F.^].IB>3)U*G_FH6V0<<VI+V<!FKX24H(N>
M%TC=A^X&Q-)]"-U:FCT@ 9#N;$U%>(SOE1B;==&PJ9K!+V%3/&PJ:.M+V!0/
MF](JJ5E;^B1LBH9-F2W\Y(QO6W\ECFM0[BQ]49WOQ(7/U^]#6(ZM0!*SEU.1
MH6B)5!7[1T*K6M"JD(TDH54M:%7(CI+0JA:TJF=KB9CU%7DEILUJ%M%ZW1I(
MS9Q^T5*J8K:5A%))H50]6TI"J:10JI[M)*%44BA5R%8*FX"8F+;_A5C$44VP
M0=OZP+ ,ZCI ]E>R1?9XV!AD 8H4+;FJ8D])N%4?;A6RN23<J@^W"MEE$F[5
MAUN%;+?)JL&@MTS;LCS5O!X,37M$""P14N258/$:$)HM4%@O5W4$SJX47(XF
M18N\<AIT:2I7)08W!8.E5;O)05J)P4W#8&D]C:DA.8G!#<1@5>S!A(ZL2%>'
MD?/)H!/G;& 9WQ/NHO#(/7'CFTO\AVQ,9\8):ER,7D;#L9U,<T@W'XDKCNB"
M6%I_H#KC38J35BJ;P; ^V*QKJ9AZ=%_+! B*-DE*:Q:O@Q4WIE&F9,7E6;&P
MYJ&2%:.LV'>(U(N2&4,82'9<<-N5-%(E,V;*C*4Q4LL9-UL3*THC5;)B>8S4
M[69%::1*9BR5D5I.=IS14D(:J9(9,V7&<ABI94ZLK8,5I9$J6;$D1FJ967%:
MZQ.I%24K9LJ*I=&*Y4SUKXD5I5:4K%@>K;C=K"A#-Y(9RQ.Z*2T[KAY);6N:
M[5DNK+)&C%>U8Q)IIY:6'Z<MUM:9JJ6-I:Z/(:6U*AFR/ :K9$AILTJ6+)G9
M6EJF7-V+E&:K9,GJF:VE]2/7QY#2;)4,61ZS53*D-%LE2Y;,;)5,Z=S8GB-Y
M4O)D! B2)6,LV:8/W<D^/#>J9I@PR3NBT@U1:L@M#]VVXZA6CW48BZ D8;KK
MAHEA 1C@*9.1 _^7+->[<<: V!P7J(;5>X:7Z:JCTZ]#'6 &UQ[7FT*Z JM]
M^Z*^&P-OL!F@:.M_ N#Q ?3&=N[)6TB'1\>VX*/&L$(3!=IL:F4GW9X0LGP$
M7-A%5J XG/H8RA.GR N'P N%X2P+9C[,C9G#V/SA?O.LLN0:#[;B9!8.MAZN
M(0-R'%#Y!(!?<2H?+T/EDPC#YV6(G.PW3RI&VSC#XP3R9GAXQU'X-M]N8P;,
M"W$&AL6[I_; %46IOQGJ>I8--V?J12>0<+V6X+802#ERVVG5N>UT#=QV&+Y-
M<EL%N.UP&6X[S9O;8M&N&\^Q#-=S2-O2;XQW_+0AS;S!>0)*N2-LONC"[*[_
M\@QVM$I2U&HZ&3;;"9_ P^^D;V@;<Q#T0AB(3WW+UIT)T[YMZK>#H6._\HC#
M%H)@!ATV%1%SJ^NF$G L([)QY\@OA)PY5,HV\5'!$^Y+6\&V//"%#7YKO<)W
MMC.2J"\0]<PG&%L*"?@INK^YWZA:A#:N#G$">:O#)JQ%9<DU#D6<S,)0C%(Y
M+]G;"@+:K>JG#5K+!+1;:]!PA_OUX^!3U8)MD\F9^O$2R9GZ&D(K863N&9Y%
MZ,43T0D98,')I0W*R7$-^/CHD"YQ'*(_N[;V?3/,AD M7YHJ!8JPJ454\Z+T
M*-K=RBNB.X:6T'G:5G1$BKFV$0^AC(9W'"^.C,VKB%D'5M*,IVQU+^-J$/&R
MA'>15X9A&I K;FR4C,IQ]5$QVA:A8V.'V:()TMY2_3IC]D7KUL)"VQ(1)4%$
M92)G"?"YV&KX),Y^ZP1*)!4 'YP_5"Q9V9 B'($ ,:<'Y\GH]=VQH/O$I*4
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M^5J8 ;L[<3M@SMXS_[9?V$V7_)YD?'5^^]MYN]1'7W[M98FOKFK2!( E#DP
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M1KQ^VJ_-"-Y20P-<@)A%43''JW:[AFGP?#" 1R,.QGSA$28KA@#6PMAE#=C
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M D&B:@;3LBP]N;5>B=#D  IF'$0K=EYM$VT(5>D;(%MT@ELT$'D.P(:?OY2
M(]^>ZQ"8'?.4L:4\ADO/*AEH+[QR?L7!WQ,#A2B>$9>J;,QBQVZ)0O4H'K3P
M&I1S43-8!T\\^+,[6?R%EP3*BMFOXVH"_G(=S^UW/5/QSQV .T 9P%"B:@L5
MNNT'0$ D@TY@V@%DVR#0)B Z)=:F##ZC<>8Q0O;/PS/>-3I%@Y'Z0?*^[923
MV*C1+].COE%\C_JD1/:,%CQ<?YTE=A5?5]_TV6-(FM C>!C/?F*&#T$4?8Q/
M<E8']5GOW5"BA54R,:HQW24I.(^"K%MB/O194\_^P^.DO1V/23M?Q^<9*51=
M6]?Z:9<G/GQ.__V*#GM&?&S./)*KD-)/;.;]\V>:XO6YMV),,8;LW+^O?M0'
M60@,>'9VE\B#!I8^_4R]H6@(Y@UCE<CYM"[.*2P[>13G,L]MAL]5)LO8B^WY
MG&%<0)",CS']/[,F\9*TG<),L^70,L(GC<!9E(:IIE)TN\\4PWET;(T0G?*C
M!K&  K=#8G4.^N8T1SY82Y??C1](GAU$,W"1,\[5Y72^6VR?W?QR]PP;,Z[>
M47325EKB0:O$-\::D!;>9O+%[^F6]C^QK!I+V3E$(YC\PN FB$$>S,3*2=%T
MT0]L3C7&6&YPL5'$NO0$NXEK8?XH(1"KLL*W&J_-\=N>\NTI+/7J5PDL-I(4
M%63+G?IPL-@XIC:<BI:9IGXYRQDK[/QPOQUCVO^,/\T_@#R QE =,<$D!C.>
MIIV=1EYL+)%<3M0OF)[+.6TQ/*@BK3CTJQ"3)K P3B96>*(!4Z;-E]8;N%UC
M_C"7NK ><@BK\CD\VM?5D6(/H\(K!<M,%J0?'A[6X/_SV\_N[GP F?@1D.??
MDMB>3128LN(!NUN+=WQKA#W4%NRI&>OO&13-_*B((4V=B_^ Z0-)>D6T+(=W
M99O6([?&2\*L4::%4]5H$+(&Z#.E&T,P^C&\B$,GIO'JES;%SL@-"EU9<23*
MR@[6QRSG$2[W3\!%YN5TLR@>=!,J(?;6F,:?=0;U:<IN-(;U_?HOSW!'Q0ZW
M(H1=C;7]C4$)IG !W%KJQ5Z'! ^&F+#%=+PU65.V)LN\-5D%J)#43V!QRJRI
MK5JY6"Z+Q@)KKJ]9XY"#SA'8^(#N-]1O]7HCTD$BP+W?]N'T^ 2[0/AGS)_4
M>1>(8BW=I=9GMJ!M24$K>T!NM+0:9WW@_.82G"_-MS'S;;9<.91RI1IR!6O
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MXCI5=33,!H(& 1*!6J0 >%366F2!N^!@FLSPJ %,#'B*"6^S*$%Z8-@%_41
MI0F/<?AG-A+3&W1PJA^^7#_^& 4M>X$]@$7C:E[#V%D$F"%B%3JBH!<1':"Q
M82UPU2-CV]V)# XFB(,;8M-JBNH:3 I<&/$(9FRP@*)F&@-<K+&7X ->?U14
M@ Q,2F<WX[(,.;,@GP47PG5WUU<*,R.1#7=W.H"2?K"RX+BQ=P=H[;)@JX[4
MCXP?GP1#QLR',!#Q;G]<.F%<78M-P8VRFX>+@(^.40]&XP^,/R\^7[X\\&)&
M+&!+,!Q?T5 RP&6P6! W$"CX;(1>2&8>N@NY3L KLJ US@O[0:CNU6#VW+[
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MG'2()I2(W230E]DC\-T(90QA@B,BX#:#.4593NQ3)6<RNUKN6%;+95<MUW:
M';7)2KF&K)0KJE)N81[-6(R4J+"M:%*4W]SY W198+6#F4&)^1I:SR(B@&$
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MA'23.S,[1YHB&M--D5WXAN=27 3*")#E=##?X)8)=^#)9UD]D[I/>5G*WBM
M\DR*EIWAS6W7JTPEG";C*/)WCOO16[Q,8IM17%'TG>OZDX"">06ZI4)>\/P7
M38SQ#P^@25HM\"E>50_CV)-_976>>2[!/I%&@,AO(N3U:BWNDD):K(#VM] W
MP8<6-B(-D>H)T*$KJD+CTX.8^N,\:DW7C8&:(QY3&":_:@>655[RB'5Y.F.1
MGM<2P/Z 6S^>)SLPBO$\N1,KO_/GR:]U+B'";C,TA8N)8A$OF'-0VN]JH\<!
M>K#DY;QF7$9K>9U7;Y__WQ^2G_EV;JMF]&\YPI9)UC3KFJF9K 4O6]KBQY=*
M#ZF*7-^MF10-A<J3,OUMNCDLZ1ZG\<SS"BJ]</Y,C/X\<PJ HU,'C6> D2ND
M2G56(<1J08U6V:-6V:60MFD_K5%I[L H1J5Y)U;^#BO-3V[_^=(@_S)$5F1Y
M.879NURZ60[[<I8+]Z*A>]%HD73-&3?XGH!8V#?T9 8G:6EBG1U]H_2X8V6S
M7D(-D3)%6(&[-9::95K5[@ <*NB4*'TBE9S8K?LM5>X4@/?.8Y<^A\/L>>A]
M^;)DJ 0$8L=;P=Q]Z6#ZM1!B8W)$P#?(@(##IR2%#YX^2MY4ZW:1_)H[\O>2
M4^')2-^LP:KZ/$W^4:WSYAPN=YH\KPI:2;(.GAX=G3P1]J'6%6ZU0&=#=5C)
M/+GWX.C!_>39LP<'CTZ>W%(ONEW=6C>_Z!=NTF#QLMFL5NJ]SN/X?63]5<+*
M^9V$4 IRA/_TGQ<7%X=3EP7"Y$-2FCH/ CW*PQXV+]I>F*-5KP/C"Q+T;25T
MQ[[WK6KSG#LV(&??KAMNVBQ7(M[B&\N&*T;IN69+O&^\NN#96%UPH]4%#\?J
M@IVI+OB2W3 _JWKA!EIA#4W]1Q<V_+%Z8,DT?<Y(Y<Y\]G_^E/W[]_]'QMR?
M;,AO__YB?^_53S^]>/WRE[_=XJ=\QN.')"C60O2(#=TO*N,.'N\W<[[V!_<I
MQ24G-UY<\CFQC$&=KN]_\/0O-QG78)]5NJLSY$ ZVG+7G]EWG2WQ>>&9JS[I
MY$:_Z$;CB?UARY;R(W\,6?C"D:>3]-EC_/>!KI!$C>YMB0T-AH40#R\Y)UM/
M\\8'H$!520,O*F&VJ+@,YOZ-1;H_JS)J,%2Z(T*R2V,U@?["0GRSD?2[+%FD
M4'_3?6>L?+>A3$>!ZWY#=PW0!$7#[-9:W+3JEB[DA\F;@$\Q<$=U@<9,BWPE
MU.H<%VJD:T+0M4A:6DH Y,&B= ,5$2<GZVS&5HI  U?@1]><ZCR?<T/+$AV>
MT-K.M#5Z/7%C*E+\7( GRR3_^R)#:T$90S?+ZI6^)$.KN8SBS_'=V_X7 ,5,
M)FAS?ACBW8*6F$-JR*I*UA5MHT([09V7-+FLUFBIAI*\*3V00> R%FZ[@XNU
M?<6/KIG6^<JZZ. O;]QT73-JQKI96/^+@2!:\C_A55G15.$%7$2#EC<R*JU#
MU-QO0W,/[E!POV/>%ODD]SR<PC6OK7T8("0LGTAL:S.-9GLT[QO6=^-).IZD
M7^PD_=4;LYIV56T2GZ4W^;[QL!Z2Z<^,-'WYLUY/UNO^!\<9GPN6:1<ECVIN
MLQ* =\W9H<(9$?_%<R?'."3-]7S<,/S;I4X]@&D9NF0#(?.B.G/,E\A=(YF$
M?TXG5>Y[/P;L*4-,/VX4C/S%[$Y<Z:2G',I:+[@3P!(-"^B,*Y.'A\^>_26Y
M!X- FH6[(CZ .P-^AFOO?^QD2*>_=<N&A#1>B6<X,JE\ARI=B+)!([2.-= #
MNEWW/^P5KT!ENRX5R&S?Q?+ ;2Q)<*:+JL*O^K;D@/.=&BCCH^=C0\H$1<?"
MPJP2%S#K(@RVMTYSF"]3[IT^CU:.U^4C9P3&$%J03F&NWO_0,G7SE[C_;FN.
M@>CFW1_TVX6Q_9E*,M,^<7 #AB) [!*@<K*(@)$K<+ .&??6'KDJ9F;_*E34
MDMJ]_;7,RW63_/GH\.@XH"\W/(]MPY/139P\( QKE*9;&/1/1O*R=7&$IT#<
MW%"G,>PV&S=..-MT:0V R^#:C/Z'WE/5!X#23+(F%ZH7&4AXAQ=?EL2^[&G=
M'MHW<),$:=JE^A#14/N]'JG+_/V@6A5B\XT]H^%6>O,HA[<P:$0PM@$;O11M
M":SP$BH*W+0.([X0$&_IO0F:PA71W_)2.EJ#S+EM) 3#%@3B&C*,:P0W!H_[
MH3C')X4X5  _)\ZQ.4"C7KI^M,,20Q\9\EA]V\[I&/88PQY?+.SQO&/U,V P
MLK@UC#SGCG#Q@3A&+6Y5)!^FCQX_28\?/^HF9NE(>90>'1^GCX^>V2_%=92S
MY(*4/'BAO'DLG?,&D[%V3MW?6@L0J?ANB$SM\$I-<7#8#>>&48K+YE5K_5IG
M:R[9NH:U9[:<4!EX6TY&\K*; 5#.Q-X)W/VPJP;(!FBI96%F$#Q)'STX2H]/
MGOH1]O<)UN-I^O#X&:W)DQM;CS&T_T<:ZWC&W?P9]VIH?XTGV+<<=^>4]!FT
M.OR.Y.&C@QGY;*I9O>>A/6 SK>395-0;R?R/&\7#AP]3^B\J1G+/J#MXNM$Q
M\E<Z/23(:[<-^GQQY]J/&\WQH[_TZ@$'1C%X+H:82!1N\4/^R+AW-30MP]\7
M#_G*P40AG>O^I_$^L+GSH3JR<:NL9M?_,-FQV,9.!F2VA9FM@"F?<:2VOXTV
M;<1Z**(SN=S<V'2_6'4:J(XCSQ&6BMM16T@91N='O#?M)C32I$"6I#,2*?MO
MINB_'5$)Z"18B.KJF;C65R+:3?\Y'F,F?[2QCO;DS=N3_VR,+G3JW*P9+<EO
MV9)$RP,TKI5@M'$MV-ISM\DFF=?5<BAC!&+:%5W[GA]17"9_/GZ:'I\\2A\=
M'7UD=AQPB.ZC3H[2IT_Y41\?9/C(=V^+2.R&>;&3-I')J?($L9R1-"7<_#BD
M<CK"V(>D<*RL=C.W].F?X_3QHZ/(_@?$ D.@GWY(?JT=W4@W)&]@UZ01BIC]
M)= $BDFD+\3S+ZKZG3#\,4NR,+DSB.C,E4P%Z"O58=J QZXYI'?Z!)6JTU_U
MH8>:DQI-E3_86$=3Y>9-E==Y\PYM<T G--HIMRIG_U.M+5NCH,MN7IZ7YB=9
MF@]7&I I00</:U^FC#MSR;-$BB;@0:Z;1N_3Q18N_!)\^M99R2,$A%@ .)E\
MII!4:3/-C*2=HV$C/&1AF#$K\4<:ZZB:OT3!005;:);\DC6S['^3YG(YJ8I1
M2^^4-_G\Q>F/.^988,B_[=B8S1D2 M7()\JX^XJV)D^*O&F55G8+9HYA!.5E
M4F862 YI /=>09P &+ #TZ>*_2UOZ2QOS2U26MG>9:D.Y7_7=+JVEU<-QF($
M7.+I9E=$9V^</_'N,G)=<X"?KGJ_Q&BOP^D%5K_AQ-O^7ESE, "W H9R8I!F
MP'T>IB=')P- %.0<Z.'_E95KU/.>/$T3NO D3;(9QB:=-M6;9^+V_;UF5>3M
M]B*0%F2B3OMEEO9D6?B3)_+XP^2?)6<W+H" GJ%CG(OJ1O2-Z)9)T](I**%-
M0E^0[N\A41%3X&U2VGTG*W9;&^".R-=ML,;MWHB']<[U"-&$3^<&NCY?BPNI
M9[O>R:[.7]JTBP=Y"SX$<SWO!M4S Q*=UG_$M#E#V5Q1T5OQ@C%6Y<. DWN#
M.>O&8L["[<P R&I^W[ >WG")W[7E!1Q_.'?]T3;?'L?YE]X^M^YT[])81PFZ
M"ZNR>RJW1U*FW#T;J$!M<-QT5!^JP^@ISF/>KX$D[%<4CD)\Q^1BM\<Z2M!=
M6)7=4X.;EJ?6^EP'=9MJ;::@@2^!3+RJ3<AVX'&$N'2S;IN64;"_OJSL]EA'
M";H+J[)#JO&,;#A5C!KW5#/OF'DDDN-'1Q8]55]70JC,F43:;:6W]//GHU3>
ML87>[;&.$G075N7F]-I=3W5O58M=@*GPBS"@]'0#4*J,(+V<TB_5N>/J[X><
M3CKN!O;O?G;Z)I&JX\X<QSI*T-U8E1VR6=U[(4E2:$JG4.3!R:/TV<GC#Y0>
M;VOF,/RLX-^#(AQIU_5*6<6G50G;^!KU!C+8WADQ[H,[)EJ[/=91@N["JNRL
M)CT!F<^SHVVZ<U/[Q7'4&)<54PA*PKYAUL#DPN5G"P"SNARF%A)-_GQ\=/@H
M8BH=I?N."<QNCW64H+NP*KNK'T^>I$^.GWV^?@PVYQ5*D?7AL\-'SY0:P^O$
M,65TQZ1DM\<Z2M!=6)6=58J/CX_2A\>/MBE%0(7J<X7BS]?MNG:^TQ9@E?B7
M3R"=@$H2?C@"HV K0DE)7J(?*Z!&JR(KF^]QP2B_=TLD=GNLHP3=A579(0U8
M*C7B!_K##LO8C5>WW7KIR=T?=W_$?YWEY[LR]L$YIY'_?P<'R4^Y*V;?);]F
M9^0&O*$#TM'AB,=^G_PK*];X9W)P8#N'/MI>KWVUK5KGAR*CL_GX\!$-IZF*
M?+91S_.8<WW7*S+JOF.S=W>OE&@SI7AER5!WQ@LWYSN\4AAJW!Z]CJZ-)LZF
M[/OD[>6*WG]:9Y-\^GWR2[9T,JV_5)C 1_%-?[6[\)>PF6TCFW!M3'GMLG<'
M0C_Q'9-8=*NHOIT9-HF]<F;B"<5$BYS>UHZ\<1VXL;<&-]7U/TE7'\KCF >[
MF]-R>Z/>\L8)H+LW\]I/GIJ?N31^?P^>S,MR1D^K+Y,?LS;[P&S=A;'OZHDO
M-=G[>Z'>VFJS9VFGUAJ%V5E>NME U37^.'6U$ ^1/YKKXJ7P:5>NS<4-K1JN
M-_1<<4*%P/!O[7M\@;R'8Q:XN)@]'@>S*.+;5XXGP+^,'PNW.:NGBZ2JS[(R
M_SW3EMA*U;#(Z]D!.DRB:^*ZGKI&6S65I%FY3M*8'-$TXN>!7W/[!U);.?OF
M&(OP 1?T_O,L+_A8BL=;NT+ZC$TNMPT[*RX;3:1OC'-_3P?*3,$7=+[A_V>T
M*>3M,MUTMJ",T[Y>:((Q4C^%#.77E-(%IGZF\=;:G>>.FU<V:YHW/%ENQY/=
M^Q72\"5237DIOW]75A>%FX$"8Y[*39TET%4U&!>];.**W)T;/S':KE4EYNF0
M=KFO0DTA3_\6:JLF[8R7FY+; I"H"GY,@R(T0)[L<NIKJOQP3+"22*[LTP9N
MQX25#GTJLYK\&_HVWW%]76I3TU;E+&_>[>_-UOQ167).-SBA\5!JK;CL05JY
MSKC%UD0VT!7T7GB\_OEYMN8"7?J47RH:^VMWEM7\R)^JFKREV<$_JNH=<[R_
ML7Y8GAH1;.>-BZ3*2+^FV@ML[;MU<L':+$=I18))KJ7IJA*68O D"'1IXWQY
M1]@0+$I2B@PA"1*NG5QY!/3W;C.NSU./5];3=Y6F6%YW6J]_YA#_8_*?;_[Y
M\\^GK_]G?^_O+]^\??7ZY?/3?R3/7_WRYM4_7OYX^O;%C\E/+W\Y_>7Y2_KU
MZ2\_)J_>_OW%ZX3^<MKAD1I7Y4N?MLQA'[4+AA9LDL:U"/.V"U9,W#R8=CP=
ML;1=X7(P1Q\,XXRY6?*2M!7M4#D%F,M%-+.QMD!G5[,F<1Q5@6K%;V>\6_WI
M/F[&6UYV6]?.8OHVAH)[XS.*SSPYX75!+^E4M^7\D0XHQD$_.&8@])$&_H^?
M;9HF$*>,SB"\*7XMR: 7HF@$>%!904J8U >/T[Z*=/X6C;O@5E>;YM\H2C<A
M2I_7&.,SI*M=U$[L!#+@R32DYR],VMZX5<OBEB8/C@1X;XFF(V_'#[U[?V^2
M%6Q5-0M'^BWHJO!,_\AT6'37I0DO6[CY<ILBW"K#Y$M>6XB3WYQT!")+ATP7
M-]/Z_*$--/SN'&1OTZJ>\7=SI9>R6Q=DQ].?\.$SOF8MK6M6-8TM7^$0N/>W
MT]-?[XNY)B96DRVU@1TF#K^Y]E .$_"(12>(VGDR'V#'B^U</1.4E0 S;V9A
M+D1XP5:F<\7\++Z@ZX/0"NDUZ);3?\W$16_R9KP]27]$RK(6C7<(MF]N'9MI
M2Q5N/>2;A&=+3"/6D&D5:"JPM#E<FGG!=CM\@27-[E)8%T+MB13I'3\ZVM\;
M*M++N",?_6.1T6I,IVM&'BNS?\2QJT/.:O)OFM:^W8_G)O3B4!#Q6IQ2=U$O
MWFDFLO[@OM5O[\>LM\M3#7P5UT8-"MC',:I]]#BO%[3_('F:4<3ZK&@G[-Y-
MDAX(I$PBBCZV[#^;0]2=L'U(M=+@L#+_YT\G_:S#%;FC@7<.F3A_]WJ\/^C!
M$0X\]T_C1X\??5<_^K1)3I5X]-[Q_9OY\ %DRHTIANM/T?4G@$R)_YC4R5_I
M>;&#]W%C&0?]<8..'9$_PJ _95-<N0VWS<DG[=G;438(E-RT;KW3GWNR(27?
M]N<>CY_[K9^7]TXE#K)A*]PAI;T38_RG!;>^S5%>6ZC)V:0M>%97ZW(&A[.J
MOTOJL\F]$U#H/WB:GCQZ='\+-OF*#Q! V \;85#[BN&)&@"/R8.&YS^^COWU
MZUPX],!Q-+LQFL\2ZM\6M(\&)%D#*@]._C(DPL\1_RP1%FT<T-G=X5HPYB];
M=G[_LJ$W_'G;0Q_V+M>).TD?/3Y.3QX_W3J8H;<,3_?7&/^#]/'3!^G)LP<[
M._YGCQZDCYX]V='QGQRE1\]0M/_I'_"E#Y?-M[^MN'-J9Q-^*<WT,#UZ^"1]
M<+RQP;Z6JGR8/CVF'?/X\=T9T+.CI[0-[LR 3H[3HT</TX<?.Z(O<J!L/T2*
M/)OD!3?3^M(S0EKJV=/TR<,-#_AK+=$CDAFH_HT(Q-<;T/'QD_3)DSLCQ)\X
MH*^EC&]1F&EG'YVDSQ[>&=EYG!X_?)P^>_SPK@SH4?KXR4GZX.1DQP=T2PI9
M)+AU2[1=KR^U;/Q+S\G!75F<.S,0\F6>/4X?/MPP1;_:QC[^A.%\+0W,4*!%
M5<S0/^7>S,WS:=[>OR5AOO?@$>WQ!QLQV,U'WO_B0SE.'SP@V^+9-2SV+S^8
M!^F#1\]@L=^!P1P_3)\\IF5Z>IL2_;%J.#(D&.7V)<1ZPTG^BG[?]<9R.R[?
M]<9R.][>=<;RV8Z>9U+XR@"RKXQ0_,K?<2O8\YO$F=\[OK^_]S<0O'>XW>,.
MQ%!=9QM7N&2:-8L>!?Q5G+]]NE^&JG<XAO?W_GQR>)30AQ1<4:K=D.E-1=5$
MV%P;V6%R:BW=7 O4]]2Y&9>]K1NK<XL_A#DUGZ;')X_21T=':51'6>[O25ND
MF59^AIL"_=SCPR>/>- NFRX4KCQ J6R,)RD_F?['\4WX?\9]IPIG'V["B8<.
M=5PZI'ET5D+X3V'1^U6_V!<'GJ*J=HI:3(?S1?YU7[[[\.C(GCGXB?M[%UQ"
M./0 7FF,FO^!\^H\*SPROXU"F*@)_/.#]/@!]/PCK?B4<DF7E&N&N-!PMC;#
MED904EG(Q;%1&9613*.U*!@D1!PZ>/^4Y'&9Y67CL?8T;SD)5%87EYCX;?-S
M3/)P=&2B&P:R?4X@VOTO[S)F__GQDT=X:&\6A@5L8]RW4![_1:IMMK++W-41
M?X!-YGADDPDS?P-L,H]'-IF/F.&^J3<X,]=ED[FK._ .CO,_)GIG/OL_?\K^
M_?O_.SIZX*V[YZ?_?/ORU2]<F_W+J[<ODM<O_G;Z^L>7O_PM^>G5Z]_HGP?_
M>/7JO_'SF[>G;U_\_.*7MV^N491]![[[QNSP6R_&S>G4CLA+M#R0#(A0RL<%
ML$IZP.=WM<I+8:8 )\:T-6(1YK:8TS^89),,.::,@ G<Y;#@YAF>WX+.<&5R
MV-_3XCIW+G6:GIG""N.TRK)F%89"R107H<!N@II)MY06PQ/ZO=I\<R6'*(0<
M(OJN8/X5G<I%)HC8WZ.O+I-NT6A40PC^B.9J'A@=U14#4%:*[5?L[TUI$+YN
MDJL&L>SY/!=KCZLRQ:KM/X7$F6RGJJC.+KO\&X[_U-@$*2%)D]ITZ.\]J87]
M87]/_X*OSLOUYBUDBN?3?!7?Y)_&@K+QZ\:Y=QN_5-G8^#W**LO9YGA$VGH7
MT^SW?W5!#M+&[V"HVN](E&Q<B^[O,8/BOY I[YA#(*_)?3JS^LU:>45 ?I)Y
M*0?C3U;S>1HM!Z\[6[TNJ[FL-#+QZ6.F7+!;5^LS&D6[::MC$^@^C04TVD96
MA%IV-R8/25//\<Z-*(M25)+"YS/NG?(,&SDJ@^T43Z=1Q2T]Q-AKBIQ\'?KA
M,@W*A:X]JZN+=I'2H,$^<Y9#+^@&SZ9TAU B^5U^)7?-S=79CT28'V9L:)BJ
M8YN:XHKUB" (K$C";+4NY=^@"*('!N:@O'\F;%+S\+$3\_.0%*)RO%V'&NZ/
ME,:8X2A-(LFL5BMREM=EK@.;+J 3EW8*>4'4UZ:(>W@"*F$%TB"+\7B1I#)I
MM=P.Q869X5^E'\4PQ"=<LSX[<R@*(Z7/VF?SV-C?^YB393LAEE<CO.NU?ELH
M562K3M8-'7E-$VUCOV-=>9[758E7@/]H<]<F+Y%B;<'7O76=E2**)PA.CK=*
M2)&MA8H#Y?1%OF0"@+;Z;O?VU-?7!9L5R[%[UW?_/GI<'>]OJY>X4;%\_1?<
M+&6V'_"-+NM0GN,31G1"0[IIAL;;9\J^WLA8R6,D7LUX->VU3/B-QLK=>[+,
M+>9N?P6%QY1&4RU=W70^=2B=^;4$[VZ(VLW*ULX,;!2$+SO?=U7),#TC1I*3
M?R8ME:%&O,H114-FB>H7KT;,RC,O*C*+T,>>[">C?TS.D'!A2TA('^W9F@5\
M_NI?+W\\.+;&3'2)6^;3V%._P #RQM,&7>)64FXM-X$&.5Z;S>>!>(I_VAAP
M[GN,SM93_T$VFG$WC&IQ5(NC6NRI1:@N\DF]>IQW5);75I9;]KIM6G#($$HG
MIK[V.@H1.%)M?.V&IF)FX1GB ^]T&!8(Q/,*P$YPDR-55N'EG6#"*+^C(AL5
MV:C(>DZD*;+!N& PM22^30:2 YOCN2O7KFNTS?*F7J_D-B4Z']:('1/25)6,
MQ1N('+^7[%&C>?Q1?XWZ:]1?H_[:\$]+)+O)A8Q[+B!+6%?LSLU(6175"E[F
M*#BC!ADUR*A!9&2U.UL765O52,%C1(4[RQOZ#:+B,$#^39:/-$X(*@2 'H3.
M)1\I:;C:%9EDV9+I(BO/.!N71@F_>55/I2\06B],L[+,)GF3%-G%:-2,*FE4
M2:-*TI%I-0!#%3"@3CLTP!W6M?/QZN<O3I-[S^G9=544I'Y>!&!!<GI6Y]-U
M@:C[?1]C&D5LU#6CKAEU3<^!DDIB3IU)%1YI&[)MK %>G N+ T+ :>53"PUY
M>$$(5C-<;0*'#+\O:1QC2NT.[/<[.[!1$/Z8BLA'HMF/ L!RD:\:Z8?437\Q
MT\%ZM2KR$:XT*I%1B8Q*9-.:T<J;S'@#2F#9BV257;)C)'4]7'!N6:X/JYI^
M'BRRF,3 2;+9.;,VZVL:&8OO=C9B+.^";KBS QL%X8^IM+1J44;C03M!,:5=
MY8%:N^,GW\>-.;EO^W2JH,EIMLK;K$BCONK;<O1-QY,C$5+U>>$RKC"*!U%F
M[;I&&#QOLJ9E?;AP64$Z<Y']GM4S^IE^6U<UN8 T&O(?M48H@A30W_";5072
MJJG_3>*K I?9O\%_PE6M&H^W]L0*5E>,56.UKRFT+GHQDK.:B>-*'S-SRTYO
M8\D"JD)GE]4I;XN1@5@\S<J2HIH<'8=XPN.6'77WJ+M'W7T]@Y.-QQB($#6_
M'7W8N[!S[^S 1D'X8ZH4!0\8K*E;;Z.5Q)>PBB(\@O&(=!U482X@ Z? E4R&
M)J8A_Z6$X<5T<E7--<_ZQU$(1VTT:J-1&_7"\E&T*VM)"TW%J:P=1[[^=TWO
M8ZX=\I*:JBS=J$=&/3+JD2\YAEU2&766(V+#1.2L-V9NTGISA"X 3ZU2IG7"
M6L*$Y.V>V,1954V3@Y(CID3:(FR>O/JK,(?LU#L/0"*IS^N_ ^S6@T/9QH'=
MI;SVA*B[S#WS 3K7DY'.]4;I7)^,=*Y?B\[UHW?D'2-Y$HWS]7F;;L[4^4;X
MF@;U=H?$Z0]B%BE'*9DUP'@7KM6:5]K99PR[7%7,38E(LG+(33]H[HR6]>AB
MC6+P1PO4"+F202BE,G_BX"<5U04SU-)3+2(\RLNH-D:U,:J-8:MD6I584,D\
MD7=:5&<P22JO5YB)NZ7G%)=D<9>EJYE[-VN3K"B^APDS"M:H7T;]\@>-^WI"
M?6:?!A=C=IG,\G-X.[/F<$@H/K.YX)V,0GR3@=3=(0XW,GXE3Y=&%2R1$V;Y
M)(=Z[6:@I7?O%QD&H(0/>N4$E [93,H"N%.>0&*S-40;+*,12?QF5Y.OTW9A
MIXG6/VW<IT6[0 >0_;T+(>H?9OV/5ZM'Y,\$MKA9&KPP;SX*\&F5$3F\6+B2
M/@JL^A?.UC^YK-9RXQ7=!3P#_]DZ0_M%QZ!CX\&-6BQ$/+HH+/G8S@U\>]2\
M@7Y$4P'EE(QY2[C7SI:."M&X\;6,/>HV5.!M<,6\;G3YB3LF<:L%O!38<7KL
MDN0D_]W-A,O2^LG\&MH"O>%+-IK3O,Z;=\E/LJO[?_LY*[,S'HRBY)ODQ[R9
MKIN&9FE_#]-T6F;%9<-=.Y.?_%0^[TSEZS#SK\+,]][U@V*R[-?,8U<T[@)$
M5$-MCJ+.#=)XIK?.H==%0YLEGY/!4[;==A>="<8CKNJ9]!(%24;A!\L]R>>]
M!C4TCH^6K&18L"#JT*IY@\,_:,WKB MWP-CHWF.T.CK8>E.059G3@&BN6'_3
MBFV[@5[1K"?"(]AB\^75["MIZ1UOB/%IXWY)&]!STXJ*YF8WVOZFT^^FIV?-
MC$3')ZB+-;,MY:PYA5GW2GU_2)O^\@H][0^ 9?9N<.?2_V?O<&R@QL13F\^8
M%V%.4H5NO?8PV2,7+E#THA5O-:%/YWW&[+TKOC<K+Z]H%L2%+Y5V<\6+R[+"
M-/&[H[.!G@+'/&_TX?B91XC=$S>G@_\^+U!"4](:Y24?/JP=!MK)]<BNWD\=
MK7"&IC>D"[1H)@-^?<IG9)%=')(211.OO.&>7F$CSJ-F6ERI1 -<T>ZK;1/:
M,0DU@/X_0J)E??1PN0ZOK>% :)\AWO+ZJLT3%2V4"D;,@J8+NA3G7&@7A,Z_
MM&YI;/'Q^DY(.9_G[D*NB1K9T9)EWXJZ^ "&X<&(8;A1#,/3$<.P,QB&+=U.
MO\R&WX%FJC??Y_8AII.'_/KEF__>W_OI]/G;5Z^OT[_VJW^*3?B7'NG''00'
M\VR9%Y???>B%F_LX)ZOLW#%E$]O@7&A<+9<5GE^13F=;)JOAO,*"/J\*NCSV
M3\2&H[-?S#??JP[F^2*#,^W]3"O457ZI?B\96"%#Y..",A]PA0^3_R';4,_N
M*=D0\S7.>'9"9DX*?[=8F&3>--,ZG\".(3/G@KN6FK.TOP=&!P[V1$;2E2UL
M^Y4W& /.028$#5\51P;XJX0QE$P?I^[QEO'N[_4&[",+')B"W5+1',+LI 5P
M9/#JM\"]W#(%9O3B2>LRN\#_@YB42Z;E3VJUL57$H1%RH?6]MJ@IKW16-.@E
M3*+CT ICJ&]AOTJ[L_;DK,Z#X0I;OJ"/Q&SJZ-E3QE=.:4P0E2X?V:#@;(F?
M1)V(0GNTJ87\HJ (VZJ]4;L9^]72Z!G&<HK^Q[!,,\$DDZWH?,>.WD[Z*TVM
MWTSRQIF;%O0-,BJX.O+K K8[V=+L!-!@\,1+:12"[0H1(E,TOQTMM$,*\W.&
MBK@2;;373#^%_L]5\HIFW,(\=TWIWQT+X4N,&V9#_I^OD%'2I',CQ\G$N=(:
MFGI7&]URR*D5OU&Y>%0ET$+.0W=TZZO,W0^E?."R5W60*NU#%%_*SK.\@ G*
M)P.']K'U[KI,[^K:_]W[W 4XN6E]>>6YA&1V50T)"NHKQ2W$9L)O"+58PW4O
M+QK)\,<^#H^L6>#8H =P:_%*I4CCM5J+XLE*5*BZH9)@"!CY2)'1P;M@4@#Z
MY&$J$B,K"2C/H.DYX!&#/GE..)#OIF3I2)2H;M8X]_FX^]%-';=)?W"<)B='
M)T<<45MD=)[UJWWI&63(Y1R4RU8TN/?<F(JVQ9]/TA.Z\^CH2#@\<:!A?B99
MP8&WBXP&@HN>/L)%LJDD.O;&K5H=P!$/X/A3WG]\>)(LT0=+P]!#(Z!1'C[8
MW]/+>*F#,HA6%N5%0HYC.%LVG+3I35Q)W>O[QY75'%:33M?T!0W)/&D8]K2;
MK*#5X_IJ6A6._%?E6<5V8"AD(D,9>@2#@#V(>'XLGV]!(K&J:3'1\V99K350
MUI*:PX-D1+A;*%3=C!^IVFGFP&;&AFD&ZTAF+VO%1@5*1_5DSE^Z0H-MS&A2
MKGF)$#[3; I\ )->)0Z*B'2DR_6 ]*;25G$M#$0ZW('&&S#\:7_J]>'KZ,M=
MOO*10N$YHAE1%K54>7DLM8-;>E(4:/8_A?C-?QQM^T4F'<K/*@Y,(I%FGRD6
M^E=EE@N3,L JE_;R1M*3KND_,53:;0@J[9\<R=362).F+&N:@,J5,8GN$;5L
M^5(9A01XXPVJ\X#?S.&S] 1?))+S-\UZ#BW $_C!6D#3JR4=.?M[QZ0D:$D6
MMY3*^<.=QF*)O>5DKBV_#^-;VD#.9/]G/5_A?L%9GN7%VE(?3'RS("]R414S
M<-]$Y-"3JJ85=C-_-D0VF"_VI-7?W[MM&VRTR0&HJ<37I2?&23,I[>4_B!A8
M>&2;M$3'LMX1:$F4/CR6$)$F(-?KG,/FV?Z>ER@E;3NO6JD(!M*=;86+DFY=
MY"N-*.1=;SSU!H7+:LA>@]R1O#9%FIR&2S:3!05*=Y8I'[HH580!3I&]$Y'E
M!S!F(IB, RX%8B?(\'-/AMA5@5Y<5DTK802=FTE6OFOB'GIS-X.YP@UCH)P7
M^227R)WUDDDU?,!YS#4-J:(WGJ\+\ MB[\",268T-[0.I4$(=)R(M4C ).U=
M-$Q)B%@$MZEPG%I'YH[N)X4, X0A-M'<2 2HAI$P0:-2KGW2.Q(N=)H7:\1X
M@D4T; AQKC6VZ[R7)V81R\IY5E_"H*(!DLF/4(Z8/?R,LF=\1#:Y6NJ.S^-@
M?6OD)K; @[VAHV1NG>XYUW5"]O=>>O"%NA=9O7GT-71Y,[\,MJYZ*6H(J=W?
M./>.I[!IUD/[B?.WY!LUCHYE9F%DIX6E;7\O2VC=Z!:8?6P5C"=G-$9[_E7Y
MT8=C?O1&\Z//QOSHCN9'=W-OWYJM]3W7SY#?0AX-Y*BJOX,MT+K/-L?)%=SL
MJ4O.:Y2Q,%/%B( OS7<50Z!WG7C9#.$I+SUZLN>!A3R+V@JW;89_F>DT*1S\
ME!L"V7\;XG>%X(E$2'HT3A /M*'7\*VGH1:#S_R*2LWE3AAN4/HD'6ERWH]P
ME>NEHT]O$H>T-4=D-2$9S'$_)@U56%!M!0M)-H\/S7PGJ+^U; B)X$QI@\ O
MEH")3L?WR1DBB]R##;&ISD< N7:>S]99X9F\09;-.'0RV]GBM@;8WXM;U4F7
M=T-(?59P)(H[ ;M.A-FB=T//]<&HWMHTYGZ<%=4D,-I.%QGDJQ=;(GU22-",
M!K'&=,/ABP.'W_<?W8OSR,KR8DG4B=:W*$H-+&J*F!VWY:JH+IVC)\*+J'.=
M1-B^X0V<L2&OJFPX*=UO9VZMS#7#(]^!Z!]O&8Z[D^?H[Y=YBZ[K+HA6.@U-
M/0/A=0+,'9X6E73RLP"OF.,,@.VLB,E)?($/B/=IX<-%NJMXE0VT.KQYSUW8
MO3Y4'.(WL8,1$X<6<%G9URBRR] 0GJ/P(5GG/7?F9>\M37>/,X A1X">8ZG+
M:L9*)(AA34\M4H[^TMNGT<DTA<]=%#XLZ\GAR><_,W+Y^'E=?+Q$-H1Z%9^\
MS*9U->#X\C$J"L=BI"O.!)4L?NI3!D4E0[-H%C/+IQ 01PI28Z93P%+ES>H\
MIQ*KF%F>"_T!SBX%6] 8!C]RG@%P%HP APD,@2,U>%C22:55+8S3\+2P-*,"
MT8'2F<O<J>LL32:]SN&%UJ#X8?("M039O%6,S:9$ 6>?SUQP6&/#(X[D*"#(
M(M4]@9""C0VM;S$1["&_1,@A<)6'""1_ 8<<N:A&4".BV<+-TFQ  -;6RT ;
M$O!M&#G?JO4)3B-87PD%?/)%3O2O'(V\^0\*]6!Q7B*;3A&HP08%WFW)02J(
M)<X1!*!BA+K?(1JQC -?,+$][IW.$M*03:@6NPR!:HEY,7!I?R_2( K\D4H?
M'RJ25W;CA1;,"XBD@)P:!#?UK"0:2B[F%:DZH(D0>,SJ%"&@D/P+TQ%TMC\$
MXHT+)(2"H*P6S%)(&RI SAYN*<)U0\N,#,)V/7.Z!VLK/&"=#Z.A$9LD4KF-
MQ@%\P<7&6]*N#9>2-ESE,[%.RC,+/7="KFK8<:8\TUE,K1QK0$0DJ1UJ!5F;
MR3$!&X_SJ[')AG?8. ^3-PA76C=P6<YPK*IP0?GEM?:+4B6+N8>=TN(SF.*R
M:?CH*&C&#XK\G*L3Y%<<AA53TP)[=# W$H/5;VHDQWHN,HL.*^^G9I!6DZ;B
MC#ABGB4:H1_N[YUZ+)YOM*+CSVB_T%Z.*F(_C+',2Y\4."U+U+R]=HS4D#PI
M'FL'41<C2A-27L,/&!7R'4@/19 M/!!>&/1I[<Y0$HB2(3UIHWTV)\%GYS$4
MYL!V 'H4RSNKUI,6YLNZ[7L:7C%!'R>BA>AW)'_E",_ZHNO\&YFIO%LCX$DH
M7;[6"N'(#!)"6QPY1%;7,1;K0]S ^WOP%!4M1 ^1/EHB5Q[?.\]1__>*H;,?
M*Y3B)T+56LUOYRNT\'=_CX2WR,H,JA/';'9&Q]""E1X.Z%5>LEFJ!;L#8/#4
MQ)]3GQOR[]'86=F=U-*?O\%BCL$12<!&\ P, M%G%:?8]5O9+LYFD!NM&C1#
M6,\M[Y73GF2X-Y\2M)Y1=$>270%:KJE'!0@)2C]DC6VA+QSG\+S/8'A.;EVF
M2!.=!7';!76$",P&:(N%AEZSOQ<GU%0JF@4=/0>0W5#9W,FS,1I=7H6ID:$.
MB&95?W D]C7[>Q,]+B_PL# I!BMC?&%%_AF>ZE=Y \FXR L74Q68;!B4QAZ[
M=7K9Z][R? X!U\[@:F7%ED\M4)[^F\)J:A)>#FW@N_ )&P-R#6I'^(U^UNFD
M0 :3;W  ]9;6:CPDI<66V<'"RVN$EG?F*^#QTV+QKE#0 F,+(NR9B XI@EAL
MMLKG!RG&JEI0#)DJ\?%0_^*'.I3N)-9-MD@2^5!OD#M_G"/[[76=7[\K6.'$
M(8PI3_3N4!G?2,D\O%.!U=KK MJBBX@U62'?IH)[*<'=V+18K_I1<Q]SCX/6
M4QP+AJ^5RBPX[8Z/R=1C,$EQ31']M.&0EESGQ<SP1;!&SB4 :<B*I.'8^26K
MU'7C-D/R3!"P8AW7:.C2H%2,F66@)6T!D&?)*=Z=FR8JTO(U8?!)K>Z=/>M*
M2&QZ^0.FN=%R?D17,929@W=9^^BV#59B<7Y8A\G/%=\^Y5?S,=>W!QLU#_ 8
MH&R4<VG:G2'ZMG]S@!K#X1(RUOHD_@KE$D7#L.WW/ J)P9CO+M%G1!'H,KZV
MR-]!!#70)VMF"[O""%L<+.1+ Y2!\6D$6WQR%H(4%M(9 D VS'CP*0_CKVII
M-8M\WFKM5V5HFWEB>:4PWXP"7D)*5H4;F "ZF/Y])J0',(M9WIW&6Z]2ON0F
M!SB6Y"B ;#^CP>6_^S6P%W5UM:<FVJJKU:Z.=''R@V,:&[/Q:,,N:8\CS,7I
M8_E4K=()&&W[Q180N5#-R"42*^=5BSK)FF6H93G]\04HE:\:XI"R-&[5P2-(
MUS/P-B_PKV)'AVW71M**M(%XDB.K;/>T_=<_I:Z#LGHTHJQN%&5U?#3"K'8>
M9G47E,SU^ ;N@IKY')_'3&*&I<PLM*XIRG"J=S*#"9LG^4#P S+M)&D, W(P
M+!]"%'82L86 8U6!Z)O@KIVO@]A5(1FJ4H7]TK8%H$PKQG88=D97'X8OLB5;
M,C-DK7%9(]UVN5+&*ODKC*;MA5])7"!FQE[7T_(^AQB[WL2/#/J_5Q=(US$5
MAAFO36Z8_#1Q[%%('I*!&O21AD(9M.BB>B%$)3,_8(\N!$*ACDSA(I^[Z>6T
M<-[^^O#FTU1I%EFC0DIB=6+8/G[V@2&2B8_F'?@)^F6-@TIM/V\#MPD9Y,C
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MK"DVM'!GS*/;XV"P/_^S9!*X-ZVGX'].9\HL&P_N+RI@H7.&UD3XZCE6\A[
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M@9@4WR#E^-<BG^3^J",;S)P4CQSBWZ-)TXMP3I +V.O8Q#"6-6-S(U8?@$-
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MS2SW\/OX9P/*K+:/*W(C)@RH0L !2=NJ'@+H=(8./F)?LYNW_GS-E,:(2ZC
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MZ)>"@R(#% $5#J&($>KI79Z2>5*CD8V&Y$N8B71L+4+ACE&JG><,&D)]?Q3
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M)Q/[:19H2C?+F7PM&5 WG#;W?T5&=7\OW&'H7VV4'G^/%=ET.#%B3-P6E,R
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MJRAB[-!-!=25:I?AJSP,WDEH7Z<B%2G0B#^2"; \!9;Q2=&5Q IG32:3XM*
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M&:LR<W@HP6C*A=CB))<$1%VJ9-1Q)*?OLMSU;+-56WUZ +),V:1+OVKM1=;
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M80$&6+SXMEQ"?Q2PH-/#6?!^:XMPJ:]0@I-Z".T&7]ML(+VNHV<QD#TIHH'
MXM!*+84>+G2!5N1J?9.Z\H%W2]>,"-847JM,\^4PK2T@\@PQ)9O\QEINZMV
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MA.C:>0;(RHGH]'MNI]=W3SN#QYP]!LSI\,V)I&6 -#F&/1(8&7-P905$V+#
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M2+MJX7C, >R6K*HBT)80NTEHW3&I:?=#FJS93S2IZ44Q<#7XM0;&/N@=?Z'
MV$+4OJ 0&%"I,!?Z"@RJ1'=Q'OEO@#^X%15DCYK--5X8_@5? ]\]=\RP))Z3
MA.A2"?684,]:6<<</Y]!!)P/X$'2YWW]\9%/+Z:W:'!O;+QTANYINV?UN.(7
M+MY]I&XTP@6=S8-H27ZH=Q4K1?^:4&.8>4O7?DWV'M@$7'M(*).\P#!*E6X?
M8\C.6 7T,&\\CA?40"LXI>(A7\[ $79^620^/>=\,O-#GP$38*&?O&4<P>>?
M8GCPF/\41U>Q-\MM0[9-1_Z-H:]S#!0>=P;M9B-6. 9+L79PDGG@I_?=\__R
MP@6VFW=/Z./NC\[1S<J6XSX4!T)<L&*Z9,4D@'/"";^L<(*N[<!7OE7C F2E
M1\UY=$9Z>OF_@2K8TF ID)XXN9R_0E,A@,JUG''2ZVLZ-1#$%?# %;;UHA,1
MI=<.8\N"<N66PA@V1*#%](9T](9(A^ C[VXMKBM+1:VF#^K<JZNF#WA,8D%>
MU]Q;>2IJJ750YUY]J;7? 89WSO^BV8/% 6 U.U:=BEH,'=2Y5U\,56L 8<V(
M5:>B%D '=>Z'(H">>OI@I6>=;BI_?=JGK#GTU5+6%[5O<FGVL'%A9";)4&IR
M-?[0RNWJGN=AONCJSF<8\5G=:7J%P8"=MCT8\/+=;^\N/K][VVS\Z_WEYX]_
MO+\X_\VY^/CA\N-O[]^>PP?.K^\_G'^X> ]_/O_PUOGX^5_O_G#@D_-ZE.#3
M%8'G0#43)U&4O9'D"F-L+IUK'],^*%0)6!(1*RAQ-O5#T)6(A0S_[3&F)F.P
MZ@P06.%^-$D<1>(H"@5>DP;$P'+@D?"<G0*M?F-BZ?$\H \Y=[+@>J6*,8;1
M%YL+PE3"!ZU/=ZF\6)]MEA#L4,ZM+<82^'\:<[3T32,OX+1?<JU4:C'2QB<2
MR&CLWVCT4^16;S'Q\8EK6-1:$J-I\Y B="EII@(9CI-F0P6)NKU6UIR%>1P1
M9FL1</20COH;Y]3T.E8\G"#T0^6 #Y!>:\XM&;\H=GY[(^LV&\*[S@KKECVR
MC&47H69:JCWP9P]B7D2Q9^YU-C*O\Y?B*7I@(<X]S!-QH>WV%P<>ZHW'43RA
M91.>\94*8<N#8-ELP$>X;BJH0"0JP0J&I\Q1MQS]\_S\TQN>$!%F8/A<J>(Q
M//[6I/#834LQ@3.W"'#F*&XT[(\3@OA($B\&MU&K&BDOQIV7K].*P&86[X_5
ME</%(?P%<U;ZA.0[,V^Y\AHL;39OHD(&KK7A)\E_HL,8L^QL.=E$'4%?QQ*)
M#(M]QB#)&?XS'BV0'*MIH$=+^C/8W1F73V?E/'<4F,!V^U,'_G'MP6F,QPM*
M&\I4R9&"&QZ:,;- LA<'/A;&R-H-/2],'MZ!9#RLD8PSNWD72,:=&LGX'EO\
M[$C&3XU"K!=\0+,5UT::SIZF.O^LO&=@A1SRGY^7IHV B?>A<DNO_J&4_QK%
M3"IJPL]D1_[.YN,[-!^KOLU5I*D^^OKH#^GH/Z#/6)]\??+UR7\S)_^KGV!8
MX7_ ]ZU/OC[Y*N]R&0[?EE[':KJ\]F->*(^;F#03W&N[5=_9*M)4GW9]VO5I
MUZ==GW9]VD]SVKH,0@Z[4Q_V\Q[V+>)6'V/*06'&\3;VYC4'U [)/;EHS4"I
MY[H"VPVHJHA$Q'J: SV$ R+U1?%+^T /X8!(?5'\4LN7FE]J^5(I4FM^J< A
M'!"I+XE?.F<'>@BU)_A"HAY[9?"C/W4/PINJ;VD5::J/N3[F^ICK8ZZ/N3[F
MW1_S>7W(]2%794/WX$_<<XSSXT]/.K]V5@V@>V+U9 GG8[X)^H>-AUJ5"W+?
MP]SCCFXA6^Y)H$SZK#"%%=S"FO%JQJL9[V!VK6:\FO$J<*PUX]6,5S/>H6QA
MS7@UXQU.6. O+/U]>/[1 (KT"3%G5]OQA[I1X4(ECSTQ(:Z[2]IV>2DU&LOK
MO3+7JQUMX_#U?F]ISSUI#]U^;[@C>O>\K;L1*C6+'A*+=MQAK^\.AYN+5RJS
MK36+?H,LVG8'IUVW?[*Y(*\R^UKSZ+?'HP.WTSUQVYW3FD5K%JTFBYZZ@T[?
M[9YT:Q:M6;2:+-H9N-UNW^T/^@?+HQ6K?=CBK?LN.+^(DA0K'G85 GG.+@5Y
M_+:="94+P>U]";N6"%WW;'#F=H>/%@BE7', "JSF]F^(VSMNIWWJG@P>[474
MW%YS>^6Y'4P7X/;>L.;VFMM?/K?WW-/A62W;:V[_)KA]Z)X-.VZO/:BYO>;V
M%\_MG;8[/!FXP_9F2)I#8?<#*=39XZ;\,XZ2! >_3?VT+IY[#OFYS^MZTC]Q
M.X_/@U1\#VO.JQ[G#;H#]ZSS:"U1\3VL.:]ZG-=U>R=]M].NI5[->T\?UNX.
M3MSN\-'U6Q7?Q9KWJLA[@T'7/1N>U+Q7\]X3\U[?'?1/W=-![[!X[_!*6%9'
M%>\[_";P'>$5$ZV^SE68U+4MU;C\AQ(U=#NG9^Y)IXZ1U]S^\KG]M'WJ#DYJ
M7J]Y_>7S>L_MG0[=7N?13D?-[36W'P"WM\\Z[NE)7:-;<_NWP.UGG8$[.'L9
MJ?Z:VVMNW[2&@7LZ.'/[_4>GC2K![75AR_MP',W441 ER1MG&D<S)S) M'4
M^J4%H(_@XKJ#?I7CSYO1K&NN.T2NZYYVW>'C6_9JKJO.AAT UW7<=J?K=A\?
M3J_YKCH;=A!\=XH(6IU:WM5\]Z1:UNT-0<]V:[ZK^>YIY5V/$-D>C1CX9'Q7
M%[1L4="27JN8"0ZC\#C2]2V.3Q$#YTA*7!YYH^OPX3<5/D3#J%=W/->L_O)9
M'7W/;EW>4K/ZRV?UDZ';.:VS_36KOWQ6!ZG>Z]=2O6;UE\_JPW;//6O7QGK-
MZR^?UX^Z)^[9R0&6YSY'8&OG]2RK&]?=\67[H&32LHY>4<'+KH][UU0_5$00
M'<XD6HP"50T9L0YP?%_D[[YPI@T"8O?H9=TG%A UD]=,ODD)MMU^[]%YG)K)
M:R:O+I.?]89NN[?S:OV:R6LFKPZ3=]S3;M?M/GZ*7\WF-9M7F<U/!J?N2>?1
M\U1K-J_9O,ILWNN=NH/AP;/Y2RR\VO6]XXXLIECZLN8*MNO:BY4+JTW\L>.%
M$V?B!XM436HQ4HN1+<5(N]4]> E2<WC-X9LX?/<0*S6'UQQ>)0X?U#Y]S>$O
MF,,[K=J=KSG\A7/XSN%3:@ZO.;PZ'-YNG>Z\;O!EQJH>64NUP]7_I9 +U,3Q
M@'KO2G'$*7&B19JD7HAGL?/P4]W/6[U^WHX[..VY@WHH4<U[S\%[)T/WM%]E
M"(.:]UXL[YUVW,[CD0TKOHLU[U62]X9]]Z3_Z,!'Q7>QYKU*\MY)W^T/:IU;
M\]XS\%[G!.3>NF#!,Z$!?Y]ZHT#!OYN-G^;Y#>NT[]ZQF1=?^4 Q?K5=5D)"
M?_'#B<(GMEL#/\SHF?-KB0)GK() XB#_^*[]'?TW$#S6_WUOTB2"-(Z"P)LG
ML!?Z7S\ZM_XDO<:GM%]_5Q[XV.8%Y9&/M0&.NQ_YX"/?BO]'43!Y:B*RK8#-
MQS__X[ON=P\B*\];8V G%3^"U//$B::5VZY*$%&?67UF+_W,U@:\:[G_LOGQ
M4LU3-1MIN+]>VZW<WE6"B,H>X%LUIO-S>IWZZ.JCJU7"'MERU\ P]^;6;1%5
MGH>?N^WNYL1AA;:YRK0=-@NT#V6;JTS;0;- 9W.5<H6V>1]*[OZ5/@>B_?;$
MX(\WQ!X5'=ZM9-CJ)FUYXJ.?C_X,O<4$6&?RYJ?O1S_OGL3*[%S-6T_.6^<U
M9]6<57/6TQD!6[>F/\>V_.(%7CC&PE^E4F?BI=[&DZO&O7M^UGDL18]+JN^%
MI"IL4LT\-?/4S%,SSX%H]L>Z]Z8 IS]\O=,MN5C$,=ASCI<D*MT\T_L>5'9?
M5^6*Z;JEW>[:NA:\^]/5?[W;2]=SSP8]=W"V&>CB^79N1T*AYK-GY[/A:<_M
MGFT>%E_S6<UGC^.SKCL8=MSN<'/#<*7XK&K!@B<VLCY'J1?LQIZHRJ6KGES:
MY17KXQP?,!LVMQ<=XC[5_/,T_'/: 5/@#OS10]RGFG^>AG_:_1.WUWF\BG\1
M>OWQH8(]A <"WQOY@9_ZJM;IAW"G!FX'6^=.:IE<\\_#^.>LC2[^YCJM0]RG
MFG^>@G]Z[MG9J7O2WUSJ^?S[5/OJX*O7ROVP+M? '9YTW5YW,Q;-(>Y3S3]/
MP3]#M],?NF?#S9@>A[A/-?\\C</>;W?=LW[5C<-OT6%GC9ZJV3R*O7CIJ'\O
M_'197ZL#N%9==W V=/O]QZ?NJ[9/-?\\!?\<UWQ3\\T+Y)O:1P>-/E%3?^RG
M]84Z@ MUU'-[@S/,BE;I9FV>T%#S3D5X!Z=Y]MSA6:6RH37O' 3O] 8#=WC'
M\/IGY9QOUR.W8NPT("-)H_&7ZRB8J#CY7__W:;=S\F.MX]?1]?CRU+I>KF:=
M2K!.72I7L\ZW426W/YAL T"@X;#W]/CBKOS@A%$\ V6^S74H;$TYI5OW\3^,
MW.VOK3_YQW?>W__Y/^U.YSN#R##Z^??S#^?_?/?[NP^?Q4:Y;#;>OK^\^//R
M\OW'#\[YA[?PO^>__<_E^TOGXZ_.K^\_G'^X>'_^FW/Q\</;]Y_A.S^-8N=[
M6#M^]8]WEW_^]IF^^?'3NS_.\?/+' 1$97=IJ]-\)(E_+Y+4GR[+ > ?QXP_
M^3]_OE;-QC0*@NC6#Z^<B9^,%TGB1_#0ZV@!&SQ23JR\B>.'SC@*_UZ$XQ0_
MO?73:R=:Q/A'P@[S< K<U ^]<.S#ZY,4_C #4MFNC55 7PBC5"S=*+U6L?4#
M/YPBX?CP9L.;SY47(T$J2-0M?%,A >FUGSCS.$KF:IPN8!VWU_[X&CX9!XN)
M<A#U"W^??YKCC:)%2K1ZXS'X RD^=PXTCWW<BWGLP9+&^$^D"\ARTM@+$X\6
MFC0;X$&H.%CBK_ A&<FQ2A9!FK2<]Z%YMY-&#E"91C'Z)#8=;I%\W+K4\\/$
M@>_<>O'D.(BB+_@:F_KTVDOA#S=1<*. F-A/OO &PDF YP._1^>AY7RD]:6+
MC"YX/A[@Q)].8:?A<7#H7A LG6D<S>"Y40);!K\>^W,ZF]'221:PG9NHF2Q@
M=Z)F W=I"J^+XD3SC$*28*<<E G=]H\7WH(.(UXZEX89Z+/.C\YV!VP.9,VJ
MFXV)2L:Q/X)W1S%(*WB%/_45<:N0\0?\U/F52=5O7WW33]_[/[<.]AY740QM
M*7\^!<I+0 1Y01(!XR*GP@V2L_L0A<?_/#__Y/QJ[MSO\/4%,+@^RHSY-C%2
M"\_W(/=''^TSDE\62KGE4,H#U_4HI8/RX)=%XH<J29Q$\2<B2N]@ Y;P1:T%
MI*Q36Z@P9K!$$OZLNX [[U9YHI$F9:Q(DOIW+_2NZ,MB08$L>YMM [[['/38
M,O$1]M_B_XLH%$6#W_E#)#U\Y>-<Q22C$^=(KL_O;_^7-YO_>"YWY8WCXX9=
MQ>J** <9&H&P!VID%V%_F'!8[0_/P6[=TU8'Q_7NFM^>63[N?D%@@X-L>/=5
MC4''WL!E^GBCXAM?W;*@&/W<<CY?^]GU /:[ >T(3 TJ?C9#G0PL@T<?,=N@
M1:1BTO,(YH6\-?82L 7@BA);3&!Y\*LT5N$D,=<(_@:L=.6/X1O E1X2DSR+
M'JU9YUZL<Q'[%#0'#RRSB3^)34S'^PYH0ILQT2SU$UE(_L]YSM(&6$)RV3*P
M/1#@B<.2>&:D'?SS"WQW+*]WE'X+F)2H_^=1G!:L['%.XL69Q(N,Q'L^RVU?
MYV.K_15'&!;X?QT?@U)0P>0'YQ-L[8_PZW\O%%S='YS>R8_.?WO! O[9<8Z/
M==1LXM]H8NZ&@>;-,-\8$GKRO::+;3<S+#=A#7<'7V-R0,7,3AK-2\-46;1K
MU;4OC"BS-TYOV8_.Y^4<WG\>>R-__*/SP9LIWM8/$6Y@KVO_ZGO],_PHBVWI
MN-9/W\-&E^TY7(<OQR,%(A8>/J<SDUV&9;VD+=:LNW%G[ W%G69&W<'-W>>]
M.WRQ(O9BLY$S&&T)[^!_K+$=4 )G-NE*\*=4-&,T@6,JMV@X@S$=DY6 YH8?
M38"4.?P.^8B,Y:TB2K6!47U.^\W_]\('O;UTFXT+;^YCLANX#\YW+ 9&YM-\
MBA)2\)LMC75\:.Q4E[S 6()@T0C6[HE; ^]K-B1P))%'L#I =L'3IE-\P4IP
M;RY$?6.VQ7Z6]QB*WX/,&*<DLE".7'S\[_=OCSMGH*!ALV;@>@!OH$NM8P)/
M*+AK6;!-H,>G W3D_*XBL#E"\@5T='>DHSD*+G"$1PHJ80X7%V/-^4.?ZT._
M]O35!24!?^)H31PE[(C,O+\C\#&,FPL;\D6AXL/O3?PD7LSQA[=1_,5AV?(W
M/"I!M[GL;2!IU-<YOPP#_!XH,!0V?KB OW@36!(0JXB>!!](SK$7<'Z!GNW
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MI"!LCN'4R$#"  K6Z<C'?X8X8XEK<DR/ <OF9<OY%6N# N5-EPX800JSR5]
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M!;">EYI)TS3ZAF:^^>DB)9!8U@ST6OTRMF)7L5Q=.'*0G+'*CV:[6^HXO_+
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MJES,HU&>9%.)1-F7TYE6$KG**]C.FV]+W G=WT$?<MT@#>R.E 3=^6!:79"
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M^^;C+L['H!+N:80_2A/I)G-DK2 J.]L2HK(.7? O.)H_R]%\OGPTMV4[-HQ
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MY5%\>7%TRP,<UXN=:O2'/,E/F0'EBRBYN@*=0Q,8:4P2Q*OPM802&1/-K;P
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M-19\'"G8ADNH%]?M$=>SL_6XTY]%6-T]I%V06U*[LZTU1U(!%D!>/0T<K[X
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M*![6A6XL2UM/SQ"2.[9I%2M 6.^%&=?]<G^P\SMV"-  )/D G<$J"'=4!Z^
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MDS>&[5M4TH#QD>L^O4\_YH 9Z8I&?'[Y-)FAGJ_*V'Q,WD1)VTS*2HFYPY(
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MWG7(!;UE(?>C'R3Y;K'[!CN2=[I!W$*22::X2B0.L7IC5J'[/=P2GWN3DW_
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M6MI-IP8B#BO+O=+50M=-,A[+<9=>6_K#=!:E57+#>6)UKKAT 0XE3XG6G_N
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ML\,).I"MR>7R(H+A[BQ*$NO0^>F-I$THFI&2#%\.^KE+X!_6SJPW?# :,?:
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MHQ_8E@^L%]M^8!L_L*=@MZ@Y X;Q>)U<SJ2/;9C4 @#E>G3"\HA>WON!;?G
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MO+?Q8"?H%6,9UM?HA6XG3/LNHZS]20)J+'C@Y99:"'W1I,=8=3LG; %+$ZU
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M"EL^*Y1LXG]V"9C&+5_*O6[J.^/N[BX@:PRL5\*HY306[M> <G1_Q17MA%%
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M7#+-,$!/9NV03"8,@VDP4B9^I@E[^XS+R;38V%>4_?SJI>MIP\7R,R_0*^;
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M9[ ;>O-UDV?S.Z[BP,J3K##L$=^9'/37NQ0(>K"9K(7M-YA9TJ^SQ,:"I&1
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M:0/.R+JGY&@&RVI6,E+M3]+FX]O>/G/-\)>SB6O5@+RK([>KKFL+L1K+NL(
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MMB7= 7!@&7[*^#U1[3X%1+M!<ST5U3Y*61=K$V:@@8=Z\) "&5CPH63F!R6
MT<+/22^[5%?I9@AOJ38\&0HE)E9GFOQ)ZRF[9I/M@(J[)-"4KJ<LH26?I-Q;
M6LJZW;/D<HJ2M*0YYR,.Q,&!IX\JVOC:?1,-_H:?R2BER13%&(?(?E&\^6R\
MA9'ZA+O+C\F;MUIO9IP8?3TKX/O;W63!@H@P&-NF>48,.!O6P<Y!:'P@LK6'
MH84D15D2"MQR0H,L$G)NDJP1_K @O69+OA2NP=%KQ7AK/PE?L45W;X!RD!O?
M6R[N]M^.?L\Y,&^AK?Q-+SC2?]OM(1M1(AU=RQ-F_+R5M;E12_&9F7+T@LRJ
M_W# ?<<;0.L]IVD.TF*KPI6.#\NT^NP^T4ALB-.679ZF>3H%$B4P/8*>[+$
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M%]2A3$9L,Z$:E5 JS6 ?HC>U(\VQS7*T,5JXV%J68>^"!A&$,H\J];J [R$
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MYZW!]R<4I,,6>6G%7*),_Z+\&77RV<A*G,Q-50F@;'[%;)LD'<;SRI;G*GB
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M*I&/P#1NIAQ4-030>7[TI,@XM=B^U?WH0YW!5(<R\5!D6)JAG\F; "DDMW4
M9K9!S=Y6)CY@29L^8OY[$1>U=AO+-C)#Z0O5,K/#T05SUYK"0-L[;O\SYKT'
M<6;!U'S):0K:TH+W0A9V"[(SZK!AO#2R3K!]'?C>T5PP!W=Q "I(AT(2RF(&
MI!U=??)VMK_'(H1\1\A^ML4Y<$&Z=#'\LE1RD](^+E<D!6]FP#P:]&%D!P/^
M';_;)2+Y[TH2Y7@R<V-&#R=%N2[FU$TF\$[Q[,!-.!/Z(9F']\5[N]LHCQ>#
MKQWCT2Y1RQ&> #I\_2@/]_2@15?V.K2YG2/*XFUKUR^G44Z.!&,#]!T6'52M
M3+E;.H'"%$,S@LJ4DHX6>@R</A;/W;!3EHM%@I)S9W6[:@;UQ9M9M3A ,K5>
M)H.QU\G(@6>:7$Q\.;*$E!'[O[B>Z1I(2QL"J"7#I^XQBZ;B;89!V "\$W15
MT/V$[9$B0'M#Q8(,#^-:%D;/LZ\;A88PCH!#&,"WV=)J&QCZXB^%L]4D*5#V
MX?[8"RG</RX :@ %K44@P!PI^<D7#^9JNB]:[W*S>4/65G"NEHZ.^$-=.DRL
MJA-RQ$JANU)G0.WZ+"M8G(1ZO/KAFR[8U]QIGYX,TY'M=.5U&Q=(MG)E5O.[
M=>%M7"&9.HM;7?=;9]<,AKEWLW&^>/KLQ;>E ;W<R!QY6W!91+!LG*^E/<RL
M>[E<>[ZVC*%?M374^FSA/1I8+QUW,+!U53UJ@&I3+F^%2CJHB2<,?!F+''0&
M2-) #7*1\<'3G8-'R>-'>X^C#NB@5L,?<PSN+1=>]U+:#ZS78>N[">NJPYSY
MQ$'55DQW*?K.VBV! #"18YUDKN8H2"<"X5\'H9!>^OJ!];II?3=A[763:Q,5
MKP PD,9Q = P/S4KS6G"-9 >PN"2>KY#W$7/5P<S*TTR6J I-G)H8HY)2+-5
M:=&[F.LF2O=H8+UT]"K0C8S3>6GB>\:S12;8&^T8V>1_=VI.VT#Z<D;!>#FL
MBY922V>F--<LW9G1I+SI9;(?6*^QUG<3UE5CM:TF:23@*T.EK#IL,=@;1_W
M>E6SQINPKJK&^8<C4S%/7Q$-DHPAEP(MD2P])[$516T;)Z0Y QL=0L8QYJ3Y
MGY[VB=/[I:DF'-*?*7^=HG+9_<MI;.K\_>C:/O0"VP^L5V=KNPGKJLZ2+'-(
M!LM<FB5GP-TO]P3G%GM"%!KYMN=1HWQBNUO4OFWS%^$,^*:$&+L](<;M$F(\
M[0DQUID0HVM$?<^4^P=0_01^L<T-E)OE1<0DC"-TX$NG\ZG'< .1W8%=3;)Z
MX@JXFD5]#J[*(&Q%J0)UDDHE))#7RKLDW/^FJ@&&!Z]B52\EA2TR.JS3TEX
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MF&5\S#Z0HX3N75GT0=M WR-L2!?^Z0%#88Z3C*[?O]"$7Q;Y_*^$=;I5+I<
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MU"9CM78YVYLI9%SSC=UGJZEH6B9ZP$;3X<IM;H@O!_<9*L\.S!'/5%SV!Q6
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M#Z>IIV6O9R3JUZ(^7]P8>(J7"K,G0@=#(N$81HM02K%V3I=U-\7)$W; \P9
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M0];/>)R=S0*Y)49D9AV-YY+>+3XC2@V=>2T##5JJ\!&65"B?+LPD1D]F8%C
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MPEA/'GO7W#/W.Z\'Y&Q:@5.Y[\FX(&!5@'5Q?/[Q\[?K]]_\_C_1^_]]6JU
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M)L5(:O9<:?WV7%QY-O+5)SOG:0FCSL=N"_\S]O-N3QO_<']MCYD"/&EIGL>
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MQ;H-(8E2(Z^6Z^7M\"6R0Z@+"YF*%#+;ACLI9%87BM@J\9$<BBC-F?]\:NL
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M6N?X7N]I=I=<:CXY[G0(%LHP;XYZ<:-/PR\'X\_5PH^;#'IQJW#73 XY;)-
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MZ?8UW^%?TS7;!B.5_:-'^@,5-%B?X/9+8ZC#%Q0$*ES:&2#A& [ %6D&@#
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M0:?@T]@7TZC,!XGIGLC9 7:6%:BU0/<"7I(/2ST7^C3+L;LT2N;V]Y4CD)>
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MIDE945/^YDGH=\WF19"!YE%R#V!E:UU&.32)"&8K+H? O "S^#3/&_8'(AX
M%C@+IL$34.NC)]+'@PKSD,7)C6 !QV9U=2F_7TPN*7\9)-D$4IBPOQC)@/1
MA:>4E'<.TM@A"_ZAP,"DM7.G4JJ*5?$^3,?4Y6H3@G%29 -"'3Y-Z>([<CS
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M!_4-68UO>Q19>C+QZMT=<;#I,P?^<GBY.)XB#JYH6T3,8^=<_$GQKR%"L"3
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M I5H0OP9.FQ1-YVR\??09CUNQ& $R8;:\B6_S$RA!HD>"@.LJ0AE@3389]Z
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M;.-!1+AQ!<'B)'=TPI2X"F=2Y+R^"4SB@\$D:7-+:-/I4'6)^TU<)((<)0Q
MH(N+;0A?I.33L!D6%3&+.O@'/'Z(MLC09>*;-OEX;#L*R$4AGSF=\RUE"A?
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MPZ6,GCZ-"[!/L<0B]@;Q!@T:.#1,3[<<[$^A/7SSABL,--?G$P!$%(8UC=@
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M?I.),ZQ5L'W6-JL/*0N)QF0V"R*@T:!Q;4JA8%,9*YL4$HE/,J J*S"S)XY
MU1":6:Y)^VK"60OX$CZ#R0M5.AL$ A3)(!>TQ]$_,N@_-WMLB1ZQHNP1VT2/
M6$GVB,FF+MG4)9NZ9%/7LVKJ:GK4S)N?Q8X840]XY?%X8V*=3<*2DB".&0DT
MAW'F90MM%GIHNI4V=;5<KJOY_)SE/4^L"*%56.@^3\$W84WRPO --[J .#1]
M\@F+AD]M7[.[)FAV5H%^,/JL_7;<0RRTFM@#(Q)9(KD57^B7-MZ"M2DSCK&"
MI2EJM5Q*%Z_3"<WRL@B-)#+-TX0: Y;!+.6_7&E7'^OELK82S,Q*43Z*MQY(
M3";L)5U-8I(7!VJ^[YKMH2_<O(2FMN1!9)BSH/TY0<4]HA*'=6.0)EX!RL)B
M8AQ3F&*A,<F90W@3I_C\C7\NYM],3=4=:*81'II^JO#F%8^=BO&@&#T-?=UP
MHN, 6ZQX<)/-/'G@^2RFBQ'7=C"^AU4^"[^9NJ^BMA5L?R^2O(B7B+<)OL0P
MO: =@H]TP4_16#:.QW19A):&WF:-I4Z>&TI/0B.Z;?"O'3LZG4PXVVVB:T,O
M:)68#$AA>#$2G>5AJ>G(/"911"B>*DBVMUI</ZQ?UWL8]\'C=H. 8A#'"4*9
M--]T2\MI,4CKYT0(9'<GB)X8SIV-4]WHZ]AH/0S0! \U3)>-/=M7FAU?-'D(
MV",5]S6#T+E[$T2+=*\)TIB> HIM)^U@+G>0[XOVD 342L.M&%4+*2Z17.-U
M.VS2%*_C;Q,?3R_X5(RJ9+7R8<'R1'4U"WX%A<TL>T '!+'85J2MCI)<!'MA
M #86E@E"\F% #-,&\";,K](6&/XR(0RBEPYZ'X34B#!HM!=Y=A0LO.J,V)>X
M-F7F97,M04@KC.,&YQ!RPR,BHX/S!]EP>SIEF+],S"EFMN'N#GPKP>@,\IAM
MQ[D!\+,.2^KO>(GE64LKQT1KIXGCQ8X 4_%-Q==WSG7/&7IP^Z9M7-\!ED;P
MN_4:-7SQ[]RSK* VO)%/M&M65-S%\NV$2JUH?'TR8X=].6R4-,M+!^-D:0(/
MI8EO6D@K195FZVDV;E]Y1S- 3'33 H<PCASE&0TX'<D\&,]HPEOU0.S;(%4Q
MENXZMD:CR;L[0K3&15 ;I!NY%=/SQ+7X8 01R0ZU(L9_0]VGL!223I[C_-O8
M,ID%2TL)T.0 0Y<N+C1Z!/L<\Q*&:RH$SSM76MC2>(VJX1H.<0#FU<U>;+]-
MH[FL\%C\3:UQK^F-WW4KIU^_I;LY9_6301XN-PF*1J:F/?L]UQEV>Y1%^216
MD$U@V]YYKS<1(0R0?5!KC>^_W-]=58_*SF6($K P!\"7KX'[[:6V9.V]O=)[
MQ!A:S%8/"$>942VG',>!%A9W/DVT)C/B4JF*9>&?P[3#:Q[2?#C/4<,T1SRV
MB%_=6_6^SB>MY=R&+7OTLW>$@:CM6,9ZUQ\#XO#7_]T#AUOP3;E1;#W-8#JW
M"3>8QLU/GSK?/_XZ//E23&GY;P($%\H>+ H^ $4AO0VY4Z>71#F#* M/),K0
MBA^??/QP=G95]/4/V:7)HJ3)S=-D1%".;Z[*C6'O\*S[J991JJ)[1C-+5N$V
M\  _^4;8&#3?RO<N62O2M7,<A@[/;6MTH9E&D%.@L74, ;3ZVN7EQ?GXSJRV
MQC_^-"^/N]J[[@]];W663=(F<K?;_KN8+ZO%4ETM5BJOGKB4G-MJE>)?*UU"
M&FE1P,,M,$#N@1CS"DB27[7X5[H+C!^3ZU\M\*<6%3_A9)-TD<Y:8-H:MPKN
M?&Q(+;!65Y$L+%4J\Y.%3T?+:@EF90I:LIADL35$K8OU!ZHL)(-)!GN6#+:6
M6I8,<$^2H5];WM"_8*GH8Y&47<#2_W!T_>T'*9:Z?ZHI6_K?>Z9/GFC>3V)A
M]0[S\I;^0_G_M+S/=$7F:MW\=>F>]$Z]!4)V+G=O@:=046OYU$3QC #,-AHU
MDELEMZ;$K2MT.@KYHN15R:L+^"B23=-Q72IJ/9]:9&TC/)CDQBS?*&->!XZ*
M'SHJM>+M\2^O5OGV/6U'9<4IB8=]EN(3A0Y-<K$S/ECTE )I/?7XCY69]+V*
MX0S;UE(E3YL3FJLY<3I2<RVEOBOT-NIJOI):V#21Q+-AP4ANE-RX/87WDA<E
M+TI>7&='=L88C;L,?.8*+?K^)]9^$>MU:-9:8W(Y:)2MX?'%1RN=CH0G#N=(
MKF2?O-2J6TRN?)#LFFM<N Y.7/JNN:X&(OX"''1]%&\8*4>[S>9^KS6^=ZN5
M;S^_-WN6EIWVCW_; -^W_$:[.^).@(.W:Q]SD8DI.JEOY[UC*/!$7S(BAO>=
MF3[.I1QB^Q&=7LLZ<_D71F(I)L%>:3&V%V>YLI%[A2+N6/5[?&6;YVNNGQL.
ML#FM4.=_VMUA?^N)J8])"XG"]^&$08.(G;/8%3303!>G#M\Y[@WM1(9?@=(B
MHM<ZN,_?\3; X.%LSN\K/EBXHYGT)MQ!I[VY8M@@R&T<0"CFFR:?%3[N&CE,
M.XX4;XCS"^F>7<MSQ#7XA,S@8*Q[V3-!2&NX^P,WV$7'HPYP[U;8]<3!/+6T
M230\/KM^OXV=/^P +CXLDX] _KOF(&S_C6_96%H^[SU."RVD=R)GG1 %&IW'
M2I@HZ)E 4BX=O!APH&YI9M\37=T1V6"$! WO5'GK.UR^JDY]FR[$HPMDZ=#0
M>]I/;XUV=PI_T=G7MAUIZN8+;/U@CJ,7"JE]Y4"+#'B<+3>HPE3IK %==_'I
M9GQ+)+ ^>SGKZG=!#&"<+I!3XC3[4[;"T_9918>1(X9-;&.G$PX8*EC3,!]*
MRO:O104P=B*[MW1Q13"&%(>K@H$:SKZ,X)$C %OMV8 (/L5V]GXT-E7V@3TG
MN"E0P!8'&DP=+YC]/M5<?Q)AK0DR;3)4)7;3'[ -<E>X0.Z3PP3RQ* @G!^,
MFQ8OV$YC<*R;['R1A;;+M-DGGVZA84&+'V4%J<-:22U5*VEUV2,U3"$QOQ 2
M^5Z3C"!1K#G9#!+K%;58FEZ-DL:RMUD;Q#5^WV I.)WNRUD\NAIRAO2=L_%Q
MO39*QIS%0\?SL>W__[/WIKUM(\O^\'L#_@[\!V<>S "TCQ9;2W)N -F.$\\D
MMF,[R21O#$IJ68PI4B$I+_KT3U5U-]F4J)V41(<'N',=26SV4E5=ZZ] D>:&
MW@1H@8-ZI&W4I(=NA^]:ORZ<Z\N_[:_UK)F)N"PJ?:>5;<1&3&%5DJZROIK@
M=#B$3@"L(]0S L(&PTNV/M8%))1F&4V'-VA&C*DN,]K\IW_I9 CV)?)1%_Y#
M:AAB0=@>T[%5A <&8*2 BQX%F:9\%@)=PZR-.VX,$GX]Q^;""1LNM;5%2'50
M,#LF=C!I@;4&OWPP/9/KL8$JDV&K:AZ:2U^FV>BXX]U?KDSO_A@[=?CXUXA0
M.XSVPIOTU.W0OBD./Y<ZG\M?R]F3:LJZ-B/57HJ-OH3!Y3*P\$)\**'F@([2
MB0'&G$J.(1QE<7:;S=O)XQP](S+Z9)S3Z*^%NCMUO"-FM[JPP_<C@](U*D(E
MY\R70WFNO[?'$5?EOD3Q#>3'"M!&]=V_/S_Z1_^\_S)'J\F)^S9?;] XU-78
M39&_BU^GB+:.+289P-!2+3W T&D.J9PL705JX\N]\^/<._SV_D<[JW2Y:.1_
M!ET68X!L$W0&C))F)2?-"&GB?2.)\_%]X_KP],/%D7V?6>(,UY,0>8Z'RY,B
MSXE0I=RQW!GKY[R[,^8 W=?@F@AA:Z=K"^]RVD?:AQV3WTC*_]$  ^Y+J=YK
MWF6-\L=6DPS='\0T/MX:NB_6,VSP9M]$"2-R88M&Z8WE^,WDD.48LX^.@G9+
MD-J#_DNW8Z0O_BK8C%5,F:?KUH>>]>#=FP=;*)PFKC5=<^8@QIQ)46ULY 0Z
MV:AI5-G/$_>?'[\N:ADFT(3MFG**]G8T/B9[EF,E3Q#),N(#YO%909.E-ZK3
M<\CODV79HUB7[#$6?LTV>ZB8KV:?G==^E JLDC1[%.N2/<;BP5LNOP_KZW-'
MG>;4.5EX_^O]^\_G^W*Q^J&;8>I,VBE528\ZX]2+<DZATQQ3!]5?U^WZP9G1
M3]QKNDX:78=O:M,J1FZ:;SYZJ"1V3_4';LZHN18S3$+J2,D!DVMU#8]Y%YTS
M^P&><=SGL>$$=@,B-SS?N(;M<;[QCI[5;Z(#R\DJ*EVA]\O]>/"IU?Y[G9[R
M6;LFY,V4C1"_&%M10B'&ZOITNJ5OS-^3=A6%[^"'T[LX/W[GGE>S3+L):WRE
M\93D-/U).?DN1KZ1,*5_^/.J#_M7+&>:@!-7!TOK#MGTY6*I\YM<[N[.> @G
MKM,A[ZB(#J9Y%9;-N9DRR36*PG+TN?2S/"S[E;/6&BVH;5=8RBD:4-OCA,HD
M[2H*2_O#\.CNXY=A_>]ZEFDW:1=5C+*=HL*R=(3V-R5?56'YT'G_XVOQGU_?
MZMDFX-]98<FT7VN.&@O>N98]48W,V__]O[T][=1D5ONU=@FT]P9&^C4 7F*O
MM5+YC?;5L ;P9U';VY.P0FWS87[03]$*TW?ZM!?!!_(1]3/1+[- :$@+-?6<
MW9>S6,#&G 1#XYE#QG<37Q/TY!R%?H0IQ\+:A+ YXW PD=>]>GNZIVZOW-@W
M&LJ^UUK#-9IFZXUV#G*!;_ZY@]M</%"?^J]\#+\*T7 D%L[__@O'$7,R8UOZ
M1FNZS+C?:S)@ 7A?GPY[CN.ANIC(J.)C267]Z"34N>.B^+P5DDN4I5X172<Y
MW/8[E%>$'@(9<3UP;6-WY\QN[:^OXF?U:9\[/K9,]QT0]TI-[ZEI&W8+NRM<
M(SP*%MEY<<M2*/-J8+&]@#K'^":Z#M[[=YF6("0%8@0F\=L\TE)LS[S['^'W
M6%9.")0+^5W\5^7WR+9N;>D84))<3MSMF'8-XA7S0/EH=1MV^X0],,LAQ*%W
MO+0T%HJK'D%'GOGT[?!]U2WVZ\WG9JV9M9K$ )!+65U>F;@Q3"Y1\1S64K?#
M8Q%UU0957 ]<E[7WM3.4\3:(XBF_=YD<MJT^+/V$ 6[5[D[,(%[<*(]=QK$?
M9#\=_,QQ[S4P 3C C\#10B :%U\*0H^!S6,C=)<WL/P(&%"K:\(+836GW%K8
MW4%SP9ODX-3F0*:1BQS'+"G-R]RQ08&YP$:F#CN?=SP9\-=2:3P9+$T\F/(B
M>SOFOTAG;\<-^02:!)2*>B&FD".E'!$[CKLW:C67"_NE>!3=;498N>Z"%"/D
M,!030##DN;D@0#2@IS-RY\"F7UJ&[<5J!D45$&[QT6Z'#Z9G/3Q>&OWGS&&R
MB&PLZL*&;AU:_QX'8E-W8!OP3=*ASXSJ% @?=V>;0P'OA_>YN(411H72T0W+
MTCPZ3XX>UU+.4R,H% ZF F_@:"_X)-SG8%!Q'$T/L3@]'_B4\#+I&^/1<-L>
MS\L<^Q(%J@ ;5>_M.XY(RK$Q\1?8P,^G^YQSD]:W\,KA.(01J*E.8)9Z@5D:
M@.$AS">B;]+X&CZ D)^N]H#^-JYX\.EJWJ!)"#)@]4K4&'A-VQ2KC.R,4(@0
M5##89 YN0XMZ@$6+KA\(EXJS,&!RKH%6XYYEV@369R(*W]B[U4XAX?M)#3-\
MV,KF@/:2@>9&((H4UF6@2@5OA??8K2Z3*8:T/([EY3*\8H+YP@!&$T?@A0DL
M6#=N.ITNWS"!0"K'YYLHWRK>IH?P@P)5MLD!PYYQ'N)17BNA?$=@0F+_$7E5
MZPP06W+2)B"&(QX<'3N]W65]QU7W&M<YZ:B,-K(<@9/%3U6",&[\FOV]DRX;
M4GZX=/H( (4:/;%P:+Y,)-<F@TD3HB[8&#T@*) ,)%<\1$=%6A&<<<^>-4+?
M%503T)G*.;L[3>8_,A;!O NF -QD]@E#*K" %)31B'PAD2< C;6VZ;5<1G,&
M[N*$R=\9(&<&,]"Y:31AM<B(W@#A_/AKX*ZV$)L5S"1X#PZBB#Z8H['*EL"9
MD#29?TMLQ]>>F3]]:T"J<TC"*:<J5N3Q:81K&I',=,F97H!;2,1 +9@$N\</
MGW/[QN9_/6AZ%'KQR>,<D]84%W<\<I .,5N>(.8<U]/^Q-_A#TJ%-_0U_5U\
M\Q=''7Y +PA'&@Z5BJB^(^0.S*+%7-\ LF2]ON4\,Q:"8L*'8)OL(0*ZV3$#
MM2;0AB)WRUBT5+G7D%_H#I/O4($T^46/(])TB,'5AV5XE=PBZ#39A^UD&CKN
MM6*%W[-3IJD]@D25 A6U#W$"6OP!X*]W=Y"5%44%\7_;7#R@ZB78RD6]S0T!
M^.A%9J_'VB975U 5X/C+.']B;2%[:#I\ZJC26:.RD,YN=V?:X?&[ 2S[)D>D
MG[8%P75"4VPS%'N@F8DQ8.P>J*HMV5<:9R /2E=V+)YF^2I0Z>G1 +$:21PZ
M<E6Q,QN6Y=#[XPW.:=ZJ,.4"C5 ,?$:3*N+Z#P5V*[]^%P'9G6^F<Z:'3FF1
M%#O%!,!W2S7]( 9\-R&/F=*=/&#9D(BE]FL$=Q9JH1-*C:\)9)VDP?@()MAR
M3;S@?-_BB+Y3!17QE+@EX^AS=R=0:5H6Z,5\$-(@R,4*G"E!@9\U] ]8'+M\
M+N:#&[IC/B&(_,#U!@:7/(9059K/-!+)\/W=G88OS$7853[MD;7#)&$!3-J,
M>^%T-WJMEZK[M=_=%1%K=A-B_2@Y1.Y-"MGN7;>Z#N+,?G+:S.(B->8+>>5X
ML(KV'5X\>'5XWJ G!Y>.B]V=!P=8D5,L7;]/Z&U%U@39KV,3TFXLBC[^SC4Q
M.83/PC6]^[T.YEF;&(9AZ%?!):K+^+)_#3]VF>$-W.?H[^!.?^PZ< /@:_$A
M,G+@6H2M(BN8+AMU;O(.Y/N54_6V4O6X*VRR"VR4YEN6XY$CPT4]2APX&6G6
ML^)ULP.]B9PGH>*4W3U]$301ML: >\@2K(LM/-H#@L&?X&.5RB J]/!_'6;R
MQDL&]]FJ'SDMN'=%GQ75\&X[C-O9&%F%6SN46T E!L9A(ZT_Z*9%@P@(C:OD
M4D^-RAVI[6I<,3:$']*F94DW'#I9:' ,))NM@66@J]49]#VBSM!\HJBO!T=
M[91L'U[;-CL=1GI$N$KQ>OZR7,YMT"H/"79W9\S# L9V& X(4A<"/W*L6JEV
MD!A1B<?,\M E+\PL;!8TGV++2^KC$@ JR=A6:[>(5C=P#@J'>B6FO"'-E(#E
M+-GE<@.6W^TTD@2*>JE>T@OIM>11<^NG)\M0?DPTK0",2#0?)UY(8=:/8O69
M<W1\B0W#B0<].*[='5B*S2@KR.QP(S;R9C2!^X9);VL97O?%:33SE@,<Y.4
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M=Q!T\-$=#F63"6K:=+_>&>$-C$:H&!8O4)MWAH.YHP%NC*[Q><3W3(H(=Q?
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M%3G0@U.$S\8A!*N'=;U0&.]H,K/V;[ZCC" K892Y/5["20S>-:@X!*VW06_
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M$1;S3=K2B,FPNQ/T1J--1"VU:5B&+6OPX_56M9N1:2N^-MH H8DJOY7';(.
MT_Q'9CU@5R+;[P8-Q2*9"0-;.OI,6]C1,FZJ![A'C^AYDQ:/FL\_,M'E&&]W
M9SG.T\89CXHM)E9/\)X=6-4AH475+&(5#E1Y2 @HR5=T22HMSZC[$_K8I>D0
MS 562U5<1".FI^8>9 2[?Z.]<S^B\XH%ENI')$UO4CU#53&RIS]X.S3?]Z\N
MWU\\_W-0V?(:AH.)-0R5V^'W8>ECZ?/?Y^X0'N&+7$/MPDN.NZQ46'K*FNX
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M+^OI$2B ?,L,=%A?$PT<N8.7,B^B"(B[.TC1Q$ M?.&8L"PKPO*&QCQ3AMR
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M+5)(I*Q'W4$3G#R;X+W?V &3EE"?H*"'NFB63+^U*:2S+;\$C3PD2$4C2>M
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MCS&;<S(^L@A:UVC^?FEX[+YW_FE\>O?SU>)W29P6/@6W-Y%]G%07$ U]R[J
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M^T-[&:S45[.+R($[)59!')_N>:SUNCUP>^C'C1;L;F2GX)(OCA7*YQ+@I4B
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ML&)EGZ,V. =@!K/!<0=\)F;J6=GI,T=;?/-NW&D-C.]'OP8/AN+24Y*-H2*
MQ %3H65@I7! 9TIPVS-58Y:YG#W--2<##/8)P.&]KEFJA TY3?^ 8S(FBC,U
M?*GN[G2L>Q@%YVL0?J@)N/^+I U);EB%?T,<I+2#V]-Q;%(N&LIVW#_X]W;]
MM?=G^$NW83AN=D$4 6E%;I*31HO<(WCBSZ0;A8YP)W5:O*JC%SRV 0![Z<D"
M.IK$&Z?1+H/VOL%!>@[\;$4;(3Q]K=\'MQJ'G2097'U3PR]QD,Q23-J$Q[UL
M=V<(/X2OL"?O!&8G7=MM-]Z)>/7@V2K8G:2K!@Y..!?C>8@P4YWF1>F<9?M
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MB9$" 5,#D #NA"77[E5\]KI?$:%7_)JP$?S*;@_O8P._RL&Q[P GAV__*'N
M]\16ZS>4.<-/B;_0[ &0D\Z-+AZZ]WML^8/=_!L!I#BS21*9(YT[F=C,-@C=
M<_8"-XJU"K]L2C0:OP+LT?3EBZPH7(_D=QR>!2-6I];L*XS11,IH[NZ3Q!;E
M"H:J835K?X1_5[F3S&^4#YTC(Q*S%6ZTZY?S$W3V:$YV,"WCT\?"."2/+EDZ
MZ48W'1=(E_1@4$Q'.A9:$M&XD;;:8WIM<\7JWLO(?0&@-%K0]<$N,I!54(_7
MKI.RNT-,8XYRU70>+G\DR.X2KFR-=VC^,N2PS>E=6X(HZK@G3!^?8J:]T!//
MPDSX<-N6&#[8PP_8)5Y%<:5K?63@\FU!.84'V84ESLD_TR=OQ@3C=X9NPF6X
MIATWA)'D9UD"<VOZ0"%W6L?.K)8Q3*:G-JNZJN)45ZVE(":G%LT:=0Q]2%(_
M#,&V1W!^?2B,2"Y7=@)#>]QQM(,Z(W4Z\M6,8A"C19CT$53U47\4QD^^,MPZ
MJ+;+KNULLNM80JUK_J)7M[29/9+<"M1(<P_EY;;+R^V,\')X"*12K%8:&PF
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MJ:O3PR[1HV:B;;.580; (>A55"P)'7S\3ZG$G<I(D3YP5\(]VH=KGRP$I/K
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MI\GT=NA.H_,I<GY=(1N&156"Y/A?>[L['0/GB@-&*]BJFBDH,!_XJ7:OPE/
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M.Q[1-@E7M5ULS"NTCK_>#0Q!%;V M28,AYJ,3P^=Y3?9F9"%HK2*<4W^X*U
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M($@.WLHJQO(6U[/(Q[L[JF9R/814%X4MU905BOR2A5&<$SB<!K!,1!%:(%0
MN'?L?TY[1E21Z C62K>A?* I5%*$5Q@QW*>'N*$@D[%Y QQ]'!W1T:-LF@3R
M[:^%X5#7AKJ,DR!P"TZPS(&FRZ8,-P.ET+=TS 9X:* +##JU"PU^7*G@6\/M
M"+,0#0->F0E#0:I(KN[!@/?R&T[*;C@L:K TD-4YZ??!?Y2?T>Y.!]9<X:IE
MQY28!M1R'(#JVW1&L_F7?5H;A]'2<;9J?)NJ]'*M6EX?+"6CVZH?-?_*U79B
M:#EG9K.4=:W$MYU7,,V8H3!B??A"_%N9MSSFYA[W27M!@%;40L4(A7%,02)I
MP@#(0^MCR;<DKI!%*<L[2D0;O^\R<E\)1\*)''P KH*54V05%0[.8<54BAV$
M4;E#3;4,9$SG=G)'@;RO8'< 2^)H^8& /4P3Z4138TE#NBF SOZ__]?B^?*^
M8)9>9$4A[RK[MFV!48T3P+I#5)<3^\.YT T_[G&WF!NPT!K(\W,JY.[/=G>P
M9XE@OG)/(6:&#HXK\ UG# &PB*]J<Q+,%3-2CS)2D0-+Y%G&KBZ^X:$&,$OF
M(R&8SR,PH53$U@?@(][%A(A-HB/,J$5J@'G'@6=8:>[#<(9()R"*C1Y\.V*&
M"78)"+CF/;#(8%J.EPX&D2*+.-/G#I@,D!N2;4,X!"H;[E=T!I,9T9_"#X;"
MB-Q#4Y41)_=I8LHUY41B*5FPK#"AR3=D(<"]\=AM#!HWFT\41%&SB%G+#2U]
MJ!%&]=K5IHX$T["E8@&+8XL:JTA\-V+-(T$<T"\=?@4'07^6@54INW'$\MC=
MT2B;]'&9DNL%$W;%U@AG,[\)X\=?W./"ICWNY!GARS3K?F"/SQT'B*AA]?Z"
M1L822F6-N )P\^+DQO27ME.#1[R[0X8\/4@D"G!?$$W,^H\:7*/(#P@X'^02
M;"[-G @H?18&(?N!R#,/FHRP)^M UK2HVN %0W'$R2OBI'X"[K7'W<C$S_'/
M!1A# RP1;"^-Q,%(ZD0$9T93Z7H59Q#;)H0KY")<?6^;-+@P 6,1K#YVOX '
MP<H9RJ:@;)L(PPS JD2O.$:##C[^IU3B3F6D2!^X*UBG?;CVR0(?$"S#:FN?
M5K; T[A2R:E^DN3GZ#M5Z<Q+IC8DLW<_<"[Q?D:*6IR#:DBU!J@Q1;&+1HB=
MC-_#;$3GO7\<HJ8HPM" \3JO]H%5)7. R55^%V+V>C8;3&\@@"&'5J9,*E^\
M7XI$;?L>!Q!4\I+7(>P^AYVB#UQ'%WJRN,_A8B=*_ L-DYEO>Z]Z[UR&OYH4
MM#CE+!_?PW*$K$R I/M<#Z#NH=1#(&OPO"%9[ C+4SB8<+R'CR?<-?0/PCMV
M/"DZ;@_+Q2I$!<+7<=XN^]J2\MKJ/D/OX,;256%W!YP"0+=>2M;_^L/&D2N#
MP#6N(,  0Q3!*2@$E2CN&Q,^(&9MV+0\G'EM*:CD<F= ;OSS$"Q36VXO@@\%
M0@"3R%L4M+3)$Y7^/GD/%>68ZNJPO-M_O?+N(VO2JG(=3G*F$V027V5@I,1-
M@4,&V I8(>AXWVN44INKB<E#(SXT+#6I'^W@0)]LCKH8Y;LPA$,%+)N"KU2Q
MO?A$G16?<S>63T\N6[?MZMDO)3\ED)W='<-ZA(>/'),OU))W#,I[V@W95Z5#
M8R;D6KY<:7(TK\+A"F-.\B=V9R:#P>VPL\'$9AT"V9%J6ZS$SB>F30\IVLN'
M5(W+=;6;+\C<.BS?C>N\\*MA=/O]F[;+)K[M$(6#&W& ), %\(+ZG!N&HO$G
MKD-7XFRR$F[!V(S(U%)VX;)$M-L74<!?;%0VL4WI1UY\:2'N7:QK[5 MK%6Q
M37[[@NCD>IHBI;LC'$B./_Y?@5^B.\X+[F=5PNR ,!.^Z,)P.?4=,NE00V8X
MQ]I>YGG1K/!5Z4OS&Y2F4?_3^CZY6^;2*/_EA')497HHD<"6^@"O96$G%9/Z
MW$N]LUV2R3'8A30&N=S\B4U2PMM+&0D+!WB'[7*3)Y%#AIT,._.'G6ZM')-\
M7#E@UPLR8A0.\@]JN>DIO-:T&W6^V68=N9/5=)GL7)8]0C$F8DS$F(@Q42[U
M>,S-$NW >9U_MP8U;NU-S>'M$2NM&-;.'N=:PXQ9[IR<\KM4VYCQ,>PB#.]O
MZ!3<5^B>J_D[K9PQN/DC4L1,<D@TA>1T4MA(&R%G-Z(DA30_I+,L<N[TB]SA
M6L?+.XS OXL7^)+81;E@Z?V;+3K&9=^SV\SN(+%HR=?L(!U#+_]*I<@GTR<Z
M39EG*+E28[5* @"YL)GC=F)F>(?'DC3=X?'MPN=BQL@WHOH.?FOLM1BHODU0
M/4ZW>:Y_2_Q68NN\MI4N'7*%K,D?=S*#/[8(8OE:L1K2.2=/()N;?$;8&8GK
MY"@Q.\5P F)VM$R*48U S[!5\,-&"6*$&<ZY=&>Z9AC+]0/+G2X)QC9L9MS\
MN<S>"V>W-:Y5ZK&V-<Z>&?DFI?HT,:F.=$+>%DM\5,\\=SC09#BP+3C TH89
M,I<3.F,M%LN9=GUBHA6+X1QW7S'WJ.\MTZ9C$?VJ-O@_KP]E98XA[;1CW#"8
M13GG.X6^:R$MA3,?7TD^*9BIH[RW$@63/D?))P;,MPCU+0+GNF4$&M- QI4.
MU\XC6*:2[\N>Y[&5H,F\LLQ[9<DD,>+?WW:JZ7TDQ^&D;>3\^L7[[;+#>3[C
MIAZC<>,F3^WW[II..7S;;=P$/3R7#DMLS\QZ&)6O)GI*9"4_1\ZF@"YYH.0$
M4D[2@!3F0D5+SP2Q)V9F2@UPXLW?,L#).^!DDYW3'&MNG9)84T5Q["IS-Y31
M<=B[RMK,ZU]%_U=3VC^V;2I][OZQD]7/EM^(MF95%ELHV4GL#(VX\6G;A#VJ
M_9XWN6\SN=\6N6=Q_ R9S&PS0OX%:J)(.\EO1HA^\'+N=&?^-R-4*TQ-;I]4
M!P+?Z6Y&V&*)W];-"-5XLV@,!_)$&V8NYR3"'-%RCG:N"MN*L+J"3?R(<W<K
MPI;ITO$%?W;^\_SW^>?39O:W(D36GFQ+[Q8*>< W3J?<?LLD/L_E]E'%G^68
MMD;\F?&<(>.9U8RSFO%Y&KJQF9KQ+=;0;Z-FO!IO<CCOA8?94>^;KQEO9Z9F
M?(M1YLW5C-?B3;,QP,D[X&23G5G-^.8B^@ZI^#4%9/X!);CA:NRKN^Z05W51
MR',Y2;-Z"LJLCW*83A'ZUMD(RQ2A)\@=J5D(R6YCY?.CUU) DSQ0TI>'V%"Q
M^]:!2@K%[A'X)35,27:G*L.4O&%*-MDYS;$FYG6\-P6P,^ 5?DW[2($% U>)
M^.!Q!\Q;G<.[\<@Z'QR+J//WO.E#F"AE.\Z1TN0LZ<D__R3_ A+*_9']H:P"
M+N#3K/?JLKIRM=#4S(=TIL/<C/]4TW=WS 'B1DC0#0[!3:6@<\2!!B(;;HL<
M_BU6LH(ZXG0D8@M3XOY+G^[JYO+BPV*2#N5=(P6?K'(EZ.:H"]K,H,W+C,.1
M]YL%*G)8'I97.^LDK!L<7W:ZP<&K5;K!K=;>K0S2!!X\(J^\;=X*!\'>;EA,
M?8IQ-;;"_!)@BJ-(3)%D3Y ,,L7:+0)C9XI:K<B7VXEQA@%$F)"$0Z_X-0(L
M(0O F1IG'WQDX&GO[O3PQ#F!S)R3#<.B/T+.M(N<BDSL#_=I5-P"IQB_#;"?
MKTTHOC<Q<I%T;.F@'6D=/[%SP[T)-^B^/<BU!A$8O@49K!,C@VT'"L;,8-G#
MRCG-4==AK^+N#J#8$(EX2LIHC^L02 O89<0<TQ'W JBJ:C V;)'=J_(8PR>F
M;XD0V(^X'J2U5"_6<EZHW>.Z P2FH68*"B>[Q],]XZ7#8PE>X> VE@T#F:8"
MKU]D<T!'0J!;@&4B@PTS&-<.YBP\/,X]<,]_>!PMJP3.NR&CQI?F'N/7.^,T
M1DHR11%J"&>-V7.M;S+-[-E36O56D:\EQO$P.FZ)@,*4IO-%4C[^IU3B3F6D
M2!^XFZ$BFZ4;=(_IO,_A8/D'KERN<J720=(1EY6C*Q][;H"H=S =))H.A_G>
M1D+- H=@C8<P)&!=5)BROH"]M$?4%5Z/94-4- ,<HR[<\5 !9BOXHF_EEL=R
MG7?9W?A4;=;ZE\*WEUHET2#=.B2_T$RP7"IU[O_^7XNO5/8Y/_["9W?C'S7K
M6^7B^^E%MU<XH%/F8,[(<%<IN&!Q\=@>7Y?5%!DM9]'(OJR"G2B#V:FCH::;
MX#9P0TL?:@;^I6WPXC]@\0YU[5DV,$AC5.1N]V[VN#Z2D"XH17@\SE_!QV"^
M(ETE^H 8LV2U3;S:W#RTVMUQX0I^A=&*D\#X!;O9$P0E/-;<-V@48@A/)@,&
MP8'A<O_@K_GR_L7E5X.\K.S_"P/@#$L<<$/B#!D$"_N6HA#CFMKH@J)H+\1:
M=F*LNSO"O0#*QR0/QP^34!_I.C;DA5=.@,>9QEZJ2Q]ST#QN_+L1!TBR<$KT
MI-^G"L;%MFO@C&N@+/"9(A.2=W&>8@8^MIM>SWZ-V]Z-S^6?U5KW>^?\9R,_
M20[B"4HR3%='P),&UT/F"T*J7Y1P)$\D#B#E4:\P$EFT3$T?>:[A="R?F/OQ
MSZFPP^6N3!/A]#T"S+?='<-Z!#H0'U?  HQ%Q?B0#N=C@PU,L(,IC7+(WXV/
MNA>M!]'J_3![*ZRL)!M#11A] %!34>' 8;+='7"U"2%/;4+>N(2<:"WNVB'D
MM4/$*Q\1PQ1<G*)+DGQ '$6Q<XW$ZL3OX7>B\W[%!;&W* DPZWW.+FD28=6%
MH0$FH//*/=Z\67[G7DE2L/320MPUD)OJB1M;6IC\]@51$O4T14JW*AD6#G_\
MOP)?< 6IUCZZ"PF\C'_^_G']Q_@J_M;EA+;;A!!CMMRO0(F$2DSM N+ Z!E_
MS>"O\EU(K&-\]NFW]K/:4WH5/K?\%4,W[$WQUZ1"W5VH<CG,)?7;5N[')S2'
M>(A4U)?-CFGK2E=5^NRS.]D.)N6J'-Y6;@VLW&(LW*&4H2.C)A9.%5@>*RYH
MP&&K+096LV?$O\M._9D]I$J\- Z<7+G&R!KOXJTQ6W"H;*R"%RT3L$1X$RCP
MOT)I.KI9;;2+Y61.>4V&/]8_\)4)$Q.FT$S#VL+$MRIY%J8PPZ*^V+# )$<=
M5?JJ@:IW?X/;CZ5B.B35WB-&,A,*&1Z[85*%9=L+/<K&QMJ<DAU$RV(=^N;Q
M:Y:PI*3ND]/VF5+Q3 JV1PH2T-/U:NZD($PW5Q;KYE--1S 8GS%T;*<F3%E0
M\NG>)ZRNKQ!PEPH$HH/TI'(8,&TY,"V2EY34=*7:R!U",7'(LCBD)@WKJ.LI
M(6CF0 8BQN<]N^]GT+JK6^AVV)%P10*IJV3NLUM0 :0I64,Z1&%"(08_.8<?
M4HD<51[B5KU38%.IYQ-M&-^_0;Z/4<FV\Q 1BJAE0PNS_>2]T'#1J@63["G(
MSB$P)SB$Y!,.M./66DC-+D.BW"#1:OYPF+BDY0/GP?QG+C"3@,3"U*W\!8'"
MM/+18JU\-,#;#L_58WN3!OR@0[9H_'#V>'2<+1Y;YA;'7^5):4D'+JMANV3R
MV9 Y9^=+)#[JC40$EQ#49/WU6C,Q<,Q[-V\FADP,YXMA?.$#[,]NDQA&3K/[
MRP_OY.Y1'F,(BZV1=7N>.EOL''O$W<WXCUWR]J_3TRR?#5NSVU)^5NWO%K0Y
M;[*6Q(S#MYO#&_GG\"5[&K?NQJ.G^E"Z^OGG^\4JF\*7WI"^Y!/2[\00,.]P
MR:0L], ,-&5DS&W"T EMPK#4'>_&Z.%0ONB,C=>G'#69)OT7\,8\#=?PD5:
M<YJ X*X(8<T"W9Y+N(U"^JT38FH:0BZ>-%ZHWHT')GH<GU8O5'.RI//:*3@<
M0SHG4)Z9QB76UH"U-5C1Q@C?=G[B:6: %/'E\JEVTZOF=J\YZV60!:8Z\G0P
MZ*.^J-RBH?FMG5NNVHH.!GD.EJQ!$T>INEL";6/DP]I+RM+):;ERB0PJ&X1B
M3,28:*FP>,"MO'3*Q+YJAG$DZ/JHK^FD6^^=?)[K!'Y"K64ND%UG-]T4D[6[
M6#\@N,K(XFYW,3_/MX0 ^1-Z'>.ROU+1W:SC;(HM/F=-+&+#4"8GVRXG*Y3F
MS923<MZ:O<2AUW&C<_LS.P/N.SY E>R$N!%^I->19IAI&0#Y*K>GQRK0$7K/
MGV&V?&YL^261*P912M84J%1:.:@_9BXO$Y,5Q"0^2Z#:YO,I)F'*OSK7J<>G
M2>3=?T^^ )^0R6X=$\PWLZI?5O6[O)>#62IA;9]<:SA64,]$*W^B%9^%4*EM
MEV@M;3A<(%PA?Y[+$GF_#<&G9$-T\4&RS(9@0!<?T($0)FM!U(N5<F(1 V9#
M,-'*FVC%F6UH\(E%&39L0V0^BI!HW9<R*;YGQ5_Y"6+FI&Z',1%CHD3<O6:X
MN^?92F0'BR^V-MF;7N#8HR.8><K,TX6=K.8(9-P>X*QC1G+L!\9QP!B3,29C
ML;F"LPXQV1H9"S,P^(4&!M@67=NXN)/DN[$Q^'M5[;_TOMTHN4M-;SJLS"P,
MAG[KHU^RX65F4S"I8E(5=V1YNZV(QKRL])FN&:EM1\ON7F1WYUE8<Y0> @9#
MB32197'&C&:SB%PDG2HNU\KYK)IEK/X66#W.U&V]D5B/U/0#_\?S-&I8M_8+
MKX]^U+WM?WU]N7C0\^"C)^^/?T6&?2PX:]/.?(8U?89H':!SI<J99\ZD+,=2
MEA,K(@N>>F>>7>&)AN2YE#SY;NOS?'G6?9IUG_9>.+O[=+U<RW_W:<;AC,/G
M</@6G""P9'_UVMVX]_A\_%>Z;E]?/^2GOSKML(Y>1<62T,''_Y1*W*F,%.D#
M=R7< ZO=H"<+@0'V@:NV]SELF,'+"E<J.:(FR<_1#5"[9[2I#<E$W0^<2[R?
MV8VERP0AENI^O;B!=:6,&\P1#C'D,:+TPX]Q"^:GS1@8<BC'33@ZN%*^QQ4.
M3DM>\CJ$W>>ZHR&,H*.#%2;N<Q=@&E/B7VB8S-6R]ZKWSF7XJPFC.FSZ\3TL
M1\C*!$@*]IB.A(<2S4!\ !'#BQUA>4@??-]=[8\=[AKZ!^$=.YX4';>'Y6+M
M\EX@?+W*[<)6+QHY8A3&A+K=KXD;'WL'-Y:N"KL[YZJX]_%][R OP[[03&3L
M[I@:=Z2I!(($$ZSV4UD%GU(6%.[&A _(.>!AT_+P[K6EH)++OP')\L^#MM%?
M1L/Y<"($4@D+1L%3FSR1^_Y[$2$2=Z^H43$BV'^]B. CZSJ,M$"EQ,M6SMS2
M$H0DCO'H&/;Y$U,'<Q3):1ZXQX^@CKB!8'"W>S=[7!\!&X+ X&,[#"PT(<>5
MP^/^^;__U^+Y\O[%Y5>#O*SL_XO/_Q"&0UU[E1_A0F7$_==_<$;;5T@PI[>M
MZ)Y;0,,3"_)1FVKR66D7JXOV$]+_K;9T1;)R+P-9' 1)>7J'1& 7[;%4ND!F
MD 2GE 2XV9,(6-C5X)6LH\ZC9JEF5 K?7%]T/BQ_^Z0;JA4K[4:1;U06D)U;
MD>XOLJ+L[B RH2(G]SE5,SG+E!6P(*4B/@T8B\X(";K!32]+<_:R$ J1:&<7
MZ8]T"<J5<N7./:;#78;E3D&:LU;^9^+S#JHU&+VN6?<#@(%J,^#KQ,2X ^T%
M@6E=Y#!"</=(Q8,"E6Q8/8-8MB98VM.H5&F"YTNH38G/]2P3<'/$:2J@20]Q
ME@&W$.X%635,'),CSH)S&J(66(QCSV)HBG%K@ +JT*N[]&)Z$.45TK&R@&]Q
M'9,TO+.N+!UYA&1\>79VV^QVCIZZ\T4EVE-BD(_SBU-70DJ\1T3PR L'K80@
MZ=T>-@XY'1E#,+0(T<FA4-HS4F!2NJ8*S[)N&=S1Y8_SXQ(@I*UF)M]T9)"A
M:Z3(J%\D:N8$B*$] K??P&KILCGB.B*L+GH<:KJ@@PT"CQLBF*E$[C6]R)78
M%OE:&8Q_OJB?__ZLOO%5WMU1Y$?9I)ET&"F58E@, ]L  (! LE;1/M>+'/#%
ME_<X&)1A"52R82W)Q=46[YP<=H[-,15LBVM !M7"7"$A_&6EW6H4\=E@0&*P
M>8 ]0,[A"S#H)R8*MC(JS7V##D7T:GD"$8 .9,S )39 XZ>8^/ZB]6@I,)=G
MQ(GDQ%\#_T1[ 4PR!O(0_^01E^>9\&6 O4X])@OM+OL-F0--.E>?D6%BE^+2
MN9&?PX:R%,IE/>FI?CKZ5&GBPHKYADWDYR7/:O7D6.U%-@>P'D* ]%6_9/LL
M.Z)"I=>O86KT;OSMH3,\_C1H\8_W!<Z433RF#Q]^'?_Z\.&J^CMZ?+/"%PY
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M8%1^YFJGH/SL=V7 ?__UZ^'769*!YDW5G"VJ%P!VSA@[;\(?*.5R6-- M3-
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M$CW@D<USP">[L[N!HTNFZ/P05>S6 @_7X_7K;H7/ ;/0ELA0[IK]J2F4<.X
M_\,@ \!_O7.?*"@9*U-)LX;KTU<2G'-W%/<_S1A+C2[SU3C_;?$LO!!E:'L
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MJ@\JO[M7_'[*]\3K:0MYMBC%K@T!1CD\N;V%6E" V>'!+)T:SCR+E0N;XTH
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MI>BQ)JUGOQ'5<ZYE/=P]OR%)W..Q[9.:>$>Z4\&PX8.8U9K4%=E-0GR=+E<
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MVQN=O6\(B*U^"_'4+X#F $ #8@,0  @X; 3$5APQD\4 &@#-"#0Q;X4": X
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M31VY2Y%M&TLF.70"#'HG?8$10'U!DGVN&1$':\D;KQ,SG22V5,C(Q&@ T*8
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MP0KV>K^H0&)(P@(!&D$2^>M?=T\ 0((YB)2Y]YY=B2(&,SV=HP5G:^.]&JJ
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M0G(JR'A"K.-A_X#%:+__''2!3C(;GHZ&"!G1>XQP),:*T.(0F<;E"_)-_K%
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M_,]PJ_BHS^,"482+S]]"6#'NEN?9^:+"R?50!7&Q:0Q\47GBU<@7! $O'Q_
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MH30@^>*U$?!*9?.*>2@OC29#JC []^$5R(TX860+=_^R@I\-#DO3$<:HERV
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MF@,7?N" ).F-81E31S /$C"&C:.!E4G$'(Z%2$CX,*^P%PXHU+B!!39$R_Z
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M/Y]+=T,3C[:S;Y^6H\?-JK<3V++[,?)B 5WXQ+;XPIG80T\&DWEG'W^/PN:
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MFS8,6&"DZ#+Z"V,F- >'I& '>_E(G(%FZ4YG/@I.^_5Z JTY@HS_(=/%WAD
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MAZWKF5D6<^U\!6C@KVJL!1?/Q3@J#+D'<A5K,@#MKXNC"PA/<3XF/Z13.$
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MM>?*.H6F1>&E01W624-21(Z,S]0QP0M#: '&^JNMFDU3AX.;5%S1H;SV")K
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MZE"4X5":JO!#23-U[O#RX?1HM]"P1(WS35,".KH194GLY(BH.8;+4/N \;<
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M1BL&Z!!V BHF)O.".MJ%G2I<(\\)_,CZ%HA+Y-N8_:N@$B3:(>$][LC4+ N
M>+DY4HP,"I!"U/-9>2,#7A+\N0E'L^4N3130+SNNSUB(I#96LWV1;YP\_*E7
MK^NS@B5SK#6IU++FZ6T3/EEA+#.DFJO72O.GSH:C&E)":2$B(@(0$4 %@&^C
MW)KPKQ5KEK=V*L(Q1@DG#0KU5&-,?.;I_:H@2<.+/W<_WEMIUQK+$Y/XFD_O
MQ:OC'^6SCF1^:^_L.^?EZ(&S3+[5R$J<RL2WT?E!?!Q$&VO>'G+U2B5'$GO]
M@)+V_5E^(K7CT8$BR^YD'!(HUVVYA,^A@YRZ(6P?N6[[R+>W7D%C<GE+B/+'
MRGWWN O5MG@#5E';1%V#373@-X'IB2HLK%&/"FQ;QRQ$$_THLOJ:T(#9CU4"
M'F[_EX"%%^J0 <M=YJVT-9%Z;DP-9\&R;G<<L%_)0*U%14V&:X'RAI*;>/>)
MG\[Z <E1SW%VRN/4BG&0?ZI""@[&V^O9M4>%0KXT5D;A8MP8(ATKHAC[A5VM
M]G[VV#&UTYXPN\)W\K8FY&<40%"5[&J)P!TL56]6KY $U< DU8C4$73*"2+:
M592MZ$0[01!/+&]T)\9[RT=BAZ9Q<23__797_RG/+/2:OK,5 ;2P"H".%Y*L
M+__:6/Y+A;'#=H'=TJH@(L#=,]M9U5"3L_&;NZ6LE_+=5TK! UDT:%#$7J],
MU\O GP[PEUW@9SX*&NS0K-HVOVE^XC'-[7*S&U$7M:%XK+<U]=7-<\OARAR=
MW]!"P1 EC0MQ[T*Y/[QXT"H*7YOM# @^W12^77;X]I1C1,';_44-N5*U$B=3
M)Z$ND=P K2J4:3"/Q:CM4D+[R-M;MQFO]^U_)4V6LB,L<81UOK0QYNWNFDN(
MLT<[C] D\1L2L1>ILCJ0)5KE5;03H^&O0NWI2=<,%RN_;8L*KTDJ9;_T._;1
MB0I"A==MWEML?=>>W]6C1K%L9U2S-9FJK^.J.>X(V8Q$XO9A*IJ*=H,[\A?L
M$;;Q%+P+GP=O]BU0H?F#5TQ>&W&%&A&:Q5Q@ /] Y34!+= C%D32:47CD.2;
M:/[#<IB4P!%G.FG_HHB[P/]WT=#MF8I /!Q@_W2DCC': XZ*B11!KT&=2T*5
M"V$"#XE66S7.VGB1;7QO0KT6"3D,>(UE*+@"'VB*D>L@JRBJL;W%D]>CF^;4
MWXZ/I$M@X@GN!3Z%[01L>?X+I)H)<>30R)RCK6YO64X ;]".^93&Z: ZGR>
M(?[RVL?#X& X/%,/+__.[ELSIR? 0OWX#,=B?K+A:.&0RRDSRX0_GMN$Q\J,
M2,!0+$AG[P^2+M1;,9CP!!+%6"%1F0,0\9K>*Q%K&Z.7-;%.V,UAP11CC7]R
MG,H2UY!X!F"MT71F*P$-V2"@$+#;'ACN6/NDD7X=.N7_P/>Z-)QM:"I/)0&5
M"9;";DE>(N-H/@4Z]&E!DNZ\:A,0)LHCS'$ I_XDR54O%4?FUP.4%<R9U43
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MD__X>3VG!0%);Z[%ZQ+C;XYX#J6Z<DW%87W,\L=?@= T*)'[[LT'/]8@8!H
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M5ZLVKX:98QERS@+.50 / /V,[+J$FR-U7"2_T5I<PCYNH@86&M$5L V"S/G
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M5-9V>K3LS._C6$_P0E=58R\9^#8O7A3P-"+0B%:GXU.[OU26X62<4K8%3%/
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M):57,7N?'=0;T"<<U_T*2S=)DPT&2@#:00NTC-JV5R2 EM$4G(E<^-DP@#R
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MZ5A2DH7.Q>.L;?2?6$V9)$-_W+AUZA4G!Z \@V+25FI6\3>EFX2^T"TX @7
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M-8F%&643*I_N06*^EF5AK4+^0&(N1SG.IXL_=#X(/,JS\[8O,*B@'C@]:5\
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M>12O7=+Z;9#Z\1*O( R8K9-+D0R( ;UV; S)LG G0S&'+DIOKXYO]H_[?(R
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MT1NB3,Z@AY8""1FNF(DZR7&I@MHCA$428T6L6MH),_[Z_5&204V\7JA+M5!
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M=?F(32 <[;0TU>>7BGW6^7KQ+CC].7I/#-IA G/>/4XD*R'L^(#7F-R2G9!
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MJ9"^U:ZJ^RM;T<]B$ 1H?,1Q_^U\)E#(6%GMJHZ_?3L:W=)HI0$6F7=F^@)
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M/[V;#-9P;VC\=%P1+*,:>'8#V*.! LM)VU/YB2]4QCM"[2)_TJ*=T,).=TR
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M+@_3%AZ=0,/Z[U&C631%N].7<I[4_S3*3 ?-8D@#01[+C*MFY/,'N\IUAYU
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M>/9X!1H'61JMOJU1QZ6) I9,_@,5>QQ'EKFGB%FLY?*;3]H9)6,=;C'0BQ<
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M.-$9^#+?7S"?HMBM($6IL:-RD.3C$FT3=Z#-\3%N,N )<?K'_F^#U+\ G[^
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MZ,XE 1*>(0S\5+=:2+RM79'U'3=\6N,=A7A[+_U_H<DYBSC['%V\_ CH[3O
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M>7 @KQ.KZ*AEU\N:E]XGWW+[5Q>.%$4PFWF&G?F,;-]8.?>9Q*J(2J-?>8R
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M<HC&K+Q?Q,7NR*RH>5;)$_C\6@+52SQO7F3WH87RFJ[3?<<L\M8!:-)]I2/
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M4]U[)S,1N!=L,:HDT\O GV?BP4*2.-3:9T/3IV5WGIN8MM+^WLZV2=BJ"QM
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M GW4S^^)N<7^8\0RT;?RPGD.ZGYBZ.(#0,HC3%.!7PIZ4DL&5ONE?<,J8KG
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MS8X\RLC&KHNT3?N[<<OVK3#;?CBGP-\DY2#II_S-(< .MB4U"$64]16$%Z;
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M)C[<<P%5>YE6?ZR1A7G0J;M178>EB$:M9-@, ]!L#I63VF3W);?)DP8+(6N
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MU@>'G3#G2 Q!KQP[W"Z1XITRJ4U>E&9=W"ZZ1JL;#$N]LG >*CO8:17+5<V
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M)K\K7VU9'-R8ED$3;""Y)E!:]B)\>CV1_S$;8;*7;1ON&85>^6S.,+D0(+9
MRGB[FCJ\@3-2M[28@6C(VA=1*C9 1)TU'EL(>Z;?2^DZKI%.1]$,+0:7HR:'
MX)UB.;@O>: 8 !'I55,&]CHXS=G?\F3QGBR7^XK5%IN=/(SJU[" 3Y<NM0"^
M._MI^TO.I<H25T2RQN)\B=)L8VM236&2ZL<TDIEH'Z0.;E.3K_UIS\11Y-)@
MAF33!L9P^(-#UB9'7H[J:MZ%T' #.>[@6V(N&AW T%0/C;EOGQFJT/Z9D7LH
MUN.P"?VFGEEIOMN(]4B1IS;./RR)IW#9-QFWG"* QY:LFQ\FZE<F":F*^F"I
M/)!^%'J [=H^I_"K10.&?P#%(3^;Z)]"U%;G284L%O\ D,\F"4D_E]UR0OSP
M?6[!/"Q2:7ZZV8Q\MW& B#S';RFE/DS]U<;ZP0R_;]1- _^639S=S'4'Q)5"
M"SZ_8,V8NOBO*$G3D1DIJDK3)F\Q^J?-_U,YT_+_@W)FT(^QEH4_)DE&']RU
M02LW8!'ZPT@W_E?CJ86GOCGWZZ^?BHQOV0A B4*&J:\_?AMGF_U>_!_H.9]A
M9@:X6#S4O"X:^DD>OUKE\N_L R'98YF)#Y[=OZ%E-DNFG6%8UMOTT,_ V'%I
M@L -P#S%5:<RHR-J@%V5;FL!Q>!0!E+JJ?:HKZN3B>LD2WX>.Z6E)EWV4)=(
MZ<>3BF[W#'C=<_:".$>^Y:)3KJK</1Q"!]X/M%V^,VQG.9ON"]$X:4()E\5_
M0)"!>14GC7;]8+?<>%'=I,8[;2^/(^U^.-5Z@K0:!A,J+^!LE%,[ A)".<7?
MHQZ>KWG!A>QB[[E:U?Q6: BRXJVXHD1DK#Y8K:U:+(L:0@<G<V)G( $Q,3NI
M;N-1G@AM;N\#!V6^HIL.;O8K7OAFL6^0VZ^C8U#B2T6A0>V-?W60I@UE =C5
MWFP3'U.-2ZAK&B&XKG,N</$^?E-^,\9\I R! ]R,XZ Q;A.RB\JY&-8[Y; #
M.0N!=(-OE!W@1D@A3AGOH*H0+-_T=J#9MSXM3TC [:PZWU4$84%B+W[@H]!K
M>0?MF@1ASE/S?;PLQ<&;2#$]?(YA=S)D\+WGJ]6$?+=DI_H:TWEK[^C!][8=
M8'7F!?0G,]8!1PLWD25R N&2N0,940"NR!F"_'C1MJ&W$+B\?>"'D V<Q+Z%
M63.)T+L'D Y4_QF,O[8XN,UFJZJKH&UV;G3X".P:5+SK5ER2H$5%U;4T=YV1
M"@9>A7EF_@.(+[4M<GRGUL=EJHLX1'I8:#X&6]R,4"X_%$ND"T0-9:W$=%P,
MD3HZS8__:+X3_8/G1.6!X TMQB;S'YG./^I(X-M-^W35#CFUZ&0:_A*7GI@F
MR=D3@[V@E!*B-9^/K?&Q-.X?<YW+<;T9KL_"@^%GNT/K#/.4N OM#C49:TK_
MMG)2G\\98&+J$?DMV^)\L4].8:O@Q4<%55UUYQB8"AS;K@OFR3.\=&?S>183
M7=5%5I"=>W//J9K%7>@[-]>FV'D;9+PL6RQDWIKI3E>G]@I NJ-0P-311?&;
MM;FO>8.5AK2O+D?'Q &MIDK,:!6/5"XWUNKJTBZO-'()-(EB1=>I*[*1;"Z9
M0N]/;,"^S@HGM*;[=VF3HEA*D^GU.8'<XYXQC:U*GMP36DU34ER@D88Z'N3U
MA,U0)GJ18=S4G3J0Z\O.7RX7KZ/JX]BVM6"NR( R6>$E72>Y5 V=A=C2[8K'
M;?Y5J/M0L?=)&XPD%/W5]-;U3KK-M 5</WML^=.%>I25+RTP?2S->1I[/I*6
M3Y-U8ZN4$)/ NUCQ3Z;F+(B/\DVH][*V(\+0P1O5/4>-]D#G+>WK(6)8(:$-
MT#W66/MQ@K47)A4TQMXH6;1Q56W3J=,\:4=O3DOJ+K=5^+O71M/91S>]!YWD
ML5[]\I4[A9-!F-89X9QW=E$*T'QEX.8M8(YF<L%JJ:B81.%-QJ)NA7+#*6$7
M43/@%^_5@ ><)TT'$>.2$?KHBN0<0]F=5PN*?T=&RX:;M;-##*G0]NAAX>]T
M';WBSYM!GQMI>V91T]$OA1JF:JZ_6BJR!^1@#%M"/O*X>Z5,8DC[8)OELF%M
MLML%+CMNYY;KZ9#[W,3WY]\<!DPIMD1?KY&-7!E%&G!'?J=C9K7S09,G6J3=
MA:=9B^8[Q,G8,[(4B^TYL@*\W;0RJWJ2-<37]<Q8=;7_@T F^=:'5+X6A3KU
MXG1A2>>>Z)Q(UZ_3R9'S])/A:6L6A\ZVN#Z>C204>9$1=ND ),7UO!FM"7@'
M_$*RB,*JC4&Y6PXEC,BV$+_F07ZG9SONR+"!%0P^+("M$!X[*6_@G.Y$\LGM
M0A3LHT_+H)S[(ADJTOJZ"S]DO;M8R0&:=<I5^?V=BM^2B1>JZVW.TO43780/
M;XE;WCO0J/SY!Z+48^!5;-]M4-97T"]'?MA_(4F#!<S5!?[$P)5]QY?#H"@X
MJQ&OY5WJDS >\D<7 9UGG*K*,4Z\[6SP2Q="#="5MX*+N++I347G?K@0;OK'
MTQ*+D2<Y49"MKN:K4Z_H0>\0;X@>P]%DL<;"Q<;3<7%UI^U,OW\ KG6@K@8(
M!-KL7PF 7Y\>%.(%=6*+0$QN[OU:3$<DW7*0><[JP@/.:T_R@S>#RP7J*S#O
MYK\TO&1J&V[YN\?VY=&CXGJ=@EJ_(:@*<&E:O:\B$:'7DUM-ANSMU^$BYF^4
M?'Q\U3TQ?TY(^X,=TVT6X*=/?=\\>='>BC$(G+)-F63:96L!FQ!X<=(CS=41
M(MLE "Q9(V0WPI Q2_+M!_=!BGY(5?)F9B?N36^A3HH=G.JH?*:D]OX>Q&!#
M'-VL*8:(RP^1+?/<ZK#X:"F[I#-O;@&\KTV(:K7;]ANZ?#V:;*32W-_4<N;_
ML]FI/+!K=S+\Q6&#\-(0NL#_1!N65K%Y0AC3KB_*M2R"LU07.F[ JNW123S@
M8$*U1(K#@8F5F,=2@6]AOHN_52A-:[UKPQ!XP[>2HPD15,A UNCJWZ(_GOGX
M*@<Y <?-&'?'3;,-F6U!-5#DY>B<ZZ>C6.YAYS<;C,TFZ<U2'>"Q99PQDFP4
MB7.A-*ZL.5F\S6[?R@"KJ3IG#4MT/0T>=_=LJ?+YF )IOE-/4&-:K2[ N@"M
M?+8W3QKE.*BV)I2:C1N+9%2MOZ(&3[69T_/*Q>8"S</OSM;?G6267S0;"EQV
M<*DK"+V+3CEI*-$BHZS6N>R&S3<G=ZH@HZJ^M>G1F+[FML"FKN\R);PVX>/J
MS)[T@%'"<DY1K)'G9WO8C5AB \L@C(C8KRU;"VS.\_J,; !P<5C%]U.:RSM
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M\BDA"$[,6FI\@OQU&5=UKG\[F1 7Z.ZR4ILR/W>$\T&7SGP7L2W'#$BXXSR
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M_T'<>T<UU?1A@*$)(@@HD0Y2I"2 =.E-Z83>NX"4@$CO2!<-O4/H)?0@O8J
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M-!@XR1<5'3DI^T3=%+?4QS15 ;H3<0T]LFAPR!&*W4,N7Q?'L<I1!:7H5[C
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M^C7.'83^,U5T0WX+>'@+^$$[>G,-B_J0O.7(K0,=9,3/8"DABP/_UNT1)W$
M>CJ1D)EZ<ARQY-P"B/:B;@&R;V5N 3BZ5V#E'T[E74NSK4?+LPU]A9=X]SX7
MS/;XLRZ+0Q+Z_UKIW\A70A9V<5U?.OXL/U%\T[\"[?CHSMJ+7)SZ@O71<7YI
M41NT_ZOO%7O?G@,3D[<L0W !$])O$G;U#.F0^ 4STS!1)-,9M:8E9=IV(US*
MD[!KZT;UB(:CWR2]D$);/J+61D?9M3$EELN'JWT7VOI@U0EDR.Y,9H)ITGD,
M7TN2>G6-^0&5QV[4V,LJ*B[V+UNJE$8=ZT3? AY%/\P[VLE;-->*_;D.F<X3
MVBL2^XRXLRB,/X,WR$IO 0L"P9'/KU@OGE_C"MT"KNYI[E><VGHP/1_6?FYR
MD7#F\TK*\ZWD+6"V(C@R\&29D[GI(+><A()-^UD/P1VP)*RAS'86VK-%B([I
MC54 5+G /[X^,C6==TH?=L/7Y6S&OT_.1^AZ4I(Z'W*TY2II.-8Y=6%YC>=\
M5R%W#2A22FB8J'YU:I;=?_>38K!JIQVOS2K&L?C 4C?HP]A-D-4MH-/ZR^PR
M:0/YIHDCC/K'^6A2!>%K74YC,P1O5&+O"U4"3Y&R)\Q&3?>_R@:!_>Y1$C\-
M<[9HT*'5-I!]K"R@#+"%;U_)+(#1^C:M'39.#G-WWH2'.@!O;"L8="SUO,=$
M(Z%HI\EQ#2]/1*[UZ$1*AMB1Z/"!%)[A5\#LYB1O:<(LD>7(@8G*@B6%^(=+
M(K-3QP2F=8M^!4-.1O' !TO/^KCUOR9SG(V+?>'Y+'__+>]*Z#5J_JK>8EZ!
M/C_PA$520^>5[6LL7W?9!?P"]X]F?6<,8KY*L)K_LI>025-UL7'TPT'"V 9&
MH/GJ4MF=[&>\9K^,"01G/<1-&:J6P=Z8LY K$J<G86QD%:X=JFQ%(,DJ,Z\S
M=4Q3,NFW/WPC<V?IM^&W $'9.&JYYU='P9<K/ZS2F;;R;LZ%CX%  [SU>I+6
M6X#>+>#O8/'AG=_(U;P%!,(OGL#,\@//FL9:O_6P,LD68PN'MF^"[.Z*VJ[C
M B8FNX_WYHXG2M<'_ZY7%WEAM;[SSY6EG+82)Y.T<.K/6T"Z\5WM39?%QD[)
M'&S+7%\*'RM0NL>M?[\%O&Z_\\__QI8;]/WY[T._AA?&:;4>K32EDRNRI?W2
MDW>E20C1G"@@!&X%/Y99N>]T"S"_!11\!DM!36H>];_Q\$;D-\&U1-F%>.*'
M<JX3R^ZZK/2?FZOF,\."*]Y;0+SYR^N3&_T-2LR#/.E@6ZC,,=G=:SMY;B@[
MIVGC9%:8?&X![TVOP!L@KL/(4=SXE^/%.C:8SQF>0[.M-RD'B[M.-Z%4MX S
MDKM.8'&B\(1BX<YAQF];'A/=6=PN^SMK#3/GT(F2=LGSSMAN>T)]#?[M4/IZ
M[GQUV3?+^>/ KQ@^Q\9C[II^<><TH429MBVBJCL+?V_#),3Z%$P2>^7*$!&P
MX'8.,WB0"U8SSVW>/SWM)ID)C/4CI[&=C6*2E?Z[:.8$9@5:Z8=VXUN%*^,7
M)@L] N03? =)C7)7DG".LB94P 2,<KMTV=+Q8-Z1TH&&"#+3ECM"SZS+8?T&
M3+6\?_K5-.?)69#5N_WRX$7*2;OE2_:=(&O6\\DOVB^+<W?*!E'S@MUDX5XG
M@;'L*W=Y<K3=C__(WY=X5ZV!AAW:QM<F[+DSAJU'X/J78,6%2JYNPMJRXB\X
M(44Z*;$6QTSG.[> D8D DEKAL##UM?)/R=-P4O<JL [9_>UF[X,Y.839($D%
M X/N!\*":A\FGB"NQ>?GCX^#+X[NS(T<T+6X9 ==<Y;)-B:I=$,^2A%_'GY7
MO;^!^%])#^1D>#_YW=7.]L86^$V46GG#P6-X4_\(YHP#I<XG!!Z[!3AO*7]E
M.D.^GFM[-LA1.T.V @D"*UC6*;&&N:R/@/>743L[?PKF @*';X2B]]?[:)XU
M@&-.S].OG#8O.$\=-.#VPSS[O_N<+^/"W8,7U&Z$-M_3^:)^/"XPL_6>ZURV
MU-'63"2L5QJ*6BR-I8O?>9!WN1G<EW#U_"#9ZT=U\)\[NTA[40<3([^&2ZN/
M7^$L:9)M5I9!_6U,9Y\0T0_3T>>&.U@K::IV$2O9G!N._::T-O["W-BG-$-^
M$VM!<TJMGN=I(,R>O_.&TWC#?8'>4R;U.6NC5]YT[8M]& PBP/=0%J74]"I
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MG'#V<>[J0:8Q'JS>_?(JWDZ(126QDI+LE=4HVFW"@:5U5QZ;N,44,;-I9"=
M3=^'1,L21:UGH%(\G\R7M#(>G0RL-<YQ1]M3A_GW)4_]>H\19DU3-UJH>6;%
M$X\*Q*U\TQ(KODVY2FJ9_V.YZV],0B]QM JE"&L%J6*.NJ_CT7/3[6KR@$'6
MK-2;]#EQ)MF:<9Q$8K/L5)[WK)MC7^QJ^E_5.*G(R9;QM9$ 8$P9EF\DGS=+
MMUT40!=EZDR@8&D9#*7*'KMTM@%"P\^ZLS\=*?3I\P.SOB0ZZ&Q=]1(A0Z-T
M>+?EKOYF#J2/Q?A?>1%6L1KU>.0Y8<3].7L8TX!180AY*"[+OZ\;W( QKUK)
M!DSV @2M%"NZ*885K)/FRME;<">D7ZF;N@O9)J].*1X]*]90H%4RY3%1]4B]
M)!(T]RXCCFC/EDWIB*([TXPG-XOQU;E%27VS+"5DAA\^Z\H5G#=/(G(B(;1^
M/^Q=5*$$%/'Y_@*0L2N6R,JY:ND+XU6+D*Y3]5G/RL-J_(0U1,LYKZS2#1)0
M\96>]U'J]M\)^JBB!L9CT^YJD>A)/Y:7)>#@SWSG")14L=+#\;05V?_<+?8)
MB'K=L/D(8!FNEQV8^T(Y0"PAM(^NPR2RH9"84V-8TJ\6Q=%S XSU8"^0D<$<
MW,W,>ED@KT>:S H &&+&=%#:'.$[+[^0V4%0_:9';F6A7LM<:2ZM1V'-* 3)
M9[E@CS_YECLSOJQ&:FTRK24OGZM#EJX ?VG X*!@Z2$'A8%VU_-Y'W1;0#2+
M1.3-V)I9.-7+/T=Z5*&;A#DA8)=##$?F;_YU0NM1%AQ:$\D9E'\M+IO[R[8\
M<MV"YUACQ]7)Q8W1*)ZKG2P<D;DT,ZB=7,)NSDG0AT:EFB%DVCLY)SD7YE=?
MB(L> 5YIY]<S, Q3ZFH7@: Y9QF[$[#DQTU/-5O+.J]AAG12PLF^GIBLQ3J8
M]\=V 'OS86,O_/GJ-YK6/;53M?5:]K 752L=7U23$9KU(<\MJB_2EF" YZIU
M#K@?(0)\E@] ^HXBC)+YJ8C8 HAK"&!%T1=O*V5Y&Q@KZ5I^H)Q!+,"G\:"Y
MI<* K']2815%E&3YCB%*R+:#_A%@(+,KSN1NH%,@D2?(8P;\0!@T+F -'O_6
M?_3Z*$N2=?@E,4^=8)?CC%(5900KBB=J)Y,5$1/:W@*.;'#M<SO=&ZNF.%)_
M7K+ 4OJ8ER;HGC/3AJ<XG<JAT@RZ)P<BG-OK0=CRV_96"CR&%WFOG(B^%F@S
MY>N\:"@)L?GCI,V)/0OP]_^]75[RJ3:YNX?OHHC.&1Y<'B9(_U&/6V?O:B"E
M.51UCK"/O1N:LX+."VL&*?@Y%TDR\K@7?KI"!8T7-(KG=E.$V'FII[VFC!>B
MK(%*@-Z;+2P<1SY8\P])))?.)?9K2&:J@968AK)'>:3?%-R+RXI[K;NX2J &
MZ<;_L#2.Y98FPC4ZQGS]J5)N$6.]H970DE2BV&X2B7C#E6R9!-)S6LQ+:4#E
MHQPAR+"[IZ;Z(VK?^C.E\'.%XWHOIV%K+1SJ".I5=6LN9#IV[)X<[1\$-*+O
M;ZR2F*$6]8GV:M[#4Q%C_BDMNN<ZKYB-Z#U\U,AO2!8 F^-U>444<Y7/T2LQ
M$K5A?(XK+,)RM?7A*+)."C.2'\?BMB. 7<I)QU'TDA]]^/(G-U?#JL;+2E0P
M.R/$/<A^/P*P<JO73]WYH[_DYJ<1*6 DMC_S--QJ705IK^FS17=Y(YT8R+S3
M?V4]WMK4DI+&!P?> 'HF>7:TN_2@JE79'ERXRMHIPN+ E!)KC7G,A*M:+7K,
M2?']0P^D&T+ 6&83@^:I2V5Q?[=U7A"F2\?+^73/C=(-S<\+?'W#3JF7 NTV
MMQ)!)T-ONZ'= ?TXJXLZ.]L_G.J^H1;"R2)+S<:Y9+W-Y7[ IRJ)BY))"ST+
MKEY 70E<@FAS43SOB+P5%>O*&^1/="7&>EO20PAOWJJ.YXU5!S?S[\D,V3)(
M=.QZ/*!MMW24I@EQ[AE/= =ZM;K\7=),^QN_17'VZF92WM*)/U@VU3&9-&;=
M?4]>.<WJAVS^NEUVI!:^YFW6VLA]] ,9O"[M 6U&61?2WA?R"'A=Y?YR6/D1
M((T/-M*!A>7\B[O@""_C4_\@ :XBR]%KB!+WV "2.UYOF%Q*I_FVZGP]"<_Z
MEU#3VA<(:W[U"!#_"3F,3=[O_@AM#\DKO[ %GB^FO1%0.=2J#A0&+84"[K_G
M3_0LT[$;'KPU>9AZ!*"/'+ =VEY*7TF.X8)'7$D%3@7LRPF;5GTF$</-3Y4,
M6T M\MC6S.12'7$N1#/<^!N,>6<<V'<OU7/_(9[O$9 :^0C8%6EZI7*=MT&;
MQ&K-X<U=>JU!FG'ZL<LC)4MKGS\FNJT3)Z3PA:3"CX(6MZHPCTB'T7T:80>[
M7F^&[Y,7U@'4YJ$O#7+HKU-/7'&CKG^Y1Q2A%.^UV[-618;UJYW_SMV<R(ZH
MI[SB')H:#<7FQ&[N/&U+6*)XKGL;'717V#_]D>&5IY33UF_"[D0^7N1G+1S7
MWE:U*V_N0<BO^[]D.K(E^QG.4DP$W2G\*$:0 .O_I*4*V9UR)]@*N,,D\G&]
M<[(!& "R;;*,PH2Y\4:#P)JTSZ<.=61GE\_X=NKZ'P&'F76_MNOH+:E=US8L
MD(DO#Y2AKE9?%*HCQW^F8UIV1/NH4(K?JMBH1 5-6JA(  K>>X<&)4N>V2)#
M#7U1J:,FSXK48Y;BNM)70\:VD;MXD$P.Y%8Q=J"VE0SAQG4'VJ1D,9!VR9P2
MR-8Q K<U/M8?@;WXZJ[39&C@D \(![WK3?.Q;&J-Y)B:LKA';L;3\D,?JW2(
MS0IDI@/1^A(%[*Y%A-FMIQ];B2$]G6FWV/F4()87=43R[,H*FNKAY"T^)Z,]
M?E61>^9X\.\,;=(CP#_+1(^ 2 .91T"I%(++U?V^G:-EJ031EHS_XQVUN%_#
M,AZB>YSD"?V"SKB2D1Z.0V\B%#<,1,$I]UH3*-VQ)ODH?34QW9U8:T8K"_0@
M_N'2#D?JDG L3YSR3?02"H;?+QI$@OJ&1&S&;I[5JR5&2<1WD J]WS,A01C/
M,44#";"/EV 5MMN=G,/L$WW/-_]ML&CL'$_]_<2@_I%>SOA58V2"I$;A^8HG
MI>_D>N_!E5X>E)H6WUVC##:K-S58,>SXAAS5Q^53?Y&MBN]&&X/S[Q&O%/'K
M/]A]3LHP <<,L2+\%\SI65;$9PP:S4L08+A+:JBJ-\W%>(BP[ HH_/6E :BD
MJ),M3W+<E;T4V[D4V?QWP.#FQA\.1U=VM?'017"_=]!-9,60C_8[5NP!#9FB
M+\:XQW^%PJ5QA&.<C2;HG11* 3B<8NQL&B3HR81[36RG..O#\(],QF;0:1%L
M,SMMBGU%A\L][<7&U$IQP*99D EZ3M%>V0&AX'(:_Z^P=?:?I#WE]YA8:V"+
M=*P$[64](4L8C5Y%^S:/ZJROK[JI3;2>:V<1J.RZ_R@&$.V78#(9!E&R#F:)
MUO>JB@U7($/I(."Z-(7\ _8"ZRW%X0_:#RC.X[ST=OQ!M#"Y]A;[ZU\.&TM@
M> /6PW/PV.6Y:Z?!#9FSP>TNZ );6=4XTVEU4^5X/2$OZ&6Q#$E#\]O5O9$@
M!)L>C"+:1%;_BW[PB<TCH$O=]1&@[X] 0VV')>39*\0H:L!H;YK90.I.R8',
MN,)%FNF;>C;8NA-SR/[#]4:P$=#/^Q^Y0(6Q*S'Z42XTF\LT?VW[ZE']TYA
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MP4Z0F0$(5<DPS 9)'%<5N??>&]\ .+BR$HJE^/<3/';0G@%V'?P(H""'S*#
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M/Q?=5LL/+=AVL"4V?1P&IO!F^+>'@_36Z\S0[I0LD=1P^X7*1P"2+H3_C(U
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MZAHR4?>4!R_/LD[N8( N^"V(ME3LO+W,RW+D)Q?9%=Y3-GRS9BH+P4G.]2/
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M4.76E^5T@?:=1\!G4-Z6OE5HLN]T2W-]S:^S:1WK@&G-SRIAH6,^1P:";H^
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MF6%M44?$A/'PN-M%'[^^C/,=  UXDKO5$3$.W3"< N_-<MP"M+Y:C^?!6,.
MJU @NSH^R:C.:9@8&.="X;)_G< 2$>K<_"F(M&GLFK=@/_15#.ONN7[_PL='
M6A;)KU*M!6UCUGZ;JM?,:B@8'BLK631G59O*;]N0YS+!-!)L<. 6.90P,YPD
M$QS''W 3!JX$UQT](;57);E4:&72I%73NW:^TI.%D4^;]C0$==$APG(P$5O\
M0C[I*$IGS6<:%'BV#M=]^[-&$SJM62<K&-D/=GX*/,43+;#=L4M%>+BN&*(<
MZCGC6]*9:<B; .+[5+?W)QRP+/S9&Q7?HL&"A8IO#QQKB5B+'M%3R9U68080
M([KPW.;O (>,8"1K1V1>;3+SX,]TF?J\BM@LDE6KR/Z;'K,[0%?:'0!1YGG#
MNDP"'1<"WSR,O0/ JG.M2\\)V?9X1)[.K4)A$L+[:RH5.V,;MOJ=H1U,\!]Y
M^HLHQ&\XV[X LPU1%7GS_02W+]XWQU"QR#BO<)C",]2DRQR+,M:4M6!PRX4M
M'U$H&-RWT(K71W-+G#PR/[C55>4[]S(Y7=: AELIWO[+ET(,D$@-Y8:F5Z_Y
M2%P?]5GGX=: T8WD% 9&+:.W,I[8;@+8 ,+C_"X^R@I^$/"HBUT$XNL2\!8W
M%R,K- TJ;F>KUA8?[;WP\@+&G-<ZQLG6(R8V;#'-ZVM_1*S"#EZBA>XG_W%?
M,2;=)$(42;U427Q*B]U(T70'Z"@7BID@%YGL=78GNP">0KN_):?V)'[)AK.,
M4??*GF%U.$<$&3"R+7;@+T$+=Y\5W $J(A@HH6YQT-/GNI+:"=*OEX*M*E"'
MW*0X),'/JNX6F>B3GZ)+YRCZD/X2?M:R&L"FZU_<'3^,/8(Y]-EU/@A_5UI:
M)33QA9N7#X\,MS3_M816ER,K(EIA!5;*EU*;T+4RAYYDM"7R>7XB3(([S"B9
M16_X_:!MJXI"4UV8$:N>-*/H'%V\2==@CIP_RV-XTE"MJ>/".Y9Y[8VSDD*#
M*HFM'%T#].)*,:/NEY26E39F2"9MFK,C&F0(&^\S)L9Z-RMLO1KL?T$Z;\77
MB=.X'6F,0N NQ=_P-B=BDV>MW23V\C8=Y2Z#!KC?1GM2<ZKZ:51L_P>AAP$3
M#' VU7]L.<]NI80UP?X+DU^.3C]V T F O =E@@F%V=_6N=7+/(6SR_>%\].
MEY="!UA/D$U@% K>GK?RM4NKHA,VC^@II0H7!)Z^.@[[U*S._>0-_H;=UIF+
M_,A;W>_Y@G4[CX63VFJ"=GF2X*!XE1JRTKU$A&?)X^5'/83@M@:/B.;?TP$A
M^-TM0POL.]Q3+3@G4)@'S=%Z2>A9X.*9&@J00@H@_.O?B/Q7]E;RN<4[?(YN
MEU1VX!_+>X,ALDE>TM-><PIJTT/W0/W"6-#KF1DXEO?S&+K&?4WV%5]=;AUO
MAN!3"6EB[0UJXZ-"V(Z0$7B[#G4Z&?%\V9BKO;%_\&O!\M^15^3\/FN51W43
M/7< 7))7J:XX9^"0'O+>7RBP['S_)*EZ-Y5&A8?9F9:G=X"_X>XR%O 2/:6^
M#W6#-#$DQP73Q&MZ_<M5Q#\!;OVS4<3OSP@F#;'PSBOR<>RQN;IS8'8KD&&L
M.:(L9NM3XD.V6DGOLL:G5C"[L> WD1>3L946C.[J8<7C4"P9$=P[@!/'+=MX
M>0A"(<LXJ!MU2]2#*?S9*\KNBK*]L4>!G3J>P?\3HPNUX9QSQ("/-O.A<_+0
MA+GHX$ #]P">CM3#N&.[/=S_ >K5"1>NQKH[T.-'J&]>Q7(3ZJ!8.JAZ3X+V
MO346\-,F0T270EOQD3"]*[$.9T3I'> %B?H=P -E_0V92I%AVQ32Q V!)?M'
M1I&')MM]GC1G:RAT10[)@.3=D-P!XB?7D6W&J 6H4.(GIZY'?:]Z*?\>\M'/
M%O6>I\H=H+H:A=6+YM)N' 0.M[*@.WLH" +B0>BJ_CC&Y5:J!5:%XHE7*8PZ
MU,%V*Q?=3&:Y+.1M%51 .V#\MC?4H(FJY2>=1_O]37\Z5XWL?:;'O[UH&^15
M5I<R&1KR?N!924BEDLM<Y=0MQFCH\^U;6ME2-]@K/WK]N@LJM,,F<6\GP(,*
MAP8VP5?L:T]?T_:P(,V6VJ"]601-AZ=;7IZ*Q:UO&?YDC2!%]Q98A2.]'']O
M!'G-RA50Z)*:$\J7!YY\Y"T)L-WS,UPI/97U_0:RJ5\?%-7C,/M]8 #+AM<U
MA.D9)9U,IA7#O 2)NQQ>D>:E/8(9J$D#F'RTB/&4V+US\'/,_C?4'?"?4'?O
MC35XK:+C/A_^N<'EB!LU#Q/RZ;>#BP_'P."H::[D MX)=7DR$/4DJ[C:;*$:
M7&Z=J5*9!#T$.]>/@U1)=C?[/NI]LAKL6LHNY&T%OICQH;+^?)\3U;7905L.
M#C7'*8R%9V+9#8A\5+FIA5YOS$T0J]NN^%U2%?8<IAS7G&HR?CX=>[#GDY0#
M*M?KC6]1? _!F'<'_296W\3@D1S_[48EZN 0)K\ECP]QTM!S4]-$DP:.(JI[
MGR%IIGZJ2]E=D,)>;L2>A^^#,P'.G4!0R1_&QDF3=TORW$H-3;CC^"5D-WO#
MA1Y::_5_7B3LKLEON1P/]&;&JJMH:&Z]B4E.]$1O;ZT1F4W)ZK\V^H9L+49M
M>4*<KTVK=2AM9XW_;H&LXE?R ;^NU"<Y?M(HZ/WXVRXQK4V7KF?MUI1W5?U8
M%<O'KZ\&.8_MD]A7]^EHMJTC]03_QF\6+;EFMCGSCXH0O]@/;)\KGM4?64Z!
M;OUGKV]&_(HL[<^J2P-(,I?QZA.@VQ_O<\1L<+\H;!NCK*$04[-U\O3Z7+NM
MIJ'9@A3+6FN )KS<315+[;#_PYCAXS=@?;D[0'=6%O4$/:D2C8H:<J06?T=/
M4[T6 WR-+2OJEDYSWT<E_QI;!K4A*7U 8C AM$.)7:IZMOR'[P#[5#3(0#X:
MQ)/L56,P8D^IT?B9K5K/4ZE(EH7P7/$K-&,YR%@''\IFOFF,W9R#QL)K%?IE
MJ%P_?^Q2PI!2:%0H.R1PP9)VJ^U*B.*\L>-;5TD021O5K@U53)OK;FK]VFM6
M/VT1*%#.(R-!&T5><@04K(P?M)H^SPX6$R3DOZ$72NYZZ%V7('-P!Q"YO.E?
M$V5;W%M;-)T8J,WG;HD;&GHG0=7K3W,XMT9,S5 ;^Z8S7D,[E&OP#F"4C_C0
M67)C)Z>86_%B_%2(.:_^Y;^&TM@481$FS?IK_7G@OJT",T:W"/1PHEXF46.2
M,/N-2)ONRW$H[/K\8,_(,[QKL1.]H\5-ES!^FINSA^U)D"BN%_0K1YBLXHF[
M ]ZC%_4,];._^$E]$SK*;\K)>LJXDX3R1_A[6M&^]!I]FA]5F"5Z$]'JI+<P
MX3*[&2,TJS[?)G01K$X_K 4<L25H-<[M1V^Q>9]PBK&GMJM]E$?2-<I*^[MT
M9]!H8(N])7!'4\?OS&?]@$@S=GG$ =WR X[,CC)Z$&OHN-NC5(-3$.\ZF=ID
M MKQ5J%.U(GLTS/+4A6-;$(52U7G!A\-NOA&9T.WEJ<O%4A=8:,.0@(T@9!A
M5^8D^J:WM-I493V9W1$FPQDX-NK%0"$R.1,C:Y81.4Q0!!4S(1$[/F]47I8W
MY930%&E09B<&<5JOC(Q>FJ-BVU8PBYXTJ1Y,8XRXXD&VM:VQ"/\3@;)=^5(M
M%^]B<^'G9,%N>M)=#^+53ZDP972VWC<Q/RF(8>E:46?0C\M8N=)X+_ EA^SL
M9^'<%3$-[?WV,E1T#;E&+ZB#@6OT#\$SU<>E;26WF+:.6O?#L0W03ZQCR30Y
MA<=YI\1HD-_&^SC&_XR1Y.0/Q8ZK8MY?,M]_MM);[0I'!/6W .W[R^98,J6M
M'JOC]2?+DZWXK. _L$T11]BG[PZDE_]WI#_I_T^D?WK!]6^?4P6 ]3]BDF/_
MMYCDB-<>4FKD-?+[O?10-94LIO>>4>?ZUO>5:.EVD7N>8>VPR6+4C@7LTVW?
M$AW"6&=8)\:ZV_AGQ!)U\A6LU:4S=)*6OYR7R.XN9[ET5?%^QGPA..JC)?OV
MA]]4A?/J4;#!;*EIHR/#!T$FTEX'T=H?:"^K0T]SWW#=#E-/9[]KN&"Q\;"S
MP:<E*>C,THQ[VW1:3NWR,NK1!GRDW6SK]Z@-_[C2\;Z8\(\FC:44':1I3VD%
M4FWZ>C8C"K=E0&BMSC?A3(I9WU/$-&O4>/-QK ^!=S!]I8 YI6FP\+Q<!'[,
M3%6(K%.VWJ@69ACK:?Z% AO+'UCD>/@/1])>U19+P?)Y+:#R=L:*UFL7AN%9
MCPT,=;U2!OAK,D$&S1JJ,CNK&IP+=.5]O!E"WU3_LG=B#8QG^ DLT5SXR7H$
MB\]\9<.>\_#S7O.':2W\/M&$N/)\Y?;JU?C42/3C]S),>WS"UO&QNG=T'6(F
MS=P-C523Y:TS_E4S#T(SOK*[A@@_MV*#M\*AFPL=;4<= Q:#Y[!^!W#3Z'VX
MZ9M0.B+'^GQ:XTL.(3/Q(2M(9.I+7@^#4</V$NMT]'G)0'2:R271CPMP]C%P
M<=F00I_%X@'6X^/MN0;OGS/-+](V$ESDRX,@S6H\GAKRQ4*_&7.9X/,SCQ'3
M<<WX7XH<5C3CHT#HEB5Q:?V3.2Y*8O1M:.HM91RBMF^&=] &03B?R2N47>31
MRZS@%I71=@2U<CP++3J\#0G?JZKT!^LDOJVGB,&$X1]Z.DB_/YP!61V_4G4B
MK/GR=M<?NU%#RSW:O4'P,/M%F3.Q/Z>H\Y[.YTTV*3+)HY0M2;4'SM4/@S]=
MG(F=J6 JXRIE9#6(MK<N*<>]II!GRRPKXY:O9,]K8/)\^SD5BQ]#1+LKT67.
MM?A&<"I5DL"H]-HW>D2(GZO1!%L2>V_LLZ!O.[H#GBOP^]B% 1ZE#^QDQ^R7
M*>,Z=MF-W\2,R"L%&P5][H+7C[.2GU0VK54(APE(]&HT1U]5Z_V*V5*W*O5Z
M$8PPFJ?TBUJ/O8A -HRO^$ X5AYN1_9 =PA;B'B >%S)71N^[E7EH..T%I?S
MD[K=,2A>M8*0&T7@C@'35ZFO<-]S-MJ;SW> :,_F*M?>!:K11@?'5WJ<ARDO
M#-;?"?R"XDRA^7B%#SFI(!Z8[@A.V+)I?#/#&!9Q5M:W3'#$!KKX$ZE_2G>8
MR:BIOJA)OND'<N<:QLL4%KH Q2D3?"%3)\45NJN^?-EM'_06Y=U=@1F/6N3Q
MQO,:W<$/%"VLV4W21AI<63$W?.)WV?(/ES^DRH6,\%$?2YSPF]/\I)EMW-MV
MUJU?UV(%X]RH:,<\<C$J.C@4T;.4RU_9F,E^M$@Q8O^#<TB_ZL]'BEB,J^SN
MEF6@ER"'J6\[B,\ SPBXPS0U?@<0*ETU%*R_9>*F9YCBLM0FI76C#.B,]LDV
M+M;'V\0];]3T;H+Q%++)_4"!FS$N'.:\1-16PX*FH6EX);T+]<&^KQCGC:$C
M-G<URO5 J\N@#N,;VS1XVIOA;/19_W!@]J/10WW!$?WC&&9-VB,-@.]<27Q)
M;[@9W'#E'8ON^Q+Y+V5R[(HM02XLS6MQ4P3M;+^BL9'2O_F1[:8H%T/:;V^I
M S8.W3#ZA]1XH/7\ZSVI <.Y3%^W^*(2#F$&;X<87^'Z\QAS^#F!CUP</]QR
MWK=5*DWI3NG/J',\4%*37\HB@25(J\J7HH_GJ"?"7E/4$\4DT:7&R00S3*T%
MZ7^4I,NN=+^2":5\R!"'NW3&#8]9-:V*S#6[:,00>S\G22]E6(;%\L*TO$$&
M4/2("[:>D9'9/QPG0D;%4E(H\[!4:U!LADN+#1ZRU./ LRA&]<2+2/D.\+GS
M"E1>6F6V>G 3?@6];;@#3$0;BOK$(>X5M#31_IL\'C,F^CTR%N,>,N8%/56'
M"#L0A+T0%X*H';%$&8G,4)[2T=^KO#?;>7\-]O"J%LN_^+@SA2#)M3FJ@W]K
M;=8Y1BLG(:$D8&/4LJ& AU27%GUF-N 9N&28:_1#K[$^S43A69J74_T/!?_
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ME0TROXHYS6N@,)LIXZ,!L0Z47Y1*/''59! DBK'U?^DP9\]U!P!SW<M.PG.
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M 6K_Z1:@C,]8CK*A-S?,Z >V^ J62"&UEO>"=P *J@[\3O"_ H&.Q0\37JU
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M=+)^E,?>==^^2^\A:U6^)3PLT]EZA?"EA?<O?#,$><.]OIWSX\4?@P^"\2F
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ML=[NY@HI^4EP6VQYM*D,VSY_:S$42)ONC&.I*1.MKB^+6S]:QCUU((>5<97
M6*+\BE[L9;QSSH=@Z!N;(D19J-EHV5ISH)RVPOIWO*L:<"LDUYFE$N.D34;_
M^4?1Y_SU_G'O0VP9/YBZTXJ3+M UH^*)3DF)YF@4B:T.XV*?:(!5ATY+K $
M@##A/Y:%=,H(\5>_&6K"Z>MM>4^Y%F^L5SH<+G80]DA]K_)U8\8GITH8-RYZ
MAZ#D>9-M@BPH-@<TP5N5PDEA[]60]VC+VH-_W!G4>_-ST&R9;NBO-X-SU3]-
M4\'WFPT?+=#>K(>CU^2@^C<3XT@),$)+#U)/CPKBC&7Y[A.NP=?J(BW_HIHS
M8,4J9^R>JIP*U38]@8*;F!2JGO48M M<:\&/_)\S]6)^\K\Z#%[$O2A,:\A^
M/BI<Y_(6(%0&N?AT"V"D*T3M0+8ZR@!4Q=;V*K0XHJKJ+I,).6JTL'[3BOLL
M43?+R-UM= 1.L%YG-:LD(KFZ[]\"[J/<3DT-=U1O1G1&=^1L,J[8LJKO:W:!
M@8_HR4[;=ITGSD"^P0CSE^)/=HEW':WX]=3'A$0<":A*]$4#"V9)KVS3^S5H
M7]Z?@.=5"$?DW[@KWN"K@0H_)N;/\4 *%<\EQ),>7<7?F5CMOOU;A;[N0,\D
M$.G6Z'JMAZ;G?)^+0R+<4,(II+2[-K< 16>(\'J?*6QSQ[B[A\')4 ')PHP4
M&.VY!>2E7]%H]AVPC!DJ(IF%+FQRT^]J]S*K]01H!42LT=\91'@(GL54?*X[
M"MY=N'M#?FGP'%'91OV[!;X=NZUC-C KA<59Q1Z=[[0T>N?V\ZG+1<-_K/X%
M?@G3X68G4_XG-]+K4_E;0(C7JO)8&^S3S55Q/=&?7N5!PFAV8VQQ:5!EOJ\P
M(J[;P]/]]-5NTQOTVJR;OSP$]6WFDSD^-4046F4QIW7QT  $,ZZFWK60BNJU
M'&/>>>E^15KE+Q^$HQ-S-+#KYJ1E52XAJ:"O8L T'#8R5GHY+:\SWOAH19ZC
M57=WC\62.PO0&*YY+RYP^"I&;U;/BQ?N,][[2/+$?)EIK)'\10TB+?D) WMT
M9D^7.M,E[+SW,N[=>../9)OJ'DM3S9_BGT GC>3<'7=%<@VAV!ZX9:254O9/
M?O?'WA5^I;0A0C["OH8X[*W(C_[Y'2PVOGF)98!+X@F.\.,Q4%PE_52KI-\#
MR=*MFCPB&]7-_XV>N-]%HHP&C'2(K[NW,OF:)KTN\VK[.:Q*-FM$S(.DH[(S
M#3=59[:I0S-9OUJ9./%"*J@8_!2MUZMGQO+^Y.=N.Q3NUF@X%;)8)2C@.O+V
M=(VQ-'^5F(9FEV/6I6-Y/CEA$0[-+/_=L*?5B?_9ST_> S@E2<*I"LU_+M!P
MUPS&''B4WVZ%&D/@:3O*S#B.'/&<>Z(23KD7^MTU7!;DTI]1SDIU95"!>YM%
MQI_!SI7J&UP2$R5=+F"=E2-,^235MB4P@ZIX#3SIT&BH&XM0!CZ5-VR'3Y!_
M>K^+I7XT.8549^]DZXT6PUEAP8F0DZ*"RO=0T@'G-+;W>ECZ;>W"L-5&9?K^
M'.\12<V8-OR9E&%FZF2'E!1'B7<+$ASBU#^(91B-<SC5JQDFM/W=LA;]EQ[E
M>[\?E/Y1&\G.;YP_BXD8S?*%Q;WD#93TS B4S3[*X_G$\DT3Q/-S6YKM7@R7
MVL&SG*POD:N$ >PET20<JLH5&0^4@\V_80SHSE)'<0(U.39G:MX^?'@+..V!
M)"@ BLXB<2*:%9&5ANLJH-;GWI4J\E4?U,T;#3JS;-K2V##/T2Q=*=*+3L%;
M_?N:(QOF:[F8WUDWR]MR%4,Z "='SEC$C_W0OG"CY$O"7>PW]8JTX:_-4.@,
M_D3/Z]-U54MIO@'6S0IXZFU,9+Y! K:;\$E9;-*ITV,)"@VSD/_J5$#7)4&A
M^3N=Z#]ZM[L#J(U"P$'J*$0&+EW\K-.V_-^Z 5R2/#CIQ0V2H_L?I\'%U@#N
MLXR3K.#1 "'Z,/"18K7BM=DM(%NE$;-O(&2B=UVFB[$Y!'%$(/J@('/+M^R&
MLGK9@PBZ?)^(<+,DF]S]H8=,]JP42/?/2)GUO=@NBH6-BO&>"FK*P 6HQC>[
MSI%+-14A('V_O'J(NT%-71L&;%2USKS^M%L(6.' LA5BH2+VJK*#;P7>YUCD
M*$_PLM8[Y.&CITP@[)K>)80&!=: "(#$6RE9%R><G=$R/2V!(N6DQ"=>1A!;
MPW;$MF25,[H[FXO2I-J:R6N87HGS*?TFR'M0CRR_B4S_;7?NR^A-$#DFCJ5>
M1RCK8QMQ<T T1]:^#$$?=<5#C:Q &2$F:-+T<]D\XI/GDL[5Q@(K!;H]"4*%
MVH@@8O/AR?7OGIEXWY;4V+1_=EC-ZMK2S&9U%E20?3;)JWPHQ"=B+_B8G5.H
M]P\--436-B94(7[%BCG&Y'V<2F,8'_?:\0?)@W#Z$CEMF/JH'',%UM@&_>91
MB?#T1FPEIZ'=$2XBID[#10\1 L#0.'U_J1RXJ_V+8%<&UK;\!&:L()/7AC7?
M#7P4ZS3 7!AD8R-59?GDV+3;8XO42'-8J-AR>NYI:D-GAOU./YZJ9OR$VZY*
M">/#G(^K<:/UW)KO?79[GE&F5"QYD[0VB-2W6Y.+UAKFJKS$TGDCK#?[8'AY
MOWBMVIC629T0DU>_Y.3!^_27P7HE"Q6AJH%'$W89(!/A=S^[=Y5%C=6'WG!*
MZR8U[YP6HE><?JOZNNQO/E0: 95_0-O-Y(C<_$^BPE=F'<6C/'6\>.'A'PHH
M?UWY5V_N5+2N!0Z\_PX_!258.Y4\(K#MHNHEVPC;44;*U21T1RE$1W;D8EU1
M?T\3(A,F-WU 0-/B%8NW;F!H;D(6T(79@'W4?:D([%'D;.VR1''M:C4,%>[J
M)DI/#(=J  H?=Z@E>4^R!E<'>F'#3#^=3ZXZF]ZL#9T((CM<G26=#-YO-Z@F
M"+F*]8N9"19F)TR=)$RX]I1$$?F;BH<+0SZM&J@S5A='T%8DN(IH2Z]1GQ,8
ML8IJLJXXW(O0 8L35RP4[$8R/PZ\!5!O_UI)8.T12U\R^V8D7IX@[2N'$!TH
M<W:'*@TPK(WP)XOE]DDXD4MQG&I0%FHP17X"[>752@V!+,SQB[PWJDY2Q>UD
M$1]JE7?ZI0C%Y*7RMC6%4V?GYC).+<0HO&$G):PRM:/<[^X356S(X*\/7>YI
M3986PKE[[-MG_=-)4JW+6\&_32:B2G1S!@ ;C87\"S.8(Q+ ;SAL.;E +IP<
M^_BJC^:YGY5'$PKQ*,AAT>P['A#CL?5O]VF)6""-WII?%W3T]'JUU[$MF#U
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MZ-LZ-A"7BN;S_9-MY8I"_IBQW#>;,.E-H"9+PB >15 0,195BFH(C5]!)WN
MLB0[50 % *16%V?%F.,E24+\=KTJ#\;.*+@A!._U( RT^RP6(CM84<IFXB\U
M_;!<1/OU,?VI#;)P8Z))!J[Q]@;W'S'](>=;5=X_)=)VZ:/5+]AFV;#X!=<D
M!V<;/W%V%_)#W^"R 8C8!MB4)7$ #$9ZZ9'2+V8@C>A(UM2MTGRZ&HW]_TU?
M8'A 7:V>7IB!/R1K)WB2-WQW%0OO'UD!\(,;2.].9_#JX9886\9)!HEAU^(1
MLS7X[!\]/78D7*AGH^EXA8KI)RSF,<3M;J>@V2-6R/=FC58#Z,$H@8+'R'\
M%&37M86 ^%*@[?W%[=2QHB\ZI!CWJ'(B%64S>4:-02QY50V"OPJ8:;["PF@H
M,;_HXZ>=NX@O644/]G6 W=<9QIC"?P2(6;D^+K6938QQ]B;LFW13)??B2;-1
M,7_HSGPB6,JQ8<+7W[[)DL)0YG3YJ.24_1[QG@[CNOECFQ2@,3M,],-$798.
M:"W\&7XN]$TI?L%RBNP+>05$/,;77,48[D<Y=+94CYVT!FBH'&V,!]H_:V36
MU3ZHL%7KF)FFWE&GC'B!\V;I09P&*8>\6OP9'+OZ,<6/UU1P62(HCW:[G=YD
M7DKK&QQV.Z<Y58/6>0[,UI+>>3L=XYIVRCSR.-BO[A%HHTJ<#,R$7VA/>SJQ
M/5$]W!3V<QR$ZUM$AU%X*M+,7UAL&ZM@DY?"5=I?YJ+:-D4$R_&)(DT HR/=
M$#@[A?$!I3[O<#.)^^/*93YL7[59_[?6U00[OD2'I?Z2G7CG]Y3+J&IG&4&
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M ?(^0U'-#!>Z>H>2N7G;5_FI;B\S(L&5O?5MA:()6!F@%:=.,D8G+8V87.
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MX6J+U_;>@E+35-\*7_V&+,C@BF8AM3'@,Y*!K%F#D,,-XU#&NR8!^A ? #7
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M-2OQ^''SI9@W$6%![8/C9K;R*<\Z_;%)/B.P-U9WQB?IC6=PR=>-93O=$U?
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M5!+/+N/KE6H;3:[[GV/NFG$)%I@"GX9%MPO 4:Z9PA_E37QZJ:Y/',5H[P9
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MT^QB/'FU1K<)38NV-N6EM+EVSZ>M9.L"TNS:8X:&V=1G*"QM@N&$*&$PWK*
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M!. ^7SP^8K?88>+K3?7;?VLQ;>Y&*_C,"8 T]R60OSR6Q7*=Z99A%TFW?PU
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M\QXC"Q;M*DUZQ<X%7ZHPY-@6KM&%:!PX3BDE)!I2 SZU-(0LS,*[?:U'S>R
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M&&]&-<$2[EI7]QN\8?N7^FY8-ASA;G>!Z1KVF]KF\!G7Q4&>),8%IP)"Z=_
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ME&.YEUWI VM/&BTKOCQM;XO;C%=0X1CHFL0X9')A33ZJEVO5C'UC MB8,I"
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M4GNN/'^ (D\F9BZDEQ(:S&P @O^N06SBV3GEH%,^A?%BG)[S1;>'ZG"OY_X
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ML_2[;*%K89]L2;R^DT"A'G>"\@P$YTRV74:E"(.':ZO=A&5UCB554?>;=9*
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M+B)]E0F:/9O-:NIP5[B5!Z]<6=@,1V$4MHU-N[GK;S.EX++*87+\T+O 5N^
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M6JE1'/<+VOKQM(5;J61H3-_Y?>,DE#(S&"IK;T:XSN,S0V;HQO6 <(PP;X[
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M!V#EK#IY,>.B+)'\N#3]%G_%J%,84EJE, $?HHAX%<\V2AFAC$^4&R.[,4.
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MTZ\2&].SIJXKC#^?[G5DJ=A&M?8SA5Z0LK3KIV_]+99O'Q/@N[P:,XH;,@<
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MGVG^,KXQ-NV+_D0R\ =@?G96^:_LS-?-5RLV<ZD<J N4UEJ#E.DT)72-&_Q
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MB+#>ZX)O=MX40=*UP9>#GU^(J4W- FZ/!FH'-/1SL'W='FIM'J++EX_@^4\
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MXIDQX<M/-D517A0X;J<*XQM.BO#],6B31& 3MH8PH/FHU1E^<Y9/;(S@VVW
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M'E:NI<>??OE^?8?![E NU^GKP^.V_[&5_6RKE6EJO5IANR;BY<7'6[%/GQ$
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M7PI] 2+4WWXO3B\@0Z+TF$$T3($*R[CA+VI'@=#Z8K@.:TP21 6WHN5$9QN
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MZPI"^#$7#02>A7$,#V#PGB%R \RI&BHJ-]2BLZF+,RFU!]NPG%CXVVCVJXC
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MG/2A_9H 05;>5M31T;:3K[ZNZ=&,Z1*3 @@N"4SF0M5T2RACVHN[MS07M2D
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M[$ZM<35MT9+>%0+_G@6D1)/WWT,N%L;HXK;KR"A!?BBXAGU(OOJG'4-"ES
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MP,U\&<S#=X5%[W;WPVA(+;95]B/Q\2@6&?W]<E$:&@6>@&&5-226WF+"M9/
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M&5.78UM1&8YS6FP51T %!2@7C=?( @DT]8.+G8H)T%2Q0[3I1+2_)W$(1FZ
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ML9XXIZWXDZ<?&OAG-2,FS7P3R#+=9GW$G#.])8W>7]?V>/_FG(B>G#Y<UOS
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MO395?D:R_=N_+IHI,:"DZM3/K6X-@':M]_RUKEVST4B@U%10XSN()[V-/??
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MF$L4M WYJ,0-!(S!*B9..82I=;%,YDJ?;5;J3)7%HS  L-E_[#BP-Q%F>@@
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M''V!N5N\#:&PD[J\A>/W#\\WL6$;"EU^&PJ=@,_E+'11.\YO5_E9G: 1-K,
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M;<MKUL<NXLDOGA'NU^(UW$&/_DJ .@Y-REN _7Q[&SY.W!<YH-\4"<M 7_]
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M@1-'Y(@1(HDTSYU;'F[?'=Z"%SV#ZF6;W8^D[)(V>SSV?/<RA'70/'XJ,77
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MH9@)RR50!''?TY\6LBRTQGQ\F:G-8;CB1!I^NN@F4(/V98Y@;4[)H5S.D7&
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M3_FEY'L-(2L!8>W03>482J>A[SO9IS1; K_V9O=AV7W7PH,;6QP]"/PFUQ9
M</VW=W-=KCH62)YS#Z\^/M%+BX?Z>UU0CY4RSL$\(__,F/_E_!;)DYJH,4&/
MU;0?EBTQ!XX_#\U/,:&BT3RG?I#US7JNRS;ND-GMUX6>] N]EV[U8:4Z?ZDI
M!C>\<H1Z:"BH&CHG=6 O&D:H1 KVZ,I=EK)\?PS[R]D[H2-HNH[76>W [==)
MW%[S=TYHXI;:L].Q3GWF-6[12N8I2U0W'4U?+!_JC/=EP.>=4MMTY;X\O;>A
M5LJ_)UV JCGE)\XKJV<5?JGQ'NL.F2=?$GWHFG4-WM_Q8(0.5K0BG9*#9 @<
M9W[!IU'E'B:1F6G4-3Q1<!(25/[GCBJ$ WWY)P)1=3"'PG;T7*/LO38R#PEU
MJT]?%K@.XH0J+3Z7,T$<5J+5^DDTZRD25H).IL>3F97 8FWRVMOF0!T5W921
M_:4 F(0X-O 2(X]0URX?%<-G@LII@R:;6 I,N5NU)&LV-^]L2L6*?O?%#UJ%
MC2,1 &85TI"350 V!S,(R&J&P)L)\GI^\3 2%H\$<0_%$Z6UHSIOJ^\Q5[%^
M+0843BIMJ;3:TFJ8K0;_P/HI>C0F ;9%FIE!C+/!BBJ>;>B+')8-!<I]=NLI
MO<PM@6APBIDQ;(/E%V'3UE+76Y%KE%^38;Z6!3*(0P3>,VQVN-0F(.7B/IX:
M3<J-?_B1(;*S>*?OQ/5K6N>/B-3-U/OXO8OAP(Q"*ZP?Q:!6]>C00\88?"X_
M*)PF=QSL!QD$5H]EN'0))(<-HF,,&(+LK;W-](P8,8/D4:Q0P:>&:(N7& =<
MP:=Q!O]A;LTJ@50.T:JVB;I^V#;AL!C\E;SL'DPC'= ^>13OSFUJ)>77+1[=
M3M@7GN.5PH R6T<.^+X .+%,,VF%T]6#Q*KYC%!-9#D%LCAAWU5?2LRM5UF8
ME5=G!7P=RQ8_<%7A3C38_;-A)BWIG?L0S=FP)QD)2X%,,L#AVV8C>"@"U*+"
MGR!_)LVDI9J#;6^A.D>O/ZUZJ^EU=)0&C)GSW]/?N9O9IU%EOA5.F"N00I9N
M">57<)R&AVK@P,F$YQ%IMPYNWJ+I<B+7SIEP- GS$BOQZ)+'-4'2,>J#S8(A
M18].XA/W6RAXA9)Y]IZ[4=64*MB2Z1:>)]B6*M'"$%[Y,4J>[\?1/*T)2W:>
M6Z BZ580(A0)VU-4GN$\1'8>HO32P;9*W5N\O 6BK1=)YF[)="!UAAZ*:/("
M,E1I!"TK9S;'V?]-E@0)H$0\"'MYZ )=\5@@%V-GA>)7?6S^AB'P-FSG6/;@
MZ4M.FWP4?:0VY<Q]8HB(L;G\KC]HIIA/<*(0NY:<KA)O#,U-6KSI6,G?TXV6
M+X%PR333L7#)#/P8^(G\@/S ;ZXZ^\P7NSJ2+I3;[R8:'^>8<:XT&]9Y/;Z-
M2@:5Z!346)/\G_<S(9H&\)FII5BX(.(6Q1)' E$T)X3LF@*P'7'P.@U \2>-
M*NH ]<.+.$B#_%(:THHMT:HGU=:$# L:=8B;J2 Z:<QY, 1C,E-MUU/&0%/5
M3N<V=6*)]30QZZ#\0>;.&Y7 =4]R:'<EVIM.>.4!?W#>6X@IY]I,E3=RPC,@
M^7@=2MZ@P3OW3H5Q'7F.7HOW-.=5'4\7^B"57(L&_QP\C\BHDT  !KO!W^8)
M=0W30)Y])!X-NNR8-3(,_@R5>'0)@T_@-O= $%BV0Z4&$5^% ))8-(O <RKS
MS7Q^P],&* EQ(?/<+ISNS<NB,X_K;'-N\\=*7G7J)C8^P)L89E]"^AD1^$IS
MMEG);V$*(D"@/.?LG>H^QZ^R.Y" ;TMG7-AHYBJG[H!AO(5H,$.P,V*K(12L
ME#R(:GZHHE7N;?GR'HU.<H<[J9L"&9 '\3G&QV'%%(/2*RR@1L03Q/WI "9P
M(?L3-\&:.2<#:2M!,@[;9^D%_HF(CJLMQN5+.]"B<G;&L:D;!NT0N15)Z @J
MLF8!*(J,YZ4/T9B8Z?'IQOH)<Z!VI43']ESY6_J-L6R2_,^+ M2-Q-W ,+?3
M<N>%GM3>/%%)&O"-WAV0W:R2NC5^+(<344JQ;V4(=<7[5(74-%6]$^1 6<N3
MBVM\V3G'W(,D<N838%*T[D*I,N\R9.>]_!#:=Z69-.I&F,V_WK7UWZ[%]V\Y
M7;U=10.4/CM&?)^=6AUO=N:A^GBLH+]SV;=?(WGROYS/5?9V8-?>]#/ID[KT
ME=U-MY"[R 3(/N<["X#43KIIS2O H,:K0EXXB'A/WTJ&C1&WDM\P!.MMWS"A
M?QQLWZ2K4Q7-MZG?CL>*F*O;R: !R_%0?0W88'2S+8D. G?Z;1,)U72CT\+'
M-XTQ!)H70*[#H./6JWZ:<H[&#)/<6F\R3"HRU$OD[I584F*2H,J=DN.YO7?)
M/.3GWZP=7G)Q35-/GI/0Y%;'BT6,\&_C<WA, ]=H9"\"&4;FOHY1;)/RTIL1
M__=E2P,DU-/SRB$@5$JAR\(.8-#>B/=K+!JPXMIVK;C522? -O6H-8X>#I,$
M7CVZ5^$'+_<7-\K.UO'\DW4"LA_IKG/X_0D?OZ/>L9>A"+4-*V(90O&B>('3
M!MFUT,WV(ECAAU<C-'$Z6,D+*LFR"07H H Q3$OK)D82>&-Q7H%HYGW4JG%(
M9]9T)"RK8#NZ@4/\#KM8L$EYAO-C%"MLC4=<+ !(>4?'7AH_T*UZ@W4[9Z/1
MR@AM!L<>EJ.,[[74JWPS%^J2-I8%Y$M:1YBJ*HR;]]\BQK/.UL?T4!5E$Z5S
M4)=F+D"^7?&.'KHEM,N> <8RQ3-30HB"1*Q@" D_Q@*$4N0=,O O%I:RM=Z>
MF@ OUIA^F%U0=(_ N\T_)B)^3K7.^;VO!3^ PKQ5K1F>9FU<5TA[T):+^[;9
M%0(OGS%=LUOZ OGHK@.YV24GYEG@U]HIV'KR:;GW3MZ-&]T'S#>P>5R+&,+V
M2!V\-4QJWT&_DA;R;FE1 33L9$B#=$RQ()0UM:&%W*',K1-K2?()K'3>LF5>
M%:=\DHA=LTV<E?UU-,6+=XU"SYVX_88";.LQAA@PS#@\EMV1Y%/QE<,"C<='
M*)WT=W%5 G%R10S!+7S^#D4JV^A)+0T;%)490H-/(/#[#8$?80G\W"!3TS4Q
M\Y]G9L/JH?\KXBZLN7)AVFGY_\JW+DP3^.,O=-Y).( /AU]=+;[=\;'H131,
M[.DUJM,7.B/RHDI^5S-5KB2[A3,+WX*$W:)'U]B7I_-09:YG'GY$2^*Y.7N0
MNFZ314_6P23HRW_7JV)B>.)YJ%KXWO/C6;MN(0[>])V_CRG8(ZU* [ 6S7R&
ML.N RQ;GTEQAWYZL)JK:XTZ=\:R7$Z@D3#\$=7\1+H8%<QQ0BPKAC.8T"V=[
MBPM--R9"SL_+1;6V"P89#J_M /Q9=\,C&,%>S]191G>_I-KY^U8,D0(EAS<9
M? IV6"6_+;OKN\OL7E,W#CN8^0BJYTUMFNNR[M:?B :V0I[7*#/4W+:=L)>R
MQDGSHPP1_G*W1LLC*7;I0Q/,ZQJ?3 ]J'CL,,R+P'[ZDWF'CU5NC&4)L3_*Z
M0L'*$P3.]3F97;6=P>;,CA"<@@J>6*H1>'JZUO.K>YOPNY57(:!,V7XL*@!Q
M12UWTD>S1S._JQ>*O^)89H;[$Q3YWZX**WM%R6E+FHP6QHHXV"AT5-J>:3C%
M^YK,@[!&C'5FD%_ZMV4PZO@HSWQ:-7%F> 8?(IJ=A(@*_O.F%U36,#$G:YC
M>Q&'7 ]AK@)+@R1!@E#2]#_0>/&Z$=+0!WF<:1IF@-_&07$\ D(Z*.4K,*5J
MM00*9$" :%BWM3/O6YI!A0I5X[6E%*DW.%"8P\G9FI(E)?+HIM%@-QPX4PAG
MRXE-3D<JC#E?+ 0LO&14^.\;,(1YD,;$W[2(EA0_?]I](P)O$$V/%J@1 NS2
MKF8CIG=BQ>!BF^MWC&5!)?7WB-D,@4'$"40_$O:47X[?B :\FW=LASN2>>D
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ME-I=)(5N"<RJ@]DI2=8871UC"-D*V>/\=N74.?Y*04YEPZ:RVX=EW>@'WH2
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M5Q80JEE:Y?XZJ[78DDT54)7._.=K/$X ;V<PUX"5\G2('V<^<F_#H#7:,*3
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M*K A<!88[O-MG==B3P(RD3CHY\+3,$:@E]81GM:1:(=T1()'FKF'-7-/-*.
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M>>VSL0VMM=)'\+O7<G.!=>>U[*7*>I-Q&*N.^A1$JG(Z"#3R)#Z<)R87',$
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MW6O.(YE2"&X,3G*<-?9-:[&#"7/]=V[?J&$OZGYZ=R10O>;+0,20('>$EM(
M$01_LMZ_E,?TMKM:I?]FXZ50[*&3+ PWQO!3U7N&DB]S+?8:#([=<Q9NB*V\
MM.]J5_XG(1M6;%5E'2^))9/X_2E1>U3KJ6;,>8YC I!&;(;U=.9Y.P],E[P)
M';,NB<]P?.'(?\1,?N1\B5ATV'2U?*42%QAZNO9D<'Q4^[#)>;9S!R*=>3MX
M[S"RL.;3EV[!AR1BG$6L7VFU/[I_'^L2'+AX1&@H6^B +W-A2]\MD3ERFX"<
MX[77%[^=5'.INKOT<Y7)GW.P[.:G/M:V,NG<$ZG''14:OQ8F8(3TI0A@>Y6?
M;2JV9Y\6(F-M=O!$VO<&'(7YF.+>1Q;WU8O/"YG[=3\,53.'<]"4M5:I2+7=
MLA13WSR4[_?(O^EUV@DO6_EZOAGB]"VI.6_+KP7; DF#73><>RL=!:Z F890
MVE2UULYD)O&[[_:VWN(OQ;>.E29."^OM #O/ZX[=89<T5\.!>Q_GO/1LB+2\
M^ ^;HIBS=S_\,:DS$'5S?]-GT1QH^C0-JD+3Y_WN[+FTAOAH[G^L,R._/,%[
M4/?J PX.^MHK/)5#H](3HG,.'V\'U,Q GPF 9-L@"E[0,GNE;5,YL_]+UJN>
M;DVIV[2HXZ3D:T720_?G[W^2>.OXNI55>3"6JNVNY[^Z?X;B>/W(-;O<)^<,
M2^CN&@4F>PV^,PIXUX\#ZSE_O$LTF5M)#3CYM-[=@;MQWS[2*XBX]+1%!>1N
MVD?>?C^LVQ(P]8%O"YB-4Q-V0._5!3W%TVWB3\SPCKGID#T(,M.FVH-JU>\>
MWI';MPKR-I9%=@"[U?O!R)_(0DAN0]I<O?!6(9;O OIS\*1HH\J16]CV6R(O
M++Y^M?BFC4SX8'--0^3H@QN7:CZ+ML1NX;;HO+VJ4W\>OOY^JBI@R;89<9I\
MRSKDEKS83#Y2+XNS2\[Q>J5EEOJ11^X\:2*<FX&5+Q0V!IN(,QFL=.WE22$U
MB72E47Z-6S6J$7(OCJ'24RZ'<G1I7[Z8=??DN10 /*6G<.R5GC%=Z.6&4^>&
MO1<Z.BK5PE]76P[S*A 45H>B&%3XUJ:JN/KOYSX7=WK7B1>0C_-[C$B@&98Q
M97(/;.*3?2%: &'[!:D/,5NQ]3<;L%G. C*,^US#IQM[PJ(D#)KWX96DYF;J
M/R1M3,JP=Q[X8Z7Z(-/W<\,O%8N87!<"P_RE1]])KKEF?_6.O'HOT])R8O4,
M$Z^5]6<1SK.J'V!*AX9X%E@ 3_;FI7F>T9'7%A:TB[*"FKRK>QN1B;6JAFF9
M3O&/=L#>T]6J2QP0I-H%K!&G"_B"#^4+U.=9*U%"$;6%BB8@.>C3E4".<7;N
M!=].=<^YS ^RAV:1-PYT*]H>J'(924SIOL?;$XSEOAHRGS)SZ%QAMU#Q712O
M7U:W,%;^J';7IV2/+H2JSK*B\JE6L]"^]6K/I*XK/1&0R:^(N,VKEI>ZZ?I]
MCY+@\_N>T:.O']^J]SGOXIIB%B%QSJO&AI6SRE.5?OE\HG$9A>$+4^B( 9\H
MS;.;EX?99JO[?<'*$\H[S[6T'7"4U7A=?0<\37A'Y!$=LR9:+Q@NBT.@A[:#
M-_LSG9C=8[4#.A<#Q@OR-!#<7(MY0?T+Z+X_5VE>:<* \N)T09<E#-'%!=^W
M!!M3Y:B#*(U"#]_/;8,MV%2MDN0.$+P:O@.LFP/&J_(N[;I('/-W0.;P#FCF
M+;OYD6]!QNZW"PNL1]]!]D39Z^!A633E-7+K[2$<1H%F5QM_\.$*WGOXH>!5
M[\37;!1%:Z6[M8SE7IRK<4->]"F+ZO5]V>BB>D<DUC(Q4!J-><^%CZDI>_YZ
MKY>ZW]OX;2L_K)",<LA-]JK#WDYEB%L+PJ-%=L-AP^&Y92?\UFQ4N7Y.$E1*
M <QL-B_7HYXSS_F:EMB3"TV"2_#U5*?1#(-E[8F"LTV\*O/D)J+TV2*B7JE9
MV6TUKN$]DC4/OH'A%01);ED(GM'Q#M,C77'AH/Z]BU:OK&C.K_%]>"ZSF#*F
MY/'"8OM00)A4=5[DQHT[.^!NEA+/P'UH<O:JQNV JZ_NWW-Z* N^?C>][*2L
M.*<*_'Q;OQO<SITV1E^_4NJ:7"_V,=3I9@B_?QQL;/U:M;)OYV?=C9L6XYV*
MW7BBYE3$V1&.H35?UNIRZX_^HJVWSE_NY+I96G#M^LO/($;U#,$ D<_W9;_5
ME2&^$%>[==.NE$A/5\R-22X+GT3W(:675^ $R4H>F/RT)?V]W'[O -/[AJTC
M"Z/Z#$HY>9Z7>OBVBRM!,Z*=WZ:DZ9!W]YFYL#TKN:V]G].K'/<?OCN6(#+S
MPKMIF(79$5\T/YET@;RI4\_S1?38'0Y^B=HF:]S/R$^X3UVK=\6ET=4=2:=.
MS=U ?3_+SS0 I")<L3Q7,^>#/WD]2F@0NW[0?]ANJ.^[SX>8;XA)B)R?G[]E
M-'_+1/!-QJMC+X_R=AV76)(S=/&[*UTRM_&]*O$NYDF.?9/+$;PKK>3)K&C3
M[_=Y]??45E0.R0^?M7Y^2V!N>OKE!3G=C,9RG@MDD]J-SS4I4LT1Y>-PD0\[
M@$-]>AWGL-*Q4B]ZR>G)42.%BR=C7!0VOPU%2,9:I9_C-1V37MBT8N_([$QO
M$6@=<3RE-'-WX"++<"Q!X>(80I!'W>_@=V7>L5-S[0F/?=Q7[GT_(Q6DQ2D4
MPOD#5K'"@] !PRK\WAMF<RE%SM=LG:\(N77OT7[,$:4K,<0D-V#6?T=%IJW,
M<ITXN0_WA]CM*RJ-826];W=!;M ?LP-J.Z_L "O1'?"DW&[S@%RBQ>HYU15?
ML#SJY#V:/9GT)I7T57HETR-AY7O0S$5MH27 %..?<H>2^[K&^6"#U'/7IPE>
M[@22F[9RR*W>H0"VAL%RSQFX3H+DK81F1=;HFRER=8(B>9=B (FEZ?Q:NXL3
MS7C2]5-L4T?'CZ8&;A[[Z"P_XUZC,Q)9Q<HQMGUJ5QI!MBUW8 ?067N73GPR
M6'% %2=,Q+HP1R"9PFOF!_PYE]^RWNYC*[Q-KBI8#=/W:E!$\WZ\VA+Y4:D9
M04?>O-3IR*0=X.S@QQ5;3GR0[E\\XF\4H7J'M.D0\"G@D,F&JD%I\P%V'U[U
ME+V?%(>ZBYP9>UD,Y%4?""1^LJ:?QO4YA-.,GAL[_-CQVL7:/F)N)620;LH/
M"7GF\25Q.F;&[!GR'@DGELI5&BL$*7*!E??0!-OGZ8R<6IA8[5@Q^I30@++;
M__'RR8@?WL.=&6>#-[EV0'3CT':9]0XXK;-*!',U:TV#1Z/CSN.]:2.7C0/F
M/2G6MR[EOYG;2D_()X_F'3_=>%>T!LE:E!QS\J/711^P(-<4XQWT65GV$RX^
M[/@T6_F7Z"-N>_=Q0'B>XW]HKG '$)>-KEU]*VB)664ZF2^>O2SR<G:)EL#\
M*(_8=Z*X&&_S+K2=11(I,V[F/5TFN=F@:SOO7F4>LCF1Z^QERV='8$[5>^2[
M,4;VU8O\8,V(.V5\T^%^AXC*Y<67@E^O=TFN74LIK/+> =_);T(RZI]/'*A?
MN>PZVJT=/!(J=%E2ON*HAH2!? /P90U6\K0=7+M@IE(?P'[20FI&,: L$R[8
M&<$Z8'#>^IB=;T'7H2)\=L7)E07Z[IHOY9P^"$[:L*&PSG:M[F@+CMH&(/8K
M/9NF54\A:I!P$%/<P(%\4 60TDA9'6#T*[2HI^K[&%H(W I&V EU($$MIACJ
M2%+X546NUO;KF[E^!6NU? U!.?IP[K%?%16_&O?FPJ'EU_?"_AG:93Q-20BF
M$+C*[::T%%KO( %,;[<W2.0VSA"^G@3(59Q50+K42&TTSH-$A[Q#IJ48@H(A
M2E)!)M4/JI_!4O"CF:9%.TF>!,=XIB$+ ,%X\&\),>G*:#PK-<,VB@@M2R3:
M1A0B"46B$XYH>]"@2 9'-@I3>BZ,%K#JD'S>;J)H!B4$XCPQ'\C8*Q.ZA^DQ
M,/XT:JU#2"R?!#E\E<5WW?2V9Y9.O#P2IHS\=(OH!T3L[R4B7+*SY90,Z?U:
MG02+I.W[']38Y]X@[=/,/5^T \Q1-+@_,TFA:X5. <'RMU+._[_R5?^Y"QC5
MU?M8#T%)BS&[ZV9'@].8,//_JLA$.=RG,@UP.$\3]F2_+I7N[0: <RY#JYO(
MIDK\Q/=?AS",(-9B1MW Y_B?WAQO?9;:+;]1X%>TE01*U$TWG#<PNZ]?J0,S
MZS<!KS6[ [Z1]EY-8C;?N 9MRH,V%>AQ##Y[U+1B1]T99F=HP69J9;N&9QXU
MZ"7M/1HN(DQBMX6.^)+U.VGO87RW?1%TB/3=?1V0Q<_>4\\H=OK]CV:Z+\9<
MV2O]T'&@(\/<B-DK3;]?._UZS1ZL%&9(]TP^W9SI)!H:Z2W8/^]9&@88:2>=
M1,'LTGO0LM2.(3.[V; /W\5Z FUUS5CM6&JVM$O63W(E"3&## F1Q:<Y L$B
MFCA59%@9HUL>$CBG]^IWH6\0P=4A[;IL"3H9PN&&$ZT&U.Z&>W5?)2NT4 A'
MNC>Z$NW8.)W[B*ZV6)8!DSVC$=KD;BP"XRB<2.94B0-L@[=GU420;2))(&HW
MZ94VV410Q!'HJ4L)AZ7J ',R#SI3I)"3WX.$:#7H2Z]+KVL T-3DC>MIB;&#
ML?9FBNO87A:3UZX"*L7OB5R#=MO,Q8%'OWD&;$<>"$^/5[TUL-(='=W\<J+C
M+7>JSD](V:24EM;<3R\*Z:G,S/M6<?S&0YAB+2T3]^:[#5B3#O@^U>]AP.LM
MHMYRO.!KX6U11\;J\]?)V!\(L?"R VX&)7G[7K5X7M Y*!WQ\*;G@3>4.6PC
M:;D:.U6[.=FT*9 BN -(])"&(K@%A(";>9MBK(B 9DA/'<V@?@DZO/J=U%S
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M>N%QG*,5<R@F '=31@$.48-5YS+%63%Q@!%AQ%80*\@S+S--/MF98>.&%3-
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M$I>>VJYRKV0>#*LQT=?]0N%K2X\&G 9U.918K,Y(Z2[V/#-,/7ACEP4<BE1
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MU6G>;9N?H8:=9BOY907!13^!2SM#.CS5FY^9+F>Q3U >V!1OQ8K69XE=Z@P
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M3 +0$ WKWC@WL+_$00IZ?,Q-,,7#6,%KRN;Q=:BDQ+OX.XMX($E0YKX$UHC
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MY%LWTT4JUY_A@'0P/KKA&[4UNL@)7(#<$PS?LP:2?_Y3-A(*"$1YRH?8R+F
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M#,,B9Y1I5BQQUKBH.<PL?,,F! ?DP)P)C!<ZM.Q'6.DF^SJQ*EU4>'\JS>Z
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M97?.#JM"_CL.W9K7RFB&/GE#2':&$7'^2Q\X5Q-@K*_L?QCD!2FI$@]2C3L
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M<(#:JC.U8P/XV.?'6&OFEZE=JH YM^GK#^0O5<-FX2?*O5RP!\H@L[@[4"W
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M(0-\*TL2U&^)AM2Y_,C(7\J#OTGXF9'2JA"0V 033"!!7"L^,+FI8DNY.H:
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MSPLYQ=5?EC-^9IXQQ_AG?T\.[TA=QT"GPX4_<]P 5BY+NS9 Z='RA2K^I0W
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MJ.2PO.S@U^ 6U#,/N7C*TO-8U]KOUJN7Y#= V>@&,"2,GT[_;K(: ;TOC]P
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MVZ3E==O@&0(6!C7K12WN_9B>I\O]9YKOD:5$ :'W"!C[*[XTV@HA&^O9^[R
M'7K,)R_/&:)Y-<CL*LXE8AG<:83&M0:+FPSEVR$V0#FU@"5URGS*J/?9ZT5V
MG5_=@,WK?$WSI&DJ0H^K*.PUEZ2/G7&/K+>C-$G6*<\U5N',:F6VKFV3RDE!
M+[\)3D^ AS"?GB>Z9I!4(P3/)VV;*[;U#]ZM[O6>3R'#C=:[@TYG_\'(S5XS
ME_1,U,6[B>;*=),4>D+K?5M*3A1BY!.1QN,]Y<B7 W36>Q:I[/R,;$:)\UN!
MH-@",C@9&Y1MT?6JW..6]+ _Y5XKL'V\TK+^O>3Z(L;VH5>'PDI77P/<AN7!
M"0K'X*%U.X44+8,H4V-V@&M;]A&:<C3!YH4/S84JC$VAMUJ>Y%$Q)G:>H_(L
MR5PXUY\N-2_H+9SR!^=3FEZ2BE37KIB!1#^?NB;@86M[</^K=$$Y?S0K,[BG
MXQ;M/T:4_AD_:,'HT*&SCN5-83U@!:6J/^$CNF3)9"J,SR'Y6I,JQRYR$".$
M#I*6/83^3!JM$:CL 8/XG@6%"\)N0:A]6.O/*/D^*I<V7J=C!:_S2SW[IU'C
MQQH:HCXNV[#?.K/3=4RAU;%"4D9BJ>G0?P9BCL\_S0K<V 1BVZL>6V^ W4)/
MF7Z:NRWE5]\XKARQ=IG5D5I[SO8N-'P#2+W.7A[\M,Q5QE*[L@&6V/O"W^W:
M '3+D,/[U_K.6C.,[8\6_A@D(DI"@C(/T/R__*&2F^JG:;M^P3'!*J-@CU!)
M%>^5S ++(N<E6Q[$EX^Q\/"LKO<;X/98R+E%:9>FS*=%!J-D _J<GLY*PK[!
MMY\ZLW\T^8;\N]/DZ(3=;$_HA$'C.N?HF%M?X[^#M(GKJ!T$@GZ<<HE!0/7!
M'RUKG$]GRQ54BZX5]5ND-)JT?^DZ-9TR%A9L0%U<M__P6BD_IF X BX0K1";
MM\R/\TAQLA2U;F%!R C9BYO-2>2]X_RO(&L!PD:I'?>[SRZO/-WO=->3DK=,
M:[NU[]6-WRLVM;="%<V= F;O3/5M>77/9HDSJT"K7"-/KN;NSZ>GD%9YP;>^
M;0">-TM3#\>??@@)7_U)V "?DC< M\']BF]+WRLWP%/%=<$1"'.5-:4UKH>6
M-ZY&33FZ=H;__>M1RGR>@TAKTV-P+>D2-6-(2BRLLNN\XKKA#@@A^S/AF7^8
MHL&,[9%0Z -#P7RUE//G.VVAR@.Q0;X6-%KVSUL?PM^=WP 0(OQ&#A]V>@P!
MPBN*) @06NU].CEH *' \,'RI9WE^C>@AT0^M&>]#;\\AKBX]X<T,8\.0<L?
M#!4]SOKL68[? +#346G 8(D5ZD4NG$Q/S\3I,9^G#7&WW_%'L<-MG5+^W3/H
M1TDYUB5GO]?PV,>5'VN>YRVB3 CJ7^R>&G%LE9+_E!&.37G_!>(4/]3Z\UBL
M0Y(D/&W1@ORWHOUQ&#XMU\1O#@@J6S.-)>5_P^^UM,F)ZK_A7X<C3?L7'D7>
M/] E%Z5EB][Z.S5%6ILG 0&[[$H3;M*GV-F 9NG+XY92'8FTS<2T?VHON0G
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ML<3$);=X&)7?&=7L,GBT<I#R[86EPX39B?;2G/ND[S=?/7%[K'$TS#8A(OJ
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M-)'5!HCT"/NH$+$DTCZ4MZ-6<1,6@!669B:NAA.UI=KA)/EP[(09?.9PPBM
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M<82PQ@F96[@[*#LHQ?3H($LG\9+<D;(K(PP%3(E)$O8.,MI94O5'#R,GM5
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M.KN;+@PM5QV_"EL]P?C+@K6P/6Q..0D*$5TX7 EG#X?UUBXSM]9'I1Q#R5%
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M[Z%I9$YG1$[1*2<(++<$(XIU?&^)5/U>FLXS7./H*X7TN>YE)RE&7J'A F*
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M+IF+4B'V?NKYQBR_^79CN=\FRY2?*HU+?RG>5D\Q"CB3$1=% 5+$:%P.+*$
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MV30Y(1""_\(^@6(*-\S5Q[+K4EMKY=J_('CR] J?4=T#F=4V6W<=<E#Z*F>
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M-N?ADMY8:07T3D!>SD>#UY]EG0A8+= TYV\1 *@W?^>[RF #8/Y7J<>JGJK
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M1;XBB:,:<U;07"!TM;.TM$&QC9V>>#LR9"3H4FO_0N%!?TOJ5N<>0&2X!RB
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M+HKW--UMO<BF6[5"$"+D>NA<T/L\KR?[?=8[3'"PA=I)SKDH&?L/CE=$D)+
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M:Z0*5:MNR9%F &]=W:'60SXYR8C/K9]6E;5(44S CCCVM=U&SE'LJ]'C^[^
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M2@*#.MW#J9I5*WL7=#UWZHGKI48JSK<:^9)Q)NK[G5'&S/8A+>:C_>@8]Z5
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M=AI&I/6)5]KL57Q7+^-L=JT'CC8)9\IK-"J@3 S8/"7@!$S@%^R [GP&-\9
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MF<Q2_38P$$&0)M4 MH,1.$5CIPT?0,F1DAK$C"A"J:S%3P7M@&R+'/9N83O
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MMU(H=\E!_OLL1Y4.)O8EQ-&N)^2\KS (5:)4%POM:K?PYYP>(#54]RL-"[T
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MY8NJNKQQ/Y@UKKQ# O<'-0:$&"X])FW5B2<<@3,/PN^*6IF^8<5.#[%+9B*
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M+^!.DV(&H((^4"D,8,R"5I5ZMUL"=+*Y^NC"U?F R\1L$-0 04"^!R'"9H#
M =QL9,0,W 4G^Z@#HN!'AKHC<)9,XQJDIZ1V%XH4875]$(EGX9(:+B"7@CZF
M,SXNY02_@/B;['Q\!@6DC__/$D52B!:M0K_(/J>LH0^]V2#4N2^N!H9:EV&[
M#(9H&7;7?B>9.1CQ-^_9"/V*0TVN'O;A>SD^T//U!]]*6X1(?1:HW>S:=E'$
MO!0QQ:;*ZA)+5Q+F3*4>=16F#Q!_P127%-+GLQ((E5DZ\^)\VV[)$\%(TCEC
M!=W.F8MP2"L#0@\_ $MN2R6F0&#9SF+JI5#_<JE_PEMF>Q\E[.IH<_O\B_X7
ME5R?LWK%^9YV"[0$IN5LS.)GC<W$OCF=WKTJVOI^?>5+IX!D$VF-G9X4DKP\
M=5S]VZ33M6=NLYR-'6O%^^U!X!)<^64K'X]]-@FDU<L4*21R?MQ=^U[C+.33
M1YH0.-*3[MFWQ)IK\K9V_(D(5RFLY!WRHD$M/9>$##L]&<05M[., OZ'KN1E
M6E%M2 _PH^$"IT]_(A'C4]KJ-X8PS_H,X\8&[AA')7P$<VPN6E_)+-JWK_PP
MT:B!U+/!2?6B)6!IXM,R@2_DS0Z8"_2,(\Z>R96V95TJ$O#,+/IXD4#LAYJ<
M]&+ -R1>-WF*SCF^:W!,9EXZVI@BV\TW[Z[KA-<X0J)R_V;ICMCZ,!QCS4J3
MI7+[%*#H@>_T>8TP?+!U:G+D\#_JW4*1>:JL+[18UO'TL@[+3TB5\/[\F0PJ
MC-S._[9=<309<I),[[-\ ".!3RQKD**=XU1'HL\R0;D/CK]JD.Y&.L_/CF[E
MRS(M0YD9V3%V(2/>P4\[7/U\EJ$7GQ*V0,9#1X(W:_H@DCNJA8#+K3"7V9&:
M37R#AAEQMEBXE(JME9CXW^:(;BQKLM=>E5RH6M1PWD9148JB&6VM^OLZJQ8U
M#S2K%J','*)H",](3<U?&ZD715_^NFR9L\C>6LC4L'T,(33PWL[WWJ[X</:F
M3OCW0U$IOQN)>3=2(_G76KLT5E?P.7Y_S8F@#$"]V*Z8_->UGI\"7?]%.[(T
M5A_.WE##4SE<!QB:5'93BOGL%N7<;XN-?UYS"HR@J,1^UU/+CNX_40=<+S N
M:U4HN\N=-5I <O]+SZ]VSM%8]9T"6O@>')\"9WWEBE(8PO?.B5#ERTDM4\X1
M M_X:XRGK=6'W\5^_Q+J^AZ,A+UA#^I4&M(<)U\^,):8\J8:E0*5<GP&CZ63
M?=0#U15>6W*\8J #1 T]M\(HFEWWM/=#O$AKG>H#;H)-R'VCA6!+H0C@3-VB
M7[ORQWZ(&V"(34UP=0$JLKQ6WVRK8FO+_P1H(/L1@OC.>9C7>/A[^0>OF/Z3
M4?/W%\,5CSXN0VS5L#F'.(KLX0HX*A/78:<P %A SE9V)N(\DRF;?,6$;.SA
ME(9#2"KQ#"R<Y+ZW K;LKM23]#E<,F#$3N+"2UU+R_>15 <@O^RM8/+ &V+:
M5HA7@P:,+>%@26(&YE*'I"$LG$'-H0&7C?-?U(627[^K?!%-?0SO$RJ:,I "
MN#T6*EV/707)VP%!N67#1+RR5M#M]UT()A.;# !@^PC=ZTY'WPDR<S9VV6ZR
M"2L_E75%#K0#D )E5U<:*\#J#W'#DY8L?;-W[Z36WJO!K39NXVS1QQ[Y \C-
M  \;=?H<E8 JSG$)K)>(J(ZJ!)4;O'<J&S\%*N]M0"\&+1LVI<I9L<Y-&Z=X
M0T"1,ODA,V5CKQDCAJ0#]JYNE04BJ.]C0"[;Q8$EOH8O0DR6U,! A\U/B%G_
M3=Q!S"@/YRP8:-%3]>HU[%";WBYU(5 "J^!6QHI9F9\^N)J- XFZN4.XD\6X
MTVJ!*_I#$=@"XW;*W,AK%5<]I$"R5@X"/@:,J$TH+;FLSU0AFY"@,6N558B,
M9@N@R%32!1EC$[(-(2."$0@3Z@3AM;"@12.2+A21(Z5\$<FX]V2(2:N5>XD;
M ',[<J\&.I67(E\E">7.4>NY_,NS:2"+D*D7'KU6UHE\G1]/@<^D+W9W3P'N
MU:J0$1DJWO!EQD=7HZ>S3X%XZ?8:R6HGOO3,1'UMZ:_.3!$%+9'*O+MA:?LU
M(5)K:^*"D*(DVTL) V=,E$O:]3R>K>8EHGEDWL8C\2RWY ]VRXMGLEIZ1$-N
M6*X79XQ8^%KT!(6.8*WV^4\F.^9#B[NZ/IZ'-T(B!A_G[I3-#9&CN2=OC,Q-
M;JT(FT:8U6[:*]X(PNLD5T_8HZI&DS]]F70==??#5PCB_*64X#R*K<LM*L^?
M?XGRIK&A11Y<8A>>Z,!^9CN?(RX"-KQ1&/D/ZYQ,XQC.MS6@3:XW*IWXV7RT
ME$G3AB[-H[^RD7GO'1./W&YE")UIW0O.B(<T;@#66-_KE1NO/ -/V#LH):*P
M)*]4#V"PFK^23U!A:IW;DQ,"N+7->?(N+.M_&#P%:!AN^V#LTX#M>;CPN4C5
M<()L(WE2CD*9&>F)MO:K=')Z7Y]VN@%)78[=1@:S>A=6^&7G'+*I=%DG&FYA
M#G$X /0  5G^/2^YE@2WWN&,OY]Y'$ >\Q?&?W577>&[ 3=R(=1<U'3KO^AU
M_$YS?'++&,K,BAT)F1*[(Y%@[N"]G "E%B"4BD#>>;3OE'&1&\[VT75RB#=>
M0]*4>6LA4@H4"K8O"2L]!5ZYJGS"C[T4*#<"(828$O-ZKF<3<]2.UT@<P%CY
M7P"D 8P%A2B U5!M67L*SC:>,94UG@BGN"D((<4+_+/-@@=GYPYE=8RQ\<?C
M@&%78?LY;"J<'FR?B@"N_]4_D:B=L3#O7V5SS9SQLCOIG_RP)= WSG>V^AF"
M]Z.'(8"K#>T47#2>S>V""'-\B/$#<59V=04S8R8!,"B3=TQ8;,U ]%+?SW7!
MZN(,P;99Z;R$LLO /%RR^?E=N%\.6JYBT&]THSSFI-'M2NYC*5 67V<&^]!(
MA55G2G=)I=VGNY#B"=U'XZ12(-=)SK9ET\O)^Z$9E6X]_/I6><VWOFWW 0K]
MQS<LRT;"EY;FW%]!(00?\+-J;2KGG^T6$/':4=!D^"C_B>F[I!OM^!N;WS?F
M/1MTQRNJFOM9#>:KU>MERN_=>3PT[!@7&)GFF]Z;7C.%$CR DUXWSZ&WVGG-
MT_" @2_&R921*%-V)OQ@.-8@)C_*U]2_I99BW:\V1I5.B$W>\O5Z/+%<OT-G
M_2E@U:A0&U9B4*+#;@\04I0/F$JXYXB]?T=_ _=PR.ZA3TPZ?AK62ZU1ZWH3
MI=W.U>\2;XB^GY+*0674W.A:GB3(U_CDR<\&K<&L?G7#1'?]B7=INXRN#'97
M(]*49K\K'K*:6[O?]G+,$)DQ(2UE,\!M2_5FZ?1\F E]9$9*K-9+T^9W<_M2
M=@IDTU[@0+3Y#<[+@5N4O$URX8;620;XLJH2+F<=87$*]%OG'"Z&OTTY,G##
M!INM]TI%/BSR+NN46Y[XB7Z#;7+YZBU]N;1=,>3$L>Z#Z)[ZI? %=/_Q5NM7
MT^+UAXD=YUZ2J)@F2/8W<GPUF@HJ]/#B>^!Q[LFGREE^"<V;8FXN]TR+M29L
M/SYQ4,R24,ET'+G,="<CZNG1H*Q\;PNA4:W +HGI1]FKF\[KRP=FAE77ZYKK
MFF^,;!9$ /'%"3F&N/O2-T\!C9<X7Z=G=.']U[ZV'APKCICZIM?V7;$-WW^:
M_U&[ &]X0AN')#F/MQLZUX .E?Q:1_,T!>/BRY;EDDPN#(NO_+W5BZW1]6(_
MB/7%$Y;"EC^0H\-$WZ=965U2I'/W&:0A"E#B*%U#KO9NG,^5[1\MN>*JK/_.
M-I9<2C<'XUW6E#S+*^LU&M?1/( <'CY2"RBG$7FK"7CT,D=O?B17]NM_L5/Q
MT'76O:-6]YWC];F"+1'7UI\,>)VE<O$4R*78MOH9(W8*O!_O/VDJ/GDD/+S<
M)+S'MWS ;#2&YW<W<TO^SKB^CZ;^;F:GXB@G,(X13-+@CYR5>T?I*XD OA6$
MIX>Y&XVF1T$K+'T35^S42(F8/]7(/X$1H_,'C!C8DQMG(K!P9F +O)*/37#%
M 1F:A5R&$>T*R$Y@@%CK$].3SI ZDQ!3LHQCWF/WJVA H\T95<S)N*CU)20S
M"P(*C-.1B=/!3WG\+P4^0:,#V '9#]-<ML#/1G*@Y)@00TS(&63Q?R\!,W'X
MY8%#,AB;'*E9*'>V V<70B&F3"SJ9M !I\K'QN1CXQO8OI]%YKSHLI7OLE6
M3\8L+_UZE>@'V0^S;X0W"S:E*:L#<I!.'8!U'3+5L(3/P,$(GS!^%P13;H&Q
MLX>XC,[=$@*#M $8=*MDEV;-N+Y288 PF=(?W*2)*LIW]'9U^:-O9V::43Z;
ML,+"4PU2>31%?\.\M_)W MRM#"+$O7Q:UA"C(F]!OM^^+B\?)]2860TREX]G
M7G];M8VBT+M]C'6-8DHJ,IBU M\'@[+YGBL@0J821A%U7<6U&AZ#313 M2:-
MI;<%F[2OF"M'H%MR)<CQ:ZSR4B!4 7ORTH</WQ61OI\5CK])@?+_7'ZSMAY6
MUA"*JH*DW.JT#R\$+OR/O4+[L[_QI,0O<&.$'HUT\T8OE*+(F'\J.9/D7C1L
M\J5AD,= !5L=U:#D.PUM'50<=^*FXEX6BH[Q[*)(I&<"^\@#+AI1XZT@Q]BX
MEWR P 3/EE3KG;B!P9UK^3^>0FE;QNFC68U3E_A8"?4/>?U9KJ$(5Q(.F*\&
MLRMBCQ,@A]Q.<.Z+AM5SS/$W.N3>%%Y(0*AT)0,/?ZJ&N$\)W!DZZ4H.2X 0
M2+UZXA=A()MP^+L.C"#LI=+=DKYQ\3=]NF</2A@@5)^$.I!D[70=4W$XZIRU
M$?437V1D24:>$]>*S^GFT'<AJ-S@&_=@-4O3B109I%;7@8#PVJ35U9%?SE^_
M]Q$/'S.8#>)9P#*R5I3,#9WHNS %%Q%*]'6=02B?26<J(WB-_G1@N42UT!7<
M!8===#8&Y$%/.)6UHJO'*\H/I[OZ9$(EQ:AKC@-]?3_!>HB!*O[$'W2KS5.P
M/'U/6>CJ2+0G(XJ8%2M6Y-@1O&@48 5$%P6SN?:\7P_!EJY<+0H& ZNN+-E4
MW*H.(YE!*#)$^D=-'9^$*W/8;NZ.1]5E0E4^7*IOD$#-3L/QDDQ#=/9^J4HO
M<^S6,"9.?A[.7.\^L, @,)[/C@E+55#I>;X&I9(U7&B1FNR0!X:0PZ1H):M<
M,##<?$6^3_%L' Q>"K2(CM%+ 5&K$@K,<2LNZ#9IT3&ZN)>:^/'NVIB*"&;:
M+I1YJKUSC1T#\FU_E%L 3-]K7=@J3R$NT&5HH!!/2C+^EUHGL<>50:^* OBL
M#].54%FWKT4(W6"DH$E^Z1N2%HJ:[1M"RCJLT;Q+*IHGCR?VS1.0M[]8WL3F
MO&]E. E[/6L5(.\?RJHFE;SHX'([:/+60,JM[^IBR'U]LZSG-6=VOD[!DSN"
MY"ADS>WBR26Z])79S]&>]M[@4"3V?/)XM.D858IVL3KE*+418[8&H9PZ[^QZ
M94__.QFS::G]AOCSOI.0(]5.Z2I6PW>,L;PF:H,F=C1O6Y!,TIIH2^N-\#FG
ML;:K>4O&JV/.D(G1H#$\!W:0IE^T>J@H^+*A2TXN.F$_MO;[EKGMCK3P/8-U
MVF^5%;%=2Z;)TP_%U(KH;^;Z>!!/\@L_2;VFG.Z_R_YXJO&S[EM#"2ED*-A;
M@LLA?JHM.^M@8;W2:LQ42_C-YGTGSTMS@D*Z3_AJL[X^I]!Z3%E<>_5FN+#^
MA^Y?^C->HX;B)3P&H\R[?''*,%Z3C@K+&O,^E&9YX#YT69_:US#V!]WK)_<?
MY_95V#C.*YJH-B>= K?93X'>GZ18V@M2)NH4"+$R$H ]N3<TR$,$2\9#3D<I
M%#LL$G;A(A4S;;UYXQ#93U0>0KC@Q3_YSIV;^QE .DMQ"H@M5(:<-*(/.D>&
M:"AS]?5-ZG^>8(#X.FAI]SZ58;V#V<_  8)V(QSM?,%^"P1T9&+,OUU\JV0>
MSHFXD<.S7<[RH(-*8_WQ,BS]!DUWTK842.3-O@+6FN;SB32AIM3C>4:&V^?S
M/,# F#U5U^';U(M=G[X$!92*N6%Z',*6)P>(RP11J0 V\VQ_I!MLMX $%(>:
MC$#Z*#)/;5K6@+(Z!&.UI[[;</]!45G@HV]PU#G]T@%J5R-BPT3!KHS[GEN)
M\EXI+@2UV$H5PSZ5KB,XL^7HG?MSIA;.08\)\<Q4]*!&[]D#4^9O71V"Y;Y+
M- 3P2S=\,TU@;Y(_P[HE&^;LT>,JQF 0=T>T.,(!"NIB-8DM8$4+J6ST6P%H
M);?!K&;FQ &Q*U02BSJYM_1K>'-1YU2V6>1(T3(S5UF#R\2?\MW;A#*SN\VB
M"4S9EEK'+'95LT@&$G!XUF#W\7G!)K;\'"L[>A][_"R[>!-U[J;;T/7O0K1N
MFG[[6.7LT)R/\$O!76_CI(&RO ^Q"YN%AUS*_0O0"\1O:?7I^8P/:?N-]W'E
MK@]P T1%_N \1^[RVK-*D1A.!P%\:_RWVR7[KYOHN6EU&"Q</Z0E+,6;U@,-
M.BH#*1:6^')I/VZN[ \0QV'X1,?IRL.>?6Y5,*CF,,9G56'X.%QTRG=XEL(5
M5-Z'&>"?^7H@.2Q7J.I3'+Z10]IMU2S ZO"*X<ZCLE9[E>+-_!^:9WUR[[>U
M"FGP3,G>B2Z/-UA0+ZC@<$51"0F2<O_A:.3 '"8="8BW#C/GLOQ(/W8[BJ!E
M'89<].];1 )-+6QNA2/3,A%ORFFH6;SYRR=+>#BW4.0>5_)"D=4- 64[/4Q"
M7KPA2,!!;#.U<$KH0G1P;Y_N-TH8H>-MQS=E@7/D<2/H5T F,I\N-?G!,O3B
ME)T<@]4TU7/I6[=@\DK#H>@FF8@^0,_YI!(CDK8F^]5R)WQIV0CTY#&;"X'.
MOY"0G"VG0-RYN(.Y+UVC9'IW[[9N?/4[!6PR]IFGNZM29X@/>^[';2JLKVD0
M80WU^)O!,=8$K@R6GX0>6F0"\KQ8<VO4HK 'W6?]QRN4<I0JTV> AI\NL6Y(
MR_/4FW_J\7O)EO<]K_O:)MR3;#I0[40Z-S3<Z];YQ*\["ZMP"8M#4^37 %R6
MM.6C#Q_(/S@F:@QU$4IO-3RO:*5.83P%;HSU;2AK5S5K!@>D/#K.5MVA^1#.
ML=[N<+81,=IGBC;"-)8IIE3GYFDD+LOTS/+XR.T""0>(U4J^GR*%&9YK(N<<
MY#Z2N,>O%Q]%YIPTY,P+%XS,NTBY%\/(Q^IS_.*6;=523M;(!0].R*+ZE1T2
M#=!22/*BI)L$&AYQL99<\=KT+^6^]WAKSMZXD#$S9IBJN$W');=I<NMQ(V'5
MU[B.QD*S0(HRR_1I0$*[,D=SO3Z]U*?D(8A5K4ME3/EUSDG9EI@N;;^;JLH7
MU:6YHK5<G+K4Q;JW6F.WH]06XS5S.;"-!K1!=[NI0NUSFI9Y=536&G9V5K86
M1]4IO35XHJ1C2-4-X1"$Q7RT-O@I-WOT8Y[-*A3ZBG1NK['OI&=%/X0_7<\_
M&S)PTBTZX6'?7A-><6Z09?$3Q^9X8Z+[@MM@BF"#UGRBZ]@#J;<N_$@]G6NI
M6^_PP^,N>K":<W"^RK**=XCF2.]'Z_*K\.]76CQ;*NJ_II6VL*4;JC,LLORC
M2Q5K40UMA)%GD\T:DTI+N%63_=@CHZ!4T;W==,&/.JDK/U2S-.V^O *#BEH@
MRH)EKIV% /=0:;D^BB __:N03M3TC"24::/^0"-LV5#?A+E+GZ_/_9KO0SCM
MZVUY0?1(9O)O0"@:'8@R!%0^DJ5W$[/T+S=5!:E$N.18!P %F%MSFDXF@1!'
M7:8_&!0J#1XBLJKPBA5_@(RL_S F!4@E*CJR"[X5[/JXE JQH)PI9K<[H84R
M*#T_6 4'2YX"0:8?NH\'K[LRAI.A*"*=C*,1MOP.7;?,KC0J(A!WUT"'>7"A
M?>.<&?!#P;@-BJ:T98S)[<FL7'7 =$Q&JP\2Y7!DZFHZNJ<NYW7R'45Q_]HI
M, 5F+#;<C;2Y-.U84M(=K.@#99C)&CCJ1 QH4C<R&*Z,1?D87DJTSJ1M!UP'
M3>Y/;!7(OE\G!FSN4I!+9[>V- JP$JI)3+*G,_@R7M-=@]+%$LN8@WPFAV[J
M-5-C>(/WXZR //0WO:0IC&G]9;42YWHZRMA:$ZF1!<8N%-5E7$NYDBV'FN[.
M['<(P<:B5E$IRVSLP[BZ:3QU0A)>F8K6WYV)"$T8AU]>(?*[[F+X"E$FBJ>6
MYD1Z(!C$,\XU!PB+&CW1_#:+&]YM=F*$"2L<R:[VWN6'"U0O":,B5A$+?ZS'
MPB\-_A<[GW]>ILY+;GUFX<U_PIC\_H:>MXNZX8<P"0V(_*.['EM)P<+9AOS(
M'^-<4(@B AOAK1%!&JN;6X_/:F3]AODED&\=1J(=CH*WRR6.WR&K;N-3J'-A
M0C)W,BF8?GH+&HJ/H@&IRD_=93LYRY/#C7)7346"GO<!-@*Q027[\0<@W0^/
MCY%!C*PP0HM;9.PI.J-<O=0:(::+U#RJ.J5.9/^'L_,.:ZK9&OT.50%!)4@7
M!*0*2),B)4B3$B!T0A-I(0C2A2 25%"07C6T4$+H"(+T8J&IM!!  9$F5:2#
M]!OT/><[Y;W/?;[[1_+L/9D]>W:26>LW:]9:TQ.,(.M18[OG(2Q R<Z+TRFA
MB01.T<D7M!M.;!9Z]8(?4W'TD?OH4T<^37A"C5/A; -$\%Y#SYUH6F19\.%;
M1358R3(E!.B)'['IK2D1$@DP<;";<0.%DE" SJ=-.$8H[W8Z"<Q1,$("F@TU
MD(J3"3\CCS(D+\CK%@7 SV=3(DG*'ZJ !L6KSM\$@P(U!VG3)VZG_%_<_XLP
M&9\K![ZG^0^//E[(Z,#;]:X6^WT**%IH['0'WE)N,-3-,'S,ZJF3&#P,OVAL
M]:/)$F;NHOBSI^WK,RF.!'UMZ0]"(E/1:30W$/SYKZJ#1CM+^R8Z/_=B?X8(
MU[9U%91^.9.R&<UC8W0G'5?/E7$,8'>.3,=4*?S[\JYB;_;=$LP?@7<XN7$V
M<O]0#4U,"(9"[>Q"WVB=85A1^K8P[_SU;:0P>WORE3(VCMV<:T*AB0T<7N,-
M5I5WU(GF&$YCPV,@:REK?^_;M,$3.''"NRM(@L]ASGUZ7;Y<R'ES?"TDE&-^
M,U(D9:#1MIR_^X9,%,>4Q9O6;=[$I=X%FQL*G9'S;Y+#U<CC-%!@+_"2R)LD
M$H-60\7.F!';!$>FG\^0)ZE,+MO>"W%2SO =VCE=W<$=$Z6D58U*=EH:,1ST
MG=4X!NPNVO( ,],_-SX? T]P/@Z>R**YV/<MYP5HBW.[(_+[7/.&'\;W4 QV
M"\#<Q8W#YUUNR<5KK0DM*D3MQ7H*1T@3W&[*7LBKI_P1),H4,7E](!#[GB5A
ME?$T'V@@7^('I+1^#^EC')FPZ(?W\\R)%&[_KP4+-7/H-N6KZ"CVI=&]P;V'
M6TP_7.@DKS'^BM$ [$>K;:EG2D9]NA&7=@5!:R;58-,_Z>DYYTECY(9@MR@8
M>!B?) OW%\12D)/%%Q*'L)2V257/"'\XA+M^]@*3;2<#IL3Z&"A$%GI8G,]M
M JSBNW;-,HO C@0>]Z4AS$RG?[D.$+[094MY.:>8N[-;VS.;1T7'*590.0DD
MU1[*0)8@.)R59))P#!1)?X[]"#EKTY[M+9??BO\PUN0ZG(Z?UJ^:O(H@,TGD
MI?"!QIW;$!5I]ZES[?S"L86EV9&\^S@F/.7305(JS.DT>$GF$A1@?B+AP,19
M7%0NQR3Z6=G&T.3*:% ?%3XS,R>UQV"%)N^UGJ:W$#3-I12PWDC<?YO88[="
M4[C-OP4.CFC2 *RD! JP>D]^A1GO,[J4"E5X8".!FEGQ MP&,]%4U8W[2%CM
MSE$5R*=;=<Q8K^MPTE2YZ]**SA6K.C (H8.OQ0=&JCPUM4>8A;]V&#.DF'7L
M'0=+=\4VDI OC6AX)XV3= =&@9TP\?2L<28]2]F"W!^BBX)D<Z13<&#7HG#6
M9RLB;/O"%ACDTV, TTK/S"D\#&O2X+*_"X,P*\YL_6TE4E,&)\V0>ER I84*
M,_'R%&K$5J4;.X7EY(P>>B#(#7W!58^P?[9Q)(LC$-@ QR<S,C=XS)QY\Y$'
M68O=1C6L+TB/Y6<A=Y1LNWC>9 KG)WA/5*XVH!N O4YJ;X,BPNDDSS@E?9,"
M+1F<_TA^:R;6'L+,?H@B?I7O=@DN?.;!W3?L<0P(/]HUI*@QOE]+E=)SE=EK
MR=16=K2NZ!.]7I!Y*6#AW_5V,"CO"T-A+[SR*=AQ2P:^_,::O@K85^99LJ*Y
MAKWXL/(.1)CZMIOMWYI:N)N/@;C@WD/ONS-N#\O6]X]4=U2VNEKBRR@PNU''
MP*^XS9 7 ZKSOQ=2AL/CW=,N<@UT?YT@B97!&ZKS#YR7=_W**F=GK^NZ9!K=
MX.YJ[2H:T7A1.7 [ GW^7-WJ]:RYF*RP6P$Y6WD-5AJ=-\.MOCX]!AB6[$SU
MOSR@Q8QO''S;Y>C>N$GLVTHL8.5)([NE*\8,E!\#\+RAS?)E=O=^2N;3.]I'
MEP['AEDI5MR]./K3%:YIW$-YX.CQ=V>UUFLGIP625297C$/?=S!K3RXM'@,J
MOP0-M'P#UR8VAM)L8JHG5U[+UU6-O+IHPP Z[&CR(HAH_HC!V>B?XJ5@6Y>0
MTWD>N/[1([8V[9JBA&1;2=%+^7A6*B74,:"S)&-!L.%?L':ZGW_'I9:5JZ",
M4;=V7ZS8_9H),''^*Z#(N,NVZ6SJ*]PJ^?(-A>,YVR&3W=5U_-*O'#-\<N*-
MXNN4IE<^>0*L?,14P^IJXLL*REQO_%W],[[*3 2CV\,[YWZ>^OSTXHN?P8<M
M;.L(^^]F^%>:5@UL<"IT/>I96AS;PA/R@BA4</ QT-5/W)*3+C:6[K@2<//-
M]][=%=W"10E7?ZB7H&C/(.P ^CG(/ /)]G@O>L#:^IK%*C"?VV=>8UMUU7=0
M6-=NR<PD#UOR3"&_*;#PNLA-!W3F)>-VI4/4/3R";<#U7JBCS[8VPPHS:\>^
MVL'F@0@WQE5FIFA0"5_5G,_1LZ/D@;A=7X-P5N73OVJRP_0=DY&V,/)XJ,P;
M5JN<6W%07+.:@MON%O_Q,R3(/6RO?'7[0(4&/QT$NEQB/G\ZH#?E%\4!/EOY
MN4I/TWT3)A1-R3V[@6N8V5A).6_7O#ZH-&;=2/X9RO(8B&A+/;RO]=NR/++.
M*7*D=L%N:XWKZ+'(</'PQV963K"_O0;8/.?.?PIC9[>U0(S5M1^!=]CQMM^&
M*DO8=V[7;)T:@BI,6CL&.A[QQEM_?39)"=S)GLI3$C[U^7;^F 2$;* 0'6GS
M%LUI>I?]'%M%?9'-]Z.3G$WDCS"#Z%F)S9(!QMOE5NG<5&@^CZJ9_,1N)07#
M/UN9* EB-[%4Y7 _&=1? 9C_?,6EGVSJP<3^H2(* _C(P7%>WMHCR>S=?,O5
M"J9/W4WE[;L!-3JZ.7&S@\?D+$S<K2QYM\&&%% ZI%25<X+<&_D.\ 1M>F:R
M( ES0 ,X47"'9PL<X-R.1/+K0T\]SN@VVJ<!KAM+=:O(T-:)5AF2=;Y?K9K1
MH]O)9N2"^R- 0<8^'3@A11_# P*'/Q;TO.&6;R%DI!8L',:"4Q($;%T3>!SB
MI/3'@&Y-D$\B <U[$YP>)PSS>#$OK-K:)JX#0"(50-![(U?EI:^'MBY!U>=\
M_+!4[2_<NXTW\Z=G\;Y8\FI5,?;OY,J;.]X=M$/)C'=MJX"V&FAC0;?XEP$N
M7Q,B00-0MX]BJ!>^1-:P2D6I8]'IJ6#RE$3?4C\68A[&8_5\F621#B]-L:<^
M211MLN;S@6)TB)&X'G@^.3D8Q-;ZZ&7)5]<;)2PG'@5-Q0)PE2LGD22@E/^U
M_;B8%V@O-=,@&BD-),>%=G"% 19B0@T=I2;[5UHVB(3@!+O='PBRV;4ES4F3
MHX\\L5OM&-'O H>N6-K1)RC92/RV9<A<(7;DXS&@! 6LQP3'*(W< @&26$)8
M609]0I#]7--<(UTH?K EW>*4R+4$!:S&!<>5D!$UJ2I+T==_D!1OKP.$^<3O
M&[^M'3)7@1WII-Z;)I7$PF4C<UX3LG;ON'YS2CU"88"Z1EBCJ4IEU\F]>*TZ
MJ10',$!#+8TL2:M6GC2C^Z<SM&EM["0%>M+_@0>]8EYS;$ 3Z4KGPL,4@]U%
MQ/Z5VI/ND<U.DAZINPH;4BK]QEV(U!G [HJ@&$GCI=B=U.)[? R428-\/-LH
MPXR" JF I+[7"?&?VM%B/^&R-'_ZFOLC 714VT?YPH*E5\9H,$T,ZPF]5).4
MT6S/4S+Z9J9,*@%!9FKMAR?0,)"PFN,@O-!**.C)9K'D^46OU@)W94MK0\H^
M"0AV3<^Y0[\*2'AI<F?/U$U,M;=4W]A;2A:O\_!35'SF)@@1X_H8_#T0O+V%
MXR#A#-,C;R$#&48AM?A=X\$:&L M^H -_&-B$R\+-ZH# [?8"E$MPL'(ULOT
M#*CP7]\9ER",ZKD?F03ACBJ+BSI =.''UOP6.&D8,Y>*ZRC0Z !N%UW5;F-0
MA&4LM0>X(4S*G5T0M!_&'B9UMXD]>)YTJ'!%NE-I ^:^4\C-4FO0L6OXMWLI
M2<F,UEW9)/2?+^>EH&,0(<YM'KH]<W:Y_:GMCUO"4$#ND6K\,3!L?Q#MS3?\
MP<4H\?UZ3<[-\<QX,M<J(_.DN-$35(_#Y+"3N16M9CRW<&JZ=4]^?8 [-LE/
M^8"DWV>6^JH09IP7^TT2Z.QWMSP,-LJM!//P=B\.DX\!H+MR"VSF@2N#NWKG
M&5\I^='P,I*>>DJKY;N=KE&>4 ?&HU,SF<GVP_:9&U\\1$>]+YY2,MGC0E68
ML@J)E*)G&]4F5U2"EQ,>[)?$@W8..UIJ0LIMKS79UF8Q?VYS#SSS"2*>R8X*
M/5#C.)(_5%IJ_^3II3WTI/?@4Y%688^YZF0&4M>J]H?3G=$/GTE 2G[Q^;9
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M0[5,GRX@BSC$*A-BH[*F3%19FCP&7I1,N7TH+!G=<)&N<>KF(Y'P[#])^')
M3T+(E-__D#"FB8/Z'2^2_6I.I$CCV'^Z)(A$O^856+))]DJ9+A]"RTSP,CF>
MB\2?DBN&<!B2OP'7@5L%WV"I9V#Q>B.(-UBJ0O8BZ\A0U6]&9Q&@7;"C\4G
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M/O+.SMD"VT)('FKPJ-'T^DIM[CB:B_.3SB,Q*0-9PV/@OJE3J%>/E,&%XI-
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MB$OLRIWP\:4H,9I=MPK,1<#@YY70]*DXW#C:!P]ISS&]>$.=O.V%M\VH"0]
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M$_C+2L-&)G5V@,H-HI("_DM"-SZMGUNQ_&8!=:%8N%8LT 2IW'^M%D:3@]%
M5O"[_3\HPJ&<,'Y#DPT9 &N0F;20;01@Z^3QRKV /<.1C-9AHOAP6 /&U[^;
M58>CX R@=237A7PZE*!. 9"U[#&RJ;^,].% W23&TJTG^S_DG*?^-57<79N
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MJYHTZ)+1MI^_):)@56Q[L_T!:I+=MQU:D*6ZB38C<7#@1U8M$QMNP(7\4@=
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M6/4-L5PFV1'.< B8P2:0QY8WZ6?^!%$@*5\%>>V&BG.A[99E1?,?TM\#GT!
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M&.2=/FP/@N5!T@E/%0,Y'8NS]R*6X M@@TC?0,W1,>LWB[JK63_S'FAT,?F
MLPF)O71=3F-A?E='*$E0&&59ZT!"XD'YDVVW*>0YAWW1:3Y(Y=345:<0R?X
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M(Y4'_\Q]F1M>\\J^?]W5\>';^2<J!)&GU[L@-NX-=J&,*@]--3HOSW'U-JZ
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M<>1[;1!1@P+?TXZ>BX3F*D_33)*T8_43;GZ^?D*IEQJK4 8J9UGETP1*E$=
M!F]C74!_M#Y@V_RW5'W_X-6EPS2D;*?R_ T!:/V(DW]T9:/( C:KW2WDGCQ
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M\PF44@5 !JQCU*W(K!?\1/7TZ58%Q-GBZ[;M>#%?FY\ N;Z1<$,U<-3+N!E
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MR[DC/@ E64\5K!2JEAB#[V%.R:@+UP"P_"_B@4B-X0QWM@@4.<I<BTI&G5D
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M\<T<>[G@T_ KY4'$J:PX!],L4$V>,L[*SN;4K5E99RQ.LL++&.@(LZ5SQ!D
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M.WQ)F#&L%&QUD9*YU;6@???5N#WNJ&(@6)]ZH#T8Q<!5.HWY:1Q!/V3YQ3Y
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M0=JD]VZB6*C<D'?." [_X)9[)@</P^V'$9]3;OK6LY?2(0H>N!QL"].B9"4
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M5??H<]$-@L?/\3ASW]'F6+C\DJ(?Q];THA&N]UF'EMU:#:FR)5OD$"OWW7Q
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MO0X9[:]&*)IH#7=S!=GZ*!61I(?%K0?5)FH8K*UL^;B4FS0+FCUA-JECK;X
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M+;!K7XV[,>";V&Q_'.TA+TO;>TJ*=F,'6!3> 2*./^\^J,(6Y?!\/8;?1UC
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M+PMCM%+!"RY/VYE?6TJT>I1G:DR)S5AB\T^O7T#R<_D8>Q3(ID9N5'%TSNX
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MO5+VGQ24DA*+=%J?]L_=SAEKFQMJ"R&O;D5GUSVE@FS?TFV)OVR!+!?NG'_
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M>4ZGG?V5  O5_5;*GT9J2",GH(52AG"32*Y;1[*/R@?O\RLR\LQ5OCBT<*D
MOR)_']C[F%M6.I;V0CY#IGKO=.N04^>P8]Q6_CM\4YWVM=C@L;)M-D3%<-K
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M7J$_R[1>,W^D-Q'=MKU8LV5O6W>V9F)C\\[%$5.P1-+6@=[0K87*'>"UXPZ
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MR4"(.,903 (:,]>/59,),)*"DJ%;8?0HBL_F2X9$LM>C!E\A^Y8<=SL@=[5
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MZ0&8+"!EW)LLAX?[!V"/#1A"@CC]-O&CS&"@(Q?\/E=6*H>W'.AXE 3)A1&
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M"A,T@%=F M37B\+=)2MC5S!HJ& -8YCI=Q2_BP:@N%RXH+,]L"FKQ:&R^>"
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M1#L@6-JL" U Z^JHJB[!K>&\RI:K=_6]9-J7OX95J;]SY*S/#<>Y=%5H V#
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M"NL(JN[)^8:\Y<YBMW?OUK/,9T'2<5H.+6_<O5-JDVJ5[VUP+08-SSZJK17
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M=.6HDYE@(/K9 ,IBXUA2FG]O<KM@&Q<5V4O8 @.!;#3S0:<K1$3#\X5F+VL
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M+2#_LME$KSXR&$KA$=/=_EGL[]<YPJ^"QA3M[#]^^6;G:DB !:(R,Z!O174
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M3TO_.I=Q.+!ZTH";\Z@\43N^Y:I+.HKZNW*'Q0"Y6Y$.)P$.IY'SFB_P7T@
M8M'XZUZ&0VIFYFU?E)'1^S<A(IR?GEED+CJ6ISPFVQ^/A89-EG(R<'XBRK:%
M='IPS%2D].J%"BH>MCQ-2MSQ35#E=B4@W].370[)7WE3,.1[VG^]L238+,DZ
M3DR\W;#V;X>WO(U&XN$+9_(N_GCI?YKC[&=SQ<JHQ%7+ADJ9AGT&:S*%;I$
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MF'OD_H> +J3:@)Z9@-':V*)CA!H+ 5\H4U<%5WV^KUX$E&FB]Q3D0$/VD2@
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M71?2EOGR;2O,IV?',*?$9Q--G&@9&QDN6^QZ0,Z8BN0KC9\@*, "S.&OL@P
M]M.>!AQ;I<MN,A@\HIGOB*?+RS3*7HTGQ:)Z:8[0*]-5"+$[=5^-%8L57*9,
MIV-S_X5F]7_2;B]/2TKBW#G;( '160;36IXN[@&/G1/"%F9*0GV6U8@B'='C
M <U\R')&=PI\/,<G0!1T8"@_RHHE$F!@QT]'3)$%Z?@&P^;-+19BC@,^P^=P
M";@!D-Z;:/@I7[$(3SNZ: *5&S$C@JU_NR&YH\-DZX%&0F*I* S\I>U P""&
M"-H3<I0#P.RA+H:V<,.(OL\785:U/)F%'J?&U6.:XW63&FYC9'S]TKG.A#%Y
M73><UWU<[RM*+0(E]4;.>=EW7FPTGR['XQG3^<[9>!>P3BEREHR9[LH*W9"T
M3G@W<^Z5DHEZ.U\W1GBT;BJ04$TE(_ZLHH%'8')W=4\N+&%S'W1*[=R,> 2T
MX;5<!F&Y=$]2T59Q'QS ]D23YA)#H$)%LU07:]-\3$0R,-YQRC(6?]?XXAEO
MGL4R#!"YC+!(4!X8;OKFH>FZA'&M#RB2C#I!671_\(>Z*(1.S!/K;ZSQ9PBP
MD[N&5I4'-CP\P\\P9-F@A$:I[9\J:4L7-IBJOB")JC;>RR'19E3ZH@EZ;=FE
M$$QE''><*>KZDQ\#)+I;WB.ST\6*C#S/5"UODC]A/*_XECY>642PCL]FYWZ3
M+\P6X@26=?EK,$ABY)Q'TYI\Z;0(/O?=)2T$IV&<OU:)T]SU&SH!:R47+;88
M: SG1*DJ7QR=.3<PV*L'_JZF(X1%(%[H>Q[+IVS8@A<#(/V>DX^+D88]26V[
M_?\T;?W_HK$S#;Y#VA-[NE48U^7E Y"5JZ^JI4]H6/@-16D0(><KC&7UVB@B
M:W [<-[ZA(F7 7LC_M#M<08T(Y>6 8L<1%(^B55G0=$/P9K,4WRL:LP?%4!.
M9X%!["Z(^)DHQ-_J>^H^%A\+@]#?A<P;W*_M4HD/IW!P!09G_BY]W)4I$E4Q
M0\AC,5C?,IXNB;M0E,C6)28'R%I5.78#D;@GL9U&)E$8+LE)]2*F]+"[1L0]
M#ZK<"V5*L+F<3TTEC)Z1I4#U<HM\LI_I@?X?^Q#K>/ONO,DH@NF#Z+"8OQ@:
M"SRUC$0KQ?BM'.<@371BG,=ALE^IQY*R4H0QK&8621S9!UD'.0JE31A$S0T1
M#&@K]U+]3'%9BKPR)R?<740P^R3UDC-U84UDC!"/6"DY7<5"'HBOY1=D_VN:
M=VK[Y3X1@X#?%AWF?V/10:T3^H^7_IEZ7&M2!KKY)DE@H8/<>NS_G'?FGSI7
MR?L7-5,^A,O,J'[;<"QC#1!T87._N<8_=:VJGSHPC-CWC&^1:)Z5P;@"%-3G
MBS\8F*GB +NII8D3P*<SN)_R/ZC^[IS8EW#E^Q%Q(XSXH0Z77QY4$C>?.@1V
MV3FG(G.)U.TMI_!MW*Q]&$X?Z?82\4]WM;RB.->++@2GQR0!F=DL@]OSYUKF
M4'W/KIAU8XI:@$5E^ODT@Z-AJ+9/;-M1C\FPT!?-Z0,%8YH&X-[2@]UFW4^P
M"$C17A=?/I];;!]&=F>GFR.[:+K:QH%6WOGKZFR^U,?<-3S#(8T3'ZQF,FC?
MX 4]2RSM\;'YNMY49Z[&K('/E>4;3.?\E.*#[\A'?.W=LI"ONX(VH_6BI>76
MJ P46[)^VGKXUJ*M**366%ALJB\(3^=<:G-I<WM'O'?%^HSQF'HA5;<A5_@9
MHB@5;BGS&(:[+I$8'KCN8&E^-A;M=]5OA$1[ ;#-JB^,SXE'1OZ,SD*2>&@I
M3 =MZ>\!&; T!B3J8AEEPDS<.IX6^3O_UD%!-R8@<ZDZ//EB+^;^CS%"RNZ%
M8G+\LE'F$_QA?A_E)=-N]2*-N8*$2_G@1.>NV.=&[=, UNK][BR)1J%M]T2+
M [O!@%-(#[(6P81R%V14B8PW14FW (?;5^2N3_HNT!I>P"XQI@VX/^?-(9J_
MO<^#9OVK^L'_M;EZ'9_@>$0T8BP[,^)^>$^X%'4\I_5S.+4J7#QQ:U?BB?OU
M:4\AI^XV(1RXBM(OI1><-S]WW. UPV4SZB1G]M.Z^<+*L-T<#'=;/MQB"<:.
MIVG,A9(?$2^3()&+>A_S9^(2$8<3]3,]SYE7FU&YRTW#&-E,_CU6LU3MG\^8
M@S1:].K]6_>2Q]BS'J!+6)0JL[!K@\*>N=8)ZTHKEB?+F!TKOHJ_R<&_B3:C
MU;ZM\Y-W7;2*[^WG9%-MH/.L]75S5JF:J#D&;%GT_F./3V@[/S8+SWF,!0]*
M)WW>AC&=)Q,V[<+E45C06GO;URKU0[F_<HLAZ]O+-OG27_2576<'S&A/89'Q
M2W;^]T*>%YI,*_%'SFD#%2QB@ @YNCMI,6"X\4A_[$^HSC_CPF<]>F"\GBIF
M$"OW7V76J!6ZHJZ6/B[@W)I-<BXJT70SKJ>U37H<3[]>4CQR>1W/X'T5RB->
MP50:V85ZL<R[GB(J8$.'X8''<HZOSMLZU=AND?UGE6#3.C_H9!%<X[?%4$JW
M#G6I_7':-_M[A$#?!3.C.7]$BT=7H+SIS!/9K-2P+]8<EL=T[FY(F4R2,7)S
M!:T3YYGKZ?_C,A?_L\9NL_?M@OU*H[N:^.S.*@*V_NA<NVG%>:OV29:]]GVP
M2!80]BQ#7G@?X__>W[3>(4H<!+(.KIF(BR:R>^K"0-\96GYX?V8\FD2UU$7K
MZ7G#C"9PO,[2%!DZCSA4%5]-<(N?@Q '^90)E@?%$Q*]Y59-.WX#2)C3W7E#
M!),@SD)4,]3, \)QD_AVSO-K.-(I4 ZL$XX5G/8<=_F!H/?WK)]?VO",C$0<
MA;3)D0G!>>%)(#*^1:?WI>,@OQ+R4?KSX7H/*O4RARO5*Q85WI" +N4C ML#
ME^F29BL!K_VS[@67J^>\1>1=4\5G2EIEWI)H\F4[ELQKCRM=3):H8ELTNG^S
M!D__3B5ZN2@N(;T?O@]82O4B44X8=K3E/-9S#?0;J:/.]>6J>X#\B\0#'P/U
M@P!&]5AV/C1("L2O99O"F+6!=*C\29U05.C\WTQ;5(JC>29)OWT-?OL"_5:G
MQZWEYU'P4 DYR^@B\8_6QKF/\#>A]"=2$/DBZ/^0^?:_IQ@VII[I4EK+HW$_
MJ MA##.C%8N87/Q6\I!DK?S7P9^I:6WX]8OT@6+XRS:%1CT^^4M+_@0_@U/Z
M27!,F=(1<.JCNMBO%BE@Y7YJ; # :W[F)3F=%D><$>?\\+413X=4$&A:+YK>
M!U:C"Q+6[RD<ZJR%0H\<A.<Y_RR[%S^VW#O*8>!UX+89T.F/-TY:CIXL-3BC
MK:62;*$-))^\UWQD@CJLN2ZO_#O[&"1C?JU[(B.=1!,0P*/KV=M0*?1YH4O7
MJ[>0JM63,M!HTN=@C/APV+Q&I>]O#P-RZ3J>NE22*@X'/%>L+?<TPY[;U*,R
M]>L:*8S[ZD<E6'8PEFHB_A,6&'_8ZBO^D6BLO8PZZRM*E5=G1'E&(+MVQX\F
M=5G;>UH(.H]6#[DD8$8+W"A2=,%;5.Y>*5")ZZ-L"4BCOGYC('.M&G580_!G
MEZG45H5UZ2%7B4]RD,O/ S!*151?/ &#6/X#)1A0%KFE0SHRD4Y'*_V)P0]Q
MY-,^*(] UEB5OAZJ=X2!@[*LCPSJ12%/B?%&Y)6%>X5[E2+(1RERD+R8LNRD
M*=ZHQR^^/"G-&F2QWJO,BWG![ZIL22+]-MG];[F0>/WT5+#92KC=[B"/7>_U
MZSQ)JI\?:P;IVLAW.XYVA"EL?-$=-2<Q )?^CA#IQY:/U:&7U6E5E&+S3YG/
ME+U-Y1$%6 %5Z_QQ2]N806$=%3,JMG;",JQ;MB\%"X(]NA1YUYQCB."+H5'3
M>FX\@J6@4MB8AD05[936ZAGBI]_J 5J4C84]D"#LWPJZ/Y%+<.,_84IW2)0#
M0"M).0#&XH+*OW10=DN=_CLL!B^*89<9&0!6U;?NI<A:T2M&AO^B6.R_M/AD
MARL8 8I8*3I90F7D+KA=4+(L[JL%)9$SM-5?F51?C?R84HAG7->4+@JP*I,\
M[:U_3?9FQ!@UQQ;VOJ&P)MF,[K%'E_M*'(4[&2AV[ -U46I=>?8F7D-KF>\1
M/0:/\N-VGG1[4+4<R!2;89G(S'6O0CQ=)I%"\3S]$(>BK3EUMY#N!>+?Y V<
M]Y*20 *C01:RZIW!%#,J[W,81;!X;*>4 O$J'1:ZPM2Z3U'0 M0/<)VNZ(WI
M,)](/9"?L)MFOV[NRPPU*/(/$*4FEY6/\AF 2_F2(@;J<W^C[/]0Z3Z:N*5"
MHI'N)O>Y%_/5O283>\GGF>^)H[G>Q0>8W)XNC:(?Y2/D U2OL>Z%(RKPHCG/
M@?]49?.?-]NZNIAW;(+?34?-!Q^!XRGQ'YOKN_6WBU6>E[E=GZI-[13K^#V;
M%+P>^,S*O/,WU?K HF71PBD'XMM2V'/AH3SB2A/-#-7'L< I!A4^>&31XB>>
M3ET>W3^&J_> ;.81+'B3()R+ICQB]TKU**(:Z]4_7]Z'$<PS;? <G2_:Z *F
MYB^1B95_8M-;Y"F]:1TGF7A<JS=IHRPV/DF=#":]6>PCC7D\M%3?O%0?03\J
M+CU@]:@O=P5QU!WK%=B1SP[?.4&%X:RN:9RWR*'A7?L0? ?>'XUI(&ER@0 X
M8V:R%51&5NJ<I9&)].+9(T5DC(!CES"YZ'F,6/SMGKK^'B30I_^(+7] $R;N
M,&/$UI<AP51-A^&D6I[Z6<+4EW/75Z-2(A!/<U%;4L#R/IZZ4@?=/T_96F#,
M1(MR)/";-Q\H/7@;9DO3PBTNBGBA?W/WP*3GZT%E(/K_OZ"QRD]F?Y?8CJ=!
M>87UZ[E'[P-VZ0(C/AR&_^&>!FK:[ ')P3T$525LNF)&W3&1JDG^747U<O+A
MW06 BQYP<N%K,9S5742P'U@F7[\IC6PLMM"+FE5>LKG3<:L=?\BC\'W'HIXK
M0F,=&%I+F1Z*J2G:F=I;MWF5(%LQLX)@TSDL*FF127L^48=MQ=*HL.UQ"U!]
M[*-BA?'F'6@2NARVX&5T9UP>J*>%'#:.\W[X+9^%:Z-P643;I*8+G$P+7X22
M"Y+<A(O)[Z/@;)$6<AW/DU[*@4X;$&_3WEY,W@<**->3)A06J7QN25_ZG=4]
MW.V;.?  Q&'W/<)JT?:@O3[KB29YQ0S><,K[:>L>]$UM;A_44WAL_ZK9$^>>
M,<+UWGV QAR]MNZ60YQ2)&?(%4VG<WD31J\%((ZA+31'\T5@Y&EC8$/<[@M#
M35M4!=DDBM1?D-6)P&)X/<4:G()1H2<*(81ZBOA*V;3.41DT?GLQ<!8&\4Z#
M,Q?$2060[SKX>UZX70J$Q^D\&.RF^@4=,EHI#X58F*YO;I1@?,6C$U@T,^G0
M@]GBSBMF-,34+AU7TQ6+ZQT'>M]\>/_-3<H+ZV;P;=P%:H'X]8+?+QRKH$:Y
MG!#7_[L[^C-M!S>7"C,I=L=N#V2B(M"80PU?"D^U"NR@]-UBK_RJM5)X]$H]
MM\"#JEG:YUAF"3$ X6"A^I/' P)?O:5WG-Y820JF2GL.P;ZT#X9J2FX7V<.[
M9\JPP,NBW$"'(O0 D14GBJ=_$F 4$U+IA!@A%,\0!.5A#^,17.8&B3H\+- U
M EF&&*>P^2'6_,.NE\[8D@C'=NQN7T0RL/OOEO'^!_*.C"FB2X\,E1)T1TFM
MK[%?W =V=A7L53SMV^-34IMD;KHG#^)21(J<$Q&L]6LI 4].LX@4J$#F;7(?
M"A=SVYQ+/]I0&3SXWD7B^^MW&,FV8U"#9P]-$'DN1W0+\UM%(7XMA]OS.O(M
M$1 XUI%XYX=)%U#TYB#T(AAG8CS?/,9PXLYZ;A;$(X! C)B?L1S ,_:WZ,B(
MO?/X9_;(L#_J08BAMGBNGF_N(H(>X@2F<)4PB++:R^\$78Y'OBH;<EO_*PAP
MEIJ*GH:77GU19L60AACG-T+8C+B+,D? MYIP<?8V&8//XPW;8L\$[ZV[5O9B
MS\$CO6+HY<!KER+!*FME09Q'_25SPY^5ZS"(.P='+MSZ6F5Y8>Z2UX(H58M*
M25AIF+;(I^,41A;98I&Z#_(*BQH&\H+8;?2M";9K>-JL$XD\ 28?-0+BC1(N
M=]\C#=X*X:-(28A_F+@T8]-#OT3+A\0><\M<B6@L*#B1G"6);<AEH.6 $?\S
MV0-A&_ !9TV!Y;2KB=V@F*LG>NVK*.3R "_Y*L9(=T5JG;WFFA_/>P&[;JVO
MZ%AG.[]//K_2_>90Y]U?^O;R-(S&DC&*'L7DH0>^9WPI<PR]*][UO]#L75#<
M>G<NM;2J?2KLF__Q'0^JT?6=8#T9Q78TO]*.5UIUIF%-=$)Z(BF8FF3EFI?<
M62O[?,%N:J"W#0?TG#I*.7(:"[2.J5H/(L%E!Z6BY[>,!)G%9O.![EC^DCES
MI>@\@A&MO6B"1JWC#XFQ&!P4ZA%41VD7]B =)C!"!?**?OAT$F0,EW6SKT_D
MLQQ$_?PH"OG@%8F:G&&,# +RK_IBDAZ1TU7,J%VV*X\&RDOL#C]0X0+H]2)Q
M?C_#5QCXJ%A&"^T+T37\(6T9;<8\KA"4EQF-(;-&LH#.\7@3RQ85#*< '7S
MB76,D-<%^,U*;OUA2G* ?(<M<^TZPM_SH]Q18R"^1E TT,X_< \V+9 R,$<<
MQD:O%QTZJ$ B9EMZ$OQ L#BWG DB\":-K8$)I7Q+P^%4)3G(2>F[2H'X:!*5
M&,$JC$F-]X\5PFMW^/R\P3X(CF>!FU%7&.J3S/Y<$#LT$:E%&9.+E2=U7J/S
M_AB^U<4#LPN1(,CE_X,TTT\I//1=3V9EKO7)RWDD6I&7U-5=9^Q]]>6]/$4D
MS\'%\(R;^-U]@*SX>671_$V +VH)6&^+MH86'I-:2W>O]."KM6;;T]1D !$?
M*W0_(DKDS.@<GCE=97CQC HJ]_$WZ>(.I3&CT1F*(0Y$PJ5+Q#^.]ZG,QE,0
MQ;;"C8$(5^X&U(O2#^OYKG08_FU1=6DC+P>N%T^MQOMCZ/$,G3[29!R9@EEM
MI)]M6T8Q =MM#<1,?"FUOZE!^B."8+ZRGAJ)UO4E;>AX7R7>=6.]:)3%G)S,
M)\@S1Z5DV<FQ8B&S#).)7,^SG866 GXG EU.31PX7A9:-'(S;Y CJ</WXYR*
M&<USY!5T?\,[61M$(WX=S[ /7'._-JR[84&A=Q0:&_(QK,4(C?7]?6&2L\@Y
M6J>:_:0B!<THCA(L+RV3:#E.C/7!-XH:.E:,*0(OHMY6E*JH4CV-G?L4*7WY
ME+KXO%PJGEX@52.@::-P@/IZ%NJT@'B("#)JS*BGYA6)[L$)'<];AOYH]$'@
M:;H)+>"?G-=/Z%HRY@Q8LL  /(-L*Z\#"S+=WH^<$S<3T5H6<QLCL9LV%EM!
M.=EWJP78',L=3OF:.TSH%@M L.]UKE%>?^)I'R\1<NEKPUJ6ZP8[*HY$&_%B
M5TRC,W,=12&.A)//K(4?M[-(\(<<\%@;5'U)^-RM(3F(:QJ<@?U&)E%\0^YI
MDS9@;I34)28+]=^>G4'9*)W#@?)KL>JKMN(9S[N:X_O*S*B1R6@+>?&UWTP6
M%-0?E#3HJV&G;HN,;X+?%B?-&[OB:2+-0G_F-?NO?1X)"_,ZJVQA-<I-QSN8
M+,!H)>YZZ^7Y:=.7$6\PBH5/YX*LNS_='8ZHJXM]1V0?') YXZI.KPP#Q/_.
MQF1E.=)\M;8@CG\IDS GP3MK'[]G[_)!LV$DJY/P \]DG_;IAO;[%\#O38S^
MC@3#BE7FUZOFT[ISA,1U>0/C[](A;F[J!QF]1?6I,()Z/VQR[@WGQ["@B/&W
M$(QZ.LKLL*HTB,OTC5B#5\>R$)S/WI/6IGCQ@]/)0@[ET_/F#O9TG01H]7HQ
MMHM[RE<;>*SJLC-:GL)0-Z.MWD'P-((X!S[D6658M1RXO-7;Q8%2QE/[K>7Z
MX;ED$8=?Q>&4\I3PT(,(. <&!1($=RS:$M/R1X'^[[DC#Q8I:GWZDPV&_4C[
M!QY57/5]UF"LH!87+6SA_V0^%,]?QU[4S3QFO5VZRU)IGX-1MDC0/1&C]^Z9
MDD#F0=D9\OKTR\SL%.XAPNM*]^RF)@[!0CF(X96]+[G.$;[D5*H,HAF=3?-N
M,R+ZX.9L<X29*+44Y5+?]:MMW'JEWOB^JPXD6CW):M7B2R]:->]8#4PBV+N*
MV;=SLE^>='7I 8/+@]J:D],-1$AH4'Y>GF0D@CDG[DS^7]Q63/8?_:O-#57>
MJMOWR\.'M,+MOID&S%NS(VT;IS+7@"JQ/+%#G=8NANF.;-#:6E'V+2=.)<E%
M"QD2C5MJIX4392T$F_@K"6:SNS%I3PXG,G7V1_BMKQ>P%WZ$+"*X6=\E"L]]
M./.30&;X%:<PEU[T<\7VRB!TM-J1L-W9OE-(K8,]'Q3$&,UIZAOP'V0G^G?M
M]\Q,*X@W"^ZQ7(-!)+4"KM/FS%P ZDG^IE\N'%?Y&IM<:1RYO=2Q\\K&GO.D
M?Y^L+&]>.@Z\O%YB&JP@^CUWS;)C"U<$OT!H.R1<I@V!0> V>X/>_""0\-0E
MN @C!^%P+"BXF-0G!A' P'973=7%93,FT@,03"L6,<GL2FX8]OD2\FU3BEQ%
M'.VWZ^TZD^ !J.7&B9%RRQY@6(QA(L9#N07(U@N$_3 <^VU'6Q!>-)U)#9NC
M\,O"IH.[?(A?^IY$XD*T$$R)RP.>8^FS @DGR!C>8RG>*A0.QLAP+5]Y/K<4
M:,17P[X<)#^C6OL3$'5""9]N>0@/<%0S&+$="())HD4AO15'9PS4=411YGH#
MX(%!:)Z%6%Z"!T2_2UBTA88$:*4,((UYW1Y 1*Y8E"J#C&'@L,"J,  4+DPG
M5&X\ $'-H*U$Z.=PPO"1L:A*,3Q-Q*N#V*? PL[[0\(8WN4C =9[@XEON"XS
M^?[2#"X]A:(3I7H]W!T^:;%;>%#HNXMC+?MLIB@57R7?LKS(<.P&TX4/ZF(,
MIU7,:%U?S2YSA5!.<641)=SA5A@Q/+U&7T2UA^+Y"$@)][%(#CF(W>A1C4FS
MER)\?L6.V:%RZPAMH/4S=[?YPO!3"K:QBF8C5P6S&'22DV@C>?]WF7N-^V6.
MHJ:MXV\GXL"#!O.N\_Z_OHK%^N>M=JM:&?OKO6D= ,^B'<+9_0N1"?U3V-<(
M>C178=;JKTWK"M+@>0KI['F#.7T &74"'A97Y[&S&WQ-3O/EU$@ZV5PF\P@+
MJIJA LF7!,=2*TIBJO.O=%N1J)_(MN?9?/6TKB#'IZAA@9\#UNFY9:159=JO
MP%%J\X;[$H;>7J?:X4?SD_4YVWPD6GM:K['R5B%M=[<2]\%#/$N0DD NA4\B
M3IHPZ?F^P1P),.(O:E_1%?6]3HAF10#E@A<_XAU"'JE%>(W_6EK2SKWH^*[A
MRGW-QT5\_$<_J"70-_+$^+4ZCI??5VB0PDT,#,MG3!G.T#_\A5W]=HCI5KL0
M(^N(L]HX]3/+K%+&FCQ7=5T8M'T-3^]S4CQ--3-I._#3D1X'*^C&$$/$*]0X
M!P<>RG"._/C -D813-2\$4?GSIA\ZRJ=?][)S1YX@\CX5(G_=J@\@;&WA\&8
M\8&0A:A+X&7KI._T@H7EJ6JV^T PZN4^N/1C'\RUEN?4B6M.Q/1J+KYAV3U&
MA%204V#O<3(>D%;<Y\#>+L&P?L01Y(%ZU@-'\,R@B'^;FH.0#Z-9N0 $?7.P
M5O&9PIBOR_,.*X\T^)&;9STDP]LW4A*E4IU8IHMUVSNN\NK37&9N4YJ45SLQ
M^3""\Y*QCR2N>^'DF.#G&3JC6W$?X+=U.9:E,WTAH[_N0R^*J[^;+:>(HZ_/
MV6KS=6F8VYFW0'59),:3$6LB:W;8G:]-]Z.]\F<$DW^)Z&R]_5%1'E1-Q2E_
M9,K7\MTM\,SEW%B<7D,E]..E[;6PY'WP&G%,L;Q4)+6A$E3=W-W20NWLK$%<
M]%(7]5Q,D46GF#$WUPH^MF^O0:Z]-T4R/ERT;BF97.G]Z;ZW"^Q^'"?'M1/J
MM0[^XW.-6"'1)+SZY8XK=[,VF]H@I.FJ'<^S5S YYX<XQF7%,T\M-H6;W3$L
M]QP[]LR^U,!=6.<33!JXQ&TT"OFJ).CQJ,:Q)*!>LP=M=S3UOT??E.AEM[%1
M8ZE[+ST O\Q</T?]F??\87+NJ:>$F8F&$$W6'3L=YJ<1WWBE]H1KI1AO6MM_
M&G@QY!0U8/#!L/ !:]$DY%8W]%*:$MP%DHC@S?>^)3M1-LBM_4DVIA*-X1HH
MZ8LOLLW_(V+_JA4JY@DU0 *L=?M$XF4)T\1\OB8$.Y+?^/PQO4LWKUK7:YM6
MODP<SL*\P1SCL3FOE'FF>;NS:1]H)E^,VAJ^2AM'I_3+/C+QT^=O3U]&N[,?
M;EI"\+"S=PNE'''N3!Y@CE0+=Q1_BZY\'WI4H!UJ&<VVJVD /N6\Z$<^O+9R
M(DAYKEKSB^4CY/M"88N:KU:K6V:TP^)\5<A]T/-><^-#$2M9^T#>G"4(8'A^
MRS\9_9R'O"[WG\S78+K.;Y#OYS]ZZ\*R7&4Z1:&G[&>-W;J.BW^=56<WB7"P
M#AF*4UQ>^ABE^:!J'SP"7GU'V0VE 23!%#6;1Y;BX[X@V+9A6SZ+RUN2^_##
M):3-^+V)*'5VEBT1,WD];C;/6;/<H#/K0DTJ>_0I@S#E:]U%U\\/=-""LR'M
MTQE/4M=/^7O.'Y+WE-PM?G.6%E@=N5DO_E[:S_)^JYCS16/ D%I$U3?YET:/
M%\5YY0)4C96$S<3Y(3B['W$'M&6SJRG:ZWS47"E^9FYW!2-0;'BUX]U.YTXA
MU8Q6$\_\>AJ\B^]<_!QJRO]IY+3:%@72RM,]Z>*4 U]T:.44*T\O $<B&1F\
MX&4&>3F6B LM",%3"UD.S"3$F5'_6^<JL0-+RQI8KF.H@84C)XO4/1^O7KZF
M;JIE2?J_VQPIS:J\M(,7'40]P[&@CEJ"06)B<1G&VM>A'_.97R^,; 5J)!7^
M@D'$8$X8"FY@FC?P:#D)A*\3N PL$9!Y*\L]#?M%VUB#7+Z=FR_)&*D^]BY)
M&'B3E(Y-2(0!TAX1/Y/B(==7@.$SOM+J62.0I( F 0(YRSP+A4[' J1HH5N-
MW2:?;(0XB!\U#Y%N++9T(*:?MH[(T/FN5IJ@KW[7+JH_KB^"0IIA"DMBT!ST
MX-0C9\=B)0( C1Q_N9S86=*W&!H+8 1A[/F"L"=X.O;"X3.H<.(=,UHCP\,^
M#SZR/%^T<1J<.DNS&G5I102ZLV?%WH58I49PD3Y_,GWT M/&)^$;GKGN5O/X
MWO =W 3C=?]7MTCNL9WY('# AA'=0ED XGI_+8 7N*]V&BXR8FL6+)MF=*7L
M>JBJ\[=FQ[.L!;>L/E^MW =9J1$KX_A#<P6Y>5A.S@L'\_\@QMI2""?J-]/^
M(#,ME9%$/5>\$N&!M1MYB]A;=-D[6])1>D%@VC%]-J>H9Q$+2#G/IU9IKMQ+
M\7DOO6,<NUILX67[PME3;W5W</'7#$;E[-DB(0Q4*'/0P!O9QX:9.3?/T;/8
M5]-VW<V[3U5Y_K$R7L>#^FR8V\QE&WX!RQ'_SQGN,A7/W82>3R6.$>R*7>^I
M%U(1S1*'GS[E'531?EEI= QS(@;.12S">G 0EO'0N_F%&^:O,+S:%.126W2H
M"W#^:M%#6PGM3&2]PAP)*M(U>"A76TC!5U+(<QUX.!>XP2L6B:/<-X&!$[>B
MX93O"N6IBZ45CB(@BT:F#5[M\OL N[7\9(+I[)O#QLHY5=6A<74^=A@]SN88
ME*3@Q%ZIPG-/IMVR]*H7[XHD"@-%#[4NM=SGZ+[.4QN$9T$M&?D0H>TT_BSH
M<P=UN08YE'*#@ :NM286'EJ^Q^I(,WI>X$:'P\DZ?_]#"_J<4( .$:CKW#NN
M>/_U;*<A15Y81*P&0I9%\D^I+\9_@V*OW;3-&1F[I'T-'N_ D81X2J=0-"OT
MHRLH/MT-(Y)3]VD"&KM^B<'K&#GXV$]_7<GJY.BYM[,!S&>:8R02]L'=G@G-
M7]_[]L'*0-:.([B1ME[PXR(\7#;T_C[H?)RR#\+S]L'$O.:7@-#[$?]Z8HYZ
M9 _%;!QZ;>=T!"MEC_S;A<7";\??&E]JT>"_<7CQANB$?7 2!VNS"SO/A]4N
M@#:C,>_B+NE4\UR5NO!M!7LZL%/5"WK[Y-E2.1_[9)I91FB$ 5@_A3OCU1Q!
M^<&'>S?77F^OB^R#XY1^'\YZ&_%C.G\??"[2W'P%-DY[=)2S5VP.EN2]_>P9
M;*G]\BZFSCC+(6'DAE/M9\:;YWMW3%8_":KG;[-L_DS9O,^I:I\;?B^R!00]
M$4ZBUC>LA8&; VPZ"V<#$+0<+; \$I5; E84@NZ[A9A(D0,YCQ/5S''@8E*&
MIZ);BL8 <,;Z^'I^S%,C4=_J@F:*828R:N7 ':=D9/0,+E0.O("?D#<V+W!B
M1I3(O%Q.FS<?WAT&\="4[Y.QR+1*Z1I88XL)$S!LD4ZI)KA%DZ@DW+%^\^8O
M"[,O"68206Z9&+UX@ $!%QS0 A@:L4'GM2Q;U%BQP*OLB_%9V\A^<N8 QL4)
MPRLA8?\[14#I$8-TKBYRP^^\OY#'?]($..S&FCO2\ 6:T>+^"]]UAHZ:F)!J
M7_KOFVW3R$$+&P9]$1C$^%2OLB N!56<;GGRE=:;.&-;F1Y^S=I&//1?$GL=
MNW7GLR+RGV-=DTN;6SV5%\2?YLJ;3$E7_T+WWZG04381A:QX$)(7S?;VZ#J:
MD,]21$?UH'WY[ZK7\?0VKN&ZR"=V7%'VET=NZ_:57'O\$2.1O(YGV#MU:3-/
MOF(?F+!1$&!5>4K)_#Y@:W\1JFC//[MW\L?ODZFBU(L)LD865N-])<%R3VOO
MU0,Q3GB_QOQ//!S.=;T)!IF*8+]YHF0!^1;=FN8I.<+G;C>M-U*;2Z?.5D9_
MY<V6-'^0Q#?"&QPYN7@$-7PW;=B^XRHII^M[^]MJS9!"ZBN+,;F<Y7;=S3T&
MH4TP0!UO-A(7_Y@'9<2N7-SW,DWJL2CDYX.[I]"9J$%IND&J=(_?!6--UG[K
M2VZ^G'C]"Q[T>HNRB^X#'?DPSB^FO]@"3;>A%-"20VX(6+VT$\/U>3>B9Q_D
M<C4\_)9-V594*</Y[";?EJ0'M:/G0(O<5Q)5_Z7EOIGXV$X$YXNQMH+YC:%^
M":)-;UWW$:H6*Y=)]<TR6]/-EW@4,KDT6@&=T!D@<_;N1+3H*01G\]I,U8[6
M/A"(>;T/+LK^'K&L.K$#9/V @JR_1<RUX%F*1%N$/;I Z&P+"_7"2^0:;BS%
M2W)$MC43K1.BHO*%[@ACG,[8D[FWXTYYF^9?PBX9DF<&U@\K5D89NCTX=NVQ
MSLFF[7H$-XM#$$<7>EX=]2*B;9P"G1[&KC.M%99&#++D&_KM93<DLQ.VLM?P
MAU)*52.-+61-1D0A-WKUJRU\8&!!3)'!>(#R41OE,2)*53EY68J<;V)E[37^
M_OBU4KL[$]*UI<!(Q8)+D>$P PB"I=WEODM!C;\_;LZOBCBDV:TF?]6Y8%R:
M%#7&D05..$#Y66QH9HLXUH#73=7-$);[2VDV@TCKYQ<4M!E<C=ZR)MCS!13O
MU,VJ10=T;O:1O4RY%J6[TWC*II(8([_77K-L*WZF^0@]^T;2C?LS/8\<4\7\
M=YGJ#M7DCQGV!="343+ARS=(U$%\=\.Y:Q_AB;?M.7T-.N%/-Y64VOW]92-O
M1;:97Q0KGG^IHE$20' L^[@T)3IRA%F%-8Z9O@E:+="0F>"!3YYYK!TC2JJH
M31>_U2&4>;OAVJK/2[[[=>8WBL\=;H&]SV9ME[QKAD\/40V(^;B )D%?[(@/
M%@RJ27!U:]Q04,BN_I6,D&BDYF"$?LE<'[/-V.&K2/CTQLU6W&;ARS2"A9]1
M1./7N4VG^J/_&=".,=%6"AOATE>QV >T0,>1VBGN0*%+C:H9-1HY7VL;CX"<
M2'=>+3)PL1!KOEPF:T&B83HBSX90%Y_IU:_"R Y_'L[QBD#UBRT9NW#@&<L%
MAW%7!"II+O=QZ.8#M^LB?8D=&LD%5WB3KO,.0%*FL@Q\[Y!3XI=TXZ HT'V$
M;3B=7R,9+\";M")J1LL>.9QG'X&J><;@>PD%BOF!5=&1%@-;K/\M+/#0FC<Y
M;)*#8;ME9%*05]C&A#C*)?;'H1IRJ+$@2.[GO!$4!E@1-'VS6&NX&>WUTN;T
M<L8(\>)SK2/3=C8/%L0NRL?[-J^NX1F>.[H_T%1YP2TH;V+O%GLRW'576T8Y
M4[;IW187>!VO"VO/UT?#%;.+%$A4ERW.$+P+GLF!R[V1AET4Y@Y2Y:8Y\NC2
MF3W^Y@2A8AD28*#C62L*"<$J1AJYOI'NDF&M09-H/K6HT!SMB&E.-/K^W<\6
M'_LN6BJ@ W_H/]3\%=3F>5S4M3(?>-X(B^^"OT.*L0[ 7>U8+;NXOW\V_[BL
M@14M/O+/K5(R^LY1LD)EA9$ETHU\CY@^^?)IV\;L=7O2^#DV+J/%VP]I1J%:
M3IZ43*6%F1O]0TU20ZXN;IU?PV$2].\E9SSROB1-O&)H'[HZ;-<W<<90A!&Z
M$1;!LHA@LL]3I^R]GK'D%TZ@O:3ZN_C[9]=#^=.Y0.W/U!_DE"7IK4&%\]_/
M^<S@H]T0AR8P<N&D)XL&/L[SN/*3+Y>;+ +,WV(/,7]0PA_.\HR%<Q4FB&:D
M5:&$'/N]>]@]E^@^)Y%H/GO&<G9)#>>N%Q_BL!5=&GXL1&?$U@(<MPW0)!]G
M'F/;QT/3[Q+- ,.7-#J,G 8IDQB6KX[*KSM[7D0>%B_G$Y >C#\\,Z&)/*?F
M7F]^GR[I=FB.'5)A!0M>N6N-W?*/K#<#\=V>""K,J8[@KC<W<X?JM>&F)W[I
M3J"MM.O%!XGC3 3*-6TJ79)KO;&Q?IR.]K]&+<%XD\S09M1^...<=#$/2"KL
MLN7]7!AHQ/?!. F3, 80_59=7 '#.XA*I,*(5CY;*QP>0-O$#'N:HD"G0L-
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M6&#VE7>_+PUZ3XY]+;G[!$(= :=.D%'_KHJY:?7M+;HM:FI@_*[&Y\L-;M^
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M^OZD\9>WT/_YOF0!->W^/G=).@L-ZIBU5>*8_XKA+DC.%X&-)"(.O1Q+H;&
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M>+(#]9R>NM=,SZ:VVC]\<7T?W!GV7L[X\NE#^==E21>O%^\2W[;K?:C#Z!J
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M[GN!9\E.H"Y8P;WSYX"+&=43FE>J9Y>D?ML.))+'MN2#-(,ID&1$Q]U8A2L
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M[\!BTU?Y#D0VD,<3C%)4G4B.=BC$HG(T]8@!*DPW(FD '+*?;,WZ?)C;(?N
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MJN0CU7=-QK0D.A_1$I/P6[A@61(_,<!4ME=&$Z!UQH<!O,-S3>F]<_>1%Z-
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MX(%="9>1OLO:!'!*4T(_IT"!YV%]LT%J^,_C4S7E%N-3$(#KC)+PW:\EP44
MO+^ 3;#/#$Y;ACM5L.?W)7 [[*"!T$II:DN F,V)+<T2#W=$F89MVAB,<$9F
M1F94N0AH9G)#61#)J%=IEB  XX;@AK@@*C40$K^UDQ-[XE@GP/I43B[%,L42
MB4^1!H$BB1ZR@IP58VVY#  R 3FATT?@OKS93-^X=\@K$K-15/8<^VG-'FK
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M$(4VL?-D;-V[$W8E@%O50#N(2Z03(')RF+"64H^WZ[(::P*$>X?@3FQ"Q#U
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MFH(**\C;FM>JYAEH#T8Z@3">C60,806])GIH.1OFNP8CW9 /L<2+M$(2(-5
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MOSW'KWNT<AB6>I' 8*($OX1/5J$B(_2$IH=P&QQ[":#:2]I)_)&"-BHV/3O
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ML1:%H.U!ME-^F[;('[,Q [YIFB+<FK7PNW?T766 LWX%IBY?":W, .K21ME
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MV_G'#,](0@_V9EXND_<*888JB8F?^Z:X7C_T#@+AG@.;>G!-$[W P# 8;WA
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MY931E+&\:6E%L!,()]6N ?PL.*Z2) CZ9_]7810*2,YW/ED?BA74#OM:G1M
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MC\1UOB/[8]!H+N).\QKTX/XMEC<[/!UQL%A&WP$U; =/AF2:"RI5/0P31F(
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MUXI6$%)*;;! '9,A,.?!S>;:=\="&G^E:GY!_U8SX>T:Q2O5::S9W)L,35C
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M+/D&/<.H28.?&'*8%ZL47^9);AS2M?;PCZ5YFV/YW0CQ,'EG7L,RD9\B*U"
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M>;)180I$,QZSP24<Y^NOPH1A)_-_(H]G^DT#7K3);AX'N\>Y),6]!U^_76V
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M_PB=5NQ]<NUV7CQ^SPTJ*U.<CFADB5G:?V44WL1APU/#+ICW-<SSAUNOS#2
M[Y.0G4RB>,6]/($"EA;5SOJ."G-J)B2Y(VV#&,C?WG>R4Q*%;/"CNY(VQG@C
M"F X.+C".M?#.0A"/NF ;9U CBD+%HQ&'OO"<7',MFCD8NI-[Y^(VTKAV#.J
M;-<_Q,:*9CP3Q%B&@NJ7'?\9:+5MJOP.;M)G\_6P%>R1D!&_%U+_G=DKW4^>
M^L,VMV=/U""<O9 3,7&3T?O@\@C&4JAV9'J<]]VV^<+LPRC.2!ZRGY&E_;)=
MI1+M$3#XP24NYY.NO*R@N[)7L[4^E=>4S1YZ031O!_/J>LT I<LQ[_%>J0.I
M'Z57&V@'MT^*R4N<YFOLBX&4UO5N0X-D% #=[(+4[\QMC766?+?5[N<-N;!>
M'OWE]#)SY9W9'N?\$GM68:87NDE(GN\7?"Q491\NZ7C[%=8MQT,K##AH^WD0
MUW)@^98@QIQB.LKC6+14I8Y:[4RT4  &U_C55O@!)/0$1O$AK99/SO9V5R/
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M55ZO3SY*6MAZP7.<"RUN93X/J9XX',>"\$GYE=2<M2L#)6)Z?3!R- J#U:(
MAP?7@%[MQ^5VY;52-5P$S&"8X5)CR&LK%A X'^25IJ+CQNA7QP;C!_J QU%
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M>)81=NBZR2<G;K&,WBZ-Q L'5ZK($%/&M6TI41HNW*@'<1[5FP6W?FLNB95
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MLF,;OZBGQ-BC,+)#YY_,H/_KV:8$U=12@0&E-RV,?YI)!&<F[;/:KPUFBJ
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M.KP5NX[T;V*:_#UIWYO5/WJW9%.Z27KM$<.ASPSQ+CJD!3@$QS]65TRZK1V
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MP^CQ>:<=YJE@VC6YV<%QE 1WL+]OD?YT_&3FC'[8W9X@S_&3!E%**0^#M:K
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M08OBP$'\W@&WA_EF[+63]"O4#=L91JM<@!]S"^$6#NR$F+F T-".PVCA^H4
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M+[)[S"QD</P'E0D#YUG2(KBL#NLDQ:@^]8'#L@T:5 /4S3,A"CD;CJCZAOT
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MM4]4H)KL%0ZG"2D!7U'5V/5:*JC:Z"C :<_'A%#R8R3S>8\,VO2T3<=!"$W
MYHA!RH\:R]:<+V<74\]!(>;3$)6)NIX5_0#'+ADEM4J/WTJ R:EISH9BZ;IF
MR*#F(W,;/ 3'J6DNG9'PEV95Z/9+$ ?1GH^J3'2I5U;"&OB?&L7B(8&H#:MM
M_G?+C\L"'.DVD?9&_>)(X.6&84@I6?J[N#EH._WC?CX\6,UB7 WR Y?.)E*V
MYB*@G>X#"K1K.Z99TTBADY W.7L)#\%%=S\0[?K!T2=&K0<O^9U==C;9XAK2
M\2<>*/$WD8$0U<I"#)A*XM[\F\-TQJI*^#)_G<((&1"W845E?VK:(<MN@S9\
M)]8%]K]E#,9HX--ANHL.(\E7A5*X,&23&"][;RG4#XSEQW)$Q_.?FX'2H.2P
MU-U!"4W[,$='03>9PAW()C@UE>,[-2TB@%,W\ >_!3M,$U*J'_(^<"0/"A;U
M/%QJ$DYY:@H.MXW8K>26B#@^L)B7&]9@YX(X]X$KBE^@(,[*<@(3&&::G9!9
M"JH\O"@B</"P<DU=5\2*2LYA7FP?"F&;Z.!H9 DRG-8]7\[E*P&[\?Q!N,9A
M-K\QN[;Z2*;I?C9)R]A%2X+?+O.7%A.AB;0 9=<.<F\A?6YV*B7)+T)#" X)
MZTBO3D<W07@/7@X?_2P5'^3=UE#5P;TG[VB6M1R/U8G5^T9'KG\.G\(!ZH#&
M_[UW26A^Z:C=JCW>E8[;^V)<5 Y/@O,1USM $N9=,>XP?,Y6G:5I5 DG"S2
M'%=JB[9?6!A!LN?_M]-HL3ILJ)7L(_57$*GDB.H"@48:K;,GHSE#Q3_W=<H
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M@^9J5[YRX!$2?E"0Z\;\$GL]E_7<3 =YP/O^?6USK.'S;YK+X>XD+*_V]LB
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MS&Q%)6WKLPJ7#>3?L?LO?Q$U'$!J&17VKT<XF^2*67G!G(OS [.TVL9P)"B
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MG(I_*(0\$M9R$]Y4,>@:_A[[A%7I8? ?KE(2ULAV'J/^ZYS"T5,G;Y71:4O
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MYSF]D[5NIRJPH/U\?[9VMNW7S;L7W"MN_2WU29:([\;,!D7(S%@C6TS])?N
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M&SA5+B?"P1Z_.U0RY"?Y^33L,,/FC!X')'1NG3>Q@0A&Y3Z,6=K>\G#GPK3
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M?$%3XY!I7?.:5GR7(2'KSHYG-W55! 3D"@9AMG6R?D]'W\B\DOW'9E:,@OZ
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MBDJO9]D-Y))D)&V.8!4/&]O86E,%HT_VH[217U4]W86!V_YZ8VOH,?%BQ G
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MHE0!DHT-9&!=/ A)3K#6PD1O.0S"/\"<7F/>4LPE/18,$K,LGD2K(3.G (#
M$2L)8 C+I\Y/DOZY)VO?@FH(0,2P4Q(>XOB083U="R7!><\6@8+X9 %GI3D&
M<_B>S2GM'#0Q"6KP=/:95"1M^0-B+47G0OAGA[/_[IL>M>$FG69@!8ZUB5@X
M,M<+40K\C0)5)^ 2Y.7H;_\BO/B_^\%D<N2(PTN?V3W'G^+/&K8@ Y\4U#VD
MH"\>;@PFJ2+W$;'/AQFKS+S+)6G -2)5EL4?_%&^EQ/Q\IS663*XI2Y![):$
M*^8JH1LA'BTCVD<?K]'6]]': G[#"2#F(Q(>S^0C86E\FZ+MDW"\Y_GD#S D
M,&B0>2#G#6(6"<L\D$?'J-;LU0(;+QWD)\9X1C'BO@F?U<0@ZJYE1EUO#NRW
M<AW [B# T2VZD[E2FUW/-C-YX1C)3[QW!&NL[@J?QJ%\,1+7+RD_P3>:4P5[
MC4NI#S[H')LNV*<CLM_7\XRY+E6@]&U [D93 R+3>Q%TW/2Z+B9#4OFQ6\+L
MU:#J]ON&AI,\'^=*@'F-@8GBK7/H9YZ='51GH^D\'I=<C02SEP*VMB$W[D_G
M:==G56)@+0> )V;U.4G!4K?02=W6\@55D-H[B? V?F>RQRM]$<AM_^BR""2!
MN=R!<6)7HJQ,Y->WNNUF']O"),&!G=N9&C37%]GKZMOS#5]7SP^"&P?U4ABI
MAYT*ISP6)A4\PD9PO'.<Z5PT.9 _9TXSJYNF?5M/"UA'D_4:*VHF)0]Z=<YQ
MJDYPLPTK]C!-HVG7K#28Z7&5YJ5O!3JHJ_@:%8(3#H5X*MPWFLZO\K@PRH'M
M-B][$90;4?9*GV/:?C^#D[EWLAVS+L6DUNFPAE'E_@N7%R95XK_$<&!N+VF3
M]-?AS04A&9=-Z>,*<QS8CH!Z)]\$L^!;HSM1;AR35>;EZIAU.FJR*0RUO 75
MR*]?C<CAIZ#16K4;:G-Q0:RHXX['IV52OS+C*C%K4;;OOA'GWI?G&;Z%1IVF
M/0QUMZA/A6EZS.Y%8-YO8C8=W>GJU\/6.X&,0V 0^7TMQU[AQ)&?]E'ME\=P
M?%')F*%]C@Z]E(O.NWI+=)U+]5A\I$$!_GN3N2)WW::-V'=";BR"RAH/SZ*D
MU;U?-K/@M_\? JC78[UT)W)9RV[P%\$;[%^,BD+D?=S/2R?R[NP\JF5@'+"0
MQ^+57@2G>^AF_J>O9M[(WSAW<2%9\M-;MX4DV)D/D8(UEBWWU7.O:2EL<VQF
MSN=C!I&P[_%*NVY-?=2P=USS2GE'U;;@IM^-FLC ,EHJ-@1EMV#@.&!5WKW3
M@-BOX6F8!$JK!HUD+D# [\8)37Z#@?&QM3A>[=L[3&P>*'44M(9'F.R+B8S$
MB(D6#_L\S<34:-TUT3A,?$(5\/!P35H0I+W4DN^^W$*")Y^*37IS_Z&8ZOZ-
M\ZJ5GPQM:[$@<_ODW@'\=FRLTMS-"49D#3 D>Q/J@![9.Z2_OA+H1;+3LH(U
M,8*&DX;7Q='#3TD;.A+C-!'ETKD1^J^!7ZRJ09>C -/0M#JO])IF,VG-CIF7
M^3DA'^MM;;=>"HZVRY%Z5>\$TICJ9HFF5L#"9/EO'^(&.A(-QJ;S W-%^E+Y
M2:LGZ0A8'8K*DV'.]X_H;$J0G/-.4E_BULO?#18L!R+EH7 &3^* J%Y:+!)2
ML<VI>+8$!@R9;!RRIO)'D@,V(3P0X!R-/V/$G #JY(B:9%<D3\G3U\]ZART\
M3<U]'@MHZ3,D*!';UH;M,0%Z)]3G2@8]MT0<$Y ;=#Z^>9UW>7X]' W#BESY
M8.14H;'??<,=J:F"0WFPW>S$\$3C%ZH5WS#"%>G?,:+U6=L5SM[N 3#V#9$]
M6OFB0.NA_1J=ZZT"[?G*(5<GN].\+XK6-9.VF @#!@2_BO\+VX< 11SB*0&F
M37$U4;;:UGT>Q[/V)<,G-[$>ZT(&AYZF*J;52,D7@^R4M+A@#8QX;HD*^F(6
M%@3VVNE17+*PF" J7XTP4;-.E?Q/V!!_#,?3N+OQ'JJR'W:^,5\W!Q)FF+Y8
MY$LJ'TTYFHV#-6=8))@2@/*UZ+Y4-+"E[,%\0:=QIA'@6VZX54?9D'$ G F,
M=',G<X40TPPAQ#FJ0'?\F$7?=J;RY"25CV&GPV!NO_X8@AO$XK3WS:2AV&(0
M)FF8T_'H(9<M407P.E@;C1"BR-788IBUPLQ,&/-PO=8>1=ZO(8-]D^_\,.+9
M-Z#*EJH81#T^.LOU20CTXBEN"19#EI6^S20%$YVWAYWTN7796GU?WYP8/,OB
M75^YCE:Z"/"J&TIYMXE:P)$7>0@\-8A.C1 "E(4D]X\R>!GNX_6?0Z=B2<7U
MT/F%/ZN*6S+Q9SE%OZ9.,GSL(+%O2H0Z$:=A0(!]1%/[*(+#E@F85>;$,ZB=
M2)YD=M_^ E]?J3P/\%(UH L#56)!<?J7$=3_W4^F'76U.9-[(&T9-M4T\T3"
M:$=)1 X;">/8&?\*NF'>ON2,,LI0EE/=EVWMPLD0!4HA8S9Y]9V26Y:G!AO%
MP<&-)QEVYE09$+!7RPI7AUEC-LWUTM*&& 1[K09L:$IH<"(E+1H?^:<M@D?"
MBC\SV X"C^U(2&O$@K,HPB^7G;8F<GD\&M/Y?=?U&JM_A1O^9;GVIZ;C(7I)
M1< L(?6+:4DQE<7Q%&(#M+@6DPUT+50=FY($QC7WZ<N$;)*F"LXU=-!J9'&\
M]L4_F=).X+ALXWCQ13*(.CSI97%R6M,ZZ81VWG"ZF+@4=95*PK[V#P$W6_6%
M#[Q7< )G"@N=3N?0><<P,-V\5]M.Z^$LW,/9F?PM %17TP<LK=S#,8('A#$0
M8%+,=T_$B^E2>?LUL'HXSM/VR\HD_E.G]9H=[CYR6',^<5[MH*."T]OE.+-(
MGMW_>:R[L K/.NA X-%D_V-QR3YLG$W+6P2?Z1 G^V4EP!T*NZ5EL#=@@<;B
MW1'R5-R)_/WWZA'\DVDQU0U%XR(LWBFR3)NW='YH_>HOA%LXUZV^P\JT!=:^
M *J0-V*KNZR=6WTRSB;PWL8GV:L2ID6!Y>D@W&X.XZKO1)["=*K@[OTW3)5J
MZ<M!PK-VS#?:G[T\;11CN7TVERJH3@(<NHY(; DOB$Y@W[[YDLIK'8AF2J%W
M?D]H3G;6E\\F*1E'EN1_AM&/MUN)&#^A\HOD?)K(;8]KNZ;J('UKVNOWHA:2
M\M5YW*S=TUZ[HQ!L,DQ6A*BYA:C=6"-5 W2(.5Z[T3)+1HW[0Q88H7NDXO)L
MTH;2Z^NWX^6+&Q9*2?Q6SZ3S1AMB@R0-$##!X][9*4H9;781/,3!\& <X).B
MUTA1>6N4^78CRJC\1U.73"0:)GJ):)"TO,;S%^V^'>FT@;YJB6#A3LG!>"W5
MB64/LKD/((++@YEA-<S%(0+'$(/97(TQB<K28T$(81,"3G8"7GKQ#11P<H<M
M):[^,#8Y2;<O9TZ/Q6L]K :HX1U9BI*_PUKH^U>Q['[GQ?$=4'GJ%DDYJ+Q-
M&[G+8-".9RTV;ZTN!-.23-9$#0WA(SNH\9J/=PNG;W]#!J:Z>$_!I(I+]<%W
M34U%54G\?$ %ZS*&)=)P? =AUPY5AA=@W&!6+0+8P &, -;IOQJ;>+V3JE$'
M[_J:A^3!;+#K$I63=B" ?'9&L9U0K]T#8:!-UF;W1;/@IPE?FM-1!-@-],7&
M&70S%7ZN1%8&IYO;HTQ:SY.)NG[3">*).[2MC-!_"I#+Z*?1YSF0#KWU#K^?
M[0NY*S]N/<\Z6^!L>*CV)E6H]+%>0]&\)R1U8.MJ)W-.A@73N$A&TWV6F^RT
MA\!CP!RR@%!Y*E,=F!35!IN*%*1S:-W9:4EH&$[Z^"D!2!W[_.4+K00/.S+D
MN#\< :,XV"JW3Z(B\%7!R453.8YBVC@^R0=)87*ZK6_F9TLO^EGSGB AKP95
M59E]I"_,'^YIB2:#G*F@L"H+[L$Q7)K>34+.9QX>:5BZOH>"M/K0^FVA\PHG
M4N<FSU7N_D=VW^G!18!8HX&1)FY(57M$2?O:"%NX]WM53]>\IN-Y%M_V^Z_#
M8N/N6\W/5G(_JK&=0W=V4IU?&\46<K_BD1[RV=;SG3V?Z3/25#+W@O:2*FP$
M/6(BA (E=)%UI[C7:;^NOQGD;<;QG[K[LJR-TQNQI\+ *FC:@;X4Q9;GP<?<
M!:AU:7.3@1)F\AR8V=?&L-"X^Y;08VM+9,_C^!3N0UTWK-L^/3B-6(/DB?LS
M_WG%I<X3J[B]J:IRG,E1)&FV=+@4UF/=DM:<:WJ@I)C^W L-2R]0.^;=EWGW
M3:93EL]SAF')\=1T,F \/M!)]%;]Y+!1MLDYY14(J'.)/L('='Z]/23/HQQO
MV<8I0X$Z+'?Q!M+DCA; 7^4C:]'_VH+Y[W[- _M<BZ>X!]AV3^3PL@*&AN2'
MI94B)%@WHHL!7H8;/4DI;OY(OF!>S]PPGL5K-D*.M]N0BJB(A"1Z=,,OD"[(
M@/0U_AP*38E"ML.LJ?U3,G$%IEZC#7^&L325ES\EC9TD\RL&=SR. +7A)C+X
M+P'&(?DXC)&(J\3;NX_8?<? T"3;: J$M:,BB$@NUI:#P&SN))4=CN%';:#K
M4=J1P#5IT-.?P36Y>]JET;60L FH%YMRY4LV#=AR0=@&0BO704QIA(8US0 )
MNW@AM\!BK?@-W0*5FXSM2BVD3>'/MHD[W? L9B5YC;%K_:E''K+X;G=?M_ +
MQVFQ/:09JY(@Q>@ G%"S'1LY;!%;G.4)<?)5(AA)*;Y83_'B GDK_4.FNG7@
M &)_6(D*4^D0=02S=O=9.8))ZZLAG/IK,3_K.?O (<PZ/0>'!]-NLUD#CJ'O
M%9@G!ANW9LN>52:M^]]<LD)=_]&_- )+*:+ULXEV]CI&@S' V-MBKZUK6 &B
MG[X?+VH6@#P&<+RK?#9?378Z]W'+PF=+.#;_F:^=3QH$^>R^7EL$9U._WHN,
MS[U]0UGZ"]W&:SLE?9(JR*0>W^5=HM]YACY@NR_L+ %6FC48)G/M\*25[<%%
MP/7M'=:T@RKH=9G7_B+B%#FB5=7*J2L/B @.F3_3CS1_5=QKE\J+XU&+?!%T
MDV3PXV8.[_% --GXTR0"<$YIB.Y[!'^EG*LJU70^MU5,' W;:J811\<*(%[Z
M?HZC6U  =A>7S.BUB&(<W->2S/5]8D D4/D5*DT-3S5T9&'X-B&*H[C1OB9J
M&*P_5V-D;1/,VXD:&+$VE!#B.L*+*G ,OP:U UD#=J.+WT6E_V4M.X9]Z>9#
M7/&2=4TKWY&NA"_$+AOB3MKE,S% %A]I58\X05*P(!.4(3TZAZFN#5&T7D,Z
MG@T1]A[5G9]M]II=#Q$%1G2][._B-VG0CRIDI8+U@!+ECTR@8=LK-PW9!EUF
ML7]<9K'@HYI85?4OK(8^A;V8-13KI/H=LS+ZS_H)/$X:N!'#J-2WAE$D6<[G
M 5LTE'LS=*&<S:TVAYN^Y;\[%=)K'!MO"MJ\JY]8N%MUOA&S+LG7LI9^(JT<
MT^4\GD?YYO>!##A'RX?,I35)0;>C,MU_[C=(6]-;](HJJOYXPJT1:@GQ M0:
M6%M#XH#54K6[H*O6.+H6S9;3'?-S0LMZ="SA21UP%7M<3(J>O&V[E7JZ"5EV
M7:R/I/7=O I;YUP>]K S^6!L5_U^G]<DY<.//3T+UZYSIQ3] BT-%@F0ZLV'
M. $)Q,US47FMLM:+P.D1:O[C[?XTKUH.BS^7,& NY@#!#;L\FC*)AXA<VG!!
M$:(-8?AV^I3C.7;SSS"K#RHDQ05?.[UG36[V/27B;-.5JB;98!R?8$]0Z*ET
MSF,7ZID7M.)N#<K=T &JL 6BXN>+Y&O[7;YI>>UNV"Y! 3D*:1O?61F]3IM[
MD77,PF&VZ5T2;._K5*/ AL]U\SV.]ZW4ZX#=>-_"&'T\=V&L("VO'8.XD']_
M.F8WMPCS"^4L@2<U66<Z9E,LSG"LX"--!6+]$AO.NZ5S%NS+YEY<6T)$KN]$
M 7Z<OC"6PRUUYTM+-"355'U&9'CQ7T9D'E$T,=(#B$=I?>A%L,UEOL<AZ>>+
MK X2*@@/,?R&SU900_*HPH;VG1WHI:2F021\V[%X=U_T3$\2M:56TJ"KR],R
M;%*1I/9CA2)V8=P2/'')VZ%FD@^/R%29<QN]S1!J3JI"8%.#)48Z]OC>:$KB
MFZ38W)3>!&0M\]#A,L,DF'%.JMHKAA3=H,XI<43=J 2<D QT.1/$%'SG+CUQ
MZT%5H-CDT75OW61 X=F;I\U<FEXN?)K=;WDG9\@A9RYBB;WS^DQ?TO?/->I
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M(F,=@3Y_;[/CWGV_;P823EBN,.<;K0&^P(83ZFEFB,TS/D@,PC98PD=NW+X
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M/U^D2A4^V)8S@YKEB9I6-/IND#O%!PC_3'L9/&[RK[8\P@=@9V[KW<?#VML
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M95; MEHOS@USMPWQ&L8-W0\HAF8_^FD=IZ92C-P&(X/\+!T%6TD"^ ]3G^(
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MME$0G!\!HQGD[."^86QI"'\YKLC=8%%2@\$B9EP:MQ(\&!U:,' \E36'96G
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MUETV8RF]N6B+U(_4HI^R#O!)]F(DD"#22NYCM/8OK06_NRQ])<'4H%SX+7
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M1A8DAU3;PPI:Y7B!(]-]ULZ.['O4/;.$8FT+WL!C+0=J&X1XX8YE!,.%#ZG
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MD.*E'YSE_I9=@..?G8\\;(+RUG81YVY+-.L6JJ*V(_1Y4/>K@P":C I^WN*
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MR_Z>A(J1D?$<\SFN\^>Y9/EY^67_ST;^ K Q %"J,!"5 $#-1@5BHR*W 7P
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M7]W:?64V6XT?* +#4VPV&W.O_QX(/>*(?Z$IC,X0N$8QKUF/K)T@W09X73>
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MR;XM*)SQ;]Q<N_J1JW]RT?;NEK$&$:0=KYM)"]>UD56L20 :&E2,U]<X$9G
MAB#;U\QK @E*!'KY=$T@ZN%+C/U-B!R#Z[XB<Q08/Z*L9X+^1H7DK:^OD+4&
M^TBB'A6U;%1@WG7Z"ESM;8\D[W%>25G<[!FY_>(=N>SO^EMS'Y"89)( &R_6
MN=X>5*\FGI%0DG*@B+]V-=ZN^+1[\'+WU<'>'8L*3OLP4:BA'Q,:;PTF&E]
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MU%.W:%-G2;9UAN5)I<E:71A+TGX'N&W[H>I!AU&U8U<6)4X(7[-<ZL^9%,$
M\5=^T20?OTL!HNX8OHYV/S[5;F.;'>M5_2/'@@_[+%QP7OC/_P=02P,$%
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M+J;P#\ASM"1,;'%:3]=J"C]BJA$PD\K^@91=#8X?927/K9!I.OO&U@ZG1LI
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M4FCJX>RPF>KR]2R.4Z[E9O/D%,T(1:5GYRY>>)3E)L<QI*LK;C;6OG.HPW?
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M-<B&:Z:AY#N*@D5]]BF)4W;R#&G(/HNA(VL.L]6B=M?RO;909%/_+3L ZQY
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MBM(UBK19ZMAKT+43/.;:<]K@=%-J#KARO_U.;U=T&S&S\8;PDP8A06KM<*+
M&G*\KTI76S6" 76G+:@'5RC#*8T%@HX/ D/4>_%F 'A(&8 @>=,W)/PNH=3F
M]CMK\C0/B"G8U+]@JVBC 6@UF83@?VO6:(C"N+!OL7]5]RSVJ\4M/SCR=ST]
M'AV\==: C<?: DW'9^C!O()6!P+@_O#C57++QV_Q5O[#+?W$SOKQ$VB)-+$I
M&Z1G^U"*A  Q-7ET;D&B!1.ES=D=X+U:I;N@Q?2N.V*RX'Y"X58J[-.['7K
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MCH:,\GE>)QOVN3>W1.!REPF?2ECHQU+502-*[G;2NN4B-ZN@>?_><:%P:QC
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MQXK.&*/UNN@+$EV1D2*ALD-P4UL[[I 6@H>1P^[I. PBS%Z&#F"T4]+XN$4
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M(=A^T:2E?;S>U7*6456>P%EI=DM4>ISAEGO'Y\N+P/,??6_KK.$'3H"FJ+=
MF&P(!+,A"^TP^,./5\G3.ES+5O[#+?T4Q+[@>>PF-F6#]/^NB1@) 6)J\L#Q
MVHD-,%%N:]T!WNMV]B7\+W82BJYO&!EK\B3<RAK;]KZ-'3"#J HOX&PS>W(8
M_?M<:MN7YE-;9J.?IJ>VY$1CVGRFI[94&.OI3DD+L7,:$M>)X*-2@:MRVP7F
MI[?$5(,VN.W;]%S-3M=.%,V723J))-H![H)ZAY&3#X%DN4Q$D5#9G4=36TLQ
M#E(Y4RGE6)UZAR&"<LLQAAKN6 82^B0ZN0JS\-.$;FE$ ]QI\=Z.XTXP6:@6
M[1!0[VWO2T,O%'=D?I*W"7GY;*'\VY%H!;"] ,CX!1^(;F2XD@GQZ0>S6/Q(
MJ?96/T2,1@]-BP323\OK7IX7493"9]^Y2][Z.-VR/XD2F%5Z#T4CU'D!K<3!
MOADW$(B:Z09M/]LSZR[>5WXY=UQRO*%;\6QJ[C$4>,3T]W,K>"!,Q<<,DJ.)
MIU+H4'V,84(IYZ@?GWD+;Q,[??#BXR2,T@"Z:\)VZ(@D?[AY8$N[R.\D[3P4
M.)59P>J1VK^AK5[(0M!I*+A)60"/T[9-D>+Q7QTR<;^AH*;"!02<[;*<G.)K
MXO' *F\>GCKK==.#K))%4S[ 4*#48@?"U/:#1S(>DM)=!T":]!\-H@5NP#.[
M9:?2-7E8,^N:FV;7)"+A(_D4,9%]AS&$>@P%-3']X(&\X%SIK>C'+=D\T- )
MGU)#2ZUVPOMJ[83=*+-T&'2E$_)[FQIR@@O<STC*)>3TR HE5-KA*9$ "A^Z
M>QYD6821A HT8W!PD(!EQ_$4)# %"?SL00)0<?CT#CPU,OFD/Z7!(PECG_VH
M& F05!W7',921JL\-* M,UA7/FTT=]X<,<N63''EV X5^D',;,=WF [$>8<<
M+!GMH*<7!5#';8!J[#20B"F8=M#%:Q8HI9#J:QX= >>!%/Z,U-PN$PE:<I8D
M*XI0+S7H/YNC+C7:3%I/UK%QH:*T?]4%CR[[XHOSP]]L-R+IEYK8R.5K4EPJ
M( _4;<N1/]E>\T>23!_/P^0Q0+&G1- %Z=(M)QQ4?X3H*![0FSO9\9W():^
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ME#1;,7B4$;"9"$,5:'Q#54)3A05;[.*FYR1;J,-HE7@0TBA 2YDSD(5''SE
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MF&4 *&PPU^) ^'--1M:(IO5<XJC$M\GC4W6]_%KR5J+PV*#CDTE6\+MTTBJ
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M\"TNJR)95,WMH"]1$;-SA[JNV-V6][M QKHK#(^NA@ %+N/1JVI0]J[BHG_
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M=TQHUUMNVY2OH<UOF\)H\-YJ:D_$^GW-V>EUY^QTWCD[77#K=%$ ;^VCG#P
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M6H&%A*:/! @X]MQ&+U](AU@D46HD3U\V"'=D<*74Z0K"8XX$G1#I1"]HU<A
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M,;"&[EE\LYC%,^7=3[[X:GBET[N88^X^)0)0#77Z5^O4@*=[_/XT[,E]=I[
M VO^NCOO.Y4)VJH$PS.7NQCRVAA'.]IK4\Y6X#2-L= MAK3);MF ,J@U#@4=
MUQQ![-70-NH%3SJZ.2& MK<;Q/MPMT4!F62>Y\42)]6FV+ZVF288TB>!:N#C
M7]64DTS)8_PTU1]X4\W84HNV4O]\+EH,S+4RCK\_H147Z?'.?6F+IAY,\EY"
M#-+.,$"UXIE>\J0#M2,&. %W&,>=1^FVC]B7GL$8VK3YA3./TM(G@6K?XU_5
ME*.TY#'O;916NV@U?9[D]C8H([/D7829/CO" -5R9WK)$T^AG3"\PTGT&/^!
M7>[H/XUEVCM4=H$!_Q:%W5_R[B4VQV,('HL'=MS8U-7Y5/UTC;/W=.3B)US2
M5YC%I&/#"_+/^YS^J>[V:/UXNTME > !%3+,_=JGG!*,!O,><[QV?1DC<\">
MV6,1^2_4/!A5.?OS1!T.F)"CWG2',3JT8-YQ^#%XX0&#D!K)[S44Z;N_4T R
M4>:*KE.8(U'6U/9G?:;?)N[A]?5;\HP/!-1@Y_=RY ANT2(!!Z0!]XB!G2*:
MR3OUTG/>+#TOVPWBQ50;Q&""OGK=#,8XW()YQT'?X(4'#/IJ),%;.0CWE4%?
M5 =]11OT+3I!7\6"/FQ>? 8\Q 0J6P'HUO?YG70L7&%>6=@//D$MJ?"^N6?E
M^DY%%=[9RA>, >E=AST XATH6^MAW7_'VVT[O,[.-D)_"4)5!'C.!^Y3C13S
MBYNR%(KZ:4 ']#E]=5@/Z]C:[]A2L0OH90IC^^SW&%TZ^VZQK);+MUGQ<)L5
M@QMH=LJ!;5MB@!)^UD_?IYP-QU<Z;=*VU:/?7W_@YOC80Y&6X]5^QIF68;N'
M -0>R9Y&IJZO>J:0U19&\!7Y\+[/6;VO@VJRZGV A\=WDM+X^PFJ'5Y&D*1&
MP%S?@ZV'S[!Z=X\>S[SCL!^T#%GY\_TD])A]'-DSOA>:^=S(?Y<]VL WQ^4L
M\Y(58!KMP7K*^^G)7#V>>2D%,"W?R3SF_?26N[\#L&>RX&T6S'KOEN0Y>[H!
M,%_<(SSDW;1CE6<6,0_N#"[A8Y[WD,8 ++*9U\G9,ACVJ(\?ELDG_W7JZU"_
MY;/W:2QP>IUS7N4@?3"LQNW)6X=6[N'TK-><R[9L((P4T Z<=YQJ++ST@#G'
M+9;@+1_("]@I_?B]5>'LG$OETVA#I30O0<&NH/8I6ICF \QT$'L$HN"]#*C7
M,&<220=@LQ#50$1)ACA(27K)(.39T[78@#5Q@4V09_)NFH*X@!D$9$O<[VJ\
M[X.@TRZ[[_7N4: UXG>8M:9VTOX2+*#+>#O,C*[RC&]+<:>OETQ:>[_J'$_;
MIP1MPRN;<L%=\2A8H<1L_AG;)6KU#]YIJQQ,%]H%R_,H*8R3:4\ ]K+M6K_8
M69JS\>GOKX7;NFQ<:&.:AU054=UVHPUR:0_R%GC623-A:KT>'I.:_W%[LX)N
M\=(F6R'7/"MX4_3DH')V%8O3J[95@V]V'.9,;[0QOD]-JO]"IFQ W/*[:2X]
M=X:-@PU":# (N86C@!<=AKOD>:F>W4S[&,\+#U-<)+2#DTX3'&!WRT_Z6G::
MYOA$L4^;A"-?\7PM?,]F/=[]'COU@9U]U'9AHM_EC%=W6#UV_P(W\TN</J13
M/S-X@_7LJ',8"'#0WN%%_>1OIT#^J'U::M2]K"D7%67/ 7D#[SP^.L70W,Z[
M:HVA=@BLG[Y_;3;(WH#EHX./N&'\'1L:3]/@_4?&/\V_;*E^Z'N(BG^:>9E3
M]<3@[=.KF\[Q\+L:@%N_^LF_OG-I3$_?IP'8\97.LCFO?_1["ZW=W':*MD$>
M>YGC507/TAD!Z%WT"F&S>)S1! \.P+R"L?'\9%W*3"&]Z/"L1VFUC]N;,-[B
MI4T6P&N>%;QU>G+0.6B'WNB&O5$3N73/*\T\F38\>6^:HMNKG'Y:K7WL^VB@
M3KZZI<";3]8!:J4>F^7^MT-?#>]=MS3+FW--B>9[U<H4TWDQ2O#8'-TQ[6V[
M'?OZ9VO@KH#>9T\P\BVX9P&'/^O^OA=C@555\.CQ]"NQ^\#$<$=N0YR(OZNB
MHO*R^#\%R8[Q8Y)E^UM+=6_.AKYO*MK[/S:"#T74=W4J$A0)O7D[[I#DOA-N
M]C.#[Y), ]^<)P]6K-FC[7/+$_#S/VZ?MKYM^OJYG_5NYE@3GH W)[(!)A6
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M:1_CN<I"A8L2S[)B8>&B.7ADEO9OG1= UN+(3#R_*PH$QD/NDW^3EWT50B,
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M++CO8!5ZDW!W1:B-Q2S01=KG1@5%C4Z@]#;%7%?[B?NBGHM=5+2(R:7-YU/
M''Z56[S."SHG3]J9.OJVGKK\ 6%0!2X$[ETW7>TEZ6E/HJ)X6^8%*_:B>#M.
M%GQV2R-<ZY+301U,1^..63C@+(RV8+9Y!.?(/YJ_U2VSMXJ>Q75#+>7+[+1R
MD.U[G.110<D_X<O2MI()G@.W.4WGW+#=U>=DNB?WH#8[EL-OW0%QX;#]?A>P
MOHNGDG#IUX4W)! _5177*BSFB)@25!J1D<;6;R8:E$(=L%H"$3E8L:L&H;!
M1&WM!X,ND^B!S**J!-OV1J)&(#ZIH"MH-10/<7N();\44"TZJG2K"9IK3N\
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M/J?W/F8)ISR7H<=LM7+BU^G\T5^$/H?&"=,SUXVR,.5[UWT4<+ 88"WO.?
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M+-PQS 47UG]0OD+N#<:\[C'H@2Y3IICL,Z9M^[\I+;T&.]3[@"DQ>PUJ]_W
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MG*;8"6Y"CWW]W^Q5Q>Q64RBW4>ZB2O+0V'T?^\(=XM%W]0JDW1;*<)0;J)I
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MJNR$E_9]&)0!'"&B6F=L):*TXE?H$Y2T UYB^6$PTW"""%X/S&-LE?O#\^U
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MWV9SIYWS7:<=O@M_<6(Q<1F40W\$/29UN$N..6]IV]]SR=[)N-#O6:4Q!'J
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M8N7I:$L#CFYADD% T)12./5M9R@^)3BH-*PH.XT(&"4=1"PGDCGJ["B:;C1
M @@?#+&!+"Y#50;E&[<H>Z5R#BG;=C3%OC^ !*Y9Q5-&L:5KX)GWS/@](RE>
MV3\Y\1],;(GB,3!,-$XAP+[8P31&,!C09167\D7]DM\,@BB__^6'6"4>FC[8
MN7F,<0#Q@,@-^)$%?-#%KRQDL2.RT9]Y*WZ7$P=*$;.A74_59FLV#!!2:T6*
M^VBX7IPB@O)9D(]>1ORV3 'EW!4W.6!_;*.H]$;1?*@QX@=V%$KO L6EX>!.
MI#\6,MIMFVA5 !N@5''YY<GFTR?CQ2FXY13<<@IN&4]PRV8S>719Z,1^)(]N
MD30=*3!R@A#C6ZJ)? Z3-7/YWL,\57R+HCE^?(M2LNHHR(FP8N8P N(ZBIGK
M)*DJMYFL+6;,BU:0.@#HII7(V?YB*9[Q;L+MIGF5I#Y?W^S\=<:_KC;DPGJ/
M5),9T6@G >> <(JIZHR^L-XTX#017#"B=3)IV((WQ6Q_<X*L8''H39\2SJ>$
MZQ=7[K>W,58 !P"JU1]L7;]-1+=EU3=B$A'5>^V'?LIN^?6V5<3Q_/63\\\H
MO@B<)%%K8*-!:*S<OHK8B-2:>9THQML90\HM& ]$ ^L>,@Y'O9MP&GJ["NG;
M^*YI7_)D'8!Z^6=;>KFG"#?W7#4_B*CDJ>#E-"[U$F?PN>/^$43:R&-=/^AC
MH+52 L. "&,/$2R/(\C';(OL#M[YX12\<\S!.X<))?GEV$-)!A+V<R<H,HHR
M!O2&D_>@(?Y]E9&<KIK/!36H="I*U8<&7#H!!*!$ZR@-*6FN.Z"9C &V+]O2
MB'JY;&X^QAPBHBSY;4"4'(YS$A_\Y ^0T5G5B<8:[&UK5I%6JRQ""C.095G5
MB09F %G4H47/?%R[=N].U< <T=T1JB6MQ:4!Y%!N@U Q@XAN?,S6Z\#O 9VV
M(S2BT)J+N#ET0&80@:Y#E9RST%VNG/@/X[VMT9.&LAQP@VO05W/>I05A-4WC
MK:[5DP:$4"'5(M@DC\;.EP>3E"'&=TSN:%()='=S>KN<1 Z;^E)%/1$M6=U:
M'IC+_&>A-*"WN'8/*$[6#.P]<=+QP%:<31:[2R=AB2@F6+Z=JX-L%!WH'2<T
MO-<19'.5@+SDBB>9\K0J<P#@#;O:T=A<^KB-=E%3>]P\- CB-6PZWYF4RF=4
MT1S?9U0N4#7^*RBP\YA1?467?:RC'=Z^K&946]%(B;2DVJOOZ5Z%.MI!F6HE
MF7DOIAXJG]CF>[P53%9W6D(9.[QO76_&M@FUQ%J^+JJ/*AG;T0[*5BM9W8W8
M*B72LKQ>1YF:JUT-H1'3P[\(]Y76-IE$KCAE6C.1U.QU%CMAXN1N,\GY:_TO
M:I.0R1@C/?SUH+3FE4 %8)UAJ*LM#<#,Q52!G-TS8V4(UIT9.]JAWU/EPE)7
M:E(*+>T5U?=T!\:.=E".6K..F7'T4*?%S?>TI\7.EE"N6DL=8\C5X8^*0P5+
M!TXHSA/J_76W%0V%W#L<>H<6,D'KY:QT&V2S'0TLNJ1(PO;#^W[>Y)9/_YGE
M7I3J1$D&_:$JR%J*G6Z1T?F$*KEA2=GOSN-1/+FDC(4B@7'Z*L@PP$31&QI!
M0 81+2?LX[')\G\6AID37*W60?3*V$9*ZDE[3)#J.RX40VNA/$88[L<](D>
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M QZ_X3. "ON(7O .SL.3Z'=I")R#.G@"4,%_>V]ZAA@>C]P/LS,"#X"'.=S
M)P-=#R-ZYL-DYU$9#H_)F\/ 1/-A1$^)%-AZ;/O!6S!8?H2OAK?WG&G Q*/2
M]Y127ICHZQ&]:QZ";<<JDX=_O#30DJ?'R_CH].%8K!HFNO+M/3\:,/&HI/>H
M;F]P3?QQ1&^0%-AZ5#)?(]GV::'C4U )'>D+H@U<*,G=T;QE&YP'/H[T@<\:
MW^B)Y1[+KIE9CO_K\H#;/?#S4%%]>T]R1O@=C9]]&4U R-.^-B.HL([HO0R=
MIT>E<VNQ,,6)7)/RX%#*>-]Y007_[3V>#8/XD8@_=M(AD[/OVWO9DC#LJ"20
MU"N6@=WJ](JEMDN]7:\"3*N6B3Y]>V]@G>RR)+E__Z[%?$[>']5?._^X,Q?V
M-66AMSUP[R"49/SZ]ZT;K8I)/&:KE1._3N=W4?CN.;<OBY_^[*@0?.:F_K,H
M8L92QP^VG!;%S_[QS??Y__WXR^3=Y-)/W"#B'V+\'^4')M%\LOW$9.<;D_PC
MD^(KD^HSD_\H/_2?WR NZ2TMTWE==,I:HA=1DB:M"U-R]I3D5R#Y^MUW7%0U
M-W3ES@[U-MPG:%0['4:.FEIM."[5,W2.<@MM[0 #[IFUL6E(D^T"X4-PJAXJ
MBBE1]X$3WCDKIBX2O]OJ;:"\2W.M)B %N'1%WIOM:$#6)6P2KMLM9#Q[B6;+
M*$OXK>LL]![9,Y\[8^'5GQD_6HDI*,OM@GMC%YKLEI:ZP=N0$98>5[2SX+_=
M;3-[X4U>IR$;"C*3+Z#G!!P 5W..$K&+E4?">R=.7V=<PR?\ "CNH.>O];^H
MMS.3,6AH3MN;G0E':M5 J0B";COL:DL#6'-Q5B!G=],<O#(]_@8IER%P]7F[
MZC&)T]J*X/]JK@;^J]]GPL8TG=^$GO_L>YD32+0?;RMI2F,M6%-R<L)K!6/1
M4?OBI\M<(,7Z7_KK6705IKY"N761I1L$&6DY$GK$=*39T7J7?LQ<WEBMYUJM
MT,H<]N%<6^5)J+9T_A]\9S')1#?\YC(,!%H"21W+]_6<NHO"\GTE?T JMP"=
MN=+&!X%R,\Y'/GL('9L<-KR5-EZGUXX?0_PH#C0'[!,T?7$% TG4<Y@34D0V
M5:Y*FXEW154,X<6J_"(X!^9H!,XZRZB+5[%.[ E3-3XX=/&MB<XN )1VT@&C
M-J+$QN.SZF- >1M1C()-;K6$;]09>0?CSK[GP$-.!"CP;R\VH2>DU+?L]LP3
MNX740%]&,WV-8YO7@T;I + 'Q;\=U)[3_36@+(XTZ, 2.,=2>GMO]B#:@, 3
M $KX2(,2#@?A^/;ZWPYR;9=_%RAY(TJU=2#&'=4NOZ%W-PP8X2%'-P&PJ7P\
M GMH%I[.!SJ.47@VZC$GO,?RT:Z-L9\LVA.VG7%&^46H!+ZQAR4 2D3EJ[EP
MJKVDGH/!_O%5\W&HU+W5-RD0=B,1P,-*G+&(C>@9RBJ_1B53DI-R6VL?5OC,
MIP65TA&]'=%@[.FRCW!3-?'_'=$[U.&9>)S2B^QC;"*=;^]E2L&T/5U4BI1"
MCZD3I\=D@J)@<M+.P43FW]Y;E1D?:2R#M^#N;"*U;^^=2\6U8Y?1P_A,FY0T
M&M&SU> \HB%M1 X&!NIS4%>+?:)%WMZ[DNUP$2+"2.;.95#$<$1/3/:9-HAJ
M)92 ^.W<N PD?D3/6RA\I+ (WL1]RT!FW]Y[F8IKQRVA![IM&4C?6WT'HR)K
M1(X$=.Y:)J:"M_?D9<-4-9Q3JR7%N7G7.]C6KOPB5#I'].1EG6=26\!ARV!L
M$O,]\'44^Z*X<EZ5XG/HIPFD\L5/W[<J7Y1CBM(7VU'+8A?YN*=:%Z=:%Z=:
M%Z=:%WMKZU.MBU.M"^=4Z^)4Z^*0D)UJ7;SQ6A>GA-Z(";T'+DYP2NA]/ F]
M-WF5-SFNG1Y9IS6=T;3AP+FG03RBY*K0YZA:[  W(;]A9;DNFJ9+%L^63MC]
M/&[A7F$^A:-.4WU(%(_):\PNWS!2(0XZ.^PSZI@739]T!Z-?3WW,^EJ6GBT6
M<?YFM%OMO58&WL+KX2"S.K[<WR38>GSKQHHJVDWBBK'7-&=P? G-#\["-W*#
MP,\I/?P43^G5#R4&1[\\=MUS,*2_.8-3*O6!0#R69($'8!G);<%XBL>7_IT>
MC]_(MM!RC<-8 !V3..ZL\H>%\K0_Z+F6<?DBN3F8S>^X4]438/ ;V1;H/<<9
M!%^,*$T(!A<'L842BBTB\BA#\T7.)+W.B-*;$./PL2VITZ-<;5:XE>Z/^5W.
MXM)!"MZZ"5T^HO_,SJ,P2W(^5:7G9M'6Y4L5QO5>%<:U&7^2?V!2?&%2?F*2
M1I/-1TXA7:>0KE-(URFDZQ32=0KIVD>B"F+Y9]0Q78UF;P/G!M%$HKKZT[JE
M)_2@L6%VOD9#?CIEWW2M]Z+?3F#&YOB8YP"HG5&5$1G:7N2=?O<0^'K,!I!]
M1*S#IUA<HUC<@>/93K&XIUC<4RSN*1;W(+&X'T^QN(=!>L2QN+"@6W3]-G!T
M[;!*SG;ZS=W<T!:SPTH^=W01KW;9-0ZATKY@6I<SR RP#U3$90\.(I';YP&>
MYG??%5'],)I3.>XP3@Q8QR[6G>%)O\918N/!1?6Q4T2E.32]W1-2%B>,BE?/
M8+S!\(D[A5!:%7?[N2?XP$\1G<6PQZ'LMX-66^K^VG$'3UH"9]] F!DE;;XW
MCQ!++($G<-R1CH>#D-+I>8CKL+JLNCW!!4_@N.,7#P?AZ;@AYQB%&GD]YG3<
M,8JH0 ^\6@[J1%\9B$H7&_%"73G*WSF<A^*7W1[S'YH>\\50-6?Y?+"-0_QD
M,][)-?[D&G]RC>_492?7^)-KO W?NV-RC3]Y6)ZJG9P\+'<<"W?.;_U=+3N'
MP781V-/G4L$:S%ON*/QHK1GXR/G1@N"XXWNAF,3CFKF^$_0"13L&=+F1P0;(
M%?L(S5XX<:_3D)D#H^@*?;BG@8>6!^1UWAXHJGM#@;26Q\AT89E@B>Z&?@H>
MV(7S5,CK%#S05R'R[[.UL."&Z:9,E2945-X!S?%LF) "/2\L'2RZ/LQUL3$.
MM3YHWB/VH&AQA-[+(4@S5@1)X>6-FFWPLE/MCV<'.;:/Z7?LQ5BQZ;N!7;X)
M@@"CT"HNE&I&?AC>&_1XBD:"M-C%TF?S:S]T0G$3G\[GOLN4*DW9 >K#2Q$V
M'6U6%Q5,M_5593]2/1]8TEQ#O4-R1N;WN.(V+2YY49@_R2J?D33=COP6"V."
MG7!X8X0;D].]-TF:$T$4(JT-E"0$V;FCWD7A?W,MX<]]YN5Y>4KO*:7*TW7"
M?I902E!=U<&H)Z+Y3JGD3%/)_4#=9^:42NZ-II*SH'8-$FWC^<T/E$I.SPFK
M%X//NY[&2M D;<D7XQ@(*26KB&RL#WR&L>^FI2Q]#OTT>7C\+(6U[*?IAF<M
M.2#$,%98-O!C9N7\B%?V8UQI.3&=!@RVQH]XF1L&PM. )X="=@__M_V=WS[B
M17$/CRA2(LH>6VH>/7'OQ.GKC/,C<=Q\_S]_K?]%?9$U&8/&+<7V+=>$([5'
M:"J"H+O =K6E :RY."N0.U#&RK,>#X#=?;!OE7(9ZGS=4Q%N^_G52II0>V=,
M0\X>Z$18G5A 3)4WA[Y[6DLC!^.NCEY+;+Z.XA6+JV\J6=S=%,I>:R8,&'M5
M=!(Y+.7[OHA(!QCVM\UH[(P',>QOB:Z]')% 3'>D:36D@5JGQ,DX;_>\<K:.
M_8!KOT(-;I2A4B%I^D M;]9"W23B45=+(+*)Z"?)Z;?7[>TMZ2XE"VJ'9H+8
MFES5.KK1P!<@MS#$1G9C,S!W_F!-!X($"WQ_&\Y:N8=;YL:9Y]%EH1/[D3Q8
M2M*4QKJP&2PE(;R6E>K@J)43^1PF(K)5/!FKPJ(4S?$#H)026$=!3H0='?9?
M&3_*+/VX.LI4_QTIM9BV%U2+67&EU0I.77L!&6#I,B_Y.N^C/D@#^D$A&-Z9
M;R (VDPX* C7429WW9=/N]X-"L'P!MAA(&BS@,C%AF]ZJRC,W[TOG+6?.D&1
M/O.!\S=^9MYU%%]G:1:SFR3)G-!5Y$7K,=31E0OJSPI24E$=1!_Y;'V7=?-I
MDVVR\)6819S,^M]%WKB[*/T?ECXP-UJ$_K^V>1P[?-CM?1([[8\U,;,.T[&+
M8U&Z@*_&\E>B75<Q*]O\ELSC:(L X0!*1)KOXVC.DH3/S FNF2K9>+OET=;>
MD3&%"&;Y5BXV:W[TRV(_7!2"5NSJ(NI9_$D9>P?K?[S%9HP82 7UOMS8Y-4^
MXV2M"K_OJZ_\\L"UV6^1B$0-_/3UP4G9)S_T5]E*(3D'G,-QUX0Y*)!O2(*=
MK_@27,T!.^QRU!*\"R0E">Y3$T%%^(S%*\4YW^8WL3T)Z16O  -%22*'6HH/
M?O+'=<S839@R+@GIX<\$RAD<=ZF5 X+X9F3WH*<!Y0S(QY?2E5VZ)X$6V::2
M9F ./A+!Z("12#[#PZFOPLYPG\7N4OSI.HKS7UM04](OX>58)*N/-*A8>J2N
M94N81=7'Q1MYLHP"+[EG\3R*5^)5+I^PY,W:>!0H_B.RYO?B@U5L=VM ;NK?
M\1_$3<(/BQQP$DBAG:%(CL@*;T+^" X%?8N8_QI'B8TB7:J/0:5IA#9_>]A0
MDKX^-H^2PFF6)JD3>GZX:)3H?&#"P8C__B(*\S)[F1.(9?A!(YV'G@Q4>D?Z
M9H"#+27IOH]]E=-7O0UZO1^[LK##"4H0]1'2_+]$#7@NA@]".L5)363!X?)I
M0<6H/P<5G#=D%(?@8^M^I&-&[2W_+/1J>DYV5=IC0*AHC,@"O2]+CD,!524-
MDS3.\C";:;ID\6SIA.7^>;98Q&SAI,(R&?MAXKNYZ?*WW"7,@HK:=T)021VI
MO1D/8YMJ[O!4\>OT(TO3(/^$2F&B3PVO'HE]U8O.W.-0XB7A!86[]B-[]]3N
MKZ%G/*"G?@'H4!% <=K)S3V[[J'Y^NFF?V.?U#C=]AX5*E CLM</PA=:@M.7
M1[O+X>S9\0,1SLWIS!ECP0:L_2)4X$;TK&"=9\<EC&>>ET>L5.&"9UFZC&)U
MW)S5C])/X(TFDGJLQBZ5G:\PAWH<@\O>2%\6!D=D[.+&J<G_T'@LR:WNU0ZP
M<16Q((:&WX>*YT@?.PZ&8(?8_OV[%D?YG/^H_MKYQYW1V-=45"#=?&.'[4D6
MA\ZW;K0JG-NVF8 ^?YM\>\TX:ERE\X$SOD+X;9\W9#/GJW"+/ N]![:.8I'3
M*8Z>_:0X&&_:L.22I?R(LF6LJ$3XCV^^S__OIX^3=Y-+/W&#B$^!\7]4GYY$
M\\GG;Q^_G91?GVP^/RG&GO#!)V(&$R?T)M4<)IM)3.917&O*DLE_E#/YSV\0
M5<&&,5NJSYZ2_,53OGZ5G3 5VU84F!N%KA_XN?!M?BU"%L*$G;.0S?WT+%6*
M$H#^83Z#G&$#( (-[6.%S43V1@EM>4HKKEQN^:>#FC8Q%A+Y0-@I, :3 QVO
M:"/-=PN^-X8[,GKIS^=,L-!W F/$]0-BYY 8#'DH[^S56.J:U2S.V.?UF??/
M+$GS1P')DPZ\.W:*!P/ S @;PP*]B\2Y,7-3_RE@Y59CO"B[!\%.[3#80E3Q
MB#:Z%TMQA;D)+\OH%][@+$E8F@C+=P%$$$0OZC1G0XR-G6AA,%GHP5%J(K)[
MH 3@WNR G7-@#S"[:>\=*):*%$V-,#&DRWQ+()57\Q]45_-JJ/P67@QVNE\/
M3TT+L>F:7^R$_^-ME"073AR_SJ,X3P4FI\YHD-'=C7NPB(BV;<U<D%W^KE1"
M.\;&T"MU4M)MC12YWPRD8)"OC>\.;9/K5 4K=\HR41!%^_%=D]644X7GCIFL
MV[SUB"[$2CHL'*Z0(;WUG2>1/LIG!LNNW6E\-V, #\QQ_J7 .<Q=2#VR2)N"
M/,;;KIKR?:&=T5O)A9K2A#_+VH_O JRFG.K>:6*E&M(,92WL;@#@0':F(U#
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MB/]ZXI=8_IO_'U!+ 0(4 !0   @( .N&/U0#0WNGG ,  '40   *
M              !E>#(S+3$N:'1M4$L! A0 %   " @ ZX8_5-9^%@G# P
MQ1,   H                 Q ,  &5X,C,M,BYH=&U02P$"%  4   (" #K
MAC]4\UA-" P"  !A#P  "0                "O!P  97@S+3$N:'1M4$L!
M A0 %   " @ ZX8_5(:4.EU,N   [R@%  D                 X@D  &5X
M-"TV+FAT;5!+ 0(4 !0   @( .N&/U2&,ECKXTL  .T1 @ )
M     %7"  !E>#0M."YH=&U02P$"%  4   (" #KAC]43MIH \(*  !5-P
M"0                !?#@$ 97@U+3$N:'1M4$L! A0 %   " @ ZX8_5*AW
M2OHWJP$ 8K$!  \                 2!D! &9O<FUS+3%?,# R+FIP9U!+
M 0(4 !0 " @(  &'/U1*'@,09%D% -@5/0 ,                 *S$ @!F
M;W)M<RTQ82YH=&U02P$"%  4   (" #KAC]43ASLFZ 6" !VX0@ $
M          !*'@@ 9F]R;7,M,6%?,# Q+FIP9U!+ 0(4 !0   @( .N&/U3+
MQ.ARL#L  /A*   0                 !@U$ !F;W)M<RTQ85\P,#,N:G!G
M4$L! A0 %   " @ ZX8_5+[\A\%L%0  ^A8   @                 ]G 0
M &QO9V\N:G!G4$L! A0 %   " @ ZX8_5 5=,C4+&   V"<! !$
M        B(80 '-R;F$M,C R,3 Y,S N>'-D4$L! A0 %   " @ ZX8_5+G?
MGL88%0  ^ $! !4                 PIX0 '-R;F$M,C R,3 Y,S!?8V%L
M+GAM;%!+ 0(4 !0   @( .N&/U2S_?5B[TT  'K#!0 5
M  VT$ !S<FYA+3(P,C$P.3,P7V1E9BYX;6Q02P$"%  4   (" #KAC]4',E-
MZ7Z?  "-DPD %0                 O A$ <W)N82TR,#(Q,#DS,%]L86(N
M>&UL4$L! A0 %   " @ ZX8_5/#$H&SR;@  V/0' !4
MX*$1 '-R;F$M,C R,3 Y,S!?<')E+GAM;%!+!08     $  0 , #   %$1(
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
